inchi	names	iupac_name	smiles	cid	record_ids	logBB	logBB_group	BBB+/BBB-	BBB+/BBB-_group	split
InChI=1S/Ar	Argon	argon	[Ar]	23968.0	R3_abraham_2006:1|R12_garg_2006:24|R21_muehlbacher_2011:230|R40_vilar_2010:342|R44_bujak_2015:13|R49_norinder_2002:71	0.03	B	BBB+	A	training
InChI=1S/C10H10BrNO2/c1-10(2)7-5-6(11)3-4-8(7)12-9(13)14-10/h3-5H,1-2H3,(H,12,13)	Brofoxine	6-bromo-4,4-dimethyl-1H-3,1-benzoxazin-2-one	CC1(C)OC(=O)Nc2ccc(Br)cc21	30630.0	R6_adenot_2004:481			BBB+	C	training
InChI=1S/C10H10Cl2N2O/c11-8-2-1-7(5-9(8)12)15-6-10-13-3-4-14-10/h1-2,5H,3-4,6H2,(H,13,14)	Fenmetozole	2-[(3,4-dichlorophenoxy)methyl]-4,5-dihydro-1H-imidazole	Clc1ccc(OCC2=NCCN2)cc1Cl	32049.0	R6_adenot_2004:542			BBB+	C	training
InChI=1S/C10H10ClNO2/c11-6-5-9-12-10(13)7-3-1-2-4-8(7)14-9/h1-4,9H,5-6H2,(H,12,13)	Chlorthenoxazine	2-(2-chloroethyl)-2,3-dihydro-1,3-benzoxazin-4-one	O=C1NC(CCCl)Oc2ccccc21	8602.0	R6_adenot_2004:1547			BBB+	C	training
InChI=1S/C10H10FN3S/c1-13-9(12-14(2)10(13)15)7-4-3-5-8(11)6-7/h3-6H,1-2H3	Suritozole	5-(3-fluorophenyl)-2,4-dimethyl-1,2,4-triazole-3-thione	Cn1nc(-c2cccc(F)c2)n(C)c1=S	25431.0	R6_adenot_2004:573			BBB+	C	training
InChI=1S/C10H10N2O/c1-8-7-10(13)12(11-8)9-5-3-2-4-6-9/h2-6H,7H2,1H3	Edaravone	5-methyl-2-phenyl-4H-pyrazol-3-one	CC1=NN(c2ccccc2)C(=O)C1	4021.0	R6_adenot_2004:1264			BBB+	C	training
InChI=1S/C10H10N2O3/c11-9(13)5-12-7-3-1-2-4-8(7)15-6-10(12)14/h1-4H,5-6H2,(H2,11,13)	Paraxazone	2-(3-oxo-1,4-benzoxazin-4-yl)acetamide	NC(=O)CN1C(=O)COc2ccccc21	3047812.0	R6_adenot_2004:593			BBB+	C	test
InChI=1S/C10H10N2O3/c11-9(13)6-12-5-7-3-1-2-4-8(7)15-10(12)14/h1-4H,5-6H2,(H2,11,13)	Caroxazone	2-(2-oxo-4H-1,3-benzoxazin-3-yl)acetamide	NC(=O)CN1Cc2ccccc2OC1=O	29083.0	R6_adenot_2004:503			BBB+	C	training
InChI=1S/C10H10N4O2S/c11-9(12)14-10-13-6(4-17-10)5-1-2-7(15)8(16)3-5/h1-4,15-16H,(H4,11,12,13,14)	Guanidinothiazol Analogue 17 Ac1Lbibi -- Pubmed|Benzene-1,2-Diol, 4-(2-Guanidinothiazol-4-Yl)-	2-[4-(3,4-dihydroxyphenyl)-1,3-thiazol-2-yl]guanidine	NC(N)=Nc1nc(-c2ccc(O)c(O)c2)cs1	536278.0	R47_radchenko_2020:375	-1.54	A	BBB-	A	training
InChI=1S/C10H10N4S/c11-9(12)14-10-13-8(6-15-10)7-4-2-1-3-5-7/h1-6H,(H4,11,12,13,14)	Skb19|Bbcpd15|2507-81-5|N-(4-Phenylthiazol-2-Yl)-Guanidine|B-052|16|10|1-(4-Phenyl-1,3-Thiazol-2-Yl)Guanidine	2-(4-phenyl-1,3-thiazol-2-yl)guanidine	NC(N)=Nc1nc(-c2ccccc2)cs1	3763607.0	R3_abraham_2006:259|R3_abraham_2006:309|R4_mente_2005:117|R12_garg_2006:31|R21_muehlbacher_2011:317|R25_brito_sanchez_2015:10|R26_chico_2009:51|R28_li_2005:154|R40_vilar_2010:245|R41_toropov_2017:231|R41_toropov_2017:276|R46_mendoza_valencia_2017:10|R47_radchenko_2020:214|R48_hou_2003:63|R49_norinder_2002:16|R52_liu_2001:16			BBB+	C	training
InChI=1S/C10H10N6O2/c1-15-8(13-6-9(15)16(17)18)3-2-7-4-5-12-10(11)14-7/h2-6H,1H3,(H2,11,12,14)/b3-2+	Azanidazole	4-[(E)-2-(1-methyl-5-nitroimidazol-2-yl)ethenyl]pyrimidin-2-amine	Cn1c([N+](=O)[O-])cnc1/C=C/c1ccnc(N)n1	6436171.0	R14_ghose_2012:368			BBB-	C	training
InChI=1S/C10H11BrN2O3/c1-3-4-10(5-6(2)11)7(14)12-9(16)13-8(10)15/h3H,1-2,4-5H2,(H2,12,13,14,15,16)	Brallobarbital	5-(2-bromoprop-2-enyl)-5-prop-2-enyl-1,3-diazinane-2,4,6-trione	C=CCC1(CC(=C)Br)C(=O)NC(=O)NC1=O	68416.0	R6_adenot_2004:1641			BBB+	C	test
InChI=1S/C10H11ClF3N3/c11-9-7(10(12,13)14)1-2-8(16-9)17-5-3-15-4-6-17/h1-2,15H,3-6H2	210821-63-9|Chebi: 568657|Org12962|B-103, Org12962|Org-12962|Org12692|1-(6-Chloro-5-(Trifluoromethyl)Pyridin-2-Yl)Piperazine	1-[6-chloro-5-(trifluoromethyl)pyridin-2-yl]piperazine	FC(F)(F)c1ccc(N2CCNCC2)nc1Cl	9796408.0	R4_mente_2005:161|R21_muehlbacher_2011:327|R25_brito_sanchez_2015:334|R26_chico_2009:70|R28_li_2005:33|R40_vilar_2010:170|R47_radchenko_2020:302|R49_norinder_2002:143	1.64	B	BBB+	A	test
InChI=1S/C10H11ClFN5O3/c11-10-15-7(13)5-8(16-10)17(2-14-5)9-4(12)6(19)3(1-18)20-9/h2-4,6,9,18-19H,1H2,(H2,13,15,16)/t3-,4+,6-,9-/m1/s1	Clofarabine	(2R,3R,4S,5R)-5-(6-amino-2-chloropurin-9-yl)-4-fluoro-2-(hydroxymethyl)oxolan-3-ol	Nc1nc(Cl)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1F	119182.0	R23_gupta_2019:471			BBB-	C	training
InChI=1S/C10H11ClO3/c1-10(2,9(12)13)14-8-5-3-7(11)4-6-8/h3-6H,1-2H3,(H,12,13)	Clofibric Acid	2-(4-chlorophenoxy)-2-methylpropanoic acid	CC(C)(Oc1ccc(Cl)cc1)C(=O)O	2797.0	R7_andres_2006:37|R29_subramanian_2003:38			BBB-	C	training
InChI=1S/C10H11ClO3/c1-6-5-8(11)3-4-9(6)14-7(2)10(12)13/h3-5,7H,1-2H3,(H,12,13)	Mecoprop	2-(4-chloro-2-methylphenoxy)propanoic acid	Cc1cc(Cl)ccc1OC(C)C(=O)O	7153.0	R7_andres_2006:99			BBB+	C	training
InChI=1S/C10H11F3N2O5/c11-10(12,13)4-2-15(9(19)14-8(4)18)7-1-5(17)6(3-16)20-7/h2,5-7,16-17H,1,3H2,(H,14,18,19)/t5-,6+,7+/m0/s1	Trifluridine	1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-(trifluoromethyl)pyrimidine-2,4-dione	O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1C(F)(F)F	6256.0	R23_gupta_2019:1001			BBB-	C	training
InChI=1S/C10H11I2NO3/c1-2-3-16-9(14)6-13-4-7(11)10(15)8(12)5-13/h4-5H,2-3,6H2,1H3	Propyliodone	propyl 2-(3,5-diiodo-4-oxopyridin-1-yl)acetate	CCCOC(=O)Cn1cc(I)c(=O)c(I)c1	4949.0	R23_gupta_2019:1081			BBB-	C	training
InChI=1S/C10H11N5S/c11-7-3-1-2-6(4-7)8-5-16-10(14-8)15-9(12)13/h1-5H,11H2,(H4,12,13,14,15)	Skb20|Bbcpd57|72801-60-6|Chebi: 338063|B-053|17|11|1-(4-(3-Aminophenyl)Thiazol-2-Yl)Guanidine	2-[4-(3-aminophenyl)-1,3-thiazol-2-yl]guanidine	NC(N)=Nc1nc(-c2cccc(N)c2)cs1	14022509.0	R3_abraham_2006:261|R3_abraham_2006:310|R4_mente_2005:144|R12_garg_2006:41|R21_muehlbacher_2011:353|R25_brito_sanchez_2015:11|R26_chico_2009:52|R28_li_2005:155|R40_vilar_2010:247|R41_toropov_2017:233|R46_mendoza_valencia_2017:11|R47_radchenko_2020:216|R48_hou_2003:45|R49_norinder_2002:17|R49_norinder_2002:169|R52_liu_2001:17	-1.15	B	BBB-	A	training
InChI=1S/C10H11NO4S2/c1-6(9(14)11-5-8(12)13)17-10(15)7-3-2-4-16-7/h2-4,6H,5H2,1H3,(H,11,14)(H,12,13)	Stepronin	2-[2-(thiophene-2-carbonylsulfanyl)propanoylamino]acetic acid	CC(SC(=O)c1cccs1)C(=O)NCC(=O)O	54120.0	R23_gupta_2019:924			BBB-	C	training
InChI=1S/C10H12ClN3/c1-7-2-3-9(8(11)6-7)14-10-12-4-5-13-10/h2-3,6H,4-5H2,1H3,(H2,12,13,14)	4201-22-3|Tz-13|Tolonidine	N-(2-chloro-4-methylphenyl)-4,5-dihydro-1H-imidazol-2-amine	Cc1ccc(NC2=NCCN2)c(Cl)c1	72138.0	R4_mente_2005:5|R25_brito_sanchez_2015:561|R40_vilar_2010:285|R47_radchenko_2020:483	-0.65	B	BBB+	A	training
InChI=1S/C10H12ClN3/c1-7-6-8(11)2-3-9(7)14-10-12-4-5-13-10/h2-3,6H,4-5H2,1H3,(H2,12,13,14)	4201-26-7|Tz-12|2-(2-Methyl-4-Chlorophenylamino)-2-Imidazoline	N-(4-chloro-2-methylphenyl)-4,5-dihydro-1H-imidazol-2-amine	Cc1cc(Cl)ccc1NC1=NCCN1	77870.0	R4_mente_2005:4|R25_brito_sanchez_2015:560|R40_vilar_2010:284|R47_radchenko_2020:482	-0.87	B	BBB+	A	training
InChI=1S/C10H12ClN3O3S/c1-2-9-13-7-4-6(11)8(18(12,16)17)3-5(7)10(15)14-9/h3-4,9,13H,2H2,1H3,(H,14,15)(H2,12,16,17)	Quinethazone	7-chloro-2-ethyl-4-oxo-2,3-dihydro-1H-quinazoline-6-sulfonamide	CCC1NC(=O)c2cc(S(N)(=O)=O)c(Cl)cc2N1	6307.0	R14_ghose_2012:812|R23_gupta_2019:872			BBB-	C	training
InChI=1S/C10H12ClN5O3/c11-10-14-8(12)7-9(15-10)16(3-13-7)6-1-4(18)5(2-17)19-6/h3-6,17-18H,1-2H2,(H2,12,14,15)/t4-,5+,6+/m0/s1	Cladribine	(2R,3S,5R)-5-(6-amino-2-chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol	Nc1nc(Cl)nc2c1ncn2[C@H]1C[C@H](O)[C@@H](CO)O1	20279.0	R28_li_2005:249			BBB+	C	training
InChI=1S/C10H12ClNO/c11-7-6-10(13)12-8-9-4-2-1-3-5-9/h1-5H,6-8H2,(H,12,13)	Beclamide	N-benzyl-3-chloropropanamide	O=C(CCCl)NCc1ccccc1	10391.0	R6_adenot_2004:423			BBB+	C	training
InChI=1S/C10H12ClNO2/c11-9-3-1-7(2-4-9)8(6-12)5-10(13)14/h1-4,8H,5-6,12H2,(H,13,14)	Baclofen	4-amino-3-(4-chlorophenyl)butanoic acid	NCC(CC(=O)O)c1ccc(Cl)cc1	2284.0	R7_andres_2006:15|R14_ghose_2012:15|R25_brito_sanchez_2015:372|R29_subramanian_2003:15|R46_mendoza_valencia_2017:325|R53_friden_2009:4	-1.51	B	BBB-	A	training
InChI=1S/C10H12ClNO4/c11-7-1-3-9(4-2-7)15-5-8(13)6-16-10(12)14/h1-4,8,13H,5-6H2,(H2,12,14)	Chlorphenesin-Carbamate|Chlorphenesin Carbamate	[3-(4-chlorophenoxy)-2-hydroxypropyl] carbamate	NC(=O)OCC(O)COc1ccc(Cl)cc1	2724.0	R6_adenot_2004:1440			BBB+	C	training
InChI=1S/C10H12N2O/c1-12-9(4-5-10(12)13)8-3-2-6-11-7-8/h2-3,6-7,9H,4-5H2,1H3	1-Methyl-5-(3-Pyridinyl)-2-Pyrrolidinone	1-methyl-5-pyridin-3-ylpyrrolidin-2-one	CN1C(=O)CCC1c1cccnc1	408.0	R41_toropov_2017:142|R46_mendoza_valencia_2017:180	-0.35	B	BBB+	A	training
InChI=1S/C10H12N2O/c1-12-9(4-5-10(12)13)8-3-2-6-11-7-8/h2-3,6-7,9H,4-5H2,1H3/t9-/m0/s1	Cotinine|486-56-6	(5S)-1-methyl-5-pyridin-3-ylpyrrolidin-2-one	CN1C(=O)CC[C@H]1c1cccnc1	854019.0	R3_abraham_2006:152|R3_abraham_2006:153|R4_mente_2005:174|R6_adenot_2004:516|R21_muehlbacher_2011:8|R25_brito_sanchez_2015:194|R26_chico_2009:137|R40_vilar_2010:87|R47_radchenko_2020:128	-0.38	D	BBB+	A	training
InChI=1S/C10H12N2O2/c13-10(9-2-1-3-11-8-9)12-4-6-14-7-5-12/h1-3,8H,4-7H2	Nicopholine	morpholin-4-yl(pyridin-3-yl)methanone	O=C(c1cccnc1)N1CCOCC1	68116.0	R6_adenot_2004:1263			BBB+	C	test
InChI=1S/C10H12N2O2S/c13-15(14)9-5-2-1-4-8(9)12-7-3-6-10(12)11-15/h1-2,4-5,10-11H,3,6-7H2/t10-/m1/s1	S18986|(3As)-2,3,3A,4-Tetrahydro-1H-Pyrrolo[2,1-C][1,2,4]Benzothiadiazine 5,5-Dioxide	(3aS)-2,3,3a,4-tetrahydro-1H-pyrrolo[2,1-c][1,2,4]benzothiadiazine 5,5-dioxide	O=S1(=O)N[C@H]2CCCN2c2ccccc21	637863.0	R26_chico_2009:360	-0.6	A	BBB+	A	training
InChI=1S/C10H12N2O3/c1-3-5-10(6-4-2)7(13)11-9(15)12-8(10)14/h3-4H,1-2,5-6H2,(H2,11,12,13,14,15)	Allobarbital	5,5-bis(prop-2-enyl)-1,3-diazinane-2,4,6-trione	C=CCC1(CC=C)C(=O)NC(=O)NC1=O	5842.0	R6_adenot_2004:1674|R25_brito_sanchez_2015:115|R46_mendoza_valencia_2017:113	-0.22	B	BBB+	A	test
InChI=1S/C10H12N2O4/c1-6-4-12(10(15)11-9(6)14)8-3-2-7(5-13)16-8/h2-4,7-8,13H,5H2,1H3,(H,11,14,15)	1-[5-(Hydroxymethyl)-2,5-Dihydrofuran-2-Yl]-5-Methylpyrimidine-2,4-Dione	1-[5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]-5-methylpyrimidine-2,4-dione	Cc1cn(C2C=CC(CO)O2)c(=O)[nH]c1=O	5155.0	R41_toropov_2017:249|R46_mendoza_valencia_2017:153	-0.48	B	BBB+	A	training
InChI=1S/C10H12N2O4/c1-6-4-12(10(15)11-9(6)14)8-3-2-7(5-13)16-8/h2-4,7-8,13H,5H2,1H3,(H,11,14,15)/t7-,8+/m0/s1	Stavudine	1-[(2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]-5-methylpyrimidine-2,4-dione	Cc1cn([C@H]2C=C[C@@H](CO)O2)c(=O)[nH]c1=O	18283.0	R3_abraham_2006:277|R14_ghose_2012:854|R21_muehlbacher_2011:125|R23_gupta_2019:923|R25_brito_sanchez_2015:157|R26_chico_2009:390|R28_li_2005:287|R40_vilar_2010:261|R47_radchenko_2020:232	-0.48	B	BBB+	A	training
InChI=1S/C10H12N2O6S/c1-3(13)5-7(14)12-6(9(15)16)4(19-8(5)12)2-18-10(11)17/h3,5,8,13H,2H2,1H3,(H2,11,17)(H,15,16)/t3-,5+,8-/m1/s1	Ritipenem	(5R,6S)-3-(carbamoyloxymethyl)-6-[(1R)-1-hydroxyethyl]-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid	C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)S[C@H]12	65633.0	R6_adenot_2004:261			BBB-	C	test
InChI=1S/C10H12N4O3/c1-14-4-9(16)5-2-6(12-13-10(11)17)8(15)3-7(5)14/h2-3,9,15-16H,4H2,1H3,(H2,11,17)/b13-12+	Carbazochrome	(3,6-dihydroxy-1-methyl-2,3-dihydroindol-5-yl)iminourea	CN1CC(O)c2cc(/N=N/C(N)=O)c(O)cc21	2557.0	R14_ghose_2012:418			BBB-	C	training
InChI=1S/C10H12N4O3/c15-3-6-1-2-7(17-6)14-5-13-8-9(14)11-4-12-10(8)16/h4-7,15H,1-3H2,(H,11,12,16)	9-[5-(Hydroxymethyl)Tetrahydrofuran-2-Yl]-9H-Purin-6-Ol	9-[5-(hydroxymethyl)oxolan-2-yl]-1H-purin-6-one	O=c1[nH]cnc2c1ncn2C1CCC(CO)O1	135422442.0	R41_toropov_2017:150|R46_mendoza_valencia_2017:194	-1.3	B	BBB-	A	training
InChI=1S/C10H12N4O3/c15-3-6-1-2-7(17-6)14-5-13-8-9(14)11-4-12-10(8)16/h4-7,15H,1-3H2,(H,11,12,16)/t6-,7+/m0/s1	Didanosine|69655-05-6	9-[(2R,5S)-5-(hydroxymethyl)oxolan-2-yl]-1H-purin-6-one	O=c1[nH]cnc2c1ncn2[C@H]1CC[C@@H](CO)O1	135398739.0	R3_abraham_2006:162|R4_mente_2005:37|R5_guerra_2008:38|R7_andres_2006:194|R12_garg_2006:73|R14_ghose_2012:495|R17_fu_2008:52|R23_gupta_2019:520|R25_brito_sanchez_2015:210|R26_chico_2009:162|R28_li_2005:19|R47_radchenko_2020:136|R49_norinder_2002:103	-1.3	B	BBB-	A	training
InChI=1S/C10H12N4O3/c15-3-6-1-2-7(17-6)14-5-13-8-9(14)11-4-12-10(8)16/h4-7,15H,1-3H2,(H,11,12,16)/t6-,7+/m1/s1	9-[(2S,5R)-5-(Hydroxymethyl)Oxolan-2-Yl]-3H-Purin-6-One	9-[(2S,5R)-5-(hydroxymethyl)oxolan-2-yl]-1H-purin-6-one	O=c1[nH]cnc2c1ncn2[C@@H]1CC[C@H](CO)O1	135483777.0	R48_hou_2003:43	-1.3	A	BBB-	A	training
InChI=1S/C10H12N4O5S/c1-10(5-13-3-2-11-12-13)8(9(16)17)14-6(15)4-7(14)20(10,18)19/h2-3,7-8H,4-5H2,1H3,(H,16,17)/t7-,8+,10+/m1/s1	Tazobactam	(2S,3S,5R)-3-methyl-4,4,7-trioxo-3-(triazol-1-ylmethyl)-4lambda6-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid	C[C@]1(Cn2ccnn2)[C@H](C(=O)O)N2C(=O)C[C@H]2S1(=O)=O	123630.0	R6_adenot_2004:281|R23_gupta_2019:955			BBB-	C	training
InChI=1S/C10H12N4OS/c1-7(15)13-9-4-2-8(3-5-9)6-12-14-10(11)16/h2-6H,1H3,(H,13,15)(H3,11,14,16)/b12-6+	Thiacetazone|N-(4-((2-Carbamothioylhydrazono)Methyl)Phenyl)Acetamide	N-[4-[(Z)-(carbamothioylhydrazinylidene)methyl]phenyl]acetamide	CC(=O)Nc1ccc(/C=N\NC(N)=S)cc1	5370664.0	R14_ghose_2012:888			BBB-	C	training
InChI=1S/C10H13ClN2/c11-9-2-1-3-10(8-9)13-6-4-12-5-7-13/h1-3,8,12H,4-7H2	1-(3-Chlorophenyl)Piperazine	1-(3-chlorophenyl)piperazine	Clc1cccc(N2CCNCC2)c1	1355.0	R29_subramanian_2003:93			BBB+	C	test
InChI=1S/C10H13ClN2O3S/c1-2-7-12-10(14)13-17(15,16)9-5-3-8(11)4-6-9/h3-6H,2,7H2,1H3,(H2,12,13,14)	Chlorpropamide	1-(4-chlorophenyl)sulfonyl-3-propylurea	CCCNC(=O)NS(=O)(=O)c1ccc(Cl)cc1	2727.0	R14_ghose_2012:446|R23_gupta_2019:453|R51_doninger_2002:24			BBB-	C	training
InChI=1S/C10H13FN2O4/c1-5-3-13(10(16)12-9(5)15)8-2-6(11)7(4-14)17-8/h3,6-8,14H,2,4H2,1H3,(H,12,15,16)	Alovudine Ok|3'-Fluorothymidine	1-[4-fluoro-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione	Cc1cn(C2CC(F)C(CO)O2)c(=O)[nH]c1=O	284240.0	R3_abraham_2006:120|R40_vilar_2010:29|R41_toropov_2017:115|R46_mendoza_valencia_2017:115	-0.59	B	BBB+	A	training
InChI=1S/C10H13FN2O4/c1-5-3-13(10(16)12-9(5)15)8-2-6(11)7(4-14)17-8/h3,6-8,14H,2,4H2,1H3,(H,12,15,16)/t6-,7+,8+/m0/s1	Alovudine	1-[(2R,4S,5R)-4-fluoro-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione	Cc1cn([C@H]2C[C@H](F)[C@@H](CO)O2)c(=O)[nH]c1=O	33039.0	R21_muehlbacher_2011:243|R25_brito_sanchez_2015:117|R26_chico_2009:23|R47_radchenko_2020:102	-0.59	D	BBB+	A	training
InChI=1S/C10H13FN2O5/c1-4-2-13(10(17)12-8(4)16)9-6(11)7(15)5(3-14)18-9/h2,5-7,9,14-15H,3H2,1H3,(H,12,16,17)	Clevudine|2'-Fluorothymidine	1-[3-fluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione	Cc1cn(C2OC(CO)C(O)C2F)c(=O)[nH]c1=O	352992.0	R23_gupta_2019:468			BBB-	C	training
InChI=1S/C10H13N3/c1-8-4-2-3-5-9(8)13-10-11-6-7-12-10/h2-5H,6-7H2,1H3,(H2,11,12,13)	36318-56-6|Tz-17|Imidazolidine, 2-(2-Methylphenylimino)-	N-(2-methylphenyl)-4,5-dihydro-1H-imidazol-2-amine	Cc1ccccc1NC1=NCCN1	142067.0	R4_mente_2005:8|R25_brito_sanchez_2015:564|R40_vilar_2010:288|R47_radchenko_2020:477	-1.39	B	BBB-	A	training
InChI=1S/C10H13N3/c11-10(12)13-6-5-8-3-1-2-4-9(8)7-13/h1-4H,5-7H2,(H3,11,12)	Debrisoquin|Debrisoquine	3,4-dihydro-1H-isoquinoline-2-carboximidamide	[H]/N=C(\N)N1CCc2ccccc2C1	2966.0	R23_gupta_2019:500			BBB-	C	training
InChI=1S/C10H13N3O5S/c1-8-7-19(16,17)5-4-12(8)11-6-9-2-3-10(18-9)13(14)15/h2-3,6,8H,4-5,7H2,1H3/b11-6+	Nifurtimox|(Z)-N-(3-Methyl-1,1-Dioxo-1,4-Thiazinan-4-Yl)-1-(5-Nitrofuran-2-Yl)Methanimine	(Z)-N-(3-methyl-1,1-dioxo-1,4-thiazinan-4-yl)-1-(5-nitrofuran-2-yl)methanimine	CC1CS(=O)(=O)CCN1/N=C\c1ccc([N+](=O)[O-])o1	6178305.0	R14_ghose_2012:719			BBB-	C	training
InChI=1S/C10H13N5O4/c1-5-3-15(10(18)12-9(5)17)8-2-6(13-14-11)7(4-16)19-8/h3,6-8,11,16H,2,4H2,1H3/p+1	1-[2,3-Dideoxy-3-(Triaza-1,2-Dien-2-Ium-1-Yl)Pentofuranosyl]-4-Hydroxy-5-Methylpyrimidin-2(1H)-One	[2-(hydroxymethyl)-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]imino-iminoazanium	Cc1cn(C2CC(N=[N+]=N)C(CO)O2)c(=O)[nH]c1=O	6327751.0	R46_mendoza_valencia_2017:238	-0.72	A	BBB+	A	training
InChI=1S/C10H13N5O4/c1-5-3-15(10(18)12-9(5)17)8-2-6(13-14-11)7(4-16)19-8/h3,6-8,16H,2,4H2,1H3,(H,12,17,18)	1-[(2R,4S,5S)-4-Azido-5-(Hydroxymethyl)Oxolan-2-Yl]-5-Methyl-Pyrimidine-2,4-Dione	1-[4-azido-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione	Cc1cn(C2CC(N=[N+]=[N-])C(CO)O2)c(=O)[nH]c1=O	5726.0	R41_toropov_2017:269|R42_ciura_2020:45	-0.86	C	BBB+	A	training
InChI=1S/C10H13N5O4/c1-5-3-15(10(18)12-9(5)17)8-2-6(13-14-11)7(4-16)19-8/h3,6-8,16H,2,4H2,1H3,(H,12,17,18)/t6-,7+,8+/m0/s1	Zidovudine|30516-87-1	1-[(2R,4S,5S)-4-azido-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione	Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O	35370.0	R3_abraham_2006:302|R4_mente_2005:42|R5_guerra_2008:107|R7_andres_2006:223|R17_fu_2008:53|R21_muehlbacher_2011:140|R25_brito_sanchez_2015:265|R26_chico_2009:444|R28_li_2005:129|R34_broccatelli_2012:100|R40_vilar_2010:305|R47_radchenko_2020:307|R49_norinder_2002:104|R51_doninger_2002:145|R53_friden_2009:42	-0.72	D	BBB+	A	training
InChI=1S/C10H13N5O4/c1-5-3-15(10(18)12-9(5)17)8-2-6(13-14-11)7(4-16)19-8/h3,6-8,16H,2,4H2,1H3,(H,12,17,18)/t6-,7-,8-/m0/s1	1-[(2S,4S,5R)-4-Azido-5-(Hydroxymethyl)Oxolan-2-Yl]-5-Methylpyrimidine-2,4-Dione	1-[(2S,4S,5R)-4-azido-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione	Cc1cn([C@@H]2C[C@H](N=[N+]=[N-])[C@H](CO)O2)c(=O)[nH]c1=O	6713644.0	R48_hou_2003:51	-0.72	A	BBB+	A	training
InChI=1S/C10H13NO2/c1-2-7-13-10(12)8-3-5-9(11)6-4-8/h3-6H,2,7,11H2,1H3	Propyl-4-Aminobenzoate|Risocaine	propyl 4-aminobenzoate	CCCOC(=O)c1ccc(N)cc1	7174.0	R3_abraham_2006:242|R21_muehlbacher_2011:173|R25_brito_sanchez_2015:366|R40_vilar_2010:222|R41_toropov_2017:216|R46_mendoza_valencia_2017:320|R47_radchenko_2020:201	0.55	B	BBB+	A	training
InChI=1S/C10H13NO2/c11-10(12)13-8-4-7-9-5-2-1-3-6-9/h1-3,5-6H,4,7-8H2,(H2,11,12)	Phenprobamate	3-phenylpropyl carbamate	NC(=O)OCCCc1ccccc1	4770.0	R6_adenot_2004:1502|R51_doninger_2002:283			BBB+	C	test
InChI=1S/C10H13NO3/c12-6-7-14-10(13)11-8-9-4-2-1-3-5-9/h1-5,12H,6-8H2,(H,11,13)	Buramate	2-hydroxyethyl N-benzylcarbamate	O=C(NCc1ccccc1)OCCO	20787.0	R6_adenot_2004:1424|R51_doninger_2002:168			BBB+	C	training
InChI=1S/C10H13NO4/c1-10(11,9(14)15)5-6-2-3-7(12)8(13)4-6/h2-4,12-13H,5,11H2,1H3,(H,14,15)/t10-/m0/s1	Methyldopa	(2S)-2-amino-3-(3,4-dihydroxyphenyl)-2-methylpropanoic acid	C[C@](N)(Cc1ccc(O)c(O)c1)C(=O)O	38853.0	R50_sobanska_2019:47|R51_doninger_2002:91			BBB-	C	test
InChI=1S/C10H14/c1-10(2,3)9-7-5-4-6-8-9/h4-8H,1-3H3	T-Butylbenzene|Tert-Butylbenzene	tert-butylbenzene	CC(C)(C)c1ccccc1	7366.0	R3_abraham_2006:93|R21_muehlbacher_2011:178|R25_brito_sanchez_2015:149|R40_vilar_2010:397|R41_toropov_2017:88|R46_mendoza_valencia_2017:146|R47_radchenko_2020:75	0.43	B	BBB+	A	training
InChI=1S/C10H14N2/c1-12-7-3-5-10(12)9-4-2-6-11-8-9/h2,4,6,8,10H,3,5,7H2,1H3	3-(1-Methylpyrrolidin-2-Yl)Pyridine	3-(1-methylpyrrolidin-2-yl)pyridine	CN1CCCC1c1cccnc1	942.0	R41_toropov_2017:190|R42_ciura_2020:27|R46_mendoza_valencia_2017:282	0.24	D	BBB+	A	test
InChI=1S/C10H14N2/c1-12-7-3-5-10(12)9-4-2-6-11-8-9/h2,4,6,8,10H,3,5,7H2,1H3/t10-/m0/s1	Nicotine|54-11-5|Nicotrol	3-[(2S)-1-methylpyrrolidin-2-yl]pyridine	CN1CCC[C@H]1c1cccnc1	89594.0	R3_abraham_2006:208|R4_mente_2005:176|R6_adenot_2004:1301|R14_ghose_2012:167|R21_muehlbacher_2011:13|R23_gupta_2019:166|R25_brito_sanchez_2015:321|R26_chico_2009:283|R37_chen_2011:62|R40_vilar_2010:161|R47_radchenko_2020:175|R51_doninger_2002:261	0.24	D	BBB+	A	test
InChI=1S/C10H14N2O/c1-3-12(4-2)10(13)9-6-5-7-11-8-9/h5-8H,3-4H2,1-2H3	Nikethamide	N,N-diethylpyridine-3-carboxamide	CCN(CC)C(=O)c1cccnc1	5497.0	R6_adenot_2004:401			BBB+	C	training
InChI=1S/C10H14N2O2/c1-10(2,3)12(14)8-9-4-6-11(13)7-5-9/h4-8H,1-3H3	Alpha-(4-Pyridyl-1-Oxide)-N-Tert-Butylnitrone|Cid 92375	tert-butyl-[(1-oxidopyridin-4-ylidene)methyl]-oxoazanium	CC(C)(C)[N+](=O)C=C1C=CN([O-])C=C1	92375.0	R21_muehlbacher_2011:281	-0.38	A	BBB+	A	training
InChI=1S/C10H14N2O2/c1-10(2,3)12(14)8-9-4-6-11(13)7-5-9/h4-8H,1-3H3/b12-8+	Alpha-(4-Pyridyl N-Oxide)-N-Tert-Butylnitrone	N-tert-butyl-1-(1-oxidopyridin-1-ium-4-yl)methanimine oxide	CC(C)(C)/[N+]([O-])=C\c1cc[n+]([O-])cc1	135465079.0	R41_toropov_2017:116|R46_mendoza_valencia_2017:116	-0.38	B	BBB+	A	training
InChI=1S/C10H14N2O2/c1-10(2,3)12(14)8-9-4-6-11(13)7-5-9/h4-8H,1-3H3/b12-8-	Alpha-(4-Pyridyl-1-Oxide)-N-Tert-Butylnitrone	N-tert-butyl-1-(1-oxidopyridin-1-ium-4-yl)methanimine oxide	CC(C)(C)/[N+]([O-])=C/c1cc[n+]([O-])cc1	135532295.0	R25_brito_sanchez_2015:118|R40_vilar_2010:30|R47_radchenko_2020:103	-0.38	B	BBB+	A	training
InChI=1S/C10H14N2O3/c1-4-5-10(6(2)3)7(13)11-9(15)12-8(10)14/h4,6H,1,5H2,2-3H3,(H2,11,12,13,14,15)	Aprobarbital	5-propan-2-yl-5-prop-2-enyl-1,3-diazinane-2,4,6-trione	C=CCC1(C(C)C)C(=O)NC(=O)NC1=O	6464.0	R6_adenot_2004:1638			BBB+	C	test
InChI=1S/C10H14N2O4/c1-3-4-10(5-6(2)13)7(14)11-9(16)12-8(10)15/h3,6,13H,1,4-5H2,2H3,(H2,11,12,14,15,16)	Proxibarbal	5-(2-hydroxypropyl)-5-prop-2-enyl-1,3-diazinane-2,4,6-trione	C=CCC1(CC(C)O)C(=O)NC(=O)NC1=O	17336.0	R6_adenot_2004:1664			BBB+	C	test
InChI=1S/C10H14N2O4S2/c11-18(15,16)10-5-3-9(4-6-10)12-7-1-2-8-17(12,13)14/h3-6H,1-2,7-8H2,(H2,11,15,16)	Sultiame|Sulthiame	4-(1,1-dioxothiazinan-2-yl)benzenesulfonamide	NS(=O)(=O)c1ccc(N2CCCCS2(=O)=O)cc1	5356.0	R6_adenot_2004:471|R14_ghose_2012:234|R23_gupta_2019:314			BBB+	C	training
InChI=1S/C10H14N2O5/c1-5-3-12(10(16)11-9(5)15)8-2-6(14)7(4-13)17-8/h3,6-8,13-14H,2,4H2,1H3,(H,11,15,16)/t6-,7+,8+/m1/s1	Telbivudine	1-[(2S,4R,5S)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione	Cc1cn([C@@H]2C[C@@H](O)[C@H](CO)O2)c(=O)[nH]c1=O	159269.0	R23_gupta_2019:959			BBB-	C	training
InChI=1S/C10H14N4O3/c1-6(15)4-14-5-11-8-7(14)9(16)13(3)10(17)12(8)2/h5-6,15H,4H2,1-3H3	Proxyphylline	7-(2-hydroxypropyl)-1,3-dimethylpurine-2,6-dione	CC(O)Cn1cnc2c1c(=O)n(C)c(=O)n2C	4977.0	R6_adenot_2004:1686			BBB+	C	training
InChI=1S/C10H14N4O4/c1-12-8-7(9(17)13(2)10(12)18)14(5-11-8)3-6(16)4-15/h5-6,15-16H,3-4H2,1-2H3	Dyphylline	7-(2,3-dihydroxypropyl)-1,3-dimethylpurine-2,6-dione	Cn1c(=O)c2c(ncn2CC(O)CO)n(C)c1=O	3182.0	R14_ghose_2012:518			BBB-	C	training
InChI=1S/C10H14N5O4/c1-5-3-15(10(18)12-9(5)17)8-2-6(13-14-11)7(4-16)19-8/h3,5-8,11,16H,2,4H2,1H3/q+1/p+1			CC1C=[N+](C2CC(N=[N+]=N)C(CO)O2)C(=O)NC1=O		R45_hemmateenejad_2006:6	-0.05	A	BBB+	A	test
InChI=1S/C10H14N5O7P/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(22-10)1-21-23(18,19)20/h2-4,6-7,10,16-17H,1H2,(H2,11,12,13)(H2,18,19,20)/t4-,6-,7-,10-/m1/s1	Adenosine Monophosphate|Adenosine Phosphate	[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate	Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]1O	6083.0	R23_gupta_2019:327			BBB-	C	training
InChI=1S/C10H15N/c1-10(2,11)8-9-6-4-3-5-7-9/h3-7H,8,11H2,1-2H3	Phentermine	2-methyl-1-phenylpropan-2-amine	CC(C)(N)Cc1ccccc1	4771.0	R14_ghose_2012:199|R23_gupta_2019:199			BBB+	C	training
InChI=1S/C10H15N/c1-9(11-2)8-10-6-4-3-5-7-10/h3-7,9,11H,8H2,1-2H3	Pervertin|Dl-Methamphetamine	N-methyl-1-phenylpropan-2-amine	CNC(C)Cc1ccccc1	1206.0	R21_muehlbacher_2011:20|R41_toropov_2017:179|R46_mendoza_valencia_2017:256	0.92	B	BBB+	A	training
InChI=1S/C10H15N/c1-9(11-2)8-10-6-4-3-5-7-10/h3-7,9,11H,8H2,1-2H3/t9-/m0/s1	Methamphetamine|Metamphetamine	(2S)-N-methyl-1-phenylpropan-2-amine	CN[C@@H](C)Cc1ccccc1	10836.0	R3_abraham_2006:195|R6_adenot_2004:382|R12_garg_2006:106|R14_ghose_2012:144|R21_muehlbacher_2011:211|R23_gupta_2019:143|R25_brito_sanchez_2015:287|R26_chico_2009:262|R39_shayanfar_2011:58|R40_vilar_2010:145|R47_radchenko_2020:165|R51_doninger_2002:248	0.9	D	BBB+	A	training
InChI=1S/C10H15N3/c1-11-10(12-2)13-8-9-6-4-3-5-7-9/h3-7H,8H2,1-2H3,(H2,11,12,13)	Bethanidine Sulfate|Bethanidine	1-benzyl-2,3-dimethylguanidine	C/N=C(\NC)NCc1ccccc1	2368.0	R14_ghose_2012:393|R23_gupta_2019:390			BBB-	C	training
InChI=1S/C10H15N3/c1-9-10(12-6-5-11-9)13-7-3-2-4-8-13/h5-6H,2-4,7-8H2,1H3	Modaline	2-methyl-3-piperidin-1-ylpyrazine	Cc1nccnc1N1CCCCC1	17860.0	R6_adenot_2004:578			BBB+	C	training
InChI=1S/C10H15N3O/c1-14-12-10(6-11)9-7-13-4-2-8(9)3-5-13/h8-9H,2-5,7H2,1H3/b12-10+/t9-/m0/s1	Sabcomeline|(3E,3R)-N-Methoxy-1-Azabicyclo[2.2.2]Octane-3-Carboximidoyl Cyanide	(3E,3R)-N-methoxy-1-azabicyclo[2.2.2]octane-3-carboximidoyl cyanide	CO/N=C(/C#N)[C@H]1CN2CCC1CC2	5491428.0	R6_adenot_2004:1252			BBB+	C	training
InChI=1S/C10H15N3O/c11-10(12)13-7-4-8-14-9-5-2-1-3-6-9/h1-3,5-6H,4,7-8H2,(H4,11,12,13)	Guanoxyfen	2-(3-phenoxypropyl)guanidine	NC(N)=NCCCOc1ccccc1	13923.0	R6_adenot_2004:554			BBB+	C	training
InChI=1S/C10H15N3O4/c11-8-1-2-13(10(16)12-8)9-3-6(4-14)7(5-15)17-9/h1-2,6-7,9,14-15H,3-5H2,(H2,11,12,16)	2',3'-Dideoxy-3'-Hydroxymethylcytidine|4-Amino-1-[4,5-Bis(Hydroxymethyl)Oxolan-2-Yl]Pyrimidin-2-One	4-amino-1-[4,5-bis(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one	Nc1ccn(C2CC(CO)C(CO)O2)c(=O)n1	14840722.0	R40_vilar_2010:8|R47_radchenko_2020:478	-0.79	B	BBB+	A	training
InChI=1S/C10H15N3O4/c11-8-1-2-13(10(16)12-8)9-3-6(4-14)7(5-15)17-9/h1-2,6-7,9,14-15H,3-5H2,(H2,11,12,16)/t6-,7-,9-/m1/s1	132235-73-5|2',3'-Dideoxy-3'-Hydroxymethyl Cytidine	4-amino-1-[(2R,4R,5S)-4,5-bis(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one	Nc1ccn([C@H]2C[C@H](CO)[C@@H](CO)O2)c(=O)n1	451819.0	R4_mente_2005:34	-0.79	A	BBB+	A	training
InChI=1S/C10H15N3O4/c11-8-1-2-13(10(16)12-8)9-3-6(4-14)7(5-15)17-9/h1-2,6-7,9,14-15H,3-5H2,(H2,11,12,16)/t6?,7?,9-/m0/s1	2´,3´-Dideoxy-3´-Hydroxymethylcytidine		Nc1ccn([C@@H]2CC(CO)C(CO)O2)c(=O)n1		R25_brito_sanchez_2015:67|R46_mendoza_valencia_2017:65	-0.79	B	BBB+	A	training
InChI=1S/C10H15N3O5/c11-6(4-14)10(18)13-12-3-5-1-2-7(15)9(17)8(5)16/h1-2,6,12,14-17H,3-4,11H2,(H,13,18)	Benserazide	2-amino-3-hydroxy-N'-[(2,3,4-trihydroxyphenyl)methyl]propanehydrazide	NC(CO)C(=O)NNCc1ccc(O)c(O)c1O	2327.0	R6_adenot_2004:87			BBB-	C	training
InChI=1S/C10H15N3S/c1-2-5-13-6-3-8-9(4-7-13)14-10(11)12-8/h2H,1,3-7H2,(H2,11,12)	Talipexole	6-prop-2-enyl-4,5,7,8-tetrahydro-[1,3]thiazolo[4,5-d]azepin-2-amine	C=CCN1CCc2nc(N)sc2CC1	5374.0	R14_ghose_2012:237|R23_gupta_2019:232|R37_chen_2011:94			BBB+	C	training
InChI=1S/C10H15N5/c1-4-14(5-2)9-6-8(3)13-10-11-7-12-15(9)10/h6-7H,4-5H2,1-3H3	Trapidil	N,N-diethyl-5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-amine	CCN(CC)c1cc(C)nc2ncnn12	5531.0	R14_ghose_2012:909			BBB-	C	training
InChI=1S/C10H15N5/c11-9(12)15-10(13)14-7-6-8-4-2-1-3-5-8/h1-5H,6-7H2,(H6,11,12,13,14,15)	Phenformin	1-(diaminomethylidene)-2-(2-phenylethyl)guanidine	NC(N)=N/C(N)=N/CCc1ccccc1	8249.0	R14_ghose_2012:765			BBB-	C	test
InChI=1S/C10H15NO/c1-4-11(2,3)9-6-5-7-10(12)8-9/h5-8H,4H2,1-3H3/p+1	Edrophonium	ethyl-(3-hydroxyphenyl)-dimethylazanium	CC[N+](C)(C)c1cccc(O)c1	3202.0	R23_gupta_2019:550			BBB-	C	training
InChI=1S/C10H15NO2/c1-2-11-7-10(13)8-4-3-5-9(12)6-8/h3-6,10-13H,2,7H2,1H3	Etilefrine	3-[2-(ethylamino)-1-hydroxyethyl]phenol	CCNCC(O)c1cccc(O)c1	3306.0	R6_adenot_2004:89|R14_ghose_2012:543			BBB-	C	training
InChI=1S/C10H15NO2/c1-2-6-10(13-9(11)12)7-4-3-5-8-10/h1H,3-8H2,(H2,11,12)	Hexapropymate	(1-prop-2-ynylcyclohexyl) carbamate	C#CCC1(OC(N)=O)CCCCC1	9661.0	R6_adenot_2004:1365|R51_doninger_2002:226			BBB+	C	training
InChI=1S/C10H15NO2/c1-3-4-6-11-7-5-9(12)10(13)8(11)2/h5,7,13H,3-4,6H2,1-2H3	Cp24|4(1H)-Pyridinone, 1-Butyl-3-Hydroxy-2-Methyl-	1-butyl-3-hydroxy-2-methylpyridin-4-one	CCCCn1ccc(=O)c(O)c1C	121733.0	R28_li_2005:343			BBB+	C	training
InChI=1S/C10H15NO2/c1-4-10(5-2)8(12)7(3)6-11-9(10)13/h6H,4-5H2,1-3H3,(H,11,13)	Ethypicone	3,3-diethyl-5-methyl-1H-pyridine-2,4-dione	CCC1(CC)C(=O)NC=C(C)C1=O	68842.0	R6_adenot_2004:1360			BBB+	C	test
InChI=1S/C10H15NO2/c1-7(11-2)10(13)8-3-5-9(12)6-4-8/h3-7,10-13H,1-2H3	Oxilofrine|Suprifen	4-[1-hydroxy-2-(methylamino)propyl]phenol	CNC(C)C(O)c1ccc(O)cc1	9701.0	R14_ghose_2012:745			BBB-	C	training
InChI=1S/C10H15NO2/c1-7(11-2)10(13)8-3-5-9(12)6-4-8/h3-7,10-13H,1-2H3/t7-,10-/m0/s1	Hydroxyephedrine|Oxilofrine	4-[(1R,2S)-1-hydroxy-2-(methylamino)propyl]phenol	CN[C@@H](C)[C@H](O)c1ccc(O)cc1	688009.0	R6_adenot_2004:92			BBB-	C	training
InChI=1S/C10H16Br2N2O2/c11-3-1-9(15)13-5-7-14(8-6-13)10(16)2-4-12/h1-8H2	Pipobroman	3-bromo-1-[4-(3-bromopropanoyl)piperazin-1-yl]propan-1-one	O=C(CCBr)N1CCN(C(=O)CCBr)CC1	4842.0	R14_ghose_2012:778|R23_gupta_2019:841			BBB-	C	training
InChI=1S/C10H16N2O/c1-2-7(1)9(8-3-4-8)12-10-11-5-6-13-10/h7-9H,1-6H2,(H,11,12)	Rilmenidine	N-(dicyclopropylmethyl)-4,5-dihydro-1,3-oxazol-2-amine	C1COC(NC(C2CC2)C2CC2)=N1	68712.0	R14_ghose_2012:827			BBB-	C	training
InChI=1S/C10H16N2O2/c13-9-5-4-8(11-9)10(14)12-6-2-1-3-7-12/h8H,1-7H2,(H,11,13)/t8-/m1/s1	Fasoracetam	(5R)-5-(piperidine-1-carbonyl)pyrrolidin-2-one	O=C1CC[C@H](C(=O)N2CCCCC2)N1	198695.0	R6_adenot_2004:588			BBB+	C	training
InChI=1S/C10H16N2O3/c1-3-5-6-10(4-2)7(13)11-9(15)12-8(10)14/h3-6H2,1-2H3,(H2,11,12,13,14,15)	Butethal|Butobarbitone	5-butyl-5-ethyl-1,3-diazinane-2,4,6-trione	CCCCC1(CC)C(=O)NC(=O)NC1=O	6473.0	R3_abraham_2006:109|R21_muehlbacher_2011:166|R23_gupta_2019:33|R25_brito_sanchez_2015:95|R40_vilar_2010:16|R41_toropov_2017:104|R46_mendoza_valencia_2017:93|R47_radchenko_2020:91	0.19	B	BBB+	A	test
InChI=1S/C10H16N2O3/c1-4-6(3)10(5-2)7(13)11-9(15)12-8(10)14/h6H,4-5H2,1-3H3,(H2,11,12,13,14,15)	Secbutabarbital|Butabarbital	5-butan-2-yl-5-ethyl-1,3-diazinane-2,4,6-trione	CCC(C)C1(CC)C(=O)NC(=O)NC1=O	2479.0	R6_adenot_2004:1665			BBB+	C	test
InChI=1S/C10H16N2O3S/c13-8(14)4-2-1-3-7-9-6(5-16-7)11-10(15)12-9/h6-7,9H,1-5H2,(H,13,14)(H2,11,12,15)/t6-,7-,9-/m0/s1	Biotin	5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoic acid	O=C(O)CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@@H]21	171548.0	R6_adenot_2004:1678			BBB+	C	training
InChI=1S/C10H16N2O4S3/c1-3-12-8-4-6(2)18(13,14)10-7(8)5-9(17-10)19(11,15)16/h5-6,8,12H,3-4H2,1-2H3,(H2,11,15,16)/t6-,8-/m0/s1	Dorzolamide	(4S,6S)-4-(ethylamino)-6-methyl-7,7-dioxo-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide	CCN[C@H]1C[C@H](C)S(=O)(=O)c2sc(S(N)(=O)=O)cc21	5284549.0	R23_gupta_2019:535			BBB-	C	test
InChI=1S/C10H16N2O8.Ca.2Na/c13-7(14)3-11(4-8(15)16)1-2-12(5-9(17)18)6-10(19)20;;;/h1-6H2,(H,13,14)(H,15,16)(H,17,18)(H,19,20);;;	Edetate Calcium Disodium|Cid 9842726		O=C(O)CN(CCN(CC(=O)O)CC(=O)O)CC(=O)O.[Ca].[Na].[Na]	9842726.0	R14_ghose_2012:520			BBB-	C	training
InChI=1S/C10H16N2O8/c13-7(14)3-11(4-8(15)16)1-2-12(5-9(17)18)6-10(19)20/h1-6H2,(H,13,14)(H,15,16)(H,17,18)(H,19,20)	Edetic Acid	2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetic acid	O=C(O)CN(CCN(CC(=O)O)CC(=O)O)CC(=O)O	6049.0	R23_gupta_2019:548			BBB-	C	training
InChI=1S/C10H16N2OS/c1-4-5-12-9(13)8(6-7(2)3)11-10(12)14/h4,7-8H,1,5-6H2,2-3H3,(H,11,14)	Albutoin	5-(2-methylpropyl)-3-prop-2-enyl-2-sulfanylideneimidazolidin-4-one	C=CCN1C(=O)C(CC(C)C)NC1=S	3032361.0	R6_adenot_2004:1673			BBB+	C	test
InChI=1S/C10H16N5O13P3/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(26-10)1-25-30(21,22)28-31(23,24)27-29(18,19)20/h2-4,6-7,10,16-17H,1H2,(H,21,22)(H,23,24)(H2,11,12,13)(H2,18,19,20)/t4-,6-,7-,10-/m1/s1	Adenosine Triphosphate|Adenosine-5'-Triphosphate	[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate	Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]1O	5957.0	R23_gupta_2019:328			BBB-	C	training
InChI=1S/C10H16N6S/c1-8-9(16-7-15-8)5-17-4-3-13-10(12-2)14-6-11/h7H,3-5H2,1-2H3,(H,15,16)(H2,12,13,14)	51481-61-9|Cimetidine|1	1-cyano-2-methyl-3-[2-[(5-methyl-1H-imidazol-4-yl)methylsulfanyl]ethyl]guanidine	C/N=C(\NC#N)NCCSCc1nc[nH]c1C	2756.0	R4_mente_2005:118|R5_guerra_2008:26|R6_adenot_2004:12|R7_andres_2006:33|R12_garg_2006:59|R14_ghose_2012:451|R21_muehlbacher_2011:55|R25_brito_sanchez_2015:188|R26_chico_2009:105|R28_li_2005:15|R29_subramanian_2003:35|R31_carpenter_2014:2|R34_broccatelli_2012:111|R39_shayanfar_2011:29|R40_vilar_2010:77|R46_mendoza_valencia_2017:175|R47_radchenko_2020:311|R48_hou_2003:10|R49_norinder_2002:1|R49_norinder_2002:123|R49_norinder_2002:152|R50_sobanska_2019:2|R52_liu_2001:1	-1.4	B1	BBB-	A	training
InChI=1S/C10H16N8S2/c1-14-9(16-6-11)15-2-3-19-4-7-5-20-10(17-7)18-8(12)13/h5H,2-4H2,1H3,(H2,14,15,16)(H4,12,13,17,18)	Tiotidine|69014-14-8|5-6|10	1-cyano-3-[2-[[2-(diaminomethylideneamino)-1,3-thiazol-4-yl]methylsulfanyl]ethyl]-2-methylguanidine	C/N=C(\NC#N)NCCSCc1csc(N=C(N)N)n1	50287.0	R3_abraham_2006:290|R4_mente_2005:119|R5_guerra_2008:102|R7_andres_2006:219|R12_garg_2006:166|R21_muehlbacher_2011:249|R25_brito_sanchez_2015:84|R26_chico_2009:419|R28_li_2005:51|R28_li_2005:142|R39_shayanfar_2011:94|R40_vilar_2010:275|R41_toropov_2017:259|R46_mendoza_valencia_2017:82|R47_radchenko_2020:242|R48_hou_2003:49|R49_norinder_2002:10|R52_liu_2001:10	-0.82	B	BBB+	A	training
InChI=1S/C10H16O/c1-9(2)7-4-5-10(9,3)8(11)6-7/h7H,4-6H2,1-3H3	Camphor	1,7,7-trimethylbicyclo[2.2.1]heptan-2-one	CC12CCC(CC1=O)C2(C)C	2537.0	R6_adenot_2004:396			BBB+	C	training
InChI=1S/C10H17N/c11-10-4-7-1-8(5-10)3-9(2-7)6-10/h7-9H,1-6,11H2	Amantadine	adamantan-1-amine	NC12CC3CC(CC(C3)C1)C2	2130.0	R6_adenot_2004:641|R7_andres_2006:7|R14_ghose_2012:5|R26_chico_2009:26|R28_li_2005:178|R29_subramanian_2003:6|R34_broccatelli_2012:3|R51_doninger_2002:150			BBB+	C	training
InChI=1S/C10H17N3O2/c11-7-10(4-2-1-3-5-10)6-8-12-9(14)15-13-8/h1-7,11H2,(H,12,13,14)	Compound-9|3-[[1-(Aminomethyl)Cyclohexyl]Methyl]-1,2,4-Oxadiazol-5(2H)-One	3-[[1-(aminomethyl)cyclohexyl]methyl]-4H-1,2,4-oxadiazol-5-one	NCC1(Cc2noc(=O)[nH]2)CCCCC1	135529433.0	R26_chico_2009:135	-1.3	A	BBB-	A	training
InChI=1S/C10H17N3O6S/c11-5(10(18)19)1-2-7(14)13-6(4-20)9(17)12-3-8(15)16/h5-6,20H,1-4,11H2,(H,12,17)(H,13,14)(H,15,16)(H,18,19)/t5-,6-/m0/s1	Glutathione	(2S)-2-amino-5-[[(2R)-1-(carboxymethylamino)-1-oxo-3-sulfanylpropan-2-yl]amino]-5-oxopentanoic acid	N[C@@H](CCC(=O)N[C@@H](CS)C(=O)NCC(=O)O)C(=O)O	124886.0	R23_gupta_2019:640			BBB-	C	test
InChI=1S/C10H17N3S/c1-2-5-12-7-3-4-8-9(6-7)14-10(11)13-8/h7,12H,2-6H2,1H3,(H2,11,13)/t7-/m0/s1	Pramipexole	(6S)-6-N-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine	CCCN[C@H]1CCc2nc(N)sc2C1	119570.0	R14_ghose_2012:206|R23_gupta_2019:205|R26_chico_2009:315|R37_chen_2011:74			BBB+	C	training
InChI=1S/C10H17NO2/c1-4-10(5-2)8(12)7(3)6-11-9(10)13/h7H,4-6H2,1-3H3,(H,11,13)	Methyprylon	3,3-diethyl-5-methylpiperidine-2,4-dione	CCC1(CC)C(=O)NCC(C)C1=O	4162.0	R6_adenot_2004:1372|R51_doninger_2002:255			BBB+	C	training
InChI=1S/C10H17NOS/c1-8-12-10(7-13-8)6-11-4-2-9(10)3-5-11/h8-9H,2-7H2,1H3	Cevimeline|2-Methylspiro[1,3-Oxathiolane-5,3'-1-Azabicyclo[2.2.2]Octane]	2-methylspiro[1,3-oxathiolane-5,3'-1-azabicyclo[2.2.2]octane]	CC1OC2(CS1)CN1CCC2CC1	2684.0	R23_gupta_2019:446			BBB-	C	training
InChI=1S/C10H18O21S4/c11-3-1-26-10(8(31-35(22,23)24)5(3)28-32(13,14)15)27-4-2-25-9(12)7(30-34(19,20)21)6(4)29-33(16,17)18/h3-12H,1-2H2,(H,13,14,15)(H,16,17,18)(H,19,20,21)(H,22,23,24)	Pentosan Polysulfate|[2-Hydroxy-5-(5-Hydroxy-3,4-Disulfooxyoxan-2-Yl)Oxy-3-Sulfooxyoxan-4-Yl] Hydrogen Sulfate	[2-hydroxy-5-(5-hydroxy-3,4-disulfooxyoxan-2-yl)oxy-3-sulfooxyoxan-4-yl] hydrogen sulfate	O=S(=O)(O)OC1C(O)COC(OC2COC(O)C(OS(=O)(=O)O)C2OS(=O)(=O)O)C1OS(=O)(=O)O	22052964.0	R23_gupta_2019:822			BBB-	C	test
InChI=1S/C10H19N3O2/c11-9(12)13-6-8-7-14-10(15-8)4-2-1-3-5-10/h8H,1-7H2,(H4,11,12,13)	Guanadrel	2-(1,4-dioxaspiro[4.5]decan-3-ylmethyl)guanidine	NC(N)=NCC1COC2(CCCCC2)O1	38521.0	R28_li_2005:304			BBB-	C	training
InChI=1S/C10H19NO2/c1-2-9(13-10(11)12)8-6-4-3-5-7-8/h8-9H,2-7H2,1H3,(H2,11,12)	Procymate	1-cyclohexylpropyl carbamate	CCC(OC(N)=O)C1CCCCC1	3050432.0	R6_adenot_2004:1308			BBB+	C	training
InChI=1S/C10H19NO5/c1-10(2,6-12)8(15)9(16)11-5-3-4-7(13)14/h8,12,15H,3-6H2,1-2H3,(H,11,16)(H,13,14)/t8-/m0/s1	Hopantenic-Acid|Hopantenic Acid	4-[[(2R)-2,4-dihydroxy-3,3-dimethylbutanoyl]amino]butanoic acid	CC(C)(CO)[C@@H](O)C(=O)NCCCC(=O)O	28281.0	R6_adenot_2004:1293			BBB+	C	training
InChI=1S/C10H19O6PS2/c1-5-15-9(11)7-8(10(12)16-6-2)19-17(18,13-3)14-4/h8H,5-7H2,1-4H3	Malathion	diethyl 2-dimethoxyphosphinothioylsulfanylbutanedioate	CCOC(=O)CC(SP(=S)(OC)OC)C(=O)OCC	4004.0	R23_gupta_2019:720			BBB-	C	training
InChI=1S/C10H20/c1-10(2,3)9-7-5-4-6-8-9/h9H,4-8H2,1-3H3	T-Butylcyclohexane|Tert-Butylcyclohexane	tert-butylcyclohexane	CC(C)(C)C1CCCCC1	18508.0	R3_abraham_2006:27|R21_muehlbacher_2011:226|R25_brito_sanchez_2015:150|R40_vilar_2010:398|R41_toropov_2017:22|R46_mendoza_valencia_2017:147|R47_radchenko_2020:12	0.61	B	BBB+	A	training
InChI=1S/C10H20/c1-3-5-7-9-10-8-6-4-2/h3H,1,4-10H2,2H3	1-Decene	dec-1-ene	C=CCCCCCCCC	13381.0	R3_abraham_2006:49|R21_muehlbacher_2011:221|R25_brito_sanchez_2015:54|R40_vilar_2010:321|R41_toropov_2017:44|R46_mendoza_valencia_2017:53|R47_radchenko_2020:32	0.96	B	BBB+	A	training
InChI=1S/C10H20N2O4/c1-4-7(2)10(3,5-15-8(11)13)6-16-9(12)14/h7H,4-6H2,1-3H3,(H2,11,13)(H2,12,14)	Mebutamate	[2-(carbamoyloxymethyl)-2,3-dimethylpentyl] carbamate	CCC(C)C(C)(COC(N)=O)COC(N)=O	6151.0	R6_adenot_2004:1482			BBB+	C	training
InChI=1S/C10H20O/c1-7(2)9-5-4-8(3)6-10(9)11/h7-11H,4-6H2,1-3H3	Menthol	5-methyl-2-propan-2-ylcyclohexan-1-ol	CC1CCC(C(C)C)C(O)C1	1254.0	R23_gupta_2019:729			BBB-	C	training
InChI=1S/C10H20O/c1-8(2)10(11)9-6-4-3-5-7-9/h8-11H,3-7H2,1-2H3	Cimepanol	1-cyclohexyl-2-methylpropan-1-ol	CC(C)C(O)C1CCCCC1	65765.0	R6_adenot_2004:1329			BBB+	C	training
InChI=1S/C10H20O3/c1-7(2)10(8(3)4)12-6-9(5-11)13-10/h7-9,11H,5-6H2,1-4H3	Promoxolane	[2,2-di(propan-2-yl)-1,3-dioxolan-4-yl]methanol	CC(C)C1(C(C)C)OCC(CO)O1	10105.0	R6_adenot_2004:1505			BBB+	C	training
InChI=1S/C10H21N/c1-9(11-2)8-10-6-4-3-5-7-10/h9-11H,3-8H2,1-2H3	101-40-6|Propylhexedrine	1-cyclohexyl-N-methylpropan-2-amine	CNC(C)CC1CCCCC1	7558.0	R4_mente_2005:1|R21_muehlbacher_2011:182|R25_brito_sanchez_2015:343|R40_vilar_2010:223|R47_radchenko_2020:354	1.08	B	BBB+	A	training
InChI=1S/C10H21N/c1-9(11-2)8-10-6-4-3-5-7-10/h9-11H,3-8H2,1-2H3/t9-/m1/s1	Propylhexedrine, (+)-	(2R)-1-cyclohexyl-N-methylpropan-2-amine	CN[C@H](C)CC1CCCCC1	111165.0	R46_mendoza_valencia_2017:301	1.08	A	BBB+	A	training
InChI=1S/C10H21NO4/c1-2-3-4-11-5-8(13)10(15)9(14)7(11)6-12/h7-10,12-15H,2-6H2,1H3/t7-,8+,9-,10-/m1/s1	Miglustat	(2R,3R,4R,5S)-1-butyl-2-(hydroxymethyl)piperidine-3,4,5-triol	CCCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO	51634.0	R23_gupta_2019:297			BBB+	C	training
InChI=1S/C10H21NO7/c12-2-5(3-13)11-6-1-10(18,4-14)9(17)8(16)7(6)15/h5-9,11-18H,1-4H2/t6-,7-,8+,9-,10-/m0/s1	Voglibose	(1S,2S,3R,4S,5S)-5-(1,3-dihydroxypropan-2-ylamino)-1-(hydroxymethyl)cyclohexane-1,2,3,4-tetrol	OCC(CO)N[C@H]1C[C@](O)(CO)[C@@H](O)[C@H](O)[C@H]1O	444020.0	R14_ghose_2012:935|R23_gupta_2019:1031			BBB-	C	training
InChI=1S/C10H22/c1-3-5-7-9-10-8-6-4-2/h3-10H2,1-2H3	Decane	decane	CCCCCCCCCC	15600.0	R3_abraham_2006:14|R21_muehlbacher_2011:223|R25_brito_sanchez_2015:201|R40_vilar_2010:350|R41_toropov_2017:9|R46_mendoza_valencia_2017:187|R47_radchenko_2020:475	0.67	B	BBB+	A	training
InChI=1S/C10H22/c1-4-5-6-7-8-9-10(2)3/h10H,4-9H2,1-3H3	2-Methylnonane|2-Methyl Nonane	2-methylnonane	CCCCCCCC(C)C	13379.0	R21_muehlbacher_2011:220|R25_brito_sanchez_2015:72|R40_vilar_2010:330|R46_mendoza_valencia_2017:70|R47_radchenko_2020:3	1.05	B	BBB+	A	training
InChI=1S/C10H22N4/c11-10(12)13-6-9-14-7-4-2-1-3-5-8-14/h1-9H2,(H4,11,12,13)	Guanethidine|Guanethidine Sulfate	2-[2-(azocan-1-yl)ethyl]guanidine	NC(N)=NCCN1CCCCCCC1	3518.0	R23_gupta_2019:648|R51_doninger_2002:63			BBB-	C	test
InChI=1S/C10H24N2O2/c1-3-9(7-13)11-5-6-12-10(4-2)8-14/h9-14H,3-8H2,1-2H3/t9-,10-/m0/s1	Ethambutol	(2S)-2-[2-[[(2S)-1-hydroxybutan-2-yl]amino]ethylamino]butan-1-ol	CC[C@@H](CO)NCCN[C@@H](CC)CO	14052.0	R23_gupta_2019:577|R28_li_2005:200			BBB-	C	training
InChI=1S/C10H26N4/c11-5-3-9-13-7-1-2-8-14-10-4-6-12/h13-14H,1-12H2	Spermine	N,N'-bis(3-aminopropyl)butane-1,4-diamine	NCCCNCCCCNCCCN	1103.0	R23_gupta_2019:919			BBB-	C	test
InChI=1S/C10H6Cl3N3/c11-7-1-2-8(9(12)3-7)10(13)4-16-6-14-5-15-16/h1-6H/b10-4-	Loreclezole	1-[(Z)-2-chloro-2-(2,4-dichlorophenyl)ethenyl]-1,2,4-triazole	Cl/C(=C\n1cncn1)c1ccc(Cl)cc1Cl	3034012.0	R6_adenot_2004:447|R25_brito_sanchez_2015:278|R46_mendoza_valencia_2017:251|R47_radchenko_2020:465	0.28	B	BBB+	A	test
InChI=1S/C10H6O4/c11-7-5-9(10(12)13)14-8-4-2-1-3-6(7)8/h1-5H,(H,12,13)	Chromocarb	4-oxochromene-2-carboxylic acid	O=C(O)c1cc(=O)c2ccccc2o1	2741.0	R6_adenot_2004:1354			BBB+	C	training
InChI=1S/C10H7Cl2N3O/c11-6-1-2-7-5(9(6)12)3-15-4-8(16)14-10(15)13-7/h1-2H,3-4H2,(H,13,14,16)	Anagrelide Hydrochloride|Anagrelide	6,7-dichloro-3,5-dihydro-1H-imidazo[2,1-b]quinazolin-2-one	O=C1CN2Cc3c(ccc(Cl)c3Cl)N=C2N1	135409400.0	R14_ghose_2012:354|R23_gupta_2019:354			BBB-	C	training
InChI=1S/C10H7N3S/c1-2-4-8-7(3-1)12-10(13-8)9-5-14-6-11-9/h1-6H,(H,12,13)	Thiabendazole	4-(1H-benzimidazol-2-yl)-1,3-thiazole	c1ccc2[nH]c(-c3cscn3)nc2c1	5430.0	R14_ghose_2012:887|R23_gupta_2019:973			BBB-	C	training
InChI=1S/C10H7NO3/c12-9-5-8(10(13)14)11-7-4-2-1-3-6(7)9/h1-5H,(H,11,12)(H,13,14)	Kynurenic Acid	4-oxo-1H-quinoline-2-carboxylic acid	O=C(O)c1cc(=O)c2ccccc2[nH]1	3845.0	R51_doninger_2002:235			BBB+	C	training
InChI=1S/C10H8BrNO2/c11-7-3-1-2-6(4-7)8-5-9(13)12-10(8)14/h1-4,8H,5H2,(H,12,13,14)	Brosuximide	3-(3-bromophenyl)pyrrolidine-2,5-dione	O=C1CC(c2cccc(Br)c2)C(=O)N1	65706.0	R6_adenot_2004:425			BBB+	C	training
InChI=1S/C10H8F2N4O/c11-7-2-1-3-8(12)6(7)4-16-5-9(10(13)17)14-15-16/h1-3,5H,4H2,(H2,13,17)	Rufinamide	1-[(2,6-difluorophenyl)methyl]triazole-4-carboxamide	NC(=O)c1cn(Cc2c(F)cccc2F)nn1	129228.0	R6_adenot_2004:428|R23_gupta_2019:224			BBB+	C	training
InChI=1S/C10H8N6O/c1-6-3-2-4-16-9(6)11-5-7(10(16)17)8-12-14-15-13-8/h2-5H,1H3,(H,12,13,14,15)	Pemirolast	9-methyl-3-(2H-tetrazol-5-yl)pyrido[1,2-a]pyrimidin-4-one	Cc1cccn2c(=O)c(-c3nn[nH]n3)cnc12	57697.0	R23_gupta_2019:817			BBB-	C	training
InChI=1S/C10H8O3/c1-6-4-10(12)13-9-5-7(11)2-3-8(6)9/h2-5,11H,1H3	Hymecromone	7-hydroxy-4-methylchromen-2-one	Cc1cc(=O)oc2cc(O)ccc12	5280567.0	R6_adenot_2004:35			BBB-	C	test
InChI=1S/C10H9N3O/c11-9-5-8(6-13-10(9)14)7-1-3-12-4-2-7/h1-6H,11H2,(H,13,14)	Amrinone	3-amino-5-pyridin-4-yl-1H-pyridin-2-one	Nc1cc(-c2ccncc2)c[nH]c1=O	3698.0	R23_gupta_2019:350			BBB-	C	training
InChI=1S/C10H9NO2/c1-2-9(13-10(11)12)8-6-4-3-5-7-8/h1,3-7,9H,(H2,11,12)	Carfimate	1-phenylprop-2-ynyl carbamate	C#CC(OC(N)=O)c1ccccc1	19111.0	R6_adenot_2004:1350			BBB+	C	test
InChI=1S/C11H10Cl2N4/c1-5-9(10(14)17-11(15)16-5)6-2-3-7(12)8(13)4-6/h2-4H,1H3,(H4,14,15,16,17)	Metoprine	5-(3,4-dichlorophenyl)-6-methylpyrimidine-2,4-diamine	Cc1nc(N)nc(N)c1-c1ccc(Cl)c(Cl)c1	24466.0	R26_chico_2009:269	0.81	A	BBB+	A	training
InChI=1S/C11H10N2O/c12-9-4-3-5-10(8-9)13-7-2-1-6-11(13)14/h1-8H,12H2	Amphenidone	1-(3-aminophenyl)pyridin-2-one	Nc1cccc(-n2ccccc2=O)c1	8641.0	R6_adenot_2004:1415			BBB+	C	training
InChI=1S/C11H10O2/c1-7-6-10(12)8-4-2-3-5-9(8)11(7)13/h2-6,12-13H,1H3	Menadiol	2-methylnaphthalene-1,4-diol	Cc1cc(O)c2ccccc2c1O	10209.0	R14_ghose_2012:673			BBB-	C	test
InChI=1S/C11H11Cl2N3O5S/c1-22(20,21)16(2-3-17)9-7(13)5(12)4-6-8(9)15-11(19)10(18)14-6/h4,17H,2-3H2,1H3,(H,14,18)(H,15,19)	Uk-240,455|Unii-9Qu5W0O2Dx	N-(6,7-dichloro-2,3-dioxo-1,4-dihydroquinoxalin-5-yl)-N-(2-hydroxyethyl)methanesulfonamide	CS(=O)(=O)N(CCO)c1c(Cl)c(Cl)cc2[nH]c(=O)c(=O)[nH]c12	9842188.0	R26_chico_2009:437	-2.15	A	BBB-	A	training
InChI=1S/C11H11Cl2NO3S/c1-14-10(15)4-5-18(16,17)11(14)7-2-3-8(12)9(13)6-7/h2-3,6,11H,4-5H2,1H3	Dichlormezanone	2-(3,4-dichlorophenyl)-3-methyl-1,1-dioxo-1,3-thiazinan-4-one	CN1C(=O)CCS(=O)(=O)C1c1ccc(Cl)c(Cl)c1	71209.0	R6_adenot_2004:1445			BBB+	C	training
InChI=1S/C11H11ClN4O2/c1-16-6-9(17)14-10(16)15-11(18)13-8-4-2-3-7(12)5-8/h2-5H,6H2,1H3,(H2,13,14,15,17,18)	Fenobam|3-(3-Chlorophenyl)-1-(1-Methyl-4-Oxo-5H-Imidazol-2-Yl)Urea	1-(3-chlorophenyl)-3-(1-methyl-4-oxoimidazolidin-2-ylidene)urea	CN1CC(=O)NC1=NC(=O)Nc1cccc(Cl)c1	135497698.0	R6_adenot_2004:1468			BBB+	C	training
InChI=1S/C11H11ClO3/c1-2-5-15-10-4-3-8(6-9(10)12)7-11(13)14/h2-4,6H,1,5,7H2,(H,13,14)	Alclofenac	2-(3-chloro-4-prop-2-enoxyphenyl)acetic acid	C=CCOc1ccc(CC(=O)O)cc1Cl	30951.0	R7_andres_2006:5|R14_ghose_2012:333|R29_subramanian_2003:4			BBB-	C	training
InChI=1S/C11H11F3N2O2/c12-11(13,14)7-2-1-3-8(4-7)18-9-5-16(6-9)10(15)17/h1-4,9H,5-6H2,(H2,15,17)	Dezinamide	3-[3-(trifluoromethyl)phenoxy]azetidine-1-carboxamide	NC(=O)N1CC(Oc2cccc(C(F)(F)F)c2)C1	146291.0	R6_adenot_2004:416			BBB+	C	training
InChI=1S/C11H11F3N2O3/c1-6(2)10(17)15-7-3-4-9(16(18)19)8(5-7)11(12,13)14/h3-6H,1-2H3,(H,15,17)	Flutamide	2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide	CC(C)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1	3397.0	R14_ghose_2012:572			BBB-	C	test
InChI=1S/C11H11FN2O/c1-8-10(12)11(15)14(13(8)2)9-6-4-3-5-7-9/h3-7H,1-2H3	4-Fluoro-1,5-Dimethyl-2-Phenyl-1,2-Dihydro-3H-Pyrazol-3-One	4-fluoro-1,5-dimethyl-2-phenylpyrazol-3-one	Cc1c(F)c(=O)n(-c2ccccc2)n1C	12718749.0	R41_toropov_2017:99|R46_mendoza_valencia_2017:87	-0.05	B	BBB+	A	test
InChI=1S/C11H11FN2O/c1-8-7-11(15)14(13(8)2)10-5-3-9(12)4-6-10/h3-7H,1-2H3	4-Fluoroantipyrine	2-(4-fluorophenyl)-1,5-dimethylpyrazol-3-one	Cc1cc(=O)n(-c2ccc(F)cc2)n1C	94957.0	R21_muehlbacher_2011:282|R47_radchenko_2020:86	-0.05	B	BBB+	A	test
InChI=1S/C11H11IN2O/c1-8-10(12)11(15)14(13(8)2)9-6-4-3-5-7-9/h3-7H,1-2H3	4-Iodoantipyrine Ok|Iodophenazone|4-Iodoantipyrine|Iodoantipyrine	4-iodo-1,5-dimethyl-2-phenylpyrazol-3-one	Cc1c(I)c(=O)n(-c2ccccc2)n1C	8522.0	R3_abraham_2006:107|R21_muehlbacher_2011:201|R25_brito_sanchez_2015:93|R40_vilar_2010:14|R41_toropov_2017:102|R46_mendoza_valencia_2017:91|R47_radchenko_2020:89	-0.1	B	BBB+	A	test
InChI=1S/C11H11N3O/c1-15-11-7-9(12)8-13-14(11)10-5-3-2-4-6-10/h2-8,12H,1H3/p+1	Amezinium	6-methoxy-1-phenylpyridazin-1-ium-4-amine	COc1cc(N)cn[n+]1-c1ccccc1	71927.0	R26_chico_2009:27	-1.0	A	BBB+	A	training
InChI=1S/C11H11N3O2S/c12-9-4-6-10(7-5-9)17(15,16)14-11-3-1-2-8-13-11/h1-8H,12H2,(H,13,14)	Sulfapyridine	4-amino-N-pyridin-2-ylbenzenesulfonamide	Nc1ccc(S(=O)(=O)Nc2ccccn2)cc1	5336.0	R14_ghose_2012:863			BBB-	C	training
InChI=1S/C11H11N5/c12-10-7-6-9(11(13)14-10)16-15-8-4-2-1-3-5-8/h1-7H,(H4,12,13,14)/b16-15+	Phenazopyridine	3-phenyldiazenylpyridine-2,6-diamine	Nc1ccc(/N=N/c2ccccc2)c(N)n1	4756.0	R14_ghose_2012:764|R23_gupta_2019:828|R28_li_2005:218|R51_doninger_2002:107			BBB-	C	training
InChI=1S/C11H11NO2/c1-12-10(13)7-9(11(12)14)8-5-3-2-4-6-8/h2-6,9H,7H2,1H3	Phensuximide	1-methyl-3-phenylpyrrolidine-2,5-dione	CN1C(=O)CC(c2ccccc2)C1=O	6839.0	R6_adenot_2004:461|R14_ghose_2012:198|R23_gupta_2019:308			BBB+	C	training
InChI=1S/C11H12BrNO/c1-2-13-11(14)7-6-9-4-3-5-10(12)8-9/h3-8H,2H2,1H3,(H,13,14)/b7-6+	Cinromide	(E)-3-(3-bromophenyl)-N-ethylprop-2-enamide	CCNC(=O)/C=C/c1cccc(Br)c1	688145.0	R6_adenot_2004:429			BBB+	C	test
InChI=1S/C11H12Cl2N2O/c1-7(11-14-5-6-15-11)16-10-8(12)3-2-4-9(10)13/h2-4,7H,5-6H2,1H3,(H,14,15)	Lofexidine	2-[1-(2,6-dichlorophenoxy)ethyl]-4,5-dihydro-1H-imidazole	CC(Oc1c(Cl)cccc1Cl)C1=NCCN1	30668.0	R14_ghose_2012:125|R23_gupta_2019:294|R37_chen_2011:46			BBB+	C	training
InChI=1S/C11H12ClF2N3/c1-6-10-7(12)3-2-4-8(10)17-11(16-6)15-5-9(13)14/h2-4,6,9H,5H2,1H3,(H2,15,16,17)	5-Chloro-N-(2,2-Difluoroethyl)-4-Methyl-1,4-Dihydroquinazolin-2-Amine	5-chloro-N-(2,2-difluoroethyl)-4-methyl-3,4-dihydro-1H-quinazolin-2-imine	CC1N/C(=N\CC(F)F)Nc2cccc(Cl)c21	135458393.0	R46_mendoza_valencia_2017:395	0.6	A	BBB+	A	training
InChI=1S/C11H12ClNO3S/c1-13-10(14)6-7-17(15,16)11(13)8-2-4-9(12)5-3-8/h2-5,11H,6-7H2,1H3	Chlormezanone	2-(4-chlorophenyl)-3-methyl-1,1-dioxo-1,3-thiazinan-4-one	CN1C(=O)CCS(=O)(=O)C1c1ccc(Cl)cc1	2717.0	R6_adenot_2004:1428|R14_ghose_2012:41|R23_gupta_2019:42			BBB+	C	training
InChI=1S/C11H12I3NO2/c1-2-5(11(16)17)3-6-7(12)4-8(13)10(15)9(6)14/h4-5H,2-3,15H2,1H3,(H,16,17)	Iopanoic Acid	2-[(3-amino-2,4,6-triiodophenyl)methyl]butanoic acid	CCC(Cc1c(I)cc(I)c(N)c1I)C(=O)O	3735.0	R14_ghose_2012:625|R23_gupta_2019:680			BBB-	C	test
InChI=1S/C11H12N2O/c1-9-8-11(14)13(12(9)2)10-6-4-3-5-7-10/h3-8H,1-2H3	Antipyrine Ok|Phenazone|Antipyrine	1,5-dimethyl-2-phenylpyrazol-3-one	Cc1cc(=O)n(-c2ccccc2)n1C	2206.0	R3_abraham_2006:126|R3_abraham_2006:127|R3_abraham_2006:225|R5_guerra_2008:17|R12_garg_2006:23|R17_fu_2008:33|R21_muehlbacher_2011:33|R25_brito_sanchez_2015:127|R26_chico_2009:34|R28_li_2005:8|R34_broccatelli_2012:6|R39_shayanfar_2011:17|R40_vilar_2010:38|R41_toropov_2017:120|R42_ciura_2020:4|R44_bujak_2015:12|R46_mendoza_valencia_2017:125|R47_radchenko_2020:107|R48_hou_2003:3|R49_norinder_2002:86|R49_norinder_2002:115|R51_doninger_2002:154	-0.11	B1	BBB+	A	test
InChI=1S/C11H12N2O2/c1-13(2)11-12-10(14)9(15-11)8-6-4-3-5-7-8/h3-7,9H,1-2H3	Tozalinone|Thozalinone	2-(dimethylamino)-5-phenyl-1,3-oxazol-4-one	CN(C)C1=NC(=O)C(c2ccccc2)O1	12602.0	R6_adenot_2004:627			BBB+	C	training
InChI=1S/C11H12N2O2/c1-2-12-11-13-10(14)9(15-11)8-6-4-3-5-7-8/h3-7,9H,2H2,1H3,(H,12,13,14)	Fenozolone	2-ethylimino-5-phenyl-1,3-oxazolidin-4-one	CC/N=C1/NC(=O)C(c2ccccc2)O1	135436543.0	R6_adenot_2004:1289			BBB+	C	training
InChI=1S/C11H12N2O2/c1-2-13-10(14)9(12-11(13)15)8-6-4-3-5-7-8/h3-7,9H,2H2,1H3,(H,12,15)	Ethotoin	3-ethyl-5-phenylimidazolidine-2,4-dione	CCN1C(=O)NC(c2ccccc2)C1=O	3292.0	R6_adenot_2004:1649|R14_ghose_2012:89|R23_gupta_2019:87			BBB+	C	test
InChI=1S/C11H12N2O2/c12-9(11(14)15)5-7-6-13-10-4-2-1-3-8(7)10/h1-4,6,9,13H,5,12H2,(H,14,15)/t9-/m0/s1	L-Tryptophan|Tryptophan	(2S)-2-amino-3-(1H-indol-3-yl)propanoic acid	N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O	6305.0	R6_adenot_2004:631			BBB+	C	training
InChI=1S/C11H12N2O2S/c1-7(13(15)11(12)14)10-6-8-4-2-3-5-9(8)16-10/h2-7,15H,1H3,(H2,12,14)	Zileuton	1-[1-(1-benzothiophen-2-yl)ethyl]-1-hydroxyurea	CC(c1cc2ccccc2s1)N(O)C(N)=O	60490.0	R23_gupta_2019:1039			BBB-	C	training
InChI=1S/C11H12N2O3/c12-9(11(15)16)3-6-5-13-10-2-1-7(14)4-8(6)10/h1-2,4-5,9,13-14H,3,12H2,(H,15,16)/t9-/m0/s1	Oxitriptan	(2S)-2-amino-3-(5-hydroxy-1H-indol-3-yl)propanoic acid	N[C@@H](Cc1c[nH]c2ccc(O)cc12)C(=O)O	439280.0	R6_adenot_2004:592			BBB+	C	training
InChI=1S/C11H12N2S/c1-2-4-9(5-3-1)10-8-13-6-7-14-11(13)12-10/h1-5,10H,6-8H2/t10-/m0/s1	Dexamisole	(6R)-6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b][1,3]thiazole	c1ccc([C@@H]2CN3CCSC3=N2)cc1	66374.0	R6_adenot_2004:525			BBB+	C	training
InChI=1S/C11H12N2S/c1-2-4-9(5-3-1)10-8-13-6-7-14-11(13)12-10/h1-5,10H,6-8H2/t10-/m1/s1	Levamisole Hydrochloride|Levamisole	(6S)-6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b][1,3]thiazole	c1ccc([C@H]2CN3CCSC3=N2)cc1	26879.0	R14_ghose_2012:651|R23_gupta_2019:707			BBB-	C	training
InChI=1S/C11H12N2S/c12-7-6-11-13-10(8-14-11)9-4-2-1-3-5-9/h1-5,8H,6-7,12H2	61887-92-1|Y-G19|Zinc 04226975|Yg19|5-62|2-(4-Phenyl-1,3-Thiazol-2-Yl)Ethanamine	2-(4-phenyl-1,3-thiazol-2-yl)ethanamine	NCCc1nc(-c2ccccc2)cs1	1497794.0	R4_mente_2005:111|R12_garg_2006:178|R21_muehlbacher_2011:326|R25_brito_sanchez_2015:36|R28_li_2005:127|R28_li_2005:143|R46_mendoza_valencia_2017:35|R48_hou_2003:24|R48_hou_2003:56|R49_norinder_2002:81|R52_liu_2001:61			BBB-	C	training
InChI=1S/C11H12N4O2S/c1-8-6-7-13-11(14-8)15-18(16,17)10-4-2-9(12)3-5-10/h2-7H,12H2,1H3,(H,13,14,15)	Sulfamerazine	4-amino-N-(4-methylpyrimidin-2-yl)benzenesulfonamide	Cc1ccnc(NS(=O)(=O)c2ccc(N)cc2)n1	5325.0	R23_gupta_2019:933			BBB-	C	test
InChI=1S/C11H12N4O3S/c1-18-11-10(13-6-7-14-11)15-19(16,17)9-4-2-8(12)3-5-9/h2-7H,12H2,1H3,(H,13,15)	Sulfametopyrazine|Sulfalene	4-amino-N-(3-methoxypyrazin-2-yl)benzenesulfonamide	COc1nccnc1NS(=O)(=O)c1ccc(N)cc1	9047.0	R23_gupta_2019:937			BBB-	C	training
InChI=1S/C11H12N4O3S/c1-18-11-7-6-10(13-14-11)15-19(16,17)9-4-2-8(12)3-5-9/h2-7H,12H2,1H3,(H,13,15)	Sulfamethoxypyridazine	4-amino-N-(6-methoxypyridazin-3-yl)benzenesulfonamide	COc1ccc(NS(=O)(=O)c2ccc(N)cc2)nn1	5330.0	R26_chico_2009:392	-0.85	A	BBB+	A	test
InChI=1S/C11H12N4O3S/c1-18-9-6-13-11(14-7-9)15-19(16,17)10-4-2-8(12)3-5-10/h2-7H,12H2,1H3,(H,13,14,15)	Sulfameter	4-amino-N-(5-methoxypyrimidin-2-yl)benzenesulfonamide	COc1cnc(NS(=O)(=O)c2ccc(N)cc2)nc1	5326.0	R14_ghose_2012:859|R23_gupta_2019:934			BBB-	C	test
InChI=1S/C11H13BrN2O/c12-11-8-4-7(5-13-11)6-14-9(8)2-1-3-10(14)15/h1-3,7-8,11,13H,4-6H2		12-bromo-7,11-diazatricyclo[7.3.1.02,7]trideca-2,4-dien-6-one	O=c1cccc2n1CC1CNC(Br)C2C1	75107290.0	R46_mendoza_valencia_2017:351	-0.05	A	BBB+	A	training
InChI=1S/C11H13BrN2O/c12-11-8-4-7(5-13-11)6-14-9(8)2-1-3-10(14)15/h1-3,7-8,11,13H,4-6H2/t7-,8-,11?/m1/s1	3-Bromocytisine	(1R,9R)-12-bromo-7,11-diazatricyclo[7.3.1.02,7]trideca-2,4-dien-6-one	O=c1cccc2n1C[C@H]1CNC(Br)[C@@H]2C1	45268400.0	R21_muehlbacher_2011:362	-0.05	A	BBB+	A	training
InChI=1S/C11H13BrN2O/c12-9-1-2-10-8-3-7(4-13-5-8)6-14(10)11(9)15/h1-2,7-8,13H,3-6H2	207390-15-6|Bromocytisine|3-Br-Cytisine	5-bromo-7,11-diazatricyclo[7.3.1.02,7]trideca-2,4-dien-6-one	O=c1c(Br)ccc2n1CC1CNCC2C1	9807561.0	R4_mente_2005:173|R40_vilar_2010:60|R47_radchenko_2020:463	-0.05	B	BBB+	A	training
InChI=1S/C11H13BrN2O5/c12-2-1-6-4-14(11(18)13-10(6)17)9-3-7(16)8(5-15)19-9/h1-2,4,7-9,15-16H,3,5H2,(H,13,17,18)/b2-1+/t7-,8+,9+/m0/s1	Brivudine	5-[(E)-2-bromoethenyl]-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione	O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1/C=C/Br	446727.0	R14_ghose_2012:403			BBB-	C	training
InChI=1S/C11H13BrN2O6/c12-2-1-5-3-14(11(19)13-9(5)18)10-8(17)7(16)6(4-15)20-10/h1-3,6-8,10,15-17H,4H2,(H,13,18,19)/b2-1+/t6-,7-,8+,10-/m1/s1	Sorivudine	5-[(E)-2-bromoethenyl]-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione	O=c1[nH]c(=O)n([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O)cc1/C=C/Br	5282192.0	R14_ghose_2012:847			BBB-	C	training
InChI=1S/C11H13ClF3N3O4S3/c1-18-10(4-23-5-11(13,14)15)17-7-2-6(12)8(24(16,19)20)3-9(7)25(18,21)22/h2-3,10,17H,4-5H2,1H3,(H2,16,19,20)	Polythiazide	6-chloro-2-methyl-1,1-dioxo-3-(2,2,2-trifluoroethylsulfanylmethyl)-3,4-dihydro-1lambda6,2,4-benzothiadiazine-7-sulfonamide	CN1C(CSCC(F)(F)F)Nc2cc(Cl)c(S(N)(=O)=O)cc2S1(=O)=O	4870.0	R14_ghose_2012:786|R23_gupta_2019:849			BBB-	C	test
InChI=1S/C11H13F2N/c12-7-10(8-14)2-1-9-3-5-11(13)6-4-9/h3-7H,1-2,8,14H2/b10-7+	Mofegiline	(2E)-2-(fluoromethylidene)-4-(4-fluorophenyl)butan-1-amine	NC/C(=C/F)CCc1ccc(F)cc1	6437850.0	R6_adenot_2004:973			BBB+	C	training
InChI=1S/C11H13N/c1-3-9-12(2)10-11-7-5-4-6-8-11/h1,4-8H,9-10H2,2H3	Pargyline	N-benzyl-N-methylprop-2-yn-1-amine	C#CCN(C)Cc1ccccc1	4688.0	R6_adenot_2004:989			BBB+	C	training
InChI=1S/C11H13N3/c1-2-4-9(5-3-1)10-8-13-11-12-6-7-14(10)11/h1-5,10H,6-8H2,(H,12,13)	Deximafen|Imafen	5-phenyl-2,3,5,6-tetrahydro-1H-imidazo[1,2-a]imidazole	c1ccc(C2CN=C3NCCN32)cc1	163316.0	R6_adenot_2004:526|R6_adenot_2004:559			BBB+	C	training
InChI=1S/C11H13N3O3S/c1-7-8(2)17-11(13-7)14-18(15,16)10-5-3-9(12)4-6-10/h3-6H,12H2,1-2H3,(H,13,14)	Sulfamoxole	4-amino-N-(4,5-dimethyl-1,3-oxazol-2-yl)benzenesulfonamide	Cc1nc(NS(=O)(=O)c2ccc(N)cc2)oc1C	12894.0	R23_gupta_2019:938			BBB-	C	training
InChI=1S/C11H13N5O5/c12-15-13-5-10(18)14-9(6-17)11(19)7-1-3-8(4-2-7)16(20)21/h1-4,9,11,17,19H,5-6H2,(H,14,18)/t9-,11-/m1/s1	Azidamfenicol	2-azido-N-[(1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl]acetamide	[N-]=[N+]=NCC(=O)N[C@H](CO)[C@H](O)c1ccc([N+](=O)[O-])cc1	62858.0	R6_adenot_2004:652			BBB+	C	training
InChI=1S/C11H13NO2/c1-8-11(14-7-10(13)12-8)9-5-3-2-4-6-9/h2-6,8,11H,7H2,1H3,(H,12,13)	Fenmetramide	5-methyl-6-phenylmorpholin-3-one	CC1NC(=O)COC1c1ccccc1	21789.0	R6_adenot_2004:543			BBB+	C	training
InChI=1S/C11H13NO2S/c15-11-12-7-6-10(14-11)8-13-9-4-2-1-3-5-9/h1-5,10H,6-8H2,(H,12,15)	Tifemoxone	6-(phenoxymethyl)-1,3-oxazinane-2-thione	S=C1NCCC(COc2ccccc2)O1	3033964.0	R6_adenot_2004:619			BBB+	C	test
InChI=1S/C11H13NO3/c1-8-3-2-4-9(5-8)12-6-10(7-13)15-11(12)14/h2-5,10,13H,6-7H2,1H3	Toloxatone	5-(hydroxymethyl)-3-(3-methylphenyl)-1,3-oxazolidin-2-one	Cc1cccc(N2CC(CO)OC2=O)c1	34521.0	R6_adenot_2004:984|R14_ghose_2012:253|R23_gupta_2019:246			BBB+	C	training
InChI=1S/C11H13NO4/c1-12-11(14)16-10-8-6-3-2-5(4-6)7(8)9(13)15-10/h2-3,5-8,10H,4H2,1H3,(H,12,14)/t5-,6+,7+,8-,10+/m1/s1	Moxadolen	[(1R,2R,3S,6S,7S)-5-oxo-4-oxatricyclo[5.2.1.02,6]dec-8-en-3-yl] N-methylcarbamate	CNC(=O)O[C@@H]1OC(=O)[C@@H]2[C@H]1[C@H]1C=C[C@@H]2C1	71995.0	R6_adenot_2004:1491			BBB+	C	training
InChI=1S/C11H13NO4/c1-14-9-4-2-3-5-10(9)15-7-8-6-12-11(13)16-8/h2-5,8H,6-7H2,1H3,(H,12,13)	Mephenoxalone	5-[(2-methoxyphenoxy)methyl]-1,3-oxazolidin-2-one	COc1ccccc1OCC1CNC(=O)O1	6257.0	R6_adenot_2004:1483			BBB+	C	training
InChI=1S/C11H14BrN3/c1-7-5-9(12)6-8(2)10(7)15-11-13-3-4-14-11/h5-6H,3-4H2,1-2H3,(H2,13,14,15)	65936-23-4|Tz-28|(4-Bromo-2,6-Dimethyl-Phenyl)-Imidazolidin-2-Ylidene-Amine	N-(4-bromo-2,6-dimethylphenyl)-4,5-dihydro-1H-imidazol-2-amine	Cc1cc(Br)cc(C)c1NC1=NCCN1	12406830.0	R4_mente_2005:13|R40_vilar_2010:293|R47_radchenko_2020:469	-0.28	B	BBB+	A	training
InChI=1S/C11H14ClNO/c12-8-6-11(14)13-9-7-10-4-2-1-3-5-10/h1-5H,6-9H2,(H,13,14)	Fenaclon	3-chloro-N-(2-phenylethyl)propanamide	O=C(CCCl)NCCc1ccccc1	9376.0	R6_adenot_2004:441			BBB+	C	training
InChI=1S/C11H14N2O/c14-11-3-1-2-10-9-4-8(5-12-6-9)7-13(10)11/h1-3,8-9,12H,4-7H2	Citizin	7,11-diazatricyclo[7.3.1.02,7]trideca-2,4-dien-6-one	O=c1cccc2n1CC1CNCC2C1	22407.0	R46_mendoza_valencia_2017:184	-1.09	A	BBB-	A	training
InChI=1S/C11H14N2O/c14-11-3-1-2-10-9-4-8(5-12-6-9)7-13(10)11/h1-3,8-9,12H,4-7H2/t8-,9+/m0/s1	485-35-8|Cytisine	(1R,9S)-7,11-diazatricyclo[7.3.1.02,7]trideca-2,4-dien-6-one	O=c1cccc2n1C[C@@H]1CNC[C@H]2C1	10235.0	R4_mente_2005:175|R21_muehlbacher_2011:228|R25_brito_sanchez_2015:198|R40_vilar_2010:89|R47_radchenko_2020:358	-1.09	B	BBB-	A	training
InChI=1S/C11H14N2O2/c1-2-13-11(15)9(10(12)14)8-6-4-3-5-7-8/h3-7,9H,2H2,1H3,(H2,12,14)(H,13,15)	Ethyl-2-Phenylmalonamide|N'-Ethyl-2-Phenylpropanediamide	N'-ethyl-2-phenylpropanediamide	CCNC(=O)C(C(N)=O)c1ccccc1	118753220.0	R25_brito_sanchez_2015:374|R46_mendoza_valencia_2017:327	-0.19	B	BBB+	A	test
InChI=1S/C11H14N2O2/c1-2-9(10(14)13-11(12)15)8-6-4-3-5-7-8/h3-7,9H,2H2,1H3,(H3,12,13,14,15)	Pheneturide	N-carbamoyl-2-phenylbutanamide	CCC(C(=O)NC(N)=O)c1ccccc1	72060.0	R6_adenot_2004:460			BBB+	C	test
InChI=1S/C11H14N2O4/c12-10(14)16-6-9(7-17-11(13)15)8-4-2-1-3-5-8/h1-5,9H,6-7H2,(H2,12,14)(H2,13,15)	Felbamate	(3-carbamoyloxy-2-phenylpropyl) carbamate	NC(=O)OCC(COC(N)=O)c1ccccc1	3331.0	R6_adenot_2004:1651|R7_andres_2006:61|R14_ghose_2012:90|R23_gupta_2019:90|R26_chico_2009:185|R29_subramanian_2003:58|R37_chen_2011:35	-0.19	A	BBB+	A	test
InChI=1S/C11H14N2S/c1-13-8-3-7-12-11(13)6-5-10-4-2-9-14-10/h2,4-6,9H,3,7-8H2,1H3/b6-5+	Pyrantel	1-methyl-2-[(E)-2-thiophen-2-ylethenyl]-5,6-dihydro-4H-pyrimidine	CN1CCCN=C1/C=C/c1cccs1	708857.0	R14_ghose_2012:805			BBB-	C	training
InChI=1S/C11H14N4O4/c1-13-9-8(10(16)14(2)11(13)17)15(6-12-9)5-7-18-3-4-19-7/h6-7H,3-5H2,1-2H3	Doxofylline	7-(1,3-dioxolan-2-ylmethyl)-1,3-dimethylpurine-2,6-dione	Cn1c(=O)c2c(ncn2CC2OCCO2)n(C)c1=O	50942.0	R14_ghose_2012:512			BBB-	C	training
InChI=1S/C11H15BrN2O/c1-14(2)11(15)7-8-13-10-5-3-9(12)4-6-10/h3-6,13H,7-8H2,1-2H3	Bromamid|Bromamide	3-(4-bromoanilino)-N,N-dimethylpropanamide	CN(C)C(=O)CCNc1ccc(Br)cc1	68839.0	R6_adenot_2004:1345			BBB+	C	training
InChI=1S/C11H15ClN2O2/c1-8(2)13-14-11(15)7-16-10-5-3-9(12)4-6-10/h3-6,8,13H,7H2,1-2H3,(H,14,15)	Iproclozide	2-(4-chlorophenoxy)-N'-propan-2-ylacetohydrazide	CC(C)NNC(=O)COc1ccc(Cl)cc1	19063.0	R6_adenot_2004:969			BBB+	C	training
InChI=1S/C11H15ClO2/c1-10(2,13)11(3,14)8-4-6-9(12)7-5-8/h4-7,13-14H,1-3H3	Phenaglycodol	2-(4-chlorophenyl)-3-methylbutane-2,3-diol	CC(C)(O)C(C)(O)c1ccc(Cl)cc1	6617.0	R6_adenot_2004:1501			BBB+	C	training
InChI=1S/C11H15ClO2/c1-10(2,13)11(3,14)8-5-4-6-9(12)7-8/h4-7,13-14H,1-3H3	Metaglycodol	2-(3-chlorophenyl)-3-methylbutane-2,3-diol	CC(C)(O)C(C)(O)c1cccc(Cl)c1	26369.0	R6_adenot_2004:1485			BBB+	C	training
InChI=1S/C11H15I3N2O4/c1-3(17)15-9-6(12)5(11(19)20)7(13)10(8(9)14)16-4(2)18/h5-10H,1-2H3,(H,15,17)(H,16,18)(H,19,20)	Sodiumamidotrizoate|3,5-Diacetamido-2,4,6-Triiodocyclohexane-1-Carboxylic Acid	3,5-diacetamido-2,4,6-triiodocyclohexane-1-carboxylic acid	CC(=O)NC1C(I)C(NC(C)=O)C(I)C(C(=O)O)C1I	44228116.0	R28_li_2005:285			BBB-	C	training
InChI=1S/C11H15N/c1-2-6-11(12)9-10-7-4-3-5-8-10/h2-5,7-8,11H,1,6,9,12H2	Alfetamine|Aletamine	1-phenylpent-4-en-2-amine	C=CCC(N)Cc1ccccc1	20254.0	R6_adenot_2004:369			BBB+	C	test
InChI=1S/C11H15N/c12-11-8-4-7-10(11)9-5-2-1-3-6-9/h1-3,5-6,10-11H,4,7-8,12H2	Cypenamine	2-phenylcyclopentan-1-amine	NC1CCCC1c1ccccc1	21786.0	R6_adenot_2004:517			BBB+	C	training
InChI=1S/C11H15N3/c1-8-3-4-10(9(2)7-8)14-11-12-5-6-13-11/h3-4,7H,5-6H2,1-2H3,(H2,12,13,14)	4794-83-6|Tz-14|N-(2,4-Dimethylphenyl)-4,5-Dihydro-1H-Imidazol-2-Amine	N-(2,4-dimethylphenyl)-4,5-dihydro-1H-imidazol-2-amine	Cc1ccc(NC2=NCCN2)c(C)c1	12296938.0	R4_mente_2005:6|R25_brito_sanchez_2015:562|R40_vilar_2010:286|R46_mendoza_valencia_2017:469|R47_radchenko_2020:484	-1.3	B	BBB-	A	training
InChI=1S/C11H15N5O5/c1-20-9-5-8(14-11(12)15-9)16(3-13-5)10-7(19)6(18)4(2-17)21-10/h3-4,6-7,10,17-19H,2H2,1H3,(H2,12,14,15)/t4-,6-,7+,10-/m1/s1	Nelarabine	(2R,3S,4S,5R)-2-(2-amino-6-methoxypurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol	COc1nc(N)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O	3011155.0	R23_gupta_2019:773			BBB-	C	training
InChI=1S/C11H15NO/c1-11(2,3)12(13)9-10-7-5-4-6-8-10/h4-9H,1-3H3/b12-9+	Cid 10313352|Phenyl-N-Tert-Butylnitrone, (E)-	N-tert-butyl-1-phenylmethanimine oxide	CC(C)(C)/[N+]([O-])=C\c1ccccc1	10313352.0	R21_muehlbacher_2011:336|R25_brito_sanchez_2015:356|R41_toropov_2017:206|R46_mendoza_valencia_2017:311	0.05	B	BBB+	A	training
InChI=1S/C11H15NO/c1-11(2,3)12(13)9-10-7-5-4-6-8-10/h4-9H,1-3H3/b12-9-	Phenyl-N-Tert-Butylnitrone|N-Tert-Butyl-Alpha-Phenylnitrone	N-tert-butyl-1-phenylmethanimine oxide	CC(C)(C)/[N+]([O-])=C/c1ccccc1	638877.0	R3_abraham_2006:228|R40_vilar_2010:209|R47_radchenko_2020:191	0.05	B	BBB+	A	training
InChI=1S/C11H15NO/c1-9(12(2)3)11(13)10-7-5-4-6-8-10/h4-9H,1-3H3	Metamfepramone	2-(dimethylamino)-1-phenylpropan-1-one	CC(C(=O)c1ccccc1)N(C)C	71872.0	R6_adenot_2004:380			BBB+	C	training
InChI=1S/C11H15NO/c1-9-11(13-8-7-12-9)10-5-3-2-4-6-10/h2-6,9,11-12H,7-8H2,1H3	Phenmetrazine	3-methyl-2-phenylmorpholine	CC1NCCOC1c1ccccc1	4762.0	R6_adenot_2004:1304|R14_ghose_2012:280|R23_gupta_2019:196			BBB+	C	training
InChI=1S/C11H15NO2/c1-2-11(14,8-10(12)13)9-6-4-3-5-7-9/h3-7,14H,2,8H2,1H3,(H2,12,13)	Beta-Ethyl-Beta-Hydroxybenzenepropanamide|3-Hydroxy-3-Phenylpentamide|3-Hydroxy-3-Phenylpentanamide	3-hydroxy-3-phenylpentanamide	CCC(O)(CC(N)=O)c1ccccc1	64814.0	R3_abraham_2006:177|R21_muehlbacher_2011:263|R25_brito_sanchez_2015:247|R40_vilar_2010:122|R41_toropov_2017:164|R46_mendoza_valencia_2017:222|R47_radchenko_2020:150	0.04	B	BBB+	A	test
InChI=1S/C11H15NO2/c1-2-3-8-14-11(13)9-4-6-10(12)7-5-9/h4-7H,2-3,8,12H2,1H3	Butyl 4-Aminobenzoate|Butamben	butyl 4-aminobenzoate	CCCCOC(=O)c1ccc(N)cc1	2482.0	R3_abraham_2006:139|R21_muehlbacher_2011:45|R25_brito_sanchez_2015:175|R40_vilar_2010:67|R41_toropov_2017:132|R46_mendoza_valencia_2017:165|R47_radchenko_2020:118	0.42	B	BBB+	A	training
InChI=1S/C11H15NO2/c1-8(12-2)11(13)9-4-6-10(14-3)7-5-9/h4-8,12H,1-3H3	Methoxyphedrine	1-(4-methoxyphenyl)-2-(methylamino)propan-1-one	CNC(C)C(=O)c1ccc(OC)cc1	216281.0	R6_adenot_2004:94			BBB-	C	training
InChI=1S/C11H15NO3/c1-2-11(14,8-15-10(12)13)9-6-4-3-5-7-9/h3-7,14H,2,8H2,1H3,(H2,12,13)	Oxyfenamate|Hydroxyphenamate	(2-hydroxy-2-phenylbutyl) carbamate	CCC(O)(COC(N)=O)c1ccccc1	5752.0	R6_adenot_2004:1498|R51_doninger_2002:229			BBB+	C	test
InChI=1S/C11H15NO5/c1-15-9-4-2-3-5-10(9)16-6-8(13)7-17-11(12)14/h2-5,8,13H,6-7H2,1H3,(H2,12,14)	Methocarbamol	[2-hydroxy-3-(2-methoxyphenoxy)propyl] carbamate	COc1ccccc1OCC(O)COC(N)=O	4107.0	R14_ghose_2012:146|R23_gupta_2019:145|R51_doninger_2002:250			BBB+	C	training
InChI=1S/C11H16ClN3O4S2/c1-6(2)3-11-14-8-4-7(12)9(20(13,16)17)5-10(8)21(18,19)15-11/h4-6,11,14-15H,3H2,1-2H3,(H2,13,16,17)	Butizide|Buthiazide	6-chloro-3-(2-methylpropyl)-1,1-dioxo-3,4-dihydro-2H-1lambda6,2,4-benzothiadiazine-7-sulfonamide	CC(C)CC1Nc2cc(Cl)c(S(N)(=O)=O)cc2S(=O)(=O)N1	16274.0	R14_ghose_2012:411			BBB-	C	test
InChI=1S/C11H16ClN5/c1-7(2)15-10(13)17-11(14)16-9-5-3-8(12)4-6-9/h3-7H,1-2H3,(H5,13,14,15,16,17)	Proguanil|(1E)-1-[Amino-(4-Chloroanilino)Methylidene]-2-Propan-2-Ylguanidine	1-[amino-(4-chloroanilino)methylidene]-2-propan-2-ylguanidine	CC(C)/N=C(\N)N=C(N)Nc1ccc(Cl)cc1	4923.0	R23_gupta_2019:864			BBB-	C	training
InChI=1S/C11H16N2O/c1-7-5-4-6-8(2)10(7)13-11(14)9(3)12/h4-6,9H,12H2,1-3H3,(H,13,14)	Tocainide|Tocainide Hydrochloride	2-amino-N-(2,6-dimethylphenyl)propanamide	Cc1cccc(C)c1NC(=O)C(C)N	38945.0	R7_andres_2006:174|R14_ghose_2012:901|R29_subramanian_2003:169			BBB-	C	training
InChI=1S/C11H16N2O2/c1-3-10-8(6-15-11(10)14)4-9-5-12-7-13(9)2/h5,7-8,10H,3-4,6H2,1-2H3/t8-,10-/m0/s1	Pilocarpine	(3S,4R)-3-ethyl-4-[(3-methylimidazol-4-yl)methyl]oxolan-2-one	CC[C@@H]1C(=O)OC[C@@H]1Cc1cncn1C	5910.0	R23_gupta_2019:836			BBB-	C	training
InChI=1S/C11H16N2O2/c1-3-15-11(14)13-12-9(2)10-7-5-4-6-8-10/h4-9,12H,3H2,1-2H3,(H,13,14)	Carbenzide	ethyl N-(1-phenylethylamino)carbamate	CCOC(=O)NNC(C)c1ccccc1	18608.0	R6_adenot_2004:502			BBB+	C	training
InChI=1S/C11H16N2O2/c1-8-6-11(7-14)9(2)13(8)5-4-12-10(3)15/h6-7H,4-5H2,1-3H3,(H,12,15)	Aloracetam	N-[2-(3-formyl-2,5-dimethylpyrrol-1-yl)ethyl]acetamide	CC(=O)NCCn1c(C)cc(C=O)c1C	178134.0	R6_adenot_2004:1241			BBB+	C	training
InChI=1S/C11H16N2O3/c1-4-5-11(6-7(2)3)8(14)12-10(16)13-9(11)15/h4,7H,1,5-6H2,2-3H3,(H2,12,13,14,15,16)	Butalbital	5-(2-methylpropyl)-5-prop-2-enyl-1,3-diazinane-2,4,6-trione	C=CCC1(CC(C)C)C(=O)NC(=O)NC1=O	2481.0	R6_adenot_2004:1642|R14_ghose_2012:29|R23_gupta_2019:32			BBB+	C	test
InChI=1S/C11H16N2O3/c1-4-6-11(7(3)5-2)8(14)12-10(16)13-9(11)15/h4,7H,1,5-6H2,2-3H3,(H2,12,13,14,15,16)	Talbutal	5-butan-2-yl-5-prop-2-enyl-1,3-diazinane-2,4,6-trione	C=CCC1(C(C)CC)C(=O)NC(=O)NC1=O	8275.0	R6_adenot_2004:1676			BBB+	C	test
InChI=1S/C11H16N2O3/c1-4-6-7(3)11(5-2)8(14)12-10(16)13-9(11)15/h5,7H,2,4,6H2,1,3H3,(H2,12,13,14,15,16)	Vinylbital	5-ethenyl-5-pentan-2-yl-1,3-diazinane-2,4,6-trione	C=CC1(C(C)CCC)C(=O)NC(=O)NC1=O	72135.0	R6_adenot_2004:1672			BBB+	C	test
InChI=1S/C11H16N2O3/c1-4-6-7(3)11(5-2)8(14)12-10(16)13-9(11)15/h6H,4-5H2,1-3H3,(H2,12,13,14,15,16)/b7-6+	Vinbarbital	5-ethyl-5-[(E)-pent-2-en-2-yl]-1,3-diazinane-2,4,6-trione	CC/C=C(\C)C1(CC)C(=O)NC(=O)NC1=O	5284636.0	R6_adenot_2004:1671			BBB+	C	test
InChI=1S/C11H16N2S/c1-2-3-9-12-11(14)13-10-7-5-4-6-8-10/h4-8H,2-3,9H2,1H3,(H2,12,13,14)	1-Butyl-3-Phenylthiourea	1-butyl-3-phenylthiourea	CCCCNC(=S)Nc1ccccc1	3034183.0	R25_brito_sanchez_2015:489|R46_mendoza_valencia_2017:410	0.03	B	BBB+	A	training
InChI=1S/C11H16N4O/c1-7-5-4-6-8(2)9(7)14-11(16)15-10(12)13-3/h4-6H,1-3H3,(H4,12,13,14,15,16)	Lidamidine Hydrochloride|Lidamidine	1-(2,6-dimethylphenyl)-3-(N'-methylcarbamimidoyl)urea	C/N=C(\N)NC(=O)Nc1c(C)cccc1C	47510.0	R23_gupta_2019:1070			BBB-	C	training
InChI=1S/C11H16N4O4/c1-7(15-5-10(18)13-11(19)6-15)2-14-3-8(16)12-9(17)4-14/h7H,2-6H2,1H3,(H,12,16,17)(H,13,18,19)/t7-/m0/s1	Dexrazoxane	4-[(2S)-2-(3,5-dioxopiperazin-1-yl)propyl]piperazine-2,6-dione	C[C@@H](CN1CC(=O)NC(=O)C1)N1CC(=O)NC(=O)C1	71384.0	R14_ghose_2012:487|R23_gupta_2019:512|R28_li_2005:190			BBB-	C	training
InChI=1S/C11H17BrN/c1-4-13(2,3)9-10-7-5-6-8-11(10)12/h5-8H,4,9H2,1-3H3/q+1	Bretyliumtosilate|Bretylium	(2-bromophenyl)methyl-ethyl-dimethylazanium	CC[N+](C)(C)Cc1ccccc1Br	2431.0	R28_li_2005:237			BBB-	C	training
InChI=1S/C11H17N/c1-10(12(2)3)9-11-7-5-4-6-8-11/h4-8,10H,9H2,1-3H3/t10-/m0/s1	Dimethamphetamine|Dimetamfetamine	(2S)-N,N-dimethyl-1-phenylpropan-2-amine	C[C@@H](Cc1ccccc1)N(C)C	65682.0	R6_adenot_2004:373			BBB+	C	training
InChI=1S/C11H17N3O5/c1-2-3-4-11(5-6-19-9(12)17)7(15)13-10(18)14-8(11)16/h2-6H2,1H3,(H2,12,17)(H2,13,14,15,16,18)	Carbubarb	2-(5-butyl-2,4,6-trioxo-1,3-diazinan-5-yl)ethyl carbamate	CCCCC1(CCOC(N)=O)C(=O)NC(=O)NC1=O	13743.0	R6_adenot_2004:1675			BBB+	C	test
InChI=1S/C11H17N5O2/c1-13(2)5-6-16-7-12-9-8(16)10(17)15(4)11(18)14(9)3/h7H,5-6H2,1-4H3	Dimethazan	7-[2-(dimethylamino)ethyl]-1,3-dimethylpurine-2,6-dione	CN(C)CCn1cnc2c1c(=O)n(C)c(=O)n2C	10612.0	R6_adenot_2004:1313			BBB+	C	training
InChI=1S/C11H17NO/c1-8-5-4-6-9(2)11(8)13-7-10(3)12/h4-6,10H,7,12H2,1-3H3	Mexiletine	1-(2,6-dimethylphenoxy)propan-2-amine	Cc1cccc(C)c1OCC(C)N	4178.0	R6_adenot_2004:482|R7_andres_2006:104|R29_subramanian_2003:99|R34_broccatelli_2012:52			BBB+	C	training
InChI=1S/C11H17NO2/c1-3-4-5-7-12-8-6-10(13)11(14)9(12)2/h6,8,14H,3-5,7H2,1-2H3	Cp25|Cp29|4(1H)-Pyridinone, 3-Hydroxy-2-Methyl-1-Pentyl-	3-hydroxy-2-methyl-1-pentylpyridin-4-one	CCCCCn1ccc(=O)c(O)c1C	121734.0	R28_li_2005:344|R28_li_2005:345			BBB+	C	training
InChI=1S/C11H17NO3/c1-13-9-6-8(4-5-12)7-10(14-2)11(9)15-3/h6-7H,4-5,12H2,1-3H3	Mescaline	2-(3,4,5-trimethoxyphenyl)ethanamine	COc1cc(CCN)cc(OC)c1OC	4076.0	R51_doninger_2002:246			BBB+	C	training
InChI=1S/C11H17NO3/c1-2-9-11(15)10(14)5-7-12(9)6-3-4-8-13/h5,7,13,15H,2-4,6,8H2,1H3	Cp107|4(1H)-Pyridinone, 2-Ethyl-3-Hydroxy-1-(4-Hydroxybutyl)-	2-ethyl-3-hydroxy-1-(4-hydroxybutyl)pyridin-4-one	CCc1c(O)c(=O)ccn1CCCCO	10330791.0	R28_li_2005:340			BBB-	C	training
InChI=1S/C11H17NO3/c1-7(12)11(13)9-6-8(14-2)4-5-10(9)15-3/h4-7,11,13H,12H2,1-3H3	Methoxamine	2-amino-1-(2,5-dimethoxyphenyl)propan-1-ol	COc1ccc(OC)c(C(O)C(C)N)c1	6082.0	R23_gupta_2019:738			BBB-	C	training
InChI=1S/C11H17NO3/c1-7(2)12-6-11(15)8-3-4-9(13)10(14)5-8/h3-5,7,11-15H,6H2,1-2H3	Isoproterenol Hydrochloride|Isoproterenol	4-[1-hydroxy-2-(propan-2-ylamino)ethyl]benzene-1,2-diol	CC(C)NCC(O)c1ccc(O)c(O)c1	3779.0	R14_ghose_2012:631|R51_doninger_2002:73			BBB-	C	training
InChI=1S/C11H17NO3/c1-7(2)12-6-11(15)8-3-9(13)5-10(14)4-8/h3-5,7,11-15H,6H2,1-2H3	Metaproterenol|Orciprenaline	5-[1-hydroxy-2-(propan-2-ylamino)ethyl]benzene-1,3-diol	CC(C)NCC(O)c1cc(O)cc(O)c1	4086.0	R14_ghose_2012:681|R23_gupta_2019:796			BBB-	C	training
InChI=1S/C11H18ClN5S/c1-13-11-14-9(12)8(18-3)10(15-11)17-6-4-16(2)5-7-17/h4-7H2,1-3H3,(H,13,14,15)	Mezilamine	4-chloro-N-methyl-6-(4-methylpiperazin-1-yl)-5-methylsulfanylpyrimidin-2-amine	CNc1nc(Cl)c(SC)c(N2CCN(C)CC2)n1	68678.0	R6_adenot_2004:1181			BBB+	C	training
InChI=1S/C11H18FN3O2/c12-7-5-3-1-2-4-6-9-14-10-8-13-11(14)15(16)17/h8,10H,1-7,9H2	1-(8-Fluorooctyl)-2-Nitroimidazole|Moli001285	1-(8-fluorooctyl)-2-nitroimidazole	O=[N+]([O-])c1nccn1CCCCCCCCF	10377120.0	R3_abraham_2006:99|R21_muehlbacher_2011:338|R25_brito_sanchez_2015:39|R40_vilar_2010:2|R41_toropov_2017:94|R46_mendoza_valencia_2017:38|R47_radchenko_2020:81	-0.17	B	BBB+	A	training
InChI=1S/C11H18N2O2S/c1-4-6-7(3)11(5-2)8(14)12-10(16)13-9(11)15/h7H,4-6H2,1-3H3,(H2,12,13,14,15,16)	Thiopental|76-75-5	5-ethyl-5-pentan-2-yl-2-sulfanylidene-1,3-diazinane-4,6-dione	CCCC(C)C1(CC)C(=O)NC(=S)NC1=O	3000715.0	R3_abraham_2006:283|R3_abraham_2006:284|R4_mente_2005:46|R5_guerra_2008:98|R7_andres_2006:170|R12_garg_2006:162|R21_muehlbacher_2011:315|R25_brito_sanchez_2015:141|R26_chico_2009:413|R28_li_2005:118|R29_subramanian_2003:165|R37_chen_2011:96|R39_shayanfar_2011:91|R40_vilar_2010:271|R41_toropov_2017:255|R46_mendoza_valencia_2017:139|R47_radchenko_2020:238|R53_friden_2009:37	-0.15	B1	BBB+	A	training
InChI=1S/C11H18N2O3/c1-3-5-6-7-11(4-2)8(14)12-10(16)13-9(11)15/h3-7H2,1-2H3,(H2,12,13,14,15,16)	5-Pentyl-5-Ethyl Barbituric Acid|5-Ethyl-5-Pentylbarbituric Acid	5-ethyl-5-pentyl-1,3-diazinane-2,4,6-trione	CCCCCC1(CC)C(=O)NC(=O)NC1=O	66994.0	R3_abraham_2006:114|R25_brito_sanchez_2015:100|R40_vilar_2010:21|R41_toropov_2017:109|R46_mendoza_valencia_2017:98|R47_radchenko_2020:96	0.09	B	BBB+	A	test
InChI=1S/C11H18N2O3/c1-4-11(6-5-7(2)3)8(14)12-10(16)13-9(11)15/h7H,4-6H2,1-3H3,(H2,12,13,14,15,16)	Amobarbital	5-ethyl-5-(3-methylbutyl)-1,3-diazinane-2,4,6-trione	CCC1(CCC(C)C)C(=O)NC(=O)NC1=O	2164.0	R3_abraham_2006:125|R6_adenot_2004:1637|R7_andres_2006:9|R12_garg_2006:21|R14_ghose_2012:10|R21_muehlbacher_2011:32|R23_gupta_2019:11|R25_brito_sanchez_2015:123|R28_li_2005:66|R29_subramanian_2003:9|R39_shayanfar_2011:15|R40_vilar_2010:35|R41_toropov_2017:119|R44_bujak_2015:11|R46_mendoza_valencia_2017:121|R47_radchenko_2020:106|R51_doninger_2002:152	0.05	B1	BBB+	A	test
InChI=1S/C11H18N2O3/c1-4-6-7(3)11(5-2)8(14)12-10(16)13-9(11)15/h7H,4-6H2,1-3H3,(H2,12,13,14,15,16)	Pentobarbital	5-ethyl-5-pentan-2-yl-1,3-diazinane-2,4,6-trione	CCCC(C)C1(CC)C(=O)NC(=O)NC1=O	4737.0	R3_abraham_2006:222|R3_abraham_2006:223|R5_guerra_2008:80|R6_adenot_2004:1660|R12_garg_2006:131|R14_ghose_2012:186|R17_fu_2008:36|R21_muehlbacher_2011:110|R23_gupta_2019:187|R25_brito_sanchez_2015:348|R26_chico_2009:304|R28_li_2005:42|R39_shayanfar_2011:71|R40_vilar_2010:179|R41_toropov_2017:202|R44_bujak_2015:49|R47_radchenko_2020:187|R49_norinder_2002:85|R49_norinder_2002:122|R51_doninger_2002:275	0.11	B1	BBB+	A	test
InChI=1S/C11H18N2O3/c1-4-6-7(3)11(5-2)8(14)12-10(16)13-9(11)15/h7H,4-6H2,1-3H3,(H2,12,13,14,15,16)/t7-/m1/s1	(+)-Pentobarbital	5-ethyl-5-[(2R)-pentan-2-yl]-1,3-diazinane-2,4,6-trione	CCC[C@@H](C)C1(CC)C(=O)NC(=O)NC1=O	88983.0	R48_hou_2003:9	0.12	A	BBB+	A	test
InChI=1S/C11H18N2OS/c1-4-12-6-10-9(7-15-3)5-13-8(2)11(10)14/h5,12,14H,4,6-7H2,1-3H3	Tamitinol	4-(ethylaminomethyl)-2-methyl-5-(methylsulfanylmethyl)pyridin-3-ol	CCNCc1c(CSC)cnc(C)c1O	3085156.0	R6_adenot_2004:1272|R7_andres_2006:163|R28_li_2005:411|R29_subramanian_2003:160			BBB+	C	training
InChI=1S/C11H21N/c1-10(2)8-5-6-9(7-8)11(10,3)12-4/h8-9,12H,5-7H2,1-4H3	Mecamylamine	N,2,3,3-tetramethylbicyclo[2.2.1]heptan-2-amine	CNC1(C)C2CCC(C2)C1(C)C	4032.0	R23_gupta_2019:724			BBB-	C	training
InChI=1S/C11H23NO/c1-4-7-11(8-5-2,9-6-3)10(12)13/h4-9H2,1-3H3,(H2,12,13)	Valdipromide	2,2-dipropylpentanamide	CCCC(CCC)(CCC)C(N)=O	68689.0	R6_adenot_2004:1311			BBB+	C	test
InChI=1S/C11H8ClNO2/c12-7-3-1-6(2-4-7)11-5-8(11)9(14)13-10(11)15/h1-4,8H,5H2,(H,13,14,15)/t8-,11+/m1/s1	Ciproximide|Cyproximide	(1R,5S)-1-(4-chlorophenyl)-3-azabicyclo[3.1.0]hexane-2,4-dione	O=C1NC(=O)[C@]2(c3ccc(Cl)cc3)C[C@H]12	12719804.0	R6_adenot_2004:1434			BBB+	C	test
InChI=1S/C11H8N2/c1-2-4-10-8(3-1)9-5-6-12-7-11(9)13-10/h1-7,13H	Norharman|9H-Pyrido[3,4-B]Indole	9H-pyrido[3,4-b]indole	c1ccc2c(c1)[nH]c1cnccc12	64961.0	R25_brito_sanchez_2015:448|R46_mendoza_valencia_2017:374	0.48	B	BBB+	A	training
InChI=1S/C11H8O2/c1-7-6-10(12)8-4-2-3-5-9(8)11(7)13/h2-6H,1H3	Menadione	2-methylnaphthalene-1,4-dione	CC1=CC(=O)c2ccccc2C1=O	4055.0	R23_gupta_2019:728			BBB-	C	training
InChI=1S/C11H9FN2O3/c12-6-1-2-8-7(5-6)11(3-4-17-8)9(15)13-10(16)14-11/h1-2,5H,3-4H2,(H2,13,14,15,16)/t11-/m0/s1	Sorbinil	(4S)-6-fluorospiro[2,3-dihydrochromene-4,5'-imidazolidine]-2',4'-dione	O=C1NC(=O)[C@@]2(CCOc3ccc(F)cc32)N1	337359.0	R14_ghose_2012:846			BBB-	C	training
InChI=1S/C11H9I3N2O4/c1-3(17)15-9-6(12)5(11(19)20)7(13)10(8(9)14)16-4(2)18/h1-2H3,(H,15,17)(H,16,18)(H,19,20)	Diatrizoic Acid	3,5-diacetamido-2,4,6-triiodobenzoic acid	CC(=O)Nc1c(I)c(NC(C)=O)c(I)c(C(=O)O)c1I	2140.0	R23_gupta_2019:514			BBB-	C	test
InChI=1S/C11H9N3O3/c12-11(13)10-6-5-9(17-10)7-3-1-2-4-8(7)14(15)16/h1-6H,(H3,12,13)	Nitrafudam	5-(2-nitrophenyl)furan-2-carboximidamide	[H]/N=C(\N)c1ccc(-c2ccccc2[N+](=O)[O-])o1	163304.0	R6_adenot_2004:585			BBB+	C	training
InChI=1S/C12H10ClN3O/c1-8(16-5-4-14-7-16)12-10-6-9(13)2-3-11(10)17-15-12/h2-8H,1H3	Zoniclezole	5-chloro-3-(1-imidazol-1-ylethyl)-1,2-benzoxazole	CC(c1noc2ccc(Cl)cc12)n1ccnc1	60745.0	R6_adenot_2004:479			BBB+	C	training
InChI=1S/C12H10F3N3O4/c1-11(2)9(19)17(10(20)16-11)6-3-4-8(18(21)22)7(5-6)12(13,14)15/h3-5H,1-2H3,(H,16,20)	Nilutamide	5,5-dimethyl-3-[4-nitro-3-(trifluoromethyl)phenyl]imidazolidine-2,4-dione	CC1(C)NC(=O)N(c2ccc([N+](=O)[O-])c(C(F)(F)F)c2)C1=O	4493.0	R14_ghose_2012:720|R23_gupta_2019:779			BBB-	C	training
InChI=1S/C12H10N2/c1-8-12-10(6-7-13-8)9-4-2-3-5-11(9)14-12/h2-7,14H,1H3	Harman	1-methyl-9H-pyrido[3,4-b]indole	Cc1nccc2c1[nH]c1ccccc12	5281404.0	R51_doninger_2002:224			BBB+	C	training
InChI=1S/C12H10N2O3S/c1-18-8-2-3-10-9(6-8)12(17)14(7-13-10)5-4-11(15)16/h2-7H,1H3,(H,15,16)/b5-4+	Tiacrilast	(E)-3-(6-methylsulfanyl-4-oxoquinazolin-3-yl)prop-2-enoic acid	CSc1ccc2ncn(/C=C/C(=O)O)c(=O)c2c1	6435375.0	R7_andres_2006:171|R29_subramanian_2003:166			BBB-	C	training
InChI=1S/C12H10N2O5/c1-2-14-7-4-9-8(18-5-19-9)3-6(7)11(15)10(13-14)12(16)17/h3-4H,2,5H2,1H3,(H,16,17)	Cinoxacin	1-ethyl-4-oxo-[1,3]dioxolo[4,5-g]cinnoline-3-carboxylic acid	CCn1nc(C(=O)O)c(=O)c2cc3c(cc21)OCO3	2762.0	R14_ghose_2012:452|R23_gupta_2019:463			BBB-	C	training
InChI=1S/C12H11ClN2O5S/c13-9-5-10(15-6-7-2-1-3-20-7)8(12(16)17)4-11(9)21(14,18)19/h1-5,15H,6H2,(H,16,17)(H2,14,18,19)	Furosemide	4-chloro-2-(furan-2-ylmethylamino)-5-sulfamoylbenzoic acid	NS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl	3440.0	R7_andres_2006:74|R14_ghose_2012:584|R23_gupta_2019:619|R28_li_2005:357|R29_subramanian_2003:69|R50_sobanska_2019:54|R51_doninger_2002:59			BBB-	C	training
InChI=1S/C12H11ClO4/c1-16-9-6-10(14)17-12(9)11(15)7-4-2-3-5-8(7)13/h2-6,11-12,15H,1H3/t11-,12-/m0/s1	Losigamone|(+)-Losigamone	(2R)-2-[(S)-(2-chlorophenyl)-hydroxymethyl]-3-methoxy-2H-furan-5-one	COC1=CC(=O)O[C@@H]1[C@@H](O)c1ccccc1Cl	6918049.0	R6_adenot_2004:448			BBB+	C	training
InChI=1S/C12H11N3/c1-9-11(7-8-13)15-12(14-9)10-5-3-2-4-6-10/h2-6H,7H2,1H3,(H,14,15)	Mefenidil	2-(5-methyl-2-phenyl-1H-imidazol-4-yl)acetonitrile	Cc1[nH]c(-c2ccccc2)nc1CC#N	65475.0	R7_andres_2006:100|R29_subramanian_2003:94			BBB+	C	training
InChI=1S/C12H11N7/c13-9-7(6-4-2-1-3-5-6)16-8-10(14)18-12(15)19-11(8)17-9/h1-5H,(H6,13,14,15,17,18,19)	Triamterene	6-phenylpteridine-2,4,7-triamine	Nc1nc(N)c2nc(-c3ccccc3)c(N)nc2n1	5546.0	R14_ghose_2012:913|R23_gupta_2019:997|R51_doninger_2002:139			BBB-	C	training
InChI=1S/C12H11NO/c1-10-7-8-12(14)13(9-10)11-5-3-2-4-6-11/h2-9H,1H3	Pirfenidone	5-methyl-1-phenylpyridin-2-one	Cc1ccc(=O)n(-c2ccccc2)c1	40632.0	R23_gupta_2019:844			BBB-	C	training
InChI=1S/C12H12Cl2N4/c1-2-9-10(11(15)18-12(16)17-9)6-3-4-7(13)8(14)5-6/h3-5H,2H2,1H3,(H4,15,16,17,18)	Etoprine	5-(3,4-dichlorophenyl)-6-ethylpyrimidine-2,4-diamine	CCc1nc(N)nc(N)c1-c1ccc(Cl)c(Cl)c1	29142.0	R26_chico_2009:182	0.65	A	BBB+	A	training
InChI=1S/C12H12N2O/c1-7-12-10(4-5-13-7)9-3-2-8(15)6-11(9)14-12/h2-3,6,14-15H,4-5H2,1H3	Harmalol	1-methyl-4,9-dihydro-3H-pyrido[3,4-b]indol-7-ol	CC1=NCCc2c1[nH]c1cc(O)ccc21	3565.0	R51_doninger_2002:223			BBB+	C	training
InChI=1S/C12H12N2O2/c15-10-12(14-11(16)13-10)6-5-8-3-1-2-4-9(8)7-12/h1-4H,5-7H2,(H2,13,14,15,16)	Tetrantoin	spiro[2,4-dihydro-1H-naphthalene-3,5'-imidazolidine]-2',4'-dione	O=C1NC(=O)C2(CCc3ccccc3C2)N1	71726.0	R6_adenot_2004:1668			BBB+	C	training
InChI=1S/C12H12N2O2/c15-11-10(8-4-2-1-3-5-8)16-12(14-11)13-9-6-7-9/h1-5,9-10H,6-7H2,(H,13,14,15)	Cyclazodone	2-cyclopropylimino-5-phenyl-1,3-oxazolidin-4-one	O=C1N/C(=N/C2CC2)OC1c1ccccc1	135438121.0	R6_adenot_2004:1282			BBB+	C	training
InChI=1S/C12H12N2O2S/c1-7-10(14-12(16)13-7)11(15)8-3-5-9(17-2)6-4-8/h3-6H,1-2H3,(H2,13,14,16)	Enoximone	4-methyl-5-(4-methylsulfanylbenzoyl)-1,3-dihydroimidazol-2-one	CSc1ccc(C(=O)c2[nH]c(=O)[nH]c2C)cc1	53708.0	R14_ghose_2012:527|R23_gupta_2019:559			BBB-	C	training
InChI=1S/C12H12N2O3/c1-2-12(8-6-4-3-5-7-8)9(15)13-11(17)14-10(12)16/h3-7H,2H2,1H3,(H2,13,14,15,16,17)	Phenobarbital	5-ethyl-5-phenyl-1,3-diazinane-2,4,6-trione	CCC1(c2ccccc2)C(=O)NC(=O)NC1=O	4763.0	R6_adenot_2004:1661|R7_andres_2006:132|R14_ghose_2012:196|R23_gupta_2019:197|R25_brito_sanchez_2015:353|R28_li_2005:219|R29_subramanian_2003:129|R46_mendoza_valencia_2017:309|R51_doninger_2002:282	-0.12	B	BBB+	A	training
InChI=1S/C12H12N2O3/c1-3-14-6-9(12(16)17)10(15)8-5-4-7(2)13-11(8)14/h4-6H,3H2,1-2H3,(H,16,17)	Nalidixic Acid|Nalidixic-Acid|Nalidixicacid	1-ethyl-7-methyl-4-oxo-1,8-naphthyridine-3-carboxylic acid	CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21	4421.0	R3_abraham_2006:206|R6_adenot_2004:247|R14_ghose_2012:709|R21_muehlbacher_2011:103|R23_gupta_2019:767|R25_brito_sanchez_2015:315|R28_li_2005:209|R40_vilar_2010:158|R41_toropov_2017:188|R46_mendoza_valencia_2017:278|R47_radchenko_2020:173	-0.66	B	BBB+	A	training
InChI=1S/C12H12N2O4S/c15-11-9(5-3-7-13-11)14-12(16)8-4-1-2-6-10(8)19(14,17)18/h1-2,4,6,9H,3,5,7H2,(H,13,15)	Supidimide	1,1-dioxo-2-(2-oxopiperidin-3-yl)-1,2-benzothiazol-3-one	O=C1NCCCC1N1C(=O)c2ccccc2S1(=O)=O	39528.0	R6_adenot_2004:1383			BBB+	C	training
InChI=1S/C12H12N4O3/c17-11(14-8-10-4-2-1-3-5-10)9-15-7-6-13-12(15)16(18)19/h1-7H,8-9H2,(H,14,17)	Benznidazole	N-benzyl-2-(2-nitroimidazol-1-yl)acetamide	O=C(Cn1ccnc1[N+](=O)[O-])NCc1ccccc1	31593.0	R14_ghose_2012:384			BBB-	C	training
InChI=1S/C12H13BrN4O2S/c13-9-2-1-4-14-10(9)8-20-7-6-16-12-11(17(18)19)3-5-15-12/h1-5,15-16H,6-8H2	Skb15|Bbcpd12|112598-28-4|Chebi: 339093|13|N-(2-{[(3-Bromopyridin-2-Yl)Methyl]Sulfanyl}Ethyl)-3-Nitro-1H-Pyrrol-2-Amine	N-[2-[(3-bromopyridin-2-yl)methylsulfanyl]ethyl]-3-nitro-1H-pyrrol-2-amine	O=[N+]([O-])c1cc[nH]c1NCCSCc1ncccc1Br	14022480.0	R3_abraham_2006:256|R3_abraham_2006:306|R4_mente_2005:122|R12_garg_2006:28|R21_muehlbacher_2011:347|R25_brito_sanchez_2015:7|R40_vilar_2010:244|R41_toropov_2017:228|R41_toropov_2017:273|R46_mendoza_valencia_2017:7|R47_radchenko_2020:211|R52_liu_2001:13	-0.67	B	BBB+	A	training
InChI=1S/C12H13BrN4O2S/c13-9-2-1-4-14-11(9)8-20-7-6-15-10-3-5-16-12(10)17(18)19/h1-5,15-16H,6-8H2	B-049		O=[N+]([O-])c1[nH]ccc1NCCSCc1ncccc1Br		R26_chico_2009:48	-0.67	A	BBB+	A	training
InChI=1S/C12H13ClN4/c1-2-9-10(11(14)17-12(15)16-9)7-3-5-8(13)6-4-7/h3-6H,2H2,1H3,(H4,14,15,16,17)	Pyrimethamine	5-(4-chlorophenyl)-6-ethylpyrimidine-2,4-diamine	CCc1nc(N)nc(N)c1-c1ccc(Cl)cc1	4993.0	R14_ghose_2012:807|R26_chico_2009:339|R28_li_2005:279	0.49	A	BBB+	A	training
InChI=1S/C12H13F3N2O2/c1-16-11(18)17-6-10(7-17)19-9-4-2-3-8(5-9)12(13,14)15/h2-5,10H,6-7H2,1H3,(H,16,18)	Fluzinamide	N-methyl-3-[3-(trifluoromethyl)phenoxy]azetidine-1-carboxamide	CNC(=O)N1CC(Oc2cccc(C(F)(F)F)c2)C1	53467.0	R6_adenot_2004:442			BBB+	C	training
InChI=1S/C12H13I3N2O2/c1-17(2)6-16-12-9(14)5-8(13)7(11(12)15)3-4-10(18)19/h5-6H,3-4H2,1-2H3,(H,18,19)/b16-6+	Ipodate	3-[3-(dimethylaminomethylideneamino)-2,4,6-triiodophenyl]propanoic acid	CN(C)/C=N/c1c(I)cc(I)c(CCC(=O)O)c1I	5241.0	R14_ghose_2012:626			BBB-	C	training
InChI=1S/C12H13I3N2O3/c1-5(12(19)20)4-17(6(2)18)11-8(14)3-7(13)10(16)9(11)15/h3,5H,4,16H2,1-2H3,(H,19,20)	Iocetamic Acid	3-(N-acetyl-3-amino-2,4,6-triiodoanilino)-2-methylpropanoic acid	CC(=O)N(CC(C)C(=O)O)c1c(I)cc(I)c(N)c1I	27648.0	R14_ghose_2012:622			BBB-	C	training
InChI=1S/C12H13N/c1-2-9-13-12-8-7-10-5-3-4-6-11(10)12/h1,3-6,12-13H,7-9H2/t12-/m1/s1	Rasagiline	(1R)-N-prop-2-ynyl-2,3-dihydro-1H-inden-1-amine	C#CCN[C@@H]1CCc2ccccc21	3052776.0	R6_adenot_2004:981|R23_gupta_2019:215|R37_chen_2011:80			BBB+	C	training
InChI=1S/C12H13N3O2/c1-9-7-11(15-17-9)12(16)14-13-8-10-5-3-2-4-6-10/h2-7,13H,8H2,1H3,(H,14,16)	Isocarboxazid	N'-benzyl-5-methyl-1,2-oxazole-3-carbohydrazide	Cc1cc(C(=O)NNCc2ccccc2)no1	3759.0	R6_adenot_2004:971|R14_ghose_2012:116|R23_gupta_2019:117			BBB+	C	test
InChI=1S/C12H13N5OS/c1-7(18)15-9-4-2-3-8(5-9)10-6-19-12(16-10)17-11(13)14/h2-6H,1H3,(H,15,18)(H4,13,14,16,17)	Skb22|Bbcpd16|B-057; Compound34|18|12|N-[3-[2-(Diaminomethylideneamino)-1,3-Thiazol-4-Yl]Phenyl]Acetamide	N-[3-[2-(diaminomethylideneamino)-1,3-thiazol-4-yl]phenyl]acetamide	CC(=O)Nc1cccc(-c2csc(N=C(N)N)n2)c1	14022511.0	R3_abraham_2006:262|R3_abraham_2006:311|R12_garg_2006:32|R25_brito_sanchez_2015:12|R26_chico_2009:56|R28_li_2005:156|R40_vilar_2010:248|R41_toropov_2017:234|R41_toropov_2017:277|R46_mendoza_valencia_2017:12|R47_radchenko_2020:217|R48_hou_2003:40|R49_norinder_2002:18|R49_norinder_2002:170|R52_liu_2001:18	-1.57	B	BBB-	A	training
InChI=1S/C12H13N5OS/c1-8(18)16-10-4-2-3-9(5-10)11-6-19-12(17-11)14-7-15-13/h2-7H,13H2,1H3,(H,16,18)(H,14,15,17)	72801-74-2|N-(3-{2-[(Hydrazinylmethylidene)Amino]-1,3-Thiazol-4-Yl}Phenyl)Acetamide	N-[3-[2-(hydrazinylmethylideneamino)-1,3-thiazol-4-yl]phenyl]acetamide	CC(=O)Nc1cccc(-c2csc(N=CNN)n2)c1	71404351.0	R4_mente_2005:126	-1.57	A	BBB-	A	training
InChI=1S/C12H13NO2/c1-12(9-6-4-3-5-7-9)8-10(14)13(2)11(12)15/h3-7H,8H2,1-2H3	Mesuximide|Methsuximide	1,3-dimethyl-3-phenylpyrrolidine-2,5-dione	CN1C(=O)CC(C)(c2ccccc2)C1=O	6476.0	R6_adenot_2004:450|R14_ghose_2012:140|R23_gupta_2019:147			BBB+	C	training
InChI=1S/C12H13NO3/c1-16-10-6-4-9(5-7-10)12(15)13-8-2-3-11(13)14/h4-7H,2-3,8H2,1H3	Aniracetam	1-(4-methoxybenzoyl)pyrrolidin-2-one	COc1ccc(C(=O)N2CCCC2=O)cc1	2196.0	R6_adenot_2004:1243|R14_ghose_2012:11|R23_gupta_2019:14|R37_chen_2011:5			BBB+	C	training
InChI=1S/C12H14Cl2FNO4S/c1-21(19,20)8-4-2-7(3-5-8)10(17)9(6-15)16-12(18)11(13)14/h2-5,9-11,17H,6H2,1H3,(H,16,18)/t9-,10-/m1/s1	Florfenicol	2,2-dichloro-N-[(1R,2S)-3-fluoro-1-hydroxy-1-(4-methylsulfonylphenyl)propan-2-yl]acetamide	CS(=O)(=O)c1ccc([C@@H](O)[C@@H](CF)NC(=O)C(Cl)Cl)cc1	114811.0	R6_adenot_2004:655			BBB+	C	training
InChI=1S/C12H14N2/c1-10(12-6-4-3-5-7-12)14-9-8-13-11(14)2/h3-10H,1-2H3	Efetozole	2-methyl-1-(1-phenylethyl)imidazole	Cc1nccn1C(C)c1ccccc1	208911.0	R6_adenot_2004:965			BBB+	C	training
InChI=1S/C12H14N2/c1-2-5-12-10(4-1)8-11-9-13-6-3-7-14(11)12/h1-2,4-5,8,13H,3,6-7,9H2	Azepindole	2,3,4,5-tetrahydro-1H-[1,4]diazepino[1,2-a]indole	c1ccc2c(c1)cc1n2CCCNC1	33471.0	R6_adenot_2004:489			BBB+	C	training
InChI=1S/C12H14N2/c1-9-4-3-5-11(10(9)2)6-12-7-13-8-14-12/h3-5,7-8H,6H2,1-2H3,(H,13,14)	Detomidine	5-[(2,3-dimethylphenyl)methyl]-1H-imidazole	Cc1cccc(Cc2cnc[nH]2)c1C	56032.0	R6_adenot_2004:1444			BBB+	C	training
InChI=1S/C12H14N2O2/c1-2-12(9-6-4-3-5-7-9)10(15)13-8-14-11(12)16/h3-7H,2,8H2,1H3,(H,13,15)(H,14,16)	Primidone	5-ethyl-5-phenyl-1,3-diazinane-4,6-dione	CCC1(c2ccccc2)C(=O)NCNC1=O	4909.0	R6_adenot_2004:464|R7_andres_2006:141|R12_garg_2006:138|R14_ghose_2012:209|R21_muehlbacher_2011:113|R23_gupta_2019:207|R25_brito_sanchez_2015:363|R26_chico_2009:320|R29_subramanian_2003:136|R34_broccatelli_2012:70|R39_shayanfar_2011:119|R40_vilar_2010:215|R46_mendoza_valencia_2017:317|R47_radchenko_2020:284|R51_doninger_2002:292	-0.07	B	BBB+	A	training
InChI=1S/C12H14N2O2/c1-2-12(9-6-4-3-5-7-9)11(16)14-10(15)8-13-12/h3-7,13H,2,8H2,1H3,(H,14,15,16)	Iminophenimide	3-ethyl-3-phenylpiperazine-2,6-dione	CCC1(c2ccccc2)NCC(=O)NC1=O	163317.0	R6_adenot_2004:1367			BBB+	C	training
InChI=1S/C12H14N2O2/c1-3-12(9-7-5-4-6-8-9)10(15)13-11(16)14(12)2/h4-8H,3H2,1-2H3,(H,13,15,16)	Metetoin|Methetoin	5-ethyl-1-methyl-5-phenylimidazolidine-2,4-dione	CCC1(c2ccccc2)C(=O)NC(=O)N1C	21908.0	R6_adenot_2004:1656			BBB+	C	test
InChI=1S/C12H14N2O2/c1-3-12(9-7-5-4-6-8-9)10(15)14(2)11(16)13-12/h4-8H,3H2,1-2H3,(H,13,16)	Mephenytoin	5-ethyl-3-methyl-5-phenylimidazolidine-2,4-dione	CCC1(c2ccccc2)NC(=O)N(C)C1=O	4060.0	R6_adenot_2004:1655|R14_ghose_2012:135|R23_gupta_2019:137			BBB+	C	test
InChI=1S/C12H14N4O2S/c1-8-7-9(2)15-12(14-8)16-19(17,18)11-5-3-10(13)4-6-11/h3-7H,13H2,1-2H3,(H,14,15,16)	Sulfamethazine	4-amino-N-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide	Cc1cc(C)nc(NS(=O)(=O)c2ccc(N)cc2)n1	5327.0	R23_gupta_2019:935			BBB-	C	test
InChI=1S/C12H14N4O2S/c17-16(18)11-4-6-14-12(11)15-7-8-19-9-10-3-1-2-5-13-10/h1-6,14-15H,7-9H2	Skb16|Bbcpd13|112598-30-8|Chebi: 339092|B-050|14|3-Nitro-N-(2-{[(Pyridin-2-Yl)Methyl]Sulfanyl}Ethyl)-1H-Pyrrol-2-Amine	3-nitro-N-[2-(pyridin-2-ylmethylsulfanyl)ethyl]-1H-pyrrol-2-amine	O=[N+]([O-])c1cc[nH]c1NCCSCc1ccccn1	14022481.0	R3_abraham_2006:257|R3_abraham_2006:307|R4_mente_2005:123|R12_garg_2006:29|R21_muehlbacher_2011:348|R25_brito_sanchez_2015:8|R26_chico_2009:49|R28_li_2005:152|R40_vilar_2010:43|R41_toropov_2017:229|R41_toropov_2017:274|R46_mendoza_valencia_2017:8|R47_radchenko_2020:212|R48_hou_2003:53|R52_liu_2001:14	-0.66	B	BBB+	A	training
InChI=1S/C12H14N4O3S/c1-2-16-8-7-11(14-12(16)17)15-20(18,19)10-5-3-9(13)4-6-10/h3-8H,2,13H2,1H3,(H,14,15,17)	Sulfacytine	4-amino-N-(1-ethyl-2-oxopyrimidin-4-yl)benzenesulfonamide	CCn1ccc(NS(=O)(=O)c2ccc(N)cc2)nc1=O	5322.0	R14_ghose_2012:857|R23_gupta_2019:929			BBB-	C	training
InChI=1S/C12H14N4O4S/c1-19-10-11(14-7-15-12(10)20-2)16-21(17,18)9-5-3-8(13)4-6-9/h3-7H,13H2,1-2H3,(H,14,15,16)	Sulfadoxine	4-amino-N-(5,6-dimethoxypyrimidin-4-yl)benzenesulfonamide	COc1ncnc(NS(=O)(=O)c2ccc(N)cc2)c1OC	17134.0	R23_gupta_2019:932			BBB-	C	test
InChI=1S/C12H14N4O4S/c1-19-11-7-10(14-12(15-11)20-2)16-21(17,18)9-5-3-8(13)4-6-9/h3-7H,13H2,1-2H3,(H,14,15,16)	Sulfadimethoxine	4-amino-N-(2,6-dimethoxypyrimidin-4-yl)benzenesulfonamide	COc1cc(NS(=O)(=O)c2ccc(N)cc2)nc(OC)n1	5323.0	R23_gupta_2019:931			BBB-	C	test
InChI=1S/C12H14N6O10S2/c13-11-15-4(3-29-11)7(17-28-2-6(19)20)9(21)16-8-5(1-27-12(14)23)18(10(8)22)30(24,25)26/h3,5,8H,1-2H2,(H2,13,15)(H2,14,23)(H,16,21)(H,19,20)(H,24,25,26)/b17-7-/t5-,8+/m1/s1	Carumonam|(3S,4S)-3-[(Z)-2-(2-Amino-4-Thiazolyl)-2-[(Carboxymethoxy)Imino]Acetamido]-4-Carbamoyloxymethyl-2-Oxo-1-Azetidinesulphonic Acid	2-[(E)-[1-(2-amino-1,3-thiazol-4-yl)-2-[[(2S,3S)-2-(carbamoyloxymethyl)-4-oxo-1-sulfoazetidin-3-yl]amino]-2-oxoethylidene]amino]oxyacetic acid	NC(=O)OC[C@@H]1[C@H](NC(=O)/C(=N/OCC(=O)O)c2csc(N)n2)C(=O)N1S(=O)(=O)O	6857983.0	R6_adenot_2004:149			BBB-	C	training
InChI=1S/C12H15Cl2NO5S/c1-21(19,20)8-4-2-7(3-5-8)10(17)9(6-16)15-12(18)11(13)14/h2-5,9-11,16-17H,6H2,1H3,(H,15,18)	Racefenicol	2,2-dichloro-N-[1,3-dihydroxy-1-(4-methylsulfonylphenyl)propan-2-yl]acetamide	CS(=O)(=O)c1ccc(C(O)C(CO)NC(=O)C(Cl)Cl)cc1	5433.0	R6_adenot_2004:656			BBB+	C	training
InChI=1S/C12H15ClO3/c1-4-15-11(14)12(2,3)16-10-7-5-9(13)6-8-10/h5-8H,4H2,1-3H3	Clofibrate	ethyl 2-(4-chlorophenoxy)-2-methylpropanoate	CCOC(=O)C(C)(C)Oc1ccc(Cl)cc1	2796.0	R14_ghose_2012:462|R51_doninger_2002:27			BBB-	C	training
InChI=1S/C12H15N/c1-13-9-7-12(8-10-13)11-5-3-2-4-6-11/h2-7H,8-10H2,1H3	Mptp|1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine	1-methyl-4-phenyl-3,6-dihydro-2H-pyridine	CN1CC=C(c2ccccc2)CC1	1388.0	R51_doninger_2002:259			BBB+	C	training
InChI=1S/C12H15N5O3/c1-5-6(3-18)8(19)2-7(5)17-4-14-9-10(17)15-12(13)16-11(9)20/h4,6-8,18-19H,1-3H2,(H3,13,15,16,20)/t6-,7-,8-/m0/s1	Entecavir	2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-1H-purin-6-one	C=C1[C@H](CO)[C@@H](O)C[C@@H]1n1cnc2c(=O)[nH]c(N)nc21	135398508.0	R23_gupta_2019:561			BBB-	C	test
InChI=1S/C12H15N5O6S/c1-5-8(11(21)17(5)23-3-7(18)19)15-10(20)9(16-22-2)6-4-24-12(13)14-6/h4-5,8H,3H2,1-2H3,(H2,13,14)(H,15,20)(H,18,19)/b16-9+/t5-,8-/m0/s1	Oximonam|Oximonamum	2-[(2S,3S)-3-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-2-methyl-4-oxoazetidin-1-yl]oxyacetic acid	CO/N=C(\C(=O)N[C@@H]1C(=O)N(OCC(=O)O)[C@H]1C)c1csc(N)n1	9690097.0	R6_adenot_2004:270			BBB-	C	training
InChI=1S/C12H15N5O9S2/c1-12(2)8(10(21)17(12)26-28(22,23)24)15-9(20)7(16-25-3-6(18)19)5-4-27-11(13)14-5/h4,8H,3H2,1-2H3,(H2,13,14)(H,15,20)(H,18,19)(H,22,23,24)/b16-7-/t8-/m1/s1	Tigemonam|Sq30836 (Tigemonam Dicholate)	2-[(E)-[1-(2-amino-1,3-thiazol-4-yl)-2-[[(3S)-2,2-dimethyl-4-oxo-1-sulfooxyazetidin-3-yl]amino]-2-oxoethylidene]amino]oxyacetic acid	CC1(C)[C@H](NC(=O)/C(=N/OCC(=O)O)c2csc(N)n2)C(=O)N1OS(=O)(=O)O	5486705.0	R6_adenot_2004:279			BBB-	C	training
InChI=1S/C12H15NO3/c1-8-3-9(2)5-10(4-8)15-7-11-6-13-12(14)16-11/h3-5,11H,6-7H2,1-2H3,(H,13,14)	Metaxalone	5-[(3,5-dimethylphenoxy)methyl]-1,3-oxazolidin-2-one	Cc1cc(C)cc(OCC2CNC(=O)O2)c1	15459.0	R6_adenot_2004:1486|R14_ghose_2012:142|R23_gupta_2019:141			BBB+	C	training
InChI=1S/C12H15NO4/c1-15-9-6-8(4-5-11(13)14)7-10(16-2)12(9)17-3/h4-7H,1-3H3,(H2,13,14)/b5-4+	Cintramide|Cintriamide	(E)-3-(3,4,5-trimethoxyphenyl)prop-2-enamide	COc1cc(/C=C/C(N)=O)cc(OC)c1OC	6154037.0	R6_adenot_2004:1432			BBB+	C	training
InChI=1S/C12H15NO5S/c1-5(14)7-10(15)13-8(12(16)17)9(19-11(7)13)6-3-2-4-18-6/h5-7,11,14H,2-4H2,1H3,(H,16,17)/t5-,6-,7+,11-/m1/s1	Faropenem	(5R,6S)-6-[(1R)-1-hydroxyethyl]-7-oxo-3-[(2R)-oxolan-2-yl]-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid	C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C([C@H]3CCCO3)S[C@H]12	65894.0	R6_adenot_2004:230			BBB-	C	training
InChI=1S/C12H15NO5S3/c1-5(14)7-9(15)13-8(11(16)17)12(20-10(7)13)19-6-2-3-21(18)4-6/h5-7,10,14H,2-4H2,1H3,(H,16,17)/t5-,6+,7+,10-,21-/m1/s1	Sulopenem	(5R,6S)-6-[(1R)-1-hydroxyethyl]-7-oxo-3-[(1R,3S)-1-oxothiolan-3-yl]sulfanyl-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid	C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@H]3CC[S@@](=O)C3)S[C@H]12	9950244.0	R6_adenot_2004:214			BBB-	C	training
InChI=1S/C12H16BrN5S/c1-2-15-12(18-9-14)17-6-7-19-8-11-10(13)4-3-5-16-11/h3-5H,2,6-8H2,1H3,(H2,15,17,18)	"52378-66-2|Chebi: 338620|Bbcpd11|B-048|12|Y-G13|Comp13|30|N-Cyano-N'-[2-((3-Bromo-2-Pyridyl)Methylthio)-Ethyl]-N""-Ethylguanidine"	2-[2-[(3-bromopyridin-2-yl)methylsulfanyl]ethyl]-1-cyano-3-ethylguanidine	CCN/C(=N/CCSCc1ncccc1Br)NC#N	14022517.0	R4_mente_2005:121|R21_muehlbacher_2011:354|R25_brito_sanchez_2015:6|R25_brito_sanchez_2015:412|R26_chico_2009:47|R28_li_2005:151|R40_vilar_2010:301|R46_mendoza_valencia_2017:6|R46_mendoza_valencia_2017:349|R47_radchenko_2020:301|R49_norinder_2002:12|R52_liu_2001:12	-2.15	B	BBB-	A	training
InChI=1S/C12H16ClNO3/c1-14(2)7-8-16-12(15)9-17-11-5-3-10(13)4-6-11/h3-6H,7-9H2,1-2H3	Meclofenoxate	2-(dimethylamino)ethyl 2-(4-chlorophenoxy)acetate	CN(C)CCOC(=O)COc1ccc(Cl)cc1	4039.0	R6_adenot_2004:1295|R51_doninger_2002:241			BBB+	C	training
InChI=1S/C12H16F3N/c1-3-16-9(2)7-10-5-4-6-11(8-10)12(13,14)15/h4-6,8-9,16H,3,7H2,1-2H3	Fenfluramine	N-ethyl-1-[3-(trifluoromethyl)phenyl]propan-2-amine	CCNC(C)Cc1cccc(C(F)(F)F)c1	3337.0	R14_ghose_2012:65|R23_gupta_2019:91			BBB+	C	training
InChI=1S/C12H16N2/c1-2-10(13)7-9-8-14-12-6-4-3-5-11(9)12/h3-6,8,10,14H,2,7,13H2,1H3	Etryptamine	1-(1H-indol-3-yl)butan-2-amine	CCC(N)Cc1c[nH]c2ccccc12	8367.0	R6_adenot_2004:988			BBB+	C	training
InChI=1S/C12H16N2/c1-2-4-11-10(3-1)5-7-14-8-6-13-9-12(11)14/h1-4,12-13H,5-9H2	Azaquinzole	2,3,4,6,7,11b-hexahydro-1H-pyrazino[2,1-a]isoquinoline	c1ccc2c(c1)CCN1CCNCC21	179345.0	R6_adenot_2004:1418			BBB+	C	test
InChI=1S/C12H16N2O/c1-14(2)6-5-9-8-13-12-4-3-10(15)7-11(9)12/h3-4,7-8,13,15H,5-6H2,1-2H3	Bufotenine	3-[2-(dimethylamino)ethyl]-1H-indol-5-ol	CN(C)CCc1c[nH]c2ccc(O)cc12	10257.0	R26_chico_2009:87|R51_doninger_2002:166	-1.19	A	BBB-	A	training
InChI=1S/C12H16N2O/c13-7-11-6-12(15)14(9-11)8-10-4-2-1-3-5-10/h1-5,11H,6-9,13H2	Nebracetam	4-(aminomethyl)-1-benzylpyrrolidin-2-one	NCC1CC(=O)N(Cc2ccccc2)C1	65926.0	R6_adenot_2004:635			BBB+	C	training
InChI=1S/C12H16N2O2/c1-2-10(14-6-4-13-5-7-14)12-11(3-1)15-8-9-16-12/h1-3,13H,4-9H2	Eltoprazine	1-(2,3-dihydro-1,4-benzodioxin-5-yl)piperazine	c1cc2c(c(N3CCNCC3)c1)OCCO2	65853.0	R6_adenot_2004:536			BBB+	C	training
InChI=1S/C12H16N2O3/c1-12(8-6-4-3-5-7-8)9(15)13-11(17)14(2)10(12)16/h6H,3-5,7H2,1-2H3,(H,13,15,17)	Hexobarbital|56-29-1	5-(cyclohexen-1-yl)-1,5-dimethyl-1,3-diazinane-2,4,6-trione	CN1C(=O)NC(=O)C(C)(C2=CCCCC2)C1=O	3608.0	R3_abraham_2006:178|R3_abraham_2006:179|R4_mente_2005:43|R5_guerra_2008:53|R6_adenot_2004:1653|R12_garg_2006:87|R21_muehlbacher_2011:84|R23_gupta_2019:656|R25_brito_sanchez_2015:250|R28_li_2005:91|R39_shayanfar_2011:112|R40_vilar_2010:123|R41_toropov_2017:165|R44_bujak_2015:34|R46_mendoza_valencia_2017:225|R47_radchenko_2020:151	0.04	B1	BBB+	A	training
InChI=1S/C12H16N2O3/c1-2-12(8-6-4-3-5-7-8)9(15)13-11(17)14-10(12)16/h6H,2-5,7H2,1H3,(H2,13,14,15,16,17)	Cyclobarbital	5-(cyclohexen-1-yl)-5-ethyl-1,3-diazinane-2,4,6-trione	CCC1(C2=CCCCC2)C(=O)NC(=O)NC1=O	5838.0	R6_adenot_2004:1644|R7_andres_2006:45|R25_brito_sanchez_2015:195|R29_subramanian_2003:45|R46_mendoza_valencia_2017:181	-0.3	B	BBB+	A	training
InChI=1S/C12H16N2S/c1-9-5-3-6-10(2)11(9)14-12-13-7-4-8-15-12/h3,5-6H,4,7-8H2,1-2H3,(H,13,14)	Xylazine	N-(2,6-dimethylphenyl)-5,6-dihydro-4H-1,3-thiazin-2-amine	Cc1cccc(C)c1NC1=NCCCS1	5707.0	R6_adenot_2004:958			BBB+	C	training
InChI=1S/C12H17Cl2NO/c1-12(8-16,15(2)3)7-9-4-5-10(13)11(14)6-9/h4-6,16H,7-8H2,1-3H3	Cericlamine	3-(3,4-dichlorophenyl)-2-(dimethylamino)-2-methylpropan-1-ol	CN(C)C(C)(CO)Cc1ccc(Cl)c(Cl)c1	131074.0	R6_adenot_2004:563			BBB+	C	test
InChI=1S/C12H17ClO2/c1-11(2,14)8-12(3,15)9-4-6-10(13)7-5-9/h4-7,14-15H,8H2,1-3H3	Fenpentadiol	2-(4-chlorophenyl)-4-methylpentane-2,4-diol	CC(C)(O)CC(C)(O)c1ccc(Cl)cc1	85896.0	R6_adenot_2004:544			BBB+	C	training
InChI=1S/C12H17N2O4P/c1-14(2)7-6-9-8-13-10-4-3-5-11(12(9)10)18-19(15,16)17/h3-5,8,13H,6-7H2,1-2H3,(H2,15,16,17)	Psilocybine	[3-[2-(dimethylamino)ethyl]-1H-indol-4-yl] dihydrogen phosphate	CN(C)CCc1c[nH]c2cccc(OP(=O)(O)O)c12	10624.0	R6_adenot_2004:385			BBB+	C	training
InChI=1S/C12H17N3O4S/c1-6(16)9-7-4-8(20-3-2-14-5-13)10(12(18)19)15(7)11(9)17/h5-7,9,16H,2-4H2,1H3,(H2,13,14)(H,18,19)/t6-,7-,9-/m1/s1	Imipenem	(5R,6S)-3-[2-(aminomethylideneamino)ethylsulfanyl]-6-[(1R)-1-hydroxyethyl]-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid	C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(SCC/N=C/N)C[C@H]12	104838.0	R6_adenot_2004:235			BBB-	C	training
InChI=1S/C12H17NO/c1-10-12(14-9-8-13(10)2)11-6-4-3-5-7-11/h3-7,10,12H,8-9H2,1-2H3/t10-,12+/m0/s1	Phendimetrazine	(2S,3S)-3,4-dimethyl-2-phenylmorpholine	C[C@H]1[C@H](c2ccccc2)OCCN1C	30487.0	R6_adenot_2004:1303|R14_ghose_2012:193|R23_gupta_2019:193			BBB+	C	training
InChI=1S/C12H17NO/c1-9-11(13(2)3)8-10-6-4-5-7-12(10)14-9/h4-7,9,11H,8H2,1-3H3	Trebenzomine	N,N,2-trimethyl-3,4-dihydro-2H-chromen-3-amine	CC1Oc2ccccc2CC1N(C)C	32142.0	R6_adenot_2004:628			BBB+	C	training
InChI=1S/C12H17NO2/c1-9(14)13-10-5-7-11(8-6-10)15-12(2,3)4/h5-8H,1-4H3,(H,13,14)	Butacetin	N-[4-[(2-methylpropan-2-yl)oxy]phenyl]acetamide	CC(=O)Nc1ccc(OC(C)(C)C)cc1	16426.0	R6_adenot_2004:500			BBB+	C	training
InChI=1S/C12H17NO2/c1-9-7-11(13(15)12(14)8-9)10-5-3-2-4-6-10/h7-8,10,15H,2-6H2,1H3	Ciclopirox	6-cyclohexyl-1-hydroxy-4-methylpyridin-2-one	Cc1cc(C2CCCCC2)n(O)c(=O)c1	2749.0	R23_gupta_2019:456			BBB-	C	training
InChI=1S/C12H17NO3/c1-2-3-4-5-6-7-8-9(14)10-11(16-10)12(13)15/h2-3,5-6,10-11H,4,7-8H2,1H3,(H2,13,15)/b3-2+,6-5+/t10-,11-/m1/s1	Cerulenin	(2R,3S)-3-[(4E,7E)-nona-4,7-dienoyl]oxirane-2-carboxamide	C/C=C/C/C=C/CCC(=O)[C@H]1O[C@H]1C(N)=O	5282054.0	R23_gupta_2019:445			BBB-	C	training
InChI=1S/C12H17NOS/c1-2-13-12(11-7-5-9-15-11)8-4-3-6-10(12)14/h5,7,9,13H,2-4,6,8H2,1H3	Tiletamine	2-(ethylamino)-2-thiophen-2-ylcyclohexan-1-one	CCNC1(c2cccs2)CCCCC1=O	26533.0	R6_adenot_2004:954			BBB+	C	training
InChI=1S/C12H18Cl2N2O/c1-12(2,3)16-6-10(17)7-4-8(13)11(15)9(14)5-7/h4-5,10,16-17H,6,15H2,1-3H3	Clenbuterol	1-(4-amino-3,5-dichlorophenyl)-2-(tert-butylamino)ethanol	CC(C)(C)NCC(O)c1cc(Cl)c(N)c(Cl)c1	2783.0	R14_ghose_2012:458|R23_gupta_2019:466			BBB-	C	training
InChI=1S/C12H18FNO/c1-12(2,3)14-8-11(15)9-6-4-5-7-10(9)13/h4-7,11,14-15H,8H2,1-3H3	Flerobuterol	2-(tert-butylamino)-1-(2-fluorophenyl)ethanol	CC(C)(C)NCC(O)c1ccccc1F	71254.0	R6_adenot_2004:547			BBB+	C	training
InChI=1S/C12H18N2O2S/c1-4-6-8(3)12(7-5-2)9(15)13-11(17)14-10(12)16/h5,8H,2,4,6-7H2,1,3H3,(H2,13,14,15,16,17)	Thiamylal	5-pentan-2-yl-5-prop-2-enyl-2-sulfanylidene-1,3-diazinane-4,6-dione	C=CCC1(C(C)CCC)C(=O)NC(=S)NC1=O	3032285.0	R6_adenot_2004:953			BBB+	C	training
InChI=1S/C12H18N2O3/c1-4-6-8(3)12(7-5-2)9(15)13-11(17)14-10(12)16/h5,8H,2,4,6-7H2,1,3H3,(H2,13,14,15,16,17)	76-73-3|Secobarbital|Quinalbarbitone	5-pentan-2-yl-5-prop-2-enyl-1,3-diazinane-2,4,6-trione	C=CCC1(C(C)CCC)C(=O)NC(=O)NC1=O	5193.0	R4_mente_2005:45|R6_adenot_2004:1666|R14_ghose_2012:219|R21_muehlbacher_2011:127|R23_gupta_2019:213|R25_brito_sanchez_2015:212|R40_vilar_2010:242|R47_radchenko_2020:346|R51_doninger_2002:304	0.2	B	BBB+	A	test
InChI=1S/C12H18N2O3/c1-4-6-8(3)12(7-5-2)9(15)13-11(17)14-10(12)16/h5,8H,2,4,6-7H2,1,3H3,(H2,13,14,15,16,17)/t8-/m1/s1	(+)-Secobarbital	5-[(2R)-pentan-2-yl]-5-prop-2-enyl-1,3-diazinane-2,4,6-trione	C=CCC1([C@H](C)CCC)C(=O)NC(=O)NC1=O	31143.0	R46_mendoza_valencia_2017:196	0.2	A	BBB+	A	test
InChI=1S/C12H18N2O3/c1-5-6-12(7-11(2,3)4)8(15)13-10(17)14-9(12)16/h5H,1,6-7H2,2-4H3,(H2,13,14,15,16,17)	Nealbarbital	5-(2,2-dimethylpropyl)-5-prop-2-enyl-1,3-diazinane-2,4,6-trione	C=CCC1(CC(C)(C)C)C(=O)NC(=O)NC1=O	521716.0	R6_adenot_2004:1658			BBB+	C	test
InChI=1S/C12H18N2O3S/c1-3-4-9-13-12(15)14-18(16,17)11-7-5-10(2)6-8-11/h5-8H,3-4,9H2,1-2H3,(H2,13,14,15)	Tolbutamide	1-butyl-3-(4-methylphenyl)sulfonylurea	CCCCNC(=O)NS(=O)(=O)c1ccc(C)cc1	5505.0	R14_ghose_2012:903|R23_gupta_2019:988|R25_brito_sanchez_2015:518|R46_mendoza_valencia_2017:434|R47_radchenko_2020:472|R51_doninger_2002:137	-0.7	D	BBB+	A	training
InChI=1S/C12H18N2O4/c1-17-8-3-4-11(18-2)9(5-8)10(15)7-14-12(16)6-13/h3-5,10,15H,6-7,13H2,1-2H3,(H,14,16)	Midodrine Hydrochloride|Midodrine	2-amino-N-[2-(2,5-dimethoxyphenyl)-2-hydroxyethyl]acetamide	COc1ccc(OC)c(C(O)CNC(=O)CN)c1	4195.0	R14_ghose_2012:694|R23_gupta_2019:749			BBB-	C	training
InChI=1S/C12H18N2O5/c1-6(2)7-4-14(12(18)13-11(7)17)10-3-8(16)9(5-15)19-10/h4,6,8-10,15-16H,3,5H2,1-2H3,(H,13,17,18)/t8-,9+,10+/m0/s1	Epervudine	1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-propan-2-ylpyrimidine-2,4-dione	CC(C)c1cn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)[nH]c1=O	512735.0	R23_gupta_2019:1058			BBB-	C	training
InChI=1S/C12H18N4O4/c17-9(7-15-5-1-3-11(15)19)13-14-10(18)8-16-6-2-4-12(16)20/h1-8H2,(H,13,17)(H,14,18)	Dupracetam	2-(2-oxopyrrolidin-1-yl)-N'-[2-(2-oxopyrrolidin-1-yl)acetyl]acetohydrazide	O=C(CN1CCCC1=O)NNC(=O)CN1CCCC1=O	68793.0	R6_adenot_2004:1256			BBB+	C	training
InChI=1S/C12H18O/c1-8(2)10-6-5-7-11(9(3)4)12(10)13/h5-9,13H,1-4H3	Propofol|Propofol, Diprivan	2,6-di(propan-2-yl)phenol	CC(C)c1cccc(C(C)C)c1O	4943.0	R3_abraham_2006:239|R3_abraham_2006:240|R6_adenot_2004:948|R21_muehlbacher_2011:116|R25_brito_sanchez_2015:370|R26_chico_2009:333|R37_chen_2011:76|R40_vilar_2010:220|R41_toropov_2017:214|R42_ciura_2020:34|R46_mendoza_valencia_2017:324|R47_radchenko_2020:199|R51_doninger_2002:298			BBB+	C	training
InChI=1S/C12H19NO3/c1-12(2,3)13-7-11(16)8-4-9(14)6-10(15)5-8/h4-6,11,13-16H,7H2,1-3H3	Terbutaline	5-[2-(tert-butylamino)-1-hydroxyethyl]benzene-1,3-diol	CC(C)(C)NCC(O)c1cc(O)cc(O)c1	5403.0	R7_andres_2006:166|R23_gupta_2019:967|R29_subramanian_2003:162			BBB-	C	training
InChI=1S/C12H20N2/c1-9-7-12(14(3)4)6-5-11(9)8-10(2)13/h5-7,10H,8,13H2,1-4H3	Amiflamine|4-(Dimethylamino)-Alpha,2-Dimethylphenethylamine	4-(2-aminopropyl)-N,N,3-trimethylaniline	Cc1cc(N(C)C)ccc1CC(C)N	3043606.0	R6_adenot_2004:986			BBB+	C	training
InChI=1S/C12H20N2O2S/c1-4-7-8(5-2)12(6-3)9(15)13-11(17)14-10(12)16/h8H,4-7H2,1-3H3,(H2,13,14,15,16,17)	Thiotetrabarbital	5-ethyl-5-hexan-3-yl-2-sulfanylidene-1,3-diazinane-4,6-dione	CCCC(CC)C1(CC)C(=O)NC(=S)NC1=O	3083570.0	R6_adenot_2004:1670			BBB+	C	training
InChI=1S/C12H20N2O2S2/c1-4-5-8(2)12(6-7-18-3)9(15)13-11(17)14-10(12)16/h8H,4-7H2,1-3H3,(H2,13,14,15,16,17)	Methitural	5-(2-methylsulfanylethyl)-5-pentan-2-yl-2-sulfanylidene-1,3-diazinane-4,6-dione	CCCC(C)C1(CCSC)C(=O)NC(=S)NC1=O	3032307.0	R6_adenot_2004:940			BBB+	C	training
InChI=1S/C12H20N2O3/c1-12(2,3)13-6-11(17)8-4-5-10(16)9(7-15)14-8/h4-5,11,13,15-17H,6-7H2,1-3H3	Pirbuterol	6-[2-(tert-butylamino)-1-hydroxyethyl]-2-(hydroxymethyl)pyridin-3-ol	CC(C)(C)NCC(O)c1ccc(O)c(CO)n1	4845.0	R23_gupta_2019:842|R51_doninger_2002:112			BBB-	C	training
InChI=1S/C12H20N2O3/c1-3-5-6-7-8-12(4-2)9(15)13-11(17)14-10(12)16/h3-8H2,1-2H3,(H2,13,14,15,16,17)	5-Hexyl-5-Ethyl Barbituric Acid|Ortal	5-ethyl-5-hexyl-1,3-diazinane-2,4,6-trione	CCCCCCC1(CC)C(=O)NC(=O)NC1=O	8942.0	R3_abraham_2006:111|R21_muehlbacher_2011:205|R25_brito_sanchez_2015:97|R40_vilar_2010:18|R41_toropov_2017:106|R46_mendoza_valencia_2017:95|R47_radchenko_2020:93	0.36	B	BBB+	A	test
InChI=1S/C12H20N2O3/c1-4-7-8(5-2)12(6-3)9(15)13-11(17)14-10(12)16/h8H,4-7H2,1-3H3,(H2,13,14,15,16,17)	Tetrabarbital	5-ethyl-5-hexan-3-yl-1,3-diazinane-2,4,6-trione	CCCC(CC)C1(CC)C(=O)NC(=O)NC1=O	101534.0	R6_adenot_2004:1667			BBB+	C	test
InChI=1S/C12H20N2O3S/c1-9(2)13-8-12(15)10-4-6-11(7-5-10)14-18(3,16)17/h4-7,9,12-15H,8H2,1-3H3	3930-20-9|Sotalol Hydrochloride|Sotalol	N-[4-[1-hydroxy-2-(propan-2-ylamino)ethyl]phenyl]methanesulfonamide	CC(C)NCC(O)c1ccc(NS(C)(=O)=O)cc1	5253.0	R4_mente_2005:70|R14_ghose_2012:848|R21_muehlbacher_2011:129|R23_gupta_2019:916|R25_brito_sanchez_2015:163|R28_li_2005:286|R40_vilar_2010:259|R42_ciura_2020:41|R46_mendoza_valencia_2017:158|R47_radchenko_2020:347|R50_sobanska_2019:17	-0.28	B	BBB+	A	training
InChI=1S/C12H20N4/c1-10(2)15-11-4-3-5-14-12(11)16-8-6-13-7-9-16/h3-5,10,13,15H,6-9H2,1-2H3	U 88703|3-Pyridinamine, N-(1-Methylethyl)-2-(1-Piperazinyl)-	2-piperazin-1-yl-N-propan-2-ylpyridin-3-amine	CC(C)Nc1cccnc1N1CCNCC1	10013750.0	R26_chico_2009:436	-0.14	A	BBB+	A	test
InChI=1S/C12H20N4O3S/c1-13-11(9-16(17)18)14-6-7-20-12-5-4-10(19-12)8-15(2)3/h4-5,9,13-14H,6-8H2,1-3H3/b11-9-			CN/C(=C/[N+](=O)[O-])NCCSc1ccc(CN(C)C)o1		R48_hou_2003:4	-1.23	A	BBB-	A	training
InChI=1S/C12H20N4O7/c1-4(18)15-8-5(16-12(13)14)2-7(11(21)22)23-10(8)9(20)6(19)3-17/h2,5-6,8-10,17,19-20H,3H2,1H3,(H,15,18)(H,21,22)(H4,13,14,16)/t5-,6+,8+,9+,10+/m0/s1	Zanamivir	(2R,3R,4S)-3-acetamido-4-(diaminomethylideneamino)-2-[(1R,2R)-1,2,3-trihydroxypropyl]-3,4-dihydro-2H-pyran-6-carboxylic acid	CC(=O)N[C@H]1[C@H]([C@H](O)[C@H](O)CO)OC(C(=O)O)=C[C@@H]1N=C(N)N	60855.0	R23_gupta_2019:1038			BBB-	C	training
InChI=1S/C12H21N/c1-10-3-9-4-11(2,6-10)8-12(13,5-9)7-10/h9H,3-8,13H2,1-2H3	Memantine	3,5-dimethyladamantan-1-amine	CC12CC3CC(C)(C1)CC(N)(C3)C2	4054.0	R6_adenot_2004:649|R14_ghose_2012:134			BBB+	C	training
InChI=1S/C12H21N3O5S3/c1-3-14-10-8-15(5-4-6-20-2)23(18,19)12-9(10)7-11(21-12)22(13,16)17/h7,10,14H,3-6,8H2,1-2H3,(H2,13,16,17)/t10-/m0/s1	Brinzolamide	(4R)-4-(ethylamino)-2-(3-methoxypropyl)-1,1-dioxo-3,4-dihydrothieno[3,2-e]thiazine-6-sulfonamide	CCN[C@H]1CN(CCCOC)S(=O)(=O)c2sc(S(N)(=O)=O)cc21	68844.0	R23_gupta_2019:401			BBB-	C	training
InChI=1S/C12H21N5O2S2/c1-13-11(6-17(18)19)14-4-5-20-8-10-9-21-12(15-10)7-16(2)3/h6,9,13-14H,4-5,7-8H2,1-3H3/b11-6+	Nizatidine|Nizax	(E)-1-N'-[2-[[2-[(dimethylamino)methyl]-1,3-thiazol-4-yl]methylsulfanyl]ethyl]-1-N-methyl-2-nitroethene-1,1-diamine	CN/C(=C\[N+](=O)[O-])NCCSCc1csc(CN(C)C)n1	3033637.0	R14_ghose_2012:727			BBB-	C	training
InChI=1S/C12H21N5O3/c1-4-17(8-9(3)18)11-7-6-10(13-15-11)14-16-12(19)20-5-2/h6-7,9,18H,4-5,8H2,1-3H3,(H,13,14)(H,16,19)	Cadralazine	ethyl N-[[6-[ethyl(2-hydroxypropyl)amino]pyridazin-3-yl]amino]carbamate	CCOC(=O)NNc1ccc(N(CC)CC(C)O)nn1	2515.0	R23_gupta_2019:1047|R26_chico_2009:90	-1.0	A	BBB+	A	training
InChI=1S/C12H21NO8S/c1-10(2)18-7-5-16-12(6-17-22(13,14)15)9(8(7)19-10)20-11(3,4)21-12/h7-9H,5-6H2,1-4H3,(H2,13,14,15)/t7-,8-,9+,12+/m1/s1	Topiramate|Topiramate, Topamax	[(1R,2S,6S,9R)-4,4,11,11-tetramethyl-3,5,7,10,12-pentaoxatricyclo[7.3.0.02,6]dodecan-6-yl]methyl sulfamate	CC1(C)O[C@@H]2[C@@H](CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@H]23)O1	5284627.0	R6_adenot_2004:473|R7_andres_2006:177|R14_ghose_2012:254|R23_gupta_2019:247|R25_brito_sanchez_2015:388|R26_chico_2009:422|R29_subramanian_2003:172|R34_broccatelli_2012:91|R46_mendoza_valencia_2017:333|R53_friden_2009:39	-0.07	B1	BBB+	A	training
InChI=1S/C12H22N2O2/c1-6-9-11(15)14(8-3)10(7-2)12(16)13(4)5/h6,9-10H,7-8H2,1-5H3/b9-6+	Crotetamide	2-[[(E)-but-2-enoyl]-ethylamino]-N,N-dimethylbutanamide	C/C=C/C(=O)N(CC)C(CC)C(=O)N(C)C	5368010.0	R6_adenot_2004:398			BBB+	C	training
InChI=1S/C12H22O11/c13-1-4-6(16)7(17)8(18)11(21-4)22-9-5(2-14)23-12(20,3-15)10(9)19/h4-11,13-20H,1-3H2	Lactulose|4-O-Hexopyranosylhex-2-Ulofuranose	2-[4,5-dihydroxy-2,5-bis(hydroxymethyl)oxolan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol	OCC1OC(OC2C(CO)OC(O)(CO)C2O)C(O)C(O)C1O	3872.0	R23_gupta_2019:695			BBB-	C	training
InChI=1S/C12H22O11/c13-1-4-6(16)8(18)9(19)11(21-4)23-12(3-15)10(20)7(17)5(2-14)22-12/h4-11,13-20H,1-3H2/t4-,5-,6-,7-,8+,9-,10+,11-,12+/m1/s1	Sucrose	(2R,3R,4S,5S,6R)-2-[(2S,3S,4S,5R)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol	OC[C@H]1O[C@@](CO)(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@@H]1O	5988.0	R47_radchenko_2020:457	-1.7	A	BBB-	A	training
InChI=1S/C12H24N2O4/c1-5-6-12(4,7-17-10(13)15)8-18-11(16)14-9(2)3/h9H,5-8H2,1-4H3,(H2,13,15)(H,14,16)	Carisoprodol	[2-(carbamoyloxymethyl)-2-methylpentyl] N-propan-2-ylcarbamate	CCCC(C)(COC(N)=O)COC(=O)NC(C)C	2576.0	R23_gupta_2019:38|R37_chen_2011:19			BBB+	C	training
InChI=1S/C12H24O11/c13-1-4(16)7(18)11(5(17)2-14)23-12-10(21)9(20)8(19)6(3-15)22-12/h4-21H,1-3H2/t4-,5+,6+,7+,8-,9-,10+,11+,12-/m0/s1	Lactitol	(2S,3R,4R,5R)-4-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexane-1,2,3,5,6-pentol	OC[C@@H](O)[C@@H](O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)[C@H](O)[C@@H](O)CO	157355.0	R14_ghose_2012:643			BBB-	C	training
InChI=1S/C12H25NO2/c1-4-6-7-11(5-2)9-13-12(15)8-10(3)14/h10-11,14H,4-9H2,1-3H3,(H,13,15)	Butoctamide|Butoctamidehydrogensuccinate	N-(2-ethylhexyl)-3-hydroxybutanamide	CCCCC(CC)CNC(=O)CC(C)O	65780.0	R6_adenot_2004:1347|R14_ghose_2012:31			BBB+	C	training
InChI=1S/C12H6Cl4O2S/c13-5-1-7(15)11(17)9(3-5)19-10-4-6(14)2-8(16)12(10)18/h1-4,17-18H	Bithionol	2,4-dichloro-6-(3,5-dichloro-2-hydroxyphenyl)sulfanylphenol	Oc1c(Cl)cc(Cl)cc1Sc1cc(Cl)cc(Cl)c1O	2406.0	R14_ghose_2012:400			BBB-	C	training
InChI=1S/C12H7Cl3O2/c13-7-1-3-11(9(15)5-7)17-12-4-2-8(14)6-10(12)16/h1-6,16H	Triclosan	5-chloro-2-(2,4-dichlorophenoxy)phenol	Oc1cc(Cl)ccc1Oc1ccc(Cl)cc1Cl	5564.0	R50_sobanska_2019:113			BBB+	C	training
InChI=1S/C12H7ClF2N2O/c13-11-4-2-8(6-16-11)17-12(18)7-1-3-9(14)10(15)5-7/h1-6H,(H,17,18)	Ica-27243|N-(6-Chloropyridin-3-Yl)-3,4-Difluorobenzamide	N-(6-chloropyridin-3-yl)-3,4-difluorobenzamide	O=C(Nc1ccc(Cl)nc1)c1ccc(F)c(F)c1	9903497.0	R26_chico_2009:216	0.44	A	BBB+	A	training
InChI=1S/C12H8O4/c1-14-12-10-8(4-5-15-10)6-7-2-3-9(13)16-11(7)12/h2-6H,1H3	Methoxsalen	9-methoxyfuro[3,2-g]chromen-7-one	COc1c2occc2cc2ccc(=O)oc12	4114.0	R14_ghose_2012:687|R23_gupta_2019:739			BBB-	C	training
InChI=1S/C12H9F3N2O2/c1-7-10(6-16-19-7)11(18)17-9-4-2-8(3-5-9)12(13,14)15/h2-6H,1H3,(H,17,18)	Leflunomide	5-methyl-N-[4-(trifluoromethyl)phenyl]-1,2-oxazole-4-carboxamide	Cc1oncc1C(=O)Nc1ccc(C(F)(F)F)cc1	3899.0	R14_ghose_2012:647|R23_gupta_2019:703			BBB-	C	test
InChI=1S/C12H9N3O/c1-8-11(9-2-4-14-5-3-9)6-10(7-13)12(16)15-8/h2-6H,1H3,(H,15,16)	Milrinone	6-methyl-2-oxo-5-pyridin-4-yl-1H-pyridine-3-carbonitrile	Cc1[nH]c(=O)c(C#N)cc1-c1ccncc1	4197.0	R23_gupta_2019:750			BBB-	C	training
InChI=1S/C12H9N3O/c13-15-7-14-11-6-9-4-2-1-3-8(9)5-10(11)12(15)16/h1-7H,13H2	Centazolone	3-aminobenzo[g]quinazolin-4-one	Nn1cnc2cc3ccccc3cc2c1=O	72846.0	R51_doninger_2002:176			BBB+	C	training
InChI=1S/C12H9N3O5/c16-9-3-1-8(2-4-9)12(17)14-13-7-10-5-6-11(20-10)15(18)19/h1-7,16H,(H,14,17)	Nifuroxazide|Akabar	4-hydroxy-N-[(5-nitrofuran-2-yl)methylideneamino]benzamide	O=C(NN=Cc1ccc([N+](=O)[O-])o1)c1ccc(O)cc1	13764.0	R50_sobanska_2019:52			BBB-	C	training
InChI=1S/C12H9N3O5S/c1-7(16)20-9-5-3-2-4-8(9)11(17)14-12-13-6-10(21-12)15(18)19/h2-6H,1H3,(H,13,14,17)	Nitazoxanide	[2-[(5-nitro-1,3-thiazol-2-yl)carbamoyl]phenyl] acetate	CC(=O)Oc1ccccc1C(=O)Nc1ncc([N+](=O)[O-])s1	41684.0	R14_ghose_2012:722|R23_gupta_2019:782			BBB-	C	test
InChI=1S/C12H9NO6/c1-17-13-4-7(12(15)16)11(14)6-2-9-10(3-8(6)13)19-5-18-9/h2-4H,5H2,1H3,(H,15,16)	Miloxacin	5-methoxy-8-oxo-[1,3]dioxolo[4,5-g]quinoline-7-carboxylic acid	COn1cc(C(=O)O)c(=O)c2cc3c(cc21)OCO3	37614.0	R3_abraham_2006:201|R21_muehlbacher_2011:244|R25_brito_sanchez_2015:301|R26_chico_2009:272|R40_vilar_2010:151|R41_toropov_2017:183|R46_mendoza_valencia_2017:268|R47_radchenko_2020:169	-0.92	B	BBB+	A	test
InChI=1S/C13H10N2O4/c16-10-6-5-9(11(17)14-10)15-12(18)7-3-1-2-4-8(7)13(15)19/h1-4,9H,5-6H2,(H,14,16,17)	Thalidomide	2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	5426.0	R6_adenot_2004:1384|R14_ghose_2012:242|R23_gupta_2019:237|R26_chico_2009:410	-0.05	A	BBB+	A	test
InChI=1S/C13H10O2/c14-13(15)12-8-6-11(7-9-12)10-4-2-1-3-5-10/h1-9H,(H,14,15)	P-Phenylbenzoic Acid|4-Carboxybiphenyl|4-Biphenylcarboxylic Acid	4-phenylbenzoic acid	O=C(O)c1ccc(-c2ccccc2)cc1	66724.0	R3_abraham_2006:235|R21_muehlbacher_2011:265|R25_brito_sanchez_2015:575|R40_vilar_2010:214|R41_toropov_2017:211|R46_mendoza_valencia_2017:480|R47_radchenko_2020:196	-1.26	B	BBB-	A	training
InChI=1S/C13H10O3/c14-12-9-5-4-8-11(12)13(15)16-10-6-2-1-3-7-10/h1-9,14H	Phenyl-Salicylate|Phenyl Salicylate	phenyl 2-hydroxybenzoate	O=C(Oc1ccccc1)c1ccccc1O	8361.0	R6_adenot_2004:1321			BBB+	C	test
InChI=1S/C13H11ClN2O2/c1-8-10(14)5-2-6-11(8)16-12-9(13(17)18)4-3-7-15-12/h2-7H,1H3,(H,15,16)(H,17,18)	Clonixin	2-(3-chloro-2-methylanilino)pyridine-3-carboxylic acid	Cc1c(Cl)cccc1Nc1ncccc1C(=O)O	28718.0	R14_ghose_2012:463			BBB-	C	training
InChI=1S/C13H11N3/c14-10-3-1-8-5-9-2-4-11(15)7-13(9)16-12(8)6-10/h1-7H,14-15H2	Proflavine	acridine-3,6-diamine	Nc1ccc2cc3ccc(N)cc3nc2c1	7099.0	R23_gupta_2019:861			BBB-	C	training
InChI=1S/C13H11N3O4S2/c1-16-10(13(18)15-9-4-2-3-6-14-9)11(17)12-8(5-7-21-12)22(16,19)20/h2-7,17H,1H3,(H,14,15,18)	Tenoxicam	4-hydroxy-2-methyl-1,1-dioxo-N-pyridin-2-ylthieno[2,3-e]thiazine-3-carboxamide	CN1C(C(=O)Nc2ccccn2)=C(O)c2sccc2S1(=O)=O	54677971.0	R14_ghose_2012:882|R28_li_2005:412			BBB-	C	training
InChI=1S/C13H11NO3/c14-9-6-7-11(12(15)8-9)13(16)17-10-4-2-1-3-5-10/h1-8,15H,14H2	Phenyl Aminosalicylate	phenyl 4-amino-2-hydroxybenzoate	Nc1ccc(C(=O)Oc2ccccc2)c(O)c1	8609.0	R14_ghose_2012:770			BBB-	C	test
InChI=1S/C13H11NO5/c1-2-14-5-8(13(16)17)12(15)7-3-10-11(4-9(7)14)19-6-18-10/h3-5H,2,6H2,1H3,(H,16,17)	Oxolinic|Oxolinic Acid	5-ethyl-8-oxo-[1,3]dioxolo[4,5-g]quinoline-7-carboxylic acid	CCn1cc(C(=O)O)c(=O)c2cc3c(cc21)OCO3	4628.0	R14_ghose_2012:746			BBB-	C	test
InChI=1S/C13H12Cl2O4/c1-3-7(2)13(18)8-4-5-9(12(15)11(8)14)19-6-10(16)17/h4-5H,2-3,6H2,1H3,(H,16,17)	Ethacrynic Acid|Etacrynicacid	2-[2,3-dichloro-4-(2-methylidenebutanoyl)phenoxy]acetic acid	C=C(CC)C(=O)c1ccc(OCC(=O)O)c(Cl)c1Cl	3278.0	R14_ghose_2012:538|R23_gupta_2019:576|R28_li_2005:199|R51_doninger_2002:53			BBB-	C	test
InChI=1S/C13H12F2N6O/c14-10-1-2-11(12(15)3-10)13(22,4-20-8-16-6-18-20)5-21-9-17-7-19-21/h1-3,6-9,22H,4-5H2	Fluconazole	2-(2,4-difluorophenyl)-1,3-bis(1,2,4-triazol-1-yl)propan-2-ol	OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F	3365.0	R6_adenot_2004:668|R14_ghose_2012:563|R25_brito_sanchez_2015:233|R28_li_2005:205|R46_mendoza_valencia_2017:214|R50_sobanska_2019:87	-0.22	B	BBB+	A	test
InChI=1S/C13H12N2O2/c16-13(17)6-5-11-1-3-12(4-2-11)9-15-8-7-14-10-15/h1-8,10H,9H2,(H,16,17)/b6-5+	Ozagrel	(E)-3-[4-(imidazol-1-ylmethyl)phenyl]prop-2-enoic acid	O=C(O)/C=C/c1ccc(Cn2ccnc2)cc1	5282440.0	R23_gupta_2019:808			BBB-	C	training
InChI=1S/C13H12N2O5S/c1-21(18,19)14-12-8-7-10(15(16)17)9-13(12)20-11-5-3-2-4-6-11/h2-9,14H,1H3	Nimesulide	N-(4-nitro-2-phenoxyphenyl)methanesulfonamide	CS(=O)(=O)Nc1ccc([N+](=O)[O-])cc1Oc1ccccc1	4495.0	R14_ghose_2012:721|R23_gupta_2019:780			BBB-	C	training
InChI=1S/C13H12N8O4S3/c22-7(1-20-4-14-18-19-20)16-8-10(23)21-9(12(24)25)6(2-26-11(8)21)3-27-13-17-15-5-28-13/h4-5,8,11H,1-3H2,(H,16,22)(H,24,25)/t8-,11-/m1/s1	Ceftezole	(6R,7R)-8-oxo-7-[[2-(tetrazol-1-yl)acetyl]amino]-3-(1,3,4-thiadiazol-2-ylsulfanylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid	O=C(Cn1cnnn1)N[C@@H]1C(=O)N2C(C(=O)O)=C(CSc3nncs3)CS[C@H]12	65755.0	R6_adenot_2004:199			BBB-	C	training
InChI=1S/C13H13ClN2O2S/c1-8-4-3-5-9(14)13(8)15-10(17)6-12-16(2)11(18)7-19-12/h3-6H,7H2,1-2H3,(H,15,17)/b12-6-	Ralitoline	(2Z)-N-(2-chloro-6-methylphenyl)-2-(3-methyl-4-oxo-1,3-thiazolidin-2-ylidene)acetamide	Cc1cccc(Cl)c1NC(=O)/C=C1\SCC(=O)N1C	6436118.0	R6_adenot_2004:467|R7_andres_2006:150|R29_subramanian_2003:147			BBB+	C	training
InChI=1S/C13H13F3N6O4S3/c1-21-12(18-19-20-21)28-3-5-2-27-10-7(9(24)22(10)8(5)11(25)26)17-6(23)4-29-13(14,15)16/h7,10H,2-4H2,1H3,(H,17,23)(H,25,26)/t7-,10-/m1/s1	Cefazaflur	(6R,7R)-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-7-[[2-(trifluoromethylsulfanyl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid	Cn1nnnc1SCC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)CSC(F)(F)F)[C@H]2SC1	40240.0	R6_adenot_2004:163			BBB-	C	training
InChI=1S/C13H13N3/c1-2-16-13-5-11-9-3-8(6-14-7-9)10(11)4-12(13)15-1/h1-2,4-5,8-9,14H,3,6-7H2	Varenicline|6,10-Methano-6H-Pyrazino[2,3-H][3]Benzazepine, 7,8,9,10-Tetrahydro-	5,8,14-triazatetracyclo[10.3.1.02,11.04,9]hexadeca-2,4,6,8,10-pentaene	c1cnc2cc3c(cc2n1)C1CNCC3C1	170361.0	R34_broccatelli_2012:96|R37_chen_2011:102			BBB+	C	training
InChI=1S/C13H13N3/c14-13(15-11-7-3-1-4-8-11)16-12-9-5-2-6-10-12/h1-10H,(H3,14,15,16)	1,3-Diphenylguanidine	1,2-diphenylguanidine	N/C(=N\c1ccccc1)Nc1ccccc1	7594.0	R47_radchenko_2020:376	0.0	A	BBB+	A	training
InChI=1S/C13H13N3O6S/c1-6(17)22-4-7-5-23-12-9(15-8(18)2-3-14)11(19)16(12)10(7)13(20)21/h9,12H,2,4-5H2,1H3,(H,15,18)(H,20,21)/t9-,12-/m1/s1	Cefacetrile	(6R,7R)-3-(acetyloxymethyl)-7-[(2-cyanoacetyl)amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid	CC(=O)OCC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)CC#N)[C@H]2SC1	91562.0	R6_adenot_2004:150|R23_gupta_2019:415			BBB-	C	training
InChI=1S/C13H13N5O5S2/c1-23-17-7(5-4-25-13(14)15-5)9(19)16-8-10(20)18-6(12(21)22)2-3-24-11(8)18/h2,4,8,11H,3H2,1H3,(H2,14,15)(H,16,19)(H,21,22)/b17-7-/t8-,11-/m1/s1	Ceftizoxime|7-[2-(2-Amino-Thiazol-4-Yl)-2-Methoxyimino-Acetylamino]-8-Oxo-5-Thia-1-Aza-Bicyclo[4.2.0]Oct-2-Ene-2-Carboxylic Acid	(6R,7R)-7-[[(2E)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid	CO/N=C(/C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=CCS[C@H]12)c1csc(N)n1	5361848.0	R6_adenot_2004:203|R23_gupta_2019:438			BBB-	C	training
InChI=1S/C13H14BrN3O2S/c14-10-2-1-4-15-11(10)8-20-7-6-17-12-9(13(18)19)3-5-16-12/h1-5,16-17H,6-8H2,(H,18,19)			O=C(O)c1cc[nH]c1NCCSCc1ncccc1Br		R48_hou_2003:52	-0.67	A	BBB+	A	training
InChI=1S/C13H14Cl2O3/c1-12(2,11(16)17)18-9-5-3-8(4-6-9)10-7-13(10,14)15/h3-6,10H,7H2,1-2H3,(H,16,17)	Ciprofibrate	2-[4-(2,2-dichlorocyclopropyl)phenoxy]-2-methylpropanoic acid	CC(C)(Oc1ccc(C2CC2(Cl)Cl)cc1)C(=O)O	2763.0	R14_ghose_2012:453			BBB-	C	test
InChI=1S/C13H14N2/c14-13-9-5-1-3-7-11(9)15-12-8-4-2-6-10(12)13/h1,3,5,7H,2,4,6,8H2,(H2,14,15)	Tacrine|Tacrine, Cognex	1,2,3,4-tetrahydroacridin-9-amine	Nc1c2c(nc3ccccc13)CCCC2	1935.0	R5_guerra_2008:94|R12_garg_2006:156|R14_ghose_2012:236|R21_muehlbacher_2011:23|R23_gupta_2019:231|R25_brito_sanchez_2015:146|R26_chico_2009:398|R28_li_2005:292|R34_broccatelli_2012:89|R39_shayanfar_2011:87|R40_vilar_2010:263|R47_radchenko_2020:288|R51_doninger_2002:306|R53_friden_2009:36			BBB+	C	training
InChI=1S/C13H14N2O/c14-13-8-4-1-2-5-9(8)15-10-6-3-7-11(16)12(10)13/h1-2,4-5,11,16H,3,6-7H2,(H2,14,15)	Velnacrine	9-amino-1,2,3,4-tetrahydroacridin-1-ol	Nc1c2c(nc3ccccc13)CCCC2O	3655.0	R6_adenot_2004:1276			BBB+	C	training
InChI=1S/C13H14N2O/c16-13-6-7-14-12-8-11(9-15(12)13)10-4-2-1-3-5-10/h1-5,11H,6-9H2	Rofelodine	7-phenyl-3,6,7,8-tetrahydro-2H-pyrrolo[1,2-a]pyrimidin-4-one	O=C1CCN=C2CC(c3ccccc3)CN12	71152.0	R6_adenot_2004:605			BBB+	C	training
InChI=1S/C13H14N2O2/c1-10(11-6-4-3-5-7-11)15-9-14-8-12(15)13(16)17-2/h3-10H,1-2H3	Metomidate	methyl 3-(1-phenylethyl)imidazole-4-carboxylate	COC(=O)c1cncn1C(C)c1ccccc1	21474.0	R6_adenot_2004:1334			BBB+	C	training
InChI=1S/C13H14N2O2/c1-8-5-4-6-9(2)12(8)13(16)14-11-7-10(3)17-15-11/h4-7H,1-3H3,(H,14,15,16)	Soretolide	2,6-dimethyl-N-(5-methyl-1,2-oxazol-3-yl)benzamide	Cc1cc(NC(=O)c2c(C)cccc2C)no1	198730.0	R6_adenot_2004:435			BBB+	C	training
InChI=1S/C13H14N2O2/c1-9(13(14)15-16)17-12-8-4-6-10-5-2-3-7-11(10)12/h2-9,16H,1H3,(H2,14,15)	Naprodoxime|N-Hydroxy-2-[(Naphthalen-1-Yl)Oxy]Propanimidamide	N'-hydroxy-2-naphthalen-1-yloxypropanimidamide	CC(Oc1cccc2ccccc12)C(N)=NO	164527.0	R6_adenot_2004:1493			BBB+	C	test
InChI=1S/C13H14N2O3/c1-3-13(9-7-5-4-6-8-9)10(16)14-12(18)15(2)11(13)17/h4-8H,3H2,1-2H3,(H,14,16,18)	Methylphenobarbital|Mephobarbital	5-ethyl-1-methyl-5-phenyl-1,3-diazinane-2,4,6-trione	CCC1(c2ccccc2)C(=O)NC(=O)N(C)C1=O	8271.0	R6_adenot_2004:1654|R14_ghose_2012:147|R23_gupta_2019:148			BBB+	C	training
InChI=1S/C13H14N2O4/c1-8(16)14-9-2-4-10(5-3-9)19-13(18)11-6-7-12(17)15-11/h2-5,11H,6-7H2,1H3,(H,14,16)(H,15,17)/t11-/m0/s1	Pidolacetamol	(4-acetamidophenyl) (2S)-5-oxopyrrolidine-2-carboxylate	CC(=O)Nc1ccc(OC(=O)[C@@H]2CCC(=O)N2)cc1	65920.0	R6_adenot_2004:410			BBB+	C	training
InChI=1S/C13H14N8S/c1-17-12(18-7-14)19-9-4-2-3-8(5-9)10-6-22-13(20-10)21-11(15)16/h2-6H,1H3,(H2,17,18,19)(H4,15,16,20,21)	Skb23|Bbcpd58|72801-63-9|Chebi: 145922|B-054|19|13|Guanidinenmethylncyanon32Nguanidylthiazol4Ylphen	1-cyano-3-[3-[2-(diaminomethylideneamino)-1,3-thiazol-4-yl]phenyl]-2-methylguanidine	C/N=C(\NC#N)Nc1cccc(-c2csc(N=C(N)N)n2)c1	14022519.0	R3_abraham_2006:263|R3_abraham_2006:312|R4_mente_2005:127|R12_garg_2006:42|R21_muehlbacher_2011:355|R25_brito_sanchez_2015:13|R25_brito_sanchez_2015:413|R26_chico_2009:53|R28_li_2005:157|R40_vilar_2010:47|R41_toropov_2017:235|R41_toropov_2017:278|R41_toropov_2017:296|R46_mendoza_valencia_2017:13|R46_mendoza_valencia_2017:350|R47_radchenko_2020:218|R48_hou_2003:41|R49_norinder_2002:19	-1.53	B1	BBB-	A	training
InChI=1S/C13H15Cl2NO/c1-3-7-16(2)8-4-9-17-13-6-5-11(14)10-12(13)15/h1,5-6,10H,4,7-9H2,2H3	Clorgiline	3-(2,4-dichlorophenoxy)-N-methyl-N-prop-2-ynylpropan-1-amine	C#CCN(C)CCCOc1ccc(Cl)cc1Cl	4380.0	R6_adenot_2004:967			BBB+	C	training
InChI=1S/C13H15Cl2NO4/c1-7(18)8-2-4-9(5-3-8)11(19)10(6-17)16-13(20)12(14)15/h2-5,10-12,17,19H,6H2,1H3,(H,16,20)/t10-,11-/m1/s1	Cetofenicol|Cetophenicol	N-[(1R,2R)-1-(4-acetylphenyl)-1,3-dihydroxypropan-2-yl]-2,2-dichloroacetamide	CC(=O)c1ccc([C@@H](O)[C@@H](CO)NC(=O)C(Cl)Cl)cc1	10358610.0	R6_adenot_2004:653			BBB+	C	training
InChI=1S/C13H15N3/c1-2-4-12-11(3-1)5-6-13(15-12)16-9-7-14-8-10-16/h1-6,14H,7-10H2	Quipazine	2-piperazin-1-ylquinoline	c1ccc2nc(N3CCNCC3)ccc2c1	5011.0	R7_andres_2006:148|R29_subramanian_2003:145			BBB+	C	training
InChI=1S/C13H15N3O4S/c1-19-7-8-20-11-9-14-13(15-10-11)16-21(17,18)12-5-3-2-4-6-12/h2-6,9-10H,7-8H2,1H3,(H,14,15,16)	Glycodiazine|Glymidine	N-[5-(2-methoxyethoxy)pyrimidin-2-yl]benzenesulfonamide	COCCOc1cnc(NS(=O)(=O)c2ccccc2)nc1	9565.0	R23_gupta_2019:643			BBB-	C	test
InChI=1S/C13H15N3O4S/c1-8-9(2)15-20-13(8)16(10(3)17)21(18,19)12-6-4-11(14)5-7-12/h4-7H,14H2,1-3H3	Sulfisoxazole Acetyl	N-(4-aminophenyl)sulfonyl-N-(3,4-dimethyl-1,2-oxazol-5-yl)acetamide	CC(=O)N(c1onc(C)c1C)S(=O)(=O)c1ccc(N)cc1	6662.0	R14_ghose_2012:867			BBB-	C	training
InChI=1S/C13H15N5O2/c1-5-9-7(2)18-6-10(11-14-8(3)20-17-11)15-13(18)16-12(9)19-4/h6H,5H2,1-4H3	Fasiplon	3-(6-ethyl-7-methoxy-5-methylimidazo[1,2-a]pyrimidin-2-yl)-5-methyl-1,2,4-oxadiazole	CCc1c(OC)nc2nc(-c3noc(C)n3)cn2c1C	208954.0	R6_adenot_2004:1466			BBB+	C	training
InChI=1S/C13H15NO2/c1-13(2)14-12(15)11(16-13)9-8-10-6-4-3-5-7-10/h3-9,11H,1-2H3,(H,14,15)	Methastyridone	2,2-dimethyl-5-(2-phenylethenyl)-1,3-oxazolidin-4-one	CC1(C)NC(=O)C(C=Cc2ccccc2)O1	68936.0	R6_adenot_2004:1299			BBB+	C	training
InChI=1S/C13H15NO2/c1-2-13(10-6-4-3-5-7-10)9-8-11(15)14-12(13)16/h3-7H,2,8-9H2,1H3,(H,14,15,16)	Glutethimide	3-ethyl-3-phenylpiperidine-2,6-dione	CCC1(c2ccccc2)CCC(=O)NC1=O	3487.0	R6_adenot_2004:1364|R51_doninger_2002:221			BBB+	C	training
InChI=1S/C13H15NO2/c1-3-10-11(15)14-12(16)13(10,2)9-7-5-4-6-8-9/h4-8,10H,3H2,1-2H3,(H,14,15,16)	Fenimide	4-ethyl-3-methyl-3-phenylpyrrolidine-2,5-dione	CCC1C(=O)NC(=O)C1(C)c1ccccc1	6068.0	R6_adenot_2004:1530			BBB+	C	training
InChI=1S/C13H16Cl12O8/c14-10(15,16)5(26)30-1-9(2-31-6(27)11(17,18)19,3-32-7(28)12(20,21)22)4-33-8(29)13(23,24)25/h5-8,26-29H,1-4H2	Petrichloral	2,2,2-trichloro-1-[3-(2,2,2-trichloro-1-hydroxyethoxy)-2,2-bis[(2,2,2-trichloro-1-hydroxyethoxy)methyl]propoxy]ethanol	OC(OCC(COC(O)C(Cl)(Cl)Cl)(COC(O)C(Cl)(Cl)Cl)COC(O)C(Cl)(Cl)Cl)C(Cl)(Cl)Cl	6519.0	R6_adenot_2004:1337			BBB+	C	training
InChI=1S/C13H16ClNO/c1-15-13(9-5-4-8-12(13)16)10-6-2-3-7-11(10)14/h2-3,6-7,15H,4-5,8-9H2,1H3	Ketamine	2-(2-chlorophenyl)-2-(methylamino)cyclohexan-1-one	CNC1(c2ccccc2Cl)CCCCC1=O	3821.0	R7_andres_2006:88|R26_chico_2009:231|R29_subramanian_2003:82|R51_doninger_2002:234			BBB+	C	training
InChI=1S/C13H16N2/c1-9-5-4-6-12(10(9)2)11(3)13-7-14-8-15-13/h4-8,11H,1-3H3,(H,14,15)/t11-/m0/s1	Dexmedetomidine	5-[(1S)-1-(2,3-dimethylphenyl)ethyl]-1H-imidazole	Cc1cccc([C@H](C)c2cnc[nH]2)c1C	5311068.0	R14_ghose_2012:66|R23_gupta_2019:279			BBB+	C	training
InChI=1S/C13H16N2O2S/c1-2-8-13(9-6-4-3-5-7-9)10(16)14-12(18)15-11(13)17/h2,4,6,9H,1,3,5,7-8H2,(H2,14,15,16,17,18)	Thialbarbital	5-cyclohex-2-en-1-yl-5-prop-2-enyl-2-sulfanylidene-1,3-diazinane-4,6-dione	C=CCC1(C2C=CCCC2)C(=O)NC(=S)NC1=O	3032306.0	R6_adenot_2004:1669			BBB+	C	training
InChI=1S/C13H16N2O3/c1-2-8-14-12(16)15-9-11(18-13(15)17)10-6-4-3-5-7-10/h3-7,11H,2,8-9H2,1H3,(H,14,16)	Profexalone	2-oxo-5-phenyl-N-propyl-1,3-oxazolidine-3-carboxamide	CCCNC(=O)N1CC(c2ccccc2)OC1=O	65786.0	R6_adenot_2004:1375			BBB+	C	test
InChI=1S/C13H16N2O4S/c1-9(2)14-20(18,19)8-7-15-12(16)10-5-3-4-6-11(10)13(15)17/h3-6,9,14H,7-8H2,1-2H3	Taltrimide	2-(1,3-dioxoisoindol-2-yl)-N-propan-2-ylethanesulfonamide	CC(C)NS(=O)(=O)CCN1C(=O)c2ccccc2C1=O	71248.0	R6_adenot_2004:472|R7_andres_2006:162|R29_subramanian_2003:159			BBB+	C	training
InChI=1S/C13H16N4O3S/c1-8(11-3-4-20-13(19)21-11)17(7-18)6-10-5-15-9(2)16-12(10)14/h5,7H,3-4,6H2,1-2H3,(H2,14,15,16)/b11-8-	Cycotiamine	N-[(4-amino-2-methylpyrimidin-5-yl)methyl]-N-[(1Z)-1-(2-oxo-1,3-oxathian-4-ylidene)ethyl]formamide	C/C(=C1\CCOC(=O)S1)N(C=O)Cc1cnc(C)nc1N	10357917.0	R6_adenot_2004:390			BBB+	C	training
InChI=1S/C13H17ClN2O2/c14-12-3-1-11(2-4-12)13(17)15-5-6-16-7-9-18-10-8-16/h1-4H,5-10H2,(H,15,17)	Moclobemide	4-chloro-N-(2-morpholin-4-ylethyl)benzamide	O=C(NCCN1CCOCC1)c1ccc(Cl)cc1	4235.0	R6_adenot_2004:975|R14_ghose_2012:155|R23_gupta_2019:154|R28_li_2005:275|R37_chen_2011:55			BBB+	C	training
InChI=1S/C13H17N/c1-4-10-14(3)12(2)11-13-8-6-5-7-9-13/h1,5-9,12H,10-11H2,2-3H3/t12-/m1/s1	Selegiline	(2R)-N-methyl-1-phenyl-N-prop-2-ynylpropan-2-amine	C#CCN(C)[C@H](C)Cc1ccccc1	26757.0	R6_adenot_2004:982|R14_ghose_2012:228|R26_chico_2009:373|R34_broccatelli_2012:84|R37_chen_2011:89	0.57	A	BBB+	A	training
InChI=1S/C13H17N3O/c1-10-12(14(2)3)13(17)16(15(10)4)11-8-6-5-7-9-11/h5-9H,1-4H3	Aminopyrine Ok|Aminopyrine|Aminophenazone|Amidazophen	4-(dimethylamino)-1,5-dimethyl-2-phenylpyrazol-3-one	Cc1c(N(C)C)c(=O)n(-c2ccccc2)n1C	6009.0	R3_abraham_2006:124|R5_guerra_2008:15|R12_garg_2006:19|R21_muehlbacher_2011:148|R23_gupta_2019:345|R25_brito_sanchez_2015:121|R26_chico_2009:28|R28_li_2005:65|R39_shayanfar_2011:13|R40_vilar_2010:34|R41_toropov_2017:118|R44_bujak_2015:9|R44_bujak_2015:85|R46_mendoza_valencia_2017:119|R47_radchenko_2020:105	0.0	B	BBB+	A	test
InChI=1S/C13H17N3O4S/c1-10-12(14(2)9-21(18,19)20)13(17)16(15(10)3)11-7-5-4-6-8-11/h4-8H,9H2,1-3H3,(H,18,19,20)	Dipyrone|Metamizole	[(1,5-dimethyl-3-oxo-2-phenylpyrazol-4-yl)-methylamino]methanesulfonic acid	Cc1c(N(C)CS(=O)(=O)O)c(=O)n(-c2ccccc2)n1C	3111.0	R14_ghose_2012:505			BBB-	C	test
InChI=1S/C13H17N5O8S2/c1-5-7(10(20)18(5)28(23,24)25)16-9(19)8(6-4-27-12(14)15-6)17-26-13(2,3)11(21)22/h4-5,7H,1-3H3,(H2,14,15)(H,16,19)(H,21,22)(H,23,24,25)/b17-8-/t5-,7-/m0/s1	Aztreonam|Aztreonam E-Isomer	2-[(E)-[1-(2-amino-1,3-thiazol-4-yl)-2-[[(2S,3S)-2-methyl-4-oxo-1-sulfoazetidin-3-yl]amino]-2-oxoethylidene]amino]oxy-2-methylpropanoic acid	C[C@H]1[C@H](NC(=O)/C(=N/OC(C)(C)C(=O)O)c2csc(N)n2)C(=O)N1S(=O)(=O)O	5459211.0	R6_adenot_2004:142|R23_gupta_2019:375			BBB-	C	training
InChI=1S/C13H17N7S/c1-16-12(17-2)18-9-5-3-4-8(6-9)10-7-21-13(19-10)20-11(14)15/h3-7H,1-2H3,(H2,16,17,18)(H4,14,15,19,20)	19		C/N=C(\NC)Nc1cccc(-c2csc(N=C(N)N)n2)c1		R52_liu_2001:19	-1.54	A	BBB-	A	training
InChI=1S/C13H17NO/c1-4-8-13(15)14(5-2)12-10-7-6-9-11(12)3/h4,6-10H,5H2,1-3H3/b8-4+	Crotamiton|2-Butenamide, N-Ethyl-N-(2-Methylphenyl)-	(E)-N-ethyl-N-(2-methylphenyl)but-2-enamide	C/C=C/C(=O)N(CC)c1ccccc1C	688020.0	R23_gupta_2019:483			BBB-	C	training
InChI=1S/C13H17NO2/c1-2-16-13(15)14(12-8-9-12)10-11-6-4-3-5-7-11/h3-7,12H,2,8-10H2,1H3	Encyprate	ethyl N-benzyl-N-cyclopropylcarbamate	CCOC(=O)N(Cc1ccccc1)C1CC1	17298.0	R6_adenot_2004:537			BBB+	C	training
InChI=1S/C13H18Br2N2O/c14-9-5-8(13(16)12(15)6-9)7-17-10-1-3-11(18)4-2-10/h5-6,10-11,17-18H,1-4,7,16H2	Ambroxol	4-[(2-amino-3,5-dibromophenyl)methylamino]cyclohexan-1-ol	Nc1c(Br)cc(Br)cc1CNC1CCC(O)CC1	2132.0	R14_ghose_2012:342			BBB-	C	training
InChI=1S/C13H18Cl2N2O2/c14-5-7-17(8-6-15)11-3-1-10(2-4-11)9-12(16)13(18)19/h1-4,12H,5-9,16H2,(H,18,19)	Sarcolysin	2-amino-3-[4-[bis(2-chloroethyl)amino]phenyl]propanoic acid	NC(Cc1ccc(N(CCCl)CCCl)cc1)C(=O)O	4053.0	R46_mendoza_valencia_2017:423	-0.5	A	BBB+	A	training
InChI=1S/C13H18Cl2N2O2/c14-5-7-17(8-6-15)11-3-1-10(2-4-11)9-12(16)13(18)19/h1-4,12H,5-9,16H2,(H,18,19)/t12-/m0/s1	Melphalan	(2S)-2-amino-3-[4-[bis(2-chloroethyl)amino]phenyl]propanoic acid	N[C@@H](Cc1ccc(N(CCCl)CCCl)cc1)C(=O)O	460612.0	R14_ghose_2012:672|R25_brito_sanchez_2015:505|R51_doninger_2002:83	-0.5	A	BBB+	A	training
InChI=1S/C13H18ClN3O/c1-15(2)6-7-16-8-9-17(13(16)18)12-5-3-4-11(14)10-12/h3-5,10H,6-9H2,1-2H3	Imidoline	1-(3-chlorophenyl)-3-[2-(dimethylamino)ethyl]imidazolidin-2-one	CN(C)CCN1CCN(c2cccc(Cl)c2)C1=O	23728.0	R6_adenot_2004:1478			BBB+	C	training
InChI=1S/C13H18ClNO/c1-15(2)11-6-4-5-9-12(16-3)8-7-10(14)13(9)11/h7-8,11H,4-6H2,1-3H3	Lometraline	8-chloro-5-methoxy-N,N-dimethyl-1,2,3,4-tetrahydronaphthalen-1-amine	COc1ccc(Cl)c2c1CCCC2N(C)C	34789.0	R6_adenot_2004:378			BBB+	C	test
InChI=1S/C13H18ClNO/c1-9(15-13(2,3)4)12(16)10-6-5-7-11(14)8-10/h5-9,15H,1-4H3	34911-55-2|Bupropion|Buproprion, Wellbutrin	2-(tert-butylamino)-1-(3-chlorophenyl)propan-1-one	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	444.0	R4_mente_2005:178|R6_adenot_2004:499|R14_ghose_2012:27|R21_muehlbacher_2011:10|R25_brito_sanchez_2015:171|R26_chico_2009:88|R28_li_2005:240|R34_broccatelli_2012:10|R40_vilar_2010:64|R46_mendoza_valencia_2017:162|R47_radchenko_2020:331|R51_doninger_2002:167|R53_friden_2009:5	1.34	B1	BBB+	A	training
InChI=1S/C13H18ClNO2/c1-9(15)12(16)17-13(2,3)8-10-4-6-11(14)7-5-10/h4-7,9H,8,15H2,1-3H3	Alaproclate	[1-(4-chlorophenyl)-2-methylpropan-2-yl] 2-aminopropanoate	CC(N)C(=O)OC(C)(C)Cc1ccc(Cl)cc1	2081.0	R6_adenot_2004:417			BBB+	C	test
InChI=1S/C13H18N2/c1-9-3-4-12-10(7-9)11-8-15(2)6-5-13(11)14-12/h3-4,7,11,13-14H,5-6,8H2,1-2H3	Dicarbine	2,8-dimethyl-1,3,4,4a,5,9b-hexahydropyrido[4,3-b]indole	Cc1ccc2c(c1)C1CN(C)CCC1N2	65684.0	R6_adenot_2004:1146			BBB+	C	training
InChI=1S/C13H18N2O/c1-10(2)11-5-3-4-6-12(11)16-9-13-14-7-8-15-13/h3-6,10H,7-9H2,1-2H3,(H,14,15)	Fenoxazoline	2-[(2-propan-2-ylphenoxy)methyl]-4,5-dihydro-1H-imidazole	CC(C)c1ccccc1OCC1=NCCN1	71899.0	R6_adenot_2004:90			BBB-	C	training
InChI=1S/C13H18N2O3/c1-2-13(9-7-5-3-4-6-8-9)10(16)14-12(18)15-11(13)17/h7H,2-6,8H2,1H3,(H2,14,15,16,17,18)	Heptabarb|Heptabarbital	5-(cyclohepten-1-yl)-5-ethyl-1,3-diazinane-2,4,6-trione	CCC1(C2=CCCCCC2)C(=O)NC(=O)NC1=O	10518.0	R6_adenot_2004:1652			BBB+	C	training
InChI=1S/C13H18N2O4S2/c1-4-5-20-6-7(16)14-8-10(17)15-9(12(18)19)13(2,3)21-11(8)15/h4,8-9,11H,1,5-6H2,2-3H3,(H,14,16)(H,18,19)/t8-,9+,11-/m1/s1	Almecillin	(2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(2-prop-2-enylsulfanylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid	C=CCSCC(=O)N[C@@H]1C(=O)N2[C@@H]1SC(C)(C)[C@@H]2C(=O)O	71365.0	R6_adenot_2004:135			BBB-	C	training
InChI=1S/C13H18N4O3/c1-9(18)6-4-5-7-17-12(19)10-11(14-8-15(10)2)16(3)13(17)20/h8H,4-7H2,1-3H3	Pentoxifylline	3,7-dimethyl-1-(5-oxohexyl)purine-2,6-dione	CC(=O)CCCCn1c(=O)c2c(ncn2C)n(C)c1=O	4740.0	R14_ghose_2012:760			BBB-	C	training
InChI=1S/C13H18N4O3S/c1-16(2)9-10-3-4-12(20-10)21-8-7-15-13-11(17(18)19)5-6-14-13/h3-6,14-15H,7-9H2,1-2H3	Bbcpd17		CN(C)Cc1ccc(SCCNc2[nH]ccc2[N+](=O)[O-])o1		R3_abraham_2006:313|R41_toropov_2017:279	-1.12	B	BBB-	A	training
InChI=1S/C13H18O2/c1-9(2)8-11-4-6-12(7-5-11)10(3)13(14)15/h4-7,9-10H,8H2,1-3H3,(H,14,15)	Ibuprofen|15687-27-1|Lbuprofen	2-[4-(2-methylpropyl)phenyl]propanoic acid	CC(C)Cc1ccc(C(C)C(=O)O)cc1	3672.0	R3_abraham_2006:183|R4_mente_2005:25|R5_guerra_2008:55|R12_garg_2006:89|R17_fu_2008:34|R21_muehlbacher_2011:86|R23_gupta_2019:112|R25_brito_sanchez_2015:254|R26_chico_2009:215|R28_li_2005:22|R31_carpenter_2014:7|R40_vilar_2010:127|R41_toropov_2017:169|R42_ciura_2020:21|R46_mendoza_valencia_2017:229|R47_radchenko_2020:155|R49_norinder_2002:107|R49_norinder_2002:119|R50_sobanska_2019:18|R51_doninger_2002:70	-0.18	B1	BBB+	A	training
InChI=1S/C13H18O2/c1-9(2)8-11-4-6-12(7-5-11)10(3)13(14)15/h4-7,9-10H,8H2,1-3H3,(H,14,15)/t10-/m1/s1	(R)-(-)-Ibuprofen	(2R)-2-[4-(2-methylpropyl)phenyl]propanoic acid	CC(C)Cc1ccc([C@@H](C)C(=O)O)cc1	114864.0	R48_hou_2003:6	-0.18	A	BBB+	A	training
InChI=1S/C13H18O7/c14-5-7-3-1-2-4-8(7)19-13-12(18)11(17)10(16)9(6-15)20-13/h1-4,9-18H,5-6H2/t9-,10-,11+,12-,13-/m1/s1	Salicin	(2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-[2-(hydroxymethyl)phenoxy]oxane-3,4,5-triol	OCc1ccccc1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O	439503.0	R6_adenot_2004:1318			BBB+	C	training
InChI=1S/C13H19N5/c1-10(13(2,3)4)17-12(16-9-14)18-11-5-7-15-8-6-11/h5-8,10H,1-4H3,(H2,15,16,17,18)	Pinacidil	1-cyano-2-(3,3-dimethylbutan-2-yl)-3-pyridin-4-ylguanidine	CC(/N=C(\NC#N)Nc1ccncc1)C(C)(C)C	4826.0	R14_ghose_2012:773|R23_gupta_2019:837			BBB-	C	training
InChI=1S/C13H19NO2/c1-2-3-8-14-9-11-10-15-12-6-4-5-7-13(12)16-11/h4-7,11,14H,2-3,8-10H2,1H3	Butamoxane	N-(2,3-dihydro-1,4-benzodioxin-3-ylmethyl)butan-1-amine	CCCCNCC1COc2ccccc2O1	20504.0	R6_adenot_2004:1426			BBB+	C	training
InChI=1S/C13H19NO2/c1-9-4-3-5-12(10(9)2)16-13-6-7-14-8-11(13)15/h3-5,11,13-15H,6-8H2,1-2H3/t11-,13+/m1/s1	Ifoxetine	(3R,4S)-4-(2,3-dimethylphenoxy)piperidin-3-ol	Cc1cccc(O[C@H]2CCNC[C@H]2O)c1C	71971.0	R6_adenot_2004:558			BBB+	C	training
InChI=1S/C13H19NO3/c1-2-15-12-5-3-4-6-13(12)17-10-11-9-14-7-8-16-11/h3-6,11,14H,2,7-10H2,1H3	Viloxazine	2-[(2-ethoxyphenoxy)methyl]morpholine	CCOc1ccccc1OCC1CNCCO1	5666.0	R6_adenot_2004:633|R14_ghose_2012:270|R23_gupta_2019:264			BBB+	C	training
InChI=1S/C13H19NO4S/c1-3-9-14(10-4-2)19(17,18)12-7-5-11(6-8-12)13(15)16/h5-8H,3-4,9-10H2,1-2H3,(H,15,16)	Probenecid	4-(dipropylsulfamoyl)benzoic acid	CCCN(CCC)S(=O)(=O)c1ccc(C(=O)O)cc1	4911.0	R7_andres_2006:142|R14_ghose_2012:793|R23_gupta_2019:858|R25_brito_sanchez_2015:512|R28_li_2005:225|R29_subramanian_2003:137|R46_mendoza_valencia_2017:429|R51_doninger_2002:117	-0.4	B	BBB+	A	training
InChI=1S/C13H20ClN3O/c1-3-17(4-2)8-7-16-13(18)10-5-6-12(15)11(14)9-10/h5-6,9H,3-4,7-8,15H2,1-2H3,(H,16,18)	Declopramide	4-amino-3-chloro-N-[2-(diethylamino)ethyl]benzamide	CCN(CC)CCNC(=O)c1ccc(N)c(Cl)c1	70177.0	R26_chico_2009:146	0.14	A	BBB+	A	training
InChI=1S/C13H20N2O2/c1-3-15(4-2)9-10-17-13(16)11-5-7-12(14)8-6-11/h5-8H,3-4,9-10,14H2,1-2H3	Procaine	2-(diethylamino)ethyl 4-aminobenzoate	CCN(CC)CCOC(=O)c1ccc(N)cc1	4914.0	R3_abraham_2006:236|R21_muehlbacher_2011:114|R25_brito_sanchez_2015:364|R26_chico_2009:327|R40_vilar_2010:216|R41_toropov_2017:212|R46_mendoza_valencia_2017:318|R47_radchenko_2020:197|R51_doninger_2002:293	0.05	B	BBB+	A	training
InChI=1S/C13H20N2O2/c16-11-13(17)10-14-6-8-15(9-7-14)12-4-2-1-3-5-12/h1-5,13,16-17H,6-11H2/t13-/m0/s1	Levodropropizine	(2S)-3-(4-phenylpiperazin-1-yl)propane-1,2-diol	OC[C@@H](O)CN1CCN(c2ccccc2)CC1	65859.0	R14_ghose_2012:654			BBB-	C	test
InChI=1S/C13H20N2O3S/c1-3-18-11(16)9-10-14(2)12(17)13(19-10)15-7-5-4-6-8-15/h9,13H,3-8H2,1-2H3	Etozolin|Ethyl 2-(3-Methyl-4-Oxo-5-Piperidin-1-Yl-1,3-Thiazolidin-2-Ylidene)Acetate	ethyl 2-(3-methyl-4-oxo-5-piperidin-1-yl-1,3-thiazolidin-2-ylidene)acetate	CCOC(=O)C=C1SC(N2CCCCC2)C(=O)N1C	6304.0	R14_ghose_2012:546			BBB-	C	test
InChI=1S/C13H20N2O3S/c1-3-18-11(16)9-10-14(2)12(17)13(19-10)15-7-5-4-6-8-15/h9,13H,3-8H2,1-2H3/b10-9-	Etozoline|Etozolin	ethyl (2Z)-2-(3-methyl-4-oxo-5-piperidin-1-yl-1,3-thiazolidin-2-ylidene)acetate	CCOC(=O)/C=C1\SC(N2CCCCC2)C(=O)N1C	5743585.0	R23_gupta_2019:587			BBB-	C	test
InChI=1S/C13H21N3/c1-2-5-16-6-3-4-10-7-12-11(8-13(10)16)9-14-15-12/h9-10,13H,2-8H2,1H3,(H,14,15)/t10-,13-/m1/s1	Quinpirole	(4aR,8aR)-5-propyl-1,4,4a,6,7,8,8a,9-octahydropyrazolo[3,4-g]quinoline	CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@H]21	54562.0	R7_andres_2006:147|R29_subramanian_2003:144			BBB+	C	training
InChI=1S/C13H21N3O/c1-3-16(4-2)10-9-15-13(17)11-5-7-12(14)8-6-11/h5-8H,3-4,9-10,14H2,1-2H3,(H,15,17)	Procainamide Hydrochloride|Procainamide	4-amino-N-[2-(diethylamino)ethyl]benzamide	CCN(CC)CCNC(=O)c1ccc(N)cc1	4913.0	R14_ghose_2012:795			BBB-	C	training
InChI=1S/C13H21N3O3/c1-13(2,3)15-7-11(18)8-4-5-10(17)9(6-8)16-12(14)19/h4-6,11,15,17-18H,7H2,1-3H3,(H3,14,16,19)	Carbuterol	[5-[2-(tert-butylamino)-1-hydroxyethyl]-2-hydroxyphenyl]urea	CC(C)(C)NCC(O)c1ccc(O)c(NC(N)=O)c1	36976.0	R6_adenot_2004:99			BBB-	C	test
InChI=1S/C13H21N5O2/c1-5-17(6-2)7-8-18-9-14-11-10(18)12(19)16(4)13(20)15(11)3/h9H,5-8H2,1-4H3	Etamiphyllin|Etamiphylline	7-[2-(diethylamino)ethyl]-1,3-dimethylpurine-2,6-dione	CCN(CC)CCn1cnc2c1c(=O)n(C)c(=O)n2C	28329.0	R6_adenot_2004:1685			BBB+	C	training
InChI=1S/C13H21NO2/c1-10(2)14-8-12(15)9-16-13-6-4-5-11(3)7-13/h4-7,10,12,14-15H,8-9H2,1-3H3	Toliprolol	1-(3-methylphenoxy)-3-(propan-2-ylamino)propan-2-ol	Cc1cccc(OCC(O)CNC(C)C)c1	18047.0	R3_abraham_2006:291|R3_abraham_2006:292|R7_andres_2006:176|R21_muehlbacher_2011:225|R25_brito_sanchez_2015:79|R26_chico_2009:421|R29_subramanian_2003:171|R40_vilar_2010:276|R41_toropov_2017:260|R46_mendoza_valencia_2017:77|R47_radchenko_2020:243	0.28	D	BBB+	A	test
InChI=1S/C13H21NO3/c1-13(2,3)14-7-12(17)9-4-5-11(16)10(6-9)8-15/h4-6,12,14-17H,7-8H2,1-3H3	Salbutamol|Albuterol|Salbutamol, Albuterol|Albuterol Sulfate	4-[2-(tert-butylamino)-1-hydroxyethyl]-2-(hydroxymethyl)phenol	CC(C)(C)NCC(O)c1ccc(O)c(CO)c1	2083.0	R3_abraham_2006:251|R5_guerra_2008:12|R7_andres_2006:155|R12_garg_2006:17|R21_muehlbacher_2011:27|R23_gupta_2019:898|R25_brito_sanchez_2015:113|R26_chico_2009:361|R28_li_2005:393|R29_subramanian_2003:153|R31_carpenter_2014:4|R39_shayanfar_2011:11|R40_vilar_2010:236|R41_toropov_2017:225|R46_mendoza_valencia_2017:111|R47_radchenko_2020:208|R51_doninger_2002:3	-1.3	D	BBB-	A	test
InChI=1S/C13H22ClN5S/c1-9(2)15-13-16-11(14)10(20-4)12(17-13)19-7-5-18(3)6-8-19/h9H,5-8H2,1-4H3,(H,15,16,17)	Iprozilamine	4-chloro-6-(4-methylpiperazin-1-yl)-5-methylsulfanyl-N-propan-2-ylpyrimidin-2-amine	CSc1c(Cl)nc(NC(C)C)nc1N1CCN(C)CC1	68725.0	R6_adenot_2004:1170			BBB+	C	training
InChI=1S/C13H22N2O3/c1-3-5-6-7-8-9-13(4-2)10(16)14-12(18)15-11(13)17/h3-9H2,1-2H3,(H2,14,15,16,17,18)	5-Heptyl-5-Ethyl Barbituric Acid|5-Ethyl-5-Heptyl-1,3-Diazinane-2,4,6-Trione|5-Ethyl-5-N-Heptylbarbituric Acid	5-ethyl-5-heptyl-1,3-diazinane-2,4,6-trione	CCCCCCCC1(CC)C(=O)NC(=O)NC1=O	43473.0	R3_abraham_2006:110|R21_muehlbacher_2011:246|R25_brito_sanchez_2015:96|R40_vilar_2010:17|R41_toropov_2017:105|R46_mendoza_valencia_2017:94|R47_radchenko_2020:92	0.02	B	BBB+	A	test
InChI=1S/C13H22N4O3S/c1-14-13(9-17(18)19)15-6-7-21-10-12-5-4-11(20-12)8-16(2)3/h4-5,9,14-15H,6-8,10H2,1-3H3/b13-9+	66357-35-5|Ranitidine|9|Zantac	(E)-1-N'-[2-[[5-[(dimethylamino)methyl]furan-2-yl]methylsulfanyl]ethyl]-1-N-methyl-2-nitroethene-1,1-diamine	CN/C(=C\[N+](=O)[O-])NCCSCc1ccc(CN(C)C)o1	3001055.0	R4_mente_2005:143|R7_andres_2006:211|R12_garg_2006:146|R21_muehlbacher_2011:119|R25_brito_sanchez_2015:310|R26_chico_2009:345|R28_li_2005:40|R34_broccatelli_2012:149|R39_shayanfar_2011:80|R40_vilar_2010:227|R46_mendoza_valencia_2017:274|R47_radchenko_2020:312|R49_norinder_2002:9|R49_norinder_2002:117|R50_sobanska_2019:4|R52_liu_2001:9	-1.23	B	BBB-	A	training
InChI=1S/C13H24N2O2/c1-6-9-12(16)15(10-7-2)11(8-3)13(17)14(4)5/h6,9,11H,7-8,10H2,1-5H3/b9-6+	Cropropamide	2-[[(E)-but-2-enoyl]-propylamino]-N,N-dimethylbutanamide	C/C=C/C(=O)N(CCC)C(CC)C(=O)N(C)C	5369258.0	R6_adenot_2004:397			BBB+	C	training
InChI=1S/C13H24N4O3S/c1-13(2,3)14-8-10(18)9-20-12-11(15-21-16-12)17-4-6-19-7-5-17/h10,14,18H,4-9H2,1-3H3/t10-/m0/s1	Timolol	(2S)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol	CC(C)(C)NC[C@H](O)COc1nsnc1N1CCOCC1	33624.0	R23_gupta_2019:980			BBB-	C	test
InChI=1S/C13H25NO2/c1-14(2)10-11-16-13(15)9-8-12-6-4-3-5-7-12/h12H,3-11H2,1-2H3	Cyprodenate	2-(dimethylamino)ethyl 3-cyclohexylpropanoate	CN(C)CCOC(=O)CCC1CCCCC1	71875.0	R6_adenot_2004:1283			BBB+	C	training
InChI=1S/C13H26N2O4/c1-4-6-8-15-12(17)19-10-13(3,7-5-2)9-18-11(14)16/h4-10H2,1-3H3,(H2,14,16)(H,15,17)	Tybamate	[2-(carbamoyloxymethyl)-2-methylpentyl] N-butylcarbamate	CCCCNC(=O)OCC(C)(CCC)COC(N)=O	20266.0	R6_adenot_2004:1524|R51_doninger_2002:322			BBB+	C	training
InChI=1S/C13H26N2O4/c1-6-10(4)13(5,7-18-11(14)16)8-19-12(17)15-9(2)3/h9-10H,6-8H2,1-5H3,(H2,14,16)(H,15,17)	Nisobamate	[2-(carbamoyloxymethyl)-2,3-dimethylpentyl] N-propan-2-ylcarbamate	CCC(C)C(C)(COC(N)=O)COC(=O)NC(C)C	31767.0	R6_adenot_2004:1495			BBB+	C	training
InChI=1S/C13H8Cl2N2O4/c14-7-1-4-12(18)9(5-7)13(19)16-11-3-2-8(17(20)21)6-10(11)15/h1-6,18H,(H,16,19)	Niclosamide	5-chloro-N-(2-chloro-4-nitrophenyl)-2-hydroxybenzamide	O=C(Nc1ccc([N+](=O)[O-])cc1Cl)c1cc(Cl)ccc1O	4477.0	R14_ghose_2012:716			BBB-	C	training
InChI=1S/C13H8Cl2O4S/c14-11-7(13(18)9-2-1-5-20-9)3-4-8(12(11)15)19-6-10(16)17/h1-5H,6H2,(H,16,17)	Ticrynafen|Tienilic Acid	2-[2,3-dichloro-4-(thiophene-2-carbonyl)phenoxy]acetic acid	O=C(O)COc1ccc(C(=O)c2cccs2)c(Cl)c1Cl	38409.0	R14_ghose_2012:894			BBB-	C	training
InChI=1S/C13H9F3N2O2/c14-13(15,16)8-3-1-4-9(7-8)18-11-10(12(19)20)5-2-6-17-11/h1-7H,(H,17,18)(H,19,20)	Niflumic|Niflumic Acid	2-[3-(trifluoromethyl)anilino]pyridine-3-carboxylic acid	O=C(O)c1cccnc1Nc1cccc(C(F)(F)F)c1	4488.0	R14_ghose_2012:718|R23_gupta_2019:777			BBB-	C	training
InChI=1S/C13H9IN2OS/c14-9-5-7(1-3-10(9)15)13-16-11-4-2-8(17)6-12(11)18-13/h1-6,17H,15H2	Cid 10451635|2-(3'-Iodo-4'-Aminophenyl)-6-Hydroxybenzothiazole	2-(4-amino-3-iodophenyl)-1,3-benzothiazol-6-ol	Nc1ccc(-c2nc3ccc(O)cc3s2)cc1I	10451635.0	R21_muehlbacher_2011:341|R25_brito_sanchez_2015:411|R45_hemmateenejad_2006:1|R46_mendoza_valencia_2017:348|R47_radchenko_2020:304	0.18	D	BBB+	A	training
InChI=1S/C13H9NO/c1-2-4-12-11(3-1)9-13(15-12)10-5-7-14-8-6-10/h1-9H	Pyridarone	4-(1-benzofuran-2-yl)pyridine	c1ccc2oc(-c3ccncc3)cc2c1	65590.0	R6_adenot_2004:1506			BBB+	C	training
InChI=1S/C14H10BrN3O/c15-9-4-5-11-10(7-9)14(17-8-13(19)18-11)12-3-1-2-6-16-12/h1-7H,8H2,(H,18,19)	Bromazepam	7-bromo-5-pyridin-2-yl-1,3-dihydro-1,4-benzodiazepin-2-one	O=C1CN=C(c2ccccn2)c2cc(Br)ccc2N1	2441.0	R6_adenot_2004:684|R14_ghose_2012:22|R23_gupta_2019:25|R34_broccatelli_2012:9|R37_chen_2011:10|R50_sobanska_2019:64|R51_doninger_2002:164			BBB+	C	training
InChI=1S/C14H10Cl4/c15-10-7-5-9(6-8-10)13(14(17)18)11-3-1-2-4-12(11)16/h1-8,13-14H	Mitotane	1-chloro-2-[2,2-dichloro-1-(4-chlorophenyl)ethyl]benzene	Clc1ccc(C(c2ccccc2Cl)C(Cl)Cl)cc1	4211.0	R14_ghose_2012:699|R23_gupta_2019:756			BBB-	C	training
InChI=1S/C14H10F3NO2/c15-14(16,17)9-4-3-5-10(8-9)18-12-7-2-1-6-11(12)13(19)20/h1-8,18H,(H,19,20)	Flufenamic|Flufenamic Acid	2-[3-(trifluoromethyl)anilino]benzoic acid	O=C(O)c1ccccc1Nc1cccc(C(F)(F)F)c1	3371.0	R14_ghose_2012:566			BBB-	C	training
InChI=1S/C14H10F3NO5/c15-14(16,17)7-4-5-8(9(6-7)18(22)23)13(21)12-10(19)2-1-3-11(12)20/h4-6,12H,1-3H2	Nitisinone	2-[2-nitro-4-(trifluoromethyl)benzoyl]cyclohexane-1,3-dione	O=C1CCCC(=O)C1C(=O)c1ccc(C(F)(F)F)cc1[N+](=O)[O-]	115355.0	R14_ghose_2012:723|R23_gupta_2019:783			BBB-	C	test
InChI=1S/C14H10N2O6/c17-11-3-1-7(5-9(11)13(19)20)15-16-8-2-4-12(18)10(6-8)14(21)22/h1-6,17-18H,(H,19,20)(H,21,22)/b16-15+	Olsalazine	5-[(3-carboxy-4-hydroxyphenyl)diazenyl]-2-hydroxybenzoic acid	O=C(O)c1cc(/N=N/c2ccc(O)c(C(=O)O)c2)ccc1O	22419.0	R7_andres_2006:123|R23_gupta_2019:793|R29_subramanian_2003:119			BBB-	C	training
InChI=1S/C14H10N4O5/c19-13-8-17(14(20)16-13)15-7-11-5-6-12(23-11)9-1-3-10(4-2-9)18(21)22/h1-7H,8H2,(H,16,19,20)/b15-7-	Dantrolene	1-[(E)-[5-(4-nitrophenyl)furan-2-yl]methylideneamino]imidazolidine-2,4-dione	O=C1CN(/N=C/c2ccc(-c3ccc([N+](=O)[O-])cc3)o2)C(=O)N1	6914273.0	R23_gupta_2019:58			BBB+	C	training
InChI=1S/C14H10O4/c15-13(11-7-3-1-4-8-11)17-18-14(16)12-9-5-2-6-10-12/h1-10H	Benzoyl Peroxide	benzoyl benzenecarboperoxoate	O=C(OOC(=O)c1ccccc1)c1ccccc1	7187.0	R23_gupta_2019:1045			BBB-	C	test
InChI=1S/C14H11Cl2NO2/c1-8-6-7-10(15)13(12(8)16)17-11-5-3-2-4-9(11)14(18)19/h2-7,17H,1H3,(H,18,19)	Meclofenamate Sodium|Meclofenamate|Meclofenamic Acid	2-(2,6-dichloro-3-methylanilino)benzoic acid	Cc1ccc(Cl)c(Nc2ccccc2C(=O)O)c1Cl	4037.0	R14_ghose_2012:666|R51_doninger_2002:80			BBB-	C	training
InChI=1S/C14H11Cl2NO2/c15-10-5-3-6-11(16)14(10)17-12-7-2-1-4-9(12)8-13(18)19/h1-7,17H,8H2,(H,18,19)	Diclofenac	2-[2-(2,6-dichloroanilino)phenyl]acetic acid	O=C(O)Cc1ccccc1Nc1c(Cl)cccc1Cl	3033.0	R14_ghose_2012:73|R23_gupta_2019:66|R26_chico_2009:161	-1.3	A	BBB-	A	training
InChI=1S/C14H12ClN3O3S/c15-10-7-11-9(6-12(10)22(16,20)21)14(19)18-13(17-11)8-4-2-1-3-5-8/h1-7,13,17H,(H,18,19)(H2,16,20,21)	Fenquizone	7-chloro-4-oxo-2-phenyl-2,3-dihydro-1H-quinazoline-6-sulfonamide	NS(=O)(=O)c1cc2c(cc1Cl)NC(c1ccccc1)NC2=O	68548.0	R14_ghose_2012:556			BBB-	C	training
InChI=1S/C14H12ClNO2/c1-8-13(17)12-7-18-14(11(12)6-16-8)9-2-4-10(15)5-3-9/h2-6,14,17H,7H2,1H3	Cicletanine	3-(4-chlorophenyl)-6-methyl-1,3-dihydrofuro[3,4-c]pyridin-7-ol	Cc1ncc2c(c1O)COC2c1ccc(Cl)cc1	54910.0	R14_ghose_2012:448|R23_gupta_2019:455			BBB-	C	training
InChI=1S/C14H12FNO3/c1-7-2-3-8-4-9(15)5-10-12(8)16(7)6-11(13(10)17)14(18)19/h4-7H,2-3H2,1H3,(H,18,19)	Flumequine	7-fluoro-12-methyl-4-oxo-1-azatricyclo[7.3.1.05,13]trideca-2,5,7,9(13)-tetraene-3-carboxylic acid	CC1CCc2cc(F)cc3c(=O)c(C(=O)O)cn1c23	3374.0	R14_ghose_2012:567			BBB-	C	training
InChI=1S/C14H12N6O/c1-9-6-13(21)19-20-14(9)10-2-4-11(5-3-10)17-18-12(7-15)8-16/h2-5,9,17H,6H2,1H3,(H,19,21)/t9-/m1/s1	Levosimendan	2-[[4-[(4R)-4-methyl-6-oxo-4,5-dihydro-1H-pyridazin-3-yl]phenyl]hydrazinylidene]propanedinitrile	C[C@@H]1CC(=O)NN=C1c1ccc(NN=C(C#N)C#N)cc1	3033825.0	R23_gupta_2019:709			BBB-	C	training
InChI=1S/C14H12O2/c15-14(13-9-5-2-6-10-13)16-11-12-7-3-1-4-8-12/h1-10H,11H2	Benzyl Benzoate	benzyl benzoate	O=C(OCc1ccccc1)c1ccccc1	2345.0	R23_gupta_2019:385			BBB-	C	training
InChI=1S/C14H12O2/c15-14(16)10-11-6-8-13(9-7-11)12-4-2-1-3-5-12/h1-9H,10H2,(H,15,16)	Felbinac	2-(4-phenylphenyl)acetic acid	O=C(O)Cc1ccc(-c2ccccc2)cc1	3332.0	R14_ghose_2012:550			BBB-	C	training
InChI=1S/C14H12O3/c1-7-4-12(15)17-14-9(3)13-10(6-11(7)14)5-8(2)16-13/h4-6H,1-3H3	Trioxsalen	2,5,9-trimethylfuro[3,2-g]chromen-7-one	Cc1cc2cc3c(C)cc(=O)oc3c(C)c2o1	5585.0	R14_ghose_2012:920|R23_gupta_2019:1006			BBB-	C	training
InChI=1S/C14H12O3S/c1-9(14(16)17)11-7-8-12(18-11)13(15)10-5-3-2-4-6-10/h2-9H,1H3,(H,16,17)	Tiaprofenic|Tiaprofenic Acid	2-(5-benzoylthiophen-2-yl)propanoic acid	CC(C(=O)O)c1ccc(C(=O)c2ccccc2)s1	5468.0	R14_ghose_2012:892			BBB-	C	training
InChI=1S/C14H13N3O4S2/c1-8-7-15-14(22-8)16-13(19)11-12(18)9-5-3-4-6-10(9)23(20,21)17(11)2/h3-7,18H,1-2H3,(H,15,16,19)	Meloxicam	4-hydroxy-2-methyl-N-(5-methyl-1,3-thiazol-2-yl)-1,1-dioxo-1lambda6,2-benzothiazine-3-carboxamide	Cc1cnc(NC(=O)C2=C(O)c3ccccc3S(=O)(=O)N2C)s1	54677470.0	R14_ghose_2012:671|R28_li_2005:382|R50_sobanska_2019:55			BBB-	C	training
InChI=1S/C14H13N3O5S/c1-8-7-11(16-22-8)15-14(19)12-13(18)9-5-3-4-6-10(9)23(20,21)17(12)2/h3-7,18H,1-2H3,(H,15,16,19)	Isoxicam	4-hydroxy-2-methyl-N-(5-methyl-1,2-oxazol-3-yl)-1,1-dioxo-1lambda6,2-benzothiazine-3-carboxamide	Cc1cc(NC(=O)C2=C(O)c3ccccc3S(=O)(=O)N2C)no1	54677972.0	R14_ghose_2012:634|R28_li_2005:377			BBB-	C	training
InChI=1S/C14H13N5O5S2/c1-2-5-3-25-12-8(11(21)19(12)9(5)13(22)23)17-10(20)7(18-24)6-4-26-14(15)16-6/h2,4,8,12,24H,1,3H2,(H2,15,16)(H,17,20)(H,22,23)/b18-7-/t8-,12-/m1/s1	Cefdinir|E-Cefdinir	(6R,7R)-7-[[(2E)-2-(2-amino-1,3-thiazol-4-yl)-2-hydroxyiminoacetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid	C=CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)/C(=N/O)c3csc(N)n3)[C@H]2SC1	6399253.0	R6_adenot_2004:227|R14_ghose_2012:428|R23_gupta_2019:420			BBB-	C	training
InChI=1S/C14H13NO3/c16-11-5-7-14(8-6-12(17)15-13(14)18)10-4-2-1-3-9(10)11/h1-4H,5-8H2,(H,15,17,18)	Alonimid	spiro[2,3-dihydronaphthalene-4,3'-piperidine]-1,2',6'-trione	O=C1CCC2(CCC(=O)c3ccccc32)C(=O)N1	17928.0	R6_adenot_2004:1343			BBB+	C	training
InChI=1S/C14H14ClNS/c15-13-4-2-1-3-11(13)9-16-7-5-14-12(10-16)6-8-17-14/h1-4,6,8H,5,7,9-10H2	Ticlopidine Hydrochloride|Ticlopidine	5-[(2-chlorophenyl)methyl]-6,7-dihydro-4H-thieno[3,2-c]pyridine	Clc1ccccc1CN1CCc2sccc2C1	5472.0	R14_ghose_2012:893			BBB-	C	test
InChI=1S/C14H14N2/c1-2-7-13-11(4-1)5-3-6-12(13)10-14-15-8-9-16-14/h1-7H,8-10H2,(H,15,16)	Naphazoline	2-(naphthalen-1-ylmethyl)-4,5-dihydro-1H-imidazole	c1ccc2c(CC3=NCCN3)cccc2c1	4436.0	R23_gupta_2019:770			BBB-	C	test
InChI=1S/C14H14N2O/c1-14(2,12-6-4-8-16-10-12)13(17)11-5-3-7-15-9-11/h3-10H,1-2H3	Metyrapone	2-methyl-1,2-dipyridin-3-ylpropan-1-one	CC(C)(C(=O)c1cccnc1)c1cccnc1	4174.0	R14_ghose_2012:693|R23_gupta_2019:747			BBB-	C	training
InChI=1S/C14H14N4O2/c1-9-13-14(16-15-9)17(2)11(19)8-12(20)18(13)10-6-4-3-5-7-10/h3-7H,8H2,1-2H3,(H,15,16)	Razobazam	3,8-dimethyl-4-phenyl-2H-pyrazolo[3,4-b][1,4]diazepine-5,7-dione	Cc1[nH]nc2c1N(c1ccccc1)C(=O)CC(=O)N2C	71228.0	R6_adenot_2004:1267			BBB+	C	test
InChI=1S/C14H14N8O4S3/c1-6-17-18-14(29-6)28-4-7-3-27-12-9(11(24)22(12)10(7)13(25)26)16-8(23)2-21-5-15-19-20-21/h5,9,12H,2-4H2,1H3,(H,16,23)(H,25,26)/t9-,12-/m1/s1	Cefazolin	(6R,7R)-3-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanylmethyl]-8-oxo-7-[[2-(tetrazol-1-yl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid	Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1	33255.0	R6_adenot_2004:165|R23_gupta_2019:419|R51_doninger_2002:19			BBB-	C	training
InChI=1S/C14H14O3/c1-9(14(15)16)10-3-4-12-8-13(17-2)6-5-11(12)7-10/h3-9H,1-2H3,(H,15,16)/t9-/m0/s1	Naproxen	(2S)-2-(6-methoxynaphthalen-2-yl)propanoic acid	COc1ccc2cc([C@H](C)C(=O)O)ccc2c1	156391.0	R7_andres_2006:113|R23_gupta_2019:301|R25_brito_sanchez_2015:507|R29_subramanian_2003:110|R46_mendoza_valencia_2017:425|R50_sobanska_2019:103	0.1	B	BBB+	A	test
InChI=1S/C14H15ClN4/c1-9-12-13(10-4-3-5-11(15)8-10)16-6-7-17-14(12)19(2)18-9/h3-5,8,17H,6-7H2,1-2H3	Zometapine	4-(3-chlorophenyl)-1,3-dimethyl-7,8-dihydro-6H-pyrazolo[3,4-e][1,4]diazepine	Cc1nn(C)c2c1C(c1cccc(Cl)c1)=NCCN2	135410917.0	R6_adenot_2004:638			BBB+	C	training
InChI=1S/C14H15FN2O2/c1-3-19-14(18)13-8-16-9-17(13)10(2)11-4-6-12(15)7-5-11/h4-10H,3H2,1-2H3	Flutomidate	ethyl 3-[1-(4-fluorophenyl)ethyl]imidazole-4-carboxylate	CCOC(=O)c1cncn1C(C)c1ccc(F)cc1	65635.0	R6_adenot_2004:1363			BBB+	C	training
InChI=1S/C14H15N2O2P/c15-16-14(17)11-19(18,12-7-3-1-4-8-12)13-9-5-2-6-10-13/h1-10H,11,15H2,(H,16,17)	Fosenazide	2-diphenylphosphorylacetohydrazide	NNC(=O)CP(=O)(c1ccccc1)c1ccccc1	27918.0	R6_adenot_2004:1473			BBB+	C	training
InChI=1S/C14H15N3O5/c1-3-16(4-2)14(20)10(8-15)5-9-6-11(17(21)22)13(19)12(18)7-9/h5-7,18-19H,3-4H2,1-2H3/b10-5+	Entacapone	(E)-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylprop-2-enamide	CCN(CC)C(=O)/C(C#N)=C/c1cc(O)c(O)c([N+](=O)[O-])c1	5281081.0	R14_ghose_2012:307			BBB+	C	training
InChI=1S/C14H15N5O2/c1-8-15-12(18-21-8)10-7-19-11-6-4-3-5-9(11)13(20-2)17-14(19)16-10/h7H,3-6H2,1-2H3	Taniplon	3-(5-methoxy-6,7,8,9-tetrahydroimidazo[1,2-a]quinazolin-2-yl)-5-methyl-1,2,4-oxadiazole	COc1nc2nc(-c3noc(C)n3)cn2c2c1CCCC2	3086516.0	R6_adenot_2004:1516			BBB+	C	training
InChI=1S/C14H15N5O5S2/c1-5-3-25-12-8(11(21)19(12)9(5)13(22)23)17-10(20)7(18-24-2)6-4-26-14(15)16-6/h4,8,12H,3H2,1-2H3,(H2,15,16)(H,17,20)(H,22,23)/b18-7-/t8-,12-/m1/s1	Cefetamet|(6R,7R)-7-[[(2E)-2-(2-Amino-1,3-Thiazol-4-Yl)-2-Methoxyiminoacetyl]Amino]-3-Methyl-8-Oxo-5-Thia-1-Azabicyclo[4.2.0]Oct-2-Ene-2-Carboxylic Acid	(6R,7R)-7-[[(2E)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid	CO/N=C(/C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(C)CS[C@H]12)c1csc(N)n1	5486821.0	R6_adenot_2004:171|R14_ghose_2012:431			BBB-	C	training
InChI=1S/C14H15N5O6S2/c1-25-2-5-3-26-12-8(11(21)19(12)9(5)13(22)23)17-10(20)7(18-24)6-4-27-14(15)16-6/h4,8,12,24H,2-3H2,1H3,(H2,15,16)(H,17,20)(H,22,23)/b18-7+/t8-,12-/m1/s1	Cefdaloxime	(6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-hydroxyiminoacetyl]amino]-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid	COCC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)/C(=N\O)c3csc(N)n3)[C@H]2SC1	9571072.0	R6_adenot_2004:264			BBB-	C	training
InChI=1S/C14H15NOS/c15-9-11-5-1-3-7-13(11)17-14-8-4-2-6-12(14)10-16/h1-8,16H,9-10,15H2	Bipenamol	[2-[2-(aminomethyl)phenyl]sulfanylphenyl]methanol	NCc1ccccc1Sc1ccccc1CO	43961.0	R6_adenot_2004:496			BBB+	C	training
InChI=1S/C14H16BrNO2/c1-17-11-6-10-7-13(9-2-4-16-5-3-9)18-14(10)12(15)8-11/h6-9,16H,2-5H2,1H3	Brofaromine	4-(7-bromo-5-methoxy-1-benzofuran-2-yl)piperidine	COc1cc(Br)c2oc(C3CCNCC3)cc2c1	44571.0	R6_adenot_2004:964			BBB+	C	training
InChI=1S/C14H16Cl6O5/c1-8-4-2-3-5-10(8)23-6-9(25-12(22)14(18,19)20)7-24-11(21)13(15,16)17/h2-5,9,11-12,21-22H,6-7H2,1H3	Toloxychlorinol	2,2,2-trichloro-1-[3-(2-methylphenoxy)-2-(2,2,2-trichloro-1-hydroxyethoxy)propoxy]ethanol	Cc1ccccc1OCC(COC(O)C(Cl)(Cl)Cl)OC(O)C(Cl)(Cl)Cl	71215.0	R6_adenot_2004:1386			BBB+	C	training
InChI=1S/C14H16ClN3O4S2/c15-10-5-11-13(6-12(10)23(16,19)20)24(21,22)18-14(17-11)9-4-7-1-2-8(9)3-7/h1-2,5-9,14,17-18H,3-4H2,(H2,16,19,20)	Cyclothiazide	3-(2-bicyclo[2.2.1]hept-5-enyl)-6-chloro-1,1-dioxo-3,4-dihydro-2H-1lambda6,2,4-benzothiadiazine-7-sulfonamide	NS(=O)(=O)c1cc2c(cc1Cl)NC(C1CC3C=CC1C3)NS2(=O)=O	2910.0	R14_ghose_2012:476|R23_gupta_2019:487			BBB-	C	training
InChI=1S/C14H16F2N2/c1-18(2)9-3-4-13-10(7-9)11-5-8(15)6-12(16)14(11)17-13/h5-6,9,17H,3-4,7H2,1-2H3	Flucindol|Flucindole	6,8-difluoro-N,N-dimethyl-2,3,4,9-tetrahydro-1H-carbazol-3-amine	CN(C)C1CCc2[nH]c3c(F)cc(F)cc3c2C1	38531.0	R6_adenot_2004:1290			BBB+	C	training
InChI=1S/C14H16N2/c1-15-14(16-2)10-11-7-8-12-5-3-4-6-13(12)9-11/h3-9H,10H2,1-2H3,(H,15,16)	Napactadine	N,N'-dimethyl-2-naphthalen-2-ylethanimidamide	C/N=C(/Cc1ccc2ccccc2c1)NC	42153.0	R6_adenot_2004:581			BBB+	C	test
InChI=1S/C14H16N2/c1-2-4-13-9-11(5-6-12(13)3-1)10-14-15-7-8-16-14/h1-4,9H,5-8,10H2,(H,15,16)	Napamezole	2-(3,4-dihydronaphthalen-2-ylmethyl)-4,5-dihydro-1H-imidazole	C1=C(CC2=NCCN2)CCc2ccccc21	55718.0	R6_adenot_2004:582			BBB+	C	training
InChI=1S/C14H16N2O2/c1-3-18-14(17)13-9-15-10-16(13)11(2)12-7-5-4-6-8-12/h4-11H,3H2,1-2H3	Etomidate|Ethyl 1-(1-Phenylethyl)-1H-Imidazole-5-Carboxylate	ethyl 3-(1-phenylethyl)imidazole-4-carboxylate	CCOC(=O)c1cncn1C(C)c1ccccc1	36339.0	R6_adenot_2004:933			BBB+	C	training
InChI=1S/C14H16N2O3/c1-3-14(4-2)11(17)15-13(19)16(12(14)18)10-8-6-5-7-9-10/h5-9H,3-4H2,1-2H3,(H,15,17,19)	Phetharbital	5,5-diethyl-1-phenyl-1,3-diazinane-2,4,6-trione	CCC1(CC)C(=O)NC(=O)N(c2ccccc2)C1=O	9650.0	R6_adenot_2004:1663			BBB+	C	training
InChI=1S/C14H16N2O4/c17-9-4-3-8(12(18)15-9)16-13(19)10-6-1-2-7(5-6)11(10)14(16)20/h6-8,10-11H,1-5H2,(H,15,17,18)/t6-,7+,8-,10-,11+/m1/s1	Biglumide|Taglutimida	(1R,2R,6S,7S)-4-[(3R)-2,6-dioxopiperidin-3-yl]-4-azatricyclo[5.2.1.02,6]decane-3,5-dione	O=C1CC[C@@H](N2C(=O)[C@@H]3[C@@H]4CC[C@@H](C4)[C@@H]3C2=O)C(=O)N1	76958691.0	R6_adenot_2004:1322			BBB+	C	training
InChI=1S/C14H16N2O6S3/c17-23(18)9-15-11-1-5-13(6-2-11)25(21,22)14-7-3-12(4-8-14)16-10-24(19)20/h1-8,15-16H,9-10H2,(H,17,18)(H,19,20)	Sulfoxone	[4-[4-(sulfinomethylamino)phenyl]sulfonylanilino]methanesulfinic acid	O=S(O)CNc1ccc(S(=O)(=O)c2ccc(NCS(=O)O)cc2)cc1	5351.0	R23_gupta_2019:944			BBB-	C	training
InChI=1S/C14H16N4/c1-9(2)7-18-8-16-12-13(18)10-5-3-4-6-11(10)17-14(12)15/h3-6,8-9H,7H2,1-2H3,(H2,15,17)	Imiquimod	1-(2-methylpropyl)imidazo[4,5-c]quinolin-4-amine	CC(C)Cn1cnc2c(N)nc3ccccc3c21	57469.0	R23_gupta_2019:674			BBB-	C	training
InChI=1S/C14H17N3O9/c1-6(18)23-5-9-11(24-7(2)19)12(25-8(3)20)13(26-9)17-14(22)16-10(21)4-15-17/h4,9,11-13H,5H2,1-3H3,(H,16,21,22)	Azaribine|Azauridine Triacetate	[3,4-diacetyloxy-5-(3,5-dioxo-1,2,4-triazin-2-yl)oxolan-2-yl]methyl acetate	CC(=O)OCC1OC(n2ncc(=O)[nH]c2=O)C(OC(C)=O)C1OC(C)=O	249187.0	R14_ghose_2012:369			BBB-	C	test
InChI=1S/C14H17N5O3/c1-2-18-8-10(13(21)22)11(20)9-7-16-14(17-12(9)18)19-5-3-15-4-6-19/h7-8,15H,2-6H2,1H3,(H,21,22)	Pipemidic|Pipemidic Acid	8-ethyl-5-oxo-2-piperazin-1-ylpyrido[2,3-d]pyrimidine-6-carboxylic acid	CCn1cc(C(=O)O)c(=O)c2cnc(N3CCNCC3)nc21	4831.0	R14_ghose_2012:776			BBB-	C	training
InChI=1S/C14H17NO2/c1-3-11-4-2-6-14(13(11)5-1)17-10-12-9-15-7-8-16-12/h1-4,6,12,15H,5,7-10H2	Indeloxazine	2-(3H-inden-4-yloxymethyl)morpholine	C1=Cc2cccc(OCC3CNCCO3)c2C1	3704.0	R6_adenot_2004:560|R14_ghose_2012:115|R23_gupta_2019:115|R37_chen_2011:43			BBB+	C	training
InChI=1S/C14H17NO2/c16-14(12-4-2-1-3-5-12)17-13-10-15-8-6-11(13)7-9-15/h1-5,11,13H,6-10H2	Benzoclidine	1-azabicyclo[2.2.2]octan-3-yl benzoate	O=C(OC1CN2CCC1CC2)c1ccccc1	65630.0	R6_adenot_2004:1344			BBB+	C	training
InChI=1S/C14H18F3NO/c1-10(2)18-6-7-19-13(9-18)11-4-3-5-12(8-11)14(15,16)17/h3-5,8,10,13H,6-7,9H2,1-2H3	Oxaflozane	4-propan-2-yl-2-[3-(trifluoromethyl)phenyl]morpholine	CC(C)N1CCOC(c2cccc(C(F)(F)F)c2)C1	432824.0	R6_adenot_2004:591			BBB+	C	training
InChI=1S/C14H18N2/c1-16(2)10-7-8-14-12(9-10)11-5-3-4-6-13(11)15-14/h3-6,10,15H,7-9H2,1-2H3	Ciclindole|Cyclindole	N,N-dimethyl-2,3,4,9-tetrahydro-1H-carbazol-3-amine	CN(C)C1CCc2[nH]c3ccccc3c2C1	36082.0	R6_adenot_2004:508			BBB+	C	training
InChI=1S/C14H18N2O/c1-10(2)13-11(3)15(4)16(14(13)17)12-8-6-5-7-9-12/h5-10H,1-4H3	Propyphenazone	1,5-dimethyl-2-phenyl-4-propan-2-ylpyrazol-3-one	Cc1c(C(C)C)c(=O)n(-c2ccccc2)n1C	3778.0	R14_ghose_2012:802			BBB-	C	test
InChI=1S/C14H18N2O/c1-9(2)13-12(14(17)10(3)4)11-7-5-6-8-16(11)15-13/h5-10H,1-4H3	Ibudilast	2-methyl-1-(2-propan-2-ylpyrazolo[1,5-a]pyridin-3-yl)propan-1-one	CC(C)C(=O)c1c(C(C)C)nn2ccccc12	3671.0	R23_gupta_2019:664			BBB-	C	test
InChI=1S/C14H18N2O2/c1-10-5-3-6-11(2)14(10)15-12(17)9-16-8-4-7-13(16)18/h3,5-6H,4,7-9H2,1-2H3,(H,15,17)	Nefiracetam	N-(2,6-dimethylphenyl)-2-(2-oxopyrrolidin-1-yl)acetamide	Cc1cccc(C)c1NC(=O)CN1CCCC1=O	71157.0	R6_adenot_2004:1248			BBB+	C	training
InChI=1S/C14H18N2O3/c1-5-7-8-10(3)14(9-6-2)11(17)15-13(19)16(4)12(14)18/h6,10H,2,5,9H2,1,3-4H3,(H,15,17,19)	Methohexital|151-83-7|Methohexitone	5-hex-3-yn-2-yl-1-methyl-5-prop-2-enyl-1,3-diazinane-2,4,6-trione	C=CCC1(C(C)C#CCC)C(=O)NC(=O)N(C)C1=O	9034.0	R3_abraham_2006:196|R4_mente_2005:44|R5_guerra_2008:64|R6_adenot_2004:941|R12_garg_2006:108|R21_muehlbacher_2011:206|R25_brito_sanchez_2015:290|R28_li_2005:95|R39_shayanfar_2011:60|R40_vilar_2010:146|R41_toropov_2017:180|R44_bujak_2015:88|R46_mendoza_valencia_2017:259|R47_radchenko_2020:166	-0.06	B1	BBB+	A	test
InChI=1S/C14H18N2O4/c15-11(9-10-5-2-1-3-6-10)14(19)20-16-8-4-7-12(16)13(17)18/h1-3,5-6,11-12H,4,7-9,15H2,(H,17,18)/t11-,12+/m1/s1	D-Phenylalanine-L-Proline		N[C@H](Cc1ccccc1)C(=O)ON1CCC[C@H]1C(=O)O		R25_brito_sanchez_2015:509|R46_mendoza_valencia_2017:427	-0.8	B	BBB+	A	training
InChI=1S/C14H18N2O5/c1-21-14(20)11(7-9-5-3-2-4-6-9)16-13(19)10(15)8-12(17)18/h2-6,10-11H,7-8,15H2,1H3,(H,16,19)(H,17,18)/t10-,11-/m0/s1	Aspartame	(3S)-3-amino-4-[[(2S)-1-methoxy-1-oxo-3-phenylpropan-2-yl]amino]-4-oxobutanoic acid	COC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CC(=O)O	134601.0	R14_ghose_2012:361			BBB-	C	training
InChI=1S/C14H18N6O/c15-14-18-12(17-9-2-3-9)11-13(19-14)20(7-16-11)10-4-1-8(5-10)6-21/h1,4,7-10,21H,2-3,5-6H2,(H3,15,17,18,19)/t8-,10+/m1/s1	Abacavir	[(1S,4R)-4-[2-amino-6-(cyclopropylamino)purin-9-yl]cyclopent-2-en-1-yl]methanol	Nc1nc(NC2CC2)c2ncn([C@H]3C=C[C@@H](CO)C3)c2n1	441300.0	R25_brito_sanchez_2015:460|R28_li_2005:174	-0.22	A	BBB+	A	training
InChI=1S/C14H18N6O/c15-14-18-12(17-9-2-3-9)11-13(19-14)20(7-16-11)10-4-1-8(5-10)6-21/h1,4,7-10,21H,2-3,5-6H2,(H3,15,17,18,19)/t8-,10-/m0/s1	Abacavir, Trans-	[(1R,4R)-4-[2-amino-6-(cyclopropylamino)purin-9-yl]cyclopent-2-en-1-yl]methanol	Nc1nc(NC2CC2)c2ncn([C@H]3C=C[C@H](CO)C3)c2n1	10660866.0	R46_mendoza_valencia_2017:385	-0.22	A	BBB+	A	training
InChI=1S/C14H18O3/c1-14(2,3)13(15)7-5-10-4-6-11-12(8-10)17-9-16-11/h4-8,13,15H,9H2,1-3H3/b7-5+	Stiripentol	(E)-1-(1,3-benzodioxol-5-yl)-4,4-dimethylpent-1-en-3-ol	CC(C)(C)C(O)/C=C/c1ccc2c(c1)OCO2	5311454.0	R6_adenot_2004:1511|R7_andres_2006:158|R14_ghose_2012:308|R23_gupta_2019:228|R29_subramanian_2003:155			BBB+	C	training
InChI=1S/C14H19Cl2NO2/c15-8-10-17(11-9-16)13-6-4-12(5-7-13)2-1-3-14(18)19/h4-7H,1-3,8-11H2,(H,18,19)	Chlorambucil	4-[4-[bis(2-chloroethyl)amino]phenyl]butanoic acid	O=C(O)CCCc1ccc(N(CCCl)CCCl)cc1	2708.0	R5_guerra_2008:24|R17_fu_2008:30|R21_muehlbacher_2011:53|R23_gupta_2019:447|R25_brito_sanchez_2015:185|R26_chico_2009:102|R28_li_2005:13|R39_shayanfar_2011:27|R40_vilar_2010:75|R46_mendoza_valencia_2017:172|R47_radchenko_2020:309|R49_norinder_2002:38|R51_doninger_2002:21	-1.7	B	BBB-	A	training
InChI=1S/C14H19ClN2O2/c15-13-4-2-12(3-5-13)14(18)16-6-1-7-17-8-10-19-11-9-17/h2-5H,1,6-11H2,(H,16,18)	Eprobemide	4-chloro-N-(3-morpholin-4-ylpropyl)benzamide	O=C(NCCCN1CCOCC1)c1ccc(Cl)cc1	65659.0	R6_adenot_2004:565			BBB+	C	training
InChI=1S/C14H19F3N2O2/c1-4-21-13(20)19(9-8-18(2)3)12-7-5-6-11(10-12)14(15,16)17/h5-7,10H,4,8-9H2,1-3H3	Flubanilate	ethyl N-[2-(dimethylamino)ethyl]-N-[3-(trifluoromethyl)phenyl]carbamate	CCOC(=O)N(CCN(C)C)c1cccc(C(F)(F)F)c1	172309.0	R6_adenot_2004:549			BBB+	C	training
InChI=1S/C14H19F3N4O/c15-14(16,17)11-2-1-3-12(10-11)21-8-6-20(7-9-21)5-4-19-13(18)22/h1-3,10H,4-9H2,(H3,18,19,22)	Fluprazine	2-[4-[3-(trifluoromethyl)phenyl]piperazin-1-yl]ethylurea	NC(=O)NCCN1CCN(c2cccc(C(F)(F)F)c2)CC1	71153.0	R6_adenot_2004:1160			BBB+	C	test
InChI=1S/C14H19FN2O2/c15-11-14(19)16-10-6-2-5-9-13(18)17-12-7-3-1-4-8-12/h1,3-4,7-8H,2,5-6,9-11H2,(H,16,19)(H,17,18)	Faha|6-[(2-Fluoroacetyl)Amino]-N-Phenylhexanamide	6-[(2-fluoroacetyl)amino]-N-phenylhexanamide	O=C(CF)NCCCCCC(=O)Nc1ccccc1	11995317.0	R47_radchenko_2020:514	-0.51	A	BBB+	A	training
InChI=1S/C14H19N3S/c1-16(2)9-10-17(12-13-6-5-11-18-13)14-7-3-4-8-15-14/h3-8,11H,9-10,12H2,1-2H3	Methapyrilene	N,N-dimethyl-N'-pyridin-2-yl-N'-(thiophen-2-ylmethyl)ethane-1,2-diamine	CN(C)CCN(Cc1cccs1)c1ccccn1	4098.0	R6_adenot_2004:1339			BBB+	C	test
InChI=1S/C14H19N5O2/c1-5-19-13-10(8-16-19)12(18-17-9(3)4)11(7-15-13)14(20)21-6-2/h7-8H,5-6H2,1-4H3,(H,15,18)	Etazolate	ethyl 1-ethyl-4-(2-propan-2-ylidenehydrazinyl)pyrazolo[3,4-b]pyridine-5-carboxylate	CCOC(=O)c1cnc2c(cnn2CC)c1NN=C(C)C	3277.0	R6_adenot_2004:1461|R51_doninger_2002:212			BBB+	C	training
InChI=1S/C14H19NO2/c1-11(16)17-14(12-7-3-2-4-8-12)13-9-5-6-10-15-13/h2-4,7-8,13-15H,5-6,9-10H2,1H3	Phacetoperane|Levophacetoperane	[phenyl(piperidin-2-yl)methyl] acetate	CC(=O)OC(c1ccccc1)C1CCCCN1	558526.0	R6_adenot_2004:596			BBB+	C	test
InChI=1S/C14H19NO2/c1-17-14(16)13(11-7-3-2-4-8-11)12-9-5-6-10-15-12/h2-4,7-8,12-13,15H,5-6,9-10H2,1H3	Methylphenidate	methyl 2-phenyl-2-piperidin-2-ylacetate	COC(=O)C(c1ccccc1)C1CCCCN1	4158.0	R6_adenot_2004:1297|R14_ghose_2012:67|R26_chico_2009:267|R34_broccatelli_2012:50|R37_chen_2011:49|R51_doninger_2002:254	1.08	A	BBB+	A	test
InChI=1S/C14H19NO2/c1-17-14(16)13(11-7-3-2-4-8-11)12-9-5-6-10-15-12/h2-4,7-8,12-13,15H,5-6,9-10H2,1H3/t12-,13-/m1/s1	Dexmethylphenidate	methyl (2R)-2-phenyl-2-[(2R)-piperidin-2-yl]acetate	COC(=O)[C@H](c1ccccc1)[C@H]1CCCCN1	154101.0	R23_gupta_2019:61|R26_chico_2009:154|R37_chen_2011:26			BBB+	C	test
InChI=1S/C14H19NO5/c1-17-11-8-10(9-12(18-2)13(11)19-3)14(16)15-4-6-20-7-5-15/h8-9H,4-7H2,1-3H3	Trimetozine	morpholin-4-yl-(3,4,5-trimethoxyphenyl)methanone	COc1cc(C(=O)N2CCOCC2)cc(OC)c1OC	12478.0	R6_adenot_2004:1523|R51_doninger_2002:320			BBB+	C	training
InChI=1S/C14H19NO5/c1-6(16)9-11-7-4-3-5-8(20-2)10(7)12(14(18)19)15(11)13(9)17/h6-9,11,16H,3-5H2,1-2H3,(H,18,19)/t6-,7+,8+,9-,11-/m1/s1	Sanfetrinem	(1S,5S,8aS,8bR)-1-[(1R)-1-hydroxyethyl]-5-methoxy-2-oxo-5,6,7,8,8a,8b-hexahydro-1H-azeto[1,2-b]isoindole-4-carboxylic acid	CO[C@H]1CCC[C@H]2C1=C(C(=O)O)N1C(=O)[C@H]([C@@H](C)O)[C@@H]21	71452.0	R6_adenot_2004:217			BBB-	C	training
InChI=1S/C14H20Br2N2/c1-18(12-5-3-2-4-6-12)9-10-7-11(15)8-13(16)14(10)17/h7-8,12H,2-6,9,17H2,1H3	Bromhexine	2,4-dibromo-6-[[cyclohexyl(methyl)amino]methyl]aniline	CN(Cc1cc(Br)cc(Br)c1N)C1CCCCC1	2442.0	R14_ghose_2012:405|R23_gupta_2019:402			BBB-	C	training
InChI=1S/C14H20Cl2N2O2/c1-4-18(5-2)7-6-17-14(19)11-8-10(15)9-12(16)13(11)20-3/h8-9H,4-7H2,1-3H3,(H,17,19)	Diclometide	3,5-dichloro-N-[2-(diethylamino)ethyl]-2-methoxybenzamide	CCN(CC)CCNC(=O)c1cc(Cl)cc(Cl)c1OC	208832.0	R6_adenot_2004:1446			BBB+	C	training
InChI=1S/C14H20ClN3O3/c1-20-12-6-10(16)9(15)5-8(12)14(19)18-11-3-4-17-7-13(11)21-2/h5-6,11,13,17H,3-4,7,16H2,1-2H3,(H,18,19)	Norcisapride	4-amino-5-chloro-2-methoxy-N-(3-methoxypiperidin-4-yl)benzamide	COc1cc(N)c(Cl)cc1C(=O)NC1CCNCC1OC	3019427.0	R46_mendoza_valencia_2017:100	-0.22	A	BBB+	A	training
InChI=1S/C14H20ClN3O3/c1-20-12-6-10(16)9(15)5-8(12)14(19)18-11-3-4-17-7-13(11)21-2/h5-6,11,13,17H,3-4,7,16H2,1-2H3,(H,18,19)/t11-,13+/m1/s1	Ticalopride	4-amino-5-chloro-2-methoxy-N-[(3S,4R)-3-methoxypiperidin-4-yl]benzamide	COc1cc(N)c(Cl)cc1C(=O)N[C@@H]1CCNC[C@@H]1OC	216236.0	R25_brito_sanchez_2015:102|R47_radchenko_2020:437	-0.22	B	BBB+	A	training
InChI=1S/C14H20N2O/c1-10(2)12-5-4-11(3)8-13(12)17-9-14-15-6-7-16-14/h4-5,8,10H,6-7,9H2,1-3H3,(H,15,16)	Tymazoline	2-[(5-methyl-2-propan-2-ylphenoxy)methyl]-4,5-dihydro-1H-imidazole	Cc1ccc(C(C)C)c(OCC2=NCCN2)c1	34154.0	R6_adenot_2004:97			BBB-	C	training
InChI=1S/C14H20N2O2/c1-10(2)16-8-11(17)9-18-14-5-3-4-13-12(14)6-7-15-13/h3-7,10-11,15-17H,8-9H2,1-2H3	Pindolol	1-(1H-indol-4-yloxy)-3-(propan-2-ylamino)propan-2-ol	CC(C)NCC(O)COc1cccc2[nH]ccc12	4828.0	R3_abraham_2006:232|R3_abraham_2006:233|R21_muehlbacher_2011:112|R25_brito_sanchez_2015:359|R26_chico_2009:313|R28_li_2005:221|R40_vilar_2010:212|R41_toropov_2017:209|R42_ciura_2020:31|R46_mendoza_valencia_2017:314|R47_radchenko_2020:194|R53_friden_2009:30	-0.07	B1	BBB+	A	training
InChI=1S/C14H20N2O2/c1-14(2,3)16-9-12(17)10-18-13-7-5-4-6-11(13)8-15/h4-7,12,16-17H,9-10H2,1-3H3	Bunitrolol	2-[3-(tert-butylamino)-2-hydroxypropoxy]benzonitrile	CC(C)(C)NCC(O)COc1ccccc1C#N	2473.0	R21_muehlbacher_2011:43|R25_brito_sanchez_2015:397|R40_vilar_2010:63|R47_radchenko_2020:337	0.38	B	BBB+	A	training
InChI=1S/C14H20N2O2S/c15-13-5-7-14(8-6-13)19(17,18)16-9-11-1-2-12(10-16)4-3-11/h5-8,11-12H,1-4,9-10,15H2	Azabon	4-(3-azabicyclo[3.2.2]nonan-3-ylsulfonyl)aniline	Nc1ccc(S(=O)(=O)N2CC3CCC(CC3)C2)cc1	14380.0	R6_adenot_2004:1278			BBB+	C	training
InChI=1S/C14H20N2O3/c1-4-16(5-2)10-14(18)19-13-8-6-12(7-9-13)15-11(3)17/h6-9H,4-5,10H2,1-3H3,(H,15,17)	Propacetamol	(4-acetamidophenyl) 2-(diethylamino)acetate	CCN(CC)CC(=O)Oc1ccc(NC(C)=O)cc1	68865.0	R6_adenot_2004:411			BBB+	C	training
InChI=1S/C14H20N4O3S/c1-17(2)9-11-3-4-12(21-11)10-22-8-7-16-14-13(18(19)20)5-6-15-14/h3-6,15-16H,7-10H2,1-2H3	Skb24|74188-86-6|Bbcpd17|B-056|20|2-[2-(5-Dimethylaminomethyl-2-Furylmethylthio)Ethylamino]-3-Nitropyrrole	N-[2-[[5-[(dimethylamino)methyl]furan-2-yl]methylsulfanyl]ethyl]-3-nitro-1H-pyrrol-2-amine	CN(C)Cc1ccc(CSCCNc2[nH]ccc2[N+](=O)[O-])o1	13646638.0	R3_abraham_2006:264|R4_mente_2005:128|R12_garg_2006:33|R25_brito_sanchez_2015:14|R26_chico_2009:54|R40_vilar_2010:45|R41_toropov_2017:236|R46_mendoza_valencia_2017:14|R47_radchenko_2020:219|R48_hou_2003:46|R52_liu_2001:20	-1.12	B	BBB-	A	training
InChI=1S/C14H21BO2/c1-4-9-14(3)10-16-15(17-11-14)13-7-5-12(2)6-8-13/h5-8H,4,9-11H2,1-3H3	Tolboxane	5-methyl-2-(4-methylphenyl)-5-propyl-1,3,2-dioxaborinane	CCCC1(C)COB(c2ccc(C)cc2)OC1	72134.0	R6_adenot_2004:1518			BBB+	C	training
InChI=1S/C14H21ClN2O2/c1-18-10-3-2-4-14(17-19-11-9-16)12-5-7-13(15)8-6-12/h5-8H,2-4,9-11,16H2,1H3/b17-14-	Clovoxamine	2-[(E)-[1-(4-chlorophenyl)-5-methoxypentylidene]amino]oxyethanamine	COCCCC/C(=N\OCCN)c1ccc(Cl)cc1	6335903.0	R6_adenot_2004:515			BBB+	C	training
InChI=1S/C14H21ClN2O2/c1-3-17(4-2)10-9-16-14(18)11-19-13-7-5-12(15)6-8-13/h5-8H,3-4,9-11H2,1-2H3,(H,16,18)	Clofexamide	2-(4-chlorophenoxy)-N-[2-(diethylamino)ethyl]acetamide	CCN(CC)CCNC(=O)COc1ccc(Cl)cc1	28554.0	R6_adenot_2004:1281			BBB+	C	training
InChI=1S/C14H21IN2/c1-12(2)11-16-7-9-17(10-8-16)14-5-3-13(15)4-6-14/h3-6,12H,7-11H2,1-2H3	1-Isobutyl-4-(4-Iodophenyl)Piperazine	1-(4-iodophenyl)-4-(2-methylpropyl)piperazine	CC(C)CN1CCN(c2ccc(I)cc2)CC1	13720674.0	R25_brito_sanchez_2015:57|R40_vilar_2010:7|R46_mendoza_valencia_2017:56	1.38	B	BBB+	A	test
InChI=1S/C14H21IN2/c1-3-12(2)16-8-10-17(11-9-16)14-6-4-13(15)5-7-14/h4-7,12H,3,8-11H2,1-2H3	1-Butan-2-Yl-4-(4-Iodophenyl)Piperazine	1-butan-2-yl-4-(4-iodophenyl)piperazine	CCC(C)N1CCN(c2ccc(I)cc2)CC1	142271743.0	R41_toropov_2017:98	1.38	A	BBB+	A	test
InChI=1S/C14H21N/c1-2-15-14(11-7-4-8-12-14)13-9-5-3-6-10-13/h3,5-6,9-10,15H,2,4,7-8,11-12H2,1H3	Eticyclidine	N-ethyl-1-phenylcyclohexan-1-amine	CCNC1(c2ccccc2)CCCCC1	16622.0	R6_adenot_2004:932			BBB+	C	training
InChI=1S/C14H21N3O2S/c1-15-20(18,19)10-11-4-5-14-13(8-11)12(9-16-14)6-7-17(2)3/h4-5,8-9,15-16H,6-7,10H2,1-3H3	Sumatriptan	1-[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]-N-methylmethanesulfonamide	CNS(=O)(=O)Cc1ccc2[nH]cc(CCN(C)C)c2c1	5358.0	R7_andres_2006:161|R14_ghose_2012:235|R25_brito_sanchez_2015:516|R26_chico_2009:396|R29_subramanian_2003:158|R34_broccatelli_2012:88|R46_mendoza_valencia_2017:432|R47_radchenko_2020:507|R50_sobanska_2019:80	-0.4	D	BBB+	A	training
InChI=1S/C14H21N3O3/c1-9(2)15-7-12-4-3-10-5-11(8-18)14(17(19)20)6-13(10)16-12/h5-6,9,12,15-16,18H,3-4,7-8H2,1-2H3	Oxamniquine	[7-nitro-2-[(propan-2-ylamino)methyl]-1,2,3,4-tetrahydroquinolin-6-yl]methanol	CC(C)NCC1CCc2cc(CO)c([N+](=O)[O-])cc2N1	4612.0	R14_ghose_2012:742|R23_gupta_2019:802			BBB-	C	training
InChI=1S/C14H21N3O3S/c1-12-6-8-13(9-7-12)21(19,20)16-14(18)15-17-10-4-2-3-5-11-17/h6-9H,2-5,10-11H2,1H3,(H2,15,16,18)	Tolazamide	1-(azepan-1-yl)-3-(4-methylphenyl)sulfonylurea	Cc1ccc(S(=O)(=O)NC(=O)NN2CCCCCC2)cc1	5503.0	R14_ghose_2012:902|R23_gupta_2019:987|R51_doninger_2002:136			BBB-	C	training
InChI=1S/C14H21N3O4S/c1-17-7-3-4-10(17)9-16-14(18)12-8-11(22(15,19)20)5-6-13(12)21-2/h5-6,8,10H,3-4,7,9H2,1-2H3,(H,16,18)(H2,15,19,20)	Sulmepride	2-methoxy-N-[(1-methylpyrrolidin-2-yl)methyl]-5-sulfamoylbenzamide	COc1ccc(S(N)(=O)=O)cc1C(=O)NCC1CCCN1C	3018598.0	R6_adenot_2004:1223			BBB+	C	training
InChI=1S/C14H21N3O6S/c1-14(2)9(13(22)23)17-10(19)8(11(17)24-14)16-7(18)5-3-4-6(15)12(20)21/h6,8-9,11H,3-5,15H2,1-2H3,(H,16,18)(H,20,21)(H,22,23)/t6-,8-,9+,11-/m1/s1	Adicillin	(2S,5R,6R)-6-[[(5R)-5-amino-5-carboxypentanoyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid	CC1(C)S[C@@H]2[C@H](NC(=O)CCC[C@@H](N)C(=O)O)C(=O)N2[C@H]1C(=O)O	71724.0	R6_adenot_2004:134			BBB-	C	training
InChI=1S/C14H21NO/c1-2-15-13(14-9-6-10-16-14)11-12-7-4-3-5-8-12/h3-5,7-8,13-15H,2,6,9-11H2,1H3/t13-,14-/m1/s1	Zylofuramine	(1R)-N-ethyl-1-[(2R)-oxolan-2-yl]-2-phenylethanamine	CCN[C@H](Cc1ccccc1)[C@H]1CCCO1	71129.0	R6_adenot_2004:1312			BBB+	C	training
InChI=1S/C14H21NO2/c1-11(2)7-8-15-9-12-10-16-13-5-3-4-6-14(13)17-12/h3-6,11-12,15H,7-10H2,1-2H3	Pentamoxane	N-(2,3-dihydro-1,4-benzodioxin-3-ylmethyl)-3-methylbutan-1-amine	CC(C)CCNCC1COc2ccccc2O1	3083868.0	R6_adenot_2004:1500			BBB+	C	training
InChI=1S/C14H21NO2/c16-13(17)12-1-2-15(12)14-6-9-3-10(7-14)5-11(4-9)8-14/h9-12H,1-8H2,(H,16,17)	Carmantadine	1-(1-adamantyl)azetidine-2-carboxylic acid	O=C(O)C1CCN1C12CC3CC(CC(C3)C1)C2	37906.0	R6_adenot_2004:644			BBB+	C	training
InChI=1S/C14H21NO3/c1-14(2,3)13(17)18-11-7-5-6-10(8-11)12(16)9-15-4/h5-8,12,15-16H,9H2,1-4H3	Pivenfrine	[3-[1-hydroxy-2-(methylamino)ethyl]phenyl] 2,2-dimethylpropanoate	CNCC(O)c1cccc(OC(=O)C(C)(C)C)c1	130545.0	R6_adenot_2004:103			BBB-	C	training
InChI=1S/C14H22BrN3O2/c1-4-18(5-2)7-6-17-14(19)10-8-11(15)12(16)9-13(10)20-3/h8-9H,4-7,16H2,1-3H3,(H,17,19)	Bromopride	4-amino-5-bromo-N-[2-(diethylamino)ethyl]-2-methoxybenzamide	CCN(CC)CCNC(=O)c1cc(Br)c(N)cc1OC	2446.0	R6_adenot_2004:1422			BBB+	C	training
InChI=1S/C14H22ClN3O2/c1-4-18(5-2)7-6-17-14(19)10-8-11(15)12(16)9-13(10)20-3/h8-9H,4-7,16H2,1-3H3,(H,17,19)	Metoclopramide	4-amino-5-chloro-N-[2-(diethylamino)ethyl]-2-methoxybenzamide	CCN(CC)CCNC(=O)c1cc(Cl)c(N)cc1OC	4168.0	R14_ghose_2012:150|R25_brito_sanchez_2015:429|R34_broccatelli_2012:148|R37_chen_2011:50|R50_sobanska_2019:97	0.9	A	BBB+	A	training
InChI=1S/C14H22ClNO/c1-11(10-16(3)4)14(2,17)9-12-5-7-13(15)8-6-12/h5-8,11,17H,9-10H2,1-4H3	Clobutinol	1-(4-chlorophenyl)-4-(dimethylamino)-2,3-dimethylbutan-2-ol	CC(CN(C)C)C(C)(O)Cc1ccc(Cl)cc1	26937.0	R14_ghose_2012:460			BBB-	C	test
InChI=1S/C14H22N2O/c1-5-16(6-2)10-13(17)15-14-11(3)8-7-9-12(14)4/h7-9H,5-6,10H2,1-4H3,(H,15,17)	Lidocaine	2-(diethylamino)-N-(2,6-dimethylphenyl)acetamide	CCN(CC)CC(=O)Nc1c(C)cccc1C	3676.0	R3_abraham_2006:189|R6_adenot_2004:43|R7_andres_2006:92|R21_muehlbacher_2011:87|R25_brito_sanchez_2015:272|R26_chico_2009:240|R29_subramanian_2003:86|R40_vilar_2010:137|R41_toropov_2017:174|R42_ciura_2020:24|R46_mendoza_valencia_2017:245|R47_radchenko_2020:160|R51_doninger_2002:238	0.34	B	BBB+	A	training
InChI=1S/C14H22N2O2/c1-6-16(5)14(17)18-13-9-7-8-12(10-13)11(2)15(3)4/h7-11H,6H2,1-5H3/t11-/m0/s1	123441-03-2|Rivastigmine	[3-[(1S)-1-(dimethylamino)ethyl]phenyl] N-ethyl-N-methylcarbamate	CCN(C)C(=O)Oc1cccc([C@H](C)N(C)C)c1	77991.0	R4_mente_2005:74|R6_adenot_2004:1253|R14_ghose_2012:224|R21_muehlbacher_2011:272|R23_gupta_2019:220|R25_brito_sanchez_2015:305|R34_broccatelli_2012:79|R37_chen_2011:86|R40_vilar_2010:231|R46_mendoza_valencia_2017:271|R47_radchenko_2020:367	0.88	B	BBB+	A	training
InChI=1S/C14H22N2O3/c1-10(2)15-8-13(18)9-19-14-6-4-12(5-7-14)16-11(3)17/h4-7,10,13,15,18H,8-9H2,1-3H3,(H,16,17)	Practolol	N-[4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl]acetamide	CC(=O)Nc1ccc(OCC(O)CNC(C)C)cc1	4883.0	R7_andres_2006:136|R25_brito_sanchez_2015:362|R29_subramanian_2003:132	-0.55	A	BBB+	A	test
InChI=1S/C14H22N2O3/c1-10(2)15-8-13(18)9-19-14-6-4-12(5-7-14)16-11(3)17/h4-7,10,13,15,18H,8-9H2,1-3H3,(H,16,17)/t13-/m0/s1	(S)-Practolol	N-[4-[(2S)-2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl]acetamide	CC(=O)Nc1ccc(OC[C@@H](O)CNC(C)C)cc1	443371.0	R46_mendoza_valencia_2017:316	-0.55	A	BBB+	A	test
InChI=1S/C14H23IN2/c1-5-10(3)16-12-7-8-13(15)14(9-12)17-11(4)6-2/h7-11,16-17H,5-6H2,1-4H3	4-Iodo-N,N'-Isopropyl-M-Xylenediamine		CCC(C)Nc1ccc(I)c(NC(C)CC)c1		R3_abraham_2006:108|R25_brito_sanchez_2015:94|R40_vilar_2010:15|R41_toropov_2017:103|R46_mendoza_valencia_2017:92|R47_radchenko_2020:90	0.64	B	BBB+	A	training
InChI=1S/C14H23N3O3S/c1-4-17(5-2)11-10-15-14(18)12-6-8-13(9-7-12)16-21(3,19)20/h6-9,16H,4-5,10-11H2,1-3H3,(H,15,18)	Sematilide	N-[2-(diethylamino)ethyl]-4-(methanesulfonamido)benzamide	CCN(CC)CCNC(=O)c1ccc(NS(C)(=O)=O)cc1	58505.0	R14_ghose_2012:841			BBB-	C	training
InChI=1S/C14H23N3OS/c1-3-4-5-6-10-18-14-13(15-19-16-14)12-8-7-9-17(2)11-12/h8H,3-7,9-11H2,1-2H3	Xanomeline	3-hexoxy-4-(1-methyl-3,6-dihydro-2H-pyridin-5-yl)-1,2,5-thiadiazole	CCCCCCOc1nsnc1C1=CCCN(C)C1	60809.0	R6_adenot_2004:1262			BBB+	C	training
InChI=1S/C14H23N3S2/c1-3-4-5-6-10-18-14-13(15-19-16-14)12-8-7-9-17(2)11-12/h8H,3-7,9-11H2,1-2H3	Tazomeline	3-hexylsulfanyl-4-(1-methyl-3,6-dihydro-2H-pyridin-5-yl)-1,2,5-thiadiazole	CCCCCCSc1nsnc1C1=CCCN(C)C1	131460.0	R6_adenot_2004:1251			BBB+	C	training
InChI=1S/C14H23NO/c1-5-14(11(2)10-15(3)4)12-7-6-8-13(16)9-12/h6-9,11,14,16H,5,10H2,1-4H3/t11-,14+/m0/s1	Tapentadol	3-[(2R,3R)-1-(dimethylamino)-2-methylpentan-3-yl]phenol	CC[C@@H](c1cccc(O)c1)[C@@H](C)CN(C)C	9838022.0	R23_gupta_2019:234			BBB+	C	training
InChI=1S/C14H23NO3/c1-9-6-10(8-14(2,3)7-9)18-13(17)11-4-5-12(16)15-11/h9-11H,4-8H2,1-3H3,(H,15,16)/t9?,10?,11-/m0/s1	Crilvastatin	(3,3,5-trimethylcyclohexyl) (2S)-5-oxopyrrolidine-2-carboxylate	CC1CC(OC(=O)[C@@H]2CCC(=O)N2)CC(C)(C)C1	22845140.0	R6_adenot_2004:1400			BBB+	C	test
InChI=1S/C14H24N2O3/c1-3-5-6-7-8-9-10-14(4-2)11(17)15-13(19)16-12(14)18/h3-10H2,1-2H3,(H2,15,16,17,18,19)	5-Octyl-5-Ethyl Barbituric Acid|5-Ethyl-5-Octylbarbituric Acid	5-ethyl-5-octyl-1,3-diazinane-2,4,6-trione	CCCCCCCCC1(CC)C(=O)NC(=O)NC1=O	13755681.0	R3_abraham_2006:113|R21_muehlbacher_2011:346|R25_brito_sanchez_2015:99|R40_vilar_2010:20|R41_toropov_2017:108|R46_mendoza_valencia_2017:97|R47_radchenko_2020:95	0.24	B	BBB+	A	test
InChI=1S/C14H24N2O4/c1-4-10(5-2)20-12-7-9(14(18)19)6-11(15)13(12)16-8(3)17/h7,10-13H,4-6,15H2,1-3H3,(H,16,17)(H,18,19)/t11-,12+,13+/m0/s1	Ro 64-0802|Oseltamivir Acid	(3R,4R,5S)-4-acetamido-5-amino-3-pentan-3-yloxycyclohexene-1-carboxylic acid	CCC(CC)O[C@@H]1C=C(C(=O)O)C[C@H](N)[C@H]1NC(C)=O	449381.0	R26_chico_2009:355	-1.96	A	BBB-	A	training
InChI=1S/C14H24N2O7/c1-5-4-6(17)14(20)13(21-5)22-12-10(19)7(15-2)9(18)8(16-3)11(12)23-14/h5,7-13,15-16,18-20H,4H2,1-3H3/t5-,7-,8+,9+,10+,11-,12-,13+,14+/m1/s1	Spectinomycin	(1R,3S,5R,8R,10R,11S,12S,13R,14S)-8,12,14-trihydroxy-5-methyl-11,13-bis(methylamino)-2,4,9-trioxatricyclo[8.4.0.03,8]tetradecan-7-one	CN[C@@H]1[C@H](O)[C@H](NC)[C@H]2O[C@@]3(O)C(=O)C[C@@H](C)O[C@H]3O[C@@H]2[C@H]1O	15541.0	R23_gupta_2019:918			BBB-	C	test
InChI=1S/C14H26O4/c1-6-8-11(9-7-2)12(15)17-10-18-13(16)14(3,4)5/h11H,6-10H2,1-5H3	Valproate-Pivoxil|Valproate Pivoxil	2,2-dimethylpropanoyloxymethyl 2-propylpentanoate	CCCC(CCC)C(=O)OCOC(=O)C(C)(C)C	71160.0	R6_adenot_2004:477|R7_andres_2006:181|R29_subramanian_2003:176			BBB+	C	training
InChI=1S/C14H27N3O2/c1-11(2)17(12(3)4)9-7-15-13(18)10-16-8-5-6-14(16)19/h11-12H,5-10H2,1-4H3,(H,15,18)	Pramiracetam	N-[2-[di(propan-2-yl)amino]ethyl]-2-(2-oxopyrrolidin-1-yl)acetamide	CC(C)N(CCNC(=O)CN1CCCC1=O)C(C)C	51712.0	R6_adenot_2004:1307			BBB+	C	training
InChI=1S/C14H30N2O4/c1-15(2,3)9-11-19-13(17)7-8-14(18)20-12-10-16(4,5)6/h7-12H2,1-6H3/q+2	Succinylcholine	trimethyl-[2-[4-oxo-4-[2-(trimethylazaniumyl)ethoxy]butanoyl]oxyethyl]azanium	C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C	5314.0	R23_gupta_2019:927			BBB-	C	training
InChI=1S/C14H30O4S/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-18-19(15,16)17/h2-14H2,1H3,(H,15,16,17)	Sodium Tetradecyl Sulfate|Myristyl Sulfate	tetradecyl hydrogen sulfate	CCCCCCCCCCCCCCOS(=O)(=O)O	5248.0	R23_gupta_2019:914			BBB-	C	training
InChI=1S/C14H7Cl2NO3/c15-9-3-8(4-10(16)6-9)13-17-11-2-1-7(14(18)19)5-12(11)20-13/h1-6H,(H,18,19)	Tafamidis	2-(3,5-dichlorophenyl)-1,3-benzoxazole-6-carboxylic acid	O=C(O)c1ccc2nc(-c3cc(Cl)cc(Cl)c3)oc2c1	11001318.0	R23_gupta_2019:947			BBB-	C	training
InChI=1S/C14H8ClN3OS/c15-9-1-2-10-11(5-9)18-13(19)6-12(17-10)14-8(7-16)3-4-20-14/h1-5H,6H2,(H,18,19)	21		N#Cc1ccsc1C1=Nc2ccc(Cl)cc2NC(=O)C1		R47_radchenko_2020:445	-0.14	A	BBB+	A	test
InChI=1S/C14H9Cl2F3N2O2/c15-8-2-4-12(22)11(6-8)21-13(23)20-10-5-7(14(17,18)19)1-3-9(10)16/h1-6,22H,(H2,20,21,23)	Ns1738|Urea, N-(5-Chloro-2-Hydroxyphenyl)-N'-(2-Chloro-5-(Trifluoromethyl)Phenyl)-	1-(5-chloro-2-hydroxyphenyl)-3-[2-chloro-5-(trifluoromethyl)phenyl]urea	O=C(Nc1cc(Cl)ccc1O)Nc1cc(C(F)(F)F)ccc1Cl	310378.0	R26_chico_2009:289	-0.3	A	BBB+	A	training
InChI=1S/C14H9Cl2N3O2/c15-8-4-2-1-3-7(8)11-12-9(5-6-10(16)18-12)17-13(20)14(21)19-11/h1-6,14,21H,(H,17,20)	Lopirazepam	7-chloro-5-(2-chlorophenyl)-3-hydroxy-1,3-dihydropyrido[3,2-e][1,4]diazepin-2-one	O=C1Nc2ccc(Cl)nc2C(c2ccccc2Cl)=NC1O	68672.0	R6_adenot_2004:721			BBB+	C	training
InChI=1S/C14H9Cl3N2OS/c1-21-14-18-9-5-8(16)12(6-10(9)19-14)20-11-4-2-3-7(15)13(11)17/h2-6H,1H3,(H,18,19)	Triclabendazole	6-chloro-5-(2,3-dichlorophenoxy)-2-methylsulfanyl-1H-benzimidazole	CSc1nc2cc(Oc3cccc(Cl)c3Cl)c(Cl)cc2[nH]1	50248.0	R23_gupta_2019:999			BBB-	C	test
InChI=1S/C14H9ClF3NO2/c15-9-3-4-11-10(7-9)13(14(16,17)18,21-12(20)19-11)6-5-8-1-2-8/h3-4,7-8H,1-2H2,(H,19,20)/t13-/m0/s1	Efavirenz	(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-1H-3,1-benzoxazin-2-one	O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1	64139.0	R14_ghose_2012:521|R23_gupta_2019:551|R28_li_2005:196			BBB-	C	training
InChI=1S/C14H9NO4/c16-11(17)7-15-13(18)9-5-1-3-8-4-2-6-10(12(8)9)14(15)19/h1-6H,7H2,(H,16,17)	Alrestatin	2-(1,3-dioxobenzo[de]isoquinolin-2-yl)acetic acid	O=C(O)CN1C(=O)c2cccc3cccc(c23)C1=O	2120.0	R6_adenot_2004:1398			BBB+	C	training
InChI=1S/C15H10BrClN4S/c1-8-19-20-13-7-18-14(9-4-2-3-5-11(9)17)10-6-12(16)22-15(10)21(8)13/h2-6H,7H2,1H3	Brotizolam	4-bromo-7-(2-chlorophenyl)-13-methyl-3-thia-1,8,11,12-tetrazatricyclo[8.3.0.02,6]trideca-2(6),4,7,10,12-pentaene	Cc1nnc2n1-c1sc(Br)cc1C(c1ccccc1Cl)=NC2	2451.0	R6_adenot_2004:685|R14_ghose_2012:25|R37_chen_2011:12			BBB+	C	training
InChI=1S/C15H10Cl2N2O/c16-9-5-6-13-11(7-9)15(18-8-14(20)19-13)10-3-1-2-4-12(10)17/h1-7H,8H2,(H,19,20)	Delorazepam	7-chloro-5-(2-chlorophenyl)-1,3-dihydro-1,4-benzodiazepin-2-one	O=C1CN=C(c2ccccc2Cl)c2cc(Cl)ccc2N1	17925.0	R6_adenot_2004:698|R14_ghose_2012:291|R23_gupta_2019:59			BBB+	C	training
InChI=1S/C15H10Cl2N2O2/c16-8-5-6-12-10(7-8)13(19-15(21)14(20)18-12)9-3-1-2-4-11(9)17/h1-7,15,21H,(H,18,20)	Lorazepam	7-chloro-5-(2-chlorophenyl)-3-hydroxy-1,3-dihydro-1,4-benzodiazepin-2-one	O=C1Nc2ccc(Cl)cc2C(c2ccccc2Cl)=NC1O	3958.0	R3_abraham_2006:190|R3_abraham_2006:191|R6_adenot_2004:723|R7_andres_2006:95|R14_ghose_2012:127|R21_muehlbacher_2011:94|R25_brito_sanchez_2015:277|R26_chico_2009:249|R29_subramanian_2003:89|R34_broccatelli_2012:46|R37_chen_2011:47|R40_vilar_2010:139|R41_toropov_2017:175|R46_mendoza_valencia_2017:250|R47_radchenko_2020:161|R50_sobanska_2019:33|R51_doninger_2002:239	0.43	B1	BBB+	A	training
InChI=1S/C15H10ClN3O3/c16-12-4-2-1-3-10(12)15-11-7-9(19(21)22)5-6-13(11)18-14(20)8-17-15/h1-7H,8H2,(H,18,20)	Clonazepam	5-(2-chlorophenyl)-7-nitro-1,3-dihydro-1,4-benzodiazepin-2-one	O=C1CN=C(c2ccccc2Cl)c2cc([N+](=O)[O-])ccc2N1	2802.0	R6_adenot_2004:694|R7_andres_2006:39|R14_ghose_2012:53|R26_chico_2009:111|R29_subramanian_2003:40|R34_broccatelli_2012:18|R37_chen_2011:23|R51_doninger_2002:185			BBB+	C	training
InChI=1S/C15H10O2/c16-14-11-8-4-5-9-12(11)15(17)13(14)10-6-2-1-3-7-10/h1-9,13H	Phenindione	2-phenylindene-1,3-dione	O=C1c2ccccc2C(=O)C1c1ccccc1	4760.0	R14_ghose_2012:766			BBB-	C	training
InChI=1S/C15H10O4/c16-10-3-1-9(2-4-10)13-8-19-14-7-11(17)5-6-12(14)15(13)18/h1-8,16-17H	Daidzein Ok|Daidzein	7-hydroxy-3-(4-hydroxyphenyl)chromen-4-one	O=c1c(-c2ccc(O)cc2)coc2cc(O)ccc12	5281708.0	R3_abraham_2006:154|R21_muehlbacher_2011:319|R25_brito_sanchez_2015:199|R26_chico_2009:145|R40_vilar_2010:90|R41_toropov_2017:143|R46_mendoza_valencia_2017:185|R47_radchenko_2020:129	-0.15	B	BBB+	A	training
InChI=1S/C15H10O7/c16-7-4-10(19)12-11(5-7)22-15(14(21)13(12)20)6-1-2-8(17)9(18)3-6/h1-5,16-19,21H	Quercetin	2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxychromen-4-one	O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12	5280343.0	R25_brito_sanchez_2015:513	-1.7	A	BBB-	A	training
InChI=1S/C15H11ClN2O/c1-10-17-13-8-4-2-6-11(13)15(19)18(10)14-9-5-3-7-12(14)16/h2-9H,1H3	Mecloqualone	3-(2-chlorophenyl)-2-methylquinazolin-4-one	Cc1nc2ccccc2c(=O)n1-c1ccccc1Cl	9567.0	R6_adenot_2004:1369|R51_doninger_2002:242			BBB+	C	training
InChI=1S/C15H11ClN2O/c16-11-6-7-13-12(8-11)15(17-9-14(19)18-13)10-4-2-1-3-5-10/h1-8H,9H2,(H,18,19)	Nordazepam|1088-11-5|Desmethyldiazepam|Nordiazepam|Desmethyldiazepam, Nordazepam	7-chloro-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one	O=C1CN=C(c2ccccc2)c2cc(Cl)ccc2N1	2997.0	R3_abraham_2006:304|R4_mente_2005:53|R5_guerra_2008:34|R6_adenot_2004:734|R12_garg_2006:69|R21_muehlbacher_2011:59|R23_gupta_2019:305|R25_brito_sanchez_2015:206|R26_chico_2009:151|R28_li_2005:188|R31_carpenter_2014:9|R34_broccatelli_2012:62|R39_shayanfar_2011:38|R40_vilar_2010:164|R41_toropov_2017:271|R47_radchenko_2020:251|R51_doninger_2002:263	0.52	B1	BBB+	A	training
InChI=1S/C15H11ClN2O/c16-11-7-4-8-12-14(11)15(17-9-13(19)18-12)10-5-2-1-3-6-10/h1-8H,9H2,(H,18,19)	6-Chloro-5-Phenyl-1,3-Dihydro-1,4-Benzodiazepin-2-One	6-chloro-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one	O=C1CN=C(c2ccccc2)c2c(Cl)cccc2N1	14590445.0	R41_toropov_2017:147	0.5	A	BBB+	A	training
InChI=1S/C15H11ClN2O2/c16-10-6-7-12-11(8-10)13(9-4-2-1-3-5-9)18-15(20)14(19)17-12/h1-8,15,20H,(H,17,19)	Oxazepam|604-75-1	7-chloro-3-hydroxy-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one	O=C1Nc2ccc(Cl)cc2C(c2ccccc2)=NC1O	4616.0	R3_abraham_2006:216|R3_abraham_2006:217|R4_mente_2005:61|R6_adenot_2004:736|R12_garg_2006:127|R14_ghose_2012:175|R17_fu_2008:39|R21_muehlbacher_2011:107|R23_gupta_2019:176|R25_brito_sanchez_2015:341|R26_chico_2009:295|R28_li_2005:39|R40_vilar_2010:176|R41_toropov_2017:198|R42_ciura_2020:30|R44_bujak_2015:48|R47_radchenko_2020:183|R49_norinder_2002:93|R49_norinder_2002:127|R50_sobanska_2019:37|R51_doninger_2002:267	0.6	B1	BBB+	A	training
InChI=1S/C15H11ClN2O2/c16-10-6-7-12-11(8-10)13(9-4-2-1-3-5-9)18-15(20)14(19)17-12/h1-8,15,20H,(H,17,19)/t15-/m0/s1	S-Oxazepam	(3S)-7-chloro-3-hydroxy-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one	O=C1Nc2ccc(Cl)cc2C(c2ccccc2)=N[C@H]1O	667436.0	R48_hou_2003:14	0.61	A	BBB+	A	training
InChI=1S/C15H11ClN2O2/c16-10-6-7-12-13(8-10)18(11-4-2-1-3-5-11)15(20)9-14(19)17-12/h1-8H,9H2,(H,17,19)	Desmethylclobazam|22316-55-8|N-Desmethylclobazam|Norclobazam	7-chloro-5-phenyl-1H-1,5-benzodiazepine-2,4-dione	O=C1CC(=O)N(c2ccccc2)c2cc(Cl)ccc2N1	89657.0	R3_abraham_2006:157|R4_mente_2005:52|R5_guerra_2008:33|R5_guerra_2008:71|R12_garg_2006:67|R12_garg_2006:118|R21_muehlbacher_2011:276|R25_brito_sanchez_2015:204|R28_li_2005:187|R39_shayanfar_2011:36|R40_vilar_2010:94|R41_toropov_2017:146|R46_mendoza_valencia_2017:189|R47_radchenko_2020:132	0.36	D	BBB+	A	test
InChI=1S/C15H11ClN2O2/c16-11-6-7-13-12(8-11)15(10-4-2-1-3-5-10)18(20)9-14(19)17-13/h1-8,20H,9H2	Demoxepam	7-chloro-4-hydroxy-5-phenyl-3H-1,4-benzodiazepin-2-one	O=C1CN(O)C(c2ccccc2)=c2cc(Cl)ccc2=N1	13756.0	R6_adenot_2004:699			BBB+	C	training
InChI=1S/C15H11I4NO4/c16-8-4-7(5-9(17)13(8)21)24-14-10(18)1-6(2-11(14)19)3-12(20)15(22)23/h1-2,4-5,12,21H,3,20H2,(H,22,23)/t12-/m1/s1	Dextrothyroxine Sodium|Dextrothyroxine	(2R)-2-amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoic acid	N[C@H](Cc1cc(I)c(Oc2cc(I)c(O)c(I)c2)c(I)c1)C(=O)O	8730.0	R14_ghose_2012:488			BBB-	C	training
InChI=1S/C15H11N3O3/c19-14-9-16-15(10-4-2-1-3-5-10)12-8-11(18(20)21)6-7-13(12)17-14/h1-8H,9H2,(H,17,19)	Nitrazepam	7-nitro-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one	O=C1CN=C(c2ccccc2)c2cc([N+](=O)[O-])ccc2N1	4506.0	R6_adenot_2004:733|R7_andres_2006:117|R14_ghose_2012:169|R23_gupta_2019:167|R29_subramanian_2003:114|R34_broccatelli_2012:60|R47_radchenko_2020:470|R51_doninger_2002:262	0.32	A	BBB+	A	training
InChI=1S/C15H11N5O2/c16-8-10-11(9-22-13-5-1-2-6-18-13)19-15(17)20-14(10)12-4-3-7-21-12/h1-7H,9H2,(H2,17,19,20)	20		N#Cc1c(COc2ccccn2)nc(N)nc1-c1ccco1		R47_radchenko_2020:444	0.0	A	BBB+	A	training
InChI=1S/C15H12BrNO3/c16-11-6-4-9(5-7-11)15(20)12-3-1-2-10(14(12)17)8-13(18)19/h1-7H,8,17H2,(H,18,19)	Bromfenac	2-[2-amino-3-(4-bromobenzoyl)phenyl]acetic acid	Nc1c(CC(=O)O)cccc1C(=O)c1ccc(Br)cc1	60726.0	R14_ghose_2012:404			BBB-	C	training
InChI=1S/C15H12I3NO4/c16-9-6-8(1-2-13(9)20)23-14-10(17)3-7(4-11(14)18)5-12(19)15(21)22/h1-4,6,12,20H,5,19H2,(H,21,22)/t12-/m0/s1	Liothyronine	(2S)-2-amino-3-[4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl]propanoic acid	N[C@@H](Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1)C(=O)O	5920.0	R14_ghose_2012:657			BBB-	C	training
InChI=1S/C15H12N2O/c16-15(18)17-13-7-3-1-5-11(13)9-10-12-6-2-4-8-14(12)17/h1-10H,(H2,16,18)	Carbamazepine|Carbamazepine; Tegretol|31	benzo[b][1]benzazepine-11-carboxamide	NC(=O)N1c2ccccc2C=Cc2ccccc21	2554.0	R3_abraham_2006:142|R5_guerra_2008:22|R6_adenot_2004:426|R7_andres_2006:193|R12_garg_2006:52|R14_ghose_2012:35|R21_muehlbacher_2011:48|R23_gupta_2019:36|R25_brito_sanchez_2015:24|R26_chico_2009:93|R28_li_2005:12|R34_broccatelli_2012:13|R37_chen_2011:18|R39_shayanfar_2011:24|R40_vilar_2010:69|R41_toropov_2017:134|R44_bujak_2015:19|R46_mendoza_valencia_2017:24|R47_radchenko_2020:120|R48_hou_2003:69|R49_norinder_2002:31|R49_norinder_2002:150|R50_sobanska_2019:20|R51_doninger_2002:173|R52_liu_2001:65	0.0	D	BBB+	A	training
InChI=1S/C15H12N2O/c18-15(10-17-8-7-16-11-17)14-6-5-12-3-1-2-4-13(12)9-14/h1-9,11H,10H2	Nafimidone	2-imidazol-1-yl-1-naphthalen-2-ylethanone	O=C(Cn1ccnc1)c1ccc2ccccc2c1	51200.0	R6_adenot_2004:454			BBB+	C	training
InChI=1S/C15H12N2O2/c16-15(18)17-11-7-3-1-5-9(11)13-14(19-13)10-6-2-4-8-12(10)17/h1-8,13-14H,(H2,16,18)	Carbamazepine-10,11-Epoxide|Carbamazepine Epoxide|B-096|32	3-oxa-11-azatetracyclo[10.4.0.02,4.05,10]hexadeca-1(16),5,7,9,12,14-hexaene-11-carboxamide	NC(=O)N1c2ccccc2C2OC2c2ccccc21	2555.0	R5_guerra_2008:23|R12_garg_2006:53|R21_muehlbacher_2011:49|R25_brito_sanchez_2015:25|R26_chico_2009:67|R39_shayanfar_2011:25|R40_vilar_2010:70|R46_mendoza_valencia_2017:25|R47_radchenko_2020:265|R49_norinder_2002:32|R49_norinder_2002:151|R52_liu_2001:66	-0.34	B1	BBB+	A	training
InChI=1S/C15H12N2O2/c16-15(18)17-11-7-3-1-5-9(11)13-14(19-13)10-6-2-4-8-12(10)17/h1-8,13-14H,(H2,16,18)/t13-,14-/m1/s1	Carbamazepineepoxide|(2R,4R)-3-Oxa-11-Azatetracyclo[10.4.0.02,4.05,10]Hexadeca-1(16),5,7,9,12,14-Hexaene-11-Carboxamide	(2R,4R)-3-oxa-11-azatetracyclo[10.4.0.02,4.05,10]hexadeca-1(16),5,7,9,12,14-hexaene-11-carboxamide	NC(=O)N1c2ccccc2[C@H]2O[C@@H]2c2ccccc21	29975387.0	R28_li_2005:134			BBB+	C	training
InChI=1S/C15H12N2O2/c16-15(19)17-12-7-3-1-5-10(12)9-14(18)11-6-2-4-8-13(11)17/h1-8H,9H2,(H2,16,19)	Oxcarbazepine|Rivastigmine, Exelon	5-oxo-6H-benzo[b][1]benzazepine-11-carboxamide	NC(=O)N1c2ccccc2CC(=O)c2ccccc21	34312.0	R6_adenot_2004:456|R7_andres_2006:125|R14_ghose_2012:176|R23_gupta_2019:177|R26_chico_2009:296|R26_chico_2009:353|R29_subramanian_2003:121|R34_broccatelli_2012:65|R37_chen_2011:66			BBB+	C	training
InChI=1S/C15H12N2O2/c18-13-15(17-14(19)16-13,11-7-3-1-4-8-11)12-9-5-2-6-10-12/h1-10H,(H2,16,17,18,19)	Phenytoin	5,5-diphenylimidazolidine-2,4-dione	O=C1NC(=O)C(c2ccccc2)(c2ccccc2)N1	1775.0	R3_abraham_2006:229|R3_abraham_2006:230|R5_guerra_2008:84|R6_adenot_2004:1662|R12_garg_2006:136|R14_ghose_2012:200|R21_muehlbacher_2011:22|R25_brito_sanchez_2015:357|R26_chico_2009:311|R28_li_2005:106|R34_broccatelli_2012:68|R37_chen_2011:72|R39_shayanfar_2011:75|R40_vilar_2010:210|R41_toropov_2017:207|R44_bujak_2015:51|R46_mendoza_valencia_2017:312|R47_radchenko_2020:192|R50_sobanska_2019:19|R51_doninger_2002:284	-0.13	B1	BBB+	A	training
InChI=1S/C15H13ClN2O/c16-11-6-7-13-14(10-11)18(15(19)8-9-17-13)12-4-2-1-3-5-12/h1-7,10,17H,8-9H2	Lofendazam	7-chloro-5-phenyl-2,3-dihydro-1H-1,5-benzodiazepin-4-one	O=C1CCNc2ccc(Cl)cc2N1c1ccccc1	71709.0	R6_adenot_2004:719			BBB+	C	training
InChI=1S/C15H13F2N3O3/c1-8(16)23-15(22)13-12-6-19(2)14(21)10-5-9(17)3-4-11(10)20(12)7-18-13/h3-5,7-8H,6H2,1-2H3	Ffmz		CC(F)OC(=O)c1ncn2c1CN(C)C(=O)c1cc(F)ccc1-2		R3_abraham_2006:170|R25_brito_sanchez_2015:232|R40_vilar_2010:111|R41_toropov_2017:157|R46_mendoza_valencia_2017:213|R47_radchenko_2020:143	-0.1	B1	BBB+	A	training
InChI=1S/C15H13FO2/c1-10(15(17)18)12-7-8-13(14(16)9-12)11-5-3-2-4-6-11/h2-10H,1H3,(H,17,18)	Flurbiprofen	2-(3-fluoro-4-phenylphenyl)propanoic acid	CC(C(=O)O)c1ccc(-c2ccccc2)c(F)c1	3394.0	R23_gupta_2019:98|R25_brito_sanchez_2015:475|R26_chico_2009:195|R46_mendoza_valencia_2017:399	-1.68	B	BBB-	A	training
InChI=1S/C15H13N3O4S/c1-18-13(15(20)17-12-8-4-5-9-16-12)14(19)10-6-2-3-7-11(10)23(18,21)22/h2-9,19H,1H3,(H,16,17,20)	Piroxicam	4-hydroxy-2-methyl-1,1-dioxo-N-pyridin-2-yl-1lambda6,2-benzothiazine-3-carboxamide	CN1C(C(=O)Nc2ccccn2)=C(O)c2ccccc2S1(=O)=O	54676228.0	R14_ghose_2012:783|R28_li_2005:388|R50_sobanska_2019:48			BBB-	C	training
InChI=1S/C15H13NO3S2/c1-10(7-11-5-3-2-4-6-11)8-12-14(19)16(9-13(17)18)15(20)21-12/h2-8H,9H2,1H3,(H,17,18)/b10-7+,12-8-	Epalrestat	2-[(5Z)-5-[(E)-2-methyl-3-phenylprop-2-enylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid	CC(/C=C1\SC(=S)N(CC(=O)O)C1=O)=C\c1ccccc1	1549120.0	R14_ghose_2012:529|R23_gupta_2019:562			BBB-	C	training
InChI=1S/C15H13NO4/c1-10(17)16-11-6-8-12(9-7-11)20-15(19)13-4-2-3-5-14(13)18/h2-9,18H,1H3,(H,16,17)	Acetaminosalol	(4-acetamidophenyl) 2-hydroxybenzoate	CC(=O)Nc1ccc(OC(=O)c2ccccc2O)cc1	1984.0	R6_adenot_2004:405			BBB+	C	test
InChI=1S/C15H14ClN3O/c16-12-6-4-11(5-7-12)15(20,14-18-9-10-19-14)13-3-1-2-8-17-13/h1-8,20H,9-10H2,(H,18,19)	Dazadrol	(4-chlorophenyl)-(4,5-dihydro-1H-imidazol-2-yl)-pyridin-2-ylmethanol	OC(C1=NCCN1)(c1ccc(Cl)cc1)c1ccccn1	32940.0	R6_adenot_2004:521			BBB+	C	training
InChI=1S/C15H14ClN3O4S/c16-8-6-24-14-10(13(21)19(14)11(8)15(22)23)18-12(20)9(17)7-4-2-1-3-5-7/h1-5,9-10,14H,6,17H2,(H,18,20)(H,22,23)/t9-,10-,14-/m1/s1	Cefaclor	(6R,7R)-7-[[(2R)-2-amino-2-phenylacetyl]amino]-3-chloro-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid	N[C@@H](C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(Cl)CS[C@H]12)c1ccccc1	51039.0	R6_adenot_2004:151|R14_ghose_2012:427|R23_gupta_2019:416			BBB-	C	training
InChI=1S/C15H14ClN3O4S3/c16-11-6-12-14(7-13(11)25(17,20)21)26(22,23)19-15(18-12)9-24-8-10-4-2-1-3-5-10/h1-7H,8-9H2,(H,18,19)(H2,17,20,21)	Benzthiazide	3-(benzylsulfanylmethyl)-6-chloro-1,1-dioxo-4H-1lambda6,2,4-benzothiadiazine-7-sulfonamide	NS(=O)(=O)c1cc2c(cc1Cl)NC(CSCc1ccccc1)=NS2(=O)=O	2343.0	R14_ghose_2012:387|R23_gupta_2019:384			BBB-	C	training
InChI=1S/C15H14ClNO3/c1-9-7-12(8-13(18)19)17(2)14(9)15(20)10-3-5-11(16)6-4-10/h3-7H,8H2,1-2H3,(H,18,19)	Zomepirac	2-[5-(4-chlorobenzoyl)-1,4-dimethylpyrrol-2-yl]acetic acid	Cc1cc(CC(=O)O)n(C)c1C(=O)c1ccc(Cl)cc1	5733.0	R14_ghose_2012:942			BBB-	C	training
InChI=1S/C15H14F3N3O4S2/c16-15(17,18)10-7-11-13(8-12(10)26(19,22)23)27(24,25)21-14(20-11)6-9-4-2-1-3-5-9/h1-5,7-8,14,20-21H,6H2,(H2,19,22,23)	Bendroflumethiazide	3-benzyl-1,1-dioxo-6-(trifluoromethyl)-3,4-dihydro-2H-1lambda6,2,4-benzothiadiazine-7-sulfonamide	NS(=O)(=O)c1cc2c(cc1C(F)(F)F)NC(Cc1ccccc1)NS2(=O)=O	2315.0	R14_ghose_2012:378|R23_gupta_2019:381			BBB-	C	training
InChI=1S/C15H14FN3O3/c1-3-22-15(21)13-12-7-18(2)14(20)10-6-9(16)4-5-11(10)19(12)8-17-13/h4-6,8H,3,7H2,1-2H3	Flumazenil|78755-81-4	ethyl 8-fluoro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate	CCOC(=O)c1ncn2c1CN(C)C(=O)c1cc(F)ccc1-2	3373.0	R3_abraham_2006:171|R4_mente_2005:55|R5_guerra_2008:44|R7_andres_2006:67|R14_ghose_2012:92|R21_muehlbacher_2011:77|R23_gupta_2019:93|R25_brito_sanchez_2015:234|R26_chico_2009:189|R28_li_2005:83|R29_subramanian_2003:63|R37_chen_2011:37|R39_shayanfar_2011:109|R40_vilar_2010:113|R41_toropov_2017:158|R46_mendoza_valencia_2017:215|R47_radchenko_2020:144	-0.29	B	BBB+	A	training
InChI=1S/C15H14IN3O3/c1-3-22-15(21)13-11-7-18(2)14(20)12-9(16)5-4-6-10(12)19(11)8-17-13/h4-6,8H,3,7H2,1-2H3	Iomazenil	ethyl 7-iodo-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate	CCOC(=O)c1ncn2c1CN(C)C(=O)c1c(I)cccc1-2	10251042.0	R14_ghose_2012:304|R23_gupta_2019:291			BBB+	C	training
InChI=1S/C15H14N2O/c18-14-15(17-11-16-14,12-7-3-1-4-8-12)13-9-5-2-6-10-13/h1-10,17H,11H2,(H,16,18)	Doxenitoin	5,5-diphenylimidazolidin-4-one	O=C1NCNC1(c1ccccc1)c1ccccc1	18622.0	R6_adenot_2004:1646			BBB+	C	training
InChI=1S/C15H14N2O2/c16-15(19)17-12-7-3-1-5-10(12)9-14(18)11-6-2-4-8-13(11)17/h1-8,14,18H,9H2,(H2,16,19)	S-Licarbizine|Licarbazepine	5-hydroxy-5,6-dihydrobenzo[b][1]benzazepine-11-carboxamide	NC(=O)N1c2ccccc2CC(O)c2ccccc21	114709.0	R26_chico_2009:383	-0.59	A	BBB+	A	training
InChI=1S/C15H14N4O/c1-19-15(13-7-3-2-5-12(13)10-20)17-14(18-19)11-6-4-8-16-9-11/h2-9,20H,10H2,1H3	Fepitrizol	[2-(2-methyl-5-pyridin-3-yl-1,2,4-triazol-3-yl)phenyl]methanol	Cn1nc(-c2cccnc2)nc1-c1ccccc1CO	68702.0	R6_adenot_2004:1362			BBB+	C	training
InChI=1S/C15H14N4O/c1-9-6-8-17-14-12(9)18-15(20)11-3-2-7-16-13(11)19(14)10-4-5-10/h2-3,6-8,10H,4-5H2,1H3,(H,18,20)	Nevirapine|129618-40-2	2-cyclopropyl-7-methyl-2,4,9,15-tetrazatricyclo[9.4.0.03,8]pentadeca-1(11),3,5,7,12,14-hexaen-10-one	Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1	4463.0	R3_abraham_2006:207|R4_mente_2005:40|R5_guerra_2008:72|R12_garg_2006:120|R14_ghose_2012:713|R17_fu_2008:54|R21_muehlbacher_2011:104|R25_brito_sanchez_2015:320|R28_li_2005:32|R40_vilar_2010:160|R41_toropov_2017:189|R47_radchenko_2020:174|R48_hou_2003:76|R49_norinder_2002:105	0.0	B	BBB+	A	training
InChI=1S/C15H14N4O2S/c16-12-6-8-14(9-7-12)22(20,21)18-15-10-11-17-19(15)13-4-2-1-3-5-13/h1-11,18H,16H2	Sulfaphenazole	4-amino-N-(2-phenylpyrazol-3-yl)benzenesulfonamide	Nc1ccc(S(=O)(=O)Nc2ccnn2-c2ccccc2)cc1	5335.0	R14_ghose_2012:862|R23_gupta_2019:940			BBB-	C	training
InChI=1S/C15H14N4O6S2/c16-15-17-7(5-27-15)6(1-2-9(20)21)11(22)18-10-12(23)19-8(14(24)25)3-4-26-13(10)19/h1,3,5,10,13H,2,4H2,(H2,16,17)(H,18,22)(H,20,21)(H,24,25)/b6-1-/t10-,13-/m1/s1	Ceftibuten|Ceftibuten Dihydrate	(6R,7R)-7-[[(Z)-2-(2-amino-1,3-thiazol-4-yl)-4-carboxybut-2-enoyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid	Nc1nc(/C(=C/CC(=O)O)C(=O)N[C@@H]2C(=O)N3C(C(=O)O)=CCS[C@H]23)cs1	5282242.0	R6_adenot_2004:133|R14_ghose_2012:435|R23_gupta_2019:437			BBB-	C	training
InChI=1S/C15H15BrN2/c1-17-10-8-15(13-3-2-9-18-11-13)12-4-6-14(16)7-5-12/h2-9,11,17H,10H2,1H3/b15-8-	Nomelidine	(Z)-3-(4-bromophenyl)-N-methyl-3-pyridin-3-ylprop-2-en-1-amine	CNC/C=C(/c1ccc(Br)cc1)c1cccnc1	5378630.0	R6_adenot_2004:586			BBB+	C	training
InChI=1S/C15H15Cl2N3O/c16-10-1-2-12(13(17)9-10)14-3-4-15(19-18-14)20-7-5-11(21)6-8-20/h1-4,9,11,21H,5-8H2	Endixaprine	1-[6-(2,4-dichlorophenyl)pyridazin-3-yl]piperidin-4-ol	OC1CCN(c2ccc(-c3ccc(Cl)cc3Cl)nn2)CC1	65836.0	R6_adenot_2004:1459			BBB+	C	test
InChI=1S/C15H15ClN2O/c16-11-6-7-13-12(8-11)15(17-9-14(19)18-13)10-4-2-1-3-5-10/h4,6-8H,1-3,5,9H2,(H,18,19)	Nortetrazepam	7-chloro-5-(cyclohexen-1-yl)-1,3-dihydro-1,4-benzodiazepin-2-one	O=C1CN=C(C2=CCCCC2)c2cc(Cl)ccc2N1	166581.0	R6_adenot_2004:735			BBB+	C	training
InChI=1S/C15H15ClN2S/c16-11-6-7-15-13(10-11)18(9-3-8-17)12-4-1-2-5-14(12)19-15/h1-2,4-7,10H,3,8-9,17H2	2095-17-2|Nor-2-Chlorpromazine|Didemethylchlorpromazine|Cid 74981	3-(2-chlorophenothiazin-10-yl)propan-1-amine	NCCCN1c2ccccc2Sc2ccc(Cl)cc21	74981.0	R4_mente_2005:157|R12_garg_2006:124|R21_muehlbacher_2011:270|R25_brito_sanchez_2015:325|R28_li_2005:100|R39_shayanfar_2011:67|R40_vilar_2010:163|R46_mendoza_valencia_2017:286|R47_radchenko_2020:280	0.97	B	BBB+	A	training
InChI=1S/C15H15FN4O/c1-9-13-14(10-6-4-5-7-11(10)16)17-8-12(21)19(2)15(13)20(3)18-9/h4-7H,8H2,1-3H3	Zolazepam	4-(2-fluorophenyl)-1,3,8-trimethyl-6H-pyrazolo[3,4-e][1,4]diazepin-7-one	Cc1nn(C)c2c1C(c1ccccc1F)=NCC(=O)N2C	35775.0	R6_adenot_2004:758			BBB+	C	training
InChI=1S/C15H15N3O/c1-10-14-12(9-18(10)2)17-13(19)8-16-15(14)11-6-4-3-5-7-11/h3-7,9H,8H2,1-2H3,(H,17,19)	Premazepam	6,7-dimethyl-5-phenyl-1,3-dihydropyrrolo[3,4-e][1,4]diazepin-2-one	Cc1c2c(cn1C)NC(=O)CN=C2c1ccccc1	72104.0	R6_adenot_2004:742			BBB+	C	training
InChI=1S/C15H15N3O2/c1-10(19)17-12-8-6-11(7-9-12)15(20)18-14-5-3-2-4-13(14)16/h2-9H,16H2,1H3,(H,17,19)(H,18,20)	Ci-994|Tacedinaline	4-acetamido-N-(2-aminophenyl)benzamide	CC(=O)Nc1ccc(C(=O)Nc2ccccc2N)cc1	2746.0	R47_radchenko_2020:518	-0.58	A	BBB+	A	training
InChI=1S/C15H15N7O4S3/c1-21-15(18-19-20-21)29-6-8-5-28-13-10(12(24)22(13)11(8)14(25)26)17-9(23)7-27-4-2-3-16/h2,4,10,13H,5-7H2,1H3,(H,17,23)(H,25,26)/b4-2-/t10-,13-/m1/s1	Cefivitril	(6R,7R)-7-[[2-[(Z)-2-cyanoethenyl]sulfanylacetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid	Cn1nnnc1SCC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)CS/C=C\C#N)[C@H]2SC1	6443795.0	R6_adenot_2004:173			BBB-	C	training
InChI=1S/C15H15NO2S/c16-14(17)11-19(18)15(12-7-3-1-4-8-12)13-9-5-2-6-10-13/h1-10,15H,11H2,(H2,16,17)	Modafinil	2-benzhydrylsulfinylacetamide	NC(=O)CS(=O)C(c1ccccc1)c1ccccc1	4236.0	R6_adenot_2004:1300|R14_ghose_2012:156|R23_gupta_2019:155|R37_chen_2011:56			BBB+	C	training
InChI=1S/C15H16Cl3N5/c1-22-2-4-23(5-3-22)15-20-8-11(14(19)21-15)10-6-9(16)7-12(17)13(10)18/h6-8H,2-5H2,1H3,(H2,19,20,21)	Sipatrigine	2-(4-methylpiperazin-1-yl)-5-(2,3,5-trichlorophenyl)pyrimidin-4-amine	CN1CCN(c2ncc(-c3cc(Cl)cc(Cl)c3Cl)c(N)n2)CC1	60803.0	R6_adenot_2004:1245			BBB+	C	training
InChI=1S/C15H16ClN3O/c16-13-4-2-1-3-12(13)14-5-6-15(18-17-14)19-9-7-11(20)8-10-19/h1-6,11,20H,7-10H2	Lodaxaprine	1-[6-(2-chlorophenyl)pyridazin-3-yl]piperidin-4-ol	OC1CCN(c2ccc(-c3ccccc3Cl)nn2)CC1	65835.0	R6_adenot_2004:432			BBB+	C	test
InChI=1S/C15H16ClN3O4S2/c1-9(10-5-3-2-4-6-10)15-18-12-7-11(16)13(24(17,20)21)8-14(12)25(22,23)19-15/h2-9,15,18-19H,1H3,(H2,17,20,21)	Bemetizide	6-chloro-1,1-dioxo-3-(1-phenylethyl)-3,4-dihydro-2H-1lambda6,2,4-benzothiadiazine-7-sulfonamide	CC(c1ccccc1)C1Nc2cc(Cl)c(S(N)(=O)=O)cc2S(=O)(=O)N1	72070.0	R14_ghose_2012:376			BBB-	C	training
InChI=1S/C15H16ClNO3/c1-9-7-12(8-13(18)14(9)15(19)20-2)17-11-5-3-10(16)4-6-11/h3-6,8-9,14,17H,7H2,1-2H3	156154-42-6|Methyl 4-((4-Chlorophenyl)Amino)-6-Methyl-2-Oxo-3-Cyclohexene-1-Carboxylate	methyl 4-(4-chloroanilino)-6-methyl-2-oxocyclohex-3-ene-1-carboxylate	COC(=O)C1C(=O)C=C(Nc2ccc(Cl)cc2)CC1C	197322.0	R4_mente_2005:23	-0.95	A	BBB+	A	test
InChI=1S/C15H16ClNO3/c1-9-7-12(8-13(18)14(9)15(19)20-2)17-11-5-3-10(16)4-6-11/h3-6,8-9,14,17H,7H2,1-2H3/t9-,14-/m0/s1			COC(=O)[C@@H]1C(=O)C=C(Nc2ccc(Cl)cc2)C[C@@H]1C		R46_mendoza_valencia_2017:355	0.0	A	BBB+	A	test
InChI=1S/C15H16N2O/c1-10-4-3-5-11(2)14(10)17-15(18)12-6-8-13(16)9-7-12/h3-9H,16H2,1-2H3,(H,17,18)	Ameltolide	4-amino-N-(2,6-dimethylphenyl)benzamide	Cc1cccc(C)c1NC(=O)c1ccc(N)cc1	13086.0	R6_adenot_2004:449			BBB+	C	training
InChI=1S/C15H16N2O/c1-12(13-8-4-2-5-9-13)16-17-15(18)14-10-6-3-7-11-14/h2-12,16H,1H3,(H,17,18)	Benmoxin	N'-(1-phenylethyl)benzohydrazide	CC(NNC(=O)c1ccccc1)c1ccccc1	71671.0	R6_adenot_2004:492			BBB+	C	test
InChI=1S/C15H16N2O5/c1-9-6-11(8-13(18)14(9)15(19)22-2)16-10-4-3-5-12(7-10)17(20)21/h3-5,7-9,14,16H,6H2,1-2H3	156154-71-1|Dm44|Methyl 6-Methyl-4-(3-Nitroanilino)-2-Oxocyclohex-3-Ene-1-Carboxylate	methyl 6-methyl-4-(3-nitroanilino)-2-oxocyclohex-3-ene-1-carboxylate	COC(=O)C1C(=O)C=C(Nc2cccc([N+](=O)[O-])c2)CC1C	15186924.0	R4_mente_2005:21|R25_brito_sanchez_2015:532|R40_vilar_2010:99|R46_mendoza_valencia_2017:446|R47_radchenko_2020:430	-1.0	B	BBB+	A	test
InChI=1S/C15H16N2S/c1-9-8-18-13-4-3-12-15(14(9)13)10-7-17(2)6-5-11(10)16-12/h3-4,8,16H,5-7H2,1-2H3	Tienocarbine	3,14-dimethyl-5-thia-10,14-diazatetracyclo[7.7.0.02,6.011,16]hexadeca-1(9),2(6),3,7,11(16)-pentaene	Cc1csc2ccc3[nH]c4c(c3c12)CN(C)CC4	71140.0	R6_adenot_2004:1628			BBB+	C	training
InChI=1S/C15H16N4O/c1-3-19-15-13(10(2)18-19)17-12(20)9-16-14(15)11-7-5-4-6-8-11/h4-8H,3,9H2,1-2H3,(H,17,20)	Ripazepam	1-ethyl-3-methyl-8-phenyl-4,6-dihydropyrazolo[4,3-e][1,4]diazepin-5-one	CCn1nc(C)c2c1C(c1ccccc1)=NCC(=O)N2	33474.0	R6_adenot_2004:746			BBB+	C	training
InChI=1S/C15H16N4O2/c1-10-14-15(18(3)16-10)17(2)12(20)9-13(21)19(14)11-7-5-4-6-8-11/h4-8H,9H2,1-3H3	Zomebazam	1,3,8-trimethyl-4-phenylpyrazolo[3,4-b][1,4]diazepine-5,7-dione	Cc1nn(C)c2c1N(c1ccccc1)C(=O)CC(=O)N2C	132677.0	R6_adenot_2004:1528			BBB+	C	training
InChI=1S/C15H16N4O3/c1-10-16-14(13(19(21)22)15(20)17-10)18-8-6-11-4-2-3-5-12(11)7-9-18/h2-5H,6-9H2,1H3,(H,16,17,20)	5|2-Methyl-5-Nitro-4-(1,2,4,5-Tetrahydro-3-Benzazepin-3-Yl)-1H-Pyrimidin-6-One	2-methyl-5-nitro-4-(1,2,4,5-tetrahydro-3-benzazepin-3-yl)-1H-pyrimidin-6-one	Cc1nc(N2CCc3ccccc3CC2)c([N+](=O)[O-])c(=O)[nH]1	135819130.0	R47_radchenko_2020:442	-0.59	A	BBB+	A	training
InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3	Bisphenol A	4-[2-(4-hydroxyphenyl)propan-2-yl]phenol	CC(C)(c1ccc(O)cc1)c1ccc(O)cc1	6623.0	R3_abraham_2006:134|R21_muehlbacher_2011:172|R25_brito_sanchez_2015:573|R40_vilar_2010:54|R41_toropov_2017:127|R47_radchenko_2020:114	-0.12	B	BBB+	A	training
InChI=1S/C15H17ClN2O2/c1-18-5-4-15-12(8-18)10(7-14(19)17-15)11-6-9(16)2-3-13(11)20-15/h2-3,6,10,12H,4-5,7-8H2,1H3,(H,17,19)/t10-,12+,15+/m0/s1	Lortalamine|Cid 6917700	(1R,9R,10S)-6-chloro-12-methyl-2-oxa-12,15-diazatetracyclo[7.5.3.01,10.03,8]heptadeca-3(8),4,6-trien-16-one	CN1CC[C@@]23NC(=O)C[C@@H](c4cc(Cl)ccc4O2)[C@H]3C1	6917700.0	R6_adenot_2004:567			BBB+	C	training
InChI=1S/C15H17FN2S/c1-18(2)10-11-5-3-4-6-14(11)19-15-8-7-12(16)9-13(15)17/h3-9H,10,17H2,1-2H3	2-[(2-Amino-4-Fluorophenyl)Thio]-N,N-Dimethylbenzenemethanamine|2-[[2-[(Dimethylamino)Methyl]Phenyl]Thio]-5-Fluoroaniline	2-[2-[(dimethylamino)methyl]phenyl]sulfanyl-5-fluoroaniline	CN(C)Cc1ccccc1Sc1ccc(F)cc1N	10265481.0	R25_brito_sanchez_2015:486|R46_mendoza_valencia_2017:407	0.2	B	BBB+	A	training
InChI=1S/C15H17FN4O2/c1-2-22-15(21)19-12-7-8-13(20-14(12)17)18-9-10-3-5-11(16)6-4-10/h3-8H,2,9H2,1H3,(H,19,21)(H3,17,18,20)	Flupirtine	ethyl N-[2-amino-6-[(4-fluorophenyl)methylamino]pyridin-3-yl]carbamate	CCOC(=O)Nc1ccc(NCc2ccc(F)cc2)nc1N	53276.0	R14_ghose_2012:98|R23_gupta_2019:96			BBB+	C	training
InChI=1S/C15H17N3O/c1-17-7-8-18-13-4-3-10(19-2)9-12(13)11-5-6-16-15(17)14(11)18/h3-4,9H,5-8H2,1-2H3	Metralindole	12-methoxy-4-methyl-1,4,6-triazatetracyclo[7.6.1.05,16.010,15]hexadeca-5,9(16),10(15),11,13-pentaene	COc1ccc2c(c1)c1c3n2CCN(C)C3=NCC1	68713.0	R6_adenot_2004:575			BBB+	C	training
InChI=1S/C15H17N3O3S/c1-15(2,3)21-14(20)11-10-7-17(4)13(19)12-9(5-6-22-12)18(10)8-16-11/h5-6,8H,7H2,1-4H3	99632-94-7|Ro 19-4603|Ro19-4603|Tert-Butyl 5-Methyl-6-Oxo-5,6-Dihydro-4H-Imidazo[1,5-A]Thieno[2,3-F][1,4]Diazepine-3-Carboxylate	tert-butyl 8-methyl-7-oxo-5-thia-1,8,12-triazatricyclo[8.3.0.02,6]trideca-2(6),3,10,12-tetraene-11-carboxylate	CN1Cc2c(C(=O)OC(C)(C)C)ncn2-c2ccsc2C1=O	127382.0	R4_mente_2005:62|R21_muehlbacher_2011:294|R25_brito_sanchez_2015:295|R28_li_2005:111|R40_vilar_2010:232|R46_mendoza_valencia_2017:263|R47_radchenko_2020:303	-0.25	B	BBB+	A	training
InChI=1S/C15H17N5O6S2/c1-25-3-6-4-27-13-9(12(22)20(13)10(6)14(23)24)18-11(21)8(19-26-2)7-5-28-15(16)17-7/h5,9,13H,3-4H2,1-2H3,(H2,16,17)(H,18,21)(H,23,24)/b19-8-/t9-,13-/m1/s1	Cefpodoxime|(6R,7R)-7-[[(2E)-2-(2-Amino-1,3-Thiazol-4-Yl)-2-Methoxyiminoacetyl]Amino]-3-(Methoxymethyl)-8-Oxo-5-Thia-1-Azabicyclo[4.2.0]Oct-2-Ene-2-Carboxylic Acid	(6R,7R)-7-[[(2E)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid	COCC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)/C(=N/OC)c3csc(N)n3)[C@H]2SC1	6321413.0	R6_adenot_2004:190|R14_ghose_2012:433|R23_gupta_2019:433			BBB-	C	training
InChI=1S/C15H17N5S/c1-18-8-10-19(11-9-18)14-17-12-4-2-3-5-13(12)21-15-16-6-7-20(14)15/h2-7H,8-11H2,1H3	Pentiapine	5-(4-methylpiperazin-1-yl)imidazo[2,1-b][1,3,5]benzothiadiazepine	CN1CCN(C2=Nc3ccccc3Sc3nccn32)CC1	54742.0	R6_adenot_2004:1130			BBB+	C	training
InChI=1S/C15H17N7O5S3/c1-21-14(18-19-20-21)30-6-8-5-29-13-15(27-2,17-9(23)7-28-4-3-16)12(26)22(13)10(8)11(24)25/h13H,4-7H2,1-2H3,(H,17,23)(H,24,25)/t13-,15+/m1/s1	Cefmetazole	(6R,7S)-7-[[2-(cyanomethylsulfanyl)acetyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid	CO[C@@]1(NC(=O)CSCC#N)C(=O)N2C(C(=O)O)=C(CSc3nnnn3C)CS[C@@H]21	42008.0	R6_adenot_2004:176|R23_gupta_2019:425			BBB-	C	training
InChI=1S/C15H17NO3/c17-15(16-8-2-1-3-9-16)7-5-12-4-6-13-14(10-12)19-11-18-13/h4-7,10H,1-3,8-9,11H2/b7-5+	Ilepcimide	(E)-3-(1,3-benzodioxol-5-yl)-1-piperidin-1-ylprop-2-en-1-one	O=C(/C=C/c1ccc2c(c1)OCO2)N1CCCCC1	641115.0	R6_adenot_2004:421			BBB+	C	training
InChI=1S/C15H18ClNO3/c1-10-14(18)17-15(20-10)8-3-2-7-13(15)19-12-6-4-5-11(16)9-12/h4-6,9-10,13H,2-3,7-8H2,1H3,(H,17,18)/t10-,13-,15?/m1/s1	Enilospirone|Enilospirona	(2R,6R)-6-(3-chlorophenoxy)-2-methyl-1-oxa-4-azaspiro[4.5]decan-3-one	C[C@H]1OC2(CCCC[C@H]2Oc2cccc(Cl)c2)NC1=O	10063117.0	R6_adenot_2004:1285			BBB+	C	training
InChI=1S/C15H18F2N6O7S2/c1-29-15(18-8(25)6-31-13(16)17)11(28)23-9(10(26)27)7(4-30-12(15)23)5-32-14-19-20-21-22(14)2-3-24/h12-13,24H,2-6H2,1H3,(H,18,25)(H,26,27)/t12-,15+/m1/s1	Flomoxef	(6R,7R)-7-[[2-(difluoromethylsulfanyl)acetyl]amino]-3-[[1-(2-hydroxyethyl)tetrazol-5-yl]sulfanylmethyl]-7-methoxy-8-oxo-5-oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid	CO[C@@]1(NC(=O)CSC(F)F)C(=O)N2C(C(=O)O)=C(CSc3nnnn3CCO)CO[C@@H]21	65864.0	R6_adenot_2004:228			BBB-	C	training
InChI=1S/C15H18F3NO5/c1-22-9-12-8-19(14(21)24-12)10-2-4-11(5-3-10)23-7-6-13(20)15(16,17)18/h2-5,12-13,20H,6-9H2,1H3/t12-,13-/m1/s1	Befloxatone	(5R)-5-(methoxymethyl)-3-[4-[(3R)-4,4,4-trifluoro-3-hydroxybutoxy]phenyl]-1,3-oxazolidin-2-one	COC[C@H]1CN(c2ccc(OCC[C@@H](O)C(F)(F)F)cc2)C(=O)O1	60824.0	R6_adenot_2004:963			BBB+	C	training
InChI=1S/C15H18I3NO3/c1-3-5-12(20)19-14-11(17)7-10(16)9(13(14)18)6-8(4-2)15(21)22/h7-8H,3-6H2,1-2H3,(H,19,20)(H,21,22)	Tyropanoate Sodium|Tyropanic Acid	2-[[3-(butanoylamino)-2,4,6-triiodophenyl]methyl]butanoic acid	CCCC(=O)Nc1c(I)cc(I)c(CC(CC)C(=O)O)c1I	5611.0	R14_ghose_2012:924			BBB-	C	test
InChI=1S/C15H18N2/c1-10-5-6-14-12(9-10)11-3-2-4-13-15(11)17(14)8-7-16-13/h5-6,9,13,16H,2-4,7-8H2,1H3	Pirlindole	12-methyl-1,4-diazatetracyclo[7.6.1.05,16.010,15]hexadeca-9(16),10(15),11,13-tetraene	Cc1ccc2c(c1)c1c3n2CCNC3CCC1	68802.0	R6_adenot_2004:599			BBB+	C	training
InChI=1S/C15H18N2O2/c1-3-9-19-15(18)14-10-16-11-17(14)12(2)13-7-5-4-6-8-13/h4-8,10-12H,3,9H2,1-2H3	Propoxate	propyl 3-(1-phenylethyl)imidazole-4-carboxylate	CCCOC(=O)c1cncn1C(C)c1ccccc1	65591.0	R6_adenot_2004:1376			BBB+	C	training
InChI=1S/C15H18N4O4S/c1-7-11-10(8(2)20)14(21)19(11)12(15(22)23)13(7)24-9-3-17-5-16-6-18(17)4-9/h5-11,20H,3-4H2,1-2H3/t7-,8-,10-,11-/m1/s1	Biapenem	(4R,5S,6S)-3-(6,7-dihydro-5H-pyrazolo[1,2-a][1,2,4]triazol-4-ium-6-ylsulfanyl)-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate	C[C@@H](O)[C@H]1C(=O)N2C(C(=O)[O-])=C(SC3Cn4cnc[n+]4C3)[C@H](C)[C@H]12	71339.0	R6_adenot_2004:240			BBB-	C	training
InChI=1S/C15H18N4O5/c1-5-9(16)12(21)8-6(4-24-14(17)22)15(23-2)13-7(18-13)3-19(15)10(8)11(5)20/h6-7,13,18H,3-4,16H2,1-2H3,(H2,17,22)/t6-,7+,13+,15-/m1/s1	Mitomycin	[(4S,6S,7R,8S)-11-amino-7-methoxy-12-methyl-10,13-dioxo-2,5-diazatetracyclo[7.4.0.02,7.04,6]trideca-1(9),11-dien-8-yl]methyl carbamate	CO[C@@]12[C@H](COC(N)=O)C3=C(C(=O)C(C)=C(N)C3=O)N1C[C@@H]1N[C@@H]12	5746.0	R6_adenot_2004:49|R23_gupta_2019:755			BBB-	C	training
InChI=1S/C15H18N8O5/c1-17-13(27)6-2-19-23(3-6)15-20-11(16)8-12(21-15)22(5-18-8)14-10(26)9(25)7(4-24)28-14/h2-3,5,7,9-10,14,24-26H,4H2,1H3,(H,17,27)(H2,16,20,21)/t7-,9-,10-,14-/m1/s1	Regadenoson	1-[6-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-2-yl]-N-methylpyrazole-4-carboxamide	CNC(=O)c1cnn(-c2nc(N)c3ncn([C@@H]4O[C@H](CO)[C@@H](O)[C@H]4O)c3n2)c1	219024.0	R23_gupta_2019:878			BBB-	C	test
InChI=1S/C15H18O3/c1-8-4-7-15-11(8)12-10(9(2)13(16)17-12)5-6-14(15,3)18-15/h4,10-12H,2,5-7H2,1,3H3/t10-,11+,12-,14-,15+/m0/s1	Arglabin	(1R,3S,6S,10S,11R)-3,12-dimethyl-7-methylidene-2,9-dioxatetracyclo[9.3.0.01,3.06,10]tetradec-12-en-8-one	C=C1C(=O)O[C@@H]2[C@H]3C(C)=CC[C@@]34O[C@@]4(C)CC[C@@H]12	5574924.0	R23_gupta_2019:362			BBB-	C	test
InChI=1S/C15H19N5/c1-19(2)6-5-13-8-17-15-4-3-12(7-14(13)15)9-20-11-16-10-18-20/h3-4,7-8,10-11,17H,5-6,9H2,1-2H3	Rizatriptan	N,N-dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]ethanamine	CN(C)CCc1c[nH]c2ccc(Cn3cncn3)cc12	5078.0	R14_ghose_2012:225|R26_chico_2009:354|R34_broccatelli_2012:80|R47_radchenko_2020:505|R50_sobanska_2019:39			BBB+	C	training
InChI=1S/C15H19NO/c1-13(11-14-7-4-3-5-8-14)16(2)12-15-9-6-10-17-15/h3-10,13H,11-12H2,1-2H3	Furfenorex	N-(furan-2-ylmethyl)-N-methyl-1-phenylpropan-2-amine	CC(Cc1ccccc1)N(C)Cc1ccco1	26762.0	R6_adenot_2004:375			BBB+	C	training
InChI=1S/C15H20Cl2N2O3/c1-3-19-6-4-5-9(19)8-18-15(21)12-13(20)10(16)7-11(17)14(12)22-2/h7,9,20H,3-6,8H2,1-2H3,(H,18,21)/t9-/m0/s1	Raclopride	3,5-dichloro-N-[[(2S)-1-ethylpyrrolidin-2-yl]methyl]-2-hydroxy-6-methoxybenzamide	CCN1CCC[C@H]1CNC(=O)c1c(O)c(Cl)cc(Cl)c1OC	3033769.0	R7_andres_2006:149|R29_subramanian_2003:146			BBB+	C	training
InChI=1S/C15H20N2/c1-2-4-15-14(3-1)13(11-17-15)6-5-12-7-9-16-10-8-12/h1-4,11-12,16-17H,5-10H2	Indalpine	3-(2-piperidin-4-ylethyl)-1H-indole	c1ccc2c(CCC3CCNCC3)c[nH]c2c1	44668.0	R6_adenot_2004:1582			BBB+	C	training
InChI=1S/C15H20N2O4S/c1-10(18)16-12-4-6-13(7-5-12)21-15(20)14(8-9-22-3)17-11(2)19/h4-7,14H,8-9H2,1-3H3,(H,16,18)(H,17,19)	Sumacetamol	(4-acetamidophenyl) 2-acetamido-4-methylsulfanylbutanoate	CSCCC(NC(C)=O)C(=O)Oc1ccc(NC(C)=O)cc1	10041933.0	R6_adenot_2004:407			BBB+	C	training
InChI=1S/C15H20N2O4S/c1-11(18)12-7-9-14(10-8-12)22(20,21)17-15(19)16-13-5-3-2-4-6-13/h7-10,13H,2-6H2,1H3,(H2,16,17,19)	Acetohexamide	1-(4-acetylphenyl)sulfonyl-3-cyclohexylurea	CC(=O)c1ccc(S(=O)(=O)NC(=O)NC2CCCCC2)cc1	1989.0	R14_ghose_2012:325			BBB-	C	training
InChI=1S/C15H21Cl2N3O/c1-12(21)18-5-2-6-19-7-9-20(10-8-19)15-11-13(16)3-4-14(15)17/h3-4,11H,2,5-10H2,1H3,(H,18,21)	Acaprazine	N-[3-[4-(2,5-dichlorophenyl)piperazin-1-yl]propyl]acetamide	CC(=O)NCCCN1CCN(c2cc(Cl)ccc2Cl)CC1	176864.0	R6_adenot_2004:1411			BBB+	C	test
InChI=1S/C15H21ClN6/c16-14-12-19-22(13-14)7-2-1-6-20-8-10-21(11-9-20)15-17-4-3-5-18-15/h3-5,12-13H,1-2,6-11H2	Lesopitron	2-[4-[4-(4-chloropyrazol-1-yl)butyl]piperazin-1-yl]pyrimidine	Clc1cnn(CCCCN2CCN(c3ncccn3)CC2)c1	60813.0	R6_adenot_2004:1455			BBB+	C	training
InChI=1S/C15H21F3N2O2/c1-21-10-3-2-4-14(20-22-11-9-19)12-5-7-13(8-6-12)15(16,17)18/h5-8H,2-4,9-11,19H2,1H3/b20-14+	54739-18-3|Fluvoxamine|Fluvoxamine, (Z)-	2-[(Z)-[5-methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene]amino]oxyethanamine	COCCCC/C(=N/OCCN)c1ccc(C(F)(F)F)cc1	5361192.0	R4_mente_2005:27|R6_adenot_2004:552|R14_ghose_2012:102|R21_muehlbacher_2011:322|R23_gupta_2019:101|R25_brito_sanchez_2015:241|R26_chico_2009:196|R34_broccatelli_2012:33|R37_chen_2011:39|R40_vilar_2010:117|R47_radchenko_2020:372	0.79	B	BBB+	A	training
InChI=1S/C15H21N3O2/c1-15-7-8-17(3)13(15)18(4)12-6-5-10(9-11(12)15)20-14(19)16-2/h5-6,9,13H,7-8H2,1-4H3,(H,16,19)	1,3A,8-Trimethyl-1,2,3,3A,8,8A-Hexahydropyrrolo[2,3-B]Indol-5-Yl Methylcarbamate	(3,4,8b-trimethyl-2,3a-dihydro-1H-pyrrolo[2,3-b]indol-7-yl) N-methylcarbamate	CNC(=O)Oc1ccc2c(c1)C1(C)CCN(C)C1N2C	4811.0	R41_toropov_2017:208|R42_ciura_2020:17|R46_mendoza_valencia_2017:313	0.08	B	BBB+	A	training
InChI=1S/C15H21N3O2/c1-15-7-8-17(3)13(15)18(4)12-6-5-10(9-11(12)15)20-14(19)16-2/h5-6,9,13H,7-8H2,1-4H3,(H,16,19)/t13-,15+/m1/s1	Physostigmine	[(3aR,8bS)-3,4,8b-trimethyl-2,3a-dihydro-1H-pyrrolo[2,3-b]indol-7-yl] N-methylcarbamate	CNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)[C@@H]1N2C	5983.0	R3_abraham_2006:231|R5_guerra_2008:85|R6_adenot_2004:365|R12_garg_2006:137|R17_fu_2008:50|R21_muehlbacher_2011:147|R23_gupta_2019:833|R25_brito_sanchez_2015:358|R26_chico_2009:312|R28_li_2005:44|R40_vilar_2010:211|R44_bujak_2015:52|R47_radchenko_2020:193|R49_norinder_2002:102|R51_doninger_2002:285	0.08	B1	BBB+	A	training
InChI=1S/C15H21N3O2/c1-15-7-8-17(3)13(15)18(4)12-6-5-10(9-11(12)15)20-14(19)16-2/h5-6,9,13H,7-8H2,1-4H3,(H,16,19)/t13-,15-/m1/s1	Tocris-0622	[(3aR,8bR)-3,4,8b-trimethyl-2,3a-dihydro-1H-pyrrolo[2,3-b]indol-7-yl] N-methylcarbamate	CNC(=O)Oc1ccc2c(c1)[C@@]1(C)CCN(C)[C@@H]1N2C	6603845.0	R48_hou_2003:81	0.08	A	BBB+	A	training
InChI=1S/C15H21N3O4S/c1-7(19)12-10-5-11(13(15(21)22)18(10)14(12)20)23-9-3-4-17(6-9)8(2)16/h7,9-10,12,16,19H,3-6H2,1-2H3,(H,21,22)/b16-8+/t7-,9-,10-,12-/m1/s1	Panipenem|(5R,6S)-3-[(3R)-1-Ethanimidoylpyrrolidin-3-Yl]Sulfanyl-6-[(1R)-1-Hydroxyethyl]-7-Oxo-1-Azabicyclo[3.2.0]Hept-2-Ene-2-Carboxylic Acid	(5R,6S)-3-[(3R)-1-ethanimidoylpyrrolidin-3-yl]sulfanyl-6-[(1R)-1-hydroxyethyl]-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid	[H]/N=C(\C)N1CC[C@@H](SC2=C(C(=O)O)N3C(=O)[C@H]([C@@H](C)O)[C@H]3C2)C1	9840851.0	R6_adenot_2004:263			BBB-	C	training
InChI=1S/C15H21NO/c1-10-14-8-11-4-5-12(17)9-13(11)15(10,2)6-7-16(14)3/h4-5,9-10,14,17H,6-8H2,1-3H3	Metazocine	1,10,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol	CC1C2Cc3ccc(O)cc3C1(C)CCN2C	62518.0	R6_adenot_2004:1057			BBB+	C	training
InChI=1S/C15H21NO/c1-15-5-6-16(2)10-11(9-15)7-12-3-4-13(17)8-14(12)15/h3-4,8,11,17H,5-7,9-10H2,1-2H3/t11-,15-/m1/s1	Eptazocine	(1S,9S)-1,11-dimethyl-11-azatricyclo[7.4.1.02,7]tetradeca-2(7),3,5-trien-4-ol	CN1CC[C@]2(C)C[C@@H](Cc3ccc(O)cc32)C1	3042090.0	R6_adenot_2004:1035			BBB+	C	training
InChI=1S/C15H21NO2/c1-2-7-16-8-9-18-15-13-10-12(17)5-3-11(13)4-6-14(15)16/h3,5,10,14-15,17H,2,4,6-9H2,1H3	(+)-4-Propyl-3,4,4A,5,6,10B-Hexahydro-2H-Naphtho[1,2-B][1,4]Oxazin-9-Ol|4-Propyl-3,4,4A,5,6,10B-Hexahydro-2H-Naphtho[1,2-B][1,4]Oxazin-9-Ol	4-propyl-2,3,4a,5,6,10b-hexahydrobenzo[h][1,4]benzoxazin-9-ol	CCCN1CCOC2c3cc(O)ccc3CCC21	10060538.0	R25_brito_sanchez_2015:488|R46_mendoza_valencia_2017:409	0.26	B	BBB+	A	training
InChI=1S/C15H21NO2/c1-3-14(18)15(7-9-16(2)10-8-15)12-5-4-6-13(17)11-12/h4-6,11,17H,3,7-10H2,1-2H3	Ketobemidone	1-[4-(3-hydroxyphenyl)-1-methylpiperidin-4-yl]propan-1-one	CCC(=O)C1(c2cccc(O)c2)CCN(C)CC1	10101.0	R6_adenot_2004:1098			BBB+	C	training
InChI=1S/C15H21NO2/c1-3-18-14(17)15(9-11-16(2)12-10-15)13-7-5-4-6-8-13/h4-8H,3,9-12H2,1-2H3	Pethidine|Meperidine|Meperidine, Demerol|Demerol	ethyl 1-methyl-4-phenylpiperidine-4-carboxylate	CCOC(=O)C1(c2ccccc2)CCN(C)CC1	4058.0	R6_adenot_2004:1077|R14_ghose_2012:61|R23_gupta_2019:136|R25_brito_sanchez_2015:458|R26_chico_2009:257|R28_li_2005:217|R46_mendoza_valencia_2017:383|R47_radchenko_2020:501|R51_doninger_2002:194|R51_doninger_2002:279	0.84	B	BBB+	A	training
InChI=1S/C15H21NO3/c1-3-19-14(18)15(7-9-16(2)10-8-15)12-5-4-6-13(17)11-12/h4-6,11,17H,3,7-10H2,1-2H3	Hydroxypethidine	ethyl 4-(3-hydroxyphenyl)-1-methylpiperidine-4-carboxylate	CCOC(=O)C1(c2cccc(O)c2)CCN(C)CC1	61120.0	R6_adenot_2004:1095|R7_andres_2006:83|R29_subramanian_2003:76			BBB+	C	training
InChI=1S/C15H22N2O/c1-3-17(4-2)14(18)15(10-13(15)11-16)12-8-6-5-7-9-12/h5-9,13H,3-4,10-11,16H2,1-2H3/t13-,15+/m1/s1	Milnacipran	(1R,2S)-2-(aminomethyl)-N,N-diethyl-1-phenylcyclopropane-1-carboxamide	CCN(CC)C(=O)[C@]1(c2ccccc2)C[C@@H]1CN	65833.0	R6_adenot_2004:577|R14_ghose_2012:153|R23_gupta_2019:152|R37_chen_2011:52			BBB+	C	test
InChI=1S/C15H22N2O/c1-4-11-9(2)16-13-7-10-5-6-17(3)8-12(10)15(18)14(11)13/h10,12,16H,4-8H2,1-3H3/t10-,12+/m0/s1	Piquindone	(4aS,8aS)-3-ethyl-2,6-dimethyl-4a,5,7,8,8a,9-hexahydro-1H-pyrrolo[2,3-g]isoquinolin-4-one	CCc1c(C)[nH]c2c1C(=O)[C@@H]1CN(C)CC[C@H]1C2	121903.0	R6_adenot_2004:1203			BBB+	C	training
InChI=1S/C15H22N2O2/c1-17-8-3-5-12-4-2-6-14(15(12)17)19-11-13-10-16-7-9-18-13/h2,4,6,13,16H,3,5,7-11H2,1H3	Dabelotine	2-[(1-methyl-3,4-dihydro-2H-quinolin-8-yl)oxymethyl]morpholine	CN1CCCc2cccc(OCC3CNCCO3)c21	177949.0	R6_adenot_2004:1270			BBB+	C	training
InChI=1S/C15H22N2O4/c1-19-12-7-10(8-13(20-2)14(12)21-3)15(18)17-11-5-4-6-16-9-11/h7-8,11,16H,4-6,9H2,1-3H3,(H,17,18)	Troxipide	3,4,5-trimethoxy-N-piperidin-3-ylbenzamide	COc1cc(C(=O)NC2CCCNC2)cc(OC)c1OC	5597.0	R23_gupta_2019:1009			BBB-	C	training
InChI=1S/C15H22N4O2/c1-4-7-8-16-13-11-10-18-19(5-2)14(11)17-9-12(13)15(20)21-6-3/h9-10H,4-8H2,1-3H3,(H,16,17)	Cartazolate	ethyl 4-(butylamino)-1-ethylpyrazolo[3,4-b]pyridine-5-carboxylate	CCCCNc1c(C(=O)OCC)cnc2c1cnn2CC	37015.0	R6_adenot_2004:505|R51_doninger_2002:175			BBB+	C	training
InChI=1S/C15H22N6O5S/c1-27(3-2-7(16)15(24)25)4-8-10(22)11(23)14(26-8)21-6-20-9-12(17)18-5-19-13(9)21/h5-8,10-11,14,22-23H,2-4,16H2,1H3,(H2-,17,18,19,24,25)/t7-,8+,10+,11+,14+,27?/m0/s1	Adenosyl-Methionine|Ademetionine	(2S)-2-amino-4-[[(2S,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl-methylsulfonio]butanoate	C[S+](CC[C@H](N)C(=O)[O-])C[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O	34755.0	R6_adenot_2004:356			BBB+	C	training
InChI=1S/C15H22O3/c1-11-6-7-12(2)13(10-11)18-9-5-8-15(3,4)14(16)17/h6-7,10H,5,8-9H2,1-4H3,(H,16,17)	Gemfibrozil	5-(2,5-dimethylphenoxy)-2,2-dimethylpentanoic acid	Cc1ccc(C)c(OCCCC(C)(C)C(=O)O)c1	3463.0	R14_ghose_2012:588|R23_gupta_2019:628			BBB-	C	training
InChI=1S/C15H22O4/c1-11(2)9-14(17)13-6-5-12(10-15(13)18)19-8-4-3-7-16/h5-6,10-11,16,18H,3-4,7-9H2,1-2H3	Cube-2		CC(C)CC(=O)c1ccc(OCCCCO)cc1O		R26_chico_2009:139	-1.52	A	BBB-	A	test
InChI=1S/C15H23N/c1-2-8-15(16-11-6-7-12-16)13-14-9-4-3-5-10-14/h3-5,9-10,15H,2,6-8,11-13H2,1H3	Prolintane	1-(1-phenylpentan-2-yl)pyrrolidine	CCCC(Cc1ccccc1)N1CCCC1	14592.0	R6_adenot_2004:1309			BBB+	C	training
InChI=1S/C15H23N3O2/c1-4-18(5-2)11-10-16-15(20)13-6-8-14(9-7-13)17-12(3)19/h6-9H,4-5,10-11H2,1-3H3,(H,16,20)(H,17,19)	Acecainide	4-acetamido-N-[2-(diethylamino)ethyl]benzamide	CCN(CC)CCNC(=O)c1ccc(NC(C)=O)cc1	4342.0	R14_ghose_2012:321			BBB-	C	training
InChI=1S/C15H23N3O3S/c1-15(2)11(14(20)21)18-12(19)10(13(18)22-15)16-9-17-7-5-3-4-6-8-17/h9-11,13H,3-8H2,1-2H3,(H,20,21)/b16-9+/t10-,11+,13-/m1/s1	Mecillinam|Amdinocillin	(2S,5R,6R)-6-(azepan-1-ylmethylideneamino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid	CC1(C)S[C@@H]2[C@H](/N=C/N3CCCCCC3)C(=O)N2[C@H]1C(=O)O	36273.0	R6_adenot_2004:242|R23_gupta_2019:340			BBB-	C	test
InChI=1S/C15H23N3O4S/c1-14(2)9(12(20)21)18-10(19)8(11(18)23-14)17-13(22)15(16)6-4-3-5-7-15/h8-9,11H,3-7,16H2,1-2H3,(H,17,22)(H,20,21)/t8-,9+,11-/m1/s1	Cyclacillin	(2S,5R,6R)-6-[(1-aminocyclohexanecarbonyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid	CC1(C)S[C@@H]2[C@H](NC(=O)C3(N)CCCCC3)C(=O)N2[C@H]1C(=O)O	19003.0	R6_adenot_2004:215|R14_ghose_2012:471|R23_gupta_2019:484			BBB-	C	training
InChI=1S/C15H23N3O4S/c1-3-18-8-4-5-11(18)10-17-15(19)13-9-12(23(16,20)21)6-7-14(13)22-2/h6-7,9,11H,3-5,8,10H2,1-2H3,(H,17,19)(H2,16,20,21)	Sulpiride	N-[(1-ethylpyrrolidin-2-yl)methyl]-2-methoxy-5-sulfamoylbenzamide	CCN1CCCC1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC	5355.0	R6_adenot_2004:611|R7_andres_2006:160|R14_ghose_2012:233|R23_gupta_2019:230|R26_chico_2009:395|R29_subramanian_2003:157|R34_broccatelli_2012:87|R37_chen_2011:93|R50_sobanska_2019:90	-1.11	A	BBB-	A	training
InChI=1S/C15H23NO/c1-3-15(9-4-5-10-16(2)12-15)13-7-6-8-14(17)11-13/h6-8,11,17H,3-5,9-10,12H2,1-2H3	Meptazinol	3-(3-ethyl-1-methylazepan-3-yl)phenol	CCC1(c2cccc(O)c2)CCCCN(C)C1	41049.0	R14_ghose_2012:137|R23_gupta_2019:139			BBB+	C	training
InChI=1S/C15H23NO2/c17-10-5-11-18-15-7-4-6-14(12-15)13-16-8-2-1-3-9-16/h4,6-7,12,17H,1-3,5,8-11,13H2	Skb34|Bbcpd22|87078-26-0|Chebi: 338140|B-062|26|18|1-Propanol, 3-[3-(1-Piperidinylmethyl)Phenoxy]-	3-[3-(piperidin-1-ylmethyl)phenoxy]propan-1-ol	OCCCOc1cccc(CN2CCCCC2)c1	10444765.0	R3_abraham_2006:270|R3_abraham_2006:319|R4_mente_2005:135|R12_garg_2006:37|R21_muehlbacher_2011:340|R25_brito_sanchez_2015:570|R26_chico_2009:61|R28_li_2005:163|R40_vilar_2010:253|R41_toropov_2017:242|R46_mendoza_valencia_2017:476|R47_radchenko_2020:225|R48_hou_2003:74|R49_norinder_2002:26|R49_norinder_2002:177|R52_liu_2001:26	-0.02	B	BBB+	A	training
InChI=1S/C15H23NO3/c1-3-5-9-16-10-12-11-18-14-8-6-7-13(17-4-2)15(14)19-12/h6-8,12,16H,3-5,9-11H2,1-2H3	Ethomoxane	N-[(5-ethoxy-2,3-dihydro-1,4-benzodioxin-3-yl)methyl]butan-1-amine	CCCCNCC1COc2cccc(OCC)c2O1	19127.0	R6_adenot_2004:1462			BBB+	C	training
InChI=1S/C15H23NO3/c1-4-9-18-14-7-5-6-8-15(14)19-11-13(17)10-16-12(2)3/h4-8,12-13,16-17H,1,9-11H2,2-3H3	Oxprenolol	1-(propan-2-ylamino)-3-(2-prop-2-enoxyphenoxy)propan-2-ol	C=CCOc1ccccc1OCC(O)CNC(C)C	4631.0	R7_andres_2006:126|R14_ghose_2012:277|R25_brito_sanchez_2015:382|R29_subramanian_2003:122|R34_broccatelli_2012:66|R53_friden_2009:26	0.03	B	BBB+	A	training
InChI=1S/C15H24N2O3/c1-4-17(5-2)11-10-16-15(18)12-20-14-8-6-13(19-3)7-9-14/h6-9H,4-5,10-12H2,1-3H3,(H,16,18)	Mefexamide	N-[2-(diethylamino)ethyl]-2-(4-methoxyphenoxy)acetamide	CCN(CC)CCNC(=O)COc1ccc(OC)cc1	4045.0	R6_adenot_2004:1296			BBB+	C	test
InChI=1S/C15H24N2O4S/c1-5-17(6-2)10-9-16-15(18)13-11-12(22(4,19)20)7-8-14(13)21-3/h7-8,11H,5-6,9-10H2,1-4H3,(H,16,18)	Tiapride	N-[2-(diethylamino)ethyl]-2-methoxy-5-methylsulfonylbenzamide	CCN(CC)CCNC(=O)c1cc(S(C)(=O)=O)ccc1OC	5467.0	R6_adenot_2004:1227|R50_sobanska_2019:82			BBB+	C	training
InChI=1S/C15H24N4/c1-2-3-4-5-6-7-8-10-16-14-13-9-11-17-15(13)19-12-18-14/h9,11-12H,2-8,10H2,1H3,(H2,16,17,18,19)	Nonapyrimine	N-nonyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine	CCCCCCCCCNc1ncnc2[nH]ccc12	3047795.0	R6_adenot_2004:455			BBB+	C	training
InChI=1S/C15H24N4S/c20-15(18-13-4-2-1-3-5-13)19-8-6-12(7-9-19)14-10-16-11-17-14/h10-13H,1-9H2,(H,16,17)(H,18,20)	Thioperamide|5-69	N-cyclohexyl-4-(1H-imidazol-5-yl)piperidine-1-carbothioamide	S=C(NC1CCCCC1)N1CCC(c2cnc[nH]2)CC1	3035905.0	R3_abraham_2006:285|R5_guerra_2008:99|R7_andres_2006:217|R12_garg_2006:163|R21_muehlbacher_2011:316|R25_brito_sanchez_2015:132|R26_chico_2009:414|R28_li_2005:147|R28_li_2005:317|R39_shayanfar_2011:92|R40_vilar_2010:272|R41_toropov_2017:256|R46_mendoza_valencia_2017:130|R47_radchenko_2020:239|R48_hou_2003:31|R49_norinder_2002:110	-0.16	B1	BBB+	A	training
InChI=1S/C15H25N3O/c1-11(2)16-9-6-10-17-15(19)18-14-12(3)7-5-8-13(14)4/h5,7-8,11,16H,6,9-10H2,1-4H3,(H2,17,18,19)	Recainam	1-(2,6-dimethylphenyl)-3-[3-(propan-2-ylamino)propyl]urea	Cc1cccc(C)c1NC(=O)NCCCNC(C)C	53084.0	R14_ghose_2012:818			BBB-	C	training
InChI=1S/C15H25N3O/c1-12(11-13-7-3-2-4-8-13)18-15(19)14(17)9-5-6-10-16/h2-4,7-8,12,14H,5-6,9-11,16-17H2,1H3,(H,18,19)/t12-,14-/m0/s1	Lisdexamfetamine	(2S)-2,6-diamino-N-[(2S)-1-phenylpropan-2-yl]hexanamide	C[C@@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCCN	11597698.0	R23_gupta_2019:124			BBB+	C	training
InChI=1S/C15H25N3O/c1-3-4-5-6-15(18-19-10-9-16)13-8-7-12(2)14(17)11-13/h7-8,11H,3-6,9-10,16-17H2,1-2H3/b18-15+	Caproxamine|5-[(Z)-N-(2-Aminoethoxy)-C-Pentylcarbonimidoyl]-2-Methylaniline	5-[(Z)-N-(2-aminoethoxy)-C-pentylcarbonimidoyl]-2-methylaniline	CCCCC/C(=N/OCCN)c1ccc(C)c(N)c1	9578268.0	R6_adenot_2004:501			BBB+	C	training
InChI=1S/C15H25N5O3/c1-10(2)21-6-12(7-22-11(3)4)23-9-20-8-18-13-5-17-15(16)19-14(13)20/h5,8,10-12H,6-7,9H2,1-4H3,(H2,16,17,19)	Rociclovir	9-[1,3-di(propan-2-yloxy)propan-2-yloxymethyl]purin-2-amine	CC(C)OCC(COC(C)C)OCn1cnc2cnc(N)nc21	65905.0	R6_adenot_2004:678			BBB+	C	training
InChI=1S/C15H25NO3/c1-12(2)16-10-14(17)11-19-15-6-4-13(5-7-15)8-9-18-3/h4-7,12,14,16-17H,8-11H2,1-3H3	51384-51-1|Metoprolol	1-[4-(2-methoxyethyl)phenoxy]-3-(propan-2-ylamino)propan-2-ol	COCCc1ccc(OCC(O)CNC(C)C)cc1	4171.0	R4_mente_2005:68|R7_andres_2006:103|R21_muehlbacher_2011:99|R25_brito_sanchez_2015:298|R28_li_2005:271|R29_subramanian_2003:98|R34_broccatelli_2012:51|R40_vilar_2010:148|R47_radchenko_2020:342|R53_friden_2009:19	1.04	B1	BBB+	A	test
InChI=1S/C15H29N3O5/c1-8(2)7-9(10(19)13(21)18-23)12(20)17-11(14(22)16-6)15(3,4)5/h8-11,19,23H,7H2,1-6H3,(H,16,22)(H,17,20)(H,18,21)/t9-,10+,11-/m1/s1	Marimastat	(2R,3S)-N-[(2S)-3,3-dimethyl-1-(methylamino)-1-oxobutan-2-yl]-N',3-dihydroxy-2-(2-methylpropyl)butanediamide	CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)[C@H](O)C(=O)NO)C(C)(C)C	119031.0	R14_ghose_2012:663|R23_gupta_2019:722			BBB-	C	training
InChI=1S/C15H29NO4/c1-3-4-5-6-7-8-9-10-15(2)19-12-13(20-15)11-18-14(16)17/h13H,3-12H2,1-2H3,(H2,16,17)	Dioxamate	(2-methyl-2-nonyl-1,3-dioxolan-4-yl)methyl carbamate	CCCCCCCCCC1(C)OCC(COC(N)=O)O1	45285.0	R6_adenot_2004:439			BBB+	C	training
InChI=1S/C15H32N2/c1-16(12-6-7-13-16)10-4-3-5-11-17(2)14-8-9-15-17/h3-15H2,1-2H3/q+2	Pentolinium	1-methyl-1-[5-(1-methylpyrrolidin-1-ium-1-yl)pentyl]pyrrolidin-1-ium	C[N+]1(CCCCC[N+]2(C)CCCC2)CCCC1	5850.0	R23_gupta_2019:821			BBB-	C	training
InChI=1S/C16H10/c1-3-11-7-9-13-5-2-6-14-10-8-12(4-1)15(11)16(13)14/h1-10H	Pyrene	pyrene	c1cc2ccc3cccc4ccc(c1)c2c34	31423.0	R3_abraham_2006:243|R21_muehlbacher_2011:240|R25_brito_sanchez_2015:319|R26_chico_2009:338|R40_vilar_2010:224|R41_toropov_2017:217|R46_mendoza_valencia_2017:281|R47_radchenko_2020:202	0.23	B	BBB+	A	training
InChI=1S/C16H10ClF4NO2/c1-24-13-5-3-9(17)7-11(13)15(18)10-4-2-8(16(19,20)21)6-12(10)22-14(15)23/h2-7H,1H3,(H,22,23)/t15-/m0/s1	Bms-204352|Flindokalner	(3S)-3-(5-chloro-2-methoxyphenyl)-3-fluoro-6-(trifluoromethyl)-1H-indol-2-one	COc1ccc(Cl)cc1[C@]1(F)C(=O)Nc2cc(C(F)(F)F)ccc21	214350.0	R26_chico_2009:80	1.04	A	BBB+	A	training
InChI=1S/C16H10N2O8S2/c19-15-9-5-7(27(21,22)23)1-3-11(9)17-13(15)14-16(20)10-6-8(28(24,25)26)2-4-12(10)18-14/h1-6,17,19H,(H,21,22,23)(H,24,25,26)	Indigotindisulfonate|Indigotindisulfonic Acid	2-(3-hydroxy-5-sulfo-1H-indol-2-yl)-3-oxoindole-5-sulfonic acid	O=C1C(c2[nH]c3ccc(S(=O)(=O)O)cc3c2O)=Nc2ccc(S(=O)(=O)O)cc21	3705.0	R14_ghose_2012:618			BBB-	C	training
InChI=1S/C16H11ClN2O3/c17-10-6-7-12-11(8-10)13(9-4-2-1-3-5-9)19-14(16(21)22)15(20)18-12/h1-8,14H,(H,18,20)(H,21,22)	Chlorazepate|Clorazepate|Clorazepic Acid	7-chloro-2-oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepine-3-carboxylic acid	O=C(O)C1N=C(c2ccccc2)c2cc(Cl)ccc2NC1=O	2809.0	R14_ghose_2012:39|R23_gupta_2019:50|R26_chico_2009:113|R50_sobanska_2019:67			BBB+	C	training
InChI=1S/C16H11ClN4/c17-12-6-7-14-13(8-12)16(11-4-2-1-3-5-11)18-9-15-20-19-10-21(14)15/h1-8,10H,9H2	Estazolam	8-chloro-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine	Clc1ccc2c(c1)C(c1ccccc1)=NCc1nncn1-2	3261.0	R6_adenot_2004:703|R14_ghose_2012:86|R23_gupta_2019:83|R26_chico_2009:177|R51_doninger_2002:210			BBB+	C	training
InChI=1S/C16H12Cl2N2O2/c1-20-13-7-6-9(17)8-11(13)14(19-15(21)16(20)22)10-4-2-3-5-12(10)18/h2-8,15,21H,1H3	Lormetazepam	7-chloro-5-(2-chlorophenyl)-3-hydroxy-1-methyl-3H-1,4-benzodiazepin-2-one	CN1C(=O)C(O)N=C(c2ccccc2Cl)c2cc(Cl)ccc21	13314.0	R6_adenot_2004:724|R14_ghose_2012:128|R23_gupta_2019:127|R50_sobanska_2019:66			BBB+	C	training
InChI=1S/C16H12ClFN2O/c1-20-14-7-6-10(17)8-12(14)16(19-9-15(20)21)11-4-2-3-5-13(11)18/h2-8H,9H2,1H3	Fludiazepam	7-chloro-5-(2-fluorophenyl)-1-methyl-3H-1,4-benzodiazepin-2-one	CN1C(=O)CN=C(c2ccccc2F)c2cc(Cl)ccc21	3369.0	R6_adenot_2004:706			BBB+	C	training
InChI=1S/C16H12ClFN2O2/c1-20-13-7-6-9(17)8-11(13)14(19-15(21)16(20)22)10-4-2-3-5-12(10)18/h2-8,15,21H,1H3	Flutemazepam	7-chloro-5-(2-fluorophenyl)-3-hydroxy-1-methyl-3H-1,4-benzodiazepin-2-one	CN1C(=O)C(O)N=C(c2ccccc2F)c2cc(Cl)ccc21	40344.0	R6_adenot_2004:747			BBB+	C	training
InChI=1S/C16H12ClN3O3/c1-9-16(21)19-14-7-6-10(20(22)23)8-12(14)15(18-9)11-4-2-3-5-13(11)17/h2-9H,1H3,(H,19,21)/t9-/m0/s1	Meclonazepam	(3S)-5-(2-chlorophenyl)-3-methyl-7-nitro-1,3-dihydro-1,4-benzodiazepin-2-one	C[C@@H]1N=C(c2ccccc2Cl)c2cc([N+](=O)[O-])ccc2NC1=O	3033985.0	R6_adenot_2004:725			BBB+	C	training
InChI=1S/C16H12ClNO3/c1-9(16(19)20)11-4-7-14-13(8-11)18-15(21-14)10-2-5-12(17)6-3-10/h2-9H,1H3,(H,19,20)	Benoxaprofen	2-[2-(4-chlorophenyl)-1,3-benzoxazol-5-yl]propanoic acid	CC(C(=O)O)c1ccc2oc(-c3ccc(Cl)cc3)nc2c1	39941.0	R14_ghose_2012:381			BBB-	C	training
InChI=1S/C16H12FN3O3/c1-19-14-7-6-10(20(22)23)8-12(14)16(18-9-15(19)21)11-4-2-3-5-13(11)17/h2-8H,9H2,1H3	Flunitrazepam|1622-62-4|Flunitrazepam, Rohypnol	5-(2-fluorophenyl)-1-methyl-7-nitro-3H-1,4-benzodiazepin-2-one	CN1C(=O)CN=C(c2ccccc2F)c2cc([N+](=O)[O-])ccc21	3380.0	R3_abraham_2006:172|R4_mente_2005:56|R5_guerra_2008:45|R6_adenot_2004:707|R7_andres_2006:68|R12_garg_2006:80|R14_ghose_2012:94|R21_muehlbacher_2011:78|R25_brito_sanchez_2015:235|R26_chico_2009:190|R28_li_2005:84|R29_subramanian_2003:64|R39_shayanfar_2011:45|R40_vilar_2010:114|R41_toropov_2017:159|R44_bujak_2015:29|R47_radchenko_2020:145	0.06	B1	BBB+	A	training
InChI=1S/C16H12O3/c1-19-11-8-6-10(7-9-11)14-15(17)12-4-2-3-5-13(12)16(14)18/h2-9,14H,1H3	Anisindione	2-(4-methoxyphenyl)indene-1,3-dione	COc1ccc(C2C(=O)c3ccccc3C2=O)cc1	2197.0	R14_ghose_2012:356			BBB-	C	training
InChI=1S/C16H13Cl2NO4/c17-11-5-3-6-12(18)16(11)19-13-7-2-1-4-10(13)8-15(22)23-9-14(20)21/h1-7,19H,8-9H2,(H,20,21)	Aceclofenac	2-[2-[2-(2,6-dichloroanilino)phenyl]acetyl]oxyacetic acid	O=C(O)COC(=O)Cc1ccccc1Nc1c(Cl)cccc1Cl	71771.0	R14_ghose_2012:322			BBB-	C	training
InChI=1S/C16H13Cl3N2OS/c17-12-1-2-13(14(18)7-12)15(8-21-5-4-20-10-21)22-9-11-3-6-23-16(11)19/h1-7,10,15H,8-9H2	Tioconazole|Tz-3	1-[2-[(2-chlorothiophen-3-yl)methoxy]-2-(2,4-dichlorophenyl)ethyl]imidazole	Clc1ccc(C(Cn2ccnc2)OCc2ccsc2Cl)c(Cl)c1	5482.0	R23_gupta_2019:982|R40_vilar_2010:294|R47_radchenko_2020:402	-0.2	B	BBB+	A	training
InChI=1S/C16H13ClN2O/c1-19-14-8-7-12(17)9-13(14)16(18-10-15(19)20)11-5-3-2-4-6-11/h2-9H,10H2,1H3	Diazepam|439-14-5	7-chloro-1-methyl-5-phenyl-3H-1,4-benzodiazepin-2-one	CN1C(=O)CN=C(c2ccccc2)c2cc(Cl)ccc21	3016.0	R3_abraham_2006:160|R3_abraham_2006:161|R4_mente_2005:54|R5_guerra_2008:36|R6_adenot_2004:700|R7_andres_2006:48|R12_garg_2006:71|R14_ghose_2012:71|R21_muehlbacher_2011:61|R25_brito_sanchez_2015:208|R26_chico_2009:157|R28_li_2005:76|R29_subramanian_2003:48|R34_broccatelli_2012:22|R39_shayanfar_2011:39|R40_vilar_2010:96|R41_toropov_2017:149|R42_ciura_2020:14|R44_bujak_2015:25|R46_mendoza_valencia_2017:192|R47_radchenko_2020:135|R50_sobanska_2019:29|R51_doninger_2002:198|R53_friden_2009:8	0.52	D	BBB+	A	training
InChI=1S/C16H13ClN2O/c17-12-7-5-11(6-8-12)16(20)14-4-2-1-3-13(14)15-18-9-10-19(15)16/h1-8,20H,9-10H2	Mazindol	5-(4-chlorophenyl)-2,3-dihydroimidazo[1,2-b]isoindol-5-ol	OC1(c2ccc(Cl)cc2)c2ccccc2C2=NCCN21	4020.0	R6_adenot_2004:572|R14_ghose_2012:132|R23_gupta_2019:131			BBB+	C	training
InChI=1S/C16H13ClN2O2/c1-18-13-8-7-11(17)9-14(13)19(16(21)10-15(18)20)12-5-3-2-4-6-12/h2-9H,10H2,1H3	Clobazam|22316-47-8	7-chloro-1-methyl-5-phenyl-1,5-benzodiazepine-2,4-dione	CN1C(=O)CC(=O)N(c2ccccc2)c2cc(Cl)ccc21	2789.0	R3_abraham_2006:148|R4_mente_2005:51|R5_guerra_2008:27|R6_adenot_2004:693|R7_andres_2006:36|R12_garg_2006:60|R14_ghose_2012:51|R21_muehlbacher_2011:56|R25_brito_sanchez_2015:190|R26_chico_2009:109|R28_li_2005:72|R29_subramanian_2003:37|R39_shayanfar_2011:30|R40_vilar_2010:78|R41_toropov_2017:138|R44_bujak_2015:21|R46_mendoza_valencia_2017:176|R47_radchenko_2020:124|R50_sobanska_2019:30|R51_doninger_2002:183	0.35	B1	BBB+	A	test
InChI=1S/C16H13ClN2O2/c1-19-13-8-7-11(17)9-12(13)14(18-15(20)16(19)21)10-5-3-2-4-6-10/h2-9,15,20H,1H3	Temazepam	7-chloro-3-hydroxy-1-methyl-5-phenyl-3H-1,4-benzodiazepin-2-one	CN1C(=O)C(O)N=C(c2ccccc2)c2cc(Cl)ccc21	5391.0	R6_adenot_2004:749|R14_ghose_2012:240|R26_chico_2009:404|R28_li_2005:294|R34_broccatelli_2012:90|R50_sobanska_2019:62|R51_doninger_2002:307			BBB+	C	training
InChI=1S/C16H13ClN2O4S/c17-13-8-11(24(18,22)23)6-7-14(13)19-15(20)9-12(16(19)21)10-4-2-1-3-5-10/h1-8,12H,9H2,(H2,18,22,23)	Suclofenide	3-chloro-4-(2,5-dioxo-3-phenylpyrrolidin-1-yl)benzenesulfonamide	NS(=O)(=O)c1ccc(N2C(=O)CC(c3ccccc3)C2=O)c(Cl)c1	72094.0	R6_adenot_2004:470			BBB+	C	training
InChI=1S/C16H13ClN2S/c1-19-14-8-7-12(17)9-13(14)16(18-10-15(19)20)11-5-3-2-4-6-11/h2-9H,10H2,1H3	Sulazepam	7-chloro-1-methyl-5-phenyl-3H-1,4-benzodiazepine-2-thione	CN1C(=S)CN=C(c2ccccc2)c2cc(Cl)ccc21	17931.0	R6_adenot_2004:748			BBB+	C	training
InChI=1S/C16H13ClN6/c1-22-15-8-12(4-7-14(15)20-21-22)16(23-10-18-9-19-23)11-2-5-13(17)6-3-11/h2-10,16H,1H3	Vorozole|(+)-Vorozole	6-[(4-chlorophenyl)-(1,2,4-triazol-1-yl)methyl]-1-methylbenzotriazole	Cn1nnc2ccc(C(c3ccc(Cl)cc3)n3cncn3)cc21	60796.0	R25_brito_sanchez_2015:34|R46_mendoza_valencia_2017:33|R47_radchenko_2020:438	-0.16	B	BBB+	A	test
InChI=1S/C16H13N3O3/c1-18-14-8-7-12(19(21)22)9-13(14)16(17-10-15(18)20)11-5-3-2-4-6-11/h2-9H,10H2,1H3	Nimetazepam	1-methyl-7-nitro-5-phenyl-3H-1,4-benzodiazepin-2-one	CN1C(=O)CN=C(c2ccccc2)c2cc([N+](=O)[O-])ccc21	4496.0	R6_adenot_2004:732			BBB+	C	training
InChI=1S/C16H13N3O3/c1-22-16(21)19-15-17-12-8-7-11(9-13(12)18-15)14(20)10-5-3-2-4-6-10/h2-9H,1H3,(H2,17,18,19,21)	Mebendazole	methyl N-(6-benzoyl-1H-benzimidazol-2-yl)carbamate	COC(=O)Nc1nc2ccc(C(=O)c3ccccc3)cc2[nH]1	4030.0	R14_ghose_2012:664|R23_gupta_2019:723			BBB-	C	training
InChI=1S/C16H13NO/c17-16(18)15-13-7-3-1-5-11(13)9-10-12-6-2-4-8-14(12)15/h1-10,15H,(H2,17,18)	Citenamide	tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,9,11,13-heptaene-2-carboxamide	NC(=O)C1c2ccccc2C=Cc2ccccc21	25255.0	R6_adenot_2004:430|R48_hou_2003:32	0.0	A	BBB+	A	training
InChI=1S/C16H13NO2/c17-16(18)13-9-5-1-3-7-11(9)14-15(19-14)12-8-4-2-6-10(12)13/h1-8,13-15H,(H2,17,18)/t13-,14+,15-			NC(=O)[C@H]1c2ccccc2[C@H]2O[C@H]2c2ccccc21		R48_hou_2003:33	-0.34	A	BBB+	A	test
InChI=1S/C16H14ClN3O/c1-18-15-10-20(21)16(11-5-3-2-4-6-11)13-9-12(17)7-8-14(13)19-15/h2-9,21H,10H2,1H3/b18-15-	Chlordiazepoxide	7-chloro-4-hydroxy-N-methyl-5-phenyl-3H-1,4-benzodiazepin-2-imine	C/N=C1/CN(O)C(c2ccccc2)=c2cc(Cl)ccc2=N1	2712.0	R6_adenot_2004:688|R7_andres_2006:35|R14_ghose_2012:40|R14_ghose_2012:292|R23_gupta_2019:41|R26_chico_2009:103|R29_subramanian_2003:33|R50_sobanska_2019:65|R51_doninger_2002:178			BBB+	C	training
InChI=1S/C16H14ClNO/c17-10-5-6-16-12(7-10)14-9-18-8-13(14)11-3-1-2-4-15(11)19-16/h1-7,13-14,18H,8-9H2	Org30526|Org-30526|9-Chloro-13-Oxa-4-Azatetracyclo[12.4.0.02,6.07,12]Octadeca-1(18),7(12),8,10,14,16-Hexaene	9-chloro-13-oxa-4-azatetracyclo[12.4.0.02,6.07,12]octadeca-1(18),7(12),8,10,14,16-hexaene	Clc1ccc2c(c1)C1CNCC1c1ccccc1O2	14577084.0	R3_abraham_2006:212|R25_brito_sanchez_2015:337|R40_vilar_2010:172|R41_toropov_2017:194|R46_mendoza_valencia_2017:296|R47_radchenko_2020:179|R49_norinder_2002:146	0.39	B	BBB+	A	training
InChI=1S/C16H14ClNO/c17-10-5-6-16-12(7-10)14-9-18-8-13(14)11-3-1-2-4-15(11)19-16/h1-7,13-14,18H,8-9H2/t13-,14+/m0/s1	Org30526|(2R,6S)-9-Chloro-13-Oxa-4-Azatetracyclo[12.4.0.02,6.07,12]Octadeca-1(18),7(12),8,10,14,16-Hexaene	(2R,6S)-9-chloro-13-oxa-4-azatetracyclo[12.4.0.02,6.07,12]octadeca-1(18),7(12),8,10,14,16-hexaene	Clc1ccc2c(c1)[C@H]1CNC[C@H]1c1ccccc1O2	93535113.0	R28_li_2005:34			BBB+	C	training
InChI=1S/C16H14ClNO/c17-10-5-6-16-12(7-10)14-9-18-8-13(14)11-3-1-2-4-15(11)19-16/h1-7,13-14,18H,8-9H2/t13-,14-/m1/s1	128915-56-0|N-Desmethyl Asenapine	(2S,6S)-9-chloro-13-oxa-4-azatetracyclo[12.4.0.02,6.07,12]octadeca-1(18),7(12),8,10,14,16-hexaene	Clc1ccc2c(c1)[C@H]1CNC[C@@H]1c1ccccc1O2	44568616.0	R4_mente_2005:163	0.39	A	BBB+	A	training
InChI=1S/C16H14F3N3O2S/c1-10-13(20-7-6-14(10)24-9-16(17,18)19)8-25(23)15-21-11-4-2-3-5-12(11)22-15/h2-7H,8-9H2,1H3,(H,21,22)	Lansoprazole	2-[[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methylsulfinyl]-1H-benzimidazole	Cc1c(OCC(F)(F)F)ccnc1CS(=O)c1nc2ccccc2[nH]1	3883.0	R14_ghose_2012:646|R23_gupta_2019:698			BBB-	C	training
InChI=1S/C16H14F3N5O/c1-10(15-14(19)5-20-7-22-15)16(25,6-24-9-21-8-23-24)12-3-2-11(17)4-13(12)18/h2-5,7-10,25H,6H2,1H3/t10-,16+/m0/s1	Voriconazole	(2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1,2,4-triazol-1-yl)butan-2-ol	C[C@@H](c1ncncc1F)[C@](O)(Cn1cncn1)c1ccc(F)cc1F	71616.0	R14_ghose_2012:936			BBB-	C	test
InChI=1S/C16H14N2O/c1-11-7-3-6-10-15(11)18-12(2)17-14-9-5-4-8-13(14)16(18)19/h3-10H,1-2H3	Methaqualone	2-methyl-3-(2-methylphenyl)quinazolin-4-one	Cc1ccccc1-n1c(C)nc2ccccc2c1=O	6292.0	R6_adenot_2004:1371|R51_doninger_2002:249			BBB+	C	training
InChI=1S/C16H14N2O/c17-16(19)18-14-7-3-1-5-10(14)12-9-13(12)11-6-2-4-8-15(11)18/h1-8,12-13H,9H2,(H2,17,19)	Cbz-Epo	11-azatetracyclo[10.4.0.02,4.05,10]hexadeca-1(16),5,7,9,12,14-hexaene-11-carboxamide	NC(=O)N1c2ccccc2C2CC2c2ccccc21	12323381.0	R3_abraham_2006:325|R41_toropov_2017:288	-0.34	B	BBB+	A	test
InChI=1S/C16H14N2O2/c17-14(19)10-18-13-9-5-4-8-12(13)15(16(18)20)11-6-2-1-3-7-11/h1-9,15H,10H2,(H2,17,19)	Doliracetam	2-(2-oxo-3-phenyl-3H-indol-1-yl)acetamide	NC(=O)CN1C(=O)C(c2ccccc2)c2ccccc21	208851.0	R6_adenot_2004:1249			BBB+	C	training
InChI=1S/C16H14N2O4/c1-7(2)8-3-4-12-9(5-8)13(19)10-6-11(16(20)21)14(17)18-15(10)22-12/h3-7H,1-2H3,(H2,17,18)(H,20,21)	Amlexanox	2-amino-5-oxo-7-propan-2-ylchromeno[2,3-b]pyridine-3-carboxylic acid	CC(C)c1ccc2oc3nc(N)c(C(=O)O)cc3c(=O)c2c1	2161.0	R23_gupta_2019:347			BBB-	C	training
InChI=1S/C16H14O3/c17-15(10-11-16(18)19)14-8-6-13(7-9-14)12-4-2-1-3-5-12/h1-9H,10-11H2,(H,18,19)	Fenbufen	4-oxo-4-(4-phenylphenyl)butanoic acid	O=C(O)CCC(=O)c1ccc(-c2ccccc2)cc1	3335.0	R14_ghose_2012:552			BBB-	C	training
InChI=1S/C16H14O6/c1-21-13-3-2-8(4-10(13)18)14-7-12(20)16-11(19)5-9(17)6-15(16)22-14/h2-6,14,17-19H,7H2,1H3/t14-/m0/s1	Hesperetin	(2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-2,3-dihydrochromen-4-one	COc1ccc([C@@H]2CC(=O)c3c(O)cc(O)cc3O2)cc1O	72281.0	R23_gupta_2019:652			BBB-	C	test
InChI=1S/C16H14O6/c17-9-3-8-4-10(7-1-2-11(18)12(19)5-7)15(21)16(22)14(8)13(20)6-9/h1-3,5-6,10,15,17-21H,4H2			O=C1c2c(O)cc(O)cc2CC(c2ccc(O)c(O)c2)C1O		R46_mendoza_valencia_2017:430	-1.7	A	BBB-	A	test
InChI=1S/C16H15Cl2N/c1-19-16-9-13(11-4-2-3-5-12(11)16)10-6-7-14(17)15(18)8-10/h2-8,13,16,19H,9H2,1H3/t13-,16+/m0/s1	Indatraline	(1R,3S)-3-(3,4-dichlorophenyl)-N-methyl-2,3-dihydro-1H-inden-1-amine	CN[C@@H]1C[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21	126280.0	R6_adenot_2004:376			BBB+	C	test
InChI=1S/C16H15ClN2/c1-19-10-9-18-16(12-5-3-2-4-6-12)14-11-13(17)7-8-15(14)19/h2-8,11H,9-10H2,1H3	Medazepam	7-chloro-1-methyl-5-phenyl-2,3-dihydro-1,4-benzodiazepine	CN1CCN=C(c2ccccc2)c2cc(Cl)ccc21	4041.0	R6_adenot_2004:726|R14_ghose_2012:289|R23_gupta_2019:133|R50_sobanska_2019:63|R51_doninger_2002:243			BBB+	C	training
InChI=1S/C16H15ClN2OS/c1-3-10-8-12-15(11-6-4-5-7-13(11)17)18-9-14(20)19(2)16(12)21-10/h4-8H,3,9H2,1-2H3	Clotiazepam	5-(2-chlorophenyl)-7-ethyl-1-methyl-3H-thieno[2,3-e][1,4]diazepin-2-one	CCc1cc2c(s1)N(C)C(=O)CN=C2c1ccccc1Cl	2811.0	R6_adenot_2004:695|R14_ghose_2012:298|R23_gupta_2019:52|R47_radchenko_2020:460	0.51	A	BBB+	A	training
InChI=1S/C16H15ClN2S/c1-2-18-16-19-14-9-8-12(17)10-13(14)15(20-16)11-6-4-3-5-7-11/h3-10,15H,2H2,1H3,(H,18,19)	Etasuline	6-chloro-N-ethyl-4-phenyl-1,4-dihydro-3,1-benzothiazin-2-imine	CC/N=C1/Nc2ccc(Cl)cc2C(c2ccccc2)S1	135407187.0	R6_adenot_2004:1154			BBB+	C	training
InChI=1S/C16H15F2N3O3/c1-2-24-16(23)14-13-8-20(6-5-17)15(22)11-7-10(18)3-4-12(11)21(13)9-19-14/h3-4,7,9H,2,5-6,8H2,1H3	Fluoroethylfumazrnil|Fluoroethylflumazenil|Cid 6426759	ethyl 8-fluoro-5-(2-fluoroethyl)-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate	CCOC(=O)c1ncn2c1CN(CCF)C(=O)c1cc(F)ccc1-2	6426759.0	R3_abraham_2006:173|R21_muehlbacher_2011:293|R25_brito_sanchez_2015:236|R40_vilar_2010:115|R41_toropov_2017:160|R46_mendoza_valencia_2017:216|R47_radchenko_2020:146	-0.14	B	BBB+	A	training
InChI=1S/C16H15F2N3O4S/c1-23-13-5-6-19-12(14(13)24-2)8-26(22)16-20-10-4-3-9(25-15(17)18)7-11(10)21-16/h3-7,15H,8H2,1-2H3,(H,20,21)	Pantoprazole	6-(difluoromethoxy)-2-[(3,4-dimethoxypyridin-2-yl)methylsulfinyl]-1H-benzimidazole	COc1ccnc(CS(=O)c2nc3ccc(OC(F)F)cc3[nH]2)c1OC	4679.0	R14_ghose_2012:753|R23_gupta_2019:811			BBB-	C	training
InChI=1S/C16H15F6N5O/c17-10-6-12(19)11(18)4-8(10)3-9(23)5-14(28)26-1-2-27-13(7-26)24-25-15(27)16(20,21)22/h4,6,9H,1-3,5,7,23H2/t9-/m1/s1	Sitagliptin	(3R)-3-amino-1-[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)butan-1-one	N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)c(F)cc1F	4369359.0	R23_gupta_2019:911			BBB-	C	training
InChI=1S/C16H15N/c1-16-13-8-4-2-6-11(13)10-15(17-16)12-7-3-5-9-14(12)16/h2-9,15,17H,10H2,1H3	Neurogard	1-methyl-16-azatetracyclo[7.6.1.02,7.010,15]hexadeca-2,4,6,10,12,14-hexaene	CC12NC(Cc3ccccc31)c1ccccc12	1207.0	R46_mendoza_valencia_2017:199	1.11	A	BBB+	A	training
InChI=1S/C16H15N/c1-16-13-8-4-2-6-11(13)10-15(17-16)12-7-3-5-9-14(12)16/h2-9,15,17H,10H2,1H3/t15-,16+/m1/s1	77086-21-6|Dizocilpine|Mk-801	(1S,9R)-1-methyl-16-azatetracyclo[7.6.1.02,7.010,15]hexadeca-2,4,6,10,12,14-hexaene	C[C@]12N[C@H](Cc3ccccc31)c1ccccc12	180081.0	R4_mente_2005:100|R6_adenot_2004:1489|R7_andres_2006:51|R25_brito_sanchez_2015:215|R29_subramanian_2003:104|R40_vilar_2010:154|R47_radchenko_2020:480	1.11	B	BBB+	A	training
InChI=1S/C16H15N2O6P/c19-14-16(12-7-3-1-4-8-12,13-9-5-2-6-10-13)17-15(20)18(14)11-24-25(21,22)23/h1-10H,11H2,(H,17,20)(H2,21,22,23)	Fosphenytoin	(2,5-dioxo-4,4-diphenylimidazolidin-1-yl)methyl dihydrogen phosphate	O=C1NC(c2ccccc2)(c2ccccc2)C(=O)N1COP(=O)(O)O	56339.0	R6_adenot_2004:1635|R23_gupta_2019:102			BBB+	C	training
InChI=1S/C16H15N3/c17-16-18-10-15-13-7-3-1-5-11(13)9-12-6-2-4-8-14(12)19(15)16/h1-8,15H,9-10H2,(H2,17,18)	Epinastine	2,4-diazatetracyclo[12.4.0.02,6.07,12]octadeca-1(18),3,7,9,11,14,16-heptaen-3-amine	NC1=NCC2c3ccccc3Cc3ccccc3N12	3241.0	R23_gupta_2019:563|R25_brito_sanchez_2015:423|R46_mendoza_valencia_2017:356	-0.16	B	BBB+	A	training
InChI=1S/C16H15N5O2/c17-15(20-23)14-16(22)21(10-11-6-2-1-3-7-11)13-9-5-4-8-12(13)18-19-14/h1-9,17-19,22H,10H2/b17-15-	Trizoxime	5-benzyl-4-hydroxy-N-oxo-1,2-dihydro-1,2,5-benzotriazepine-3-carboximidamide	[H]/N=C(\N=O)c1[nH][nH]c2ccccc2n(Cc2ccccc2)c1O	3047751.0	R6_adenot_2004:629			BBB+	C	test
InChI=1S/C16H15N5O4S3/c22-10(4-9-2-1-3-26-9)19-11-13(23)21-12(15(24)25)8(5-27-14(11)21)6-28-16-17-7-18-20-16/h1-3,7,11,14H,4-6H2,(H,19,22)(H,24,25)(H,17,18,20)/t11-,14-/m1/s1	Cefetrizole	(6R,7R)-8-oxo-7-[(2-thiophen-2-ylacetyl)amino]-3-(1H-1,2,4-triazol-5-ylsulfanylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid	O=C(Cc1cccs1)N[C@@H]1C(=O)N2C(C(=O)O)=C(CSc3ncn[nH]3)CS[C@H]12	193956.0	R6_adenot_2004:172			BBB-	C	training
InChI=1S/C16H15N5O7S2/c1-2-6-4-29-14-10(13(25)21(14)11(6)15(26)27)19-12(24)9(20-28-3-8(22)23)7-5-30-16(17)18-7/h2,5,10,14H,1,3-4H2,(H2,17,18)(H,19,24)(H,22,23)(H,26,27)/b20-9-/t10-,14-/m1/s1	Cefixime|Cefixime Anhydrous, (E)-	(6R,7R)-7-[[(2E)-2-(2-amino-1,3-thiazol-4-yl)-2-(carboxymethoxyimino)acetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid	C=CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)/C(=N/OCC(=O)O)c3csc(N)n3)[C@H]2SC1	6321411.0	R6_adenot_2004:174|R14_ghose_2012:432|R23_gupta_2019:423			BBB-	C	training
InChI=1S/C16H15N7O2/c17-14-20-15(18-8-7-10-3-5-11(24)6-4-10)21-16-19-13(22-23(14)16)12-2-1-9-25-12/h1-6,9,24H,7-8H2,(H3,17,18,19,20,21,22)	17 Zm0241385|4-(2-((7-Amino-2-(Furan-2-Yl)-[1,2,4]Triazolo[1,5-A][1,3,5]Triazin-5-Yl)Amino)Ethyl)Phenol	4-[2-[[7-amino-2-(furan-2-yl)-[1,2,4]triazolo[1,5-a][1,3,5]triazin-5-yl]amino]ethyl]phenol	Nc1nc(NCCc2ccc(O)cc2)nc2nc(-c3ccco3)nn12	176407.0	R47_radchenko_2020:443	-1.3	A	BBB-	A	test
InChI=1S/C16H15N7O5S4/c1-28-21-9(7-5-31-16(17)19-7)12(24)20-10-13(25)23-11(15(26)27)6(4-30-14(10)23)3-29-8-2-18-22-32-8/h2,5,10,14H,3-4H2,1H3,(H2,17,19)(H,20,24)(H,26,27)/b21-9+/t10-,14-/m1/s1	Cefuzonam|Cefuzonam Sodium	(6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-8-oxo-3-(thiadiazol-5-ylsulfanylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid	CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(CSc3cnns3)CS[C@H]12)c1csc(N)n1	6336505.0	R6_adenot_2004:209			BBB-	C	training
InChI=1S/C16H15NO/c17-16(18)15-13-7-3-1-5-11(13)9-10-12-6-2-4-8-14(12)15/h1-8,15H,9-10H2,(H2,17,18)	Cyheptamide	tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,11,13-hexaene-2-carboxamide	NC(=O)C1c2ccccc2CCc2ccccc21	23603.0	R6_adenot_2004:433			BBB+	C	test
InChI=1S/C16H16ClN3O3S/c1-10-8-11-4-2-3-5-14(11)20(10)19-16(21)12-6-7-13(17)15(9-12)24(18,22)23/h2-7,9-10H,8H2,1H3,(H,19,21)(H2,18,22,23)	Indapamide	4-chloro-N-(2-methyl-2,3-dihydroindol-1-yl)-3-sulfamoylbenzamide	CC1Cc2ccccc2N1NC(=O)c1ccc(Cl)c(S(N)(=O)=O)c1	3702.0	R14_ghose_2012:616|R23_gupta_2019:676			BBB-	C	training
InChI=1S/C16H16ClN3O3S/c1-9-5-3-4-6-14(9)20-10(2)19-13-8-12(17)15(24(18,22)23)7-11(13)16(20)21/h3-8,10,19H,1-2H3,(H2,18,22,23)	Metolazone	7-chloro-2-methyl-3-(2-methylphenyl)-4-oxo-1,2-dihydroquinazoline-6-sulfonamide	Cc1ccccc1N1C(=O)c2cc(S(N)(=O)=O)c(Cl)cc2NC1C	4170.0	R14_ghose_2012:691|R23_gupta_2019:745			BBB-	C	training
InChI=1S/C16H16ClN3O4/c17-9-6-7-10-12(15(22)20(10)13(9)16(23)24)19-14(21)11(18)8-4-2-1-3-5-8/h1-5,10-12H,6-7,18H2,(H,19,21)(H,23,24)/t10-,11-,12+/m1/s1	Loracarbef	(6R,7S)-7-[[(2R)-2-amino-2-phenylacetyl]amino]-3-chloro-8-oxo-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid	N[C@@H](C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(Cl)CC[C@H]12)c1ccccc1	5284585.0	R6_adenot_2004:241|R23_gupta_2019:715			BBB-	C	training
InChI=1S/C16H16ClN3O5S/c1-6-5-26-15-11(14(23)20(15)12(6)16(24)25)19-13(22)10(18)7-2-3-9(21)8(17)4-7/h2-4,10-11,15,21H,5,18H2,1H3,(H,19,22)(H,24,25)/t10-,11-,15-/m1/s1	Cefedrolor	(6R,7R)-7-[[(2R)-2-amino-2-(3-chloro-4-hydroxyphenyl)acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid	CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)[C@H](N)c3ccc(O)c(Cl)c3)[C@H]2SC1	193953.0	R6_adenot_2004:168			BBB-	C	training
InChI=1S/C16H16ClNO2S/c1-20-16(19)15(12-4-2-3-5-13(12)17)18-8-6-14-11(10-18)7-9-21-14/h2-5,7,9,15H,6,8,10H2,1H3/t15-/m0/s1	Clopidogrel Bisulfate|Clopidogrel	methyl (2S)-2-(2-chlorophenyl)-2-(6,7-dihydro-4H-thieno[3,2-c]pyridin-5-yl)acetate	COC(=O)[C@H](c1ccccc1Cl)N1CCc2sccc2C1	60606.0	R14_ghose_2012:464|R23_gupta_2019:475			BBB-	C	test
InChI=1S/C16H16ClNO3/c17-15-11-5-6-18-8-13(9-1-3-10(19)4-2-9)12(11)7-14(20)16(15)21/h1-4,7,13,18-21H,5-6,8H2	Fenoldopam	9-chloro-5-(4-hydroxyphenyl)-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diol	Oc1ccc(C2CNCCc3c2cc(O)c(O)c3Cl)cc1	3341.0	R23_gupta_2019:596			BBB-	C	test
InChI=1S/C16H16F3NO/c17-16(18,19)13-6-8-14(9-7-13)21-15(10-11-20)12-4-2-1-3-5-12/h1-9,15H,10-11,20H2/t15-/m0/s1	Seproxetine	(3S)-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine	NCC[C@H](Oc1ccc(C(F)(F)F)cc1)c1ccccc1	3058751.0	R6_adenot_2004:607			BBB+	C	training
InChI=1S/C16H16F3NO4/c1-9-6-11(8-13(21)14(9)15(22)23-2)20-10-4-3-5-12(7-10)24-16(17,18)19/h3-5,7-9,14,20H,6H2,1-2H3	156154-42-6|Dm49|Methyl 6-Methyl-2-Oxo-4-[3-(Trifluoromethoxy)Anilino]Cyclohex-3-Ene-1-Carboxylate	methyl 6-methyl-2-oxo-4-[3-(trifluoromethoxy)anilino]cyclohex-3-ene-1-carboxylate	COC(=O)C1C(=O)C=C(Nc2cccc(OC(F)(F)F)c2)CC1C	15186911.0	R4_mente_2005:22|R25_brito_sanchez_2015:533|R40_vilar_2010:100|R46_mendoza_valencia_2017:447|R47_radchenko_2020:431	-0.17	B	BBB+	A	test
InChI=1S/C16H16N2O3S/c1-9(2)8-21-13-5-4-11(6-12(13)7-17)15-18-10(3)14(22-15)16(19)20/h4-6,9H,8H2,1-3H3,(H,19,20)	Febuxostat	2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methyl-1,3-thiazole-5-carboxylic acid	Cc1nc(-c2ccc(OCC(C)C)c(C#N)c2)sc1C(=O)O	134018.0	R23_gupta_2019:1061			BBB-	C	training
InChI=1S/C16H16N2O6S2/c1-8(19)24-6-9-7-26-15-12(14(21)18(15)13(9)16(22)23)17-11(20)5-10-3-2-4-25-10/h2-4,12,15H,5-7H2,1H3,(H,17,20)(H,22,23)/t12-,15-/m1/s1	Cefalotin|Cephalotin|Cephalothin	(6R,7R)-3-(acetyloxymethyl)-8-oxo-7-[(2-thiophen-2-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid	CC(=O)OCC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)Cc3cccs3)[C@H]2SC1	6024.0	R6_adenot_2004:158|R7_andres_2006:29|R23_gupta_2019:417|R29_subramanian_2003:30			BBB-	C	training
InChI=1S/C16H16N2OS/c1-17(2)11-16(19)18-12-7-3-5-9-14(12)20-15-10-6-4-8-13(15)18/h3-10H,11H2,1-2H3	Dacemazine	2-(dimethylamino)-1-phenothiazin-10-ylethanone	CN(C)CC(=O)N1c2ccccc2Sc2ccccc21	68846.0	R6_adenot_2004:1561			BBB+	C	training
InChI=1S/C16H16N4O3/c1-19(2)15-7-6-14(23-15)11-4-3-5-12(10-11)18-16-13(20(21)22)8-9-17-16/h3-10,17-18H,1-2H3	Bbcpd18		CN(C)c1ccc(-c2cccc(Nc3[nH]ccc3[N+](=O)[O-])c2)o1		R12_garg_2006:34|R25_brito_sanchez_2015:142|R46_mendoza_valencia_2017:140|R47_radchenko_2020:262	-0.27	B	BBB+	A	training
InChI=1S/C16H16N4O8S/c1-26-19-9(8-3-2-4-27-8)12(21)18-10-13(22)20-11(15(23)24)7(5-28-16(17)25)6-29-14(10)20/h2-4,10,14H,5-6H2,1H3,(H2,17,25)(H,18,21)(H,23,24)/b19-9-/t10-,14-/m1/s1	Cefuroxime|Cefuroxim|(6R,7R)-3-(Carbamoyloxymethyl)-7-[[(2E)-2-(Furan-2-Yl)-2-Methoxyiminoacetyl]Amino]-8-Oxo-5-Thia-1-Azabicyclo[4.2.0]Oct-2-Ene-2-Carboxylic Acid	(6R,7R)-3-(carbamoyloxymethyl)-7-[[(2E)-2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid	CO/N=C(/C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1	5361202.0	R6_adenot_2004:208|R23_gupta_2019:440|R34_broccatelli_2012:14|R50_sobanska_2019:50			BBB-	C	training
InChI=1S/C16H17BrN2/c1-19(2)11-9-16(14-4-3-10-18-12-14)13-5-7-15(17)8-6-13/h3-10,12H,11H2,1-2H3/b16-9-	Zimeldine|Zimelidine	(Z)-3-(4-bromophenyl)-N,N-dimethyl-3-pyridin-3-ylprop-2-en-1-amine	CN(C)C/C=C(/c1ccc(Br)cc1)c1cccnc1	5365247.0	R6_adenot_2004:637|R7_andres_2006:184|R29_subramanian_2003:179|R51_doninger_2002:325			BBB+	C	training
InChI=1S/C16H17ClN2O/c1-19-14-8-7-12(17)9-13(14)16(18-10-15(19)20)11-5-3-2-4-6-11/h5,7-9H,2-4,6,10H2,1H3	Tetrazepam	7-chloro-5-(cyclohexen-1-yl)-1-methyl-3H-1,4-benzodiazepin-2-one	CN1C(=O)CN=C(C2=CCCCC2)c2cc(Cl)ccc21	25215.0	R6_adenot_2004:750|R23_gupta_2019:236			BBB+	C	training
InChI=1S/C16H17ClN2S/c1-18-10-5-11-19-13-7-2-3-8-14(13)20-15-9-4-6-12(17)16(15)19/h2-4,6-9,18H,5,10-11H2,1H3	Nor-1-Chlorpromazine|3-(1-Chlorophenothiazin-10-Yl)-N-Methylpropan-1-Amine	3-(1-chlorophenothiazin-10-yl)-N-methylpropan-1-amine	CNCCCN1c2ccccc2Sc2cccc(Cl)c21	154294793.0	R26_chico_2009:285	1.37	A	BBB+	A	training
InChI=1S/C16H17ClN2S/c1-18-9-4-10-19-13-5-2-3-6-15(13)20-16-8-7-12(17)11-14(16)19/h2-3,5-8,11,18H,4,9-10H2,1H3	1225-64-5|Norchlorpromazine|Nor-1-Chlorpromazine|Nor-2-Chlorpromazine	3-(2-chlorophenothiazin-10-yl)-N-methylpropan-1-amine	CNCCCN1c2ccccc2Sc2ccc(Cl)cc21	62875.0	R4_mente_2005:158|R5_guerra_2008:73|R12_garg_2006:123|R21_muehlbacher_2011:260|R25_brito_sanchez_2015:324|R26_chico_2009:286|R28_li_2005:99|R39_shayanfar_2011:66|R40_vilar_2010:162|R46_mendoza_valencia_2017:285|R47_radchenko_2020:279	1.33	B1	BBB+	A	training
InChI=1S/C16H17FN2S/c1-3-19-5-4-12-10(7-19)15-13(18-12)6-11(17)16-14(15)9(2)8-20-16/h6,8,18H,3-5,7H2,1-2H3	Tiflucarbine	14-ethyl-7-fluoro-3-methyl-5-thia-10,14-diazatetracyclo[7.7.0.02,6.011,16]hexadeca-1,3,6,8,11(16)-pentaene	CCN1CCc2[nH]c3cc(F)c4scc(C)c4c3c2C1	65677.0	R6_adenot_2004:620			BBB+	C	training
InChI=1S/C16H17N3/c1-2-12-18(15-7-10-17-11-8-15)19-13-9-14-5-3-4-6-16(14)19/h3-11,13H,2,12H2,1H3	Besipirdine	N-propyl-N-pyridin-4-ylindol-1-amine	CCCN(c1ccncc1)n1ccc2ccccc21	60691.0	R6_adenot_2004:1244			BBB+	C	training
InChI=1S/C16H17N3O3/c1-18-14-8-7-12(19(21)22)9-13(14)16(17-10-15(18)20)11-5-3-2-4-6-11/h5,7-9H,2-4,6,10H2,1H3	Menitrazepam	5-(cyclohexen-1-yl)-1-methyl-7-nitro-3H-1,4-benzodiazepin-2-one	CN1C(=O)CN=C(C2=CCCCC2)c2cc([N+](=O)[O-])ccc21	189875.0	R6_adenot_2004:727			BBB+	C	training
InChI=1S/C16H17N3O4S/c1-8-7-24-15-11(14(21)19(15)12(8)16(22)23)18-13(20)10(17)9-5-3-2-4-6-9/h2-6,10-11,15H,7,17H2,1H3,(H,18,20)(H,22,23)/t10-,11-,15-/m1/s1	Cefalexin|Cephalexin	(6R,7R)-7-[[(2R)-2-amino-2-phenylacetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid	CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)[C@H](N)c3ccccc3)[C@H]2SC1	27447.0	R6_adenot_2004:153|R7_andres_2006:28|R14_ghose_2012:438|R23_gupta_2019:442|R29_subramanian_2003:29			BBB-	C	training
InChI=1S/C16H17N3O5S/c1-7-6-25-15-11(14(22)19(15)12(7)16(23)24)18-13(21)10(17)8-2-4-9(20)5-3-8/h2-5,10-11,15,20H,6,17H2,1H3,(H,18,21)(H,23,24)/t10-,11-,15-/m1/s1	Cefadroxil	(6R,7R)-7-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid	CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)[C@H](N)c3ccc(O)cc3)[C@H]2SC1	47965.0	R6_adenot_2004:152			BBB-	C	training
InChI=1S/C16H17N3O7S2/c1-25-16(18-10(20)5-9-3-2-4-27-9)13(23)19-11(12(21)22)8(6-26-15(17)24)7-28-14(16)19/h2-4,14H,5-7H2,1H3,(H2,17,24)(H,18,20)(H,21,22)/t14-,16+/m1/s1	Cefoxitin	(6R,7S)-3-(carbamoyloxymethyl)-7-methoxy-8-oxo-7-[(2-thiophen-2-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid	CO[C@@]1(NC(=O)Cc2cccs2)C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@@H]21	441199.0	R6_adenot_2004:186|R23_gupta_2019:432			BBB-	C	training
InChI=1S/C16H17N5O4S/c1-16(2)11(15(24)25)21-13(23)10(14(21)26-16)18-12(22)9(19-20-17)8-6-4-3-5-7-8/h3-7,9-11,14H,1-2H3,(H,18,22)(H,24,25)/t9-,10-,11+,14-/m1/s1	Azidocillin	(2S,5R,6R)-6-[[(2R)-2-azido-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid	CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N=[N+]=[N-])c3ccccc3)C(=O)N2[C@H]1C(=O)O	15574941.0	R6_adenot_2004:141|R23_gupta_2019:372			BBB-	C	test
InChI=1S/C16H17N5O7S2/c1-6(22)28-3-7-4-29-14-10(13(24)21(14)11(7)15(25)26)19-12(23)9(20-27-2)8-5-30-16(17)18-8/h5,10,14H,3-4H2,1-2H3,(H2,17,18)(H,19,23)(H,25,26)/b20-9-/t10-,14-/m1/s1	Cefotaxime|Claforan	(6R,7R)-3-(acetyloxymethyl)-7-[[(2E)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid	CO/N=C(/C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(C)=O)CS[C@H]12)c1csc(N)n1	5479527.0	R6_adenot_2004:182|R23_gupta_2019:429			BBB-	C	training
InChI=1S/C16H17N5O8S2/c1-6(22)29-3-7-5-31(27)14-10(13(24)21(14)11(7)15(25)26)19-12(23)9(20-28-2)8-4-30-16(17)18-8/h4,10,14H,3,5H2,1-2H3,(H2,17,18)(H,19,23)(H,25,26)/b20-9-/t10-,14-,31?/m1/s1	Ceftioxide|Ceftioxid	(6R,7R)-3-(acetyloxymethyl)-7-[[(2E)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-5,8-dioxo-5lambda4-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid	CO/N=C(/C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(C)=O)CS(=O)[C@H]12)c1csc(N)n1	5748700.0	R6_adenot_2004:202			BBB-	C	training
InChI=1S/C16H17N9O5S2/c1-6-20-23-24(21-6)3-7-4-31-14-10(13(27)25(14)11(7)15(28)29)19-12(26)9(22-30-2)8-5-32-16(17)18-8/h5,10,14H,3-4H2,1-2H3,(H2,17,18)(H,19,26)(H,28,29)/b22-9+/t10-,14-/m1/s1	Cefteram|Cefteramum	(6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(5-methyltetrazol-2-yl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid	CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(Cn3nnc(C)n3)CS[C@H]12)c1csc(N)n1	6537431.0	R6_adenot_2004:198			BBB-	C	training
InChI=1S/C16H17N9O5S3/c1-24-16(20-22-23-24)33-4-6-3-31-13-9(12(27)25(13)10(6)14(28)29)19-11(26)8(21-30-2)7-5-32-15(17)18-7/h5,9,13H,3-4H2,1-2H3,(H2,17,18)(H,19,26)(H,28,29)/b21-8-/t9-,13-/m1/s1	Cefmenoxime|(6R,7R)-7-[[(2E)-2-(2-Amino-1,3-Thiazol-4-Yl)-2-Methoxyiminoacetyl]Amino]-3-[(1-Methyltetrazol-5-Yl)Sulfanylmethyl]-8-Oxo-5-Thia-1-Azabicyclo[4.2.0]Oct-2-Ene-2-Carboxylic Acid	(6R,7R)-7-[[(2E)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid	CO/N=C(/C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(CSc3nnnn3C)CS[C@H]12)c1csc(N)n1	5361486.0	R6_adenot_2004:175|R23_gupta_2019:424			BBB-	C	training
InChI=1S/C16H17NO3/c18-11-3-1-8-7-10-9-2-4-12(19)15-16(9,5-6-17-10)13(8)14(11)20-15/h1-4,9-10,12,15,17-19H,5-7H2/t9-,10+,12-,15-,16-/m0/s1	Normorphine	(4R,4aR,7S,7aR,12bS)-1,2,3,4,4a,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-7,9-diol	Oc1ccc2c3c1O[C@H]1[C@@H](O)C=C[C@H]4[C@@H](C2)NCC[C@@]341	5462508.0	R6_adenot_2004:1070			BBB+	C	test
InChI=1S/C16H18ClN3O3/c17-13-3-1-11(2-4-13)12-7-15(22)20(8-12)10-16(23)19-6-5-18-14(21)9-19/h1-4,12H,5-10H2,(H,18,21)	Cebaracetam	4-[2-[4-(4-chlorophenyl)-2-oxopyrrolidin-1-yl]acetyl]piperazin-2-one	O=C1CN(C(=O)CN2CC(c3ccc(Cl)cc3)CC2=O)CCN1	65919.0	R6_adenot_2004:1246			BBB+	C	training
InChI=1S/C16H18FN3O2/c1-2-22-16(21)20-15-8-7-13(9-14(15)18)19-10-11-3-5-12(17)6-4-11/h3-9,19H,2,10,18H2,1H3,(H,20,21)	Retigabine|Ezogabine	ethyl N-[2-amino-4-[(4-fluorophenyl)methylamino]phenyl]carbamate	CCOC(=O)Nc1ccc(NCc2ccc(F)cc2)cc1N	121892.0	R6_adenot_2004:434|R23_gupta_2019:89			BBB+	C	training
InChI=1S/C16H18FN3O3/c1-2-19-9-11(16(22)23)15(21)10-7-12(17)14(8-13(10)19)20-5-3-18-4-6-20/h7-9,18H,2-6H2,1H3,(H,22,23)	Norfloxacin	1-ethyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid	CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21	4539.0	R6_adenot_2004:55|R6_adenot_2004:299|R14_ghose_2012:729|R23_gupta_2019:788|R25_brito_sanchez_2015:381|R28_li_2005:385|R42_ciura_2020:28|R46_mendoza_valencia_2017:331|R53_friden_2009:25	-1.15	D	BBB-	A	training
InChI=1S/C16H18N2/c1-17-14-11-12-7-3-5-9-15(12)18(2)16-10-6-4-8-13(14)16/h3-10,14,17H,11H2,1-2H3	Metapramine	N,11-dimethyl-5,6-dihydrobenzo[b][1]benzazepin-5-amine	CNC1Cc2ccccc2N(C)c2ccccc21	65700.0	R6_adenot_2004:381			BBB+	C	training
InChI=1S/C16H18N2/c1-18-10-14(12-6-3-2-4-7-12)13-8-5-9-16(17)15(13)11-18/h2-9,14H,10-11,17H2,1H3	Nomifensine	2-methyl-4-phenyl-3,4-dihydro-1H-isoquinolin-8-amine	CN1Cc2c(N)cccc2C(c2ccccc2)C1	4528.0	R6_adenot_2004:587			BBB+	C	test
InChI=1S/C16H18N2O4S/c1-16(2)12(15(21)22)18-13(20)11(14(18)23-16)17-10(19)8-9-6-4-3-5-7-9/h3-7,11-12,14H,8H2,1-2H3,(H,17,19)(H,21,22)/t11-,12+,14-/m1/s1	Benzylpenicillin|Penicillin G	(2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid	CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O	5904.0	R6_adenot_2004:144|R7_andres_2006:128|R29_subramanian_2003:124|R51_doninger_2002:105			BBB-	C	test
InChI=1S/C16H18N2O4S2/c1-16(2)12(15(21)22)18-13(20)11(14(18)24-16)17-10(19)8-23-9-6-4-3-5-7-9/h3-7,11-12,14H,8H2,1-2H3,(H,17,19)(H,21,22)/t11-,12+,14-/m1/s1	Tifencillin	(2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(2-phenylsulfanylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid	CC1(C)S[C@@H]2[C@H](NC(=O)CSc3ccccc3)C(=O)N2[C@H]1C(=O)O	10248346.0	R6_adenot_2004:278			BBB-	C	training
InChI=1S/C16H18N2O5S/c1-16(2)12(15(21)22)18-13(20)11(14(18)24-16)17-10(19)8-23-9-6-4-3-5-7-9/h3-7,11-12,14H,8H2,1-2H3,(H,17,19)(H,21,22)/t11-,12+,14-/m1/s1	Penicillin V|Phenoxymethylpenicillin	(2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(2-phenoxyacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid	CC1(C)S[C@@H]2[C@H](NC(=O)COc3ccccc3)C(=O)N2[C@H]1C(=O)O	6869.0	R14_ghose_2012:758|R28_li_2005:220			BBB-	C	test
InChI=1S/C16H18N2O7S2/c1-15(2)9(12(22)23)18-13(24)16(25-3,14(18)27-15)17-10(19)8(11(20)21)7-4-5-26-6-7/h4-6,8-9,14H,1-3H3,(H,17,19)(H,20,21)(H,22,23)/t8?,9-,14+,16-/m0/s1	Temocillin	(2S,5R,6S)-6-[(2-carboxy-2-thiophen-3-ylacetyl)amino]-6-methoxy-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid	CO[C@@]1(NC(=O)C(C(=O)O)c2ccsc2)C(=O)N2[C@@H](C(=O)O)C(C)(C)S[C@@H]21	171758.0	R6_adenot_2004:276			BBB-	C	training
InChI=1S/C16H18N2O7S2/c1-16(2)11(15(21)22)18-13(20)9(14(18)26-16)17-12(19)10(27(23,24)25)8-6-4-3-5-7-8/h3-7,9-11,14H,1-2H3,(H,17,19)(H,21,22)(H,23,24,25)	Sulbenicillin|Cid 5317	3,3-dimethyl-7-oxo-6-[(2-phenyl-2-sulfoacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid	CC1(C)SC2C(NC(=O)C(c3ccccc3)S(=O)(=O)O)C(=O)N2C1C(=O)O	5317.0	R6_adenot_2004:271			BBB-	C	test
InChI=1S/C16H18N2S/c1-17-11-6-12-18-13-7-2-4-9-15(13)19-16-10-5-3-8-14(16)18/h2-5,7-10,17H,6,11-12H2,1H3	Desmonomethylpromazine|2095-20-7|Methyl[3-(10H-Phenothiazin-10-Yl)Propyl]Amine	N-methyl-3-phenothiazin-10-ylpropan-1-amine	CNCCCN1c2ccccc2Sc2ccccc21	28315.0	R3_abraham_2006:159|R4_mente_2005:153|R5_guerra_2008:35|R12_garg_2006:70|R21_muehlbacher_2011:233|R25_brito_sanchez_2015:207|R26_chico_2009:152|R28_li_2005:189|R39_shayanfar_2011:105|R40_vilar_2010:95|R41_toropov_2017:148|R46_mendoza_valencia_2017:191|R47_radchenko_2020:134	0.59	B	BBB+	A	training
InChI=1S/C16H18N4O2/c1-4-17-16(18-5-1)20-8-6-19(7-9-20)11-13-2-3-14-15(10-13)22-12-21-14/h1-5,10H,6-9,11-12H2	Piribedil	2-[4-(1,3-benzodioxol-5-ylmethyl)piperazin-1-yl]pyrimidine	c1cnc(N2CCN(Cc3ccc4c(c3)OCO4)CC2)nc1	4850.0	R6_adenot_2004:994			BBB+	C	training
InChI=1S/C16H18N4O2/c21-15(18-12-13-4-2-1-3-5-13)8-11-19-20-16(22)14-6-9-17-10-7-14/h1-7,9-10,19H,8,11-12H2,(H,18,21)(H,20,22)	Nialamide	N-benzyl-3-[2-(pyridine-4-carbonyl)hydrazinyl]propanamide	O=C(CCNNC(=O)c1ccncc1)NCc1ccccc1	4472.0	R6_adenot_2004:976			BBB+	C	training
InChI=1S/C16H19BrN2/c1-19(2)12-10-15(16-5-3-4-11-18-16)13-6-8-14(17)9-7-13/h3-9,11,15H,10,12H2,1-2H3	Brompheniramine	3-(4-bromophenyl)-N,N-dimethyl-3-pyridin-2-ylpropan-1-amine	CN(C)CCC(c1ccc(Br)cc1)c1ccccn1	6834.0	R14_ghose_2012:24|R23_gupta_2019:29			BBB+	C	training
InChI=1S/C16H19ClN2/c1-19(2)12-10-15(16-5-3-4-11-18-16)13-6-8-14(17)9-7-13/h3-9,11,15H,10,12H2,1-2H3	Chlorpheniramine	3-(4-chlorophenyl)-N,N-dimethyl-3-pyridin-2-ylpropan-1-amine	CN(C)CCC(c1ccc(Cl)cc1)c1ccccn1	2725.0	R14_ghose_2012:43|R23_gupta_2019:43|R34_broccatelli_2012:16|R47_radchenko_2020:473	1.53	A	BBB+	A	training
InChI=1S/C16H19ClN2/c1-2-7-19-8-5-12(6-9-19)15-11-18-16-4-3-13(17)10-14(15)16/h3-5,10-11,18H,2,6-9H2,1H3	Tepirindole	5-chloro-3-(1-propyl-3,6-dihydro-2H-pyridin-4-yl)-1H-indole	CCCN1CC=C(c2c[nH]c3ccc(Cl)cc23)CC1	68915.0	R6_adenot_2004:1213			BBB+	C	training
InChI=1S/C16H19FN2S/c1-19(2)14-5-3-4-6-16(14)20-15-8-7-12(9-10-17)11-13(15)18/h3-8,11H,9-10,18H2,1-2H3			CN(C)c1ccccc1Sc1ccc(CCF)cc1N		R41_toropov_2017:112|R46_mendoza_valencia_2017:108	0.55	B	BBB+	A	training
InChI=1S/C16H19IN2O/c17-8-1-9-19-10-6-15(7-11-19)13-20-16-4-2-14(12-18)3-5-16/h1-5,8,15H,6-7,9-11,13H2	I-4	4-[[1-(3-iodoprop-2-enyl)piperidin-4-yl]methoxy]benzonitrile	N#Cc1ccc(OCC2CCN(CC=CI)CC2)cc1	78391575.0	R3_abraham_2006:182	1.13	A	BBB+	A	training
InChI=1S/C16H19IN2O/c17-8-1-9-19-10-6-15(7-11-19)13-20-16-4-2-14(12-18)3-5-16/h1-5,8,15H,6-7,9-11,13H2/b8-1+	Chebi: 167165|I-4|4-[1-((E)-3-Iodo-Allyl)-Piperidin-4-Ylmethoxy]-Benzonitrile	4-[[1-[(E)-3-iodoprop-2-enyl]piperidin-4-yl]methoxy]benzonitrile	N#Cc1ccc(OCC2CCN(C/C=C/I)CC2)cc1	9864749.0	R21_muehlbacher_2011:329|R25_brito_sanchez_2015:253|R40_vilar_2010:126|R41_toropov_2017:168|R46_mendoza_valencia_2017:228|R47_radchenko_2020:154	1.13	B	BBB+	A	training
InChI=1S/C16H19N3/c1-17-9-10-19-14-6-3-2-5-13(14)11-18-8-4-7-15(18)16(19)12-17/h2-8,16H,9-12H2,1H3	Aptazapine	17-methyl-6,14,17-triazatetracyclo[12.4.0.02,6.08,13]octadeca-2,4,8,10,12-pentaene	CN1CCN2c3ccccc3Cn3cccc3C2C1	51355.0	R6_adenot_2004:1544			BBB+	C	training
InChI=1S/C16H19N3O/c1-19(2)11-12-7-9-13(10-8-12)16(20)18-15-6-4-3-5-14(15)17/h3-10H,11,17H2,1-2H3,(H,18,20)	23|N-(2-Aminophenyl)-4-[(Dimethylamino)Methyl]Benzamide	N-(2-aminophenyl)-4-[(dimethylamino)methyl]benzamide	CN(C)Cc1ccc(C(=O)Nc2ccccc2N)cc1	53245487.0	R47_radchenko_2020:525	0.6	A	BBB+	A	training
InChI=1S/C16H19N3O3/c20-13-16(11-6-2-1-3-7-11,14(21)19-15(22)18-13)10-12-8-4-5-9-17-12/h1-3,6-7,12,17H,4-5,8-10H2,(H2,18,19,20,21,22)	Prazitone	5-phenyl-5-(piperidin-2-ylmethyl)-1,3-diazinane-2,4,6-trione	O=C1NC(=O)C(CC2CCCCN2)(c2ccccc2)C(=O)N1	3050417.0	R6_adenot_2004:601			BBB+	C	training
InChI=1S/C16H19N3O4S/c1-16(2)11(15(22)23)19-13(21)10(14(19)24-16)18-12(20)9(17)8-6-4-3-5-7-8/h3-7,9-11,14H,17H2,1-2H3,(H,18,20)(H,22,23)/t9-,10-,11+,14-/m1/s1	Ampicillin|Ampicilline	(2S,5R,6R)-6-[[(2R)-2-amino-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid	CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccccc3)C(=O)N2[C@H]1C(=O)O	6249.0	R6_adenot_2004:138|R7_andres_2006:10|R14_ghose_2012:351|R29_subramanian_2003:10|R51_doninger_2002:9			BBB-	C	test
InChI=1S/C16H19N3O4S/c1-8-7-24-15-11(14(21)19(15)12(8)16(22)23)18-13(20)10(17)9-5-3-2-4-6-9/h2-3,6,10-11,15H,4-5,7,17H2,1H3,(H,18,20)(H,22,23)/t10-,11-,15-/m1/s1	Cefradine|Cephradine	(6R,7R)-7-[[(2R)-2-amino-2-cyclohexa-1,4-dien-1-ylacetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid	CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)[C@H](N)C3=CCC=CC3)[C@H]2SC1	38103.0	R6_adenot_2004:192|R14_ghose_2012:440|R23_gupta_2019:435|R28_li_2005:244			BBB-	C	training
InChI=1S/C16H19N3O5S/c1-16(2)11(15(23)24)19-13(22)10(14(19)25-16)18-12(21)9(17)7-3-5-8(20)6-4-7/h3-6,9-11,14,20H,17H2,1-2H3,(H,18,21)(H,23,24)/t9-,10-,11+,14-/m1/s1	Amoxicillin	(2S,5R,6R)-6-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid	CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccc(O)cc3)C(=O)N2[C@H]1C(=O)O	33613.0	R6_adenot_2004:137|R14_ghose_2012:349|R50_sobanska_2019:56|R51_doninger_2002:8			BBB-	C	test
InChI=1S/C16H19N3O7S2/c1-16(2)11(15(22)23)19-13(21)10(14(19)27-16)17-12(20)9(18-28(24,25)26)8-6-4-3-5-7-8/h3-7,9-11,14,18H,1-2H3,(H,17,20)(H,22,23)(H,24,25,26)/t9-,10-,11+,14-/m1/s1	Suncillin	(2S,5R,6R)-3,3-dimethyl-7-oxo-6-[[(2R)-2-phenyl-2-(sulfoamino)acetyl]amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid	CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](NS(=O)(=O)O)c3ccccc3)C(=O)N2[C@H]1C(=O)O	3034014.0	R6_adenot_2004:273			BBB-	C	test
InChI=1S/C16H19N3S/c1-18(2)11-6-12-19-13-7-3-4-8-14(13)20-15-9-5-10-17-16(15)19/h3-5,7-10H,6,11-12H2,1-2H3	Prothipendyl	N,N-dimethyl-3-pyrido[3,2-b][1,4]benzothiazin-10-ylpropan-1-amine	CN(C)CCCN1c2ccccc2Sc2cccnc21	14670.0	R6_adenot_2004:1616			BBB+	C	test
InChI=1S/C16H19N5O/c1-19-7-9-21(10-8-19)15-11-13-16(18-17-15)22-14-6-4-3-5-12(14)20(13)2/h3-6,11H,7-10H2,1-2H3	Pipofezine	5-methyl-3-(4-methylpiperazin-1-yl)pyridazino[3,4-b][1,4]benzoxazine	CN1CCN(c2cc3c(nn2)Oc2ccccc2N3C)CC1	159977.0	R6_adenot_2004:598			BBB+	C	training
InChI=1S/C16H19NO/c1-2-4-15-11-13(5-6-14(15)3-1)12-18-16-7-9-17-10-8-16/h1-6,11,16-17H,7-10,12H2	Litoxetine	4-(naphthalen-2-ylmethoxy)piperidine	c1ccc2cc(COC3CCNCC3)ccc2c1	65650.0	R6_adenot_2004:609			BBB+	C	training
InChI=1S/C16H19NO2/c1-17(2)13-16(18-14-9-5-3-6-10-14)19-15-11-7-4-8-12-15/h3-12,16H,13H2,1-2H3	Medifoxamine	N,N-dimethyl-2,2-diphenoxyethanamine	CN(C)CC(Oc1ccccc1)Oc1ccccc1	36109.0	R6_adenot_2004:379			BBB+	C	training
InChI=1S/C16H19NO2S/c1-2-6-16(19-12-14-11-17-7-8-18-14)13(4-1)10-15-5-3-9-20-15/h1-6,9,14,17H,7-8,10-12H2	Teniloxazine	2-[[2-(thiophen-2-ylmethyl)phenoxy]methyl]morpholine	c1csc(Cc2ccccc2OCC2CNCCO2)c1	119114.0	R6_adenot_2004:1274			BBB+	C	training
InChI=1S/C16H19NO3/c1-17-7-9-3-4-12(19-2)16-15(9)14-10(8-17)5-11(18)6-13(14)20-16/h3-5,11,13-14,18H,6-8H2,1-2H3	12-Methoxy-7-Methyl-16-Oxa-7-Azatetracyclo[11.2.1.05,15.09,14]Hexadeca-4,9(14),10,12-Tetraen-3-Ol	12-methoxy-7-methyl-16-oxa-7-azatetracyclo[11.2.1.05,15.09,14]hexadeca-4,9(14),10,12-tetraen-3-ol	COc1ccc2c3c1OC1CC(O)C=C(CN(C)C2)C31	59664531.0	R46_mendoza_valencia_2017:219	0.2	A	BBB+	A	training
InChI=1S/C16H19NO3/c1-19-12-3-2-10-9-17-7-6-16-5-4-11(18)8-13(16)20-15(12)14(10)16/h2-5,11,13,17-18H,6-9H2,1H3/t11-,13-,16-/m0/s1	Norgalanthamine	(1S,12S,14R)-9-methoxy-11-oxa-4-azatetracyclo[8.6.1.01,12.06,17]heptadeca-6(17),7,9,15-tetraen-14-ol	COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CCNC2	9838394.0	R47_radchenko_2020:464	0.18	A	BBB+	A	training
InChI=1S/C16H19NO4/c1-17-11-7-8-12(17)14(15(18)19)13(9-11)21-16(20)10-5-3-2-4-6-10/h2-6,11-14H,7-9H2,1H3,(H,18,19)/t11-,12+,13-,14+/m0/s1	Benzoylecgonine	(1R,2R,3S,5S)-3-benzoyloxy-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid	CN1[C@H]2CC[C@@H]1[C@@H](C(=O)O)[C@@H](OC(=O)c1ccccc1)C2	448223.0	R26_chico_2009:77	-1.35	A	BBB-	A	training
InChI=1S/C16H19NO4/c1-19-14-10-12(11-15(20-2)16(14)21-3)13(18)6-9-17-7-4-5-8-17/h4-6,9-11H,7-8H2,1-3H3	Roletamide	3-(2,5-dihydropyrrol-1-yl)-1-(3,4,5-trimethoxyphenyl)prop-2-en-1-one	COc1cc(C(=O)C=CN2CC=CC2)cc(OC)c1OC	24909.0	R6_adenot_2004:1380			BBB+	C	training
InChI=1S/C16H20ClN3S/c1-10(2)4-5-19-9-12-6-13(17)7-14-15(12)20(8-11(19)3)16(21)18-14/h4,6-7,11H,5,8-9H2,1-3H3,(H,18,21)	9-Chloro-5-Methyl-6-(3-Methylbut-2-En-1-Yl)-4,5,6,7-Tetrahydroimidazo(4,5,1-Jk)(1,4)Benzodiazepine-2(1H)-Thione	6-chloro-11-methyl-10-(3-methylbut-2-enyl)-1,3,10-triazatricyclo[6.4.1.04,13]trideca-4,6,8(13)-triene-2-thione	CC(C)=CCN1Cc2cc(Cl)cc3[nH]c(=S)n(c23)CC1C	3010454.0	R46_mendoza_valencia_2017:273	0.28	A	BBB+	A	test
InChI=1S/C16H20ClN3S/c1-10(2)4-5-19-9-12-6-13(17)7-14-15(12)20(8-11(19)3)16(21)18-14/h4,6-7,11H,5,8-9H2,1-3H3,(H,18,21)/t11-/m0/s1	R82913|4-Chloro-8-Methyl-7-(3-Methyl-But-2-Enyl)-6,7,8,9-Tetrahydro-2H-2,7,9A-Triaza-Benzo[Cd]Azulene-1-Thione	(11S)-6-chloro-11-methyl-10-(3-methylbut-2-enyl)-1,3,10-triazatricyclo[6.4.1.04,13]trideca-4,6,8(13)-triene-2-thione	CC(C)=CCN1Cc2cc(Cl)cc3[nH]c(=S)n(c23)C[C@@H]1C	3000237.0	R25_brito_sanchez_2015:309|R47_radchenko_2020:440	0.28	B	BBB+	A	test
InChI=1S/C16H20N2/c1-18(2)13-11-15(14-8-4-3-5-9-14)16-10-6-7-12-17-16/h3-10,12,15H,11,13H2,1-2H3	Pheniramine	N,N-dimethyl-3-phenyl-3-pyridin-2-ylpropan-1-amine	CN(C)CCC(c1ccccc1)c1ccccn1	4761.0	R7_andres_2006:133|R26_chico_2009:309|R29_subramanian_2003:128|R51_doninger_2002:108			BBB-	C	training
InChI=1S/C16H20N2O2/c19-15(12-18-9-5-2-6-10-18)14-11-16(20-17-14)13-7-3-1-4-8-13/h1,3-4,7-8,11,15,19H,2,5-6,9-10,12H2	Perisoxal	1-(5-phenyl-1,2-oxazol-3-yl)-2-piperidin-1-ylethanol	OC(CN1CCCCC1)c1cc(-c2ccccc2)on1	71109.0	R6_adenot_2004:1374			BBB+	C	training
InChI=1S/C16H20N2O3/c1-16(13-5-3-2-4-6-13)11-14(19)18(15(16)20)12-17-7-9-21-10-8-17/h2-6H,7-12H2,1H3	Morsuximide	3-methyl-1-(morpholin-4-ylmethyl)-3-phenylpyrrolidine-2,5-dione	CC1(c2ccccc2)CC(=O)N(CN2CCOCC2)C1=O	71165.0	R6_adenot_2004:452			BBB+	C	training
InChI=1S/C16H20N2O4S2/c1-9-15(21)13(5-19)11(3-17-9)7-23-24-8-12-4-18-10(2)16(22)14(12)6-20/h3-4,19-22H,5-8H2,1-2H3	Pyritinol	5-[[[5-hydroxy-4-(hydroxymethyl)-6-methylpyridin-3-yl]methyldisulfanyl]methyl]-4-(hydroxymethyl)-2-methylpyridin-3-ol	Cc1ncc(CSSCc2cnc(C)c(O)c2CO)c(CO)c1O	14190.0	R6_adenot_2004:1310			BBB+	C	test
InChI=1S/C16H20N2O5/c1-4-16(12-8-6-5-7-9-12)13(19)17(10-22-2)15(21)18(11-23-3)14(16)20/h5-9H,4,10-11H2,1-3H3	Eterobarb	5-ethyl-1,3-bis(methoxymethyl)-5-phenyl-1,3-diazinane-2,4,6-trione	CCC1(c2ccccc2)C(=O)N(COC)C(=O)N(COC)C1=O	33925.0	R6_adenot_2004:1647			BBB+	C	training
InChI=1S/C16H20N4O3S/c1-11(2)18-16(21)20-24(22,23)15-10-17-8-7-14(15)19-13-6-4-5-12(3)9-13/h4-11H,1-3H3,(H,17,19)(H2,18,20,21)	Torsemide|Torasemide	1-[4-(3-methylanilino)pyridin-3-yl]sulfonyl-3-propan-2-ylurea	Cc1cccc(Nc2ccncc2S(=O)(=O)NC(=O)NC(C)C)c1	41781.0	R14_ghose_2012:906|R23_gupta_2019:990			BBB-	C	training
InChI=1S/C16H21ClN4/c1-13-11-15(19-18-13)5-6-20-7-9-21(10-8-20)16-4-2-3-14(17)12-16/h2-4,11-12H,5-10H2,1H3,(H,18,19)	Mepiprazole	1-(3-chlorophenyl)-4-[2-(5-methyl-1H-pyrazol-3-yl)ethyl]piperazine	Cc1cc(CCN2CCN(c3cccc(Cl)c3)CC2)n[nH]1	71897.0	R6_adenot_2004:1176			BBB+	C	test
InChI=1S/C16H21ClN4/c1-19-13-14(12-18-19)6-7-20-8-10-21(11-9-20)16-5-3-2-4-15(16)17/h2-5,12-13H,6-11H2,1H3	Enpiprazole	1-(2-chlorophenyl)-4-[2-(1-methylpyrazol-4-yl)ethyl]piperazine	Cn1cc(CCN2CCN(c3ccccc3Cl)CC2)cn1	208921.0	R6_adenot_2004:1460			BBB+	C	training
InChI=1S/C16H21N3/c1-18(2)12-13-19(16-10-6-7-11-17-16)14-15-8-4-3-5-9-15/h3-11H,12-14H2,1-2H3	Tripelennamine	N'-benzyl-N,N-dimethyl-N'-pyridin-2-ylethane-1,2-diamine	CN(C)CCN(Cc1ccccc1)c1ccccn1	5587.0	R14_ghose_2012:264|R23_gupta_2019:258			BBB+	C	training
InChI=1S/C16H21N3/c17-13-14-1-3-15(4-2-14)19-11-7-16(8-12-19)5-9-18-10-6-16/h1-4,18H,5-12H2	Mepenzolatebromide|4-(3,9-Diazaspiro[5.5]Undecan-3-Yl)Benzonitrile	4-(3,9-diazaspiro[5.5]undecan-3-yl)benzonitrile	N#Cc1ccc(N2CCC3(CCNCC3)CC2)cc1	15940810.0	R28_li_2005:268			BBB-	C	training
InChI=1S/C16H21N3O2/c1-19(2)6-5-12-9-17-15-4-3-11(8-14(12)15)7-13-10-21-16(20)18-13/h3-4,8-9,13,17H,5-7,10H2,1-2H3,(H,18,20)	Zolmitriptane|2-Oxazolidinone, 4-[[3-[2-(Dimethylamino)Ethyl]-1H-Indol-5-Yl]Methyl]-	4-[[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]methyl]-1,3-oxazolidin-2-one	CN(C)CCc1c[nH]c2ccc(CC3COC(=O)N3)cc12	5731.0	R50_sobanska_2019:84			BBB+	C	test
InChI=1S/C16H21N3O2/c1-19(2)6-5-12-9-17-15-4-3-11(8-14(12)15)7-13-10-21-16(20)18-13/h3-4,8-9,13,17H,5-7,10H2,1-2H3,(H,18,20)/t13-/m0/s1	Zolmitriptan	(4S)-4-[[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]methyl]-1,3-oxazolidin-2-one	CN(C)CCc1c[nH]c2ccc(C[C@H]3COC(=O)N3)cc12	60857.0	R7_andres_2006:185|R26_chico_2009:446|R29_subramanian_2003:180|R34_broccatelli_2012:143|R47_radchenko_2020:508	-1.02	B	BBB-	A	test
InChI=1S/C16H21N3O4S/c1-16(2)11(15(22)23)19-13(21)10(14(19)24-16)18-12(20)9(17)8-6-4-3-5-7-8/h3-4,7,9-11,14H,5-6,17H2,1-2H3,(H,18,20)(H,22,23)/t9-,10-,11+,14-/m1/s1	Epicillin	(2S,5R,6R)-6-[[(2R)-2-amino-2-cyclohexa-1,4-dien-1-ylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid	CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)C3=CCC=CC3)C(=O)N2[C@H]1C(=O)O	71392.0	R6_adenot_2004:223			BBB-	C	training
InChI=1S/C16H21N3O8S/c1-7(20)27-5-8-6-28-14-11(13(22)19(14)12(8)16(25)26)18-10(21)4-2-3-9(17)15(23)24/h9,11,14H,2-6,17H2,1H3,(H,18,21)(H,23,24)(H,25,26)/t9-,11-,14-/m1/s1	Cephalosporin-C|Cephalosporin C	(6R,7R)-3-(acetyloxymethyl)-7-[[(5R)-5-amino-5-carboxypentanoyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid	CC(=O)OCC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)CCC[C@@H](N)C(=O)O)[C@H]2SC1	65536.0	R6_adenot_2004:210			BBB-	C	training
InChI=1S/C16H21N7O7S3/c1-22-15(19-20-21-22)33-4-7-3-32-14-16(30-2,13(29)23(14)10(7)12(27)28)18-9(24)6-31-5-8(17)11(25)26/h8,14H,3-6,17H2,1-2H3,(H,18,24)(H,25,26)(H,27,28)/t8-,14-,16+/m1/s1	Cefminox	(6R,7S)-7-[[2-[(2S)-2-amino-2-carboxyethyl]sulfanylacetyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid	CO[C@@]1(NC(=O)CSC[C@@H](N)C(=O)O)C(=O)N2C(C(=O)O)=C(CSc3nnnn3C)CS[C@@H]21	71141.0	R6_adenot_2004:177			BBB-	C	training
InChI=1S/C16H21NO/c18-12-5-4-11-9-15-13-3-1-2-6-16(13,7-8-17-15)14(11)10-12/h4-5,10,13,15,17-18H,1-3,6-9H2/t13-,15+,16+/m0/s1	Norlevorphanol	(1R,9R,10R)-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-trien-4-ol	Oc1ccc2c(c1)[C@@]13CCCC[C@H]1[C@@H](C2)NCC3	5463854.0	R6_adenot_2004:1068			BBB+	C	training
InChI=1S/C16H21NO2/c1-12(2)17-10-14(18)11-19-16-9-5-7-13-6-3-4-8-15(13)16/h3-9,12,14,17-18H,10-11H2,1-2H3	Propranolol|525-66-6|1-Propanolol	1-naphthalen-1-yloxy-3-(propan-2-ylamino)propan-2-ol	CC(C)NCC(O)COc1cccc2ccccc12	4946.0	R3_abraham_2006:241|R4_mente_2005:69|R6_adenot_2004:60|R7_andres_2006:145|R12_garg_2006:143|R14_ghose_2012:214|R21_muehlbacher_2011:117|R25_brito_sanchez_2015:367|R26_chico_2009:335|R28_li_2005:109|R29_subramanian_2003:141|R34_broccatelli_2012:73|R39_shayanfar_2011:77|R40_vilar_2010:221|R41_toropov_2017:215|R42_ciura_2020:35|R44_bujak_2015:56|R46_mendoza_valencia_2017:321|R47_radchenko_2020:200|R50_sobanska_2019:43|R51_doninger_2002:119|R53_friden_2009:31	0.64	D	BBB+	A	test
InChI=1S/C16H21NO2/c1-2-15(18)17-9-7-12-4-3-11-5-6-14-13(16(11)12)8-10-19-14/h5-6,12H,2-4,7-10H2,1H3,(H,17,18)/t12-/m0/s1	Ramelteon	N-[2-[(8S)-2,6,7,8-tetrahydro-1H-cyclopenta[e][1]benzofuran-8-yl]ethyl]propanamide	CCC(=O)NCC[C@@H]1CCc2ccc3c(c21)CCO3	208902.0	R23_gupta_2019:214|R26_chico_2009:344|R34_broccatelli_2012:76|R37_chen_2011:79			BBB+	C	training
InChI=1S/C16H21NO3/c1-19-14-7-6-11(12-9-16(18)17-10-12)8-15(14)20-13-4-2-3-5-13/h6-8,12-13H,2-5,9-10H2,1H3,(H,17,18)	Rolipram	4-(3-cyclopentyloxy-4-methoxyphenyl)pyrrolidin-2-one	COc1ccc(C2CNC(=O)C2)cc1OC1CCCC1	5092.0	R3_abraham_2006:248|R6_adenot_2004:1211|R21_muehlbacher_2011:122|R25_brito_sanchez_2015:281|R26_chico_2009:358|R40_vilar_2010:233|R41_toropov_2017:222|R46_mendoza_valencia_2017:252|R47_radchenko_2020:206	0.61	B	BBB+	A	test
InChI=1S/C16H21NO4/c1-10(2)17-8-13(19)9-20-14-6-4-5-12-7-15(11(3)18)21-16(12)14/h4-7,10,13,17,19H,8-9H2,1-3H3	Befunolol	1-[7-[2-hydroxy-3-(propan-2-ylamino)propoxy]-1-benzofuran-2-yl]ethanone	CC(=O)c1cc2cccc(OCC(O)CNC(C)C)c2o1	2309.0	R14_ghose_2012:375			BBB-	C	test
InChI=1S/C16H21NO4S/c1-3-5-7-9-14(18)17-13(16(20)21)11-12-22-15(19)10-8-6-4-2/h3-10,13H,11-12H2,1-2H3,(H,17,18)(H,20,21)/b5-3+,6-4+,9-7-,10-8-/t13-/m0/s1	Compound 5|(2S)-2-[[(2Z,4E)-Hexa-2,4-Dienoyl]Amino]-4-[(2Z,4E)-Hexa-2,4-Dienoyl]Sulfanylbutanoic Acid	(2S)-2-[[(2Z,4E)-hexa-2,4-dienoyl]amino]-4-[(2Z,4E)-hexa-2,4-dienoyl]sulfanylbutanoic acid	C/C=C/C=C\C(=O)N[C@@H](CCSC(=O)/C=C\C=C\C)C(=O)O	169492136.0	R26_chico_2009:120	-1.22	A	BBB-	A	training
InChI=1S/C16H22Cl2N2O/c1-4-16(21)20(11-8-9-12(17)13(18)10-11)15-7-5-6-14(15)19(2)3/h8-10,14-15H,4-7H2,1-3H3/t14-,15-/m1/s1	Eclanamine	N-(3,4-dichlorophenyl)-N-[(1R,2R)-2-(dimethylamino)cyclopentyl]propanamide	CCC(=O)N(c1ccc(Cl)c(Cl)c1)[C@@H]1CCC[C@H]1N(C)C	130380.0	R6_adenot_2004:534			BBB+	C	training
InChI=1S/C16H22ClN3O/c1-16(2)11-18(12-16)6-7-19-8-9-20(15(19)21)14-5-3-4-13(17)10-14/h3-5,10H,6-9,11-12H2,1-2H3	Zetidoline	1-(3-chlorophenyl)-3-[2-(3,3-dimethylazetidin-1-yl)ethyl]imidazolidin-2-one	CC1(C)CN(CCN2CCN(c3cccc(Cl)c3)C2=O)C1	72155.0	R6_adenot_2004:1235			BBB+	C	training
InChI=1S/C16H22FNO/c1-13-8-11-18(12-9-13)10-2-3-16(19)14-4-6-15(17)7-5-14/h4-7,13H,2-3,8-12H2,1H3	Melperone	1-(4-fluorophenyl)-4-(4-methylpiperidin-1-yl)butan-1-one	CC1CCN(CCCC(=O)c2ccc(F)cc2)CC1	15387.0	R6_adenot_2004:1175|R14_ghose_2012:285|R23_gupta_2019:135|R26_chico_2009:255	0.83	A	BBB+	A	training
InChI=1S/C16H22N2O3/c1-4-12(17-9(2)3)16(21)11-5-7-13(19)15-10(11)6-8-14(20)18-15/h5-9,12,16-17,19,21H,4H2,1-3H3,(H,18,20)	Procaterol	8-hydroxy-5-[1-hydroxy-2-(propan-2-ylamino)butyl]-1H-quinolin-2-one	CCC(NC(C)C)C(O)c1ccc(O)c2[nH]c(=O)ccc12	4916.0	R23_gupta_2019:860			BBB-	C	training
InChI=1S/C16H22N2O3S/c1-22(20,21)15-4-2-12(3-5-15)7-16(19)18-10-13-6-14(11-18)9-17-8-13/h2-5,13-14,17H,6-11H2,1H3/t13-,14+	Bmsp|1-(3,7-Diazabicyclo[3.3.1]Nonan-3-Yl)-2-(4-(Methylsulfonyl)Phenyl)Ethanone	1-[(1R,5S)-3,7-diazabicyclo[3.3.1]nonan-3-yl]-2-(4-methylsulfonylphenyl)ethanone	CS(=O)(=O)c1ccc(CC(=O)N2C[C@@H]3CNC[C@@H](C3)C2)cc1	72696635.0	R40_vilar_2010:56	-0.55	A	BBB+	A	test
InChI=1S/C16H22N4O3/c1-3-7-19-14-12(15(22)20(8-4-2)16(19)23)17-13(18-14)10-5-6-11(21)9-10/h10H,3-9H2,1-2H3,(H,17,18)/t10-/m0/s1	151581-23-6|Apaxifylline	8-[(1S)-3-oxocyclopentyl]-1,3-dipropyl-7H-purine-2,6-dione	CCCn1c(=O)c2[nH]c([C@H]3CCC(=O)C3)nc2n(CCC)c1=O	60949.0	R4_mente_2005:102|R21_muehlbacher_2011:257|R25_brito_sanchez_2015:128|R40_vilar_2010:39|R46_mendoza_valencia_2017:126|R47_radchenko_2020:362	-1.4	B	BBB-	A	training
InChI=1S/C16H22N4O4S/c1-10(15(25-13(4)23)5-6-24-12(3)22)20(9-21)8-14-7-18-11(2)19-16(14)17/h7,9H,5-6,8H2,1-4H3,(H2,17,18,19)/b15-10-	Acetiamine	[(Z)-3-acetylsulfanyl-4-[(4-amino-2-methylpyrimidin-5-yl)methyl-formylamino]pent-3-enyl] acetate	CC(=O)OCC/C(SC(C)=O)=C(\C)N(C=O)Cc1cnc(C)nc1N	3033984.0	R6_adenot_2004:393			BBB+	C	training
InChI=1S/C16H23BrN2O3/c1-4-19-9-5-6-11(19)10-18-16(20)14-13(21-2)8-7-12(17)15(14)22-3/h7-8,11H,4-6,9-10H2,1-3H3,(H,18,20)/t11-/m0/s1	Remoxipride	3-bromo-N-[[(2S)-1-ethylpyrrolidin-2-yl]methyl]-2,6-dimethoxybenzamide	CCN1CCC[C@H]1CNC(=O)c1c(OC)ccc(Br)c1OC	54477.0	R6_adenot_2004:1208|R14_ghose_2012:222|R23_gupta_2019:218			BBB+	C	training
InChI=1S/C16H23N5O/c1-3-4-5-8-18-16(17)21-20-11-12-10-19-15-7-6-13(22-2)9-14(12)15/h6-7,9-11,19H,3-5,8H2,1-2H3,(H3,17,18,21)/b20-11+	Tegaserod|Sdz Htf 919	1-[(Z)-(5-methoxy-1H-indol-3-yl)methylideneamino]-2-pentylguanidine	CCCCC/N=C(\N)N/N=C\c1c[nH]c2ccc(OC)cc12	135409452.0	R23_gupta_2019:957			BBB-	C	training
InChI=1S/C16H23NO/c1-16-8-4-2-3-5-12(15(16)17)9-11-6-7-13(18)10-14(11)16/h6-7,10,12,15,18H,2-5,8-9,17H2,1H3/t12-,15-,16+/m0/s1	Dezocine	(1R,9S,15S)-15-amino-1-methyltricyclo[7.5.1.02,7]pentadeca-2(7),3,5-trien-4-ol	C[C@@]12CCCCC[C@@H](Cc3ccc(O)cc31)[C@@H]2N	3033053.0	R6_adenot_2004:1028			BBB+	C	test
InChI=1S/C16H23NO/c1-3-14-6-8-15(9-7-14)16(18)13(2)12-17-10-4-5-11-17/h6-9,13H,3-5,10-12H2,1-2H3	Inaperisone	1-(4-ethylphenyl)-2-methyl-3-pyrrolidin-1-ylpropan-1-one	CCc1ccc(C(=O)C(C)CN2CCCC2)cc1	65860.0	R47_radchenko_2020:488	1.08	A	BBB+	A	training
InChI=1S/C16H23NO/c1-3-16(18)7-9-17-8-6-13-5-4-12(2)10-14(13)15(17)11-16/h4-5,10,15,18H,3,6-9,11H2,1-2H3	Tolquinzole	2-ethyl-10-methyl-1,3,4,6,7,11b-hexahydrobenzo[a]quinolizin-2-ol	CCC1(O)CCN2CCc3ccc(C)cc3C2C1	3083943.0	R6_adenot_2004:625			BBB+	C	training
InChI=1S/C16H23NO/c1-3-6-15(17-11-4-5-12-17)16(18)14-9-7-13(2)8-10-14/h7-10,15H,3-6,11-12H2,1-2H3	Pyrovalerone	1-(4-methylphenyl)-2-pyrrolidin-1-ylpentan-1-one	CCCC(C(=O)c1ccc(C)cc1)N1CCCC1	14373.0	R6_adenot_2004:402			BBB+	C	training
InChI=1S/C16H23NO2/c1-2-16(13-8-4-3-5-9-13)18-12-15(19-16)14-10-6-7-11-17-14/h3-5,8-9,14-15,17H,2,6-7,10-12H2,1H3/t14-,15+,16-/m0/s1	Etoxadrol	(2S)-2-[(2S,4S)-2-ethyl-2-phenyl-1,3-dioxolan-4-yl]piperidine	CC[C@]1(c2ccccc2)OC[C@H]([C@@H]2CCCCN2)O1	14208380.0	R6_adenot_2004:934			BBB+	C	test
InChI=1S/C16H23NO2/c1-4-15(18)19-16(14-8-6-5-7-9-14)10-11-17(3)12-13(16)2/h5-9,13H,4,10-12H2,1-3H3/t13-,16+/m0/s1	Alphaprodine|Nisintil	[(3S,4R)-1,3-dimethyl-4-phenylpiperidin-4-yl] propanoate	CCC(=O)O[C@]1(c2ccccc2)CCN(C)C[C@@H]1C	120738.0	R6_adenot_2004:1010			BBB+	C	training
InChI=1S/C16H23NO2/c1-4-15(18)19-16(14-8-6-5-7-9-14)10-11-17(3)12-13(16)2/h5-9,13H,4,10-12H2,1-3H3/t13-,16-/m1/s1	Betaprodine	[(3R,4R)-1,3-dimethyl-4-phenylpiperidin-4-yl] propanoate	CCC(=O)O[C@]1(c2ccccc2)CCN(C)C[C@H]1C	5284516.0	R6_adenot_2004:1014			BBB+	C	training
InChI=1S/C16H23NO2/c1-5-11-7-6-8-12-9-14(19-15(11)12)13(18)10-17-16(2,3)4/h6-9,13,17-18H,5,10H2,1-4H3	Bufuralol	2-(tert-butylamino)-1-(7-ethyl-1-benzofuran-2-yl)ethanol	CCc1cccc2cc(C(O)CNC(C)(C)C)oc12	71733.0	R7_andres_2006:20|R29_subramanian_2003:18			BBB-	C	test
InChI=1S/C16H24N2/c1-11-8-13(16(3,4)5)9-12(2)14(11)10-15-17-6-7-18-15/h8-9H,6-7,10H2,1-5H3,(H,17,18)	Xylometazoline	2-[(4-tert-butyl-2,6-dimethylphenyl)methyl]-4,5-dihydro-1H-imidazole	Cc1cc(C(C)(C)C)cc(C)c1CC1=NCCN1	5709.0	R23_gupta_2019:1035			BBB-	C	training
InChI=1S/C16H24N2O/c1-10-8-13(16(3,4)5)15(19)11(2)12(10)9-14-17-6-7-18-14/h8,19H,6-7,9H2,1-5H3,(H,17,18)	Oxymetazoline	6-tert-butyl-3-(4,5-dihydro-1H-imidazol-2-ylmethyl)-2,4-dimethylphenol	Cc1cc(C(C)(C)C)c(O)c(C)c1CC1=NCCN1	4636.0	R23_gupta_2019:806			BBB-	C	training
InChI=1S/C16H24N2O/c1-3-8-18(9-4-2)10-7-13-5-6-15-14(11-13)12-16(19)17-15/h5-6,11H,3-4,7-10,12H2,1-2H3,(H,17,19)	5-[2-(Dipropylamino)Ethyl]-1,3-Dihydroindol-2-One	5-[2-(dipropylamino)ethyl]-1,3-dihydroindol-2-one	CCCN(CCC)CCc1ccc2c(c1)CC(=O)N2	44383796.0	R48_hou_2003:27	0.25	A	BBB+	A	training
InChI=1S/C16H24N2O/c1-3-9-18(10-4-2)11-8-13-6-5-7-15-14(13)12-16(19)17-15/h5-7H,3-4,8-12H2,1-2H3,(H,17,19)	Ropinirole|91374-21-9|Skf-101468|Skf101468|Skf-101468, Ropinirole|Ropinirole Hydrochloride|Skf 101468	4-[2-(dipropylamino)ethyl]-1,3-dihydroindol-2-one	CCCN(CCC)CCc1cccc2c1CC(=O)N2	5095.0	R3_abraham_2006:249|R4_mente_2005:76|R6_adenot_2004:650|R7_andres_2006:214|R12_garg_2006:152|R14_ghose_2012:226|R21_muehlbacher_2011:123|R23_gupta_2019:221|R25_brito_sanchez_2015:85|R26_chico_2009:381|R28_li_2005:112|R34_broccatelli_2012:81|R37_chen_2011:87|R39_shayanfar_2011:84|R40_vilar_2010:234|R41_toropov_2017:223|R42_ciura_2020:39|R46_mendoza_valencia_2017:83|R47_radchenko_2020:329|R48_hou_2003:58|R49_norinder_2002:84|R52_liu_2001:64	0.25	D	BBB+	A	training
InChI=1S/C16H24N2O2/c1-3-13-11(2)17-14-5-4-12(16(19)15(13)14)10-18-6-8-20-9-7-18/h12,17H,3-10H2,1-2H3	Molindone	3-ethyl-2-methyl-5-(morpholin-4-ylmethyl)-1,5,6,7-tetrahydroindol-4-one	CCc1c(C)[nH]c2c1C(=O)C(CN1CCOCC1)CC2	23897.0	R6_adenot_2004:1490|R14_ghose_2012:157|R23_gupta_2019:156|R26_chico_2009:277			BBB+	C	test
InChI=1S/C16H24N2O2/c1-3-6-18(7-4-2)8-5-12-9-13-11-15(20)17-16(13)14(19)10-12/h9-10,19H,3-8,11H2,1-2H3,(H,17,20)			CCCN(CCC)CCc1cc(O)c2c(c1)CC(=O)N2		R48_hou_2003:26	-0.43	A	BBB+	A	training
InChI=1S/C16H24N2O2/c1-3-8-18(9-4-2)10-7-12-5-6-14(19)16-13(12)11-15(20)17-16/h5-6,19H,3-4,7-11H2,1-2H3,(H,17,20)	Skf 89124|104535-64-0|Skf89124|7-Hydroxy Ropinirole|Skf-89124|4-(2-Di-N-Propylaminoethyl)-7-Hydroxy-2-(3H)Indolone	4-[2-(dipropylamino)ethyl]-7-hydroxy-1,3-dihydroindol-2-one	CCCN(CCC)CCc1ccc(O)c2c1CC(=O)N2	133741.0	R3_abraham_2006:274|R4_mente_2005:167|R7_andres_2006:215|R12_garg_2006:153|R21_muehlbacher_2011:296|R25_brito_sanchez_2015:86|R26_chico_2009:382|R28_li_2005:113|R39_shayanfar_2011:85|R40_vilar_2010:256|R41_toropov_2017:246|R46_mendoza_valencia_2017:84|R47_radchenko_2020:229|R48_hou_2003:72|R49_norinder_2002:83|R52_liu_2001:63	-0.43	D	BBB+	A	training
InChI=1S/C16H24N2O3/c1-16(2,3)17-9-11(19)10-21-14-6-4-5-13-12(14)7-8-15(20)18-13/h4-6,11,17,19H,7-10H2,1-3H3,(H,18,20)	Carteolol|Carteolol Hydrochloride	5-[3-(tert-butylamino)-2-hydroxypropoxy]-3,4-dihydro-1H-quinolin-2-one	CC(C)(C)NCC(O)COc1cccc2c1CCC(=O)N2	2583.0	R3_abraham_2006:144|R14_ghose_2012:425|R21_muehlbacher_2011:51|R25_brito_sanchez_2015:182|R26_chico_2009:97|R40_vilar_2010:72|R41_toropov_2017:136|R46_mendoza_valencia_2017:170|R47_radchenko_2020:122	-0.4	D	BBB+	A	training
InChI=1S/C16H24N2O5/c1-6-18(7-2)14(19)10-17-16(20)11-8-12(21-3)15(23-5)13(9-11)22-4/h8-9H,6-7,10H2,1-5H3,(H,17,20)	Tricetamide	N-[2-(diethylamino)-2-oxoethyl]-3,4,5-trimethoxybenzamide	CCN(CC)C(=O)CNC(=O)c1cc(OC)c(OC)c(OC)c1	67763.0	R6_adenot_2004:1388			BBB+	C	test
InChI=1S/C16H24N2O6/c1-11-16(22)13(9-19)12(8-17-11)10-24-15(21)5-4-14(20)23-7-6-18(2)3/h8,19,22H,4-7,9-10H2,1-3H3	Pirisudanol	1-O-[2-(dimethylamino)ethyl] 4-O-[[5-hydroxy-4-(hydroxymethyl)-6-methylpyridin-3-yl]methyl] butanedioate	Cc1ncc(COC(=O)CCC(=O)OCCN(C)C)c(CO)c1O	65782.0	R6_adenot_2004:1306			BBB+	C	training
InChI=1S/C16H24N4O2/c1-5-8-9-17-14-12-10-18-20(6-2)15(12)19-11(4)13(14)16(21)22-7-3/h10H,5-9H2,1-4H3,(H,17,19)	Tracazolate	ethyl 4-(butylamino)-1-ethyl-6-methylpyrazolo[3,4-b]pyridine-5-carboxylate	CCCCNc1c(C(=O)OCC)c(C)nc2c1cnn2CC	5522.0	R6_adenot_2004:1520			BBB+	C	training
InChI=1S/C16H24N4O3/c1-4-6-8-19-14-13(18(11-17-14)10-12(3)21)15(22)20(16(19)23)9-7-5-2/h11H,4-10H2,1-3H3	Denbufylline	1,3-dibutyl-7-(2-oxopropyl)purine-2,6-dione	CCCCn1c(=O)c2c(ncn2CC(C)=O)n(CCCC)c1=O	2984.0	R6_adenot_2004:1684			BBB+	C	training
InChI=1S/C16H25IN2/c1-2-3-4-5-10-18-11-13-19(14-12-18)16-8-6-15(17)7-9-16/h6-9H,2-5,10-14H2,1H3	1-Hexyl-4-(4-Iodophenyl)Piperazine|Chebi: 287982	1-hexyl-4-(4-iodophenyl)piperazine	CCCCCCN1CCN(c2ccc(I)cc2)CC1	13720676.0	R3_abraham_2006:101|R21_muehlbacher_2011:345|R25_brito_sanchez_2015:55|R40_vilar_2010:5|R41_toropov_2017:96|R46_mendoza_valencia_2017:54|R47_radchenko_2020:83	1.01	B	BBB+	A	test
InChI=1S/C16H25N3O4S/c1-3-8-19-9-4-5-12(19)11-18-16(20)14-10-13(24(17,21)22)6-7-15(14)23-2/h6-7,10,12H,3-5,8-9,11H2,1-2H3,(H,18,20)(H2,17,21,22)	Prosulpride	2-methoxy-N-[(1-propylpyrrolidin-2-yl)methyl]-5-sulfamoylbenzamide	CCCN1CCCC1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC	68880.0	R6_adenot_2004:1206			BBB+	C	training
InChI=1S/C16H25NO/c1-4-8-16(9-10-17(3)12-13(16)2)14-6-5-7-15(18)11-14/h5-7,11,13,18H,4,8-10,12H2,1-3H3/t13-,16-/m0/s1	Picenadol	3-[(3R,4S)-1,3-dimethyl-4-propylpiperidin-4-yl]phenol	CCC[C@]1(c2cccc(O)c2)CCN(C)C[C@@H]1C	53077.0	R6_adenot_2004:1101			BBB+	C	training
InChI=1S/C16H25NO2/c1-17(2)12-14-7-4-5-10-16(14,18)13-8-6-9-15(11-13)19-3/h6,8-9,11,14,18H,4-5,7,10,12H2,1-3H3	Ultram	2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexan-1-ol	COc1cccc(C2(O)CCCCC2CN(C)C)c1	5523.0	R42_ciura_2020:43	0.7	A	BBB+	A	training
InChI=1S/C16H25NO2/c1-17(2)12-14-7-4-5-10-16(14,18)13-8-6-9-15(11-13)19-3/h6,8-9,11,14,18H,4-5,7,10,12H2,1-3H3/t14-,16+/m1/s1	Tramadol	(1R,2R)-2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexan-1-ol	COc1cccc([C@@]2(O)CCCC[C@@H]2CN(C)C)c1	33741.0	R6_adenot_2004:1090|R14_ghose_2012:255|R23_gupta_2019:248|R25_brito_sanchez_2015:389|R26_chico_2009:424|R37_chen_2011:99|R46_mendoza_valencia_2017:334|R53_friden_2009:40	0.72	B	BBB+	A	training
InChI=1S/C16H25NO2/c1-17(2)12-15(13-6-8-14(18)9-7-13)16(19)10-4-3-5-11-16/h6-9,15,18-19H,3-5,10-12H2,1-2H3	Desvenlafaxine	4-[2-(dimethylamino)-1-(1-hydroxycyclohexyl)ethyl]phenol	CN(C)CC(c1ccc(O)cc1)C1(O)CCCCC1	125017.0	R23_gupta_2019:60|R26_chico_2009:153			BBB+	C	training
InChI=1S/C16H25NO3/c1-11(2)14-10-15(20-13(4)18)12(3)9-16(14)19-8-7-17(5)6/h9-11H,7-8H2,1-6H3	Thymoxamine|Moxisylyte	[4-[2-(dimethylamino)ethoxy]-2-methyl-5-propan-2-ylphenyl] acetate	CC(=O)Oc1cc(C(C)C)c(OCCN(C)C)cc1C	4260.0	R14_ghose_2012:891			BBB-	C	training
InChI=1S/C16H25NO4/c1-12(2)17-10-14(18)11-21-15-7-4-13(5-8-15)6-9-16(19)20-3/h4-5,7-8,12,14,17-18H,6,9-11H2,1-3H3	Esmolol	methyl 3-[4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl]propanoate	COC(=O)CCc1ccc(OCC(O)CNC(C)C)cc1	59768.0	R23_gupta_2019:572			BBB-	C	test
InChI=1S/C16H25NO4S/c1-4-20-11-14(18)12-21-15-7-5-13(6-8-15)17-16(19)9-10-22(2)3/h5-8,14,18H,4,9-12H2,1-3H3/p+1	Suplatast|3-Dimethylsulfonio-N-[4-(3-Ethoxy-2-Oxoniopropoxy)Phenyl]Propanimidate	3-dimethylsulfonio-N-[4-(3-ethoxy-2-oxoniopropoxy)phenyl]propanimidate	CCOCC([OH2+])COc1ccc(/N=C(\[O-])CC[S+](C)C)cc1	101611567.0	R23_gupta_2019:945			BBB-	C	training
InChI=1S/C16H25NS/c1-13(2)14-6-8-16(9-7-14)18-12-4-5-15-10-11-17(15)3/h6-9,13,15H,4-5,10-12H2,1-3H3	12		CC(C)c1ccc(SCCCC2CCN2C)cc1		R47_radchenko_2020:467	1.7	A	BBB+	A	training
InChI=1S/C16H25NS/c1-14-8-3-4-10-16(14,15-9-7-13-18-15)17-11-5-2-6-12-17/h7,9,13-14H,2-6,8,10-12H2,1H3/t14-,16+/m0/s1	Gacyclidine	1-[(1R,2S)-2-methyl-1-thiophen-2-ylcyclohexyl]piperidine	C[C@H]1CCCC[C@@]1(c1cccs1)N1CCCCC1	176265.0	R6_adenot_2004:445			BBB+	C	training
InChI=1S/C16H26N2O5S/c1-16(2)8-10(16)13(19)18-12(15(22)23)6-4-3-5-7-24-9-11(17)14(20)21/h6,10-11H,3-5,7-9,17H2,1-2H3,(H,18,19)(H,20,21)(H,22,23)/b12-6-/t10-,11+/m1/s1	Cilastatin	(Z)-7-[(2R)-2-amino-2-carboxyethyl]sulfanyl-2-[[(1S)-2,2-dimethylcyclopropanecarbonyl]amino]hept-2-enoic acid	CC1(C)C[C@@H]1C(=O)N/C(=C\CCCCSC[C@H](N)C(=O)O)C(=O)O	6435415.0	R23_gupta_2019:458			BBB-	C	training
InChI=1S/C16H26O5/c1-9-5-6-12-10(2)13(17-4)18-14-16(12)11(9)7-8-15(3,19-14)20-21-16/h9-14H,5-8H2,1-4H3/t9-,10-,11+,12+,13+,14-,15-,16-/m1/s1	Artemether	(1R,4S,5R,8S,9R,10S,12R,13R)-10-methoxy-1,5,9-trimethyl-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadecane	CO[C@H]1O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]([C@H]1C)[C@@]24OO3	68911.0	R23_gupta_2019:363			BBB-	C	training
InChI=1S/C16H27NO4/c1-10-11-8-12(18)16(9-17-6-4-3-5-7-17)13(11)15(19-2)20-14(10)21-16/h10-15,18H,3-9H2,1-2H3/t10-,11+,12-,13+,14-,15+,16+/m0/s1	Valperinol		CO[C@@H]1O[C@H]2O[C@@]3(CN4CCCCC4)[C@@H]1[C@H](C[C@@H]3O)[C@@H]2C		R6_adenot_2004:1392			BBB+	C	training
InChI=1S/C16H28N2O4/c1-5-12(6-2)22-14-9-11(16(20)21-7-3)8-13(17)15(14)18-10(4)19/h9,12-15H,5-8,17H2,1-4H3,(H,18,19)/t13-,14+,15+/m0/s1	Oseltamivir Phosphate|Oseltamivir	ethyl (3R,4R,5S)-4-acetamido-5-amino-3-pentan-3-yloxycyclohexene-1-carboxylate	CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1	65028.0	R14_ghose_2012:739|R23_gupta_2019:798|R26_chico_2009:294	-1.0	A	BBB+	A	training
InChI=1S/C16H31N3O.CH4NO/c1-10-11(2)13(20-12(10)3)14(4,5)19(15(6,7)17)16(8,9)18;1-2-3/h17-18H2,1-9H3;3H,1H3	22		C[N]O.Cc1oc(C(C)(C)N(C(C)(C)N)C(C)(C)N)c(C)c1C		R28_li_2005:159			BBB+	C	training
InChI=1S/C16H34O/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17/h17H,2-16H2,1H3	Cetyl Alcohol	hexadecan-1-ol	CCCCCCCCCCCCCCCCO	2682.0	R23_gupta_2019:1050			BBB-	C	training
InChI=1S/C16H38N2/c1-17(2,3)15-13-11-9-7-8-10-12-14-16-18(4,5)6/h7-16H2,1-6H3/q+2	Decamethonium	trimethyl-[10-(trimethylazaniumyl)decyl]azanium	C[N+](C)(C)CCCCCCCCCC[N+](C)(C)C	2968.0	R23_gupta_2019:501			BBB-	C	training
InChI=1S/C17H11ClF4N2S/c18-10-5-6-14-12(7-10)16(11-3-1-2-4-13(11)19)23-8-15(25)24(14)9-17(20,21)22/h1-7H,8-9H2	Quazepam	7-chloro-5-(2-fluorophenyl)-1-(2,2,2-trifluoroethyl)-3H-1,4-benzodiazepine-2-thione	Fc1ccccc1C1=NCC(=S)N(CC(F)(F)F)c2ccc(Cl)cc21	4999.0	R6_adenot_2004:744|R14_ghose_2012:216|R26_chico_2009:340|R37_chen_2011:77|R51_doninger_2002:301			BBB+	C	training
InChI=1S/C17H11F6N7O/c18-16(19,20)11-5-10(6-12(7-11)17(21,22)23)15-26-9-30(29-15)4-1-14(31)28-27-13-8-24-2-3-25-13/h1-9H,(H,25,27)(H,28,31)/b4-1-	Selinexor	(Z)-3-[3-[3,5-bis(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]-N'-pyrazin-2-ylprop-2-enehydrazide	O=C(/C=C\n1cnc(-c2cc(C(F)(F)F)cc(C(F)(F)F)c2)n1)NNc1cnccn1	71481097.0	R23_gupta_2019:906			BBB-	C	training
InChI=1S/C17H11N5/c18-9-13-1-5-15(6-2-13)17(22-12-20-11-21-22)16-7-3-14(10-19)4-8-16/h1-8,11-12,17H	Letrozole	4-[(4-cyanophenyl)-(1,2,4-triazol-1-yl)methyl]benzonitrile	N#Cc1ccc(C(c2ccc(C#N)cc2)n2cncn2)cc1	3902.0	R14_ghose_2012:649|R23_gupta_2019:705			BBB-	C	training
InChI=1S/C17H11N5O/c23-16(14-3-1-2-7-19-14)13-11-21-22-15(6-10-20-17(13)22)12-4-8-18-9-5-12/h1-11H	Ocinaplon	pyridin-2-yl-(7-pyridin-4-ylpyrazolo[1,5-a]pyrimidin-3-yl)methanone	O=C(c1ccccn1)c1cnn2c(-c3ccncc3)ccnc12	216456.0	R6_adenot_2004:1435			BBB+	C	training
InChI=1S/C17H12Br2O3/c1-2-13-15(10-5-3-4-6-14(10)22-13)16(20)9-7-11(18)17(21)12(19)8-9/h3-8,21H,2H2,1H3	Benzbromarone	(3,5-dibromo-4-hydroxyphenyl)-(2-ethyl-1-benzofuran-3-yl)methanone	CCc1oc2ccccc2c1C(=O)c1cc(Br)c(O)c(Br)c1	2333.0	R14_ghose_2012:383			BBB-	C	training
InChI=1S/C17H12Cl2F3N5/c1-9-23-15-11(4-6-26(15)13-3-2-10(18)8-12(13)19)16(24-9)27-7-5-14(25-27)17(20,21)22/h2-3,5,7-8H,4,6H2,1H3	Compound-4Fi|7-(2,4-Dichlorophenyl)-2-Methyl-4-[3-(Trifluoromethyl)Pyrazol-1-Yl]-5,6-Dihydropyrrolo[2,3-D]Pyrimidine	7-(2,4-dichlorophenyl)-2-methyl-4-[3-(trifluoromethyl)pyrazol-1-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidine	Cc1nc2c(c(-n3ccc(C(F)(F)F)n3)n1)CCN2c1ccc(Cl)cc1Cl	16721039.0	R26_chico_2009:130	0.36	A	BBB+	A	test
InChI=1S/C17H12Cl2N4/c1-10-21-22-16-9-20-17(12-4-2-3-5-14(12)19)13-8-11(18)6-7-15(13)23(10)16/h2-8H,9H2,1H3	Triazolam|28911-01-5	8-chloro-6-(2-chlorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine	Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1Cl)=NC2	5556.0	R3_abraham_2006:293|R4_mente_2005:63|R6_adenot_2004:753|R7_andres_2006:179|R12_garg_2006:168|R14_ghose_2012:258|R21_muehlbacher_2011:137|R23_gupta_2019:251|R25_brito_sanchez_2015:66|R28_li_2005:120|R29_subramanian_2003:174|R39_shayanfar_2011:96|R40_vilar_2010:277|R44_bujak_2015:63|R46_mendoza_valencia_2017:64|R47_radchenko_2020:290	0.74	D	BBB+	A	training
InChI=1S/C17H12ClF3N2O/c18-12-6-7-14-13(8-12)16(11-4-2-1-3-5-11)22-9-15(24)23(14)10-17(19,20)21/h1-8H,9-10H2	Halazepam	7-chloro-5-phenyl-1-(2,2,2-trifluoroethyl)-3H-1,4-benzodiazepin-2-one	O=C1CN=C(c2ccccc2)c2cc(Cl)ccc2N1CC(F)(F)F	31640.0	R6_adenot_2004:715|R14_ghose_2012:106|R23_gupta_2019:108			BBB+	C	training
InChI=1S/C17H12ClFN2O2/c18-12-3-1-11(2-4-12)15-10-21(20-16(15)9-17(22)23)14-7-5-13(19)6-8-14/h1-8,10H,9H2,(H,22,23)	Pirazolac	2-[4-(4-chlorophenyl)-1-(4-fluorophenyl)pyrazol-3-yl]acetic acid	O=C(O)Cc1nn(-c2ccc(F)cc2)cc1-c1ccc(Cl)cc1	51222.0	R14_ghose_2012:779			BBB-	C	test
InChI=1S/C17H13ClF4N2/c18-11-5-6-15-13(9-11)16(12-3-1-2-4-14(12)19)23-7-8-24(15)10-17(20,21)22/h1-6,9H,7-8,10H2	Fletazepam	7-chloro-5-(2-fluorophenyl)-1-(2,2,2-trifluoroethyl)-2,3-dihydro-1,4-benzodiazepine	Fc1ccccc1C1=NCCN(CC(F)(F)F)c2ccc(Cl)cc21	36834.0	R6_adenot_2004:705			BBB+	C	training
InChI=1S/C17H13ClN4/c1-11-20-21-16-10-19-17(12-5-3-2-4-6-12)14-9-13(18)7-8-15(14)22(11)16/h2-9H,10H2,1H3	Alprazolam|28981-97-7	8-chloro-1-methyl-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine	Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1)=NC2	2118.0	R3_abraham_2006:122|R3_abraham_2006:123|R4_mente_2005:49|R5_guerra_2008:14|R6_adenot_2004:681|R12_garg_2006:18|R14_ghose_2012:4|R17_fu_2008:37|R21_muehlbacher_2011:28|R23_gupta_2019:6|R25_brito_sanchez_2015:119|R26_chico_2009:24|R28_li_2005:5|R31_carpenter_2014:8|R34_broccatelli_2012:1|R37_chen_2011:2|R39_shayanfar_2011:12|R40_vilar_2010:32|R41_toropov_2017:117|R42_ciura_2020:3|R44_bujak_2015:8|R46_mendoza_valencia_2017:117|R47_radchenko_2020:104|R48_hou_2003:11|R49_norinder_2002:91|R49_norinder_2002:124|R50_sobanska_2019:24	0.02	B	BBB+	A	training
InChI=1S/C17H13ClN4/c18-14-3-1-2-12(8-14)17(22-7-6-19-11-22)13-4-5-15-16(9-13)21-10-20-15/h1-11,17H,(H,20,21)	Liarozole	6-[(3-chlorophenyl)-imidazol-1-ylmethyl]-1H-benzimidazole	Clc1cccc(C(c2ccc3nc[nH]c3c2)n2ccnc2)c1	60652.0	R25_brito_sanchez_2015:271|R46_mendoza_valencia_2017:244	-1.0	B	BBB+	A	test
InChI=1S/C17H13ClN4O/c1-10-20-21-16-17(23)19-15(11-5-3-2-4-6-11)13-9-12(18)7-8-14(13)22(10)16/h2-9,17,23H,1H3	4-Hydroxyalprazolam	8-chloro-1-methyl-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-ol	Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1)=NC2O	182017.0	R12_garg_2006:12|R21_muehlbacher_2011:302|R25_brito_sanchez_2015:90|R40_vilar_2010:11|R46_mendoza_valencia_2017:88|R47_radchenko_2020:258	-1.48	B	BBB-	A	training
InChI=1S/C17H13ClN4O/c18-12-6-7-14-13(8-12)17(11-4-2-1-3-5-11)19-9-15-20-21-16(10-23)22(14)15/h1-8,23H,9-10H2	Alpha-Hydroxyalprazolam|Α-Hydroxyalprazolam	(8-chloro-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-1-yl)methanol	OCc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1)=NC2	162244.0	R5_guerra_2008:13|R12_garg_2006:182|R21_muehlbacher_2011:299|R25_brito_sanchez_2015:35|R40_vilar_2010:31|R46_mendoza_valencia_2017:34|R47_radchenko_2020:291	-1.28	B	BBB-	A	training
InChI=1S/C17H13F3N2O2/c1-21-13-8-7-11(17(18,19)20)9-14(13)22(16(24)10-15(21)23)12-5-3-2-4-6-12/h2-9H,10H2,1H3	Triflubazam	1-methyl-5-phenyl-7-(trifluoromethyl)-1,5-benzodiazepine-2,4-dione	CN1C(=O)CC(=O)N(c2ccccc2)c2cc(C(F)(F)F)ccc21	31157.0	R6_adenot_2004:754			BBB+	C	test
InChI=1S/C17H13N3O3/c1-10-18-17(20-23-10)19-16(21)15-11-6-2-4-8-13(11)22-14-9-5-3-7-12(14)15/h2-9,15H,1H3,(H,19,20,21)	49|N-(5-Methyl-1,2,4-Oxadiazol-3-Yl)-9H-Xanthene-9-Carboxamide	N-(5-methyl-1,2,4-oxadiazol-3-yl)-9H-xanthene-9-carboxamide	Cc1nc(NC(=O)C2c3ccccc3Oc3ccccc32)no1	44573698.0	R47_radchenko_2020:453	-0.4	A	BBB+	A	training
InChI=1S/C17H14BrFN2O2/c18-11-5-6-15-13(9-11)17(12-3-1-2-4-14(12)19)21(7-8-23-17)10-16(22)20-15/h1-6,9H,7-8,10H2,(H,20,22)	Haloxazolam	10-bromo-11b-(2-fluorophenyl)-2,3,5,7-tetrahydro-[1,3]oxazolo[3,2-d][1,4]benzodiazepin-6-one	O=C1CN2CCOC2(c2ccccc2F)c2cc(Br)ccc2N1	3563.0	R6_adenot_2004:716			BBB+	C	training
InChI=1S/C17H14Cl2F2N2O3/c18-11-6-22-7-12(19)15(11)23-16(24)10-3-4-13(26-17(20)21)14(5-10)25-8-9-1-2-9/h3-7,9,17H,1-2,8H2,(H,22,23,24)	Roflumilast	3-(cyclopropylmethoxy)-N-(3,5-dichloropyridin-4-yl)-4-(difluoromethoxy)benzamide	O=C(Nc1c(Cl)cncc1Cl)c1ccc(OC(F)F)c(OCC2CC2)c1	449193.0	R23_gupta_2019:892			BBB-	C	training
InChI=1S/C17H14Cl2N2O2/c18-11-5-6-15-13(9-11)17(12-3-1-2-4-14(12)19)21(7-8-23-17)10-16(22)20-15/h1-6,9H,7-8,10H2,(H,20,22)	Cloxazolam	10-chloro-11b-(2-chlorophenyl)-2,3,5,7-tetrahydro-[1,3]oxazolo[3,2-d][1,4]benzodiazepin-6-one	O=C1CN2CCOC2(c2ccccc2Cl)c2cc(Cl)ccc2N1	2816.0	R6_adenot_2004:696			BBB+	C	training
InChI=1S/C17H14Cl2N2O3S/c1-9-15(25-8-21(9)2)3-4-24-17(23)13-7-14(22)16-11(19)5-10(18)6-12(16)20-13/h5-8H,3-4H2,1-2H3/p+1	N-Methylthiazolium-Dcka		Cc1c(CCOC(=O)c2cc(=O)c3c(Cl)cc(Cl)cc3[nH]2)sc[n+]1C		R25_brito_sanchez_2015:457|R46_mendoza_valencia_2017:382	-0.78	B	BBB+	A	training
InChI=1S/C17H14ClFN2O3/c18-10-5-6-14-12(9-10)15(11-3-1-2-4-13(11)19)20-16(23)17(24)21(14)7-8-22/h1-6,9,16,22-23H,7-8H2	Doxefazepam	7-chloro-5-(2-fluorophenyl)-3-hydroxy-1-(2-hydroxyethyl)-3H-1,4-benzodiazepin-2-one	O=C1C(O)N=C(c2ccccc2F)c2cc(Cl)ccc2N1CCO	38668.0	R6_adenot_2004:701			BBB+	C	training
InChI=1S/C17H14F3N3O2S/c1-11-2-4-12(5-3-11)15-10-16(17(18,19)20)22-23(15)13-6-8-14(9-7-13)26(21,24)25/h2-10H,1H3,(H2,21,24,25)	Celecoxib|Celecoxib, Celebrex	4-[5-(4-methylphenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide	Cc1ccc(-c2cc(C(F)(F)F)nn2-c2ccc(S(N)(=O)=O)cc2)cc1	2662.0	R14_ghose_2012:437|R23_gupta_2019:272|R26_chico_2009:99	-1.0	A	BBB+	A	training
InChI=1S/C17H14N2O3/c1-2-19-10-14(17(21)22)16(20)13-4-3-12(9-15(13)19)11-5-7-18-8-6-11/h3-10H,2H2,1H3,(H,21,22)	Rosoxacin	1-ethyl-4-oxo-7-pyridin-4-ylquinoline-3-carboxylic acid	CCn1cc(C(=O)O)c(=O)c2ccc(-c3ccncc3)cc21	287180.0	R14_ghose_2012:833|R23_gupta_2019:894			BBB-	C	training
InChI=1S/C17H14N2O6S/c1-26(22,23)19-13-8-15-12(17(21)14(9-24-15)18-10-20)7-16(13)25-11-5-3-2-4-6-11/h2-10,19H,1H3,(H,18,20)	Iguratimod	N-[7-(methanesulfonamido)-4-oxo-6-phenoxychromen-3-yl]formamide	CS(=O)(=O)Nc1cc2occ(NC=O)c(=O)c2cc1Oc1ccccc1	124246.0	R23_gupta_2019:669			BBB-	C	training
InChI=1S/C17H14N6/c1-11-8-12(5-7-19-11)13-9-15(18)23-16(10-13)21-17(22-23)14-4-2-3-6-20-14/h2-10H,18H2,1H3	48|7-(2-Methyl-Pyridin-4-Yl)-2-Pyridin-2-Yl-[1,2,4]Triazolo[1,5-A]Pyridin-5-Ylamine	7-(2-methylpyridin-4-yl)-2-pyridin-2-yl-[1,2,4]triazolo[1,5-a]pyridin-5-amine	Cc1cc(-c2cc(N)n3nc(-c4ccccn4)nc3c2)ccn1	22629653.0	R47_radchenko_2020:452	-0.1	A	BBB+	A	training
InChI=1S/C17H14O4S/c1-22(19,20)14-9-7-12(8-10-14)15-11-21-17(18)16(15)13-5-3-2-4-6-13/h2-10H,11H2,1H3	Rofecoxib|Rofecoxib, Vioxx	3-(4-methylsulfonylphenyl)-4-phenyl-2H-furan-5-one	CS(=O)(=O)c1ccc(C2=C(c3ccccc3)C(=O)OC2)cc1	5090.0	R25_brito_sanchez_2015:478|R26_chico_2009:357|R46_mendoza_valencia_2017:402	-0.1	B	BBB+	A	training
InChI=1S/C17H15Cl3N2O2/c18-17(19,20)15(24)22-11-21-16(14(22)23,12-7-3-1-4-8-12)13-9-5-2-6-10-13/h1-10,15,21,24H,11H2	Triclodazol	5,5-diphenyl-3-(2,2,2-trichloro-1-hydroxyethyl)imidazolidin-4-one	O=C1N(C(O)C(Cl)(Cl)Cl)CNC1(c1ccccc1)c1ccccc1	3083540.0	R6_adenot_2004:1522			BBB+	C	training
InChI=1S/C17H15ClN2O/c18-13-6-3-5-12(11-13)17(21)14-7-1-2-8-15(14)20-10-4-9-19-16(17)20/h1-3,5-8,11,21H,4,9-10H2	Ciclazindol	10-(3-chlorophenyl)-3,4-dihydro-2H-pyrimido[1,2-a]indol-10-ol	OC1(c2cccc(Cl)c2)C2=NCCCN2c2ccccc21	37825.0	R6_adenot_2004:507			BBB+	C	test
InChI=1S/C17H15ClN4S/c1-3-11-8-13-16(12-6-4-5-7-14(12)18)19-9-15-21-20-10(2)22(15)17(13)23-11/h4-8H,3,9H2,1-2H3	Etizolam	7-(2-chlorophenyl)-4-ethyl-13-methyl-3-thia-1,8,11,12-tetrazatricyclo[8.3.0.02,6]trideca-2(6),4,7,10,12-pentaene	CCc1cc2c(s1)-n1c(C)nnc1CN=C2c1ccccc1Cl	3307.0	R6_adenot_2004:704|R14_ghose_2012:297|R23_gupta_2019:88			BBB+	C	training
InChI=1S/C17H15N3O2/c1-10-6-12-7-15-16(22-9-21-15)8-14(12)17(20-19-10)11-2-4-13(18)5-3-11/h2-5,7-8H,6,9,18H2,1H3	Gyki-52466|4-(8-Methyl-9H-1,3-Dioxolo(4,5-H)(2,3)Benzodiazepin-5-Yl)Benzenamine	4-(8-methyl-9H-[1,3]dioxolo[4,5-h][2,3]benzodiazepin-5-yl)aniline	CC1=NN=C(c2ccc(N)cc2)c2cc3c(cc2C1)OCO3	3538.0	R7_andres_2006:80|R29_subramanian_2003:70			BBB+	C	training
InChI=1S/C17H15N3O4/c1-24-11-19-15-8-7-13(20(22)23)9-14(15)17(18-10-16(19)21)12-5-3-2-4-6-12/h2-9H,10-11H2,1H3	Motrazepam	1-(methoxymethyl)-7-nitro-5-phenyl-3H-1,4-benzodiazepin-2-one	COCN1C(=O)CN=C(c2ccccc2)c2cc([N+](=O)[O-])ccc21	65764.0	R6_adenot_2004:731			BBB+	C	training
InChI=1S/C17H15N3O6/c21-14-6-5-12(9-13(14)17(25)26)20-19-11-3-1-10(2-4-11)16(24)18-8-7-15(22)23/h1-6,9,21H,7-8H2,(H,18,24)(H,22,23)(H,25,26)/b20-19+	Balsalazide	5-[[4-(2-carboxyethylcarbamoyl)phenyl]diazenyl]-2-hydroxybenzoic acid	O=C(O)CCNC(=O)c1ccc(/N=N/c2ccc(O)c(C(=O)O)c2)cc1	54585.0	R14_ghose_2012:373|R23_gupta_2019:377			BBB-	C	training
InChI=1S/C17H15N5O/c1-3-21(12(2)23)15-6-4-5-13(9-15)16-7-8-19-17-14(10-18)11-20-22(16)17/h4-9,11H,3H2,1-2H3	Zaleplon	N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-N-ethylacetamide	CCN(C(C)=O)c1cccc(-c2ccnc3c(C#N)cnn23)c1	5719.0	R6_adenot_2004:1436|R14_ghose_2012:271|R23_gupta_2019:265|R26_chico_2009:443|R34_broccatelli_2012:99|R37_chen_2011:107			BBB+	C	test
InChI=1S/C17H15N5O2/c1-2-22-20-17(19-21-22)18-16(23)15-11-7-3-5-9-13(11)24-14-10-6-4-8-12(14)15/h3-10,15H,2H2,1H3,(H,18,20,23)	51|N-(2-Ethyltetrazol-5-Yl)-9H-Xanthene-9-Carboxamide	N-(2-ethyltetrazol-5-yl)-9H-xanthene-9-carboxamide	CCn1nnc(NC(=O)C2c3ccccc3Oc3ccccc32)n1	9923127.0	R47_radchenko_2020:454	-0.8	A	BBB+	A	training
InChI=1S/C17H16Cl2N2O/c1-21-12(10-22)9-20-17(13-4-2-3-5-15(13)19)14-8-11(18)6-7-16(14)21/h2-8,12,22H,9-10H2,1H3	Tuclazepam	[7-chloro-5-(2-chlorophenyl)-1-methyl-2,3-dihydro-1,4-benzodiazepin-2-yl]methanol	CN1c2ccc(Cl)cc2C(c2ccccc2Cl)=NCC1CO	11724484.0	R6_adenot_2004:756			BBB+	C	training
InChI=1S/C17H16ClN3O/c18-12-5-6-15-13(11-12)17(21-9-7-19-8-10-21)20-14-3-1-2-4-16(14)22-15/h1-6,11,19H,7-10H2	Amoxapine	8-chloro-6-piperazin-1-ylbenzo[b][1,4]benzoxazepine	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	2170.0	R6_adenot_2004:1543|R23_gupta_2019:12|R25_brito_sanchez_2015:491|R26_chico_2009:32|R34_broccatelli_2012:5|R46_mendoza_valencia_2017:411	0.6	B	BBB+	A	training
InChI=1S/C17H16ClN3O2/c1-20-14-8-7-12(18)9-13(14)16(11-5-3-2-4-6-11)21(17(19)23)10-15(20)22/h2-9,16H,10H2,1H3,(H2,19,23)	Carburazepam	7-chloro-1-methyl-2-oxo-5-phenyl-3,5-dihydro-1,4-benzodiazepine-4-carboxamide	CN1C(=O)CN(C(N)=O)C(c2ccccc2)c2cc(Cl)ccc21	68787.0	R6_adenot_2004:687			BBB+	C	test
InChI=1S/C17H16ClN5O2/c1-9(2)16-20-15(21-25-16)14-12-7-22(3)17(24)13-10(18)5-4-6-11(13)23(12)8-19-14/h4-6,8-9H,7H2,1-3H3	L-663,581|122384-14-9|Chebi 218555|L663581|L-663581|33|7-Chloro-5-Methyl-3-(5-Propan-2-Yl-1,2,4-Oxadiazol-3-Yl)-4H-Imidazo[1,5-A][1,4]Benzodiazepin-6-One	7-chloro-5-methyl-3-(5-propan-2-yl-1,2,4-oxadiazol-3-yl)-4H-imidazo[1,5-a][1,4]benzodiazepin-6-one	CC(C)c1nc(-c2ncn3c2CN(C)C(=O)c2c(Cl)cccc2-3)no1	129710.0	R3_abraham_2006:326|R4_mente_2005:57|R12_garg_2006:97|R21_muehlbacher_2011:295|R25_brito_sanchez_2015:26|R28_li_2005:26|R40_vilar_2010:133|R41_toropov_2017:289|R46_mendoza_valencia_2017:26|R47_radchenko_2020:254|R48_hou_2003:34|R49_norinder_2002:33|R49_norinder_2002:161|R52_liu_2001:67	-0.3	B	BBB+	A	training
InChI=1S/C17H16ClN5O3/c1-17(2,25)16-20-14(21-26-16)13-11-7-22(3)15(24)12-9(18)5-4-6-10(12)23(11)8-19-13/h4-6,8,25H,7H2,1-3H3	M1L-663,581|128246-10-6|Monohydroxy L-663,581 Metabolite|Chebi: 338585|Mono-Hydroxylated-L-663581|L-663,581 Mono-Hydroxylated Metabolite|34|7-Chloro-3-[5-(2-Hydroxypropan-2-Yl)-1,2,4-Oxadiazol-3-Yl]-5-Methyl-4H-Imidazo[1,5-A][1,4]Benzodiazepin-6-One	7-chloro-3-[5-(2-hydroxypropan-2-yl)-1,2,4-oxadiazol-3-yl]-5-methyl-4H-imidazo[1,5-a][1,4]benzodiazepin-6-one	CN1Cc2c(-c3noc(C(C)(C)O)n3)ncn2-c2cccc(Cl)c2C1=O	10384745.0	R3_abraham_2006:327|R4_mente_2005:58|R12_garg_2006:115|R21_muehlbacher_2011:339|R25_brito_sanchez_2015:27|R28_li_2005:316|R40_vilar_2010:155|R41_toropov_2017:290|R46_mendoza_valencia_2017:27|R47_radchenko_2020:255|R48_hou_2003:35|R49_norinder_2002:34|R49_norinder_2002:162|R52_liu_2001:68	-1.34	B	BBB-	A	training
InChI=1S/C17H16ClN5O4/c1-17(26,7-24)16-20-14(21-27-16)13-11-6-22(2)15(25)12-9(18)4-3-5-10(12)23(11)8-19-13/h3-5,8,24,26H,6-7H2,1-2H3	M2L-663,581|130073-36-8|Lin_Test_35|Chebi: 338584|M2L-663581|Bis-Hydroxylated L-663,581|L-663,581 Bis-Hydrolated|35|7-Chloro-3-[5-(1,2-Dihydroxypropan-2-Yl)-1,2,4-Oxadiazol-3-Yl]-5-Methyl-4H-Imidazo[1,5-A][1,4]Benzodiazepin-6-One	7-chloro-3-[5-(1,2-dihydroxypropan-2-yl)-1,2,4-oxadiazol-3-yl]-5-methyl-4H-imidazo[1,5-a][1,4]benzodiazepin-6-one	CN1Cc2c(-c3noc(C(C)(O)CO)n3)ncn2-c2cccc(Cl)c2C1=O	10091748.0	R3_abraham_2006:328|R4_mente_2005:59|R12_garg_2006:100|R21_muehlbacher_2011:335|R25_brito_sanchez_2015:28|R40_vilar_2010:53|R41_toropov_2017:291|R46_mendoza_valencia_2017:28|R47_radchenko_2020:256|R49_norinder_2002:35|R49_norinder_2002:163|R52_liu_2001:69	-1.82	B	BBB-	A	training
InChI=1S/C17H16ClN5O4/c1-17(26,7-24)16-20-14(21-27-16)13-11-6-22(2)15(25)12-9(18)4-3-5-10(12)23(11)8-19-13/h3-5,8,24,26H,6-7H2,1-2H3/t17-/m1/s1	35		CN1Cc2c(-c3noc([C@](C)(O)CO)n3)ncn2-c2cccc(Cl)c2C1=O		R28_li_2005:1|R48_hou_2003:36	-1.82	A	BBB-	A	training
InChI=1S/C17H16ClNO/c1-19-9-14-12-4-2-3-5-16(12)20-17-7-6-11(18)8-13(17)15(14)10-19/h2-8,14-15H,9-10H2,1H3	Org 5222|Asenapine|5-Chloro-2-Methyl-2,3,3A,12B-Tetrahydrodibenzo[2,3:6,7]Oxepino[4,5-C]Pyrrole	9-chloro-4-methyl-13-oxa-4-azatetracyclo[12.4.0.02,6.07,12]octadeca-1(18),7(12),8,10,14,16-hexaene	CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1	9903970.0	R21_muehlbacher_2011:330|R23_gupta_2019:17|R25_brito_sanchez_2015:340|R41_toropov_2017:197|R46_mendoza_valencia_2017:299|R49_norinder_2002:142	1.03	B	BBB+	A	training
InChI=1S/C17H16ClNO/c1-19-9-14-12-4-2-3-5-16(12)20-17-7-6-11(18)8-13(17)15(14)10-19/h2-8,14-15H,9-10H2,1H3/t14-,15-/m1/s1	Org5222|Asenapine	(2S,6S)-9-chloro-4-methyl-13-oxa-4-azatetracyclo[12.4.0.02,6.07,12]octadeca-1(18),7(12),8,10,14,16-hexaene	CN1C[C@@H]2c3ccccc3Oc3ccc(Cl)cc3[C@H]2C1	163091.0	R3_abraham_2006:215|R28_li_2005:38|R47_radchenko_2020:182	1.03	B	BBB+	A	training
InChI=1S/C17H16ClNO/c18-11-5-6-17-14(9-11)12-7-8-19-10-15(12)13-3-1-2-4-16(13)20-17/h1-6,9,12,15,19H,7-8,10H2	B-106, Org30526		Clc1ccc2c(c1)C1CCNCC1c1ccccc1O2		R26_chico_2009:73	0.39	A	BBB+	A	training
InChI=1S/C17H16ClNO/c18-11-5-6-17-14(9-11)12-7-8-19-10-15(12)13-3-1-2-4-16(13)20-17/h1-6,9,12,15,19H,7-8,10H2/t12-,15+/m1/s1	7-K10		Clc1ccc2c(c1)[C@H]1CCNC[C@@H]1c1ccccc1O2		R28_li_2005:150			BBB+	C	training
InChI=1S/C17H16F6N2O/c18-16(19,20)11-5-3-4-9-10(15(26)12-6-1-2-7-24-12)8-13(17(21,22)23)25-14(9)11/h3-5,8,12,15,24,26H,1-2,6-7H2	Mefloquine|Lariam	[2,8-bis(trifluoromethyl)quinolin-4-yl]-piperidin-2-ylmethanol	OC(c1cc(C(F)(F)F)nc2c(C(F)(F)F)cccc12)C1CCCCN1	4046.0	R14_ghose_2012:669|R41_toropov_2017:178	0.63	A	BBB+	A	test
InChI=1S/C17H16F6N2O/c18-16(19,20)11-5-3-4-9-10(15(26)12-6-1-2-7-24-12)8-13(17(21,22)23)25-14(9)11/h3-5,8,12,15,24,26H,1-2,6-7H2/t12-,15+/m1/s1	Mefloquine	(S)-[2,8-bis(trifluoromethyl)quinolin-4-yl]-[(2R)-piperidin-2-yl]methanol	O[C@@H](c1cc(C(F)(F)F)nc2c(C(F)(F)F)cccc12)[C@H]1CCCCN1	40692.0	R3_abraham_2006:194|R21_muehlbacher_2011:95|R25_brito_sanchez_2015:284|R26_chico_2009:254|R28_li_2005:321|R40_vilar_2010:143|R47_radchenko_2020:164|R51_doninger_2002:82	0.63	B	BBB+	A	test
InChI=1S/C17H16FNOS/c1-19-8-9-21-17-10-12-4-2-3-5-15(12)20-16-7-6-13(18)11-14(16)17/h2-7,10-11,19H,8-9H2,1H3	Fluradoline	2-(3-fluorobenzo[b][1]benzoxepin-5-yl)sulfanyl-N-methylethanamine	CNCCSC1=Cc2ccccc2Oc2ccc(F)cc21	6917740.0	R6_adenot_2004:551			BBB+	C	training
InChI=1S/C17H16N2O/c1-2-7-15(18)12-8-3-4-9-13(12)17-14-10-5-6-11-16(14)20-19-17/h2-6,8-11,15H,1,7,18H2	Cid 9861160|B-109, Org34167|1-[2-(1,2-Benzoxazol-3-Yl)Phenyl]But-3-En-1-Amine	1-[2-(1,2-benzoxazol-3-yl)phenyl]but-3-en-1-amine	C=CCC(N)c1ccccc1-c1noc2ccccc12	9861160.0	R21_muehlbacher_2011:328|R25_brito_sanchez_2015:339|R26_chico_2009:74|R41_toropov_2017:196|R46_mendoza_valencia_2017:298|R49_norinder_2002:158	0.0	B	BBB+	A	training
InChI=1S/C17H16N2O/c1-2-7-15(18)12-8-3-4-9-13(12)17-14-10-5-6-11-16(14)20-19-17/h2-6,8-11,15H,1,7,18H2/t15-/m0/s1	Org34167|198968-25-1|Org-34167|Um4N969Cjq	(1S)-1-[2-(1,2-benzoxazol-3-yl)phenyl]but-3-en-1-amine	C=CC[C@H](N)c1ccccc1-c1noc2ccccc12	9795264.0	R3_abraham_2006:214|R4_mente_2005:165|R28_li_2005:36|R40_vilar_2010:174|R47_radchenko_2020:181	0.0	B	BBB+	A	training
InChI=1S/C17H16N2O/c1-3-13-8-4-7-11-16(13)19-12(2)18-15-10-6-5-9-14(15)17(19)20/h4-11H,3H2,1-2H3	Etaqualone	3-(2-ethylphenyl)-2-methylquinazolin-4-one	CCc1ccccc1-n1c(C)nc2ccccc2c1=O	23914.0	R6_adenot_2004:1358|R51_doninger_2002:211			BBB+	C	training
InChI=1S/C17H16N2OS/c20-14-10-18-16(11-6-2-1-3-7-11)15-12-8-4-5-9-13(12)21-17(15)19-14/h1-3,6-7H,4-5,8-10H2,(H,19,20)	Bentazepam	5-phenyl-1,3,6,7,8,9-hexahydro-[1]benzothiolo[2,3-e][1,4]diazepin-2-one	O=C1CN=C(c2ccccc2)c2c(sc3c2CCCC3)N1	135412795.0	R6_adenot_2004:683			BBB+	C	test
InChI=1S/C17H16N4S2/c1-20-4-6-21(7-5-20)17-15-10-22-8-13(15)12(2-3-18)14-9-23-11-16(14)19-17/h2,8-11H,4-7H2,1H3/b12-2+	Tenilapine	(2E)-2-[9-(4-methylpiperazin-1-yl)-5,12-dithia-8-azatricyclo[8.3.0.03,7]trideca-1(13),3,6,8,10-pentaen-2-ylidene]acetonitrile	CN1CCN(C2=Nc3cscc3/C(=C/C#N)c3cscc32)CC1	6450478.0	R6_adenot_2004:1622			BBB+	C	training
InChI=1S/C17H17Cl2N/c1-20-17-9-7-12(13-4-2-3-5-14(13)17)11-6-8-15(18)16(19)10-11/h2-6,8,10,12,17,20H,7,9H2,1H3	4-(3,4-Dichlorophenyl)-N-Methyl-1,2,3,4-Tetrahydronaphthalen-1-Amine	4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	5203.0	R42_ciura_2020:40	1.6	A	BBB+	A	training
InChI=1S/C17H17Cl2N/c1-20-17-9-7-12(13-4-2-3-5-14(13)17)11-6-8-15(18)16(19)10-11/h2-6,8,10,12,17,20H,7,9H2,1H3/t12-,17-/m0/s1	79559-97-0|Sertraline	(1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine	CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21	68617.0	R4_mente_2005:30|R6_adenot_2004:608|R14_ghose_2012:230|R21_muehlbacher_2011:267|R25_brito_sanchez_2015:191|R26_chico_2009:375|R34_broccatelli_2012:151|R37_chen_2011:91|R40_vilar_2010:243|R46_mendoza_valencia_2017:177|R47_radchenko_2020:365	1.57	B1	BBB+	A	training
InChI=1S/C17H17Cl2NO/c1-2-3-10-20-17(13-6-4-5-7-15(13)19)14-11-12(18)8-9-16(14)21/h4-9,11,21H,2-3,10H2,1H3/b20-17+	Fengabine	2-[N-butyl-C-(2-chlorophenyl)carbonimidoyl]-4-chlorophenol	CCCC/N=C(/c1cc(Cl)ccc1O)c1ccccc1Cl	54471.0	R6_adenot_2004:541			BBB+	C	training
InChI=1S/C17H17Cl2NO/c1-20-9-12-7-13(21-2)4-5-14(12)15(10-20)11-3-6-16(18)17(19)8-11/h3-8,15H,9-10H2,1-2H3	Diclofensine	4-(3,4-dichlorophenyl)-7-methoxy-2-methyl-3,4-dihydro-1H-isoquinoline	COc1ccc2c(c1)CN(C)CC2c1ccc(Cl)c(Cl)c1	68871.0	R6_adenot_2004:528			BBB+	C	test
InChI=1S/C17H17ClN2O/c1-3-19-16-20-15-10-9-13(18)11-14(15)17(2,21-16)12-7-5-4-6-8-12/h4-11H,3H2,1-2H3,(H,19,20)	Etifoxine	6-chloro-N-ethyl-4-methyl-4-phenyl-1H-3,1-benzoxazin-2-imine	CC/N=C1\Nc2ccc(Cl)cc2C(C)(c2ccccc2)O1	135413553.0	R6_adenot_2004:1463			BBB+	C	test
InChI=1S/C17H17ClN6O3/c1-22-6-8-23(9-7-22)17(26)27-16-14-13(19-4-5-20-14)15(25)24(16)12-3-2-11(18)10-21-12/h2-5,10,16H,6-9H2,1H3/t16-/m0/s1	Eszopiclone|Eszopiclone, Lunesta	[(7S)-6-(5-chloropyridin-2-yl)-5-oxo-7H-pyrrolo[3,4-b]pyrazin-7-yl] 4-methylpiperazine-1-carboxylate	CN1CCN(C(=O)O[C@H]2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1	969472.0	R23_gupta_2019:84|R26_chico_2009:178|R37_chen_2011:33			BBB+	C	training
InChI=1S/C17H17ClO6/c1-8-5-9(19)6-12(23-4)17(8)16(20)13-10(21-2)7-11(22-3)14(18)15(13)24-17/h6-8H,5H2,1-4H3/t8-,17+/m1/s1	Griseofulvin	(2S,5'R)-7-chloro-3',4,6-trimethoxy-5'-methylspiro[1-benzofuran-2,4'-cyclohex-2-ene]-1',3-dione	COC1=CC(=O)C[C@@H](C)[C@]12Oc1c(Cl)c(OC)cc(OC)c1C2=O	441140.0	R23_gupta_2019:645			BBB-	C	training
InChI=1S/C17H17N3O2/c1-4-13-11(2)20-10-14(18-17(20)19-16(13)22-3)15(21)12-8-6-5-7-9-12/h5-10H,4H2,1-3H3	Divaplon	(6-ethyl-7-methoxy-5-methylimidazo[1,2-a]pyrimidin-2-yl)-phenylmethanone	CCc1c(OC)nc2nc(C(=O)c3ccccc3)cn2c1C	65822.0	R6_adenot_2004:1451			BBB+	C	training
InChI=1S/C17H17N3O6S2/c1-9(21)26-6-10-7-28-16-13(15(23)20(16)14(10)17(24)25)19-12(22)8-27-11-2-4-18-5-3-11/h2-5,13,16H,6-8H2,1H3,(H,19,22)(H,24,25)/t13-,16-/m1/s1	Cefapirin|Cephapirin	(6R,7R)-3-(acetyloxymethyl)-8-oxo-7-[(2-pyridin-4-ylsulfanylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid	CC(=O)OCC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)CSc3ccncc3)[C@H]2SC1	30699.0	R6_adenot_2004:161|R23_gupta_2019:444|R51_doninger_2002:20			BBB-	C	training
InChI=1S/C17H17N3O8S/c1-8(21)28-6-9-7-29-16-12(15(23)20(16)13(9)17(24)25)18-14(22)11(19-26-2)10-4-3-5-27-10/h3-5,12,16H,6-7H2,1-2H3,(H,18,22)(H,24,25)/b19-11+/t12-,16-/m1/s1	Cefuracetime|Cefuracetima	(6R,7R)-3-(acetyloxymethyl)-7-[[(2Z)-2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid	CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(C)=O)CS[C@H]12)c1ccco1	9571078.0	R6_adenot_2004:205			BBB-	C	training
InChI=1S/C17H17N7O8S4/c1-23-16(20-21-22-23)34-4-5-3-33-15-17(32-2,14(31)24(15)7(5)11(29)30)19-9(26)13-35-12(36-13)6(8(18)25)10(27)28/h13,15H,3-4H2,1-2H3,(H2,18,25)(H,19,26)(H,27,28)(H,29,30)/t13?,15-,17+/m1/s1	Cefotetan|Yamatetan	(6R,7S)-7-[[4-(2-amino-1-carboxy-2-oxoethylidene)-1,3-dithietane-2-carbonyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid	CO[C@@]1(NC(=O)C2SC(=C(C(N)=O)C(=O)O)S2)C(=O)N2C(C(=O)O)=C(CSc3nnnn3C)CS[C@@H]21	53025.0	R6_adenot_2004:183|R12_garg_2006:55|R21_muehlbacher_2011:252|R21_muehlbacher_2011:253|R23_gupta_2019:430|R25_brito_sanchez_2015:183|R25_brito_sanchez_2015:405|R39_shayanfar_2011:26|R40_vilar_2010:73|R47_radchenko_2020:266	-1.89	B	BBB-	A	training
InChI=1S/C17H17NO2/c1-11-5-4-6-12-14-9-18-10-17(14,19)13-7-2-3-8-15(13)20-16(11)12/h2-8,14,18-19H,9-10H2,1H3	Org-30526		Cc1cccc2c1Oc1ccccc1C1(O)CNCC21		R47_radchenko_2020:474	0.39	A	BBB+	A	training
InChI=1S/C17H17NO2/c1-18-8-7-10-3-2-4-12-15(10)13(18)9-11-5-6-14(19)17(20)16(11)12/h2-6,13,19-20H,7-9H2,1H3/t13-/m0/s1	Apomorphine_R|(6As)-6-Methyl-5,6,6A,7-Tetrahydro-4H-Dibenzo[De,G]Quinoline-10,11-Diol	(6aS)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol	CN1CCc2cccc3c2[C@@H]1Cc1ccc(O)c(O)c1-3	736083.0	R28_li_2005:325			BBB+	C	training
InChI=1S/C17H17NO2/c1-18-8-7-10-3-2-4-12-15(10)13(18)9-11-5-6-14(19)17(20)16(11)12/h2-6,13,19-20H,7-9H2,1H3/t13-/m1/s1	Apomorphine	(6aR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol	CN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3	6005.0	R6_adenot_2004:642|R7_andres_2006:11|R14_ghose_2012:12|R26_chico_2009:35|R29_subramanian_2003:11|R37_chen_2011:6|R51_doninger_2002:155			BBB+	C	training
InChI=1S/C17H17NO2/c1-3-20-16-12-8-4-5-9-13(12)17(19)18(2)15-11-7-6-10-14(15)16/h4-11,16H,3H2,1-2H3	Etazepine	11-ethoxy-5-methyl-11H-benzo[c][1]benzazepin-6-one	CCOC1c2ccccc2C(=O)N(C)c2ccccc21	65662.0	R6_adenot_2004:1568			BBB+	C	training
InChI=1S/C17H17NS/c1-18(2)12-14-11-13-7-3-5-9-16(13)19-17-10-6-4-8-15(14)17/h3-11H,12H2,1-2H3	Damotepine	1-benzo[b][1]benzothiepin-5-yl-N,N-dimethylmethanamine	CN(C)CC1=Cc2ccccc2Sc2ccccc21	71644.0	R6_adenot_2004:1330			BBB+	C	training
InChI=1S/C17H18Br2FN3O3S/c1-26-16-3-2-12(10-15(16)23-6-4-21-5-7-23)27(24,25)22-14-9-11(18)8-13(20)17(14)19/h2-3,8-10,21-22H,4-7H2,1H3	Sb 357134|N-(2,5-Dibromo-3-Fluorophenyl)-4-Methoxy-3-Piperazin-1-Ylbenzenesulfonamide	N-(2,5-dibromo-3-fluorophenyl)-4-methoxy-3-piperazin-1-ylbenzenesulfonamide	COc1ccc(S(=O)(=O)Nc2cc(Br)cc(F)c2Br)cc1N1CCNCC1	6918553.0	R26_chico_2009:367	-0.52	A	BBB+	A	training
InChI=1S/C17H18Cl2N2O5S/c1-17(2)12(16(24)25)21-14(23)10(15(21)27-17)20-13(22)11(26-3)7-4-5-8(18)9(19)6-7/h4-6,10-12,15H,1-3H3,(H,20,22)(H,24,25)/t10-,11?,12+,15-/m1/s1	Clometocillin	(2S,5R,6R)-6-[[2-(3,4-dichlorophenyl)-2-methoxyacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid	COC(C(=O)N[C@@H]1C(=O)N2[C@@H]1SC(C)(C)[C@@H]2C(=O)O)c1ccc(Cl)c(Cl)c1	71807.0	R6_adenot_2004:212			BBB-	C	test
InChI=1S/C17H18Cl2N4/c1-10-21-22-16-9-20-17(12-4-2-3-5-14(12)19)13-8-11(18)6-7-15(13)23(10)16/h2-5,11,13,15H,6-9H2,1H3			Cc1nnc2n1C1CCC(Cl)CC1C(c1ccccc1Cl)=NC2		R41_toropov_2017:261	0.57	A	BBB+	A	training
InChI=1S/C17H18ClNO/c1-19-8-7-13-9-16(18)17(20)10-14(13)15(11-19)12-5-3-2-4-6-12/h2-6,9-10,15,20H,7-8,11H2,1H3/t15-/m1/s1	Sch-23390|(R)-2,3,4,5-Tetrahydro-8-Chloro-3-Methyl-5-Phenyl-1H-3-Benzazepin-7-Ol	(5R)-8-chloro-3-methyl-5-phenyl-1,2,4,5-tetrahydro-3-benzazepin-7-ol	CN1CCc2cc(Cl)c(O)cc2[C@@H](c2ccccc2)C1	3036864.0	R7_andres_2006:156|R29_subramanian_2003:151			BBB+	C	test
InChI=1S/C17H18F3N3O3/c1-21-4-6-22(7-5-21)15-12(19)8-10-14(13(15)20)23(3-2-18)9-11(16(10)24)17(25)26/h8-9H,2-7H2,1H3,(H,25,26)	Fleroxacin|Fleroxacine	6,8-difluoro-1-(2-fluoroethyl)-7-(4-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid	CN1CCN(c2c(F)cc3c(=O)c(C(=O)O)cn(CCF)c3c2F)CC1	3357.0	R6_adenot_2004:31|R7_andres_2006:66|R14_ghose_2012:560|R23_gupta_2019:601|R25_brito_sanchez_2015:431|R28_li_2005:355|R29_subramanian_2003:62|R46_mendoza_valencia_2017:362	-0.43	B	BBB+	A	training
InChI=1S/C17H18F3NO/c1-21-12-11-16(13-5-3-2-4-6-13)22-15-9-7-14(8-10-15)17(18,19)20/h2-10,16,21H,11-12H2,1H3	Fluoxetine|54910-89-3	N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	3386.0	R3_abraham_2006:175|R4_mente_2005:26|R6_adenot_2004:550|R7_andres_2006:69|R14_ghose_2012:95|R21_muehlbacher_2011:79|R23_gupta_2019:95|R25_brito_sanchez_2015:238|R26_chico_2009:192|R29_subramanian_2003:65|R34_broccatelli_2012:31|R37_chen_2011:38|R40_vilar_2010:116|R41_toropov_2017:162|R47_radchenko_2020:148	0.36	D	BBB+	A	training
InChI=1S/C17H18FN3O3/c18-13-7-11-14(8-15(13)20-5-3-19-4-6-20)21(10-1-2-10)9-12(16(11)22)17(23)24/h7-10,19H,1-6H2,(H,23,24)	Ciprofloxacin	1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid	O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O	2764.0	R14_ghose_2012:454|R23_gupta_2019:464|R28_li_2005:336			BBB-	C	training
InChI=1S/C17H18FN3O3S/c1-19-2-4-20(5-3-19)14-12(18)8-10-13-16(14)25-7-6-21(13)9-11(15(10)22)17(23)24/h8-9H,2-7H2,1H3,(H,23,24)	Rufloxacin	7-fluoro-6-(4-methylpiperazin-1-yl)-10-oxo-4-thia-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid	CN1CCN(c2c(F)cc3c(=O)c(C(=O)O)cn4c3c2SCC4)CC1	58258.0	R28_li_2005:392			BBB-	C	training
InChI=1S/C17H18FN3S/c1-20-6-7-21-13(11-20)10-19-17(16-3-2-8-22-16)14-5-4-12(18)9-15(14)21/h2-5,8-9,13H,6-7,10-11H2,1H3	Timelotem	10-fluoro-3-methyl-7-thiophen-2-yl-2,4,4a,5-tetrahydro-1H-pyrazino[1,2-a][1,4]benzodiazepine	CN1CCN2c3cc(F)ccc3C(c3cccs3)=NCC2C1	65844.0	R6_adenot_2004:1228			BBB+	C	training
InChI=1S/C17H18N2/c1-13-18-16-11-7-6-10-15(16)12-17(19(13)2)14-8-4-3-5-9-14/h3-11,17H,12H2,1-2H3	Dazepinil	2,3-dimethyl-4-phenyl-4,5-dihydro-1,3-benzodiazepine	CC1=Nc2ccccc2CC(c2ccccc2)N1C	53432.0	R6_adenot_2004:522			BBB+	C	training
InChI=1S/C17H18N2/c1-14(12-15-8-4-2-5-9-15)19-17(13-18)16-10-6-3-7-11-16/h2-11,14,17,19H,12H2,1H3	Amfetaminil	2-phenyl-2-(1-phenylpropan-2-ylamino)acetonitrile	CC(Cc1ccccc1)NC(C#N)c1ccccc1	28615.0	R6_adenot_2004:370			BBB+	C	training
InChI=1S/C17H18N2O3/c1-13(20)18-19-16(21)12-17(22,14-8-4-2-5-9-14)15-10-6-3-7-11-15/h2-11,22H,12H2,1H3,(H,18,20)(H,19,21)	Diphoxazide	N'-acetyl-3-hydroxy-3,3-diphenylpropanehydrazide	CC(=O)NNC(=O)CC(O)(c1ccccc1)c1ccccc1	160415.0	R6_adenot_2004:1450			BBB+	C	training
InChI=1S/C17H18N2O3S/c1-9(2)16-19-18-15(23-16)8-21-12-5-6-13-10(3)11(4)17(20)22-14(13)7-12/h5-7,9H,8H2,1-4H3	Atibeprone	3,4-dimethyl-7-[(5-propan-2-yl-1,3,4-thiadiazol-2-yl)methoxy]chromen-2-one	Cc1c(C)c2ccc(OCc3nnc(C(C)C)s3)cc2oc1=O	179342.0	R6_adenot_2004:972			BBB+	C	training
InChI=1S/C17H18N4O/c1-11-13(19-10-18-11)9-21-8-7-15-16(17(21)22)12-5-3-4-6-14(12)20(15)2/h3-6,10H,7-9H2,1-2H3,(H,18,19)	Alosetron	5-methyl-2-[(5-methyl-1H-imidazol-4-yl)methyl]-3,4-dihydropyrido[4,3-b]indol-1-one	Cc1[nH]cnc1CN1CCc2c(c3ccccc3n2C)C1=O	2099.0	R14_ghose_2012:338|R23_gupta_2019:338			BBB-	C	training
InChI=1S/C17H18N4O2/c18-11-15-16(19-12-21(9-10-22)17(15)23)20-7-5-13-3-1-2-4-14(13)6-8-20/h1-4,12,22H,5-10H2	46|1-(2-Hydroxyethyl)-6-Oxo-4-(1,2,4,5-Tetrahydro-3-Benzazepin-3-Yl)Pyrimidine-5-Carbonitrile	1-(2-hydroxyethyl)-6-oxo-4-(1,2,4,5-tetrahydro-3-benzazepin-3-yl)pyrimidine-5-carbonitrile	N#Cc1c(N2CCc3ccccc3CC2)ncn(CCO)c1=O	9796717.0	R47_radchenko_2020:451	0.0	A	BBB+	A	training
InChI=1S/C17H18N4O3/c1-20(2)11-14-6-7-16(24-14)12-4-3-5-13(10-12)19-17-15(21(22)23)8-9-18-17/h3-10,18-19H,11H2,1-2H3	Skb26|Bbcpd18|112598-45-5|B-058|22|Pyrrole3Nitro235Dimethylaminomethylfuran2Ylpheny	N-[3-[5-[(dimethylamino)methyl]furan-2-yl]phenyl]-3-nitro-1H-pyrrol-2-amine	CN(C)Cc1ccc(-c2cccc(Nc3[nH]ccc3[N+](=O)[O-])c2)o1	14022491.0	R3_abraham_2006:266|R3_abraham_2006:315|R4_mente_2005:130|R25_brito_sanchez_2015:16|R26_chico_2009:57|R40_vilar_2010:249|R41_toropov_2017:238|R41_toropov_2017:281|R46_mendoza_valencia_2017:16|R47_radchenko_2020:221|R48_hou_2003:60|R52_liu_2001:22	-0.27	B	BBB+	A	training
InChI=1S/C17H18N6/c18-7-5-15(12-3-1-2-4-12)23-10-13(9-22-23)16-14-6-8-19-17(14)21-11-20-16/h6,8-12,15H,1-5H2,(H,19,20,21)/t15-/m1/s1	Ruxolitinib	(3R)-3-cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)pyrazol-1-yl]propanenitrile	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1	25126798.0	R23_gupta_2019:897			BBB-	C	training
InChI=1S/C17H19ClN2S/c1-19(2)10-5-11-20-14-6-3-4-7-16(14)21-17-9-8-13(18)12-15(17)20/h3-4,6-9,12H,5,10-11H2,1-2H3	Chlorpromazine|50-53-3	3-(2-chlorophenothiazin-10-yl)-N,N-dimethylpropan-1-amine	CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21	2726.0	R3_abraham_2006:145|R3_abraham_2006:146|R3_abraham_2006:147|R4_mente_2005:152|R6_adenot_2004:1689|R12_garg_2006:58|R14_ghose_2012:44|R17_fu_2008:45|R21_muehlbacher_2011:54|R23_gupta_2019:44|R25_brito_sanchez_2015:187|R26_chico_2009:104|R28_li_2005:14|R31_carpenter_2014:11|R34_broccatelli_2012:145|R37_chen_2011:20|R40_vilar_2010:76|R41_toropov_2017:137|R42_ciura_2020:9|R44_bujak_2015:20|R46_mendoza_valencia_2017:174|R47_radchenko_2020:123|R48_hou_2003:21|R49_norinder_2002:98|R49_norinder_2002:134|R50_sobanska_2019:41|R51_doninger_2002:179	1.06	D	BBB+	A	training
InChI=1S/C17H19ClN4/c18-16-8-9-17(20-19-16)22-13-11-21(12-14-22)10-4-7-15-5-2-1-3-6-15/h1-9H,10-14H2/b7-4+	Lorcinadol	3-chloro-6-[4-[(E)-3-phenylprop-2-enyl]piperazin-1-yl]pyridazine	Clc1ccc(N2CCN(C/C=C/c3ccccc3)CC2)nn1	6436126.0	R6_adenot_2004:1103			BBB+	C	training
InChI=1S/C17H19F2N3O3/c1-3-21-8-11(17(24)25)16(23)10-6-12(18)15(13(19)14(10)21)22-5-4-20-9(2)7-22/h6,8-9,20H,3-5,7H2,1-2H3,(H,24,25)	Lomefloxacin	1-ethyl-6,8-difluoro-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid	CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNC(C)C3)c(F)c21	3948.0	R23_gupta_2019:713|R28_li_2005:379			BBB-	C	training
InChI=1S/C17H19FN4S/c1-11-9-13-16(22-7-5-21(2)6-8-22)19-15-10-12(18)3-4-14(15)20-17(13)23-11/h3-4,9-10,20H,5-8H2,1-2H3	Flumezapine	7-fluoro-2-methyl-4-(4-methylpiperazin-1-yl)-10H-thieno[2,3-b][1,5]benzodiazepine	Cc1cc2c(s1)Nc1ccc(F)cc1N=C2N1CCN(C)CC1	135413528.0	R6_adenot_2004:1570			BBB+	C	training
InChI=1S/C17H19N/c1-18-17-12-11-14(13-7-3-2-4-8-13)15-9-5-6-10-16(15)17/h2-10,14,17-18H,11-12H2,1H3/t14-,17+/m0/s1	Tametraline	(1R,4S)-N-methyl-4-phenyl-1,2,3,4-tetrahydronaphthalen-1-amine	CN[C@@H]1CC[C@@H](c2ccccc2)c2ccccc21	163308.0	R6_adenot_2004:615			BBB+	C	training
InChI=1S/C17H19N3/c1-19-9-10-20-16(12-19)15-7-3-2-5-13(15)11-14-6-4-8-18-17(14)20/h2-8,16H,9-12H2,1H3	Mirtazapine|85650-52-8|Mirtazepine	5-methyl-2,5,19-triazatetracyclo[13.4.0.02,7.08,13]nonadeca-1(15),8,10,12,16,18-hexaene	CN1CCN2c3ncccc3Cc3ccccc3C2C1	4205.0	R3_abraham_2006:202|R4_mente_2005:188|R5_guerra_2008:69|R6_adenot_2004:1599|R12_garg_2006:114|R14_ghose_2012:154|R21_muehlbacher_2011:102|R23_gupta_2019:153|R25_brito_sanchez_2015:302|R26_chico_2009:276|R28_li_2005:31|R34_broccatelli_2012:53|R37_chen_2011:54|R39_shayanfar_2011:63|R40_vilar_2010:152|R41_toropov_2017:184|R44_bujak_2015:67|R46_mendoza_valencia_2017:269|R47_radchenko_2020:170|R49_norinder_2002:147|R50_sobanska_2019:36	0.53	B1	BBB+	A	training
InChI=1S/C17H19N3/c1-20-10-11(5-6-18)7-14-13-3-2-4-15-17(13)12(9-19-15)8-16(14)20/h2-4,9,11,14,16,19H,5,7-8,10H2,1H3/t11-,14+,16+/m0/s1	Delergotrile	2-[(6aR,9R,10aR)-7-methyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinolin-9-yl]acetonitrile	CN1C[C@@H](CC#N)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21	10264850.0	R6_adenot_2004:646			BBB+	C	test
InChI=1S/C17H19N3O/c1-13-5-7-14(8-6-13)20(12-17-18-9-10-19-17)15-3-2-4-16(21)11-15/h2-8,11,21H,9-10,12H2,1H3,(H,18,19)	Phentolamine	3-[N-(4,5-dihydro-1H-imidazol-2-ylmethyl)-4-methylanilino]phenol	Cc1ccc(N(CC2=NCCN2)c2cccc(O)c2)cc1	5775.0	R23_gupta_2019:831			BBB-	C	training
InChI=1S/C17H19N3O/c21-17(16-8-4-5-9-18-16)20-12-10-19(11-13-20)14-15-6-2-1-3-7-15/h1-9H,10-14H2	Piberaline	(4-benzylpiperazin-1-yl)-pyridin-2-ylmethanone	O=C(c1ccccn1)N1CCN(Cc2ccccc2)CC1	65975.0	R6_adenot_2004:597			BBB+	C	training
InChI=1S/C17H19N3O3S/c1-10-8-18-15(11(2)16(10)23-4)9-24(21)17-19-13-6-5-12(22-3)7-14(13)20-17/h5-8H,9H2,1-4H3,(H,19,20)	73590-58-6|Omeprazole	6-methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]-1H-benzimidazole	COc1ccc2nc(S(=O)Cc3ncc(C)c(OC)c3C)[nH]c2c1	4594.0	R4_mente_2005:33|R14_ghose_2012:737|R21_muehlbacher_2011:106|R23_gupta_2019:795|R25_brito_sanchez_2015:333|R28_li_2005:212|R40_vilar_2010:169|R46_mendoza_valencia_2017:293|R47_radchenko_2020:343	-0.82	B	BBB+	A	training
InChI=1S/C17H19N3O3S/c1-10-8-18-15(11(2)16(10)23-4)9-24(21)17-19-13-6-5-12(22-3)7-14(13)20-17/h5-8H,9H2,1-4H3,(H,19,20)/t24-/m0/s1	Esomeprazole	6-methoxy-2-[(S)-(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]-1H-benzimidazole	COc1ccc2nc([S@@](=O)Cc3ncc(C)c(OC)c3C)[nH]c2c1	9568614.0	R23_gupta_2019:573			BBB-	C	training
InChI=1S/C17H19N3O4S/c1-17(2)12(16(23)24)20-14(22)11(15(20)25-17)19-13(21)10(18-3)9-7-5-4-6-8-9/h4-8,10-12,15H,3H2,1-2H3,(H,19,21)(H,23,24)/t10-,11-,12+,15-/m1/s1	Metampicillin	(2S,5R,6R)-3,3-dimethyl-6-[[(2R)-2-(methylideneamino)-2-phenylacetyl]amino]-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid	C=N[C@@H](C(=O)N[C@@H]1C(=O)N2[C@@H]1SC(C)(C)[C@@H]2C(=O)O)c1ccccc1	6713928.0	R6_adenot_2004:243			BBB-	C	test
InChI=1S/C17H19N5/c1-16(2,9-18)14-5-13(8-22-12-20-11-21-22)6-15(7-14)17(3,4)10-19/h5-7,11-12H,8H2,1-4H3	Anastrozole	2-[3-(2-cyanopropan-2-yl)-5-(1,2,4-triazol-1-ylmethyl)phenyl]-2-methylpropanenitrile	CC(C)(C#N)c1cc(Cn2cncn2)cc(C(C)(C)C#N)c1	2187.0	R14_ghose_2012:355|R23_gupta_2019:355			BBB-	C	training
InChI=1S/C17H19N5O/c18-13-15-12-16(14-4-2-1-3-5-14)20-21-17(15)19-6-7-22-8-10-23-11-9-22/h1-5,12H,6-11H2,(H,19,21)	Bazinaprine	3-(2-morpholin-4-ylethylamino)-6-phenylpyridazine-4-carbonitrile	N#Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1	72119.0	R6_adenot_2004:983			BBB+	C	training
InChI=1S/C17H19N5O2/c1-3-24-17(23)21-13-9-12-15(16(18)20-13)22-14(10(2)19-12)11-7-5-4-6-8-11/h4-10,19H,3H2,1-2H3,(H3,18,20,21,23)	Nsc 350386|Ethyl N-(5-Amino-2-Methyl-3-Phenyl-1,2-Dihydropyrido[3,4-B]Pyrazin-7-Yl)Carbamate	ethyl N-(5-amino-2-methyl-3-phenyl-1,2-dihydropyrido[3,4-b]pyrazin-7-yl)carbamate	CCOC(=O)Nc1cc2c(c(N)n1)N=C(c1ccccc1)C(C)N2	134196.0	R26_chico_2009:292	0.27	A	BBB+	A	training
InChI=1S/C17H19N5O2/c1-9-11(6-10-7-12(23-2)4-5-13(10)24-3)8-20-16-14(9)15(18)21-17(19)22-16/h4-5,7-8H,6H2,1-3H3,(H4,18,19,20,21,22)	Piritrexim	6-[(2,5-dimethoxyphenyl)methyl]-5-methylpyrido[2,3-d]pyrimidine-2,4-diamine	COc1ccc(OC)c(Cc2cnc3nc(N)nc(N)c3c2C)c1	54369.0	R14_ghose_2012:781			BBB-	C	test
InChI=1S/C17H19N5O6S2/c1-2-3-8(9-6-30-16(18)20-9)12(23)21-10-13(24)22-11(15(25)26)7(4-28-17(19)27)5-29-14(10)22/h3,6,10,14H,2,4-5H2,1H3,(H2,18,20)(H2,19,27)(H,21,23)(H,25,26)/b8-3-/t10-,14-/m1/s1	Cefcapene	(6R,7R)-7-[[(Z)-2-(2-amino-1,3-thiazol-4-yl)pent-2-enoyl]amino]-3-(carbamoyloxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid	CC/C=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1csc(N)n1	6436055.0	R6_adenot_2004:265			BBB-	C	training
InChI=1S/C17H19NO/c1-18-11-12-19-17(14-7-3-2-4-8-14)16-10-6-5-9-15(16)13-18/h2-10,17H,11-13H2,1H3	Nefopam	5-methyl-1-phenyl-1,3,4,6-tetrahydro-2,5-benzoxazocine	CN1CCOC(c2ccccc2)c2ccccc2C1	4450.0	R6_adenot_2004:403|R14_ghose_2012:165|R23_gupta_2019:164			BBB+	C	training
InChI=1S/C17H19NO3/c1-18-7-6-17-10-3-5-13(20)16(17)21-15-12(19)4-2-9(14(15)17)8-11(10)18/h2,4,10-11,16,19H,3,5-8H2,1H3/t10-,11+,16-,17-/m0/s1	Hydromorphone	(4R,4aR,7aR,12bS)-9-hydroxy-3-methyl-1,2,4,4a,5,6,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one	CN1CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@H]3[C@H]1C5	5284570.0	R6_adenot_2004:1041|R14_ghose_2012:109|R23_gupta_2019:110|R26_chico_2009:212			BBB+	C	training
InChI=1S/C17H19NO3/c1-18-7-6-17-10-3-5-13(20)16(17)21-15-12(19)4-2-9(14(15)17)8-11(10)18/h2-5,10-11,13,16,19-20H,6-8H2,1H3	Morphinan-3,6Alpha-Diol, 7,8-Didehydro-4,5Alpha-Epoxy-17-Methyl-	3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7,9-diol	CN1CCC23c4c5ccc(O)c4OC2C(O)C=CC3C1C5	4253.0	R41_toropov_2017:186	-0.65	A	BBB+	A	test
InChI=1S/C17H19NO3/c1-18-7-6-17-10-3-5-13(20)16(17)21-15-12(19)4-2-9(14(15)17)8-11(10)18/h2-5,10-11,13,16,19-20H,6-8H2,1H3/t10-,11+,13-,16-,17-/m0/s1	Morphine|52-26-6	(4R,4aR,7S,7aR,12bS)-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7,9-diol	CN1CC[C@]23c4c5ccc(O)c4O[C@H]2[C@@H](O)C=C[C@H]3[C@H]1C5	5288826.0	R3_abraham_2006:204|R4_mente_2005:101|R5_guerra_2008:70|R6_adenot_2004:1691|R7_andres_2006:109|R12_garg_2006:116|R14_ghose_2012:158|R21_muehlbacher_2011:321|R25_brito_sanchez_2015:306|R26_chico_2009:278|R28_li_2005:98|R29_subramanian_2003:105|R34_broccatelli_2012:54|R37_chen_2011:57|R39_shayanfar_2011:64|R40_vilar_2010:156|R47_radchenko_2020:171|R51_doninger_2002:258|R53_friden_2009:20	-0.16	D	BBB+	A	test
InChI=1S/C17H19NO3/c1-20-13-5-2-9-8-11-10-3-4-12(19)16-17(10,6-7-18-11)14(9)15(13)21-16/h2-5,10-12,16,18-19H,6-8H2,1H3/t10-,11+,12-,16-,17-/m0/s1	Norcodeine	(4R,4aR,7S,7aR,12bS)-9-methoxy-1,2,3,4,4a,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinolin-7-ol	COc1ccc2c3c1O[C@H]1[C@@H](O)C=C[C@H]4[C@@H](C2)NCC[C@@]341	9925873.0	R6_adenot_2004:1067			BBB+	C	test
InChI=1S/C17H19NO4/c1-18-7-6-16-13-9-2-3-10(19)14(13)22-15(16)11(20)4-5-17(16,21)12(18)8-9/h2-3,12,15,19,21H,4-8H2,1H3/t12-,15+,16+,17-/m1/s1	Oxymorphone	(4R,4aS,7aR,12bS)-4a,9-dihydroxy-3-methyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one	CN1CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@@]3(O)[C@H]1C5	5284604.0	R6_adenot_2004:1074|R14_ghose_2012:179|R23_gupta_2019:179|R25_brito_sanchez_2015:384|R26_chico_2009:298|R51_doninger_2002:270|R53_friden_2009:28	0.35	B	BBB+	A	training
InChI=1S/C17H20BrNO/c1-19(2)12-13-20-17(14-6-4-3-5-7-14)15-8-10-16(18)11-9-15/h3-11,17H,12-13H2,1-2H3	Bromazine|Bromodiphenhydramine	2-[(4-bromophenyl)-phenylmethoxy]-N,N-dimethylethanamine	CN(C)CCOC(c1ccccc1)c1ccc(Br)cc1	2444.0	R6_adenot_2004:1323|R14_ghose_2012:279|R23_gupta_2019:27			BBB+	C	training
InChI=1S/C17H20ClNO/c1-19(2)12-16(20)17(13-7-4-3-5-8-13)14-9-6-10-15(18)11-14/h3-11,16-17,20H,12H2,1-2H3	Clemeprol|1-(3-Chlorophenyl)-3-(Dimethylamino)-1-Phenyl-2-Propanol	1-(3-chlorophenyl)-3-(dimethylamino)-1-phenylpropan-2-ol	CN(C)CC(O)C(c1ccccc1)c1cccc(Cl)c1	10108256.0	R6_adenot_2004:512			BBB+	C	training
InChI=1S/C17H20F6N2O3/c18-16(19,20)9-27-12-4-5-14(28-10-17(21,22)23)13(7-12)15(26)25-8-11-3-1-2-6-24-11/h4-5,7,11,24H,1-3,6,8-10H2,(H,25,26)	Flecainide Acetate|Flecainide	N-(piperidin-2-ylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide	O=C(NCC1CCCCN1)c1cc(OCC(F)(F)F)ccc1OCC(F)(F)F	3356.0	R14_ghose_2012:559|R23_gupta_2019:600			BBB-	C	training
InChI=1S/C17H20FN3O3/c1-3-20-10-12(17(23)24)16(22)11-8-13(18)15(9-14(11)20)21-6-4-19(2)5-7-21/h8-10H,3-7H2,1-2H3,(H,23,24)	Pefloxacin	1-ethyl-6-fluoro-7-(4-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid	CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCN(C)CC3)cc21	51081.0	R23_gupta_2019:815|R25_brito_sanchez_2015:430|R28_li_2005:386|R46_mendoza_valencia_2017:361	-0.16	B	BBB+	A	training
InChI=1S/C17H20N2/c18-12-5-13-19-16-8-3-1-6-14(16)10-11-15-7-2-4-9-17(15)19/h1-4,6-9H,5,10-13,18H2	Didesipramine|2095-95-6|Desmethyldesipramine|Desmethydesipramine	3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)propan-1-amine	NCCCN1c2ccccc2CCc2ccccc21	159642.0	R3_abraham_2006:156|R4_mente_2005:186|R5_guerra_2008:32|R12_garg_2006:68|R21_muehlbacher_2011:298|R25_brito_sanchez_2015:205|R26_chico_2009:150|R28_li_2005:75|R39_shayanfar_2011:37|R40_vilar_2010:93|R41_toropov_2017:145|R46_mendoza_valencia_2017:190|R47_radchenko_2020:131	1.05	B1	BBB+	A	training
InChI=1S/C17H20N2O/c1-17(19-16(20)13-18,15-10-6-3-7-11-15)12-14-8-4-2-5-9-14/h2-11H,12-13,18H2,1H3,(H,19,20)	Remacemide	2-amino-N-(1,2-diphenylpropan-2-yl)acetamide	CC(Cc1ccccc1)(NC(=O)CN)c1ccccc1	60511.0	R6_adenot_2004:468|R7_andres_2006:151|R29_subramanian_2003:148			BBB+	C	training
InChI=1S/C17H20N2O2/c1-19-11-6-7-12(19)9-13(8-11)21-17(20)15-10-18-16-5-3-2-4-14(15)16/h2-5,10-13,18H,6-9H2,1H3/t11-,12+,13?	Tropisetron	[(1R,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] 1H-indole-3-carboxylate	CN1[C@@H]2CC[C@H]1CC(OC(=O)c1c[nH]c3ccccc13)C2	656665.0	R14_ghose_2012:266|R23_gupta_2019:260|R34_broccatelli_2012:95|R37_chen_2011:101			BBB+	C	training
InChI=1S/C17H20N2O2/c1-2-19(12-14-8-10-18-11-9-14)17(21)16(13-20)15-6-4-3-5-7-15/h3-11,16,20H,2,12-13H2,1H3	Tropicamide	N-ethyl-3-hydroxy-2-phenyl-N-(pyridin-4-ylmethyl)propanamide	CCN(Cc1ccncc1)C(=O)C(CO)c1ccccc1	5593.0	R23_gupta_2019:1007			BBB-	C	training
InChI=1S/C17H20N2O5S/c1-2-3-9-19-14-10-12(17(20)21)11-15(25(18,22)23)16(14)24-13-7-5-4-6-8-13/h4-8,10-11,19H,2-3,9H2,1H3,(H,20,21)(H2,18,22,23)	Bumetanide	3-(butylamino)-4-phenoxy-5-sulfamoylbenzoic acid	CCCCNc1cc(C(=O)O)cc(S(N)(=O)=O)c1Oc1ccccc1	2471.0	R14_ghose_2012:408|R23_gupta_2019:403			BBB-	C	training
InChI=1S/C17H20N2O5S/c1-9(24-10-7-5-4-6-8-10)13(20)18-11-14(21)19-12(16(22)23)17(2,3)25-15(11)19/h4-9,11-12,15H,1-3H3,(H,18,20)(H,22,23)/t9?,11-,12+,15-/m1/s1	Pheneticillin	(2S,5R,6R)-3,3-dimethyl-7-oxo-6-(2-phenoxypropanoylamino)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid	CC(Oc1ccccc1)C(=O)N[C@@H]1C(=O)N2[C@@H]1SC(C)(C)[C@@H]2C(=O)O	272833.0	R6_adenot_2004:251			BBB-	C	test
InChI=1S/C17H20N2O6S/c1-17(2)12(16(22)23)19-14(21)11(15(19)26-17)18-13(20)10-8(24-3)6-5-7-9(10)25-4/h5-7,11-12,15H,1-4H3,(H,18,20)(H,22,23)/t11-,12+,15-/m1/s1	Meticillin|Methicillin	(2S,5R,6R)-6-[(2,6-dimethoxybenzoyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid	COc1cccc(OC)c1C(=O)N[C@@H]1C(=O)N2[C@@H]1SC(C)(C)[C@@H]2C(=O)O	6087.0	R6_adenot_2004:244|R23_gupta_2019:743			BBB-	C	training
InChI=1S/C17H20N2OS/c1-18(2)12-7-13-19-14-8-3-5-10-16(14)21(20)17-11-6-4-9-15(17)19/h3-6,8-11H,7,12-13H2,1-2H3	146-21-4|Phenothiazine|Promazine-Sulfoxide|Promazine 5-Sulfoxide	N,N-dimethyl-3-(5-oxophenothiazin-10-yl)propan-1-amine	CN(C)CCCN1c2ccccc2S(=O)c2ccccc21	547559.0	R4_mente_2005:170|R21_muehlbacher_2011:310|R40_vilar_2010:218|R47_radchenko_2020:371	-0.48	B	BBB+	A	training
InChI=1S/C17H20N2S/c1-13(12-18(2)3)19-14-8-4-6-10-16(14)20-17-11-7-5-9-15(17)19/h4-11,13H,12H2,1-3H3	Isopromethazine	N,N-dimethyl-2-phenothiazin-10-ylpropan-1-amine	CC(CN(C)C)N1c2ccccc2Sc2ccccc21	110669.0	R51_doninger_2002:233			BBB+	C	training
InChI=1S/C17H20N2S/c1-13(18(2)3)12-19-14-8-4-6-10-16(14)20-17-11-7-5-9-15(17)19/h4-11,13H,12H2,1-3H3	Promethazine	N,N-dimethyl-1-phenothiazin-10-ylpropan-2-amine	CC(CN1c2ccccc2Sc2ccccc21)N(C)C	4927.0	R6_adenot_2004:1613|R7_andres_2006:144|R14_ghose_2012:213|R28_li_2005:141|R29_subramanian_2003:140|R34_broccatelli_2012:72|R42_ciura_2020:33|R47_radchenko_2020:471|R50_sobanska_2019:71	1.3	B	BBB+	A	training
InChI=1S/C17H20N2S/c1-18(2)11-5-12-19-15-7-4-3-6-14(15)8-9-17-16(19)10-13-20-17/h3-4,6-10,13H,5,11-12H2,1-2H3	Tienopramine	N,N-dimethyl-3-thieno[3,2-b][1]benzazepin-10-ylpropan-1-amine	CN(C)CCCN1c2ccccc2C=Cc2sccc21	216992.0	R6_adenot_2004:1629			BBB+	C	training
InChI=1S/C17H20N2S/c1-18(2)12-7-13-19-14-8-3-5-10-16(14)20-17-11-6-4-9-15(17)19/h3-6,8-11H,7,12-13H2,1-2H3	Promazine|53-60-1	N,N-dimethyl-3-phenothiazin-10-ylpropan-1-amine	CN(C)CCCN1c2ccccc2Sc2ccccc21	4926.0	R3_abraham_2006:237|R3_abraham_2006:238|R4_mente_2005:169|R6_adenot_2004:1612|R12_garg_2006:139|R14_ghose_2012:212|R17_fu_2008:44|R21_muehlbacher_2011:115|R23_gupta_2019:209|R25_brito_sanchez_2015:365|R26_chico_2009:330|R28_li_2005:45|R31_carpenter_2014:12|R34_broccatelli_2012:71|R40_vilar_2010:217|R41_toropov_2017:213|R42_ciura_2020:32|R46_mendoza_valencia_2017:319|R47_radchenko_2020:198|R48_hou_2003:20|R49_norinder_2002:97|R49_norinder_2002:133|R50_sobanska_2019:40|R51_doninger_2002:295	1.23	D	BBB+	A	training
InChI=1S/C17H20N4O/c1-12(20(2)3)11-21-15-9-5-4-8-14(15)19-16-13(17(21)22)7-6-10-18-16/h4-10,12H,11H2,1-3H3,(H,18,19)	Propizepine	6-[2-(dimethylamino)propyl]-11H-pyrido[3,2-c][1,5]benzodiazepin-5-one	CC(CN1C(=O)c2cccnc2Nc2ccccc21)N(C)C	112029.0	R6_adenot_2004:1615			BBB+	C	training
InChI=1S/C17H20N4O3/c1-3-20-12(2)18-16(15(17(20)22)21(23)24)19-10-8-13-6-4-5-7-14(13)9-11-19/h4-7H,3,8-11H2,1-2H3	44|3-Ethyl-2-Methyl-5-Nitro-6-(1,2,4,5-Tetrahydro-3-Benzazepin-3-Yl)Pyrimidin-4-One	3-ethyl-2-methyl-5-nitro-6-(1,2,4,5-tetrahydro-3-benzazepin-3-yl)pyrimidin-4-one	CCn1c(C)nc(N2CCc3ccccc3CC2)c([N+](=O)[O-])c1=O	9840385.0	R47_radchenko_2020:450	0.04	A	BBB+	A	training
InChI=1S/C17H20N4O6/c1-7-3-9-10(4-8(7)2)21(5-11(23)14(25)12(24)6-22)15-13(18-9)16(26)20-17(27)19-15/h3-4,11-12,14,22-25H,5-6H2,1-2H3,(H,20,26,27)/t11-,12+,14-/m0/s1	Riboflavin	7,8-dimethyl-10-[(2S,3S,4R)-2,3,4,5-tetrahydroxypentyl]benzo[g]pteridine-2,4-dione	Cc1cc2nc3c(=O)[nH]c(=O)nc-3n(C[C@H](O)[C@H](O)[C@H](O)CO)c2cc1C	493570.0	R14_ghose_2012:822			BBB-	C	training
InChI=1S/C17H20N4O6S2/c1-8-7-28-16-12(15(23)21(16)13(8)17(24)25)19-14(22)11(18)9-4-3-5-10(6-9)20-29(2,26)27/h3-6,11-12,16,20H,7,18H2,1-2H3,(H,19,22)(H,24,25)/t11-,12-,16-/m1/s1	Cefsumide	(6R,7R)-7-[[(2R)-2-amino-2-[3-(methanesulfonamido)phenyl]acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid	CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)[C@H](N)c3cccc(NS(C)(=O)=O)c3)[C@H]2SC1	68718.0	R6_adenot_2004:196			BBB-	C	training
InChI=1S/C17H20N4S/c1-12-11-13-16(21-9-7-20(2)8-10-21)18-14-5-3-4-6-15(14)19-17(13)22-12/h3-6,11,19H,7-10H2,1-2H3	Olanzapine	2-methyl-4-(4-methylpiperazin-1-yl)-10H-thieno[2,3-b][1,5]benzodiazepine	Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1	135398745.0	R3_abraham_2006:210|R6_adenot_2004:1173|R14_ghose_2012:172|R23_gupta_2019:171|R25_brito_sanchez_2015:332|R26_chico_2009:293|R34_broccatelli_2012:64|R37_chen_2011:65|R40_vilar_2010:168|R41_toropov_2017:192|R42_ciura_2020:29|R46_mendoza_valencia_2017:292|R47_radchenko_2020:177|R50_sobanska_2019:81	0.72	B1	BBB+	A	training
InChI=1S/C17H20O6/c1-9(5-7-13(18)19)4-6-11-15(20)14-12(8-23-17(14)21)10(2)16(11)22-3/h4,20H,5-8H2,1-3H3,(H,18,19)/b9-4+	Mycophenolate|Mycophenolic Acid	(E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-2-benzofuran-5-yl)-4-methylhex-4-enoic acid	COc1c(C)c2c(c(O)c1C/C=C(\C)CCC(=O)O)C(=O)OC2	446541.0	R14_ghose_2012:705|R23_gupta_2019:764			BBB-	C	training
InChI=1S/C17H21N/c1-15(13-16-9-5-3-6-10-16)18(2)14-17-11-7-4-8-12-17/h3-12,15H,13-14H2,1-2H3/t15-/m0/s1	Benzfetamine|Benzphetamine	(2S)-N-benzyl-N-methyl-1-phenylpropan-2-amine	C[C@@H](Cc1ccccc1)N(C)Cc1ccccc1	5311017.0	R6_adenot_2004:372|R14_ghose_2012:18|R23_gupta_2019:22			BBB+	C	training
InChI=1S/C17H21N5O5/c1-20-15-14(16(26)21(2)17(20)27)22(9-19-15)6-5-18-8-13(25)10-3-4-11(23)12(24)7-10/h3-4,7,9,13,18,23-25H,5-6,8H2,1-2H3	Theodrenaline	7-[2-[[2-(3,4-dihydroxyphenyl)-2-hydroxyethyl]amino]ethyl]-1,3-dimethylpurine-2,6-dione	Cn1c(=O)c2c(ncn2CCNCC(O)c2ccc(O)c(O)c2)n(C)c1=O	71857.0	R6_adenot_2004:96			BBB-	C	training
InChI=1S/C17H21N5OS/c1-20(2)12-7-8-18-16-13(12)14-15(24-16)17(23)22(11-19-14)21-9-5-3-4-6-10-21/h7-8,11H,3-6,9-10H2,1-2H3	Compound 4B|Pyrido(3',2':4,5)Thieno(3,2-D)Pyrimidin-4(3H)-One, 9-(Dimethylamino)-3-(Hexahydro-1H-Azepin-1-Yl)-	5-(azepan-1-yl)-13-(dimethylamino)-8-thia-3,5,10-triazatricyclo[7.4.0.02,7]trideca-1(13),2(7),3,9,11-pentaen-6-one	CN(C)c1ccnc2sc3c(=O)n(N4CCCCCC4)cnc3c12	11559235.0	R25_brito_sanchez_2015:473|R46_mendoza_valencia_2017:398	0.43	B	BBB+	A	training
InChI=1S/C17H21NO/c1-14-8-6-7-11-16(14)17(19-13-12-18-2)15-9-4-3-5-10-15/h3-11,17-18H,12-13H2,1-2H3	Tofenacin	N-methyl-2-[(2-methylphenyl)-phenylmethoxy]ethanamine	CNCCOC(c1ccccc1)c1ccccc1C	25315.0	R6_adenot_2004:624			BBB+	C	training
InChI=1S/C17H21NO/c1-14-8-6-7-11-16(14)19-17(12-13-18-2)15-9-4-3-5-10-15/h3-11,17-18H,12-13H2,1-2H3	Tomoxetine	N-methyl-3-(2-methylphenoxy)-3-phenylpropan-1-amine	CNCCC(Oc1ccccc1C)c1ccccc1	6850813.0	R6_adenot_2004:626			BBB+	C	training
InChI=1S/C17H21NO/c1-14-8-6-7-11-16(14)19-17(12-13-18-2)15-9-4-3-5-10-15/h3-11,17-18H,12-13H2,1-2H3/t17-/m1/s1	Atomoxetine	(3R)-N-methyl-3-(2-methylphenoxy)-3-phenylpropan-1-amine	CNCC[C@@H](Oc1ccccc1C)c1ccccc1	54841.0	R14_ghose_2012:13|R23_gupta_2019:18|R26_chico_2009:40|R34_broccatelli_2012:144|R37_chen_2011:9			BBB+	C	training
InChI=1S/C17H21NO/c1-15(13-16-9-5-3-6-10-16)18(2,19)14-17-11-7-4-8-12-17/h3-12,15H,13-14H2,1-2H3	Oxifentorex	N-benzyl-N-methyl-1-phenylpropan-2-amine oxide	CC(Cc1ccccc1)[N+](C)([O-])Cc1ccccc1	176171.0	R6_adenot_2004:383			BBB+	C	training
InChI=1S/C17H21NO/c1-18(2)13-14-19-17(15-9-5-3-6-10-15)16-11-7-4-8-12-16/h3-12,17H,13-14H2,1-2H3	Diphenhydramine	2-benzhydryloxy-N,N-dimethylethanamine	CN(C)CCOC(c1ccccc1)c1ccccc1	3100.0	R3_abraham_2006:163|R6_adenot_2004:1563|R7_andres_2006:50|R14_ghose_2012:76|R21_muehlbacher_2011:63|R25_brito_sanchez_2015:213|R26_chico_2009:164|R28_li_2005:350|R29_subramanian_2003:50|R34_broccatelli_2012:23|R40_vilar_2010:98|R41_toropov_2017:151|R42_ciura_2020:16|R46_mendoza_valencia_2017:197|R47_radchenko_2020:137|R50_sobanska_2019:75|R51_doninger_2002:201|R53_friden_2009:9	1.25	B	BBB+	A	training
InChI=1S/C17H21NO2/c1-18-13-12-15(14-8-4-3-5-9-14)20-17-11-7-6-10-16(17)19-2/h3-11,15,18H,12-13H2,1-2H3	Nisoxetine	3-(2-methoxyphenoxy)-N-methyl-3-phenylpropan-1-amine	CNCCC(Oc1ccccc1OC)c1ccccc1	4500.0	R6_adenot_2004:584			BBB+	C	training
InChI=1S/C17H21NO2/c1-18-8-7-17-11-3-2-4-14(17)20-16-13(19)6-5-10(15(16)17)9-12(11)18/h5-6,11-12,14,19H,2-4,7-9H2,1H3/t11-,12+,14-,17+/m0/s1	Desomorphine	(4R,4aR,7aS,12bS)-3-methyl-2,4,4a,5,6,7,7a,13-octahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-9-ol	CN1CC[C@]23c4c5ccc(O)c4O[C@H]2CCC[C@H]3[C@H]1C5	5362456.0	R6_adenot_2004:1023			BBB+	C	training
InChI=1S/C17H21NO3/c1-12(17(21)14-4-8-16(20)9-5-14)18-11-10-13-2-6-15(19)7-3-13/h2-9,12,17-21H,10-11H2,1H3/t12-,17-/m0/s1	Ritodrine Hydrochloride|Ritodrine	4-[2-[[(1R,2S)-1-hydroxy-1-(4-hydroxyphenyl)propan-2-yl]amino]ethyl]phenol	C[C@H](NCCc1ccc(O)cc1)[C@H](O)c1ccc(O)cc1	33572.0	R14_ghose_2012:829			BBB-	C	training
InChI=1S/C17H21NO3/c1-18-7-6-17-10-3-5-13(20)16(17)21-15-12(19)4-2-9(14(15)17)8-11(10)18/h2,4,10-11,13,16,19-20H,3,5-8H2,1H3/t10-,11+,13-,16-,17-/m0/s1	Dihydromorphine	(4R,4aR,7S,7aR,12bS)-3-methyl-2,4,4a,5,6,7,7a,13-octahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7,9-diol	CN1CC[C@]23c4c5ccc(O)c4O[C@H]2[C@@H](O)CC[C@H]3[C@H]1C5	5359421.0	R51_doninger_2002:200			BBB+	C	training
InChI=1S/C17H21NO3/c1-18-8-7-17-6-5-12(19)9-14(17)21-16-13(20-2)4-3-11(10-18)15(16)17/h3-6,12,14,19H,7-10H2,1-2H3	Epigalanthamin	9-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.01,12.06,17]heptadeca-6(17),7,9,15-tetraen-14-ol	COc1ccc2c3c1OC1CC(O)C=CC31CCN(C)C2	3449.0	R46_mendoza_valencia_2017:343	0.32	A	BBB+	A	training
InChI=1S/C17H21NO3/c1-18-8-7-17-6-5-12(19)9-14(17)21-16-13(20-2)4-3-11(10-18)15(16)17/h3-6,12,14,19H,7-10H2,1-2H3/t12-,14-,17-/m0/s1	357-70-0|Galantamine|Galanthamine	(1S,12S,14R)-9-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.01,12.06,17]heptadeca-6(17),7,9,15-tetraen-14-ol	COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CCN(C)C2	9651.0	R4_mente_2005:72|R6_adenot_2004:414|R14_ghose_2012:104|R21_muehlbacher_2011:207|R23_gupta_2019:104|R25_brito_sanchez_2015:403|R26_chico_2009:202|R34_broccatelli_2012:35|R40_vilar_2010:118|R47_radchenko_2020:355	0.32	B	BBB+	A	training
InChI=1S/C17H21NO3/c1-3-11-6-5-7-12-13-8-9-21-17(4-2,10-14(19)20)16(13)18-15(11)12/h5-7,18H,3-4,8-10H2,1-2H3,(H,19,20)	Etodolac	2-(1,8-diethyl-4,9-dihydro-3H-pyrano[3,4-b]indol-1-yl)acetic acid	CCc1cccc2c3c([nH]c12)C(CC)(CC(=O)O)OCC3	3308.0	R14_ghose_2012:544|R21_muehlbacher_2011:72|R23_gupta_2019:285|R41_toropov_2017:220|R41_toropov_2017:295|R46_mendoza_valencia_2017:275	-1.42	B	BBB-	A	test
InChI=1S/C17H21NO3/c1-3-11-6-5-7-12-13-8-9-21-17(4-2,10-14(19)20)16(13)18-15(11)12/h5-7,18H,3-4,8-10H2,1-2H3,(H,19,20)/t17-/m0/s1	S-Etodolac|(S)-(+)-Etodolac	2-[(1S)-1,8-diethyl-4,9-dihydro-3H-pyrano[3,4-b]indol-1-yl]acetic acid	CCc1cccc2c3c([nH]c12)[C@](CC)(CC(=O)O)OCC3	688461.0	R3_abraham_2006:255	-1.34	A	BBB-	A	test
InChI=1S/C17H21NO3/c1-3-11-6-5-7-12-13-8-9-21-17(4-2,10-14(19)20)16(13)18-15(11)12/h5-7,18H,3-4,8-10H2,1-2H3,(H,19,20)/t17-/m1/s1	R-Etodolac|(R)-Etodolac	2-[(1R)-1,8-diethyl-4,9-dihydro-3H-pyrano[3,4-b]indol-1-yl]acetic acid	CCc1cccc2c3c([nH]c12)[C@@](CC)(CC(=O)O)OCC3	667528.0	R3_abraham_2006:246|R25_brito_sanchez_2015:312|R26_chico_2009:348|R40_vilar_2010:228|R47_radchenko_2020:204	-1.47	B	BBB-	A	test
InChI=1S/C17H21NO4/c1-11(6-12-2-4-14(19)5-3-12)18-10-17(22)13-7-15(20)9-16(21)8-13/h2-5,7-9,11,17-22H,6,10H2,1H3	Fenoterol	5-[1-hydroxy-2-[1-(4-hydroxyphenyl)propan-2-ylamino]ethyl]benzene-1,3-diol	CC(Cc1ccc(O)cc1)NCC(O)c1cc(O)cc(O)c1	3343.0	R14_ghose_2012:555|R51_doninger_2002:55			BBB-	C	training
InChI=1S/C17H21NO4/c1-18-12-8-9-13(18)15(17(20)21-2)14(10-12)22-16(19)11-6-4-3-5-7-11/h3-7,12-15H,8-10H2,1-2H3	Methyl 3-(Benzoyloxy)-8-Methyl-8-Azabicyclo[3.2.1]Octane-2-Carboxylate	methyl 3-benzoyloxy-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate	COC(=O)C1C(OC(=O)c2ccccc2)CC2CCC1N2C	2826.0	R41_toropov_2017:140|R46_mendoza_valencia_2017:178	0.6	B	BBB+	A	training
InChI=1S/C17H21NO4/c1-18-12-8-9-13(18)15(17(20)21-2)14(10-12)22-16(19)11-6-4-3-5-7-11/h3-7,12-15H,8-10H2,1-2H3/t12-,13+,14-,15+/m0/s1	Cocaine	methyl (1R,2R,3S,5S)-3-benzoyloxy-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate	COC(=O)[C@H]1[C@@H](OC(=O)c2ccccc2)C[C@@H]2CC[C@H]1N2C	446220.0	R3_abraham_2006:150|R14_ghose_2012:56|R21_muehlbacher_2011:142|R23_gupta_2019:275|R25_brito_sanchez_2015:192|R26_chico_2009:116|R40_vilar_2010:80|R47_radchenko_2020:126|R51_doninger_2002:188	0.6	B	BBB+	A	training
InChI=1S/C17H21NO4/c1-18-13-7-11(8-14(18)16-15(13)22-16)21-17(20)12(9-19)10-5-3-2-4-6-10/h2-6,11-16,19H,7-9H2,1H3	Scopolamine|(-)-Scopolamine	(9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-7-yl) 3-hydroxy-2-phenylpropanoate	CN1C2CC(OC(=O)C(CO)c3ccccc3)CC1C1OC12	5184.0	R14_ghose_2012:111			BBB+	C	training
InChI=1S/C17H21NO4/c1-18-13-7-11(8-14(18)16-15(13)22-16)21-17(20)12(9-19)10-5-3-2-4-6-10/h2-6,11-16,19H,7-9H2,1H3/t11?,12-,13-,14+,15-,16+/m1/s1	51-34-3|Scopolamine	[(1R,2R,4S,5S)-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-7-yl] (2S)-3-hydroxy-2-phenylpropanoate	CN1[C@@H]2CC(OC(=O)[C@H](CO)c3ccccc3)C[C@H]1[C@@H]1O[C@@H]12	3000322.0	R4_mente_2005:148|R21_muehlbacher_2011:126|R21_muehlbacher_2011:143|R25_brito_sanchez_2015:240|R34_broccatelli_2012:83|R40_vilar_2010:241|R47_radchenko_2020:345|R51_doninger_2002:126	0.23	B	BBB+	A	training
InChI=1S/C17H21NO4/c1-18-13-7-11(8-14(18)16-15(13)22-16)21-17(20)12(9-19)10-5-3-2-4-6-10/h2-6,11-16,19H,7-9H2,1H3/t11?,12-,13?,14?,15?,16?/m0/s1	(9-Methyl-3-Oxa-9-Azatricyclo[3.3.1.02,4]Nonan-7-Yl) (2R)-3-Hydroxy-2-Phenylpropanoate	(9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-7-yl) (2R)-3-hydroxy-2-phenylpropanoate	CN1C2CC(OC(=O)[C@@H](CO)c3ccccc3)CC1C1OC12	24211936.0	R46_mendoza_valencia_2017:218	0.23	A	BBB+	A	training
InChI=1S/C17H21NO4/c1-18-7-6-16-13-9-2-3-10(19)14(13)22-15(16)11(20)4-5-17(16,21)12(18)8-9/h2-3,11-12,15,19-21H,4-8H2,1H3/t11-,12+,15-,16-,17+/m0/s1	Hydromorphinol	(4R,4aS,7S,7aR,12bS)-3-methyl-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,7,9-triol	CN1CC[C@]23c4c5ccc(O)c4O[C@H]2[C@@H](O)CC[C@@]3(O)[C@H]1C5	5463858.0	R6_adenot_2004:1040			BBB+	C	training
InChI=1S/C17H21NO4/c1-21-11-3-2-9-8-12-17(20)5-4-10(19)15-16(17,6-7-18-12)13(9)14(11)22-15/h2-3,10,12,15,18-20H,4-8H2,1H3/t10?,12?,15-,16+,17-/m1/s1			COc1ccc2c3c1O[C@@H]1C(O)CC[C@@]4(O)C(C2)NCC[C@]314		R46_mendoza_valencia_2017:364	-0.6	A	BBB+	A	training
InChI=1S/C17H22I3N3O8/c1-6(28)15(29)23-14-12(19)9(16(30)21-7(2-24)3-25)11(18)10(13(14)20)17(31)22-8(4-26)5-27/h6-8,24-28H,2-5H2,1H3,(H,21,30)(H,22,31)(H,23,29)/t6-/m0/s1	Iopamidol	1-N,3-N-bis(1,3-dihydroxypropan-2-yl)-5-[[(2S)-2-hydroxypropanoyl]amino]-2,4,6-triiodobenzene-1,3-dicarboxamide	C[C@H](O)C(=O)Nc1c(I)c(C(=O)NC(CO)CO)c(I)c(C(=O)NC(CO)CO)c1I	65492.0	R23_gupta_2019:679			BBB-	C	training
InChI=1S/C17H22N2O/c1-17(20-14-13-19(2)3,15-9-5-4-6-10-15)16-11-7-8-12-18-16/h4-12H,13-14H2,1-3H3	Doxylamine|Doxylamine Succinate	N,N-dimethyl-2-(1-phenyl-1-pyridin-2-ylethoxy)ethanamine	CN(C)CCOC(C)(c1ccccc1)c1ccccn1	3162.0	R3_abraham_2006:165|R6_adenot_2004:1331|R7_andres_2006:55|R14_ghose_2012:82|R21_muehlbacher_2011:67|R23_gupta_2019:76|R25_brito_sanchez_2015:219|R26_chico_2009:170|R28_li_2005:351|R29_subramanian_2003:54|R40_vilar_2010:105|R41_toropov_2017:153|R47_radchenko_2020:139|R51_doninger_2002:206	0.64	B	BBB+	A	training
InChI=1S/C17H22N2O/c1-17(20-14-13-19(2)3,15-9-5-4-6-10-15)16-11-7-8-12-18-16/h4-12H,13-14H2,1-3H3/t17-/m0/s1	Doxylamine, (S)-	N,N-dimethyl-2-[(1S)-1-phenyl-1-pyridin-2-ylethoxy]ethanamine	CN(C)CCO[C@@](C)(c1ccccc1)c1ccccn1	25271652.0	R46_mendoza_valencia_2017:202	0.64	A	BBB+	A	training
InChI=1S/C17H22N2OS/c1-3-4-7-12-20-17-9-6-5-8-15(17)16(13-21-2)19-11-10-18-14-19/h5-6,8-11,13-14H,3-4,7,12H2,1-2H3/b16-13+	Neticonazole Hydrochloride|Neticonazole	1-[(E)-2-methylsulfanyl-1-(2-pentoxyphenyl)ethenyl]imidazole	CCCCCOc1ccccc1/C(=C\SC)n1ccnc1	5282433.0	R23_gupta_2019:1078			BBB-	C	training
InChI=1S/C17H22N4O/c1-14-13-16(15-5-3-2-4-6-15)19-20-17(14)18-7-8-21-9-11-22-12-10-21/h2-6,13H,7-12H2,1H3,(H,18,20)	Minaprine	4-methyl-N-(2-morpholin-4-ylethyl)-6-phenylpyridazin-3-amine	Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1	4199.0	R6_adenot_2004:1488|R26_chico_2009:273|R37_chen_2011:53	0.3	A	BBB+	A	training
InChI=1S/C17H22N4O2/c1-13-12-16(14-2-4-15(22)5-3-14)19-20-17(13)18-6-7-21-8-10-23-11-9-21/h2-5,12,22H,6-11H2,1H3,(H,18,20)	Moxiraprine	4-[5-methyl-6-(2-morpholin-4-ylethylamino)pyridazin-3-yl]phenol	Cc1cc(-c2ccc(O)cc2)nnc1NCCN1CCOCC1	71258.0	R6_adenot_2004:556			BBB+	C	training
InChI=1S/C17H23Cl2NO/c1-10(2)20-16-11-3-5-12(6-4-11)17(16,21)13-7-8-14(18)15(19)9-13/h7-12,16,20-21H,3-6H2,1-2H3/t11?,12?,16-,17-/m1/s1	Cilobamine	(2R,3R)-2-(3,4-dichlorophenyl)-3-(propan-2-ylamino)bicyclo[2.2.2]octan-2-ol	CC(C)N[C@@H]1C2CCC(CC2)[C@@]1(O)c1ccc(Cl)c(Cl)c1	10381819.0	R6_adenot_2004:509			BBB+	C	training
InChI=1S/C17H23FN2O/c18-15-7-5-14(6-8-15)17(21)4-2-9-19-11-12-20-10-1-3-16(20)13-19/h5-8,16H,1-4,9-13H2	Azabuperone	4-(3,4,6,7,8,8a-hexahydro-1H-pyrrolo[1,2-a]pyrazin-2-yl)-1-(4-fluorophenyl)butan-1-one	O=C(CCCN1CCN2CCCC2C1)c1ccc(F)cc1	18484.0	R6_adenot_2004:1117			BBB+	C	training
InChI=1S/C17H23N3O/c1-19(2)12-13-20(17-6-4-5-11-18-17)14-15-7-9-16(21-3)10-8-15/h4-11H,12-14H2,1-3H3	Pyrilamine|Mepyramine|Mepiramine|7	N'-[(4-methoxyphenyl)methyl]-N,N-dimethyl-N'-pyridin-2-ylethane-1,2-diamine	COc1ccc(CN(CCN(C)C)c2ccccn2)cc1	4992.0	R3_abraham_2006:244|R5_guerra_2008:61|R5_guerra_2008:86|R7_andres_2006:207|R12_garg_2006:104|R14_ghose_2012:138|R21_muehlbacher_2011:118|R25_brito_sanchez_2015:285|R26_chico_2009:259|R28_li_2005:28|R39_shayanfar_2011:114|R40_vilar_2010:225|R41_toropov_2017:218|R42_ciura_2020:36|R44_bujak_2015:57|R46_mendoza_valencia_2017:255|R47_radchenko_2020:203|R48_hou_2003:12|R48_hou_2003:100|R49_norinder_2002:7|R49_norinder_2002:125|R49_norinder_2002:154|R51_doninger_2002:85|R51_doninger_2002:245|R52_liu_2001:7	0.49	B	BBB+	A	training
InChI=1S/C17H23N5O2/c23-15-4-5-16(24)22(15)11-13-2-3-14-12-21(9-8-20(14)10-13)17-18-6-1-7-19-17/h1,6-7,13-14H,2-5,8-12H2/t13-,14-/m0/s1	Sunepitron	1-[[(7S,9aS)-2-pyrimidin-2-yl-1,3,4,6,7,8,9,9a-octahydropyrido[1,2-a]pyrazin-7-yl]methyl]pyrrolidine-2,5-dione	O=C1CCC(=O)N1C[C@H]1CC[C@H]2CN(c3ncccn3)CCN2C1	183092.0	R6_adenot_2004:1453			BBB+	C	training
InChI=1S/C17H23N7O5/c1-23-13(25)6-10(22-17(23)29)15(27)21-11(5-9-7-19-8-20-9)16(28)24-4-2-3-12(24)14(18)26/h7-8,10-12H,2-6H2,1H3,(H2,18,26)(H,19,20)(H,21,27)(H,22,29)/t10-,11-,12-/m0/s1	Taltirelin	(4S)-N-[(2S)-1-[(2S)-2-carbamoylpyrrolidin-1-yl]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-1-methyl-2,6-dioxo-1,3-diazinane-4-carboxamide	CN1C(=O)C[C@@H](C(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N2CCC[C@H]2C(N)=O)NC1=O	114750.0	R14_ghose_2012:238|R23_gupta_2019:315			BBB+	C	training
InChI=1S/C17H23NO/c1-17(9-10-18(2)3)16-12-13-6-4-5-7-14(13)15(16)8-11-19-17/h4-7H,8-12H2,1-3H3	Pirandamine	N,N-dimethyl-2-(1-methyl-4,9-dihydro-3H-indeno[2,1-c]pyran-1-yl)ethanamine	CN(C)CCC1(C)OCCC2=C1Cc1ccccc12	431429.0	R6_adenot_2004:1608			BBB+	C	training
InChI=1S/C17H23NO/c1-18-9-8-17-7-3-2-4-14(17)16(18)10-12-5-6-13(19)11-15(12)17/h5-6,11,14,16,19H,2-4,7-10H2,1H3	Racemorphan	17-methyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-trien-4-ol	CN1CCC23CCCCC2C1Cc1ccc(O)cc13	3918.0	R46_mendoza_valencia_2017:243	0.0	A	BBB+	A	training
InChI=1S/C17H23NO/c1-18-9-8-17-7-3-2-4-14(17)16(18)10-12-5-6-13(19)11-15(12)17/h5-6,11,14,16,19H,2-4,7-10H2,1H3/t14-,16+,17+/m0/s1	Levorphanol|Racemorphan	(1R,9R,10R)-17-methyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-trien-4-ol	CN1CC[C@]23CCCC[C@H]2[C@H]1Cc1ccc(O)cc13	5359272.0	R6_adenot_2004:1053|R6_adenot_2004:1084|R12_garg_2006:99|R14_ghose_2012:123|R21_muehlbacher_2011:323|R23_gupta_2019:123|R25_brito_sanchez_2015:270|R26_chico_2009:239|R39_shayanfar_2011:113|R40_vilar_2010:136|R47_radchenko_2020:274|R51_doninger_2002:237	0.0	B	BBB+	A	training
InChI=1S/C17H23NO/c1-18-9-8-17-7-3-2-4-14(17)16(18)10-12-5-6-13(19)11-15(12)17/h5-6,11,14,16,19H,2-4,7-10H2,1H3/t14-,16+,17+/m1/s1	Dextrorphan	(1S,9S,10S)-17-methyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-trien-4-ol	CN1CC[C@@]23CCCC[C@@H]2[C@@H]1Cc1ccc(O)cc13	5360697.0	R6_adenot_2004:1027			BBB+	C	training
InChI=1S/C17H23NO2/c1-4-20-16(19)17(14-10-6-5-7-11-14)13-9-8-12-15(17)18(2)3/h5-8,10-12,15H,4,9,13H2,1-3H3/t15-,17+/m1/s1	Tilidine|Dextilidine	ethyl (1S,2R)-2-(dimethylamino)-1-phenylcyclohex-3-ene-1-carboxylate	CCOC(=O)[C@]1(c2ccccc2)CCC=C[C@H]1N(C)C	30131.0	R6_adenot_2004:1105|R14_ghose_2012:251|R23_gupta_2019:244			BBB+	C	training
InChI=1S/C17H23NO3/c1-18-13-7-8-14(18)10-15(9-13)21-17(20)16(11-19)12-5-3-2-4-6-12/h2-6,13-16,19H,7-11H2,1H3	Atropine Sulfate	(8-methyl-8-azabicyclo[3.2.1]octan-3-yl) 3-hydroxy-2-phenylpropanoate	CN1C2CCC1CC(OC(=O)C(CO)c1ccccc1)C2	3661.0	R46_mendoza_valencia_2017:478	-0.06	A	BBB+	A	training
InChI=1S/C17H23NO3/c1-18-13-7-8-14(18)10-15(9-13)21-17(20)16(11-19)12-5-3-2-4-6-12/h2-6,13-16,19H,7-11H2,1H3/t13-,14+,15?,16?	Atropine	[(1R,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] 3-hydroxy-2-phenylpropanoate	CN1[C@@H]2CC[C@H]1CC(OC(=O)C(CO)c1ccccc1)C2	174174.0	R6_adenot_2004:359|R12_garg_2006:26|R21_muehlbacher_2011:301|R25_brito_sanchez_2015:572|R28_li_2005:232|R39_shayanfar_2011:18|R40_vilar_2010:41|R44_bujak_2015:15|R47_radchenko_2020:261|R50_sobanska_2019:21|R51_doninger_2002:13	-0.06	B	BBB+	A	training
InChI=1S/C17H23NO4/c1-18(21)13-7-8-14(18)10-15(9-13)22-17(20)16(11-19)12-5-3-2-4-6-12/h2-6,13-16,19H,7-11H2,1H3/t13-,14+,15?,16-,18?/m1/s1	Atropine-Oxide	[(1R,5S)-8-methyl-8-oxido-8-azoniabicyclo[3.2.1]octan-3-yl] (2S)-3-hydroxy-2-phenylpropanoate	C[N+]1([O-])[C@@H]2CC[C@H]1CC(OC(=O)[C@H](CO)c1ccccc1)C2	76969140.0	R6_adenot_2004:363			BBB+	C	training
InChI=1S/C17H24N2O3/c1-4-19-9-5-6-14(19)11-18-17(21)15-10-13(12(2)20)7-8-16(15)22-3/h7-8,10,14H,4-6,9,11H2,1-3H3,(H,18,21)	Etacepride	5-acetyl-N-[(1-ethylpyrrolidin-2-yl)methyl]-2-methoxybenzamide	CCN1CCCC1CNC(=O)c1cc(C(C)=O)ccc1OC	3085389.0	R6_adenot_2004:1153			BBB+	C	training
InChI=1S/C17H24N4/c1-14-4-3-5-17(12-14)21-10-8-20(9-11-21)7-6-16-13-15(2)18-19-16/h3-5,12-13H,6-11H2,1-2H3,(H,18,19)	Tolpiprazole	1-(3-methylphenyl)-4-[2-(5-methyl-1H-pyrazol-3-yl)ethyl]piperazine	Cc1cccc(N2CCN(CCc3cc(C)[nH]n3)CC2)c1	3084338.0	R6_adenot_2004:1519			BBB+	C	test
InChI=1S/C17H24N4O2S2/c1-17(2,3)12-8-19-13(23-12)10-24-14-9-20-16(25-14)21-15(22)11-4-6-18-7-5-11/h8-9,11,18H,4-7,10H2,1-3H3,(H,20,21,22)	Bms-387032|Bms-387032, Sns-032|N-(5-(((5-(1,1-Dimethylethyl)-2-Oxazolyl)Methyl)Thio)-2-Thiazolyl)-4-Piperidinecarboxamide	N-[5-[(5-tert-butyl-1,3-oxazol-2-yl)methylsulfanyl]-1,3-thiazol-2-yl]piperidine-4-carboxamide	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1	3025986.0	R25_brito_sanchez_2015:479|R26_chico_2009:82|R46_mendoza_valencia_2017:403	-0.01	D	BBB+	A	training
InChI=1S/C17H24NO3/c1-18(2)13-8-9-14(18)11-15(10-13)21-17(20)16(19)12-6-4-3-5-7-12/h3-7,13-16,19H,8-11H2,1-2H3/q+1	Homatropine Methylbromide|8,8-Dimethyl-8Lambda(5)-Azabicyclo[3.2.1]Oct-3-Yl Hydroxy(Phenyl)Acetate	(8,8-dimethyl-8-azoniabicyclo[3.2.1]octan-3-yl) 2-hydroxy-2-phenylacetate	C[N+]1(C)C2CCC1CC(OC(=O)C(O)c1ccccc1)C2	3622.0	R14_ghose_2012:607			BBB-	C	training
InChI=1S/C17H24O3/c1-12-9-14(11-17(2,3)10-12)20-16(19)15(18)13-7-5-4-6-8-13/h4-8,12,14-15,18H,9-11H2,1-3H3	Cyclandelate	(3,3,5-trimethylcyclohexyl) 2-hydroxy-2-phenylacetate	CC1CC(OC(=O)C(O)c2ccccc2)CC(C)(C)C1	2893.0	R14_ghose_2012:472|R23_gupta_2019:485			BBB-	C	training
InChI=1S/C17H25N/c1-4-10-16(11-5-1)17(12-6-2-7-13-17)18-14-8-3-9-15-18/h1,4-5,10-11H,2-3,6-9,12-15H2	Phencyclidine	1-(1-phenylcyclohexyl)piperidine	c1ccc(C2(N3CCCCC3)CCCCC2)cc1	6468.0	R3_abraham_2006:226|R5_guerra_2008:82|R6_adenot_2004:946|R12_garg_2006:133|R21_muehlbacher_2011:165|R25_brito_sanchez_2015:352|R26_chico_2009:307|R39_shayanfar_2011:73|R40_vilar_2010:206|R41_toropov_2017:204|R46_mendoza_valencia_2017:308|R47_radchenko_2020:189|R51_doninger_2002:280	0.44	D	BBB+	A	training
InChI=1S/C17H25N3O2/c18-9-14-2-1-3-20(14)15(21)10-19-16-5-12-4-13(6-16)8-17(22,7-12)11-16/h12-14,19,22H,1-8,10-11H2/t12?,13?,14-,16?,17?/m0/s1	Vildagliptin	(2S)-1-[2-[(3-hydroxy-1-adamantyl)amino]acetyl]pyrrolidine-2-carbonitrile	N#C[C@@H]1CCCN1C(=O)CNC12CC3CC(CC(O)(C3)C1)C2	6918537.0	R23_gupta_2019:1026			BBB-	C	training
InChI=1S/C17H25N3O2S/c1-18-23(21,22)10-7-13-3-4-17-15(11-13)16(12-19-17)14-5-8-20(2)9-6-14/h3-4,11-12,14,18-19H,5-10H2,1-2H3	Naratriptan	N-methyl-2-[3-(1-methylpiperidin-4-yl)-1H-indol-5-yl]ethanesulfonamide	CNS(=O)(=O)CCc1ccc2[nH]cc(C3CCN(C)CC3)c2c1	4440.0	R23_gupta_2019:162|R26_chico_2009:281|R47_radchenko_2020:503	-0.41	B1	BBB+	A	test
InChI=1S/C17H25N3O2S/c1-19(2)10-7-15-12-18-17-6-5-14(11-16(15)17)13-23(21,22)20-8-3-4-9-20/h5-6,11-12,18H,3-4,7-10,13H2,1-2H3	Almotriptan	N,N-dimethyl-2-[5-(pyrrolidin-1-ylsulfonylmethyl)-1H-indol-3-yl]ethanamine	CN(C)CCc1c[nH]c2ccc(CS(=O)(=O)N3CCCC3)cc12	123606.0	R14_ghose_2012:301|R26_chico_2009:22			BBB+	C	training
InChI=1S/C17H25N3O5S/c1-4-7-20-8-5-6-12(20)11-19-17(21)14-9-13(26(18,22)23)10-15(24-2)16(14)25-3/h4,9-10,12H,1,5-8,11H2,2-3H3,(H,19,21)(H2,18,22,23)	Veralipride	2,3-dimethoxy-N-[(1-prop-2-enylpyrrolidin-2-yl)methyl]-5-sulfamoylbenzamide	C=CCN1CCCC1CNC(=O)c1cc(S(N)(=O)=O)cc(OC)c1OC	47979.0	R6_adenot_2004:1233			BBB+	C	training
InChI=1S/C17H25N3O5S/c1-7-12-11(8(2)21)16(23)20(12)13(17(24)25)14(7)26-9-5-10(18-6-9)15(22)19(3)4/h7-12,18,21H,5-6H2,1-4H3,(H,24,25)/t7-,8-,9+,10+,11-,12-/m1/s1	Meropenem	(4R,5S,6S)-3-[(3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]sulfanyl-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid	C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12	441130.0	R6_adenot_2004:269			BBB-	C	training
InChI=1S/C17H25NO2/c1-4-14-13-18(3)12-11-17(14,20-16(19)5-2)15-9-7-6-8-10-15/h6-10,14H,4-5,11-13H2,1-3H3/t14-,17+/m0/s1	Alphameprodine	[(3S,4R)-3-ethyl-1-methyl-4-phenylpiperidin-4-yl] propanoate	CCC(=O)O[C@]1(c2ccccc2)CCN(C)C[C@@H]1CC	61119.0	R6_adenot_2004:1008			BBB+	C	training
InChI=1S/C17H25NO2/c1-4-14-13-18(3)12-11-17(14,20-16(19)5-2)15-9-7-6-8-10-15/h6-10,14H,4-5,11-13H2,1-3H3/t14-,17-/m1/s1	Betameprodine	[(3R,4R)-3-ethyl-1-methyl-4-phenylpiperidin-4-yl] propanoate	CCC(=O)O[C@]1(c2ccccc2)CCN(C)C[C@H]1CC	12218309.0	R6_adenot_2004:1012			BBB+	C	training
InChI=1S/C17H25NO2/c1-4-5-6-18-10-13-7-12-8-16(19-2)17(20-3)9-14(12)15(13)11-18/h8-9,13,15H,4-7,10-11H2,1-3H3	Ar 1D9859|Ar-1D9859|2-Butyl-6,7-Dimethoxy-3,3A,4,8B-Tetrahydro-1H-Indeno[1,2-C]Pyrrole	2-butyl-6,7-dimethoxy-3,3a,4,8b-tetrahydro-1H-indeno[1,2-c]pyrrole	CCCCN1CC2Cc3cc(OC)c(OC)cc3C2C1	6086.0	R21_muehlbacher_2011:150|R25_brito_sanchez_2015:401|R46_mendoza_valencia_2017:341|R47_radchenko_2020:353	0.31	B	BBB+	A	training
InChI=1S/C17H25NO4/c1-20-14-11-13(12-15(21-2)16(14)22-3)17(19)18-9-7-5-4-6-8-10-18/h11-12H,4-10H2,1-3H3	Trocimine	azocan-1-yl-(3,4,5-trimethoxyphenyl)methanone	COc1cc(C(=O)N2CCCCCCC2)cc(OC)c1OC	26650.0	R6_adenot_2004:630			BBB+	C	test
InChI=1S/C17H26ClN/c1-13(2)12-16(19(3)4)17(10-5-11-17)14-6-8-15(18)9-7-14/h6-9,13,16H,5,10-12H2,1-4H3	Sibutramine	1-[1-(4-chlorophenyl)cyclobutyl]-N,N,3-trimethylbutan-1-amine	CC(C)CC(N(C)C)C1(c2ccc(Cl)cc2)CCC1	5210.0	R6_adenot_2004:497|R14_ghose_2012:231|R23_gupta_2019:227			BBB+	C	training
InChI=1S/C17H26FNO2/c1-13(2)16(6-4-3-5-7-17(20)21)19-12-14-8-10-15(18)11-9-14/h8-11,13,16,19H,3-7,12H2,1-2H3,(H,20,21)	Zafuleptine	7-[(4-fluorophenyl)methylamino]-8-methylnonanoic acid	CC(C)C(CCCCCC(=O)O)NCc1ccc(F)cc1	68789.0	R6_adenot_2004:636			BBB+	C	test
InChI=1S/C17H26N2O/c1-4-11-19-12-6-5-10-15(19)17(20)18-16-13(2)8-7-9-14(16)3/h7-9,15H,4-6,10-12H2,1-3H3,(H,18,20)/t15-/m0/s1	Ropivacaine	(2S)-N-(2,6-dimethylphenyl)-1-propylpiperidine-2-carboxamide	CCCN1CCCC[C@H]1C(=O)Nc1c(C)cccc1C	175805.0	R14_ghose_2012:227|R23_gupta_2019:222|R37_chen_2011:88			BBB+	C	training
InChI=1S/C17H26N2O/c1-4-9-19(10-5-2)11-8-14-6-7-16(20)17-15(14)12-13(3)18-17/h6-7,18,20H,3-5,8-12H2,1-2H3	1-48		C=C1Cc2c(CCN(CCC)CCC)ccc(O)c2N1		R28_li_2005:3			BBB+	C	training
InChI=1S/C17H26N2O2/c1-15(20)18-9-6-12-21-17-8-5-7-16(13-17)14-19-10-3-2-4-11-19/h5,7-8,13H,2-4,6,9-12,14H2,1H3,(H,18,20)	Skb30|Bbcpd20|78273-74-2|Chebi: 338581|B-060|24|16|Acetamide, N-[3-[3-(1-Piperidinylmethyl)Phenoxy]Propyl]-	N-[3-[3-(piperidin-1-ylmethyl)phenoxy]propyl]acetamide	CC(=O)NCCCOc1cccc(CN2CCCCC2)c1	9971484.0	R3_abraham_2006:268|R3_abraham_2006:317|R4_mente_2005:133|R21_muehlbacher_2011:332|R25_brito_sanchez_2015:18|R26_chico_2009:59|R28_li_2005:161|R40_vilar_2010:251|R41_toropov_2017:240|R41_toropov_2017:283|R46_mendoza_valencia_2017:18|R47_radchenko_2020:223|R48_hou_2003:55|R49_norinder_2002:24|R49_norinder_2002:175|R52_liu_2001:24	-0.46	B	BBB+	A	training
InChI=1S/C17H26N2O3S/c1-14-5-9-18(10-6-14)11-7-15-8-12-19(15)23(21,22)17-4-2-3-16(20)13-17/h2-4,13-15,20H,5-12H2,1H3	S118		CC1CCN(CCC2CCN2S(=O)(=O)c2cccc(O)c2)CC1		R47_radchenko_2020:326	-0.08	A	BBB+	A	test
InChI=1S/C17H26N2O4S/c1-4-19-10-6-7-13(19)12-18-17(20)15-11-14(24(21,22)5-2)8-9-16(15)23-3/h8-9,11,13H,4-7,10,12H2,1-3H3,(H,18,20)	Sultopride	N-[(1-ethylpyrrolidin-2-yl)methyl]-5-ethylsulfonyl-2-methoxybenzamide	CCN1CCCC1CNC(=O)c1cc(S(=O)(=O)CC)ccc1OC	5357.0	R6_adenot_2004:612			BBB+	C	training
InChI=1S/C17H26N4O/c1-2-6-16-14(5-1)7-8-15(22-16)13-18-9-3-10-19-17-20-11-4-12-21-17/h1-2,5-6,15,18H,3-4,7-13H2,(H2,19,20,21)	N-(3,4-Dihydro-2H-Chromen-2-Ylmethyl)-N'-(1,4,5,6-Tetrahydropyrimidin-2-Yl)Propane-1,3-Diamine	N-(3,4-dihydro-2H-chromen-2-ylmethyl)-N'-(1,4,5,6-tetrahydropyrimidin-2-yl)propane-1,3-diamine	c1ccc2c(c1)CCC(CNCCCNC1=NCCCN1)O2	9817881.0	R46_mendoza_valencia_2017:114|R47_radchenko_2020:439	-0.01	B	BBB+	A	test
InChI=1S/C17H26N4O/c1-2-6-16-14(5-1)7-8-15(22-16)13-18-9-3-10-19-17-20-11-4-12-21-17/h1-2,5-6,15,18H,3-4,7-13H2,(H2,19,20,21)/t15-/m1/s1	Alniditan Dihydrochloride|Alniditan	N-[[(2R)-3,4-dihydro-2H-chromen-2-yl]methyl]-N'-(1,4,5,6-tetrahydropyrimidin-2-yl)propane-1,3-diamine	c1ccc2c(c1)CC[C@H](CNCCCNC1=NCCCN1)O2	66004.0	R25_brito_sanchez_2015:116	-0.01	A	BBB+	A	test
InChI=1S/C17H26N4O3S2/c1-12(16(5-6-22)26-25-10-15-4-3-7-24-15)21(11-23)9-14-8-19-13(2)20-17(14)18/h8,11,15,22H,3-7,9-10H2,1-2H3,(H2,18,19,20)/b16-12+	Fursultiamine	N-[(4-amino-2-methylpyrimidin-5-yl)methyl]-N-[(E)-5-hydroxy-3-(oxolan-2-ylmethyldisulfanyl)pent-2-en-2-yl]formamide	C/C(=C(/CCO)SSCC1CCCO1)N(C=O)Cc1cnc(C)nc1N	3002119.0	R6_adenot_2004:391			BBB+	C	training
InChI=1S/C17H26N4O4S/c1-4-7-21-8-5-6-12(21)11-20-17(22)13-9-16(26(23,24)19-2)14(18)10-15(13)25-3/h4,9-10,12,19H,1,5-8,11,18H2,2-3H3,(H,20,22)	Alpiropride	4-amino-2-methoxy-5-(methylsulfamoyl)-N-[(1-prop-2-enylpyrrolidin-2-yl)methyl]benzamide	C=CCN1CCCC1CNC(=O)c1cc(S(=O)(=O)NC)c(N)cc1OC	71253.0	R6_adenot_2004:1111			BBB+	C	training
InChI=1S/C17H27N/c1-18(2)14-13-17(15-9-5-3-6-10-15)16-11-7-4-8-12-16/h3,5-6,9-10,16-17H,4,7-8,11-14H2,1-2H3	Gamfexine	3-cyclohexyl-N,N-dimethyl-3-phenylpropan-1-amine	CN(C)CCC(c1ccccc1)C1CCCCC1	31041.0	R6_adenot_2004:553			BBB+	C	training
InChI=1S/C17H27N3O4S/c1-4-20-8-6-7-12(20)11-19-17(21)13-9-16(25(22,23)5-2)14(18)10-15(13)24-3/h9-10,12H,4-8,11,18H2,1-3H3,(H,19,21)	Amisulpride	4-amino-N-[(1-ethylpyrrolidin-2-yl)methyl]-5-ethylsulfonyl-2-methoxybenzamide	CCN1CCCC1CNC(=O)c1cc(S(=O)(=O)CC)c(N)cc1OC	2159.0	R6_adenot_2004:1113|R14_ghose_2012:7|R23_gupta_2019:9|R34_broccatelli_2012:104|R37_chen_2011:3			BBB+	C	training
InChI=1S/C17H27NO/c1-15(2)10-13-19-17(14-18-11-6-7-12-18)16-8-4-3-5-9-16/h3-5,8-9,15,17H,6-7,10-14H2,1-2H3	Amixetrine	1-[2-(3-methylbutoxy)-2-phenylethyl]pyrrolidine	CC(C)CCOC(CN1CCCC1)c1ccccc1	71911.0	R6_adenot_2004:487			BBB+	C	training
InChI=1S/C17H27NO2/c1-18(2)13-16(17(19)11-5-4-6-12-17)14-7-9-15(20-3)10-8-14/h7-10,16,19H,4-6,11-13H2,1-3H3	Venlafaxine	1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]cyclohexan-1-ol	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	5656.0	R6_adenot_2004:632|R14_ghose_2012:268|R23_gupta_2019:261|R26_chico_2009:440|R34_broccatelli_2012:97|R37_chen_2011:103	0.62	A	BBB+	A	training
InChI=1S/C17H27NO3/c1-4-17(5-2,13-18-16(20)10-7-11-19)14-8-6-9-15(12-14)21-3/h6,8-9,12,19H,4-5,7,10-11,13H2,1-3H3,(H,18,20)	Embutramide	N-[2-ethyl-2-(3-methoxyphenyl)butyl]-4-hydroxybutanamide	CCC(CC)(CNC(=O)CCCO)c1cccc(OC)c1	27453.0	R6_adenot_2004:1097			BBB+	C	training
InChI=1S/C17H27NO4/c1-17(2,3)18-9-12(19)10-22-16-6-4-5-11-7-14(20)15(21)8-13(11)16/h4-6,12,14-15,18-21H,7-10H2,1-3H3	Solgol	5-[3-(tert-butylamino)-2-hydroxypropoxy]-1,2,3,4-tetrahydronaphthalene-2,3-diol	CC(C)(C)NCC(O)COc1cccc2c1CC(O)C(O)C2	4411.0	R46_mendoza_valencia_2017:330	-0.95	A	BBB+	A	test
InChI=1S/C17H27NO4/c1-17(2,3)18-9-12(19)10-22-16-6-4-5-11-7-14(20)15(21)8-13(11)16/h4-6,12,14-15,18-21H,7-10H2,1-3H3/t12?,14-,15+/m1/s1	Nadolol	(2R,3S)-5-[3-(tert-butylamino)-2-hydroxypropoxy]-1,2,3,4-tetrahydronaphthalene-2,3-diol	CC(C)(C)NCC(O)COc1cccc2c1C[C@H](O)[C@H](O)C2	39147.0	R6_adenot_2004:50|R7_andres_2006:110|R25_brito_sanchez_2015:380|R29_subramanian_2003:107|R53_friden_2009:22	-0.95	B	BBB+	A	test
InChI=1S/C17H28N2O2/c1-5-18(6-2)16(20)14-12-9-10-13(11-12)15(14)17(21)19(7-3)8-4/h9-10,12-15H,5-8,11H2,1-4H3/t12-,13+,14-,15-/m0/s1	Endomide	(1S,2S,3S,4R)-2-N,2-N,3-N,3-N-tetraethylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxamide	CCN(CC)C(=O)[C@@H]1[C@@H](C(=O)N(CC)CC)[C@H]2C=C[C@@H]1C2	20055317.0	R6_adenot_2004:400			BBB+	C	training
InChI=1S/C17H28N2O3/c1-4-7-11-21-16-13-14(8-9-15(16)18)17(20)22-12-10-19(5-2)6-3/h8-9,13H,4-7,10-12,18H2,1-3H3	Oxybuprocaine	2-(diethylamino)ethyl 4-amino-3-butoxybenzoate	CCCCOc1cc(C(=O)OCCN(CC)CC)ccc1N	4633.0	R23_gupta_2019:805			BBB-	C	training
InChI=1S/C17H28N2O3S/c1-14-5-9-18(10-6-14)11-7-15-8-12-19(15)23(21,22)17-4-2-3-16(20)13-17/h3,13-15,20H,2,4-12H2,1H3			CC1CCN(CCC2CCN2S(=O)(=O)C2=CC(O)=CCC2)CC1		R45_hemmateenejad_2006:2	-0.89	A	BBB+	A	training
InChI=1S/C17H28N2O5/c1-3-6-12(16(21)22)18-10(2)15(20)19-13-8-5-4-7-11(13)9-14(19)17(23)24/h10-14,18H,3-9H2,1-2H3,(H,21,22)(H,23,24)/t10-,11-,12-,13-,14-/m0/s1	Perindoprilat	(2S,3aS,7aS)-1-[(2S)-2-[[(1S)-1-carboxybutyl]amino]propanoyl]-2,3,3a,4,5,6,7,7a-octahydroindole-2-carboxylic acid	CCC[C@H](N[C@@H](C)C(=O)N1[C@H](C(=O)O)C[C@@H]2CCCC[C@@H]21)C(=O)O	72022.0	R14_ghose_2012:763			BBB-	C	test
InChI=1S/C17H30N2O7/c1-4-5-6-8-7-9(20)17(23)16(24-8)25-15-13(22)10(18-2)12(21)11(19-3)14(15)26-17/h8,10-16,18-19,21-23H,4-7H2,1-3H3/t8-,10-,11+,12+,13+,14-,15-,16+,17+/m1/s1	Trospectomycin	(1R,3S,5R,8R,10R,11S,12S,13R,14S)-5-butyl-8,12,14-trihydroxy-11,13-bis(methylamino)-2,4,9-trioxatricyclo[8.4.0.03,8]tetradecan-7-one	CCCC[C@@H]1CC(=O)[C@]2(O)O[C@@H]3[C@@H](NC)[C@@H](O)[C@@H](NC)[C@H](O)[C@H]3O[C@@H]2O1	55886.0	R6_adenot_2004:132			BBB-	C	test
InChI=1S/C17H32NO2/c1-5-7-13(8-6-2)17(19)20-16-11-14-9-10-15(12-16)18(14,3)4/h13-16H,5-12H2,1-4H3/q+1	Anisotropine|8,8-Dimethyl-3-[(2-Propylpentanoyl)Oxy]-8-Azoniabicyclo[3.2.1]Octane	(8,8-dimethyl-8-azoniabicyclo[3.2.1]octan-3-yl) 2-propylpentanoate	CCCC(CCC)C(=O)OC1CC2CCC(C1)[N+]2(C)C	4157.0	R14_ghose_2012:357			BBB-	C	training
InChI=1S/C17H35N5O6/c1-7(19)9-5-4-8(20)17(27-9)28-15-11(21)13(24)16(26-3)12(14(15)25)22(2)10(23)6-18/h7-9,11-17,24-25H,4-6,18-21H2,1-3H3/t7-,8+,9-,11-,12-,13-,14+,15+,16+,17+/m0/s1	Astromicin	2-amino-N-[(1S,2R,3R,4S,5S,6R)-4-amino-3-[(2R,3R,6S)-3-amino-6-[(1S)-1-aminoethyl]oxan-2-yl]oxy-2,5-dihydroxy-6-methoxycyclohexyl]-N-methylacetamide	CO[C@H]1[C@@H](O)[C@H](N)[C@@H](O[C@H]2O[C@H]([C@H](C)N)CC[C@H]2N)[C@H](O)[C@@H]1N(C)C(=O)CN	5284517.0	R6_adenot_2004:112			BBB-	C	test
InChI=1S/C17H9Cl3N4O2/c18-10-3-1-9(2-4-10)12(7-21)16-13(19)5-11(6-14(16)20)24-17(26)23-15(25)8-22-24/h1-6,8,12H,(H,23,25,26)	Diclazuril	2-(4-chlorophenyl)-2-[2,6-dichloro-4-(3,5-dioxo-1,2,4-triazin-2-yl)phenyl]acetonitrile	N#CC(c1ccc(Cl)cc1)c1c(Cl)cc(-n2ncc(=O)[nH]c2=O)cc1Cl	456389.0	R25_brito_sanchez_2015:209|R46_mendoza_valencia_2017:193	-1.3	B	BBB-	A	training
InChI=1S/C18H12N2O2/c1-19-17(11-13-3-7-15(21)8-4-13)18(20-2)12-14-5-9-16(22)10-6-14/h3-12,21-22H/b17-11-,18-12-	Xantocillin	4-[(1Z,3Z)-4-(4-hydroxyphenyl)-2,3-diisocyanobuta-1,3-dienyl]phenol	[C-]#[N+]C(=C\c1ccc(O)cc1)/C(=C/c1ccc(O)cc1)[N+]#[C-]	5378293.0	R6_adenot_2004:280			BBB-	C	training
InChI=1S/C18H13Cl2N3/c1-11-21-9-13-10-22-18(14-4-2-3-5-16(14)20)15-8-12(19)6-7-17(15)23(11)13/h2-9H,10H2,1H3	Climazolam	8-chloro-6-(2-chlorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepine	Cc1ncc2n1-c1ccc(Cl)cc1C(c1ccccc1Cl)=NC2	68790.0	R6_adenot_2004:692			BBB+	C	training
InChI=1S/C18H13Cl2N3O2/c19-11-5-6-15-13(9-11)17(12-3-1-2-4-14(12)20)21-7-8-23(15)18-22-16(24)10-25-18/h1-6,9H,7-8,10H2	Reclazepam	2-[7-chloro-5-(2-chlorophenyl)-2,3-dihydro-1,4-benzodiazepin-1-yl]-1,3-oxazol-4-one	O=C1COC(N2CCN=C(c3ccccc3Cl)c3cc(Cl)ccc32)=N1	3052777.0	R6_adenot_2004:745			BBB+	C	training
InChI=1S/C18H13Cl4N3O/c19-13-2-1-12(16(21)7-13)10-26-24-18(9-25-6-5-23-11-25)15-4-3-14(20)8-17(15)22/h1-8,11H,9-10H2/b24-18+	Oxiconazole|1-(2,4-Dichlorophenyl)-N-[(2,4-Dichlorophenyl)Methoxy]-2-(1-Imidazolyl)Ethanimine	(E)-1-(2,4-dichlorophenyl)-N-[(2,4-dichlorophenyl)methoxy]-2-imidazol-1-ylethanimine	Clc1ccc(CO/N=C(/Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1	5361463.0	R23_gupta_2019:804			BBB-	C	training
InChI=1S/C18H13ClFN3/c1-11-21-9-13-10-22-18(14-4-2-3-5-16(14)20)15-8-12(19)6-7-17(15)23(11)13/h2-9H,10H2,1H3	Midazolam|59467-70-8|Midazolam Maleate	8-chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepine	Cc1ncc2n1-c1ccc(Cl)cc1C(c1ccccc1F)=NC2	4192.0	R3_abraham_2006:198|R3_abraham_2006:199|R3_abraham_2006:200|R4_mente_2005:60|R5_guerra_2008:68|R6_adenot_2004:730|R12_garg_2006:113|R14_ghose_2012:152|R17_fu_2008:42|R21_muehlbacher_2011:101|R25_brito_sanchez_2015:300|R26_chico_2009:271|R28_li_2005:30|R37_chen_2011:51|R40_vilar_2010:150|R41_toropov_2017:182|R44_bujak_2015:41|R46_mendoza_valencia_2017:267|R47_radchenko_2020:168|R48_hou_2003:18|R49_norinder_2002:95|R49_norinder_2002:131|R50_sobanska_2019:31|R51_doninger_2002:256	0.38	B1	BBB+	A	training
InChI=1S/C18H13ClFN3O/c1-10-21-9-16-18(24)22-17(12-4-2-3-5-14(12)20)13-8-11(19)6-7-15(13)23(10)16/h2-9,18,24H,1H3	4-Hydroxymidazolam|59468-85-8	8-chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepin-4-ol	Cc1ncc2n1-c1ccc(Cl)cc1C(c1ccccc1F)=NC2O	124449.0	R3_abraham_2006:105|R4_mente_2005:48|R5_guerra_2008:10|R12_garg_2006:13|R21_muehlbacher_2011:292|R25_brito_sanchez_2015:91|R26_chico_2009:11|R28_li_2005:63|R39_shayanfar_2011:9|R40_vilar_2010:12|R41_toropov_2017:100|R44_bujak_2015:89|R47_radchenko_2020:87			BBB+	C	training
InChI=1S/C18H13ClFN3O/c1-10-21-9-16-18(24)22-17(12-4-2-3-5-14(12)20)13-8-11(19)6-7-15(13)23(10)16/h2-9,18,24H,1H3/t18-/m1/s1	(4R)-8-Chloro-6-(2-Fluorophenyl)-1-Methyl-4H-Imidazo[1,5-A][1,4]Benzodiazepin-4-Ol	(4R)-8-chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepin-4-ol	Cc1ncc2n1-c1ccc(Cl)cc1C(c1ccccc1F)=N[C@@H]2O	25745047.0	R46_mendoza_valencia_2017:89	-0.03	A	BBB+	A	training
InChI=1S/C18H13ClFN3O/c19-11-5-6-16-14(7-11)18(13-3-1-2-4-15(13)20)22-9-12-8-21-17(10-24)23(12)16/h1-8,24H,9-10H2	1-Hydroxymidazolam|59468-90-5	[8-chloro-6-(2-fluorophenyl)-4H-imidazo[1,5-a][1,4]benzodiazepin-1-yl]methanol	OCc1ncc2n1-c1ccc(Cl)cc1C(c1ccccc1F)=NC2	107917.0	R3_abraham_2006:102|R4_mente_2005:47|R5_guerra_2008:3|R21_muehlbacher_2011:285|R26_chico_2009:4|R28_li_2005:55|R39_shayanfar_2011:3|R40_vilar_2010:6|R41_toropov_2017:97|R44_bujak_2015:86|R47_radchenko_2020:84	-0.07	B1	BBB+	A	training
InChI=1S/C18H13ClFN3O2/c19-11-6-7-15-13(10-11)16(12-4-1-2-5-14(12)20)22-17(24)18(25)23(15)9-3-8-21/h1-2,4-7,10,17,24H,3,9H2	Cinolazepam	3-[7-chloro-5-(2-fluorophenyl)-3-hydroxy-2-oxo-3H-1,4-benzodiazepin-1-yl]propanenitrile	N#CCCN1C(=O)C(O)N=C(c2ccccc2F)c2cc(Cl)ccc21	3033621.0	R6_adenot_2004:690|R14_ghose_2012:48|R23_gupta_2019:47			BBB+	C	training
InChI=1S/C18H13ClN2O/c1-2-10-21-16-9-8-14(19)11-15(16)18(20-12-17(21)22)13-6-4-3-5-7-13/h1,3-9,11H,10,12H2	Pinazepam	7-chloro-5-phenyl-1-prop-2-ynyl-3H-1,4-benzodiazepin-2-one	C#CCN1C(=O)CN=C(c2ccccc2)c2cc(Cl)ccc21	40391.0	R6_adenot_2004:739			BBB+	C	training
InChI=1S/C18H14Cl2N2/c19-14-9-13-6-5-12-3-1-2-4-15(12)18(17(13)16(20)10-14)22-8-7-21-11-22/h1-4,7-11,18H,5-6H2	Eberconazole	1-(4,6-dichloro-2-tricyclo[9.4.0.03,8]pentadeca-1(15),3(8),4,6,11,13-hexaenyl)imidazole	Clc1cc(Cl)c2c(c1)CCc1ccccc1C2n1ccnc1	72051.0	R23_gupta_2019:544			BBB-	C	training
InChI=1S/C18H14ClFN2O3/c1-2-25-18(24)16-17(23)21-14-8-7-10(19)9-12(14)15(22-16)11-5-3-4-6-13(11)20/h3-9,16H,2H2,1H3,(H,21,23)	Ethyl-Loflazepate|Ethyl Loflazepate	ethyl 7-chloro-5-(2-fluorophenyl)-2-oxo-1,3-dihydro-1,4-benzodiazepine-3-carboxylate	CCOC(=O)C1N=C(c2ccccc2F)c2cc(Cl)ccc2NC1=O	3299.0	R6_adenot_2004:720			BBB+	C	training
InChI=1S/C18H14F4N2O4S/c1-17(26,10-29(27,28)14-6-3-12(19)4-7-14)16(25)24-13-5-2-11(9-23)15(8-13)18(20,21)22/h2-8,26H,10H2,1H3,(H,24,25)	Bicalutamide	N-[4-cyano-3-(trifluoromethyl)phenyl]-3-(4-fluorophenyl)sulfonyl-2-hydroxy-2-methylpropanamide	CC(O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1	2375.0	R14_ghose_2012:397|R23_gupta_2019:393			BBB-	C	training
InChI=1S/C18H14N4O5S/c23-16-9-6-13(11-15(16)18(24)25)21-20-12-4-7-14(8-5-12)28(26,27)22-17-3-1-2-10-19-17/h1-11,23H,(H,19,22)(H,24,25)/b21-20+	Sulfasalazine|Sulphasalazine	2-hydroxy-5-[[4-(pyridin-2-ylsulfamoyl)phenyl]diazenyl]benzoic acid	O=C(O)c1cc(/N=N/c2ccc(S(=O)(=O)Nc3ccccn3)cc2)ccc1O	5339.0	R7_andres_2006:159|R14_ghose_2012:864|R25_brito_sanchez_2015:387|R29_subramanian_2003:156|R34_broccatelli_2012:86|R46_mendoza_valencia_2017:332|R51_doninger_2002:129|R53_friden_2009:35	-2.69	B	BBB-	A	training
InChI=1S/C18H15Cl2N3O/c1-2-9-24-23-17-11-21-18(13-5-3-4-6-15(13)20)14-10-12(19)7-8-16(14)22-17/h2-8,10H,1,9,11H2,(H,22,23)	Uldazepam	7-chloro-5-(2-chlorophenyl)-N-prop-2-enoxy-3H-1,4-benzodiazepin-2-amine	C=CCONC1=Nc2ccc(Cl)cc2C(c2ccccc2Cl)=NC1	34274.0	R6_adenot_2004:757			BBB+	C	training
InChI=1S/C18H15Cl2N5O5S3/c1-7-22-23-18(33-7)32-6-8-5-31-16-12(15(28)25(16)13(8)17(29)30)21-11(26)4-24-2-9(19)14(27)10(20)3-24/h2-3,12,16H,4-6H2,1H3,(H,21,26)(H,29,30)/t12-,16-/m1/s1	Cefazedone	(6R,7R)-7-[[2-(3,5-dichloro-4-oxopyridin-1-yl)acetyl]amino]-3-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid	Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cc(Cl)c(=O)c(Cl)c4)[C@H]3SC2)s1	71736.0	R6_adenot_2004:164			BBB-	C	test
InChI=1S/C18H15Cl3N2O/c19-14-3-1-13(2-4-14)11-24-18(10-23-8-7-22-12-23)16-6-5-15(20)9-17(16)21/h1-9,12,18H,10-11H2	Econazole	1-[2-[(4-chlorophenyl)methoxy]-2-(2,4-dichlorophenyl)ethyl]imidazole	Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1	3198.0	R23_gupta_2019:547|R51_doninger_2002:46			BBB-	C	training
InChI=1S/C18H15Cl3N2S/c19-14-3-1-13(2-4-14)11-24-18(10-23-8-7-22-12-23)16-6-5-15(20)9-17(16)21/h1-9,12,18H,10-11H2	Sulconazole Nitrate|Sulconazole	1-[2-[(4-chlorophenyl)methylsulfanyl]-2-(2,4-dichlorophenyl)ethyl]imidazole	Clc1ccc(CSC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1	5318.0	R23_gupta_2019:1084			BBB-	C	training
InChI=1S/C18H15ClFN3O/c1-18(24)22-10-12-9-21-17(13-4-2-3-5-15(13)20)14-8-11(19)6-7-16(14)23(12)18/h2-8,10,22,24H,9H2,1H3		8-chloro-6-(2-fluorophenyl)-1-methyl-2,4-dihydroimidazo[1,5-a][1,4]benzodiazepin-1-ol	CC1(O)NC=C2CN=C(c3ccccc3F)c3cc(Cl)ccc3N21	14205604.0	R46_mendoza_valencia_2017:55	-0.07	A	BBB+	A	training
InChI=1S/C18H15ClN2O2S/c1-12-3-4-14(10-20-12)18-17(9-15(19)11-21-18)13-5-7-16(8-6-13)24(2,22)23/h3-11H,1-2H3	Etoricoxib	5-chloro-2-(6-methylpyridin-3-yl)-3-(4-methylsulfonylphenyl)pyridine	Cc1ccc(-c2ncc(Cl)cc2-c2ccc(S(C)(=O)=O)cc2)cn1	123619.0	R14_ghose_2012:545|R23_gupta_2019:586			BBB-	C	training
InChI=1S/C18H15ClN2O6S2/c1-9-5-13-14(26-8-25-13)7-11(9)6-12(22)17-15(3-4-28-17)29(23,24)21-18-16(19)10(2)20-27-18/h3-5,7,21H,6,8H2,1-2H3	Sitaxentan	N-(4-chloro-3-methyl-1,2-oxazol-5-yl)-2-[2-(6-methyl-1,3-benzodioxol-5-yl)acetyl]thiophene-3-sulfonamide	Cc1cc2c(cc1CC(=O)c1sccc1S(=O)(=O)Nc1onc(C)c1Cl)OCO2	216235.0	R23_gupta_2019:912			BBB-	C	training
InChI=1S/C18H16Cl2N2O2/c1-11-10-24-18(13-4-2-3-5-15(13)20)14-8-12(19)6-7-16(14)21-17(23)9-22(11)18/h2-8,11H,9-10H2,1H3,(H,21,23)	Mexazolam	10-chloro-11b-(2-chlorophenyl)-3-methyl-2,3,5,7-tetrahydro-[1,3]oxazolo[3,2-d][1,4]benzodiazepin-6-one	CC1COC2(c3ccccc3Cl)c3cc(Cl)ccc3NC(=O)CN12	4177.0	R6_adenot_2004:729			BBB+	C	training
InChI=1S/C18H16ClFN2O3/c19-11-5-6-16-14(7-11)18(13-3-1-2-4-15(13)20)21-8-17(25)22(16)9-12(24)10-23/h1-7,12,23-24H,8-10H2	Proflazepam	7-chloro-1-(2,3-dihydroxypropyl)-5-(2-fluorophenyl)-3H-1,4-benzodiazepin-2-one	O=C1CN=C(c2ccccc2F)c2cc(Cl)ccc2N1CC(O)CO	3050433.0	R6_adenot_2004:743			BBB+	C	training
InChI=1S/C18H16N2O/c1-10-15-9-20(3)7-6-13(15)11(2)18-17(10)14-8-12(21)4-5-16(14)19-18/h4-9,21H,1-3H3/p+1	Elliptinium Acetate|Elliptinium	2,5,11-trimethyl-6H-pyrido[4,3-b]carbazol-2-ium-9-ol	Cc1c2cc[n+](C)cc2c(C)c2c1[nH]c1ccc(O)cc12	42723.0	R23_gupta_2019:1056			BBB-	C	training
InChI=1S/C18H16N2O/c19-12-13-4-3-7-17(10-13)20-18(21)16-9-8-14-5-1-2-6-15(14)11-16/h1-11H,12,19H2,(H,20,21)	11|N-[3-(Aminomethyl)Phenyl]Naphthalene-2-Carboxamide	N-[3-(aminomethyl)phenyl]naphthalene-2-carboxamide	NCc1cccc(NC(=O)c2ccc3ccccc3c2)c1	16777599.0	R47_radchenko_2020:466	0.74	A	BBB+	A	training
InChI=1S/C18H16N2O3/c1-2-20-11-15(18(22)23)16(21)14-9-8-13(19-17(14)20)10-12-6-4-3-5-7-12/h3-9,11H,2,10H2,1H3,(H,22,23)	Amfonelic-Acid|Amfonelic Acid	7-benzyl-1-ethyl-4-oxo-1,8-naphthyridine-3-carboxylic acid	CCn1cc(C(=O)O)c(=O)c2ccc(Cc3ccccc3)nc21	2137.0	R6_adenot_2004:1314			BBB+	C	training
InChI=1S/C18H16N4O6S/c1-18(2)12(17(27)28)22-14(24)11(15(22)29-18)21-13(23)9-10(16(25)26)20-8-6-4-3-5-7(8)19-9/h3-6,11-12,15H,1-2H3,(H,21,23)(H,25,26)(H,27,28)/t11-,12+,15-/m1/s1	Quinacillin	(2S,5R,6R)-6-[(3-carboxyquinoxaline-2-carbonyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid	CC1(C)S[C@@H]2[C@H](NC(=O)c3nc4ccccc4nc3C(=O)O)C(=O)N2[C@H]1C(=O)O	92894.0	R6_adenot_2004:260			BBB-	C	training
InChI=1S/C18H16O3/c1-12(2)21-14-8-9-15-17(10-14)20-11-16(18(15)19)13-6-4-3-5-7-13/h3-12H,1-2H3	Ipriflavone	3-phenyl-7-propan-2-yloxychromen-4-one	CC(C)Oc1ccc2c(=O)c(-c3ccccc3)coc2c1	3747.0	R14_ghose_2012:627			BBB-	C	training
InChI=1S/C18H16O3/c1-2-13(12-8-4-3-5-9-12)16-17(19)14-10-6-7-11-15(14)21-18(16)20/h3-11,13,19H,2H2,1H3	Phenprocoumon	4-hydroxy-3-(1-phenylpropyl)chromen-2-one	CCC(c1ccccc1)c1c(O)c2ccccc2oc1=O	54680692.0	R14_ghose_2012:769			BBB-	C	training
InChI=1S/C18H17Cl2N3O2S/c19-13-2-1-3-14(12-13)26(24,25)23-9-6-15-17(23)5-4-16(20)18(15)22-10-7-21-8-11-22/h1-6,9,12,21H,7-8,10-11H2	Compound-12|5-Chloro-1-(3-Chlorophenyl)Sulfonyl-4-Piperazin-1-Ylindole	5-chloro-1-(3-chlorophenyl)sulfonyl-4-piperazin-1-ylindole	O=S(=O)(c1cccc(Cl)c1)n1ccc2c(N3CCNCC3)c(Cl)ccc21	9822810.0	R26_chico_2009:126	0.48	A	BBB+	A	training
InChI=1S/C18H17Cl2N3O3/c1-23(17(25)10-22-16(24)9-21)15-7-6-11(19)8-13(15)18(26)12-4-2-3-5-14(12)20/h2-8H,9-10,21H2,1H3,(H,22,24)	Lorzafone	2-amino-N-[2-[4-chloro-2-(2-chlorobenzoyl)-N-methylanilino]-2-oxoethyl]acetamide	CN(C(=O)CNC(=O)CN)c1ccc(Cl)cc1C(=O)c1ccccc1Cl	54760.0	R6_adenot_2004:1409			BBB+	C	training
InChI=1S/C18H17ClN2O/c1-20-16-7-6-13(19)10-15(16)18-14-5-3-2-4-12(14)8-9-21(18)11-17(20)22/h2-7,10,18H,8-9,11H2,1H3	Clazolam	2-chloro-5-methyl-7,9,10,14b-tetrahydroisoquinolino[2,1-d][1,4]benzodiazepin-6-one	CN1C(=O)CN2CCc3ccccc3C2c2cc(Cl)ccc21	24107.0	R6_adenot_2004:691			BBB+	C	training
InChI=1S/C18H17ClN2O2/c1-11-7-13-9-16(22-2)17(23-3)10-15(13)18(21-20-11)12-5-4-6-14(19)8-12/h4-6,8-10H,7H2,1-3H3	Girisopam	1-(3-chlorophenyl)-7,8-dimethoxy-4-methyl-5H-2,3-benzodiazepine	COc1cc2c(cc1OC)C(c1cccc(Cl)c1)=NN=C(C)C2	71257.0	R6_adenot_2004:713			BBB+	C	training
InChI=1S/C18H17ClN2O2/c1-12-10-21-11-17(22)20-16-8-7-14(19)9-15(16)18(21,23-12)13-5-3-2-4-6-13/h2-9,12H,10-11H2,1H3,(H,20,22)	Oxazolam	10-chloro-2-methyl-11b-phenyl-2,3,5,7-tetrahydro-[1,3]oxazolo[3,2-d][1,4]benzodiazepin-6-one	CC1CN2CC(=O)Nc3ccc(Cl)cc3C2(c2ccccc2)O1	4617.0	R6_adenot_2004:737			BBB+	C	training
InChI=1S/C18H17ClN2O3/c1-2-24-18(23)20-11-10-17(22)21(14-6-4-3-5-7-14)16-12-13(19)8-9-15(16)20/h3-9,12H,2,10-11H2,1H3	Arfendazam	ethyl 7-chloro-4-oxo-5-phenyl-2,3-dihydro-1,5-benzodiazepine-1-carboxylate	CCOC(=O)N1CCC(=O)N(c2ccccc2)c2cc(Cl)ccc21	65803.0	R6_adenot_2004:682			BBB+	C	training
InChI=1S/C18H17F3N2O3/c19-18(20,21)15-7-3-5-13(11-15)17(14-6-4-9-22-12-14)23-26-10-2-1-8-16(24)25/h3-7,9,11-12H,1-2,8,10H2,(H,24,25)/b23-17+	Ridogrel|5-[[Pyridin-3-Yl-[3-(Trifluoromethyl)Phenyl]Methylidene]Amino]Oxypentanoic Acid	5-[(Z)-[pyridin-3-yl-[3-(trifluoromethyl)phenyl]methylidene]amino]oxypentanoic acid	O=C(O)CCCCO/N=C(\c1cccnc1)c1cccc(C(F)(F)F)c1	6324661.0	R23_gupta_2019:885|R25_brito_sanchez_2015:313	-1.0	A	BBB+	A	training
InChI=1S/C18H17F3N2O3/c19-18(20,21)15-7-3-5-13(11-15)17(14-6-4-9-22-12-14)23-26-10-2-1-8-16(24)25/h3-7,9,11-12H,1-2,8,10H2,(H,24,25)/b23-17-	Ridogrel	5-[(E)-[pyridin-3-yl-[3-(trifluoromethyl)phenyl]methylidene]amino]oxypentanoic acid	O=C(O)CCCCO/N=C(/c1cccnc1)c1cccc(C(F)(F)F)c1	5362391.0	R46_mendoza_valencia_2017:276	-1.0	A	BBB+	A	training
InChI=1S/C18H17F3N4O/c1-12-23-16(15(10-22)17(26)25(12)11-18(19,20)21)24-8-6-13-4-2-3-5-14(13)7-9-24/h2-5H,6-9,11H2,1H3	47|2-Methyl-6-Oxo-4-(1,2,4,5-Tetrahydro-3-Benzazepin-3-Yl)-1-(2,2,2-Trifluoroethyl)Pyrimidine-5-Carbonitrile	2-methyl-6-oxo-4-(1,2,4,5-tetrahydro-3-benzazepin-3-yl)-1-(2,2,2-trifluoroethyl)pyrimidine-5-carbonitrile	Cc1nc(N2CCc3ccccc3CC2)c(C#N)c(=O)n1CC(F)(F)F	22004013.0	R47_radchenko_2020:428	0.6	A	BBB+	A	training
InChI=1S/C18H17N5O2/c1-10(2)23-13-6-4-3-5-12(13)22-9-19-14(15(22)18(23)24)16-20-17(25-21-16)11-7-8-11/h3-6,9-11H,7-8H2,1-2H3	Panadiplon	3-(5-cyclopropyl-1,2,4-oxadiazol-3-yl)-5-propan-2-ylimidazo[1,5-a]quinoxalin-4-one	CC(C)n1c(=O)c2c(-c3noc(C4CC4)n3)ncn2c2ccccc21	3033821.0	R6_adenot_2004:738			BBB+	C	training
InChI=1S/C18H17N5O2/c1-11(2)23-21-18(20-22-23)19-17(24)16-12-7-3-5-9-14(12)25-15-10-6-4-8-13(15)16/h3-11,16H,1-2H3,(H,19,21,24)	35|9H-Xanthene-9-Carboxamide, N-[2-(1-Methylethyl)-2H-Tetrazol-5-Yl]-	N-(2-propan-2-yltetrazol-5-yl)-9H-xanthene-9-carboxamide	CC(C)n1nnc(NC(=O)C2c3ccccc3Oc3ccccc32)n1	9862542.0	R47_radchenko_2020:449	-0.12	A	BBB+	A	training
InChI=1S/C18H18BrClN2O/c1-22-13(11-23-2)10-21-18(14-5-3-4-6-16(14)20)15-9-12(19)7-8-17(15)22/h3-9,13H,10-11H2,1-2H3	Metaclazepam	7-bromo-5-(2-chlorophenyl)-2-(methoxymethyl)-1-methyl-2,3-dihydro-1,4-benzodiazepine	COCC1CN=C(c2ccccc2Cl)c2cc(Br)ccc2N1C	71272.0	R6_adenot_2004:728|R14_ghose_2012:141			BBB+	C	training
InChI=1S/C18H18ClN2O2P/c1-24(2,23)12-21-16-9-8-14(19)10-15(16)18(20-11-17(21)22)13-6-4-3-5-7-13/h3-10H,11-12H2,1-2H3	Fosazepam	7-chloro-1-(dimethylphosphorylmethyl)-5-phenyl-3H-1,4-benzodiazepin-2-one	CP(C)(=O)CN1C(=O)CN=C(c2ccccc2)c2cc(Cl)ccc21	37114.0	R6_adenot_2004:711			BBB+	C	training
InChI=1S/C18H18ClN3O/c1-21-8-10-22(11-9-21)18-14-12-13(19)6-7-16(14)23-17-5-3-2-4-15(17)20-18/h2-7,12H,8-11H2,1H3	Loxapine	8-chloro-6-(4-methylpiperazin-1-yl)benzo[b][1,4]benzoxazepine	CN1CCN(C2=Nc3ccccc3Oc3ccc(Cl)cc32)CC1	3964.0	R6_adenot_2004:1172|R14_ghose_2012:129|R23_gupta_2019:128|R25_brito_sanchez_2015:503|R26_chico_2009:251|R46_mendoza_valencia_2017:421	0.8	B	BBB+	A	training
InChI=1S/C18H18ClN3S/c1-21-8-10-22(11-9-21)18-14-12-13(19)6-7-16(14)23-17-5-3-2-4-15(17)20-18/h2-7,12H,8-11H2,1H3	Clotiapine|Clothiapine	8-chloro-6-(4-methylpiperazin-1-yl)benzo[b][1,4]benzothiazepine	CN1CCN(C2=Nc3ccccc3Sc3ccc(Cl)cc32)CC1	16351.0	R6_adenot_2004:1554|R14_ghose_2012:294|R23_gupta_2019:51			BBB+	C	test
InChI=1S/C18H18ClN5O4/c1-18(7-25,8-26)17-21-15(22-28-17)14-12-6-23(2)16(27)13-10(19)4-3-5-11(13)24(12)9-20-14/h3-5,9,25-26H,6-8H2,1-2H3	Bishydroxy L-663,581 Metabolite|Bis-Hydroxylated-L-663581		CN1Cc2c(-c3noc(C(C)(CO)CO)n3)ncn2-c2cccc(Cl)c2C1=O		R12_garg_2006:46|R25_brito_sanchez_2015:103|R46_mendoza_valencia_2017:101	-1.82	B	BBB-	A	training
InChI=1S/C18H18ClNO/c1-20-9-8-13-15-10-12(19)6-7-18(15)21-17-5-3-2-4-14(17)16(13)11-20/h2-7,10,13,16H,8-9,11H2,1H3/t13-,16+/m1/s1	7-K06		CN1CC[C@@H]2c3cc(Cl)ccc3Oc3ccccc3[C@H]2C1		R28_li_2005:148			BBB+	C	training
InChI=1S/C18H18ClNO2/c1-20-9-8-18(21)14-4-2-3-5-17(14)22-16-7-6-12(19)10-13(16)15(18)11-20/h2-7,10,15,21H,8-9,11H2,1H3	B-102, Asenapine, Org5222		CN1CCC2(O)c3ccccc3Oc3ccc(Cl)cc3C2C1		R26_chico_2009:69	1.03	A	BBB+	A	training
InChI=1S/C18H18ClNOS/c1-20(2)9-10-21-16-11-13-5-3-4-6-17(13)22-18-8-7-14(19)12-15(16)18/h3-8,11-12H,9-10H2,1-2H3	Zotepine	2-(3-chlorobenzo[b][1]benzothiepin-5-yl)oxy-N,N-dimethylethanamine	CN(C)CCOC1=Cc2ccccc2Sc2ccc(Cl)cc21	5736.0	R6_adenot_2004:1634|R14_ghose_2012:275|R14_ghose_2012:306|R23_gupta_2019:269|R37_chen_2011:111			BBB+	C	training
InChI=1S/C18H18ClNS/c1-20(2)11-5-7-14-15-6-3-4-8-17(15)21-18-10-9-13(19)12-16(14)18/h3-4,6-10,12H,5,11H2,1-2H3/b14-7+	Chlorprothixine|(3E)-3-(2-Chloro-9H-Thioxanthen-9-Ylidene)-N,N-Dimethylpropan-1-Amine	(3E)-3-(2-chlorothioxanthen-9-ylidene)-N,N-dimethylpropan-1-amine	CN(C)CC/C=C1\c2ccccc2Sc2ccc(Cl)cc21	667466.0	R14_ghose_2012:45			BBB+	C	training
InChI=1S/C18H18ClNS/c1-20(2)11-5-7-14-15-6-3-4-8-17(15)21-18-10-9-13(19)12-16(14)18/h3-4,6-10,12H,5,11H2,1-2H3/b14-7-	Chlorprothixene	(3Z)-3-(2-chlorothioxanthen-9-ylidene)-N,N-dimethylpropan-1-amine	CN(C)CC/C=C1/c2ccccc2Sc2ccc(Cl)cc21	667467.0	R6_adenot_2004:1546|R7_andres_2006:41|R29_subramanian_2003:34|R50_sobanska_2019:92|R51_doninger_2002:180			BBB+	C	training
InChI=1S/C18H18FN3/c19-14-1-2-17-15(11-14)16-12-22(10-6-18(16)21-17)9-5-13-3-7-20-8-4-13/h1-4,7-8,11,21H,5-6,9-10,12H2	Carvotroline	8-fluoro-2-(2-pyridin-4-ylethyl)-1,3,4,5-tetrahydropyrido[4,3-b]indole	Fc1ccc2[nH]c3c(c2c1)CN(CCc1ccncc1)CC3	72038.0	R6_adenot_2004:1129			BBB+	C	training
InChI=1S/C18H18FN3O/c19-14-7-5-13(6-8-14)12-22-16-4-2-1-3-15(16)21-18(22)17-11-20-9-10-23-17/h1-8,17,20H,9-12H2/t17-/m1/s1	9B|(2R)-2-[1-[(4-Fluorophenyl)Methyl]Benzimidazol-2-Yl]Morpholine	(2R)-2-[1-[(4-fluorophenyl)methyl]benzimidazol-2-yl]morpholine	Fc1ccc(Cn2c([C@H]3CNCCO3)nc3ccccc32)cc1	57402315.0	R25_brito_sanchez_2015:525|R46_mendoza_valencia_2017:439	0.77	B	BBB+	A	training
InChI=1S/C18H18FN3S/c19-14-7-5-13(6-8-14)12-22-16-4-2-1-3-15(16)21-18(22)17-11-20-9-10-23-17/h1-8,17,20H,9-12H2/t17-/m1/s1	10E|(2R)-2-[1-[(4-Fluorophenyl)Methyl]Benzimidazol-2-Yl]Thiomorpholine	(2R)-2-[1-[(4-fluorophenyl)methyl]benzimidazol-2-yl]thiomorpholine	Fc1ccc(Cn2c([C@H]3CNCCS3)nc3ccccc32)cc1	57397056.0	R25_brito_sanchez_2015:526|R46_mendoza_valencia_2017:440	0.89	B	BBB+	A	training
InChI=1S/C18H18N2O/c1-12(2)20-16-11-13(3)9-10-15(16)17(19-18(20)21)14-7-5-4-6-8-14/h4-12H,1-3H3	Proquazone	7-methyl-4-phenyl-1-propan-2-ylquinazolin-2-one	Cc1ccc2c(-c3ccccc3)nc(=O)n(C(C)C)c2c1	31508.0	R14_ghose_2012:803			BBB-	C	test
InChI=1S/C18H18N2O/c1-19-12-13-21-20-18-16-8-4-2-6-14(16)10-11-15-7-3-5-9-17(15)18/h2-11,19H,12-13H2,1H3	Demexiptiline	N-methyl-2-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,9,11,13-heptaenylideneamino)oxyethanamine	CNCCON=c1c2ccccc2ccc2ccccc12	28876.0	R6_adenot_2004:1558			BBB+	C	training
InChI=1S/C18H18N2O2/c1-20(2)11-12-6-8-13(9-7-12)15-10-19-18(22)14-4-3-5-16(21)17(14)15/h3-10,21H,11H2,1-2H3,(H,19,22)	Klp-440|4-(4-((Dimethylamino)Methyl)Phenyl)-5-Hydroxyisoquinolin-1(2H)-One	4-[4-[(dimethylamino)methyl]phenyl]-5-hydroxy-2H-isoquinolin-1-one	CN(C)Cc1ccc(-c2c[nH]c(=O)c3cccc(O)c23)cc1	9839073.0	R25_brito_sanchez_2015:452|R46_mendoza_valencia_2017:378	-0.09	B	BBB+	A	training
InChI=1S/C18H18N2O2/c1-22-14-8-6-13(7-9-14)17-12-18(19-10-11-21)15-4-2-3-5-16(15)20-17/h2-9,12,21H,10-11H2,1H3,(H,19,20)	25 Test|2-[[2-(4-Methoxyphenyl)Quinolin-4-Yl]Amino]Ethanol	2-[[2-(4-methoxyphenyl)quinolin-4-yl]amino]ethanol	COc1ccc(-c2cc(NCCO)c3ccccc3n2)cc1	9971682.0	R47_radchenko_2020:447	0.9	A	BBB+	A	test
InChI=1S/C18H18N2O6S/c1-10(21)26-8-12-9-27-17-14(16(23)20(17)15(12)18(24)25)19-13(22)7-11-5-3-2-4-6-11/h2-6,14,17H,7-9H2,1H3,(H,19,22)(H,24,25)/t14-,17-/m1/s1	Cefaloram	(6R,7R)-3-(acetyloxymethyl)-8-oxo-7-[(2-phenylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid	CC(=O)OCC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)Cc3ccccc3)[C@H]2SC1	68940.0	R6_adenot_2004:156			BBB-	C	training
InChI=1S/C18H18N4O2/c1-14(12-15-8-4-2-5-9-15)22-13-17(24-21-22)20-18(23)19-16-10-6-3-7-11-16/h2-11,13-14H,12H2,1H3,(H-,19,20,21,23)	Mesocarb|Mesocarb (1 Mg/Ml In Methanol)	N-phenyl-N'-[3-(1-phenylpropan-2-yl)oxadiazol-3-ium-5-yl]carbamimidate	CC(Cc1ccccc1)[n+]1cc(N=C([O-])Nc2ccccc2)on1	71932.0	R6_adenot_2004:1298			BBB+	C	training
InChI=1S/C18H18N6O5S2/c1-23-18(20-21-22-23)31-8-10-7-30-16-11(15(27)24(16)12(10)17(28)29)19-14(26)13(25)9-5-3-2-4-6-9/h2-6,11,13,16,25H,7-8H2,1H3,(H,19,26)(H,28,29)/t11-,13-,16-/m1/s1	Cefamandole	(6R,7R)-7-[[(2R)-2-hydroxy-2-phenylacetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid	Cn1nnnc1SCC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)[C@H](O)c3ccccc3)[C@H]2SC1	456255.0	R6_adenot_2004:159|R23_gupta_2019:418			BBB-	C	training
InChI=1S/C18H18N6O5S2/c19-12(8-1-3-10(25)4-2-8)15(26)21-13-16(27)24-14(18(28)29)9(7-31-17(13)24)6-30-11-5-20-23-22-11/h1-5,12-13,17,25H,6-7,19H2,(H,21,26)(H,28,29)(H,20,22,23)/t12-,13-,17-/m1/s1	Cefatrizine	(6R,7R)-7-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-8-oxo-3-(2H-triazol-4-ylsulfanylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid	N[C@@H](C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(CSc3cn[nH]n3)CS[C@H]12)c1ccc(O)cc1	6410758.0	R6_adenot_2004:162			BBB-	C	training
InChI=1S/C18H18N6O8S3/c25-13(9-4-2-1-3-5-9)14(26)19-11-15(27)24-12(17(28)29)10(6-33-16(11)24)7-34-18-20-21-22-23(18)8-35(30,31)32/h1-5,11,13,16,25H,6-8H2,(H,19,26)(H,28,29)(H,30,31,32)/t11-,13-,16-/m1/s1	Cefonicid	(6R,7R)-7-[[(2R)-2-hydroxy-2-phenylacetyl]amino]-8-oxo-3-[[1-(sulfomethyl)tetrazol-5-yl]sulfanylmethyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid	O=C(O)C1=C(CSc2nnnn2CS(=O)(=O)O)CS[C@@H]2[C@H](NC(=O)[C@H](O)c3ccccc3)C(=O)N12	43594.0	R6_adenot_2004:179|R23_gupta_2019:426			BBB-	C	training
InChI=1S/C18H18N8O7S3/c1-25-18(22-12(28)13(29)23-25)36-4-6-3-34-15-9(14(30)26(15)10(6)16(31)32)21-11(27)8(24-33-2)7-5-35-17(19)20-7/h5,9,15H,3-4H2,1-2H3,(H2,19,20)(H,21,27)(H,23,29)(H,31,32)/b24-8-/t9-,15-/m1/s1	Ceftriaxone|Ceftriaxone Sodium|(E)-Ceftriaxone	(6R,7R)-7-[[(2E)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-5,6-dioxo-1H-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid	CO/N=C(/C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(CSc3nc(=O)c(=O)[nH]n3C)CS[C@H]12)c1csc(N)n1	5361919.0	R6_adenot_2004:204|R7_andres_2006:27|R23_gupta_2019:439|R29_subramanian_2003:28			BBB-	C	training
InChI=1S/C18H18O2/c1-3-17(13-5-9-15(19)10-6-13)18(4-2)14-7-11-16(20)12-8-14/h3-12,19-20H,1-2H3/b17-3+,18-4+	Dienestrol	4-[(2E,4E)-4-(4-hydroxyphenyl)hexa-2,4-dien-3-yl]phenol	C/C=C(C(=C/C)/c1ccc(O)cc1)\c1ccc(O)cc1	667476.0	R23_gupta_2019:521			BBB-	C	training
InChI=1S/C18H19Cl2NO4/c1-5-25-18(23)14-10(3)21-9(2)13(17(22)24-4)15(14)11-7-6-8-12(19)16(11)20/h6-8,15,21H,5H2,1-4H3	Felodipine	5-O-ethyl 3-O-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate	CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc(Cl)c1Cl	3333.0	R6_adenot_2004:29|R7_andres_2006:62|R14_ghose_2012:551|R29_subramanian_2003:59			BBB-	C	training
InChI=1S/C18H19ClN2O3/c1-20-10-17-11-21(18(22)24-17)15-5-7-16(8-6-15)23-12-13-3-2-4-14(19)9-13/h2-9,17,20H,10-12H2,1H3/t17-/m1/s1	Almoxatone	(5R)-3-[4-[(3-chlorophenyl)methoxy]phenyl]-5-(methylaminomethyl)-1,3-oxazolidin-2-one	CNC[C@@H]1CN(c2ccc(OCc3cccc(Cl)c3)cc2)C(=O)O1	172287.0	R6_adenot_2004:962			BBB+	C	training
InChI=1S/C18H19ClN4/c1-22-8-10-23(11-9-22)18-14-4-2-3-5-15(14)20-16-7-6-13(19)12-17(16)21-18/h2-7,12,20H,8-11H2,1H3	Clozapine	3-chloro-6-(4-methylpiperazin-1-yl)-11H-benzo[b][1,4]benzodiazepine	CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1	135398737.0	R6_adenot_2004:1555|R7_andres_2006:40|R14_ghose_2012:55|R25_brito_sanchez_2015:494|R26_chico_2009:114|R29_subramanian_2003:42|R34_broccatelli_2012:147|R37_chen_2011:24|R46_mendoza_valencia_2017:414|R50_sobanska_2019:83	0.67	B1	BBB+	A	test
InChI=1S/C18H19ClN4/c19-16-4-6-17(7-5-16)22-11-9-21(10-12-22)14-15-13-20-23-8-2-1-3-18(15)23/h1-8,13H,9-12,14H2	3-[4-(4-Chloro-Phenyl)-Piperazin-1-Ylmethyl]-Pyrazolo[1,5-A]Pyridine|Pyrazolo[1,5-A]Pyridine, 3-[[4-(4-Chlorophenyl)-1-Piperazinyl]Methyl]-	3-[[4-(4-chlorophenyl)piperazin-1-yl]methyl]pyrazolo[1,5-a]pyridine	Clc1ccc(N2CCN(Cc3cnn4ccccc34)CC2)cc1	10404144.0	R25_brito_sanchez_2015:487|R46_mendoza_valencia_2017:408	0.64	B	BBB+	A	training
InChI=1S/C18H19F3N2S/c1-22(2)10-5-11-23-14-6-3-4-7-16(14)24-17-9-8-13(12-15(17)23)18(19,20)21/h3-4,6-9,12H,5,10-11H2,1-2H3	Triflupromazine|Trifluopromazine	N,N-dimethyl-3-[2-(trifluoromethyl)phenothiazin-10-yl]propan-1-amine	CN(C)CCCN1c2ccccc2Sc2ccc(C(F)(F)F)cc21	5568.0	R6_adenot_2004:1632|R14_ghose_2012:260|R21_muehlbacher_2011:139|R25_brito_sanchez_2015:558|R28_li_2005:312|R40_vilar_2010:280|R47_radchenko_2020:350|R51_doninger_2002:317	1.44	B	BBB+	A	training
InChI=1S/C18H19N/c1-19-12-18-11-10-13(14-6-2-4-8-16(14)18)15-7-3-5-9-17(15)18/h2-9,13,19H,10-12H2,1H3	Benzoctamine	N-methyl-1-(1-tetracyclo[6.6.2.02,7.09,14]hexadeca-2,4,6,9,11,13-hexaenyl)methanamine	CNCC12CCC(c3ccccc31)c1ccccc12	28425.0	R6_adenot_2004:1421			BBB+	C	training
InChI=1S/C18H19N3O/c1-12-19-9-10-21(12)11-13-7-8-16-17(18(13)22)14-5-3-4-6-15(14)20(16)2/h3-6,9-10,13H,7-8,11H2,1-2H3	Ondansetron	9-methyl-3-[(2-methylimidazol-1-yl)methyl]-2,3-dihydro-1H-carbazol-4-one	Cc1nccn1CC1CCc2c(c3ccccc3n2C)C1=O	4595.0	R6_adenot_2004:56|R6_adenot_2004:1397|R14_ghose_2012:173|R23_gupta_2019:172|R25_brito_sanchez_2015:419	0.28	A	BBB+	A	training
InChI=1S/C18H19N3O2/c1-11-8-13-9-16(22-2)17(23-3)10-15(13)18(21-20-11)12-4-6-14(19)7-5-12/h4-7,9-10H,8,19H2,1-3H3	Nerisopam	4-(7,8-dimethoxy-4-methyl-5H-2,3-benzodiazepin-1-yl)aniline	COc1cc2c(cc1OC)C(c1ccc(N)cc1)=NN=C(C)C2	65875.0	R6_adenot_2004:714			BBB+	C	training
InChI=1S/C18H19N3O5S/c1-2-3-10-8-27-17-13(16(24)21(17)14(10)18(25)26)20-15(23)12(19)9-4-6-11(22)7-5-9/h2-7,12-13,17,22H,8,19H2,1H3,(H,20,23)(H,25,26)/b3-2+/t12-,13-,17-/m1/s1	Cefprozil	(6R,7R)-7-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-8-oxo-3-[(E)-prop-1-enyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid	C/C=C/C1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)[C@H](N)c3ccc(O)cc3)[C@H]2SC1	5281006.0	R6_adenot_2004:145|R14_ghose_2012:434|R23_gupta_2019:434			BBB-	C	training
InChI=1S/C18H19N3O6S/c1-9(22)27-7-11-8-28-17-13(16(24)21(17)14(11)18(25)26)20-15(23)12(19)10-5-3-2-4-6-10/h2-6,12-13,17H,7-8,19H2,1H3,(H,20,23)(H,25,26)/t12-,13-,17-/m1/s1	Cefaloglycin|Cephaloglycin	(6R,7R)-3-(acetyloxymethyl)-7-[[(2R)-2-amino-2-phenylacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid	CC(=O)OCC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)[C@H](N)c3ccccc3)[C@H]2SC1	19150.0	R6_adenot_2004:154|R14_ghose_2012:439|R23_gupta_2019:443			BBB-	C	training
InChI=1S/C18H19N5O2/c1-22(2)12-13-6-8-19-16(10-13)14-4-3-5-15(11-14)21-18-17(23(24)25)7-9-20-18/h3-11,20-21H,12H2,1-2H3	Skb29|Bbcpd19|112598-49-9|B-059|23|N-[3-[4-[(Dimethylamino)Methyl]Pyridin-2-Yl]Phenyl]-3-Nitro-1H-Pyrrol-2-Amine	N-[3-[4-[(dimethylamino)methyl]pyridin-2-yl]phenyl]-3-nitro-1H-pyrrol-2-amine	CN(C)Cc1ccnc(-c2cccc(Nc3[nH]ccc3[N+](=O)[O-])c2)c1	14022486.0	R3_abraham_2006:267|R3_abraham_2006:316|R4_mente_2005:131|R25_brito_sanchez_2015:17|R26_chico_2009:58|R40_vilar_2010:250|R41_toropov_2017:239|R41_toropov_2017:282|R46_mendoza_valencia_2017:17|R47_radchenko_2020:222|R48_hou_2003:59|R52_liu_2001:23	-0.28	B	BBB+	A	training
InChI=1S/C18H19N5O4/c1-18(8-24,9-25)17-20-15(21-27-17)14-13-7-22(2)16(26)11-5-3-4-6-12(11)23(13)10-19-14/h3-6,10,24-25H,7-9H2,1-2H3	Bis-Hydroxylated-L-663581		CN1Cc2c(-c3noc(C(C)(CO)CO)n3)ncn2-c2ccccc2C1=O		R28_li_2005:314			BBB-	C	training
InChI=1S/C18H19NO2/c1-12-5-4-6-13-15-11-19-10-9-18(15,20)14-7-2-3-8-16(14)21-17(12)13/h2-8,15,19-20H,9-11H2,1H3	Org32104|129234-06-6|Cid 22154175|B-105, Org32104|Org-32104	16-methyl-14-oxa-4-azatetracyclo[13.4.0.02,7.08,13]nonadeca-1(19),8,10,12,15,17-hexaen-7-ol	Cc1cccc2c1Oc1ccccc1C1(O)CCNCC21	22154175.0	R3_abraham_2006:213|R4_mente_2005:164|R21_muehlbacher_2011:358|R25_brito_sanchez_2015:338|R26_chico_2009:72|R40_vilar_2010:173|R41_toropov_2017:195|R46_mendoza_valencia_2017:297|R47_radchenko_2020:180|R49_norinder_2002:145	0.52	B	BBB+	A	training
InChI=1S/C18H19NO2/c1-12-5-4-6-13-15-11-19-10-9-18(15,20)14-7-2-3-8-16(14)21-17(12)13/h2-8,15,19-20H,9-11H2,1H3/t15-,18+/m1/s1	Org32104		Cc1cccc2c1Oc1ccccc1[C@@]1(O)CCNC[C@H]21		R28_li_2005:35			BBB+	C	training
InChI=1S/C18H19NO3/c1-19-8-5-11-9-14(22-2)17(21)16-15(11)13(19)10-18(16)6-3-12(20)4-7-18/h3-4,6-7,9,13,21H,5,8,10H2,1-2H3	Glaziovine	11-hydroxy-10-methoxy-5-methylspiro[5-azatricyclo[6.3.1.04,12]dodeca-1(12),8,10-triene-2,4'-cyclohexa-2,5-diene]-1'-one	COc1cc2c3c(c1O)C1(C=CC(=O)C=C1)CC3N(C)CC2	65631.0	R6_adenot_2004:1474|R51_doninger_2002:220			BBB+	C	training
InChI=1S/C18H19NOS/c1-19-12-11-17(18-10-5-13-21-18)20-16-9-4-7-14-6-2-3-8-15(14)16/h2-10,13,17,19H,11-12H2,1H3/t17-/m0/s1	Duloxetine	(3S)-N-methyl-3-naphthalen-1-yloxy-3-thiophen-2-ylpropan-1-amine	CNCC[C@H](Oc1cccc2ccccc12)c1cccs1	60835.0	R6_adenot_2004:571|R14_ghose_2012:312|R23_gupta_2019:79|R34_broccatelli_2012:26|R37_chen_2011:30			BBB+	C	training
InChI=1S/C18H19NS/c1-19(2)13-7-10-14-15-8-3-5-11-17(15)20-18-12-6-4-9-16(14)18/h3-6,8-12H,7,13H2,1-2H3	Prothixene	N,N-dimethyl-3-thioxanthen-9-ylidenepropan-1-amine	CN(C)CCC=C1c2ccccc2Sc2ccccc21	71115.0	R6_adenot_2004:1617			BBB+	C	training
InChI=1S/C18H20ClN3O/c1-20(2)11-6-12-21-16-10-9-14(19)13-17(16)22(18(21)23)15-7-4-3-5-8-15/h3-5,7-10,13H,6,11-12H2,1-2H3	Clodazon	5-chloro-1-[3-(dimethylamino)propyl]-3-phenylbenzimidazol-2-one	CN(C)CCCn1c(=O)n(-c2ccccc2)c2cc(Cl)ccc21	20883.0	R6_adenot_2004:513			BBB+	C	training
InChI=1S/C18H20FN3O4/c1-10-9-26-17-14-11(16(23)12(18(24)25)8-22(10)14)7-13(19)15(17)21-5-3-20(2)4-6-21/h7-8,10H,3-6,9H2,1-2H3,(H,24,25)	Ofloxacin	7-fluoro-2-methyl-6-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid	CC1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23	4583.0	R28_li_2005:322|R46_mendoza_valencia_2017:329	-0.76	A	BBB+	A	training
InChI=1S/C18H20FN3O4/c1-10-9-26-17-14-11(16(23)12(18(24)25)8-22(10)14)7-13(19)15(17)21-5-3-20(2)4-6-21/h7-8,10H,3-6,9H2,1-2H3,(H,24,25)/t10-/m0/s1	Levofloxacin	(2S)-7-fluoro-2-methyl-6-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid	C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23	149096.0	R6_adenot_2004:42|R25_brito_sanchez_2015:376|R28_li_2005:266|R53_friden_2009:14	-0.77	B	BBB+	A	training
InChI=1S/C18H20FN5O4/c1-28-22-14-8-23(6-9(14)5-20)17-13(19)4-11-15(25)12(18(26)27)7-24(10-2-3-10)16(11)21-17/h4,7,9-10H,2-3,5-6,8,20H2,1H3,(H,26,27)/b22-14+	Gemifloxacin|7-[(4E)-3-(Aminomethyl)-4-Methoxyiminopyrrolidin-1-Yl]-1-Cyclopropyl-6-Fluoro-4-Oxo-1,8-Naphthyridine-3-Carboxylic Acid	7-[(4E)-3-(aminomethyl)-4-methoxyiminopyrrolidin-1-yl]-1-cyclopropyl-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid	CO/N=C1/CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN	5464436.0	R14_ghose_2012:589|R23_gupta_2019:629			BBB-	C	training
InChI=1S/C18H20N2/c1-19-10-11-20-17-9-5-3-7-15(17)12-14-6-2-4-8-16(14)18(20)13-19/h2-9,18H,10-13H2,1H3	Mianserin|24219-97-4	5-methyl-2,5-diazatetracyclo[13.4.0.02,7.08,13]nonadeca-1(19),8,10,12,15,17-hexaene	CN1CCN2c3ccccc3Cc3ccccc3C2C1	4184.0	R3_abraham_2006:197|R4_mente_2005:187|R6_adenot_2004:576|R7_andres_2006:206|R12_garg_2006:112|R14_ghose_2012:151|R21_muehlbacher_2011:100|R23_gupta_2019:151|R25_brito_sanchez_2015:299|R26_chico_2009:270|R28_li_2005:29|R39_shayanfar_2011:116|R40_vilar_2010:149|R41_toropov_2017:181|R42_ciura_2020:26|R44_bujak_2015:40|R46_mendoza_valencia_2017:266|R47_radchenko_2020:167|R49_norinder_2002:139|R50_sobanska_2019:42	0.99	B	BBB+	A	test
InChI=1S/C18H20N2/c1-19-16-11-12-20-17-8-3-2-5-13(17)9-10-14-6-4-7-15(16)18(14)20/h2-8,16,19H,9-12H2,1H3	Ciclopramine	N-methyl-1-azatetracyclo[8.7.1.02,7.014,18]octadeca-2,4,6,10(18),11,13-hexaen-15-amine	CNC1CCN2c3ccccc3CCc3cccc1c32	160410.0	R6_adenot_2004:1549			BBB+	C	training
InChI=1S/C18H20N2O/c1-19(2)12-7-13-20-17-11-6-5-9-15(17)14-8-3-4-10-16(14)18(20)21/h3-6,8-11H,7,12-13H2,1-2H3	Fantridone	5-[3-(dimethylamino)propyl]phenanthridin-6-one	CN(C)CCCn1c(=O)c2ccccc2c2ccccc21	28692.0	R6_adenot_2004:539			BBB+	C	training
InChI=1S/C18H20N2S/c1-19-11-10-14(12-19)13-20-15-6-2-4-8-17(15)21-18-9-5-3-7-16(18)20/h2-9,14H,10-13H2,1H3	Methdilazine	10-[(1-methylpyrrolidin-3-yl)methyl]phenothiazine	CN1CCC(CN2c3ccccc3Sc3ccccc32)C1	14677.0	R14_ghose_2012:145|R23_gupta_2019:144			BBB+	C	test
InChI=1S/C18H20O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h3-5,10,14,16,19H,2,6-9H2,1H3/t14-,16+,18+/m1/s1	Equilin	(9S,13S,14S)-3-hydroxy-13-methyl-9,11,12,14,15,16-hexahydro-6H-cyclopenta[a]phenanthren-17-one	C[C@]12CC[C@H]3C(=CCc4cc(O)ccc43)[C@@H]1CCC2=O	223368.0	R23_gupta_2019:1059			BBB-	C	training
InChI=1S/C18H20O2/c1-3-17(13-5-9-15(19)10-6-13)18(4-2)14-7-11-16(20)12-8-14/h5-12,19-20H,3-4H2,1-2H3/b18-17+	Diethylstilbestrol	4-[(E)-4-(4-hydroxyphenyl)hex-3-en-3-yl]phenol	CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1	448537.0	R23_gupta_2019:523|R26_chico_2009:163|R51_doninger_2002:38			BBB-	C	test
InChI=1S/C18H21Cl2N5O/c19-14-4-3-13(9-15(14)20)10-17(26)24-7-8-25-18(21-12-22-25)16(24)11-23-5-1-2-6-23/h3-4,9,12,16H,1-2,5-8,10-11H2/t16-/m1/s1	Sb204484|2-(3,4-Dichlorophenyl)-1-[(8R)-8-(Pyrrolidin-1-Ylmethyl)-6,8-Dihydro-5H-[1,2,4]Triazolo[1,5-A]Pyrazin-7-Yl]Ethanone	2-(3,4-dichlorophenyl)-1-[(8R)-8-(pyrrolidin-1-ylmethyl)-6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazin-7-yl]ethanone	O=C(Cc1ccc(Cl)c(Cl)c1)N1CCn2ncnc2[C@H]1CN1CCCC1	44310743.0	R28_li_2005:399			BBB+	C	training
InChI=1S/C18H21ClN2/c1-20-11-13-21(14-12-20)18(15-5-3-2-4-6-15)16-7-9-17(19)10-8-16/h2-10,18H,11-14H2,1H3	Chlorcyclizine	1-[(4-chlorophenyl)-phenylmethyl]-4-methylpiperazine	CN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1	2710.0	R6_adenot_2004:1394			BBB+	C	training
InChI=1S/C18H21ClN2/c1-21(2)11-5-7-14-15-6-3-4-8-17(15)20-18-10-9-13(19)12-16(14)18/h3-4,6,8-10,12,14,20H,5,7,11H2,1-2H3	Clomacran	3-(2-chloro-9,10-dihydroacridin-9-yl)-N,N-dimethylpropan-1-amine	CN(C)CCCC1c2ccccc2Nc2ccc(Cl)cc21	21382.0	R6_adenot_2004:1138			BBB+	C	training
InChI=1S/C18H21FN2O2/c1-12(9-19)20-10-13(22)11-23-17-8-4-7-16-18(17)14-5-2-3-6-15(14)21-16/h2-8,12-13,20-22H,9-11H2,1H3/t12?,13-/m0/s1	S-1-Fluorocarazolol|(S)-Flurocarazolol	(2S)-1-(9H-carbazol-4-yloxy)-3-(1-fluoropropan-2-ylamino)propan-2-ol	CC(CF)NC[C@H](O)COc1cccc2[nH]c3ccccc3c12	10358392.0	R25_brito_sanchez_2015:425|R46_mendoza_valencia_2017:358	0.58	B	BBB+	A	training
InChI=1S/C18H21N3O/c1-19(2)12-13-21-17-11-7-6-10-16(17)20(3)15-9-5-4-8-14(15)18(21)22/h4-11H,12-13H2,1-3H3	Dibenzepin|Noveril	5-[2-(dimethylamino)ethyl]-11-methylbenzo[b][1,4]benzodiazepin-6-one	CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21	9419.0	R6_adenot_2004:1559|R14_ghose_2012:72|R23_gupta_2019:170			BBB+	C	training
InChI=1S/C18H21N3O3S/c1-13-16(19-9-8-17(13)24-11-5-10-23-2)12-25(22)18-20-14-6-3-4-7-15(14)21-18/h3-4,6-9H,5,10-12H2,1-2H3,(H,20,21)	Rabeprazole	2-[[4-(3-methoxypropoxy)-3-methylpyridin-2-yl]methylsulfinyl]-1H-benzimidazole	COCCCOc1ccnc(CS(=O)c2nc3ccccc3[nH]2)c1C	5029.0	R23_gupta_2019:873			BBB-	C	training
InChI=1S/C18H21N5O2/c1-21-17(24)9-16(22-8-4-7-15(20)12-22)23(18(21)25)11-14-6-3-2-5-13(14)10-19/h2-3,5-6,9,15H,4,7-8,11-12,20H2,1H3/t15-/m1/s1	Alogliptin	2-[[6-[(3R)-3-aminopiperidin-1-yl]-3-methyl-2,4-dioxopyrimidin-1-yl]methyl]benzonitrile	Cn1c(=O)cc(N2CCC[C@@H](N)C2)n(Cc2ccccc2C#N)c1=O	11450633.0	R23_gupta_2019:337			BBB-	C	training
InChI=1S/C18H21N5O2/c1-22(2)12-13-6-8-19-16(10-13)14-4-3-5-15(11-14)21-18-17(23(24)25)7-9-20-18/h3-11,17-18,20-21H,12H2,1-2H3	Bbcpd19		CN(C)Cc1ccnc(-c2cccc(NC3NC=CC3[N+](=O)[O-])c2)c1		R12_garg_2006:35	-0.28	A	BBB+	A	training
InChI=1S/C18H21N5O3S/c24-17-15-5-1-2-6-16(15)27(25,26)23(17)10-4-9-21-11-13-22(14-12-21)18-19-7-3-8-20-18/h1-3,5-8H,4,9-14H2	Revospirone	1,1-dioxo-2-[3-(4-pyrimidin-2-ylpiperazin-1-yl)propyl]-1,2-benzothiazol-3-one	O=C1c2ccccc2S(=O)(=O)N1CCCN1CCN(c2ncccn2)CC1	72024.0	R6_adenot_2004:1508			BBB+	C	training
InChI=1S/C18H21NO/c20-18(15-7-3-1-4-8-15,16-9-5-2-6-10-16)17-11-13-19-14-12-17/h1-10,17,19-20H,11-14H2	Azacyclonol	diphenyl(piperidin-4-yl)methanol	OC(c1ccccc1)(c1ccccc1)C1CCNCC1	15723.0	R6_adenot_2004:1417			BBB+	C	training
InChI=1S/C18H21NO/c20-18(15-9-3-1-4-10-15,16-11-5-2-6-12-16)17-13-7-8-14-19-17/h1-6,9-12,17,19-20H,7-8,13-14H2	Pipradrol	diphenyl(piperidin-2-yl)methanol	OC(c1ccccc1)(c1ccccc1)C1CCCCN1	10083.0	R6_adenot_2004:1305			BBB+	C	training
InChI=1S/C18H21NO2/c1-10-3-5-12-13-9-11-4-6-14(20)16-15(11)18(12,17(10)21-16)7-8-19(13)2/h3-4,6,12-13,17,20H,5,7-9H2,1-2H3/t12-,13+,17-,18-/m0/s1	Methyldesorphine	(4R,4aR,7aS,12bS)-3,7-dimethyl-2,4,4a,5,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-9-ol	CC1=CC[C@H]2[C@H]3Cc4ccc(O)c5c4[C@@]2(CCN3C)[C@H]1O5	5362518.0	R6_adenot_2004:1055			BBB+	C	training
InChI=1S/C18H21NO2/c1-12-10-19(2)11-14-9-16-15-6-4-3-5-13(15)7-8-17(16)21-18(12,14)20/h3-8,12,14,20H,9-11H2,1-2H3	Naranol	13,15-dimethyl-11-oxa-15-azatetracyclo[8.8.0.02,7.012,17]octadeca-1(10),2,4,6,8-pentaen-12-ol	CC1CN(C)CC2Cc3c(ccc4ccccc34)OC12O	31117.0	R6_adenot_2004:1494			BBB+	C	training
InChI=1S/C18H21NO3/c1-17-14(21)6-4-11-12-9-10-3-5-13(20)16(22-17)15(10)18(11,17)7-8-19(12)2/h3,5,11-12,20H,4,6-9H2,1-2H3/t11-,12+,17-,18-/m0/s1	Metopon	(4R,4aR,7aR,12bS)-9-hydroxy-3,7a-dimethyl-2,4,4a,5,6,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one	CN1CC[C@]23c4c5ccc(O)c4O[C@@]2(C)C(=O)CC[C@H]3[C@H]1C5	5359353.0	R6_adenot_2004:1059			BBB+	C	training
InChI=1S/C18H21NO3/c1-19-8-7-18-11-4-5-13(20)17(18)22-16-14(21-2)6-3-10(15(16)18)9-12(11)19/h3,6,11-12,17H,4-5,7-9H2,1-2H3/t11-,12+,17-,18-/m0/s1	Hydrocodone	(4R,4aR,7aR,12bS)-9-methoxy-3-methyl-1,2,4,4a,5,6,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one	COc1ccc2c3c1O[C@H]1C(=O)CC[C@H]4[C@@H](C2)N(C)CC[C@]314	5284569.0	R6_adenot_2004:1043|R14_ghose_2012:108|R23_gupta_2019:109|R26_chico_2009:211|R34_broccatelli_2012:38|R37_chen_2011:42|R51_doninger_2002:228	0.32	A	BBB+	A	training
InChI=1S/C18H21NO3/c1-19-8-7-18-11-4-5-13(20)17(18)22-16-14(21-2)6-3-10(15(16)18)9-12(11)19/h3-6,11-13,17,20H,7-9H2,1-2H3/t11-,12+,13+,17-,18-/m0/s1	Isocodeine	(4R,4aR,7R,7aR,12bS)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-ol	COc1ccc2c3c1O[C@H]1[C@H](O)C=C[C@H]4[C@@H](C2)N(C)CC[C@@]341	5324288.0	R48_hou_2003:8	0.55	A	BBB+	A	test
InChI=1S/C18H21NO3/c1-19-8-7-18-11-4-5-13(20)17(18)22-16-14(21-2)6-3-10(15(16)18)9-12(11)19/h3-6,11-13,17,20H,7-9H2,1-2H3/t11-,12+,13-,17-,18-/m0/s1	Codeine|76-57-3	(4R,4aR,7S,7aR,12bS)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-ol	COc1ccc2c3c1O[C@H]1[C@@H](O)C=C[C@H]4[C@@H](C2)N(C)CC[C@@]341	5284371.0	R3_abraham_2006:151|R4_mente_2005:20|R5_guerra_2008:29|R6_adenot_2004:1018|R12_garg_2006:62|R14_ghose_2012:57|R17_fu_2008:35|R21_muehlbacher_2011:320|R23_gupta_2019:53|R25_brito_sanchez_2015:193|R26_chico_2009:117|R28_li_2005:17|R39_shayanfar_2011:32|R44_bujak_2015:23|R47_radchenko_2020:127|R49_norinder_2002:90|R49_norinder_2002:121|R51_doninger_2002:189|R53_friden_2009:6	0.55	D	BBB+	A	test
InChI=1S/C18H21NO4/c1-19-8-7-17-14-10-3-4-12(22-2)15(14)23-16(17)11(20)5-6-18(17,21)13(19)9-10/h3-4,13,16,21H,5-9H2,1-2H3/t13-,16+,17+,18-/m1/s1	Oxycodone	(4R,4aS,7aR,12bS)-4a-hydroxy-9-methoxy-3-methyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one	COc1ccc2c3c1O[C@H]1C(=O)CC[C@@]4(O)[C@@H](C2)N(C)CC[C@]314	5284603.0	R6_adenot_2004:1073|R14_ghose_2012:178|R23_gupta_2019:178|R26_chico_2009:297|R34_broccatelli_2012:67|R37_chen_2011:67|R51_doninger_2002:269|R53_friden_2009:27	0.34	C	BBB+	A	training
InChI=1S/C18H21NO5/c1-11(6-12-2-5-17-18(7-12)24-10-23-17)19-9-16(22)13-3-4-14(20)15(21)8-13/h2-5,7-8,11,16,19-22H,6,9-10H2,1H3	Protokylol Hydrochloride|Protokylol	4-[2-[1-(1,3-benzodioxol-5-yl)propan-2-ylamino]-1-hydroxyethyl]benzene-1,2-diol	CC(Cc1ccc2c(c1)OCO2)NCC(O)c1ccc(O)c(O)c1	4969.0	R14_ghose_2012:804			BBB-	C	training
InChI=1S/C18H22ClNO/c1-16(15-21-18-10-6-3-7-11-18)20(13-12-19)14-17-8-4-2-5-9-17/h2-11,16H,12-15H2,1H3	Phenoxybenzamine Hydrochloride|Phenoxybenzamine	N-benzyl-N-(2-chloroethyl)-1-phenoxypropan-2-amine	CC(COc1ccccc1)N(CCCl)Cc1ccccc1	4768.0	R14_ghose_2012:768|R23_gupta_2019:830|R51_doninger_2002:110			BBB-	C	test
InChI=1S/C18H22ClNO/c1-18(21-14-13-20(2)3,15-7-5-4-6-8-15)16-9-11-17(19)12-10-16/h4-12H,13-14H2,1-3H3	Chlorphenoxamine	2-[1-(4-chlorophenyl)-1-phenylethoxy]-N,N-dimethylethanamine	CN(C)CCOC(C)(c1ccccc1)c1ccc(Cl)cc1	6475.0	R6_adenot_2004:1556			BBB+	C	training
InChI=1S/C18H22I3N3O8/c1-5(26)22-12-9(19)8(10(20)14(11(12)21)24(3)6(2)27)17(30)23-13-16(29)15(28)7(4-25)32-18(13)31/h7,13,15-16,18,25,28-29,31H,4H2,1-3H3,(H,22,26)(H,23,30)	Metrizamide|3-Acetamido-5-[Acetyl(Methyl)Amino]-2,4,6-Triiodo-N-[2,4,5-Trihydroxy-6-(Hydroxymethyl)Oxan-3-Yl]Benzamide	3-acetamido-5-[acetyl(methyl)amino]-2,4,6-triiodo-N-[2,4,5-trihydroxy-6-(hydroxymethyl)oxan-3-yl]benzamide	CC(=O)Nc1c(I)c(C(=O)NC2C(O)OC(CO)C(O)C2O)c(I)c(N(C)C(C)=O)c1I	342467.0	R23_gupta_2019:746			BBB-	C	test
InChI=1S/C18H22N2/c1-15-7-8-17(14-16-5-3-2-4-6-16)18(13-15)20-11-9-19-10-12-20/h2-8,13,19H,9-12,14H2,1H3	Delfaprazine	1-(2-benzyl-5-methylphenyl)piperazine	Cc1ccc(Cc2ccccc2)c(N2CCNCC2)c1	205972.0	R6_adenot_2004:523			BBB+	C	training
InChI=1S/C18H22N2/c1-19-11-13-20(14-12-19)18-10-6-5-9-17(18)15-16-7-3-2-4-8-16/h2-10H,11-15H2,1H3	Sifaprazine	1-(2-benzylphenyl)-4-methylpiperazine	CN1CCN(c2ccccc2Cc2ccccc2)CC1	3058753.0	R6_adenot_2004:545			BBB+	C	training
InChI=1S/C18H22N2/c1-19-11-6-12-20-14-17-9-3-2-7-15(17)13-16-8-4-5-10-18(16)20/h2-5,7-10,19H,6,11-14H2,1H3	Mezepine	3-(6,11-dihydrobenzo[c][1]benzazepin-5-yl)-N-methylpropan-1-amine	CNCCCN1Cc2ccccc2Cc2ccccc21	3047746.0	R6_adenot_2004:1594			BBB+	C	training
InChI=1S/C18H22N2/c1-19-12-14-20(15-13-19)18(16-8-4-2-5-9-16)17-10-6-3-7-11-17/h2-11,18H,12-15H2,1H3	Cyclizine	1-benzhydryl-4-methylpiperazine	CN1CCN(C(c2ccccc2)c2ccccc2)CC1	6726.0	R14_ghose_2012:58|R23_gupta_2019:54			BBB+	C	training
InChI=1S/C18H22N2/c1-19-13-6-14-20-17-9-4-2-7-15(17)11-12-16-8-3-5-10-18(16)20/h2-5,7-10,19H,6,11-14H2,1H3	Desipramine|50-47-5	3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N-methylpropan-1-amine	CNCCCN1c2ccccc2CCc2ccccc21	2995.0	R3_abraham_2006:155|R4_mente_2005:185|R6_adenot_2004:524|R12_garg_2006:66|R14_ghose_2012:63|R17_fu_2008:41|R21_muehlbacher_2011:58|R25_brito_sanchez_2015:203|R26_chico_2009:149|R28_li_2005:18|R34_broccatelli_2012:21|R40_vilar_2010:92|R41_toropov_2017:144|R42_ciura_2020:13|R44_bujak_2015:24|R46_mendoza_valencia_2017:188|R47_radchenko_2020:130|R48_hou_2003:114|R49_norinder_2002:87|R49_norinder_2002:130|R49_norinder_2002:137|R51_doninger_2002:196	1.2	D	BBB+	A	training
InChI=1S/C18H22N2/c1-4-15-8-6-10-17(12-15)19-14(3)20-18-11-7-9-16(5-2)13-18/h6-13H,4-5H2,1-3H3,(H,19,20)	9-C17|N,N'-Bis(3-Ethylphenyl)Acetamidine	N,N'-bis(3-ethylphenyl)ethanimidamide	CCc1cccc(/N=C(\C)Nc2cccc(CC)c2)c1	19427054.0	R28_li_2005:172|R47_radchenko_2020:328|R48_hou_2003:17	1.2	B	BBB+	A	training
InChI=1S/C18H22N2O/c1-19-11-4-12-20-17-6-3-2-5-14(17)7-8-15-13-16(21)9-10-18(15)20/h2-3,5-6,9-10,13,19,21H,4,7-8,11-12H2,1H3	1977-15-7|2-Hydroxydesipramine|Zinc 05140934|2-Oh Desm. Imipramine|Zinc-05140934	11-[3-(methylamino)propyl]-5,6-dihydrobenzo[b][1]benzazepin-3-ol	CNCCCN1c2ccccc2CCc2cc(O)ccc21	121249.0	R4_mente_2005:183|R21_muehlbacher_2011:291|R21_muehlbacher_2011:360|R25_brito_sanchez_2015:70|R40_vilar_2010:9|R46_mendoza_valencia_2017:68|R47_radchenko_2020:373	0.53	B	BBB+	A	training
InChI=1S/C18H22N2O2S/c1-14(12-19(2)3)13-20-15-8-4-6-10-17(15)23(21,22)18-11-7-5-9-16(18)20/h4-11,14H,12-13H2,1-3H3	Oxomemazine	3-(5,5-dioxophenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine	CC(CN(C)C)CN1c2ccccc2S(=O)(=O)c2ccccc21	19396.0	R6_adenot_2004:1603			BBB+	C	test
InChI=1S/C18H22N2O5S/c1-17(2,25-10-8-6-5-7-9-10)16(24)19-11-13(21)20-12(15(22)23)18(3,4)26-14(11)20/h5-9,11-12,14H,1-4H3,(H,19,24)(H,22,23)/t11-,12+,14-/m1/s1	Isopropicillin	(2S,5R,6R)-3,3-dimethyl-6-[(2-methyl-2-phenoxypropanoyl)amino]-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid	CC(C)(Oc1ccccc1)C(=O)N[C@@H]1C(=O)N2[C@@H]1SC(C)(C)[C@@H]2C(=O)O	3038477.0	R6_adenot_2004:236			BBB-	C	test
InChI=1S/C18H22N2O5S/c1-4-11(25-10-8-6-5-7-9-10)14(21)19-12-15(22)20-13(17(23)24)18(2,3)26-16(12)20/h5-9,11-13,16H,4H2,1-3H3,(H,19,21)(H,23,24)/t11?,12-,13+,16-/m1/s1	Propicillin	(2S,5R,6R)-3,3-dimethyl-7-oxo-6-(2-phenoxybutanoylamino)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid	CCC(Oc1ccccc1)C(=O)N[C@@H]1C(=O)N2[C@@H]1SC(C)(C)[C@@H]2C(=O)O	92879.0	R6_adenot_2004:259|R14_ghose_2012:799			BBB-	C	test
InChI=1S/C18H22N2OS/c1-19(2)11-6-12-20-15-7-4-5-8-17(15)22-18-10-9-14(21-3)13-16(18)20/h4-5,7-10,13H,6,11-12H2,1-3H3	Methopromazine	3-(2-methoxyphenothiazin-10-yl)-N,N-dimethylpropan-1-amine	COc1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2	18847.0	R6_adenot_2004:1590|R51_doninger_2002:251			BBB+	C	training
InChI=1S/C18H22N2S/c1-14(12-19(2)3)13-20-15-8-4-6-10-17(15)21-18-11-7-5-9-16(18)20/h4-11,14H,12-13H2,1-3H3	Alimemazine|Trimeprazine|Trimeprazine, Alimemazine, Alimezine	N,N,2-trimethyl-3-phenothiazin-10-ylpropan-1-amine	CC(CN(C)C)CN1c2ccccc2Sc2ccccc21	5574.0	R6_adenot_2004:1539|R14_ghose_2012:261|R23_gupta_2019:254|R26_chico_2009:433			BBB+	C	training
InChI=1S/C18H22N2S/c1-3-19(4-2)13-14-20-15-9-5-7-11-17(15)21-18-12-8-6-10-16(18)20/h5-12H,3-4,13-14H2,1-2H3	Diethazine	N,N-diethyl-2-phenothiazin-10-ylethanamine	CCN(CC)CCN1c2ccccc2Sc2ccccc21	65535.0	R6_adenot_2004:1560			BBB+	C	training
InChI=1S/C18H22N4O2/c23-18(24-13-16-4-2-1-3-5-16)22-10-7-15(8-11-22)12-20-17-6-9-19-14-21-17/h1-6,9,14-15H,7-8,10-13H2,(H,19,20,21)	Liv-21|Benzyl 4-[(Pyrimidin-4-Ylamino)Methyl]Piperidine-1-Carboxylate	benzyl 4-[(pyrimidin-4-ylamino)methyl]piperidine-1-carboxylate	O=C(OCc1ccccc1)N1CCC(CNc2ccncn2)CC1	10268255.0	R26_chico_2009:246	-0.2	A	BBB+	A	training
InChI=1S/C18H22N4O2/c23-18(24-14-16-5-2-1-3-6-16)22-11-7-15(8-12-22)13-21-17-19-9-4-10-20-17/h1-6,9-10,15H,7-8,11-14H2,(H,19,20,21)	Liv-20A|Benzyl 4-[(2-Pyrimidinylamino)Methyl]-1-Piperidinecarboxylate	benzyl 4-[(pyrimidin-2-ylamino)methyl]piperidine-1-carboxylate	O=C(OCc1ccccc1)N1CCC(CNc2ncccn2)CC1	9923385.0	R26_chico_2009:245	-0.37	A	BBB+	A	test
InChI=1S/C18H22O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h3,5,10,14-16,19H,2,4,6-9H2,1H3/t14-,15-,16+,18+/m1/s1	Estrone	(8R,9S,13S,14S)-3-hydroxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-one	C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CCC2=O	5870.0	R51_doninger_2002:52			BBB-	C	training
InChI=1S/C18H22O5S/c1-18-9-8-14-13-5-3-12(23-24(20,21)22)10-11(13)2-4-15(14)16(18)6-7-17(18)19/h3,5,10,14-16H,2,4,6-9H2,1H3,(H,20,21,22)/t14?,15?,16?,18-/m0/s1	Conjugated Estrogens|Sulfuric Acid [(13S)-13-Methyl-17-Oxo-7,8,9,11,12,14,15,16-Octahydro-6H-Cyclopenta[A]Phenanthren-3-Yl] Ester	[(13S)-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-yl] hydrogen sulfate	C[C@]12CCC3c4ccc(OS(=O)(=O)O)cc4CCC3C1CCC2=O	10861069.0	R23_gupta_2019:481			BBB-	C	training
InChI=1S/C18H23FINO2/c1-23-18(22)17-15(12-3-5-13(20)6-4-12)11-14-7-8-16(17)21(14)10-2-9-19/h3-6,14-17H,2,7-11H2,1H3/t14-,15+,16+,17-/m0/s1	Ioflupane	methyl (1R,2S,3S,5S)-8-(3-fluoropropyl)-3-(4-iodophenyl)-8-azabicyclo[3.2.1]octane-2-carboxylate	COC(=O)[C@H]1[C@@H](c2ccc(I)cc2)C[C@@H]2CC[C@H]1N2CCCF	10048368.0	R14_ghose_2012:303|R23_gupta_2019:290			BBB+	C	training
InChI=1S/C18H23FN2O2/c19-16-8-7-14(18(20)22)15-9-13(10-23-17(15)16)21(11-3-1-4-11)12-5-2-6-12/h7-8,11-13H,1-6,9-10H2,(H2,20,22)/t13-/m1/s1	Robalzotan	(3R)-3-[di(cyclobutyl)amino]-8-fluoro-3,4-dihydro-2H-chromene-5-carboxamide	NC(=O)c1ccc(F)c2c1C[C@@H](N(C1CCC1)C1CCC1)CO2	3055171.0	R6_adenot_2004:533			BBB+	C	training
InChI=1S/C18H23FO2/c1-18-7-6-13-12-5-3-11(20)8-10(12)2-4-14(13)15(18)9-16(19)17(18)21/h3,5,8,13-17,20-21H,2,4,6-7,9H2,1H3	16A-Fluoroestradiol|16-Fluoro-13-Methyl-6,7,8,9,11,12,14,15,16,17-Decahydrocyclopenta[A]Phenanthrene-3,17-Diol	16-fluoro-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol	CC12CCC3c4ccc(O)cc4CCC3C1CC(F)C2O	14211618.0	R3_abraham_2006:100|R21_muehlbacher_2011:356|R40_vilar_2010:4|R41_toropov_2017:95|R46_mendoza_valencia_2017:48|R47_radchenko_2020:82	-0.3	B	BBB+	A	training
InChI=1S/C18H23FO2/c1-18-7-6-13-12-5-3-11(20)8-10(12)2-4-14(13)15(18)9-16(19)17(18)21/h3,5,8,13-17,20-21H,2,4,6-7,9H2,1H3/t13-,14-,15+,16+,17+,18+/m1/s1	16A-Fluoroestradiol|16Beta-Fluoroestradiol	(8R,9S,13S,14S,16S,17R)-16-fluoro-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol	C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1C[C@H](F)[C@@H]2O	67101.0	R21_muehlbacher_2011:266	-0.3	A	BBB+	A	training
InChI=1S/C18H23FO2/c1-18-7-6-13-12-5-3-11(20)8-10(12)2-4-14(13)15(18)9-16(19)17(18)21/h3,5,8,13-17,20-21H,2,4,6-7,9H2,1H3/t13-,14-,15+,16-,17+,18+/m1/s1	16Alpha-Fluoroestradiol|16Alpha-Fluoro-17Beta-Estradiol	(8R,9S,13S,14S,16R,17R)-16-fluoro-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol	C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1C[C@@H](F)[C@@H]2O	10401972.0	R25_brito_sanchez_2015:49	-0.3	A	BBB+	A	training
InChI=1S/C18H23N3O/c1-4-21(5-2)14-10-11-17(13(3)12-14)20-18(22)15-8-6-7-9-16(15)19/h6-12H,4-5,19H2,1-3H3,(H,20,22)	Atolide	2-amino-N-[4-(diethylamino)-2-methylphenyl]benzamide	CCN(CC)c1ccc(NC(=O)c2ccccc2N)c(C)c1	27761.0	R6_adenot_2004:422			BBB+	C	training
InChI=1S/C18H23N5O2/c1-13(11-14-7-5-4-6-8-14)19-9-10-23-12-20-16-15(23)17(24)22(3)18(25)21(16)2/h4-8,12-13,19H,9-11H2,1-3H3	Fenetylline|Fenethylline	1,3-dimethyl-7-[2-(1-phenylpropan-2-ylamino)ethyl]purine-2,6-dione	CC(Cc1ccccc1)NCCn1cnc2c1c(=O)n(C)c(=O)n2C	19527.0	R6_adenot_2004:1288			BBB+	C	training
InChI=1S/C18H23N5O3/c1-12(15(24)13-7-5-4-6-8-13)19-9-10-23-11-20-16-14(23)17(25)22(3)18(26)21(16)2/h4-8,11-12,15,19,24H,9-10H2,1-3H3	Cafedrine	7-[2-[(1-hydroxy-1-phenylpropan-2-yl)amino]ethyl]-1,3-dimethylpurine-2,6-dione	CC(NCCn1cnc2c1c(=O)n(C)c(=O)n2C)C(O)c1ccccc1	71740.0	R6_adenot_2004:395			BBB+	C	training
InChI=1S/C18H23N9O4S3/c1-25(2)3-4-26-18(22-23-24-26)34-7-9-6-32-15-12(14(29)27(15)13(9)16(30)31)21-11(28)5-10-8-33-17(19)20-10/h8,12,15H,3-7H2,1-2H3,(H2,19,20)(H,21,28)(H,30,31)/t12-,15-/m1/s1	Cefotiam	(6R,7R)-7-[[2-(2-amino-1,3-thiazol-4-yl)acetyl]amino]-3-[[1-[2-(dimethylamino)ethyl]tetrazol-5-yl]sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid	CN(C)CCn1nnnc1SCC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)Cc3csc(N)n3)[C@H]2SC1	43708.0	R6_adenot_2004:184|R23_gupta_2019:431			BBB-	C	training
InChI=1S/C18H23NO/c1-19-13-7-8-14-20-18-12-6-5-11-17(18)15-16-9-3-2-4-10-16/h2-6,9-12,19H,7-8,13-15H2,1H3	Bifemelane	4-(2-benzylphenoxy)-N-methylbutan-1-amine	CNCCCCOc1ccccc1Cc1ccccc1	2377.0	R6_adenot_2004:494			BBB+	C	training
InChI=1S/C18H23NO2/c1-11-16-17(21)14-6-5-13(20)9-15(14)18(11,2)7-8-19(16)10-12-3-4-12/h5-6,9,11-12,16,20H,3-4,7-8,10H2,1-2H3/t11-,16-,18+/m0/s1	Ketazocine	(1R,9S,13R)-10-(cyclopropylmethyl)-4-hydroxy-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-8-one	C[C@H]1[C@H]2C(=O)c3ccc(O)cc3[C@]1(C)CCN2CC1CC1	3054741.0	R6_adenot_2004:1045			BBB+	C	training
InChI=1S/C18H23NO3/c1-13(12-22-17-6-4-3-5-7-17)19-14(2)18(21)15-8-10-16(20)11-9-15/h3-11,13-14,18-21H,12H2,1-2H3	Isoxsuprine|Duvadilan	4-[1-hydroxy-2-(1-phenoxypropan-2-ylamino)propyl]phenol	CC(COc1ccccc1)NC(C)C(O)c1ccc(O)cc1	3783.0	R14_ghose_2012:635			BBB-	C	training
InChI=1S/C18H23NO3/c1-17(21)6-5-11-12-9-10-3-4-13(20)15-14(10)18(11,16(17)22-15)7-8-19(12)2/h3-4,11-12,16,20-21H,5-9H2,1-2H3/t11-,12+,16-,17-,18-/m0/s1	Methyldihydromorphine	(4R,4aR,7S,7aR,12bS)-3,7-dimethyl-1,2,4,4a,5,6,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-7,9-diol	CN1CC[C@]23c4c5ccc(O)c4O[C@H]2[C@@](C)(O)CC[C@H]3[C@H]1C5	5464303.0	R6_adenot_2004:1056			BBB+	C	training
InChI=1S/C18H23NO3/c1-19-8-7-18-11-4-5-13(20)17(18)22-16-14(21-2)6-3-10(15(16)18)9-12(11)19/h3,6,11-13,17,20H,4-5,7-9H2,1-2H3/t11-,12+,13-,17-,18-/m0/s1	Dihydrocodeine	(4R,4aR,7S,7aR,12bS)-9-methoxy-3-methyl-2,4,4a,5,6,7,7a,13-octahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-ol	COc1ccc2c3c1O[C@H]1[C@@H](O)CC[C@H]4[C@@H](C2)N(C)CC[C@@]341	5284543.0	R6_adenot_2004:1031|R14_ghose_2012:75|R23_gupta_2019:67|R25_brito_sanchez_2015:480|R46_mendoza_valencia_2017:404|R51_doninger_2002:199	0.55	B	BBB+	A	training
InChI=1S/C18H23NO4/c1-19-8-7-17-14-10-3-4-12(22-2)15(14)23-16(17)11(20)5-6-18(17,21)13(19)9-10/h3-4,11,13,16,20-21H,5-9H2,1-2H3/t11-,13?,16+,17+,18-/m1/s1	Beta-Oxycodol	(4aS,7R,7aR,12bS)-9-methoxy-3-methyl-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,7-diol	COc1ccc2c3c1O[C@H]1[C@H](O)CC[C@@]4(O)C(C2)N(C)CC[C@]314	131770023.0	R25_brito_sanchez_2015:437	-0.6	A	BBB+	A	training
InChI=1S/C18H23NO4/c1-22-17-8-3-13(11-18(17)23-2)9-10-19-12-16(21)14-4-6-15(20)7-5-14/h3-8,11,16,19-21H,9-10,12H2,1-2H3/t16-/m0/s1	Denopamine	4-[(1R)-2-[2-(3,4-dimethoxyphenyl)ethylamino]-1-hydroxyethyl]phenol	COc1ccc(CCNC[C@H](O)c2ccc(O)cc2)cc1OC	5311064.0	R23_gupta_2019:509			BBB-	C	training
InChI=1S/C18H24Cl2N2O/c19-16-7-6-14(11-17(16)20)12-18(23)22-10-2-1-5-15(22)13-21-8-3-4-9-21/h6-7,11,15H,1-5,8-10,12-13H2/t15-/m0/s1	Brl52537|2-(3,4-Dichlorophenyl)-1-[(2S)-2-(Pyrrolidin-1-Ylmethyl)Piperidin-1-Yl]Ethanone	2-(3,4-dichlorophenyl)-1-[(2S)-2-(pyrrolidin-1-ylmethyl)piperidin-1-yl]ethanone	O=C(Cc1ccc(Cl)c(Cl)c1)N1CCCC[C@H]1CN1CCCC1	6603740.0	R28_li_2005:327			BBB+	C	training
InChI=1S/C18H24ClF3N4O/c19-15-12-14(18(20,21)22)13-16(23-15)25-10-8-24(9-11-25)5-1-2-6-26-7-3-4-17(26)27/h12-13H,1-11H2	7-K08		O=C1CCCN1CCCCN1CCN(c2cc(C(F)(F)F)cc(Cl)n2)CC1		R28_li_2005:149			BBB+	C	test
InChI=1S/C18H24ClN3O2/c19-14-7-13(17(8-15(14)20)24-10-11-1-2-11)18(23)21-16-9-22-5-3-12(16)4-6-22/h7-8,11-12,16H,1-6,9-10,20H2,(H,21,23)	Pancopride	4-amino-N-(1-azabicyclo[2.2.2]octan-3-yl)-5-chloro-2-(cyclopropylmethoxy)benzamide	Nc1cc(OCC2CC2)c(C(=O)NC2CN3CCC2CC3)cc1Cl	71342.0	R6_adenot_2004:1499			BBB+	C	training
InChI=1S/C18H24FNO/c19-17-9-7-16(8-10-17)18(21)2-1-11-20-12-14-3-4-15(13-20)6-5-14/h7-10,14-15H,1-6,11-13H2	Nonaperone	4-(3-azabicyclo[3.2.2]nonan-3-yl)-1-(4-fluorophenyl)butan-1-one	O=C(CCCN1CC2CCC(CC2)C1)c1ccc(F)cc1	3037070.0	R6_adenot_2004:1189			BBB+	C	training
InChI=1S/C18H24I3N3O9/c19-13-11(17(32)22-3-8(29)5-26)14(20)16(24(1-2-25)10(31)7-28)15(21)12(13)18(33)23-4-9(30)6-27/h8-9,25-30H,1-7H2,(H,22,32)(H,23,33)	Ioversol	1-N,3-N-bis(2,3-dihydroxypropyl)-5-[(2-hydroxyacetyl)-(2-hydroxyethyl)amino]-2,4,6-triiodobenzene-1,3-dicarboxamide	O=C(NCC(O)CO)c1c(I)c(C(=O)NCC(O)CO)c(I)c(N(CCO)C(=O)CO)c1I	3741.0	R23_gupta_2019:682			BBB-	C	training
InChI=1S/C18H24N2O5/c1-12(16(21)20-11-5-8-15(20)18(24)25)19-14(17(22)23)10-9-13-6-3-2-4-7-13/h2-4,6-7,12,14-15,19H,5,8-11H2,1H3,(H,22,23)(H,24,25)/t12-,14-,15-/m0/s1	Enalaprilat	(2S)-1-[(2S)-2-[[(1S)-1-carboxy-3-phenylpropyl]amino]propanoyl]pyrrolidine-2-carboxylic acid	C[C@H](N[C@@H](CCc1ccccc1)C(=O)O)C(=O)N1CCC[C@H]1C(=O)O	5462501.0	R23_gupta_2019:1057			BBB-	C	training
InChI=1S/C18H24N4O/c1-21-13-6-5-7-14(21)11-12(10-13)19-18(23)17-15-8-3-4-9-16(15)22(2)20-17/h3-4,8-9,12-14H,5-7,10-11H2,1-2H3,(H,19,23)	Granisetronum	1-methyl-N-(9-methyl-9-azabicyclo[3.3.1]nonan-3-yl)indazole-3-carboxamide	CN1C2CCCC1CC(NC(=O)c1nn(C)c3ccccc13)C2	3510.0	R46_mendoza_valencia_2017:339	-0.69	A	BBB+	A	training
InChI=1S/C18H24N4O/c1-21-13-6-5-7-14(21)11-12(10-13)19-18(23)17-15-8-3-4-9-16(15)22(2)20-17/h3-4,8-9,12-14H,5-7,10-11H2,1-2H3,(H,19,23)/t12?,13-,14+	Granisetron	1-methyl-N-[(1R,5S)-9-methyl-9-azabicyclo[3.3.1]nonan-3-yl]indazole-3-carboxamide	CN1[C@@H]2CCC[C@H]1CC(NC(=O)c1nn(C)c3ccccc13)C2	5284566.0	R14_ghose_2012:105|R21_muehlbacher_2011:81|R23_gupta_2019:106|R25_brito_sanchez_2015:399|R47_radchenko_2020:306	-0.69	B	BBB+	A	training
InChI=1S/C18H24O3/c1-18-7-6-13-12-5-3-11(19)8-10(12)2-4-14(13)15(18)9-16(20)17(18)21/h3,5,8,13-17,19-21H,2,4,6-7,9H2,1H3/t13-,14-,15+,16-,17+,18+/m1/s1	Estriol	(8R,9S,13S,14S,16R,17R)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,16,17-triol	C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1C[C@@H](O)[C@@H]2O	5756.0	R23_gupta_2019:575			BBB-	C	training
InChI=1S/C18H25Cl2N3O/c1-21-8-9-23(15(12-21)13-22-6-2-3-7-22)18(24)11-14-4-5-16(19)17(20)10-14/h4-5,10,15H,2-3,6-9,11-13H2,1H3/t15-/m1/s1	Sankyo|2-(3,4-Dichlorophenyl)-1-[(2R)-4-Methyl-2-(Pyrrolidin-1-Ylmethyl)Piperazin-1-Yl]Ethanone	2-(3,4-dichlorophenyl)-1-[(2R)-4-methyl-2-(pyrrolidin-1-ylmethyl)piperazin-1-yl]ethanone	CN1CCN(C(=O)Cc2ccc(Cl)c(Cl)c2)[C@@H](CN2CCCC2)C1	44309990.0	R28_li_2005:394			BBB+	C	training
InChI=1S/C18H25F3N4O/c19-18(20,21)15-5-6-22-16(14-15)24-12-10-23(11-13-24)7-1-2-8-25-9-3-4-17(25)26/h5-6,14H,1-4,7-13H2	Org13011|142494-12-0|Chebi: 568728|B-104, Org13011|Org-13011|2-Pyrrolidinone, 1-(4-(4-(4-(Trifluoromethyl)-2-Pyridinyl)-1-Piperazinyl)Butyl)-	1-[4-[4-[4-(trifluoromethyl)pyridin-2-yl]piperazin-1-yl]butyl]pyrrolidin-2-one	O=C1CCCN1CCCCN1CCN(c2cc(C(F)(F)F)ccn2)CC1	9907401.0	R3_abraham_2006:211|R4_mente_2005:162|R21_muehlbacher_2011:331|R25_brito_sanchez_2015:335|R26_chico_2009:71|R28_li_2005:102|R40_vilar_2010:171|R41_toropov_2017:193|R46_mendoza_valencia_2017:294|R47_radchenko_2020:178|R49_norinder_2002:144	0.16	B	BBB+	A	test
InChI=1S/C18H25N/c1-13-6-7-14-12-17-15-5-3-4-8-18(15,16(14)11-13)9-10-19(17)2/h6-7,11,15,17H,3-5,8-10,12H2,1-2H3/t15-,17+,18+/m1/s1	Dimemorfan	(1S,9S,10S)-4,17-dimethyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene	Cc1ccc2c(c1)[C@]13CCCC[C@@H]1[C@H](C2)N(C)CC3	3037918.0	R6_adenot_2004:1093			BBB+	C	training
InChI=1S/C18H25N3O2/c19-8-13-2-12-3-14(12)21(13)16(22)15(20)17-4-10-1-11(5-17)7-18(23,6-10)9-17/h10-15,23H,1-7,9,20H2	Saxagliptin|2-[2-Amino-2-(3-Hydroxy-1-Adamantyl)Acetyl]-2-Azabicyclo[3.1.0]Hexane-3-Carbonitrile	2-[2-amino-2-(3-hydroxy-1-adamantyl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile	N#CC1CC2CC2N1C(=O)C(N)C12CC3CC(CC(O)(C3)C1)C2	58391580.0	R23_gupta_2019:904			BBB-	C	training
InChI=1S/C18H25N3O3/c22-18-19-8-12-21(18)14-5-9-20(10-6-14)11-7-15-13-23-16-3-1-2-4-17(16)24-15/h1-4,14-15H,5-13H2,(H,19,22)/t15-/m0/s1	Azaloxan	1-[1-[2-[(3S)-2,3-dihydro-1,4-benzodioxin-3-yl]ethyl]piperidin-4-yl]imidazolidin-2-one	O=C1NCCN1C1CCN(CC[C@H]2COc3ccccc3O2)CC1	6328465.0	R6_adenot_2004:488			BBB+	C	training
InChI=1S/C18H25N3OS/c1-2-10-21(11-3-1)15-16-6-4-7-17(14-16)22-12-5-8-19-18-20-9-13-23-18/h4,6-7,9,13-14H,1-3,5,8,10-12,15H2,(H,19,20)	Skb37|Bbcpd24|104076-45-1|Chebi: 338961|B-064, Skb-37|28|20|2-[3-[3-(Piperidinomethyl)Phenoxy]Propylamino]Thiazole	N-[3-[3-(piperidin-1-ylmethyl)phenoxy]propyl]-1,3-thiazol-2-amine	c1cc(CN2CCCCC2)cc(OCCCNc2nccs2)c1	14022497.0	R3_abraham_2006:272|R3_abraham_2006:321|R4_mente_2005:137|R12_garg_2006:39|R21_muehlbacher_2011:351|R25_brito_sanchez_2015:21|R26_chico_2009:63|R28_li_2005:165|R40_vilar_2010:254|R41_toropov_2017:244|R41_toropov_2017:285|R46_mendoza_valencia_2017:21|R47_radchenko_2020:227|R48_hou_2003:99|R49_norinder_2002:28|R49_norinder_2002:179|R52_liu_2001:28	0.44	B	BBB+	A	training
InChI=1S/C18H25N5O8S/c1-9-13(21-15(26)14(22-28-5)10-8-32-17(19)20-10)16(27)23(9)30-7-11(24)29-6-12(25)31-18(2,3)4/h8-9,13H,6-7H2,1-5H3,(H2,19,20)(H,21,26)/b22-14+/t9-,13-/m0/s1	Gloximonam	tert-butyl 2-[2-[(2S,3S)-3-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-2-methyl-4-oxoazetidin-1-yl]oxyacetyl]oxyacetate	CO/N=C(\C(=O)N[C@@H]1C(=O)N(OCC(=O)OCC(=O)OC(C)(C)C)[C@H]1C)c1csc(N)n1	5492073.0	R6_adenot_2004:233			BBB-	C	training
InChI=1S/C18H25NO/c1-12-17-9-14-5-6-15(20)10-16(14)18(12,2)7-8-19(17)11-13-3-4-13/h5-6,10,12-13,17,20H,3-4,7-9,11H2,1-2H3	Cyclazocine	10-(cyclopropylmethyl)-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol	CC1C2Cc3ccc(O)cc3C1(C)CCN2CC1CC1	19143.0	R6_adenot_2004:1021|R28_li_2005:348|R51_doninger_2002:191			BBB+	C	training
InChI=1S/C18H25NO/c1-19-10-9-18-8-4-3-5-15(18)17(19)11-13-6-7-14(20-2)12-16(13)18/h6-7,12,15,17H,3-5,8-11H2,1-2H3/t15-,17+,18+/m0/s1	Levomethorphan|Racemethorphan	(1R,9R,10R)-4-methoxy-17-methyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene	COc1ccc2c(c1)[C@@]13CCCC[C@H]1[C@@H](C2)N(C)CC3	5362449.0	R6_adenot_2004:1049|R6_adenot_2004:1082			BBB+	C	training
InChI=1S/C18H25NO/c1-19-10-9-18-8-4-3-5-15(18)17(19)11-13-6-7-14(20-2)12-16(13)18/h6-7,12,15,17H,3-5,8-11H2,1-2H3/t15-,17+,18+/m1/s1	Dextromethorphan	(1S,9S,10S)-4-methoxy-17-methyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene	COc1ccc2c(c1)[C@]13CCCC[C@@H]1[C@H](C2)N(C)CC3	5360696.0	R6_adenot_2004:1024|R14_ghose_2012:296|R23_gupta_2019:62|R25_brito_sanchez_2015:461|R26_chico_2009:156|R28_li_2005:191	0.12	C	BBB+	A	training
InChI=1S/C18H25NO/c1-19-10-9-18-8-4-3-5-15(18)17(19)11-13-6-7-14(20-2)12-16(13)18/h6-7,12,15,17H,3-5,8-11H2,1-2H3/t15-,17-,18-/m1/s1	(1R,9R,10S)-4-Methoxy-17-Methyl-17-Azatetracyclo[7.5.3.01,10.02,7]Heptadeca-2(7),3,5-Triene	(1R,9R,10S)-4-methoxy-17-methyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene	COc1ccc2c(c1)[C@@]13CCCC[C@@H]1[C@@H](C2)N(C)CC3	6916184.0	R46_mendoza_valencia_2017:386	0.22	A	BBB+	A	training
InChI=1S/C18H25NO3/c1-18(12-20,13-6-4-3-5-7-13)17(21)22-16-10-14-8-9-15(11-16)19(14)2/h3-7,14-16,20H,8-12H2,1-2H3/t14-,15+,16?,18-/m1/s1	Atromepine	[(1S,5R)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] (2S)-3-hydroxy-2-methyl-2-phenylpropanoate	CN1[C@@H]2CC[C@H]1CC(OC(=O)[C@](C)(CO)c1ccccc1)C2	20055097.0	R6_adenot_2004:358			BBB+	C	training
InChI=1S/C18H26Cl2N2O/c1-13(2)17(12-22-8-4-5-9-22)21(3)18(23)11-14-6-7-15(19)16(20)10-14/h6-7,10,13,17H,4-5,8-9,11-12H2,1-3H3/t17-/m1/s1	Ici197067|1-[(2S)-2-[Methyl[(3,4-Dichlorophenyl)Acetyl]Amino]-3-Methylbutyl]Pyrrolidine	2-(3,4-dichlorophenyl)-N-methyl-N-[(2S)-3-methyl-1-pyrrolidin-1-ylbutan-2-yl]acetamide	CC(C)[C@@H](CN1CCCC1)N(C)C(=O)Cc1ccc(Cl)c(Cl)c1	3081078.0	R28_li_2005:375			BBB+	C	test
InChI=1S/C18H26ClN3O/c1-3-22(11-12-23)10-4-5-14(2)21-17-8-9-20-18-13-15(19)6-7-16(17)18/h6-9,13-14,23H,3-5,10-12H2,1-2H3,(H,20,21)	Hydroxychloroquine	2-[4-[(7-chloroquinolin-4-yl)amino]pentyl-ethylamino]ethanol	CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12	3652.0	R23_gupta_2019:661			BBB-	C	training
InChI=1S/C18H26ClN3O3/c1-24-9-2-6-22-7-3-12(4-8-22)21-18(23)14-11-15(19)16(20)13-5-10-25-17(13)14/h11-12H,2-10,20H2,1H3,(H,21,23)	Prucalopride	4-amino-5-chloro-N-[1-(3-methoxypropyl)piperidin-4-yl]-2,3-dihydro-1-benzofuran-7-carboxamide	COCCCN1CCC(NC(=O)c2cc(Cl)c(N)c3c2OCC3)CC1	3052762.0	R25_brito_sanchez_2015:336|R46_mendoza_valencia_2017:295|R47_radchenko_2020:418	-0.1	B	BBB+	A	training
InChI=1S/C18H26N2O4/c1-3-12-20(13-4-2)18(24)15(10-11-16(21)22)19-17(23)14-8-6-5-7-9-14/h5-9,15H,3-4,10-13H2,1-2H3,(H,19,23)(H,21,22)	Proglumide	4-benzamido-5-(dipropylamino)-5-oxopentanoic acid	CCCN(CCC)C(=O)C(CCC(=O)O)NC(=O)c1ccccc1	4922.0	R14_ghose_2012:798			BBB-	C	training
InChI=1S/C18H26N2S/c1-5-20-16-9-7-6-8-14(16)15-10-13-21-18(2,17(15)20)11-12-19(3)4/h6-9H,5,10-13H2,1-4H3	Tandamine	2-(9-ethyl-1-methyl-3,4-dihydrothiopyrano[3,4-b]indol-1-yl)-N,N-dimethylethanamine	CCn1c2c(c3ccccc31)CCSC2(C)CCN(C)C	39187.0	R6_adenot_2004:617			BBB+	C	training
InChI=1S/C18H26N4O2S/c1-20(2)25(23,24)19-13-9-15-14-6-5-7-16-18(14)12(10-21(16)3)8-17(15)22(4)11-13/h5-7,10,13,15,17,19H,8-9,11H2,1-4H3/t13-,15+,17+/m0/s1	Mesulergine	(6aR,9S,10aR)-9-(dimethylsulfamoylamino)-4,7-dimethyl-6,6a,8,9,10,10a-hexahydroindolo[4,3-fg]quinoline	CN1C[C@@H](NS(=O)(=O)N(C)C)C[C@@H]2c3cccc4c3c(cn4C)C[C@H]21	68848.0	R6_adenot_2004:997			BBB+	C	test
InChI=1S/C18H26N4O6S/c1-5-26-17(24)28-8-7-15(29-18(25)27-6-2)12(3)22(11-23)10-14-9-20-13(4)21-16(14)19/h9,11H,5-8,10H2,1-4H3,(H2,19,20,21)/b15-12-	Cetotiamine	ethyl [(Z)-2-[(4-amino-2-methylpyrimidin-5-yl)methyl-formylamino]-5-ethoxycarbonyloxypent-2-en-3-yl]sulfanylformate	CCOC(=O)OCC/C(SC(=O)OCC)=C(\C)N(C=O)Cc1cnc(C)nc1N	3033983.0	R6_adenot_2004:389			BBB+	C	training
InChI=1S/C18H26O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h10,13-17,20H,2-9H2,1H3/t13-,14+,15+,16-,17-,18-/m0/s1	Nandrolone	(8R,9S,10R,13S,14S,17S)-17-hydroxy-13-methyl-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-one	C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@H]43)[C@@H]1CC[C@@H]2O	9904.0	R51_doninger_2002:95			BBB-	C	training
InChI=1S/C18H27Cl2NO2/c1-18(2,3)23-17(22)6-4-5-15-7-9-16(10-8-15)21(13-11-19)14-12-20/h7-10H,4-6,11-14H2,1-3H3	Tertbutylchlorambucil|Chlorambucil-Tertiary Butyl Ester|Chlorambucil-T-Butylester	tert-butyl 4-[4-[bis(2-chloroethyl)amino]phenyl]butanoate	CC(C)(C)OC(=O)CCCc1ccc(N(CCCl)CCCl)cc1	83909.0	R3_abraham_2006:280|R12_garg_2006:159|R17_fu_2008:51|R21_muehlbacher_2011:274|R25_brito_sanchez_2015:136|R28_li_2005:136|R40_vilar_2010:268|R41_toropov_2017:252|R46_mendoza_valencia_2017:134|R47_radchenko_2020:235|R48_hou_2003:110|R49_norinder_2002:109	1.0	B	BBB+	A	training
InChI=1S/C18H27IN2/c19-18-8-7-16(14-20-9-3-1-4-10-20)13-17(18)15-21-11-5-2-6-12-21/h7-8,13H,1-6,9-12,14-15H2	4-Iodo-Alpha,Alpha'-Dipiperidino-M-Xylene|Chebi: 385616|1-[[2-Iodo-5-(Piperidin-1-Ylmethyl)Phenyl]Methyl]Piperidine	1-[[2-iodo-5-(piperidin-1-ylmethyl)phenyl]methyl]piperidine	Ic1ccc(CN2CCCCC2)cc1CN1CCCCC1	12780299.0	R3_abraham_2006:106|R21_muehlbacher_2011:343|R25_brito_sanchez_2015:92|R40_vilar_2010:13|R41_toropov_2017:101|R46_mendoza_valencia_2017:90|R47_radchenko_2020:88	0.98	B	BBB+	A	training
InChI=1S/C18H27NO2/c1-2-3-15-21-17-9-7-16(8-10-17)18(20)11-14-19-12-5-4-6-13-19/h7-10H,2-6,11-15H2,1H3	Dyclonine	1-(4-butoxyphenyl)-3-piperidin-1-ylpropan-1-one	CCCCOc1ccc(C(=O)CCN2CCCCC2)cc1	3180.0	R51_doninger_2002:45			BBB-	C	training
InChI=1S/C18H27NO5/c1-5-10-23-18(21)12-14-8-9-15(16(11-14)22-4)24-13-17(20)19(6-2)7-3/h8-9,11H,5-7,10,12-13H2,1-4H3	Propanidid	propyl 2-[4-[2-(diethylamino)-2-oxoethoxy]-3-methoxyphenyl]acetate	CCCOC(=O)Cc1ccc(OCC(=O)N(CC)CC)c(OC)c1	15004.0	R6_adenot_2004:947			BBB+	C	training
InChI=1S/C18H28ClNO/c1-3-20(4-2)14-15-21-18(12-6-5-7-13-18)16-8-10-17(19)11-9-16/h8-11H,3-7,12-15H2,1-2H3	Clofenciclan	2-[1-(4-chlorophenyl)cyclohexyl]oxy-N,N-diethylethanamine	CCN(CC)CCOC1(c2ccc(Cl)cc2)CCCCC1	25904.0	R6_adenot_2004:514			BBB+	C	training
InChI=1S/C18H28N2O3S/c1-15-7-11-19(12-8-15)13-9-16-4-3-10-20(16)24(22,23)18-6-2-5-17(21)14-18/h2,5-6,14-16,21H,3-4,7-13H2,1H3/t16-/m1/s1	Sb 269970A|(R)-3-((2-(2-(4-Methylpiperidin-1-Yl)Ethyl)Pyrrolidin-1-Yl)Sulfonyl)Phenol	3-[(2R)-2-[2-(4-methylpiperidin-1-yl)ethyl]pyrrolidin-1-yl]sulfonylphenol	CC1CCN(CC[C@H]2CCCN2S(=O)(=O)c2cccc(O)c2)CC1	6604889.0	R26_chico_2009:366	-0.17	A	BBB+	A	training
InChI=1S/C18H28N2O4/c1-5-6-18(23)20-14-7-8-17(16(9-14)13(4)21)24-11-15(22)10-19-12(2)3/h7-9,12,15,19,22H,5-6,10-11H2,1-4H3,(H,20,23)	37517-30-9|Acebutolol	N-[3-acetyl-4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl]butanamide	CCCC(=O)Nc1ccc(OCC(O)CNC(C)C)c(C(C)=O)c1	1978.0	R4_mente_2005:64|R6_adenot_2004:1|R14_ghose_2012:320|R21_muehlbacher_2011:24|R25_brito_sanchez_2015:105|R28_li_2005:175|R34_broccatelli_2012:103|R40_vilar_2010:24|R42_ciura_2020:1|R46_mendoza_valencia_2017:103|R47_radchenko_2020:333	-0.15	B	BBB+	A	training
InChI=1S/C18H29N3O5/c1-18(2,3)19-11-15(22)12-8-13(25-16(23)20(4)5)10-14(9-12)26-17(24)21(6)7/h8-10,15,19,22H,11H2,1-7H3	Bambuterol	[3-[2-(tert-butylamino)-1-hydroxyethyl]-5-(dimethylcarbamoyloxy)phenyl] N,N-dimethylcarbamate	CN(C)C(=O)Oc1cc(OC(=O)N(C)C)cc(C(O)CNC(C)(C)C)c1	54766.0	R23_gupta_2019:378			BBB-	C	test
InChI=1S/C18H29N3O5S/c1-8-14-13(9(2)22)17(24)21(14)15(18(25)26)16(8)27-10-6-11(20-7-10)12(23)4-5-19-3/h8-14,19-20,22-23H,4-7H2,1-3H3,(H,25,26)/t8-,9-,10+,11+,12-,13-,14-/m1/s1	Lenapenem	(4R,5S,6S)-6-[(1R)-1-hydroxyethyl]-3-[(3S,5S)-5-[(1R)-1-hydroxy-3-(methylamino)propyl]pyrrolidin-3-yl]sulfanyl-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid	CNCC[C@@H](O)[C@@H]1C[C@H](SC2=C(C(=O)O)N3C(=O)[C@H]([C@@H](C)O)[C@H]3[C@H]2C)CN1	216262.0	R6_adenot_2004:218			BBB-	C	training
InChI=1S/C18H29NO3/c1-14(2)19-11-17(20)13-22-18-7-5-15(6-8-18)9-10-21-12-16-3-4-16/h5-8,14,16-17,19-20H,3-4,9-13H2,1-2H3	63659-18-7|Betaxolol|Betaxolol Hydrochloride	1-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]-3-(propan-2-ylamino)propan-2-ol	CC(C)NCC(O)COc1ccc(CCOCC2CC2)cc1	2369.0	R4_mente_2005:67|R7_andres_2006:18|R14_ghose_2012:391|R21_muehlbacher_2011:39|R25_brito_sanchez_2015:160|R29_subramanian_2003:16|R40_vilar_2010:51|R42_ciura_2020:8|R46_mendoza_valencia_2017:155|R47_radchenko_2020:336	0.39	B	BBB+	A	training
InChI=1S/C18H31NO4/c1-14(2)19-11-17(20)13-23-18-7-5-16(6-8-18)12-21-9-10-22-15(3)4/h5-8,14-15,17,19-20H,9-13H2,1-4H3	Bisoprolol Fumarate|Bisoprolol	1-(propan-2-ylamino)-3-[4-(2-propan-2-yloxyethoxymethyl)phenoxy]propan-2-ol	CC(C)NCC(O)COc1ccc(COCCOC(C)C)cc1	2405.0	R14_ghose_2012:399|R50_sobanska_2019:59			BBB-	C	training
InChI=1S/C18H33ClN2O5S/c1-5-6-10-7-11(21(3)8-10)17(25)20-12(9(2)19)16-14(23)13(22)15(24)18(26-16)27-4/h9-16,18,22-24H,5-8H2,1-4H3,(H,20,25)/t9-,10+,11-,12+,13-,14+,15+,16+,18+/m0/s1	Clindamycin	(2S,4R)-N-[(1S,2S)-2-chloro-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide	CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1	446598.0	R6_adenot_2004:211|R23_gupta_2019:469			BBB-	C	training
InChI=1S/C18H34ClN2O8PS/c1-5-6-10-7-11(21(3)8-10)17(24)20-12(9(2)19)15-13(22)14(23)16(18(28-15)31-4)29-30(25,26)27/h9-16,18,22-23H,5-8H2,1-4H3,(H,20,24)(H2,25,26,27)	Clindamycin Phosphate|[6-[2-Chloro-1-[(1-Methyl-4-Propylpyrrolidine-2-Carbonyl)Amino]Propyl]-4,5-Dihydroxy-2-Methylsulfanyloxan-3-Yl] Dihydrogen Phosphate	[6-[2-chloro-1-[(1-methyl-4-propylpyrrolidine-2-carbonyl)amino]propyl]-4,5-dihydroxy-2-methylsulfanyloxan-3-yl] dihydrogen phosphate	CCCC1CC(C(=O)NC(C(C)Cl)C2OC(SC)C(OP(=O)(O)O)C(O)C2O)N(C)C1	32603.0	R23_gupta_2019:1053			BBB-	C	training
InChI=1S/C18H34ClN2O8PS/c1-5-6-10-7-11(21(3)8-10)17(24)20-12(9(2)19)15-13(22)14(23)16(18(28-15)31-4)29-30(25,26)27/h9-16,18,22-23H,5-8H2,1-4H3,(H,20,24)(H2,25,26,27)/t9-,10+,11-,12+,13+,14-,15+,16+,18+/m0/s1	Clindamycin-Phosphate|Clindamycin Phosphate	[(2R,3R,4S,5R,6R)-6-[(1S,2S)-2-chloro-1-[[(2S,4R)-1-methyl-4-propylpyrrolidine-2-carbonyl]amino]propyl]-4,5-dihydroxy-2-methylsulfanyloxan-3-yl] dihydrogen phosphate	CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](OP(=O)(O)O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1	443385.0	R6_adenot_2004:114			BBB-	C	training
InChI=1S/C18H34N2O6S/c1-5-6-10-7-11(20(3)8-10)17(25)19-12(9(2)21)16-14(23)13(22)15(24)18(26-16)27-4/h9-16,18,21-24H,5-8H2,1-4H3,(H,19,25)/t9-,10-,11+,12-,13+,14-,15-,16-,18-/m1/s1	Lincomycin|Lincomycin Hydrochloride	(2S,4R)-N-[(1R,2R)-2-hydroxy-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide	CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1	3000540.0	R6_adenot_2004:336|R14_ghose_2012:656|R23_gupta_2019:711			BBB-	C	training
InChI=1S/C18H34N5O2/c1-11-10-22-25-15(14(11)24)13(19)9-12(2)17(6,7)23(16(3,4)5)18(8,20)21/h10,12-13,19H,9,20-21H2,1-8H3	23		Cc1cn[o+]c(C([NH])CC(C)C(C)(C)N(C(C)(C)C)C(C)(N)N)c1[O-]		R28_li_2005:160			BBB+	C	training
InChI=1S/C18H34O2.C2H7NO/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20;3-1-2-4/h9-10H,2-8,11-17H2,1H3,(H,19,20);4H,1-3H2/b10-9-;	Ethanolamine Oleate	2-aminoethanol;(Z)-octadec-9-enoic acid	CCCCCCCC/C=C\CCCCCCCC(=O)O.NCCO	5282489.0	R23_gupta_2019:578			BBB-	C	test
InChI=1S/C18H36N4O11/c19-2-6-10(25)12(27)13(28)18(30-6)33-16-5(21)1-4(20)15(14(16)29)32-17-11(26)8(22)9(24)7(3-23)31-17/h4-18,23-29H,1-3,19-22H2/t4-,5+,6-,7-,8+,9-,10-,11-,12+,13-,14-,15+,16-,17-,18-/m1/s1	Kanamycin|Kanamycin Sulfate	(2R,3S,4S,5R,6R)-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-3-[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxyoxane-3,4,5-triol	NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O	6032.0	R6_adenot_2004:121|R14_ghose_2012:640|R23_gupta_2019:692|R28_li_2005:262			BBB-	C	training
InChI=1S/C18H37N5O10/c19-2-6-11(26)12(27)9(23)17(30-6)32-15-4(20)1-5(21)16(14(15)29)33-18-13(28)8(22)10(25)7(3-24)31-18/h4-18,24-29H,1-3,19-23H2/t4-,5+,6+,7+,8-,9+,10+,11+,12+,13+,14-,15+,16-,17+,18+/m0/s1	Bekanamycin	(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2S,3S,4R,6S)-4,6-diamino-3-[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxyoxane-3,4-diol	NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)[C@@H](O)[C@@H]1O	439318.0	R6_adenot_2004:120			BBB-	C	training
InChI=1S/C18H37N5O8/c19-4-6-1-2-7(20)17(28-6)30-15-8(21)3-9(22)16(14(15)27)31-18-13(26)11(23)12(25)10(5-24)29-18/h6-18,24-27H,1-5,19-23H2/t6-,7+,8-,9+,10+,11-,12+,13+,14-,15+,16-,17+,18+/m0/s1	Dibekacin	(2S,3R,4S,5S,6R)-4-amino-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2R,3R,6S)-3-amino-6-(aminomethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-6-(hydroxymethyl)oxane-3,5-diol	NC[C@@H]1CC[C@@H](N)[C@@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)O1	470999.0	R6_adenot_2004:115			BBB-	C	training
InChI=1S/C18H37N5O9/c19-3-9-8(25)2-7(22)17(29-9)31-15-5(20)1-6(21)16(14(15)28)32-18-13(27)11(23)12(26)10(4-24)30-18/h5-18,24-28H,1-4,19-23H2/t5-,6+,7+,8-,9+,10+,11-,12+,13+,14-,15+,16-,17+,18+/m0/s1	Tobramycin	(2S,3R,4S,5S,6R)-4-amino-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2R,3R,5S,6R)-3-amino-6-(aminomethyl)-5-hydroxyoxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-6-(hydroxymethyl)oxane-3,5-diol	NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O	36294.0	R6_adenot_2004:131|R23_gupta_2019:985			BBB-	C	training
InChI=1S/C19H12O6/c20-16-10-5-1-3-7-14(10)24-18(22)12(16)9-13-17(21)11-6-2-4-8-15(11)25-19(13)23/h1-8,20-21H,9H2	Dicumarol	4-hydroxy-3-[(4-hydroxy-2-oxochromen-3-yl)methyl]chromen-2-one	O=c1oc2ccccc2c(O)c1Cc1c(O)c2ccccc2oc1=O	54676038.0	R14_ghose_2012:493|R23_gupta_2019:518|R51_doninger_2002:36			BBB-	C	test
InChI=1S/C19H12O8/c1-8(20)26-13-5-3-4-11-15(13)18(23)16-12(17(11)22)6-10(19(24)25)7-14(16)27-9(2)21/h3-7H,1-2H3,(H,24,25)	Diacerein	4,5-diacetyloxy-9,10-dioxoanthracene-2-carboxylic acid	CC(=O)Oc1cccc2c1C(=O)c1c(OC(C)=O)cc(C(=O)O)cc1C2=O	26248.0	R14_ghose_2012:489			BBB-	C	training
InChI=1S/C19H14F2N6O/c1-27-18(22-8-23-27)15-16(9-2-4-10(20)5-3-9)24-13-7-11(21)6-12-14(13)17(15)25-26-19(12)28/h2-8,15-16,24H,1H3,(H,26,28)/t15-,16-/m1/s1	Talazoparib	(11S,12R)-7-fluoro-11-(4-fluorophenyl)-12-(2-methyl-1,2,4-triazol-3-yl)-2,3,10-triazatricyclo[7.3.1.05,13]trideca-1,5(13),6,8-tetraen-4-one	Cn1ncnc1[C@H]1c2n[nH]c(=O)c3cc(F)cc(c23)N[C@@H]1c1ccc(F)cc1	135565082.0	R23_gupta_2019:950			BBB-	C	training
InChI=1S/C19H15ClN2O4/c20-13-7-5-11(6-8-13)18(24)22-16(19(25)26)9-12-10-17(23)21-15-4-2-1-3-14(12)15/h1-8,10,16H,9H2,(H,21,23)(H,22,24)(H,25,26)	Rebamipide	2-[(4-chlorobenzoyl)amino]-3-(2-oxo-1H-quinolin-4-yl)propanoic acid	O=C(NC(Cc1cc(=O)[nH]c2ccccc12)C(=O)O)c1ccc(Cl)cc1	5042.0	R14_ghose_2012:817			BBB-	C	training
InChI=1S/C19H15F3N4O3/c20-9-1-2-15(13(21)5-9)26-8-12(19(28)29)16(27)11-6-14(22)18(24-17(11)26)25-4-3-10(23)7-25/h1-2,5-6,8,10H,3-4,7,23H2,(H,28,29)	Tosufloxacin	7-(3-aminopyrrolidin-1-yl)-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid	NC1CCN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3-c2ccc(F)cc2F)C1	5517.0	R23_gupta_2019:992			BBB-	C	test
InChI=1S/C19H16ClFN2O/c20-13-7-8-17-15(9-13)19(14-3-1-2-4-16(14)21)22-10-18(24)23(17)11-12-5-6-12/h1-4,7-9,12H,5-6,10-11H2	Flutoprazepam	7-chloro-1-(cyclopropylmethyl)-5-(2-fluorophenyl)-3H-1,4-benzodiazepin-2-one	O=C1CN=C(c2ccccc2F)c2cc(Cl)ccc2N1CC1CC1	3400.0	R6_adenot_2004:710|R14_ghose_2012:101|R23_gupta_2019:100			BBB+	C	test
InChI=1S/C19H16ClNO4/c1-11-15(10-18(22)23)16-9-14(25-2)7-8-17(16)21(11)19(24)12-3-5-13(20)6-4-12/h3-9H,10H2,1-2H3,(H,22,23)	Indomethacin|Indometacin	2-[1-(4-chlorobenzoyl)-5-methoxy-2-methylindol-3-yl]acetic acid	COc1ccc2c(c1)c(CC(=O)O)c(C)n2C(=O)c1ccc(Cl)cc1	3715.0	R3_abraham_2006:186|R3_abraham_2006:187|R5_guerra_2008:57|R6_adenot_2004:640|R7_andres_2006:203|R12_garg_2006:94|R14_ghose_2012:621|R17_fu_2008:38|R21_muehlbacher_2011:89|R23_gupta_2019:116|R25_brito_sanchez_2015:259|R26_chico_2009:219|R28_li_2005:25|R34_broccatelli_2012:41|R40_vilar_2010:131|R41_toropov_2017:172|R46_mendoza_valencia_2017:233|R47_radchenko_2020:158|R49_norinder_2002:92|R49_norinder_2002:126|R50_sobanska_2019:3|R51_doninger_2002:71|R53_friden_2009:12	-1.31	B1	BBB-	A	training
InChI=1S/C19H16N2O4/c1-2-19(14-11-7-4-8-12-14)16(23)20-18(25)21(17(19)24)15(22)13-9-5-3-6-10-13/h3-12H,2H2,1H3,(H,20,23,25)	Benzobarbital	1-benzoyl-5-ethyl-5-phenyl-1,3-diazinane-2,4,6-trione	CCC1(c2ccccc2)C(=O)NC(=O)N(C(=O)c2ccccc2)C1=O	12938.0	R6_adenot_2004:1640			BBB+	C	training
InChI=1S/C19H16O4/c1-12(20)11-15(13-7-3-2-4-8-13)17-18(21)14-9-5-6-10-16(14)23-19(17)22/h2-10,15,21H,11H2,1H3/t15-/m0/s1	S-Warfarin|(S)-Warfarin	4-hydroxy-3-[(1S)-3-oxo-1-phenylbutyl]chromen-2-one	CC(=O)C[C@@H](c1ccccc1)c1c(O)c2ccccc2oc1=O	54688261.0	R7_andres_2006:183			BBB-	C	training
InChI=1S/C19H17Cl2N3O5S/c1-7-10(12(23-29-7)11-8(20)5-4-6-9(11)21)15(25)22-13-16(26)24-14(18(27)28)19(2,3)30-17(13)24/h4-6,13-14,17H,1-3H3,(H,22,25)(H,27,28)/t13-,14+,17-/m1/s1	Dicloxacillin|Dicloxacillin Sodium	(2S,5R,6R)-6-[[3-(2,6-dichlorophenyl)-5-methyl-1,2-oxazole-4-carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid	Cc1onc(-c2c(Cl)cccc2Cl)c1C(=O)N[C@@H]1C(=O)N2[C@@H]1SC(C)(C)[C@@H]2C(=O)O	18381.0	R6_adenot_2004:216|R14_ghose_2012:492|R23_gupta_2019:517			BBB-	C	training
InChI=1S/C19H17Cl3N2S/c20-15-7-4-14(5-8-15)6-9-16(12-24-11-10-23-13-24)25-19-17(21)2-1-3-18(19)22/h1-5,7-8,10-11,13,16H,6,9,12H2	Butoconazole	1-[4-(4-chlorophenyl)-2-(2,6-dichlorophenyl)sulfanylbutyl]imidazole	Clc1ccc(CCC(Cn2ccnc2)Sc2c(Cl)cccc2Cl)cc1	47472.0	R23_gupta_2019:404			BBB-	C	test
InChI=1S/C19H17ClFN3O5S/c1-7-10(12(23-29-7)11-8(20)5-4-6-9(11)21)15(25)22-13-16(26)24-14(18(27)28)19(2,3)30-17(13)24/h4-6,13-14,17H,1-3H3,(H,22,25)(H,27,28)/t13-,14+,17-/m1/s1	Flucloxacillin|Floxacillin	(2S,5R,6R)-6-[[3-(2-chloro-6-fluorophenyl)-5-methyl-1,2-oxazole-4-carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid	Cc1onc(-c2c(F)cccc2Cl)c1C(=O)N[C@@H]1C(=O)N2[C@@H]1SC(C)(C)[C@@H]2C(=O)O	21319.0	R6_adenot_2004:229|R14_ghose_2012:562|R23_gupta_2019:603|R51_doninger_2002:57			BBB-	C	training
InChI=1S/C19H17ClN2O/c20-15-8-9-17-16(10-15)19(14-4-2-1-3-5-14)21-11-18(23)22(17)12-13-6-7-13/h1-5,8-10,13H,6-7,11-12H2	Prazepam	7-chloro-1-(cyclopropylmethyl)-5-phenyl-3H-1,4-benzodiazepin-2-one	O=C1CN=C(c2ccccc2)c2cc(Cl)ccc2N1CC1CC1	4890.0	R6_adenot_2004:741|R14_ghose_2012:207|R23_gupta_2019:206|R51_doninger_2002:290			BBB+	C	test
InChI=1S/C19H17N3O4S2/c23-14(9-13-5-4-8-27-13)20-15-17(24)22-16(19(25)26)12(11-28-18(15)22)10-21-6-2-1-3-7-21/h1-8,15,18H,9-11H2,(H-,20,23,25,26)/t15-,18-/m1/s1	Cefaloridine|Cephaloridine	(6R,7R)-8-oxo-3-(pyridin-1-ium-1-ylmethyl)-7-[(2-thiophen-2-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate	O=C(Cc1cccs1)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(C[n+]3ccccc3)CS[C@H]12	5773.0	R6_adenot_2004:157			BBB-	C	training
InChI=1S/C19H17N5O7S3/c1-30-23-11(9-7-34-19(20)21-9)14(25)22-12-15(26)24-13(17(27)28)8(5-32-16(12)24)6-33-18(29)10-3-2-4-31-10/h2-4,7,12,16H,5-6H2,1H3,(H2,20,21)(H,22,25)(H,27,28)/b23-11+/t12-,16-/m1/s1	Ceftiofur	(6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-(furan-2-carbonylsulfanylmethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid	CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(CSC(=O)c3ccco3)CS[C@H]12)c1csc(N)n1	6328657.0	R6_adenot_2004:200			BBB-	C	training
InChI=1S/C19H17N9O5S2/c1-33-24-11(14-23-19(20)35-25-14)15(29)22-12-16(30)28-13(18(31)32)9(8-34-17(12)28)7-26-5-6-27-10(26)3-2-4-21-27/h2-6,12,17H,7-8H2,1H3,(H3-,20,22,23,25,29,31,32)/b24-11+/t12-,17-/m1/s1	Cefozopran	(6R,7R)-7-[[(2Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-methoxyiminoacetyl]amino]-3-(imidazo[1,2-b]pyridazin-1-ium-1-ylmethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate	CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(C[n+]3ccn4ncccc43)CS[C@H]12)c1nsc(N)n1	9571080.0	R6_adenot_2004:268			BBB-	C	training
InChI=1S/C19H17NO7/c1-3-5-9-16-10(13(21)7-12(18(23)24)20(16)4-2)6-11-14(22)8-15(19(25)26)27-17(9)11/h6-8H,3-5H2,1-2H3,(H,23,24)(H,25,26)	Nedocromil	9-ethyl-4,6-dioxo-10-propylpyrano[3,2-g]quinoline-2,8-dicarboxylic acid	CCCc1c2oc(C(=O)O)cc(=O)c2cc2c(=O)cc(C(=O)O)n(CC)c12	50294.0	R23_gupta_2019:772			BBB-	C	test
InChI=1S/C19H18Cl2N2O2/c1-23(18(24)11-22-13-7-8-13)17-9-6-12(20)10-15(17)19(25)14-4-2-3-5-16(14)21/h2-6,9-10,13,22H,7-8,11H2,1H3	Ciprazafone	N-[4-chloro-2-(2-chlorobenzoyl)phenyl]-2-(cyclopropylamino)-N-methylacetamide	CN(C(=O)CNC1CC1)c1ccc(Cl)cc1C(=O)c1ccccc1Cl	193989.0	R6_adenot_2004:1433			BBB+	C	test
InChI=1S/C19H18Cl2N4O4S/c1-8-7-22-25(13-9(20)5-4-6-10(13)21)12(8)15(26)23-11-16(27)24-14(18(28)29)19(2,3)30-17(11)24/h4-7,11,14,17H,1-3H3,(H,23,26)(H,28,29)/t11-,14+,17-/m1/s1	Prazocillin	(2S,5R,6R)-6-[[2-(2,6-dichlorophenyl)-4-methylpyrazole-3-carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid	Cc1cnn(-c2c(Cl)cccc2Cl)c1C(=O)N[C@@H]1C(=O)N2[C@@H]1SC(C)(C)[C@@H]2C(=O)O	65622.0	R6_adenot_2004:258			BBB-	C	training
InChI=1S/C19H18ClFN2O3/c20-13-5-6-17-15(11-13)19(14-3-1-2-4-16(14)21)22(8-10-26-19)12-18(25)23(17)7-9-24/h1-6,11,24H,7-10,12H2	Flutazolam	10-chloro-11b-(2-fluorophenyl)-7-(2-hydroxyethyl)-3,5-dihydro-2H-[1,3]oxazolo[3,2-d][1,4]benzodiazepin-6-one	O=C1CN2CCOC2(c2ccccc2F)c2cc(Cl)ccc2N1CCO	3398.0	R6_adenot_2004:709			BBB+	C	training
InChI=1S/C19H18ClFN2O3S/c1-2-27(25,26)10-9-23-17-8-7-13(20)11-15(17)19(22-12-18(23)24)14-5-3-4-6-16(14)21/h3-8,11H,2,9-10,12H2,1H3	Elfazepam	7-chloro-1-(2-ethylsulfonylethyl)-5-(2-fluorophenyl)-3H-1,4-benzodiazepin-2-one	CCS(=O)(=O)CCN1C(=O)CN=C(c2ccccc2F)c2cc(Cl)ccc21	65445.0	R6_adenot_2004:702			BBB+	C	training
InChI=1S/C19H18ClN3O/c20-15-8-9-17-16(10-15)19(14-4-2-1-3-5-14)23(24)12-18(22-17)21-11-13-6-7-13/h1-5,8-10,13,24H,6-7,11-12H2/b21-18-	Cyprazepam	7-chloro-N-(cyclopropylmethyl)-4-hydroxy-5-phenyl-3H-1,4-benzodiazepin-2-imine	ON1C/C(=N/CC2CC2)N=c2ccc(Cl)cc2=C1c1ccccc1	27452.0	R6_adenot_2004:697			BBB+	C	test
InChI=1S/C19H18ClN3O3/c1-22(2)19(25)26-17-18(24)23(3)15-10-9-13(20)11-14(15)16(21-17)12-7-5-4-6-8-12/h4-11,17H,1-3H3	Camazepam	(7-chloro-1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl) N,N-dimethylcarbamate	CN(C)C(=O)OC1N=C(c2ccccc2)c2cc(Cl)ccc2N(C)C1=O	37367.0	R6_adenot_2004:686			BBB+	C	training
InChI=1S/C19H18ClN3O5S/c1-8-11(12(22-28-8)9-6-4-5-7-10(9)20)15(24)21-13-16(25)23-14(18(26)27)19(2,3)29-17(13)23/h4-7,13-14,17H,1-3H3,(H,21,24)(H,26,27)/t13-,14+,17-/m1/s1	Cloxacillin|Cloxacillin Sodium	(2S,5R,6R)-6-[[3-(2-chlorophenyl)-5-methyl-1,2-oxazole-4-carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid	Cc1onc(-c2ccccc2Cl)c1C(=O)N[C@@H]1C(=O)N2[C@@H]1SC(C)(C)[C@@H]2C(=O)O	6098.0	R6_adenot_2004:213|R14_ghose_2012:466			BBB-	C	training
InChI=1S/C19H18ClN3O5S/c20-16-6-5-15(29-16)18(25)21-9-14-10-23(19(26)28-14)13-3-1-12(2-4-13)22-7-8-27-11-17(22)24/h1-6,14H,7-11H2,(H,21,25)/t14-/m0/s1	Rivaroxaban	5-chloro-N-[[(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl]methyl]thiophene-2-carboxamide	O=C(NC[C@H]1CN(c2ccc(N3CCOCC3=O)cc2)C(=O)O1)c1ccc(Cl)s1	9875401.0	R23_gupta_2019:890			BBB-	C	training
InChI=1S/C19H18ClN5/c1-24(2)12-18-23-22-17-11-21-19(13-6-4-3-5-7-13)15-10-14(20)8-9-16(15)25(17)18/h3-10H,11-12H2,1-2H3	Adinazolam	1-(8-chloro-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-1-yl)-N,N-dimethylmethanamine	CN(C)Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1)=NC2	37632.0	R6_adenot_2004:680|R14_ghose_2012:293|R23_gupta_2019:3			BBB+	C	training
InChI=1S/C19H18ClNO/c1-21-10-8-13(9-11-21)19-15-4-2-3-5-17(15)22-18-7-6-14(20)12-16(18)19/h2-7,12H,8-11H2,1H3	Clopipazan	4-(2-chloroxanthen-9-ylidene)-1-methylpiperidine	CN1CCC(=C2c3ccccc3Oc3ccc(Cl)cc32)CC1	43215.0	R6_adenot_2004:1140			BBB+	C	training
InChI=1S/C19H18ClNO4/c1-11-15(10-18(22)23)16-9-14(25-2)7-8-17(16)21(11)19(24)12-3-5-13(20)6-4-12/h3-9,11,15H,10H2,1-2H3,(H,22,23)/t11-,15-/m0/s1	2-[(2S,3R)-1-(4-Chlorobenzoyl)-5-Methoxy-2-Methyl-2,3-Dihydroindol-3-Yl]Acetic Acid	2-[(2S,3R)-1-(4-chlorobenzoyl)-5-methoxy-2-methyl-2,3-dihydroindol-3-yl]acetic acid	COc1ccc2c(c1)[C@@H](CC(=O)O)[C@H](C)N2C(=O)c1ccc(Cl)cc1	35025677.0	R47_radchenko_2020:327|R48_hou_2003:13	-1.26	B	BBB-	A	training
InChI=1S/C19H18N2O4/c1-23-13-18-11-21(19(22)25-18)16-5-7-17(8-6-16)24-12-15-4-2-3-14(9-15)10-20/h2-9,18H,11-13H2,1H3	Cimoxatone	3-[[4-[5-(methoxymethyl)-2-oxo-1,3-oxazolidin-3-yl]phenoxy]methyl]benzonitrile	COCC1CN(c2ccc(OCc3cccc(C#N)c3)cc2)C(=O)O1	52542.0	R6_adenot_2004:966			BBB+	C	training
InChI=1S/C19H18N3O/c1-21-16-9-5-3-7-14(16)19(23)22-11-10-13-12-6-2-4-8-15(12)20-17(13)18(21)22/h2-9,13,17,20H,10-11H2,1H3/q+1	21-Methyl-3,13-Diaza-21-Azoniapentacyclo[11.8.0.02,10.04,9.015,20]Henicosa-1(21),4,6,8,15,17,19-Heptaen-14-One	21-methyl-3,13-diaza-21-azoniapentacyclo[11.8.0.02,10.04,9.015,20]henicosa-1(21),4,6,8,15,17,19-heptaen-14-one	C[n+]1c2n(c(=O)c3ccccc31)CCC1c3ccccc3NC21	125676.0	R46_mendoza_valencia_2017:372	0.11	A	BBB+	A	training
InChI=1S/C19H18N4O2S/c1-13-17(20-8-7-18(13)25-2)12-26(24)19-21-15-6-5-14(11-16(15)22-19)23-9-3-4-10-23/h3-11H,12H2,1-2H3,(H,21,22)	Ilaprazole	2-[(4-methoxy-3-methylpyridin-2-yl)methylsulfinyl]-6-pyrrol-1-yl-1H-benzimidazole	COc1ccnc(CS(=O)c2nc3ccc(-n4cccc4)cc3[nH]2)c1C	214351.0	R23_gupta_2019:670			BBB-	C	training
InChI=1S/C19H18N4O5S3/c1-9-21-22-19(31-9)30-8-11-7-29-17-12(16(26)23(17)13(11)18(27)28)20-15(25)14(24)10-5-3-2-4-6-10/h2-6,12,14,17,24H,7-8H2,1H3,(H,20,25)(H,27,28)/t12-,14-,17-/m1/s1	Cefcanel	(6R,7R)-7-[[(2R)-2-hydroxy-2-phenylacetyl]amino]-3-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid	Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)[C@H](O)c4ccccc4)[C@H]3SC2)s1	68666.0	R6_adenot_2004:237			BBB-	C	training
InChI=1S/C19H18N4OS/c1-4-12-5-7-13(8-6-12)23-11-21-16-15-14(22(2)3)9-10-20-18(15)25-17(16)19(23)24/h5-11H,4H2,1-3H3	4-Dimethylamino-7-(4-Ethyl-Phenyl)-7H-9-Thia-1,5,7-Triaza-Fluoren-8-One	13-(dimethylamino)-5-(4-ethylphenyl)-8-thia-3,5,10-triazatricyclo[7.4.0.02,7]trideca-1(13),2(7),3,9,11-pentaen-6-one	CCc1ccc(-n2cnc3c(sc4nccc(N(C)C)c43)c2=O)cc1	11530404.0	R46_mendoza_valencia_2017:397	-0.47	A	BBB+	A	training
InChI=1S/C19H18N6O5S3/c1-8-11(33-7-21-8)4-3-9-5-31-17-13(16(27)25(17)14(9)18(28)29)23-15(26)12(24-30-2)10-6-32-19(20)22-10/h3-4,6-7,13,17H,5H2,1-2H3,(H2,20,22)(H,23,26)(H,28,29)/b4-3-,24-12-/t13-,17-/m1/s1	Cefditoren|Spectracef (Cefditoren Pivoxil)	(6R,7R)-7-[[(2E)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(Z)-2-(4-methyl-1,3-thiazol-5-yl)ethenyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid	CO/N=C(/C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(/C=C\c3scnc3C)CS[C@H]12)c1csc(N)n1	72543801.0	R6_adenot_2004:167|R14_ghose_2012:429|R23_gupta_2019:421			BBB-	C	training
InChI=1S/C19H18N6O6S2/c1-24-19(21-22-23-24)33-8-11-7-32-17-12(16(28)25(17)13(11)18(29)30)20-15(27)14(31-9-26)10-5-3-2-4-6-10/h2-6,9,12,14,17H,7-8H2,1H3,(H,20,27)(H,29,30)/t12-,14-,17-/m1/s1	Cefamandole Nafate|O-Formylcefamandole	(6R,7R)-7-[[(2R)-2-formyloxy-2-phenylacetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid	Cn1nnnc1SCC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)[C@H](OC=O)c3ccccc3)[C@H]2SC1	5284527.0	R23_gupta_2019:1048			BBB-	C	training
InChI=1S/C19H19BrClNO2/c1-22-4-2-11-7-17(21)18(23)9-14(11)16(10-22)15-8-13(20)6-12-3-5-24-19(12)15/h6-9,16,23H,2-5,10H2,1H3/t16-/m0/s1	Berupipam	(5S)-5-(5-bromo-2,3-dihydro-1-benzofuran-7-yl)-8-chloro-3-methyl-1,2,4,5-tetrahydro-3-benzazepin-7-ol	CN1CCc2cc(Cl)c(O)cc2[C@@H](c2cc(Br)cc3c2OCC3)C1	66002.0	R6_adenot_2004:1121			BBB+	C	training
InChI=1S/C19H19F2N7O/c1-19(2,3)13-8-15-24-25-17(12-7-11(20)5-6-14(12)21)28(15)26-18(13)29-9-16-22-10-23-27(16)4/h5-8,10H,9H2,1-4H3	L-838417|7-(Tert-Butyl)-3-(2,5-Difluorophenyl)-6-((1-Methyl-1H-1,2,4-Triazol-5-Yl)Methoxy)-[1,2,4]Triazolo[4,3-B]Pyridazine	7-tert-butyl-3-(2,5-difluorophenyl)-6-[(2-methyl-1,2,4-triazol-3-yl)methoxy]-[1,2,4]triazolo[4,3-b]pyridazine	Cn1ncnc1COc1nn2c(-c3cc(F)ccc3F)nnc2cc1C(C)(C)C	9908880.0	R26_chico_2009:234	-0.22	A	BBB+	A	training
InChI=1S/C19H19N/c1-20-11-10-18-16-8-4-2-6-14(16)12-15-7-3-5-9-17(15)19(18)13-20/h2-9H,10-13H2,1H3	Setiptiline	4-methyl-4-azatetracyclo[13.4.0.02,7.08,13]nonadeca-1(19),2(7),8,10,12,15,17-heptaene	CN1CCC2=C(C1)c1ccccc1Cc1ccccc12	5205.0	R6_adenot_2004:1600|R14_ghose_2012:305|R23_gupta_2019:226			BBB+	C	training
InChI=1S/C19H19N/c1-20-12-11-16-15-9-5-6-10-17(15)19(18(16)13-20)14-7-3-2-4-8-14/h2-10,19H,11-13H2,1H3	Phenindamine	2-methyl-9-phenyl-1,3,4,9-tetrahydroindeno[2,1-c]pyridine	CN1CCC2=C(C1)C(c1ccccc1)c1ccccc12	11291.0	R14_ghose_2012:195|R23_gupta_2019:195			BBB+	C	training
InChI=1S/C19H19N3/c1-2-6-15(7-3-1)19-17-9-5-4-8-16(17)14-18(21-19)22-12-10-20-11-13-22/h1-9,14,20H,10-13H2	Perafensine	1-phenyl-3-piperazin-1-ylisoquinoline	c1ccc(-c2nc(N3CCNCC3)cc3ccccc23)cc1	3047830.0	R6_adenot_2004:595			BBB+	C	training
InChI=1S/C19H19N3O5S/c1-9-11(12(21-27-9)10-7-5-4-6-8-10)15(23)20-13-16(24)22-14(18(25)26)19(2,3)28-17(13)22/h4-8,13-14,17H,1-3H3,(H,20,23)(H,25,26)/t13-,14+,17-/m1/s1	Oxacillin|Oxacillin Sodium	(2S,5R,6R)-3,3-dimethyl-6-[(5-methyl-3-phenyl-1,2-oxazole-4-carbonyl)amino]-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid	Cc1onc(-c2ccccc2)c1C(=O)N[C@@H]1C(=O)N2[C@@H]1SC(C)(C)[C@@H]2C(=O)O	6196.0	R6_adenot_2004:248|R14_ghose_2012:741|R23_gupta_2019:800|R28_li_2005:213			BBB-	C	training
InChI=1S/C19H19N5O5S3/c1-8-22-23-19(32-8)31-7-10-6-30-17-13(16(27)24(17)14(10)18(28)29)21-15(26)12(20)9-2-4-11(25)5-3-9/h2-5,12-13,17,25H,6-7,20H2,1H3,(H,21,26)(H,28,29)/t12-,13-,17-/m1/s1	Cefaparole	(6R,7R)-7-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid	Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)[C@H](N)c4ccc(O)cc4)[C@H]3SC2)s1	10413379.0	R6_adenot_2004:160			BBB-	C	training
InChI=1S/C19H19NO/c1-20-12-10-14-15(11-13-20)17-7-3-5-9-19(17)21-18-8-4-2-6-16(14)18/h2-9H,10-13H2,1H3	Maroxepin	18-methyl-8-oxa-18-azatetracyclo[13.5.0.02,7.09,14]icosa-1(15),2,4,6,9,11,13-heptaene	CN1CCC2=C(CC1)c1ccccc1Oc1ccccc12	68858.0	R6_adenot_2004:1532			BBB+	C	training
InChI=1S/C19H19NOS/c1-20-9-6-13(7-10-20)18-15-5-3-2-4-14(15)12-17(21)19-16(18)8-11-22-19/h2-5,8,11H,6-7,9-10,12H2,1H3	Ketotifen	2-(1-methylpiperidin-4-ylidene)-6-thiatricyclo[8.4.0.03,7]tetradeca-1(14),3(7),4,10,12-pentaen-8-one	CN1CCC(=C2c3ccccc3CC(=O)c3sccc32)CC1	3827.0	R50_sobanska_2019:109			BBB+	C	test
InChI=1S/C19H19NS/c1-20-12-10-14(11-13-20)19-15-6-2-4-8-17(15)21-18-9-5-3-7-16(18)19/h2-9H,10-13H2,1H3	Pimethixene	1-methyl-4-thioxanthen-9-ylidenepiperidine	CN1CCC(=C2c3ccccc3Sc3ccccc32)CC1	4822.0	R6_adenot_2004:1338			BBB+	C	training
InChI=1S/C19H20BrN3O3/c1-19(2,3)26-18(25)15-16-13-8-5-9-22(13)17(24)14-11(20)6-4-7-12(14)23(16)10-21-15/h4,6-7,10,13H,5,8-9H2,1-3H3/t13-/m0/s1	84379-13-5|Bretazenil	tert-butyl (7S)-14-bromo-12-oxo-2,4,11-triazatetracyclo[11.4.0.02,6.07,11]heptadeca-1(17),3,5,13,15-pentaene-5-carboxylate	CC(C)(C)OC(=O)c1ncn2c1[C@@H]1CCCN1C(=O)c1c(Br)cccc1-2	107926.0	R4_mente_2005:50|R21_muehlbacher_2011:286|R25_brito_sanchez_2015:166|R26_chico_2009:83|R28_li_2005:69|R39_shayanfar_2011:103|R40_vilar_2010:58|R44_bujak_2015:87|R46_mendoza_valencia_2017:160|R47_radchenko_2020:314	-0.09	B	BBB+	A	training
InChI=1S/C19H20BrN3O3/c1-19(2,3)26-18(25)15-16-14-5-4-8-22(14)17(24)12-9-11(20)6-7-13(12)23(16)10-21-15/h6-7,9-10,14H,4-5,8H2,1-3H3	Tert-Butyl 15-Bromo-12-Oxo-2,4,11-Triazatetracyclo[11.4.0.02,6.07,11]Heptadeca-1(17),3,5,13,15-Pentaene-5-Carboxylate	tert-butyl 15-bromo-12-oxo-2,4,11-triazatetracyclo[11.4.0.02,6.07,11]heptadeca-1(17),3,5,13,15-pentaene-5-carboxylate	CC(C)(C)OC(=O)c1ncn2c1C1CCCN1C(=O)c1cc(Br)ccc1-2	133109366.0	R41_toropov_2017:130	-0.09	A	BBB+	A	training
InChI=1S/C19H20ClN/c1-21-11-15-9-14-7-8-16(20)10-17(14)19(18(15)12-21)13-5-3-2-4-6-13/h2-8,10,15,18-19H,9,11-12H2,1H3/t15-,18+,19+/m0/s1	Losindole	(3aS,4R,9aR)-6-chloro-2-methyl-4-phenyl-1,3,3a,4,9,9a-hexahydrobenzo[f]isoindole	CN1C[C@@H]2Cc3ccc(Cl)cc3[C@@H](c3ccccc3)[C@@H]2C1	3045392.0	R6_adenot_2004:568			BBB+	C	training
InChI=1S/C19H20ClN3O/c1-3-6-18(24)22(2)13-16-19(14-8-10-15(20)11-9-14)21-17-7-4-5-12-23(16)17/h4-5,7-12H,3,6,13H2,1-2H3	Saripidem	N-[[2-(4-chlorophenyl)imidazo[1,2-a]pyridin-3-yl]methyl]-N-methylbutanamide	CCCC(=O)N(C)Cc1c(-c2ccc(Cl)cc2)nc2ccccn12	3058746.0	R6_adenot_2004:1510			BBB+	C	test
InChI=1S/C19H20ClNO2/c1-21-7-5-13-9-17(20)18(22)10-15(13)16(11-21)14-4-2-3-12-6-8-23-19(12)14/h2-4,9-10,16,22H,5-8,11H2,1H3/t16-/m1/s1	Odapipam	(5S)-8-chloro-5-(2,3-dihydro-1-benzofuran-7-yl)-3-methyl-1,2,4,5-tetrahydro-3-benzazepin-7-ol	CN1CCc2cc(Cl)c(O)cc2[C@@H](c2cccc3c2OCC3)C1	132421.0	R6_adenot_2004:1188			BBB+	C	training
InChI=1S/C19H20ClNO4/c1-19(2,18(23)24)25-16-9-3-13(4-10-16)11-12-21-17(22)14-5-7-15(20)8-6-14/h3-10H,11-12H2,1-2H3,(H,21,22)(H,23,24)	Bezafibrate	2-[4-[2-[(4-chlorobenzoyl)amino]ethyl]phenoxy]-2-methylpropanoic acid	CC(C)(Oc1ccc(CCNC(=O)c2ccc(Cl)cc2)cc1)C(=O)O	39042.0	R14_ghose_2012:396|R23_gupta_2019:392			BBB-	C	training
InChI=1S/C19H20F3N3O3/c20-19(21,22)14-3-1-4-15(13-14)24-17-16(5-2-6-23-17)18(26)28-12-9-25-7-10-27-11-8-25/h1-6,13H,7-12H2,(H,23,24)	Morniflumate	2-morpholin-4-ylethyl 2-[3-(trifluoromethyl)anilino]pyridine-3-carboxylate	O=C(OCCN1CCOCC1)c1cccnc1Nc1cccc(C(F)(F)F)c1	72106.0	R14_ghose_2012:703			BBB-	C	training
InChI=1S/C19H20F3NO2/c1-14(12-15-6-5-9-17(13-15)19(20,21)22)23-10-11-25-18(24)16-7-3-2-4-8-16/h2-9,13-14,23H,10-12H2,1H3	Benfluorex	2-[1-[3-(trifluoromethyl)phenyl]propan-2-ylamino]ethyl benzoate	CC(Cc1cccc(C(F)(F)F)c1)NCCOC(=O)c1ccccc1	2318.0	R14_ghose_2012:379			BBB-	C	test
InChI=1S/C19H20FN3/c1-22-8-10-23(11-9-22)19-17-5-3-2-4-14(17)12-15-6-7-16(20)13-18(15)21-19/h2-7,13H,8-12H2,1H3	Fluperlapine	3-fluoro-6-(4-methylpiperazin-1-yl)-11H-benzo[c][1]benzazepine	CN1CCN(C2=Nc3cc(F)ccc3Cc3ccccc32)CC1	49381.0	R6_adenot_2004:1571			BBB+	C	training
InChI=1S/C19H20FN3/c20-15-5-6-18-16(11-15)17-13-23(10-7-19(17)22-18)9-2-4-14-3-1-8-21-12-14/h1,3,5-6,8,11-12,22H,2,4,7,9-10,13H2	Gevotroline	8-fluoro-2-(3-pyridin-3-ylpropyl)-1,3,4,5-tetrahydropyrido[4,3-b]indole	Fc1ccc2[nH]c3c(c2c1)CN(CCCc1cccnc1)CC3	60547.0	R6_adenot_2004:1164			BBB+	C	training
InChI=1S/C19H20FN3/c20-16-9-7-14(8-10-16)13-23-18-6-2-1-5-17(18)22-19(23)15-4-3-11-21-12-15/h1-2,5-10,15,21H,3-4,11-13H2/t15-/m1/s1	1-[(4-Fluorophenyl)Methyl]-2-[(3R)-Piperidin-3-Yl]Benzimidazole	1-[(4-fluorophenyl)methyl]-2-[(3R)-piperidin-3-yl]benzimidazole	Fc1ccc(Cn2c([C@@H]3CCCNC3)nc3ccccc32)cc1	57404030.0	R46_mendoza_valencia_2017:437	0.39	A	BBB+	A	training
InChI=1S/C19H20FNO3/c20-15-3-1-13(2-4-15)17-7-8-21-10-14(17)11-22-16-5-6-18-19(9-16)24-12-23-18/h1-6,9,14,17,21H,7-8,10-12H2/t14-,17-/m0/s1	Paroxetine	(3S,4R)-3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine	Fc1ccc([C@@H]2CCNC[C@H]2COc2ccc3c(c2)OCO3)cc1	43815.0	R6_adenot_2004:594|R14_ghose_2012:183|R23_gupta_2019:184|R34_broccatelli_2012:132|R37_chen_2011:69			BBB+	C	test
InChI=1S/C19H20FNO3/c20-15-3-1-13(2-4-15)17-7-8-21-10-14(17)11-22-16-5-6-18-19(9-16)24-12-23-18/h1-6,9,14,17,21H,7-8,10-12H2/t14?,17-/m0/s1	Paroxetine, Paxil|(4R)-3-(1,3-Benzodioxol-5-Yloxymethyl)-4-(4-Fluorophenyl)Piperidine	(4R)-3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine	Fc1ccc([C@@H]2CCNCC2COc2ccc3c(c2)OCO3)cc1	44274603.0	R26_chico_2009:300	0.52	A	BBB+	A	test
InChI=1S/C19H20N2O/c22-19(14-21-13-12-20-15-21)18-10-8-17(9-11-18)7-6-16-4-2-1-3-5-16/h1-5,8-13,15,19,22H,6-7,14H2	Denzimol	2-imidazol-1-yl-1-[4-(2-phenylethyl)phenyl]ethanol	OC(Cn1ccnc1)c1ccc(CCc2ccccc2)cc1	53626.0	R6_adenot_2004:437			BBB+	C	training
InChI=1S/C19H20N2O2/c1-2-3-14-17-18(22)20(15-10-6-4-7-11-15)21(19(17)23)16-12-8-5-9-13-16/h4-13,17H,2-3,14H2,1H3	Phenylbutazone	4-butyl-1,2-diphenylpyrazolidine-3,5-dione	CCCCC1C(=O)N(c2ccccc2)N(c2ccccc2)C1=O	4781.0	R3_abraham_2006:227|R5_guerra_2008:83|R12_garg_2006:135|R14_ghose_2012:771|R21_muehlbacher_2011:111|R23_gupta_2019:832|R25_brito_sanchez_2015:355|R26_chico_2009:310|R28_li_2005:105|R39_shayanfar_2011:74|R40_vilar_2010:208|R41_toropov_2017:205|R44_bujak_2015:50|R46_mendoza_valencia_2017:310|R47_radchenko_2020:190|R50_sobanska_2019:11|R51_doninger_2002:111	-0.52	B	BBB+	A	test
InChI=1S/C19H20N2O2/c1-22-17-8-7-14(18(12-17)23-2)11-15-5-4-10-21-19(15)16-6-3-9-20-13-16/h3,6-9,11-13H,4-5,10H2,1-2H3	Dmxba, Gts-21|(3E)-3-[(2,4-Dimethoxyphenyl)Methylidene]-5,6-Dihydro-4H-2,3'-Bipyridine	3-[5-[(2,4-dimethoxyphenyl)methylidene]-3,4-dihydro-2H-pyridin-6-yl]pyridine	COc1ccc(C=C2CCCN=C2c2cccnc2)c(OC)c1	122226.0	R26_chico_2009:166	0.42	A	BBB+	A	test
InChI=1S/C19H20N2O3/c1-2-3-9-17-18(23)20(14-7-5-4-6-8-14)21(19(17)24)15-10-12-16(22)13-11-15/h4-8,10-13,17,22H,2-3,9H2,1H3	Oxyphenbutazone	4-butyl-1-(4-hydroxyphenyl)-2-phenylpyrazolidine-3,5-dione	CCCCC1C(=O)N(c2ccccc2)N(c2ccc(O)cc2)C1=O	4641.0	R14_ghose_2012:748			BBB-	C	test
InChI=1S/C19H20N2O3/c22-18-10-21-12-5-11(18)6-13(21)8-14(7-12)24-19(23)16-9-20-17-4-2-1-3-15(16)17/h1-4,9,11-14,20H,5-8,10H2/t11?,12-,13+,14?	Dolasetron	[(3S,7R)-10-oxo-8-azatricyclo[5.3.1.03,8]undecan-5-yl] 1H-indole-3-carboxylate	O=C(OC1C[C@@H]2CC3C[C@H](C1)N2CC3=O)c1c[nH]c2ccccc12	3033818.0	R14_ghose_2012:311|R23_gupta_2019:71			BBB+	C	training
InChI=1S/C19H20N2O3S/c1-2-13-3-6-15(20-12-13)9-10-24-16-7-4-14(5-8-16)11-17-18(22)21-19(23)25-17/h3-8,12,17H,2,9-11H2,1H3,(H,21,22,23)	Pioglitazone	5-[[4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione	CCc1ccc(CCOc2ccc(CC3SC(=O)NC3=O)cc2)nc1	4829.0	R14_ghose_2012:775|R23_gupta_2019:838			BBB-	C	test
InChI=1S/C19H20N4O2S/c24-23(25)18-16(12-15-6-2-1-3-7-15)13-22-19(18)21-10-11-26-14-17-8-4-5-9-20-17/h1-9,13,21-22H,10-12,14H2	Skb17|Bbcpd14|112598-32-0|Chebi: 337303|B-051|15|4-Benzyl-3-Nitro-N-[2-(Pyridin-2-Ylmethylsulfanyl)Ethyl]-1H-Pyrrol-2-Amine	4-benzyl-3-nitro-N-[2-(pyridin-2-ylmethylsulfanyl)ethyl]-1H-pyrrol-2-amine	O=[N+]([O-])c1c(Cc2ccccc2)c[nH]c1NCCSCc1ccccn1	14022483.0	R3_abraham_2006:258|R3_abraham_2006:308|R4_mente_2005:124|R12_garg_2006:30|R21_muehlbacher_2011:349|R25_brito_sanchez_2015:9|R26_chico_2009:50|R40_vilar_2010:44|R41_toropov_2017:230|R41_toropov_2017:275|R46_mendoza_valencia_2017:9|R47_radchenko_2020:213|R48_hou_2003:70|R52_liu_2001:15	-0.12	B	BBB+	A	test
InChI=1S/C19H20N6/c1-15-14-17(16-6-3-2-4-7-16)22-23-18(15)24-10-12-25(13-11-24)19-20-8-5-9-21-19/h2-9,14H,10-13H2,1H3	Minozac, Mw01-2-151Srm|Minozac Free Base	4-methyl-6-phenyl-3-(4-pyrimidin-2-ylpiperazin-1-yl)pyridazine	Cc1cc(-c2ccccc2)nnc1N1CCN(c2ncccn2)CC1	11515480.0	R26_chico_2009:275	0.18	A	BBB+	A	training
InChI=1S/C19H21ClFN3O3/c20-15-16-12(18(25)13(19(26)27)9-24(16)11-4-5-11)7-14(21)17(15)23-6-2-1-3-10(22)8-23/h7,9-11H,1-6,8,22H2,(H,26,27)/t10-/m1/s1	Besifloxacin	7-[(3R)-3-aminoazepan-1-yl]-8-chloro-1-cyclopropyl-6-fluoro-4-oxoquinoline-3-carboxylic acid	N[C@@H]1CCCCN(c2c(F)cc3c(=O)c(C(=O)O)cn(C4CC4)c3c2Cl)C1	10178705.0	R23_gupta_2019:387			BBB-	C	training
InChI=1S/C19H21ClN2S/c1-21-8-10-22(11-9-21)17-12-14-4-2-3-5-18(14)23-19-7-6-15(20)13-16(17)19/h2-7,13,17H,8-12H2,1H3	Clorotepine	1-(3-chloro-5,6-dihydrobenzo[b][1]benzothiepin-5-yl)-4-methylpiperazine	CN1CCN(C2Cc3ccccc3Sc3ccc(Cl)cc32)CC1	1238.0	R6_adenot_2004:1553			BBB+	C	training
InChI=1S/C19H21F3N2S/c1-13(11-23(2)3)12-24-15-6-4-5-7-17(15)25-18-9-8-14(10-16(18)24)19(20,21)22/h4-10,13H,11-12H2,1-3H3	Trifluomeprazine	N,N,2-trimethyl-3-[2-(trifluoromethyl)phenothiazin-10-yl]propan-1-amine	CC(CN(C)C)CN1c2ccccc2Sc2ccc(C(F)(F)F)cc21	72136.0	R6_adenot_2004:1631			BBB+	C	training
InChI=1S/C19H21FN2O4/c1-10-2-3-12-16-13(18(24)14(19(25)26)9-22(10)16)8-15(20)17(12)21-6-4-11(23)5-7-21/h8-11,23H,2-7H2,1H3,(H,25,26)	Nadifloxacin	7-fluoro-8-(4-hydroxypiperidin-1-yl)-12-methyl-4-oxo-1-azatricyclo[7.3.1.05,13]trideca-2,5,7,9(13)-tetraene-3-carboxylic acid	CC1CCc2c(N3CCC(O)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23	4410.0	R23_gupta_2019:1077			BBB-	C	training
InChI=1S/C19H21N/c1-2-20-14-13-18(15-20)19(16-9-5-3-6-10-16)17-11-7-4-8-12-17/h3-12H,2,13-15H2,1H3	Pridefine	3-benzhydrylidene-1-ethylpyrrolidine	CCN1CCC(=C(c2ccccc2)c2ccccc2)C1	31740.0	R6_adenot_2004:602			BBB+	C	test
InChI=1S/C19H21N/c1-20(2)15-14-19(17-9-4-3-5-10-17)13-12-16-8-6-7-11-18(16)19/h3-13H,14-15H2,1-2H3	Indriline	N,N-dimethyl-2-(1-phenylinden-1-yl)ethanamine	CN(C)CCC1(c2ccccc2)C=Cc2ccccc21	23878.0	R6_adenot_2004:1294			BBB+	C	test
InChI=1S/C19H21N/c1-20-14-6-11-19-17-9-4-2-7-15(17)12-13-16-8-3-5-10-18(16)19/h2-5,7-10,12-13,19-20H,6,11,14H2,1H3	Protriptyline	N-methyl-3-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,9,11,13-heptaenyl)propan-1-amine	CNCCCC1c2ccccc2C=Cc2ccccc21	4976.0	R6_adenot_2004:1618|R14_ghose_2012:215|R23_gupta_2019:210|R26_chico_2009:336|R51_doninger_2002:299			BBB+	C	training
InChI=1S/C19H21N/c1-20-14-6-11-19-17-9-4-2-7-15(17)12-13-16-8-3-5-10-18(16)19/h2-5,7-11,20H,6,12-14H2,1H3	Nortriptyline	N-methyl-3-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,11,13-hexaenylidene)propan-1-amine	CNCCC=C1c2ccccc2CCc2ccccc21	4543.0	R6_adenot_2004:1596|R7_andres_2006:121|R14_ghose_2012:171|R23_gupta_2019:169|R26_chico_2009:288|R29_subramanian_2003:117|R34_broccatelli_2012:63|R51_doninger_2002:264	1.04	A	BBB+	A	test
InChI=1S/C19H21N3/c1-21-10-12-22(13-11-21)19-17-8-4-2-6-15(17)14-16-7-3-5-9-18(16)20-19/h2-9H,10-14H2,1H3	Perlapine	6-(4-methylpiperazin-1-yl)-11H-benzo[c][1]benzazepine	CN1CCN(C2=Nc3ccccc3Cc3ccccc32)CC1	16106.0	R6_adenot_2004:1605|R51_doninger_2002:277			BBB+	C	training
InChI=1S/C19H21N3O/c1-13-5-8-15(9-6-13)19-16(11-18(23)21(3)4)22-12-14(2)7-10-17(22)20-19/h5-10,12H,11H2,1-4H3	82626-48-0|Zolpidem	N,N-dimethyl-2-[6-methyl-2-(4-methylphenyl)imidazo[1,2-a]pyridin-3-yl]acetamide	Cc1ccc(-c2nc3ccc(C)cn3c2CC(=O)N(C)C)cc1	5732.0	R4_mente_2005:145|R6_adenot_2004:759|R14_ghose_2012:272|R21_muehlbacher_2011:141|R23_gupta_2019:267|R25_brito_sanchez_2015:129|R26_chico_2009:447|R34_broccatelli_2012:101|R37_chen_2011:109|R40_vilar_2010:307|R47_radchenko_2020:351|R50_sobanska_2019:12	-0.5	B1	BBB+	A	test
InChI=1S/C19H21N3O/c1-14-6-8-15(9-7-14)13-22-17-5-3-2-4-16(17)21-19(22)18-12-20-10-11-23-18/h2-9,18,20H,10-13H2,1H3/t18-/m1/s1	9A|(2R)-2-[1-[(4-Methylphenyl)Methyl]Benzimidazol-2-Yl]Morpholine	(2R)-2-[1-[(4-methylphenyl)methyl]benzimidazol-2-yl]morpholine	Cc1ccc(Cn2c([C@H]3CNCCO3)nc3ccccc32)cc1	57395287.0	R25_brito_sanchez_2015:524|R46_mendoza_valencia_2017:438	0.36	B	BBB+	A	training
InChI=1S/C19H21N3O2/c1-22(2)16-8-9-18(24)14(10-16)11-20-17-5-3-4-13-6-7-15(12-23)21-19(13)17/h3-10,20,23-24H,11-12H2,1-2H3	Ml|4-(Dimethylamino)-2-[[[2-(Hydroxymethyl)Quinolin-8-Yl]Amino]Methyl]Phenol	4-(dimethylamino)-2-[[[2-(hydroxymethyl)quinolin-8-yl]amino]methyl]phenol	CN(C)c1ccc(O)c(CNc2cccc3ccc(CO)nc23)c1	71582706.0	R47_radchenko_2020:516	0.38	A	BBB+	A	test
InChI=1S/C19H21N3S/c1-14(12-21(2)3)13-22-16-6-4-5-7-18(16)23-19-9-8-15(11-20)10-17(19)22/h4-10,14H,12-13H2,1-3H3	Cyamemazine	10-[3-(dimethylamino)-2-methylpropyl]phenothiazine-2-carbonitrile	CC(CN(C)C)CN1c2ccccc2Sc2ccc(C#N)cc21	62865.0	R6_adenot_2004:1534			BBB+	C	training
InChI=1S/C19H21N3S/c1-14-7-8-17-15(13-14)19(22-11-9-21(2)10-12-22)20-16-5-3-4-6-18(16)23-17/h3-8,13H,9-12H2,1-2H3	Metiapine	8-methyl-6-(4-methylpiperazin-1-yl)benzo[b][1,4]benzothiazepine	Cc1ccc2c(c1)C(N1CCN(C)CC1)=Nc1ccccc1S2	22047.0	R6_adenot_2004:1591			BBB+	C	test
InChI=1S/C19H21N5O4/c1-26-15-10-12-13(11-16(15)27-2)21-19(22-17(12)20)24-7-5-23(6-8-24)18(25)14-4-3-9-28-14/h3-4,9-11H,5-8H2,1-2H3,(H2,20,21,22)	Prazosin	[4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-(furan-2-yl)methanone	COc1cc2nc(N3CCN(C(=O)c4ccco4)CC3)nc(N)c2cc1OC	4893.0	R14_ghose_2012:789|R25_brito_sanchez_2015:511|R26_chico_2009:316|R34_broccatelli_2012:133|R46_mendoza_valencia_2017:428|R51_doninger_2002:114	-0.9	D	BBB+	A	training
InChI=1S/C19H21NO/c1-20(2)13-7-11-17-16-9-4-3-8-15(16)14-21-19-12-6-5-10-18(17)19/h3-6,8-12H,7,13-14H2,1-2H3/b17-11+	Doxepine|Doxepin|Sinequan	(3E)-3-(6H-benzo[c][1]benzoxepin-11-ylidene)-N,N-dimethylpropan-1-amine	CN(C)CC/C=C1\c2ccccc2COc2ccccc21	667477.0	R7_andres_2006:54|R25_brito_sanchez_2015:499|R26_chico_2009:169|R29_subramanian_2003:53|R34_broccatelli_2012:25|R37_chen_2011:92|R46_mendoza_valencia_2017:417|R51_doninger_2002:205	1.0	B	BBB+	A	training
InChI=1S/C19H21NO/c1-20(2)13-7-11-17-16-9-4-3-8-15(16)14-21-19-12-6-5-10-18(17)19/h3-6,8-12H,7,13-14H2,1-2H3/b17-11-	Cidoxepin|Doxepin	(3Z)-3-(6H-benzo[c][1]benzoxepin-11-ylidene)-N,N-dimethylpropan-1-amine	CN(C)CC/C=C1/c2ccccc2COc2ccccc21	667468.0	R6_adenot_2004:1550|R6_adenot_2004:1564|R14_ghose_2012:81|R23_gupta_2019:75			BBB+	C	training
InChI=1S/C19H21NO2/c1-13-6-5-7-14-16-12-20(2)11-10-19(16,21)15-8-3-4-9-17(15)22-18(13)14/h3-9,16,21H,10-12H2,1-2H3	B-101, Beloxepin|2,10-Dimethyl-1,3,4,13B-Tetrahydrodibenzo[2,3:6,7]Oxepino[4,5-C]Pyridin-4A(2H)-Ol	4,16-dimethyl-14-oxa-4-azatetracyclo[13.4.0.02,7.08,13]nonadeca-1(19),8,10,12,15,17-hexaen-7-ol	Cc1cccc2c1Oc1ccccc1C1(O)CCN(C)CC21	9860946.0	R26_chico_2009:68|R41_toropov_2017:123|R41_toropov_2017:292|R46_mendoza_valencia_2017:151|R49_norinder_2002:141	0.82	B	BBB+	A	training
InChI=1S/C19H21NO2/c1-13-6-5-7-14-16-12-20(2)11-10-19(16,21)15-8-3-4-9-17(15)22-18(13)14/h3-9,16,21H,10-12H2,1-2H3/t16-,19-/m0/s1	Beloxepin|135928-30-2|Org4428	(2R,7R)-4,16-dimethyl-14-oxa-4-azatetracyclo[13.4.0.02,7.08,13]nonadeca-1(19),8,10,12,15,17-hexaen-7-ol	Cc1cccc2c1Oc1ccccc1[C@@]1(O)CCN(C)C[C@@H]21	166560.0	R3_abraham_2006:130|R4_mente_2005:166|R6_adenot_2004:1565|R21_muehlbacher_2011:300|R25_brito_sanchez_2015:154|R28_li_2005:37|R40_vilar_2010:49|R47_radchenko_2020:110	0.82	B	BBB+	A	training
InChI=1S/C19H21NO2/c1-20(2)12-6-8-15-16-7-4-5-9-18(16)22-19-11-10-14(21-3)13-17(15)19/h4-5,7-11,13H,6,12H2,1-3H3	Dimeprozan	3-(2-methoxyxanthen-9-ylidene)-N,N-dimethylpropan-1-amine	COc1ccc2c(c1)C(=CCCN(C)C)c1ccccc1O2	208840.0	R6_adenot_2004:1562			BBB+	C	test
InChI=1S/C19H21NO2/c1-20(2)18(21)13-22-19-16-9-5-3-7-14(16)11-12-15-8-4-6-10-17(15)19/h3-10,19H,11-13H2,1-2H3	Oxitriptyline	N,N-dimethyl-2-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,11,13-hexaenyloxy)acetamide	CN(C)C(=O)COC1c2ccccc2CCc2ccccc21	34624.0	R6_adenot_2004:1602			BBB+	C	test
InChI=1S/C19H21NO3/c1-2-8-20-9-7-19-12-4-6-15(22)18(19)23-17-14(21)5-3-11(16(17)19)10-13(12)20/h2-6,12-13,15,18,21-22H,1,7-10H2/t12-,13+,15-,18-,19-/m0/s1	Nalorphine	(4R,4aR,7S,7aR,12bS)-3-prop-2-enyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7,9-diol	C=CCN1CC[C@]23c4c5ccc(O)c4O[C@H]2[C@@H](O)C=C[C@H]3[C@H]1C5	5284595.0	R28_li_2005:383			BBB+	C	test
InChI=1S/C19H21NO3/c1-20(2)11-15-13-22-19(23-15)16-8-4-3-7-14(16)12-21-18-10-6-5-9-17(18)19/h3-10,15H,11-13H2,1-2H3	Spiroxepin	N,N-dimethyl-1-spiro[1,3-dioxolane-2,11'-6H-benzo[c][1]benzoxepine]-4-ylmethanamine	CN(C)CC1COC2(O1)c1ccccc1COc1ccccc12	68674.0	R6_adenot_2004:1621			BBB+	C	training
InChI=1S/C19H21NO3/c1-20-9-8-19-12-5-7-15(22-3)18(19)23-17-14(21-2)6-4-11(16(17)19)10-13(12)20/h4-7,13,18H,8-10H2,1-3H3/t13-,18+,19+/m1/s1	Thebaine	(4R,7aR,12bS)-7,9-dimethoxy-3-methyl-2,4,7a,13-tetrahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline	COC1=CC=C2[C@H]3Cc4ccc(OC)c5c4[C@@]2(CCN3C)[C@H]1O5	5324289.0	R51_doninger_2002:310			BBB+	C	training
InChI=1S/C19H21NO4/c1-2-8-20-9-7-18-15-11-3-4-12(21)16(15)24-17(18)13(22)5-6-19(18,23)14(20)10-11/h2-4,14,17,21,23H,1,5-10H2/t14-,17+,18+,19-/m1/s1	Naloxone	(4R,4aS,7aR,12bS)-4a,9-dihydroxy-3-prop-2-enyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one	C=CCN1CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@@]3(O)[C@H]1C5	5284596.0	R6_adenot_2004:1063|R7_andres_2006:111|R14_ghose_2012:162|R23_gupta_2019:160|R29_subramanian_2003:108|R34_broccatelli_2012:55|R51_doninger_2002:260			BBB+	C	training
InChI=1S/C19H21NS/c1-20(2)13-7-11-17-16-9-4-3-8-15(16)14-21-19-12-6-5-10-18(17)19/h3-6,8-12H,7,13-14H2,1-2H3/b17-11+	Dosulepin	(3E)-3-(6H-benzo[c][1]benzothiepin-11-ylidene)-N,N-dimethylpropan-1-amine	CN(C)CC/C=C1\c2ccccc2CSc2ccccc21	5284550.0	R6_adenot_2004:531|R14_ghose_2012:79|R23_gupta_2019:73			BBB+	C	training
InChI=1S/C19H21NS/c1-20-11-8-15(9-12-20)19-16-5-3-2-4-14(16)6-7-18-17(19)10-13-21-18/h2-5,10,13H,6-9,11-12H2,1H3	Pizotifen	1-methyl-4-(6-thiatricyclo[8.4.0.03,7]tetradeca-1(14),3(7),4,10,12-pentaen-2-ylidene)piperidine	CN1CCC(=C2c3ccccc3CCc3sccc32)CC1	27400.0	R6_adenot_2004:600|R14_ghose_2012:205|R23_gupta_2019:204			BBB+	C	training
InChI=1S/C19H22Cl2N4O/c20-14-4-3-13(9-15(14)21)10-18(26)25-8-5-16-19(23-12-22-16)17(25)11-24-6-1-2-7-24/h3-4,9,12,17H,1-2,5-8,10-11H2,(H,22,23)/t17-/m1/s1	Brl52974|2-(3,4-Dichlorophenyl)-1-[(4R)-4-(Pyrrolidin-1-Ylmethyl)-1,4,6,7-Tetrahydroimidazo[4,5-C]Pyridin-5-Yl]Ethanone	2-(3,4-dichlorophenyl)-1-[(4R)-4-(pyrrolidin-1-ylmethyl)-1,4,6,7-tetrahydroimidazo[4,5-c]pyridin-5-yl]ethanone	O=C(Cc1ccc(Cl)c(Cl)c1)N1CCc2[nH]cnc2[C@H]1CN1CCCC1	44310436.0	R28_li_2005:331			BBB-	C	training
InChI=1S/C19H22Cl2N4O/c20-15-4-3-14(11-16(15)21)12-18(26)25-10-9-24-8-5-22-19(24)17(25)13-23-6-1-2-7-23/h3-5,8,11,17H,1-2,6-7,9-10,12-13H2/t17-/m1/s1	Sb201708|2-(3,4-Dichlorophenyl)-1-[(8R)-8-(Pyrrolidin-1-Ylmethyl)-6,8-Dihydro-5H-Imidazo[1,2-A]Pyrazin-7-Yl]Ethanone	2-(3,4-dichlorophenyl)-1-[(8R)-8-(pyrrolidin-1-ylmethyl)-6,8-dihydro-5H-imidazo[1,2-a]pyrazin-7-yl]ethanone	O=C(Cc1ccc(Cl)c(Cl)c1)N1CCn2ccnc2[C@H]1CN1CCCC1	44310539.0	R28_li_2005:395			BBB+	C	training
InChI=1S/C19H22Cl2N4O2/c20-14-2-1-12(7-15(14)21)8-18(27)25-6-4-16-19(23-11-22-16)17(25)10-24-5-3-13(26)9-24/h1-2,7,11,13,17,26H,3-6,8-10H2,(H,22,23)/t13-,17-/m1/s1	Sb205605		O=C(Cc1ccc(Cl)c(Cl)c1)N1CCc2[nH]cnc2[C@H]1CN1CC[C@@H](O)C1		R28_li_2005:401			BBB-	C	training
InChI=1S/C19H22Cl2N4O2/c20-15-2-1-13(9-16(15)21)10-18(27)25-8-7-24-6-4-22-19(24)17(25)12-23-5-3-14(26)11-23/h1-2,4,6,9,14,17,26H,3,5,7-8,10-12H2/t14-,17-/m1/s1	Sb204459|2-(3,4-Dichlorophenyl)-1-[(8R)-8-[[(3R)-3-Hydroxypyrrolidin-1-Yl]Methyl]-6,8-Dihydro-5H-Imidazo[1,2-A]Pyrazin-7-Yl]Ethanone	2-(3,4-dichlorophenyl)-1-[(8R)-8-[[(3R)-3-hydroxypyrrolidin-1-yl]methyl]-6,8-dihydro-5H-imidazo[1,2-a]pyrazin-7-yl]ethanone	O=C(Cc1ccc(Cl)c(Cl)c1)N1CCn2ccnc2[C@H]1CN1CC[C@@H](O)C1	44310065.0	R28_li_2005:398			BBB-	C	training
InChI=1S/C19H22ClN5O/c20-16-5-3-6-17(15-16)23-13-11-22(12-14-23)8-4-10-25-19(26)24-9-2-1-7-18(24)21-25/h1-3,5-7,9,15H,4,8,10-14H2	Trazodone	2-[3-[4-(3-chlorophenyl)piperazin-1-yl]propyl]-[1,2,4]triazolo[4,3-a]pyridin-3-one	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	5533.0	R6_adenot_2004:1521|R14_ghose_2012:257|R23_gupta_2019:250|R25_brito_sanchez_2015:519|R26_chico_2009:427|R34_broccatelli_2012:92|R37_chen_2011:100|R42_ciura_2020:44|R50_sobanska_2019:86|R51_doninger_2002:315	0.3	D	BBB+	A	training
InChI=1S/C19H22ClNO2/c20-18-8-6-17(7-9-18)19(16-4-2-1-3-5-16)23-15-12-21-10-13-22-14-11-21/h1-9,19H,10-15H2	Difencloxazine	4-[2-[(4-chlorophenyl)-phenylmethoxy]ethyl]morpholine	Clc1ccc(C(OCCN2CCOCC2)c2ccccc2)cc1	9973981.0	R6_adenot_2004:1447			BBB+	C	training
InChI=1S/C19H22F2N4O3/c1-8-5-24(6-9(2)23-8)17-13(20)15(22)12-16(14(17)21)25(10-3-4-10)7-11(18(12)26)19(27)28/h7-10,23H,3-6,22H2,1-2H3,(H,27,28)/t8-,9+	Sparfloxacin	5-amino-1-cyclopropyl-7-[(3S,5R)-3,5-dimethylpiperazin-1-yl]-6,8-difluoro-4-oxoquinoline-3-carboxylic acid	C[C@@H]1CN(c2c(F)c(N)c3c(=O)c(C(=O)O)cn(C4CC4)c3c2F)C[C@H](C)N1	60464.0	R14_ghose_2012:849|R23_gupta_2019:917|R25_brito_sanchez_2015:432|R28_li_2005:410	0.41	A	BBB+	A	training
InChI=1S/C19H22F3N5O2S/c1-10-14(11-6-7-24-13(9-11)18(2,3)19(20,21)22)30-16(25-10)26-17(29)27-8-4-5-12(27)15(23)28/h6-7,9,12H,4-5,8H2,1-3H3,(H2,23,28)(H,25,26,29)/t12-/m0/s1	Alpelisib	(2S)-1-N-[4-methyl-5-[2-(1,1,1-trifluoro-2-methylpropan-2-yl)pyridin-4-yl]-1,3-thiazol-2-yl]pyrrolidine-1,2-dicarboxamide	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1	56649450.0	R23_gupta_2019:339			BBB-	C	training
InChI=1S/C19H22FN3O/c20-17-8-6-16(7-9-17)18(24)4-3-11-22-12-14-23(15-13-22)19-5-1-2-10-21-19/h1-2,5-10H,3-4,11-15H2	Azaperone	1-(4-fluorophenyl)-4-(4-pyridin-2-ylpiperazin-1-yl)butan-1-one	O=C(CCCN1CCN(c2ccccn2)CC1)c1ccc(F)cc1	15443.0	R6_adenot_2004:1118|R51_doninger_2002:157			BBB+	C	training
InChI=1S/C19H22FN3O3/c1-10-8-22(6-5-21-10)15-7-14-16(11(2)17(15)20)18(24)13(19(25)26)9-23(14)12-3-4-12/h7,9-10,12,21H,3-6,8H2,1-2H3,(H,25,26)	Grepafloxacin	1-cyclopropyl-6-fluoro-5-methyl-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid	Cc1c(F)c(N2CCNC(C)C2)cc2c1c(=O)c(C(=O)O)cn2C1CC1	72474.0	R6_adenot_2004:33|R23_gupta_2019:644			BBB-	C	training
InChI=1S/C19H22FN3O4/c1-10-8-22(6-5-21-10)16-14(20)7-12-15(18(16)27-2)23(11-3-4-11)9-13(17(12)24)19(25)26/h7,9-11,21H,3-6,8H2,1-2H3,(H,25,26)	Gatifloxacin	1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid	COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12	5379.0	R14_ghose_2012:587|R23_gupta_2019:625			BBB-	C	training
InChI=1S/C19H22N2/c1-16-7-9-17(10-8-16)18(19-6-2-3-12-20-19)11-15-21-13-4-5-14-21/h2-3,6-12H,4-5,13-15H2,1H3/b18-11+	Triprolidine	2-[(E)-1-(4-methylphenyl)-3-pyrrolidin-1-ylprop-1-enyl]pyridine	Cc1ccc(/C(=C\CN2CCCC2)c2ccccn2)cc1	5282443.0	R14_ghose_2012:265|R23_gupta_2019:259|R47_radchenko_2020:497	0.77	A	BBB+	A	training
InChI=1S/C19H22N2/c1-20(2)14-7-15-21-18-10-5-3-8-16(18)12-13-17-9-4-6-11-19(17)21/h3-6,8-13H,7,14-15H2,1-2H3	Depramine	3-benzo[b][1]benzazepin-11-yl-N,N-dimethylpropan-1-amine	CN(C)CCCN1c2ccccc2C=Cc2ccccc21	67534.0	R6_adenot_2004:647			BBB+	C	training
InChI=1S/C19H22N2O/c1-19(13-8-14-20-2)16-11-6-7-12-17(16)21(18(19)22)15-9-4-3-5-10-15/h3-7,9-12,20H,8,13-14H2,1-2H3	Amedalin	3-methyl-3-[3-(methylamino)propyl]-1-phenylindol-2-one	CNCCCC1(C)C(=O)N(c2ccccc2)c2ccccc21	31075.0	R6_adenot_2004:486			BBB+	C	training
InChI=1S/C19H22N2O/c1-20(2)12-7-13-21-17-10-5-3-8-15(17)14-19(22)16-9-4-6-11-18(16)21/h3-6,8-11H,7,12-14H2,1-2H3	Ketimipramine	11-[3-(dimethylamino)propyl]-6H-benzo[b][1]benzazepin-5-one	CN(C)CCCN1c2ccccc2CC(=O)c2ccccc21	28424.0	R6_adenot_2004:1584			BBB+	C	training
InChI=1S/C19H22N2O/c1-21(2)13-14-22-20-19-17-9-5-3-7-15(17)11-12-16-8-4-6-10-18(16)19/h3-10H,11-14H2,1-2H3	Noxiptiline|Noxiptilin	N,N-dimethyl-2-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,11,13-hexaenylideneamino)oxyethanamine	CN(C)CCON=C1c2ccccc2CCc2ccccc21	21087.0	R6_adenot_2004:1597|R7_andres_2006:122|R29_subramanian_2003:118			BBB+	C	training
InChI=1S/C19H22N2O2/c1-13-17(9-10-20)18-11-15(22)5-8-19(18)21(13)12-14-3-6-16(23-2)7-4-14/h3-8,11,22H,9-10,12,20H2,1-2H3	Hydroxindasol	3-(2-aminoethyl)-1-[(4-methoxyphenyl)methyl]-2-methylindol-5-ol	COc1ccc(Cn2c(C)c(CCN)c3cc(O)ccc32)cc1	216254.0	R6_adenot_2004:1292			BBB+	C	test
InChI=1S/C19H22N2O6S/c1-11(22)26-10-27-18(25)15-19(2,3)28-17-14(16(24)21(15)17)20-13(23)9-12-7-5-4-6-8-12/h4-8,14-15,17H,9-10H2,1-3H3,(H,20,23)/t14-,15+,17-/m1/s1	Penamecillin	acetyloxymethyl (2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate	CC(=O)OCOC(=O)[C@@H]1N2C(=O)[C@@H](NC(=O)Cc3ccccc3)[C@H]2SC1(C)C	10250769.0	R6_adenot_2004:250			BBB-	C	test
InChI=1S/C19H22N2OS/c1-13(20(3)4)12-21-16-7-5-6-8-18(16)23-19-10-9-15(14(2)22)11-17(19)21/h5-11,13H,12H2,1-4H3	Aceprometazine	1-[10-[2-(dimethylamino)propyl]phenothiazin-2-yl]ethanone	CC(=O)c1ccc2c(c1)N(CC(C)N(C)C)c1ccccc1S2	26035.0	R6_adenot_2004:1537			BBB+	C	training
InChI=1S/C19H22N2OS/c1-14(22)15-9-10-19-17(13-15)21(12-6-11-20(2)3)16-7-4-5-8-18(16)23-19/h4-5,7-10,13H,6,11-12H2,1-3H3	Acepromazine	1-[10-[3-(dimethylamino)propyl]phenothiazin-2-yl]ethanone	CC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2	6077.0	R6_adenot_2004:1536|R51_doninger_2002:146			BBB+	C	training
InChI=1S/C19H22N2OS/c1-20(2)12-13-21-16-10-6-7-11-17(16)23-18(14-19(21)22)15-8-4-3-5-9-15/h3-11,18H,12-14H2,1-2H3	Tiazesim	5-[2-(dimethylamino)ethyl]-2-phenyl-2,3-dihydro-1,5-benzothiazepin-4-one	CN(C)CCN1C(=O)CC(c2ccccc2)Sc2ccccc21	22107.0	R6_adenot_2004:618			BBB+	C	training
InChI=1S/C19H22N2S/c1-19(11-12-20(2)13-19)14-21-15-7-3-5-9-17(15)22-18-10-6-4-8-16(18)21/h3-10H,11-14H2,1-2H3	Dimelazine	10-[(1,3-dimethylpyrrolidin-3-yl)methyl]phenothiazine	CN1CCC(C)(CN2c3ccccc3Sc3ccccc32)C1	208838.0	R6_adenot_2004:1147			BBB+	C	test
InChI=1S/C19H22N2S/c1-20-12-6-7-15(13-20)14-21-16-8-2-4-10-18(16)22-19-11-5-3-9-17(19)21/h2-5,8-11,15H,6-7,12-14H2,1H3	Pecazine	10-[(1-methylpiperidin-3-yl)methyl]phenothiazine	CN1CCCC(CN2c3ccccc3Sc3ccccc32)C1	6075.0	R6_adenot_2004:1194|R51_doninger_2002:272			BBB+	C	training
InChI=1S/C19H22N4O/c1-22(2)13-14-6-5-7-16(12-14)19-20-18(21-23(19)3)15-8-10-17(24-4)11-9-15/h5-12H,13H2,1-4H3	27|1-[3-[5-(4-Methoxyphenyl)-2-Methyl-1,2,4-Triazol-3-Yl]Phenyl]-N,N-Dimethylmethanamine	1-[3-[5-(4-methoxyphenyl)-2-methyl-1,2,4-triazol-3-yl]phenyl]-N,N-dimethylmethanamine	COc1ccc(-c2nc(-c3cccc(CN(C)C)c3)n(C)n2)cc1	17807768.0	R47_radchenko_2020:448	1.26	A	BBB+	A	training
InChI=1S/C19H22N8O6S2/c1-33-24-12(10-8-35-19(21)22-10)15(29)23-13-16(30)27-14(18(31)32)9(7-34-17(13)27)6-25-3-2-11(20)26(25)4-5-28/h2-3,8,13,17,20,28H,4-7H2,1H3,(H4,21,22,23,29,31,32)/b24-12-/t13-,17-/m1/s1	Cefoselis|(6R,7R)-3-[[3-Amino-2-(2-Hydroxyethyl)Pyrazol-1-Ium-1-Yl]Methyl]-7-[[(2E)-2-(2-Amino-1,3-Thiazol-4-Yl)-2-Methoxyiminoacetyl]Amino]-8-Oxo-5-Thia-1-Azabicyclo[4.2.0]Oct-2-Ene-2-Carboxylate	(6R,7R)-3-[[3-amino-2-(2-hydroxyethyl)pyrazol-1-ium-1-yl]methyl]-7-[[(2E)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate	CO/N=C(/C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(C[n+]3ccc(N)n3CCO)CS[C@H]12)c1csc(N)n1	9589475.0	R6_adenot_2004:226			BBB-	C	training
InChI=1S/C19H23ClN2/c1-21(2)12-5-13-22-18-7-4-3-6-15(18)8-9-16-10-11-17(20)14-19(16)22/h3-4,6-7,10-11,14H,5,8-9,12-13H2,1-2H3	Clomipramine	3-(2-chloro-5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N,N-dimethylpropan-1-amine	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	2801.0	R6_adenot_2004:1552|R7_andres_2006:38|R14_ghose_2012:52|R26_chico_2009:110|R28_li_2005:252|R29_subramanian_2003:39|R34_broccatelli_2012:113|R37_chen_2011:22|R47_radchenko_2020:459|R51_doninger_2002:184	1.04	A	BBB+	A	training
InChI=1S/C19H23ClN2/c1-21-12-5-13-22(15-14-21)19(16-6-3-2-4-7-16)17-8-10-18(20)11-9-17/h2-4,6-11,19H,5,12-15H2,1H3	Homochlorcyclizine	1-[(4-chlorophenyl)-phenylmethyl]-4-methyl-1,4-diazepane	CN1CCCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1	3627.0	R6_adenot_2004:1476			BBB+	C	training
InChI=1S/C19H23FN2O3/c1-21-17(24)13-19(18(21)25)8-11-22(12-9-19)10-2-3-16(23)14-4-6-15(20)7-5-14/h4-7H,2-3,8-13H2,1H3	Roxoperone	8-[4-(4-fluorophenyl)-4-oxobutyl]-2-methyl-2,8-diazaspiro[4.5]decane-1,3-dione	CN1C(=O)CC2(CCN(CCCC(=O)c3ccc(F)cc3)CC2)C1=O	71117.0	R6_adenot_2004:1212			BBB+	C	training
InChI=1S/C19H23FN4O4/c1-13-21-18(17(24(26)27)19(25)23(13)11-12-28-2)22-9-7-15(8-10-22)14-3-5-16(20)6-4-14/h3-6,15H,7-12H2,1-2H3	37|6-[4-(4-Fluorophenyl)Piperidin-1-Yl]-3-(2-Methoxyethyl)-2-Methyl-5-Nitropyrimidin-4-One	6-[4-(4-fluorophenyl)piperidin-1-yl]-3-(2-methoxyethyl)-2-methyl-5-nitropyrimidin-4-one	COCCn1c(C)nc(N2CCC(c3ccc(F)cc3)CC2)c([N+](=O)[O-])c1=O	10178470.0	R47_radchenko_2020:426	0.2	A	BBB+	A	test
InChI=1S/C19H23N3/c1-20(2)13-14-21(3)22-15-18(16-9-5-4-6-10-16)17-11-7-8-12-19(17)22/h4-12,15H,13-14H2,1-3H3	Binedaline	N,N,N'-trimethyl-N'-(3-phenylindol-1-yl)ethane-1,2-diamine	CN(C)CCN(C)n1cc(-c2ccccc2)c2ccccc21	42510.0	R6_adenot_2004:495			BBB+	C	training
InChI=1S/C19H23N3O/c1-13-5-8-15(9-6-13)19-16(11-18(23)21(3)4)22-12-14(2)7-10-17(22)20-19/h5-10,12,17,20H,11H2,1-4H3			CC1=CN2C(CC(=O)N(C)C)=C(c3ccc(C)cc3)NC2C=C1		R46_mendoza_valencia_2017:127	-0.54	A	BBB+	A	training
InChI=1S/C19H23N3O2/c23-19(24-15-17-4-2-1-3-5-17)22-12-8-16(9-13-22)14-21-18-6-10-20-11-7-18/h1-7,10-11,16H,8-9,12-15H2,(H,20,21)	Liv-13|N-[(1-Cbz-4-Piperidyl)Methyl]Pyridin-4-Amine	benzyl 4-[(pyridin-4-ylamino)methyl]piperidine-1-carboxylate	O=C(OCc1ccccc1)N1CCC(CNc2ccncc2)CC1	9797385.0	R26_chico_2009:243	0.13	A	BBB+	A	test
InChI=1S/C19H23N3O2/c23-19(24-15-17-6-2-1-3-7-17)22-12-9-16(10-13-22)14-21-18-8-4-5-11-20-18/h1-8,11,16H,9-10,12-15H2,(H,20,21)	Liv-16|Benzyl 4-[(Pyridin-2-Ylamino)Methyl]Piperidine-1-Carboxylate	benzyl 4-[(pyridin-2-ylamino)methyl]piperidine-1-carboxylate	O=C(OCc1ccccc1)N1CCC(CNc2ccccn2)CC1	10268204.0	R26_chico_2009:244	-0.02	A	BBB+	A	training
InChI=1S/C19H23N3O4S/c1-18(2)13(17(25)26)21-15(24)12(16(21)27-18)22-14(23)11(20-19(22,3)4)10-8-6-5-7-9-10/h5-9,11-13,16,20H,1-4H3,(H,25,26)/t11-,12-,13+,16-/m1/s1	Hetacillin	(2S,5R,6R)-6-[(4R)-2,2-dimethyl-5-oxo-4-phenylimidazolidin-1-yl]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid	CC1(C)S[C@@H]2[C@H](N3C(=O)[C@@H](c4ccccc4)NC3(C)C)C(=O)N2[C@H]1C(=O)O	443387.0	R6_adenot_2004:234|R14_ghose_2012:604|R23_gupta_2019:653			BBB-	C	training
InChI=1S/C19H23N3O5S/c1-18(2)13(17(26)27)21-15(25)12(16(21)28-18)22-14(24)11(20-19(22,3)4)9-5-7-10(23)8-6-9/h5-8,11-13,16,20,23H,1-4H3,(H,26,27)/t11-,12-,13+,16-/m1/s1	Oxetacillin	(2S,5R,6R)-6-[(4R)-4-(4-hydroxyphenyl)-2,2-dimethyl-5-oxoimidazolidin-1-yl]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid	CC1(C)S[C@@H]2[C@H](N3C(=O)[C@@H](c4ccc(O)cc4)NC3(C)C)C(=O)N2[C@H]1C(=O)O	10001337.0	R6_adenot_2004:249			BBB-	C	training
InChI=1S/C19H23N4O6PS/c1-13(23(12-24)11-16-10-21-14(2)22-18(16)20)17(8-9-29-30(26,27)28)31-19(25)15-6-4-3-5-7-15/h3-7,10,12H,8-9,11H2,1-2H3,(H2,20,21,22)(H2,26,27,28)/b17-13-	Benfotiamine|S-Benzoylthiamine O-Monophosphate	S-[(Z)-2-[(4-amino-2-methylpyrimidin-5-yl)methyl-formylamino]-5-phosphonooxypent-2-en-3-yl] benzenecarbothioate	C/C(=C(\CCOP(=O)(O)O)SC(=O)c1ccccc1)N(C=O)Cc1cnc(C)nc1N	3032771.0	R6_adenot_2004:386			BBB+	C	training
InChI=1S/C19H23N5O3S/c25-18-16-6-1-2-7-17(16)28(26,27)24(18)11-4-3-10-22-12-14-23(15-13-22)19-20-8-5-9-21-19/h1-2,5-9H,3-4,10-15H2	Ipsapirone	1,1-dioxo-2-[4-(4-pyrimidin-2-ylpiperazin-1-yl)butyl]-1,2-benzothiazol-3-one	O=C1c2ccccc2S(=O)(=O)N1CCCCN1CCN(c2ncccn2)CC1	56971.0	R6_adenot_2004:1479			BBB+	C	training
InChI=1S/C19H23N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,11-12,21,23H,5-8H2,(H,24,29)(H,27,28)(H,31,32)(H4,20,22,25,26,30)/t11?,12-/m0/s1	Tetrahydrofolic Acid	(2S)-2-[[4-[(2-amino-4-oxo-5,6,7,8-tetrahydro-3H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid	Nc1nc2c(c(=O)[nH]1)NC(CNc1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1)CN2	135444742.0	R23_gupta_2019:972			BBB-	C	test
InChI=1S/C19H23NO/c1-20-14-12-18(13-15-20)21-19(16-8-4-2-5-9-16)17-10-6-3-7-11-17/h2-11,18-19H,12-15H2,1H3	Diphenylpyraline	4-benzhydryloxy-1-methylpiperidine	CN1CCC(OC(c2ccccc2)c2ccccc2)CC1	3103.0	R14_ghose_2012:282|R23_gupta_2019:69			BBB+	C	training
InChI=1S/C19H23NO2/c1-20-10-9-15-11-18(21-2)19(22-3)12-16(15)17(13-20)14-7-5-4-6-8-14/h4-8,11-12,17H,9-10,13H2,1-3H3	Trimopam	7,8-dimethoxy-3-methyl-5-phenyl-1,2,4,5-tetrahydro-3-benzazepine	COc1cc2c(cc1OC)C(c1ccccc1)CN(C)CC2	5024.0	R6_adenot_2004:755			BBB+	C	test
InChI=1S/C19H23NO2S/c1-20(2)12-6-11-19(21)15-7-4-5-8-17(15)23-18-10-9-14(22-3)13-16(18)19/h4-5,7-10,13,21H,6,11-12H2,1-3H3	Meprotixol	9-[3-(dimethylamino)propyl]-2-methoxythioxanthen-9-ol	COc1ccc2c(c1)C(O)(CCCN(C)C)c1ccccc1S2	71195.0	R6_adenot_2004:1177			BBB+	C	test
InChI=1S/C19H23NO3/c1-2-21-16-10-6-7-11-17(16)23-19(15-8-4-3-5-9-15)18-14-20-12-13-22-18/h3-11,18-20H,2,12-14H2,1H3/t18-,19-/m1/s1	Reboxetine	(2R)-2-[(R)-(2-ethoxyphenoxy)-phenylmethyl]morpholine	CCOc1ccccc1O[C@H](c1ccccc1)[C@H]1CNCCO1	127151.0	R6_adenot_2004:604|R14_ghose_2012:220|R23_gupta_2019:216|R34_broccatelli_2012:77|R37_chen_2011:81			BBB+	C	training
InChI=1S/C19H23NO5/c1-24-9-8-20-7-6-18-15-11-2-3-12(21)16(15)25-17(18)13(22)4-5-19(18,23)14(20)10-11/h2-3,14,17,21,23H,4-10H2,1H3/t14-,17+,18+,19-/m1/s1	Semorphone	(4R,4aS,7aR,12bS)-4a,9-dihydroxy-3-(2-methoxyethyl)-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one	COCCN1CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@@]3(O)[C@H]1C5	5491906.0	R6_adenot_2004:1087			BBB+	C	training
InChI=1S/C19H24ClNO/c1-15(14-21(3)4)22-19(2,16-8-6-5-7-9-16)17-10-12-18(20)13-11-17/h5-13,15H,14H2,1-4H3	Mecloxamine	2-[1-(4-chlorophenyl)-1-phenylethoxy]-N,N-dimethylpropan-1-amine	CC(CN(C)C)OC(C)(c1ccccc1)c1ccc(Cl)cc1	3045406.0	R6_adenot_2004:93			BBB-	C	training
InChI=1S/C19H24N2/c1-19(13-8-14-20-2)15-21(16-9-4-3-5-10-16)18-12-7-6-11-17(18)19/h3-7,9-12,20H,8,13-15H2,1-2H3	Daledalin	N-methyl-3-(3-methyl-1-phenyl-2H-indol-3-yl)propan-1-amine	CNCCCC1(C)CN(c2ccccc2)c2ccccc21	31707.0	R6_adenot_2004:519			BBB+	C	training
InChI=1S/C19H24N2/c1-19(2)15-9-4-6-11-17(15)21(14-8-13-20-3)18-12-7-5-10-16(18)19/h4-7,9-12,20H,8,13-14H2,1-3H3	Monometacrine	3-(9,9-dimethylacridin-10-yl)-N-methylpropan-1-amine	CNCCCN1c2ccccc2C(C)(C)c2ccccc21	145765.0	R6_adenot_2004:579			BBB+	C	training
InChI=1S/C19H24N2/c1-20(2)12-7-13-21-15-18-10-4-3-8-16(18)14-17-9-5-6-11-19(17)21/h3-6,8-11H,7,12-15H2,1-2H3	Prazepine	3-(6,11-dihydrobenzo[c][1]benzazepin-5-yl)-N,N-dimethylpropan-1-amine	CN(C)CCCN1Cc2ccccc2Cc2ccccc21	299322.0	R6_adenot_2004:1609			BBB+	C	training
InChI=1S/C19H24N2/c1-20(2)14-7-15-21-18-10-5-3-8-16(18)12-13-17-9-4-6-11-19(17)21/h3-6,8-11H,7,12-15H2,1-2H3	Imipramine|113-52-0|8	3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N,N-dimethylpropan-1-amine	CN(C)CCCN1c2ccccc2CCc2ccccc21	3696.0	R3_abraham_2006:184|R4_mente_2005:189|R6_adenot_2004:1580|R7_andres_2006:201|R12_garg_2006:92|R14_ghose_2012:114|R21_muehlbacher_2011:88|R25_brito_sanchez_2015:257|R26_chico_2009:217|R28_li_2005:24|R29_subramanian_2003:79|R31_carpenter_2014:10|R34_broccatelli_2012:40|R39_shayanfar_2011:52|R40_vilar_2010:129|R41_toropov_2017:170|R42_ciura_2020:22|R44_bujak_2015:35|R46_mendoza_valencia_2017:231|R47_radchenko_2020:156|R48_hou_2003:16|R48_hou_2003:105|R48_hou_2003:113|R49_norinder_2002:8|R49_norinder_2002:129|R49_norinder_2002:138|R51_doninger_2002:232|R52_liu_2001:8	0.83	D	BBB+	A	training
InChI=1S/C19H24N2O/c1-21(2,22)15-7-14-20-18-10-5-3-8-16(18)12-13-17-9-4-6-11-19(17)20/h3-6,8-11H,7,12-15H2,1-2H3	Imipraminoxide	3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N,N-dimethylpropan-1-amine oxide	C[N+](C)([O-])CCCN1c2ccccc2CCc2ccccc21	65589.0	R6_adenot_2004:1581			BBB+	C	training
InChI=1S/C19H24N2O/c1-22-18-12-6-5-10-16(18)14-21-17-11-7-13-20-19(17)15-8-3-2-4-9-15/h2-6,8-10,12,17,19-21H,7,11,13-14H2,1H3	Pfizer Compound 5|Cp 100263 Dihydrochloride Hydrate	N-[(2-methoxyphenyl)methyl]-2-phenylpiperidin-3-amine	COc1ccccc1CNC1CCCNC1c1ccccc1	18435769.0	R25_brito_sanchez_2015:554|R40_vilar_2010:201|R46_mendoza_valencia_2017:465|R47_radchenko_2020:433	0.87	B	BBB+	A	test
InChI=1S/C19H24N2O/c1-22-18-12-6-5-10-16(18)14-21-17-11-7-13-20-19(17)15-8-3-2-4-9-15/h2-6,8-10,12,17,19-21H,7,11,13-14H2,1H3/t17-,19-/m0/s1	145148-39-6|(2S,3S)-3-(2-Methoxybenzylamino)-2-Phenylpiperidine	(2S,3S)-N-[(2-methoxyphenyl)methyl]-2-phenylpiperidin-3-amine	COc1ccccc1CN[C@H]1CCCN[C@H]1c1ccccc1	5311057.0	R4_mente_2005:80	0.87	A	BBB+	A	test
InChI=1S/C19H24N2O/c22-19-16-6-2-4-14-3-1-5-15(18(14)16)11-21(19)17-12-20-9-7-13(17)8-10-20/h2,4,6,13,15,17H,1,3,5,7-12H2/t15-,17-/m1/s1	Palonosetron	(3aS)-2-[(3S)-1-azabicyclo[2.2.2]octan-3-yl]-3a,4,5,6-tetrahydro-3H-benzo[de]isoquinolin-1-one	O=C1c2cccc3c2[C@H](CCC3)CN1[C@@H]1CN2CCC1CC2	6337614.0	R14_ghose_2012:317|R23_gupta_2019:182			BBB+	C	training
InChI=1S/C19H24N2O3/c1-13(7-8-14-5-3-2-4-6-14)21-12-18(23)15-9-10-17(22)16(11-15)19(20)24/h2-6,9-11,13,18,21-23H,7-8,12H2,1H3,(H2,20,24)	Labetalol	2-hydroxy-5-[1-hydroxy-2-(4-phenylbutan-2-ylamino)ethyl]benzamide	CC(CCc1ccccc1)NCC(O)c1ccc(O)c(C(N)=O)c1	3869.0	R7_andres_2006:90|R23_gupta_2019:694|R29_subramanian_2003:84|R34_broccatelli_2012:126|R51_doninger_2002:76			BBB-	C	training
InChI=1S/C19H24N2O4/c1-13(9-14-3-6-16(25-2)7-4-14)20-11-19(24)15-5-8-18(23)17(10-15)21-12-22/h3-8,10,12-13,19-20,23-24H,9,11H2,1-2H3,(H,21,22)	Formoterol	N-[2-hydroxy-5-[1-hydroxy-2-[1-(4-methoxyphenyl)propan-2-ylamino]ethyl]phenyl]formamide	COc1ccc(CC(C)NCC(O)c2ccc(O)c(NC=O)c2)cc1	3410.0	R14_ghose_2012:577|R23_gupta_2019:611			BBB-	C	training
InChI=1S/C19H24N2O4/c1-14-4-2-3-5-18(14)25-13-16(22)12-21-10-11-24-17-8-6-15(7-9-17)19(20)23/h2-9,16,21-22H,10-13H2,1H3,(H2,20,23)	Tolamolol	4-[2-[[2-hydroxy-3-(2-methylphenoxy)propyl]amino]ethoxy]benzamide	Cc1ccccc1OCC(O)CNCCOc1ccc(C(N)=O)cc1	37910.0	R7_andres_2006:175|R29_subramanian_2003:170			BBB-	C	training
InChI=1S/C19H24N2O7S/c1-9(2)8-11(28-18(26)10-6-5-7-27-10)14(22)20-12-15(23)21-13(17(24)25)19(3,4)29-16(12)21/h5-7,9,11-13,16H,8H2,1-4H3,(H,20,22)(H,24,25)/t11-,12-,13+,16-/m1/s1	Furbucillin	(2S,5R,6R)-6-[[(2R)-2-(furan-2-carbonyloxy)-4-methylpentanoyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid	CC(C)C[C@@H](OC(=O)c1ccco1)C(=O)N[C@@H]1C(=O)N2[C@@H]1SC(C)(C)[C@@H]2C(=O)O	9979762.0	R6_adenot_2004:232			BBB-	C	training
InChI=1S/C19H24N2OS/c1-14(12-20(2)3)13-21-16-7-5-6-8-18(16)23-19-10-9-15(22-4)11-17(19)21/h5-11,14H,12-13H2,1-4H3/t14-/m1/s1	Levomepromazine|Methotrimeprazine	(2R)-3-(2-methoxyphenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine	COc1ccc2c(c1)N(C[C@H](C)CN(C)C)c1ccccc1S2	72287.0	R6_adenot_2004:1585|R14_ghose_2012:122|R23_gupta_2019:146|R51_doninger_2002:252			BBB+	C	training
InChI=1S/C19H24N2S/c1-4-20(5-2)15(3)14-21-16-10-6-8-12-18(16)22-19-13-9-7-11-17(19)21/h6-13,15H,4-5,14H2,1-3H3	Profenamine|Ethopropazine	N,N-diethyl-1-phenothiazin-10-ylpropan-2-amine	CCN(CC)C(C)CN1c2ccccc2Sc2ccccc21	3290.0	R6_adenot_2004:1611|R14_ghose_2012:87|R23_gupta_2019:284			BBB+	C	training
InChI=1S/C19H24N2S2/c1-14(12-20(2)3)13-21-16-7-5-6-8-18(16)23-19-10-9-15(22-4)11-17(19)21/h5-11,14H,12-13H2,1-4H3	Levometiomeprazine|Methiomeprazine	N,N,2-trimethyl-3-(2-methylsulfanylphenothiazin-10-yl)propan-1-amine	CSc1ccc2c(c1)N(CC(C)CN(C)C)c1ccccc1S2	26430.0	R6_adenot_2004:1586|R6_adenot_2004:1589			BBB+	C	training
InChI=1S/C19H24N6O5S2/c1-25(5-3-4-6-25)7-10-8-31-17-13(16(27)24(17)14(10)18(28)29)22-15(26)12(23-30-2)11-9-32-19(20)21-11/h9,13,17H,3-8H2,1-2H3,(H3-,20,21,22,26,28,29)/b23-12-/t13-,17-/m1/s1	Cefepime|Cefepime, E-	(6R,7R)-7-[[(2E)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(1-methylpyrrolidin-1-ium-1-yl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate	CO/N=C(/C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(C[N+]3(C)CCCC3)CS[C@H]12)c1csc(N)n1	5464190.0	R6_adenot_2004:170			BBB-	C	training
InChI=1S/C19H24O3/c1-18-9-7-13(20)11-12(18)3-4-14-15(18)8-10-19(2)16(14)5-6-17(21)22-19/h7,9,11,14-16H,3-6,8,10H2,1-2H3/t14-,15+,16+,18+,19+/m1/s1	Testolactone	(4aS,4bR,10aR,10bS,12aS)-10a,12a-dimethyl-4,4a,4b,5,6,10b,11,12-octahydro-3H-naphtho[2,1-f]chromene-2,8-dione	C[C@]12C=CC(=O)C=C1CC[C@@H]1[C@@H]2CC[C@]2(C)OC(=O)CC[C@@H]12	13769.0	R14_ghose_2012:885|R23_gupta_2019:969|R51_doninger_2002:131			BBB-	C	test
InChI=1S/C19H25Cl2N3O2/c1-14(25)23-8-9-24(16(13-23)12-22-6-2-3-7-22)19(26)11-15-4-5-17(20)18(21)10-15/h4-5,10,16H,2-3,6-9,11-13H2,1H3/t16-/m0/s1	Gr85571|1-[(2S)-4-Acetyl-2-(Pyrrolidin-1-Ylmethyl)Piperazin-1-Yl]-2-(3,4-Dichlorophenyl)Ethanone	1-[(2S)-4-acetyl-2-(pyrrolidin-1-ylmethyl)piperazin-1-yl]-2-(3,4-dichlorophenyl)ethanone	CC(=O)N1CCN(C(=O)Cc2ccc(Cl)c(Cl)c2)[C@@H](CN2CCCC2)C1	44310710.0	R28_li_2005:358			BBB+	C	training
InChI=1S/C19H25Cl2N3O3/c1-13(25)23-6-7-24(15(11-23)10-22-5-4-16(26)12-22)19(27)9-14-2-3-17(20)18(21)8-14/h2-3,8,15-16,26H,4-7,9-12H2,1H3	Gr94839|4-Acetyl-1-((3,4-Dichlorophenyl)Acetyl)-2-((3-Hydroxy-1-Pyrrolidinyl)Methyl)Piperazine	1-[4-acetyl-2-[(3-hydroxypyrrolidin-1-yl)methyl]piperazin-1-yl]-2-(3,4-dichlorophenyl)ethanone	CC(=O)N1CCN(C(=O)Cc2ccc(Cl)c(Cl)c2)C(CN2CCC(O)C2)C1	131626.0	R28_li_2005:364			BBB-	C	training
InChI=1S/C19H25Cl2N3O3/c1-27-19(26)23-8-9-24(15(13-23)12-22-6-2-3-7-22)18(25)11-14-4-5-16(20)17(21)10-14/h4-5,10,15H,2-3,6-9,11-13H2,1H3	Gr89696|Methyl 4-[2-(3,4-Dichlorophenyl)Acetyl]-3-(Pyrrolidin-1-Ylmethyl)Piperazine-1-Carboxylate	methyl 4-[2-(3,4-dichlorophenyl)acetyl]-3-(pyrrolidin-1-ylmethyl)piperazine-1-carboxylate	COC(=O)N1CCN(C(=O)Cc2ccc(Cl)c(Cl)c2)C(CN2CCCC2)C1	3505.0	R28_li_2005:360			BBB+	C	training
InChI=1S/C19H25F2N3O3/c1-13(25)23-4-5-24(17(11-23)10-22-3-2-18(26)12-22)19(27)8-14-6-15(20)9-16(21)7-14/h6-7,9,17-18,26H,2-5,8,10-12H2,1H3/t17-,18+/m0/s1	Gr94839_C|1-[(2S)-4-Acetyl-2-[[(3R)-3-Hydroxypyrrolidin-1-Yl]Methyl]Piperazin-1-Yl]-2-(3,5-Difluorophenyl)Ethanone	1-[(2S)-4-acetyl-2-[[(3R)-3-hydroxypyrrolidin-1-yl]methyl]piperazin-1-yl]-2-(3,5-difluorophenyl)ethanone	CC(=O)N1CCN(C(=O)Cc2cc(F)cc(F)c2)[C@@H](CN2CC[C@@H](O)C2)C1	44310781.0	R28_li_2005:367			BBB-	C	training
InChI=1S/C19H25F3N2O/c20-19(21,22)16-8-6-15(7-9-16)13-18(25)24-12-2-1-5-17(24)14-23-10-3-4-11-23/h6-9,17H,1-5,10-14H2/t17-/m0/s1	Brl52656|1-(2-Pyrrolidin-1-Ylmethyl-Piperidin-1-Yl)-2-(4-Trifluoromethyl-Phenyl)-Ethanone	1-[(2S)-2-(pyrrolidin-1-ylmethyl)piperidin-1-yl]-2-[4-(trifluoromethyl)phenyl]ethanone	O=C(Cc1ccc(C(F)(F)F)cc1)N1CCCC[C@H]1CN1CCCC1	9865223.0	R28_li_2005:329			BBB+	C	training
InChI=1S/C19H25N3O/c1-17-7-2-3-8-18(17)22-14-12-21(13-15-22)11-6-16-23-19-9-4-5-10-20-19/h2-5,7-10H,6,11-16H2,1H3	Toprilidine	1-(2-methylphenyl)-4-(3-pyridin-2-yloxypropyl)piperazine	Cc1ccccc1N1CCN(CCCOc2ccccn2)CC1	68710.0	R6_adenot_2004:1387			BBB+	C	training
InChI=1S/C19H25N3S/c1-20(2)13-15(21(3)4)14-22-16-9-5-7-11-18(16)23-19-12-8-6-10-17(19)22/h5-12,15H,13-14H2,1-4H3	Aminopromazine	1-N,1-N,2-N,2-N-tetramethyl-3-phenothiazin-10-ylpropane-1,2-diamine	CN(C)CC(CN1c2ccccc2Sc2ccccc21)N(C)C	19392.0	R6_adenot_2004:1541			BBB+	C	training
InChI=1S/C19H25N5O4/c1-26-15-10-12-13(11-16(15)27-2)21-19(22-17(12)20)24-7-5-23(6-8-24)18(25)14-4-3-9-28-14/h10-11,14H,3-9H2,1-2H3,(H2,20,21,22)	Terazosin	[4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-(oxolan-2-yl)methanone	COc1cc2nc(N3CCN(C(=O)C4CCCO4)CC3)nc(N)c2cc1OC	5401.0	R14_ghose_2012:883|R23_gupta_2019:965			BBB-	C	training
InChI=1S/C19H25NO/c1-2-10-20-11-9-19-8-4-3-5-16(19)18(20)12-14-6-7-15(21)13-17(14)19/h2,6-7,13,16,18,21H,1,3-5,8-12H2/t16-,18+,19+/m0/s1	Levallorphan	(1R,9R,10R)-17-prop-2-enyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-trien-4-ol	C=CCN1CC[C@]23CCCC[C@H]2[C@H]1Cc1ccc(O)cc13	5359371.0	R6_adenot_2004:1047|R14_ghose_2012:119|R23_gupta_2019:121|R28_li_2005:378			BBB+	C	training
InChI=1S/C19H25NO/c1-2-3-6-15-18(20)19(21,16-11-7-4-8-12-16)17-13-9-5-10-14-17/h4-5,7-14,18,21H,2-3,6,15,20H2,1H3	Hexapradol	2-amino-1,1-diphenylheptan-1-ol	CCCCCC(N)C(O)(c1ccccc1)c1ccccc1	219120.0	R6_adenot_2004:1291			BBB+	C	training
InChI=1S/C19H25NO/c1-3-8-20(9-4-2)17-10-14-6-5-7-15-12-18(21)13-16(11-17)19(14)15/h5-7,12-13,17,21H,3-4,8-11H2,1-2H3	Alentemol	5-(dipropylamino)-5,6-dihydro-4H-phenalen-2-ol	CCCN(CCC)C1Cc2cccc3cc(O)cc(c23)C1	60574.0	R6_adenot_2004:1110			BBB+	C	training
InChI=1S/C19H25NO2/c1-14(8-9-16-6-4-3-5-7-16)20-15(2)19(22)17-10-12-18(21)13-11-17/h3-7,10-15,19-22H,8-9H2,1-2H3	Nylidrin	4-[1-hydroxy-2-(4-phenylbutan-2-ylamino)propyl]phenol	CC(CCc1ccccc1)NC(C)C(O)c1ccc(O)cc1	4567.0	R14_ghose_2012:732|R51_doninger_2002:100			BBB-	C	training
InChI=1S/C19H25NO2/c21-15-4-3-14-9-18-16-5-8-22-12-19(16,17(14)10-15)6-7-20(18)11-13-1-2-13/h3-4,10,13,16,18,21H,1-2,5-9,11-12H2/t16-,18+,19-/m0/s1	Proxorphan	(1S,9R,10R)-17-(cyclopropylmethyl)-13-oxa-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-trien-4-ol	Oc1ccc2c(c1)[C@]13CCN(CC4CC4)[C@H](C2)[C@@H]1CCOC3	5361874.0	R6_adenot_2004:1081			BBB+	C	training
InChI=1S/C19H25NO3/c21-16-2-1-12(8-17(16)22)3-4-20-18(23)19-9-13-5-14(10-19)7-15(6-13)11-19/h1-2,8,13-15,21-22H,3-7,9-11H2,(H,20,23)	Dopamantine	N-[2-(3,4-dihydroxyphenyl)ethyl]adamantane-1-carboxamide	O=C(NCCc1ccc(O)c(O)c1)C12CC3CC(CC(C3)C1)C2	38361.0	R6_adenot_2004:648			BBB+	C	training
InChI=1S/C19H25NO3/c21-18(20-12-15-8-4-5-9-16(15)13-20)11-17(19(22)23)10-14-6-2-1-3-7-14/h1-3,6-7,15-17H,4-5,8-13H2,(H,22,23)/t15-,16+,17-/m0/s1	Mitiglinide	(2S)-4-[(3aS,7aR)-1,3,3a,4,5,6,7,7a-octahydroisoindol-2-yl]-2-benzyl-4-oxobutanoic acid	O=C(O)[C@H](CC(=O)N1C[C@H]2CCCC[C@H]2C1)Cc1ccccc1	121891.0	R23_gupta_2019:754			BBB-	C	training
InChI=1S/C19H25NOS/c1-2-11-20(12-10-17-6-4-13-22-17)16-8-9-18-15(14-16)5-3-7-19(18)21/h3-7,13,16,21H,2,8-12,14H2,1H3/t16-/m0/s1	Rotigotine	(6S)-6-[propyl(2-thiophen-2-ylethyl)amino]-5,6,7,8-tetrahydronaphthalen-1-ol	CCCN(CCc1cccs1)[C@H]1CCc2c(O)cccc2C1	59227.0	R23_gupta_2019:223			BBB+	C	training
InChI=1S/C19H26Cl2N2O/c1-22(19(24)13-14-8-9-15(20)16(21)12-14)17-6-2-3-7-18(17)23-10-4-5-11-23/h8-9,12,17-18H,2-7,10-11,13H2,1H3/t17-,18-/m1/s1	U-50488|U50488|U50,488|Trans-3,4-Dichloro-N-Methyl-N-[2-(1-Pyrrolidinyl)Cyclohexyl]-Benzeneacetamide	2-(3,4-dichlorophenyl)-N-methyl-N-[(1R,2R)-2-pyrrolidin-1-ylcyclohexyl]acetamide	CN(C(=O)Cc1ccc(Cl)c(Cl)c1)[C@@H]1CCCC[C@H]1N1CCCC1	3036289.0	R7_andres_2006:180|R28_li_2005:415|R29_subramanian_2003:175			BBB+	C	test
InChI=1S/C19H26I3N3O9/c1-8(29)25(4-11(32)7-28)17-15(21)12(18(33)23-2-9(30)5-26)14(20)13(16(17)22)19(34)24-3-10(31)6-27/h9-11,26-28,30-32H,2-7H2,1H3,(H,23,33)(H,24,34)	Iohexol	5-[acetyl(2,3-dihydroxypropyl)amino]-1-N,3-N-bis(2,3-dihydroxypropyl)-2,4,6-triiodobenzene-1,3-dicarboxamide	CC(=O)N(CC(O)CO)c1c(I)c(C(=O)NCC(O)CO)c(I)c(C(=O)NCC(O)CO)c1I	3730.0	R14_ghose_2012:624			BBB-	C	training
InChI=1S/C19H26N2S/c1-3-7-21-11-13(12-22-2)8-16-15-5-4-6-17-19(15)14(10-20-17)9-18(16)21/h4-6,10,13,16,18,20H,3,7-9,11-12H2,1-2H3	8-[(Methylsulfanyl)Methyl]-6-Propylergoline	9-(methylsulfanylmethyl)-7-propyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline	CCCN1CC(CSC)CC2c3cccc4[nH]cc(c34)CC21	4745.0	R46_mendoza_valencia_2017:307	0.3	A	BBB+	A	test
InChI=1S/C19H26N2S/c1-3-7-21-11-13(12-22-2)8-16-15-5-4-6-17-19(15)14(10-20-17)9-18(16)21/h4-6,10,13,16,18,20H,3,7-9,11-12H2,1-2H3/t13-,16-,18-/m1/s1	Pergolide	(6aR,9R,10aR)-9-(methylsulfanylmethyl)-7-propyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline	CCCN1C[C@H](CSC)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21	47811.0	R5_guerra_2008:81|R6_adenot_2004:993|R12_garg_2006:132|R14_ghose_2012:187|R21_muehlbacher_2011:248|R23_gupta_2019:188|R25_brito_sanchez_2015:351|R26_chico_2009:305|R37_chen_2011:70|R39_shayanfar_2011:72|R40_vilar_2010:181|R47_radchenko_2020:282|R50_sobanska_2019:28|R51_doninger_2002:276	0.3	B	BBB+	A	test
InChI=1S/C19H26N4O/c1-22-18-8-4-3-7-15(18)17(21-22)12-19(24)20-16-9-11-23(2)10-5-6-14(16)13-23/h3-4,7-8,14,16H,5-6,9-13H2,1-2H3/p+1			Cn1nc(CC(=O)NC2CC[N+]3(C)CCCC2C3)c2ccccc21		R45_hemmateenejad_2006:5	-0.08	A	BBB+	A	test
InChI=1S/C19H26N4O5/c1-14(24)21-7-8-22(17(12-21)11-20-6-5-18(25)13-20)19(26)10-15-3-2-4-16(9-15)23(27)28/h2-4,9,17-18,25H,5-8,10-13H2,1H3/t17-,18-/m0/s1	Gr94839_G|1-[(2S)-4-Acetyl-2-[[(3S)-3-Hydroxypyrrolidin-1-Yl]Methyl]Piperazin-1-Yl]-2-(3-Nitrophenyl)Ethanone	1-[(2S)-4-acetyl-2-[[(3S)-3-hydroxypyrrolidin-1-yl]methyl]piperazin-1-yl]-2-(3-nitrophenyl)ethanone	CC(=O)N1CCN(C(=O)Cc2cccc([N+](=O)[O-])c2)[C@@H](CN2CC[C@H](O)C2)C1	44310946.0	R28_li_2005:371			BBB-	C	training
InChI=1S/C19H26N4O5/c1-14(24)21-8-9-22(17(12-21)11-20-7-6-18(25)13-20)19(26)10-15-2-4-16(5-3-15)23(27)28/h2-5,17-18,25H,6-13H2,1H3/t17-,18-/m0/s1	Gr94839_E|1-[(2S)-4-Acetyl-2-[[(3S)-3-Hydroxypyrrolidin-1-Yl]Methyl]Piperazin-1-Yl]-2-(4-Nitrophenyl)Ethanone	1-[(2S)-4-acetyl-2-[[(3S)-3-hydroxypyrrolidin-1-yl]methyl]piperazin-1-yl]-2-(4-nitrophenyl)ethanone	CC(=O)N1CCN(C(=O)Cc2ccc([N+](=O)[O-])cc2)[C@@H](CN2CC[C@H](O)C2)C1	44311016.0	R28_li_2005:369			BBB-	C	training
InChI=1S/C19H26N6O/c1-4-15(11-26)22-19-23-17(20-10-14-8-6-5-7-9-14)16-18(24-19)25(12-21-16)13(2)3/h5-9,12-13,15,26H,4,10-11H2,1-3H3,(H2,20,22,23,24)/t15-/m1/s1	Roscovitine|Seliciclib	(2R)-2-[[6-(benzylamino)-9-propan-2-ylpurin-2-yl]amino]butan-1-ol	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1	160355.0	R26_chico_2009:359	-0.72	A	BBB+	A	test
InChI=1S/C19H26O3/c1-18-10-8-15(20)17(22)14(18)4-3-11-12-5-6-16(21)19(12,2)9-7-13(11)18/h11-13,22H,3-10H2,1-2H3/t11-,12-,13-,18+,19-/m0/s1	Formestane	(8R,9S,10R,13S,14S)-4-hydroxy-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-3,17-dione	C[C@]12CCC(=O)C(O)=C1CC[C@@H]1[C@@H]2CC[C@]2(C)C(=O)CC[C@@H]12	11273.0	R14_ghose_2012:576|R23_gupta_2019:610			BBB-	C	test
InChI=1S/C19H27Cl2N3O3/c20-17-2-1-14(9-18(17)21)10-19(27)24-6-5-22(7-8-25)11-15(24)12-23-4-3-16(26)13-23/h1-2,9,15-16,25-26H,3-8,10-13H2/t15-,16-/m1/s1	Sb205563|2-(3,4-Dichlorophenyl)-1-[(2R)-4-(2-Hydroxyethyl)-2-[[(3R)-3-Hydroxypyrrolidin-1-Yl]Methyl]Piperazin-1-Yl]Ethanone	2-(3,4-dichlorophenyl)-1-[(2R)-4-(2-hydroxyethyl)-2-[[(3R)-3-hydroxypyrrolidin-1-yl]methyl]piperazin-1-yl]ethanone	O=C(Cc1ccc(Cl)c(Cl)c1)N1CCN(CCO)C[C@@H]1CN1CC[C@@H](O)C1	44310721.0	R28_li_2005:400			BBB-	C	training
InChI=1S/C19H27FN2O3/c1-14(2)21-19(24)25-17-9-12-22(13-10-17)11-3-4-18(23)15-5-7-16(20)8-6-15/h5-8,14,17H,3-4,9-13H2,1-2H3,(H,21,24)	Carperone	[1-[4-(4-fluorophenyl)-4-oxobutyl]piperidin-4-yl] N-propan-2-ylcarbamate	CC(C)NC(=O)OC1CCN(CCCC(=O)c2ccc(F)cc2)CC1	30429.0	R6_adenot_2004:1128			BBB+	C	training
InChI=1S/C19H27N3O/c1-19(2)12-22(17-7-5-4-6-16(17)19)18(23)20-13-10-14-8-9-15(11-13)21(14)3/h4-7,13-15H,8-12H2,1-3H3,(H,20,23)/t13?,14-,15+	Ricasetron	3,3-dimethyl-N-[(1S,5R)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl]-2H-indole-1-carboxamide	CN1[C@@H]2CC[C@H]1CC(NC(=O)N1CC(C)(C)c3ccccc31)C2	71785.0	R6_adenot_2004:1395			BBB+	C	training
InChI=1S/C19H27N3O3/c1-15(23)21-9-10-22(19(25)11-16-5-3-2-4-6-16)17(13-21)12-20-8-7-18(24)14-20/h2-6,17-18,24H,7-14H2,1H3/t17-,18+/m0/s1	Gr94839_H|1-[(2S)-4-Acetyl-2-[[(3R)-3-Hydroxypyrrolidin-1-Yl]Methyl]Piperazin-1-Yl]-2-Phenylethanone	1-[(2S)-4-acetyl-2-[[(3R)-3-hydroxypyrrolidin-1-yl]methyl]piperazin-1-yl]-2-phenylethanone	CC(=O)N1CCN(C(=O)Cc2ccccc2)[C@@H](CN2CC[C@@H](O)C2)C1	44310943.0	R28_li_2005:372			BBB-	C	training
InChI=1S/C19H27N3O4S/c1-17(2)12(15(24)25)22-13(23)11(14(22)27-17)21-16(26)18-4-9-3-10(5-18)7-19(20,6-9)8-18/h9-12,14H,3-8,20H2,1-2H3,(H,21,26)(H,24,25)/t9?,10?,11-,12+,14-,18?,19?/m1/s1	Amantocillin	(2S,5R,6R)-6-[(3-aminoadamantane-1-carbonyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid	CC1(C)S[C@@H]2[C@H](NC(=O)C34CC5CC(CC(N)(C5)C3)C4)C(=O)N2[C@H]1C(=O)O	10318432.0	R6_adenot_2004:136			BBB-	C	training
InChI=1S/C19H27N3O5S2/c1-22(13-12-16-4-6-17(7-5-16)20-28(2,23)24)14-15-27-19-10-8-18(9-11-19)21-29(3,25)26/h4-11,20-21H,12-15H2,1-3H3	Dofetilide	N-[4-[2-[2-[4-(methanesulfonamido)phenoxy]ethyl-methylamino]ethyl]phenyl]methanesulfonamide	CN(CCOc1ccc(NS(C)(=O)=O)cc1)CCc1ccc(NS(C)(=O)=O)cc1	71329.0	R14_ghose_2012:510			BBB-	C	training
InChI=1S/C19H27N5/c1-16-6-2-3-7-17(16)23-14-12-22(13-15-23)11-9-19-21-20-18-8-4-5-10-24(18)19/h2-3,6-7H,4-5,8-15H2,1H3	Dapiprazole	3-[2-[4-(2-methylphenyl)piperazin-1-yl]ethyl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridine	Cc1ccccc1N1CCN(CCc2nnc3n2CCCC3)CC1	3033538.0	R23_gupta_2019:496			BBB-	C	training
InChI=1S/C19H27N5O3/c1-21-17(26)15-16(23-14(11-20)24-18(15)27-10-9-25)22-12-13-3-7-19(8-4-13)5-2-6-19/h13,25H,2-10,12H2,1H3,(H,21,26)(H,22,23,24)	Irie-13B|2-Cyano-4-(2-Hydroxyethoxy)-N-Methyl-6-(Spiro[3.5]Nonan-7-Ylmethylamino)Pyrimidine-5-Carboxamide	2-cyano-4-(2-hydroxyethoxy)-N-methyl-6-(spiro[3.5]nonan-7-ylmethylamino)pyrimidine-5-carboxamide	CNC(=O)c1c(NCC2CCC3(CCC3)CC2)nc(C#N)nc1OCCO	25030810.0	R26_chico_2009:224	0.7	A	BBB+	A	test
InChI=1S/C19H27N5O3/c1-4-6-17(25)23-7-5-8-24(10-9-23)19-21-14-12-16(27-3)15(26-2)11-13(14)18(20)22-19/h11-12H,4-10H2,1-3H3,(H2,20,21,22)	Bunazosin	1-[4-(4-amino-6,7-dimethoxyquinazolin-2-yl)-1,4-diazepan-1-yl]butan-1-one	CCCC(=O)N1CCCN(c2nc(N)c3cc(OC)c(OC)cc3n2)CC1	2472.0	R14_ghose_2012:409			BBB-	C	test
InChI=1S/C19H27N5O4/c1-24(8-5-7-21-18(25)14-6-4-9-28-14)19-22-13-11-16(27-3)15(26-2)10-12(13)17(20)23-19/h10-11,14H,4-9H2,1-3H3,(H,21,25)(H2,20,22,23)	Alfuzosin	N-[3-[(4-amino-6,7-dimethoxyquinazolin-2-yl)-methylamino]propyl]oxolane-2-carboxamide	COc1cc2nc(N(C)CCCNC(=O)C3CCCO3)nc(N)c2cc1OC	2092.0	R23_gupta_2019:332			BBB-	C	training
InChI=1S/C19H27N5O5/c1-21-17(14-18(26)22(2)19(21)27)20-9-11-23(12-13-25)10-3-4-15-5-7-16(8-6-15)24(28)29/h5-8,14,20,25H,3-4,9-13H2,1-2H3	Nifekalant Hydrochloride|Nifekalant	6-[2-[2-hydroxyethyl-[3-(4-nitrophenyl)propyl]amino]ethylamino]-1,3-dimethylpyrimidine-2,4-dione	Cn1c(NCCN(CCO)CCCc2ccc([N+](=O)[O-])cc2)cc(=O)n(C)c1=O	4486.0	R23_gupta_2019:1079			BBB-	C	training
InChI=1S/C19H27NO/c1-13(2)7-9-20-10-8-19(4)14(3)18(20)11-15-5-6-16(21)12-17(15)19/h5-7,12,14,18,21H,8-11H2,1-4H3	Talwin	1,13-dimethyl-10-(3-methylbut-2-enyl)-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol	CC(C)=CCN1CCC2(C)c3cc(O)ccc3CC1C2C	4736.0	R41_toropov_2017:201|R41_toropov_2017:294|R46_mendoza_valencia_2017:303	0.54	B	BBB+	A	training
InChI=1S/C19H27NO/c1-13(2)7-9-20-10-8-19(4)14(3)18(20)11-15-5-6-16(21)12-17(15)19/h5-7,12,14,18,21H,8-11H2,1-4H3/t14-,18+,19+/m0/s1	Pentazocine	(1R,9R,13R)-1,13-dimethyl-10-(3-methylbut-2-enyl)-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol	CC(C)=CCN1CC[C@@]2(C)c3cc(O)ccc3C[C@@H]1[C@@H]2C	441278.0	R3_abraham_2006:220|R3_abraham_2006:221|R6_adenot_2004:1076|R14_ghose_2012:185|R21_muehlbacher_2011:109|R25_brito_sanchez_2015:347|R26_chico_2009:303|R28_li_2005:215|R40_vilar_2010:178|R47_radchenko_2020:186|R51_doninger_2002:274			BBB+	C	training
InChI=1S/C19H27NO3/c1-12(2)7-14-11-20-6-5-13-8-18(22-3)19(23-4)9-15(13)16(20)10-17(14)21/h8-9,12,14,16H,5-7,10-11H2,1-4H3	Tetrabenazine|Tetrabenzine	9,10-dimethoxy-3-(2-methylpropyl)-1,3,4,6,7,11b-hexahydrobenzo[a]quinolizin-2-one	COc1cc2c(cc1OC)C1CC(=O)C(CC(C)C)CN1CC2	6018.0	R6_adenot_2004:1226|R14_ghose_2012:241|R23_gupta_2019:235|R51_doninger_2002:308			BBB+	C	training
InChI=1S/C19H27NO3/c1-13(2)15-8-10-16(11-9-15)18(21)20-17(19(22)23)12-14-6-4-3-5-7-14/h3-7,13,15-17H,8-12H2,1-2H3,(H,20,21)(H,22,23)/t15?,16?,17-/m1/s1	Nateglinide	(2R)-3-phenyl-2-[(4-propan-2-ylcyclohexanecarbonyl)amino]propanoic acid	CC(C)C1CCC(C(=O)N[C@H](Cc2ccccc2)C(=O)O)CC1	5311309.0	R14_ghose_2012:710			BBB-	C	test
InChI=1S/C19H27NO4/c1-20-9-8-18-11-13(21)6-7-19(18,22)15(20)10-12-4-5-14(23-2)17(24-3)16(12)18/h4-5,13,15,21-22H,6-11H2,1-3H3/t13-,15-,18-,19-/m1/s1	Drotebanol	(1R,9R,10S,13R)-3,4-dimethoxy-17-methyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene-10,13-diol	COc1ccc2c(c1OC)[C@]13CCN(C)[C@H](C2)[C@]1(O)CC[C@@H](O)C3	5463863.0	R6_adenot_2004:1094			BBB+	C	training
InChI=1S/C19H27NO4/c1-22-16-13-15(14-17(23-2)19(16)24-3)9-10-18(21)20-11-7-5-4-6-8-12-20/h9-10,13-14H,4-8,11-12H2,1-3H3/b10-9+	Cinoctramide	(E)-1-(azocan-1-yl)-3-(3,4,5-trimethoxyphenyl)prop-2-en-1-one	COc1cc(/C=C/C(=O)N2CCCCCCC2)cc(OC)c1OC	6443803.0	R6_adenot_2004:1430			BBB+	C	training
InChI=1S/C19H28ClN5O/c1-3-18-21-25(19(26)24(18)4-2)10-6-9-22-11-13-23(14-12-22)17-8-5-7-16(20)15-17/h5,7-8,15H,3-4,6,9-14H2,1-2H3	Etoperidone	2-[3-[4-(3-chlorophenyl)piperazin-1-yl]propyl]-4,5-diethyl-1,2,4-triazol-3-one	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CC	40589.0	R6_adenot_2004:1465			BBB+	C	training
InChI=1S/C19H28N2/c1-20(2)14-9-15-21-18-12-6-4-3-5-10-16(18)17-11-7-8-13-19(17)21/h7-8,11,13H,3-6,9-10,12,14-15H2,1-2H3	Iprindole	3-(6,7,8,9,10,11-hexahydrocycloocta[b]indol-5-yl)-N,N-dimethylpropan-1-amine	CN(C)CCCn1c2c(c3ccccc31)CCCCCC2	21722.0	R6_adenot_2004:561			BBB+	C	training
InChI=1S/C19H28N2O4/c1-16(22)25-15-19(23)20-9-6-12-24-18-8-5-7-17(13-18)14-21-10-3-2-4-11-21/h5,7-8,13H,2-4,6,9-12,14-15H2,1H3,(H,20,23)	Roxatidine Acetate	[2-oxo-2-[3-[3-(piperidin-1-ylmethyl)phenoxy]propylamino]ethyl] acetate	CC(=O)OCC(=O)NCCCOc1cccc(CN2CCCCC2)c1	5105.0	R23_gupta_2019:896			BBB-	C	training
InChI=1S/C19H28N4O2S/c1-12-10-16(22-14(3)13(12)2)19(6,7)26-18(4,5)11-21-17-15(23(24)25)8-9-20-17/h8-10,20-21H,11H2,1-7H3	15		Cc1cc(C(C)(C)SC(C)(C)CNc2[nH]ccc2[N+](=O)[O-])nc(C)c1C		R28_li_2005:153			BBB+	C	training
InChI=1S/C19H28N4O2S/c1-4-23(5-2)26(24,25)21-14-10-16-15-7-6-8-17-19(15)13(11-20-17)9-18(16)22(3)12-14/h6-8,11,14,16,18,20-21H,4-5,9-10,12H2,1-3H3/t14-,16+,18+/m0/s1	Etisulergine	(6aR,9S,10aR)-9-(diethylsulfamoylamino)-7-methyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline	CCN(CC)S(=O)(=O)N[C@H]1C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1	68847.0	R6_adenot_2004:995			BBB+	C	test
InChI=1S/C19H28NO3/c1-20(2)13-12-17(14-20)23-18(21)19(22,16-10-6-7-11-16)15-8-4-3-5-9-15/h3-5,8-9,16-17,22H,6-7,10-14H2,1-2H3/q+1	Glycopyrrolate|Glycopyrronium Bromide	(1,1-dimethylpyrrolidin-1-ium-3-yl) 2-cyclopentyl-2-hydroxy-2-phenylacetate	C[N+]1(C)CCC(OC(=O)C(O)(c2ccccc2)C2CCCC2)C1	3494.0	R14_ghose_2012:600|R51_doninger_2002:61			BBB-	C	training
InChI=1S/C19H28O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h11,14-17,21H,3-10H2,1-2H3	17-Hydroxyandrost-4-En-3-One	17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one	CC12CCC(=O)C=C1CCC1C2CCC2(C)C(O)CCC12	5408.0	R46_mendoza_valencia_2017:433	0.0	A	BBB+	A	training
InChI=1S/C19H28O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h11,14-17,21H,3-10H2,1-2H3/t14-,15-,16-,17-,18-,19-/m0/s1	Testosterone	(8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one	C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2O	6013.0	R7_andres_2006:168|R25_brito_sanchez_2015:517|R28_li_2005:414|R29_subramanian_2003:164|R51_doninger_2002:132	0.0	A	BBB+	A	training
InChI=1S/C19H29Cl2N3O2S/c1-27(25,26)22-16-7-5-15(6-8-16)9-10-23-11-13-24(14-12-23)18-4-2-3-17(20)19(18)21/h2-4,15-16,22H,5-14H2,1H3	Piperazinederivatives 8|N-[4-[2-[4-(2,3-Dichlorophenyl)Piperazin-1-Yl]Ethyl]Cyclohexyl]Methanesulfonamide	N-[4-[2-[4-(2,3-dichlorophenyl)piperazin-1-yl]ethyl]cyclohexyl]methanesulfonamide	CS(=O)(=O)NC1CCC(CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1	70683583.0	R47_radchenko_2020:320	1.0	A	BBB+	A	training
InChI=1S/C19H29IO2/c1-3-22-19(21)15-9-7-5-4-6-8-12-16(2)17-13-10-11-14-18(17)20/h10-11,13-14,16H,3-9,12,15H2,1-2H3	Iophendylate|Ethyl 10-(2-Iodophenyl)Undecanoate	ethyl 10-(2-iodophenyl)undecanoate	CCOC(=O)CCCCCCCCC(C)c1ccccc1I	3037234.0	R23_gupta_2019:681			BBB-	C	test
InChI=1S/C19H29N5O2/c1-19(2)14-16(25)24(17(26)15-19)9-4-3-8-22-10-12-23(13-11-22)18-20-6-5-7-21-18/h5-7H,3-4,8-15H2,1-2H3	Gepirone	4,4-dimethyl-1-[4-(4-pyrimidin-2-ylpiperazin-1-yl)butyl]piperidine-2,6-dione	CC1(C)CC(=O)N(CCCCN2CCN(c3ncccn3)CC2)C(=O)C1	55191.0	R6_adenot_2004:1472			BBB+	C	training
InChI=1S/C19H29NO/c21-19(17-9-3-1-4-10-17,18-11-5-2-6-12-18)13-16-20-14-7-8-15-20/h1,3-4,9-10,18,21H,2,5-8,11-16H2	Procyclidine Hydrochloride|Procyclidine	1-cyclohexyl-1-phenyl-3-pyrrolidin-1-ylpropan-1-ol	OC(CCN1CCCC1)(c1ccccc1)C1CCCCC1	4919.0	R7_andres_2006:138|R14_ghose_2012:211|R23_gupta_2019:208|R26_chico_2009:329|R29_subramanian_2003:138|R51_doninger_2002:294			BBB+	C	test
InChI=1S/C19H29NO5/c1-18(2,3)16(22)24-14-9-8-12(13(21)11-20-7)10-15(14)25-17(23)19(4,5)6/h8-10,13,20-21H,11H2,1-7H3	Dipivefrine|Dipivefrin	[2-(2,2-dimethylpropanoyloxy)-4-[1-hydroxy-2-(methylamino)ethyl]phenyl] 2,2-dimethylpropanoate	CNCC(O)c1ccc(OC(=O)C(C)(C)C)c(OC(=O)C(C)(C)C)c1	3105.0	R6_adenot_2004:100|R23_gupta_2019:531			BBB-	C	training
InChI=1S/C19H30N2O6S/c1-12(11-19(2,3)21(4)5)20-18(22)16-9-13-8-14(25-6)15(26-7)10-17(13)28(23,24)27-16/h8,10,12,16H,9,11H2,1-7H3,(H,20,22)	Tisocromide	N-[4-(dimethylamino)-4-methylpentan-2-yl]-6,7-dimethoxy-1,1-dioxo-3,4-dihydro-2,1lambda6-benzoxathiine-3-carboxamide	COc1cc2c(cc1OC)S(=O)(=O)OC(C(=O)NC(C)CC(C)(C)N(C)C)C2	65789.0	R6_adenot_2004:623			BBB+	C	training
InChI=1S/C19H30NO2/c1-5-15(2)18(16-9-7-6-8-10-16)19(21)22-17-11-13-20(3,4)14-12-17/h6-10,15,17-18H,5,11-14H2,1-4H3/q+1	Pentapiperium	(1,1-dimethylpiperidin-1-ium-4-yl) 3-methyl-2-phenylpentanoate	CCC(C)C(C(=O)OC1CC[N+](C)(C)CC1)c1ccccc1	27490.0	R6_adenot_2004:106			BBB-	C	training
InChI=1S/C19H30O3/c1-17-11-22-16(20)10-12(17)4-5-13-14(17)6-8-18(2)15(13)7-9-19(18,3)21/h12-15,21H,4-11H2,1-3H3/t12-,13+,14-,15-,17-,18-,19-/m0/s1	Oxandrolone	(1S,3aS,3bR,5aS,9aS,9bS,11aS)-1-hydroxy-1,9a,11a-trimethyl-2,3,3a,3b,4,5,5a,6,9,9b,10,11-dodecahydroindeno[4,5-h]isochromen-7-one	C[C@]12COC(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O	5878.0	R14_ghose_2012:743|R23_gupta_2019:803|R51_doninger_2002:101			BBB-	C	training
InChI=1S/C19H30O5/c1-14-15(12-10-8-6-4-5-7-9-11-13-20)17(22)19(24-3)18(23-2)16(14)21/h20H,4-13H2,1-3H3	Idebenone	2-(10-hydroxydecyl)-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione	COC1=C(OC)C(=O)C(CCCCCCCCCCO)=C(C)C1=O	3686.0	R14_ghose_2012:112|R23_gupta_2019:289			BBB+	C	training
InChI=1S/C19H31NO4/c1-4-5-6-7-8-9-10-11-12-24-18-16(22-2)13-15(19(20)21)14-17(18)23-3/h13-14H,4-12H2,1-3H3,(H2,20,21)	Decimemide	4-decoxy-3,5-dimethoxybenzamide	CCCCCCCCCCOc1c(OC)cc(C(N)=O)cc1OC	26929.0	R6_adenot_2004:436			BBB+	C	training
InChI=1S/C19H32N2O5/c1-4-8-14(19(25)26-5-2)20-12(3)17(22)21-15-10-7-6-9-13(15)11-16(21)18(23)24/h12-16,20H,4-11H2,1-3H3,(H,23,24)/t12-,13-,14-,15-,16-/m0/s1	Perindopril Erbumine|Perindopril	(2S,3aS,7aS)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxopentan-2-yl]amino]propanoyl]-2,3,3a,4,5,6,7,7a-octahydroindole-2-carboxylic acid	CCC[C@H](N[C@@H](C)C(=O)N1[C@H](C(=O)O)C[C@@H]2CCCC[C@@H]21)C(=O)OCC	107807.0	R14_ghose_2012:762|R23_gupta_2019:826|R50_sobanska_2019:60			BBB-	C	test
InChI=1S/C19H35ClN2O5S/c1-4-5-6-7-11-8-12(21-9-11)18(26)22-13(10(2)20)17-15(24)14(23)16(25)19(27-17)28-3/h10-17,19,21,23-25H,4-9H2,1-3H3,(H,22,26)/t10-,11?,12+,13+,14+,15-,16-,17-,19-/m1/s1	Mirincamycin	(2S)-N-[(1R,2R)-2-chloro-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-4-pentylpyrrolidine-2-carboxamide	CCCCCC1CN[C@H](C(=O)N[C@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)Cl)C1	23724965.0	R6_adenot_2004:125			BBB-	C	training
InChI=1S/C19H35N/c1-3-9-16(10-4-1)19(17-11-5-2-6-12-17)15-18-13-7-8-14-20-18/h16-20H,1-15H2	Perhexiline	2-(2,2-dicyclohexylethyl)piperidine	C1CCC(C(CC2CCCCN2)C2CCCCC2)CC1	4746.0	R23_gupta_2019:825			BBB-	C	training
InChI=1S/C19H35NO2/c1-3-20(4-2)15-16-22-18(21)19(13-9-6-10-14-19)17-11-7-5-8-12-17/h17H,3-16H2,1-2H3	Dicyclomine Hydrochloride|Dicyclomine	2-(diethylamino)ethyl 1-cyclohexylcyclohexane-1-carboxylate	CCN(CC)CCOC(=O)C1(C2CCCCC2)CCCCC1	3042.0	R14_ghose_2012:494|R23_gupta_2019:519|R51_doninger_2002:37			BBB-	C	test
InChI=1S/C19H37N5O7/c1-19(27)7-28-18(13(26)16(19)24-2)31-15-11(23)5-10(22)14(12(15)25)30-17-9(21)4-3-8(6-20)29-17/h3,9-18,24-27H,4-7,20-23H2,1-2H3/t9-,10+,11-,12+,13-,14-,15+,16-,17-,18-,19+/m1/s1	Sisomicin	(2R,3R,4R,5R)-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[[(2S,3R)-3-amino-6-(aminomethyl)-3,4-dihydro-2H-pyran-2-yl]oxy]-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol	CN[C@@H]1[C@@H](O)[C@@H](O[C@@H]2[C@@H](O)[C@H](O[C@H]3OC(CN)=CC[C@H]3N)[C@@H](N)C[C@H]2N)OC[C@]1(C)O	36119.0	R6_adenot_2004:129			BBB-	C	training
InChI=1S/C20H12O5/c21-11-5-7-15-17(9-11)24-18-10-12(22)6-8-16(18)20(15)14-4-2-1-3-13(14)19(23)25-20/h1-10,21-22H	Fluorescein	3',6'-dihydroxyspiro[2-benzofuran-3,9'-xanthene]-1-one	O=C1OC2(c3ccc(O)cc3Oc3cc(O)ccc32)c2ccccc21	16850.0	R14_ghose_2012:569|R23_gupta_2019:605			BBB-	C	training
InChI=1S/C20H14ClN3O/c21-16-7-6-15(12-17(16)25)19-18(13-8-10-22-11-9-13)23-20(24-19)14-4-2-1-3-5-14/h1-12,25H,(H,23,24)	Takle-2; L-779,450|2-Chloro-5-(2-Phenyl-5-(Pyridin-4-Yl)-1H-Imidazol-4-Yl)Phenol	2-chloro-5-(2-phenyl-5-pyridin-4-yl-1H-imidazol-4-yl)phenol	Oc1cc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)ccc1Cl	9950176.0	R26_chico_2009:400	-1.0	A	BBB+	A	training
InChI=1S/C20H14O4/c21-15-9-5-13(6-10-15)20(14-7-11-16(22)12-8-14)18-4-2-1-3-17(18)19(23)24-20/h1-12,21-22H	Phenolphthalein	3,3-bis(4-hydroxyphenyl)-2-benzofuran-1-one	O=C1OC(c2ccc(O)cc2)(c2ccc(O)cc2)c2ccccc21	4764.0	R14_ghose_2012:767|R51_doninger_2002:109			BBB-	C	training
InChI=1S/C20H15BrN6O/c1-11-7-14(10-23)8-12(2)17(11)28-19-16(21)18(24)26-20(27-19)25-15-5-3-13(9-22)4-6-15/h3-8H,1-2H3,(H3,24,25,26,27)	Etravirine	4-[6-amino-5-bromo-2-(4-cyanoanilino)pyrimidin-4-yl]oxy-3,5-dimethylbenzonitrile	Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)nc(N)c1Br	193962.0	R23_gupta_2019:588			BBB-	C	training
InChI=1S/C20H15Cl3N2OS/c21-14-4-5-16(18(23)8-14)19(9-25-7-6-24-12-25)26-10-13-11-27-20-15(13)2-1-3-17(20)22/h1-8,11-12,19H,9-10H2	Sertaconazole	1-[2-[(7-chloro-1-benzothiophen-3-yl)methoxy]-2-(2,4-dichlorophenyl)ethyl]imidazole	Clc1ccc(C(Cn2ccnc2)OCc2csc3c(Cl)cccc23)c(Cl)c1	65863.0	R23_gupta_2019:907			BBB-	C	training
InChI=1S/C20H15ClN4/c21-15-5-7-16(8-6-15)23-20-18-4-2-1-3-17(18)19(24-25-20)13-14-9-11-22-12-10-14/h1-12H,13H2,(H,23,25)	Ptk-787, Vatalanib|Vatalanib	N-(4-chlorophenyl)-4-(pyridin-4-ylmethyl)phthalazin-1-amine	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1	151194.0	R26_chico_2009:337	0.2	A	BBB+	A	training
InChI=1S/C20H16N2O4/c1-2-20(25)14-8-16-17-12(7-11-5-3-4-6-15(11)21-17)9-22(16)18(23)13(14)10-26-19(20)24/h3-8,25H,2,9-10H2,1H3/t20-/m0/s1	Camptothecin	(19S)-19-ethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaene-14,18-dione	CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3ccccc3nc2-1	24360.0	R25_brito_sanchez_2015:476|R26_chico_2009:92|R46_mendoza_valencia_2017:400	-0.29	B	BBB+	A	training
InChI=1S/C20H16N4O2/c1-14(25)13-24-18(26)11-10-16(21-24)19-17-9-5-6-12-23(17)22-20(19)15-7-3-2-4-8-15/h2-12H,13H2,1H3	210879-61-1|2-(2-Oxopropyl)-6-(2-Phenylpyrazolo[1,5-A]Pyridin-3-Yl)Pyridazin-3-One	2-(2-oxopropyl)-6-(2-phenylpyrazolo[1,5-a]pyridin-3-yl)pyridazin-3-one	CC(=O)Cn1nc(-c2c(-c3ccccc3)nn3ccccc23)ccc1=O	11110698.0	R4_mente_2005:108	-0.31	A	BBB+	A	training
InChI=1S/C20H17ClN2O3/c1-13-10-18(24)23-12-19(25)22(2)17-9-8-15(21)11-16(17)20(23,26-13)14-6-4-3-5-7-14/h3-11H,12H2,1-2H3	Ketazolam	11-chloro-2,8-dimethyl-12b-phenyl-6H-[1,3]oxazino[3,2-d][1,4]benzodiazepine-4,7-dione	CC1=CC(=O)N2CC(=O)N(C)c3ccc(Cl)cc3C2(c2ccccc2)O1	33746.0	R6_adenot_2004:718|R14_ghose_2012:117|R23_gupta_2019:119			BBB+	C	training
InChI=1S/C20H17F3N2O4/c21-20(22,23)15-6-3-5-13-17(8-9-24-18(13)15)25-16-7-2-1-4-14(16)19(28)29-11-12(27)10-26/h1-9,12,26-27H,10-11H2,(H,24,25)	Floctafenine	2,3-dihydroxypropyl 2-[[8-(trifluoromethyl)quinolin-4-yl]amino]benzoate	O=C(OCC(O)CO)c1ccccc1Nc1ccnc2c(C(F)(F)F)cccc12	3360.0	R14_ghose_2012:561			BBB-	C	training
InChI=1S/C20H18BrClN4S/c21-16-10-14-18(13-8-4-5-9-15(13)22)23-11-17-24-25-19(26(17)20(14)27-16)12-6-2-1-3-7-12/h4-5,8-10,12H,1-3,6-7,11H2	Ciclotizolam	4-bromo-7-(2-chlorophenyl)-13-cyclohexyl-3-thia-1,8,11,12-tetrazatricyclo[8.3.0.02,6]trideca-2(6),4,7,10,12-pentaene	Clc1ccccc1C1=NCc2nnc(C3CCCCC3)n2-c2sc(Br)cc21	71949.0	R6_adenot_2004:689			BBB+	C	training
InChI=1S/C20H18N2O2S/c1-13(23)11-14-4-6-15(7-5-14)20(24)22-18-12-16(8-9-17(18)21)19-3-2-10-25-19/h2-10,12H,11,21H2,1H3,(H,22,24)	8		CC(=O)Cc1ccc(C(=O)Nc2cc(-c3cccs3)ccc2N)cc1		R47_radchenko_2020:519	-0.62	A	BBB+	A	test
InChI=1S/C20H18N2S/c1-22-10-8-15-16(9-11-22)18-12-14(13-21)6-7-20(18)23-19-5-3-2-4-17(15)19/h2-7,12H,8-11H2,1H3	Citatepine	18-methyl-8-thia-18-azatetracyclo[13.5.0.02,7.09,14]icosa-1(15),2(7),3,5,9,11,13-heptaene-4-carbonitrile	CN1CCC2=C(CC1)c1cc(C#N)ccc1Sc1ccccc12	193991.0	R6_adenot_2004:1135			BBB+	C	training
InChI=1S/C20H18N4O5S2/c21-17(26)11-3-5-23(6-4-11)9-12-10-31-19-15(18(27)24(19)16(12)20(28)29)22-14(25)8-13-2-1-7-30-13/h1-7,15,19H,8-10H2,(H3-,21,22,25,26,28,29)/t15-,19-/m1/s1	Cefalonium	(6R,7R)-3-[(4-carbamoylpyridin-1-ium-1-yl)methyl]-8-oxo-7-[(2-thiophen-2-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate	NC(=O)c1cc[n+](CC2=C(C(=O)[O-])N3C(=O)[C@@H](NC(=O)Cc4cccs4)[C@H]3SC2)cc1	21743.0	R6_adenot_2004:155			BBB-	C	training
InChI=1S/C20H18N8O8S3/c1-36-26-10(9-7-39-19(21)22-9)13(30)23-11-15(32)28-12(18(34)35)8(6-38-17(11)28)2-5-37-20-25-24-14(31)16(33)27(20)3-4-29/h2,4-5,7,11,17H,3,6H2,1H3,(H2,21,22)(H,23,30)(H,24,31)(H,34,35)/b5-2+,26-10-/t11-,17-/m1/s1	Ceftiolene|Cefatiolene	(6R,7R)-7-[[(2E)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(E)-2-[[5,6-dioxo-4-(2-oxoethyl)-1H-1,2,4-triazin-3-yl]sulfanyl]ethenyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid	CO/N=C(/C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(/C=C/Sc3n[nH]c(=O)c(=O)n3CC=O)CS[C@H]12)c1csc(N)n1	6436117.0	R6_adenot_2004:201			BBB-	C	training
InChI=1S/C20H19ClN2O3/c1-20(2,3)19(25)26-18-17(24)22-15-10-9-13(21)11-14(15)16(23-18)12-7-5-4-6-8-12/h4-11,18H,1-3H3,(H,22,24)	Pivoxazepam	(7-chloro-2-oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepin-3-yl) 2,2-dimethylpropanoate	CC(C)(C)C(=O)OC1N=C(c2ccccc2)c2cc(Cl)ccc2NC1=O	68722.0	R6_adenot_2004:740			BBB+	C	training
InChI=1S/C20H19NO4/c1-24-17-8-3-14(4-9-17)20(16(13-21)7-12-19(22)23)15-5-10-18(25-2)11-6-15/h3-6,8-11H,7,12H2,1-2H3,(H,22,23)	Satigrel	4-cyano-5,5-bis(4-methoxyphenyl)pent-4-enoic acid	COc1ccc(C(=C(C#N)CCC(=O)O)c2ccc(OC)cc2)cc1	65913.0	R14_ghose_2012:840			BBB-	C	training
InChI=1S/C20H20ClN5O3S2/c1-24-6-8-25(9-7-24)20(28)29-19-16-15(30-10-11-31-16)18(27)26(19)14-5-3-12-2-4-13(21)22-17(12)23-14/h2-5,19H,6-11H2,1H3	Suriclone	[6-(7-chloro-1,8-naphthyridin-2-yl)-5-oxo-3,7-dihydro-2H-[1,4]dithiino[2,3-c]pyrrol-7-yl] 4-methylpiperazine-1-carboxylate	CN1CCN(C(=O)OC2C3=C(SCCS3)C(=O)N2c2ccc3ccc(Cl)nc3n2)CC1	40903.0	R6_adenot_2004:1513			BBB+	C	training
InChI=1S/C20H20ClNO/c1-22(2,23)14-6-10-17-16-8-4-3-7-15(16)12-13-19-18(17)9-5-11-20(19)21/h3-5,7-13H,6,14H2,1-2H3	Benzaprinoxide	3-(7-chloro-2-tricyclo[9.4.0.03,8]pentadeca-1(15),3(8),4,6,9,11,13-heptaenylidene)-N,N-dimethylpropan-1-amine oxide	C[N+](C)([O-])CCC=C1c2ccccc2C=Cc2c(Cl)cccc21	68694.0	R6_adenot_2004:493			BBB+	C	training
InChI=1S/C20H20FNO3S/c1-12(23)25-18-10-14-11-22(9-8-17(14)26-18)19(20(24)13-6-7-13)15-4-2-3-5-16(15)21/h2-5,10,13,19H,6-9,11H2,1H3	Prasugrel	[5-[2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-6,7-dihydro-4H-thieno[3,2-c]pyridin-2-yl] acetate	CC(=O)Oc1cc2c(s1)CCN(C(C(=O)C1CC1)c1ccccc1F)C2	6918456.0	R23_gupta_2019:855			BBB-	C	training
InChI=1S/C20H20N2O2/c23-20(19-14-17-8-4-5-9-18(17)24-19)22-12-10-21(11-13-22)15-16-6-2-1-3-7-16/h1-9,14H,10-13,15H2	Befuraline	1-benzofuran-2-yl-(4-benzylpiperazin-1-yl)methanone	O=C(c1cc2ccccc2o1)N1CCN(Cc2ccccc2)CC1	68664.0	R6_adenot_2004:491			BBB+	C	test
InChI=1S/C20H20N6O7S4/c1-7-10(3-11(27)28)37-20(22-7)36-5-8-4-34-17-13(16(30)26(17)14(8)18(31)32)24-15(29)12(25-33-2)9-6-35-19(21)23-9/h6,13,17H,3-5H2,1-2H3,(H2,21,23)(H,24,29)(H,27,28)(H,31,32)/b25-12+/t13-,17-/m1/s1	Cefodizime	(6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[[5-(carboxymethyl)-4-methyl-1,3-thiazol-2-yl]sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid	CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(CSc3nc(C)c(CC(=O)O)s3)CS[C@H]12)c1csc(N)n1	5361871.0	R6_adenot_2004:178			BBB-	C	training
InChI=1S/C20H20N6O9S/c1-25-19(22-23-24-25)36-8-10-7-35-18-20(34-2,17(33)26(18)13(10)16(31)32)21-14(28)12(15(29)30)9-3-5-11(27)6-4-9/h3-6,12,18,27H,7-8H2,1-2H3,(H,21,28)(H,29,30)(H,31,32)/t12?,18-,20+/m1/s1	Latamoxef|Moxalactam	(6R,7R)-7-[[2-carboxy-2-(4-hydroxyphenyl)acetyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid	CO[C@@]1(NC(=O)C(C(=O)O)c2ccc(O)cc2)C(=O)N2C(C(=O)O)=C(CSc3nnnn3C)CO[C@@H]21	47499.0	R6_adenot_2004:238|R23_gupta_2019:700|R25_brito_sanchez_2015:379|R53_friden_2009:21	-2.51	B	BBB-	A	training
InChI=1S/C20H21ClN2O2/c1-14(2)12-22-13-19(24)23(3)18-10-9-16(21)11-17(18)20(25)15-7-5-4-6-8-15/h4-11,22H,1,12-13H2,2-3H3	Dinazafone	N-(2-benzoyl-4-chlorophenyl)-N-methyl-2-(2-methylprop-2-enylamino)acetamide	C=C(C)CNCC(=O)N(C)c1ccc(Cl)cc1C(=O)c1ccccc1	68903.0	R6_adenot_2004:1449			BBB+	C	training
InChI=1S/C20H21ClN2O4/c21-16-2-4-17(5-3-16)25-13-20(24)23-9-7-22(8-10-23)12-15-1-6-18-19(11-15)27-14-26-18/h1-6,11H,7-10,12-14H2	Fipexide	1-[4-(1,3-benzodioxol-5-ylmethyl)piperazin-1-yl]-2-(4-chlorophenoxy)ethanone	O=C(COc1ccc(Cl)cc1)N1CCN(Cc2ccc3c(c2)OCO3)CC1	3351.0	R6_adenot_2004:546			BBB+	C	training
InChI=1S/C20H21ClN4O2/c21-14-2-3-17-16(10-14)20(24-23-17)22-15-5-7-25(8-6-15)11-13-1-4-18-19(9-13)27-12-26-18/h1-4,9-10,15H,5-8,11-12H2,(H2,22,23,24)	Mchr Antagonist 19|Compound-19|N-(1-(Benzo[D][1,3]Dioxol-5-Ylmethyl)Piperidin-4-Yl)-5-Chloro-1H-Indazol-3-Amine	N-[1-(1,3-benzodioxol-5-ylmethyl)piperidin-4-yl]-5-chloro-1H-indazol-3-amine	Clc1ccc2[nH]nc(NC3CCN(Cc4ccc5c(c4)OCO5)CC3)c2c1	11653882.0	R25_brito_sanchez_2015:466|R26_chico_2009:128|R46_mendoza_valencia_2017:391	0.83	B	BBB+	A	training
InChI=1S/C20H21ClO4/c1-13(2)24-19(23)20(3,4)25-17-11-7-15(8-12-17)18(22)14-5-9-16(21)10-6-14/h5-13H,1-4H3	Fenofibrate	propan-2-yl 2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoate	CC(C)OC(=O)C(C)(C)Oc1ccc(C(=O)c2ccc(Cl)cc2)cc1	3339.0	R14_ghose_2012:553|R23_gupta_2019:595			BBB-	C	training
InChI=1S/C20H21F3N2OS/c1-3-24(4-2)12-11-19(26)25-15-7-5-6-8-17(15)27-18-10-9-14(13-16(18)25)20(21,22)23/h5-10,13H,3-4,11-12H2,1-2H3	Fluacizine	3-(diethylamino)-1-[2-(trifluoromethyl)phenothiazin-10-yl]propan-1-one	CCN(CC)CCC(=O)N1c2ccccc2Sc2ccc(C(F)(F)F)cc21	161562.0	R6_adenot_2004:548			BBB+	C	training
InChI=1S/C20H21F5N2O2/c21-19(22)28-17-9-8-15(29-20(23,24)25)11-14(17)12-27-16-7-4-10-26-18(16)13-5-2-1-3-6-13/h1-3,5-6,8-9,11,16,18-19,26-27H,4,7,10,12H2	145742-22-9|Pfizer Compound 10|N-[[2-(Difluoromethoxy)-5-(Trifluoromethoxy)Phenyl]Methyl]-2-Phenylpiperidin-3-Amine	N-[[2-(difluoromethoxy)-5-(trifluoromethoxy)phenyl]methyl]-2-phenylpiperidin-3-amine	FC(F)Oc1ccc(OC(F)(F)F)cc1CNC1CCCNC1c1ccccc1	10201984.0	R4_mente_2005:85|R25_brito_sanchez_2015:536|R40_vilar_2010:183|R47_radchenko_2020:384	0.88	B	BBB+	A	test
InChI=1S/C20H21FN2O/c1-23(2)11-3-10-20(17-5-7-18(21)8-6-17)19-9-4-15(13-22)12-16(19)14-24-20/h4-9,12H,3,10-11,14H2,1-2H3	Citalopram|Citalopram/Escitalopram	1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-2-benzofuran-5-carbonitrile	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	2771.0	R6_adenot_2004:511|R14_ghose_2012:49|R23_gupta_2019:48|R25_brito_sanchez_2015:427|R26_chico_2009:106|R34_broccatelli_2012:146|R37_chen_2011:21|R42_ciura_2020:10|R46_mendoza_valencia_2017:359	0.99	D	BBB+	A	training
InChI=1S/C20H21FN2O/c1-23(2)11-3-10-20(17-5-7-18(21)8-6-17)19-9-4-15(13-22)12-16(19)14-24-20/h4-9,12H,3,10-11,14H2,1-2H3/t20-/m0/s1	Escitalopram	(1S)-1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-2-benzofuran-5-carbonitrile	CN(C)CCC[C@@]1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	146570.0	R26_chico_2009:176|R34_broccatelli_2012:28|R37_chen_2011:32	-0.37	A	BBB+	A	training
InChI=1S/C20H21FN4O2/c1-27-20-22-11-10-17(24-20)19-18(13-2-4-14(21)5-3-13)23-12-25(19)15-6-8-16(26)9-7-15/h2-5,10-12,15-16,26H,6-9H2,1H3	Sb 239063|Cyclohexanol, 4-(4-(4-Fluorophenyl)-5-(2-Methoxy-4-Pyrimidinyl)-1H-Imidazol-1-Yl)-, Trans-	4-[4-(4-fluorophenyl)-5-(2-methoxypyrimidin-4-yl)imidazol-1-yl]cyclohexan-1-ol	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1	5166.0	R26_chico_2009:365	-1.4	A	BBB-	A	training
InChI=1S/C20H21N/c1-21(2)15-7-12-20-18-10-5-3-8-16(18)13-14-17-9-4-6-11-19(17)20/h3-6,8-14H,7,15H2,1-2H3	Cyclobenzaprine|Cyclobenzaprine, Mk 130	N,N-dimethyl-3-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,9,11,13-heptaenylidene)propan-1-amine	CN(C)CCC=C1c2ccccc2C=Cc2ccccc21	2895.0	R6_adenot_2004:1441|R14_ghose_2012:59|R23_gupta_2019:55|R26_chico_2009:142|R34_broccatelli_2012:20|R37_chen_2011:25	1.06	A	BBB+	A	training
InChI=1S/C20H21N/c1-21-12-6-11-16-14-7-2-4-9-17(14)19-13-20(19)18-10-5-3-8-15(16)18/h2-5,7-11,19-21H,6,12-13H2,1H3	Octriptyline	N-methyl-3-(11-tetracyclo[10.4.0.02,4.05,10]hexadeca-1(16),5,7,9,12,14-hexaenylidene)propan-1-amine	CNCCC=C1c2ccccc2C2CC2c2ccccc21	40029.0	R6_adenot_2004:1598			BBB+	C	test
InChI=1S/C20H21N3O/c1-16-22-13-15-23(16)14-12-20(19(21)24,17-8-4-2-5-9-17)18-10-6-3-7-11-18/h2-11,13,15H,12,14H2,1H3,(H2,21,24)	Imidafenacin	4-(2-methylimidazol-1-yl)-2,2-diphenylbutanamide	Cc1nccn1CCC(C(N)=O)(c1ccccc1)c1ccccc1	6433090.0	R23_gupta_2019:673			BBB-	C	test
InChI=1S/C20H21N3OS/c1-23(2)13-14-5-7-15(8-6-14)20(24)22-18-12-16(9-10-17(18)21)19-4-3-11-25-19/h3-12H,13,21H2,1-2H3,(H,22,24)	28		CN(C)Cc1ccc(C(=O)Nc2cc(-c3cccs3)ccc2N)cc1		R47_radchenko_2020:526	0.77	A	BBB+	A	test
InChI=1S/C20H21N5O6/c21-20-24-16-15(18(29)25-20)12(9-22-16)6-3-10-1-4-11(5-2-10)17(28)23-13(19(30)31)7-8-14(26)27/h1-2,4-5,9,13H,3,6-8H2,(H,23,28)(H,26,27)(H,30,31)(H4,21,22,24,25,29)/t13-/m0/s1	Pemetrexed	(2S)-2-[[4-[2-(2-amino-4-oxo-3,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid	Nc1nc2[nH]cc(CCc3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc3)c2c(=O)[nH]1	135410875.0	R23_gupta_2019:816			BBB-	C	test
InChI=1S/C20H21N7O6S2/c21-6-11-4-2-1-3-10(11)5-13(28)22-15-17(31)27-16(19(32)33)12(8-34-18(15)27)9-35-20-23-24-25-26(20)7-14(29)30/h1-4,15,18H,5-9,21H2,(H,22,28)(H,29,30)(H,32,33)/t15-,18-/m1/s1	Ceforanide	(6R,7R)-7-[[2-[2-(aminomethyl)phenyl]acetyl]amino]-3-[[1-(carboxymethyl)tetrazol-5-yl]sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid	NCc1ccccc1CC(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(CSc3nnnn3CC(=O)O)CS[C@H]12	43507.0	R6_adenot_2004:181|R23_gupta_2019:428			BBB-	C	training
InChI=1S/C20H21NO/c1-21(2)14-17(22)13-20-18-9-5-3-7-15(18)11-12-16-8-4-6-10-19(16)20/h3-10,13H,11-12,14H2,1-2H3	Cotriptyline	1-(dimethylamino)-3-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,11,13-hexaenylidene)propan-2-one	CN(C)CC(=O)C=C1c2ccccc2CCc2ccccc21	71935.0	R6_adenot_2004:1557			BBB+	C	test
InChI=1S/C20H21NO/c1-21-12-10-14(11-13-21)19-15-6-2-4-8-17(15)20(22)18-9-5-3-7-16(18)19/h2-9,20,22H,10-13H2,1H3	Danitracen	10-(1-methylpiperidin-4-ylidene)-9H-anthracen-9-ol	CN1CCC(=C2c3ccccc3C(O)c3ccccc32)CC1	35758.0	R6_adenot_2004:520			BBB+	C	test
InChI=1S/C20H21NO4/c1-22-17-6-5-13(10-18(17)23-2)9-16-15-12-20(25-4)19(24-3)11-14(15)7-8-21-16/h5-8,10-12H,9H2,1-4H3	Papaverine	1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxyisoquinoline	COc1ccc(Cc2nccc3cc(OC)c(OC)cc23)cc1OC	4680.0	R23_gupta_2019:812|R51_doninger_2002:104			BBB-	C	training
InChI=1S/C20H22Cl2N2O2/c21-16-4-3-14(11-17(16)22)12-20(25)24-9-5-19-15(6-10-26-19)18(24)13-23-7-1-2-8-23/h3-4,6,10-11,18H,1-2,5,7-9,12-13H2/t18-/m1/s1	Gr88377|2-(3,4-Dichlorophenyl)-1-[(4S)-4-(Pyrrolidin-1-Ylmethyl)-6,7-Dihydro-4H-Furo[3,2-C]Pyridin-5-Yl]Ethanone	2-(3,4-dichlorophenyl)-1-[(4S)-4-(pyrrolidin-1-ylmethyl)-6,7-dihydro-4H-furo[3,2-c]pyridin-5-yl]ethanone	O=C(Cc1ccc(Cl)c(Cl)c1)N1CCc2occc2[C@H]1CN1CCCC1	44310763.0	R28_li_2005:359			BBB+	C	training
InChI=1S/C20H22Cl2N2O3/c21-16-2-1-13(9-17(16)22)10-20(26)24-7-4-19-15(5-8-27-19)18(24)12-23-6-3-14(25)11-23/h1-2,5,8-9,14,18,25H,3-4,6-7,10-12H2/t14-,18-/m1/s1	Gr91272|2-(3,4-Dichloro-Phenyl)-1-[(S)-4-((R)-3-Hydroxy-Pyrrolidin-1-Ylmethyl)-6,7-Dihydro-4H-Furo[3,2-C]Pyridin-5-Yl]-Ethanone	2-(3,4-dichlorophenyl)-1-[(4S)-4-[[(3R)-3-hydroxypyrrolidin-1-yl]methyl]-6,7-dihydro-4H-furo[3,2-c]pyridin-5-yl]ethanone	O=C(Cc1ccc(Cl)c(Cl)c1)N1CCc2occc2[C@H]1CN1CC[C@@H](O)C1	44308032.0	R28_li_2005:363			BBB+	C	training
InChI=1S/C20H22Cl2N2O4/c1-23(19(27)13-24(8-10-25)9-11-26)18-7-6-14(21)12-16(18)20(28)15-4-2-3-5-17(15)22/h2-7,12,25-26H,8-11,13H2,1H3	Dulozafone	2-[bis(2-hydroxyethyl)amino]-N-[4-chloro-2-(2-chlorobenzoyl)phenyl]-N-methylacetamide	CN(C(=O)CN(CCO)CCO)c1ccc(Cl)cc1C(=O)c1ccccc1Cl	71142.0	R6_adenot_2004:1454			BBB+	C	training
InChI=1S/C20H22Cl2N2OS/c21-16-4-3-14(11-17(16)22)12-19(25)24-9-5-15-6-10-26-20(15)18(24)13-23-7-1-2-8-23/h3-4,6,10-11,18H,1-2,5,7-9,12-13H2/t18-/m1/s1	Brl53080|2-(3,4-Dichlorophenyl)-1-[(7R)-7-(Pyrrolidin-1-Ylmethyl)-5,7-Dihydro-4H-Thieno[2,3-C]Pyridin-6-Yl]Ethanone	2-(3,4-dichlorophenyl)-1-[(7R)-7-(pyrrolidin-1-ylmethyl)-5,7-dihydro-4H-thieno[2,3-c]pyridin-6-yl]ethanone	O=C(Cc1ccc(Cl)c(Cl)c1)N1CCc2ccsc2[C@H]1CN1CCCC1	44310460.0	R28_li_2005:332			BBB+	C	training
InChI=1S/C20H22Cl2N2OS/c21-16-4-3-14(11-17(16)22)12-20(25)24-9-5-19-15(6-10-26-19)18(24)13-23-7-1-2-8-23/h3-4,6,10-11,18H,1-2,5,7-9,12-13H2/t18-/m1/s1	Brl52871|2-(3,4-Dichlorophenyl)-1-[(4S)-4-(Pyrrolidin-1-Ylmethyl)-6,7-Dihydro-4H-Thieno[3,2-C]Pyridin-5-Yl]Ethanone	2-(3,4-dichlorophenyl)-1-[(4S)-4-(pyrrolidin-1-ylmethyl)-6,7-dihydro-4H-thieno[3,2-c]pyridin-5-yl]ethanone	O=C(Cc1ccc(Cl)c(Cl)c1)N1CCc2sccc2[C@H]1CN1CCCC1	15697370.0	R28_li_2005:330			BBB+	C	training
InChI=1S/C20H22ClN3O/c1-3-24(4-2)13-14-11-16(6-8-20(14)25)23-18-9-10-22-19-12-15(21)5-7-17(18)19/h5-12,25H,3-4,13H2,1-2H3,(H,22,23)	Amodiaquine	4-[(7-chloroquinolin-4-yl)amino]-2-(diethylaminomethyl)phenol	CCN(CC)Cc1cc(Nc2ccnc3cc(Cl)ccc23)ccc1O	2165.0	R14_ghose_2012:348|R23_gupta_2019:348			BBB-	C	training
InChI=1S/C20H22ClN3O3S2/c1-13-16-11-14(21)3-6-19(16)28-20(13)29(25,26)23-15-4-5-18(27-2)17(12-15)24-9-7-22-8-10-24/h3-6,11-12,22-23H,7-10H2,1-2H3	Sb-271406|5-Chloro-N-(4-Methoxy-3-(Piperazin-1-Yl)Phenyl)-3-Methylbenzo[B]Thiophene-2-Sulfonamide	5-chloro-N-(4-methoxy-3-piperazin-1-ylphenyl)-3-methyl-1-benzothiophene-2-sulfonamide	COc1ccc(NS(=O)(=O)c2sc3ccc(Cl)cc3c2C)cc1N1CCNCC1	5312149.0	R26_chico_2009:370	-1.3	A	BBB-	A	test
InChI=1S/C20H22F2N2O3S/c21-16-4-1-14(19(22)13-16)7-10-24-11-8-18(9-12-24)28(26,27)17-5-2-15(3-6-17)20(23)25/h1-6,13,18H,7-12H2,(H2,23,25)	Cmpd 31|4-[[1-(2-(2,4-Difluorophenyl)Ethyl)-4-Piperidinyl]Sulfonyl]Benzamide	4-[1-[2-(2,4-difluorophenyl)ethyl]piperidin-4-yl]sulfonylbenzamide	NC(=O)c1ccc(S(=O)(=O)C2CCN(CCc3ccc(F)cc3F)CC2)cc1	9953268.0	R26_chico_2009:115	-0.47	A	BBB+	A	training
InChI=1S/C20H22FN3/c1-23-12-4-5-16(14-23)20-22-18-6-2-3-7-19(18)24(20)13-15-8-10-17(21)11-9-15/h2-3,6-11,16H,4-5,12-14H2,1H3/t16-/m1/s1	2|(R)-1-(4-Fluorobenzyl)-2-(1-Methylpiperidin-3-Yl)-1H-Benzo[D]Imidazole	1-[(4-fluorophenyl)methyl]-2-[(3R)-1-methylpiperidin-3-yl]benzimidazole	CN1CCC[C@@H](c2nc3ccccc3n2Cc2ccc(F)cc2)C1	46888857.0	R25_brito_sanchez_2015:522|R46_mendoza_valencia_2017:436	0.43	B	BBB+	A	training
InChI=1S/C20H22N2/c1-21-13-11-15-16(12-14-21)18-8-4-6-10-20(18)22(2)19-9-5-3-7-17(15)19/h3-10H,11-14H2,1-2H3	Erizepine	8,18-dimethyl-8,18-diazatetracyclo[13.5.0.02,7.09,14]icosa-1(15),2,4,6,9,11,13-heptaene	CN1CCC2=C(CC1)c1ccccc1N(C)c1ccccc12	208930.0	R6_adenot_2004:1567			BBB+	C	training
InChI=1S/C20H22N2/c1-22-13-10-16(11-14-22)19-18-7-3-2-5-15(18)8-9-17-6-4-12-21-20(17)19/h2-7,12H,8-11,13-14H2,1H3	Azatadine	2-(1-methylpiperidin-4-ylidene)-4-azatricyclo[9.4.0.03,8]pentadeca-1(15),3(8),4,6,11,13-hexaene	CN1CCC(=C2c3ccccc3CCc3cccnc32)CC1	19861.0	R14_ghose_2012:14|R23_gupta_2019:19			BBB+	C	training
InChI=1S/C20H22N2O2/c1-21-9-11-22(12-10-21)18-13-15-5-3-4-6-19(15)24-20-8-7-16(23-2)14-17(18)20/h3-8,13-14H,9-12H2,1-2H3	Metoxepin	1-(3-methoxybenzo[b][1]benzoxepin-5-yl)-4-methylpiperazine	COc1ccc2c(c1)C(N1CCN(C)CC1)=Cc1ccccc1O2	32226.0	R6_adenot_2004:1593			BBB+	C	training
InChI=1S/C20H22N4O10S/c1-9(25)33-10(2)34-19(28)15-11(7-32-20(21)29)8-35-18-14(17(27)24(15)18)22-16(26)13(23-30-3)12-5-4-6-31-12/h4-6,10,14,18H,7-8H2,1-3H3,(H2,21,29)(H,22,26)/b23-13+/t10?,14-,18-/m1/s1	Cefuroxime-Axetil|Cefuroxime Axetil	1-acetyloxyethyl (6R,7R)-3-(carbamoyloxymethyl)-7-[[(2Z)-2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate	CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)OC(C)OC(C)=O)=C(COC(N)=O)CS[C@H]12)c1ccco1	6321416.0	R6_adenot_2004:207			BBB-	C	training
InChI=1S/C20H22N4O10S/c1-9(25)33-10(2)34-19(28)15-11(7-32-20(21)29)8-35-18-14(17(27)24(15)18)22-16(26)13(23-30-3)12-5-4-6-31-12/h4-6,10,14,18H,7-8H2,1-3H3,(H2,21,29)(H,22,26)/b23-13-/t10?,14-,18-/m1/s1	Cefuroxime Axetil|Cefuroxime Axetil, (E)-	1-acetyloxyethyl (6R,7R)-3-(carbamoyloxymethyl)-7-[[(2E)-2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate	CO/N=C(/C(=O)N[C@@H]1C(=O)N2C(C(=O)OC(C)OC(C)=O)=C(COC(N)=O)CS[C@H]12)c1ccco1	5361467.0	R14_ghose_2012:436|R23_gupta_2019:441			BBB-	C	training
InChI=1S/C20H22N4O2/c1-23-8-12(9-24-10-18(25)22-19(26)11-24)5-15-14-3-2-4-16-20(14)13(7-21-16)6-17(15)23/h2-5,7,12,17,21H,6,8-11H2,1H3,(H,22,25,26)/t12-,17-/m1/s1	Romergoline	4-[[(6aR,9S)-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinolin-9-yl]methyl]piperazine-2,6-dione	CN1C[C@H](CN2CC(=O)NC(=O)C2)C=C2c3cccc4[nH]cc(c34)C[C@H]21	65898.0	R6_adenot_2004:996			BBB+	C	training
InChI=1S/C20H22N4O4S/c1-11-10-29-19-15(18(26)24(19)16(11)20(27)28)23-14(25)9-12-3-5-13(6-4-12)17-21-7-2-8-22-17/h3-6,15,19H,2,7-10H2,1H3,(H,21,22)(H,23,25)(H,27,28)/t15-,19-/m1/s1	Cefrotil	(6R,7R)-3-methyl-8-oxo-7-[[2-[4-(1,4,5,6-tetrahydropyrimidin-2-yl)phenyl]acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid	CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)Cc3ccc(C4=NCCCN4)cc3)[C@H]2SC1	68692.0	R6_adenot_2004:193			BBB-	C	training
InChI=1S/C20H22N8O5/c1-28(9-11-8-23-17-15(24-11)16(21)26-20(22)27-17)12-4-2-10(3-5-12)18(31)25-13(19(32)33)6-7-14(29)30/h2-5,8,13H,6-7,9H2,1H3,(H,25,31)(H,29,30)(H,32,33)(H4,21,22,23,26,27)/t13-/m0/s1	Methotrexate|Methotrexate Sodium	(2S)-2-[[4-[(2,4-diaminopteridin-6-yl)methyl-methylamino]benzoyl]amino]pentanedioic acid	CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1	126941.0	R5_guerra_2008:65|R6_adenot_2004:46|R12_garg_2006:109|R14_ghose_2012:686|R21_muehlbacher_2011:97|R23_gupta_2019:737|R25_brito_sanchez_2015:291|R26_chico_2009:265|R28_li_2005:270|R34_broccatelli_2012:49|R39_shayanfar_2011:115|R40_vilar_2010:147|R47_radchenko_2020:278|R51_doninger_2002:89|R53_friden_2009:18	-1.63	B1	BBB-	A	test
InChI=1S/C20H23F3N2O2/c1-26-18-10-9-16(27-20(21,22)23)12-15(18)13-25-17-8-5-11-24-19(17)14-6-3-2-4-7-14/h2-4,6-7,9-10,12,17,19,24-25H,5,8,11,13H2,1H3	Pfizer Compound 7|N-[[2-Methoxy-5-(Trifluoromethoxy)Phenyl]Methyl]-2-Phenylpiperidin-3-Amine	N-[[2-methoxy-5-(trifluoromethoxy)phenyl]methyl]-2-phenylpiperidin-3-amine	COc1ccc(OC(F)(F)F)cc1CNC1CCCNC1c1ccccc1	9864647.0	R40_vilar_2010:203|R47_radchenko_2020:405	0.63	B	BBB+	A	test
InChI=1S/C20H23F3N2O2/c1-26-18-10-9-16(27-20(21,22)23)12-15(18)13-25-17-8-5-11-24-19(17)14-6-3-2-4-7-14/h2-4,6-7,9-10,12,17,19,24-25H,5,8,11,13H2,1H3/t17-,19-/m0/s1	145877-52-7|Cp-122721|(2S,3S)-N-(2-Methoxy-5-(Trifluoromethoxy)Benzyl)-2-Phenylpiperidin-3-Amine	(2S,3S)-N-[[2-methoxy-5-(trifluoromethoxy)phenyl]methyl]-2-phenylpiperidin-3-amine	COc1ccc(OC(F)(F)F)cc1CN[C@H]1CCCN[C@H]1c1ccccc1	9821217.0	R4_mente_2005:82|R25_brito_sanchez_2015:422	0.87	C	BBB+	A	test
InChI=1S/C20H23N/c1-20(2)18-12-6-4-9-16(18)15(11-8-14-21-3)17-10-5-7-13-19(17)20/h4-7,9-13,21H,8,14H2,1-3H3	Litracen	3-(10,10-dimethylanthracen-9-ylidene)-N-methylpropan-1-amine	CNCCC=C1c2ccccc2C(C)(C)c2ccccc21	82730.0	R6_adenot_2004:566			BBB+	C	training
InChI=1S/C20H23N/c1-21(2)15-7-12-20-18-10-5-3-8-16(18)13-14-17-9-4-6-11-19(17)20/h3-6,8-12H,7,13-15H2,1-2H3	Triptanol|50-48-6|Amitriptyline|Amitriptyline, Triptanol, Elavil|Amitryptiline|36	N,N-dimethyl-3-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,11,13-hexaenylidene)propan-1-amine	CN(C)CCC=C1c2ccccc2CCc2ccccc21	2160.0	R3_abraham_2006:295|R4_mente_2005:184|R5_guerra_2008:16|R6_adenot_2004:1688|R7_andres_2006:189|R12_garg_2006:20|R14_ghose_2012:8|R21_muehlbacher_2011:31|R23_gupta_2019:10|R25_brito_sanchez_2015:29|R26_chico_2009:30|R28_li_2005:6|R29_subramanian_2003:8|R34_broccatelli_2012:4|R39_shayanfar_2011:14|R40_vilar_2010:281|R41_toropov_2017:263|R44_bujak_2015:10|R46_mendoza_valencia_2017:29|R47_radchenko_2020:245|R48_hou_2003:37|R49_norinder_2002:36|R49_norinder_2002:140|R51_doninger_2002:151|R52_liu_2001:70|R53_friden_2009:2	0.92	B1	BBB+	A	test
InChI=1S/C20H23N/c1-21-14-6-12-20-13-11-15(16-7-2-4-9-18(16)20)17-8-3-5-10-19(17)20/h2-5,7-10,15,21H,6,11-14H2,1H3	Maprotiline	N-methyl-3-(1-tetracyclo[6.6.2.02,7.09,14]hexadeca-2,4,6,9,11,13-hexaenyl)propan-1-amine	CNCCCC12CCC(c3ccccc31)c1ccccc12	4011.0	R6_adenot_2004:1531|R14_ghose_2012:131|R23_gupta_2019:130|R25_brito_sanchez_2015:504|R26_chico_2009:253|R34_broccatelli_2012:47|R46_mendoza_valencia_2017:422	1.3	B	BBB+	A	training
InChI=1S/C20H23N3/c1-22(2)12-5-13-23-19-7-4-3-6-17(19)10-11-18-9-8-16(15-21)14-20(18)23/h3-4,6-9,14H,5,10-13H2,1-2H3	Cianopramine	11-[3-(dimethylamino)propyl]-5,6-dihydrobenzo[b][1]benzazepine-2-carbonitrile	CN(C)CCCN1c2ccccc2CCc2ccc(C#N)cc21	48126.0	R6_adenot_2004:506			BBB+	C	training
InChI=1S/C20H23N3/c1-22(2)14-9-15-23-16-19(17-10-5-3-6-11-17)20(21-23)18-12-7-4-8-13-18/h3-8,10-13,16H,9,14-15H2,1-2H3	Fezolamine	3-(3,4-diphenylpyrazol-1-yl)-N,N-dimethylpropan-1-amine	CN(C)CCCn1cc(-c2ccccc2)c(-c2ccccc2)n1	54567.0	R6_adenot_2004:374			BBB+	C	test
InChI=1S/C20H23N3O2/c1-20-11-12-22(2)18(20)23(3)17-10-9-15(13-16(17)20)25-19(24)21-14-7-5-4-6-8-14/h4-10,13,18H,11-12H2,1-3H3,(H,21,24)/t18-,20+/m1/s1	Phenserine	[(3aR,8bS)-3,4,8b-trimethyl-2,3a-dihydro-1H-pyrrolo[2,3-b]indol-7-yl] N-phenylcarbamate	CN1CC[C@@]2(C)c3cc(OC(=O)Nc4ccccc4)ccc3N(C)[C@@H]12	192706.0	R12_garg_2006:134|R17_fu_2008:49|R21_muehlbacher_2011:303|R25_brito_sanchez_2015:354|R28_li_2005:43|R40_vilar_2010:207|R44_bujak_2015:73|R47_radchenko_2020:283|R48_hou_2003:109|R49_norinder_2002:101	1.0	B	BBB+	A	test
InChI=1S/C20H23N3O2/c24-20-21-18-8-4-5-9-19(18)23(20)16-10-12-22(13-11-16)14-15-25-17-6-2-1-3-7-17/h1-9,16H,10-15H2,(H,21,24)	Oxiperomide	3-[1-(2-phenoxyethyl)piperidin-4-yl]-1H-benzimidazol-2-one	O=c1[nH]c2ccccc2n1C1CCN(CCOc2ccccc2)CC1	68634.0	R6_adenot_2004:1191|R51_doninger_2002:268			BBB+	C	training
InChI=1S/C20H23N5O2S2/c1-28-19-17(29(26,27)14-6-3-2-4-7-14)18-22-16-9-5-8-15(16)20(25(18)23-19)24-12-10-21-11-13-24/h2-4,6-7,21H,5,8-13H2,1H3	Ro65-7674|10-(Benzenesulfonyl)-11-Methylsulfanyl-2-Piperazin-1-Yl-1,8,12-Triazatricyclo[7.3.0.03,7]Dodeca-2,7,9,11-Tetraene	10-(benzenesulfonyl)-11-methylsulfanyl-2-piperazin-1-yl-1,8,12-triazatricyclo[7.3.0.03,7]dodeca-2,7,9,11-tetraene	CSc1nn2c(N3CCNCC3)c3c(nc2c1S(=O)(=O)c1ccccc1)CCC3	6918479.0	R26_chico_2009:356	-1.0	A	BBB+	A	training
InChI=1S/C20H23N5O6S/c1-20(2)13(17(28)29)25-15(27)12(16(25)32-20)22-14(26)11(10-6-4-3-5-7-10)23-19(31)24-9-8-21-18(24)30/h3-7,11-13,16H,8-9H2,1-2H3,(H,21,30)(H,22,26)(H,23,31)(H,28,29)/t11-,12-,13+,16-/m1/s1	Azlocillin	(2S,5R,6R)-3,3-dimethyl-7-oxo-6-[[(2R)-2-[(2-oxoimidazolidine-1-carbonyl)amino]-2-phenylacetyl]amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid	CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](NC(=O)N3CCNC3=O)c3ccccc3)C(=O)N2[C@H]1C(=O)O	6479523.0	R23_gupta_2019:374			BBB-	C	training
InChI=1S/C20H23NO/c1-21(2)15-14-20(17-9-4-3-5-10-17)13-12-16-8-6-7-11-18(16)19(20)22/h3-11H,12-15H2,1-2H3	Nafenodone	2-[2-(dimethylamino)ethyl]-2-phenyl-3,4-dihydronaphthalen-1-one	CN(C)CCC1(c2ccccc2)CCc2ccccc2C1=O	174100.0	R6_adenot_2004:580			BBB+	C	training
InChI=1S/C20H23NO/c1-21(2)15-14-20(17-9-4-3-5-10-17)13-12-16-8-6-7-11-18(16)19(20)22/h3-11H,12-15H2,1-2H3/t20-/m0/s1	Dexnafenodone	(2S)-2-[2-(dimethylamino)ethyl]-2-phenyl-3,4-dihydronaphthalen-1-one	CN(C)CC[C@]1(c2ccccc2)CCc2ccccc2C1=O	65834.0	R6_adenot_2004:569			BBB+	C	training
InChI=1S/C20H23NO/c1-21(2,22)15-7-12-20-18-10-5-3-8-16(18)13-14-17-9-4-6-11-19(17)20/h3-6,8-12H,7,13-15H2,1-2H3	Amitriptylinoxide	N,N-dimethyl-3-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,11,13-hexaenylidene)propan-1-amine oxide	C[N+](C)([O-])CCC=C1c2ccccc2CCc2ccccc21	20313.0	R6_adenot_2004:1542			BBB+	C	test
InChI=1S/C20H23NO/c1-21-13-14(22)12-20-11-10-15(16-6-2-4-8-18(16)20)17-7-3-5-9-19(17)20/h2-9,14-15,21-22H,10-13H2,1H3	Oxaprotiline	1-(methylamino)-3-(1-tetracyclo[6.6.2.02,7.09,14]hexadeca-2,4,6,9,11,13-hexaenyl)propan-2-ol	CNCC(O)CC12CCC(c3ccccc31)c1ccccc12	38207.0	R6_adenot_2004:1601			BBB+	C	training
InChI=1S/C20H23NO/c1-21-13-14(22)12-20-11-10-15(16-6-2-4-8-18(16)20)17-7-3-5-9-19(17)20/h2-9,14-15,21-22H,10-13H2,1H3/t14-,15?,20?/m1/s1	Levoprotiline	(2R)-1-(methylamino)-3-(1-tetracyclo[6.6.2.02,7.09,14]hexadeca-2,4,6,9,11,13-hexaenyl)propan-2-ol	CNC[C@H](O)CC12CCC(c3ccccc31)c1ccccc12	53511.0	R6_adenot_2004:1587			BBB+	C	training
InChI=1S/C20H23NO2/c1-3-9-16(10-4-1)20(17-11-5-2-6-12-17)22-15-19(23-20)18-13-7-8-14-21-18/h1-6,9-12,18-19,21H,7-8,13-15H2	Dexoxadrol|Dioxadrol	2-(2,2-diphenyl-1,3-dioxolan-4-yl)piperidine	c1ccc(C2(c3ccccc3)OCC(C3CCCCN3)O2)cc1	66270.0	R6_adenot_2004:527|R6_adenot_2004:530			BBB+	C	training
InChI=1S/C20H23NO2/c1-3-9-16(10-4-1)20(17-11-5-2-6-12-17)22-15-19(23-20)18-13-7-8-14-21-18/h1-6,9-12,18-19,21H,7-8,13-15H2/t18-,19+/m1/s1	Levoxadrol	(2R)-2-[(4R)-2,2-diphenyl-1,3-dioxolan-4-yl]piperidine	c1ccc(C2(c3ccccc3)OC[C@@H]([C@H]3CCCCN3)O2)cc1	14208378.0	R6_adenot_2004:564			BBB+	C	training
InChI=1S/C20H23NO4/c1-11(22)24-16-7-5-13-14-10-12-4-6-15(23-3)18-17(12)20(13,19(16)25-18)8-9-21(14)2/h4,6-7,13-14,19H,5,8-10H2,1-3H3/t13-,14+,19-,20-/m0/s1	Thebacon|Acetyldihydrocodeinone	[(4R,4aR,7aR,12bS)-9-methoxy-3-methyl-2,4,4a,5,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-yl] acetate	COc1ccc2c3c1O[C@H]1C(OC(C)=O)=CC[C@H]4[C@@H](C2)N(C)CC[C@]314	11508377.0	R6_adenot_2004:1107			BBB+	C	training
InChI=1S/C20H23NO4/c22-13-4-3-12-9-15-20(24)6-5-14(23)18-19(20,16(12)17(13)25-18)7-8-21(15)10-11-1-2-11/h3-4,11,15,18,22,24H,1-2,5-10H2/t15-,18+,19+,20-/m1/s1	Naltrexone	(4R,4aS,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one	O=C1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5c4[C@@]2(CCN3CC2CC2)[C@H]1O5	5360515.0	R6_adenot_2004:1064|R7_andres_2006:112|R14_ghose_2012:163|R23_gupta_2019:161|R28_li_2005:384|R29_subramanian_2003:109|R34_broccatelli_2012:56|R37_chen_2011:59			BBB+	C	training
InChI=1S/C20H23NS/c1-21-12-6-7-15(14-21)13-18-16-8-2-4-10-19(16)22-20-11-5-3-9-17(18)20/h2-5,8-11,15,18H,6-7,12-14H2,1H3	Metixene	1-methyl-3-(9H-thioxanthen-9-ylmethyl)piperidine	CN1CCCC(CC2c3ccccc3Sc3ccccc32)C1	4167.0	R14_ghose_2012:286|R23_gupta_2019:150			BBB+	C	training
InChI=1S/C20H24Cl2N4/c1-3-9-25(12-14-4-5-14)19-16-8-10-26(20(16)24-13(2)23-19)18-7-6-15(21)11-17(18)22/h6-7,11,14H,3-5,8-10,12H2,1-2H3	Compound-4Ag|N-(Cyclopropylmethyl)-7-(2,4-Dichlorophenyl)-2-Methyl-N-Propyl-5,6-Dihydropyrrolo[2,3-D]Pyrimidin-4-Amine	N-(cyclopropylmethyl)-7-(2,4-dichlorophenyl)-2-methyl-N-propyl-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-amine	CCCN(CC1CC1)c1nc(C)nc2c1CCN2c1ccc(Cl)cc1Cl	69460881.0	R26_chico_2009:129	-0.22	A	BBB+	A	training
InChI=1S/C20H24Cl2N4O3/c21-15-4-3-13(9-16(15)22)10-17(27)26-8-5-20(18(28)23-19(29)24-20)11-14(26)12-25-6-1-2-7-25/h3-4,9,14H,1-2,5-8,10-12H2,(H2,23,24,28,29)/t14-,20+/m1/s1	Sb204454		O=C1NC(=O)[C@@]2(CCN(C(=O)Cc3ccc(Cl)c(Cl)c3)[C@@H](CN3CCCC3)C2)N1		R28_li_2005:396			BBB-	C	training
InChI=1S/C20H24Cl2N4O3/c21-15-4-3-13(9-16(15)22)10-17(27)26-8-5-20(18(28)23-19(29)24-20)11-14(26)12-25-6-1-2-7-25/h3-4,9,14H,1-2,5-8,10-12H2,(H2,23,24,28,29)/t14-,20-/m1/s1	Sb204457		O=C1NC(=O)[C@]2(CCN(C(=O)Cc3ccc(Cl)c(Cl)c3)[C@@H](CN3CCCC3)C2)N1		R28_li_2005:397			BBB-	C	training
InChI=1S/C20H24ClN3S/c1-22-11-13-23(14-12-22)9-4-10-24-17-5-2-3-6-19(17)25-20-8-7-16(21)15-18(20)24/h2-3,5-8,15H,4,9-14H2,1H3	Prochlorperazine	2-chloro-10-[3-(4-methylpiperazin-1-yl)propyl]phenothiazine	CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1	4917.0	R6_adenot_2004:1610|R14_ghose_2012:210|R26_chico_2009:328			BBB+	C	training
InChI=1S/C20H24F3N3OS2/c21-20(22,23)15-2-3-18-17(14-15)26(16-4-13-28-19(16)29-18)6-1-5-24-7-9-25(10-8-24)11-12-27/h2-4,13-14,27H,1,5-12H2	Flutizenol	2-[4-[3-[6-(trifluoromethyl)thieno[2,3-b][1,4]benzothiazin-4-yl]propyl]piperazin-1-yl]ethanol	OCCN1CCN(CCCN2c3cc(C(F)(F)F)ccc3Sc3sccc32)CC1	219071.0	R6_adenot_2004:1163			BBB+	C	training
InChI=1S/C20H24FN3O4S/c1-28-19-9-8-17(29(22,26)27)11-18(19)20(25)23-12-16-3-2-10-24(16)13-14-4-6-15(21)7-5-14/h4-9,11,16H,2-3,10,12-13H2,1H3,(H,23,25)(H2,22,26,27)	Flubepride	N-[[1-[(4-fluorophenyl)methyl]pyrrolidin-2-yl]methyl]-2-methoxy-5-sulfamoylbenzamide	COc1ccc(S(N)(=O)=O)cc1C(=O)NCC1CCCN1Cc1ccc(F)cc1	216225.0	R6_adenot_2004:1157			BBB+	C	training
InChI=1S/C20H24N/c1-21(2)15-13-19(14-16-21)20(17-9-5-3-6-10-17)18-11-7-4-8-12-18/h3-12H,13-16H2,1-2H3/q+1	Diphemanil Methylsulfate|Diphemanil	4-benzhydrylidene-1,1-dimethylpiperidin-1-ium	C[N+]1(C)CCC(=C(c2ccccc2)c2ccccc2)CC1	6127.0	R14_ghose_2012:503|R23_gupta_2019:530			BBB-	C	training
InChI=1S/C20H24N2/c1-15(19-10-6-7-12-21-19)20-17(11-13-22(2)3)14-16-8-4-5-9-18(16)20/h4-10,12,15H,11,13-14H2,1-3H3	Dimethindene	N,N-dimethyl-2-[3-(1-pyridin-2-ylethyl)-1H-inden-2-yl]ethanamine	CC(C1=C(CCN(C)C)Cc2ccccc21)c1ccccn1	21855.0	R50_sobanska_2019:73			BBB+	C	training
InChI=1S/C20H24N2/c1-16-18-10-5-4-9-17(18)15-22(14-8-13-21(2)3)20-12-7-6-11-19(16)20/h4-7,9-12H,1,8,13-15H2,2-3H3	Enprazepine	N,N-dimethyl-3-(11-methylidene-6H-benzo[c][1]benzazepin-5-yl)propan-1-amine	C=C1c2ccccc2CN(CCCN(C)C)c2ccccc21	208922.0	R6_adenot_2004:1566			BBB+	C	training
InChI=1S/C20H24N2O/c1-14(2)22-13-7-12-20(19(21)23)17-10-5-3-8-15(17)16-9-4-6-11-18(16)20/h3-6,8-11,14,22H,7,12-13H2,1-2H3,(H2,21,23)	Indecainide Hydrochloride|Indecainide	9-[3-(propan-2-ylamino)propyl]fluorene-9-carboxamide	CC(C)NCCCC1(C(N)=O)c2ccccc2-c2ccccc21	52195.0	R14_ghose_2012:617			BBB-	C	training
InChI=1S/C20H24N2O2/c1-3-13-12-22-9-7-14(13)10-19(22)20(23)16-6-8-21-18-5-4-15(24-2)11-17(16)18/h3-6,8,11,13-14,19-20,23H,1,7,9-10,12H2,2H3	Cinchonan-9-Ol, 6'-Methoxy-, (8Alpha,9R)-	(5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl)-(6-methoxyquinolin-4-yl)methanol	C=CC1CN2CCC1CC2C(O)c1ccnc2ccc(OC)cc12	1065.0	R42_ciura_2020:37	-0.46	A	BBB+	A	training
InChI=1S/C20H24N2OS/c1-4-22(5-2)13-12-21-16-11-10-14(3)20-18(16)19(23)15-8-6-7-9-17(15)24-20/h6-11,21H,4-5,12-13H2,1-3H3	Lucanthone	1-[2-(diethylamino)ethylamino]-4-methylthioxanthen-9-one	CCN(CC)CCNc1ccc(C)c2sc3ccccc3c(=O)c12	10180.0	R23_gupta_2019:718			BBB-	C	training
InChI=1S/C20H24N2OS/c1-5-18(23)15-10-11-20-17(12-15)22(13-14(2)21(3)4)16-8-6-7-9-19(16)24-20/h6-12,14H,5,13H2,1-4H3	Propiomazine	1-[10-[2-(dimethylamino)propyl]phenothiazin-2-yl]propan-1-one	CCC(=O)c1ccc2c(c1)N(CC(C)N(C)C)c1ccccc1S2	4940.0	R6_adenot_2004:1614|R51_doninger_2002:297			BBB+	C	training
InChI=1S/C20H24N2S2/c1-21-9-11-22(12-10-21)18-13-15-5-3-4-6-19(15)24-20-8-7-16(23-2)14-17(18)20/h3-8,14,18H,9-13H2,1-2H3	Methiothepin	1-methyl-4-(3-methylsulfanyl-5,6-dihydrobenzo[b][1]benzothiepin-5-yl)piperazine	CSc1ccc2c(c1)C(N1CCN(C)CC1)Cc1ccccc1S2	4106.0	R6_adenot_2004:1535			BBB+	C	training
InChI=1S/C20H24N2S2/c1-23-16-8-9-20-18(13-16)22(12-10-15-5-4-11-21-14-15)17-6-2-3-7-19(17)24-20/h2-3,6-9,13,15,21H,4-5,10-12,14H2,1H3	Northioridazine|2-(Methylsulfanyl)-10-[2-(Piperidin-3-Yl)Ethyl]-10H-Phenothiazine	2-methylsulfanyl-10-(2-piperidin-3-ylethyl)phenothiazine	CSc1ccc2c(c1)N(CCC1CCCNC1)c1ccccc1S2	114376.0	R21_muehlbacher_2011:287|R41_toropov_2017:191|R46_mendoza_valencia_2017:289	0.75	B	BBB+	A	training
InChI=1S/C20H24N2S2/c1-23-16-9-10-20-18(14-16)22(13-11-15-6-4-5-12-21-15)17-7-2-3-8-19(17)24-20/h2-3,7-10,14-15,21H,4-6,11-13H2,1H3	10538-32-6|Northioridazine	2-methylsulfanyl-10-(2-piperidin-2-ylethyl)phenothiazine	CSc1ccc2c(c1)N(CCC1CCCCN1)c1ccccc1S2	558813.0	R4_mente_2005:159|R5_guerra_2008:74|R12_garg_2006:125|R26_chico_2009:287|R28_li_2005:101|R39_shayanfar_2011:117|R40_vilar_2010:166	0.76	B1	BBB+	A	test
InChI=1S/C20H24N4O2/c1-23(2)13-15-6-5-7-17(12-15)20-21-19(22-24(20)14-25-3)16-8-10-18(26-4)11-9-16/h5-12H,13-14H2,1-4H3	29|1-[3-[2-(Methoxymethyl)-5-(4-Methoxyphenyl)-1,2,4-Triazol-3-Yl]Phenyl]-N,N-Dimethylmethanamine	1-[3-[2-(methoxymethyl)-5-(4-methoxyphenyl)-1,2,4-triazol-3-yl]phenyl]-N,N-dimethylmethanamine	COCn1nc(-c2ccc(OC)cc2)nc1-c1cccc(CN(C)C)c1	21180375.0	R47_radchenko_2020:425	1.38	A	BBB+	A	training
InChI=1S/C20H24N4O2/c1-23(2)14-15-5-4-6-17(13-15)20-21-19(22-24(20)11-12-25)16-7-9-18(26-3)10-8-16/h4-10,13,25H,11-12,14H2,1-3H3	28|2-[5-[3-[(Dimethylamino)Methyl]Phenyl]-3-(4-Methoxyphenyl)-1,2,4-Triazol-1-Yl]Ethanol	2-[5-[3-[(dimethylamino)methyl]phenyl]-3-(4-methoxyphenyl)-1,2,4-triazol-1-yl]ethanol	COc1ccc(-c2nc(-c3cccc(CN(C)C)c3)n(CCO)n2)cc1	21180284.0	R47_radchenko_2020:424	0.71	A	BBB+	A	training
InChI=1S/C20H24N4O3S/c1-23(2)14-17-8-9-18(27-17)28-11-10-21-20-19(24(25)26)16(13-22-20)12-15-6-4-3-5-7-15/h3-9,13,21-22H,10-12,14H2,1-2H3	Bbcpd60		CN(C)Cc1ccc(SCCNc2[nH]cc(Cc3ccccc3)c2[N+](=O)[O-])o1		R3_abraham_2006:314|R41_toropov_2017:280	-0.73	B	BBB+	A	test
InChI=1S/C20H24O2/c1-12-10-14-15-4-5-18(22)20(15,3)9-7-16(14)19(2)8-6-13(21)11-17(12)19/h6,8,11,14-16H,1,4-5,7,9-10H2,2-3H3/t14-,15-,16-,19+,20-/m0/s1	Exemestane	(8R,9S,10R,13S,14S)-10,13-dimethyl-6-methylidene-7,8,9,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,17-dione	C=C1C[C@@H]2[C@H](CC[C@]3(C)C(=O)CC[C@@H]23)[C@@]2(C)C=CC(=O)C=C12	60198.0	R23_gupta_2019:590			BBB-	C	training
InChI=1S/C20H24O2/c1-3-20(22)11-9-18-17-6-4-13-12-14(21)5-7-15(13)16(17)8-10-19(18,20)2/h1,5,7,12,16-18,21-22H,4,6,8-11H2,2H3/t16-,17-,18+,19+,20+/m1/s1	Ethinyl Estradiol|Ethinylestradiol	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol	C#C[C@]1(O)CC[C@H]2[C@@H]3CCc4cc(O)ccc4[C@H]3CC[C@@]21C	5991.0	R7_andres_2006:59|R14_ghose_2012:539|R29_subramanian_2003:57|R51_doninger_2002:54			BBB-	C	training
InChI=1S/C20H25ClN2O/c21-17-5-2-14(3-6-17)19-15-1-4-16(13-15)20(19)8-7-18(22-20)23-9-11-24-12-10-23/h2-3,5-6,15-16,19H,1,4,7-13H2/t15-,16+,19+,20+/m0/s1	Spiclamine	4-[(1'R,3'S,4'S,5R)-3'-(4-chlorophenyl)spiro[3,4-dihydropyrrole-5,2'-bicyclo[2.2.1]heptane]-2-yl]morpholine	Clc1ccc([C@@H]2[C@H]3CC[C@H](C3)[C@]23CCC(N2CCOCC2)=N3)cc1	75124296.0	R6_adenot_2004:610			BBB+	C	training
InChI=1S/C20H25ClN2O2/c1-24-19-8-7-16(15-20(19)25-2)9-10-22-11-13-23(14-12-22)18-6-4-3-5-17(18)21/h3-8,15H,9-14H2,1-2H3	Mefeclorazine	1-(2-chlorophenyl)-4-[2-(3,4-dimethoxyphenyl)ethyl]piperazine	COc1ccc(CCN2CCN(c3ccccc3Cl)CC2)cc1OC	3064105.0	R6_adenot_2004:1174			BBB+	C	training
InChI=1S/C20H25ClN4OS/c21-16-14-19-20(22-15-16)25(17-4-1-2-5-18(17)27-19)7-3-6-23-8-10-24(11-9-23)12-13-26/h1-2,4-5,14-15,26H,3,6-13H2	Cloxypendyl	2-[4-[3-(3-chloropyrido[3,2-b][1,4]benzothiazin-10-yl)propyl]piperazin-1-yl]ethanol	OCCN1CCN(CCCN2c3ccccc3Sc3cc(Cl)cnc32)CC1	65615.0	R6_adenot_2004:1142			BBB+	C	training
InChI=1S/C20H25FN4O/c1-16(23-20(26)17-3-2-9-22-15-17)8-10-24-11-13-25(14-12-24)19-6-4-18(21)5-7-19/h2-7,9,15-16H,8,10-14H2,1H3,(H,23,26)	Niaprazine	N-[4-[4-(4-fluorophenyl)piperazin-1-yl]butan-2-yl]pyridine-3-carboxamide	CC(CCN1CCN(c2ccc(F)cc2)CC1)NC(=O)c1cccnc1	71919.0	R6_adenot_2004:1335			BBB+	C	test
InChI=1S/C20H25FN8O6S2/c1-3-29(2,7-11(22)30)6-4-5-10-8-36-18-13(17(32)28(18)14(10)19(33)34)24-16(31)12(26-35-9-21)15-25-20(23)37-27-15/h4-5,13,18H,3,6-9H2,1-2H3,(H5-,22,23,24,25,27,30,31,33,34)/b5-4+,26-12+/t13-,18-,29?/m1/s1	Cefluprenam	(6R,7R)-3-[(E)-3-[(2-amino-2-oxoethyl)-ethyl-methylazaniumyl]prop-1-enyl]-7-[[(2Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-(fluoromethoxyimino)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate	CC[N+](C)(C/C=C/C1=C(C(=O)[O-])N2C(=O)[C@@H](NC(=O)/C(=N\OCF)c3nsc(N)n3)[C@H]2SC1)CC(N)=O	6536774.0	R6_adenot_2004:222			BBB-	C	training
InChI=1S/C20H25N3O2/c1-3-14(11-24)22-20(25)13-7-16-15-5-4-6-17-19(15)12(9-21-17)8-18(16)23(2)10-13/h4-7,9,13-14,18,21,24H,3,8,10-11H2,1-2H3,(H,22,25)/t13-,14+,18-/m1/s1	Methylergonovine	(6aR,9R)-N-[(2S)-1-hydroxybutan-2-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide	CC[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1	8226.0	R14_ghose_2012:689			BBB-	C	training
InChI=1S/C20H25N3S/c1-21-13-15-22(16-14-21)11-6-12-23-17-7-2-4-9-19(17)24-20-10-5-3-8-18(20)23/h2-5,7-10H,6,11-16H2,1H3	Perazine	10-[3-(4-methylpiperazin-1-yl)propyl]phenothiazine	CN1CCN(CCCN2c3ccccc3Sc3ccccc32)CC1	4744.0	R50_sobanska_2019:91			BBB+	C	training
InChI=1S/C20H25N5O7S2/c1-9-6-33-16-12(23-14(26)11(24-30-5)10-7-34-19(21)22-10)15(27)25(16)13(9)17(28)31-8-32-18(29)20(2,3)4/h7,12,16H,6,8H2,1-5H3,(H2,21,22)(H,23,26)/b24-11+/t12-,16-/m1/s1	Cefetamet Pivoxil	2,2-dimethylpropanoyloxymethyl (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate	CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)OCOC(=O)C(C)(C)C)=C(C)CS[C@H]12)c1csc(N)n1	5486182.0	R23_gupta_2019:1049			BBB-	C	training
InChI=1S/C20H25N5O7S2/c1-9-6-33-16-12(23-14(26)11(24-30-5)10-7-34-19(21)22-10)15(27)25(16)13(9)17(28)31-8-32-18(29)20(2,3)4/h7,12,16H,6,8H2,1-5H3,(H2,21,22)(H,23,26)/b24-11-/t12-,16-/m1/s1	Cefetamet Pivoxil|Cefetametpivoxil|Cefetamet Pivoxyl	2,2-dimethylpropanoyloxymethyl (6R,7R)-7-[[(2E)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate	CO/N=C(/C(=O)N[C@@H]1C(=O)N2C(C(=O)OCOC(=O)C(C)(C)C)=C(C)CS[C@H]12)c1csc(N)n1	5485222.0	R7_andres_2006:26|R29_subramanian_2003:27			BBB-	C	training
InChI=1S/C20H25N7O2/c1-13-10-26(12-17-21-5-2-6-22-17)11-16(13)18-24-19-15(20(28)25-18)9-23-27(19)14-3-7-29-8-4-14/h2,5-6,9,13-14,16H,3-4,7-8,10-12H2,1H3,(H,24,25,28)/t13-,16-/m1/s1	Pf-4447943|6-((3S,4S)-4-Methyl-1-(Pyrimidin-2-Ylmethyl)Pyrrolidin-3-Yl)-1-(Tetrahydro-2H-Pyran-4-Yl)-1,5-Dihydro-4H-Pyrazolo(3,4-D)Pyrimidin-4-One	6-[(3S,4S)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-1-(oxan-4-yl)-5H-pyrazolo[3,4-d]pyrimidin-4-one	C[C@@H]1CN(Cc2ncccn2)C[C@H]1c1nc2c(cnn2C2CCOCC2)c(=O)[nH]1	135564558.0	R47_radchenko_2020:512	-0.4	A	BBB+	A	test
InChI=1S/C20H25NO/c1-19(2)17-12-7-8-13-18(17)20(22-19,14-9-15-21-3)16-10-5-4-6-11-16/h4-8,10-13,21H,9,14-15H2,1-3H3	Talopram	3-(3,3-dimethyl-1-phenyl-2-benzofuran-1-yl)-N-methylpropan-1-amine	CNCCCC1(c2ccccc2)OC(C)(C)c2ccccc21	23573.0	R6_adenot_2004:613			BBB+	C	training
InChI=1S/C20H25NO/c1-2-3-4-11-16-21-20(22)19(17-12-7-5-8-13-17)18-14-9-6-10-15-18/h5-10,12-15,19H,2-4,11,16H2,1H3,(H,21,22)	22|N-Hexyl-2,2-Diphenylacetamide	N-hexyl-2,2-diphenylacetamide	CCCCCCNC(=O)C(c1ccccc1)c1ccccc1	4080062.0	R47_radchenko_2020:446	0.74	A	BBB+	A	training
InChI=1S/C20H25NO/c1-4-19(22)20(15-16-21(2)3,17-11-7-5-8-12-17)18-13-9-6-10-14-18/h5-14H,4,15-16H2,1-3H3	Normethadone	6-(dimethylamino)-4,4-diphenylhexan-3-one	CCC(=O)C(CCN(C)C)(c1ccccc1)c1ccccc1	10090.0	R6_adenot_2004:1069			BBB+	C	training
InChI=1S/C20H25NO2/c1-19-8-6-16-15-5-3-14(22)12-13(15)2-4-17(16)18(19)7-9-20(19,23)10-11-21/h12,17-18,23H,2-10H2,1H3/t17-,18+,19+,20-/m1/s1	Dienogest	2-[(8S,13S,14S,17R)-17-hydroxy-13-methyl-3-oxo-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl]acetonitrile	C[C@]12CCC3=C4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@@]2(O)CC#N	68861.0	R23_gupta_2019:522			BBB-	C	training
InChI=1S/C20H25NO2/c1-21-13-12-20(16-6-4-3-5-7-16)17(14-21)15-23-19-10-8-18(22-2)9-11-19/h3-11,17,20H,12-15H2,1-2H3/t17-,20-/m1/s1	Femoxetine	(3R,4S)-3-[(4-methoxyphenoxy)methyl]-1-methyl-4-phenylpiperidine	COc1ccc(OC[C@H]2CN(C)CC[C@@H]2c2ccccc2)cc1	3012003.0	R6_adenot_2004:540			BBB+	C	test
InChI=1S/C20H25NO2/c1-4-14-11-17-12-16(7-10-19(17)21-13(14)2)20(22)15-5-8-18(23-3)9-6-15/h7,10-12,15,18H,4-6,8-9H2,1-3H3	(3-Ethyl-2-Methylquinolin-6-Yl)-(4-Methoxycyclohexyl)Methanone	(3-ethyl-2-methylquinolin-6-yl)-(4-methoxycyclohexyl)methanone	CCc1cc2cc(C(=O)C3CCC(OC)CC3)ccc2nc1C	9948645.0	R47_radchenko_2020:441	0.33	A	BBB+	A	training
InChI=1S/C20H25NO2/c22-15-6-7-16-17-10-14-2-1-3-18(23)19(14)20(16,11-15)8-9-21(17)12-13-4-5-13/h1-3,13,16-17,23H,4-12H2/t16-,17+,20-/m0/s1	Ketorfanol	(1S,9R,10R)-17-(cyclopropylmethyl)-3-hydroxy-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-trien-13-one	O=C1CC[C@H]2[C@H]3Cc4cccc(O)c4[C@@]2(CCN3CC2CC2)C1	5490677.0	R6_adenot_2004:1099			BBB+	C	training
InChI=1S/C20H25NO2S2/c1-14-7-11-24-18(14)17(19-15(2)8-12-25-19)6-4-10-21-9-3-5-16(13-21)20(22)23/h6-8,11-12,16H,3-5,9-10,13H2,1-2H3,(H,22,23)/t16-/m1/s1	Tiagabine|Tigabine	(3R)-1-[4,4-bis(3-methylthiophen-2-yl)but-3-enyl]piperidine-3-carboxylic acid	Cc1ccsc1C(=CCCN1CCC[C@@H](C(=O)O)C1)c1sccc1C	60648.0	R6_adenot_2004:1496|R7_andres_2006:172|R14_ghose_2012:249|R23_gupta_2019:316|R26_chico_2009:418|R29_subramanian_2003:167|R34_broccatelli_2012:152|R37_chen_2011:97			BBB+	C	training
InChI=1S/C20H25NO3/c1-3-21(4-2)15-16-24-19(22)20(23,17-11-7-5-8-12-17)18-13-9-6-10-14-18/h5-14,23H,3-4,15-16H2,1-2H3	Benactyzine	2-(diethylamino)ethyl 2-hydroxy-2,2-diphenylacetate	CCN(CC)CCOC(=O)C(O)(c1ccccc1)c1ccccc1	9330.0	R6_adenot_2004:1419|R51_doninger_2002:158			BBB+	C	training
InChI=1S/C20H25NS/c1-19(2)17-12-7-8-13-18(17)20(22-19,14-9-15-21-3)16-10-5-4-6-11-16/h4-8,10-13,21H,9,14-15H2,1-3H3	Talsupram	3-(3,3-dimethyl-1-phenyl-2-benzothiophen-1-yl)-N-methylpropan-1-amine	CNCCCC1(c2ccccc2)SC(C)(C)c2ccccc21	33014.0	R6_adenot_2004:614|R25_brito_sanchez_2015:147|R46_mendoza_valencia_2017:144	0.22	B	BBB+	A	test
InChI=1S/C20H26ClNO3/c21-17-1-3-18(4-2-17)25-13-19(23)24-6-5-22-20-10-14-7-15(11-20)9-16(8-14)12-20/h1-4,14-16,22H,5-13H2	Adafenoxate	2-(1-adamantylamino)ethyl 2-(4-chlorophenoxy)acetate	O=C(COc1ccc(Cl)cc1)OCCNC12CC3CC(CC(C3)C1)C2	64517.0	R6_adenot_2004:1240			BBB+	C	training
InChI=1S/C20H26F3N3O3/c1-14(27)25-8-9-26(17(12-25)11-24-7-6-18(28)13-24)19(29)10-15-2-4-16(5-3-15)20(21,22)23/h2-5,17-18,28H,6-13H2,1H3/t17-,18+/m0/s1	Gr94839_A|1-[(2S)-4-Acetyl-2-[[(3R)-3-Hydroxypyrrolidin-1-Yl]Methyl]Piperazin-1-Yl]-2-[4-(Trifluoromethyl)Phenyl]Ethanone	1-[(2S)-4-acetyl-2-[[(3R)-3-hydroxypyrrolidin-1-yl]methyl]piperazin-1-yl]-2-[4-(trifluoromethyl)phenyl]ethanone	CC(=O)N1CCN(C(=O)Cc2ccc(C(F)(F)F)cc2)[C@@H](CN2CC[C@@H](O)C2)C1	44310838.0	R28_li_2005:365			BBB-	C	training
InChI=1S/C20H26N2/c1-16(14-21(2)3)15-22-19-10-6-4-8-17(19)12-13-18-9-5-7-11-20(18)22/h4-11,16H,12-15H2,1-3H3	Trimipramine	3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N,N,2-trimethylpropan-1-amine	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	5584.0	R6_adenot_2004:1633|R14_ghose_2012:263|R23_gupta_2019:257|R25_brito_sanchez_2015:428|R26_chico_2009:435|R34_broccatelli_2012:94|R46_mendoza_valencia_2017:360|R51_doninger_2002:321	0.99	B	BBB+	A	training
InChI=1S/C20H26N2/c1-20(2)16-10-5-7-12-18(16)22(15-9-14-21(3)4)19-13-8-6-11-17(19)20/h5-8,10-13H,9,14-15H2,1-4H3	Dimetacrine	3-(9,9-dimethylacridin-10-yl)-N,N-dimethylpropan-1-amine	CN(C)CCCN1c2ccccc2C(C)(C)c2ccccc21	94280.0	R6_adenot_2004:529			BBB+	C	training
InChI=1S/C20H26N2O/c1-3-15-14-21-11-9-16(15)5-4-6-17-10-12-22-20-8-7-18(23-2)13-19(17)20/h3,7-8,10,12-13,15-16,21H,1,4-6,9,11,14H2,2H3/t15-,16+/m0/s1	Viqualine	4-[3-[(3R,4R)-3-ethenylpiperidin-4-yl]propyl]-6-methoxyquinoline	C=C[C@H]1CNCC[C@H]1CCCc1ccnc2ccc(OC)cc12	3050111.0	R6_adenot_2004:634			BBB+	C	training
InChI=1S/C20H26N2O/c1-3-15-14-21-11-9-16(15)5-4-6-17-10-12-22-20-8-7-18(23-2)13-19(17)20/h3,7-8,10,12-13,15-16,21H,1,4-6,9,11,14H2,2H3/t15-,16-/m1/s1	Ivoqualine	4-[3-[(3S,4R)-3-ethenylpiperidin-4-yl]propyl]-6-methoxyquinoline	C=C[C@@H]1CNCC[C@H]1CCCc1ccnc2ccc(OC)cc12	3038482.0	R6_adenot_2004:562			BBB+	C	training
InChI=1S/C20H26N2O2/c1-3-10-11-8-14-17-20(12-6-4-5-7-13(12)21(17)2)9-15(16(11)18(20)23)22(14)19(10)24/h4-7,10-11,14-19,23-24H,3,8-9H2,1-2H3/t10-,11-,14-,15-,16-,17-,18+,19+,20+/m0/s1	Ajmaline	(1R,9R,10S,12R,13S,14R,16S,17S,18R)-13-ethyl-8-methyl-8,15-diazahexacyclo[14.2.1.01,9.02,7.010,15.012,17]nonadeca-2,4,6-triene-14,18-diol	CC[C@H]1[C@@H]2C[C@H]3[C@@H]4N(C)c5ccccc5[C@]45C[C@@H]([C@H]2[C@H]5O)N3[C@@H]1O	6100671.0	R23_gupta_2019:329			BBB-	C	test
InChI=1S/C20H26N2O3S/c1-25-19-11-10-17(26(2,23)24)13-16(19)14-22-18-9-6-12-21-20(18)15-7-4-3-5-8-15/h3-5,7-8,10-11,13,18,20-22H,6,9,12,14H2,1-2H3	145741-95-3|Pfizer Compound 12|N-[(2-Methoxy-5-Methylsulfonylphenyl)Methyl]-2-Phenylpiperidin-3-Amine	N-[(2-methoxy-5-methylsulfonylphenyl)methyl]-2-phenylpiperidin-3-amine	COc1ccc(S(C)(=O)=O)cc1CNC1CCCNC1c1ccccc1	19696721.0	R4_mente_2005:87|R25_brito_sanchez_2015:538|R40_vilar_2010:185|R46_mendoza_valencia_2017:449|R47_radchenko_2020:408	-0.15	B	BBB+	A	test
InChI=1S/C20H26N2O4/c23-18-11-20(7-3-4-8-20)12-19(24)22(18)10-9-21-13-15-14-25-16-5-1-2-6-17(16)26-15/h1-2,5-6,15,21H,3-4,7-14H2	Binospirone	8-[2-(2,3-dihydro-1,4-benzodioxin-3-ylmethylamino)ethyl]-8-azaspiro[4.5]decane-7,9-dione	O=C1CC2(CCCC2)CC(=O)N1CCNCC1COc2ccccc2O1	60769.0	R6_adenot_2004:1481			BBB+	C	test
InChI=1S/C20H26N2S/c1-5-16-10-11-20-18(12-16)22(14-15(2)13-21(3)4)17-8-6-7-9-19(17)23-20/h6-12,15H,5,13-14H2,1-4H3	Etymemazine	3-(2-ethylphenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine	CCc1ccc2c(c1)N(CC(C)CN(C)C)c1ccccc1S2	71823.0	R6_adenot_2004:1569|R51_doninger_2002:216			BBB+	C	training
InChI=1S/C20H26N4O/c1-4-24(5-2)20(25)22-14-10-16-15-7-6-8-17-19(15)13(11-21-17)9-18(16)23(3)12-14/h6-8,10-11,14,18,21H,4-5,9,12H2,1-3H3,(H,22,25)/t14-,18+/m0/s1	Lisuride|Lysuride	3-[(6aR,9S)-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinolin-9-yl]-1,1-diethylurea	CCN(CC)C(=O)N[C@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1	28864.0	R6_adenot_2004:992|R14_ghose_2012:130|R26_chico_2009:241			BBB+	C	training
InChI=1S/C20H26N4O5S/c1-14-13-18(23-29-14)19(25)21-12-11-15-7-9-17(10-8-15)30(27,28)24-20(26)22-16-5-3-2-4-6-16/h7-10,13,16H,2-6,11-12H2,1H3,(H,21,25)(H2,22,24,26)	Glisolamide	N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-5-methyl-1,2-oxazole-3-carboxamide	Cc1cc(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)NC3CCCCC3)cc2)no1	65713.0	R14_ghose_2012:594			BBB-	C	training
InChI=1S/C20H26O2/c1-3-20(22)11-9-18-17-6-4-13-12-14(21)5-7-15(13)16(17)8-10-19(18,20)2/h1,12,15-18,22H,4-11H2,2H3/t15-,16+,17+,18-,19-,20-/m0/s1	Norethindrone	(8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one	C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21C	6230.0	R14_ghose_2012:728|R51_doninger_2002:98			BBB-	C	training
InChI=1S/C20H27Cl2N3O3/c1-2-28-20(27)24-9-10-25(16(14-24)13-23-7-3-4-8-23)19(26)12-15-5-6-17(21)18(22)11-15/h5-6,11,16H,2-4,7-10,12-14H2,1H3/t16-/m0/s1	Gr89696_Et|Ethyl (3S)-4-[2-(3,4-Dichlorophenyl)Acetyl]-3-(Pyrrolidin-1-Ylmethyl)Piperazine-1-Carboxylate	ethyl (3S)-4-[2-(3,4-dichlorophenyl)acetyl]-3-(pyrrolidin-1-ylmethyl)piperazine-1-carboxylate	CCOC(=O)N1CCN(C(=O)Cc2ccc(Cl)c(Cl)c2)[C@@H](CN2CCCC2)C1	44310754.0	R28_li_2005:361			BBB+	C	training
InChI=1S/C20H27F3N6OS/c1-19(2,3)17-25-14(20(21,22)23)13-15(26-17)29-10-8-28(9-11-29)7-4-12-31-18-24-6-5-16(30)27-18/h5-6,13H,4,7-12H2,1-3H3,(H,24,27,30)	364079-69-6|Lu-201640|Abt-925 Anhydrous Free Base	2-[3-[4-[2-tert-butyl-6-(trifluoromethyl)pyrimidin-4-yl]piperazin-1-yl]propylsulfanyl]-1H-pyrimidin-6-one	CC(C)(C)c1nc(N2CCN(CCCSc3nccc(=O)[nH]3)CC2)cc(C(F)(F)F)n1	9916104.0	R4_mente_2005:73|R25_brito_sanchez_2015:534|R40_vilar_2010:140|R47_radchenko_2020:381	0.3	B	BBB+	A	training
InChI=1S/C20H27N3O/c1-4-13-23(14-5-1)17-18-8-6-9-19(16-18)24-15-7-12-22-20-10-2-3-11-21-20/h2-3,6,8-11,16H,1,4-5,7,12-15,17H2,(H,21,22)	Skb36|Bbcpd23|104076-40-6|Chebi: 338033|B-063|27|19|2-Pyridinamine, N-[3-[3-(1-Piperidinylmethyl)Phenoxy]Propyl]-	N-[3-[3-(piperidin-1-ylmethyl)phenoxy]propyl]pyridin-2-amine	c1ccc(NCCCOc2cccc(CN3CCCCC3)c2)nc1	10019237.0	R3_abraham_2006:271|R3_abraham_2006:320|R4_mente_2005:136|R12_garg_2006:38|R21_muehlbacher_2011:334|R25_brito_sanchez_2015:20|R26_chico_2009:62|R28_li_2005:164|R40_vilar_2010:46|R41_toropov_2017:243|R41_toropov_2017:284|R46_mendoza_valencia_2017:20|R47_radchenko_2020:226|R48_hou_2003:101|R49_norinder_2002:27|R49_norinder_2002:178|R52_liu_2001:27	0.69	B	BBB+	A	training
InChI=1S/C20H27N3O6/c1-3-5-11-28-13-15(29-18(21)26)12-23-17(25)20(4-2,16(24)22-19(23)27)14-9-7-6-8-10-14/h6-10,15H,3-5,11-13H2,1-2H3,(H2,21,26)(H,22,24,27)	Febarbamate	[1-butoxy-3-(5-ethyl-2,4,6-trioxo-5-phenyl-1,3-diazinan-1-yl)propan-2-yl] carbamate	CCCCOCC(CN1C(=O)NC(=O)C(CC)(c2ccccc2)C1=O)OC(N)=O	25803.0	R6_adenot_2004:1650			BBB+	C	training
InChI=1S/C20H27N3O6/c1-4-29-19(27)15(11-10-14-8-6-5-7-9-14)21-13(2)17(24)23-16(18(25)26)12-22(3)20(23)28/h5-9,13,15-16,21H,4,10-12H2,1-3H3,(H,25,26)/t13-,15-,16-/m0/s1	Imidapril Hydrochloride|Imidapril	(4S)-3-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-1-methyl-2-oxoimidazolidine-4-carboxylic acid	CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1C(=O)N(C)C[C@H]1C(=O)O	5464343.0	R23_gupta_2019:1066			BBB-	C	training
InChI=1S/C20H27N5O2/c26-20-12-9-15-14-17(10-11-18(15)21-20)27-13-5-4-8-19-22-23-24-25(19)16-6-2-1-3-7-16/h10-11,14,16H,1-9,12-13H2,(H,21,26)	Cilostazol	6-[4-(1-cyclohexyltetrazol-5-yl)butoxy]-3,4-dihydro-1H-quinolin-2-one	O=C1CCc2cc(OCCCCc3nnnn3C3CCCCC3)ccc2N1	2754.0	R14_ghose_2012:450|R23_gupta_2019:460			BBB-	C	training
InChI=1S/C20H27N5O5S/c1-15-14-18(23-30-15)19(26)21-11-10-16-6-8-17(9-7-16)31(28,29)24-20(27)22-25-12-4-2-3-5-13-25/h6-9,14H,2-5,10-13H2,1H3,(H,21,26)(H2,22,24,27)	Glisoxepide	N-[2-[4-(azepan-1-ylcarbamoylsulfamoyl)phenyl]ethyl]-5-methyl-1,2-oxazole-3-carboxamide	Cc1cc(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)NN3CCCCCC3)cc2)no1	32778.0	R14_ghose_2012:595|R23_gupta_2019:638			BBB-	C	training
InChI=1S/C20H27NO2/c22-16-6-5-15-11-18-20(23)8-2-1-7-19(20,17(15)12-16)9-10-21(18)13-14-3-4-14/h5-6,12,14,18,22-23H,1-4,7-11,13H2/t18-,19+,20-/m1/s1	Oxilorphan	(1S,9R,10S)-17-(cyclopropylmethyl)-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene-4,10-diol	Oc1ccc2c(c1)[C@@]13CCCC[C@@]1(O)[C@@H](C2)N(CC1CC1)CC3	5361090.0	R6_adenot_2004:1072			BBB+	C	training
InChI=1S/C20H27NO3/c1-18-7-6-14-12(13(18)3-4-15(18)22)5-8-20-17(24-20)16(23)11(10-21)9-19(14,20)2/h12-15,17,22-23H,3-9H2,1-2H3/t12-,13-,14-,15-,17+,18-,19+,20+/m0/s1	Trilostane	(1S,2R,6R,8S,11S,12S,15S,16S)-5,15-dihydroxy-2,16-dimethyl-7-oxapentacyclo[9.7.0.02,8.06,8.012,16]octadec-4-ene-4-carbonitrile	C[C@]12CC[C@H]3[C@@H](CC[C@@]45O[C@@H]4C(O)=C(C#N)C[C@]35C)[C@@H]1CC[C@@H]2O	656583.0	R14_ghose_2012:918			BBB-	C	test
InChI=1S/C20H27NO4/c1-15-5-4-6-18(11-15)25-14-17(22)13-21-10-9-16-7-8-19(23-2)20(12-16)24-3/h4-8,11-12,17,21-22H,9-10,13-14H2,1-3H3	Bevantolol	1-[2-(3,4-dimethoxyphenyl)ethylamino]-3-(3-methylphenoxy)propan-2-ol	COc1ccc(CCNCC(O)COc2cccc(C)c2)cc1OC	2372.0	R14_ghose_2012:394			BBB-	C	training
InChI=1S/C20H28Cl2N2O/c1-20(2)7-10-24(16(13-20)14-23-8-3-4-9-23)19(25)12-15-5-6-17(21)18(22)11-15/h5-6,11,16H,3-4,7-10,12-14H2,1-2H3/t16-/m1/s1	Brl53087|2-(3,4-Dichlorophenyl)-1-[(2R)-4,4-Dimethyl-2-(Pyrrolidin-1-Ylmethyl)Piperidin-1-Yl]Ethanone	2-(3,4-dichlorophenyl)-1-[(2R)-4,4-dimethyl-2-(pyrrolidin-1-ylmethyl)piperidin-1-yl]ethanone	CC1(C)CCN(C(=O)Cc2ccc(Cl)c(Cl)c2)[C@@H](CN2CCCC2)C1	44310254.0	R28_li_2005:333			BBB+	C	training
InChI=1S/C20H28N/c1-5-21(3,4)17(2)16-20(18-12-8-6-9-13-18)19-14-10-7-11-15-19/h6-15,17,20H,5,16H2,1-4H3/q+1	Emepronium Carragheenate|Emepronium	4,4-diphenylbutan-2-yl-ethyl-dimethylazanium	CC[N+](C)(C)C(C)CC(c1ccccc1)c1ccccc1	34055.0	R6_adenot_2004:105|R14_ghose_2012:522			BBB-	C	training
InChI=1S/C20H28N2O3/c1-22-14-8-13-21-18(22)15-25-19(23)20(24,16-9-4-2-5-10-16)17-11-6-3-7-12-17/h2,4-5,9-10,17,24H,3,6-8,11-15H2,1H3	Oxyphencyclimine Hydrochloride|Oxyphencyclimine	(1-methyl-5,6-dihydro-4H-pyrimidin-2-yl)methyl 2-cyclohexyl-2-hydroxy-2-phenylacetate	CN1CCCN=C1COC(=O)C(O)(c1ccccc1)C1CCCCC1	4642.0	R14_ghose_2012:749			BBB-	C	training
InChI=1S/C20H28N2O5/c1-3-27-20(26)16(12-11-15-8-5-4-6-9-15)21-14(2)18(23)22-13-7-10-17(22)19(24)25/h4-6,8-9,14,16-17,21H,3,7,10-13H2,1-2H3,(H,24,25)/t14-,16-,17-/m0/s1	Enalapril	(2S)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]pyrrolidine-2-carboxylic acid	CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)O	5388962.0	R14_ghose_2012:524|R23_gupta_2019:556|R28_li_2005:197|R50_sobanska_2019:49			BBB-	C	training
InChI=1S/C20H28N2O5/c1-4-17(23)22(16-8-6-5-7-9-16)20(19(25)27-3)11-14-21(15-12-20)13-10-18(24)26-2/h5-9H,4,10-15H2,1-3H3	Remifentanil	methyl 1-(3-methoxy-3-oxopropyl)-4-(N-propanoylanilino)piperidine-4-carboxylate	CCC(=O)N(c1ccccc1)C1(C(=O)OC)CCN(CCC(=O)OC)CC1	60815.0	R6_adenot_2004:1039|R14_ghose_2012:221|R23_gupta_2019:217|R26_chico_2009:346|R37_chen_2011:82			BBB+	C	training
InChI=1S/C20H28N2O5S/c1-4-26-17-7-5-6-8-18(17)27-12-11-22-15(2)13-16-9-10-19(25-3)20(14-16)28(21,23)24/h5-10,14-15,22H,4,11-13H2,1-3H3,(H2,21,23,24)/t15-/m1/s1	Tamsulosin Hydrochloride|Tamsulosin	5-[(2R)-2-[2-(2-ethoxyphenoxy)ethylamino]propyl]-2-methoxybenzenesulfonamide	CCOc1ccccc1OCCN[C@H](C)Cc1ccc(OC)c(S(N)(=O)=O)c1	129211.0	R14_ghose_2012:875			BBB-	C	training
InChI=1S/C20H28N4O/c1-4-24(5-2)20(25)22-14-10-16-15-7-6-8-17-19(15)13(11-21-17)9-18(16)23(3)12-14/h6-8,11,14,16,18,21H,4-5,9-10,12H2,1-3H3,(H,22,25)/t14-,16+,18+/m0/s1	Terguride	3-[(6aR,9S,10aR)-7-methyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinolin-9-yl]-1,1-diethylurea	CCN(CC)C(=O)N[C@H]1C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1	443951.0	R6_adenot_2004:921|R37_chen_2011:95			BBB+	C	test
InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)	3,7-Dimethyl-9-(2,6,6-Trimethylcyclohex-1-En-1-Yl)Nona-2,4,6,8-Tetraenoic Acid	3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoic acid	CC(C=CC1=C(C)CCCC1(C)C)=CC=CC(C)=CC(=O)O	5538.0	R46_mendoza_valencia_2017:340	-0.49	A	BBB+	A	training
InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+	Tretinoin	(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoic acid	CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C(=O)O)C(C)(C)CCC1	444795.0	R21_muehlbacher_2011:136|R25_brito_sanchez_2015:400|R47_radchenko_2020:349	-0.49	B	BBB+	A	training
InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14-	Isotretinoin	(2Z,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoic acid	CC1=C(/C=C/C(C)=C/C=C/C(C)=C\C(=O)O)C(C)(C)CCC1	5282379.0	R7_andres_2006:86|R14_ghose_2012:633|R29_subramanian_2003:80|R40_vilar_2010:132	-0.49	A	BBB+	A	training
InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8-,16-14+	Alitretinoin	(2E,4E,6Z,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoic acid	CC1=C(/C=C/C(C)=C\C=C\C(C)=C\C(=O)O)C(C)(C)CCC1	449171.0	R23_gupta_2019:334			BBB-	C	training
InChI=1S/C20H28O5S/c1-12(2)14-10-13-6-7-17-19(3,8-5-9-20(17,4)18(21)22)15(13)11-16(14)26(23,24)25/h10-12,17H,5-9H2,1-4H3,(H,21,22)(H,23,24,25)/t17-,19-,20-/m1/s1	Ecabet	(1R,4aS,10aR)-1,4a-dimethyl-7-propan-2-yl-6-sulfo-2,3,4,9,10,10a-hexahydrophenanthrene-1-carboxylic acid	CC(C)c1cc2c(cc1S(=O)(=O)O)[C@@]1(C)CCC[C@@](C)(C(=O)O)[C@@H]1CC2	65781.0	R23_gupta_2019:545			BBB-	C	training
InChI=1S/C20H29Cl2N3O/c1-15(26)23-17-7-5-16(6-8-17)9-10-24-11-13-25(14-12-24)19-4-2-3-18(21)20(19)22/h2-4,16-17H,5-14H2,1H3,(H,23,26)	Piperazinederivatives 6|N-[4-[2-[4-(2,3-Dichlorophenyl)Piperazin-1-Yl]Ethyl]Cyclohexyl]Acetamide	N-[4-[2-[4-(2,3-dichlorophenyl)piperazin-1-yl]ethyl]cyclohexyl]acetamide	CC(=O)NC1CCC(CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1	70683582.0	R47_radchenko_2020:318	1.08	A	BBB+	A	training
InChI=1S/C20H29FN6O3/c1-4-25-20(29)26(23-22-25)12-11-24-10-9-17(15(2)13-24)27(19(28)14-30-3)18-8-6-5-7-16(18)21/h5-8,15,17H,4,9-14H2,1-3H3/t15-,17+/m1/s1	Brifentanil	N-[(3R,4S)-1-[2-(4-ethyl-5-oxotetrazol-1-yl)ethyl]-3-methylpiperidin-4-yl]-N-(2-fluorophenyl)-2-methoxyacetamide	CCn1nnn(CCN2CC[C@H](N(C(=O)COC)c3ccccc3F)[C@H](C)C2)c1=O	60672.0	R6_adenot_2004:999			BBB+	C	training
InChI=1S/C20H29FO3/c1-17-8-6-13(22)10-12(17)4-5-15-14-7-9-19(3,24)18(14,2)11-16(23)20(15,17)21/h10,14-16,23-24H,4-9,11H2,1-3H3/t14-,15-,16-,17-,18-,19-,20-/m0/s1	Fluoxymesterone	(8S,9R,10S,11S,13S,14S,17S)-9-fluoro-11,17-dihydroxy-10,13,17-trimethyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one	C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C	6446.0	R14_ghose_2012:570			BBB-	C	training
InChI=1S/C20H29N3O2/c1-4-7-14-25-19-15-17(16-10-8-9-11-18(16)22-19)20(24)21-12-13-23(5-2)6-3/h8-11,15H,4-7,12-14H2,1-3H3,(H,21,24)	Dibucaine	2-butoxy-N-[2-(diethylamino)ethyl]quinoline-4-carboxamide	CCCCOc1cc(C(=O)NCCN(CC)CC)c2ccccc2n1	3025.0	R23_gupta_2019:515			BBB-	C	training
InChI=1S/C20H29N3O3S/c1-15(24)22-9-10-23(17(13-22)12-21-8-7-18(25)14-21)20(26)11-16-3-5-19(27-2)6-4-16/h3-6,17-18,25H,7-14H2,1-2H3/t17-,18+/m0/s1	Gr94839_B|1-[(2S)-4-Acetyl-2-[[(3R)-3-Hydroxypyrrolidin-1-Yl]Methyl]Piperazin-1-Yl]-2-(4-Methylsulfanylphenyl)Ethanone	1-[(2S)-4-acetyl-2-[[(3R)-3-hydroxypyrrolidin-1-yl]methyl]piperazin-1-yl]-2-(4-methylsulfanylphenyl)ethanone	CSc1ccc(CC(=O)N2CCN(C(C)=O)C[C@@H]2CN2CC[C@@H](O)C2)cc1	44310513.0	R28_li_2005:366			BBB-	C	training
InChI=1S/C20H29N3O4/c1-15(24)22-8-9-23(17(13-22)12-21-7-6-18(25)14-21)20(26)11-16-4-3-5-19(10-16)27-2/h3-5,10,17-18,25H,6-9,11-14H2,1-2H3/t17-,18+/m0/s1	Gr94839_D|1-[(2S)-4-Acetyl-2-[[(3R)-3-Hydroxypyrrolidin-1-Yl]Methyl]Piperazin-1-Yl]-2-(3-Methoxyphenyl)Ethanone	1-[(2S)-4-acetyl-2-[[(3R)-3-hydroxypyrrolidin-1-yl]methyl]piperazin-1-yl]-2-(3-methoxyphenyl)ethanone	COc1cccc(CC(=O)N2CCN(C(C)=O)C[C@@H]2CN2CC[C@@H](O)C2)c1	44310775.0	R28_li_2005:368			BBB-	C	training
InChI=1S/C20H29N3O4/c1-15(24)22-9-10-23(17(13-22)12-21-8-7-18(25)14-21)20(26)11-16-3-5-19(27-2)6-4-16/h3-6,17-18,25H,7-14H2,1-2H3/t17-,18+/m0/s1	Gr94839_F|1-[(2S)-4-Acetyl-2-[[(3R)-3-Hydroxypyrrolidin-1-Yl]Methyl]Piperazin-1-Yl]-2-(4-Methoxyphenyl)Ethanone	1-[(2S)-4-acetyl-2-[[(3R)-3-hydroxypyrrolidin-1-yl]methyl]piperazin-1-yl]-2-(4-methoxyphenyl)ethanone	COc1ccc(CC(=O)N2CCN(C(C)=O)C[C@@H]2CN2CC[C@@H](O)C2)cc1	44310707.0	R28_li_2005:370			BBB-	C	training
InChI=1S/C20H29N3O4S/c1-15(24)22-9-10-23(17(13-22)12-21-8-7-18(25)14-21)20(26)11-16-3-5-19(6-4-16)28(2)27/h3-6,17-18,25H,7-14H2,1-2H3/t17-,18-,28+/m0/s1	Gr94839_I		CC(=O)N1CCN(C(=O)Cc2ccc([S@@](C)=O)cc2)[C@@H](CN2CC[C@H](O)C2)C1		R28_li_2005:373			BBB-	C	training
InChI=1S/C20H29N3O5S/c1-15(24)22-9-10-23(17(13-22)12-21-8-7-18(25)14-21)20(26)11-16-3-5-19(6-4-16)29(2,27)28/h3-6,17-18,25H,7-14H2,1-2H3/t17-,18-/m0/s1	Gr94839_L|1-[(2S)-4-Acetyl-2-[[(3S)-3-Hydroxypyrrolidin-1-Yl]Methyl]Piperazin-1-Yl]-2-(4-Methylsulfonylphenyl)Ethanone	1-[(2S)-4-acetyl-2-[[(3S)-3-hydroxypyrrolidin-1-yl]methyl]piperazin-1-yl]-2-(4-methylsulfonylphenyl)ethanone	CC(=O)N1CCN(C(=O)Cc2ccc(S(C)(=O)=O)cc2)[C@@H](CN2CC[C@H](O)C2)C1	44310651.0	R28_li_2005:374			BBB-	C	training
InChI=1S/C20H29N5O3/c1-22-18(15-19(26)23(2)20(22)27)21-9-6-10-24-11-13-25(14-12-24)16-7-4-5-8-17(16)28-3/h4-5,7-8,15,21H,6,9-14H2,1-3H3	Urapidil	6-[3-[4-(2-methoxyphenyl)piperazin-1-yl]propylamino]-1,3-dimethylpyrimidine-2,4-dione	COc1ccccc1N1CCN(CCCNc2cc(=O)n(C)c(=O)n2C)CC1	5639.0	R23_gupta_2019:1013			BBB-	C	training
InChI=1S/C20H29NO/c1-4-20-9-10-21(13-14-5-6-14)18(19(20,2)3)11-15-7-8-16(22)12-17(15)20/h7-8,12,14,18,22H,4-6,9-11,13H2,1-3H3	Gemazocine	10-(cyclopropylmethyl)-1-ethyl-13,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol	CCC12CCN(CC3CC3)C(Cc3ccc(O)cc31)C2(C)C	219096.0	R6_adenot_2004:1038			BBB+	C	training
InChI=1S/C20H29NO2/c1-4-20-9-10-21(13-19(23)7-8-19)17(18(20,2)3)11-14-5-6-15(22)12-16(14)20/h5-6,12,17,22-23H,4,7-11,13H2,1-3H3	Bremazocine|6-Ethyl-1,2,3,4,5,6-Hexahydro-3-[(1-Hydroxycyclopropyl)Methyl]-11,11-Dimethyl-2,6-Methano-3-Benzazocin-8-Ol	1-ethyl-10-[(1-hydroxycyclopropyl)methyl]-13,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol	CCC12CCN(CC3(O)CC3)C(Cc3ccc(O)cc31)C2(C)C	1223.0	R6_adenot_2004:1015|R25_brito_sanchez_2015:493|R46_mendoza_valencia_2017:413	0.6	B	BBB+	A	training
InChI=1S/C20H29NO6S/c1-21(10-5-11-28(24,25)26)16-8-9-17(21)13-18(12-16)27-20(23)19(14-22)15-6-3-2-4-7-15/h2-4,6-7,16-19,22H,5,8-14H2,1H3/t16-,17+,18?,19?,21?	Sultroponium	3-[(1R,5S)-3-(3-hydroxy-2-phenylpropanoyl)oxy-8-methyl-8-azoniabicyclo[3.2.1]octan-8-yl]propane-1-sulfonate	C[N+]1(CCCS(=O)(=O)[O-])[C@@H]2CC[C@H]1CC(OC(=O)C(CO)c1ccccc1)C2	20055039.0	R6_adenot_2004:107			BBB-	C	training
InChI=1S/C20H30NO3/c1-14(2)21(3)16-9-10-17(21)12-18(11-16)24-20(23)19(13-22)15-7-5-4-6-8-15/h4-8,14,16-19,22H,9-13H2,1-3H3/q+1	Ipratropiumbromide|Atrovent	(8-methyl-8-propan-2-yl-8-azoniabicyclo[3.2.1]octan-3-yl) 3-hydroxy-2-phenylpropanoate	CC(C)[N+]1(C)C2CCC1CC(OC(=O)C(CO)c1ccccc1)C2	3746.0	R28_li_2005:259			BBB-	C	training
InChI=1S/C20H30O2/c1-18-9-6-14(21)12-13(18)4-5-15-16(18)7-10-19(2)17(15)8-11-20(19,3)22/h12,15-17,22H,4-11H2,1-3H3/t15-,16+,17+,18+,19+,20+/m1/s1	Methyltestosterone|Androsan	(8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13,17-trimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one	C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O	6010.0	R14_ghose_2012:690|R51_doninger_2002:10			BBB-	C	training
InChI=1S/C20H31N3O6S/c1-5-27-19(26)29-13(2)28-18(25)15-20(3,4)30-17-14(16(24)23(15)17)21-12-22-10-8-6-7-9-11-22/h12-15,17H,5-11H2,1-4H3/b21-12+/t13?,14-,15+,17-/m1/s1	Bacmecillinam	1-ethoxycarbonyloxyethyl (2S,5R,6R)-6-(azepan-1-ylmethylideneamino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate	CCOC(=O)OC(C)OC(=O)[C@@H]1N2C(=O)[C@@H](/N=C/N3CCCCCC3)[C@H]2SC1(C)C	68681.0	R6_adenot_2004:143			BBB-	C	test
InChI=1S/C20H31NO/c22-20(18-10-4-1-5-11-18,19-12-6-2-7-13-19)14-17-21-15-8-3-9-16-21/h1,4-5,10-11,19,22H,2-3,6-9,12-17H2	Benzhexol|Trihexyphenidyl	1-cyclohexyl-1-phenyl-3-piperidin-1-ylpropan-1-ol	OC(CCN1CCCCC1)(c1ccccc1)C1CCCCC1	5572.0	R14_ghose_2012:17|R23_gupta_2019:253|R26_chico_2009:432|R47_radchenko_2020:461|R51_doninger_2002:319	1.32	A	BBB+	A	test
InChI=1S/C20H31NO3/c1-3-21(4-2)14-15-23-16-17-24-19(22)20(12-8-9-13-20)18-10-6-5-7-11-18/h5-7,10-11H,3-4,8-9,12-17H2,1-2H3	Carbetapentane	2-[2-(diethylamino)ethoxy]ethyl 1-phenylcyclopentane-1-carboxylate	CCN(CC)CCOCCOC(=O)C1(c2ccccc2)CCCC1	2562.0	R14_ghose_2012:421			BBB-	C	training
InChI=1S/C20H31NO4/c1-23-19-8-7-15(13-20(19)24-2)10-12-25-18-6-4-3-5-17(18)21-11-9-16(22)14-21/h7-8,13,16-18,22H,3-6,9-12,14H2,1-2H3/t16-,17-,18-/m1/s1	Vernakalant	(3R)-1-[(1R,2R)-2-[2-(3,4-dimethoxyphenyl)ethoxy]cyclohexyl]pyrrolidin-3-ol	COc1ccc(CCO[C@@H]2CCCC[C@H]2N2CC[C@@H](O)C2)cc1OC	9930049.0	R23_gupta_2019:1022			BBB-	C	training
InChI=1S/C20H32F2O5/c1-2-3-11-19(21,22)20(26)12-10-15-14(16(23)13-17(15)27-20)8-6-4-5-7-9-18(24)25/h14-15,17,26H,2-13H2,1H3,(H,24,25)/t14-,15-,17-,20-/m1/s1	Lubiprostone	7-[(2R,4aR,5R,7aR)-2-(1,1-difluoropentyl)-2-hydroxy-6-oxo-3,4,4a,5,7,7a-hexahydrocyclopenta[b]pyran-5-yl]heptanoic acid	CCCCC(F)(F)[C@@]1(O)CC[C@H]2[C@@H](CC(=O)[C@@H]2CCCCCCC(=O)O)O1	157920.0	R23_gupta_2019:717			BBB-	C	training
InChI=1S/C20H32N2/c1-21(2)15-8-16-22-19-11-5-3-4-9-17(19)13-14-18-10-6-7-12-20(18)22/h6-7,10,12,17,19H,3-5,8-9,11,13-16H2,1-2H3	S113 Amitryptalline		CN(C)CCCN1c2ccccc2CCC2CCCCCC21		R47_radchenko_2020:325	0.83	A	BBB+	A	test
InChI=1S/C20H32N5O8P/c1-19(2,3)17(26)30-11-32-34(28,33-12-31-18(27)20(4,5)6)13-29-8-7-25-10-24-14-15(21)22-9-23-16(14)25/h9-10H,7-8,11-13H2,1-6H3,(H2,21,22,23)	Adefovir Dipivoxil	[2-(6-aminopurin-9-yl)ethoxymethyl-(2,2-dimethylpropanoyloxymethoxy)phosphoryl]oxymethyl 2,2-dimethylpropanoate	CC(C)(C)C(=O)OCOP(=O)(COCCn1cnc2c(N)ncnc21)OCOC(=O)C(C)(C)C	60871.0	R14_ghose_2012:331|R23_gupta_2019:1044			BBB-	C	training
InChI=1S/C20H32O/c1-3-20(21)13-11-18-17-9-8-14-6-4-5-7-15(14)16(17)10-12-19(18,20)2/h6,15-18,21H,3-5,7-13H2,1-2H3/t15-,16+,17+,18-,19-,20-/m0/s1	Ethylestrenol	(8R,9S,10R,13S,14S,17S)-17-ethyl-13-methyl-2,3,6,7,8,9,10,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-ol	CC[C@]1(O)CC[C@H]2[C@@H]3CCC4=CCCC[C@@H]4[C@H]3CC[C@@]21C	13765.0	R14_ghose_2012:541|R23_gupta_2019:581			BBB-	C	training
InChI=1S/C20H32O2/c1-12-11-20(3)13(10-17(12)21)4-5-14-15-6-7-18(22)19(15,2)9-8-16(14)20/h12-16,18,22H,4-11H2,1-3H3/t12-,13+,14+,15+,16+,18+,19+,20+/m1/s1	Drostanolone	(2R,5S,8R,9S,10S,13S,14S,17S)-17-hydroxy-2,10,13-trimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-one	C[C@@H]1C[C@@]2(C)[C@@H](CC[C@@H]3[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]32)CC1=O	6011.0	R23_gupta_2019:540			BBB-	C	test
InChI=1S/C20H33N2O/c1-22(2)15-13-21(14-16-22)17-20(23,18-9-5-3-6-10-18)19-11-7-4-8-12-19/h3,5-6,9-10,19,23H,4,7-8,11-17H2,1-2H3/q+1	Hexocyclium Methylsulfate|Hexocyclium	1-cyclohexyl-2-(4,4-dimethylpiperazin-4-ium-1-yl)-1-phenylethanol	C[N+]1(C)CCN(CC(O)(c2ccccc2)C2CCCCC2)CC1	24199.0	R14_ghose_2012:605			BBB-	C	training
InChI=1S/C20H33N3O3/c1-20(2,3)21-13-17(24)14-26-18-11-9-16(10-12-18)23-19(25)22-15-7-5-4-6-8-15/h9-12,15,17,21,24H,4-8,13-14H2,1-3H3,(H2,22,23,25)	Talinolol	1-[4-[3-(tert-butylamino)-2-hydroxypropoxy]phenyl]-3-cyclohexylurea	CC(C)(C)NCC(O)COc1ccc(NC(=O)NC2CCCCC2)cc1	68770.0	R14_ghose_2012:873|R34_broccatelli_2012:138			BBB-	C	training
InChI=1S/C20H33N3O3S/c1-4-10-22-14-17(21-27(25,26)23(5-2)6-3)11-16-12-18-15(13-19(16)22)8-7-9-20(18)24/h7-9,16-17,19,21,24H,4-6,10-14H2,1-3H3/t16-,17+,19-/m1/s1	Quinagolide	(3S,4aS,10aR)-3-(diethylsulfamoylamino)-6-hydroxy-1-propyl-3,4,4a,5,10,10a-hexahydro-2H-benzo[g]quinoline	CCCN1C[C@@H](NS(=O)(=O)N(CC)CC)C[C@@H]2Cc3c(O)cccc3C[C@H]21	3086401.0	R6_adenot_2004:991|R14_ghose_2012:218|R23_gupta_2019:212			BBB+	C	training
InChI=1S/C20H33N3O4/c1-7-23(8-2)19(26)22-15-9-10-18(17(11-15)14(3)24)27-13-16(25)12-21-20(4,5)6/h9-11,16,21,25H,7-8,12-13H2,1-6H3,(H,22,26)	Celiprolol	3-[3-acetyl-4-[3-(tert-butylamino)-2-hydroxypropoxy]phenyl]-1,1-diethylurea	CCN(CC)C(=O)Nc1ccc(OCC(O)CNC(C)(C)C)c(C(C)=O)c1	2663.0	R6_adenot_2004:9			BBB-	C	training
InChI=1S/C20H33N7O3/c1-6-26(7-2)20(30)27-13-11-25(12-14-27)10-8-9-15-21-17-16(22(15)3)18(28)24(5)19(29)23(17)4/h6-14H2,1-5H3	Stacofylline	N,N-diethyl-4-[3-(1,3,7-trimethyl-2,6-dioxopurin-8-yl)propyl]piperazine-1-carboxamide	CCN(CC)C(=O)N1CCN(CCCc2nc3c(c(=O)n(C)c(=O)n3C)n2C)CC1	132157.0	R6_adenot_2004:1250			BBB+	C	training
InChI=1S/C20H34O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h12-13,15-17,19,21,23H,2-11,14H2,1H3,(H,24,25)/b13-12+/t15-,16+,17+,19+/m0/s1	Alprostadil	7-[(1R,2R,3R)-3-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]heptanoic acid	CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O	5280723.0	R51_doninger_2002:5			BBB-	C	training
InChI=1S/C21H13FN4O/c22-17-4-2-1-3-16(17)13-5-6-18-20(10-13)26-21(27)11-19(25-18)14-7-8-24-15(9-14)12-23/h1-10H,11H2,(H,26,27)	25|4-[7-(2-Fluoro-Phenyl)-4-Oxo-4,5-Dihydro-3H-Benzo[B][1,4]Diazepin-2-Yl]-Pyridine-2-Carbonitrile	4-[8-(2-fluorophenyl)-2-oxo-1,3-dihydro-1,5-benzodiazepin-4-yl]pyridine-2-carbonitrile	N#Cc1cc(C2=Nc3ccc(-c4ccccc4F)cc3NC(=O)C2)ccn1	22224963.0	R47_radchenko_2020:422	-0.3	A	BBB+	A	training
InChI=1S/C21H14ClNO3/c22-14-9-10-17-18(12-14)23-21(25)19(20(17)24)13-5-4-8-16(11-13)26-15-6-2-1-3-7-15/h1-12H,(H2,23,24,25)	L-701,324|7-Chloro-4-Hydroxy-3-(3-Phenoxyphenyl)Quinolin-2(1H)-One	7-chloro-4-hydroxy-3-(3-phenoxyphenyl)-1H-quinolin-2-one	O=c1[nH]c2cc(Cl)ccc2c(O)c1-c1cccc(Oc2ccccc2)c1	54682505.0	R26_chico_2009:233	-2.03	A	BBB-	A	test
InChI=1S/C21H15ClF4N4O3/c1-27-19(31)18-10-13(6-7-28-18)33-12-3-5-17(16(23)9-12)30-20(32)29-11-2-4-15(22)14(8-11)21(24,25)26/h2-10H,1H3,(H,27,31)(H2,29,30,32)	Regorafenib	4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]-3-fluorophenoxy]-N-methylpyridine-2-carboxamide	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1	11167602.0	R23_gupta_2019:879			BBB-	C	training
InChI=1S/C21H15N3O4/c25-17-7-3-1-5-15(17)19-22-20(16-6-2-4-8-18(16)26)24(23-19)14-11-9-13(10-12-14)21(27)28/h1-12,25-26H,(H,27,28)	Deferasirox	4-[3,5-bis(2-hydroxyphenyl)-1,2,4-triazol-1-yl]benzoic acid	O=C(O)c1ccc(-n2nc(-c3ccccc3O)nc2-c2ccccc2O)cc1	214348.0	R23_gupta_2019:503			BBB-	C	training
InChI=1S/C21H18ClN3O7S/c1-9-14(15(24-32-9)12-5-3-4-6-13(12)22)18(27)23-16-19(28)25-17(21(29)30)11(7-31-10(2)26)8-33-20(16)25/h3-6,16,20H,7-8H2,1-2H3,(H,23,27)(H,29,30)/t16-,20-/m1/s1	Cefoxazole	(6R,7R)-3-(acetyloxymethyl)-7-[[3-(2-chlorophenyl)-5-methyl-1,2-oxazole-4-carbonyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid	CC(=O)OCC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)c3c(-c4ccccc4Cl)noc3C)[C@H]2SC1	65798.0	R6_adenot_2004:185			BBB-	C	training
InChI=1S/C21H18ClNO6/c1-12-16(10-20(26)29-11-19(24)25)17-9-15(28-2)7-8-18(17)23(12)21(27)13-3-5-14(22)6-4-13/h3-9H,10-11H2,1-2H3,(H,24,25)	Acemetacin	2-[2-[1-(4-chlorobenzoyl)-5-methoxy-2-methylindol-3-yl]acetyl]oxyacetic acid	COc1ccc2c(c1)c(CC(=O)OCC(=O)O)c(C)n2C(=O)c1ccc(Cl)cc1	1981.0	R14_ghose_2012:323			BBB-	C	training
InChI=1S/C21H18F3N3O3/c1-11-9-26(5-4-25-11)19-8-18-13(7-16(19)24)20(28)14(21(29)30)10-27(18)17-3-2-12(22)6-15(17)23/h2-3,6-8,10-11,25H,4-5,9H2,1H3,(H,29,30)	Temafloxacin	1-(2,4-difluorophenyl)-6-fluoro-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid	CC1CN(c2cc3c(cc2F)c(=O)c(C(=O)O)cn3-c2ccc(F)cc2F)CCN1	60021.0	R7_andres_2006:165|R29_subramanian_2003:161			BBB-	C	training
InChI=1S/C21H19F2N3O3/c1-24-6-8-25(9-7-24)19-11-18-15(10-17(19)23)20(27)16(21(28)29)12-26(18)14-4-2-13(22)3-5-14/h2-5,10-12H,6-9H2,1H3,(H,28,29)	Difloxacin	6-fluoro-1-(4-fluorophenyl)-7-(4-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid	CN1CCN(c2cc3c(cc2F)c(=O)c(C(=O)O)cn3-c2ccc(F)cc2)CC1	56206.0	R28_li_2005:349			BBB-	C	training
InChI=1S/C21H19N/c1-22(2)16-8-7-13-21-19-11-5-3-9-17(19)14-15-18-10-4-6-12-20(18)21/h3-6,9-15H,16H2,1-2H3	Intriptyline	N,N-dimethyl-4-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,9,11,13-heptaenylidene)but-2-yn-1-amine	CN(C)CC#CC=C1c2ccccc2C=Cc2ccccc21	71397.0	R6_adenot_2004:1583			BBB+	C	training
InChI=1S/C21H19N3O3S/c1-27-20-13-14(24-28(2,25)26)11-12-19(20)23-21-15-7-3-5-9-17(15)22-18-10-6-4-8-16(18)21/h3-13,24H,1-2H3,(H,22,23)	Amsacrine	N-[4-(acridin-9-ylamino)-3-methoxyphenyl]methanesulfonamide	COc1cc(NS(C)(=O)=O)ccc1Nc1c2ccccc2nc2ccccc12	2179.0	R23_gupta_2019:352			BBB-	C	training
InChI=1S/C21H19N3O3S/c1-3-27-17-10-6-16(7-11-17)21-20(19-5-4-14-22-24(19)23-21)15-8-12-18(13-9-15)28(2,25)26/h4-14H,3H2,1-2H3	Gw406381|2-(4-Ethoxyphenyl)-3-[4-(Methylsulfonyl)Phenyl]Pyrazolo[1,5-B]Pyridazine	2-(4-ethoxyphenyl)-3-(4-methylsulfonylphenyl)pyrazolo[1,5-b]pyridazine	CCOc1ccc(-c2nn3ncccc3c2-c2ccc(S(C)(=O)=O)cc2)cc1	9832687.0	R26_chico_2009:205	0.18	A	BBB+	A	training
InChI=1S/C21H19N5O2/c1-24(2)19(28)14-26-18(27)12-11-16(22-26)20-17-10-6-7-13-25(17)23-21(20)15-8-4-3-5-9-15/h3-13H,14H2,1-2H3	210880-09-4|Compound 17|N,N-Dimethyl-2-[6-Oxo-3-(2-Phenylpyrazolo[1,5-A]Pyridin-3-Yl)Pyridazin-1-Yl]Acetamide	N,N-dimethyl-2-[6-oxo-3-(2-phenylpyrazolo[1,5-a]pyridin-3-yl)pyridazin-1-yl]acetamide	CN(C)C(=O)Cn1nc(-c2c(-c3ccccc3)nn3ccccc23)ccc1=O	11003252.0	R4_mente_2005:105|R40_vilar_2010:82|R47_radchenko_2020:416	-1.0	B	BBB+	A	training
InChI=1S/C21H19NO/c23-21(17-7-3-1-4-8-17,18-9-5-2-6-10-18)20-15-19(20)16-11-13-22-14-12-16/h1-14,19-20,23H,15H2	Cyprolidol|Cyclopropanemethanol, Alpha,Alpha-Diphenyl-2-(4-Pyridyl)-, Hydrochloride	diphenyl-(2-pyridin-4-ylcyclopropyl)methanol	OC(c1ccccc1)(c1ccccc1)C1CC1c1ccncc1	23287.0	R6_adenot_2004:518			BBB+	C	training
InChI=1S/C21H20Cl2N6O3/c1-28(2)21(32)20-26-17(11-25-18(30)10-24)29(27-20)16-8-7-12(22)9-14(16)19(31)13-5-3-4-6-15(13)23/h3-9H,10-11,24H2,1-2H3,(H,25,30)	Rilmazafone	5-[[(2-aminoacetyl)amino]methyl]-1-[4-chloro-2-(2-chlorobenzoyl)phenyl]-N,N-dimethyl-1,2,4-triazole-3-carboxamide	CN(C)C(=O)c1nc(CNC(=O)CN)n(-c2ccc(Cl)cc2C(=O)c2ccccc2Cl)n1	5069.0	R6_adenot_2004:1410			BBB+	C	training
InChI=1S/C21H20Cl2O3/c1-21(2)17(12-18(22)23)19(21)20(24)25-13-14-7-6-10-16(11-14)26-15-8-4-3-5-9-15/h3-12,17,19H,13H2,1-2H3	Permethrin	(3-phenoxyphenyl)methyl 3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropane-1-carboxylate	CC1(C)C(C=C(Cl)Cl)C1C(=O)OCc1cccc(Oc2ccccc2)c1	40326.0	R23_gupta_2019:827			BBB-	C	training
InChI=1S/C21H20ClNS/c22-16-5-6-21-19(12-16)18(17-3-1-2-4-20(17)24-21)11-15-13-23-9-7-14(15)8-10-23/h1-6,11-12,14-15H,7-10,13H2	Nuclotixene	3-[(2-chlorothioxanthen-9-ylidene)methyl]-1-azabicyclo[2.2.2]octane	Clc1ccc2c(c1)C(=CC1CN3CCC1CC3)c1ccccc1S2	166584.0	R6_adenot_2004:589			BBB+	C	training
InChI=1S/C21H20FN3O6S/c1-10-16(31-21(29)30-10)9-23-3-5-24(6-4-23)15-8-14-12(7-13(15)22)18(26)17(20(27)28)19-25(14)11(2)32-19/h7-8,11H,3-6,9H2,1-2H3,(H,27,28)	Prulifloxacin	6-fluoro-1-methyl-7-[4-[(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl]piperazin-1-yl]-4-oxo-1H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic acid	Cc1oc(=O)oc1CN1CCN(c2cc3c(cc2F)c(=O)c(C(=O)O)c2n3C(C)S2)CC1	65947.0	R23_gupta_2019:866			BBB-	C	training
InChI=1S/C21H20N4O2/c1-21(2,27)14-25-18(26)12-11-16(22-25)19-17-10-6-7-13-24(17)23-20(19)15-8-4-3-5-9-15/h3-13,27H,14H2,1-2H3	222722-65-8|2-(2-Hydroxy-2-Methylpropyl)-6-(2-Phenylpyrazolo[1,5-A]Pyridin-3-Yl)Pyridazin-3-One	2-(2-hydroxy-2-methylpropyl)-6-(2-phenylpyrazolo[1,5-a]pyridin-3-yl)pyridazin-3-one	CC(C)(O)Cn1nc(-c2c(-c3ccccc3)nn3ccccc23)ccc1=O	10937291.0	R4_mente_2005:104	-0.23	A	BBB+	A	training
InChI=1S/C21H20N4O3/c22-18-5-1-2-6-19(18)25-20(26)17-9-7-15(8-10-17)13-24-21(27)28-14-16-4-3-11-23-12-16/h1-12H,13-14,22H2,(H,24,27)(H,25,26)	Ms-275|Entinostat	pyridin-3-ylmethyl N-[[4-[(2-aminophenyl)carbamoyl]phenyl]methyl]carbamate	Nc1ccccc1NC(=O)c1ccc(CNC(=O)OCc2cccnc2)cc1	4261.0	R47_radchenko_2020:517	-0.85	A	BBB+	A	test
InChI=1S/C21H20O10/c1-8-15(25)17(27)18(28)21(29-8)31-20-16(26)14-12(24)6-11(23)7-13(14)30-19(20)9-2-4-10(22)5-3-9/h2-8,15,17-18,21-25,27-28H,1H3/t8-,15-,17+,18+,21-/m0/s1	Afe|Afzelin	5,7-dihydroxy-2-(4-hydroxyphenyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxychromen-4-one	C[C@@H]1O[C@@H](Oc2c(-c3ccc(O)cc3)oc3cc(O)cc(O)c3c2=O)[C@H](O)[C@H](O)[C@H]1O	5316673.0	R3_abraham_2006:117|R25_brito_sanchez_2015:110|R40_vilar_2010:28|R47_radchenko_2020:99	0.55	B	BBB+	A	training
InChI=1S/C21H20O11/c22-7-16-17(27)18(28)19(29)21(32-16)31-15-6-10-12(25)4-9(23)5-14(10)30-20(15)8-1-2-11(24)13(26)3-8/h1-6,16-19,21-22,27-29H,7H2,(H3-,23,24,25,26)/p+1/t16-,17-,18+,19-,21-/m1/s1	Cyanidin 3-O-Glucoside|Kuromanin	(2S,3R,4S,5S,6R)-2-[2-(3,4-dihydroxyphenyl)-5,7-dihydroxychromenylium-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol	OC[C@H]1O[C@@H](Oc2cc3c(O)cc(O)cc3[o+]c2-c2ccc(O)c(O)c2)[C@H](O)[C@@H](O)[C@@H]1O	441667.0	R25_brito_sanchez_2015:485	0.15	A	BBB+	A	training
InChI=1S/C21H20O12/c22-6-13-15(27)17(29)18(30)21(32-13)33-20-16(28)14-11(26)4-8(23)5-12(14)31-19(20)7-1-2-9(24)10(25)3-7/h1-5,13,15,17-18,21-27,29-30H,6H2/t13-,15-,17+,18-,21+/m1/s1	Isoquercitrin|Isoquercetin	2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one	O=c1c(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12	5280804.0	R51_doninger_2002:74			BBB-	C	training
InChI=1S/C21H20O9/c1-30-11-4-2-3-8-14(11)20(28)16-15(17(8)25)18(26)9-5-21(29,12(24)7-22)6-10(23)13(9)19(16)27/h2-4,10,12,22-24,26-27,29H,5-7H2,1H3/t10-,12?,21-/m0/s1	Adriamycinol-Aglycone|Doxorubicinolone, 90%(Mixture Of Diastereomers)	(7S,9S)-9-(1,2-dihydroxyethyl)-6,7,9,11-tetrahydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione	COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(O)CO)C[C@@H]3O	10476988.0	R6_adenot_2004:75			BBB-	C	training
InChI=1S/C21H21ClFN3O2/c1-14(10-11-24)25(2)13-20(27)26(3)19-9-8-15(22)12-17(19)21(28)16-6-4-5-7-18(16)23/h4-9,12,14H,10,13H2,1-3H3	Alozafone	N-[4-chloro-2-(2-fluorobenzoyl)phenyl]-2-[1-cyanopropan-2-yl(methyl)amino]-N-methylacetamide	CC(CC#N)N(C)CC(=O)N(C)c1ccc(Cl)cc1C(=O)c1ccccc1F	172288.0	R6_adenot_2004:1412			BBB+	C	training
InChI=1S/C21H21ClN2O/c1-4-14(2)24(3)21(25)19-13-15-9-5-6-10-16(15)20(23-19)17-11-7-8-12-18(17)22/h5-14H,4H2,1-3H3	Pk-11195|Pk 11195|1-(2-Chlorophenyl)-N-Methyl-N-(1-Methylpropyl)-3-Isoquinolinecarboxamide	N-butan-2-yl-1-(2-chlorophenyl)-N-methylisoquinoline-3-carboxamide	CCC(C)N(C)C(=O)c1cc2ccccc2c(-c2ccccc2Cl)n1	1345.0	R3_abraham_2006:234|R21_muehlbacher_2011:21|R25_brito_sanchez_2015:361|R26_chico_2009:314|R40_vilar_2010:213|R41_toropov_2017:210|R46_mendoza_valencia_2017:315|R47_radchenko_2020:195	0.48	B	BBB+	A	training
InChI=1S/C21H21ClN2O2/c22-17-8-9-19-18(12-17)21(16-4-2-1-3-5-16)23-13-20(25)24(19)10-11-26-14-15-6-7-15/h1-5,8-9,12,15H,6-7,10-11,13-14H2	Iclazepam	7-chloro-1-[2-(cyclopropylmethoxy)ethyl]-5-phenyl-3H-1,4-benzodiazepin-2-one	O=C1CN=C(c2ccccc2)c2cc(Cl)ccc2N1CCOCC1CC1	68777.0	R6_adenot_2004:717			BBB+	C	test
InChI=1S/C21H21ClN2O8/c1-24(2)14-7-5-6-10(16(27)12-9(25)4-3-8(22)11(12)15(6)26)18(29)21(7,32)19(30)13(17(14)28)20(23)31/h3-4,6-7,14-15,25-27,30,32H,5H2,1-2H3,(H2,23,31)/t6-,7-,14-,15-,21-/m0/s1	Demeclocycline|Demeclocycline Hydrochloride	(4S,4aS,5aS,6S,12aR)-7-chloro-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide	CN(C)[C@@H]1C(=O)C(C(N)=O)=C(O)[C@@]2(O)C(=O)C3=C(O)c4c(O)ccc(Cl)c4[C@@H](O)[C@H]3C[C@@H]12	54680690.0	R6_adenot_2004:305|R7_andres_2006:46|R14_ghose_2012:483|R23_gupta_2019:508|R28_li_2005:186|R29_subramanian_2003:46			BBB-	C	training
InChI=1S/C21H21ClN4O3/c1-3-24(4-2)14-20-23-11-12-25(20)19-10-9-15(26(28)29)13-17(19)21(27)16-7-5-6-8-18(16)22/h5-13H,3-4,14H2,1-2H3	Nizofenone	(2-chlorophenyl)-[2-[2-(diethylaminomethyl)imidazol-1-yl]-5-nitrophenyl]methanone	CCN(CC)Cc1nccn1-c1ccc([N+](=O)[O-])cc1C(=O)c1ccccc1Cl	4514.0	R14_ghose_2012:170|R23_gupta_2019:168			BBB+	C	training
InChI=1S/C21H21ClN4OS/c22-17-13-18-15(12-20(27)23-18)11-14(17)5-6-25-7-9-26(10-8-25)21-16-3-1-2-4-19(16)28-24-21/h1-4,11,13H,5-10,12H2,(H,23,27)	Ziprasidone	5-[2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl]-6-chloro-1,3-dihydroindol-2-one	O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1	60854.0	R6_adenot_2004:1143|R23_gupta_2019:266|R26_chico_2009:445|R34_broccatelli_2012:153			BBB+	C	training
InChI=1S/C21H21N/c1-22-14-12-18(13-15-22)21-19-8-4-2-6-16(19)10-11-17-7-3-5-9-20(17)21/h2-11H,12-15H2,1H3	Cyproheptadine	1-methyl-4-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,9,11,13-heptaenylidene)piperidine	CN1CCC(=C2c3ccccc3C=Cc3ccccc32)CC1	2913.0	R14_ghose_2012:60|R23_gupta_2019:56|R50_sobanska_2019:78			BBB+	C	training
InChI=1S/C21H21N3O/c1-23-14-15-7-9-17(10-8-15)21(25)24-20-13-18(11-12-19(20)22)16-5-3-2-4-6-16/h2-13,23H,14,22H2,1H3,(H,24,25)	25		CNCc1ccc(C(=O)Nc2cc(-c3ccccc3)ccc2N)cc1		R47_radchenko_2020:523	-0.05	A	BBB+	A	test
InChI=1S/C21H21N3O6S/c1-21(2)16(20(28)29)24-18(27)15(19(24)31-21)23-17(26)14(11-5-7-12(25)8-6-11)22-10-13-4-3-9-30-13/h3-10,14-16,19,25H,1-2H3,(H,23,26)(H,28,29)/b22-10+/t14-,15-,16+,19-/m1/s1	Fumoxicillin	(2S,5R,6R)-6-[[(2R)-2-(furan-2-ylmethylideneamino)-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid	CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](/N=C/c3ccco3)c3ccc(O)cc3)C(=O)N2[C@H]1C(=O)O	20055356.0	R6_adenot_2004:231			BBB-	C	training
InChI=1S/C21H21N3O9/c1-23(2)15-9-6-7-5-8-10(24(32)33)3-4-11(25)13(8)16(26)12(7)18(28)21(9,31)19(29)14(17(15)27)20(22)30/h3-4,7,9,15,25-26,29,31H,5-6H2,1-2H3,(H2,22,30)/t7-,9-,15-,21-/m0/s1	Nitrocycline	(4S,4aS,5aR,12aR)-4-(dimethylamino)-1,10,11,12a-tetrahydroxy-7-nitro-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide	CN(C)[C@@H]1C(=O)C(C(N)=O)=C(O)[C@@]2(O)C(=O)C3=C(O)c4c(O)ccc([N+](=O)[O-])c4C[C@H]3C[C@@H]12	54688694.0	R6_adenot_2004:314			BBB-	C	training
InChI=1S/C21H21N3S/c1-24-12-14(13-25-20-7-2-3-8-22-20)9-17-16-5-4-6-18-21(16)15(11-23-18)10-19(17)24/h2-9,11,14,19,23H,10,12-13H2,1H3/t14-,19-/m1/s1	Tiomergine	(6aR,9R)-7-methyl-9-(pyridin-2-ylsulfanylmethyl)-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline	CN1C[C@H](CSc2ccccn2)C=C2c3cccc4[nH]cc(c34)C[C@H]21	9884658.0	R6_adenot_2004:622			BBB+	C	training
InChI=1S/C21H21NO2S/c1-4-24-20(23)16-7-9-17(22-14-16)8-5-15-6-10-19-18(13-15)21(2,3)11-12-25-19/h6-7,9-10,13-14H,4,11-12H2,1-3H3	Tazarotene	ethyl 6-[2-(4,4-dimethyl-2,3-dihydrothiochromen-6-yl)ethynyl]pyridine-3-carboxylate	CCOC(=O)c1ccc(C#Cc2ccc3c(c2)C(C)(C)CCS3)nc1	5381.0	R23_gupta_2019:954			BBB-	C	test
InChI=1S/C21H22Cl2FN5O/c1-12(19-16(22)2-3-17(24)20(19)23)30-18-8-13(9-27-21(18)25)14-10-28-29(11-14)15-4-6-26-7-5-15/h2-3,8-12,15,26H,4-7H2,1H3,(H2,25,27)/t12-/m1/s1	Crizotinib	3-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-(1-piperidin-4-ylpyrazol-4-yl)pyridin-2-amine	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl	11626560.0	R23_gupta_2019:482			BBB-	C	training
InChI=1S/C21H22ClFN4O2/c22-15-3-6-19-18(13-15)25-21(29)27(19)17-7-10-26(11-8-17)12-9-24-20(28)14-1-4-16(23)5-2-14/h1-6,13,17H,7-12H2,(H,24,28)(H,25,29)	Halopemide	N-[2-[4-(5-chloro-2-oxo-3H-benzimidazol-1-yl)piperidin-1-yl]ethyl]-4-fluorobenzamide	O=C(NCCN1CCC(n2c(=O)[nH]c3cc(Cl)ccc32)CC1)c1ccc(F)cc1	65490.0	R6_adenot_2004:1475			BBB+	C	training
InChI=1S/C21H22ClN3O3/c22-14-5-6-18-17(11-14)23-21(26)25(18)15-7-9-24(10-8-15)12-16-13-27-19-3-1-2-4-20(19)28-16/h1-6,11,15-16H,7-10,12-13H2,(H,23,26)	Axamozide	6-chloro-3-[1-(2,3-dihydro-1,4-benzodioxin-3-ylmethyl)piperidin-4-yl]-1H-benzimidazol-2-one	O=c1[nH]c2cc(Cl)ccc2n1C1CCN(CC2COc3ccccc3O2)CC1	170359.0	R6_adenot_2004:1116			BBB+	C	test
InChI=1S/C21H22ClN7/c1-13-4-3-5-15(22)19(13)27-20-17-10-23-12-29(17)21-16(25-20)6-7-18(26-21)28-9-8-24-14(2)11-28/h3-7,10,12,14,24H,8-9,11H2,1-2H3,(H,25,27)/t14-/m0/s1	Bms-279700|Imidazo(1,5-A)Pyrido(3,2-E)Pyrazin-6-Amine, N-(2-Chloro-6-Methylphenyl)-2-((3S)-3-Methyl-1-Piperazinyl)-	N-(2-chloro-6-methylphenyl)-12-[(3S)-3-methylpiperazin-1-yl]-2,4,8,13-tetrazatricyclo[7.4.0.02,6]trideca-1(9),3,5,7,10,12-hexaen-7-amine	Cc1cccc(Cl)c1Nc1nc2ccc(N3CCN[C@@H](C)C3)nc2n2cncc12	9844320.0	R26_chico_2009:81	-0.22	A	BBB+	A	training
InChI=1S/C21H22F3N3OS/c1-25-10-12-26(13-11-25)9-8-20(28)27-16-4-2-3-5-18(16)29-19-7-6-15(14-17(19)27)21(22,23)24/h2-7,14H,8-13H2,1H3	Ftormetazine	3-(4-methylpiperazin-1-yl)-1-[2-(trifluoromethyl)phenothiazin-10-yl]propan-1-one	CN1CCN(CCC(=O)N2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1	969494.0	R6_adenot_2004:1576			BBB+	C	training
InChI=1S/C21H22N2O5S/c1-4-28-13-10-9-11-7-5-6-8-12(11)14(13)17(24)22-15-18(25)23-16(20(26)27)21(2,3)29-19(15)23/h5-10,15-16,19H,4H2,1-3H3,(H,22,24)(H,26,27)/t15-,16+,19-/m1/s1	Nafcillin	(2S,5R,6R)-6-[(2-ethoxynaphthalene-1-carbonyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid	CCOc1ccc2ccccc2c1C(=O)N[C@@H]1C(=O)N2[C@@H]1SC(C)(C)[C@@H]2C(=O)O	8982.0	R6_adenot_2004:246|R23_gupta_2019:766|R28_li_2005:208			BBB-	C	training
InChI=1S/C21H22N2O8/c1-23(2)14-9-6-8-12(16(26)11-7(15(8)25)4-3-5-10(11)24)18(28)21(9,31)19(29)13(17(14)27)20(22)30/h3-5,8-9,14-15,24-26,29,31H,6H2,1-2H3,(H2,22,30)/t8-,9-,14-,15+,21-/m0/s1	Demecycline	(4S,4aS,5aS,6S,12aR)-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide	CN(C)[C@@H]1C(=O)C(C(N)=O)=C(O)[C@@]2(O)C(=O)C3=C(O)c4c(O)cccc4[C@@H](O)[C@H]3C[C@@H]12	54682469.0	R6_adenot_2004:306			BBB-	C	training
InChI=1S/C21H22N4O6S/c1-11-22-14-4-3-12(9-13(14)19(28)23-11)10-25(2)17-7-6-16(32-17)20(29)24-15(21(30)31)5-8-18(26)27/h3-4,6-7,9,15H,5,8,10H2,1-2H3,(H,24,29)(H,26,27)(H,30,31)(H,22,23,28)/t15-/m0/s1	Raltitrexed	(2S)-2-[[5-[methyl-[(2-methyl-4-oxo-3H-quinazolin-6-yl)methyl]amino]thiophene-2-carbonyl]amino]pentanedioic acid	Cc1nc2ccc(CN(C)c3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)s3)cc2c(=O)[nH]1	135400182.0	R23_gupta_2019:875			BBB-	C	training
InChI=1S/C21H23BrFNO2/c22-18-7-5-17(6-8-18)21(26)11-14-24(15-12-21)13-1-2-20(25)16-3-9-19(23)10-4-16/h3-10,26H,1-2,11-15H2	10457-90-6|Bromperidol	4-[4-(4-bromophenyl)-4-hydroxypiperidin-1-yl]-1-(4-fluorophenyl)butan-1-one	O=C(CCCN1CCC(O)(c2ccc(Br)cc2)CC1)c1ccc(F)cc1	2448.0	R4_mente_2005:150|R6_adenot_2004:1124|R12_garg_2006:48|R14_ghose_2012:313|R21_muehlbacher_2011:42|R23_gupta_2019:28|R25_brito_sanchez_2015:169|R26_chico_2009:85|R28_li_2005:70|R39_shayanfar_2011:104|R40_vilar_2010:61|R44_bujak_2015:78|R47_radchenko_2020:310	1.38	B	BBB+	A	training
InChI=1S/C21H23Cl2N3O/c1-3-11-25(12-4-2)20(27)13-18-21(15-5-7-16(22)8-6-15)24-19-10-9-17(23)14-26(18)19/h5-10,14H,3-4,11-13H2,1-2H3	Alpidem	2-[6-chloro-2-(4-chlorophenyl)imidazo[1,2-a]pyridin-3-yl]-N,N-dipropylacetamide	CCCN(CCC)C(=O)Cc1c(-c2ccc(Cl)cc2)nc2ccc(Cl)cn12	54897.0	R6_adenot_2004:1414|R14_ghose_2012:302|R23_gupta_2019:5			BBB+	C	test
InChI=1S/C21H23Cl2N7O2S/c1-13-25-17(11-18(26-13)30-7-5-29(6-8-30)9-10-31)27-21-24-12-16(33-21)20(32)28-19-14(22)3-2-4-15(19)23/h2-4,11-12,31H,5-10H2,1H3,(H,28,32)(H,24,25,26,27)	Sprycel, Dasatinib|N-(2,6-Dichlorophenyl)-2-[[6-[4-(2-Hydroxyethyl)Piperazin-1-Yl]-2-Methylpyrimidin-4-Yl]Amino]-1,3-Thiazole-5-Carboxamide	N-(2,6-dichlorophenyl)-2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl]amino]-1,3-thiazole-5-carboxamide	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1	16655839.0	R26_chico_2009:387	-1.3	A	BBB-	A	training
InChI=1S/C21H23Cl2NO6/c1-5-7-15(25)29-10-30-21(27)17-12(3)24-11(2)16(20(26)28-4)18(17)13-8-6-9-14(22)19(13)23/h6,8-9,18,24H,5,7,10H2,1-4H3	Clevidipine	5-O-(butanoyloxymethyl) 3-O-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate	CCCC(=O)OCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc(Cl)c1Cl	153994.0	R23_gupta_2019:467			BBB-	C	training
InChI=1S/C21H23ClFN3O/c1-3-25(4-2)11-12-26-19-10-9-15(22)13-17(19)21(24-14-20(26)27)16-7-5-6-8-18(16)23/h5-10,13H,3-4,11-12,14H2,1-2H3	Flurazepam	7-chloro-1-[2-(diethylamino)ethyl]-5-(2-fluorophenyl)-3H-1,4-benzodiazepin-2-one	CCN(CC)CCN1C(=O)CN=C(c2ccccc2F)c2cc(Cl)ccc21	3393.0	R6_adenot_2004:708|R7_andres_2006:71|R14_ghose_2012:99|R23_gupta_2019:97|R26_chico_2009:194|R29_subramanian_2003:67|R51_doninger_2002:219			BBB+	C	training
InChI=1S/C21H23ClFNO2/c22-18-7-5-17(6-8-18)21(26)11-14-24(15-12-21)13-1-2-20(25)16-3-9-19(23)10-4-16/h3-10,26H,1-2,11-15H2	52-86-8|Haloperidol	4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-1-(4-fluorophenyl)butan-1-one	O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1	3559.0	R4_mente_2005:155|R5_guerra_2008:50|R6_adenot_2004:1166|R7_andres_2006:81|R12_garg_2006:83|R14_ghose_2012:107|R21_muehlbacher_2011:82|R25_brito_sanchez_2015:245|R26_chico_2009:206|R28_li_2005:87|R29_subramanian_2003:74|R34_broccatelli_2012:37|R37_chen_2011:41|R39_shayanfar_2011:49|R40_vilar_2010:121|R42_ciura_2020:19|R44_bujak_2015:32|R47_radchenko_2020:271|R50_sobanska_2019:44|R51_doninger_2002:222	1.33	B	BBB+	A	training
InChI=1S/C21H23ClN4O2/c22-16-5-3-6-17(15-16)25-13-11-24(12-14-25)9-4-10-26-20(27)18-7-1-2-8-19(18)23-21(26)28/h1-3,5-8,15H,4,9-14H2,(H,23,28)	Cloperidone	3-[3-[4-(3-chlorophenyl)piperazin-1-yl]propyl]-1H-quinazoline-2,4-dione	O=c1[nH]c2ccccc2c(=O)n1CCCN1CCN(c2cccc(Cl)c2)CC1	10675.0	R6_adenot_2004:1437			BBB+	C	test
InChI=1S/C21H23F3N6O/c1-31-18-10-9-16(30-20(21(22,23)24)27-28-29-30)12-15(18)13-26-17-8-5-11-25-19(17)14-6-3-2-4-7-14/h2-4,6-7,9-10,12,17,19,25-26H,5,8,11,13H2,1H3	Gr 205171, Vofopitant|N-[[2-Methoxy-5-[5-(Trifluoromethyl)Tetrazol-1-Yl]Phenyl]Methyl]-2-Phenylpiperidin-3-Amine	N-[[2-methoxy-5-[5-(trifluoromethyl)tetrazol-1-yl]phenyl]methyl]-2-phenylpiperidin-3-amine	COc1ccc(-n2nnnc2C(F)(F)F)cc1CNC1CCCNC1c1ccccc1	122033.0	R26_chico_2009:204	0.24	A	BBB+	A	training
InChI=1S/C21H23FN2O3S/c22-17-3-1-15(2-4-17)13-16-7-9-24(10-8-16)11-12-28(26)18-5-6-19-20(14-18)27-21(25)23-19/h1-6,14,16H,7-13H2,(H,23,25)	Besonprodil 9|Besonprodil	6-[2-[4-[(4-fluorophenyl)methyl]piperidin-1-yl]ethylsulfinyl]-3H-1,3-benzoxazol-2-one	O=c1[nH]c2ccc(S(=O)CCN3CCC(Cc4ccc(F)cc4)CC3)cc2o1	156328.0	R47_radchenko_2020:423	-0.52	A	BBB+	A	training
InChI=1S/C21H23N/c1-2-8-17-15(6-1)11-12-16-7-5-9-18-20-10-3-4-13-22(20)14-19(17)21(16)18/h1-2,5-9,19-20H,3-4,10-14H2	Taclamine	3-azapentacyclo[11.8.1.03,8.09,22.016,21]docosa-9,11,13(22),16,18,20-hexaene	c1ccc2c(c1)CCc1cccc3c1C2CN1CCCCC31	36667.0	R6_adenot_2004:1514			BBB+	C	test
InChI=1S/C21H23N3O7/c1-24(2)14-9-6-8-5-7-3-4-10(22)15(25)11(7)16(26)12(8)18(28)21(9,31)19(29)13(17(14)27)20(23)30/h3-4,8-9,14,25-26,29,31H,5-6,22H2,1-2H3,(H2,23,30)/t8-,9-,14-,21-/m0/s1	Amicycline	(4S,4aS,5aR,12aR)-9-amino-4-(dimethylamino)-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide	CN(C)[C@@H]1C(=O)C(C(N)=O)=C(O)[C@@]2(O)C(=O)C3=C(O)c4c(ccc(N)c4O)C[C@H]3C[C@@H]12	54688693.0	R6_adenot_2004:300			BBB-	C	training
InChI=1S/C21H23N3O7S/c1-10-12(31-20(28)30-10)9-29-19(27)15-21(2,3)32-18-14(17(26)24(15)18)23-16(25)13(22)11-7-5-4-6-8-11/h4-8,13-15,18H,9,22H2,1-3H3,(H,23,25)/t13-,14-,15+,18-/m1/s1	Lenampicillin|Lenampicillin Hydrochloride	(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl (2S,5R,6R)-6-[[(2R)-2-amino-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate	Cc1oc(=O)oc1COC(=O)[C@@H]1N2C(=O)[C@@H](NC(=O)[C@H](N)c3ccccc3)[C@H]2SC1(C)C	65646.0	R6_adenot_2004:239|R23_gupta_2019:1069			BBB-	C	training
InChI=1S/C21H23N3OS/c22-15-16-6-7-21-19(14-16)24(18-4-1-2-5-20(18)26-21)11-3-10-23-12-8-17(25)9-13-23/h1-2,4-7,14,17,25H,3,8-13H2	Periciazine|Pericyazine	10-[3-(4-hydroxypiperidin-1-yl)propyl]phenothiazine-2-carbonitrile	N#Cc1ccc2c(c1)N(CCCN1CCC(O)CC1)c1ccccc1S2	4747.0	R6_adenot_2004:1196|R14_ghose_2012:188|R23_gupta_2019:189			BBB+	C	test
InChI=1S/C21H23NO/c1-22(2)20(18-10-4-3-5-11-18)15-16-23-21-14-8-12-17-9-6-7-13-19(17)21/h3-14,20H,15-16H2,1-2H3/t20-/m0/s1	Dapoxetine	(1S)-N,N-dimethyl-3-naphthalen-1-yloxy-1-phenylpropan-1-amine	CN(C)[C@@H](CCOc1cccc2ccccc12)c1ccccc1	71353.0	R6_adenot_2004:570			BBB+	C	training
InChI=1S/C21H23NO4S/c1-16(23)27-15-19(12-17-8-4-2-5-9-17)21(25)22-13-20(24)26-14-18-10-6-3-7-11-18/h2-11,19H,12-15H2,1H3,(H,22,25)/t19-/m1/s1	Ecadotril	benzyl 2-[[(2S)-2-(acetylsulfanylmethyl)-3-phenylpropanoyl]amino]acetate	CC(=O)SC[C@@H](Cc1ccccc1)C(=O)NCC(=O)OCc1ccccc1	60561.0	R6_adenot_2004:1033			BBB+	C	training
InChI=1S/C21H23NO5/c1-11(23)25-16-6-4-13-10-15-14-5-7-17(26-12(2)24)20-21(14,8-9-22(15)3)18(13)19(16)27-20/h4-7,14-15,17,20H,8-10H2,1-3H3/t14-,15+,17-,20-,21-/m0/s1	Diacetylmorphine|Diamorphine|Heroin	[(4R,4aR,7S,7aR,12bS)-9-acetyloxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-yl] acetate	CC(=O)Oc1ccc2c3c1O[C@H]1[C@@H](OC(C)=O)C=C[C@H]4[C@@H](C2)N(C)CC[C@@]341	5462328.0	R6_adenot_2004:1029|R14_ghose_2012:70|R23_gupta_2019:65|R51_doninger_2002:225			BBB+	C	test
InChI=1S/C21H24BrN5O/c1-14-9-18(22)13-25-19(14)5-3-4-8-23-21-26-12-17(20(28)27-21)10-16-7-6-15(2)24-11-16/h6-7,9,11-13H,3-5,8,10H2,1-2H3,(H2,23,26,27,28)	86181-42-2|Temelastine	2-[4-(5-bromo-3-methylpyridin-2-yl)butylamino]-5-[(6-methylpyridin-3-yl)methyl]-1H-pyrimidin-6-one	Cc1ccc(Cc2cnc(NCCCCc3ncc(Br)cc3C)[nH]c2=O)cn1	55482.0	R4_mente_2005:116|R5_guerra_2008:95|R7_andres_2006:216|R12_garg_2006:158|R21_muehlbacher_2011:254|R25_brito_sanchez_2015:152|R26_chico_2009:405|R28_li_2005:47|R39_shayanfar_2011:89|R40_vilar_2010:265|R46_mendoza_valencia_2017:149|R47_radchenko_2020:289|R48_hou_2003:39|R49_norinder_2002:37|R49_norinder_2002:164	-1.88	B	BBB-	A	test
InChI=1S/C21H24Cl2N2O/c1-24(21(26)14-16-9-10-18(22)19(23)13-16)20(15-25-11-5-6-12-25)17-7-3-2-4-8-17/h2-4,7-10,13,20H,5-6,11-12,14-15H2,1H3/t20-/m1/s1	Ici199441|2-(3,4-Dichlorophenyl)-N-Methyl-N-[(1S)-1-Phenyl-2-Pyrrolidin-1-Ylethyl]Acetamide	2-(3,4-dichlorophenyl)-N-methyl-N-[(1S)-1-phenyl-2-pyrrolidin-1-ylethyl]acetamide	CN(C(=O)Cc1ccc(Cl)c(Cl)c1)[C@H](CN1CCCC1)c1ccccc1	3082718.0	R28_li_2005:376			BBB+	C	test
InChI=1S/C21H24ClFN2O/c22-18-6-10-20(11-7-18)25-14-2-13-24(15-16-25)12-1-3-21(26)17-4-8-19(23)9-5-17/h4-11H,1-3,12-16H2	Sya013|4-[4-(4-Chlorophenyl)-1,4-Diazepan-1-Yl]-1-(4-Fluorophenyl)Butan-1-One	4-[4-(4-chlorophenyl)-1,4-diazepan-1-yl]-1-(4-fluorophenyl)butan-1-one	O=C(CCCN1CCCN(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1	11653679.0	R47_radchenko_2020:515	1.48	A	BBB+	A	training
InChI=1S/C21H24ClN3O3/c1-24(15-20(26)25-10-12-28-13-11-25)14-17-18(22)8-5-9-19(17)23-21(27)16-6-3-2-4-7-16/h2-9H,10-15H2,1H3,(H,23,27)	Fominoben	N-[3-chloro-2-[[methyl-(2-morpholin-4-yl-2-oxoethyl)amino]methyl]phenyl]benzamide	CN(CC(=O)N1CCOCC1)Cc1c(Cl)cccc1NC(=O)c1ccccc1	3407.0	R23_gupta_2019:608			BBB-	C	test
InChI=1S/C21H24F3N/c1-14-16-7-4-5-8-18(16)19(9-6-12-25(2)3)20-13-15(21(22,23)24)10-11-17(14)20/h4-5,7-8,10-11,13-14,19H,6,9,12H2,1-3H3	Fluotracen|Fluotracene	N,N-dimethyl-3-[10-methyl-2-(trifluoromethyl)-9,10-dihydroanthracen-9-yl]propan-1-amine	CC1c2ccccc2C(CCCN(C)C)c2cc(C(F)(F)F)ccc21	42291.0	R6_adenot_2004:1470			BBB+	C	training
InChI=1S/C21H24F3N3S/c1-25-11-13-26(14-12-25)9-4-10-27-17-5-2-3-6-19(17)28-20-8-7-16(15-18(20)27)21(22,23)24/h2-3,5-8,15H,4,9-14H2,1H3	117-89-5|Trifluoroperazine|Trifluoperazine|Trifluroperazine	10-[3-(4-methylpiperazin-1-yl)propyl]-2-(trifluoromethyl)phenothiazine	CN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1	5566.0	R4_mente_2005:149|R5_guerra_2008:105|R6_adenot_2004:1692|R7_andres_2006:169|R12_garg_2006:171|R14_ghose_2012:259|R17_fu_2008:46|R21_muehlbacher_2011:138|R23_gupta_2019:252|R25_brito_sanchez_2015:31|R26_chico_2009:431|R28_li_2005:121|R34_broccatelli_2012:93|R40_vilar_2010:279|R47_radchenko_2020:244|R49_norinder_2002:99|R49_norinder_2002:135|R50_sobanska_2019:45	1.43	B	BBB+	A	training
InChI=1S/C21H24F3N3S/c1-25-12-14-26(15-13-25)10-5-11-27-17-7-2-3-8-18(17)28-19-9-4-6-16(20(19)27)21(22,23)24/h2-4,6-9H,5,10-15H2,1H3	Trifluroperazine		CN1CCN(CCCN2c3ccccc3Sc3cccc(C(F)(F)F)c32)CC1		R3_abraham_2006:294|R41_toropov_2017:262	1.44	B	BBB+	A	training
InChI=1S/C21H24FN3O2S/c1-14-18(20(27)25-12-13-28-21(25)23-14)8-11-24-9-6-16(7-10-24)19(26)15-2-4-17(22)5-3-15/h2-5,16H,6-13H2,1H3	Setoperone	6-[2-[4-(4-fluorobenzoyl)piperidin-1-yl]ethyl]-7-methyl-2,3-dihydro-[1,3]thiazolo[3,2-a]pyrimidin-5-one	Cc1nc2n(c(=O)c1CCN1CCC(C(=O)c3ccc(F)cc3)CC1)CCS2	68604.0	R6_adenot_2004:1216			BBB+	C	training
InChI=1S/C21H24FN3O4/c1-29-20-17-13(19(26)14(21(27)28)9-25(17)12-4-5-12)7-15(22)18(20)24-8-11-3-2-6-23-16(11)10-24/h7,9,11-12,16,23H,2-6,8,10H2,1H3,(H,27,28)/t11-,16+/m0/s1	Moxifloxacin Hydrochloride|Moxifloxacin	7-[(4aS,7aS)-1,2,3,4,4a,5,7,7a-octahydropyrrolo[3,4-b]pyridin-6-yl]-1-cyclopropyl-6-fluoro-8-methoxy-4-oxoquinoline-3-carboxylic acid	COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12	152946.0	R14_ghose_2012:704|R23_gupta_2019:760			BBB-	C	training
InChI=1S/C21H24N2/c1-3-7-19-16(5-1)9-10-17-6-2-4-8-20(17)23(19)21-15-22-13-11-18(21)12-14-22/h1-8,18,21H,9-15H2	Quinupramine	11-(1-azabicyclo[2.2.2]octan-3-yl)-5,6-dihydrobenzo[b][1]benzazepine	c1ccc2c(c1)CCc1ccccc1N2C1CN2CCC1CC2	93154.0	R6_adenot_2004:603			BBB+	C	training
InChI=1S/C21H24N2O3/c1-12-16-10-23-8-7-14-13-5-3-4-6-18(13)22-20(14)19(23)9-15(16)17(11-26-12)21(24)25-2/h3-6,11-12,15-16,19,22H,7-10H2,1-2H3	Rauwolfia Serpentina|Lamuran	methyl 16-methyl-17-oxa-3,13-diazapentacyclo[11.8.0.02,10.04,9.015,20]henicosa-2(10),4,6,8,18-pentaene-19-carboxylate	COC(=O)C1=COC(C)C2CN3CCc4c([nH]c5ccccc45)C3CC12	251561.0	R23_gupta_2019:310			BBB+	C	test
InChI=1S/C21H24N2O4/c24-19(22-17-9-3-1-4-10-17)26-15-21(13-7-8-14-21)16-27-20(25)23-18-11-5-2-6-12-18/h1-6,9-12H,7-8,13-16H2,(H,22,24)(H,23,25)	Cyclarbamate	[1-(phenylcarbamoyloxymethyl)cyclopentyl]methyl N-phenylcarbamate	O=C(Nc1ccccc1)OCC1(COC(=O)Nc2ccccc2)CCCC1	72076.0	R6_adenot_2004:1643			BBB+	C	training
InChI=1S/C21H24N2O4S/c24-21-18-8-2-4-10-20(18)28(25,26)23(21)14-6-5-13-22-15-17-12-11-16-7-1-3-9-19(16)27-17/h1-4,7-10,17,22H,5-6,11-15H2/t17-/m1/s1	Repinotan	2-[4-[[(2R)-3,4-dihydro-2H-chromen-2-yl]methylamino]butyl]-1,1-dioxo-1,2-benzothiazol-3-one	O=C1c2ccccc2S(=O)(=O)N1CCCCNC[C@H]1CCc2ccccc2O1	198757.0	R26_chico_2009:347	0.18	A	BBB+	A	training
InChI=1S/C21H24N4O2S/c22-21-25-18(14-28-21)12-20(27)24-17-8-6-15(7-9-17)10-11-23-13-19(26)16-4-2-1-3-5-16/h1-9,14,19,23,26H,10-13H2,(H2,22,25)(H,24,27)/t19-/m0/s1	Mirabegron	2-(2-amino-1,3-thiazol-4-yl)-N-[4-[2-[[(2R)-2-hydroxy-2-phenylethyl]amino]ethyl]phenyl]acetamide	Nc1nc(CC(=O)Nc2ccc(CCNC[C@H](O)c3ccccc3)cc2)cs1	9865528.0	R23_gupta_2019:298			BBB+	C	training
InChI=1S/C21H24N4O3/c1-26-16-3-4-18-17(11-16)21(24-23-18)22-15-6-8-25(9-7-15)12-14-2-5-19-20(10-14)28-13-27-19/h2-5,10-11,15H,6-9,12-13H2,1H3,(H2,22,23,24)	Mchr Antagonist 28|N-(1-(Benzo[D][1,3]Dioxol-5-Ylmethyl)Piperidin-4-Yl)-5-Methoxy-1H-Indazol-3-Amine	N-[1-(1,3-benzodioxol-5-ylmethyl)piperidin-4-yl]-5-methoxy-1H-indazol-3-amine	COc1ccc2[nH]nc(NC3CCN(Cc4ccc5c(c4)OCO5)CC3)c2c1	11531010.0	R25_brito_sanchez_2015:467|R46_mendoza_valencia_2017:392	0.57	B	BBB+	A	training
InChI=1S/C21H24N4O7S/c1-13(25(12-26)10-16-9-23-14(2)24-20(16)22)18(33-21(29)17-5-4-7-30-17)6-8-31-19(28)11-32-15(3)27/h4-5,7,9,12H,6,8,10-11H2,1-3H3,(H2,22,23,24)	Acefurtiamine	[4-[(4-amino-2-methylpyrimidin-5-yl)methyl-formylamino]-3-(furan-2-carbonylsulfanyl)pent-3-enyl] 2-acetyloxyacetate	CC(=O)OCC(=O)OCCC(SC(=O)c1ccco1)=C(C)N(C=O)Cc1cnc(C)nc1N	170369.0	R6_adenot_2004:392			BBB+	C	training
InChI=1S/C21H24O2/c1-3-20-11-9-17-16-8-6-15(22)13-14(16)5-7-18(17)19(20)10-12-21(20,23)4-2/h2,9,11,13,18-19,23H,3,5-8,10,12H2,1H3/t18-,19+,20+,21+/m1/s1	Gestrinone	(8S,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,14,15,16-octahydrocyclopenta[a]phenanthren-3-one	C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3C=C[C@@]21CC	27812.0	R23_gupta_2019:633			BBB-	C	test
InChI=1S/C21H25BrF2O5/c1-18-8-16(27)21(24)11(10(18)3-4-20(18,29)17(28)9-25)5-14(23)12-6-15(26)13(22)7-19(12,21)2/h6-7,10-11,14,16,25,27,29H,3-5,8-9H2,1-2H3/t10-,11-,14+,16-,18-,19-,20-,21-/m0/s1	Halopredone	(6R,8S,9R,10S,11S,13S,14S,17R)-2-bromo-6,9-difluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one	C[C@]12C=C(Br)C(=O)C=C1[C@H](F)C[C@H]1[C@@H]3CC[C@](O)(C(=O)CO)[C@@]3(C)C[C@H](O)[C@@]12F	12788355.0	R6_adenot_2004:866			BBB+	C	training
InChI=1S/C21H25ClN2O3/c22-17-8-6-16(7-9-17)21(19-4-1-2-12-23-19)27-18-10-14-24(15-11-18)13-3-5-20(25)26/h1-2,4,6-9,12,18,21H,3,5,10-11,13-15H2,(H,25,26)/t21-/m0/s1	Bepotastine	4-[4-[(S)-(4-chlorophenyl)-pyridin-2-ylmethoxy]piperidin-1-yl]butanoic acid	O=C(O)CCCN1CCC(O[C@@H](c2ccc(Cl)cc2)c2ccccn2)CC1	164522.0	R14_ghose_2012:388			BBB-	C	test
InChI=1S/C21H25ClN2O3/c22-19-8-6-18(7-9-19)21(17-4-2-1-3-5-17)24-12-10-23(11-13-24)14-15-27-16-20(25)26/h1-9,21H,10-16H2,(H,25,26)	83881-51-0|Cetirizine	2-[2-[4-[(4-chlorophenyl)-phenylmethyl]piperazin-1-yl]ethoxy]acetic acid	O=C(O)COCCN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1	2678.0	R4_mente_2005:113|R6_adenot_2004:349|R7_andres_2006:30|R21_muehlbacher_2011:52|R25_brito_sanchez_2015:184|R28_li_2005:335|R29_subramanian_2003:31|R34_broccatelli_2012:109|R40_vilar_2010:74|R46_mendoza_valencia_2017:171|R47_radchenko_2020:338|R50_sobanska_2019:1	-2.15	D	BBB-	A	training
InChI=1S/C21H25ClN2O3/c22-19-8-6-18(7-9-19)21(17-4-2-1-3-5-17)24-12-10-23(11-13-24)14-15-27-16-20(25)26/h1-9,21H,10-16H2,(H,25,26)/t21-/m1/s1	Levocetirizine	2-[2-[4-[(R)-(4-chlorophenyl)-phenylmethyl]piperazin-1-yl]ethoxy]acetic acid	O=C(O)COCCN1CCN([C@H](c2ccccc2)c2ccc(Cl)cc2)CC1	1549000.0	R14_ghose_2012:653			BBB-	C	training
InChI=1S/C21H25ClN2O4S/c1-24-18-9-6-5-8-16(18)21(23-13-7-3-2-4-10-20(25)26)17-12-11-15(22)14-19(17)29(24,27)28/h5-6,8-9,11-12,14,21,23H,2-4,7,10,13H2,1H3,(H,25,26)	Tianeptine	7-[(3-chloro-6-methyl-5,5-dioxo-11H-benzo[c][2,1]benzothiazepin-11-yl)amino]heptanoic acid	CN1c2ccccc2C(NCCCCCCC(=O)O)c2ccc(Cl)cc2S1(=O)=O	68870.0	R6_adenot_2004:1627|R14_ghose_2012:250|R23_gupta_2019:243|R37_chen_2011:98			BBB+	C	test
InChI=1S/C21H25ClO5/c1-19-5-3-11(24)7-14(19)15(22)8-12-13-4-6-21(27,17(26)10-23)20(13,2)9-16(25)18(12)19/h3,5,7,12-13,15,18,23,27H,4,6,8-10H2,1-2H3/t12-,13-,15-,18+,19-,20-,21-/m0/s1	Chloroprednisone	(6S,8S,9S,10R,13S,14S,17R)-6-chloro-17-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,9,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,11-dione	C[C@]12C=CC(=O)C=C1[C@@H](Cl)C[C@@H]1[C@@H]2C(=O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO	3034026.0	R6_adenot_2004:781			BBB+	C	test
InChI=1S/C21H25ClO5/c1-19-5-3-11(24)7-14(19)15(22)8-12-13-4-6-21(27,17(26)10-23)20(13,2)9-16(25)18(12)19/h3,5,7-8,12-13,16,18,23,25,27H,4,6,9-10H2,1-2H3/t12-,13-,16-,18+,19-,20-,21-/m0/s1	Cloprednol	(8S,9S,10R,11S,13S,14S,17R)-6-chloro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-9,11,12,14,15,16-hexahydro-8H-cyclopenta[a]phenanthren-3-one	C[C@]12C=CC(=O)C=C1C(Cl)=C[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO	5284535.0	R6_adenot_2004:792			BBB+	C	test
InChI=1S/C21H25ClO6/c1-2-27-15-6-3-12(4-7-15)9-14-10-13(5-8-16(14)22)21-20(26)19(25)18(24)17(11-23)28-21/h3-8,10,17-21,23-26H,2,9,11H2,1H3/t17-,18-,19+,20-,21+/m1/s1	Dapagliflozin	(2S,3R,4R,5S,6R)-2-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-6-(hydroxymethyl)oxane-3,4,5-triol	CCOc1ccc(Cc2cc([C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)ccc2Cl)cc1	9887712.0	R23_gupta_2019:495			BBB-	C	training
InChI=1S/C21H25FN2O2/c1-26-21-7-3-2-5-19(21)24-15-13-23(14-16-24)12-4-6-20(25)17-8-10-18(22)11-9-17/h2-3,5,7-11H,4,6,12-16H2,1H3	Fluanisone	1-(4-fluorophenyl)-4-[4-(2-methoxyphenyl)piperazin-1-yl]butan-1-one	COc1ccccc1N1CCN(CCCC(=O)c2ccc(F)cc2)CC1	15139.0	R6_adenot_2004:1156			BBB+	C	training
InChI=1S/C21H25N/c1-21(2)19-13-7-5-10-17(19)16(12-9-15-22(3)4)18-11-6-8-14-20(18)21/h5-8,10-14H,9,15H2,1-4H3	Melitracen	3-(10,10-dimethylanthracen-9-ylidene)-N,N-dimethylpropan-1-amine	CN(C)CCC=C1c2ccccc2C(C)(C)c2ccccc21	25382.0	R6_adenot_2004:574|R14_ghose_2012:287|R23_gupta_2019:134			BBB+	C	training
InChI=1S/C21H25N/c1-21(2,3)15-8-5-9-16-22(4)17-19-13-10-12-18-11-6-7-14-20(18)19/h5-7,9-14H,16-17H2,1-4H3/b9-5+	Terbinafine|91161-71-6	(E)-N,6,6-trimethyl-N-(naphthalen-1-ylmethyl)hept-2-en-4-yn-1-amine	CN(C/C=C/C#CC(C)(C)C)Cc1cccc2ccccc12	1549008.0	R3_abraham_2006:279|R4_mente_2005:32|R21_muehlbacher_2011:131|R23_gupta_2019:966|R25_brito_sanchez_2015:134|R26_chico_2009:408|R40_vilar_2010:266|R41_toropov_2017:251|R46_mendoza_valencia_2017:132|R47_radchenko_2020:234	0.09	B1	BBB+	A	test
InChI=1S/C21H25N3O2/c1-14-24-18-11-16(19(25-2)12-20(18)26-14)13-23-17-9-6-10-22-21(17)15-7-4-3-5-8-15/h3-5,7-8,11-12,17,21-23H,6,9-10,13H2,1-2H3	190275-53-7|Pfizer Compound 19|N-[(6-Methoxy-2-Methyl-1,3-Benzoxazol-5-Yl)Methyl]-2-Phenylpiperidin-3-Amine	N-[(6-methoxy-2-methyl-1,3-benzoxazol-5-yl)methyl]-2-phenylpiperidin-3-amine	COc1cc2oc(C)nc2cc1CNC1CCCNC1c1ccccc1	22620080.0	R4_mente_2005:94|R25_brito_sanchez_2015:545|R40_vilar_2010:192|R46_mendoza_valencia_2017:456|R47_radchenko_2020:435	0.49	B	BBB+	A	training
InChI=1S/C21H25N3O2S/c25-14-16-26-15-13-23-9-11-24(12-10-23)21-17-5-1-3-7-19(17)27-20-8-4-2-6-18(20)22-21/h1-8,25H,9-16H2	Quetiapine	2-[2-(4-benzo[b][1,4]benzothiazepin-6-ylpiperazin-1-yl)ethoxy]ethanol	OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1	5002.0	R6_adenot_2004:1578|R14_ghose_2012:217|R23_gupta_2019:211|R25_brito_sanchez_2015:514|R26_chico_2009:341|R34_broccatelli_2012:75|R37_chen_2011:78|R46_mendoza_valencia_2017:431|R50_sobanska_2019:89	0.7	B	BBB+	A	test
InChI=1S/C21H25N3OS/c1-14-24-18-11-16(19(25-2)12-20(18)26-14)13-23-17-9-6-10-22-21(17)15-7-4-3-5-8-15/h3-5,7-8,11-12,17,21-23H,6,9-10,13H2,1-2H3	163257-80-5|Pfizer Compound 17|N-[(6-Methoxy-2-Methyl-1,3-Benzothiazol-5-Yl)Methyl]-2-Phenylpiperidin-3-Amine	N-[(6-methoxy-2-methyl-1,3-benzothiazol-5-yl)methyl]-2-phenylpiperidin-3-amine	COc1cc2sc(C)nc2cc1CNC1CCCNC1c1ccccc1	22620050.0	R4_mente_2005:92|R25_brito_sanchez_2015:543|R40_vilar_2010:190|R46_mendoza_valencia_2017:454|R47_radchenko_2020:410	0.48	B	BBB+	A	training
InChI=1S/C21H25N5O2/c1-15-8-9-16(13-24-15)12-17-14-25-21(26-20(17)27)23-10-4-3-6-18-19(28-2)7-5-11-22-18/h5,7-9,11,13-14H,3-4,6,10,12H2,1-2H3,(H2,23,25,26,27)	71351-79-6|Icotidine|B-039, Icotidine|Skf 93319|3	2-[4-(3-methoxypyridin-2-yl)butylamino]-5-[(6-methylpyridin-3-yl)methyl]-1H-pyrimidin-6-one	COc1cccnc1CCCCNc1ncc(Cc2ccc(C)nc2)c(=O)[nH]1	72108.0	R4_mente_2005:132|R5_guerra_2008:56|R7_andres_2006:200|R12_garg_2006:91|R21_muehlbacher_2011:269|R25_brito_sanchez_2015:2|R26_chico_2009:43|R28_li_2005:23|R39_shayanfar_2011:51|R40_vilar_2010:128|R46_mendoza_valencia_2017:2|R47_radchenko_2020:272|R47_radchenko_2020:313|R48_hou_2003:38|R49_norinder_2002:3|R49_norinder_2002:155|R52_liu_2001:3	-1.95	B1	BBB-	A	test
InChI=1S/C21H25N5O2/c1-3-22-18-5-4-8-23-20(18)25-9-11-26(12-10-25)21(27)19-14-15-13-16(28-2)6-7-17(15)24-19/h4-8,13-14,22,24H,3,9-12H2,1-2H3	Atevirdine, U87201|Atevirdine	[4-[3-(ethylamino)pyridin-2-yl]piperazin-1-yl]-(5-methoxy-1H-indol-2-yl)methanone	CCNc1cccnc1N1CCN(C(=O)c2cc3cc(OC)ccc3[nH]2)CC1	60848.0	R26_chico_2009:39	-0.01	A	BBB+	A	training
InChI=1S/C21H25N5O8S2/c1-21(2)14(18(29)30)26-16(28)13(17(26)35-21)22-15(27)12(11-7-5-4-6-8-11)23-19(31)24-9-10-25(20(24)32)36(3,33)34/h4-8,12-14,17H,9-10H2,1-3H3,(H,22,27)(H,23,31)(H,29,30)/t12-,13-,14+,17-/m1/s1	Mezlocillin	(2S,5R,6R)-3,3-dimethyl-6-[[(2R)-2-[(3-methylsulfonyl-2-oxoimidazolidine-1-carbonyl)amino]-2-phenylacetyl]amino]-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid	CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](NC(=O)N3CCN(S(C)(=O)=O)C3=O)c3ccccc3)C(=O)N2[C@H]1C(=O)O	656511.0	R6_adenot_2004:245|R23_gupta_2019:748			BBB-	C	training
InChI=1S/C21H25NO/c1-22-14-12-18(13-15-22)23-21-19-8-4-2-6-16(19)10-11-17-7-3-5-9-20(17)21/h2-9,18,21H,10-15H2,1H3	Hepzidine	1-methyl-4-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,11,13-hexaenyloxy)piperidine	CN1CCC(OC2c3ccccc3CCc3ccccc32)CC1	70593.0	R6_adenot_2004:555			BBB+	C	training
InChI=1S/C21H25NO/c1-22-18-12-13-19(22)15-20(14-18)23-21(16-8-4-2-5-9-16)17-10-6-3-7-11-17/h2-11,18-21H,12-15H2,1H3/t18-,19+,20?	Benzatropine|Benztropine	(1S,5R)-3-benzhydryloxy-8-methyl-8-azabicyclo[3.2.1]octane	CN1[C@@H]2CC[C@H]1CC(OC(c1ccccc1)c1ccccc1)C2	1201549.0	R6_adenot_2004:360|R14_ghose_2012:19|R23_gupta_2019:21|R26_chico_2009:78|R51_doninger_2002:162			BBB+	C	test
InChI=1S/C21H25NO2/c1-3-13-10-15-5-4-14(13)11-18(15)21(23)17-8-9-22-20-7-6-16(24-2)12-19(17)20/h3,6-9,12-15,18,21,23H,1,4-5,10-11H2,2H3	(5-Ethenyl-2-Bicyclo[2.2.2]Octanyl)-(6-Methoxyquinolin-4-Yl)Methanol	(5-ethenyl-2-bicyclo[2.2.2]octanyl)-(6-methoxyquinolin-4-yl)methanol	C=CC1CC2CCC1CC2C(O)c1ccnc2ccc(OC)cc12	5009.0	R41_toropov_2017:219|R46_mendoza_valencia_2017:279	0.1	B	BBB+	A	training
InChI=1S/C21H25NO3/c1-12-6-7-21(24)16-10-14-4-5-15(23)18-17(14)20(21,19(12)25-18)8-9-22(16)11-13-2-3-13/h4-5,13,16,19,23-24H,1-3,6-11H2/t16-,19+,20+,21-/m1/s1	Nalmefene	(4R,4aS,7aS,12bS)-3-(cyclopropylmethyl)-7-methylidene-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,9-diol	C=C1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5c4[C@@]2(CCN3CC2CC2)[C@H]1O5	5284594.0	R6_adenot_2004:1061|R14_ghose_2012:161|R23_gupta_2019:159|R37_chen_2011:58			BBB+	C	training
InChI=1S/C21H25NO3/c23-20(25-17-16-22-14-8-3-9-15-22)21(24,18-10-4-1-5-11-18)19-12-6-2-7-13-19/h1-2,4-7,10-13,24H,3,8-9,14-17H2	Pipethanate|Piperilate	2-piperidin-1-ylethyl 2-hydroxy-2,2-diphenylacetate	O=C(OCCN1CCCCC1)C(O)(c1ccccc1)c1ccccc1	20674.0	R6_adenot_2004:1504			BBB+	C	test
InChI=1S/C21H25NO4/c1-12(2)6-9-22-10-8-20-17-13-3-4-14(23)18(17)26-19(20)15(24)5-7-21(20,25)16(22)11-13/h3-4,6,16,19,23,25H,5,7-11H2,1-2H3/t16-,19+,20+,21-/m1/s1	Nalmexone	(4R,4aS,7aR,12bS)-4a,9-dihydroxy-3-(3-methylbut-2-enyl)-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one	CC(C)=CCN1CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@@]3(O)[C@H]1C5	5360516.0	R6_adenot_2004:1062			BBB+	C	training
InChI=1S/C21H25NO4/c1-22(11-12-2-3-12)9-8-20-17-13-4-5-14(23)18(17)26-19(20)15(24)6-7-21(20,25)16(22)10-13/h4-5,12,16,19,25H,2-3,6-11H2,1H3/p+1/t16-,19+,20+,21-,22?/m1/s1	Methylnaltrexone Bromide|Methylnaltrexone	(4R,4aS,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-3-methyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-3-ium-7-one	C[N+]1(CC2CC2)CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@@]3(O)[C@H]1C5	5361918.0	R29_subramanian_2003:106			BBB-	C	training
InChI=1S/C21H25NO4/c1-23-18-6-5-13-9-17-15-11-20(25-3)19(24-2)10-14(15)7-8-22(17)12-16(13)21(18)26-4/h5-6,10-11,17H,7-9,12H2,1-4H3/t17-/m0/s1	Tetrahydropalmatine	(13aS)-2,3,9,10-tetramethoxy-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinoline	COc1cc2c(cc1OC)[C@@H]1Cc3ccc(OC)c(OC)c3CN1CC2	72301.0	R46_mendoza_valencia_2017:482	-0.07	A	BBB+	A	training
InChI=1S/C21H25NO4/c1-23-18-6-5-13-9-17-15-11-20(25-3)19(24-2)10-14(15)7-8-22(17)12-16(13)21(18)26-4/h5-6,10-11,17H,7-9,12H2,1-4H3/t17-/m1/s1	(+)-Tetrahydropalmatine|D-Tetrahydropalmatine	(13aR)-2,3,9,10-tetramethoxy-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinoline	COc1cc2c(cc1OC)[C@H]1Cc3ccc(OC)c(OC)c3CN1CC2	969488.0	R25_brito_sanchez_2015:577	-0.07	A	BBB+	A	training
InChI=1S/C21H26Cl2O4/c1-18-7-5-13(25)9-12(18)3-4-15-14-6-8-20(27,17(26)11-24)19(14,2)10-16(22)21(15,18)23/h5,7,9,14-16,24,27H,3-4,6,8,10-11H2,1-2H3/t14-,15-,16-,18-,19-,20-,21-/m0/s1	Dichlorisone	(8S,9R,10S,11S,13S,14S,17R)-9,11-dichloro-17-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one	C[C@]12C=CC(=O)C=C1CC[C@H]1[C@@H]3CC[C@](O)(C(=O)CO)[C@@]3(C)C[C@H](Cl)[C@@]12Cl	20054892.0	R6_adenot_2004:821			BBB+	C	test
InChI=1S/C21H26ClN3O2/c1-14-18(9-10-25(14)13-15-7-5-4-6-8-15)24-21(26)16-11-17(22)19(23-2)12-20(16)27-3/h4-8,11-12,14,18,23H,9-10,13H2,1-3H3,(H,24,26)/t14-,18-/m0/s1	Nemonapride|(2S,3S)-Nemonapride	N-[(2S,3S)-1-benzyl-2-methylpyrrolidin-3-yl]-5-chloro-2-methoxy-4-(methylamino)benzamide	CNc1cc(OC)c(C(=O)N[C@H]2CCN(Cc3ccccc3)[C@H]2C)cc1Cl	9952220.0	R37_chen_2011:60			BBB+	C	training
InChI=1S/C21H26ClN3O2/c1-14-18(9-10-25(14)13-15-7-5-4-6-8-15)24-21(26)16-11-17(22)19(23-2)12-20(16)27-3/h4-8,11-12,14,18,23H,9-10,13H2,1-3H3,(H,24,26)/t14-,18-/m1/s1	Nemonapride	N-[(2R,3R)-1-benzyl-2-methylpyrrolidin-3-yl]-5-chloro-2-methoxy-4-(methylamino)benzamide	CNc1cc(OC)c(C(=O)N[C@@H]2CCN(Cc3ccccc3)[C@@H]2C)cc1Cl	156333.0	R6_adenot_2004:1187|R14_ghose_2012:166|R23_gupta_2019:165			BBB+	C	training
InChI=1S/C21H26ClN3OS/c22-17-6-7-21-19(16-17)25(18-4-1-2-5-20(18)27-21)9-3-8-23-10-12-24(13-11-23)14-15-26/h1-2,4-7,16,26H,3,8-15H2	Perphenazine	2-[4-[3-(2-chlorophenothiazin-10-yl)propyl]piperazin-1-yl]ethanol	OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1	4748.0	R6_adenot_2004:1606|R7_andres_2006:129|R14_ghose_2012:190|R25_brito_sanchez_2015:508|R26_chico_2009:306|R28_li_2005:387|R29_subramanian_2003:125|R46_mendoza_valencia_2017:426	0.7	B	BBB+	A	training
InChI=1S/C21H26ClNO/c1-21(17-7-4-3-5-8-17,18-10-12-19(22)13-11-18)24-16-14-20-9-6-15-23(20)2/h3-5,7-8,10-13,20H,6,9,14-16H2,1-2H3/t20-,21-/m1/s1	Clemastine	(2R)-2-[2-[(1R)-1-(4-chlorophenyl)-1-phenylethoxy]ethyl]-1-methylpyrrolidine	CN1CCC[C@@H]1CCO[C@](C)(c1ccccc1)c1ccc(Cl)cc1	26987.0	R14_ghose_2012:50|R23_gupta_2019:49|R26_chico_2009:107|R34_broccatelli_2012:17|R50_sobanska_2019:111			BBB+	C	training
InChI=1S/C21H26F2O6/c1-18-4-3-10(25)5-13(18)14(22)6-12-11-7-15(26)21(29,17(28)9-24)19(11,2)8-16(27)20(12,18)23/h3-5,11-12,14-16,24,26-27,29H,6-9H2,1-2H3/t11-,12-,14-,15+,16-,18-,19-,20-,21-/m0/s1	Fluocinolone	(6S,8S,9R,10S,11S,13S,14S,16R,17S)-6,9-difluoro-11,16,17-trihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one	C[C@]12C=CC(=O)C=C1[C@@H](F)C[C@H]1[C@@H]3C[C@@H](O)[C@](O)(C(=O)CO)[C@@]3(C)C[C@H](O)[C@@]12F	91488.0	R6_adenot_2004:846			BBB+	C	training
InChI=1S/C21H26F3N5/c22-21(23,24)16-4-2-5-17(13-16)28-11-9-27(10-12-28)8-7-19-25-26-20-18-6-1-3-15(18)14-29(19)20/h2,4-5,13,15,18H,1,3,6-12,14H2/t15-,18-/m0/s1	Lorpiprazole	(1S,8R)-5-[2-[4-[3-(trifluoromethyl)phenyl]piperazin-1-yl]ethyl]-3,4,6-triazatricyclo[6.3.0.02,6]undeca-2,4-diene	FC(F)(F)c1cccc(N2CCN(CCc3nnc4n3C[C@@H]3CCC[C@H]43)CC2)c1	20055414.0	R6_adenot_2004:1480			BBB+	C	training
InChI=1S/C21H26N2O2/c1-24-18-12-16-9-11-25-21(16)17(13-18)14-23-19-8-5-10-22-20(19)15-6-3-2-4-7-15/h2-4,6-7,12-13,19-20,22-23H,5,8-11,14H2,1H3/t19-,20+/m0/s1			COc1cc2c(c(CN[C@H]3CCCN[C@@H]3c3ccccc3)c1)OCC2		R48_hou_2003:15	0.39	A	BBB+	A	training
InChI=1S/C21H26N2O2/c1-24-18-12-16-9-11-25-21(16)17(13-18)14-23-19-8-5-10-22-20(19)15-6-3-2-4-7-15/h2-4,6-7,12-13,19-20,22-23H,5,8-11,14H2,1H3/t19-,20+/m1/s1	9-C15		COc1cc2c(c(CN[C@@H]3CCCN[C@H]3c3ccccc3)c1)OCC2		R28_li_2005:171			BBB+	C	training
InChI=1S/C21H26N2O2S2/c1-22-13-6-5-7-16(22)12-14-23-18-8-3-4-9-20(18)26-21-11-10-17(15-19(21)23)27(2,24)25/h3-4,8-11,15-16H,5-7,12-14H2,1-2H3	Sulforidazine|14759-06-9	10-[2-(1-methylpiperidin-2-yl)ethyl]-2-methylsulfonylphenothiazine	CN1CCCCC1CCN1c2ccccc2Sc2ccc(S(C)(=O)=O)cc21	31765.0	R3_abraham_2006:278|R4_mente_2005:171|R5_guerra_2008:92|R6_adenot_2004:1222|R12_garg_2006:154|R21_muehlbacher_2011:242|R25_brito_sanchez_2015:144|R26_chico_2009:393|R28_li_2005:115|R39_shayanfar_2011:86|R40_vilar_2010:262|R41_toropov_2017:250|R46_mendoza_valencia_2017:142|R47_radchenko_2020:233	0.18	B1	BBB+	A	test
InChI=1S/C21H26N2O3/c1-26-21(25)19-15-10-17-20-14(13-4-2-3-5-16(13)22-20)8-9-23(17)11-12(15)6-7-18(19)24/h2-5,12,15,17-19,22,24H,6-11H2,1H3/t12-,15-,17-,18-,19+/m0/s1	Yohimbine	methyl (1S,15R,18S,19R,20S)-18-hydroxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate	COC(=O)[C@@H]1[C@H]2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@@H]2CC[C@@H]1O	8969.0	R51_doninger_2002:144			BBB-	C	test
InChI=1S/C21H26N2O3/c1-3-20-10-6-11-22-12-9-15-14-7-4-5-8-16(14)23(17(15)18(20)22)21(25,13-20)19(24)26-2/h4-5,7-8,18,25H,3,6,9-13H2,1-2H3/t18-,20+,21+/m1/s1	Vincamine	methyl (15S,17S,19S)-15-ethyl-17-hydroxy-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18)-tetraene-17-carboxylate	CC[C@]12CCCN3CCc4c(n(c5ccccc45)[C@@](O)(C(=O)OC)C1)[C@@H]32	15376.0	R14_ghose_2012:932			BBB-	C	test
InChI=1S/C21H26N2O4/c1-26-20-9-8-16(14-21(20)27-2)19(25)15-22-10-12-23(13-11-22)17-6-4-3-5-7-18(17)24/h3-9,14,19,25H,10-13,15H2,1-2H3/t19-/m1/s1	Ciladopa	2-[4-[(2S)-2-(3,4-dimethoxyphenyl)-2-hydroxyethyl]piperazin-1-yl]cyclohepta-2,4,6-trien-1-one	COc1ccc([C@H](O)CN2CCN(c3cccccc3=O)CC2)cc1OC	133371.0	R6_adenot_2004:645			BBB+	C	training
InChI=1S/C21H26N2O7/c1-12(2)30-21(25)18-14(4)22-13(3)17(20(24)29-10-9-28-5)19(18)15-7-6-8-16(11-15)23(26)27/h6-8,11-12,19,22H,9-10H2,1-5H3	Nimodipine	3-O-(2-methoxyethyl) 5-O-propan-2-yl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate	COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)C1c1cccc([N+](=O)[O-])c1	4497.0	R14_ghose_2012:168|R23_gupta_2019:304|R25_brito_sanchez_2015:579|R34_broccatelli_2012:59|R37_chen_2011:63	0.08	A	BBB+	A	training
InChI=1S/C21H26N2OS/c1-22-13-6-5-7-16(22)12-14-23-18-8-3-4-9-20(18)25-21-11-10-17(24-2)15-19(21)23/h3-4,8-11,15-16H,5-7,12-14H2,1-2H3	Oxyridazine	2-methoxy-10-[2-(1-methylpiperidin-2-yl)ethyl]phenothiazine	COc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2	65612.0	R6_adenot_2004:1193			BBB+	C	test
InChI=1S/C21H26N2OS2/c1-22-13-6-5-7-16(22)12-14-23-18-8-3-4-9-20(18)25-21-11-10-17(26(2)24)15-19(21)23/h3-4,8-11,15-16H,5-7,12-14H2,1-2H3	32672-69-8|Mesoridazine	10-[2-(1-methylpiperidin-2-yl)ethyl]-2-methylsulfinylphenothiazine	CN1CCCCC1CCN1c2ccccc2Sc2ccc(S(C)=O)cc21	4078.0	R4_mente_2005:156|R5_guerra_2008:62|R6_adenot_2004:1178|R12_garg_2006:105|R14_ghose_2012:139|R21_muehlbacher_2011:96|R23_gupta_2019:140|R25_brito_sanchez_2015:286|R26_chico_2009:260|R28_li_2005:94|R39_shayanfar_2011:57|R40_vilar_2010:144|R47_radchenko_2020:277|R51_doninger_2002:247	-0.36	D	BBB+	A	test
InChI=1S/C21H26N2S2/c1-22-13-6-5-7-16(22)12-14-23-18-8-3-4-9-20(18)25-21-11-10-17(24-2)15-19(21)23/h3-4,8-11,15-16H,5-7,12-14H2,1-2H3	Thioridazine|50-52-2	10-[2-(1-methylpiperidin-2-yl)ethyl]-2-methylsulfanylphenothiazine	CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2	5452.0	R3_abraham_2006:286|R3_abraham_2006:287|R3_abraham_2006:288|R4_mente_2005:172|R5_guerra_2008:100|R6_adenot_2004:1626|R12_garg_2006:164|R14_ghose_2012:247|R17_fu_2008:47|R21_muehlbacher_2011:135|R23_gupta_2019:241|R25_brito_sanchez_2015:122|R26_chico_2009:415|R28_li_2005:49|R34_broccatelli_2012:140|R40_vilar_2010:273|R41_toropov_2017:257|R46_mendoza_valencia_2017:120|R47_radchenko_2020:240|R49_norinder_2002:100|R49_norinder_2002:136|R50_sobanska_2019:27|R51_doninger_2002:312|R53_friden_2009:38	0.24	D	BBB+	A	test
InChI=1S/C21H26N2S2/c1-22-13-6-5-7-16(22)12-14-23-18-8-3-4-9-20(18)25-21-11-10-17(24-2)15-19(21)23/h3-4,8-11,15-16H,5-7,12-14H2,1-2H3/t16-/m1/s1	10-{2-[(2R)-1-Methylpiperidin-2-Yl]Ethyl}-2-(Methylsulfanyl)-10H-Phenothiazine	10-[2-[(2R)-1-methylpiperidin-2-yl]ethyl]-2-methylsulfanylphenothiazine	CSc1ccc2c(c1)N(CC[C@H]1CCCCN1C)c1ccccc1S2	6604030.0	R48_hou_2003:22	0.24	A	BBB+	A	test
InChI=1S/C21H26N4O3S/c1-24(2)14-18-8-9-19(28-18)15-29-11-10-22-21-20(25(26)27)17(13-23-21)12-16-6-4-3-5-7-16/h3-9,13,22-23H,10-12,14-15H2,1-2H3	Skb25|112598-43-3|Bbcpd60|Chebi: 338035|21|4-Benzyl-N-[2-[[5-[(Dimethylamino)Methyl]Furan-2-Yl]Methylsulfanyl]Ethyl]-3-Nitro-1H-Pyrrol-2-Amine	4-benzyl-N-[2-[[5-[(dimethylamino)methyl]furan-2-yl]methylsulfanyl]ethyl]-3-nitro-1H-pyrrol-2-amine	CN(C)Cc1ccc(CSCCNc2[nH]cc(Cc3ccccc3)c2[N+](=O)[O-])o1	14022484.0	R3_abraham_2006:265|R4_mente_2005:129|R12_garg_2006:43|R21_muehlbacher_2011:350|R25_brito_sanchez_2015:15|R28_li_2005:313|R40_vilar_2010:48|R41_toropov_2017:237|R46_mendoza_valencia_2017:15|R47_radchenko_2020:220|R48_hou_2003:50|R52_liu_2001:21	-0.73	B	BBB+	A	training
InChI=1S/C21H26N8O6S2/c1-35-26-11(14-25-20(23)37-27-14)15(30)24-12-16(31)28-13(18(32)33)10(9-36-17(12)28)8-29-5-2-21(3-6-29,4-7-29)19(22)34/h12,17H,2-9H2,1H3,(H5-,22,23,24,25,27,30,32,33,34)/b26-11-/t12-,17-,21?,29?/m1/s1	Cefclidin	1-[[(6R,7R)-7-[[(2E)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-methoxyiminoacetyl]amino]-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]-1-azoniabicyclo[2.2.2]octane-4-carboximidate	[H]/N=C(\[O-])C12CC[N+](CC3=C(C(=O)O)N4C(=O)[C@@H](NC(=O)/C(=N/OC)c5nsc(N)n5)[C@H]4SC3)(CC1)CC2	132925831.0	R6_adenot_2004:221			BBB-	C	training
InChI=1S/C21H26NO3/c1-22(2)15-9-14-19(16-22)25-20(23)21(24,17-10-5-3-6-11-17)18-12-7-4-8-13-18/h3-8,10-13,19,24H,9,14-16H2,1-2H3/q+1	Mepenzolate Bromide|Mepenzolate	(1,1-dimethylpiperidin-1-ium-3-yl) 2-hydroxy-2,2-diphenylacetate	C[N+]1(C)CCCC(OC(=O)C(O)(c2ccccc2)c2ccccc2)C1	4057.0	R14_ghose_2012:677|R51_doninger_2002:84			BBB-	C	training
InChI=1S/C21H26NO3/c1-4-22(3,5-2)14-15-24-21(23)20-16-10-6-8-12-18(16)25-19-13-9-7-11-17(19)20/h6-13,20H,4-5,14-15H2,1-3H3/q+1	Methantheline Bromide|Methantheline	diethyl-methyl-[2-(9H-xanthene-9-carbonyloxy)ethyl]azanium	CC[N+](C)(CC)CCOC(=O)C1c2ccccc2Oc2ccccc21	4097.0	R14_ghose_2012:683|R23_gupta_2019:734|R51_doninger_2002:88			BBB-	C	training
InChI=1S/C21H26O2/c1-3-20-11-9-17-16-8-6-15(22)13-14(16)5-7-18(17)19(20)10-12-21(20,23)4-2/h2,10,12-13,16-19,23H,3,5-9,11H2,1H3/t16-,17+,18+,19-,20-,21-/m0/s1	Gestodene	(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14-decahydrocyclopenta[a]phenanthren-3-one	C#C[C@]1(O)C=C[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21CC	3033968.0	R23_gupta_2019:632			BBB-	C	training
InChI=1S/C21H26O2/c1-4-21(22)12-10-19-18-7-5-14-13-15(23-3)6-8-16(14)17(18)9-11-20(19,21)2/h1,6,8,13,17-19,22H,5,7,9-12H2,2-3H3/t17-,18-,19+,20+,21+/m1/s1	Mestranol	(8R,9S,13S,14S,17R)-17-ethynyl-3-methoxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-ol	C#C[C@]1(O)CC[C@H]2[C@@H]3CCc4cc(OC)ccc4[C@H]3CC[C@@]21C	6291.0	R23_gupta_2019:731|R51_doninger_2002:87			BBB-	C	training
InChI=1S/C21H26O3/c1-14(8-7-9-15(2)12-21(22)23)10-11-19-16(3)13-20(24-6)18(5)17(19)4/h7-13H,1-6H3,(H,22,23)/b9-7+,11-10+,14-8+,15-12+	Acitretin	(2E,4E,6E,8E)-9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethylnona-2,4,6,8-tetraenoic acid	COc1cc(C)c(/C=C/C(C)=C/C=C/C(C)=C/C(=O)O)c(C)c1C	5284513.0	R14_ghose_2012:329|R23_gupta_2019:1043			BBB-	C	training
InChI=1S/C21H26O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h5,7,9,14-15,18,22,26H,3-4,6,8,10-11H2,1-2H3/t14-,15-,18+,19-,20-,21-/m0/s1	Prednisone	(8S,9S,10R,13S,14S,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,9,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,11-dione	C[C@]12C=CC(=O)C=C1CC[C@@H]1[C@@H]2C(=O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO	5865.0	R6_adenot_2004:899|R7_andres_2006:140|R26_chico_2009:317|R29_subramanian_2003:135|R51_doninger_2002:116	-0.9	A	BBB+	A	test
InChI=1S/C21H27ClN2O2/c22-20-8-6-19(7-9-20)21(18-4-2-1-3-5-18)24-12-10-23(11-13-24)14-16-26-17-15-25/h1-9,21,25H,10-17H2	Hydroxyzine|68-88-2	2-[2-[4-[(4-chlorophenyl)-phenylmethyl]piperazin-1-yl]ethoxy]ethanol	OCCOCCN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1	3658.0	R3_abraham_2006:180|R4_mente_2005:114|R5_guerra_2008:54|R6_adenot_2004:1477|R12_garg_2006:88|R14_ghose_2012:110|R17_fu_2008:40|R21_muehlbacher_2011:85|R23_gupta_2019:111|R25_brito_sanchez_2015:251|R26_chico_2009:214|R28_li_2005:21|R34_broccatelli_2012:39|R40_vilar_2010:124|R41_toropov_2017:166|R42_ciura_2020:20|R46_mendoza_valencia_2017:226|R47_radchenko_2020:152|R49_norinder_2002:94|R49_norinder_2002:128|R50_sobanska_2019:26|R51_doninger_2002:230	0.39	D	BBB+	A	training
InChI=1S/C21H27ClN2O2/c22-20-8-6-19(7-9-20)21(18-4-2-1-3-5-18)24-12-10-23(11-13-24)14-16-26-17-15-25/h1-9,21,25H,10-17H2/t21-/m0/s1	(S)-Hydroxyzine	2-[2-[4-[(S)-(4-chlorophenyl)-phenylmethyl]piperazin-1-yl]ethoxy]ethanol	OCCOCCN1CCN([C@@H](c2ccccc2)c2ccc(Cl)cc2)CC1	1548976.0	R48_hou_2003:96	0.39	A	BBB+	A	training
InChI=1S/C21H27ClO5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,18(25)27-11-22)20(15,2)10-16(24)17(14)19/h5,7,9,14-17,24,26H,3-4,6,8,10-11H2,1-2H3/t14-,15-,16-,17+,19-,20-,21-/m0/s1	Loteprednol	chloromethyl (8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-17-carboxylate	C[C@]12C=CC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)OCCl	9865442.0	R6_adenot_2004:873			BBB+	C	test
InChI=1S/C21H27FN2O2/c1-26-21-7-3-2-5-19(21)24-15-13-23(14-16-24)12-4-6-20(25)17-8-10-18(22)11-9-17/h2-3,5,7-11,20,25H,4,6,12-16H2,1H3	Anisopirol	1-(4-fluorophenyl)-4-[4-(2-methoxyphenyl)piperazin-1-yl]butan-1-ol	COc1ccccc1N1CCN(CCCC(O)c2ccc(F)cc2)CC1	13333.0	R6_adenot_2004:1115			BBB+	C	training
InChI=1S/C21H27FO5/c1-11(23)21(27)16(25)9-15-14-5-4-12-8-13(24)6-7-18(12,2)20(14,22)17(26)10-19(15,21)3/h6-8,14-17,25-27H,4-5,9-10H2,1-3H3/t14-,15-,16+,17-,18-,19-,20-,21+/m0/s1	Descinolone	(8S,9R,10S,11S,13S,14S,16R,17S)-17-acetyl-9-fluoro-11,16,17-trihydroxy-10,13-dimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one	CC(=O)[C@@]1(O)[C@H](O)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C	250822.0	R6_adenot_2004:813			BBB+	C	training
InChI=1S/C21H27FO5/c1-18-7-5-13(24)9-12(18)3-4-15-14-6-8-20(27,17(26)11-23)19(14,2)10-16(25)21(15,18)22/h5,7,9,14-16,23,25,27H,3-4,6,8,10-11H2,1-2H3/t14-,15-,16-,18-,19-,20-,21-/m0/s1	Isoflupredone	(8S,9R,10S,11S,13S,14S,17R)-9-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one	C[C@]12C=CC(=O)C=C1CC[C@H]1[C@@H]3CC[C@](O)(C(=O)CO)[C@@]3(C)C[C@H](O)[C@@]12F	127516.0	R6_adenot_2004:920			BBB+	C	training
InChI=1S/C21H27N/c1-16(15-22(2)3)14-21-19-10-6-4-8-17(19)12-13-18-9-5-7-11-20(18)21/h4-11,16,21H,12-15H2,1-3H3	Butriptyline	N,N,2-trimethyl-3-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,11,13-hexaenyl)propan-1-amine	CC(CC1c2ccccc2CCc2ccccc21)CN(C)C	21772.0	R6_adenot_2004:1545			BBB+	C	test
InChI=1S/C21H27N/c1-20(2,3)22-16-14-21(15-17-22,18-10-6-4-7-11-18)19-12-8-5-9-13-19/h4-13H,14-17H2,1-3H3	Budipine	1-tert-butyl-4,4-diphenylpiperidine	CC(C)(C)N1CCC(c2ccccc2)(c2ccccc2)CC1	68778.0	R6_adenot_2004:498|R25_brito_sanchez_2015:444|R26_chico_2009:86|R37_chen_2011:13|R46_mendoza_valencia_2017:370	0.66	D	BBB+	A	test
InChI=1S/C21H27N3/c1-16-14-23(15-17(2)22-16)12-7-13-24-20-10-5-3-8-18(20)19-9-4-6-11-21(19)24/h3-6,8-11,16-17,22H,7,12-15H2,1-2H3/t16-,17+	Rimcazole	9-[3-[(3S,5R)-3,5-dimethylpiperazin-1-yl]propyl]carbazole	C[C@@H]1CN(CCCn2c3ccccc3c3ccccc32)C[C@H](C)N1	53389.0	R6_adenot_2004:1209			BBB+	C	training
InChI=1S/C21H27N3O2/c1-23(21(26)13-17-9-5-6-10-19(17)22)20(16-7-3-2-4-8-16)15-24-12-11-18(25)14-24/h2-10,18,20,25H,11-15,22H2,1H3/t18-,20+/m1/s1	Emd60400		CN(C(=O)Cc1ccccc1N)[C@@H](CN1CC[C@@H](O)C1)c1ccccc1		R28_li_2005:352			BBB-	C	test
InChI=1S/C21H27N3O2/c1-4-15(12-25)22-21(26)14-8-17-16-6-5-7-18-20(16)13(10-23(18)2)9-19(17)24(3)11-14/h5-8,10,14-15,19,25H,4,9,11-12H2,1-3H3,(H,22,26)/t14-,15+,19-/m1/s1	Methysergide	(6aR,9R)-N-[(2S)-1-hydroxybutan-2-yl]-4,7-dimethyl-6,6a,8,9-tetrahydroindolo[4,3-fg]quinoline-9-carboxamide	CC[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4c3c(cn4C)C[C@H]2N(C)C1	9681.0	R14_ghose_2012:149|R23_gupta_2019:149			BBB+	C	training
InChI=1S/C21H27N3O5S/c1-20(2)15(19(27)29-11-28-5)23-17(26)14(18(23)30-20)24-16(25)13(22-21(24,3)4)12-9-7-6-8-10-12/h6-10,13-15,18,22H,11H2,1-5H3/t13?,14-,15+,18-/m1/s1	Sarpicillin	methoxymethyl (2S,5R,6R)-6-(2,2-dimethyl-5-oxo-4-phenylimidazolidin-1-yl)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate	COCOC(=O)[C@@H]1N2C(=O)[C@@H](N3C(=O)C(c4ccccc4)NC3(C)C)[C@H]2SC1(C)C	65429.0	R6_adenot_2004:267			BBB-	C	training
InChI=1S/C21H27N3O6S/c1-20(2)15(19(28)30-10-29-5)23-17(27)14(18(23)31-20)24-16(26)13(22-21(24,3)4)11-6-8-12(25)9-7-11/h6-9,13-15,18,22,25H,10H2,1-5H3/t13?,14-,15+,18-/m1/s1	Sarmoxicillin	methoxymethyl (2S,5R,6R)-6-[4-(4-hydroxyphenyl)-2,2-dimethyl-5-oxoimidazolidin-1-yl]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate	COCOC(=O)[C@@H]1N2C(=O)[C@@H](N3C(=O)C(c4ccc(O)cc4)NC3(C)C)[C@H]2SC1(C)C	9933415.0	R6_adenot_2004:266			BBB-	C	training
InChI=1S/C21H27N3O7S/c1-5-29-20(28)31-11(2)30-19(27)15-21(3,4)32-18-14(17(26)24(15)18)23-16(25)13(22)12-9-7-6-8-10-12/h6-11,13-15,18H,5,22H2,1-4H3,(H,23,25)/t11?,13-,14-,15+,18-/m1/s1	Bacampicillin Hydrochloride|Bacampicillin	1-ethoxycarbonyloxyethyl (2S,5R,6R)-6-[[(2R)-2-amino-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate	CCOC(=O)OC(C)OC(=O)[C@@H]1N2C(=O)[C@@H](NC(=O)[C@H](N)c3ccccc3)[C@H]2SC1(C)C	441397.0	R14_ghose_2012:372|R23_gupta_2019:376			BBB-	C	test
InChI=1S/C21H27N3OS/c1-24(2)15-19-8-9-20(25-19)16-26-13-12-23-21-18(10-11-22-21)14-17-6-4-3-5-7-17/h3-11,22-23H,12-16H2,1-2H3	B-057		CN(C)Cc1ccc(CSCCNc2[nH]ccc2Cc2ccccc2)o1		R26_chico_2009:55	-0.73	A	BBB+	A	training
InChI=1S/C21H27N5O2S/c1-14-4-5-15(11-24-14)10-16-12-25-20(26-19(16)27)23-8-9-29-13-17-6-7-18(28-17)21(2,3)22/h4-7,11-12H,8-10,13,22H2,1-3H3,(H2,23,25,26,27)	Lupitidine|Lupitidinum|2-[2-[[5-(2-Aminopropan-2-Yl)Furan-2-Yl]Methylsulfanyl]Ethylamino]-5-[(6-Methylpyridin-3-Yl)Methyl]-1H-Pyrimidin-6-One	2-[2-[[5-(2-aminopropan-2-yl)furan-2-yl]methylsulfanyl]ethylamino]-5-[(6-methylpyridin-3-yl)methyl]-1H-pyrimidin-6-one	Cc1ccc(Cc2cnc(NCCSCc3ccc(C(C)(C)N)o3)[nH]c2=O)cn1	51671.0	R21_muehlbacher_2011:250|R21_muehlbacher_2011:251|R46_mendoza_valencia_2017:344	-1.06	B	BBB-	A	training
InChI=1S/C21H27N5O2S/c1-15-4-5-16(11-23-15)10-17-12-24-21(25-20(17)27)22-8-9-29-14-19-7-6-18(28-19)13-26(2)3/h4-7,11-12H,8-10,13-14H2,1-3H3,(H2,22,24,25,27)	Lupitidine|83903-06-4|B-041, Lupitidine	2-[2-[[5-[(dimethylamino)methyl]furan-2-yl]methylsulfanyl]ethylamino]-5-[(6-methylpyridin-3-yl)methyl]-1H-pyrimidin-6-one	Cc1ccc(Cc2cnc(NCCSCc3ccc(CN(C)C)o3)[nH]c2=O)cn1	4375468.0	R3_abraham_2006:192|R4_mente_2005:141|R5_guerra_2008:59|R7_andres_2006:205|R12_garg_2006:103|R25_brito_sanchez_2015:4|R26_chico_2009:45|R28_li_2005:27|R29_subramanian_2003:91|R39_shayanfar_2011:56|R40_vilar_2010:141|R41_toropov_2017:176|R46_mendoza_valencia_2017:4|R47_radchenko_2020:162|R48_hou_2003:48|R49_norinder_2002:5|R49_norinder_2002:156	-1.06	B	BBB-	A	training
InChI=1S/C21H27N5O4S/c1-15-13-24-19(14-23-15)20(27)22-12-11-16-7-9-18(10-8-16)31(29,30)26-21(28)25-17-5-3-2-4-6-17/h7-10,13-14,17H,2-6,11-12H2,1H3,(H,22,27)(H2,25,26,28)	Glipizide	N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-5-methylpyrazine-2-carboxamide	Cc1cnc(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)NC3CCCCC3)cc2)cn1	3478.0	R14_ghose_2012:592|R23_gupta_2019:636			BBB-	C	training
InChI=1S/C21H27N5O7S/c1-21(2)15(20(32)33)26-18(31)14(19(26)34-21)25-17(30)13(9-4-6-10(27)7-5-9)24-16(29)11(22)8-12(28)23-3/h4-7,11,13-15,19,27H,8,22H2,1-3H3,(H,23,28)(H,24,29)(H,25,30)(H,32,33)/t11-,13-,14-,15+,19-/m1/s1	Aspoxicillin	(2S,5R,6R)-6-[[(2R)-2-[[(2R)-2-amino-4-(methylamino)-4-oxobutanoyl]amino]-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid	CNC(=O)C[C@@H](N)C(=O)N[C@@H](C(=O)N[C@@H]1C(=O)N2[C@@H]1SC(C)(C)[C@@H]2C(=O)O)c1ccc(O)cc1	71961.0	R6_adenot_2004:140			BBB-	C	test
InChI=1S/C21H27NO/c1-5-20(23)21(16-17(2)22(3)4,18-12-8-6-9-13-18)19-14-10-7-11-15-19/h6-15,17H,5,16H2,1-4H3	Methadone	6-(dimethylamino)-4,4-diphenylheptan-3-one	CCC(=O)C(CC(C)N(C)C)(c1ccccc1)c1ccccc1	4095.0	R6_adenot_2004:1058|R7_andres_2006:208|R14_ghose_2012:143|R23_gupta_2019:142|R25_brito_sanchez_2015:506|R26_chico_2009:261|R29_subramanian_2003:97|R46_mendoza_valencia_2017:424|R47_radchenko_2020:502	0.9	D	BBB+	A	training
InChI=1S/C21H27NO/c1-5-20(23)21(16-17(2)22(3)4,18-12-8-6-9-13-18)19-14-10-7-11-15-19/h6-15,17H,5,16H2,1-4H3/t17-/m1/s1	Levomethadone	(6R)-6-(dimethylamino)-4,4-diphenylheptan-3-one	CCC(=O)C(C[C@@H](C)N(C)C)(c1ccccc1)c1ccccc1	22267.0	R6_adenot_2004:1048			BBB+	C	training
InChI=1S/C21H27NO/c1-5-20(23)21(17(2)16-22(3)4,18-12-8-6-9-13-18)19-14-10-7-11-15-19/h6-15,17H,5,16H2,1-4H3	Isomethadone	6-(dimethylamino)-5-methyl-4,4-diphenylhexan-3-one	CCC(=O)C(c1ccccc1)(c1ccccc1)C(C)CN(C)C	10072.0	R6_adenot_2004:1044			BBB+	C	training
InChI=1S/C21H27NO2/c1-16(21(24)19-7-9-20(23)10-8-19)22-13-11-18(12-14-22)15-17-5-3-2-4-6-17/h2-10,16,18,21,23-24H,11-15H2,1H3	Ifenprodil	4-[2-(4-benzylpiperidin-1-yl)-1-hydroxypropyl]phenol	CC(C(O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1	3689.0	R7_andres_2006:85|R14_ghose_2012:113|R23_gupta_2019:113|R29_subramanian_2003:78			BBB+	C	training
InChI=1S/C21H27NO3/c1-2-14-22-15-18(23)16-25-21-11-7-6-10-19(21)20(24)13-12-17-8-4-3-5-9-17/h3-11,18,22-23H,2,12-16H2,1H3	Propafenone	1-[2-[2-hydroxy-3-(propylamino)propoxy]phenyl]-3-phenylpropan-1-one	CCCNCC(O)COc1ccccc1C(=O)CCc1ccccc1	4932.0	R6_adenot_2004:59			BBB-	C	training
InChI=1S/C21H27NO4/c23-14-5-4-13-10-16-21(25)7-6-15(24)19-20(21,17(13)18(14)26-19)8-9-22(16)11-12-2-1-3-12/h4-5,12,15-16,19,23-25H,1-3,6-11H2/t15-,16+,19-,20-,21+/m0/s1	Nalbuphine	(4R,4aS,7S,7aR,12bS)-3-(cyclobutylmethyl)-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,7,9-triol	Oc1ccc2c3c1O[C@H]1[C@@H](O)CC[C@@]4(O)[C@@H](C2)N(CC2CCC2)CC[C@]314	5311304.0	R6_adenot_2004:1060|R14_ghose_2012:160|R23_gupta_2019:158|R26_chico_2009:280			BBB+	C	test
InChI=1S/C21H28N2O5/c1-23(2)10-11-28-17-8-6-15(7-9-17)14-22-21(24)16-12-18(25-3)20(27-5)19(13-16)26-4/h6-9,12-13H,10-11,14H2,1-5H3,(H,22,24)	Trimethobenzamide	N-[[4-[2-(dimethylamino)ethoxy]phenyl]methyl]-3,4,5-trimethoxybenzamide	COc1cc(C(=O)NCc2ccc(OCCN(C)C)cc2)cc(OC)c1OC	5577.0	R23_gupta_2019:256			BBB+	C	training
InChI=1S/C21H28N2OS/c1-22(18-8-2-3-9-19(18)23-12-4-5-13-23)21(24)15-16-7-6-10-20-17(16)11-14-25-20/h6-7,10-11,14,18-19H,2-5,8-9,12-13,15H2,1H3/t18-,19-/m1/s1	Pd 117302|Pd117302|(+)-2-(Benzothiophen-4-Yl)-N-Methyl-N-((1R,2R)-2-Pyrrolidin-1-Ylcyclohexyl)Acetamide	2-(1-benzothiophen-4-yl)-N-methyl-N-[(1R,2R)-2-pyrrolidin-1-ylcyclohexyl]acetamide	CN(C(=O)Cc1cccc2sccc12)[C@@H]1CCCC[C@H]1N1CCCC1	122115.0	R7_andres_2006:127|R29_subramanian_2003:123			BBB+	C	training
InChI=1S/C21H28O2/c1-13(22)17-6-7-18-16-5-4-14-12-15(23)8-10-20(14,2)19(16)9-11-21(17,18)3/h4-5,12,16-19H,6-11H2,1-3H3/t16-,17+,18-,19+,20+,21+/m0/s1	Dydrogesterone	(8S,9R,10S,13S,14S,17S)-17-acetyl-10,13-dimethyl-1,2,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-one	CC(=O)[C@H]1CC[C@H]2[C@@H]3C=CC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C	9051.0	R14_ghose_2012:517|R23_gupta_2019:543			BBB-	C	test
InChI=1S/C21H28O2/c1-3-20-11-9-17-16-8-6-15(22)13-14(16)5-7-18(17)19(20)10-12-21(20,23)4-2/h2,13,16-19,23H,3,5-12H2,1H3	Norgestrel|Ovrette	13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one	C#CC1(O)CCC2C3CCC4=CC(=O)CCC4C3CCC21CC	4542.0	R14_ghose_2012:730			BBB-	C	training
InChI=1S/C21H28O2/c1-3-20-11-9-17-16-8-6-15(22)13-14(16)5-7-18(17)19(20)10-12-21(20,23)4-2/h2,13,16-19,23H,3,5-12H2,1H3/t16-,17+,18+,19-,20-,21-/m0/s1	Levonorgestrel|Norgestrel	(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one	C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21CC	13109.0	R23_gupta_2019:708			BBB-	C	training
InChI=1S/C21H28O2/c1-4-21(23)10-8-18-19-13(2)11-14-12-15(22)5-6-16(14)17(19)7-9-20(18,21)3/h1,13,17-19,23H,5-12H2,2-3H3	Tibolon|17-Hydroxy-7Alpha-Methyl-19-Nor-17Alpha-Pregn-5(10)-En-20-Yn-3-One	17-ethynyl-17-hydroxy-7,13-dimethyl-1,2,4,6,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one	C#CC1(O)CCC2C3C(C)CC4=C(CCC(=O)C4)C3CCC21C	5470.0	R41_toropov_2017:258|R46_mendoza_valencia_2017:110|R49_norinder_2002:148|R50_sobanska_2019:32	0.4	B	BBB+	A	training
InChI=1S/C21H28O2/c1-4-21(23)10-8-18-19-13(2)11-14-12-15(22)5-6-16(14)17(19)7-9-20(18,21)3/h1,13,17-19,23H,5-12H2,2-3H3/t13-,17-,18+,19-,20+,21+/m1/s1	Tibolone|5630-53-5	(7R,8R,9S,13S,14S,17R)-17-ethynyl-17-hydroxy-7,13-dimethyl-1,2,4,6,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one	C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C	444008.0	R3_abraham_2006:289|R4_mente_2005:179|R5_guerra_2008:101|R7_andres_2006:218|R12_garg_2006:165|R21_muehlbacher_2011:307|R23_gupta_2019:976|R25_brito_sanchez_2015:112|R26_chico_2009:417|R28_li_2005:50|R39_shayanfar_2011:93|R40_vilar_2010:274|R44_bujak_2015:61|R47_radchenko_2020:241	0.4	B	BBB+	A	training
InChI=1S/C21H28O4/c1-12(22)21(25)9-7-16-15-5-4-13-10-14(23)6-8-19(13,2)18(15)17(24)11-20(16,21)3/h6,8,10,15-18,24-25H,4-5,7,9,11H2,1-3H3/t15-,16-,17-,18+,19-,20-,21-/m0/s1	Deprodone	(8S,9S,10R,11S,13S,14S,17R)-17-acetyl-11,17-dihydroxy-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one	CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C	10969997.0	R6_adenot_2004:811			BBB+	C	test
InChI=1S/C21H28O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h5,7,9,14-16,18,22,24,26H,3-4,6,8,10-11H2,1-2H3/t14-,15-,16-,18+,19-,20-,21-/m0/s1	Prednisolone	(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one	C[C@]12C=CC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO	5755.0	R6_adenot_2004:893|R7_andres_2006:139|R14_ghose_2012:790|R25_brito_sanchez_2015:481|R29_subramanian_2003:134|R51_doninger_2002:115	-0.18	A	BBB+	A	test
InChI=1S/C21H28O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h5,7,9,14-16,18,22,24,26H,3-4,6,8,10-11H2,1-2H3/t14-,15-,16?,18+,19-,20-,21-/m0/s1	(8S,9S,10R,13S,14S,17R)-11,17-Dihydroxy-17-(2-Hydroxyacetyl)-10,13-Dimethyl-7,8,9,11,12,14,15,16-Octahydro-6H-Cyclopenta[A]Phenanthren-3-One	(8S,9S,10R,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one	C[C@]12C=CC(=O)C=C1CC[C@@H]1[C@@H]2C(O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO	11245343.0	R46_mendoza_valencia_2017:405	-0.18	A	BBB+	A	test
InChI=1S/C21H28O5/c1-20-7-6-13(24)8-12(20)2-3-14-15-4-5-16(18(26)10-22)21(15,11-23)9-17(25)19(14)20/h8,11,14-17,19,22,25H,2-7,9-10H2,1H3/t14-,15-,16+,17-,19+,20-,21+/m0/s1	Aldosterone	(8S,9S,10R,11S,13R,14S,17S)-11-hydroxy-17-(2-hydroxyacetyl)-10-methyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthrene-13-carbaldehyde	C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@]2(C=O)[C@@H](C(=O)CO)CC[C@@H]12	5839.0	R6_adenot_2004:3|R28_li_2005:324			BBB-	C	training
InChI=1S/C21H28O6/c1-19-7-6-14(24)18(19)13(23)4-3-11-12-5-8-21(27,16(26)10-22)20(12,2)9-15(25)17(11)19/h6-7,11-12,15,17-18,22,25,27H,3-5,8-10H2,1-2H3/t11-,12-,15-,17+,18?,19+,20-,21-/m0/s1	Oxisopred|(1S,2R,10S,11S,14R,15S,17S)-14,17-Dihydroxy-14-(2-Hydroxyacetyl)-2,15-Dimethyltetracyclo[8.7.0.02,6.011,15]Heptadec-3-Ene-5,7-Dione	(1S,2R,10S,11S,14R,15S,17S)-14,17-dihydroxy-14-(2-hydroxyacetyl)-2,15-dimethyltetracyclo[8.7.0.02,6.011,15]heptadec-3-ene-5,7-dione	C[C@]12C=CC(=O)C1C(=O)CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO	10474664.0	R6_adenot_2004:888			BBB+	C	training
InChI=1S/C21H29Cl2N3O3/c1-2-11-29-21(28)25-9-10-26(17(15-25)14-24-7-3-4-8-24)20(27)13-16-5-6-18(22)19(23)12-16/h5-6,12,17H,2-4,7-11,13-15H2,1H3/t17-/m0/s1	Gr89696_Pr|Propyl (3S)-4-[2-(3,4-Dichlorophenyl)Acetyl]-3-(Pyrrolidin-1-Ylmethyl)Piperazine-1-Carboxylate	propyl (3S)-4-[2-(3,4-dichlorophenyl)acetyl]-3-(pyrrolidin-1-ylmethyl)piperazine-1-carboxylate	CCCOC(=O)N1CCN(C(=O)Cc2ccc(Cl)c(Cl)c2)[C@@H](CN2CCCC2)C1	44310303.0	R28_li_2005:362			BBB+	C	training
InChI=1S/C21H29FN2O2/c1-2-21(10-4-3-5-11-21)26-17-20(25)16-23-12-14-24(15-13-23)19-8-6-18(22)7-9-19/h1,6-9,20,25H,3-5,10-17H2	Fluciprazine	1-(1-ethynylcyclohexyl)oxy-3-[4-(4-fluorophenyl)piperazin-1-yl]propan-2-ol	C#CC1(OCC(O)CN2CCN(c3ccc(F)cc3)CC2)CCCCC1	216227.0	R6_adenot_2004:1158			BBB+	C	training
InChI=1S/C21H29FN2O3/c22-18-10-8-17(9-11-18)20(25)7-4-12-23-13-15-24(16-14-23)21(26)27-19-5-2-1-3-6-19/h8-11,19H,1-7,12-16H2	Fenaperone	cyclohexyl 4-[4-(4-fluorophenyl)-4-oxobutyl]piperazine-1-carboxylate	O=C(CCCN1CCN(C(=O)OC2CCCCC2)CC1)c1ccc(F)cc1	198061.0	R6_adenot_2004:1155			BBB+	C	training
InChI=1S/C21H29FO5/c1-18-7-5-13(24)9-12(18)3-4-15-14-6-8-20(27,17(26)11-23)19(14,2)10-16(25)21(15,18)22/h9,14-16,23,25,27H,3-8,10-11H2,1-2H3/t14-,15-,16-,18-,19-,20-,21-/m0/s1	Fludrocortisone	(8S,9R,10S,11S,13S,14S,17R)-9-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one	C[C@]12CCC(=O)C=C1CC[C@H]1[C@@H]3CC[C@](O)(C(=O)CO)[C@@]3(C)C[C@H](O)[C@@]12F	31378.0	R6_adenot_2004:838			BBB+	C	training
InChI=1S/C21H29N3O/c1-16(2)24(17(3)4)15-13-21(20(22)25,18-10-6-5-7-11-18)19-12-8-9-14-23-19/h5-12,14,16-17H,13,15H2,1-4H3,(H2,22,25)	Disopyramide	4-[di(propan-2-yl)amino]-2-phenyl-2-pyridin-2-ylbutanamide	CC(C)N(CCC(C(N)=O)(c1ccccc1)c1ccccn1)C(C)C	3114.0	R14_ghose_2012:507			BBB-	C	training
InChI=1S/C21H29N5O2S/c1-15-4-5-16(11-23-15)10-17-12-24-21(25-20(17)27)22-8-9-29-14-19-7-6-18(28-19)13-26(2)3/h5-7,11-12,15H,4,8-10,13-14H2,1-3H3,(H2,22,24,25,27)	5		CC1CC=C(Cc2c[nH]c(NCCSCc3ccc(CN(C)C)o3)nc2=O)C=N1		R52_liu_2001:5	-1.06	A	BBB-	A	training
InChI=1S/C21H29N5OS/c1-16-4-5-17(11-23-16)10-18-12-24-21(25-13-18)22-8-9-28-15-20-7-6-19(27-20)14-26(2)3/h4-7,11-12H,8-10,13-15H2,1-3H3,(H2,22,24,25)	8-5		Cc1ccc(CC2=CNC(NCCSCc3ccc(CN(C)C)o3)=NC2)cn1		R28_li_2005:168			BBB-	C	training
InChI=1S/C21H29NO/c1-21(2,3)19-14-10-9-13-18(19)20(23-16-15-22(4)5)17-11-7-6-8-12-17/h6-14,20H,15-16H2,1-5H3	Bufenadrine	2-[(2-tert-butylphenyl)-phenylmethoxy]-N,N-dimethylethanamine	CN(C)CCOC(c1ccccc1)c1ccccc1C(C)(C)C	21916.0	R6_adenot_2004:643			BBB+	C	training
InChI=1S/C21H29NO/c1-5-20(23)21(16-17(2)22(3)4,18-12-8-6-9-13-18)19-14-10-7-11-15-19/h6-15,17,20,23H,5,16H2,1-4H3/t17-,20+/m1/s1	Betamethadol	(3S,6R)-6-(dimethylamino)-4,4-diphenylheptan-3-ol	CC[C@H](O)C(C[C@@H](C)N(C)C)(c1ccccc1)c1ccccc1	10064061.0	R6_adenot_2004:1013			BBB+	C	training
InChI=1S/C21H29NO/c1-5-20(23)21(16-17(2)22(3)4,18-12-8-6-9-13-18)19-14-10-7-11-15-19/h6-15,17,20,23H,5,16H2,1-4H3/t17-,20-/m1/s1	Alphamethadol	(3R,6R)-6-(dimethylamino)-4,4-diphenylheptan-3-ol	CC[C@@H](O)C(C[C@@H](C)N(C)C)(c1ccccc1)c1ccccc1	62709.0	R6_adenot_2004:1009			BBB+	C	training
InChI=1S/C21H29NO/c23-21(19-7-3-1-4-8-19,11-14-22-12-5-2-6-13-22)20-16-17-9-10-18(20)15-17/h1,3-4,7-10,17-18,20,23H,2,5-6,11-16H2	Biperiden|Biperidine	1-(2-bicyclo[2.2.1]hept-5-enyl)-1-phenyl-3-piperidin-1-ylpropan-1-ol	OC(CCN1CCCCC1)(c1ccccc1)C1CC2C=CC1C2	2381.0	R3_abraham_2006:133|R7_andres_2006:19|R14_ghose_2012:21|R21_muehlbacher_2011:40|R23_gupta_2019:24|R25_brito_sanchez_2015:161|R26_chico_2009:79|R29_subramanian_2003:17|R34_broccatelli_2012:8|R40_vilar_2010:52|R41_toropov_2017:126|R41_toropov_2017:293|R46_mendoza_valencia_2017:156|R47_radchenko_2020:113|R51_doninger_2002:163	0.85	B	BBB+	A	training
InChI=1S/C21H29NO2/c1-3-20-11-9-17-16-8-6-15(22-24)13-14(16)5-7-18(17)19(20)10-12-21(20,23)4-2/h2,13,16-19,23-24H,3,5-12H2,1H3/b22-15-	Norelgestromin|E-17-Deacetylnorgestimate	(3E)-13-ethyl-17-ethynyl-3-hydroxyimino-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-ol	C#CC1(O)CCC2C3CCC4=C/C(=N/O)CCC4C3CCC21CC	167994307.0	R23_gupta_2019:787			BBB-	C	test
InChI=1S/C21H29NO2/c23-17-7-6-16-12-19-21(24)9-2-1-8-20(21,18(16)13-17)10-11-22(19)14-15-4-3-5-15/h6-7,13,15,19,23-24H,1-5,8-12,14H2/t19-,20+,21-/m1/s1	Butorphanol	(1S,9R,10S)-17-(cyclobutylmethyl)-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene-4,10-diol	Oc1ccc2c(c1)[C@@]13CCCC[C@@]1(O)[C@@H](C2)N(CC1CCC1)CC3	5361092.0	R6_adenot_2004:1017|R14_ghose_2012:32|R23_gupta_2019:34			BBB+	C	training
InChI=1S/C21H29NS2/c1-4-5-16-23-20-13-11-19(12-14-20)21(24-17-15-22(2)3)18-9-7-6-8-10-18/h6-14,21H,4-5,15-17H2,1-3H3	Captodiame	2-[(4-butylsulfanylphenyl)-phenylmethyl]sulfanyl-N,N-dimethylethanamine	CCCCSc1ccc(C(SCCN(C)C)c2ccccc2)cc1	10240.0	R6_adenot_2004:1427			BBB+	C	training
InChI=1S/C21H30FN3O2/c22-18-8-6-17(7-9-18)19(26)5-4-12-24-15-10-21(11-16-24,20(23)27)25-13-2-1-3-14-25/h6-9H,1-5,10-16H2,(H2,23,27)	Pipamperone	1-[4-(4-fluorophenyl)-4-oxobutyl]-4-piperidin-1-ylpiperidine-4-carboxamide	NC(=O)C1(N2CCCCC2)CCN(CCCC(=O)c2ccc(F)cc2)CC1	4830.0	R6_adenot_2004:1200|R51_doninger_2002:289			BBB+	C	training
InChI=1S/C21H30N2O8S/c1-5-28-20(26)30-17-8-7-15(13-18(17)31-21(27)29-6-2)9-11-22-19(25)16(10-12-32-4)23-14(3)24/h7-8,13,16H,5-6,9-12H2,1-4H3,(H,22,25)(H,23,24)/t16-/m0/s1	Docarpamine	[4-[2-[[(2S)-2-acetamido-4-methylsulfanylbutanoyl]amino]ethyl]-2-ethoxycarbonyloxyphenyl] ethyl carbonate	CCOC(=O)Oc1ccc(CCNC(=O)[C@H](CCSC)NC(C)=O)cc1OC(=O)OCC	71137.0	R23_gupta_2019:533			BBB-	C	training
InChI=1S/C21H30O2/c1-13(22)17-6-7-18-16-5-4-14-12-15(23)8-10-20(14,2)19(16)9-11-21(17,18)3/h12,16-19H,4-11H2,1-3H3/t16-,17+,18-,19-,20-,21+/m0/s1	Progesterone	(8S,9S,10R,13S,14S,17S)-17-acetyl-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one	CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C	5994.0	R23_gupta_2019:863|R25_brito_sanchez_2015:484|R28_li_2005:389|R46_mendoza_valencia_2017:406|R51_doninger_2002:118	-0.1	B	BBB+	A	training
InChI=1S/C21H30O2/c1-5-6-7-8-15-12-18(22)20-16-11-14(2)9-10-17(16)21(3,4)23-19(20)13-15/h11-13,16-17,22H,5-10H2,1-4H3/t16-,17-/m1/s1	Dronabinol|1 Del Tercero|Thc	(6aR,10aR)-6,6,9-trimethyl-3-pentyl-6a,7,8,10a-tetrahydrobenzo[c]chromen-1-ol	CCCCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1CCC(C)=C[C@@H]21	16078.0	R14_ghose_2012:316|R14_ghose_2012:514|R23_gupta_2019:77|R25_brito_sanchez_2015:527|R37_chen_2011:29|R46_mendoza_valencia_2017:441|R51_doninger_2002:309	0.0	B	BBB+	A	training
InChI=1S/C21H30O2/c1-5-6-7-8-16-12-19(22)21(20(23)13-16)18-11-15(4)9-10-17(18)14(2)3/h11-13,17-18,22-23H,2,5-10H2,1,3-4H3/t17-,18+/m0/s1	Cannabidiol	2-[(1R,6R)-3-methyl-6-prop-1-en-2-ylcyclohex-2-en-1-yl]-5-pentylbenzene-1,3-diol	C=C(C)[C@@H]1CCC(C)=C[C@H]1c1c(O)cc(CCCCC)cc1O	644019.0	R51_doninger_2002:171			BBB+	C	training
InChI=1S/C21H30O4/c1-12(22)21(25)18(24)11-17-15-5-4-13-10-14(23)6-8-19(13,2)16(15)7-9-20(17,21)3/h10,15-18,24-25H,4-9,11H2,1-3H3/t15-,16+,17+,18-,19+,20+,21-/m1/s1	Algestone	(8R,9S,10R,13S,14S,16R,17S)-17-acetyl-16,17-dihydroxy-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one	CC(=O)[C@@]1(O)[C@H](O)C[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C	11687.0	R6_adenot_2004:765			BBB+	C	training
InChI=1S/C21H30O4/c1-19-8-5-14(23)11-13(19)3-4-15-16(19)6-9-20(2)17(15)7-10-21(20,25)18(24)12-22/h11,15-17,22,25H,3-10,12H2,1-2H3/t15-,16+,17+,19+,20+,21+/m1/s1	Cortodoxone Cortifen|Cortodoxone	(8R,9S,10R,13S,14S,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one	C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO	440707.0	R6_adenot_2004:809			BBB+	C	training
InChI=1S/C21H30O4/c1-20-8-7-13(23)9-12(20)3-4-14-15-5-6-16(18(25)11-22)21(15,2)10-17(24)19(14)20/h9,14-17,19,22,24H,3-8,10-11H2,1-2H3/t14-,15-,16+,17+,19+,20-,21-/m0/s1	Epicorticosterone	(8S,9S,10R,11R,13S,14S,17S)-11-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one	C[C@]12C[C@@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2C(=O)CO	256277.0	R46_mendoza_valencia_2017:416	-0.5	A	BBB+	A	training
InChI=1S/C21H30O4/c1-20-8-7-13(23)9-12(20)3-4-14-15-5-6-16(18(25)11-22)21(15,2)10-17(24)19(14)20/h9,14-17,19,22,24H,3-8,10-11H2,1-2H3/t14-,15-,16+,17-,19+,20-,21-/m0/s1	Corticosterone	(8S,9S,10R,11S,13S,14S,17S)-11-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one	C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2C(=O)CO	5753.0	R7_andres_2006:42|R25_brito_sanchez_2015:496|R28_li_2005:337|R29_subramanian_2003:43|R51_doninger_2002:30	-0.5	A	BBB+	A	training
InChI=1S/C21H30O4S/c1-19-7-5-13(22)9-12(19)3-4-14-15-6-8-21(25,17(24)11-26)20(15,2)10-16(23)18(14)19/h9,14-16,18,23,25-26H,3-8,10-11H2,1-2H3/t14-,15-,16-,18+,19-,20-,21-/m0/s1	Tixocortol	(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-17-(2-sulfanylacetyl)-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one	C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CS	162955.0	R6_adenot_2004:911			BBB+	C	training
InChI=1S/C21H30O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h9,14-16,18,22,24,26H,3-8,10-11H2,1-2H3/t14-,15+,16+,18-,19+,20+,21+/m1/s1		(8R,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one	C[C@]12CCC(=O)C=C1CC[C@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO	12304010.0	R46_mendoza_valencia_2017:363	-0.22	A	BBB+	A	training
InChI=1S/C21H30O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h9,14-16,18,22,24,26H,3-8,10-11H2,1-2H3/t14-,15-,16-,18+,19-,20-,21-/m0/s1	Hydrocortisone|Cortisol	(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one	C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO	5754.0	R6_adenot_2004:34|R6_adenot_2004:798|R7_andres_2006:199|R14_ghose_2012:610|R25_brito_sanchez_2015:433|R28_li_2005:338|R29_subramanian_2003:75|R51_doninger_2002:67	-0.22	A	BBB+	A	training
InChI=1S/C21H31Cl2N3O/c1-2-20(27)24-17-8-6-16(7-9-17)10-11-25-12-14-26(15-13-25)19-5-3-4-18(22)21(19)23/h3-5,16-17H,2,6-15H2,1H3,(H,24,27)	Piperazinederivatives 7|N-[4-[2-[4-(2,3-Dichlorophenyl)Piperazin-1-Yl]Ethyl]Cyclohexyl]Propanamide	N-[4-[2-[4-(2,3-dichlorophenyl)piperazin-1-yl]ethyl]cyclohexyl]propanamide	CCC(=O)NC1CCC(CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1	70696192.0	R47_radchenko_2020:319	0.9	A	BBB+	A	training
InChI=1S/C21H31N3O5/c22-13-5-4-9-16(19(25)24-14-6-10-18(24)21(28)29)23-17(20(26)27)12-11-15-7-2-1-3-8-15/h1-3,7-8,16-18,23H,4-6,9-14,22H2,(H,26,27)(H,28,29)/t16-,17-,18-/m0/s1	Lisinopril	(2S)-1-[(2S)-6-amino-2-[[(1S)-1-carboxy-3-phenylpropyl]amino]hexanoyl]pyrrolidine-2-carboxylic acid	NCCCC[C@H](N[C@@H](CCc1ccccc1)C(=O)O)C(=O)N1CCC[C@H]1C(=O)O	5362119.0	R14_ghose_2012:658			BBB-	C	training
InChI=1S/C21H31N5O/c27-19(21-13-16-10-17(14-21)12-18(11-16)15-21)22-4-5-25-6-8-26(9-7-25)20-23-2-1-3-24-20/h1-3,16-18H,4-15H2,(H,22,27)	Adatanserin	N-[2-(4-pyrimidin-2-ylpiperazin-1-yl)ethyl]adamantane-1-carboxamide	O=C(NCCN1CCN(c2ncccn2)CC1)C12CC3CC(CC(C3)C1)C2	130918.0	R6_adenot_2004:1526			BBB+	C	training
InChI=1S/C21H31N5O2/c27-18-16-21(6-1-2-7-21)17-19(28)26(18)11-4-3-10-24-12-14-25(15-13-24)20-22-8-5-9-23-20/h5,8-9H,1-4,6-7,10-17H2	Buspirone	8-[4-(4-pyrimidin-2-ylpiperazin-1-yl)butyl]-8-azaspiro[4.5]decane-7,9-dione	O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2ncccn2)CC1	2477.0	R5_guerra_2008:19|R6_adenot_2004:1425|R12_garg_2006:49|R14_ghose_2012:28|R21_muehlbacher_2011:44|R23_gupta_2019:31|R25_brito_sanchez_2015:172|R26_chico_2009:89|R34_broccatelli_2012:11|R37_chen_2011:15|R39_shayanfar_2011:22|R40_vilar_2010:65|R47_radchenko_2020:264|R50_sobanska_2019:35	0.45	B1	BBB+	A	training
InChI=1S/C21H31NO/c1-4-21-10-11-22(14-15-6-5-7-15)19(20(21,2)3)12-16-8-9-17(23)13-18(16)21/h8-9,13,15,19,23H,4-7,10-12,14H2,1-3H3	Cogazocine	10-(cyclobutylmethyl)-1-ethyl-13,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol	CCC12CCN(CC3CCC3)C(Cc3ccc(O)cc31)C2(C)C	198576.0	R6_adenot_2004:1019			BBB+	C	test
InChI=1S/C21H32N2O/c1-19-11-13-12-22-23-18(13)10-14(19)4-5-15-16(19)6-8-20(2)17(15)7-9-21(20,3)24/h12,14-17,24H,4-11H2,1-3H3,(H,22,23)/t14-,15+,16-,17-,19-,20-,21-/m0/s1	Stanozolol	(1S,2S,10S,13R,14S,17S,18S)-2,17,18-trimethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5-dien-17-ol	C[C@]12Cc3cn[nH]c3C[C@@H]1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O	25249.0	R14_ghose_2012:853|R23_gupta_2019:922|R51_doninger_2002:128			BBB-	C	training
InChI=1S/C21H32N2O/c1-2-3-7-18-12-16-22(17-13-18)14-6-15-23-20-9-5-4-8-19(20)10-11-21(23)24/h4-5,8-9,18H,2-3,6-7,10-17H2,1H3	77-Lh-28-1|1-[3-(4-Butylpiperidin-1-Yl)Propyl]-3,4-Dihydroquinolin-2-One	1-[3-(4-butylpiperidin-1-yl)propyl]-3,4-dihydroquinolin-2-one	CCCCC1CCN(CCCN2C(=O)CCc3ccccc32)CC1	10236758.0	R26_chico_2009:14	0.6	A	BBB+	A	training
InChI=1S/C21H32N6O3/c1-4-19(28)27(18-9-7-6-8-10-18)21(17-30-3)11-13-24(14-12-21)15-16-26-20(29)25(5-2)22-23-26/h6-10H,4-5,11-17H2,1-3H3	Alfentanil|Alfentanil Hydrochloride	N-[1-[2-(4-ethyl-5-oxotetrazol-1-yl)ethyl]-4-(methoxymethyl)piperidin-4-yl]-N-phenylpropanamide	CCC(=O)N(c1ccccc1)C1(COC)CCN(CCn2nnn(CC)c2=O)CC1	51263.0	R6_adenot_2004:1005|R14_ghose_2012:3|R23_gupta_2019:4|R25_brito_sanchez_2015:114|R46_mendoza_valencia_2017:112|R47_radchenko_2020:400	-0.84	B1	BBB+	A	training
InChI=1S/C21H32O/c1-3-12-21(22)14-11-19-18-9-8-15-6-4-5-7-16(15)17(18)10-13-20(19,21)2/h3,6,16-19,22H,1,4-5,7-14H2,2H3/t16-,17+,18+,19-,20-,21-/m0/s1	Allylestrenol	(8R,9S,10R,13S,14S,17R)-13-methyl-17-prop-2-enyl-2,3,6,7,8,9,10,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-ol	C=CC[C@]1(O)CC[C@H]2[C@@H]3CCC4=CCCC[C@@H]4[C@H]3CC[C@@]21C	235905.0	R23_gupta_2019:336			BBB-	C	training
InChI=1S/C21H32O2/c1-12(22)15-4-5-16-14-10-18(23)21-11-13(21)6-9-20(21,3)17(14)7-8-19(15,16)2/h13-18,23H,4-11H2,1-3H3/t13-,14-,15+,16-,17-,18+,19+,20+,21+/m0/s1	Cyclopregnol	1-[(1S,2R,5S,7S,8R,10S,11S,14S,15S)-8-hydroxy-2,15-dimethyl-14-pentacyclo[8.7.0.02,7.05,7.011,15]heptadecanyl]ethanone	CC(=O)[C@H]1CC[C@H]2[C@@H]3C[C@@H](O)[C@@]45C[C@@H]4CC[C@]5(C)[C@H]3CC[C@]12C	12308830.0	R6_adenot_2004:1442			BBB+	C	training
InChI=1S/C21H32O2/c1-13(22)17-6-7-18-16-5-4-14-12-15(23)8-10-20(14,2)19(16)9-11-21(17,18)3/h4,15-19,23H,5-12H2,1-3H3/t15-,16-,17+,18-,19-,20-,21+/m0/s1	Pregnenolone	1-[(3S,8S,9S,10R,13S,14S,17S)-3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]ethanone	CC(=O)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C	8955.0	R6_adenot_2004:896			BBB+	C	training
InChI=1S/C21H32O2/c1-13-11-14-12-15(22)5-8-19(14,2)16-6-9-20(3)17(18(13)16)7-10-21(20,4)23/h12-13,16-18,23H,5-11H2,1-4H3/t13-,16-,17-,18+,19-,20-,21-/m0/s1	Calusterone	(7S,8R,9S,10R,13S,14S,17S)-17-hydroxy-7,10,13,17-tetramethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one	C[C@H]1CC2=CC(=O)CC[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](CC[C@]3(C)O)[C@H]12	28204.0	R14_ghose_2012:413			BBB-	C	training
InChI=1S/C21H32O3/c1-12(22)16-6-7-17-15-5-4-13-10-14(23)8-9-20(13,2)19(15)18(24)11-21(16,17)3/h13-17,19,23H,4-11H2,1-3H3/t13-,14+,15-,16+,17-,19+,20-,21+/m0/s1	Alfaxalone	(3R,5S,8S,9S,10S,13S,14S,17S)-17-acetyl-3-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-11-one	CC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](O)CC[C@]4(C)[C@H]3C(=O)C[C@]12C	104845.0	R6_adenot_2004:923			BBB+	C	training
InChI=1S/C21H32O3/c1-12(22)16-6-7-17-15-5-4-13-10-14(23)8-9-20(13,2)19(15)18(24)11-21(16,17)3/h13-17,19,23H,4-11H2,1-3H3/t13-,14-,15+,16-,17+,19-,20+,21-/m1/s1	Renanolone	(3R,5R,8S,9S,10S,13S,14S,17S)-17-acetyl-3-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-11-one	CC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C(=O)C[C@]12C	68930.0	R6_adenot_2004:949			BBB+	C	training
InChI=1S/C21H32O4/c1-20-8-7-13(23)9-12(20)3-4-14-15-5-6-16(18(25)11-22)21(15,2)10-17(24)19(14)20/h12-16,19,22-23H,3-11H2,1-2H3/t12-,13+,14-,15-,16+,19+,20-,21-/m0/s1	Alfadolone	(3R,5S,8S,9S,10S,13S,14S,17S)-3-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-1,2,3,4,5,6,7,8,9,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-11-one	C[C@]12CC[C@@H](O)C[C@@H]1CC[C@H]1[C@@H]3CC[C@H](C(=O)CO)[C@@]3(C)CC(=O)[C@@H]12	9798416.0	R6_adenot_2004:922			BBB+	C	training
InChI=1S/C21H33N3O2/c1-5-6-7-8-9-13-22-20(25)26-16-10-11-18-17(15-16)21(2)12-14-23(3)19(21)24(18)4/h10-11,15,19H,5-9,12-14H2,1-4H3,(H,22,25)/t19-,21+/m1/s1	Eptastigmine	[(3aR,8bS)-3,4,8b-trimethyl-2,3a-dihydro-1H-pyrrolo[2,3-b]indol-7-yl] N-heptylcarbamate	CCCCCCCNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)[C@@H]1N2C	65872.0	R6_adenot_2004:1259			BBB+	C	training
InChI=1S/C21H33N3O5S/c1-20(2,3)19(27)29-13-28-18(26)15-21(4,5)30-17-14(16(25)24(15)17)22-12-23-10-8-6-7-9-11-23/h12,14-15,17H,6-11,13H2,1-5H3/b22-12+/t14-,15+,17-/m1/s1	Pivmecillinam	2,2-dimethylpropanoyloxymethyl (2S,5R,6R)-6-(azepan-1-ylmethylideneamino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate	CC(C)(C)C(=O)OCOC(=O)[C@@H]1N2C(=O)[C@@H](/N=C/N3CCCCCC3)[C@H]2SC1(C)C	115163.0	R6_adenot_2004:257|R14_ghose_2012:785|R23_gupta_2019:846			BBB-	C	test
InChI=1S/C21H33NO/c1-19(2)18-11-12-20(19,3)21(16-18,23-14-13-22(4)5)15-17-9-7-6-8-10-17/h6-10,18H,11-16H2,1-5H3	Ramciclane	2-[(2-benzyl-1,7,7-trimethyl-2-bicyclo[2.2.1]heptanyl)oxy]-N,N-dimethylethanamine	CN(C)CCOC1(Cc2ccccc2)CC2CCC1(C)C2(C)C	3052772.0	R6_adenot_2004:1507			BBB+	C	test
InChI=1S/C21H34N2O/c1-4-6-7-11-16-23-17-14-21(15-18-23,20(24)22(3)5-2)19-12-9-8-10-13-19/h8-10,12-13H,4-7,11,14-18H2,1-3H3	Sameridine	N-ethyl-1-hexyl-N-methyl-4-phenylpiperidine-4-carboxamide	CCCCCCN1CCC(C(=O)N(C)CC)(c2ccccc2)CC1	65996.0	R6_adenot_2004:1086			BBB+	C	training
InChI=1S/C21H34NO3/c1-4-22(3,5-2)16-17-25-20(23)21(24,18-12-8-6-9-13-18)19-14-10-7-11-15-19/h6,8-9,12-13,19,24H,4-5,7,10-11,14-17H2,1-3H3/q+1	Oxyphenonium Bromide|Oxyphenonium	2-(2-cyclohexyl-2-hydroxy-2-phenylacetyl)oxyethyl-diethyl-methylazanium	CC[N+](C)(CC)CCOC(=O)C(O)(c1ccccc1)C1CCCCC1	5749.0	R14_ghose_2012:750			BBB-	C	training
InChI=1S/C21H34O2/c1-13(22)17-6-7-18-16-5-4-14-12-15(23)8-10-20(14,2)19(16)9-11-21(17,18)3/h14-19,23H,4-12H2,1-3H3/t14-,15-,16+,17-,18+,19+,20+,21-/m1/s1	Pregnanolone	1-[(3R,5R,8R,9S,10S,13S,14S,17S)-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]ethanone	CC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C	31402.0	R51_doninger_2002:291			BBB+	C	training
InChI=1S/C21H36N4O8/c1-4-5-6-7-8-9-16(28)32-11-14(27)18(31-3)19-17(24-12(2)26)13(25-21(22)23)10-15(33-19)20(29)30/h10,13-14,17-19,27H,4-9,11H2,1-3H3,(H,24,26)(H,29,30)(H4,22,23,25)/t13-,14+,17+,18+,19+/m0/s1	Laninamivir Octanoate	(2R,3R,4S)-3-acetamido-4-(diaminomethylideneamino)-2-[(1R,2R)-2-hydroxy-1-methoxy-3-octanoyloxypropyl]-3,4-dihydro-2H-pyran-6-carboxylic acid	CCCCCCCC(=O)OC[C@@H](O)[C@@H](OC)[C@@H]1OC(C(=O)O)=C[C@H](N=C(N)N)[C@H]1NC(C)=O	9847629.0	R23_gupta_2019:1068			BBB-	C	training
InChI=1S/C21H36NO/c1-4-22(5-2,6-3)18-17-21(23,19-13-9-7-10-14-19)20-15-11-8-12-16-20/h7,9-10,13-14,20,23H,4-6,8,11-12,15-18H2,1-3H3/q+1	Tridihexethyl Chloride|Tridihexethyl	(3-cyclohexyl-3-hydroxy-3-phenylpropyl)-triethylazanium	CC[N+](CC)(CC)CCC(O)(c1ccccc1)C1CCCCC1	20299.0	R14_ghose_2012:916			BBB-	C	training
InChI=1S/C21H39N7O12/c1-5-21(36,4-30)16(40-17-9(26-2)13(34)10(31)6(3-29)38-17)18(37-5)39-15-8(28-20(24)25)11(32)7(27-19(22)23)12(33)14(15)35/h4-18,26,29,31-36H,3H2,1-2H3,(H4,22,23,27)(H4,24,25,28)/t5-,6-,7+,8-,9-,10-,11+,12-,13-,14+,15+,16-,17-,18-,21+/m0/s1	Streptomycin	2-[(1R,2R,3S,4R,5R,6S)-3-(diaminomethylideneamino)-4-[(2R,3R,4R,5S)-3-[(2S,3S,4S,5R,6S)-4,5-dihydroxy-6-(hydroxymethyl)-3-(methylamino)oxan-2-yl]oxy-4-formyl-4-hydroxy-5-methyloxolan-2-yl]oxy-2,5,6-trihydroxycyclohexyl]guanidine	CN[C@@H]1[C@H](O[C@H]2[C@H](O[C@H]3[C@H](O)[C@@H](O)[C@H](N=C(N)N)[C@@H](O)[C@@H]3N=C(N)N)O[C@@H](C)[C@]2(O)C=O)O[C@@H](CO)[C@H](O)[C@H]1O	19649.0	R6_adenot_2004:130|R23_gupta_2019:925|R28_li_2005:288			BBB-	C	training
InChI=1S/C21H41N5O11/c1-26-11-14(30)18-8(33-20(11)37-21-16(32)13(29)10(25)9(4-27)34-21)3-7(24)19(36-18)35-17-6(23)2-5(22)12(28)15(17)31/h5-21,26-32H,2-4,22-25H2,1H3/t5-,6+,7-,8+,9-,10-,11+,12+,13+,14-,15-,16-,17-,18+,19+,20-,21-/m1/s1	Apramycin	(2R,3R,4S,5S,6S)-2-[[(2R,3S,4R,4aR,6S,7R,8aS)-7-amino-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2,3-dihydroxycyclohexyl]oxy-4-hydroxy-3-(methylamino)-2,3,4,4a,6,7,8,8a-octahydropyrano[3,2-b]pyran-2-yl]oxy]-5-amino-6-(hydroxymethyl)oxane-3,4-diol	CN[C@@H]1[C@@H](O[C@H]2O[C@H](CO)[C@@H](N)[C@H](O)[C@H]2O)O[C@H]2C[C@@H](N)[C@@H](O[C@H]3[C@H](O)[C@@H](O)[C@H](N)C[C@@H]3N)O[C@@H]2[C@@H]1O	3081545.0	R6_adenot_2004:110			BBB-	C	training
InChI=1S/C21H41N5O7/c1-4-26-13-7-12(24)16(32-19-11(23)6-5-10(8-22)31-19)14(27)17(13)33-20-15(28)18(25-3)21(2,29)9-30-20/h5,11-20,25-29H,4,6-9,22-24H2,1-3H3/t11-,12+,13-,14+,15-,16-,17+,18-,19-,20-,21+/m1/s1	Netilmicin	(2R,3R,4R,5R)-2-[(1S,2S,3R,4S,6R)-4-amino-3-[[(2S,3R)-3-amino-6-(aminomethyl)-3,4-dihydro-2H-pyran-2-yl]oxy]-6-(ethylamino)-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol	CCN[C@@H]1C[C@H](N)[C@@H](O[C@H]2OC(CN)=CC[C@H]2N)[C@H](O)[C@H]1O[C@H]1OC[C@](C)(O)[C@H](NC)[C@H]1O	441306.0	R6_adenot_2004:127			BBB-	C	training
InChI=1S/C21H41N7O12/c1-5-21(36,4-30)16(40-17-9(26-2)13(34)10(31)6(3-29)38-17)18(37-5)39-15-8(28-20(24)25)11(32)7(27-19(22)23)12(33)14(15)35/h5-18,26,29-36H,3-4H2,1-2H3,(H4,22,23,27)(H4,24,25,28)/t5-,6-,7+,8-,9-,10-,11+,12-,13-,14+,15+,16-,17-,18-,21+/m0/s1	Dihydrostreptomycin	2-[(1R,2R,3S,4R,5R,6S)-3-(diaminomethylideneamino)-4-[(2R,3R,4R,5S)-3-[(2S,3S,4S,5R,6S)-4,5-dihydroxy-6-(hydroxymethyl)-3-(methylamino)oxan-2-yl]oxy-4-hydroxy-4-(hydroxymethyl)-5-methyloxolan-2-yl]oxy-2,5,6-trihydroxycyclohexyl]guanidine	CN[C@@H]1[C@H](O[C@H]2[C@H](O[C@H]3[C@H](O)[C@@H](O)[C@H](N=C(N)N)[C@@H](O)[C@@H]3N=C(N)N)O[C@@H](C)[C@]2(O)CO)O[C@@H](CO)[C@H](O)[C@H]1O	439369.0	R6_adenot_2004:116			BBB-	C	training
InChI=1S/C21H43N5O12/c22-2-9-14(31)15(32)12(25)20(35-9)37-18-7(23)1-8(26-6(3-27)4-28)19(17(18)34)38-21-16(33)11(24)13(30)10(5-29)36-21/h6-21,26-34H,1-5,22-25H2/t7-,8+,9+,10+,11-,12+,13+,14+,15+,16+,17-,18+,19-,20+,21+/m0/s1	Propikacin	(2R,3S,4R,5R,6R)-5-amino-6-[(1R,2S,3S,4R,6S)-6-amino-3-[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-(1,3-dihydroxypropan-2-ylamino)-2-hydroxycyclohexyl]oxy-2-(aminomethyl)oxane-3,4-diol	NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](NC(CO)CO)C[C@@H]2N)[C@H](N)[C@@H](O)[C@@H]1O	9872451.0	R6_adenot_2004:128			BBB-	C	training
InChI=1S/C21H43N5O7/c1-9(25-3)13-6-5-10(22)19(31-13)32-16-11(23)7-12(24)17(14(16)27)33-20-15(28)18(26-4)21(2,29)8-30-20/h9-20,25-29H,5-8,22-24H2,1-4H3	Gentamicin	2-[4,6-diamino-3-[3-amino-6-[1-(methylamino)ethyl]oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol	CNC(C)C1CCC(N)C(OC2C(N)CC(N)C(OC3OCC(C)(O)C(NC)C3O)C2O)O1	3467.0	R23_gupta_2019:630			BBB-	C	training
InChI=1S/C21H46NO4P/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-20-25-27(23,24)26-21-19-22(2,3)4/h5-21H2,1-4H3	Miltefosine	hexadecyl 2-(trimethylazaniumyl)ethyl phosphate	CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C	3599.0	R14_ghose_2012:696|R25_brito_sanchez_2015:450	-1.14	A	BBB-	A	training
InChI=1S/C21H46NO4P/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-20-25-27(23,24)26-21-19-22(2,3)4/h5-21H2,1-4H3/p+1	N-Hexadecylphosphonocholine	2-[hexadecoxy(hydroxy)phosphoryl]oxyethyl-trimethylazanium	CCCCCCCCCCCCCCCCOP(=O)(O)OCC[N+](C)(C)C	3600.0	R46_mendoza_valencia_2017:376	-1.14	A	BBB-	A	training
InChI=1S/C22H15ClF6N2O/c1-31(12-13-8-14(21(24,25)26)10-15(9-13)22(27,28)29)20(32)18-11-30-7-6-16(18)17-4-2-3-5-19(17)23/h2-11H,12H2,1H3	19|N-[[3,5-Bis(Trifluoromethyl)Phenyl]Methyl]-4-(2-Chlorophenyl)-N-Methylpyridine-3-Carboxamide	N-[[3,5-bis(trifluoromethyl)phenyl]methyl]-4-(2-chlorophenyl)-N-methylpyridine-3-carboxamide	CN(Cc1cc(C(F)(F)F)cc(C(F)(F)F)c1)C(=O)c1cnccc1-c1ccccc1Cl	9847664.0	R47_radchenko_2020:397	0.89	A	BBB+	A	test
InChI=1S/C22H16F2N2/c23-19-12-10-18(11-13-19)22(26-15-14-25-16-26,17-6-2-1-3-7-17)20-8-4-5-9-21(20)24/h1-16H	Flutrimazole	1-[(2-fluorophenyl)-(4-fluorophenyl)-phenylmethyl]imidazole	Fc1ccc(C(c2ccccc2)(c2ccccc2F)n2ccnc2)cc1	3401.0	R23_gupta_2019:1063			BBB-	C	training
InChI=1S/C22H16O8/c1-2-28-20(25)15(16-18(23)11-7-3-5-9-13(11)29-21(16)26)17-19(24)12-8-4-6-10-14(12)30-22(17)27/h3-10,15,23-24H,2H2,1H3	Neodicoumarol|Ethyl Biscoumacetate	ethyl 2,2-bis(4-hydroxy-2-oxochromen-3-yl)acetate	CCOC(=O)C(c1c(O)c2ccccc2oc1=O)c1c(O)c2ccccc2oc1=O	54685524.0	R51_doninger_2002:96			BBB-	C	test
InChI=1S/C22H17ClN2/c23-21-14-8-7-13-20(21)22(25-16-15-24-17-25,18-9-3-1-4-10-18)19-11-5-2-6-12-19/h1-17H	Clotrimazole	1-[(2-chlorophenyl)-diphenylmethyl]imidazole	Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1	2812.0	R14_ghose_2012:465|R23_gupta_2019:476|R51_doninger_2002:29			BBB-	C	training
InChI=1S/C22H17N3O/c1-16-8-2-5-12-20(16)25-21(14-13-17-9-6-7-15-23-17)24-19-11-4-3-10-18(19)22(25)26/h2-15H,1H3/b14-13-	Piriqualone|4(3H)-Quinazolinone, 2-[2-(2-Pyridyl)Vinyl]-3-O-Tolyl-	3-(2-methylphenyl)-2-[(Z)-2-pyridin-2-ylethenyl]quinazolin-4-one	Cc1ccccc1-n1c(/C=C\c2ccccn2)nc2ccccc2c1=O	36791339.0	R6_adenot_2004:483			BBB+	C	training
InChI=1S/C22H18N2/c1-3-7-18(8-4-1)19-11-13-21(14-12-19)22(24-16-15-23-17-24)20-9-5-2-6-10-20/h1-17,22H	Bifonazole	1-[phenyl-(4-phenylphenyl)methyl]imidazole	c1ccc(-c2ccc(C(c3ccccc3)n3ccnc3)cc2)cc1	2378.0	R23_gupta_2019:394			BBB-	C	training
InChI=1S/C22H18N4OS/c1-23-22(27)18-7-2-3-8-21(18)28-16-10-11-17-19(25-26-20(17)14-16)12-9-15-6-4-5-13-24-15/h2-14H,1H3,(H,23,27)(H,25,26)/b12-9+	Axitinib	N-methyl-2-[[3-[(E)-2-pyridin-2-ylethenyl]-1H-indazol-6-yl]sulfanyl]benzamide	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1	6450551.0	R23_gupta_2019:369			BBB-	C	training
InChI=1S/C22H18N6/c1-15-12-18(4-3-10-23)13-16(2)21(15)27-20-9-11-25-22(28-20)26-19-7-5-17(14-24)6-8-19/h3-9,11-13H,1-2H3,(H2,25,26,27,28)/b4-3+	Rilpivirine	4-[[4-[4-[(E)-2-cyanoethenyl]-2,6-dimethylanilino]pyrimidin-2-yl]amino]benzonitrile	Cc1cc(/C=C/C#N)cc(C)c1Nc1ccnc(Nc2ccc(C#N)cc2)n1	6451164.0	R23_gupta_2019:887			BBB-	C	training
InChI=1S/C22H19ClO3/c23-16-11-9-14(10-12-16)13-5-7-15(8-6-13)19-20(24)17-3-1-2-4-18(17)21(25)22(19)26/h1-4,9-13,15,24H,5-8H2	Atovaquone	3-[4-(4-chlorophenyl)cyclohexyl]-4-hydroxynaphthalene-1,2-dione	O=C1C(=O)c2ccccc2C(O)=C1C1CCC(c2ccc(Cl)cc2)CC1	74989.0	R14_ghose_2012:366|R23_gupta_2019:367|R28_li_2005:231			BBB-	C	test
InChI=1S/C22H19N3O4/c1-24-10-19(26)25-16(22(24)27)9-14-13-4-2-3-5-15(13)23-20(14)21(25)12-6-7-17-18(8-12)29-11-28-17/h2-8,16,21,23H,9-11H2,1H3/t16-,21-/m1/s1	Tadalafil	(2R,8R)-2-(1,3-benzodioxol-5-yl)-6-methyl-3,6,17-triazatetracyclo[8.7.0.03,8.011,16]heptadeca-1(10),11,13,15-tetraene-4,7-dione	CN1CC(=O)N2[C@H](c3ccc4c(c3)OCO4)c3[nH]c4ccccc4c3C[C@@H]2C1=O	110635.0	R14_ghose_2012:872|R23_gupta_2019:946|R47_radchenko_2020:509	-1.0	A	BBB+	A	training
InChI=1S/C22H19N5/c1-15-12-27(14-25-15)18-7-4-6-17(11-18)26-22-20-10-9-16-5-2-3-8-19(16)21(20)23-13-24-22/h2-8,11-14H,9-10H2,1H3,(H,23,24,26)	Fr 260010|N-(3-(4-Methyl-1H-Imidazol-1-Yl)Phenyl)-5,6-Dihydrobenzo(H)Quinazolin-4-Amine	N-[3-(4-methylimidazol-1-yl)phenyl]-5,6-dihydrobenzo[h]quinazolin-4-amine	Cc1cn(-c2cccc(Nc3ncnc4c3CCc3ccccc3-4)c2)cn1	9968450.0	R26_chico_2009:197	0.3	A	BBB+	A	training
InChI=1S/C22H19NO4/c1-15(24)26-19-10-6-17(7-11-19)22(21-5-3-4-14-23-21)18-8-12-20(13-9-18)27-16(2)25/h3-14,22H,1-2H3	Bisacodyl	[4-[(4-acetyloxyphenyl)-pyridin-2-ylmethyl]phenyl] acetate	CC(=O)Oc1ccc(C(c2ccc(OC(C)=O)cc2)c2ccccn2)cc1	2391.0	R14_ghose_2012:398			BBB-	C	training
InChI=1S/C22H20ClN3/c1-25-10-12-26(13-11-25)22-15-16-14-17(23)6-7-18(16)20(8-9-24)19-4-2-3-5-21(19)22/h2-8,14-15H,10-13H2,1H3/b20-8-	Rilapine	(2Z)-2-[6-chloro-10-(4-methylpiperazin-1-yl)-2-tricyclo[9.4.0.03,8]pentadeca-1(15),3(8),4,6,9,11,13-heptaenylidene]acetonitrile	CN1CCN(C2=Cc3cc(Cl)ccc3/C(=C/C#N)c3ccccc32)CC1	10090005.0	R6_adenot_2004:1619			BBB+	C	training
InChI=1S/C22H20FN3O2/c1-26-18(13-25-22(27)16-9-10-28-14-16)12-24-21(15-5-3-2-4-6-15)19-8-7-17(23)11-20(19)26/h2-11,14,18H,12-13H2,1H3,(H,25,27)	Lufuradom	N-[(8-fluoro-1-methyl-5-phenyl-2,3-dihydro-1,4-benzodiazepin-2-yl)methyl]furan-3-carboxamide	CN1c2cc(F)ccc2C(c2ccccc2)=NCC1CNC(=O)c1ccoc1	3045400.0	R6_adenot_2004:1106			BBB+	C	training
InChI=1S/C22H20FN3OS/c1-26-16(13-25-22(27)15-10-11-28-14-15)12-24-21(17-6-2-4-8-19(17)23)18-7-3-5-9-20(18)26/h2-11,14,16H,12-13H2,1H3,(H,25,27)	Tifluadom	N-[[5-(2-fluorophenyl)-1-methyl-2,3-dihydro-1,4-benzodiazepin-2-yl]methyl]thiophene-3-carboxamide	CN1c2ccccc2C(c2ccccc2F)=NCC1CNC(=O)c1ccsc1	115208.0	R7_andres_2006:173|R28_li_2005:323|R29_subramanian_2003:168			BBB+	C	training
InChI=1S/C22H20N2/c1-2-6-19(7-3-1)16-24-17-20(21-8-4-5-9-22(21)24)11-10-18-12-14-23-15-13-18/h1-9,12-15,17H,10-11,16H2	Benzindopyrine	1-benzyl-3-(2-pyridin-4-ylethyl)indole	c1ccc(Cn2cc(CCc3ccncc3)c3ccccc32)cc1	21770.0	R6_adenot_2004:1420			BBB+	C	test
InChI=1S/C22H20N4O8S2/c23-18(27)13-6-8-25(9-7-13)10-14-11-35-21-15(20(29)26(21)16(14)22(30)31)24-19(28)17(36(32,33)34)12-4-2-1-3-5-12/h1-9,15,17,21H,10-11H2,(H4-,23,24,27,28,30,31,32,33,34)/t15-,17-,21-/m1/s1	Cefsulodin|Sdccgsbi-0050247.P002	(1R)-2-[[(6R,7R)-3-[(4-carbamoylpyridin-1-ium-1-yl)methyl]-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-7-yl]amino]-2-oxo-1-phenylethanesulfonate	NC(=O)c1cc[n+](CC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)[C@@H](c4ccccc4)S(=O)(=O)[O-])[C@H]3SC2)cc1	57514697.0	R6_adenot_2004:195			BBB-	C	training
InChI=1S/C22H21Cl3N4O/c1-14-20(22(30)27-28-11-3-2-4-12-28)26-29(19-10-9-17(24)13-18(19)25)21(14)15-5-7-16(23)8-6-15/h5-10,13H,2-4,11-12H2,1H3,(H,27,30)	Rimonabant	5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-piperidin-1-ylpyrazole-3-carboxamide	Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1	104850.0	R37_chen_2011:84			BBB+	C	test
InChI=1S/C22H21ClN2O8/c1-6-9-7(23)4-5-8(26)11(9)16(27)12-10(6)17(28)14-15(25(2)3)18(29)13(21(24)32)20(31)22(14,33)19(12)30/h4-5,10,14-15,17,26-28,31,33H,1H2,2-3H3,(H2,24,32)/t10-,14-,15+,17+,22+/m1/s1	Meclocycline	(4S,4aR,5S,5aR,12aR)-7-chloro-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methylidene-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide	C=C1c2c(Cl)ccc(O)c2C(O)=C2C(=O)[C@]3(O)C(O)=C(C(N)=O)C(=O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@H]12	54676539.0	R6_adenot_2004:311|R23_gupta_2019:1072|R51_doninger_2002:79			BBB-	C	training
InChI=1S/C22H21N7O6S2/c23-22-25-8-13(37-22)14(27-35-12-4-5-24-17(12)30)18(31)26-15-19(32)29-16(21(33)34)11(10-36-20(15)29)9-28-6-2-1-3-7-28/h1-3,6-8,12,15,20H,4-5,9-10H2,(H4-,23,24,25,26,27,30,31,33,34)/t12?,15-,20-/m1/s1	Cefempidone	(6R,7R)-7-[[(2E)-2-(2-amino-1,3-thiazol-5-yl)-2-(2-oxopyrrolidin-3-yl)oxyiminoacetyl]amino]-8-oxo-3-(pyridin-1-ium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate	Nc1ncc(/C(=N/OC2CCNC2=O)C(=O)N[C@@H]2C(=O)N3C(C(=O)[O-])=C(C[n+]4ccccc4)CS[C@H]23)s1	10053104.0	R6_adenot_2004:169			BBB-	C	training
InChI=1S/C22H21NO7/c1-7-4-5-10-8(2)11-6-12-16(23)19(27)13(9(3)24)20(28)22(12,30)21(29)15(11)18(26)14(10)17(7)25/h4-5,12,16,25-26,28,30H,6,23H2,1-3H3/t12-,16+,22+/m0/s1	Cetocycline	(1R,4aR,12aS)-3-acetyl-1-amino-4,4a,6,7-tetrahydroxy-8,11-dimethyl-12,12a-dihydro-1H-tetracene-2,5-dione	CC(=O)C1=C(O)[C@@]2(O)C(=O)c3c(c(C)c4ccc(C)c(O)c4c3O)C[C@H]2[C@@H](N)C1=O	71402.0	R6_adenot_2004:302			BBB-	C	test
InChI=1S/C22H22ClF4NO2/c23-19-8-5-16(14-18(19)22(25,26)27)21(30)9-12-28(13-10-21)11-1-2-20(29)15-3-6-17(24)7-4-15/h3-8,14,30H,1-2,9-13H2	Clofluperol	4-[4-[4-chloro-3-(trifluoromethyl)phenyl]-4-hydroxypiperidin-1-yl]-1-(4-fluorophenyl)butan-1-one	O=C(CCCN1CCC(O)(c2ccc(Cl)c(C(F)(F)F)c2)CC1)c1ccc(F)cc1	25293.0	R6_adenot_2004:1137			BBB+	C	training
InChI=1S/C22H22ClN5O4S2/c1-2-16(29)26-7-9-27(10-8-26)22(31)32-21-18-17(33-11-12-34-18)20(30)28(21)15-6-4-13-3-5-14(23)24-19(13)25-15/h3-6,21H,2,7-12H2,1H3	Suproclone	[6-(7-chloro-1,8-naphthyridin-2-yl)-5-oxo-3,7-dihydro-2H-[1,4]dithiino[2,3-c]pyrrol-7-yl] 4-propanoylpiperazine-1-carboxylate	CCC(=O)N1CCN(C(=O)OC2C3=C(SCCS3)C(=O)N2c2ccc3ccc(Cl)nc3n2)CC1	53696.0	R6_adenot_2004:1512			BBB+	C	training
InChI=1S/C22H22FN3O2/c23-16-7-5-14(6-8-16)18-11-15-12-25(13-19(15)18)9-10-26-21(27)17-3-1-2-4-20(17)24-22(26)28/h1-8,15,18-19H,9-13H2,(H,24,28)/t15-,18-,19+/m1/s1	Balaperidone|Belaperidone	3-[2-[(1S,5R,6S)-6-(4-fluorophenyl)-3-azabicyclo[3.2.0]heptan-3-yl]ethyl]-1H-quinazoline-2,4-dione	O=c1[nH]c2ccccc2c(=O)n1CCN1C[C@H]2C[C@H](c3ccc(F)cc3)[C@H]2C1	184841.0	R6_adenot_2004:1149			BBB+	C	training
InChI=1S/C22H22FN3O2/c23-17-9-7-16(8-10-17)21(27)6-3-13-25-14-11-18(12-15-25)26-20-5-2-1-4-19(20)24-22(26)28/h1-2,4-5,7-11H,3,6,12-15H2,(H,24,28)	Droperidol	3-[1-[4-(4-fluorophenyl)-4-oxobutyl]-3,6-dihydro-2H-pyridin-4-yl]-1H-benzimidazol-2-one	O=C(CCCN1CC=C(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1	3168.0	R6_adenot_2004:1150|R14_ghose_2012:83|R23_gupta_2019:78|R26_chico_2009:171|R51_doninger_2002:207			BBB+	C	training
InChI=1S/C22H22N2O5S/c1-22(2)17(21(27)28)24-19(26)15(20(24)30-22)23-18(25)16(13-9-5-3-6-10-13)29-14-11-7-4-8-12-14/h3-12,15-17,20H,1-2H3,(H,23,25)(H,27,28)/t15-,16?,17+,20-/m1/s1	Fenbenicillin	(2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(2-phenoxy-2-phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid	CC1(C)S[C@@H]2[C@H](NC(=O)C(Oc3ccccc3)c3ccccc3)C(=O)N2[C@H]1C(=O)O	71107.0	R6_adenot_2004:224			BBB-	C	training
InChI=1S/C22H22N2O8/c1-7-8-5-4-6-9(25)11(8)16(26)12-10(7)17(27)14-15(24(2)3)18(28)13(21(23)31)20(30)22(14,32)19(12)29/h4-6,10,14-15,17,25-27,30,32H,1H2,2-3H3,(H2,23,31)/t10-,14-,15+,17+,22+/m1/s1	Metacycline|Methacycline Hydrochloride|Methacycline	(4S,4aR,5S,5aR,12aR)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methylidene-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide	C=C1c2cccc(O)c2C(O)=C2C(=O)[C@]3(O)C(O)=C(C(N)=O)C(=O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@H]12	54675785.0	R6_adenot_2004:312|R14_ghose_2012:682|R23_gupta_2019:733			BBB-	C	training
InChI=1S/C22H22N6O5S2/c1-33-26-15(13-10-35-22(23)24-13)18(29)25-16-19(30)28-17(21(31)32)12(9-34-20(16)28)8-27-7-3-5-11-4-2-6-14(11)27/h3,5,7,10,16,20H,2,4,6,8-9H2,1H3,(H3-,23,24,25,29,31,32)/b26-15-/t16-,20-/m1/s1	Cefpirome|1-[[(6R,7R)-7-[[(2Z)-(2-Amino-4-Thiazolyl)(Methoxyimino)Acetyl]Amino]-2-Carboxy-8-Oxo-5-Thia-1-Azabicyclo[4.2.0]Oct-2-En-3-Yl]Methyl]-6,7-Dihydro-5H-Cyclopenta[B]Pyrindinium Inner Salt	(6R,7R)-7-[[(2E)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-(6,7-dihydro-5H-cyclopenta[b]pyridin-1-ium-1-ylmethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate	CO/N=C(/C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(C[n+]3cccc4c3CCC4)CS[C@H]12)c1csc(N)n1	6917674.0	R6_adenot_2004:189			BBB-	C	training
InChI=1S/C22H22N6O7S2/c1-22(2,20(33)34)35-26-13(12-10-37-21(23)24-12)16(29)25-14-17(30)28-15(19(31)32)11(9-36-18(14)28)8-27-6-4-3-5-7-27/h3-7,10,14,18H,8-9H2,1-2H3,(H4-,23,24,25,29,31,32,33,34)	Ceftazidime	2-[[1-(2-amino-1,3-thiazol-4-yl)-2-[[2-carboxy-8-oxo-3-(pyridin-1-ium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-en-7-yl]amino]-2-oxoethylidene]amino]oxy-2-methylpropanoate	CC(C)(ON=C(C(=O)NC1C(=O)N2C(C(=O)O)=C(C[n+]3ccccc3)CSC12)c1csc(N)n1)C(=O)[O-]	76552301.0	R28_li_2005:301			BBB+	C	test
InChI=1S/C22H22N6O7S2/c1-22(2,20(33)34)35-26-13(12-10-37-21(23)24-12)16(29)25-14-17(30)28-15(19(31)32)11(9-36-18(14)28)8-27-6-4-3-5-7-27/h3-7,10,14,18H,8-9H2,1-2H3,(H4-,23,24,25,29,31,32,33,34)/b26-13-/t14-,18-/m1/s1	Ceftazidime|2-[(E)-[1-(2-Amino-1,3-Thiazol-4-Yl)-2-[[(6R,7R)-2-Carboxy-8-Oxo-3-(Pyridin-1-Ium-1-Ylmethyl)-5-Thia-1-Azabicyclo[4.2.0]Oct-2-En-7-Yl]Amino]-2-Oxoethylidene]Amino]Oxy-2-Methylpropanoate	2-[(E)-[1-(2-amino-1,3-thiazol-4-yl)-2-[[(6R,7R)-2-carboxy-8-oxo-3-(pyridin-1-ium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-en-7-yl]amino]-2-oxoethylidene]amino]oxy-2-methylpropanoate	CC(C)(O/N=C(/C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(C[n+]3ccccc3)CS[C@H]12)c1csc(N)n1)C(=O)[O-]	170841818.0	R6_adenot_2004:197|R23_gupta_2019:436			BBB-	C	test
InChI=1S/C22H22N8/c1-2-6-16-15(5-1)19(13-27-29-21-23-9-10-24-21)17-7-3-4-8-18(17)20(16)14-28-30-22-25-11-12-26-22/h1-8,13-14H,9-12H2,(H2,23,24,29)(H2,25,26,30)/b27-13+,28-14+	Bisantrene Hydrochloride|N-[(Z)-[10-[(Z)-(4,5-Dihydro-1H-Imidazol-2-Ylhydrazinylidene)Methyl]Anthracen-9-Yl]Methylideneamino]-4,5-Dihydro-1H-Imidazol-2-Amine	N-[(Z)-[10-[(Z)-(4,5-dihydro-1H-imidazol-2-ylhydrazinylidene)methyl]anthracen-9-yl]methylideneamino]-4,5-dihydro-1H-imidazol-2-amine	C(=N\NC1=NCCN1)\c1c2ccccc2c(/C=N\NC2=NCCN2)c2ccccc12	5477614.0	R23_gupta_2019:1046			BBB-	C	training
InChI=1S/C22H22O8/c1-25-16-4-10(5-17(26-2)21(16)27-3)18-11-6-14-15(30-9-29-14)7-12(11)20(23)13-8-28-22(24)19(13)18/h4-7,13,18-20,23H,8-9H2,1-3H3/t13-,18+,19-,20-/m0/s1	Podofilox	(5R,5aR,8aR,9R)-5-hydroxy-9-(3,4,5-trimethoxyphenyl)-5a,6,8a,9-tetrahydro-5H-[2]benzofuro[5,6-f][1,3]benzodioxol-8-one	COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1OC	10607.0	R23_gupta_2019:848			BBB-	C	training
InChI=1S/C22H23ClFN3O2/c23-17-4-7-20-19(14-17)25-22(29)27(20)11-1-10-26-12-8-16(9-13-26)21(28)15-2-5-18(24)6-3-15/h2-7,14,16H,1,8-13H2,(H,25,29)	Milenperone	6-chloro-3-[3-[4-(4-fluorobenzoyl)piperidin-1-yl]propyl]-1H-benzimidazol-2-one	O=C(c1ccc(F)cc1)C1CCN(CCCn2c(=O)[nH]c3cc(Cl)ccc32)CC1	65489.0	R6_adenot_2004:1182			BBB+	C	test
InChI=1S/C22H23ClFNO2/c23-19-7-3-17(4-8-19)22(27)18-11-14-25(15-12-18)13-1-2-21(26)16-5-9-20(24)10-6-16/h3-10,18H,1-2,11-15H2	Cloroperone	4-[4-(4-chlorobenzoyl)piperidin-1-yl]-1-(4-fluorophenyl)butan-1-one	O=C(CCCN1CCC(C(=O)c2ccc(Cl)cc2)CC1)c1ccc(F)cc1	41536.0	R6_adenot_2004:1141			BBB+	C	training
InChI=1S/C22H23ClN2O2/c1-2-27-22(26)25-12-9-15(10-13-25)20-19-8-7-18(23)14-17(19)6-5-16-4-3-11-24-21(16)20/h3-4,7-8,11,14H,2,5-6,9-10,12-13H2,1H3	Loratadine	ethyl 4-(13-chloro-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-ylidene)piperidine-1-carboxylate	CCOC(=O)N1CCC(=C2c3ccc(Cl)cc3CCc3cccnc32)CC1	3957.0	R6_adenot_2004:413|R7_andres_2006:94|R26_chico_2009:248|R28_li_2005:381|R29_subramanian_2003:88|R34_broccatelli_2012:45|R47_radchenko_2020:500|R50_sobanska_2019:77	-0.04	C	BBB+	A	training
InChI=1S/C22H23ClN2O8/c1-21(32)7-6-8-15(25(2)3)17(28)13(20(24)31)19(30)22(8,33)18(29)11(7)16(27)12-10(26)5-4-9(23)14(12)21/h4-5,7-8,15,26-27,30,32-33H,6H2,1-3H3,(H2,24,31)/t7-,8-,15-,21-,22-/m0/s1	Chlortetracycline|Auxeomycin	(4S,4aS,5aS,6S,12aR)-7-chloro-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide	CN(C)[C@@H]1C(=O)C(C(N)=O)=C(O)[C@@]2(O)C(=O)C3=C(O)c4c(O)ccc(Cl)c4[C@@](C)(O)[C@H]3C[C@@H]12	54675777.0	R6_adenot_2004:303|R51_doninger_2002:14|R51_doninger_2002:25			BBB-	C	training
InChI=1S/C22H23ClN6O/c1-2-3-8-20-24-21(23)19(14-30)29(20)13-15-9-11-16(12-10-15)17-6-4-5-7-18(17)22-25-27-28-26-22/h4-7,9-12,30H,2-3,8,13-14H2,1H3,(H,25,26,27,28)	Losartan|Losartan Potassium	[2-butyl-5-chloro-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol	CCCCc1nc(Cl)c(CO)n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1	3961.0	R6_adenot_2004:44|R14_ghose_2012:661|R23_gupta_2019:716			BBB-	C	training
InChI=1S/C22H23F2NO2/c23-19-7-3-16(4-8-19)21(26)2-1-13-25-14-11-18(12-15-25)22(27)17-5-9-20(24)10-6-17/h3-10,18H,1-2,11-15H2	Lenperone	4-[4-(4-fluorobenzoyl)piperidin-1-yl]-1-(4-fluorophenyl)butan-1-one	O=C(CCCN1CCC(C(=O)c2ccc(F)cc2)CC1)c1ccc(F)cc1	32593.0	R6_adenot_2004:1238|R51_doninger_2002:236			BBB+	C	training
InChI=1S/C22H23F4NO2/c23-19-8-6-16(7-9-19)20(28)5-2-12-27-13-10-21(29,11-14-27)17-3-1-4-18(15-17)22(24,25)26/h1,3-4,6-9,15,29H,2,5,10-14H2	Trifluperidol	1-(4-fluorophenyl)-4-[4-hydroxy-4-[3-(trifluoromethyl)phenyl]piperidin-1-yl]butan-1-one	O=C(CCCN1CCC(O)(c2cccc(C(F)(F)F)c2)CC1)c1ccc(F)cc1	5567.0	R6_adenot_2004:1231|R51_doninger_2002:316			BBB+	C	training
InChI=1S/C22H23FN4/c1-14-15(2)24-22(25-19-10-8-18(23)9-11-19)26-21(14)27-13-12-17-6-4-5-7-20(17)16(27)3/h4-11,16H,12-13H2,1-3H3,(H,24,25,26)	Ai-9|Mp 005-942-485|Revaprazan	N-(4-fluorophenyl)-4,5-dimethyl-6-(1-methyl-3,4-dihydro-1H-isoquinolin-2-yl)pyrimidin-2-amine	Cc1nc(Nc2ccc(F)cc2)nc(N2CCc3ccccc3C2C)c1C	204104.0	R3_abraham_2006:118|R21_muehlbacher_2011:305|R23_gupta_2019:884|R41_toropov_2017:113|R41_toropov_2017:114|R46_mendoza_valencia_2017:109|R47_radchenko_2020:100			BBB-	C	training
InChI=1S/C22H23FN4O2/c23-15-7-8-17-18(25-29-21(17)14-15)5-3-11-26-12-9-16(10-13-26)27-20-6-2-1-4-19(20)24-22(27)28/h1-2,4,6-8,14,16H,3,5,9-13H2,(H,24,28)	Neflumozide	3-[1-[3-(6-fluoro-1,2-benzoxazol-3-yl)propyl]piperidin-4-yl]-1H-benzimidazol-2-one	O=c1[nH]c2ccccc2n1C1CCN(CCCc2noc3cc(F)ccc23)CC1	55463.0	R6_adenot_2004:1169			BBB+	C	training
InChI=1S/C22H23N3O/c1-25(2)15-16-8-10-18(11-9-16)22(26)24-21-14-19(12-13-20(21)23)17-6-4-3-5-7-17/h3-14H,15,23H2,1-2H3,(H,24,26)	26|N-(2-Amino-5-Phenylphenyl)-4-[(Dimethylamino)Methyl]Benzamide	N-(2-amino-5-phenylphenyl)-4-[(dimethylamino)methyl]benzamide	CN(C)Cc1ccc(C(=O)Nc2cc(-c3ccccc3)ccc2N)cc1	53245431.0	R47_radchenko_2020:524	0.88	A	BBB+	A	test
InChI=1S/C22H23NO7/c1-23-8-7-11-9-14-20(29-10-28-14)21(27-4)15(11)17(23)18-12-5-6-13(25-2)19(26-3)16(12)22(24)30-18/h5-6,9,17-18H,7-8,10H2,1-4H3/t17-,18+/m1/s1	Noscapine	(3S)-6,7-dimethoxy-3-[(5R)-4-methoxy-6-methyl-7,8-dihydro-5H-[1,3]dioxolo[4,5-g]isoquinolin-5-yl]-3H-2-benzofuran-1-one	COc1ccc2c(c1OC)C(=O)O[C@@H]2[C@H]1c2c(cc3c(c2OC)OCO3)CCN1C	275196.0	R6_adenot_2004:1071			BBB+	C	test
InChI=1S/C22H24Cl2N2O/c23-19-8-7-16(13-20(19)24)14-22(27)26-12-9-17-5-1-2-6-18(17)21(26)15-25-10-3-4-11-25/h1-2,5-8,13,21H,3-4,9-12,14-15H2/t21-/m1/s1	Brl52580|2-(3,4-Dichlorophenyl)-1-[(1S)-1-(Pyrrolidin-1-Ylmethyl)-3,4-Dihydro-1H-Isoquinolin-2-Yl]Ethanone	2-(3,4-dichlorophenyl)-1-[(1S)-1-(pyrrolidin-1-ylmethyl)-3,4-dihydro-1H-isoquinolin-2-yl]ethanone	O=C(Cc1ccc(Cl)c(Cl)c1)N1CCc2ccccc2[C@H]1CN1CCCC1	14726011.0	R28_li_2005:328			BBB+	C	training
InChI=1S/C22H24ClFN4O3/c1-29-20-13-19-16(12-21(20)31-8-2-5-28-6-9-30-10-7-28)22(26-14-25-19)27-15-3-4-18(24)17(23)11-15/h3-4,11-14H,2,5-10H2,1H3,(H,25,26,27)	Gefitinib|Iressa, Gefitinib	N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1	123631.0	R23_gupta_2019:626|R25_brito_sanchez_2015:441|R26_chico_2009:221|R46_mendoza_valencia_2017:368	-0.5	B	BBB+	A	training
InChI=1S/C22H24ClN3O/c23-19-9-4-8-18-21(19)24-20(25-22(18)27)10-5-13-26-14-11-17(12-15-26)16-6-2-1-3-7-16/h1-4,6-9,17H,5,10-15H2,(H,24,25,27)	Compound-5D|8-Chloro-2-(3-(4-Phenylpiperidin-1-Yl)Propyl)Quinazolin-4(3H)-One	8-chloro-2-[3-(4-phenylpiperidin-1-yl)propyl]-3H-quinazolin-4-one	O=c1[nH]c(CCCN2CCC(c3ccccc3)CC2)nc2c(Cl)cccc12	136104476.0	R26_chico_2009:133	-0.03	A	BBB+	A	training
InChI=1S/C22H24ClN3OS2/c23-16-6-7-20-18(14-16)26(17-4-1-2-5-19(17)29-20)11-3-10-25-12-8-22(9-13-25)24-21(27)15-28-22/h1-2,4-7,14H,3,8-13,15H2,(H,24,27)	Spiclomazine	8-[3-(2-chlorophenothiazin-10-yl)propyl]-1-thia-4,8-diazaspiro[4.5]decan-3-one	O=C1CSC2(CCN(CCCN3c4ccccc4Sc4ccc(Cl)cc43)CC2)N1	65714.0	R6_adenot_2004:1620|R51_doninger_2002:305			BBB+	C	training
InChI=1S/C22H24F3N3O2S/c23-22(24,25)16-5-6-20-18(15-16)28(17-3-1-2-4-19(17)31-20)21(30)7-8-26-9-11-27(12-10-26)13-14-29/h1-6,15,29H,7-14H2	Ftorpropazine	3-[4-(2-hydroxyethyl)piperazin-1-yl]-1-[2-(trifluoromethyl)phenothiazin-10-yl]propan-1-one	O=C(CCN1CCN(CCO)CC1)N1c2ccccc2Sc2ccc(C(F)(F)F)cc21	219081.0	R6_adenot_2004:1577			BBB+	C	training
InChI=1S/C22H24F4N2O/c23-17-4-1-15(2-5-17)19-14-21(28-9-7-27(8-10-28)11-12-29)20-13-16(22(24,25)26)3-6-18(19)20/h1-6,13,19,21,29H,7-12,14H2/t19-,21+/m0/s1	Tefludazine	2-[4-[(1R,3S)-3-(4-fluorophenyl)-6-(trifluoromethyl)-2,3-dihydro-1H-inden-1-yl]piperazin-1-yl]ethanol	OCCN1CCN([C@@H]2C[C@@H](c3ccc(F)cc3)c3ccc(C(F)(F)F)cc32)CC1	71240.0	R6_adenot_2004:1224			BBB+	C	training
InChI=1S/C22H24FN3O2/c23-17-9-7-16(8-10-17)21(27)6-3-13-25-14-11-18(12-15-25)26-20-5-2-1-4-19(20)24-22(26)28/h1-2,4-5,7-10,18H,3,6,11-15H2,(H,24,28)	Benperidol	3-[1-[4-(4-fluorophenyl)-4-oxobutyl]piperidin-4-yl]-1H-benzimidazol-2-one	O=C(CCCN1CCC(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1	16363.0	R6_adenot_2004:1119|R14_ghose_2012:16|R23_gupta_2019:20|R51_doninger_2002:159			BBB+	C	test
InChI=1S/C22H24FN3O2/c23-18-8-6-16(7-9-18)21(27)17-10-14-25(15-11-17)12-3-13-26-20-5-2-1-4-19(20)24-22(26)28/h1-2,4-9,17H,3,10-15H2,(H,24,28)	Declenperone	3-[3-[4-(4-fluorobenzoyl)piperidin-1-yl]propyl]-1H-benzimidazol-2-one	O=C(c1ccc(F)cc1)C1CCN(CCCn2c(=O)[nH]c3ccccc32)CC1	71744.0	R6_adenot_2004:1443			BBB+	C	test
InChI=1S/C22H24FN3O3/c1-28-19-5-3-2-4-18(19)26-14-12-25(13-15-26)11-10-20-21(24-22(27)29-20)16-6-8-17(23)9-7-16/h2-9H,10-15H2,1H3,(H,24,27)	Zoloperone	4-(4-fluorophenyl)-5-[2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl]-3H-1,3-oxazol-2-one	COc1ccccc1N1CCN(CCc2oc(=O)[nH]c2-c2ccc(F)cc2)CC1	68696.0	R6_adenot_2004:1236			BBB+	C	training
InChI=1S/C22H24FN3OS/c23-17-9-7-16(8-10-17)21(27)6-3-13-25-14-11-18(12-15-25)26-20-5-2-1-4-19(20)24-22(26)28/h1-2,4-5,7-10,18H,3,6,11-15H2,(H,24,28)	Timiperone	1-(4-fluorophenyl)-4-[4-(2-sulfanylidene-3H-benzimidazol-1-yl)piperidin-1-yl]butan-1-one	O=C(CCCN1CCC(n2c(=S)[nH]c3ccccc32)CC1)c1ccc(F)cc1	3033151.0	R6_adenot_2004:1229			BBB+	C	training
InChI=1S/C22H24N2/c1-2-6-18(7-3-1)22-16-19(11-10-17-12-14-23-15-13-17)20-8-4-5-9-21(20)24-22/h1-9,16-17,23H,10-15H2	Pipequaline	2-phenyl-4-(2-piperidin-4-ylethyl)quinoline	c1ccc(-c2cc(CCC3CCNCC3)c3ccccc3n2)cc1	71219.0	R6_adenot_2004:1503			BBB+	C	training
InChI=1S/C22H24N2O2/c1-14-2-5-18(22(26)24-19-10-11-19)12-20(14)16-6-8-17(9-7-16)21(25)23-13-15-3-4-15/h2,5-9,12,15,19H,3-4,10-11,13H2,1H3,(H,23,25)(H,24,26)	Angell-Br|N~3~-Cyclopropyl-N~4~'-(Cyclopropylmethyl)-6-Methylbiphenyl-3,4'-Dicarboxamide	N-cyclopropyl-3-[4-(cyclopropylmethylcarbamoyl)phenyl]-4-methylbenzamide	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1	24856363.0	R26_chico_2009:33	-0.52	A	BBB+	A	training
InChI=1S/C22H24N2O2/c1-17-7-9-18(10-8-17)20(13-16-24-14-2-3-15-24)21-6-4-5-19(23-21)11-12-22(25)26/h4-13H,2-3,14-16H2,1H3,(H,25,26)/b12-11+,20-13+	Acrivastine	(E)-3-[6-[(E)-1-(4-methylphenyl)-3-pyrrolidin-1-ylprop-1-enyl]pyridin-2-yl]prop-2-enoic acid	Cc1ccc(/C(=C\CN2CCCC2)c2cccc(/C=C/C(=O)O)n2)cc1	5284514.0	R7_andres_2006:4|R29_subramanian_2003:3|R47_radchenko_2020:462	-1.14	A	BBB-	A	training
InChI=1S/C22H24N2O8/c1-21(31)8-5-4-6-11(25)12(8)16(26)13-9(21)7-10-15(24(2)3)17(27)14(20(23)30)19(29)22(10,32)18(13)28/h4-6,9-10,15,25-26,29,31-32H,7H2,1-3H3,(H2,23,30)/t9-,10-,15-,21+,22-/m0/s1	Tetracycline|Tetracycline Hydrochloride	(4S,4aS,5aS,6S,12aR)-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide	CN(C)[C@@H]1C(=O)C(C(N)=O)=C(O)[C@@]2(O)C(=O)C3=C(O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12	54675776.0	R6_adenot_2004:320|R14_ghose_2012:886|R23_gupta_2019:970|R51_doninger_2002:133			BBB-	C	training
InChI=1S/C22H24N2O9/c1-21(32)7-5-4-6-8(25)9(7)15(26)10-12(21)17(28)13-14(24(2)3)16(27)11(20(23)31)19(30)22(13,33)18(10)29/h4-6,12-14,17,25-26,28,30,32-33H,1-3H3,(H2,23,31)/t12-,13-,14+,17+,21-,22+/m1/s1	Oxytetracycline	(4S,4aR,5S,5aR,6S,12aR)-4-(dimethylamino)-1,5,6,10,11,12a-hexahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide	CN(C)[C@@H]1C(=O)C(C(N)=O)=C(O)[C@@]2(O)C(=O)C3=C(O)c4c(O)cccc4[C@@](C)(O)[C@H]3[C@H](O)[C@@H]12	54675779.0	R6_adenot_2004:315|R14_ghose_2012:751|R23_gupta_2019:807|R51_doninger_2002:103			BBB-	C	training
InChI=1S/C22H24N4O2/c27-22(20-7-4-16-28-20)26(21-17-23-11-12-24-21)19-9-14-25(15-10-19)13-8-18-5-2-1-3-6-18/h1-7,11-12,16-17,19H,8-10,13-15H2	Mirfentanil	N-[1-(2-phenylethyl)piperidin-4-yl]-N-pyrazin-2-ylfuran-2-carboxamide	O=C(c1ccco1)N(c1cnccn1)C1CCN(CCc2ccccc2)CC1	60698.0	R6_adenot_2004:1000			BBB+	C	test
InChI=1S/C22H25BrN2O3S/c1-5-28-22(27)20-18(13-29-14-9-7-6-8-10-14)25(4)17-11-16(23)21(26)15(19(17)20)12-24(2)3/h6-11,26H,5,12-13H2,1-4H3	Arbidol	ethyl 6-bromo-4-[(dimethylamino)methyl]-5-hydroxy-1-methyl-2-(phenylsulfanylmethyl)indole-3-carboxylate	CCOC(=O)c1c(CSc2ccccc2)n(C)c2cc(Br)c(O)c(CN(C)C)c12	131411.0	R14_ghose_2012:359|R23_gupta_2019:360			BBB-	C	training
InChI=1S/C22H25ClN2OS/c23-17-7-8-22-20(16-17)18(19-4-1-2-6-21(19)27-22)5-3-9-24-10-12-25(13-11-24)14-15-26/h1-2,4-8,16,26H,3,9-15H2/b18-5+	Clopenthixol|Sordinol	2-[4-[(3E)-3-(2-chlorothioxanthen-9-ylidene)propyl]piperazin-1-yl]ethanol	OCCN1CCN(CC/C=C2\c3ccccc3Sc3ccc(Cl)cc32)CC1	5372683.0	R51_doninger_2002:186			BBB+	C	training
InChI=1S/C22H25ClN2OS/c23-17-7-8-22-20(16-17)18(19-4-1-2-6-21(19)27-22)5-3-9-24-10-12-25(13-11-24)14-15-26/h1-2,4-8,16,26H,3,9-15H2/b18-5-	Zuclopenthixol	2-[4-[(3Z)-3-(2-chlorothioxanthen-9-ylidene)propyl]piperazin-1-yl]ethanol	OCCN1CCN(CC/C=C2/c3ccccc3Sc3ccc(Cl)cc32)CC1	5311507.0	R6_adenot_2004:1237|R14_ghose_2012:276|R23_gupta_2019:270|R50_sobanska_2019:94			BBB+	C	training
InChI=1S/C22H25ClO7/c1-2-28-16-6-3-13(4-7-16)9-14-10-15(5-8-17(14)23)22-20(27)18(25)19(26)21(11-24,30-22)12-29-22/h3-8,10,18-20,24-27H,2,9,11-12H2,1H3/t18-,19-,20+,21-,22-/m0/s1	Ertugliflozin	(1S,2S,3S,4R,5S)-5-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-1-(hydroxymethyl)-6,8-dioxabicyclo[3.2.1]octane-2,3,4-triol	CCOc1ccc(Cc2cc([C@]34OC[C@](CO)(O3)[C@@H](O)[C@H](O)[C@H]4O)ccc2Cl)cc1	44814423.0	R23_gupta_2019:569			BBB-	C	training
InChI=1S/C22H25F2N3O2S/c1-26(22-25-20-4-2-3-5-21(20)30-22)15-8-10-27(11-9-15)13-16(28)14-29-17-6-7-18(23)19(24)12-17/h2-7,12,15-16,28H,8-11,13-14H2,1H3/t16-/m0/s1	Lubeluzole	(2S)-1-[4-[1,3-benzothiazol-2-yl(methyl)amino]piperidin-1-yl]-3-(3,4-difluorophenoxy)propan-2-ol	CN(c1nc2ccccc2s1)C1CCN(C[C@H](O)COc2ccc(F)c(F)c2)CC1	65998.0	R25_brito_sanchez_2015:279|R47_radchenko_2020:394	0.59	B	BBB+	A	test
InChI=1S/C22H25F2NO4/c23-15-3-7-19-13(9-15)1-5-21(28-19)17(26)11-25-12-18(27)22-6-2-14-10-16(24)4-8-20(14)29-22/h3-4,7-10,17-18,21-22,25-27H,1-2,5-6,11-12H2	Nebivolol	1-(6-fluoro-3,4-dihydro-2H-chromen-2-yl)-2-[[2-(6-fluoro-3,4-dihydro-2H-chromen-2-yl)-2-hydroxyethyl]amino]ethanol	OC(CNCC(O)C1CCc2cc(F)ccc2O1)C1CCc2cc(F)ccc2O1	71301.0	R25_brito_sanchez_2015:317|R46_mendoza_valencia_2017:280|R47_radchenko_2020:420	0.57	B	BBB+	A	training
InChI=1S/C22H25F3N2S/c1-16-9-13-26(14-10-16)11-4-12-27-18-5-2-3-6-20(18)28-21-8-7-17(15-19(21)27)22(23,24)25/h2-3,5-8,15-16H,4,9-14H2,1H3	10-[3-(4-Methylpiperidin-1-Yl)Propyl]-2-(Trifluoromethyl)Phenothiazine	10-[3-(4-methylpiperidin-1-yl)propyl]-2-(trifluoromethyl)phenothiazine	CC1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1	21440942.0	R48_hou_2003:115	1.44	A	BBB+	A	test
InChI=1S/C22H25N2OS/c25-22-23(14-17-8-3-1-4-9-17)19-16-26-13-7-12-20(26)21(19)24(22)15-18-10-5-2-6-11-18/h1-6,8-11,19-21H,7,12-16H2/q+1	Trimethaphan	3,5-dibenzyl-8-thionia-3,5-diazatricyclo[6.3.0.02,6]undecan-4-one	O=C1N(Cc2ccccc2)C2C[S+]3CCCC3C2N1Cc1ccccc1	23576.0	R23_gupta_2019:1003			BBB-	C	training
InChI=1S/C22H25N3O3/c26-21-22(25(16-23-21)17-6-2-1-3-7-17)10-12-24(13-11-22)14-18-15-27-19-8-4-5-9-20(19)28-18/h1-9,18H,10-16H2,(H,23,26)	Spiroxatrine	8-(2,3-dihydro-1,4-benzodioxin-3-ylmethyl)-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one	O=C1NCN(c2ccccc2)C12CCN(CC1COc3ccccc3O1)CC2	5268.0	R6_adenot_2004:1221			BBB+	C	test
InChI=1S/C22H25N3O4/c1-28-19-7-3-16(14-20(19)29-2)22(27)25-11-9-24(10-12-25)17-5-6-18-15(13-17)4-8-21(26)23-18/h3,5-7,13-14H,4,8-12H2,1-2H3,(H,23,26)	Vesnarinone	6-[4-(3,4-dimethoxybenzoyl)piperazin-1-yl]-3,4-dihydro-1H-quinolin-2-one	COc1ccc(C(=O)N2CCN(c3ccc4c(c3)CCC(=O)N4)CC2)cc1OC	5663.0	R23_gupta_2019:1024			BBB-	C	training
InChI=1S/C22H25N3O4S/c1-2-29-22(27)23-16-7-8-20-18(15-16)25(17-5-3-4-6-19(17)30-20)21(26)9-10-24-11-13-28-14-12-24/h3-8,15H,2,9-14H2,1H3,(H,23,27)	Moricizine Hydrochloride|Moricizine	ethyl N-[10-(3-morpholin-4-ylpropanoyl)phenothiazin-2-yl]carbamate	CCOC(=O)Nc1ccc2c(c1)N(C(=O)CCN1CCOCC1)c1ccccc1S2	34633.0	R14_ghose_2012:702			BBB-	C	training
InChI=1S/C22H25N3OS/c1-26-20-10-9-17(22-24-12-13-27-22)14-18(20)15-25-19-8-5-11-23-21(19)16-6-3-2-4-7-16/h2-4,6-7,9-10,12-14,19,21,23,25H,5,8,11,15H2,1H3	161499-49-6|Pfizer Compound 15|N-[[2-Methoxy-5-(1,3-Thiazol-2-Yl)Phenyl]Methyl]-2-Phenylpiperidin-3-Amine	N-[[2-methoxy-5-(1,3-thiazol-2-yl)phenyl]methyl]-2-phenylpiperidin-3-amine	COc1ccc(-c2nccs2)cc1CNC1CCCNC1c1ccccc1	9907851.0	R4_mente_2005:90|R25_brito_sanchez_2015:541|R40_vilar_2010:188|R46_mendoza_valencia_2017:452|R47_radchenko_2020:409	0.36	B	BBB+	A	training
InChI=1S/C22H25NO2/c1-2-5-16(6-3-1)17-11-12-23(13-17)14-18-7-4-8-20-19(18)9-10-21-22(20)25-15-24-21/h1-3,5-6,9-10,17-18H,4,7-8,11-15H2/t17-,18-/m0/s1	Napitane	(3R)-3-phenyl-1-[[(6R)-6,7,8,9-tetrahydrobenzo[g][1,3]benzodioxol-6-yl]methyl]pyrrolidine	c1ccc([C@H]2CCN(C[C@@H]3CCCc4c3ccc3c4OCO3)C2)cc1	9927709.0	R6_adenot_2004:484			BBB+	C	training
InChI=1S/C22H25NO3/c1-21(2)11-12-22(3,4)18-13-16(9-10-17(18)21)23-19(24)14-5-7-15(8-6-14)20(25)26/h5-10,13H,11-12H2,1-4H3,(H,23,24)(H,25,26)	Tamibarotene	4-[(5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)carbamoyl]benzoic acid	CC1(C)CCC(C)(C)c2cc(NC(=O)c3ccc(C(=O)O)cc3)ccc21	108143.0	R23_gupta_2019:951			BBB-	C	training
InChI=1S/C22H25NO6/c1-12(24)23-16-8-6-13-10-19(27-3)21(28-4)22(29-5)20(13)14-7-9-18(26-2)17(25)11-15(14)16/h7,9-11,16H,6,8H2,1-5H3,(H,23,24)	N-(1,2,3,10-Tetramethoxy-9-Oxo-5,6,7,9-Tetrahydrobenzo[A]Heptalen-7-Yl)Acetamide	N-(1,2,3,10-tetramethoxy-9-oxo-6,7-dihydro-5H-benzo[a]heptalen-7-yl)acetamide	COc1cc2c(c(OC)c1OC)-c1ccc(OC)c(=O)cc1C(NC(C)=O)CC2	2833.0	R46_mendoza_valencia_2017:415	-0.8	A	BBB+	A	training
InChI=1S/C22H25NO6/c1-12(24)23-16-8-6-13-10-19(27-3)21(28-4)22(29-5)20(13)14-7-9-18(26-2)17(25)11-15(14)16/h7,9-11,16H,6,8H2,1-5H3,(H,23,24)/t16-/m0/s1	Colchicine	N-[(7S)-1,2,3,10-tetramethoxy-9-oxo-6,7-dihydro-5H-benzo[a]heptalen-7-yl]acetamide	COc1cc2c(c(OC)c1OC)-c1ccc(OC)c(=O)cc1[C@@H](NC(C)=O)CC2	6167.0	R6_adenot_2004:14|R14_ghose_2012:467|R23_gupta_2019:478|R25_brito_sanchez_2015:495|R28_li_2005:253|R34_broccatelli_2012:114	-0.8	A	BBB+	A	training
InChI=1S/C22H26ClFO4/c1-12-8-16-15-5-4-13-9-14(25)6-7-19(13,2)21(15,24)17(26)10-20(16,3)22(12,28)18(27)11-23/h6-7,9,12,15-16,28H,4-5,8,10-11H2,1-3H3/t12-,15-,16-,19-,20-,21-,22-/m0/s1	Clobetasone	(8S,9R,10S,13S,14S,16S,17R)-17-(2-chloroacetyl)-9-fluoro-17-hydroxy-10,13,16-trimethyl-7,8,12,14,15,16-hexahydro-6H-cyclopenta[a]phenanthrene-3,11-dione	C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)C(=O)C[C@]2(C)[C@@]1(O)C(=O)CCl	71387.0	R6_adenot_2004:787			BBB+	C	test
InChI=1S/C22H26ClN7O2S/c1-14-4-3-5-16(23)20(14)28-21(32)17-13-24-22(33-17)27-18-12-19(26-15(2)25-18)30-8-6-29(7-9-30)10-11-31/h3-5,12-13,31H,6-11H2,1-2H3,(H,28,32)(H,24,25,26,27)	Dasatinib	N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl]amino]-1,3-thiazole-5-carboxamide	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1	3062316.0	R23_gupta_2019:498			BBB-	C	training
InChI=1S/C22H26F3N3OS/c23-22(24,25)17-6-7-21-19(16-17)28(18-4-1-2-5-20(18)30-21)9-3-8-26-10-12-27(13-11-26)14-15-29/h1-2,4-7,16,29H,3,8-15H2	146-56-5|Fluphenazine|Triflumethazine	2-[4-[3-[2-(trifluoromethyl)phenothiazin-10-yl]propyl]piperazin-1-yl]ethanol	OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1	3372.0	R4_mente_2005:154|R5_guerra_2008:46|R6_adenot_2004:1573|R12_garg_2006:81|R14_ghose_2012:97|R21_muehlbacher_2011:76|R25_brito_sanchez_2015:239|R26_chico_2009:193|R28_li_2005:85|R34_broccatelli_2012:32|R39_shayanfar_2011:46|R40_vilar_2010:278|R42_ciura_2020:18|R44_bujak_2015:30|R47_radchenko_2020:269|R50_sobanska_2019:46|R51_doninger_2002:218	1.51	B	BBB+	A	training
InChI=1S/C22H26FN3O2/c23-18-7-9-20(10-8-18)28-16-4-13-25-14-11-22(12-15-25)21(27)24-17-26(22)19-5-2-1-3-6-19/h1-3,5-10H,4,11-17H2,(H,24,27)	Spiramide	8-[3-(4-fluorophenoxy)propyl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one	O=C1NCN(c2ccccc2)C12CCN(CCCOc1ccc(F)cc1)CC2	68186.0	R6_adenot_2004:1219			BBB+	C	training
InChI=1S/C22H26FN3O2S/c1-25(22-24-20-4-2-3-5-21(20)29-22)17-10-12-26(13-11-17)14-18(27)15-28-19-8-6-16(23)7-9-19/h2-9,17-18,27H,10-15H2,1H3	Sabeluzole	1-[4-[1,3-benzothiazol-2-yl(methyl)amino]piperidin-1-yl]-3-(4-fluorophenoxy)propan-2-ol	CN(c1nc2ccccc2s1)C1CCN(CC(O)COc2ccc(F)cc2)CC1	59823.0	R6_adenot_2004:466|R25_brito_sanchez_2015:273|R46_mendoza_valencia_2017:246|R47_radchenko_2020:395	0.78	B	BBB+	A	test
InChI=1S/C22H26FN3O4/c23-17-6-4-16(5-7-17)22(28)24-8-9-25-10-12-26(13-11-25)19-2-1-3-20-21(19)29-15-18(14-27)30-20/h1-7,18,27H,8-15H2,(H,24,28)	Cid 9844747	4-fluoro-N-[2-[4-[2-(hydroxymethyl)-2,3-dihydro-1,4-benzodioxin-5-yl]piperazin-1-yl]ethyl]benzamide	O=C(NCCN1CCN(c2cccc3c2OCC(CO)O3)CC1)c1ccc(F)cc1	9844747.0	R46_mendoza_valencia_2017:337	-0.45	A	BBB+	A	training
InChI=1S/C22H26FN3O4/c23-17-6-4-16(5-7-17)22(28)24-8-9-25-10-12-26(13-11-25)19-2-1-3-20-21(19)29-15-18(14-27)30-20/h1-7,18,27H,8-15H2,(H,24,28)/t18-/m1/s1	Flesinoxan|Cid 9909776	4-fluoro-N-[2-[4-[(2R)-2-(hydroxymethyl)-2,3-dihydro-1,4-benzodioxin-5-yl]piperazin-1-yl]ethyl]benzamide	O=C(NCCN1CCN(c2cccc3c2OC[C@@H](CO)O3)CC1)c1ccc(F)cc1	9909776.0	R21_muehlbacher_2011:255|R25_brito_sanchez_2015:396|R40_vilar_2010:112|R47_radchenko_2020:361	-0.45	B	BBB+	A	training
InChI=1S/C22H26FNO2/c1-17-4-8-19(9-5-17)22(26)12-15-24(16-13-22)14-2-3-21(25)18-6-10-20(23)11-7-18/h4-11,26H,2-3,12-16H2,1H3	Moperone	1-(4-fluorophenyl)-4-[4-hydroxy-4-(4-methylphenyl)piperidin-1-yl]butan-1-one	Cc1ccc(C2(O)CCN(CCCC(=O)c3ccc(F)cc3)CC2)cc1	4249.0	R6_adenot_2004:1186|R51_doninger_2002:257			BBB+	C	training
InChI=1S/C22H26IN3O2S/c1-24-16-26(18-6-3-2-4-7-18)22(21(24)28)9-12-25(13-10-22)11-5-8-19(27)17-14-20(23)29-15-17/h2-4,6-7,14-15H,5,8-13,16H2,1H3	I-1		CN1CN(c2ccccc2)C2(CCN(CCCC(=O)c3csc(I)c3)CC2)C1=O		R3_abraham_2006:181|R25_brito_sanchez_2015:252|R40_vilar_2010:125|R41_toropov_2017:167|R46_mendoza_valencia_2017:227|R47_radchenko_2020:153	-0.25	B	BBB+	A	training
InChI=1S/C22H26N2O2/c1-3-22-11-7-12-23-13-10-16-15-8-5-6-9-17(15)24(19(16)20(22)23)18(14-22)21(25)26-4-2/h5-6,8-9,14,20H,3-4,7,10-13H2,1-2H3/t20-,22+/m1/s1	Vinpocetine	ethyl (15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaene-17-carboxylate	CCOC(=O)C1=C[C@]2(CC)CCCN3CCc4c(n1c1ccccc41)[C@@H]32	443955.0	R37_chen_2011:106			BBB+	C	training
InChI=1S/C22H26N2O2S/c1-24-12-5-6-19(24)15-18-16-23-22-10-9-17(14-21(18)22)11-13-27(25,26)20-7-3-2-4-8-20/h2-4,7-10,14,16,19,23H,5-6,11-13,15H2,1H3/t19-/m1/s1	Eletriptan	5-[2-(benzenesulfonyl)ethyl]-3-[[(2R)-1-methylpyrrolidin-2-yl]methyl]-1H-indole	CN1CCC[C@@H]1Cc1c[nH]c2ccc(CCS(=O)(=O)c3ccccc3)cc12	77993.0	R23_gupta_2019:80|R26_chico_2009:173|R34_broccatelli_2012:121|R37_chen_2011:31	-0.52	A	BBB+	A	test
InChI=1S/C22H26N2O4/c1-7-15-13(2)24(23)22(14-8-9-18(25-3)19(10-14)26-4)17-12-21(28-6)20(27-5)11-16(15)17/h8-12,23H,7H2,1-6H3	Tofisoline	[1-(3,4-dimethoxyphenyl)-4-ethyl-6,7-dimethoxy-3-methylisoquinolin-2-ium-2-yl]azanide	CCc1c(C)[n+]([NH-])c(-c2ccc(OC)c(OC)c2)c2cc(OC)c(OC)cc12	72149.0	R6_adenot_2004:1517			BBB+	C	test
InChI=1S/C22H26N2O4S/c1-15(25)28-20-21(16-9-11-17(27-4)12-10-16)29-19-8-6-5-7-18(19)24(22(20)26)14-13-23(2)3/h5-12,20-21H,13-14H2,1-4H3	Dilacor Xr	[5-[2-(dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-3-yl] acetate	COc1ccc(C2Sc3ccccc3N(CCN(C)C)C(=O)C2OC(C)=O)cc1	3076.0	R42_ciura_2020:15	0.3	A	BBB+	A	training
InChI=1S/C22H26N2O4S/c1-15(25)28-20-21(16-9-11-17(27-4)12-10-16)29-19-8-6-5-7-18(19)24(22(20)26)14-13-23(2)3/h5-12,20-21H,13-14H2,1-4H3/t20-,21+/m1/s1	Diltiazem	[(2S,3S)-5-[2-(dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-3-yl] acetate	COc1ccc([C@@H]2Sc3ccccc3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O)cc1	39186.0	R6_adenot_2004:18|R7_andres_2006:49|R25_brito_sanchez_2015:497|R29_subramanian_2003:49	0.3	A	BBB+	A	training
InChI=1S/C22H26N6O2/c1-25-20-19(21(29)26(2)22(25)30)28(14-24-20)12-11-27-9-7-15(8-10-27)17-13-23-18-6-4-3-5-16(17)18/h3-6,13-15,23H,7-12H2,1-2H3	Tameridone	7-[2-[4-(1H-indol-3-yl)piperidin-1-yl]ethyl]-1,3-dimethylpurine-2,6-dione	Cn1c(=O)c2c(ncn2CCN2CCC(c3c[nH]c4ccccc34)CC2)n(C)c1=O	71304.0	R6_adenot_2004:1378			BBB+	C	training
InChI=1S/C22H26NO3/c1-23-14-12-17(13-15-23)20(16-23)26-21(24)22(25,18-8-4-2-5-9-18)19-10-6-3-7-11-19/h2-11,17,20,25H,12-16H2,1H3/q+1	Clidinium Bromide|Clidiniumbromide|Clidinium	(1-methyl-1-azoniabicyclo[2.2.2]octan-3-yl) 2-hydroxy-2,2-diphenylacetate	C[N+]12CCC(CC1)C(OC(=O)C(O)(c1ccccc1)c1ccccc1)C2	2784.0	R14_ghose_2012:459|R28_li_2005:250			BBB-	C	training
InChI=1S/C22H27ClF2O3/c1-11-6-13-14-8-16(24)15-7-12(27)4-5-21(15,3)22(14,23)18(25)9-20(13,2)19(11)17(28)10-26/h4-5,7,11,13-14,16,18-19,26H,6,8-10H2,1-3H3/t11-,13+,14+,16+,18+,19-,20+,21+,22+/m1/s1	Halocortolone	(6S,8S,9R,10S,11S,13S,14S,16R,17S)-9-chloro-6,11-difluoro-17-(2-hydroxyacetyl)-10,13,16-trimethyl-7,8,11,12,14,15,16,17-octahydro-6H-cyclopenta[a]phenanthren-3-one	C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](F)C[C@]2(C)[C@H]1C(=O)CO	20056980.0	R6_adenot_2004:863			BBB+	C	training
InChI=1S/C22H27ClF2O4S/c1-11-6-13-14-8-16(24)15-7-12(26)4-5-19(15,2)21(14,25)17(27)9-20(13,3)22(11,29)18(28)30-10-23/h4-5,7,11,13-14,16-17,27,29H,6,8-10H2,1-3H3/t11-,13+,14+,16+,17+,19+,20+,21+,22+/m1/s1	Cloticasone	S-(chloromethyl) (6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carbothioate	C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)SCCl	44481798.0	R6_adenot_2004:794			BBB+	C	training
InChI=1S/C22H27ClF2O5/c1-10-4-11-12-5-15(24)13-6-16(27)14(23)7-19(13,2)21(12,25)17(28)8-20(11,3)22(10,30)18(29)9-26/h6-7,10-12,15,17,26,28,30H,4-5,8-9H2,1-3H3/t10-,11+,12+,15+,17+,19+,20+,21+,22+/m1/s1	Halometasone	(6S,8S,9R,10S,11S,13S,14S,16R,17R)-2-chloro-6,9-difluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one	C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C(Cl)=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO	9846332.0	R6_adenot_2004:864			BBB+	C	training
InChI=1S/C22H27ClN4O3/c1-27(20(28)14-26-22(30)18(25)9-5-6-12-24)19-11-10-16(23)13-17(19)21(29)15-7-3-2-4-8-15/h2-4,7-8,10-11,13,18H,5-6,9,12,14,24-25H2,1H3,(H,26,30)/t18-/m0/s1	Avizafone	(2S)-2,6-diamino-N-[2-(2-benzoyl-4-chloro-N-methylanilino)-2-oxoethyl]hexanamide	CN(C(=O)CNC(=O)[C@@H](N)CCCCN)c1ccc(Cl)cc1C(=O)c1ccccc1	71968.0	R6_adenot_2004:1416			BBB+	C	training
InChI=1S/C22H27F3N2O2/c1-15(2)28-20-11-10-18(29-22(23,24)25)13-17(20)14-27-19-9-6-12-26-21(19)16-7-4-3-5-8-16/h3-5,7-8,10-11,13,15,19,21,26-27H,6,9,12,14H2,1-2H3	145742-21-8|Pfizer Compound 11|2-Phenyl-N-[[2-Propan-2-Yloxy-5-(Trifluoromethoxy)Phenyl]Methyl]Piperidin-3-Amine	2-phenyl-N-[[2-propan-2-yloxy-5-(trifluoromethoxy)phenyl]methyl]piperidin-3-amine	CC(C)Oc1ccc(OC(F)(F)F)cc1CNC1CCCNC1c1ccccc1	9866153.0	R4_mente_2005:86|R25_brito_sanchez_2015:537|R40_vilar_2010:184|R47_radchenko_2020:407	0.41	B	BBB+	A	test
InChI=1S/C22H27F3O4S/c1-11-6-13-14-8-16(24)15-7-12(26)4-5-19(15,2)21(14,25)17(27)9-20(13,3)22(11,29)18(28)30-10-23/h4-5,7,11,13-14,16-17,27,29H,6,8-10H2,1-3H3/t11-,13+,14+,16+,17+,19+,20+,21+,22+/m1/s1	Fluticasone	S-(fluoromethyl) (6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carbothioate	C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)SCF	5311101.0	R6_adenot_2004:860			BBB+	C	training
InChI=1S/C22H27F3O5/c1-11-6-13-14-8-20(23,24)15-7-12(27)4-5-18(15,2)21(14,25)16(28)9-19(13,3)22(11,30)17(29)10-26/h4-5,7,11,13-14,16,26,28,30H,6,8-10H2,1-3H3/t11-,13+,14+,16+,18+,19+,21+,22+/m1/s1	Cormetasone|Cormethasone	(8S,9R,10S,11S,13S,14S,16R,17R)-6,6,9-trifluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-8,11,12,14,15,16-hexahydro-7H-cyclopenta[a]phenanthren-3-one	C[C@@H]1C[C@H]2[C@@H]3CC(F)(F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO	20055458.0	R6_adenot_2004:796			BBB+	C	training
InChI=1S/C22H27FN2O2/c1-27-17-22(26)25(21-10-6-5-9-20(21)23)19-12-15-24(16-13-19)14-11-18-7-3-2-4-8-18/h2-10,19H,11-17H2,1H3	Ocfentanil	N-(2-fluorophenyl)-2-methoxy-N-[1-(2-phenylethyl)piperidin-4-yl]acetamide	COCC(=O)N(c1ccccc1F)C1CCN(CCc2ccccc2)CC1	60575.0	R6_adenot_2004:998			BBB+	C	training
InChI=1S/C22H27FO5/c1-10-6-13-12-8-15(23)14-7-11(24)4-5-21(14,2)18(12)16(25)9-22(13,3)17(10)19(26)20(27)28/h4-5,7,10,12-13,15-18,25H,6,8-9H2,1-3H3,(H,27,28)/t10-,12+,13+,15+,16+,17-,18-,21+,22+/m1/s1	Fluocortin	2-[(6S,8S,9S,10R,11S,13S,14S,16R,17S)-6-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]-2-oxoacetic acid	C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@]2(C)[C@H]1C(=O)C(=O)O	22875828.0	R6_adenot_2004:850			BBB+	C	training
InChI=1S/C22H27FO5/c1-12-8-16-15-5-4-13-9-14(25)6-7-19(13,2)21(15,23)17(26)10-20(16,3)22(12,28)18(27)11-24/h6-7,9,15-17,24,26,28H,1,4-5,8,10-11H2,2-3H3/t15-,16-,17-,19-,20-,21-,22-/m0/s1	Fluprednidene	(8S,9R,10S,11S,13S,14S,17R)-9-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-16-methylidene-7,8,11,12,14,15-hexahydro-6H-cyclopenta[a]phenanthren-3-one	C=C1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO	11794741.0	R6_adenot_2004:856			BBB+	C	training
InChI=1S/C22H27N3O2/c1-4-13-25(14-5-1)17-18-8-6-9-19(16-18)26-15-7-12-23-22-24-20-10-2-3-11-21(20)27-22/h2-3,6,8-11,16H,1,4-5,7,12-15,17H2,(H,23,24)	Skb42|Bbcpd26|104076-32-6|Chebi: 339055|B-066, Skb-42|30|22|N-(3-{3-[(Piperidin-1-Yl)Methyl]Phenoxy}Propyl)-1,3-Benzoxazol-2-Amine	N-[3-[3-(piperidin-1-ylmethyl)phenoxy]propyl]-1,3-benzoxazol-2-amine	c1cc(CN2CCCCC2)cc(OCCCNc2nc3ccccc3o2)c1	14022499.0	R3_abraham_2006:273|R3_abraham_2006:322|R4_mente_2005:140|R12_garg_2006:40|R21_muehlbacher_2011:352|R25_brito_sanchez_2015:23|R26_chico_2009:65|R28_li_2005:166|R40_vilar_2010:255|R41_toropov_2017:245|R41_toropov_2017:286|R46_mendoza_valencia_2017:23|R47_radchenko_2020:228|R48_hou_2003:86|R49_norinder_2002:30|R49_norinder_2002:181|R52_liu_2001:30	0.22	B	BBB+	A	training
InChI=1S/C22H27N3O3S2/c1-30(27,28)17-7-8-21-19(15-17)25(18-5-2-3-6-20(18)29-21)12-4-11-24-13-9-16(10-14-24)22(23)26/h2-3,5-8,15-16H,4,9-14H2,1H3,(H2,23,26)	Metopimazine	1-[3-(2-methylsulfonylphenothiazin-10-yl)propyl]piperidine-4-carboxamide	CS(=O)(=O)c1ccc2c(c1)N(CCCN1CCC(C(N)=O)CC1)c1ccccc1S2	26388.0	R6_adenot_2004:1592			BBB+	C	test
InChI=1S/C22H27N3OS/c1-4-13-25(14-5-1)17-18-8-6-9-19(16-18)26-15-7-12-23-22-24-20-10-2-3-11-21(20)27-22/h2-3,6,8-11,16H,1,4-5,7,12-15,17H2,(H,23,24)	Zolantidine|104076-38-2|B-065, Zolantidine|29	N-[3-[3-(piperidin-1-ylmethyl)phenoxy]propyl]-1,3-benzothiazol-2-amine	c1cc(CN2CCCCC2)cc(OCCCNc2nc3ccccc3s2)c1	91769.0	R3_abraham_2006:303|R4_mente_2005:139|R5_guerra_2008:108|R7_andres_2006:224|R12_garg_2006:181|R21_muehlbacher_2011:279|R25_brito_sanchez_2015:22|R26_chico_2009:64|R28_li_2005:54|R39_shayanfar_2011:122|R40_vilar_2010:306|R41_toropov_2017:270|R46_mendoza_valencia_2017:22|R47_radchenko_2020:250|R48_hou_2003:85|R49_norinder_2002:29|R49_norinder_2002:180|R52_liu_2001:29	0.14	B1	BBB+	A	training
InChI=1S/C22H27NO/c1-16-21-14-18-8-9-19(24)15-20(18)22(16,2)11-13-23(21)12-10-17-6-4-3-5-7-17/h3-9,15-16,21,24H,10-14H2,1-2H3	Phenazocine	1,13-dimethyl-10-(2-phenylethyl)-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol	CC1C2Cc3ccc(O)cc3C1(C)CCN2CCc1ccccc1	14707.0	R6_adenot_2004:1078|R14_ghose_2012:192|R23_gupta_2019:192			BBB+	C	training
InChI=1S/C22H27NO2/c1-23-19(15-21(24)17-9-4-2-5-10-17)13-8-14-20(23)16-22(25)18-11-6-3-7-12-18/h2-7,9-12,19-21,24H,8,13-16H2,1H3	Lobeline|Inflatine	2-[6-(2-hydroxy-2-phenylethyl)-1-methylpiperidin-2-yl]-1-phenylethanone	CN1C(CC(=O)c2ccccc2)CCCC1CC(O)c1ccccc1	3945.0	R6_adenot_2004:364			BBB+	C	training
InChI=1S/C22H27NO2/c1-4-22(24)10-8-18-16-6-5-15-11-19-14(13-23-25-19)12-20(15,2)17(16)7-9-21(18,22)3/h1,11,13,16-18,24H,5-10,12H2,2-3H3/t16-,17+,18+,20+,21+,22+/m1/s1	Danazol	(1S,2R,13R,14S,17R,18S)-17-ethynyl-2,18-dimethyl-7-oxa-6-azapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-ol	C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=Cc5oncc5C[C@]4(C)[C@H]3CC[C@@]21C	28417.0	R14_ghose_2012:478|R23_gupta_2019:494			BBB-	C	training
InChI=1S/C22H27NO2/c24-21(25)13-3-1-2-8-16-23-22-19-11-6-4-9-17(19)14-15-18-10-5-7-12-20(18)22/h4-7,9-12,22-23H,1-3,8,13-16H2,(H,24,25)	Amineptine	7-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,11,13-hexaenylamino)heptanoic acid	O=C(O)CCCCCCNC1c2ccccc2CCc2ccccc21	34870.0	R6_adenot_2004:1540|R14_ghose_2012:288|R23_gupta_2019:8			BBB+	C	test
InChI=1S/C22H28Cl2O4/c1-12-8-16-15-5-4-13-9-14(25)6-7-19(13,2)21(15,24)17(26)10-20(16,3)22(12,28)18(27)11-23/h6-7,9,12,15-17,26,28H,4-5,8,10-11H2,1-3H3/t12-,15+,16+,17+,19+,20+,21+,22+/m1/s1	Mometasone	(8S,9R,10S,11S,13S,14S,16R,17R)-9-chloro-17-(2-chloroacetyl)-11,17-dihydroxy-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one	C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CCl	441335.0	R6_adenot_2004:884			BBB+	C	test
InChI=1S/C22H28Cl2O4/c1-12-8-16-15-5-4-13-9-14(26)6-7-19(13,2)21(15,24)17(23)10-20(16,3)22(12,28)18(27)11-25/h6-7,9,12,15-17,25,28H,4-5,8,10-11H2,1-3H3/t12-,15+,16+,17+,19+,20+,21+,22+/m1/s1	Meclorisone	(8S,9R,10S,11S,13S,14S,16R,17R)-9,11-dichloro-17-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one	C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](Cl)C[C@]2(C)[C@@]1(O)C(=O)CO	260706.0	R6_adenot_2004:876			BBB+	C	test
InChI=1S/C22H28ClFO4/c1-11-6-13-14-8-16(24)15-7-12(26)4-5-21(15,3)22(14,23)18(28)9-20(13,2)19(11)17(27)10-25/h4-5,7,11,13-14,16,18-19,25,28H,6,8-10H2,1-3H3/t11-,13+,14+,16+,18+,19-,20+,21+,22+/m1/s1	Clocortolone	(6S,8S,9R,10S,11S,13S,14S,16R,17S)-9-chloro-6-fluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-7,8,11,12,14,15,16,17-octahydro-6H-cyclopenta[a]phenanthren-3-one	C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@H]1C(=O)CO	5311052.0	R6_adenot_2004:790			BBB+	C	training
InChI=1S/C22H28ClFO4/c1-12-8-16-15-5-4-13-9-14(25)6-7-19(13,2)21(15,24)17(26)10-20(16,3)22(12,28)18(27)11-23/h6-7,9,12,15-17,26,28H,4-5,8,10-11H2,1-3H3/t12-,15-,16-,17-,19-,20-,21-,22-/m0/s1	Clobetasol	(8S,9R,10S,11S,13S,14S,16S,17R)-17-(2-chloroacetyl)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one	C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CCl	5311051.0	R6_adenot_2004:786			BBB+	C	test
InChI=1S/C22H28F2O4/c1-11-6-13-14-8-16(23)15-7-12(26)4-5-21(15,3)22(14,24)18(28)9-20(13,2)19(11)17(27)10-25/h4-5,7,11,13-14,16,18-19,25,28H,6,8-10H2,1-3H3/t11-,13+,14+,16+,18+,19-,20+,21+,22+/m1/s1	Diflucortolone	(6S,8S,9R,10S,11S,13S,14S,16R,17S)-6,9-difluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-7,8,11,12,14,15,16,17-octahydro-6H-cyclopenta[a]phenanthren-3-one	C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@H]1C(=O)CO	11954369.0	R6_adenot_2004:824			BBB+	C	training
InChI=1S/C22H28F2O4S/c1-11-7-13-14-9-16(23)15-8-12(25)5-6-19(15,2)21(14,24)17(26)10-20(13,3)22(11,28)18(27)29-4/h5-6,8,11,13-14,16-17,26,28H,7,9-10H2,1-4H3/t11-,13+,14+,16+,17+,19+,20+,21+,22+/m1/s1	Ticabesone	S-methyl (6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carbothioate	CSC(=O)[C@@]1(O)[C@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C	23254171.0	R6_adenot_2004:905			BBB+	C	training
InChI=1S/C22H28F2O5/c1-11-6-13-14-8-16(23)15-7-12(26)4-5-19(15,2)21(14,24)17(27)9-20(13,3)22(11,29)18(28)10-25/h4-5,7,11,13-14,16-17,25,27,29H,6,8-10H2,1-3H3/t11-,13+,14+,16+,17+,19+,20+,21+,22+/m1/s1	Flumetasone|Flumethasone	(6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one	C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO	16490.0	R6_adenot_2004:840			BBB+	C	training
InChI=1S/C22H28F2O5/c1-11-6-13-14-8-16(23)15-7-12(26)4-5-19(15,2)21(14,24)17(27)9-20(13,3)22(11,29)18(28)10-25/h4-5,7,11,13-14,16-17,25,27,29H,6,8-10H2,1-3H3/t11-,13-,14-,16-,17-,19-,20-,21-,22-/m0/s1	Diflorasone	(6S,8S,9R,10S,11S,13S,14S,16S,17R)-6,9-difluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one	C[C@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO	71415.0	R6_adenot_2004:823			BBB+	C	training
InChI=1S/C22H28N/c1-4-23(5-2)17-16-21(18(23)3)22(19-12-8-6-9-13-19)20-14-10-7-11-15-20/h6-15,18H,4-5,16-17H2,1-3H3/q+1	Prifinium	3-benzhydrylidene-1,1-diethyl-2-methylpyrrolidin-1-ium	CC[N+]1(CC)CCC(=C(c2ccccc2)c2ccccc2)C1C	4905.0	R14_ghose_2012:791			BBB-	C	test
InChI=1S/C22H28N2O/c1-2-22(25)24(20-11-7-4-8-12-20)21-14-17-23(18-15-21)16-13-19-9-5-3-6-10-19/h3-12,21H,2,13-18H2,1H3	Fentanyl	N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide	CCC(=O)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1	3345.0	R3_abraham_2006:168|R3_abraham_2006:169|R6_adenot_2004:1037|R7_andres_2006:64|R14_ghose_2012:91|R21_muehlbacher_2011:74|R23_gupta_2019:92|R25_brito_sanchez_2015:230|R26_chico_2009:186|R29_subramanian_2003:61|R37_chen_2011:36|R40_vilar_2010:109|R41_toropov_2017:156|R46_mendoza_valencia_2017:211|R47_radchenko_2020:142	0.58	D	BBB+	A	training
InChI=1S/C22H28N2O2/c1-2-26-21(25)22(19-6-4-3-5-7-19)13-16-24(17-14-22)15-12-18-8-10-20(23)11-9-18/h3-11H,2,12-17,23H2,1H3	Anileridine	ethyl 1-[2-(4-aminophenyl)ethyl]-4-phenylpiperidine-4-carboxylate	CCOC(=O)C1(c2ccccc2)CCN(CCc2ccc(N)cc2)CC1	8944.0	R6_adenot_2004:1096|R14_ghose_2012:281|R23_gupta_2019:13			BBB+	C	training
InChI=1S/C22H28N2O2/c25-22(20-10-3-1-4-11-20)23-13-8-16-26-21-12-7-9-19(17-21)18-24-14-5-2-6-15-24/h1,3-4,7,9-12,17H,2,5-6,8,13-16,18H2,(H,23,25)	Skb31|Bbcpd21|112598-52-4|B-061|25|17|Benzamide, N-[3-[3-(1-Piperidinylmethyl)Phenoxy]Propyl]-	N-[3-[3-(piperidin-1-ylmethyl)phenoxy]propyl]benzamide	O=C(NCCCOc1cccc(CN2CCCCC2)c1)c1ccccc1	10498206.0	R3_abraham_2006:269|R3_abraham_2006:318|R4_mente_2005:134|R12_garg_2006:36|R25_brito_sanchez_2015:19|R26_chico_2009:60|R28_li_2005:162|R40_vilar_2010:252|R41_toropov_2017:241|R46_mendoza_valencia_2017:19|R47_radchenko_2020:224|R48_hou_2003:61|R49_norinder_2002:25|R49_norinder_2002:176|R52_liu_2001:25	-0.24	B	BBB+	A	training
InChI=1S/C22H28N2O2S/c1-16(14-23-11-9-17(25)10-12-23)15-24-19-5-3-4-6-21(19)27-22-8-7-18(26-2)13-20(22)24/h3-8,13,16-17,25H,9-12,14-15H2,1-2H3	Perimetazine	1-[3-(2-methoxyphenothiazin-10-yl)-2-methylpropyl]piperidin-4-ol	COc1ccc2c(c1)N(CC(C)CN1CCC(O)CC1)c1ccccc1S2	62870.0	R6_adenot_2004:1604			BBB+	C	test
InChI=1S/C22H28N4O6/c27-11-9-23-5-7-25-13-1-2-14(26-8-6-24-10-12-28)18-17(13)21(31)19-15(29)3-4-16(30)20(19)22(18)32/h1-4,23-30H,5-12H2	Mitoxantrone	1,4-dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]anthracene-9,10-dione	O=C1c2c(O)ccc(O)c2C(=O)c2c(NCCNCCO)ccc(NCCNCCO)c21	4212.0	R23_gupta_2019:757			BBB-	C	training
InChI=1S/C22H28N6O3S/c1-15(2)24-19-5-4-8-23-21(19)27-9-11-28(12-10-27)22(29)20-14-16-13-17(26-32(3,30)31)6-7-18(16)25-20/h4-8,13-15,24-26H,9-12H2,1-3H3	Delavirdine Mesylate|Delavirdine	N-[2-[4-[3-(propan-2-ylamino)pyridin-2-yl]piperazine-1-carbonyl]-1H-indol-5-yl]methanesulfonamide	CC(C)Nc1cccnc1N1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1	5625.0	R14_ghose_2012:482|R23_gupta_2019:507|R25_brito_sanchez_2015:373|R26_chico_2009:147|R28_li_2005:138|R46_mendoza_valencia_2017:326|R53_friden_2009:7	-1.52	D	BBB-	A	training
InChI=1S/C22H28N6O8S2/c1-10(23)15(29)26-21-24-11(8-38-21)13(27-34-5)16(30)25-14-17(31)28-12(6-7-37-18(14)28)19(32)35-9-36-20(33)22(2,3)4/h6,8,10,14,18H,7,9,23H2,1-5H3,(H,25,30)(H,24,26,29)/b27-13+/t10-,14+,18+/m0/s1	Ceftizoxime Alapivoxil|2,2-Dimethylpropanoyloxymethyl (6R,7R)-7-[[(2Z)-2-[2-[[(2S)-2-Aminopropanoyl]Amino]-1,3-Thiazol-4-Yl]-2-Methoxyiminoacetyl]Amino]-8-Oxo-5-Thia-1-Azabicyclo[4.2.0]Oct-2-Ene-2-Carboxylate	2,2-dimethylpropanoyloxymethyl (6R,7R)-7-[[(2Z)-2-[2-[[(2S)-2-aminopropanoyl]amino]-1,3-thiazol-4-yl]-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate	CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)OCOC(=O)C(C)(C)C)=CCS[C@H]12)c1csc(NC(=O)[C@H](C)N)n1	9578661.0	R6_adenot_2004:219			BBB-	C	training
InChI=1S/C22H28NO3/c1-23(2)16-10-9-15-20(23)17-26-21(24)22(25,18-11-5-3-6-12-18)19-13-7-4-8-14-19/h3-8,11-14,20,25H,9-10,15-17H2,1-2H3/q+1	Bevonium	(1,1-dimethylpiperidin-1-ium-2-yl)methyl 2-hydroxy-2,2-diphenylacetate	C[N+]1(C)CCCCC1COC(=O)C(O)(c1ccccc1)c1ccccc1	31800.0	R6_adenot_2004:104			BBB-	C	training
InChI=1S/C22H28O2/c1-4-21-13-14(3)20-17-9-7-16(23)12-15(17)6-8-18(20)19(21)10-11-22(21,24)5-2/h2,12,17-20,24H,3-4,6-11,13H2,1H3/t17-,18-,19-,20+,21-,22-/m0/s1	Etonogestrel	(8S,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-11-methylidene-2,6,7,8,9,10,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one	C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3C(=C)C[C@@]21CC	6917715.0	R23_gupta_2019:584			BBB-	C	training
InChI=1S/C22H28O5/c1-12-8-16-15-5-4-13-9-14(24)6-7-20(13,2)19(15)17(25)10-21(16,3)22(12,27)18(26)11-23/h4-5,9,15-17,19,23,25,27H,1,6-8,10-11H2,2-3H3/t15-,16-,17-,19+,20-,21-,22-/m0/s1	Isoprednidene	(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-16-methylidene-1,2,8,9,11,12,14,15-octahydrocyclopenta[a]phenanthren-3-one	C=C1C[C@H]2[C@@H]3C=CC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO	20055344.0	R6_adenot_2004:870			BBB+	C	training
InChI=1S/C22H28O5/c1-12-8-16-15-5-4-13-9-14(24)6-7-20(13,2)19(15)17(25)10-21(16,3)22(12,27)18(26)11-23/h6-7,9,12,15-16,19,23,27H,4-5,8,10-11H2,1-3H3/t12-,15-,16-,19+,20-,21-,22-/m0/s1	Meprednisone	(8S,9S,10R,13S,14S,16S,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,9,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,11-dione	C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3C(=O)C[C@]2(C)[C@@]1(O)C(=O)CO	5284587.0	R6_adenot_2004:879			BBB+	C	test
InChI=1S/C22H28O5/c1-12-8-16-15-5-4-13-9-14(24)6-7-20(13,2)19(15)17(25)10-21(16,3)22(12,27)18(26)11-23/h6-7,9,15-17,19,23,25,27H,1,4-5,8,10-11H2,2-3H3/t15-,16-,17-,19+,20-,21-,22-/m0/s1	Prednylidene	(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-16-methylidene-6,7,8,9,11,12,14,15-octahydrocyclopenta[a]phenanthren-3-one	C=C1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO	20055008.0	R6_adenot_2004:902			BBB+	C	training
InChI=1S/C22H29ClO5/c1-12-8-16-15-5-4-13-9-14(25)6-7-19(13,2)21(15,23)17(26)10-20(16,3)22(12,28)18(27)11-24/h6-7,9,12,15-17,24,26,28H,4-5,8,10-11H2,1-3H3/t12-,15-,16-,17-,19-,20-,21-,22-/m0/s1	Beclometasone|Beclomethasone	(8S,9R,10S,11S,13S,14S,16S,17R)-9-chloro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one	C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO	20469.0	R6_adenot_2004:770			BBB+	C	test
InChI=1S/C22H29FN3O9P/c1-13(2)33-19(29)14(3)25-36(31,35-15-8-6-5-7-9-15)32-12-16-18(28)22(4,23)20(34-16)26-11-10-17(27)24-21(26)30/h5-11,13-14,16,18,20,28H,12H2,1-4H3,(H,25,31)(H,24,27,30)/t14-,16+,18+,20+,22+,36-/m0/s1	Sofosbuvir	propan-2-yl (2S)-2-[[[(2R,3R,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-4-fluoro-3-hydroxy-4-methyloxolan-2-yl]methoxy-phenoxyphosphoryl]amino]propanoate	CC(C)OC(=O)[C@H](C)N[P@](=O)(OC[C@H]1O[C@@H](n2ccc(=O)[nH]c2=O)[C@](C)(F)[C@@H]1O)Oc1ccccc1	45375808.0	R23_gupta_2019:915			BBB-	C	training
InChI=1S/C22H29FO4/c1-12-8-16-15-5-4-13-9-14(25)6-7-21(13,3)22(15,23)18(27)10-20(16,2)19(12)17(26)11-24/h6-7,9,12,15-16,18-19,24,27H,4-5,8,10-11H2,1-3H3/t12-,15+,16+,18+,19-,20+,21+,22+/m1/s1	Desoximetasone	(8S,9R,10S,11S,13S,14S,16R,17S)-9-fluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-7,8,11,12,14,15,16,17-octahydro-6H-cyclopenta[a]phenanthren-3-one	C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@H]1C(=O)CO	5311067.0	R6_adenot_2004:815			BBB+	C	training
InChI=1S/C22H29FO4/c1-12-9-17-15-6-8-21(27,13(2)24)20(15,4)11-18(26)22(17,23)19(3)7-5-14(25)10-16(12)19/h5,7,10,12,15,17-18,26-27H,6,8-9,11H2,1-4H3/t12-,15-,17-,18-,19-,20-,21-,22-/m0/s1	Fluorometholone	(6S,8S,9R,10S,11S,13S,14S,17R)-17-acetyl-9-fluoro-11,17-dihydroxy-6,10,13-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one	CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C	9878.0	R6_adenot_2004:853			BBB+	C	training
InChI=1S/C22H29FO4/c1-12-9-17-16-6-5-14-10-15(25)7-8-19(14,3)21(16,23)18(26)11-20(17,4)22(12,27)13(2)24/h7-8,10,12,16-18,26-27H,5-6,9,11H2,1-4H3/t12-,16-,17-,18-,19-,20-,21-,22-/m0/s1	Doxibetasol	(8S,9R,10S,11S,13S,14S,16S,17R)-17-acetyl-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one	CC(=O)[C@@]1(O)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C	71106.0	R6_adenot_2004:829			BBB+	C	training
InChI=1S/C22H29FO4S/c1-12-9-16-15-6-5-13-10-14(24)7-8-19(13,2)21(15,23)17(25)11-20(16,3)22(12,27)18(26)28-4/h7-8,10,12,15-17,25,27H,5-6,9,11H2,1-4H3/t12-,15-,16-,17-,19-,20-,21-,22-/m0/s1	Timobesone	S-methyl (8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carbothioate	CSC(=O)[C@@]1(O)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C	15986965.0	R6_adenot_2004:909			BBB+	C	training
InChI=1S/C22H29FO5/c1-11-6-14-13-8-16(23)15-7-12(25)4-5-20(15,2)19(13)17(26)9-21(14,3)22(11,28)18(27)10-24/h4-5,7,11,13-14,16-17,19,24,26,28H,6,8-10H2,1-3H3/t11-,13+,14+,16+,17+,19-,20+,21+,22+/m1/s1	Paramethasone	(6S,8S,9S,10R,11S,13S,14S,16R,17R)-6-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one	C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO	5875.0	R6_adenot_2004:890			BBB+	C	test
InChI=1S/C22H29FO5/c1-12(24)18(27)21(28)9-7-15-16-5-4-13-10-14(25)6-8-19(13,2)22(16,23)17(26)11-20(15,21)3/h6,8,10,12,15-17,24,26,28H,4-5,7,9,11H2,1-3H3/t12-,15-,16-,17-,19-,20-,21-,22-/m0/s1	Fluperolone	(8S,9R,10S,11S,13S,14S,17R)-9-fluoro-11,17-dihydroxy-17-[(2S)-2-hydroxypropanoyl]-10,13-dimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one	C[C@H](O)C(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C	56841872.0	R6_adenot_2004:855			BBB+	C	test
InChI=1S/C22H29FO5/c1-12-8-16-15-5-4-13-9-14(25)6-7-19(13,2)21(15,23)17(26)10-20(16,3)22(12,28)18(27)11-24/h6-7,9,12,15-17,24,26,28H,4-5,8,10-11H2,1-3H3/t12-,15+,16+,17+,19+,20+,21+,22+/m1/s1	Dexamethasone	(8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one	C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO	5743.0	R6_adenot_2004:16|R6_adenot_2004:819|R7_andres_2006:47|R14_ghose_2012:64|R23_gupta_2019:278|R25_brito_sanchez_2015:482|R29_subramanian_2003:47|R34_broccatelli_2012:117|R47_radchenko_2020:498|R51_doninger_2002:35	-0.34	C	BBB+	A	test
InChI=1S/C22H29N3O4S/c26-21(18-30(27)17-20-7-6-14-28-20)23-9-2-5-13-29-22-15-19(8-10-24-22)16-25-11-3-1-4-12-25/h2,5-8,10,14-15H,1,3-4,9,11-13,16-18H2,(H,23,26)/b5-2-	Lafutidine	2-(furan-2-ylmethylsulfinyl)-N-[(Z)-4-[4-(piperidin-1-ylmethyl)pyridin-2-yl]oxybut-2-enyl]acetamide	O=C(CS(=O)Cc1ccco1)NC/C=C\COc1cc(CN2CCCCC2)ccn1	5282136.0	R23_gupta_2019:696			BBB-	C	training
InChI=1S/C22H29N3O6S/c1-21(2,3)20(29)31-11-30-19(28)15-22(4,5)32-18-14(17(27)25(15)18)24-16(26)13(23)12-9-7-6-8-10-12/h6-10,13-15,18H,11,23H2,1-5H3,(H,24,26)/t13-,14-,15+,18-/m1/s1	Pivampicillin	2,2-dimethylpropanoyloxymethyl (2S,5R,6R)-6-[[(2R)-2-amino-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate	CC(C)(C)C(=O)OCOC(=O)[C@@H]1N2C(=O)[C@@H](NC(=O)[C@H](N)c3ccccc3)[C@H]2SC1(C)C	33478.0	R6_adenot_2004:256|R23_gupta_2019:845			BBB-	C	test
InChI=1S/C22H29N3S2/c1-3-26-18-9-10-22-20(17-18)25(19-7-4-5-8-21(19)27-22)12-6-11-24-15-13-23(2)14-16-24/h4-5,7-10,17H,3,6,11-16H2,1-2H3	Thiethylperazine	2-ethylsulfanyl-10-[3-(4-methylpiperazin-1-yl)propyl]phenothiazine	CCSc1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2	5440.0	R6_adenot_2004:1623|R14_ghose_2012:244|R23_gupta_2019:238|R51_doninger_2002:311			BBB+	C	training
InChI=1S/C22H29N7O5/c1-28(2)19-17-20(25-10-24-19)29(11-26-17)22-18(31)16(15(9-30)34-22)27-21(32)14(23)8-12-4-6-13(33-3)7-5-12/h4-7,10-11,14-16,18,22,30-31H,8-9,23H2,1-3H3,(H,27,32)/t14-,15+,16+,18+,22+/m0/s1	Puromycin	(2S)-2-amino-N-[(2S,3S,4R,5R)-5-[6-(dimethylamino)purin-9-yl]-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]-3-(4-methoxyphenyl)propanamide	COc1ccc(C[C@H](N)C(=O)N[C@H]2[C@@H](O)[C@H](n3cnc4c(N(C)C)ncnc43)O[C@@H]2CO)cc1	439530.0	R51_doninger_2002:121			BBB-	C	training
InChI=1S/C22H29NO2/c1-5-21(24)25-22(18(2)17-23(3)4,20-14-10-7-11-15-20)16-19-12-8-6-9-13-19/h6-15,18H,5,16-17H2,1-4H3/t18-,22+/m0/s1	Levopropoxyphene	[(2R,3S)-4-(dimethylamino)-3-methyl-1,2-diphenylbutan-2-yl] propanoate	CCC(=O)O[C@@](Cc1ccccc1)(c1ccccc1)[C@@H](C)CN(C)C	200742.0	R6_adenot_2004:1052			BBB+	C	training
InChI=1S/C22H29NO2/c1-5-21(24)25-22(18(2)17-23(3)4,20-14-10-7-11-15-20)16-19-12-8-6-9-13-19/h6-15,18H,5,16-17H2,1-4H3/t18-,22+/m1/s1	Dextropropoxyphene|Propoxyphene	[(2S,3R)-4-(dimethylamino)-3-methyl-1,2-diphenylbutan-2-yl] propanoate	CCC(=O)O[C@](Cc1ccccc1)(c1ccccc1)[C@H](C)CN(C)C	10100.0	R6_adenot_2004:1026|R14_ghose_2012:69|R23_gupta_2019:64|R26_chico_2009:334|R37_chen_2011:27	0.46	A	BBB+	A	training
InChI=1S/C22H30Cl2N10/c23-15-5-9-17(10-6-15)31-21(27)33-19(25)29-13-3-1-2-4-14-30-20(26)34-22(28)32-18-11-7-16(24)8-12-18/h5-12H,1-4,13-14H2,(H5,25,27,29,31,33)(H5,26,28,30,32,34)	Chlorhexidine|Nolvasan	2-[6-[[amino-[[amino-(4-chloroanilino)methylidene]amino]methylidene]amino]hexyl]-1-[amino-(4-chloroanilino)methylidene]guanidine	NC(=N/C(N)=N/CCCCCC/N=C(\N)N=C(N)Nc1ccc(Cl)cc1)Nc1ccc(Cl)cc1	2713.0	R23_gupta_2019:449			BBB-	C	training
InChI=1S/C22H30Cl2N2O2/c1-25(21(27)14-16-5-6-17(23)18(24)13-16)19-7-9-22(8-4-12-28-22)15-20(19)26-10-2-3-11-26/h5-6,13,19-20H,2-4,7-12,14-15H2,1H3/t19-,20-,22-/m0/s1	Spiradoline	2-(3,4-dichlorophenyl)-N-methyl-N-[(5R,7S,8S)-7-pyrrolidin-1-yl-1-oxaspiro[4.5]decan-8-yl]acetamide	CN(C(=O)Cc1ccc(Cl)c(Cl)c1)[C@H]1CC[C@@]2(CCCO2)C[C@@H]1N1CCCC1	55652.0	R6_adenot_2004:1104|R7_andres_2006:157|R29_subramanian_2003:154			BBB+	C	training
InChI=1S/C22H30N2O/c1-16(2)18-11-12-21(25-3)19(14-18)15-24-20-10-7-13-23-22(20)17-8-5-4-6-9-17/h4-6,8-9,11-12,14,16,20,22-24H,7,10,13,15H2,1-3H3	145742-16-1|Pfizer Compound 8|N-[(2-Methoxy-5-Propan-2-Ylphenyl)Methyl]-2-Phenylpiperidin-3-Amine	N-[(2-methoxy-5-propan-2-ylphenyl)methyl]-2-phenylpiperidin-3-amine	COc1ccc(C(C)C)cc1CNC1CCCNC1c1ccccc1	9902443.0	R4_mente_2005:83|R25_brito_sanchez_2015:556|R40_vilar_2010:204|R46_mendoza_valencia_2017:467|R47_radchenko_2020:434	0.92	B	BBB+	A	test
InChI=1S/C22H30N2O/c1-18-10-8-11-19(2)24(18)17-9-15-22(25,20-12-4-3-5-13-20)21-14-6-7-16-23-21/h3-7,12-14,16,18-19,25H,8-11,15,17H2,1-2H3/t18-,19+,22?	Pirmenol	4-[(2R,6S)-2,6-dimethylpiperidin-1-yl]-1-phenyl-1-pyridin-2-ylbutan-1-ol	C[C@@H]1CCC[C@H](C)N1CCCC(O)(c1ccccc1)c1ccccn1	65502.0	R14_ghose_2012:782			BBB-	C	training
InChI=1S/C22H30N2O2S/c1-3-21(25)24(19-8-5-4-6-9-19)22(18-26-2)12-15-23(16-13-22)14-11-20-10-7-17-27-20/h4-10,17H,3,11-16,18H2,1-2H3	Sufentanil	N-[4-(methoxymethyl)-1-(2-thiophen-2-ylethyl)piperidin-4-yl]-N-phenylpropanamide	CCC(=O)N(c1ccccc1)C1(COC)CCN(CCc2cccs2)CC1	41693.0	R6_adenot_2004:1088|R14_ghose_2012:232|R23_gupta_2019:229|R26_chico_2009:391|R47_radchenko_2020:506	0.2	A	BBB+	A	test
InChI=1S/C22H30N2O5S2/c1-3-29-21(28)17(10-9-16-7-5-4-6-8-16)23-15(2)19(25)24-14-22(30-11-12-31-22)13-18(24)20(26)27/h4-8,15,17-18,23H,3,9-14H2,1-2H3,(H,26,27)/t15-,17-,18-/m0/s1	Spirapril	(8S)-7-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-1,4-dithia-7-azaspiro[4.4]nonane-8-carboxylic acid	CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1CC2(C[C@H]1C(=O)O)SCCS2	5311447.0	R14_ghose_2012:851|R23_gupta_2019:921			BBB-	C	training
InChI=1S/C22H30N4O2S2/c1-23(2)30(27,28)18-9-10-22-20(17-18)26(19-7-4-5-8-21(19)29-22)12-6-11-25-15-13-24(3)14-16-25/h4-5,7-10,17H,6,11-16H2,1-3H3	Thioproperazine	N,N-dimethyl-10-[3-(4-methylpiperazin-1-yl)propyl]phenothiazine-2-sulfonamide	CN1CCN(CCCN2c3ccccc3Sc3ccc(S(=O)(=O)N(C)C)cc32)CC1	9429.0	R6_adenot_2004:1625|R14_ghose_2012:246|R23_gupta_2019:240			BBB+	C	training
InChI=1S/C22H30N6O/c1-15-4-3-5-19-21(15)26-22(25-17-8-11-27(12-9-17)13-10-23)28(19)14-18-20(29)7-6-16(2)24-18/h3-7,17,29H,8-14,23H2,1-2H3,(H,25,26)	2-[[2-[[1-(2-Azanylethyl)Piperidin-4-Yl]Amino]-4-Methyl-Benzimidazol-1-Yl]Methyl]-6-Methyl-Pyridin-3-Ol	2-[[2-[[1-(2-aminoethyl)piperidin-4-yl]amino]-4-methylbenzimidazol-1-yl]methyl]-6-methylpyridin-3-ol	Cc1ccc(O)c(Cn2c(NC3CCN(CCN)CC3)nc3c(C)cccc32)n1	511013.0	R47_radchenko_2020:421	0.63	A	BBB+	A	training
InChI=1S/C22H30N6O4S/c1-5-7-17-19-20(27(4)25-17)22(29)24-21(23-19)16-14-15(8-9-18(16)32-6-2)33(30,31)28-12-10-26(3)11-13-28/h8-9,14H,5-7,10-13H2,1-4H3,(H,23,24,29)	Sildenafil|Sildenafil, Viagra	5-[2-ethoxy-5-(4-methylpiperazin-1-yl)sulfonylphenyl]-1-methyl-3-propyl-6H-pyrazolo[4,3-d]pyrimidin-7-one	CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12	135398744.0	R23_gupta_2019:909|R26_chico_2009:378|R47_radchenko_2020:511	-1.3	A	BBB-	A	test
InChI=1S/C22H30O/c1-4-21-14-15(3)20-17-9-7-6-8-16(17)10-11-18(20)19(21)12-13-22(21,23)5-2/h2,8,17-20,23H,3-4,6-7,9-14H2,1H3/t17-,18-,19-,20+,21-,22-/m0/s1	Desogestrel	(8S,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-11-methylidene-1,2,3,6,7,8,9,10,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-ol	C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CCCC[C@@H]4[C@H]3C(=C)C[C@@]21CC	40973.0	R23_gupta_2019:511			BBB-	C	training
InChI=1S/C22H30O3/c1-12-9-15-17-6-5-16(13(2)23)22(17,4)11-19(25)20(15)21(3)8-7-14(24)10-18(12)21/h7-8,10,12,15-17,19-20,25H,5-6,9,11H2,1-4H3/t12-,15-,16+,17-,19-,20+,21-,22+/m0/s1	Endrisone	(6S,8S,9S,10R,11S,13S,14S,17S)-17-acetyl-11-hydroxy-6,10,13-trimethyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-one	CC(=O)[C@H]1CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@]12C	71422.0	R6_adenot_2004:834			BBB+	C	test
InChI=1S/C22H30O8/c1-12(2)6-18(24)29-17-8-16-15(9-26-14(5)23)10-27-21(20(16)22(17)11-28-22)30-19(25)7-13(3)4/h8,10,12-13,17,20-21H,6-7,9,11H2,1-5H3/t17-,20+,21-,22+/m0/s1	Valtrate	[(1S,6S,7R,7aS)-4-(acetyloxymethyl)-1-(3-methylbutanoyloxy)spiro[6,7a-dihydro-1H-cyclopenta[c]pyran-7,2'-oxirane]-6-yl] 3-methylbutanoate	CC(=O)OCC1=CO[C@@H](OC(=O)CC(C)C)[C@H]2C1=C[C@H](OC(=O)CC(C)C)[C@]21CO1	442436.0	R6_adenot_2004:1393			BBB+	C	test
InChI=1S/C22H31FO2S2/c1-5-27-21(26-4)11-9-16-17-7-6-14-12-15(24)8-10-19(14,2)22(17,23)18(25)13-20(16,21)3/h8,10,12,16-18,25H,5-7,9,11,13H2,1-4H3/t16-,17-,18-,19-,20-,21+,22-/m0/s1	Tipredane	(8S,9R,10S,11S,13S,14S,17R)-17-ethylsulfanyl-9-fluoro-11-hydroxy-10,13-dimethyl-17-methylsulfanyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one	CCS[C@]1(SC)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C	6917939.0	R6_adenot_2004:910			BBB+	C	training
InChI=1S/C22H31N3O11/c26-18(27)10-23(6-7-24(11-19(28)29)12-20(30)31)8-9-25(13-21(32)33)17(22(34)35)15-36-14-16-4-2-1-3-5-16/h1-5,17H,6-15H2,(H,26,27)(H,28,29)(H,30,31)(H,32,33)(H,34,35)	Gadobenate Dimeglumine|2-[2-[2-[Bis(Carboxymethyl)Amino]Ethyl-(Carboxymethyl)Amino]Ethyl-(Carboxymethyl)Amino]-3-Phenylmethoxypropanoic Acid	2-[2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]ethyl-(carboxymethyl)amino]-3-phenylmethoxypropanoic acid	O=C(O)CN(CCN(CC(=O)O)CC(=O)O)CCN(CC(=O)O)C(COCc1ccccc1)C(=O)O	105125.0	R23_gupta_2019:621			BBB-	C	training
InChI=1S/C22H31N3O5/c1-2-30-22(29)18(13-12-16-8-4-3-5-9-16)23-17-10-6-14-24-15-7-11-19(21(27)28)25(24)20(17)26/h3-5,8-9,17-19,23H,2,6-7,10-15H2,1H3,(H,27,28)/t17-,18-,19-/m0/s1	Cilazapril	(4S,7S)-7-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]-6-oxo-1,2,3,4,7,8,9,10-octahydropyridazino[1,2-a]diazepine-4-carboxylic acid	CCOC(=O)[C@H](CCc1ccccc1)N[C@H]1CCCN2CCC[C@@H](C(=O)O)N2C1=O	56330.0	R14_ghose_2012:449|R23_gupta_2019:459			BBB-	C	training
InChI=1S/C22H32N2O5/c1-6-23(7-2)22(26)17-13-24-9-8-15-10-20(27-4)21(28-5)11-16(15)18(24)12-19(17)29-14(3)25/h10-11,17-19H,6-9,12-13H2,1-5H3	Benzquinamide	[3-(diethylcarbamoyl)-9,10-dimethoxy-2,3,4,6,7,11b-hexahydro-1H-benzo[a]quinolizin-2-yl] acetate	CCN(CC)C(=O)C1CN2CCc3cc(OC)c(OC)cc3C2CC1OC(C)=O	2342.0	R6_adenot_2004:1120|R51_doninger_2002:161			BBB+	C	training
InChI=1S/C22H32N2O6/c25-17-7-5-15(11-19(17)27)21(29)13-23-9-3-1-2-4-10-24-14-22(30)16-6-8-18(26)20(28)12-16/h5-8,11-12,21-30H,1-4,9-10,13-14H2	Hexoprenaline	4-[2-[6-[[2-(3,4-dihydroxyphenyl)-2-hydroxyethyl]amino]hexylamino]-1-hydroxyethyl]benzene-1,2-diol	Oc1ccc(C(O)CNCCCCCCNCC(O)c2ccc(O)c(O)c2)cc1O	3609.0	R14_ghose_2012:606			BBB-	C	training
InChI=1S/C22H32N4O4/c1-23-13-9-11-19(17-23)29-21(27)25(3)15-7-5-6-8-16-26(4)22(28)30-20-12-10-14-24(2)18-20/h9-14,17-18H,5-8,15-16H2,1-4H3/q+2	Distigmine	(1-methylpyridin-1-ium-3-yl) N-methyl-N-[6-[methyl-(1-methylpyridin-1-ium-3-yl)oxycarbonylamino]hexyl]carbamate	CN(CCCCCCN(C)C(=O)Oc1ccc[n+](C)c1)C(=O)Oc1ccc[n+](C)c1	3116.0	R14_ghose_2012:508			BBB-	C	training
InChI=1S/C22H32N6/c1-8-10-27(11-9-2)20-13-16(4)24-22-21(17(5)25-28(20)22)18-14-23-19(26(6)7)12-15(18)3/h12-14H,8-11H2,1-7H3	3-(6-(Dimethylamino)-4-Methylpyridin-3-Yl)-2,5-Dimethyl-N,N-Dipropylpyrazolo[1,5-A]Pyrimidin-7-Amine	3-[6-(dimethylamino)-4-methylpyridin-3-yl]-2,5-dimethyl-N,N-dipropylpyrazolo[1,5-a]pyrimidin-7-amine	CCCN(CCC)c1cc(C)nc2c(-c3cnc(N(C)C)cc3C)c(C)nn12	9821250.0	R47_radchenko_2020:419	0.07	A	BBB+	A	training
InChI=1S/C22H32O3/c1-12-9-15-17-6-5-16(13(2)23)22(17,4)11-19(25)20(15)21(3)8-7-14(24)10-18(12)21/h10,12,15-17,19-20,25H,5-9,11H2,1-4H3/t12-,15-,16+,17-,19-,20+,21-,22+/m0/s1	Medrysone	(6S,8S,9S,10R,11S,13S,14S,17S)-17-acetyl-11-hydroxy-6,10,13-trimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one	CC(=O)[C@H]1CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@]12C	247839.0	R6_adenot_2004:877			BBB+	C	training
InChI=1S/C22H32O3/c1-13-11-16-17(20(3)8-5-15(24)12-19(13)20)6-9-21(4)18(16)7-10-22(21,25)14(2)23/h12-13,16-18,25H,5-11H2,1-4H3/t13-,16+,17-,18-,20+,21-,22-/m0/s1	Medroxyprogesterone	(6S,8R,9S,10R,13S,14S,17R)-17-acetyl-17-hydroxy-6,10,13-trimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one	CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C	10631.0	R14_ghose_2012:667			BBB-	C	training
InChI=1S/C22H32O4/c1-4-18(25)22(26)10-8-16-15-6-5-13-11-14(23)7-9-20(13,2)19(15)17(24)12-21(16,22)3/h11,15-17,19,24,26H,4-10,12H2,1-3H3/t15-,16-,17-,19+,20-,21-,22-/m0/s1	Resocortol	(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-17-propanoyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one	CCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C	20055396.0	R6_adenot_2004:832			BBB+	C	training
InChI=1S/C22H32O8/c1-12(2)6-18(24)26-9-15-10-27-21(30-19(25)7-13(3)4)20-16(15)8-17(29-14(5)23)22(20)11-28-22/h10,12-13,16-17,20-21H,6-9,11H2,1-5H3/t16-,17+,20-,21+,22-/m1/s1	Didrovaltrate	[(1S,4aS,6S,7R,7aS)-6-acetyloxy-1-(3-methylbutanoyloxy)spiro[4a,5,6,7a-tetrahydro-1H-cyclopenta[c]pyran-7,2'-oxirane]-4-yl]methyl 3-methylbutanoate	CC(=O)O[C@H]1C[C@@H]2C(COC(=O)CC(C)C)=CO[C@@H](OC(=O)CC(C)C)[C@@H]2[C@@]12CO2	65689.0	R6_adenot_2004:1356			BBB+	C	training
InChI=1S/C22H34N4O10/c1-15(2)11-33-21(31)35-13-25-17(27)7-23(8-18(25)28)5-6-24-9-19(29)26(20(30)10-24)14-36-22(32)34-12-16(3)4/h15-16H,5-14H2,1-4H3	Sobuzoxane	[4-[2-[4-(2-methylpropoxycarbonyloxymethyl)-3,5-dioxopiperazin-1-yl]ethyl]-2,6-dioxopiperazin-1-yl]methyl 2-methylpropyl carbonate	CC(C)COC(=O)OCN1C(=O)CN(CCN2CC(=O)N(COC(=O)OCC(C)C)C(=O)C2)CC1=O	5233.0	R23_gupta_2019:913			BBB-	C	training
InChI=1S/C22H34N6O3/c1-4-9-20(29)28(19-10-7-6-8-11-19)22(18-31-3)12-14-25(15-13-22)16-17-27-21(30)26(5-2)23-24-27/h6-8,10-11H,4-5,9,12-18H2,1-3H3	Alfentanil, Rapifen|N-Despropionaldehyde Alfentanil-N-Butyraldehyde	N-[1-[2-(4-ethyl-5-oxotetrazol-1-yl)ethyl]-4-(methoxymethyl)piperidin-4-yl]-N-phenylbutanamide	CCCC(=O)N(c1ccccc1)C1(COC)CCN(CCn2nnn(CC)c2=O)CC1	166177214.0	R26_chico_2009:21	-0.71	A	BBB+	A	training
InChI=1S/C22H34O2/c1-3-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22(23)24-4-2/h5-6,8-9,11-12,14-15,17-18H,3-4,7,10,13,16,19-21H2,1-2H3/b6-5-,9-8-,12-11-,15-14-,18-17-	Icosapent Ethyl	ethyl (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate	CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)OCC	9831415.0	R23_gupta_2019:665			BBB-	C	test
InChI=1S/C22H36N2O5S/c1-2-3-16-30(27,28)24-21(22(25)26)17-19-7-9-20(10-8-19)29-15-5-4-6-18-11-13-23-14-12-18/h7-10,18,21,23-24H,2-6,11-17H2,1H3,(H,25,26)/t21-/m0/s1	Tirofiban	(2S)-2-(butylsulfonylamino)-3-[4-(4-piperidin-4-ylbutoxy)phenyl]propanoic acid	CCCCS(=O)(=O)N[C@@H](Cc1ccc(OCCCCC2CCNCC2)cc1)C(=O)O	60947.0	R23_gupta_2019:984			BBB-	C	training
InChI=1S/C22H36O2/c1-14(23)17-7-8-18-16-6-5-15-13-20(2,24)11-12-21(15,3)19(16)9-10-22(17,18)4/h15-19,24H,5-13H2,1-4H3/t15-,16-,17+,18-,19-,20+,21-,22+/m0/s1	Ganaxolone	1-[(3R,5S,8R,9S,10S,13S,14S,17S)-3-hydroxy-3,10,13-trimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethanone	CC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@](C)(O)CC[C@]4(C)[C@H]3CC[C@]12C	6918305.0	R6_adenot_2004:440			BBB+	C	training
InChI=1S/C22H38O5/c1-4-5-14-22(2,26)15-10-12-18-17(19(23)16-20(18)24)11-8-6-7-9-13-21(25)27-3/h10,12,17-18,20,24,26H,4-9,11,13-16H2,1-3H3/b12-10+/t17-,18-,20-,22?/m1/s1	Misoprostol	methyl 7-[(1R,2R,3R)-3-hydroxy-2-[(E)-4-hydroxy-4-methyloct-1-enyl]-5-oxocyclopentyl]heptanoate	CCCCC(C)(O)C/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)OC	5282381.0	R23_gupta_2019:299			BBB+	C	training
InChI=1S/C22H43N5O12/c1-22(35)6-36-20(15(33)18(22)26-2)39-17-8(27-19(34)9(28)4-23)3-7(25)16(14(17)32)38-21-13(31)12(30)11(29)10(5-24)37-21/h7-18,20-21,26,28-33,35H,3-6,23-25H2,1-2H3,(H,27,34)/t7-,8+,9-,10+,11-,12?,13+,14-,15+,16+,17-,18+,20+,21+,22-/m0/s1	Isepamycin	(2S)-3-amino-N-[(1R,2S,3S,4R,5S)-5-amino-4-[(2R,3R,5R,6R)-6-(aminomethyl)-3,4,5-trihydroxyoxan-2-yl]oxy-2-[(2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methylamino)oxan-2-yl]oxy-3-hydroxycyclohexyl]-2-hydroxypropanamide	CN[C@@H]1[C@@H](O)[C@@H](O[C@@H]2[C@@H](O)[C@H](O[C@H]3O[C@H](CN)[C@H](O)C(O)[C@H]3O)[C@@H](N)C[C@H]2NC(=O)[C@@H](O)CN)OC[C@]1(C)O	15293840.0	R6_adenot_2004:119			BBB-	C	training
InChI=1S/C22H44N6O10/c23-4-3-12(30)20(34)28-11-5-10(26)18(37-21-9(25)2-1-8(6-24)35-21)17(33)19(11)38-22-16(32)14(27)15(31)13(7-29)36-22/h8-19,21-22,29-33H,1-7,23-27H2,(H,28,34)/t8-,9+,10-,11+,12-,13+,14-,15+,16+,17-,18+,19-,21+,22+/m0/s1	Arbekacin	(2S)-4-amino-N-[(1R,2S,3S,4R,5S)-5-amino-4-[(2R,3R,6S)-3-amino-6-(aminomethyl)oxan-2-yl]oxy-2-[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxycyclohexyl]-2-hydroxybutanamide	NCC[C@H](O)C(=O)N[C@@H]1C[C@H](N)[C@@H](O[C@H]2O[C@H](CN)CC[C@H]2N)[C@H](O)[C@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](N)[C@H]1O	68682.0	R6_adenot_2004:111|R23_gupta_2019:359			BBB-	C	training
InChI=1S/C22H45N5O12/c23-2-1-7(29)5-27-9-3-8(25)19(38-22-17(34)16(33)14(31)10(4-24)36-22)18(35)20(9)39-21-15(32)12(26)13(30)11(6-28)37-21/h7-22,27-35H,1-6,23-26H2/t7-,8-,9+,10+,11+,12-,13+,14+,15+,16-,17+,18-,19+,20-,21+,22+/m0/s1	Butikacin	(2R,3R,4S,5S,6R)-2-[(1R,2S,3S,4R,6S)-6-amino-3-[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-[[(2S)-4-amino-2-hydroxybutyl]amino]-2-hydroxycyclohexyl]oxy-6-(aminomethyl)oxane-3,4,5-triol	NCC[C@H](O)CN[C@@H]1C[C@H](N)[C@@H](O[C@H]2O[C@H](CN)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](N)[C@H]1O	11954318.0	R6_adenot_2004:113			BBB-	C	training
InChI=1S/C22H46O/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23/h23H,2-22H2,1H3	Docosanol	docosan-1-ol	CCCCCCCCCCCCCCCCCCCCCCO	12620.0	R23_gupta_2019:534			BBB-	C	training
InChI=1S/C23H15F2NO2/c1-13-21(23(27)28)18-12-16(24)10-11-20(18)26-22(13)15-8-6-14(7-9-15)17-4-2-3-5-19(17)25/h2-12H,1H3,(H,27,28)	Brequinar	6-fluoro-2-[4-(2-fluorophenyl)phenyl]-3-methylquinoline-4-carboxylic acid	Cc1c(-c2ccc(-c3ccccc3F)cc2)nc2ccc(F)cc2c1C(=O)O	57030.0	R14_ghose_2012:402			BBB-	C	test
InChI=1S/C23H16O11/c24-11(9-31-14-3-1-5-16-20(14)12(25)7-18(33-16)22(27)28)10-32-15-4-2-6-17-21(15)13(26)8-19(34-17)23(29)30/h1-8,11,24H,9-10H2,(H,27,28)(H,29,30)	Cromoglicicacid|Cromolyn	5-[3-(2-carboxy-4-oxochromen-5-yl)oxy-2-hydroxypropoxy]-4-oxochromene-2-carboxylic acid	O=C(O)c1cc(=O)c2c(OCC(O)COc3cccc4oc(C(=O)O)cc(=O)c34)cccc2o1	2882.0	R28_li_2005:254			BBB-	C	training
InChI=1S/C23H18ClF2N3O3S/c1-2-9-33(31,32)29-19-8-7-18(25)20(21(19)26)22(30)17-12-28-23-16(17)10-14(11-27-23)13-3-5-15(24)6-4-13/h3-8,10-12,29H,2,9H2,1H3,(H,27,28)	Vemurafenib	N-[3-[5-(4-chlorophenyl)-1H-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluorophenyl]propane-1-sulfonamide	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F	42611257.0	R23_gupta_2019:1021			BBB-	C	training
InChI=1S/C23H18F3N3O2/c1-14(13-15-7-3-2-4-8-15)29-21(16-9-5-6-10-18(16)30)28-17-11-12-27-20(23(24,25)26)19(17)22(29)31/h2-12,14,30H,13H2,1H3/t14-/m1/s1	Pfizer Compound 1|(R)-2H [Pmid:19625189]	2-(2-hydroxyphenyl)-3-[(2R)-1-phenylpropan-2-yl]-5-(trifluoromethyl)pyrido[4,3-d]pyrimidin-4-one	C[C@H](Cc1ccccc1)n1c(-c2ccccc2O)nc2ccnc(C(F)(F)F)c2c1=O	135948915.0	R40_vilar_2010:182	0.48	A	BBB+	A	test
InChI=1S/C23H18F6N2O/c1-14-5-3-4-6-18(14)19-7-8-30-12-20(19)21(32)31(2)13-15-9-16(22(24,25)26)11-17(10-15)23(27,28)29/h3-12H,13H2,1-2H3	42|N-(3,5-Bis(Trifluoromethyl)Benzyl)-N-Methyl-4-O-Tolylnicotinamide	N-[[3,5-bis(trifluoromethyl)phenyl]methyl]-N-methyl-4-(2-methylphenyl)pyridine-3-carboxamide	Cc1ccccc1-c1ccncc1C(=O)N(C)Cc1cc(C(F)(F)F)cc(C(F)(F)F)c1	9846662.0	R47_radchenko_2020:399	0.68	A	BBB+	A	test
InChI=1S/C23H18N4/c1-3-19-21(26-9-1)22-20(4-2-10-27-22)23(19,15-17-5-11-24-12-6-17)16-18-7-13-25-14-8-18/h1-14H,15-16H2	Sibopirdine	8,8-bis(pyridin-4-ylmethyl)-3,13-diazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene	c1cnc2c(c1)C(Cc1ccncc1)(Cc1ccncc1)c1cccnc1-2	195376.0	R6_adenot_2004:1271			BBB+	C	training
InChI=1S/C23H18O2/c1-2-25-22-15-14-21(18-11-5-6-12-19(18)22)23(24)20-13-7-9-16-8-3-4-10-17(16)20/h3-15H,2H2,1H3	3		CCOc1ccc(C(=O)c2cccc3ccccc23)c2ccccc12		R25_brito_sanchez_2015:528|R46_mendoza_valencia_2017:442	-1.39	B	BBB-	A	training
InChI=1S/C23H20F6N2O3/c24-22(25,26)16-10-15(11-17(12-16)23(27,28)29)19(32)31-8-6-21(7-9-31)18(13-30-20(33)34-21)14-4-2-1-3-5-14/h1-5,10-12,18H,6-9,13H2,(H,30,33)	24|9-(3,5-Bis-Trifluoromethyl-Benzoyl)-5-Phenyl-1-Oxa-3,9-Diaza-Spiro[5.5]Undecan-2-One	9-[3,5-bis(trifluoromethyl)benzoyl]-5-phenyl-1-oxa-3,9-diazaspiro[5.5]undecan-2-one	O=C1NCC(c2ccccc2)C2(CCN(C(=O)c3cc(C(F)(F)F)cc(C(F)(F)F)c3)CC2)O1	10163188.0	R47_radchenko_2020:398	-0.66	A	BBB+	A	training
InChI=1S/C23H20N2O3S/c26-22-21(16-17-29(28)20-14-8-3-9-15-20)23(27)25(19-12-6-2-7-13-19)24(22)18-10-4-1-5-11-18/h1-15,21H,16-17H2	Sulfinpyrazone	4-[2-(benzenesulfinyl)ethyl]-1,2-diphenylpyrazolidine-3,5-dione	O=C1C(CCS(=O)c2ccccc2)C(=O)N(c2ccccc2)N1c1ccccc1	5342.0	R14_ghose_2012:865|R23_gupta_2019:942			BBB-	C	training
InChI=1S/C23H20N2O5/c26-19-12-6-15(7-13-19)14-20(25-21(27)16-4-2-1-3-5-16)22(28)24-18-10-8-17(9-11-18)23(29)30/h1-13,20,26H,14H2,(H,24,28)(H,25,27)(H,29,30)/t20-/m0/s1	Bentiromide	4-[[(2S)-2-benzamido-3-(4-hydroxyphenyl)propanoyl]amino]benzoic acid	O=C(O)c1ccc(NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)c2ccccc2)cc1	6957673.0	R14_ghose_2012:382			BBB-	C	training
InChI=1S/C23H21ClN2O4/c1-13(2)29-23(27)22-16(12-28-3)20-18(11-25-22)26-17-5-4-6-19(21(17)20)30-15-9-7-14(24)8-10-15/h4-11,13,26H,12H2,1-3H3	Gedocarnil	propan-2-yl 5-(4-chlorophenoxy)-4-(methoxymethyl)-9H-pyrido[3,4-b]indole-3-carboxylate	COCc1c(C(=O)OC(C)C)ncc2[nH]c3cccc(Oc4ccc(Cl)cc4)c3c12	219095.0	R6_adenot_2004:712			BBB+	C	training
InChI=1S/C23H21ClN6O3/c1-27-8-10-28(11-9-27)14-19-23(31)29-20-7-6-15(30(32)33)12-17(20)22(25-13-21(29)26-19)16-4-2-3-5-18(16)24/h2-7,12,14H,8-11,13H2,1H3/b19-14-	Loprazolam	(2Z)-6-(2-chlorophenyl)-2-[(4-methylpiperazin-1-yl)methylidene]-8-nitro-4H-imidazo[1,2-a][1,4]benzodiazepin-1-one	CN1CCN(/C=C2\N=C3CN=C(c4ccccc4Cl)c4cc([N+](=O)[O-])ccc4N3C2=O)CC1	3033860.0	R6_adenot_2004:722|R14_ghose_2012:126|R23_gupta_2019:126			BBB+	C	training
InChI=1S/C23H21ClO3/c1-25-19-10-4-16(5-11-19)22(17-6-12-20(26-2)13-7-17)23(24)18-8-14-21(27-3)15-9-18/h4-15H,1-3H3	Chlorotrianisene	1-[1-chloro-2,2-bis(4-methoxyphenyl)ethenyl]-4-methoxybenzene	COc1ccc(C(Cl)=C(c2ccc(OC)cc2)c2ccc(OC)cc2)cc1	11289.0	R14_ghose_2012:445|R23_gupta_2019:451			BBB-	C	training
InChI=1S/C23H21F7N4O3/c1-12(14-8-15(22(25,26)27)10-16(9-14)23(28,29)30)37-20-19(13-2-4-17(24)5-3-13)34(6-7-36-20)11-18-31-21(35)33-32-18/h2-5,8-10,12,19-20H,6-7,11H2,1H3,(H2,31,32,33,35)/t12-,19+,20-/m1/s1	Aprepitant	3-[[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholin-4-yl]methyl]-1,4-dihydro-1,2,4-triazol-5-one	C[C@@H](O[C@H]1OCCN(Cc2n[nH]c(=O)[nH]2)[C@H]1c1ccc(F)cc1)c1cc(C(F)(F)F)cc(C(F)(F)F)c1	135413536.0	R23_gupta_2019:15|R34_broccatelli_2012:106|R37_chen_2011:7			BBB+	C	training
InChI=1S/C23H21N7/c1-2-5-19(6-3-1)22-20(18-7-11-24-12-8-18)17-21(27-28-22)29-13-15-30(16-14-29)23-25-9-4-10-26-23/h1-12,17H,13-16H2	Minokine, Mw01-2-069Srm|3-Phenyl-4-(Pyridin-4-Yl)-6-[4-(Pyrimidin-2-Yl)Piperazin-1-Yl]Pyridazine	3-phenyl-4-pyridin-4-yl-6-(4-pyrimidin-2-ylpiperazin-1-yl)pyridazine	c1ccc(-c2nnc(N3CCN(c4ncccn4)CC3)cc2-c2ccncc2)cc1	24743826.0	R26_chico_2009:274	-0.15	A	BBB+	A	test
InChI=1S/C23H22ClN3O2/c1-14(2)7-10-16(28)13-19-17-5-3-4-6-18(17)23(29)27(19)21-12-9-15-8-11-20(24)25-22(15)26-21/h3-6,8-9,11-12,14,19H,7,10,13H2,1-2H3	Pagoclone	2-(7-chloro-1,8-naphthyridin-2-yl)-3-(5-methyl-2-oxohexyl)-3H-isoindol-1-one	CC(C)CCC(=O)CC1c2ccccc2C(=O)N1c1ccc2ccc(Cl)nc2n1	131664.0	R6_adenot_2004:1509			BBB+	C	training
InChI=1S/C23H22FN3O/c24-19-6-4-17(5-7-19)21-9-8-20(25-21)16-26-11-13-27(14-12-26)22-3-1-2-18-10-15-28-23(18)22/h1-10,15,25H,11-14,16H2	Elopiprazole	1-(1-benzofuran-7-yl)-4-[[5-(4-fluorophenyl)-1H-pyrrol-2-yl]methyl]piperazine	Fc1ccc(-c2ccc(CN3CCN(c4cccc5ccoc45)CC3)[nH]2)cc1	208917.0	R6_adenot_2004:1151			BBB+	C	training
InChI=1S/C23H22N2O6S/c1-23(2)17(21(28)29)25-19(27)16(20(25)32-23)24-18(26)15(13-9-5-3-6-10-13)22(30)31-14-11-7-4-8-12-14/h3-12,15-17,20H,1-2H3,(H,24,26)(H,28,29)/t15?,16-,17+,20-/m1/s1	Carfecillin	(2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(3-oxo-3-phenoxy-2-phenylpropanoyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid	CC1(C)S[C@@H]2[C@H](NC(=O)C(C(=O)Oc3ccccc3)c3ccccc3)C(=O)N2[C@H]1C(=O)O	33672.0	R6_adenot_2004:147			BBB-	C	training
InChI=1S/C23H23ClN2O2/c24-18-8-9-22-20(15-18)21(16-23(27)28-22)25-19-10-13-26(14-11-19)12-4-7-17-5-2-1-3-6-17/h1-9,15-16,19,25H,10-14H2/b7-4+	Mchr Antagonist 2'|6-Chloro-4-[1-(3-Phenyl-Allyl)-Piperidin-4-Ylamino]-Chromen-2-One	6-chloro-4-[[1-[(E)-3-phenylprop-2-enyl]piperidin-4-yl]amino]chromen-2-one	O=c1cc(NC2CCN(C/C=C/c3ccccc3)CC2)c2cc(Cl)ccc2o1	11545677.0	R25_brito_sanchez_2015:464|R46_mendoza_valencia_2017:389	0.13	B	BBB+	A	training
InChI=1S/C23H23ClN2O3/c24-17-2-4-22-19(12-17)20(13-23(27)29-22)25-18-5-8-26(9-6-18)14-15-1-3-21-16(11-15)7-10-28-21/h1-4,11-13,18,25H,5-10,14H2	Mchr Antagonist 8|6-Chloro-4-[1-(2,3-Dihydro-Benzofuran-5-Ylmethyl)-Piperidin-4-Ylamino]-Chromen-2-One	6-chloro-4-[[1-(2,3-dihydro-1-benzofuran-5-ylmethyl)piperidin-4-yl]amino]chromen-2-one	O=c1cc(NC2CCN(Cc3ccc4c(c3)CCO4)CC2)c2cc(Cl)ccc2o1	11531660.0	R25_brito_sanchez_2015:465|R46_mendoza_valencia_2017:390	-0.14	B	BBB+	A	training
InChI=1S/C23H23F3N2O4/c1-30-18-12-15(13-19(31-2)22(18)32-3)8-9-21(29)27-10-11-28-17-7-5-4-6-16(17)14-20(28)23(24,25)26/h4-9,12-14H,10-11H2,1-3H3,(H,27,29)/b9-8+	5D|(E)-N-(2-(2-(Trifluoromethyl)-1H-Indol-1-Yl)Ethyl)-3-(3,4,5-Trimethoxyphenyl)Acrylamide	(E)-N-[2-[2-(trifluoromethyl)indol-1-yl]ethyl]-3-(3,4,5-trimethoxyphenyl)prop-2-enamide	COc1cc(/C=C/C(=O)NCCn2c(C(F)(F)F)cc3ccccc32)cc(OC)c1OC	71499384.0	R47_radchenko_2020:528	0.23	A	BBB+	A	training
InChI=1S/C23H23N3O5/c1-4-23(30)16-8-18-20-12(9-26(18)21(28)15(16)11-31-22(23)29)7-13-14(10-25(2)3)19(27)6-5-17(13)24-20/h5-8,27,30H,4,9-11H2,1-3H3/t23-/m0/s1	Topotecan	(19S)-8-[(dimethylamino)methyl]-19-ethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione	CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3c(CN(C)C)c(O)ccc3nc2-1	60700.0	R6_adenot_2004:70|R25_brito_sanchez_2015:477|R26_chico_2009:423|R28_li_2005:296|R46_mendoza_valencia_2017:401	-0.42	B	BBB+	A	training
InChI=1S/C23H23N5O/c1-26-15-12-18(13-16-26)28-21(29)11-10-19(24-28)22-20-9-5-6-14-27(20)25-23(22)17-7-3-2-4-8-17/h2-11,14,18H,12-13,15-16H2,1H3	202646-80-8|Fr194921|Compound 32|3(2H)-Pyridazinone, 2-(1-Methyl-4-Piperidinyl)-6-(2-Phenylpyrazolo(1,5-A)Pyridin-3-Yl)-	2-(1-methylpiperidin-4-yl)-6-(2-phenylpyrazolo[1,5-a]pyridin-3-yl)pyridazin-3-one	CN1CCC(n2nc(-c3c(-c4ccccc4)nn4ccccc34)ccc2=O)CC1	9821511.0	R4_mente_2005:107|R26_chico_2009:198|R40_vilar_2010:84|R47_radchenko_2020:417	0.06	B	BBB+	A	test
InChI=1S/C23H23N7O5/c1-2-3-14(10-15-11-26-20-18(27-15)19(24)29-23(25)30-20)12-4-6-13(7-5-12)21(33)28-16(22(34)35)8-9-17(31)32/h1,4-7,11,14,16H,3,8-10H2,(H,28,33)(H,31,32)(H,34,35)(H4,24,25,26,29,30)/t14?,16-/m0/s1	Pralatrexate	(2S)-2-[[4-[1-(2,4-diaminopteridin-6-yl)pent-4-yn-2-yl]benzoyl]amino]pentanedioic acid	C#CCC(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1	148121.0	R23_gupta_2019:852			BBB-	C	training
InChI=1S/C23H24FN3O/c24-21-9-7-18(8-10-21)22(28)6-3-11-26-12-14-27(15-13-26)23-16-19-4-1-2-5-20(19)17-25-23/h1-2,4-5,7-10,16-17H,3,6,11-15H2	Cinuperone	1-(4-fluorophenyl)-4-(4-isoquinolin-3-ylpiperazin-1-yl)butan-1-one	O=C(CCCN1CCN(c2cc3ccccc3cn2)CC1)c1ccc(F)cc1	133832.0	R6_adenot_2004:1133			BBB+	C	test
InChI=1S/C23H24FN3O3/c1-30-21-7-2-16(15-25)14-20(21)23(29)26-10-13-27-11-8-18(9-12-27)22(28)17-3-5-19(24)6-4-17/h2-7,14,18H,8-13H2,1H3,(H,26,29)	Prideperone	5-cyano-N-[2-[4-(4-fluorobenzoyl)piperidin-1-yl]ethyl]-2-methoxybenzamide	COc1ccc(C#N)cc1C(=O)NCCN1CCC(C(=O)c2ccc(F)cc2)CC1	3050428.0	R6_adenot_2004:1204			BBB+	C	training
InChI=1S/C23H24FN5/c1-17-14-25-29(15-17)20-10-12-27(13-11-20)23-26-21-4-2-3-5-22(21)28(23)16-18-6-8-19(24)9-7-18/h2-9,14-15,20H,10-13,16H2,1H3	1|Antihistamine-1	1-[(4-fluorophenyl)methyl]-2-[4-(4-methylpyrazol-1-yl)piperidin-1-yl]benzimidazole	Cc1cnn(C2CCN(c3nc4ccccc4n3Cc3ccc(F)cc3)CC2)c1	45272895.0	R25_brito_sanchez_2015:521|R46_mendoza_valencia_2017:435	0.32	B	BBB+	A	training
InChI=1S/C23H24N2O4S/c1-2-3-6-21-24-14-19(12-18(23(28)29)13-20-5-4-11-30-20)25(21)15-16-7-9-17(10-8-16)22(26)27/h4-5,7-12,14H,2-3,6,13,15H2,1H3,(H,26,27)(H,28,29)/b18-12+	Eprosartan Mesylate|Eprosartan	4-[[2-butyl-5-[(E)-2-carboxy-3-thiophen-2-ylprop-1-enyl]imidazol-1-yl]methyl]benzoic acid	CCCCc1ncc(/C=C(\Cc2cccs2)C(=O)O)n1Cc1ccc(C(=O)O)cc1	5281037.0	R14_ghose_2012:531|R23_gupta_2019:566			BBB-	C	training
InChI=1S/C23H24N4/c1-26(2)16-9-17-27-21-14-7-6-12-19(21)22(18-10-4-3-5-11-18)25-20-13-8-15-24-23(20)27/h3-8,10-15H,9,16-17H2,1-2H3	Tampramine	N,N-dimethyl-3-(6-phenylpyrido[2,3-b][1,4]benzodiazepin-11-yl)propan-1-amine	CN(C)CCCN1c2ccccc2C(c2ccccc2)=Nc2cccnc21	54961.0	R6_adenot_2004:616			BBB+	C	test
InChI=1S/C23H24N6O5S2/c1-34-27-16(14-11-36-23(24)25-14)19(30)26-17-20(31)29-18(22(32)33)13(10-35-21(17)29)9-28-8-4-6-12-5-2-3-7-15(12)28/h4,6,8,11,17,21H,2-3,5,7,9-10H2,1H3,(H3-,24,25,26,30,32,33)/b27-16-/t17-,21-/m1/s1	Cefquinome|1-[[(6R,7R)-7-[[(2Z)-(2-Amino-4-Thiazolyl)(Methoxyimino)Acetyl]Amino]-2-Carboxy-8-Oxo-5-Thia-1-Azabicyclo[4.2.0]Oct-2-En-3-Yl]Methyl]-5,6,7,8-Tetrahydro-Quinolinium Inner Salt	(6R,7R)-7-[[(2E)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-8-oxo-3-(5,6,7,8-tetrahydroquinolin-1-ium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate	CO/N=C(/C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(C[n+]3cccc4c3CCCC4)CS[C@H]12)c1csc(N)n1	9571084.0	R6_adenot_2004:191			BBB-	C	training
InChI=1S/C23H24O4/c1-16(24)26-21-12-8-19(9-13-21)23(18-6-4-3-5-7-18)20-10-14-22(15-11-20)27-17(2)25/h8-15H,3-7H2,1-2H3	Cyclofenil	[4-[(4-acetyloxyphenyl)-cyclohexylidenemethyl]phenyl] acetate	CC(=O)Oc1ccc(C(=C2CCCCC2)c2ccc(OC(C)=O)cc2)cc1	2898.0	R14_ghose_2012:474			BBB-	C	training
InChI=1S/C23H25BrFN3O2/c24-18-5-9-20(10-6-18)28-16-26-22(30)23(28)11-14-27(15-12-23)13-1-2-21(29)17-3-7-19(25)8-4-17/h3-10H,1-2,11-16H2,(H,26,30)	Bsp|P-Bromospiperone|4-Bromospiperone	1-(4-bromophenyl)-8-[4-(4-fluorophenyl)-4-oxobutyl]-1,3,8-triazaspiro[4.5]decan-4-one	O=C(CCCN1CCC2(CC1)C(=O)NCN2c1ccc(Br)cc1)c1ccc(F)cc1	156386.0	R3_abraham_2006:138|R21_muehlbacher_2011:297|R25_brito_sanchez_2015:170|R40_vilar_2010:62|R41_toropov_2017:131|R47_radchenko_2020:117	0.07	B	BBB+	A	training
InChI=1S/C23H25ClN2O9/c1-22(34)8-6-9-16(26(2)3)18(30)14(21(33)25-7-27)20(32)23(9,35)19(31)12(8)17(29)13-11(28)5-4-10(24)15(13)22/h4-5,8-9,16,27-29,32,34-35H,6-7H2,1-3H3,(H,25,33)/t8-,9-,16-,22-,23-/m0/s1	Clomocycline	(4S,4aS,5aS,6S,12aR)-7-chloro-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-N-(hydroxymethyl)-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide	CN(C)[C@@H]1C(=O)C(C(=O)NCO)=C(O)[C@@]2(O)C(=O)C3=C(O)c4c(O)ccc(Cl)c4[C@@](C)(O)[C@H]3C[C@@H]12	54680675.0	R6_adenot_2004:304|R23_gupta_2019:474			BBB-	C	training
InChI=1S/C23H25F2N3O2/c24-18-5-3-17(4-6-18)21(29)2-1-13-27-14-11-23(12-15-27)22(30)26-16-28(23)20-9-7-19(25)8-10-20/h3-10H,1-2,11-16H2,(H,26,30)	Fluspiperone	1-(4-fluorophenyl)-8-[4-(4-fluorophenyl)-4-oxobutyl]-1,3,8-triazaspiro[4.5]decan-4-one	O=C(CCCN1CCC2(CC1)C(=O)NCN2c1ccc(F)cc1)c1ccc(F)cc1	166535.0	R6_adenot_2004:1161			BBB+	C	training
InChI=1S/C23H25F3N2OS/c24-23(25,26)17-7-8-22-20(16-17)18(19-4-1-2-6-21(19)30-22)5-3-9-27-10-12-28(13-11-27)14-15-29/h1-2,4-8,16,29H,3,9-15H2	Flupenthixol	2-[4-[3-[2-(trifluoromethyl)thioxanthen-9-ylidene]propyl]piperazin-1-yl]ethanol	OCCN1CCN(CCC=C2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1	17012.0	R50_sobanska_2019:95			BBB+	C	training
InChI=1S/C23H25F3N2OS/c24-23(25,26)17-7-8-22-20(16-17)18(19-4-1-2-6-21(19)30-22)5-3-9-27-10-12-28(13-11-27)14-15-29/h1-2,4-8,16,29H,3,9-15H2/b18-5+	Flupenthixol|Trans-Flupentixol	2-[4-[(3E)-3-[2-(trifluoromethyl)thioxanthen-9-ylidene]propyl]piperazin-1-yl]ethanol	OCCN1CCN(CC/C=C2\c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1	5281878.0	R14_ghose_2012:96|R23_gupta_2019:288			BBB+	C	training
InChI=1S/C23H25F3N2OS/c24-23(25,26)17-7-8-22-20(16-17)18(19-4-1-2-6-21(19)30-22)5-3-9-27-10-12-28(13-11-27)14-15-29/h1-2,4-8,16,29H,3,9-15H2/b18-5-	Flupentixol	2-[4-[(3Z)-3-[2-(trifluoromethyl)thioxanthen-9-ylidene]propyl]piperazin-1-yl]ethanol	OCCN1CCN(CC/C=C2/c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1	5281881.0	R6_adenot_2004:1159|R7_andres_2006:70|R28_li_2005:356|R29_subramanian_2003:66|R51_doninger_2002:217			BBB+	C	training
InChI=1S/C23H25N5O5/c1-30-18-11-14-15(12-19(18)31-2)25-23(26-21(14)24)28-9-7-27(8-10-28)22(29)20-13-32-16-5-3-4-6-17(16)33-20/h3-6,11-12,20H,7-10,13H2,1-2H3,(H2,24,25,26)	Doxazosin Mesylate|Doxazosin	[4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-(2,3-dihydro-1,4-benzodioxin-3-yl)methanone	COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)CC3)nc(N)c2cc1OC	3157.0	R14_ghose_2012:511|R23_gupta_2019:536			BBB-	C	training
InChI=1S/C23H25NO5/c1-4-10-24-11-9-23-16-6-8-19(28-14(3)26)22(23)29-21-18(27-13(2)25)7-5-15(20(21)23)12-17(16)24/h4-8,16-17,19,22H,1,9-12H2,2-3H3/t16-,17+,19-,22-,23-/m0/s1	Diacetylnalorphine	[(4R,4aR,7S,7aR,12bS)-9-acetyloxy-3-prop-2-enyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-yl] acetate	C=CCN1CC[C@]23c4c5ccc(OC(C)=O)c4O[C@H]2[C@@H](OC(C)=O)C=C[C@H]3[C@H]1C5	20055473.0	R6_adenot_2004:1030			BBB+	C	test
InChI=1S/C23H26BrF3N2O2/c24-19-8-6-17(7-9-19)22(30)28-12-1-2-13-29-14-10-20(11-15-29)31-21-5-3-4-18(16-21)23(25,26)27/h3-9,16,20H,1-2,10-15H2,(H,28,30)	Piperidinederivatives 1|4-Bromo-N-[4-[4-[3-(Trifluoromethyl)Phenoxy]Piperidin-1-Yl]Butyl]Benzamide	4-bromo-N-[4-[4-[3-(trifluoromethyl)phenoxy]piperidin-1-yl]butyl]benzamide	O=C(NCCCCN1CCC(Oc2cccc(C(F)(F)F)c2)CC1)c1ccc(Br)cc1	69971149.0	R47_radchenko_2020:315	1.04	A	BBB+	A	training
InChI=1S/C23H26Cl2N2O4/c1-26(22(28)12-16-7-8-19(24)20(25)11-16)21(14-27-9-2-3-10-27)17-5-4-6-18(13-17)31-15-23(29)30/h4-8,11,13,21H,2-3,9-10,12,14-15H2,1H3,(H,29,30)	Ici-204448|2-[3-[1-[[2-(3,4-Dichlorophenyl)Acetyl]-Methylamino]-2-Pyrrolidin-1-Ylethyl]Phenoxy]Acetic Acid	2-[3-[1-[[2-(3,4-dichlorophenyl)acetyl]-methylamino]-2-pyrrolidin-1-ylethyl]phenoxy]acetic acid	CN(C(=O)Cc1ccc(Cl)c(Cl)c1)C(CN1CCCC1)c1cccc(OCC(=O)O)c1	3683.0	R7_andres_2006:84|R29_subramanian_2003:77			BBB-	C	test
InChI=1S/C23H26ClN7O3/c1-34-19-6-5-15(10-18(19)24)11-27-21-17(22(33)28-13-20-25-7-3-8-26-20)12-29-23(30-21)31-9-2-4-16(31)14-32/h3,5-8,10,12,16,32H,2,4,9,11,13-14H2,1H3,(H,28,33)(H,27,29,30)/t16-/m0/s1	Avanafil	4-[(3-chloro-4-methoxyphenyl)methylamino]-2-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-N-(pyrimidin-2-ylmethyl)pyrimidine-5-carboxamide	COc1ccc(CNc2nc(N3CCC[C@H]3CO)ncc2C(=O)NCc2ncccn2)cc1Cl	9869929.0	R23_gupta_2019:368			BBB-	C	training
InChI=1S/C23H26F3N3S/c24-23(25,26)17-6-9-22-20(16-17)29(19-4-1-2-5-21(19)30-22)11-3-10-27-12-14-28(15-13-27)18-7-8-18/h1-2,4-6,9,16,18H,3,7-8,10-15H2	Ciclofenazine|Cyclophenazine	10-[3-(4-cyclopropylpiperazin-1-yl)propyl]-2-(trifluoromethyl)phenothiazine	FC(F)(F)c1ccc2c(c1)N(CCCN1CCN(C3CC3)CC1)c1ccccc1S2	28690.0	R6_adenot_2004:1548|R51_doninger_2002:192			BBB+	C	training
InChI=1S/C23H26F4N2OS/c24-17-4-5-19-18(2-1-7-28-8-10-29(11-9-28)12-13-30)20-14-16(23(25,26)27)3-6-21(20)31-22(19)15-17/h3-6,14-15,18,30H,1-2,7-13H2	Teflutixol	2-[4-[3-[6-fluoro-2-(trifluoromethyl)-9H-thioxanthen-9-yl]propyl]piperazin-1-yl]ethanol	OCCN1CCN(CCCC2c3ccc(F)cc3Sc3ccc(C(F)(F)F)cc32)CC1	68751.0	R6_adenot_2004:1225			BBB+	C	training
InChI=1S/C23H26FN3O2/c24-19-10-8-18(9-11-19)21(28)7-4-14-26-15-12-23(13-16-26)22(29)25-17-27(23)20-5-2-1-3-6-20/h1-3,5-6,8-11H,4,7,12-17H2,(H,25,29)	Spiperone	8-[4-(4-fluorophenyl)-4-oxobutyl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one	O=C(CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1)c1ccc(F)cc1	5265.0	R3_abraham_2006:276|R6_adenot_2004:1218|R21_muehlbacher_2011:130|R25_brito_sanchez_2015:156|R26_chico_2009:386|R40_vilar_2010:260|R41_toropov_2017:248|R47_radchenko_2020:231	0.26	B	BBB+	A	training
InChI=1S/C23H26FN6O9P/c1-23(2)21(31)30(11-38-40(32,33)34)20-14(39-23)6-7-17(28-20)27-19-13(24)10-25-22(29-19)26-12-8-15(35-3)18(37-5)16(9-12)36-4/h6-10H,11H2,1-5H3,(H2,32,33,34)(H2,25,26,27,28,29)	Fostamatinib	[6-[[5-fluoro-2-(3,4,5-trimethoxyanilino)pyrimidin-4-yl]amino]-2,2-dimethyl-3-oxopyrido[3,2-b][1,4]oxazin-4-yl]methyl dihydrogen phosphate	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC	11671467.0	R23_gupta_2019:615			BBB-	C	training
InChI=1S/C23H26N2O/c26-21-9-10-23-22(16-21)20(17-24-23)8-4-5-13-25-14-11-19(12-15-25)18-6-2-1-3-7-18/h1-3,6-7,9-11,16-17,24,26H,4-5,8,12-15H2	Roxindole	3-[4-(4-phenyl-3,6-dihydro-2H-pyridin-1-yl)butyl]-1H-indol-5-ol	Oc1ccc2[nH]cc(CCCCN3CC=C(c4ccccc4)CC3)c2c1	219050.0	R7_andres_2006:153|R28_li_2005:390|R29_subramanian_2003:150			BBB+	C	training
InChI=1S/C23H26N2O2/c26-23(27-21-16-24-13-10-18(21)11-14-24)25-15-12-17-6-4-5-9-20(17)22(25)19-7-2-1-3-8-19/h1-9,18,21-22H,10-16H2/t21-,22-/m0/s1	Solifenacin	[(3R)-1-azabicyclo[2.2.2]octan-3-yl] (1S)-1-phenyl-3,4-dihydro-1H-isoquinoline-2-carboxylate	O=C(O[C@H]1CN2CCC1CC2)N1CCc2ccccc2[C@@H]1c1ccccc1	154059.0	R23_gupta_2019:312			BBB+	C	training
InChI=1S/C23H26N2O4/c1-16-13-18-7-5-6-8-19(18)25(16)12-11-24-22(26)10-9-17-14-20(27-2)23(29-4)21(15-17)28-3/h5-10,13-15H,11-12H2,1-4H3,(H,24,26)/b10-9+	5A|(E)-N-(2-(2-Methyl-1H-Indol-1-Yl)Ethyl)-3-(3,4,5-Trimethoxyphenyl)Acrylamide	(E)-N-[2-(2-methylindol-1-yl)ethyl]-3-(3,4,5-trimethoxyphenyl)prop-2-enamide	COc1cc(/C=C/C(=O)NCCn2c(C)cc3ccccc32)cc(OC)c1OC	5886965.0	R47_radchenko_2020:527	-0.52	A	BBB+	A	training
InChI=1S/C23H26N2O6/c1-28-18-5-3-17(4-6-18)25-14-19(31-22(25)26)13-24-10-8-23(27,9-11-24)16-2-7-20-21(12-16)30-15-29-20/h2-7,12,19,27H,8-11,13-15H2,1H3/t19-/m0/s1	Panamesine	(5S)-5-[[4-(1,3-benzodioxol-5-yl)-4-hydroxypiperidin-1-yl]methyl]-3-(4-methoxyphenyl)-1,3-oxazolidin-2-one	COc1ccc(N2C[C@H](CN3CCC(O)(c4ccc5c(c4)OCO5)CC3)OC2=O)cc1	3047810.0	R6_adenot_2004:1148			BBB+	C	training
InChI=1S/C23H27BrF3N3O/c24-19-8-6-17(7-9-19)22(31)28-12-1-2-13-30-14-10-20(11-15-30)29-21-5-3-4-18(16-21)23(25,26)27/h3-9,16,20,29H,1-2,10-15H2,(H,28,31)	Piperidinederivatives 2|4-Bromo-N-[4-[4-[3-(Trifluoromethyl)Anilino]Piperidin-1-Yl]Butyl]Benzamide	4-bromo-N-[4-[4-[3-(trifluoromethyl)anilino]piperidin-1-yl]butyl]benzamide	O=C(NCCCCN1CCC(Nc2cccc(C(F)(F)F)c2)CC1)c1ccc(Br)cc1	69974186.0	R47_radchenko_2020:316	1.18	A	BBB+	A	test
InChI=1S/C23H27Cl2N3O2/c24-19-4-3-5-21(23(19)25)28-13-11-27(12-14-28)10-1-2-15-30-18-8-6-17-7-9-22(29)26-20(17)16-18/h3-6,8,16H,1-2,7,9-15H2,(H,26,29)	Aripiprazole|Aripiprazole, Abilify	7-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy]-3,4-dihydro-1H-quinolin-2-one	O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1	60795.0	R6_adenot_2004:1239|R14_ghose_2012:310|R23_gupta_2019:16|R26_chico_2009:36|R37_chen_2011:8			BBB+	C	training
InChI=1S/C23H27ClN2O2/c24-19-7-8-23-22(16-19)21(20-5-2-1-4-18(20)17-28-23)6-3-9-25-10-12-26(13-11-25)14-15-27/h1-2,4-8,16,27H,3,9-15,17H2/b21-6-	Pinoxepin	2-[4-[(3Z)-3-(2-chloro-6H-benzo[c][1]benzoxepin-11-ylidene)propyl]piperazin-1-yl]ethanol	OCCN1CCN(CC/C=C2/c3ccccc3COc3ccc(Cl)cc32)CC1	6436541.0	R6_adenot_2004:1199|R51_doninger_2002:288			BBB+	C	training
InChI=1S/C23H27ClO6/c1-12(25)30-11-19(28)23(29)7-5-15-14-9-17(24)16-8-13(26)4-6-21(16,2)20(14)18(27)10-22(15,23)3/h4,6,8,14-15,17,20,29H,5,7,9-11H2,1-3H3/t14-,15-,17-,20+,21-,22-,23-/m0/s1	Chloroprednisone-Acetate|Chloroprednisone Acetate	[2-[(6S,8S,9S,10R,13S,14S,17R)-6-chloro-17-hydroxy-10,13-dimethyl-3,11-dioxo-6,7,8,9,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate	CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C[C@H](Cl)C4=CC(=O)C=C[C@]4(C)[C@H]3C(=O)C[C@@]21C	235970.0	R6_adenot_2004:780			BBB+	C	test
InChI=1S/C23H27F3N2O2S/c24-23(25,26)17-6-7-22-20(16-17)28(19-4-1-2-5-21(19)31-22)11-3-10-27-12-8-18(9-13-27)30-15-14-29/h1-2,4-7,16,18,29H,3,8-15H2	Flupimazine	2-[1-[3-[2-(trifluoromethyl)phenothiazin-10-yl]propyl]piperidin-4-yl]oxyethanol	OCCOC1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1	218089.0	R6_adenot_2004:1574			BBB+	C	test
InChI=1S/C23H27FN4O2/c1-15-18(23(29)28-10-3-2-4-21(28)25-15)9-13-27-11-7-16(8-12-27)22-19-6-5-17(24)14-20(19)30-26-22/h5-6,14,16H,2-4,7-13H2,1H3	Risperidone	3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl]-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one	Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2	5073.0	R3_abraham_2006:247|R5_guerra_2008:89|R6_adenot_2004:1210|R7_andres_2006:212|R12_garg_2006:147|R14_ghose_2012:223|R21_muehlbacher_2011:121|R25_brito_sanchez_2015:314|R26_chico_2009:350|R28_li_2005:41|R34_broccatelli_2012:150|R37_chen_2011:85|R39_shayanfar_2011:81|R40_vilar_2010:230|R41_toropov_2017:221|R42_ciura_2020:38|R44_bujak_2015:58|R46_mendoza_valencia_2017:277|R47_radchenko_2020:205|R49_norinder_2002:159|R50_sobanska_2019:23	-0.02	D	BBB+	A	test
InChI=1S/C23H27FN4O3/c1-14-17(23(30)28-9-2-3-19(29)22(28)25-14)8-12-27-10-6-15(7-11-27)21-18-5-4-16(24)13-20(18)31-26-21/h4-5,13,15,19,29H,2-3,6-12H2,1H3	9-Oh Risperidone|9-Hydroxy Risperidone|Paliperidone	3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl]-9-hydroxy-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one	Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2O	115237.0	R3_abraham_2006:116|R12_garg_2006:14|R21_muehlbacher_2011:288|R23_gupta_2019:181|R25_brito_sanchez_2015:104|R34_broccatelli_2012:131|R37_chen_2011:68|R39_shayanfar_2011:101|R41_toropov_2017:111|R46_mendoza_valencia_2017:102|R47_radchenko_2020:98|R49_norinder_2002:160	-0.67	B	BBB+	A	test
InChI=1S/C23H27FN4O3/c1-14-17(23(30)28-9-2-3-19(29)22(28)25-14)8-12-27-10-6-15(7-11-27)21-18-5-4-16(24)13-20(18)31-26-21/h4-5,13,15,19,29H,2-3,6-12H2,1H3/t19-/m1/s1	9-Oh-Risperidone|(R)-Paliperidone	(9R)-3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl]-9-hydroxy-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one	Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCC[C@H]2O	9802545.0	R28_li_2005:4			BBB+	C	test
InChI=1S/C23H27FN4O3/c1-14-18(23(30)28-13-17(29)3-5-21(28)25-14)8-11-27-9-6-15(7-10-27)22-19-4-2-16(24)12-20(19)31-26-22/h2,4,12,15,17,29H,3,5-11,13H2,1H3	9-Hydroxyrisperidone|9-Hydroxy-Risperidone	3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl]-7-hydroxy-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one	Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CC(O)CC2	475100.0	R21_muehlbacher_2011:309|R40_vilar_2010:23	-0.67	B	BBB+	A	test
InChI=1S/C23H27N3O2/c1-23-11-13-24(2)21(23)25(3)20-9-8-18(14-19(20)23)28-22(27)26-12-10-16-6-4-5-7-17(16)15-26/h4-9,14,21H,10-13,15H2,1-3H3/t21-,23+/m1/s1	Quilostigmine	[(3aR,8bS)-3,4,8b-trimethyl-2,3a-dihydro-1H-pyrrolo[2,3-b]indol-7-yl] 3,4-dihydro-1H-isoquinoline-2-carboxylate	CN1CC[C@@]2(C)c3cc(OC(=O)N4CCc5ccccc5C4)ccc3N(C)[C@@H]12	132228.0	R6_adenot_2004:415			BBB+	C	training
InChI=1S/C23H27N3O7/c1-25(2)12-5-6-13(27)15-10(12)7-9-8-11-17(26(3)4)19(29)16(22(24)32)21(31)23(11,33)20(30)14(9)18(15)28/h5-6,9,11,17,27-28,31,33H,7-8H2,1-4H3,(H2,24,32)/t9-,11-,17-,23-/m0/s1	Minocycline	(4S,4aS,5aR,12aR)-4,7-bis(dimethylamino)-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide	CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]3(O)C(=O)C1=C2O	54675783.0	R6_adenot_2004:313|R23_gupta_2019:752|R25_brito_sanchez_2015:434|R28_li_2005:274|R51_doninger_2002:94	-0.52	A	BBB+	A	training
InChI=1S/C23H27N3OS/c1-27-20-13-21-19(26-23(28-21)16-9-10-16)12-17(20)14-25-18-8-5-11-24-22(18)15-6-3-2-4-7-15/h2-4,6-7,12-13,16,18,22,24-25H,5,8-11,14H2,1H3	163257-85-0|Pfizer Compound 24|N-[(2-Cyclopropyl-6-Methoxy-1,3-Benzothiazol-5-Yl)Methyl]-2-Phenylpiperidin-3-Amine	N-[(2-cyclopropyl-6-methoxy-1,3-benzothiazol-5-yl)methyl]-2-phenylpiperidin-3-amine	COc1cc2sc(C3CC3)nc2cc1CNC1CCCNC1c1ccccc1	22620085.0	R4_mente_2005:99|R25_brito_sanchez_2015:551|R40_vilar_2010:198|R46_mendoza_valencia_2017:462|R47_radchenko_2020:414	0.62	B	BBB+	A	training
InChI=1S/C23H27N5O7S/c1-4-26-10-11-27(19(32)18(26)31)22(35)25-13(12-8-6-5-7-9-12)16(29)24-14-17(30)28-15(21(33)34)23(2,3)36-20(14)28/h5-9,13-15,20H,4,10-11H2,1-3H3,(H,24,29)(H,25,35)(H,33,34)/t13-,14-,15+,20-/m1/s1	Piperacillin	(2S,5R,6R)-6-[[(2R)-2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid	CCN1CCN(C(=O)N[C@@H](C(=O)N[C@@H]2C(=O)N3[C@@H]2SC(C)(C)[C@@H]3C(=O)O)c2ccccc2)C(=O)C1=O	43672.0	R6_adenot_2004:252			BBB-	C	test
InChI=1S/C23H27NO4/c1-16-12-19(14-23(2,3)13-16)27-22(26)20(17-8-5-4-6-9-17)28-21(25)18-10-7-11-24-15-18/h4-11,15-16,19-20H,12-14H2,1-3H3	Micinicate|Nicotinoyl Cyclandelate	[2-oxo-1-phenyl-2-(3,3,5-trimethylcyclohexyl)oxyethyl] pyridine-3-carboxylate	CC1CC(OC(=O)C(OC(=O)c2cccnc2)c2ccccc2)CC(C)(C)C1	172291.0	R23_gupta_2019:1074			BBB-	C	test
InChI=1S/C23H27NO9/c1-24-7-6-23-10-3-4-12(25)20(23)32-18-13(5-2-9(14(18)23)8-11(10)24)31-22-17(28)15(26)16(27)19(33-22)21(29)30/h2-5,10-12,15-17,19-20,22,25-28H,6-8H2,1H3,(H,29,30)/t10-,11+,12-,15-,16-,17+,19-,20-,22+,23-/m0/s1	Morphine-3-Glucuronide	(2S,3S,4S,5R,6S)-6-[[(4R,4aR,7S,7aR,12bS)-7-hydroxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-9-yl]oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid	CN1CC[C@]23c4c5ccc(O[C@@H]6O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]6O)c4O[C@H]2[C@@H](O)C=C[C@H]3[C@H]1C5	5484731.0	R25_brito_sanchez_2015:377	-2.15	A	BBB-	A	test
InChI=1S/C23H27NO9/c1-24-7-6-23-10-3-5-13(31-22-17(28)15(26)16(27)19(33-22)21(29)30)20(23)32-18-12(25)4-2-9(14(18)23)8-11(10)24/h2-5,10-11,13,15-17,19-20,22,25-28H,6-8H2,1H3,(H,29,30)/t10-,11+,13-,15-,16-,17+,19-,20-,22+,23-/m0/s1	Morphine-6-Glucuronide	(2S,3S,4S,5R,6R)-6-[[(4R,4aR,7S,7aR,12bS)-9-hydroxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-yl]oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid	CN1CC[C@]23c4c5ccc(O)c4O[C@H]2[C@@H](O[C@@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O)C=C[C@H]3[C@H]1C5	5360621.0	R25_brito_sanchez_2015:378	-2.09	A	BBB-	A	test
InChI=1S/C23H28Cl2O5/c1-13(26)30-12-19(28)22(29)9-7-16-17-5-4-14-10-15(27)6-8-20(14,2)23(17,25)18(24)11-21(16,22)3/h6,8,10,16-18,29H,4-5,7,9,11-12H2,1-3H3/t16-,17-,18-,20-,21-,22-,23-/m0/s1	Dichlorisone-Acetate|Dichlorisone Acetate	[2-[(8S,9R,10S,11S,13S,14S,17R)-9,11-dichloro-17-hydroxy-10,13-dimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate	CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](Cl)C[C@@]21C	5388959.0	R6_adenot_2004:820			BBB+	C	test
InChI=1S/C23H28ClN3O2S/c1-18(28)29-16-15-26-13-11-25(12-14-26)9-4-10-27-20-5-2-3-6-22(20)30-23-8-7-19(24)17-21(23)27/h2-3,5-8,17H,4,9-16H2,1H3	Thiopropazate	2-[4-[3-(2-chlorophenothiazin-10-yl)propyl]piperazin-1-yl]ethyl acetate	CC(=O)OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1	6762.0	R6_adenot_2004:1624|R14_ghose_2012:245|R23_gupta_2019:239			BBB+	C	training
InChI=1S/C23H28ClN3O5S/c1-32-21-12-9-17(24)15-20(21)22(28)25-14-13-16-7-10-19(11-8-16)33(30,31)27-23(29)26-18-5-3-2-4-6-18/h7-12,15,18H,2-6,13-14H2,1H3,(H,25,28)(H2,26,27,29)	Glibenclamide|Glyburide	5-chloro-N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-2-methoxybenzamide	COc1ccc(Cl)cc1C(=O)NCCc1ccc(S(=O)(=O)NC(=O)NC2CCCCC2)cc1	3488.0	R6_adenot_2004:32|R14_ghose_2012:598|R23_gupta_2019:641|R25_brito_sanchez_2015:502|R46_mendoza_valencia_2017:420	-0.9	B	BBB+	A	training
InChI=1S/C23H28F2N6O4S/c1-2-7-36-23-27-21(26-15-9-12(15)11-3-4-13(24)14(25)8-11)18-22(28-23)31(30-29-18)16-10-17(35-6-5-32)20(34)19(16)33/h3-4,8,12,15-17,19-20,32-34H,2,5-7,9-10H2,1H3,(H,26,27,28)/t12-,15+,16+,17-,19-,20+/m0/s1	Ticagrelor	(1S,2S,3R,5S)-3-[7-[[(1R,2S)-2-(3,4-difluorophenyl)cyclopropyl]amino]-5-propylsulfanyltriazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)cyclopentane-1,2-diol	CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@@H]3C[C@H](OCCO)[C@@H](O)[C@H]3O)c2n1	9871419.0	R23_gupta_2019:977			BBB-	C	training
InChI=1S/C23H28F3N3OS/c24-23(25,26)18-7-8-22-20(17-18)29(19-5-1-2-6-21(19)31-22)12-4-11-27-9-3-10-28(14-13-27)15-16-30/h1-2,5-8,17,30H,3-4,9-16H2	Homofenazine|Homophenazine	2-[4-[3-[2-(trifluoromethyl)phenothiazin-10-yl]propyl]-1,4-diazepan-1-yl]ethanol	OCCN1CCCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1	19687.0	R6_adenot_2004:1167|R51_doninger_2002:227			BBB+	C	training
InChI=1S/C23H28N2O3/c1-16-13-19-20(25-16)11-8-12-21(19)27-15-18(14-24-23(2,3)4)28-22(26)17-9-6-5-7-10-17/h5-13,18,24-25H,14-15H2,1-4H3	Bopindolol	[1-(tert-butylamino)-3-[(2-methyl-1H-indol-4-yl)oxy]propan-2-yl] benzoate	Cc1cc2c(OCC(CNC(C)(C)C)OC(=O)c3ccccc3)cccc2[nH]1	44112.0	R23_gupta_2019:397			BBB-	C	test
InChI=1S/C23H28N2O3/c1-27-21-10-6-9-20(22(21)28-2)23(26)24-17-13-18-11-12-19(14-17)25(18)15-16-7-4-3-5-8-16/h3-10,17-19H,11-15H2,1-2H3,(H,24,26)/t17?,18-,19+	Tropapride	N-[(1S,5R)-8-benzyl-8-azabicyclo[3.2.1]octan-3-yl]-2,3-dimethoxybenzamide	COc1cccc(C(=O)NC2C[C@H]3CC[C@@H](C2)N3Cc2ccccc2)c1OC	71148.0	R6_adenot_2004:1232			BBB+	C	training
InChI=1S/C23H28N2O3S/c1-3-23(4-2,22(27)28)14-20(26)24-18-10-5-7-16(13-18)11-12-21-25-19(15-29-21)17-8-6-9-17/h5,7,10-13,15,17H,3-4,6,8-9,14H2,1-2H3,(H,24,26)(H,27,28)/b12-11+	Cinalukast	4-[3-[(E)-2-(4-cyclobutyl-1,3-thiazol-2-yl)ethenyl]anilino]-2,2-diethyl-4-oxobutanoic acid	CCC(CC)(CC(=O)Nc1cccc(/C=C/c2nc(C3CCC3)cs2)c1)C(=O)O	6436135.0	R23_gupta_2019:461			BBB-	C	training
InChI=1S/C23H28N2O5S2/c1-2-30-23(29)17(11-10-16-7-4-3-5-8-16)24-18-15-32-20(19-9-6-12-31-19)13-25(22(18)28)14-21(26)27/h3-9,12,17-18,20,24H,2,10-11,13-15H2,1H3,(H,26,27)/t17-,18-,20-/m0/s1	Temocapril	2-[(2S,6R)-6-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]-5-oxo-2-thiophen-2-yl-1,4-thiazepan-4-yl]acetic acid	CCOC(=O)[C@H](CCc1ccccc1)N[C@H]1CS[C@H](c2cccs2)CN(CC(=O)O)C1=O	443874.0	R23_gupta_2019:962			BBB-	C	test
InChI=1S/C23H28N4O11S/c1-11(38-21(31)23(2,3)33-4)37-20(30)16-12(9-36-22(24)32)10-39-19-15(18(29)27(16)19)25-17(28)14(26-34-5)13-7-6-8-35-13/h6-8,11,15,19H,9-10H2,1-5H3,(H2,24,32)(H,25,28)/b26-14+/t11?,15-,19-/m1/s1	Cefuroxime-Pivoxetil|1-(2-Methoxy-2-Methylpropanoyl)Oxyethyl (6R,7R)-3-(Carbamoyloxymethyl)-7-[[(2Z)-2-(Furan-2-Yl)-2-Methoxyiminoacetyl]Amino]-8-Oxo-5-Thia-1-Azabicyclo[4.2.0]Oct-2-Ene-2-Carboxylate	1-(2-methoxy-2-methylpropanoyl)oxyethyl (6R,7R)-3-(carbamoyloxymethyl)-7-[[(2Z)-2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate	CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)OC(C)OC(=O)C(C)(C)OC)=C(COC(N)=O)CS[C@H]12)c1ccco1	6321417.0	R6_adenot_2004:206			BBB-	C	training
InChI=1S/C23H28N4O2/c1-2-7-20-10-6-11-21(23(20)29)16-24-25-22(28)18-27-14-12-26(13-15-27)17-19-8-4-3-5-9-19/h2-6,8-11,16,29H,1,7,12-15,17-18H2,(H,25,28)/b24-16-	Pac-1	2-(4-benzylpiperazin-1-yl)-N-[(E)-(2-hydroxy-3-prop-2-enylphenyl)methylideneamino]acetamide	C=CCc1cccc(/C=N/NC(=O)CN2CCN(Cc3ccccc3)CC2)c1O	135421197.0	R47_radchenko_2020:495	-0.17	A	BBB+	A	training
InChI=1S/C23H28N8/c1-3-5-11-21-25-22(12-6-4-2)31(28-21)16-17-13-14-20(24-15-17)18-9-7-8-10-19(18)23-26-29-30-27-23/h7-10,13-15H,3-6,11-12,16H2,1-2H3,(H,26,27,29,30)	Forasartan	5-[(3,5-dibutyl-1,2,4-triazol-1-yl)methyl]-2-[2-(2H-tetrazol-5-yl)phenyl]pyridine	CCCCc1nc(CCCC)n(Cc2ccc(-c3ccccc3-c3nn[nH]n3)nc2)n1	132706.0	R23_gupta_2019:609			BBB-	C	training
InChI=1S/C23H29ClN2OS/c24-18-8-9-23-21(17-18)19(20-5-1-2-7-22(20)28-23)6-3-10-25-12-14-26(15-13-25)11-4-16-27/h1-2,5,7-9,17,19,27H,3-4,6,10-16H2	Xanthiol	3-[4-[3-(2-chloro-9H-thioxanthen-9-yl)propyl]piperazin-1-yl]propan-1-ol	OCCCN1CCN(CCCC2c3ccccc3Sc3ccc(Cl)cc32)CC1	28361.0	R6_adenot_2004:1234			BBB+	C	training
InChI=1S/C23H29F2N3O/c1-2-26-23(29)28-16-14-27(15-17-28)13-3-4-22(18-5-9-20(24)10-6-18)19-7-11-21(25)12-8-19/h5-12,22H,2-4,13-17H2,1H3,(H,26,29)	Amperozide	4-[4,4-bis(4-fluorophenyl)butyl]-N-ethylpiperazine-1-carboxamide	CCNC(=O)N1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1	73333.0	R6_adenot_2004:1114			BBB+	C	training
InChI=1S/C23H29F3N2O/c1-22(2,3)18-11-12-20(29-23(24,25)26)17(14-18)15-28-19-10-7-13-27-21(19)16-8-5-4-6-9-16/h4-6,8-9,11-12,14,19,21,27-28H,7,10,13,15H2,1-3H3	145742-01-4|Pfizer Compound 9|N-[[5-Tert-Butyl-2-(Trifluoromethoxy)Phenyl]Methyl]-2-Phenylpiperidin-3-Amine	N-[[5-tert-butyl-2-(trifluoromethoxy)phenyl]methyl]-2-phenylpiperidin-3-amine	CC(C)(C)c1ccc(OC(F)(F)F)c(CNC2CCCNC2c2ccccc2)c1	9909299.0	R4_mente_2005:84|R25_brito_sanchez_2015:557|R40_vilar_2010:205|R47_radchenko_2020:406	0.96	B	BBB+	A	test
InChI=1S/C23H29FO6/c1-13(25)30-12-19(28)22(29)9-7-16-17-5-4-14-10-15(26)6-8-20(14,2)23(17,24)18(27)11-21(16,22)3/h6,8,10,16-18,27,29H,4-5,7,9,11-12H2,1-3H3/t16-,17-,18-,20-,21-,22-,23-/m0/s1	Isoflupredone-Acetate|Isoflupredone Acetate	[2-[(8S,9R,10S,11S,13S,14S,17R)-9-fluoro-11,17-dihydroxy-10,13-dimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate	CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C	224246.0	R6_adenot_2004:869			BBB+	C	test
InChI=1S/C23H29N3O/c27-19-18-25-16-14-24(15-17-25)12-5-13-26-22-8-3-1-6-20(22)10-11-21-7-2-4-9-23(21)26/h1-4,6-11,27H,5,12-19H2	Opipramol	2-[4-(3-benzo[b][1]benzazepin-11-ylpropyl)piperazin-1-yl]ethanol	OCCN1CCN(CCCN2c3ccccc3C=Cc3ccccc32)CC1	9417.0	R6_adenot_2004:590|R14_ghose_2012:300|R23_gupta_2019:173			BBB+	C	training
InChI=1S/C23H29N3O2/c1-17-19(20-15-22(27-2)23(28-3)16-21(20)24-17)9-10-25-11-13-26(14-12-25)18-7-5-4-6-8-18/h4-8,15-16,24H,9-14H2,1-3H3	Oxypertine	5,6-dimethoxy-2-methyl-3-[2-(4-phenylpiperazin-1-yl)ethyl]-1H-indole	COc1cc2[nH]c(C)c(CCN3CCN(c4ccccc4)CC3)c2cc1OC	4640.0	R6_adenot_2004:1192|R14_ghose_2012:180|R23_gupta_2019:180			BBB+	C	training
InChI=1S/C23H29N3O2/c1-28-21-12-11-19(26-14-6-10-22(26)27)15-18(21)16-25-20-9-5-13-24-23(20)17-7-3-2-4-8-17/h2-4,7-8,11-12,15,20,23-25H,5-6,9-10,13-14,16H2,1H3	163257-90-7|Pfizer Compound 16|1-[4-Methoxy-3-[[(2-Phenylpiperidin-3-Yl)Amino]Methyl]Phenyl]Pyrrolidin-2-One	1-[4-methoxy-3-[[(2-phenylpiperidin-3-yl)amino]methyl]phenyl]pyrrolidin-2-one	COc1ccc(N2CCCC2=O)cc1CNC1CCCNC1c1ccccc1	22620062.0	R4_mente_2005:91|R25_brito_sanchez_2015:542|R40_vilar_2010:189|R46_mendoza_valencia_2017:453	-0.22	B	BBB+	A	test
InChI=1S/C23H29N3O2S/c1-18(28)19-7-8-23-21(17-19)26(20-5-2-3-6-22(20)29-23)10-4-9-24-11-13-25(14-12-24)15-16-27/h2-3,5-8,17,27H,4,9-16H2,1H3	Acetophenazine	1-[10-[3-[4-(2-hydroxyethyl)piperazin-1-yl]propyl]phenothiazin-2-yl]ethanone	CC(=O)c1ccc2c(c1)N(CCCN1CCN(CCO)CC1)c1ccccc1S2	17676.0	R6_adenot_2004:1538|R14_ghose_2012:2|R14_ghose_2012:284|R23_gupta_2019:2|R51_doninger_2002:147			BBB+	C	training
InChI=1S/C23H29N3O2S2/c1-24(2)30(27,28)18-10-11-23-21(17-18)19(20-7-4-5-9-22(20)29-23)8-6-12-26-15-13-25(3)14-16-26/h4-5,7-11,17H,6,12-16H2,1-3H3/b19-8-	Tiotixene|Thiothixene	(9Z)-N,N-dimethyl-9-[3-(4-methylpiperazin-1-yl)propylidene]thioxanthene-2-sulfonamide	CN1CCN(CC/C=C2/c3ccccc3Sc3ccc(S(=O)(=O)N(C)C)cc32)CC1	941651.0	R6_adenot_2004:1630|R14_ghose_2012:248|R23_gupta_2019:242|R26_chico_2009:416|R51_doninger_2002:313			BBB+	C	training
InChI=1S/C23H29N3OS/c1-15(2)27-21-13-22-20(26-16(3)28-22)12-18(21)14-25-19-10-7-11-24-23(19)17-8-5-4-6-9-17/h4-6,8-9,12-13,15,19,23-25H,7,10-11,14H2,1-3H3	163257-88-3|Pfizer Compound 22		Cc1nc2cc(CNC3CCCNC3c3ccccc3)c(OC(C)C)cc2s1		R4_mente_2005:97|R25_brito_sanchez_2015:549|R40_vilar_2010:196|R46_mendoza_valencia_2017:460|R47_radchenko_2020:413	0.32	B	BBB+	A	training
InChI=1S/C23H29N3OS/c1-3-12-24-23(27)18-10-11-22-20(15-18)26(17(2)16-25-13-6-7-14-25)19-8-4-5-9-21(19)28-22/h4-5,8-11,15,17H,3,6-7,12-14,16H2,1-2H3,(H,24,27)/t17-/m0/s1	Rp60180|N-Propyl-10-[(2S)-1-Pyrrolidin-1-Ylpropan-2-Yl]Phenothiazine-2-Carboxamide	N-propyl-10-[(2S)-1-pyrrolidin-1-ylpropan-2-yl]phenothiazine-2-carboxamide	CCCNC(=O)c1ccc2c(c1)N([C@@H](C)CN1CCCC1)c1ccccc1S2	14536538.0	R28_li_2005:391			BBB+	C	training
InChI=1S/C23H29N3OS/c1-3-12-24-23(27)18-10-11-22-20(15-18)26(17(2)16-25-13-6-7-14-25)19-8-4-5-9-21(19)28-22/h4-5,8-11,15,17H,3,6-7,12-14,16H2,1-2H3,(H,24,27)/t17-/m1/s1	Apadoline	N-propyl-10-[(2R)-1-pyrrolidin-1-ylpropan-2-yl]phenothiazine-2-carboxamide	CCCNC(=O)c1ccc2c(c1)N([C@H](C)CN1CCCC1)c1ccccc1S2	179334.0	R6_adenot_2004:1085			BBB+	C	training
InChI=1S/C23H29N5O4S/c1-2-4-19-5-3-6-20(23(19)30)15-25-26-22(29)17-28-13-11-27(12-14-28)16-18-7-9-21(10-8-18)33(24,31)32/h2-3,5-10,15,30H,1,4,11-14,16-17H2,(H,26,29)(H2,24,31,32)/b25-15-	Spac-1|N-[(E)-(2-Hydroxy-3-Prop-2-Enylphenyl)Methylideneamino]-2-[4-[(4-Sulfamoylphenyl)Methyl]Piperazin-1-Yl]Acetamide	N-[(E)-(2-hydroxy-3-prop-2-enylphenyl)methylideneamino]-2-[4-[(4-sulfamoylphenyl)methyl]piperazin-1-yl]acetamide	C=CCc1cccc(/C=N/NC(=O)CN2CCN(Cc3ccc(S(N)(=O)=O)cc3)CC2)c1O	135905414.0	R47_radchenko_2020:496	-1.67	A	BBB-	A	training
InChI=1S/C23H29NO3/c1-2-27-22(26)23(20-11-7-4-8-12-20)14-17-24(18-15-23)16-13-21(25)19-9-5-3-6-10-19/h3-12,21,25H,2,13-18H2,1H3	Phenoperidine	ethyl 1-(3-hydroxy-3-phenylpropyl)-4-phenylpiperidine-4-carboxylate	CCOC(=O)C1(c2ccccc2)CCN(CCC(O)c2ccccc2)CC1	11226.0	R14_ghose_2012:197|R23_gupta_2019:198			BBB+	C	training
InChI=1S/C23H29NO3/c1-3-14-11-17(25)22-23-8-9-24(12-13-4-5-13)16(19(14)23)10-15-6-7-18(26-2)21(27-22)20(15)23/h6-7,13-14,16,19,22H,3-5,8-12H2,1-2H3/t14-,16+,19-,22-,23-/m0/s1	Conorfone	(4R,4aR,5S,7aR,12bS)-3-(cyclopropylmethyl)-5-ethyl-9-methoxy-1,2,4,4a,5,6,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one	CC[C@H]1CC(=O)[C@@H]2Oc3c(OC)ccc4c3[C@@]23CCN(CC2CC2)[C@H](C4)[C@H]13	5361887.0	R6_adenot_2004:1020			BBB+	C	training
InChI=1S/C23H29NO3/c1-3-18-26-23(19-10-6-4-7-11-19,20-12-8-5-9-13-20)22(25)27-21-14-16-24(2)17-15-21/h4-13,21H,3,14-18H2,1-2H3	Propiverine	(1-methylpiperidin-4-yl) 2,2-diphenyl-2-propoxyacetate	CCCOC(C(=O)OC1CCN(C)CC1)(c1ccccc1)c1ccccc1	4942.0	R14_ghose_2012:800			BBB-	C	training
InChI=1S/C23H29NO3/c1-3-21(19-10-6-4-7-11-19)23(25)27-17-15-24-14-16-26-22(18(24)2)20-12-8-5-9-13-20/h4-13,18,21-22H,3,14-17H2,1-2H3	Fenbutrazate	2-(3-methyl-2-phenylmorpholin-4-yl)ethyl 2-phenylbutanoate	CCC(C(=O)OCCN1CCOC(c2ccccc2)C1C)c1ccccc1	20395.0	R6_adenot_2004:1286			BBB+	C	training
InChI=1S/C23H30ClN3O/c1-5-27(6-2)13-7-8-16(3)25-23-19-11-9-17(24)14-22(19)26-21-12-10-18(28-4)15-20(21)23/h9-12,14-16H,5-8,13H2,1-4H3,(H,25,26)	Quinacrine	4-N-(6-chloro-2-methoxyacridin-9-yl)-1-N,1-N-diethylpentane-1,4-diamine	CCN(CC)CCCC(C)Nc1c2ccc(Cl)cc2nc2ccc(OC)cc12	237.0	R14_ghose_2012:809|R23_gupta_2019:869			BBB-	C	training
InChI=1S/C23H30FN3/c1-2-26-13-15-27(16-14-26)23-17-21(18-9-11-19(24)12-10-18)20-7-5-3-4-6-8-22(20)25-23/h9-12,17H,2-8,13-16H2,1H3	Blonanserin	2-(4-ethylpiperazin-1-yl)-4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydrocycloocta[b]pyridine	CCN1CCN(c2cc(-c3ccc(F)cc3)c3c(n2)CCCCCC3)CC1	125564.0	R6_adenot_2004:1109			BBB+	C	training
InChI=1S/C23H30N2O2/c1-2-27-22(26)23(20-10-5-3-6-11-20)14-18-25(19-15-23)17-9-16-24-21-12-7-4-8-13-21/h3-8,10-13,24H,2,9,14-19H2,1H3	Piminodine	ethyl 1-(3-anilinopropyl)-4-phenylpiperidine-4-carboxylate	CCOC(=O)C1(c2ccccc2)CCN(CCCNc2ccccc2)CC1	21950.0	R6_adenot_2004:1080			BBB+	C	test
InChI=1S/C23H30N2O6/c1-13-17(20(26)30-22(3,4)5)19(15-10-9-11-16(12-15)25(28)29)18(14(2)24-13)21(27)31-23(6,7)8/h9-12,19,24H,1-8H3	Dibudipine	ditert-butyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate	CC1=C(C(=O)OC(C)(C)C)C(c2cccc([N+](=O)[O-])c2)C(C(=O)OC(C)(C)C)=C(C)N1	10252115.0	R26_chico_2009:158	-0.42	A	BBB+	A	training
InChI=1S/C23H30N4O2S/c28-22-17-7-1-2-8-18(17)23(29)27(22)12-6-5-11-25-13-15-26(16-14-25)21-19-9-3-4-10-20(19)30-24-21/h3-4,9-10,17-18H,1-2,5-8,11-16H2/t17-,18+	Perospirone	(3aS,7aR)-2-[4-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]butyl]-3a,4,5,6,7,7a-hexahydroisoindole-1,3-dione	O=C1[C@H]2CCCC[C@H]2C(=O)N1CCCCN1CCN(c2nsc3ccccc23)CC1	115368.0	R6_adenot_2004:1217|R14_ghose_2012:189|R23_gupta_2019:190|R37_chen_2011:71			BBB+	C	training
InChI=1S/C23H30N6O4/c1-12(2)18(11-30)26-19-10-17(13-5-6-13)27-23-20(21(24)31)22(28-29(19)23)25-14-7-15(32-3)9-16(8-14)33-4/h7-10,12-13,18,26,30H,5-6,11H2,1-4H3,(H2,24,31)(H,25,28)	Compound 6H	5-cyclopropyl-2-(3,5-dimethoxyanilino)-7-[(1-hydroxy-3-methylbutan-2-yl)amino]pyrazolo[1,5-a]pyrimidine-3-carboxamide	COc1cc(Nc2nn3c(NC(CO)C(C)C)cc(C4CC4)nc3c2C(N)=O)cc(OC)c1	75029315.0	R26_chico_2009:121	-0.39	A	BBB+	A	training
InChI=1S/C23H30NO3/c1-16(2)24(5,17(3)4)14-15-26-23(25)22-18-10-6-8-12-20(18)27-21-13-9-7-11-19(21)22/h6-13,16-17,22H,14-15H2,1-5H3/q+1	Propantheline	methyl-di(propan-2-yl)-[2-(9H-xanthene-9-carbonyloxy)ethyl]azanium	CC(C)[N+](C)(CCOC(=O)C1c2ccccc2Oc2ccccc21)C(C)C	4934.0	R23_gupta_2019:865			BBB-	C	training
InChI=1S/C23H30O3/c1-8-26-23(24)14-17(3)11-9-10-16(2)12-13-21-18(4)15-22(25-7)20(6)19(21)5/h9-15H,8H2,1-7H3/b11-9+,13-12+,16-10+,17-14+	Etretinate	ethyl (2E,4E,6E,8E)-9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethylnona-2,4,6,8-tetraenoate	CCOC(=O)/C=C(C)/C=C/C=C(C)/C=C/c1c(C)cc(OC)c(C)c1C	5282375.0	R14_ghose_2012:547|R23_gupta_2019:589			BBB-	C	training
InChI=1S/C23H30O6/c1-13(24)29-12-19(27)23(28)9-7-17-16-5-4-14-10-15(25)6-8-21(14,2)20(16)18(26)11-22(17,23)3/h6,8,10,16-18,20,26,28H,4-5,7,9,11-12H2,1-3H3/t16-,17-,18-,20+,21-,22-,23-/m0/s1	Prednisolone-Acetate|Prednisolone Acetate	[2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate	CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C	5834.0	R6_adenot_2004:891			BBB+	C	test
InChI=1S/C23H31Cl2NO3/c1-23-9-8-18-17-5-3-16(29-22(28)26(12-10-24)13-11-25)14-15(17)2-4-19(18)20(23)6-7-21(23)27/h3,5,14,18-21,27H,2,4,6-13H2,1H3/t18-,19-,20+,21+,23+/m1/s1	Estramustine	[(8R,9S,13S,14S,17S)-17-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl] N,N-bis(2-chloroethyl)carbamate	C[C@]12CC[C@@H]3c4ccc(OC(=O)N(CCCl)CCCl)cc4CC[C@H]3[C@@H]1CC[C@@H]2O	259331.0	R14_ghose_2012:536|R23_gupta_2019:574			BBB-	C	training
InChI=1S/C23H31ClN2O3/c24-22-8-6-21(7-9-22)23(20-4-2-1-3-5-20)26-12-10-25(11-13-26)14-16-28-18-19-29-17-15-27/h1-9,23,27H,10-19H2	Etodroxizine	2-[2-[2-[4-[(4-chlorophenyl)-phenylmethyl]piperazin-1-yl]ethoxy]ethoxy]ethanol	OCCOCCOCCN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1	63345.0	R6_adenot_2004:1464			BBB+	C	training
InChI=1S/C23H31FO4/c1-13-9-17-16-6-5-14-10-15(26)7-8-20(14,2)23(16,24)18(27)11-21(17,3)22(13,4)19(28)12-25/h7-8,10,13,16-18,25,27H,5-6,9,11-12H2,1-4H3/t13-,16+,17+,18+,20+,21+,22-,23+/m1/s1	Dimesone	(8S,9R,10S,11S,13S,14S,16R,17S)-9-fluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16,17-tetramethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one	C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(C)C(=O)CO	208841.0	R6_adenot_2004:827			BBB+	C	test
InChI=1S/C23H31N3O3S/c1-16-12-18-14-22(29-2)19(13-21(18)26(16)30(3,27)28)15-25-20-10-7-11-24-23(20)17-8-5-4-6-9-17/h4-6,8-9,13-14,16,20,23-25H,7,10-12,15H2,1-3H3	160502-85-2|Pfizer Compound 14|N-[(5-Methoxy-2-Methyl-1-Methylsulfonyl-2,3-Dihydroindol-6-Yl)Methyl]-2-Phenylpiperidin-3-Amine	N-[(5-methoxy-2-methyl-1-methylsulfonyl-2,3-dihydroindol-6-yl)methyl]-2-phenylpiperidin-3-amine	COc1cc2c(cc1CNC1CCCNC1c1ccccc1)N(S(C)(=O)=O)C(C)C2	19696654.0	R4_mente_2005:89|R25_brito_sanchez_2015:540|R40_vilar_2010:187|R46_mendoza_valencia_2017:451|R47_radchenko_2020:386	-0.42	B	BBB+	A	training
InChI=1S/C23H31NO/c1-15-10-16(2)22-21-11-18-6-7-19(25)12-20(18)23(22,13-15)8-9-24(21)14-17-4-3-5-17/h6-7,12,16-17,21-22,25H,1,3-5,8-11,13-14H2,2H3/t16-,21+,22-,23+/m0/s1	Xorphanol	(1R,9R,10R,11S)-17-(cyclobutylmethyl)-11-methyl-13-methylidene-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-trien-4-ol	C=C1C[C@H](C)[C@H]2[C@H]3Cc4ccc(O)cc4[C@@]2(CCN3CC2CCC2)C1	5488631.0	R6_adenot_2004:1091			BBB+	C	training
InChI=1S/C23H31NO2/c1-6-22(26-19(3)25)23(17-18(2)24(4)5,20-13-9-7-10-14-20)21-15-11-8-12-16-21/h7-16,18,22H,6,17H2,1-5H3	Acetylmethadol|Levomethadyl|Methadyl Acetate	[6-(dimethylamino)-4,4-diphenylheptan-3-yl] acetate	CCC(OC(C)=O)C(CC(C)N(C)C)(c1ccccc1)c1ccccc1	10517.0	R6_adenot_2004:1004|R37_chen_2011:45			BBB+	C	training
InChI=1S/C23H31NO2/c1-6-22(26-19(3)25)23(17-18(2)24(4)5,20-13-9-7-10-14-20)21-15-11-8-12-16-21/h7-16,18,22H,6,17H2,1-5H3/t18-,22+/m1/s1	Betacetylmethadol	[(3S,6R)-6-(dimethylamino)-4,4-diphenylheptan-3-yl] acetate	CC[C@H](OC(C)=O)C(C[C@@H](C)N(C)C)(c1ccccc1)c1ccccc1	62710.0	R6_adenot_2004:1011			BBB+	C	training
InChI=1S/C23H31NO2/c1-6-22(26-19(3)25)23(17-18(2)24(4)5,20-13-9-7-10-14-20)21-15-11-8-12-16-21/h7-16,18,22H,6,17H2,1-5H3/t18-,22-/m0/s1	Levacetylmethadol|Levomethadyl Acetate	[(3S,6S)-6-(dimethylamino)-4,4-diphenylheptan-3-yl] acetate	CC[C@H](OC(C)=O)C(C[C@H](C)N(C)C)(c1ccccc1)c1ccccc1	15130.0	R6_adenot_2004:1046			BBB+	C	training
InChI=1S/C23H31NO2/c1-6-22(26-19(3)25)23(17-18(2)24(4)5,20-13-9-7-10-14-20)21-15-11-8-12-16-21/h7-16,18,22H,6,17H2,1-5H3/t18-,22-/m1/s1	Alphacetylmethadol	[(3R,6R)-6-(dimethylamino)-4,4-diphenylheptan-3-yl] acetate	CC[C@@H](OC(C)=O)C(C[C@@H](C)N(C)C)(c1ccccc1)c1ccccc1	22308.0	R6_adenot_2004:1007			BBB+	C	training
InChI=1S/C23H31NO3/c1-4-22-12-10-19-18-9-7-17(24-26)14-16(18)6-8-20(19)21(22)11-13-23(22,5-2)27-15(3)25/h2,14,18-21,26H,4,6-13H2,1,3H3/b24-17+/t18-,19+,20+,21-,22-,23-/m0/s1	Norgestimate|Syn-Norgestimate	[(3Z,8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-3-hydroxyimino-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate	C#C[C@]1(OC(C)=O)CC[C@H]2[C@@H]3CCC4=C/C(=N\O)CC[C@@H]4[C@H]3CC[C@@]21CC	5360970.0	R23_gupta_2019:789			BBB-	C	test
InChI=1S/C23H31NO7/c1-15(5-7-19(25)30-13-10-24-8-11-29-12-9-24)4-6-17-21(26)20-18(14-31-23(20)27)16(2)22(17)28-3/h4,26H,5-14H2,1-3H3/b15-4+	Mycophenolate Mofetil	2-morpholin-4-ylethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-2-benzofuran-5-yl)-4-methylhex-4-enoate	COc1c(C)c2c(c(O)c1C/C=C(\C)CCC(=O)OCCN1CCOCC1)C(=O)OC2	5281078.0	R14_ghose_2012:706|R23_gupta_2019:763			BBB-	C	training
InChI=1S/C23H32F3N5O/c1-17-7-10-31(20(32)15-17)9-6-5-8-29-11-13-30(14-12-29)19-16-18(23(24,25)26)27-21(28-19)22(2,3)4/h7,10,15-16H,5-6,8-9,11-14H2,1-4H3	Compound-7B|1-(4-(4-(2-Tert-Butyl-6-(Trifluoromethyl)Pyrimidin-4-Yl)Piperazin-1-Yl)Butyl)-4-Methylpyridin-2(1H)-One	1-[4-[4-[2-tert-butyl-6-(trifluoromethyl)pyrimidin-4-yl]piperazin-1-yl]butyl]-4-methylpyridin-2-one	Cc1ccn(CCCCN2CCN(c3cc(C(F)(F)F)nc(C(C)(C)C)n3)CC2)c(=O)c1	15949564.0	R26_chico_2009:134	0.57	A	BBB+	A	training
InChI=1S/C23H32N2O/c1-18(2)25(5,19(3)4)17-16-23(22(24)26,20-12-8-6-9-13-20)21-14-10-7-11-15-21/h6-15,18-19H,16-17H2,1-5H3,(H-,24,26)/p+1	Isopropamide Iodide|Isopropamide	(4-amino-4-oxo-3,3-diphenylbutyl)-methyl-di(propan-2-yl)azanium	CC(C)[N+](C)(CCC(C(N)=O)(c1ccccc1)c1ccccc1)C(C)C	3775.0	R14_ghose_2012:630|R23_gupta_2019:685			BBB-	C	training
InChI=1S/C23H32N2O/c1-23(2,3)19-12-13-21(26-4)18(15-19)16-25-20-11-8-14-24-22(20)17-9-6-5-7-10-17/h5-7,9-10,12-13,15,20,22,24-25H,8,11,14,16H2,1-4H3	145741-90-8|Pfizer Compound 6	N-[(5-tert-butyl-2-methoxyphenyl)methyl]-2-phenylpiperidin-3-amine	COc1ccc(C(C)(C)C)cc1CNC1CCCNC1c1ccccc1	18533772.0	R4_mente_2005:81|R25_brito_sanchez_2015:555|R40_vilar_2010:202|R46_mendoza_valencia_2017:466|R47_radchenko_2020:404	0.98	B	BBB+	A	test
InChI=1S/C23H32N2O5/c1-3-30-23(29)18(13-12-16-8-5-4-6-9-16)24-15(2)21(26)25-19-11-7-10-17(19)14-20(25)22(27)28/h4-6,8-9,15,17-20,24H,3,7,10-14H2,1-2H3,(H,27,28)/t15-,17-,18-,19-,20-/m0/s1	Ramipril	(2S,3aS,6aS)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrole-2-carboxylic acid	CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1[C@H](C(=O)O)C[C@@H]2CCC[C@@H]21	5362129.0	R14_ghose_2012:815|R23_gupta_2019:876			BBB-	C	test
InChI=1S/C23H32N2O6/c1-27-20-8-6-5-7-19(20)25-11-9-24(10-12-25)15-17(26)16-31-18-13-21(28-2)23(30-4)22(14-18)29-3/h5-8,13-14,17,26H,9-12,15-16H2,1-4H3	Enciprazine	1-[4-(2-methoxyphenyl)piperazin-1-yl]-3-(3,4,5-trimethoxyphenoxy)propan-2-ol	COc1ccccc1N1CCN(CC(O)COc2cc(OC)c(OC)c(OC)c2)CC1	50222.0	R6_adenot_2004:1458			BBB+	C	training
InChI=1S/C23H32N6O4S/c1-5-8-20-24-16(4)21-23(30)25-22(26-29(20)21)18-15-17(9-10-19(18)33-7-3)34(31,32)28-13-11-27(6-2)12-14-28/h9-10,15H,5-8,11-14H2,1-4H3,(H,25,26,30)	Vardenafil|Vardenafil Hydrochloride Hydrate	2-[2-ethoxy-5-(4-ethylpiperazin-1-yl)sulfonylphenyl]-5-methyl-7-propyl-3H-imidazo[5,1-f][1,2,4]triazin-4-one	CCCc1nc(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)nn12	135400189.0	R14_ghose_2012:931|R23_gupta_2019:1019|R47_radchenko_2020:510	-1.4	A	BBB-	A	training
InChI=1S/C23H32O3/c1-3-4-5-22(25)26-21-11-10-20-19-8-6-15-14-16(24)7-9-17(15)18(19)12-13-23(20,21)2/h7,9,14,18-21,24H,3-6,8,10-13H2,1-2H3/t18-,19-,20+,21+,23+/m1/s1	Estradiol Valerate	[(8R,9S,13S,14S,17S)-3-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl] pentanoate	CCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCc4cc(O)ccc4[C@H]3CC[C@]12C	13791.0	R7_andres_2006:58|R29_subramanian_2003:56			BBB-	C	training
InChI=1S/C23H32O6/c1-13(24)29-12-19(27)23(28)9-7-17-16-5-4-14-10-15(25)6-8-21(14,2)20(16)18(26)11-22(17,23)3/h10,16-18,20,26,28H,4-9,11-12H2,1-3H3/t16-,17-,18-,20+,21-,22-,23-/m0/s1	Hydrocortisone-Acetate|Hydrocortisone Acetate	[2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate	CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C	5744.0	R6_adenot_2004:799			BBB+	C	training
InChI=1S/C23H33FN2O2/c1-2-22(28)23(26-15-4-3-5-16-26)12-17-25(18-13-23)14-6-7-21(27)19-8-10-20(24)11-9-19/h8-11H,2-7,12-18H2,1H3	Propyperone	1-(4-fluorophenyl)-4-(4-piperidin-1-yl-4-propanoylpiperidin-1-yl)butan-1-one	CCC(=O)C1(N2CCCCC2)CCN(CCCC(=O)c2ccc(F)cc2)CC1	19607.0	R6_adenot_2004:1205			BBB+	C	training
InChI=1S/C23H33N3O6S/c1-7-25(8-2)12-13-32-22(29)18-23(3,4)33-21-17(20(28)26(18)21)24-19(27)16-14(30-5)10-9-11-15(16)31-6/h9-11,17-18,21H,7-8,12-13H2,1-6H3,(H,24,27)/t17-,18+,21-/m1/s1	Tameticillin	2-(diethylamino)ethyl (2S,5R,6R)-6-[(2,6-dimethoxybenzoyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate	CCN(CC)CCOC(=O)[C@@H]1N2C(=O)[C@@H](NC(=O)c3c(OC)cccc3OC)[C@H]2SC1(C)C	68757.0	R6_adenot_2004:275			BBB-	C	training
InChI=1S/C23H34N6O2/c1-25-21(30)19-20(27-14-16-3-9-23(10-4-16)7-2-8-23)28-18(13-24)29-22(19)31-15-17-5-11-26-12-6-17/h16-17,26H,2-12,14-15H2,1H3,(H,25,30)(H,27,28,29)	Irie-15|2-Cyano-N-Methyl-4-(Piperidin-4-Ylmethoxy)-6-(Spiro[3.5]Nonan-7-Ylmethylamino)Pyrimidine-5-Carboxamide	2-cyano-N-methyl-4-(piperidin-4-ylmethoxy)-6-(spiro[3.5]nonan-7-ylmethylamino)pyrimidine-5-carboxamide	CNC(=O)c1c(NCC2CCC3(CCC3)CC2)nc(C#N)nc1OCC1CCNCC1	44579171.0	R26_chico_2009:225	-0.67	A	BBB+	A	training
InChI=1S/C23H34O5/c1-2-3-4-7-17(24)9-10-18-19-11-15-6-5-8-22(28-14-23(26)27)20(15)12-16(19)13-21(18)25/h5-6,8,16-19,21,24-25H,2-4,7,9-14H2,1H3,(H,26,27)/t16-,17-,18+,19-,21+/m0/s1	Treprostinil	2-[[(1R,2R,3aS,9aS)-2-hydroxy-1-[(3S)-3-hydroxyoctyl]-2,3,3a,4,9,9a-hexahydro-1H-cyclopenta[g]naphthalen-5-yl]oxy]acetic acid	CCCCC[C@H](O)CC[C@@H]1[C@H]2Cc3cccc(OCC(=O)O)c3C[C@H]2C[C@H]1O	6918140.0	R23_gupta_2019:996			BBB-	C	test
InChI=1S/C23H34O5/c1-4-14(2)23(26)28-20-7-5-6-16-9-8-15(3)19(22(16)20)11-10-18-12-17(24)13-21(25)27-18/h6,8-9,14-15,17-20,22,24H,4-5,7,10-13H2,1-3H3/t14-,15-,17+,18+,19-,20-,22-/m0/s1	Mevastatin	[(1S,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-7-methyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] (2S)-2-methylbutanoate	CC[C@H](C)C(=O)O[C@H]1CCC=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21	64715.0	R6_adenot_2004:1405			BBB+	C	training
InChI=1S/C23H35NO2/c1-5-6-7-8-18(25)11-12-23(3)21-15-17-9-10-19(26)16-20(17)22(23,2)13-14-24(21)4/h9-10,16,21,26H,5-8,11-15H2,1-4H3/t21-,22+,23?/m0/s1	Tonazocine|1-[(1R,9S)-4-Hydroxy-1,10,13-Trimethyl-10-Azatricyclo[7.3.1.02,7]Trideca-2(7),3,5-Trien-13-Yl]Octan-3-One	1-[(1R,9S)-4-hydroxy-1,10,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-13-yl]octan-3-one	CCCCCC(=O)CCC1(C)[C@@H]2Cc3ccc(O)cc3[C@@]1(C)CCN2C	70689351.0	R6_adenot_2004:1089			BBB+	C	training
InChI=1S/C23H36N2O2/c1-21(2,3)25-20(27)17-8-7-15-14-6-9-18-23(5,13-11-19(26)24-18)16(14)10-12-22(15,17)4/h11,13-18H,6-10,12H2,1-5H3,(H,24,26)(H,25,27)/t14-,15-,16-,17+,18+,22-,23+/m0/s1	Finasteride	(1S,3aS,3bS,5aR,9aR,9bS,11aS)-N-tert-butyl-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamide	CC(C)(C)NC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4NC(=O)C=C[C@]4(C)[C@H]3CC[C@]12C	57363.0	R14_ghose_2012:557|R23_gupta_2019:598			BBB-	C	training
InChI=1S/C23H36N6O5S/c1-14-8-10-29(18(12-14)22(31)32)21(30)17(6-4-9-26-23(24)25)28-35(33,34)19-7-3-5-16-11-15(2)13-27-20(16)19/h3,5,7,14-15,17-18,27-28H,4,6,8-13H2,1-2H3,(H,31,32)(H4,24,25,26)/t14-,15?,17+,18-/m1/s1	Argatroban	(2R,4R)-1-[(2S)-5-(diaminomethylideneamino)-2-[(3-methyl-1,2,3,4-tetrahydroquinolin-8-yl)sulfonylamino]pentanoyl]-4-methylpiperidine-2-carboxylic acid	CC1CNc2c(cccc2S(=O)(=O)N[C@@H](CCCN=C(N)N)C(=O)N2CC[C@@H](C)C[C@@H]2C(=O)O)C1	92722.0	R23_gupta_2019:361			BBB-	C	training
InChI=1S/C23H45N5O14/c24-2-7-13(32)15(34)10(27)21(37-7)41-19-9(4-30)39-23(17(19)36)42-20-12(31)5(25)1-6(26)18(20)40-22-11(28)16(35)14(33)8(3-29)38-22/h5-23,29-36H,1-4,24-28H2/t5-,6+,7+,8-,9-,10-,11-,12+,13-,14-,15-,16-,17-,18-,19-,20-,21-,22-,23+/m1/s1	Paromomycin Sulfate|Paromomycin	(2S,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(2R,3S,4R,5S)-5-[(1R,2R,3S,5R,6S)-3,5-diamino-2-[(2S,3R,4R,5S,6R)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-hydroxycyclohexyl]oxy-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxyoxane-3,4-diol	NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O	165580.0	R14_ghose_2012:756|R23_gupta_2019:814			BBB-	C	training
InChI=1S/C23H46N6O13/c24-2-7-13(32)15(34)10(28)21(37-7)40-18-6(27)1-5(26)12(31)20(18)42-23-17(36)19(9(4-30)39-23)41-22-11(29)16(35)14(33)8(3-25)38-22/h5-23,30-36H,1-4,24-29H2/t5-,6+,7-,8+,9-,10-,11-,12+,13-,14-,15-,16-,17-,18-,19-,20-,21-,22-,23+/m1/s1	Framycetin	(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol	NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O	8378.0	R6_adenot_2004:117|R14_ghose_2012:581|R23_gupta_2019:616			BBB-	C	training
InChI=1S/C24H15N3O/c25-16-19-7-4-8-20(13-19)22-15-24(28)27-23-14-18(11-12-21(23)26-22)10-9-17-5-2-1-3-6-17/h1-8,11-14H,15H2,(H,27,28)	43|3-(4-Oxo-7-Phenylethynyl-4,5-Dihydro-3H-Benzo[B][1,4]Diazepin-2-Yl)-Benzonitrile	3-[2-oxo-8-(2-phenylethynyl)-1,3-dihydro-1,5-benzodiazepin-4-yl]benzonitrile	N#Cc1cccc(C2=Nc3ccc(C#Cc4ccccc4)cc3NC(=O)C2)c1	9820321.0	R47_radchenko_2020:427	0.3	A	BBB+	A	training
InChI=1S/C24H20Cl2N2O3S/c1-16-6-9-18(10-7-16)32(30,31)13-12-28-22-11-8-17(25)14-20(22)24(27-15-23(28)29)19-4-2-3-5-21(19)26/h2-11,14H,12-13,15H2,1H3	Tolufazepam	7-chloro-5-(2-chlorophenyl)-1-[2-(4-methylphenyl)sulfonylethyl]-3H-1,4-benzodiazepin-2-one	Cc1ccc(S(=O)(=O)CCN2C(=O)CN=C(c3ccccc3Cl)c3cc(Cl)ccc32)cc1	65647.0	R6_adenot_2004:752			BBB+	C	training
InChI=1S/C24H20Cl2N2OS/c25-19-8-11-22(23(26)14-19)24(15-28-13-12-27-17-28)29-16-18-6-9-21(10-7-18)30-20-4-2-1-3-5-20/h1-14,17,24H,15-16H2	Fenticonazole Nitrate|Fenticonazole	1-[2-(2,4-dichlorophenyl)-2-[(4-phenylsulfanylphenyl)methoxy]ethyl]imidazole	Clc1ccc(C(Cn2ccnc2)OCc2ccc(Sc3ccccc3)cc2)c(Cl)c1	51755.0	R23_gupta_2019:1062			BBB-	C	training
InChI=1S/C24H21F2NO3/c25-17-5-1-15(2-6-17)22(29)14-13-21-23(16-3-11-20(28)12-4-16)27(24(21)30)19-9-7-18(26)8-10-19/h1-12,21-23,28-29H,13-14H2/t21-,22+,23-/m1/s1	Ezetimibe	(3R,4S)-1-(4-fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)azetidin-2-one	O=C1[C@H](CC[C@H](O)c2ccc(F)cc2)[C@@H](c2ccc(O)cc2)N1c1ccc(F)cc1	150311.0	R23_gupta_2019:591			BBB-	C	training
InChI=1S/C24H22F3N/c25-24(26,27)23-7-3-6-22(17-23)20-11-14-28(15-12-20)13-10-18-8-9-19-4-1-2-5-21(19)16-18/h1-9,11,16-17H,10,12-15H2	Xaliproden	1-(2-naphthalen-2-ylethyl)-4-[3-(trifluoromethyl)phenyl]-3,6-dihydro-2H-pyridine	FC(F)(F)c1cccc(C2=CCN(CCc3ccc4ccccc4c3)CC2)c1	128919.0	R6_adenot_2004:1254			BBB+	C	training
InChI=1S/C24H23N3O6S/c1-24(2)17(22(31)33-23-14-11-7-6-10-13(14)21(30)32-23)27-19(29)16(20(27)34-24)26-18(28)15(25)12-8-4-3-5-9-12/h3-11,15-17,20,23H,25H2,1-2H3,(H,26,28)/t15-,16-,17+,20-,23?/m1/s1	Talampicillin	(3-oxo-1H-2-benzofuran-1-yl) (2S,5R,6R)-6-[[(2R)-2-amino-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate	CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccccc3)C(=O)N2[C@H]1C(=O)OC1OC(=O)c2ccccc21	71447.0	R6_adenot_2004:274			BBB-	C	training
InChI=1S/C24H24ClN3O/c25-21-8-4-7-20-22(21)26-23(27-24(20)29)18-9-10-19(15-18)28-13-11-17(12-14-28)16-5-2-1-3-6-16/h1-8,15,17,19H,9-14H2,(H,26,27,29)	Compound-S16D|8-Chloro-2-[3-(4-Phenylpiperidin-1-Yl)Cyclopenten-1-Yl]-3H-Quinazolin-4-One	8-chloro-2-[3-(4-phenylpiperidin-1-yl)cyclopenten-1-yl]-3H-quinazolin-4-one	O=c1[nH]c(C2=CC(N3CCC(c4ccccc4)CC3)CC2)nc2c(Cl)cccc12	135817291.0	R26_chico_2009:136	0.36	A	BBB+	A	test
InChI=1S/C24H24N2O4/c1-15(2)30-24(27)23-19(14-28-3)22-18-11-17(29-13-16-7-5-4-6-8-16)9-10-20(18)26-21(22)12-25-23/h4-12,15,26H,13-14H2,1-3H3	Abecarnil	propan-2-yl 4-(methoxymethyl)-6-phenylmethoxy-9H-pyrido[3,4-b]indole-3-carboxylate	COCc1c(C(=O)OC(C)C)ncc2[nH]c3ccc(OCc4ccccc4)cc3c12	65914.0	R7_andres_2006:1|R29_subramanian_2003:1			BBB+	C	training
InChI=1S/C24H25F4NOS/c25-18-4-5-20-19(2-1-10-29-11-7-16(8-12-29)9-13-30)21-14-17(24(26,27)28)3-6-22(21)31-23(20)15-18/h2-6,14-16,30H,1,7-13H2/b19-2+	Piflutixol|Piflutixolum	2-[1-[(3E)-3-[6-fluoro-2-(trifluoromethyl)thioxanthen-9-ylidene]propyl]piperidin-4-yl]ethanol	OCCC1CCN(CC/C=C2\c3ccc(F)cc3Sc3ccc(C(F)(F)F)cc32)CC1	5477380.0	R51_doninger_2002:286			BBB+	C	training
InChI=1S/C24H25F4NOS/c25-18-4-5-20-19(2-1-10-29-11-7-16(8-12-29)9-13-30)21-14-17(24(26,27)28)3-6-22(21)31-23(20)15-18/h2-6,14-16,30H,1,7-13H2/b19-2-	Piflutixol	2-[1-[(3Z)-3-[6-fluoro-2-(trifluoromethyl)thioxanthen-9-ylidene]propyl]piperidin-4-yl]ethanol	OCCC1CCN(CC/C=C2/c3ccc(F)cc3Sc3ccc(C(F)(F)F)cc32)CC1	5311360.0	R6_adenot_2004:1197			BBB+	C	training
InChI=1S/C24H25FN4O2/c1-15-4-3-10-29-23(15)26-16(2)19(24(29)30)9-13-28-11-7-17(8-12-28)22-20-6-5-18(25)14-21(20)31-27-22/h3-6,10,14,17H,7-9,11-13H2,1-2H3	Ocaperidone	3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl]-2,9-dimethylpyrido[1,2-a]pyrimidin-4-one	Cc1nc2c(C)cccn2c(=O)c1CCN1CCC(c2noc3cc(F)ccc23)CC1	71351.0	R6_adenot_2004:1207			BBB+	C	training
InChI=1S/C24H25FN6O/c1-29(23-26-13-10-22(32)28-23)19-11-14-30(15-12-19)24-27-20-4-2-3-5-21(20)31(24)16-17-6-8-18(25)9-7-17/h2-10,13,19H,11-12,14-16H2,1H3,(H,26,28,32)	Mizolastine	2-[[1-[1-[(4-fluorophenyl)methyl]benzimidazol-2-yl]piperidin-4-yl]-methylamino]-1H-pyrimidin-6-one	CN(c1nccc(=O)[nH]1)C1CCN(c2nc3ccccc3n2Cc2ccc(F)cc2)CC1	65906.0	R23_gupta_2019:1075			BBB-	C	training
InChI=1S/C24H25N3O2/c28-23(20-7-2-1-3-8-20)26-24(29)25-22-12-14-27(15-13-22)17-18-10-11-19-6-4-5-9-21(19)16-18/h1-11,16,22H,12-15,17H2,(H2,25,26,28,29)	Panuramine	N-[[1-(naphthalen-2-ylmethyl)piperidin-4-yl]carbamoyl]benzamide	O=C(NC(=O)c1ccccc1)NC1CCN(Cc2ccc3ccccc3c2)CC1	72002.0	R6_adenot_2004:384			BBB+	C	training
InChI=1S/C24H25N5O/c30-22-13-12-20(25-29(22)18-17-27-14-6-2-7-15-27)23-21-11-5-8-16-28(21)26-24(23)19-9-3-1-4-10-19/h1,3-5,8-13,16H,2,6-7,14-15,17-18H2	141060-39-1|Compound 28|6-(2-Phenylpyrazolo[1,5-A]Pyridin-3-Yl)-2-(2-Piperidin-1-Ylethyl)Pyridazin-3-One	6-(2-phenylpyrazolo[1,5-a]pyridin-3-yl)-2-(2-piperidin-1-ylethyl)pyridazin-3-one	O=c1ccc(-c2c(-c3ccccc3)nn3ccccc23)nn1CCN1CCCCC1	10884606.0	R4_mente_2005:106|R40_vilar_2010:83	0.38	B	BBB+	A	test
InChI=1S/C24H25NO4/c1-17-21(26)19-11-8-12-20(23(19)29-22(17)18-9-4-2-5-10-18)24(27)28-16-15-25-13-6-3-7-14-25/h2,4-5,8-12H,3,6-7,13-16H2,1H3	Flavoxate	2-piperidin-1-ylethyl 3-methyl-4-oxo-2-phenylchromene-8-carboxylate	Cc1c(-c2ccccc2)oc2c(C(=O)OCCN3CCCCC3)cccc2c1=O	3354.0	R14_ghose_2012:558|R23_gupta_2019:599			BBB-	C	training
InChI=1S/C24H25NS/c1-18(17-19-9-3-2-4-10-19)25-16-15-20-21-11-5-7-13-23(21)26-24-14-8-6-12-22(20)24/h2-14,18,20,25H,15-17H2,1H3	Tixadil	1-phenyl-N-[2-(9H-thioxanthen-9-yl)ethyl]propan-2-amine	CC(Cc1ccccc1)NCCC1c2ccccc2Sc2ccccc21	178145.0	R6_adenot_2004:1385			BBB+	C	training
InChI=1S/C24H26BrN3O3/c1-27-13-17-8-21-24(30-3,19-5-4-6-20(27)22(17)19)9-15(12-28(21)2)14-31-23(29)16-7-18(25)11-26-10-16/h4-7,10-11,13,15,21H,8-9,12,14H2,1-3H3/t15-,21-,24+/m1/s1	Nicergoline	[(6aR,9R,10aS)-10a-methoxy-4,7-dimethyl-6a,8,9,10-tetrahydro-6H-indolo[4,3-fg]quinolin-9-yl]methyl 5-bromopyridine-3-carboxylate	CO[C@]12C[C@@H](COC(=O)c3cncc(Br)c3)CN(C)[C@@H]1Cc1cn(C)c3cccc2c13	34040.0	R14_ghose_2012:309|R23_gupta_2019:303|R37_chen_2011:61			BBB+	C	training
InChI=1S/C24H26ClFN4O/c25-18-1-6-23-21(15-18)22(16-30(23)20-4-2-19(26)3-5-20)17-7-10-28(11-8-17)13-14-29-12-9-27-24(29)31/h1-6,15-17H,7-14H2,(H,27,31)	Sertindole	1-[2-[4-[5-chloro-1-(4-fluorophenyl)indol-3-yl]piperidin-1-yl]ethyl]imidazolidin-2-one	O=C1NCCN1CCN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(Cl)cc23)CC1	60149.0	R6_adenot_2004:1215|R14_ghose_2012:229|R23_gupta_2019:225|R37_chen_2011:90|R50_sobanska_2019:93			BBB+	C	test
InChI=1S/C24H26FN3O/c25-18-9-7-17(8-10-18)24(29)6-3-11-27-12-13-28-16-23-21(14-19(28)15-27)20-4-1-2-5-22(20)26-23/h1-2,4-5,7-10,19,26H,3,6,11-16H2	Biriperone	1-(4-fluorophenyl)-4-(3,6,17-triazatetracyclo[8.7.0.03,8.011,16]heptadeca-1(10),11,13,15-tetraen-6-yl)butan-1-one	O=C(CCCN1CCN2Cc3[nH]c4ccccc4c3CC2C1)c1ccc(F)cc1	68663.0	R6_adenot_2004:1122			BBB+	C	training
InChI=1S/C24H26N2O2/c27-24(28)20-9-10-23-22(16-20)21(17-25-23)8-4-5-13-26-14-11-19(12-15-26)18-6-2-1-3-7-18/h1-3,6-7,9-11,16-17,25H,4-5,8,12-15H2,(H,27,28)	Carmoxirol|Carmoxirole	3-[4-(4-phenyl-3,6-dihydro-2H-pyridin-1-yl)butyl]-1H-indole-5-carboxylic acid	O=C(O)c1ccc2[nH]cc(CCCCN3CC=C(c4ccccc4)CC3)c2c1	57364.0	R7_andres_2006:25|R29_subramanian_2003:26			BBB-	C	training
InChI=1S/C24H26N2O4/c1-26-11-9-24-16-6-8-19(29-23(27)15-4-3-10-25-13-15)22(24)30-21-18(28-2)7-5-14(20(21)24)12-17(16)26/h3-5,7,10,13,16-17,19,22H,6,8-9,11-12H2,1-2H3/t16-,17+,19-,22-,24-/m0/s1	Nicodicodine	[(4R,4aR,7S,7aR,12bS)-9-methoxy-3-methyl-2,4,4a,5,6,7,7a,13-octahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-yl] pyridine-3-carboxylate	COc1ccc2c3c1O[C@H]1[C@@H](OC(=O)c4cccnc4)CC[C@H]4[C@@H](C2)N(C)CC[C@@]341	5464304.0	R6_adenot_2004:1065			BBB+	C	training
InChI=1S/C24H26N2O4/c1-28-21-10-4-5-11-22(21)29-14-13-25-15-17(27)16-30-23-12-6-9-20-24(23)18-7-2-3-8-19(18)26-20/h2-12,17,25-27H,13-16H2,1H3	Carvedilol	1-(9H-carbazol-4-yloxy)-3-[2-(2-methoxyphenoxy)ethylamino]propan-2-ol	COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12	2585.0	R14_ghose_2012:426			BBB-	C	training
InChI=1S/C24H26N4/c1-20-9-8-14-23(26-20)19-25-28-17-15-27(16-18-28)24(21-10-4-2-5-11-21)22-12-6-3-7-13-22/h2-14,19,24H,15-18H2,1H3/b25-19+	Ropizine|Ropazine	(Z)-N-(4-benzhydrylpiperazin-1-yl)-1-(6-methylpyridin-2-yl)methanimine	Cc1cccc(/C=N\N2CCN(C(c3ccccc3)c3ccccc3)CC2)n1	5826113.0	R6_adenot_2004:469			BBB+	C	test
InChI=1S/C24H26N6O3/c1-4-7-19-25-21(24(2,3)33)20(23(31)32)30(19)14-15-10-12-16(13-11-15)17-8-5-6-9-18(17)22-26-28-29-27-22/h5-6,8-13,33H,4,7,14H2,1-3H3,(H,31,32)(H,26,27,28,29)	Olmesartan	5-(2-hydroxypropan-2-yl)-2-propyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazole-4-carboxylic acid	CCCc1nc(C(C)(C)O)c(C(=O)O)n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1	158781.0	R23_gupta_2019:791			BBB-	C	training
InChI=1S/C24H26N6O5S/c1-24(2)18(23(34)35)30-21(33)17(22(30)36-24)29-20(32)16(13-6-4-3-5-7-13)28-15(31)12-27-19(25)14-8-10-26-11-9-14/h3-11,16-18,22H,12H2,1-2H3,(H2,25,27)(H,28,31)(H,29,32)(H,34,35)/t16-,17-,18+,22-/m1/s1	Pirbenicillin	(2S,5R,6R)-6-[[(2R)-2-[[2-[[amino(pyridin-4-yl)methylidene]amino]acetyl]amino]-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid	CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](NC(=O)C/N=C(\N)c3ccncc3)c3ccccc3)C(=O)N2[C@H]1C(=O)O	9871712.0	R6_adenot_2004:253			BBB-	C	test
InChI=1S/C24H26O6/c1-16(2)13-21(25)20-9-8-18(14-22(20)26)28-11-3-4-12-29-19-7-5-17-6-10-24(27)30-23(17)15-19/h5-10,14-16,26H,3-4,11-13H2,1-2H3	Cube-10		CC(C)CC(=O)c1ccc(OCCCCOc2ccc3ccc(=O)oc3c2)cc1O		R26_chico_2009:138	-1.52	A	BBB-	A	training
InChI=1S/C24H27BrFN3O2/c1-27-17-29(21-10-6-19(25)7-11-21)24(23(27)31)12-15-28(16-13-24)14-2-3-22(30)18-4-8-20(26)9-5-18/h4-11H,2-3,12-17H2,1H3		1-(4-bromophenyl)-8-[4-(4-fluorophenyl)-4-oxobutyl]-3-methyl-1,3,8-triazaspiro[4.5]decan-4-one	CN1CN(c2ccc(Br)cc2)C2(CCN(CCCC(=O)c3ccc(F)cc3)CC2)C1=O	13497177.0	R41_toropov_2017:128|R46_mendoza_valencia_2017:159	-0.55	B	BBB+	A	training
InChI=1S/C24H27ClN2O3S/c25-17-6-7-22-20(16-17)27(19-4-1-2-5-21(19)31-22)12-3-11-26-13-9-24(29,10-14-26)18-8-15-30-23(18)28/h1-2,4-7,16,18,29H,3,8-15H2	Furomazine	3-[1-[3-(2-chlorophenothiazin-10-yl)propyl]-4-hydroxypiperidin-4-yl]oxolan-2-one	O=C1OCCC1C1(O)CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1	219083.0	R6_adenot_2004:1575			BBB+	C	training
InChI=1S/C24H27FN2O4/c1-16(28)18-4-7-21(23(14-18)29-2)30-13-3-10-27-11-8-17(9-12-27)24-20-6-5-19(25)15-22(20)31-26-24/h4-7,14-15,17H,3,8-13H2,1-2H3	Iloperidone	1-[4-[3-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]propoxy]-3-methoxyphenyl]ethanone	COc1cc(C(C)=O)ccc1OCCCN1CCC(c2noc3cc(F)ccc23)CC1	71360.0	R6_adenot_2004:1168|R23_gupta_2019:114			BBB+	C	training
InChI=1S/C24H27NO2/c1-3-5-12-19(4-2)18-27-24(26)22(17-25)23(20-13-8-6-9-14-20)21-15-10-7-11-16-21/h6-11,13-16,19H,3-5,12,18H2,1-2H3	Octocrylene	2-ethylhexyl 2-cyano-3,3-diphenylprop-2-enoate	CCCCC(CC)COC(=O)C(C#N)=C(c1ccccc1)c1ccccc1	22571.0	R23_gupta_2019:1080			BBB-	C	training
InChI=1S/C24H27NO2/c26-19-10-9-18-14-22-20-8-4-5-11-24(20,21(18)15-19)12-13-25(22)16-23(27)17-6-2-1-3-7-17/h1-3,6-7,9-10,15,20,22,26H,4-5,8,11-14,16H2/t20-,22+,24+/m0/s1	Levophenacylmorphan	2-[(1R,9R,10R)-4-hydroxy-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-trien-17-yl]-1-phenylethanone	O=C(CN1CC[C@]23CCCC[C@H]2[C@H]1Cc1ccc(O)cc13)c1ccccc1	5362482.0	R6_adenot_2004:1051			BBB+	C	test
InChI=1S/C24H28Cl2F2O4/c1-20(2)31-19-9-13-14-8-16(28)15-7-12(29)5-6-21(15,3)23(14,26)17(25)10-22(13,4)24(19,32-20)18(30)11-27/h5-7,13-14,16-17,19H,8-11H2,1-4H3/t13-,14-,16-,17-,19+,21-,22-,23-,24+/m0/s1	Tralonide	(1S,2S,4R,8S,9S,11S,12R,13S,19S)-11,12-dichloro-19-fluoro-8-(2-fluoroacetyl)-6,6,9,13-tetramethyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one	CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(Cl)[C@@H](Cl)C[C@]3(C)[C@]2(C(=O)CF)O1	20055296.0	R6_adenot_2004:912			BBB+	C	training
InChI=1S/C24H28Cl3FO4/c1-20(2)31-19-9-13-14-8-16(28)15-7-12(29)5-6-21(15,3)23(14,27)17(26)10-22(13,4)24(19,32-20)18(30)11-25/h5-7,13-14,16-17,19H,8-11H2,1-4H3/t13-,14-,16-,17-,19+,21-,22-,23-,24+/m0/s1	Triclonide	(1S,2S,4R,8S,9S,11S,12R,13S,19S)-11,12-dichloro-8-(2-chloroacetyl)-19-fluoro-6,6,9,13-tetramethyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one	CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(Cl)[C@@H](Cl)C[C@]3(C)[C@]2(C(=O)CCl)O1	10323902.0	R6_adenot_2004:919			BBB+	C	training
InChI=1S/C24H28ClFN2O2/c1-27(2)23(30)24(19-7-9-20(25)10-8-19)13-16-28(17-14-24)15-3-4-22(29)18-5-11-21(26)12-6-18/h5-12H,3-4,13-17H2,1-2H3	Amiperone	4-(4-chlorophenyl)-1-[4-(4-fluorophenyl)-4-oxobutyl]-N,N-dimethylpiperidine-4-carboxamide	CN(C)C(=O)C1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1	71101.0	R6_adenot_2004:1112			BBB+	C	training
InChI=1S/C24H28ClN3OS/c1-26-24(29)10-12-28-15-13-27(14-16-28)11-4-6-19-20-5-2-3-7-22(20)30-23-9-8-18(25)17-21(19)23/h2-3,5-9,17H,4,10-16H2,1H3,(H,26,29)/b19-6-	Clotixamide|3-[4-[(3Z)-3-(2-Chlorothioxanthen-9-Ylidene)Propyl]Piperazin-1-Yl]-N-Methylpropanamide	3-[4-[(3Z)-3-(2-chlorothioxanthen-9-ylidene)propyl]piperazin-1-yl]-N-methylpropanamide	CNC(=O)CCN1CCN(CC/C=C2/c3ccccc3Sc3ccc(Cl)cc32)CC1	10026342.0	R6_adenot_2004:1439			BBB+	C	training
InChI=1S/C24H28F3N3O3/c1-14-11-20(32-4)30-22-18(29-15(2)7-6-10-28)13-19(31-3)23(21(14)22)33-17-9-5-8-16(12-17)24(25,26)27/h5,8-9,11-13,15,29H,6-7,10,28H2,1-4H3	Tafenoquine	4-N-[2,6-dimethoxy-4-methyl-5-[3-(trifluoromethyl)phenoxy]quinolin-8-yl]pentane-1,4-diamine	COc1cc(C)c2c(Oc3cccc(C(F)(F)F)c3)c(OC)cc(NC(C)CCCN)c2n1	115358.0	R23_gupta_2019:948			BBB-	C	training
InChI=1S/C24H28FN3O/c1-19(20-9-11-21(25)12-10-20)6-5-15-27-16-13-24(14-17-27)23(29)26-18-28(24)22-7-3-2-4-8-22/h2-4,6-12H,5,13-18H2,1H3,(H,26,29)	Spirilene	8-[4-(4-fluorophenyl)pent-3-enyl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one	CC(=CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1)c1ccc(F)cc1	101660.0	R6_adenot_2004:1220			BBB+	C	training
InChI=1S/C24H28FN3O2/c1-26-18-28(21-6-3-2-4-7-21)24(23(26)30)13-16-27(17-14-24)15-5-8-22(29)19-9-11-20(25)12-10-19/h2-4,6-7,9-12H,5,8,13-18H2,1H3	Msp|N-Methylspiroperidol|3-N-Methylspiperone	8-[4-(4-fluorophenyl)-4-oxobutyl]-3-methyl-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one	CN1CN(c2ccccc2)C2(CCN(CCCC(=O)c3ccc(F)cc3)CC2)C1=O	119146.0	R3_abraham_2006:205|R21_muehlbacher_2011:289|R25_brito_sanchez_2015:307|R40_vilar_2010:157|R41_toropov_2017:187|R47_radchenko_2020:172	0.46	B	BBB+	A	training
InChI=1S/C24H28FN3O3/c1-15-18(24(30)28-9-2-3-21(29)23(28)26-15)8-12-27-10-6-16(7-11-27)20-14-31-22-13-17(25)4-5-19(20)22/h4-5,13-14,16,21,29H,2-3,6-12H2,1H3	Risperidone-9-Oh		Cc1nc2n(c(=O)c1CCN1CCC(c3coc4cc(F)ccc34)CC1)CCCC2O		R26_chico_2009:351	-0.8	A	BBB+	A	training
InChI=1S/C24H28N2O3/c1-23(2,3)16-11-17(24(4,5)6)20(27)12-19(16)26-22(29)15-13-25-18-10-8-7-9-14(18)21(15)28/h7-13,27H,1-6H3,(H,25,28)(H,26,29)	Ivacaftor	N-(2,4-ditert-butyl-5-hydroxyphenyl)-4-oxo-1H-quinoline-3-carboxamide	CC(C)(C)c1cc(C(C)(C)C)c(NC(=O)c2c[nH]c3ccccc3c2=O)cc1O	16220172.0	R23_gupta_2019:690			BBB-	C	test
InChI=1S/C24H28N2O3/c1-3-14-9-16-11-18(12-17(16)10-15(14)4-2)25-13-22(28)19-5-7-21(27)24-20(19)6-8-23(29)26-24/h5-10,18,22,25,27-28H,3-4,11-13H2,1-2H3,(H,26,29)/t22-/m0/s1	Indacaterol	5-[(1R)-2-[(5,6-diethyl-2,3-dihydro-1H-inden-2-yl)amino]-1-hydroxyethyl]-8-hydroxy-1H-quinolin-2-one	CCc1cc2c(cc1CC)CC(NC[C@H](O)c1ccc(O)c3[nH]c(=O)ccc13)C2	6918554.0	R23_gupta_2019:675			BBB-	C	test
InChI=1S/C24H28N2O5/c1-2-31-24(30)20(14-12-17-8-4-3-5-9-17)25-19-15-13-18-10-6-7-11-21(18)26(23(19)29)16-22(27)28/h3-11,19-20,25H,2,12-16H2,1H3,(H,27,28)/t19-,20-/m0/s1	Benazepril	2-[(3S)-3-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]-2-oxo-4,5-dihydro-3H-1-benzazepin-1-yl]acetic acid	CCOC(=O)[C@H](CCc1ccccc1)N[C@H]1CCc2ccccc2N(CC(=O)O)C1=O	5362124.0	R14_ghose_2012:377|R23_gupta_2019:380			BBB-	C	test
InChI=1S/C24H28O2/c1-15-13-20-21(24(5,6)12-11-23(20,3)4)14-19(15)16(2)17-7-9-18(10-8-17)22(25)26/h7-10,13-14H,2,11-12H2,1,3-6H3,(H,25,26)	Bexarotene	4-[1-(3,5,5,8,8-pentamethyl-6,7-dihydronaphthalen-2-yl)ethenyl]benzoic acid	C=C(c1ccc(C(=O)O)cc1)c1cc2c(cc1C)C(C)(C)CCC2(C)C	82146.0	R14_ghose_2012:395|R23_gupta_2019:391			BBB-	C	training
InChI=1S/C24H29Cl2FO5/c1-20(2)31-19-9-13-14-8-16(27)15-7-12(29)5-6-21(15,3)23(14,26)17(25)10-22(13,4)24(19,32-20)18(30)11-28/h5-7,13-14,16-17,19,28H,8-11H2,1-4H3/t13?,14?,16-,17-,19+,21-,22-,23-,24+/m0/s1	Fluclorolone-Acetonide|(4R,8S,9S,11S,12R,13S,19S)-11,12-Dichloro-19-Fluoro-8-(2-Hydroxyacetyl)-6,6,9,13-Tetramethyl-5,7-Dioxapentacyclo[10.8.0.02,9.04,8.013,18]Icosa-14,17-Dien-16-One	(4R,8S,9S,11S,12R,13S,19S)-11,12-dichloro-19-fluoro-8-(2-hydroxyacetyl)-6,6,9,13-tetramethyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one	CC1(C)O[C@@H]2CC3C4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(Cl)[C@@H](Cl)C[C@]3(C)[C@]2(C(=O)CO)O1	10345333.0	R6_adenot_2004:836			BBB+	C	training
InChI=1S/C24H29F2NO/c1-2-3-14-27-21-12-13-22(27)16-23(15-21)28-24(17-4-8-19(25)9-5-17)18-6-10-20(26)11-7-18/h4-11,21-24H,2-3,12-16H2,1H3/t21-,22?,23-/m1/s1	Jhw 007		CCCCN1C2CC[C@@H]1C[C@@H](OC(c1ccc(F)cc1)c1ccc(F)cc1)C2		R25_brito_sanchez_2015:418	0.74	A	BBB+	A	test
InChI=1S/C24H29F3O6/c1-12-7-15-16-9-22(25,26)17-8-14(29)5-6-20(17,3)23(16,27)18(30)10-21(15,4)24(12,32)19(31)11-33-13(2)28/h5-6,8,12,15-16,18,30,32H,7,9-11H2,1-4H3/t12-,15+,16?,18+,20+,21+,23+,24+/m1/s1	Cormetasone-Acetate|[2-Oxo-2-[(9R,10S,11S,13S,14S,16R,17R)-6,6,9-Trifluoro-11,17-Dihydroxy-10,13,16-Trimethyl-3-Oxo-8,11,12,14,15,16-Hexahydro-7H-Cyclopenta[A]Phenanthren-17-Yl]Ethyl] Acetate	[2-oxo-2-[(9R,10S,11S,13S,14S,16R,17R)-6,6,9-trifluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-8,11,12,14,15,16-hexahydro-7H-cyclopenta[a]phenanthren-17-yl]ethyl] acetate	CC(=O)OCC(=O)[C@@]1(O)[C@H](C)C[C@H]2C3CC(F)(F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C	10457419.0	R6_adenot_2004:795			BBB+	C	training
InChI=1S/C24H29FN2O2/c1-19(28)26-18-24(21-6-3-2-4-7-21)13-16-27(17-14-24)15-5-8-23(29)20-9-11-22(25)12-10-20/h2-4,6-7,9-12H,5,8,13-18H2,1H3,(H,26,28)	Aceperone	N-[[1-[4-(4-fluorophenyl)-4-oxobutyl]-4-phenylpiperidin-4-yl]methyl]acetamide	CC(=O)NCC1(c2ccccc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1	13122.0	R6_adenot_2004:1108			BBB+	C	training
InChI=1S/C24H29FO6/c1-4-20-30-19-10-16-15-6-5-13-9-14(27)7-8-21(13,2)23(15,25)17(28)11-22(16,3)24(19,31-20)18(29)12-26/h4,7-9,15-17,19-20,26,28H,1,5-6,10-12H2,2-3H3/t15-,16-,17-,19+,20?,21-,22-,23-,24+/m0/s1	Acrocinonide	(1S,2S,4R,8S,9S,11S,12R,13S)-6-ethenyl-12-fluoro-11-hydroxy-8-(2-hydroxyacetyl)-9,13-dimethyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one	C=CC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1	11743529.0	R6_adenot_2004:761			BBB+	C	training
InChI=1S/C24H29N3O8/c1-26(2)18-13-8-11-7-12-10(9-27(3)35-4)5-6-14(28)16(12)19(29)15(11)21(31)24(13,34)22(32)17(20(18)30)23(25)33/h5-6,11,13,18,28-29,32,34H,7-9H2,1-4H3,(H2,25,33)/t11-,13-,18-,24-/m0/s1	Sarecycline	(4S,4aS,5aR,12aR)-4-(dimethylamino)-1,10,11,12a-tetrahydroxy-7-[[methoxy(methyl)amino]methyl]-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide	CON(C)Cc1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]3(O)C(=O)C1=C2O	54681908.0	R23_gupta_2019:902			BBB-	C	training
InChI=1S/C24H29N5O2/c30-22-20-18-6-7-19(17-5-4-16(17)18)21(20)23(31)29(22)11-2-1-10-27-12-14-28(15-13-27)24-25-8-3-9-26-24/h3-9,16-21H,1-2,10-15H2/t16-,17+,18-,19+,20-,21+	Zalospirone	(1S,2S,6R,7R,8R,11S)-4-[4-(4-pyrimidin-2-ylpiperazin-1-yl)butyl]-4-azatetracyclo[5.4.2.02,6.08,11]trideca-9,12-diene-3,5-dione	O=C1[C@@H]2[C@@H]3C=C[C@@H]([C@H]4C=C[C@H]43)[C@@H]2C(=O)N1CCCCN1CCN(c2ncccn2)CC1	163925.0	R6_adenot_2004:1527			BBB+	C	training
InChI=1S/C24H29N5O3/c1-4-5-10-21(30)29(22(16(2)3)24(31)32)15-17-11-13-18(14-12-17)19-8-6-7-9-20(19)23-25-27-28-26-23/h6-9,11-14,16,22H,4-5,10,15H2,1-3H3,(H,31,32)(H,25,26,27,28)/t22-/m0/s1	Valsartan	(2S)-3-methyl-2-[pentanoyl-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]butanoic acid	CCCCC(=O)N(Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1)[C@H](C(=O)O)C(C)C	60846.0	R14_ghose_2012:929|R23_gupta_2019:1017|R50_sobanska_2019:61			BBB-	C	training
InChI=1S/C24H29NO/c1-16(2)24(26)12-13-25-15-21-19-8-4-3-6-17(19)10-11-18-7-5-9-20(23(18)21)22(25)14-24/h3-9,16,21-22,26H,10-15H2,1-2H3/t21-,22-,24-/m1/s1	Dexclamol	(1R,6R,8R)-6-propan-2-yl-3-azapentacyclo[11.8.1.03,8.09,22.016,21]docosa-9,11,13(22),16,18,20-hexaen-6-ol	CC(C)[C@@]1(O)CCN2C[C@@H]3c4ccccc4CCc4cccc(c43)[C@H]2C1	91267.0	R6_adenot_2004:1145			BBB+	C	test
InChI=1S/C24H29NO/c26-20-10-9-19-16-23-21-8-4-5-12-24(21,22(19)17-20)13-15-25(23)14-11-18-6-2-1-3-7-18/h1-3,6-7,9-10,17,21,23,26H,4-5,8,11-16H2/t21-,23+,24+/m0/s1	Phenomorphan	(1R,9R,10R)-17-(2-phenylethyl)-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-trien-4-ol	Oc1ccc2c(c1)[C@@]13CCCC[C@H]1[C@@H](C2)N(CCc1ccccc1)CC3	5362458.0	R6_adenot_2004:1079			BBB+	C	test
InChI=1S/C24H29NO3/c1-27-22-14-19-13-20(24(26)21(19)15-23(22)28-2)12-17-8-10-25(11-9-17)16-18-6-4-3-5-7-18/h3-7,14-15,17,20H,8-13,16H2,1-2H3	120014-06-4|Donepezil|Donepezil, Aricept	2-[(1-benzylpiperidin-4-yl)methyl]-5,6-dimethoxy-2,3-dihydroinden-1-one	COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2	3152.0	R4_mente_2005:71|R6_adenot_2004:1257|R14_ghose_2012:78|R21_muehlbacher_2011:66|R23_gupta_2019:72|R25_brito_sanchez_2015:217|R26_chico_2009:168|R34_broccatelli_2012:24|R37_chen_2011:28|R40_vilar_2010:103|R46_mendoza_valencia_2017:201|R47_radchenko_2020:339	0.86	B1	BBB+	A	training
InChI=1S/C24H30ClFO5/c1-12-7-15-16-9-18(26)17-8-14(28)5-6-23(17,4)24(16,25)20(30)10-22(15,3)21(12)19(29)11-31-13(2)27/h5-6,8,12,15-16,18,20-21,30H,7,9-11H2,1-4H3/t12-,15+,16+,18+,20+,21-,22+,23+,24+/m1/s1	Clocortolone-Acetate|Clocortolone Acetate	[2-[(6S,8S,9R,10S,11S,13S,14S,16R,17S)-9-chloro-6-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-7,8,11,12,14,15,16,17-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate	CC(=O)OCC(=O)[C@H]1[C@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@@]21C	11954353.0	R6_adenot_2004:789			BBB+	C	training
InChI=1S/C24H30ClN7O4S/c1-31(2)24(36)13-4-6-15(27-20(33)21(34)30-19-7-5-14(25)11-26-19)17(10-13)28-22(35)23-29-16-8-9-32(3)12-18(16)37-23/h5,7,11,13,15,17H,4,6,8-10,12H2,1-3H3,(H,27,33)(H,28,35)(H,26,30,34)/t13-,15-,17+/m0/s1	Edoxaban	N'-(5-chloropyridin-2-yl)-N-[(1S,2R,4S)-4-(dimethylcarbamoyl)-2-[(5-methyl-6,7-dihydro-4H-[1,3]thiazolo[5,4-c]pyridine-2-carbonyl)amino]cyclohexyl]oxamide	CN1CCc2nc(C(=O)N[C@@H]3C[C@@H](C(=O)N(C)C)CC[C@@H]3NC(=O)C(=O)Nc3ccc(Cl)cn3)sc2C1	10280735.0	R23_gupta_2019:549			BBB-	C	training
InChI=1S/C24H30F2N4O2/c25-23(26)12-9-18(15-23)24(32,17-5-2-1-3-6-17)22(31)29-19-10-13-30(14-11-19)16-20-7-4-8-21(27)28-20/h1-8,18-19,32H,9-16H2,(H2,27,28)(H,29,31)	Compound A|N-[1-[(6-Aminopyridin-2-Yl)Methyl]Piperidin-4-Yl]-2-(3,3-Difluorocyclopentyl)-2-Hydroxy-2-Phenylacetamide	N-[1-[(6-aminopyridin-2-yl)methyl]piperidin-4-yl]-2-(3,3-difluorocyclopentyl)-2-hydroxy-2-phenylacetamide	Nc1cccc(CN2CCC(NC(=O)C(O)(c3ccccc3)C3CCC(F)(F)C3)CC2)n1	19349126.0	R26_chico_2009:122|R40_vilar_2010:86|R47_radchenko_2020:390	-0.89	B	BBB+	A	training
InChI=1S/C24H30F2N4O2/c25-23(26)12-9-18(15-23)24(32,17-5-2-1-3-6-17)22(31)29-19-10-13-30(14-11-19)16-20-7-4-8-21(27)28-20/h1-8,18-19,32H,9-16H2,(H2,27,28)(H,29,31)/t18-,24+/m1/s1	203321-88-4|Unii-I98T8Bs72C	(2R)-N-[1-[(6-aminopyridin-2-yl)methyl]piperidin-4-yl]-2-[(1R)-3,3-difluorocyclopentyl]-2-hydroxy-2-phenylacetamide	Nc1cccc(CN2CCC(NC(=O)[C@](O)(c3ccccc3)[C@@H]3CCC(F)(F)C3)CC2)n1	9846311.0	R4_mente_2005:146	-0.89	A	BBB+	A	training
InChI=1S/C24H30F2O6/c1-20(2)31-19-9-13-14-8-16(25)15-7-12(28)5-6-21(15,3)23(14,26)17(29)10-22(13,4)24(19,32-20)18(30)11-27/h5-7,13-14,16-17,19,27,29H,8-11H2,1-4H3/t13-,14-,16-,17-,19+,21-,22-,23-,24+/m0/s1	Fluocinolone-Acetonide|Fluocinolone Acetonide	(1S,2S,4R,8S,9S,11S,12R,13S,19S)-12,19-difluoro-11-hydroxy-8-(2-hydroxyacetyl)-6,6,9,13-tetramethyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one	CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1	6215.0	R6_adenot_2004:845			BBB+	C	training
InChI=1S/C24H30N2O2/c1-2-26-19-22(13-14-25-15-17-28-18-16-25)24(23(26)27,20-9-5-3-6-10-20)21-11-7-4-8-12-21/h3-12,22H,2,13-19H2,1H3	Doxapram	1-ethyl-4-(2-morpholin-4-ylethyl)-3,3-diphenylpyrrolidin-2-one	CCN1CC(CCN2CCOCC2)C(c2ccccc2)(c2ccccc2)C1=O	3156.0	R6_adenot_2004:399|R14_ghose_2012:80|R23_gupta_2019:74			BBB+	C	training
InChI=1S/C24H30N2O2S/c1-18(28)20-7-8-24-22(17-20)26(21-5-2-3-6-23(21)29-24)13-4-12-25-14-9-19(10-15-25)11-16-27/h2-3,5-8,17,19,27H,4,9-16H2,1H3	Piperacetazine	1-[10-[3-[4-(2-hydroxyethyl)piperidin-1-yl]propyl]phenothiazin-2-yl]ethanone	CC(=O)c1ccc2c(c1)N(CCCN1CCC(CCO)CC1)c1ccccc1S2	19675.0	R6_adenot_2004:1607|R14_ghose_2012:202|R23_gupta_2019:201			BBB+	C	test
InChI=1S/C24H30N2O3/c1-3-22(27)26(21-12-8-5-9-13-21)24(23(28)29-2)15-18-25(19-16-24)17-14-20-10-6-4-7-11-20/h4-13H,3,14-19H2,1-2H3	Carfentanil	methyl 1-(2-phenylethyl)-4-(N-propanoylanilino)piperidine-4-carboxylate	CCC(=O)N(c1ccccc1)C1(C(=O)OC)CCN(CCc2ccccc2)CC1	62156.0	R6_adenot_2004:1092			BBB+	C	training
InChI=1S/C24H30N4O/c1-17-14-18(2)28(27-17)21-11-12-23(29-3)20(15-21)16-26-22-10-7-13-25-24(22)19-8-5-4-6-9-19/h4-6,8-9,11-12,14-15,22,24-26H,7,10,13,16H2,1-3H3	163257-64-5|Pfizer Compound 20|N-[[5-(3,5-Dimethylpyrazol-1-Yl)-2-Methoxyphenyl]Methyl]-2-Phenylpiperidin-3-Amine	N-[[5-(3,5-dimethylpyrazol-1-yl)-2-methoxyphenyl]methyl]-2-phenylpiperidin-3-amine	COc1ccc(-n2nc(C)cc2C)cc1CNC1CCCNC1c1ccccc1	22620075.0	R4_mente_2005:95|R25_brito_sanchez_2015:547|R40_vilar_2010:194|R46_mendoza_valencia_2017:458|R47_radchenko_2020:411	0.11	B	BBB+	A	training
InChI=1S/C24H30O3/c1-22-6-3-12(25)9-17(22)13-10-14(13)20-16(22)4-7-23(2)21(20)15-11-18(15)24(23)8-5-19(26)27-24/h9,13-16,18,20-21H,3-8,10-11H2,1-2H3/t13-,14+,15-,16+,18+,20-,21+,22-,23+,24+/m1/s1	Drospirenone	(1R,2R,4R,10R,11S,14S,15S,16S,18S,19S)-10,14-dimethylspiro[hexacyclo[9.8.0.02,4.05,10.014,19.016,18]nonadec-5-ene-15,5'-oxolane]-2',7-dione	C[C@]12CCC(=O)C=C1[C@@H]1C[C@@H]1[C@H]1[C@@H]3[C@@H]4C[C@@H]4[C@@]4(CCC(=O)O4)[C@@]3(C)CC[C@@H]12	68873.0	R14_ghose_2012:515|R23_gupta_2019:539			BBB-	C	training
InChI=1S/C24H30O7/c1-16(2)13-22(26)20-9-8-19(15-23(20)27)31-12-4-3-11-30-18-7-5-17(21(25)14-18)6-10-24(28)29/h5,7-9,14-16,25,27H,3-4,6,10-13H2,1-2H3,(H,28,29)	Cube-6		CC(C)CC(=O)c1ccc(OCCCCOc2ccc(CCC(=O)O)c(O)c2)cc1O		R26_chico_2009:140	-1.52	A	BBB-	A	training
InChI=1S/C24H31ClO7/c1-4-30-21(29)32-24(20(28)31-13-25)10-8-17-16-6-5-14-11-15(26)7-9-22(14,2)19(16)18(27)12-23(17,24)3/h7,9,11,16-19,27H,4-6,8,10,12-13H2,1-3H3/t16-,17-,18-,19+,22-,23-,24-/m0/s1	Loteprednol-Etabonate|Loteprednol Etabonate	chloromethyl (8S,9S,10R,11S,13S,14S,17R)-17-ethoxycarbonyloxy-11-hydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-17-carboxylate	CCOC(=O)O[C@]1(C(=O)OCCl)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C	444025.0	R6_adenot_2004:872			BBB+	C	training
InChI=1S/C24H31FO5/c1-13(26)24-19(29-20(2,3)30-24)11-17-16-7-6-14-10-15(27)8-9-21(14,4)23(16,25)18(28)12-22(17,24)5/h8-10,16-19,28H,6-7,11-12H2,1-5H3/t16-,17-,18-,19+,21-,22-,23-,24+/m0/s1	Descinolone-Acetonide|Descinolone Acetonide	(1S,2S,4R,8S,9S,11S,12R,13S)-8-acetyl-12-fluoro-11-hydroxy-6,6,9,13-tetramethyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one	CC(=O)[C@@]12OC(C)(C)O[C@@H]1C[C@H]1[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]12C	11954034.0	R6_adenot_2004:812			BBB+	C	training
InChI=1S/C24H31FO5/c1-13-10-19-17-7-9-23(14(2)26,30-15(3)27)22(17,5)12-20(29)24(19,25)21(4)8-6-16(28)11-18(13)21/h6,8,11,13,17,19-20,29H,7,9-10,12H2,1-5H3/t13-,17-,19-,20-,21-,22-,23-,24-/m0/s1	Fluorometholone-Acetate|Fluorometholone Acetate	[(6S,8S,9R,10S,11S,13S,14S,17R)-17-acetyl-9-fluoro-11-hydroxy-6,10,13-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] acetate	CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C	240767.0	R6_adenot_2004:852			BBB+	C	training
InChI=1S/C24H31FO5S/c1-13-10-18-17-7-6-15-11-16(27)8-9-21(15,3)23(17,25)19(28)12-22(18,4)24(13,20(29)31-5)30-14(2)26/h8-9,11,13,17-19,28H,6-7,10,12H2,1-5H3/t13-,17-,18-,19-,21-,22-,23-,24-/m0/s1	Timobesone-Acetate|Timobesone Acetate	[(8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11-hydroxy-10,13,16-trimethyl-17-methylsulfanylcarbonyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] acetate	CSC(=O)[C@@]1(OC(C)=O)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C	10095308.0	R6_adenot_2004:908			BBB+	C	training
InChI=1S/C24H31FO6/c1-13(31-14(2)26)20(29)23(30)10-8-17-18-6-5-15-11-16(27)7-9-21(15,3)24(18,25)19(28)12-22(17,23)4/h7,9,11,13,17-19,28,30H,5-6,8,10,12H2,1-4H3/t13-,17-,18-,19-,21-,22-,23-,24-/m0/s1	Fluperolone-Acetate|Fluperolone Acetate	[(2S)-1-[(8S,9R,10S,11S,13S,14S,17R)-9-fluoro-11,17-dihydroxy-10,13-dimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-1-oxopropan-2-yl] acetate	CC(=O)O[C@@H](C)C(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C	66257.0	R6_adenot_2004:854			BBB+	C	test
InChI=1S/C24H31FO6/c1-13-9-18-17-6-5-15-10-16(27)7-8-21(15,3)23(17,25)19(28)11-22(18,4)24(13,30)20(29)12-31-14(2)26/h7-8,10,13,17-19,28,30H,5-6,9,11-12H2,1-4H3/t13-,17+,18+,19+,21+,22+,23+,24+/m1/s1	Dexamethasone-Acetate|Dexamethasone Acetate	[2-[(8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate	CC(=O)OCC(=O)[C@@]1(O)[C@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C	236702.0	R6_adenot_2004:818			BBB+	C	training
InChI=1S/C24H31FO6/c1-13-9-18-17-6-5-15-10-16(27)7-8-21(15,3)23(17,25)19(28)11-22(18,4)24(13,30)20(29)12-31-14(2)26/h7-8,10,13,17-19,28,30H,5-6,9,11-12H2,1-4H3/t13-,17-,18-,19-,21-,22-,23-,24-/m0/s1	Betamethasone-Acetate|Betamethasone Acetate	[2-[(8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate	CC(=O)OCC(=O)[C@@]1(O)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C	443967.0	R6_adenot_2004:772			BBB+	C	training
InChI=1S/C24H31FO6/c1-20(2)30-19-10-16-15-6-5-13-9-14(27)7-8-21(13,3)23(15,25)17(28)11-22(16,4)24(19,31-20)18(29)12-26/h7-9,15-17,19,26,28H,5-6,10-12H2,1-4H3/t15-,16-,17-,19+,21-,22-,23-,24+/m0/s1	Triamcinolone-Acetonide|Triamcinolone Acetonide	(1S,2S,4R,8S,9S,11S,12R,13S)-12-fluoro-11-hydroxy-8-(2-hydroxyacetyl)-6,6,9,13-tetramethyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one	CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1	6436.0	R6_adenot_2004:913			BBB+	C	training
InChI=1S/C24H31FO6/c1-21(2)30-19-9-14-13-8-16(25)15-7-12(27)5-6-22(15,3)20(13)17(28)10-23(14,4)24(19,31-21)18(29)11-26/h5-7,13-14,16-17,19-20,26,28H,8-11H2,1-4H3/t13-,14-,16-,17-,19+,20+,22-,23-,24+/m0/s1	Flunisolide	(1S,2S,4R,8S,9S,11S,12S,13R,19S)-19-fluoro-11-hydroxy-8-(2-hydroxyacetyl)-6,6,9,13-tetramethyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one	CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1	82153.0	R6_adenot_2004:844			BBB+	C	training
InChI=1S/C24H31N3O/c28-20-19-26-14-5-13-25(17-18-26)15-6-16-27-23-9-3-1-7-21(23)11-12-22-8-2-4-10-24(22)27/h1-4,7-12,28H,5-6,13-20H2	Homopipramol	2-[4-(3-benzo[b][1]benzazepin-11-ylpropyl)-1,4-diazepan-1-yl]ethanol	OCCN1CCCN(CCCN2c3ccccc3C=Cc3ccccc32)CC1	3042817.0	R6_adenot_2004:557			BBB+	C	training
InChI=1S/C24H31N3O2/c1-26-18-11-12-19(26)14-16(13-18)25-24(29)21-15-27(17-7-3-2-4-8-17)22-10-6-5-9-20(22)23(21)28/h5-6,9-10,15-19H,2-4,7-8,11-14H2,1H3,(H,25,29)/t16?,18-,19+	Mirisetron	1-cyclohexyl-N-[(1R,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl]-4-oxoquinoline-3-carboxamide	CN1[C@@H]2CC[C@H]1CC(NC(=O)c1cn(C3CCCCC3)c3ccccc3c1=O)C2	60931.0	R6_adenot_2004:1396			BBB+	C	training
InChI=1S/C24H31N3O2S/c1-2-22(29)19-8-9-24-21(18-19)27(20-6-3-4-7-23(20)30-24)11-5-10-25-12-14-26(15-13-25)16-17-28/h3-4,6-9,18,28H,2,5,10-17H2,1H3	Carfenazine|Carphenazine	1-[10-[3-[4-(2-hydroxyethyl)piperazin-1-yl]propyl]phenothiazin-2-yl]propan-1-one	CCC(=O)c1ccc2c(c1)N(CCCN1CCN(CCO)CC1)c1ccccc1S2	18104.0	R6_adenot_2004:1127|R14_ghose_2012:283|R23_gupta_2019:39|R51_doninger_2002:174			BBB+	C	training
InChI=1S/C24H31N3O3/c1-17-18(19-15-23(29-3)24(30-4)16-20(19)25-17)9-10-26-11-13-27(14-12-26)21-7-5-6-8-22(21)28-2/h5-8,15-16,25H,9-14H2,1-4H3	Milipertine	5,6-dimethoxy-3-[2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl]-2-methyl-1H-indole	COc1cc2[nH]c(C)c(CCN3CCN(c4ccccc4OC)CC3)c2cc1OC	32345.0	R6_adenot_2004:1183			BBB+	C	training
InChI=1S/C24H31N3OS/c1-24(2,3)23-27-19-13-17(20(28-4)14-21(19)29-23)15-26-18-11-8-12-25-22(18)16-9-6-5-7-10-16/h5-7,9-10,13-14,18,22,25-26H,8,11-12,15H2,1-4H3	163257-86-1|Pfizer Compound 21|N-[(2-Tert-Butyl-6-Methoxy-1,3-Benzothiazol-5-Yl)Methyl]-2-Phenylpiperidin-3-Amine	N-[(2-tert-butyl-6-methoxy-1,3-benzothiazol-5-yl)methyl]-2-phenylpiperidin-3-amine	COc1cc2sc(C(C)(C)C)nc2cc1CNC1CCCNC1c1ccccc1	22620091.0	R4_mente_2005:96|R25_brito_sanchez_2015:548|R40_vilar_2010:195|R46_mendoza_valencia_2017:459|R47_radchenko_2020:412	0.85	B	BBB+	A	training
InChI=1S/C24H31N3OS/c1-3-7-22(28)19-10-11-24-21(18-19)27(20-8-4-5-9-23(20)29-24)13-6-12-26-16-14-25(2)15-17-26/h4-5,8-11,18H,3,6-7,12-17H2,1-2H3	1063-55-4|Butaperazine|Tyrylen|Butaperazine-Maleate	1-[10-[3-(4-methylpiperazin-1-yl)propyl]phenothiazin-2-yl]butan-1-one	CCCC(=O)c1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2	12598.0	R4_mente_2005:151|R6_adenot_2004:1126|R21_muehlbacher_2011:218|R21_muehlbacher_2011:325|R25_brito_sanchez_2015:174|R40_vilar_2010:66|R46_mendoza_valencia_2017:164|R47_radchenko_2020:356	0.83	B	BBB+	A	training
InChI=1S/C24H31NO/c1-3-23(26)24(21-13-7-4-8-14-21,22-15-9-5-10-16-22)19-20(2)25-17-11-6-12-18-25/h4-5,7-10,13-16,20H,3,6,11-12,17-19H2,1-2H3	Dipipanone	4,4-diphenyl-6-piperidin-1-ylheptan-3-one	CCC(=O)C(CC(C)N1CCCCC1)(c1ccccc1)c1ccccc1	13331.0	R14_ghose_2012:77|R23_gupta_2019:70			BBB+	C	training
InChI=1S/C24H31NO4/c1-5-26-21-10-9-17(14-22(21)27-6-2)13-20-19-16-24(29-8-4)23(28-7-3)15-18(19)11-12-25-20/h9-10,13-16,25H,5-8,11-12H2,1-4H3/b20-13-	Drotaverine	(1Z)-1-[(3,4-diethoxyphenyl)methylidene]-6,7-diethoxy-3,4-dihydro-2H-isoquinoline	CCOc1ccc(/C=C2\NCCc3cc(OCC)c(OCC)cc32)cc1OCC	1712095.0	R50_sobanska_2019:107			BBB+	C	training
InChI=1S/C24H31NO6/c1-25(2)16-21(31-24(28)14-13-23(26)27)17-30-22-10-5-4-8-19(22)12-11-18-7-6-9-20(15-18)29-3/h4-10,15,21H,11-14,16-17H2,1-3H3,(H,26,27)	Sarpogrelate	4-[1-(dimethylamino)-3-[2-[2-(3-methoxyphenyl)ethyl]phenoxy]propan-2-yl]oxy-4-oxobutanoic acid	COc1cccc(CCc2ccccc2OCC(CN(C)C)OC(=O)CCC(=O)O)c1	5160.0	R23_gupta_2019:903			BBB-	C	training
InChI=1S/C24H32ClFO5/c1-20(2)30-19-10-16-15-6-5-13-9-14(27)7-8-21(13,3)23(15,26)17(28)11-22(16,4)24(19,31-20)18(29)12-25/h9,15-17,19,28H,5-8,10-12H2,1-4H3/t15-,16-,17-,19+,21-,22-,23-,24+/m0/s1	Halcinonide	(1S,2S,4R,8S,9S,11S,12R,13S)-8-(2-chloroacetyl)-12-fluoro-11-hydroxy-6,6,9,13-tetramethyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icos-17-en-16-one	CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)CC[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CCl)O1	443943.0	R6_adenot_2004:862			BBB+	C	training
InChI=1S/C24H32N2O5/c1-28-14-5-6-15-16-7-8-26-12-13-9-20(29-2)23(30-3)21(24(27)31-4)17(13)11-19(26)22(16)25-18(15)10-14/h5-6,10,13,17,19-21,23,25H,7-9,11-12H2,1-4H3/t13-,17+,19-,20+,21+,23+/m1/s1	Metoserpate	methyl (1R,15S,17S,18R,19S,20S)-6,17,18-trimethoxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate	COC(=O)[C@H]1[C@H]2C[C@@H]3c4[nH]c5cc(OC)ccc5c4CCN3C[C@H]2C[C@H](OC)[C@@H]1OC	66252.0	R6_adenot_2004:1180			BBB+	C	test
InChI=1S/C24H32N4O2S/c29-21-17-24(9-3-4-10-24)18-22(30)28(21)12-6-5-11-26-13-15-27(16-14-26)23-19-7-1-2-8-20(19)31-25-23/h1-2,7-8H,3-6,9-18H2	Tiospirone	8-[4-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]butyl]-8-azaspiro[4.5]decane-7,9-dione	O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2nsc3ccccc23)CC1	55752.0	R6_adenot_2004:1185			BBB+	C	training
InChI=1S/C24H32O10/c1-13(2)7-19(27)33-22-21-17(16(11-30-22)10-29-14(3)25)8-18(24(21)12-31-24)32-20(28)9-23(5,6)34-15(4)26/h8,11,13,18,21-22H,7,9-10,12H2,1-6H3/t18-,21+,22-,24+/m0/s1	Acevaltrate	[(1S,6S,7R,7aS)-4-(acetyloxymethyl)-1-(3-methylbutanoyloxy)spiro[6,7a-dihydro-1H-cyclopenta[c]pyran-7,2'-oxirane]-6-yl] 3-acetyloxy-3-methylbutanoate	CC(=O)OCC1=CO[C@@H](OC(=O)CC(C)C)[C@H]2C1=C[C@H](OC(=O)CC(C)(C)OC(C)=O)[C@]21CO1	65717.0	R6_adenot_2004:1342			BBB+	C	test
InChI=1S/C24H32O4/c1-5-24(28-16(3)26)13-11-22-21-8-6-17-14-18(27-15(2)25)7-9-19(17)20(21)10-12-23(22,24)4/h1,14,18-22H,6-13H2,2-4H3/t18-,19-,20+,21+,22-,23-,24-/m0/s1	Ethynodiol Diacetate	[(3S,8R,9S,10R,13S,14S,17R)-17-acetyloxy-17-ethynyl-13-methyl-2,3,6,7,8,9,10,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate	C#C[C@]1(OC(C)=O)CC[C@H]2[C@@H]3CCC4=C[C@@H](OC(C)=O)CC[C@@H]4[C@H]3CC[C@@]21C	9270.0	R23_gupta_2019:582			BBB-	C	training
InChI=1S/C24H32O6/c1-13-9-16-17-6-8-24(29,20(28)12-30-14(2)25)23(17,4)11-19(27)21(16)22(3)7-5-15(26)10-18(13)22/h5,7,10,13,16-17,19,21,27,29H,6,8-9,11-12H2,1-4H3/t13-,16-,17-,19-,21+,22-,23-,24-/m0/s1	Methylprednisolone-Acetate|Methylprednisolone Acetate	[2-[(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-6,10,13-trimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate	CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C	5877.0	R6_adenot_2004:880			BBB+	C	test
InChI=1S/C24H32O6/c1-21(2)29-19-10-16-15-6-5-13-9-14(26)7-8-22(13,3)20(15)17(27)11-23(16,4)24(19,30-21)18(28)12-25/h7-9,15-17,19-20,25,27H,5-6,10-12H2,1-4H3/t15-,16-,17-,19+,20+,22-,23-,24+/m0/s1	Desonide	(1S,2S,4R,8S,9S,11S,12S,13R)-11-hydroxy-8-(2-hydroxyacetyl)-6,6,9,13-tetramethyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one	CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1	5311066.0	R6_adenot_2004:814			BBB+	C	training
InChI=1S/C24H33FO6/c1-21(2)30-19-9-14-13-8-16(25)15-7-12(27)5-6-22(15,3)20(13)17(28)10-23(14,4)24(19,31-21)18(29)11-26/h7,13-14,16-17,19-20,26,28H,5-6,8-11H2,1-4H3/t13-,14-,16-,17-,19+,20+,22-,23-,24+/m0/s1	Fludroxycortide|Flurandrenolide	(1S,2S,4R,8S,9S,11S,12S,13R,19S)-19-fluoro-11-hydroxy-8-(2-hydroxyacetyl)-6,6,9,13-tetramethyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icos-17-en-16-one	CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)CC[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1	15209.0	R6_adenot_2004:839			BBB+	C	training
InChI=1S/C24H33N3O2S/c1-20(18-26-12-10-25(11-13-26)14-16-29-17-15-28)19-27-21-6-2-4-8-23(21)30-24-9-5-3-7-22(24)27/h2-9,20,28H,10-19H2,1H3	Dixyrazine	2-[2-[4-(2-methyl-3-phenothiazin-10-ylpropyl)piperazin-1-yl]ethoxy]ethanol	CC(CN1CCN(CCOCCO)CC1)CN1c2ccccc2Sc2ccccc21	17182.0	R51_doninger_2002:203			BBB+	C	training
InChI=1S/C24H33N3O3S2/c1-25(2)32(29,30)20-8-9-24-22(18-20)27(21-6-3-4-7-23(21)31-24)14-5-13-26-15-10-19(11-16-26)12-17-28/h3-4,6-9,18-19,28H,5,10-17H2,1-2H3	Pipotiazine|Pipothiazine	10-[3-[4-(2-hydroxyethyl)piperidin-1-yl]propyl]-N,N-dimethylphenothiazine-2-sulfonamide	CN(C)S(=O)(=O)c1ccc2c(c1)N(CCCN1CCC(CCO)CC1)c1ccccc1S2	62867.0	R6_adenot_2004:1201|R14_ghose_2012:203|R23_gupta_2019:202			BBB+	C	test
InChI=1S/C24H34N2O/c1-21(2)19-27-20-24(25-15-9-10-16-25)18-26(23-13-7-4-8-14-23)17-22-11-5-3-6-12-22/h3-8,11-14,21,24H,9-10,15-20H2,1-2H3	Bepridil	N-benzyl-N-[3-(2-methylpropoxy)-2-pyrrolidin-1-ylpropyl]aniline	CC(C)COCC(CN(Cc1ccccc1)c1ccccc1)N1CCCC1	2351.0	R6_adenot_2004:8|R14_ghose_2012:389|R23_gupta_2019:386			BBB-	C	training
InChI=1S/C24H34N2O5/c1-3-31-24(30)19(14-13-17-9-5-4-6-10-17)25-16(2)22(27)26-20-12-8-7-11-18(20)15-21(26)23(28)29/h4-6,9-10,16,18-21,25H,3,7-8,11-15H2,1-2H3,(H,28,29)/t16-,18+,19-,20-,21-/m0/s1	Trandolapril	(2S,3aR,7aS)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-2,3,3a,4,5,6,7,7a-octahydroindole-2-carboxylic acid	CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1[C@H](C(=O)O)C[C@H]2CCCC[C@@H]21	5484727.0	R14_ghose_2012:907|R23_gupta_2019:994			BBB-	C	training
InChI=1S/C24H34N4O5S/c1-4-21-17(3)15-28(22(21)29)24(31)25-14-13-18-7-11-20(12-8-18)34(32,33)27-23(30)26-19-9-5-16(2)6-10-19/h7-8,11-12,16,19H,4-6,9-10,13-15H2,1-3H3,(H,25,31)(H2,26,27,30)	Glimepiride	4-ethyl-3-methyl-N-[2-[4-[(4-methylcyclohexyl)carbamoylsulfamoyl]phenyl]ethyl]-5-oxo-2H-pyrrole-1-carboxamide	CCC1=C(C)CN(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)NC3CCC(C)CC3)cc2)C1=O	3476.0	R14_ghose_2012:591|R23_gupta_2019:635			BBB-	C	test
InChI=1S/C24H34O3/c1-6-20(27)24(5)14(2)11-18-17-8-7-15-12-16(25)9-10-22(15,3)21(17)19(26)13-23(18,24)4/h9-10,12,14,17-19,21,26H,6-8,11,13H2,1-5H3/t14-,17+,18+,19+,21-,22+,23+,24-/m1/s1	Rimexolone	(8S,9S,10R,11S,13S,14S,16R,17S)-11-hydroxy-10,13,16,17-tetramethyl-17-propanoyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one	CCC(=O)[C@@]1(C)[C@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C	5311412.0	R6_adenot_2004:904			BBB+	C	test
InChI=1S/C24H34O4/c1-14(25)24-20(27-21(2,3)28-24)13-19-17-7-6-15-12-16(26)8-10-22(15,4)18(17)9-11-23(19,24)5/h12,17-20H,6-11,13H2,1-5H3/t17-,18+,19+,20-,22+,23+,24-/m1/s1	Algestone-Acetonide|Algestone Acetonide	(1R,2S,4R,8S,9S,12S,13R)-8-acetyl-6,6,9,13-tetramethyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icos-17-en-16-one	CC(=O)[C@@]12OC(C)(C)O[C@@H]1C[C@H]1[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]12C	11740874.0	R6_adenot_2004:764			BBB+	C	training
InChI=1S/C24H34O5/c1-13(4-7-21(28)29)16-5-6-17-22-18(12-20(27)24(16,17)3)23(2)9-8-15(25)10-14(23)11-19(22)26/h13-14,16-18,22H,4-12H2,1-3H3,(H,28,29)	Dehydrocholic|3,7,12-Trioxocholan-24-Oic Acid	4-(10,13-dimethyl-3,7,12-trioxo-1,2,4,5,6,8,9,11,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl)pentanoic acid	CC(CCC(=O)O)C1CCC2C3C(=O)CC4CC(=O)CCC4(C)C3CC(=O)C12C	2975.0	R14_ghose_2012:481			BBB-	C	training
InChI=1S/C24H34O5/c1-13(4-7-21(28)29)16-5-6-17-22-18(12-20(27)24(16,17)3)23(2)9-8-15(25)10-14(23)11-19(22)26/h13-14,16-18,22H,4-12H2,1-3H3,(H,28,29)/t13-,14+,16-,17+,18+,22+,23+,24-/m1/s1	Dehydrocholic Acid	(4R)-4-[(5S,8R,9S,10S,13R,14S,17R)-10,13-dimethyl-3,7,12-trioxo-1,2,4,5,6,8,9,11,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]pentanoic acid	C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3C(=O)C[C@@H]4CC(=O)CC[C@]4(C)[C@H]3CC(=O)[C@]12C	6674.0	R51_doninger_2002:34			BBB-	C	training
InChI=1S/C24H35FO6/c1-20(2)30-19-10-16-15-6-5-13-9-14(27)7-8-21(13,3)23(15,25)17(28)11-22(16,4)24(19,31-20)18(29)12-26/h13,15-17,19,26,28H,5-12H2,1-4H3/t13-,15-,16-,17-,19+,21-,22-,23-,24+/m0/s1	Drocinonide	(1S,2S,4R,8S,9S,11S,12R,13S,18S)-12-fluoro-11-hydroxy-8-(2-hydroxyacetyl)-6,6,9,13-tetramethyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosan-16-one	CC1(C)O[C@@H]2C[C@H]3[C@@H]4CC[C@H]5CC(=O)CC[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1	20055479.0	R6_adenot_2004:833			BBB+	C	training
InChI=1S/C24H35N5O5/c1-2-34-20(30)15-26-21(17-6-4-3-5-7-17)24(32)29-13-12-19(29)23(31)27-14-16-8-10-18(11-9-16)22(25)28-33/h8-11,17,19,21,26,33H,2-7,12-15H2,1H3,(H2,25,28)(H,27,31)/t19-,21+/m0/s1	Ximelagatran|Ethyl 2-[[(1R)-1-Cyclohexyl-2-[(2S)-2-[[4-(N'-Hydroxycarbamimidoyl)Phenyl]Methylcarbamoyl]Azetidin-1-Yl]-2-Oxoethyl]Amino]Acetate	ethyl 2-[[(1R)-1-cyclohexyl-2-[(2S)-2-[[4-(N'-hydroxycarbamimidoyl)phenyl]methylcarbamoyl]azetidin-1-yl]-2-oxoethyl]amino]acetate	CCOC(=O)CN[C@@H](C(=O)N1CC[C@H]1C(=O)NCc1ccc(C(N)=NO)cc1)C1CCCCC1	656635.0	R23_gupta_2019:1034			BBB-	C	training
InChI=1S/C24H36N6O2/c1-26-22(31)20-21(27-15-17-4-10-24(11-5-17)8-3-9-24)28-19(14-25)29-23(20)32-16-18-6-12-30(2)13-7-18/h17-18H,3-13,15-16H2,1-2H3,(H,26,31)(H,27,28,29)	Irie-10B|2-Cyano-N-Methyl-4-((1-Methylpiperidin-4-Yl)Methoxy)-6-(Spiro[3.5]Nonan-7-Ylmethylamino)Pyrimidine-5-Carboxamide	2-cyano-N-methyl-4-[(1-methylpiperidin-4-yl)methoxy]-6-(spiro[3.5]nonan-7-ylmethylamino)pyrimidine-5-carboxamide	CNC(=O)c1c(NCC2CCC3(CCC3)CC2)nc(C#N)nc1OCC1CCN(C)CC1	44579121.0	R26_chico_2009:222	0.37	A	BBB+	A	training
InChI=1S/C24H36O3/c1-6-7-8-9-12-23(2,3)16-13-20(26)22-18-15-17(25)10-11-19(18)24(4,5)27-21(22)14-16/h13-14,18-19,26H,6-12,15H2,1-5H3/t18-,19-/m1/s1	Nabilone	(6aR,10aR)-1-hydroxy-6,6-dimethyl-3-(2-methyloctan-2-yl)-7,8,10,10a-tetrahydro-6aH-benzo[c]chromen-9-one	CCCCCCC(C)(C)c1cc(O)c2c(c1)OC(C)(C)[C@@H]1CCC(=O)C[C@@H]21	5284592.0	R6_adenot_2004:1492|R14_ghose_2012:159|R23_gupta_2019:157			BBB+	C	test
InChI=1S/C24H36O5/c1-5-15(3)24(27)29-21-11-14(2)10-17-7-6-16(4)20(23(17)21)9-8-19-12-18(25)13-22(26)28-19/h6-7,10,14-16,18-21,23,25H,5,8-9,11-13H2,1-4H3/t14-,15-,16-,18+,19+,20-,21-,23-/m0/s1	Lovastatin	[(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] (2S)-2-methylbutanoate	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21	53232.0	R6_adenot_2004:45|R6_adenot_2004:1404|R14_ghose_2012:662|R25_brito_sanchez_2015:474|R26_chico_2009:250	0.39	C	BBB+	A	training
InChI=1S/C24H40N8O4/c33-15-11-31(12-16-34)23-26-20-19(21(27-23)29-7-3-1-4-8-29)25-24(32(13-17-35)14-18-36)28-22(20)30-9-5-2-6-10-30/h33-36H,1-18H2	Dipyridamole	2-[[2-[bis(2-hydroxyethyl)amino]-4,8-di(piperidin-1-yl)pyrimido[5,4-d]pyrimidin-6-yl]-(2-hydroxyethyl)amino]ethanol	OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1	3108.0	R6_adenot_2004:20|R14_ghose_2012:504|R23_gupta_2019:532|R25_brito_sanchez_2015:498|R34_broccatelli_2012:119	0.0	A	BBB+	A	training
InChI=1S/C24H40O4/c1-14(4-7-21(27)28)17-5-6-18-22-19(9-11-24(17,18)3)23(2)10-8-16(25)12-15(23)13-20(22)26/h14-20,22,25-26H,4-13H2,1-3H3,(H,27,28)/t14-,15+,16-,17-,18+,19+,20+,22+,23+,24-/m1/s1	Ursodiol	(4R)-4-[(3R,5S,7S,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid	C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C	31401.0	R14_ghose_2012:926			BBB-	C	training
InChI=1S/C25H20N4O/c1-29-16-23(18-12-14-26-15-13-18)25(28-29)20-7-10-22(11-8-20)30-17-21-9-6-19-4-2-3-5-24(19)27-21/h2-16H,17H2,1H3	Pf-02545920|Mardepodect	2-[[4-(1-methyl-4-pyridin-4-ylpyrazol-3-yl)phenoxy]methyl]quinoline	Cn1cc(-c2ccncc2)c(-c2ccc(OCc3ccc4ccccc4n3)cc2)n1	11581936.0	R47_radchenko_2020:513	-0.06	A	BBB+	A	training
InChI=1S/C25H22BrF3N4O4S/c1-2-19-31-21(14-8-9-14)22(24(30)34)33(19)12-13-7-10-18-16(11-13)20(26)23(37-18)15-5-3-4-6-17(15)32-38(35,36)25(27,28)29/h3-7,10-11,14,32H,2,8-9,12H2,1H3,(H2,30,34)	Saprisartan	3-[[3-bromo-2-[2-(trifluoromethylsulfonylamino)phenyl]-1-benzofuran-5-yl]methyl]-5-cyclopropyl-2-ethylimidazole-4-carboxamide	CCc1nc(C2CC2)c(C(N)=O)n1Cc1ccc2oc(-c3ccccc3NS(=O)(=O)C(F)(F)F)c(Br)c2c1	60921.0	R23_gupta_2019:900			BBB-	C	training
InChI=1S/C25H22ClF3N6O3/c1-13-8-9-35(34-13)20-11-16(26)6-7-17(20)22(25(27,28)29)38-21-12-19(32-24(31)33-21)15-4-2-14(3-5-15)10-18(30)23(36)37/h2-9,11-12,18,22H,10,30H2,1H3,(H,36,37)(H2,31,32,33)/t18-,22+/m0/s1	Telotristat	(2S)-2-amino-3-[4-[2-amino-6-[(1R)-1-[4-chloro-2-(3-methylpyrazol-1-yl)phenyl]-2,2,2-trifluoroethoxy]pyrimidin-4-yl]phenyl]propanoic acid	Cc1ccn(-c2cc(Cl)ccc2[C@@H](Oc2cc(-c3ccc(C[C@H](N)C(=O)O)cc3)nc(N)n2)C(F)(F)F)n1	25025298.0	R23_gupta_2019:961			BBB-	C	training
InChI=1S/C25H22N2O2/c1-2-20(17-11-5-3-6-12-17)27-25(29)22-19-15-9-10-16-21(19)26-23(24(22)28)18-13-7-4-8-14-18/h3-16,20,28H,2H2,1H3,(H,27,29)/t20-/m0/s1	Skb_A|Talnetant	3-hydroxy-2-phenyl-N-[(1S)-1-phenylpropyl]quinoline-4-carboxamide	CC[C@H](NC(=O)c1c(O)c(-c2ccccc2)nc2ccccc12)c1ccccc1	5311424.0	R28_li_2005:402			BBB+	C	training
InChI=1S/C25H22N4O4/c1-14-10-11-19(12-15(14)2)29-24(31)22(16(3)28-29)27-26-21-9-5-8-20(23(21)30)17-6-4-7-18(13-17)25(32)33/h4-13,28,30H,1-3H3,(H,32,33)/b27-26+	Eltrombopag	3-[3-[[2-(3,4-dimethylphenyl)-5-methyl-3-oxo-1H-pyrazol-4-yl]diazenyl]-2-hydroxyphenyl]benzoic acid	Cc1ccc(-n2[nH]c(C)c(/N=N/c3cccc(-c4cccc(C(=O)O)c4)c3O)c2=O)cc1C	135449332.0	R23_gupta_2019:553			BBB-	C	training
InChI=1S/C25H23ClN4O4/c26-20-7-5-16-6-8-21(28-23(16)27-20)30-19(17-3-1-2-4-18(17)24(30)32)15-22(31)29-11-9-25(10-12-29)33-13-14-34-25/h1-8,19H,9-15H2	Pazinaclone	2-(7-chloro-1,8-naphthyridin-2-yl)-3-[2-(1,4-dioxa-8-azaspiro[4.5]decan-8-yl)-2-oxoethyl]-3H-isoindol-1-one	O=C(CC1c2ccccc2C(=O)N1c1ccc2ccc(Cl)nc2n1)N1CCC2(CC1)OCCO2	59743.0	R6_adenot_2004:1452			BBB+	C	training
InChI=1S/C25H23N5O6S/c1-25(2)19(24(35)36)30-22(34)17(23(30)37-25)29-21(33)15(12-7-4-3-5-8-12)28-20(32)13-11-27-14-9-6-10-26-16(14)18(13)31/h3-11,15,17,19,23H,1-2H3,(H,27,31)(H,28,32)(H,29,33)(H,35,36)/t15-,17-,19+,23-/m1/s1	Apalcillin	(2S,5R,6R)-3,3-dimethyl-7-oxo-6-[[(2R)-2-[(4-oxo-1H-1,5-naphthyridine-3-carbonyl)amino]-2-phenylacetyl]amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid	CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](NC(=O)c3c[nH]c4cccnc4c3=O)c3ccccc3)C(=O)N2[C@H]1C(=O)O	6602341.0	R6_adenot_2004:139			BBB-	C	training
InChI=1S/C25H23N5OS/c1-3-17-7-9-19(10-8-17)30-16-28-22-21-20(11-14-27-24(21)32-23(22)25(30)31)29(2)15-12-18-6-4-5-13-26-18/h4-11,13-14,16H,3,12,15H2,1-2H3	5-(4-Ethylphenyl)-13-[Methyl(2-Pyridin-2-Ylethyl)Amino]-8-Thia-3,5,10-Triazatricyclo[7.4.0.02,7]Trideca-1(13),2(7),3,9,11-Pentaen-6-One	5-(4-ethylphenyl)-13-[methyl(2-pyridin-2-ylethyl)amino]-8-thia-3,5,10-triazatricyclo[7.4.0.02,7]trideca-1(13),2(7),3,9,11-pentaen-6-one	CCc1ccc(-n2cnc3c(sc4nccc(N(C)CCc5ccccn5)c43)c2=O)cc1	44416780.0	R46_mendoza_valencia_2017:396	-0.8	A	BBB+	A	training
InChI=1S/C25H24ClN3O3S/c1-31-22-14-19(8-9-21(22)32-13-12-28-10-2-3-11-28)29-16-27-20-15-23(33-24(20)25(29)30)17-4-6-18(26)7-5-17/h4-9,14-16H,2-3,10-13H2,1H3	Mchr Antagonist 7C|Thieno[3,2-D]Pyrimidin-4(3H)-One, 6-(4-Chlorophenyl)-3-[3-Methoxy-4-[2-(1-Pyrrolidinyl)Ethoxy]Phenyl]-	6-(4-chlorophenyl)-3-[3-methoxy-4-(2-pyrrolidin-1-ylethoxy)phenyl]thieno[3,2-d]pyrimidin-4-one	COc1cc(-n2cnc3cc(-c4ccc(Cl)cc4)sc3c2=O)ccc1OCCN1CCCC1	9826520.0	R25_brito_sanchez_2015:578|R46_mendoza_valencia_2017:483	0.78	B	BBB+	A	test
InChI=1S/C25H24N8O7S2/c1-11-7-16(35)15(8-26-11)20(36)27-17(12-3-5-14(34)6-4-12)21(37)28-18-22(38)33-19(24(39)40)13(9-41-23(18)33)10-42-25-29-30-31-32(25)2/h3-8,17-18,23,34H,9-10H2,1-2H3,(H,26,35)(H,27,36)(H,28,37)(H,39,40)/t17-,18-,23-/m1/s1	Cefpiramide	(6R,7R)-7-[[(2R)-2-(4-hydroxyphenyl)-2-[(6-methyl-4-oxo-1H-pyridine-3-carbonyl)amino]acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid	Cc1cc(=O)c(C(=O)N[C@@H](C(=O)N[C@@H]2C(=O)N3C(C(=O)O)=C(CSc4nnnn4C)CS[C@H]23)c2ccc(O)cc2)c[nH]1	636405.0	R6_adenot_2004:188			BBB-	C	training
InChI=1S/C25H25N5O4/c1-34-19-11-9-18(10-12-19)30-23-20(22(27-30)24(26)32)13-15-29(25(23)33)17-7-5-16(6-8-17)28-14-3-2-4-21(28)31/h5-12H,2-4,13-15H2,1H3,(H2,26,32)	Apixaban	1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5-dihydropyrazolo[3,4-c]pyridine-3-carboxamide	COc1ccc(-n2nc(C(N)=O)c3c2C(=O)N(c2ccc(N4CCCCC4=O)cc2)CC3)cc1	10182969.0	R23_gupta_2019:358			BBB-	C	test
InChI=1S/C25H25NO9/c1-10(27)25(26)7-13-18(16(8-25)35-17-6-14(28)15(29)9-34-17)24(33)20-19(23(13)32)21(30)11-4-2-3-5-12(11)22(20)31/h2-5,14-17,28-29,32-33H,6-9,26H2,1H3/t14-,15+,16-,17-,25-/m0/s1	Amrubicin	(7S,9S)-9-acetyl-9-amino-7-[(2S,4S,5R)-4,5-dihydroxyoxan-2-yl]oxy-6,11-dihydroxy-8,10-dihydro-7H-tetracene-5,12-dione	CC(=O)[C@]1(N)Cc2c(O)c3c(c(O)c2[C@@H](O[C@H]2C[C@H](O)[C@H](O)CO2)C1)C(=O)c1ccccc1C3=O	3035016.0	R6_adenot_2004:322|R23_gupta_2019:351			BBB-	C	training
InChI=1S/C25H26N2O/c26-16-19-9-10-25-23(15-19)21-12-14-27(17-18-5-1-2-6-18)13-11-20(21)22-7-3-4-8-24(22)28-25/h3-4,7-10,15,18H,1-2,5-6,11-14,17H2	Savoxepin	18-(cyclopentylmethyl)-8-oxa-18-azatetracyclo[13.5.0.02,7.09,14]icosa-1(15),2(7),3,5,9,11,13-heptaene-4-carbonitrile	N#Cc1ccc2c(c1)C1=C(CCN(CC3CCCC3)CC1)c1ccccc1O2	54359.0	R6_adenot_2004:1134			BBB+	C	training
InChI=1S/C25H27Cl2N5O4S2/c1-13(2)37-38-22(14(3)32(12-33)11-16-10-29-15(4)30-24(16)28)5-6-36-25(35)20-9-21(34)23-18(27)7-17(26)8-19(23)31-20/h7-10,12-13H,5-6,11H2,1-4H3,(H,31,34)(H2,28,29,30)/b22-14-	Tipr-Dcka		C/C(=C(\CCOC(=O)c1cc(=O)c2c(Cl)cc(Cl)cc2[nH]1)SSC(C)C)N(C=O)Cc1cnc(C)nc1N		R25_brito_sanchez_2015:456|R46_mendoza_valencia_2017:381	-0.57	B	BBB+	A	test
InChI=1S/C25H27ClN2/c1-20-6-5-7-21(18-20)19-27-14-16-28(17-15-27)25(22-8-3-2-4-9-22)23-10-12-24(26)13-11-23/h2-13,18,25H,14-17,19H2,1H3	Meclizine/Meclozine|Meclizine	1-[(4-chlorophenyl)-phenylmethyl]-4-[(3-methylphenyl)methyl]piperazine	Cc1cccc(CN2CCN(C(c3ccccc3)c3ccc(Cl)cc3)CC2)c1	4034.0	R14_ghose_2012:133|R23_gupta_2019:132			BBB+	C	test
InChI=1S/C25H27FN4O2/c1-32-23-7-3-2-6-22(23)29-17-14-28(15-18-29)16-19-30(24-8-4-5-13-27-24)25(31)20-9-11-21(26)12-10-20/h2-13H,14-19H2,1H3	Mppf|4-Fluoro-N-[2-[4-(2-Methoxyphenyl)Piperazin-1-Yl]Ethyl]-N-Pyridin-2-Ylbenzamide	4-fluoro-N-[2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl]-N-pyridin-2-ylbenzamide	COc1ccccc1N1CCN(CCN(C(=O)c2ccc(F)cc2)c2ccccn2)CC1	6603915.0	R25_brito_sanchez_2015:451|R46_mendoza_valencia_2017:377	0.09	B	BBB+	A	training
InChI=1S/C25H27N9O8S2/c1-3-32-8-9-33(21(39)20(32)38)24(42)27-15(12-4-6-14(35)7-5-12)18(36)26-16-19(37)34-17(23(40)41)13(10-43-22(16)34)11-44-25-28-29-30-31(25)2/h4-7,15-16,22,35H,3,8-11H2,1-2H3,(H,26,36)(H,27,42)(H,40,41)/t15-,16-,22-/m1/s1	Cefoperazone	(6R,7R)-7-[[(2R)-2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid	CCN1CCN(C(=O)N[C@@H](C(=O)N[C@@H]2C(=O)N3C(C(=O)O)=C(CSc4nnnn4C)CS[C@H]23)c2ccc(O)cc2)C(=O)C1=O	44187.0	R6_adenot_2004:180|R23_gupta_2019:427			BBB-	C	training
InChI=1S/C25H27NO/c1-26(19-11-14-22-12-5-2-6-13-22)20-21-27-25(23-15-7-3-8-16-23)24-17-9-4-10-18-24/h2-18,25H,19-21H2,1H3/b14-11+	Cinfenine	(E)-N-(2-benzhydryloxyethyl)-N-methyl-3-phenylprop-2-en-1-amine	CN(C/C=C/c1ccccc1)CCOC(c1ccccc1)c1ccccc1	6443800.0	R6_adenot_2004:510			BBB+	C	training
InChI=1S/C25H28N2O2/c28-23-13-16-25(24(29)26-23,21-11-5-2-6-12-21)22-14-18-27(19-15-22)17-7-10-20-8-3-1-4-9-20/h1-12,22H,13-19H2,(H,26,28,29)/b10-7+	Cinperene	3-phenyl-3-[1-[(E)-3-phenylprop-2-enyl]piperidin-4-yl]piperidine-2,6-dione	O=C1CCC(c2ccccc2)(C2CCN(C/C=C/c3ccccc3)CC2)C(=O)N1	6433620.0	R6_adenot_2004:1431			BBB+	C	training
InChI=1S/C25H28N4O/c1-28-13-15-29(16-14-28)18-19-7-9-21(10-8-19)25(30)27-24-17-22(11-12-23(24)26)20-5-3-2-4-6-20/h2-12,17H,13-16,18,26H2,1H3,(H,27,30)	16	N-(2-amino-5-phenylphenyl)-4-[(4-methylpiperazin-1-yl)methyl]benzamide	CN1CCN(Cc2ccc(C(=O)Nc3cc(-c4ccccc4)ccc3N)cc2)CC1	76511930.0	R47_radchenko_2020:520	0.56	A	BBB+	A	training
InChI=1S/C25H28N4O2S/c1-29(2)16-22-9-10-23(31-22)17-32-12-11-26-25-27-15-21(24(30)28-25)14-18-7-8-19-5-3-4-6-20(19)13-18/h3-10,13,15H,11-12,14,16-17H2,1-2H3,(H2,26,27,28,30)	145459-26-3|Skf93319|B-040, Skf-93619|4|Skf-93619|24|2-[2-[[5-[(Dimethylamino)Methyl]Furan-2-Yl]Methylsulfanyl]Ethylamino]-5-(Naphthalen-2-Ylmethyl)-1H-Pyrimidin-6-One	2-[2-[[5-[(dimethylamino)methyl]furan-2-yl]methylsulfanyl]ethylamino]-5-(naphthalen-2-ylmethyl)-1H-pyrimidin-6-one	CN(C)Cc1ccc(CSCCNc2ncc(Cc3ccc4ccccc4c3)c(=O)[nH]2)o1	14022522.0	R4_mente_2005:138|R25_brito_sanchez_2015:3|R26_chico_2009:44|R28_li_2005:167|R40_vilar_2010:257|R46_mendoza_valencia_2017:3|R48_hou_2003:42|R49_norinder_2002:4|R49_norinder_2002:165|R52_liu_2001:4	-1.3	B	BBB-	A	training
InChI=1S/C25H28N6O/c1-2-3-10-22-26-25(15-6-7-16-25)24(32)31(22)17-18-11-13-19(14-12-18)20-8-4-5-9-21(20)23-27-29-30-28-23/h4-5,8-9,11-14H,2-3,6-7,10,15-17H2,1H3,(H,27,28,29,30)	Irbesartan	2-butyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-1,3-diazaspiro[4.4]non-1-en-4-one	CCCCC1=NC2(CCCC2)C(=O)N1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1	3749.0	R14_ghose_2012:628|R23_gupta_2019:683			BBB-	C	training
InChI=1S/C25H28N6O7S3/c1-12-15(41-10-27-12)7-6-13-8-39-21-17(29-19(32)16(30-36-5)14-9-40-24(26)28-14)20(33)31(21)18(13)22(34)37-11-38-23(35)25(2,3)4/h6-7,9-10,17,21H,8,11H2,1-5H3,(H2,26,28)(H,29,32)/b7-6-,30-16-/t17-,21-/m1/s1	Cefditoren Pivoxil|Cefditorin Pivoxil	2,2-dimethylpropanoyloxymethyl (6R,7R)-7-[[(2E)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(Z)-2-(4-methyl-1,3-thiazol-5-yl)ethenyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate	CO/N=C(/C(=O)N[C@@H]1C(=O)N2C(C(=O)OCOC(=O)C(C)(C)C)=C(/C=C\c3scnc3C)CS[C@H]12)c1csc(N)n1	6917926.0	R14_ghose_2012:430|R23_gupta_2019:422			BBB-	C	training
InChI=1S/C25H28N8O2/c1-4-5-13-32-21-22(29-24(32)31-12-8-9-17(26)14-31)30(3)25(35)33(23(21)34)15-20-27-16(2)18-10-6-7-11-19(18)28-20/h6-7,10-11,17H,8-9,12-15,26H2,1-3H3/t17-/m1/s1	Linagliptin	8-[(3R)-3-aminopiperidin-1-yl]-7-but-2-ynyl-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]purine-2,6-dione	CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C	10096344.0	R23_gupta_2019:710			BBB-	C	test
InChI=1S/C25H29BrF2O7/c1-12(29)34-11-21(33)24(35-13(2)30)6-5-14-15-7-18(27)16-8-19(31)17(26)9-23(16,4)25(15,28)20(32)10-22(14,24)3/h8-9,14-15,18,20,32H,5-7,10-11H2,1-4H3/t14-,15-,18+,20-,22-,23-,24-,25-/m0/s1	Halopredone-Acetate|Halopredone Acetate	[2-[(6R,8S,9R,10S,11S,13S,14S,17R)-17-acetyloxy-2-bromo-6,9-difluoro-11-hydroxy-10,13-dimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate	CC(=O)OCC(=O)[C@@]1(OC(C)=O)CC[C@H]2[C@@H]3C[C@@H](F)C4=CC(=O)C(Br)=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C	91667.0	R6_adenot_2004:865			BBB+	C	training
InChI=1S/C25H29BrFN3O2/c1-2-29-18-30(22-11-7-20(26)8-12-22)25(24(29)32)13-16-28(17-14-25)15-3-4-23(31)19-5-9-21(27)10-6-19/h5-12H,2-4,13-18H2,1H3	Besp|1-(4-Bromophenyl)-3-Ethyl-8-[4-(4-Fluorophenyl)-4-Oxobutyl]-1,3,8-Triazaspiro[4.5]Decan-4-One	1-(4-bromophenyl)-3-ethyl-8-[4-(4-fluorophenyl)-4-oxobutyl]-1,3,8-triazaspiro[4.5]decan-4-one	CCN1CN(c2ccc(Br)cc2)C2(CCN(CCCC(=O)c3ccc(F)cc3)CC2)C1=O	13497179.0	R3_abraham_2006:131|R25_brito_sanchez_2015:158|R40_vilar_2010:50|R41_toropov_2017:124|R47_radchenko_2020:111	-0.43	B	BBB+	A	training
InChI=1S/C25H29F2N3O3/c1-18-4-2-11-28(18)12-3-15-33-21-8-6-20(7-9-21)30-14-13-29(17-24(30)31)25(32)22-10-5-19(26)16-23(22)27/h5-10,16,18H,2-4,11-15,17H2,1H3/t18-/m1/s1	Proc-22I|(R)-4-(2,4-Difluorobenzoyl)-1-(4-(3-(2-Methylpyrrolidin-1-Yl)Propoxy)Phenyl)Piperazin-2-One Formic Acid	4-(2,4-difluorobenzoyl)-1-[4-[3-[(2R)-2-methylpyrrolidin-1-yl]propoxy]phenyl]piperazin-2-one	C[C@@H]1CCCN1CCCOc1ccc(N2CCN(C(=O)c3ccc(F)cc3F)CC2=O)cc1	12001199.0	R26_chico_2009:323	-0.6	A	BBB+	A	training
InChI=1S/C25H29FN2O2/c1-17-25(22-10-9-21(30-2)16-23(22)27-17)19-11-14-28(15-12-19)13-3-4-24(29)18-5-7-20(26)8-6-18/h5-10,16,19,27H,3-4,11-15H2,1-2H3	Mindoperone	1-(4-fluorophenyl)-4-[4-(6-methoxy-2-methyl-1H-indol-3-yl)piperidin-1-yl]butan-1-one	COc1ccc2c(C3CCN(CCCC(=O)c4ccc(F)cc4)CC3)c(C)[nH]c2c1	172296.0	R6_adenot_2004:1184			BBB+	C	training
InChI=1S/C25H29I2NO3/c1-4-7-11-22-23(18-10-8-9-12-21(18)31-22)24(29)17-15-19(26)25(20(27)16-17)30-14-13-28(5-2)6-3/h8-10,12,15-16H,4-7,11,13-14H2,1-3H3	Amiodarone|Amiodarone Hydrochloride	(2-butyl-1-benzofuran-3-yl)-[4-[2-(diethylamino)ethoxy]-3,5-diiodophenyl]methanone	CCCCc1oc2ccccc2c1C(=O)c1cc(I)c(OCCN(CC)CC)c(I)c1	2157.0	R6_adenot_2004:5|R7_andres_2006:8|R14_ghose_2012:346|R23_gupta_2019:346|R26_chico_2009:29|R29_subramanian_2003:7|R51_doninger_2002:7	-1.08	A	BBB-	A	training
InChI=1S/C25H30ClN3O3S/c26-20-3-1-5-23(17-20)32-22-10-15-28(16-11-22)14-9-21-4-2-13-29(21)33(30,31)24-7-6-19-8-12-27-25(19)18-24/h1,3,5-8,12,17-18,21-22,27H,2,4,9-11,13-16H2			O=S(=O)(c1ccc2cc[nH]c2c1)N1CCCC1CCN1CCC(Oc2cccc(Cl)c2)CC1		R46_mendoza_valencia_2017:352	-0.04	A	BBB+	A	training
InChI=1S/C25H30ClN3O3S/c26-20-4-6-22(7-5-20)32-23-11-16-28(17-12-23)15-10-21-2-1-14-29(21)33(30,31)24-8-3-19-9-13-27-25(19)18-24/h3-9,13,18,21,23,27H,1-2,10-12,14-17H2	Sb 656104A|6-[2-[2-[4-(4-Chlorophenoxy)Piperidin-1-Yl]Ethyl]Pyrrolidin-1-Yl]Sulfonyl-1H-Indole	6-[2-[2-[4-(4-chlorophenoxy)piperidin-1-yl]ethyl]pyrrolidin-1-yl]sulfonyl-1H-indole	O=S(=O)(c1ccc2cc[nH]c2c1)N1CCCC1CCN1CCC(Oc2ccc(Cl)cc2)CC1	56947090.0	R26_chico_2009:368	-0.1	A	BBB+	A	training
InChI=1S/C25H30ClN3O3S/c26-20-4-6-22(7-5-20)32-23-11-16-28(17-12-23)15-10-21-2-1-14-29(21)33(30,31)24-8-3-19-9-13-27-25(19)18-24/h3-9,13,18,21,23,27H,1-2,10-12,14-17H2/t21-/m1/s1	Sb-656104-A|6-[(2R)-2-[2-[4-(4-Chlorophenoxy)Piperidin-1-Yl]Ethyl]Pyrrolidin-1-Yl]Sulfonyl-1H-Indole	6-[(2R)-2-[2-[4-(4-chlorophenoxy)piperidin-1-yl]ethyl]pyrrolidin-1-yl]sulfonyl-1H-indole	O=S(=O)(c1ccc2cc[nH]c2c1)N1CCC[C@@H]1CCN1CCC(Oc2ccc(Cl)cc2)CC1	10028436.0	R25_brito_sanchez_2015:415|R47_radchenko_2020:305	-0.04	B1	BBB+	A	training
InChI=1S/C25H30FN3O3/c26-21-7-5-20(6-8-21)25(31)28-16-17-29(24(30)19-28)22-9-11-23(12-10-22)32-18-4-15-27-13-2-1-3-14-27/h5-12H,1-4,13-19H2	Proc-19D|4-(4-Fluorobenzoyl)-1-[4-(3-Piperidin-1-Ylpropoxy)Phenyl]Piperazin-2-One	4-(4-fluorobenzoyl)-1-[4-(3-piperidin-1-ylpropoxy)phenyl]piperazin-2-one	O=C(c1ccc(F)cc1)N1CCN(c2ccc(OCCCN3CCCCC3)cc2)C(=O)C1	15986917.0	R26_chico_2009:321	-0.46	A	BBB+	A	training
InChI=1S/C25H30FNO6/c1-13-27-25(20(31)12-32-14(2)28)21(33-13)10-18-17-6-5-15-9-16(29)7-8-22(15,3)24(17,26)19(30)11-23(18,25)4/h7-9,17-19,21,30H,5-6,10-12H2,1-4H3/t17-,18-,19-,21+,22-,23-,24-,25+/m0/s1	Fluazacort	[2-[(1S,2S,4R,8S,9S,11S,12R,13S)-12-fluoro-11-hydroxy-6,9,13-trimethyl-16-oxo-5-oxa-7-azapentacyclo[10.8.0.02,9.04,8.013,18]icosa-6,14,17-trien-8-yl]-2-oxoethyl] acetate	CC(=O)OCC(=O)[C@@]12N=C(C)O[C@@H]1C[C@H]1[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]12C	10072906.0	R6_adenot_2004:835			BBB+	C	training
InChI=1S/C25H30N2O5/c1-3-32-25(31)21(14-13-18-9-5-4-6-10-18)26-17(2)23(28)27-16-20-12-8-7-11-19(20)15-22(27)24(29)30/h4-12,17,21-22,26H,3,13-16H2,1-2H3,(H,29,30)/t17-,21-,22-/m0/s1	Quinapril	(3S)-2-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-3,4-dihydro-1H-isoquinoline-3-carboxylic acid	CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1Cc2ccccc2C[C@H]1C(=O)O	54892.0	R14_ghose_2012:810|R23_gupta_2019:870			BBB-	C	training
InChI=1S/C25H30N3/c1-26(2)22-13-7-19(8-14-22)25(20-9-15-23(16-10-20)27(3)4)21-11-17-24(18-12-21)28(5)6/h7-18H,1-6H3/q+1	Gentian Violet|Gentian Violet Cation	[4-[bis[4-(dimethylamino)phenyl]methylidene]cyclohexa-2,5-dien-1-ylidene]-dimethylazanium	CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2ccc(N(C)C)cc2)cc1	3468.0	R23_gupta_2019:631			BBB-	C	training
InChI=1S/C25H30N4O9S2/c1-24(2)17(29-20(32)16(21(29)39-24)27-19(31)15(26)12-8-6-5-7-9-12)22(33)37-11-38-23(34)18-25(3,4)40(35,36)14-10-13(30)28(14)18/h5-9,14-18,21H,10-11,26H2,1-4H3,(H,27,31)/t14-,15-,16-,17+,18+,21-/m1/s1	Sultamicillin	[(2S,5R)-3,3-dimethyl-4,4,7-trioxo-4lambda6-thia-1-azabicyclo[3.2.0]heptane-2-carbonyl]oxymethyl (2S,5R,6R)-6-[[(2R)-2-amino-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate	CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccccc3)C(=O)N2[C@H]1C(=O)OCOC(=O)[C@@H]1N2C(=O)C[C@H]2S(=O)(=O)C1(C)C	444022.0	R6_adenot_2004:272|R14_ghose_2012:870			BBB-	C	training
InChI=1S/C25H30N6O2/c1-17(2)26-8-9-31(20-10-21(32-4)13-22(11-20)33-5)19-6-7-23-24(12-19)29-25(15-27-23)18-14-28-30(3)16-18/h6-7,10-17,26H,8-9H2,1-5H3	Erdafitinib	N'-(3,5-dimethoxyphenyl)-N'-[3-(1-methylpyrazol-4-yl)quinoxalin-6-yl]-N-propan-2-ylethane-1,2-diamine	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1	67462786.0	R23_gupta_2019:1060			BBB-	C	training
InChI=1S/C25H30NO3/c27-24(25(28,19-9-3-1-4-10-19)20-11-5-2-6-12-20)29-23-17-21-13-14-22(18-23)26(21)15-7-8-16-26/h1-6,9-12,21-23,28H,7-8,13-18H2/q+1/t21-,22+,23?	Trospium	[(1S,5R)-spiro[8-azoniabicyclo[3.2.1]octane-8,1'-azolidin-1-ium]-3-yl] 2-hydroxy-2,2-diphenylacetate	O=C(OC1C[C@H]2CC[C@@H](C1)[N+]21CCCC1)C(O)(c1ccccc1)c1ccccc1	5284632.0	R23_gupta_2019:320			BBB+	C	training
InChI=1S/C25H31ClF2O5S/c1-5-20(31)33-25(21(32)34-12-26)13(2)8-15-16-10-18(27)17-9-14(29)6-7-22(17,3)24(16,28)19(30)11-23(15,25)4/h6-7,9,13,15-16,18-19,30H,5,8,10-12H2,1-4H3/t13-,15+,16+,18+,19+,22+,23+,24+,25+/m1/s1	Cloticasone-Propionate|Cloticasone Propionate	[(6S,8S,9R,10S,11S,13S,14S,16R,17R)-17-(chloromethylsulfanylcarbonyl)-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate	CCC(=O)O[C@]1(C(=O)SCCl)[C@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C	9936383.0	R6_adenot_2004:793			BBB+	C	training
InChI=1S/C25H31ClN4O2/c1-5-27-14-19-6-8-20(9-7-19)25(31)28-24-12-18(4)30(29-24)15-21-13-22(26)10-11-23(21)32-16-17(2)3/h6-13,17,27H,5,14-16H2,1-4H3,(H,28,29,31)	Compound-4H|N-[1-[[5-Chloro-2-(2-Methylpropoxy)Phenyl]Methyl]-5-Methylpyrazol-3-Yl]-4-(Ethylaminomethyl)Benzamide	N-[1-[[5-chloro-2-(2-methylpropoxy)phenyl]methyl]-5-methylpyrazol-3-yl]-4-(ethylaminomethyl)benzamide	CCNCc1ccc(C(=O)Nc2cc(C)n(Cc3cc(Cl)ccc3OCC(C)C)n2)cc1	24894000.0	R26_chico_2009:131	-0.05	A	BBB+	A	test
InChI=1S/C25H31F3O5S/c1-5-20(31)33-25(21(32)34-12-26)13(2)8-15-16-10-18(27)17-9-14(29)6-7-22(17,3)24(16,28)19(30)11-23(15,25)4/h6-7,9,13,15-16,18-19,30H,5,8,10-12H2,1-4H3/t13-,15+,16+,18+,19+,22+,23+,24+,25+/m1/s1	Fluticasone-Propionate|Fluticasone Propionate	[(6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-17-(fluoromethylsulfanylcarbonyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate	CCC(=O)O[C@]1(C(=O)SCF)[C@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C	444036.0	R6_adenot_2004:859			BBB+	C	training
InChI=1S/C25H31FN6O2/c1-3-23(33)32(22-13-9-8-12-21(22)26)25(20-10-6-5-7-11-20)14-16-29(17-15-25)18-19-31-24(34)30(4-2)27-28-31/h5-13H,3-4,14-19H2,1-2H3	Trefentanil	N-[1-[2-(4-ethyl-5-oxotetrazol-1-yl)ethyl]-4-phenylpiperidin-4-yl]-N-(2-fluorophenyl)propanamide	CCC(=O)N(c1ccccc1F)C1(c2ccccc2)CCN(CCn2nnn(CC)c2=O)CC1	60728.0	R6_adenot_2004:1001			BBB+	C	training
InChI=1S/C25H31N3O4/c1-4-32-25(29)24-19(20-16-22(30-2)23(31-3)17-21(20)26-24)10-11-27-12-14-28(15-13-27)18-8-6-5-7-9-18/h5-9,16-17,26H,4,10-15H2,1-3H3	Alpertine	ethyl 5,6-dimethoxy-3-[2-(4-phenylpiperazin-1-yl)ethyl]-1H-indole-2-carboxylate	CCOC(=O)c1[nH]c2cc(OC)c(OC)cc2c1CCN1CCN(c2ccccc2)CC1	166547.0	R6_adenot_2004:1413			BBB+	C	training
InChI=1S/C25H31NO/c1-24(2,3)25(27)13-14-26-16-21-19-9-5-4-7-17(19)11-12-18-8-6-10-20(23(18)21)22(26)15-25/h4-10,21-22,27H,11-16H2,1-3H3/t21-,22-,25-/m0/s1	Butaclamol	(1S,6S,8S)-6-tert-butyl-3-azapentacyclo[11.8.1.03,8.09,22.016,21]docosa-9,11,13(22),16,18,20-hexaen-6-ol	CC(C)(C)[C@]1(O)CCN2C[C@H]3c4ccccc4CCc4cccc(c43)[C@@H]2C1	37459.0	R6_adenot_2004:1125			BBB+	C	test
InChI=1S/C25H31NO6/c1-13-26-25(20(30)12-31-14(2)27)21(32-13)10-18-17-6-5-15-9-16(28)7-8-23(15,3)22(17)19(29)11-24(18,25)4/h7-9,17-19,21-22,29H,5-6,10-12H2,1-4H3/t17-,18-,19-,21+,22+,23-,24-,25+/m0/s1	Deflazacort	[2-[(1S,2S,4R,8S,9S,11S,12S,13R)-11-hydroxy-6,9,13-trimethyl-16-oxo-5-oxa-7-azapentacyclo[10.8.0.02,9.04,8.013,18]icosa-6,14,17-trien-8-yl]-2-oxoethyl] acetate	CC(=O)OCC(=O)[C@@]12N=C(C)O[C@@H]1C[C@H]1[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]12C	189821.0	R6_adenot_2004:810			BBB+	C	training
InChI=1S/C25H32ClFO5/c1-5-21(31)32-25(20(30)13-26)14(2)10-18-17-7-6-15-11-16(28)8-9-22(15,3)24(17,27)19(29)12-23(18,25)4/h8-9,11,14,17-19,29H,5-7,10,12-13H2,1-4H3/t14-,17-,18-,19-,22-,23-,24-,25-/m0/s1	Clobetasol-Propionate|Clobetasol Propionate	[(8S,9R,10S,11S,13S,14S,16S,17R)-17-(2-chloroacetyl)-9-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate	CCC(=O)O[C@]1(C(=O)CCl)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C	32798.0	R6_adenot_2004:788			BBB+	C	training
InChI=1S/C25H32ClN5O2/c1-2-24-27-31(25(32)30(24)18-19-33-23-10-4-3-5-11-23)13-7-12-28-14-16-29(17-15-28)22-9-6-8-21(26)20-22/h3-6,8-11,20H,2,7,12-19H2,1H3	Nefazodone	2-[3-[4-(3-chlorophenyl)piperazin-1-yl]propyl]-5-ethyl-4-(2-phenoxyethyl)-1,2,4-triazol-3-one	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	4449.0	R6_adenot_2004:583|R14_ghose_2012:164|R23_gupta_2019:163|R26_chico_2009:282			BBB+	C	training
InChI=1S/C25H32ClN5OS/c1-27-11-17-30(25(27)32)18-16-29-14-12-28(13-15-29)9-4-10-31-21-5-2-3-6-23(21)33-24-8-7-20(26)19-22(24)31/h2-3,5-8,19H,4,9-18H2,1H3	Imiclopazine	1-[2-[4-[3-(2-chlorophenothiazin-10-yl)propyl]piperazin-1-yl]ethyl]-3-methylimidazolidin-2-one	CN1CCN(CCN2CCN(CCCN3c4ccccc4Sc4ccc(Cl)cc43)CC2)C1=O	23896.0	R6_adenot_2004:1579			BBB+	C	training
InChI=1S/C25H32F2O5S/c1-6-20(30)32-25(21(31)33-5)13(2)9-15-16-11-18(26)17-10-14(28)7-8-22(17,3)24(16,27)19(29)12-23(15,25)4/h7-8,10,13,15-16,18-19,29H,6,9,11-12H2,1-5H3/t13-,15+,16+,18+,19+,22+,23+,24+,25+/m1/s1	Ticabesone-Propionate|Ticabesone Propionate	[(6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-17-methylsulfanylcarbonyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate	CCC(=O)O[C@]1(C(=O)SC)[C@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C	11317660.0	R6_adenot_2004:906			BBB+	C	training
InChI=1S/C25H32F3N3O4/c1-17(30-8-12-34-21-5-2-3-6-22(21)35-16-25(26,27)28)13-18-14-19-7-10-31(9-4-11-32)23(19)20(15-18)24(29)33/h2-3,5-6,14-15,17,30,32H,4,7-13,16H2,1H3,(H2,29,33)/t17-/m1/s1	Silodosin	1-(3-hydroxypropyl)-5-[(2R)-2-[2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethylamino]propyl]-2,3-dihydroindole-7-carboxamide	C[C@H](Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2)NCCOc1ccccc1OCC(F)(F)F	5312125.0	R23_gupta_2019:910			BBB-	C	training
InChI=1S/C25H32N2O/c28-25(23-11-10-22-8-4-5-15-26-24(22)18-23)12-9-20-13-16-27(17-14-20)19-21-6-2-1-3-7-21/h1-3,6-7,10-11,18,20,26H,4-5,8-9,12-17,19H2	142852-50-4|Zanapezil|Tak-147	3-(1-benzylpiperidin-4-yl)-1-(2,3,4,5-tetrahydro-1H-1-benzazepin-8-yl)propan-1-one	O=C(CCC1CCN(Cc2ccccc2)CC1)c1ccc2c(c1)NCCCC2	198752.0	R4_mente_2005:75|R21_muehlbacher_2011:304|R25_brito_sanchez_2015:322|R40_vilar_2010:264|R46_mendoza_valencia_2017:283|R47_radchenko_2020:369	1.14	B	BBB+	A	training
InChI=1S/C25H32N2O2/c1-21(20-26-16-18-29-19-17-26)25(22-10-4-2-5-11-22,23-12-6-3-7-13-23)24(28)27-14-8-9-15-27/h2-7,10-13,21H,8-9,14-20H2,1H3	Racemoramide	3-methyl-4-morpholin-4-yl-2,2-diphenyl-1-pyrrolidin-1-ylbutan-1-one	CC(CN1CCOCC1)C(C(=O)N1CCCC1)(c1ccccc1)c1ccccc1	9648.0	R6_adenot_2004:1083			BBB+	C	training
InChI=1S/C25H32N2O2/c1-21(20-26-16-18-29-19-17-26)25(22-10-4-2-5-11-22,23-12-6-3-7-13-23)24(28)27-14-8-9-15-27/h2-7,10-13,21H,8-9,14-20H2,1H3/t21-/m0/s1	Levomoramide	(3R)-3-methyl-4-morpholin-4-yl-2,2-diphenyl-1-pyrrolidin-1-ylbutan-1-one	C[C@@H](CN1CCOCC1)C(C(=O)N1CCCC1)(c1ccccc1)c1ccccc1	10453145.0	R6_adenot_2004:1050			BBB+	C	training
InChI=1S/C25H32N2O2/c1-21(20-26-16-18-29-19-17-26)25(22-10-4-2-5-11-22,23-12-6-3-7-13-23)24(28)27-14-8-9-15-27/h2-7,10-13,21H,8-9,14-20H2,1H3/t21-/m1/s1	Dextromoramide	(3S)-3-methyl-4-morpholin-4-yl-2,2-diphenyl-1-pyrrolidin-1-ylbutan-1-one	C[C@H](CN1CCOCC1)C(C(=O)N1CCCC1)(c1ccccc1)c1ccccc1	92943.0	R6_adenot_2004:1025|R14_ghose_2012:68|R23_gupta_2019:63			BBB+	C	training
InChI=1S/C25H32N2O3/c1-4-23(28)27(22-13-9-6-10-14-22)25(24(29)30-3)16-18-26(19-20(25)2)17-15-21-11-7-5-8-12-21/h5-14,20H,4,15-19H2,1-3H3/t20-,25+/m1/s1	Lofentanil	methyl (3R,4S)-3-methyl-1-(2-phenylethyl)-4-(N-propanoylanilino)piperidine-4-carboxylate	CCC(=O)N(c1ccccc1)[C@@]1(C(=O)OC)CCN(CCc2ccccc2)C[C@H]1C	10070040.0	R6_adenot_2004:1054			BBB+	C	training
InChI=1S/C25H32N4O2S/c1-2-19-32-23-12-6-5-11-22(23)28-17-15-27(16-18-28)13-7-8-14-29-24(30)20-9-3-4-10-21(20)26-25(29)31/h3-6,9-12H,2,7-8,13-19H2,1H3,(H,26,31)	Tioperidone	3-[4-[4-(2-propylsulfanylphenyl)piperazin-1-yl]butyl]-1H-quinazoline-2,4-dione	CCCSc1ccccc1N1CCN(CCCCn2c(=O)[nH]c3ccccc3c2=O)CC1	40460.0	R6_adenot_2004:1230			BBB+	C	training
InChI=1S/C25H32N4O3S2/c1-17-18(2)33-25(28-17)29(34(4,30)31)21-12-13-23(32-3)20(15-21)16-27-22-11-8-14-26-24(22)19-9-6-5-7-10-19/h5-7,9-10,12-13,15,22,24,26-27H,8,11,14,16H2,1-4H3	164352-88-9|Pfizer Compound 18|N-(4,5-Dimethyl-1,3-Thiazol-2-Yl)-N-[4-Methoxy-3-[[(2-Phenylpiperidin-3-Yl)Amino]Methyl]Phenyl]Methanesulfonamide	N-(4,5-dimethyl-1,3-thiazol-2-yl)-N-[4-methoxy-3-[[(2-phenylpiperidin-3-yl)amino]methyl]phenyl]methanesulfonamide	COc1ccc(N(c2nc(C)c(C)s2)S(C)(=O)=O)cc1CNC1CCCNC1c1ccccc1	19696689.0	R4_mente_2005:93|R25_brito_sanchez_2015:544|R40_vilar_2010:191|R46_mendoza_valencia_2017:455|R47_radchenko_2020:387	-0.37	B	BBB+	A	test
InChI=1S/C25H32O2/c1-3-25(26)15-13-23-22-10-8-17-16-19(27-18-6-4-5-7-18)9-11-20(17)21(22)12-14-24(23,25)2/h1,9,11,16,18,21-23,26H,4-8,10,12-15H2,2H3/t21-,22-,23+,24+,25+/m1/s1	Quinestrol	(8R,9S,13S,14S,17R)-3-cyclopentyloxy-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-ol	C#C[C@]1(O)CC[C@H]2[C@@H]3CCc4cc(OC5CCCC5)ccc4[C@H]3CC[C@@]21C	9046.0	R14_ghose_2012:811|R23_gupta_2019:871			BBB-	C	training
InChI=1S/C25H32O8/c1-23-9-7-15(26)11-14(23)3-4-16-17-8-10-25(32,24(17,2)12-18(27)22(16)23)19(28)13-33-21(31)6-5-20(29)30/h7,9,11,16-18,22,27,32H,3-6,8,10,12-13H2,1-2H3,(H,29,30)/t16-,17-,18-,22+,23-,24-,25-/m0/s1	Prednisolone-Hemisuccinate|Prednisolone Hemisuccinate	4-[2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethoxy]-4-oxobutanoic acid	C[C@]12C=CC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)COC(=O)CCC(=O)O	656804.0	R6_adenot_2004:895			BBB+	C	training
InChI=1S/C25H33N3O/c1-3-11-28-23-7-6-20(25(29)27-13-8-18(2)9-14-27)15-21(23)22-17-26(12-10-24(22)28)16-19-4-5-19/h3,6-7,15,18-19H,1,4-5,8-14,16-17H2,2H3	5|5-Allyl-2-(Cyclopropylmethyl)-8-[(4-Methylpiperidin-1-Yl)Carbonyl]-2,3,4,5-Tetrahydro-1H-Pyrido[4,3-B]Indole	[2-(cyclopropylmethyl)-5-prop-2-enyl-3,4-dihydro-1H-pyrido[4,3-b]indol-8-yl]-(4-methylpiperidin-1-yl)methanone	C=CCn1c2c(c3cc(C(=O)N4CCC(C)CC4)ccc31)CN(CC1CC1)CC2	11502034.0	R25_brito_sanchez_2015:530|R46_mendoza_valencia_2017:444	-0.13	B	BBB+	A	training
InChI=1S/C25H33NO4/c1-5-8-22(2,28)17-14-23-9-10-25(17,29-4)21-24(23)11-12-26(3)18(23)13-15-6-7-16(27)20(30-21)19(15)24/h6-7,9-10,17-18,21,27-28H,5,8,11-14H2,1-4H3/t17-,18-,21-,22-,23-,24+,25-/m1/s1	Etorphine	(1R,2S,6R,14R,15R,19R)-19-[(2R)-2-hydroxypentan-2-yl]-15-methoxy-5-methyl-13-oxa-5-azahexacyclo[13.2.2.12,8.01,6.02,14.012,20]icosa-8(20),9,11,16-tetraen-11-ol	CCC[C@@](C)(O)[C@H]1C[C@@]23C=C[C@]1(OC)[C@@H]1Oc4c(O)ccc5c4[C@@]12CCN(C)[C@@H]3C5	644209.0	R6_adenot_2004:1036			BBB+	C	training
InChI=1S/C25H34F2O5/c1-18(2)32-24(30)13-9-4-3-8-12-20-21(23(29)16-22(20)28)14-15-25(26,27)17-31-19-10-6-5-7-11-19/h3,5-8,10-11,14-15,18,20-23,28-29H,4,9,12-13,16-17H2,1-2H3/b8-3-,15-14+/t20-,21-,22+,23-/m1/s1	Tafluprost	propan-2-yl (Z)-7-[(1R,2R,3R,5S)-2-[(E)-3,3-difluoro-4-phenoxybut-1-enyl]-3,5-dihydroxycyclopentyl]hept-5-enoate	CC(C)OC(=O)CCC/C=C\C[C@@H]1[C@@H](/C=C/C(F)(F)COc2ccccc2)[C@H](O)C[C@@H]1O	9868491.0	R23_gupta_2019:949			BBB-	C	training
InChI=1S/C25H34F2O6/c1-4-5-21-32-20-10-14-15-9-17(26)16-8-13(29)6-7-22(16,2)24(15,27)18(30)11-23(14,3)25(20,33-21)19(31)12-28/h8,14-15,17-18,20-21,28,30H,4-7,9-12H2,1-3H3/t14-,15-,17-,18-,20+,21+,22-,23-,24-,25+/m0/s1	Rofleponide	(1S,2S,4R,6R,8S,9S,11S,12R,13S,19S)-12,19-difluoro-11-hydroxy-8-(2-hydroxyacetyl)-9,13-dimethyl-6-propyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icos-17-en-16-one	CCC[C@@H]1O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)CC[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1	3055174.0	R6_adenot_2004:830			BBB+	C	training
InChI=1S/C25H34O6/c1-7-12(2)22(29)31-21-13(3)10-24-14(4)8-17-18(23(17,5)6)16(20(24)28)9-15(11-26)19(27)25(21,24)30/h7,9-10,14,16-19,21,26-27,30H,8,11H2,1-6H3/b12-7-/t14-,16+,17-,18+,19-,21+,24+,25+/m1/s1	Ingenol Mebutate	[(1S,4S,5S,6R,9S,10R,12R,14R)-5,6-dihydroxy-7-(hydroxymethyl)-3,11,11,14-tetramethyl-15-oxo-4-tetracyclo[7.5.1.01,5.010,12]pentadeca-2,7-dienyl] (Z)-2-methylbut-2-enoate	C/C=C(/C)C(=O)O[C@H]1C(C)=C[C@]23C(=O)[C@@H](C=C(CO)[C@@H](O)[C@]12O)[C@H]1[C@@H](C[C@H]3C)C1(C)C	6918670.0	R23_gupta_2019:678			BBB-	C	training
InChI=1S/C25H34O8/c1-23-9-7-15(26)11-14(23)3-4-16-17-8-10-25(32,24(17,2)12-18(27)22(16)23)19(28)13-33-21(31)6-5-20(29)30/h11,16-18,22,27,32H,3-10,12-13H2,1-2H3,(H,29,30)/t16-,17-,18-,22+,23-,24-,25-/m0/s1	Hydrocortisone-Hemisuccinate|Hydrocortisone Hemisuccinate	4-[2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-oxoethoxy]-4-oxobutanoic acid	C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)COC(=O)CCC(=O)O	16623.0	R6_adenot_2004:802			BBB+	C	training
InChI=1S/C25H35N3O/c1-16(2)28-15-17-13-23-21(20-10-7-11-22(28)24(17)20)12-18(14-27(23)3)25(29)26-19-8-5-4-6-9-19/h7,10-11,15-16,18-19,21,23H,4-6,8-9,12-14H2,1-3H3,(H,26,29)/t18-,21-,23-/m1/s1	Amesergide	(6aR,9R,10aR)-N-cyclohexyl-7-methyl-4-propan-2-yl-6,6a,8,9,10,10a-hexahydroindolo[4,3-fg]quinoline-9-carboxamide	CC(C)n1cc2c3c(cccc31)[C@H]1C[C@@H](C(=O)NC3CCCCC3)CN(C)[C@@H]1C2	9821951.0	R6_adenot_2004:639			BBB+	C	training
InChI=1S/C25H35N3O4S/c1-3-33(30,31)28-23-5-4-19(25(29)26-11-6-18(2)7-12-26)16-21(23)22-17-27(13-8-24(22)28)20-9-14-32-15-10-20/h4-5,16,18,20H,3,6-15,17H2,1-2H3	29|Unii-4L8Eg56Vda	[5-ethylsulfonyl-2-(oxan-4-yl)-3,4-dihydro-1H-pyrido[4,3-b]indol-8-yl]-(4-methylpiperidin-1-yl)methanone	CCS(=O)(=O)n1c2c(c3cc(C(=O)N4CCC(C)CC4)ccc31)CN(C1CCOCC1)CC2	24894028.0	R25_brito_sanchez_2015:531|R46_mendoza_valencia_2017:445	-1.15	B	BBB-	A	training
InChI=1S/C25H35N3O6S/c1-18(2)15-28(35(31,32)22-10-8-20(26)9-11-22)16-24(29)23(14-19-6-4-3-5-7-19)27-25(30)34-21-12-13-33-17-21/h3-11,18,21,23-24,29H,12-17,26H2,1-2H3,(H,27,30)/t21-,23+,24-/m1/s1	[(3R)-Oxolan-3-Yl] N-[(2S,3R)-4-[(4-Aminophenyl)Sulfonyl-(2-Methylpropyl)Amino]-3-Hydroxy-1-Phenylbutan-2-Yl]Carbamate	[(3R)-oxolan-3-yl] N-[(2S,3R)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]carbamate	CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@@H]1CCOC1)S(=O)(=O)c1ccc(N)cc1	10885665.0	R46_mendoza_valencia_2017:123	-0.56	A	BBB+	A	training
InChI=1S/C25H35N3O6S/c1-18(2)15-28(35(31,32)22-10-8-20(26)9-11-22)16-24(29)23(14-19-6-4-3-5-7-19)27-25(30)34-21-12-13-33-17-21/h3-11,18,21,23-24,29H,12-17,26H2,1-2H3,(H,27,30)/t21-,23-,24+/m0/s1	161814-49-9|Amprenavir	[(3S)-oxolan-3-yl] N-[(2S,3R)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]carbamate	CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CCOC1)S(=O)(=O)c1ccc(N)cc1	65016.0	R4_mente_2005:36|R14_ghose_2012:352|R21_muehlbacher_2011:264|R23_gupta_2019:349|R25_brito_sanchez_2015:125|R34_broccatelli_2012:105|R40_vilar_2010:37|R47_radchenko_2020:364	-0.56	B	BBB+	A	training
InChI=1S/C25H35NO5/c1-6-26(19(2)17-20-9-12-22(28-3)13-10-20)15-7-8-16-31-25(27)21-11-14-23(29-4)24(18-21)30-5/h9-14,18-19H,6-8,15-17H2,1-5H3	Mebeverine	4-[ethyl-[1-(4-methoxyphenyl)propan-2-yl]amino]butyl 3,4-dimethoxybenzoate	CCN(CCCCOC(=O)c1ccc(OC)c(OC)c1)C(C)Cc1ccc(OC)cc1	4031.0	R14_ghose_2012:665			BBB-	C	training
InChI=1S/C25H36N3O9PS/c1-18(2)15-28(39(33,34)22-10-8-20(26)9-11-22)16-24(37-38(30,31)32)23(14-19-6-4-3-5-7-19)27-25(29)36-21-12-13-35-17-21/h3-11,18,21,23-24H,12-17,26H2,1-2H3,(H,27,29)(H2,30,31,32)/t21-,23-,24+/m0/s1	Fosamprenavir	[(3S)-oxolan-3-yl] N-[(2S,3R)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-1-phenyl-3-phosphonooxybutan-2-yl]carbamate	CC(C)CN(C[C@@H](OP(=O)(O)O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CCOC1)S(=O)(=O)c1ccc(N)cc1	131536.0	R14_ghose_2012:578|R23_gupta_2019:612			BBB-	C	training
InChI=1S/C25H36N6O3/c1-17(32)31-12-6-19(7-13-31)16-34-24-21(23(33)27-2)22(29-20(14-26)30-24)28-15-18-4-10-25(11-5-18)8-3-9-25/h18-19H,3-13,15-16H2,1-2H3,(H,27,33)(H,28,29,30)	Irie-16C|4-((1-Acetylpiperidin-4-Yl)Methoxy)-2-Cyano-N-Methyl-6-(Spiro[3.5]Nonan-7-Ylmethylamino)Pyrimidine-5-Carboxamide	4-[(1-acetylpiperidin-4-yl)methoxy]-2-cyano-N-methyl-6-(spiro[3.5]nonan-7-ylmethylamino)pyrimidine-5-carboxamide	CNC(=O)c1c(NCC2CCC3(CCC3)CC2)nc(C#N)nc1OCC1CCN(C(C)=O)CC1	44579173.0	R26_chico_2009:227	-0.79	A	BBB+	A	training
InChI=1S/C25H36N6O4S/c1-5-8-20-22-23(31(4)29-20)25(32)28-24(27-22)19-16-18(10-11-21(19)35-15-6-2)36(33,34)26-13-12-17-9-7-14-30(17)3/h10-11,16-17,26H,5-9,12-15H2,1-4H3,(H,27,28,32)	Udenafil	3-(1-methyl-7-oxo-3-propyl-6H-pyrazolo[4,3-d]pyrimidin-5-yl)-N-[2-(1-methylpyrrolidin-2-yl)ethyl]-4-propoxybenzenesulfonamide	CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc2c(CCC)nn(C)c2c(=O)[nH]1	135413547.0	R23_gupta_2019:1011			BBB-	C	training
InChI=1S/C25H36O5/c1-15(26)19-6-7-20-18-5-4-16-14-17(30-23(29)9-8-22(27)28)10-12-24(16,2)21(18)11-13-25(19,20)3/h4,17-21H,5-14H2,1-3H3,(H,27,28)/t17-,18+,19+,20-,21+,24-,25+/m0/s1	Pregnenolone-Succinate	4-[[(3S,8R,9R,10R,13S,14S,17S)-17-acetyl-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-4-oxobutanoic acid	CC(=O)[C@H]1CC[C@H]2[C@H]3CC=C4C[C@@H](OC(=O)CCC(=O)O)CC[C@]4(C)[C@@H]3CC[C@]12C	51413113.0	R6_adenot_2004:897			BBB+	C	training
InChI=1S/C25H36O6/c1-4-5-21(30)31-25(20(29)14-26)11-9-18-17-7-6-15-12-16(27)8-10-23(15,2)22(17)19(28)13-24(18,25)3/h12,17-19,22,26,28H,4-11,13-14H2,1-3H3/t17-,18-,19-,22+,23-,24-,25-/m0/s1	Hydrocortisone-Butyrate|Hydrocortisone Butyrate	[(8S,9S,10R,11S,13S,14S,17R)-11-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] butanoate	CCCC(=O)O[C@]1(C(=O)CO)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C	26133.0	R6_adenot_2004:800			BBB+	C	training
InChI=1S/C25H37NO4/c27-20-23-18-22(13-14-24(23)28)25(29)19-26-15-7-1-2-8-16-30-17-9-6-12-21-10-4-3-5-11-21/h3-5,10-11,13-14,18,25-29H,1-2,6-9,12,15-17,19-20H2	Salmeterol	2-(hydroxymethyl)-4-[1-hydroxy-2-[6-(4-phenylbutoxy)hexylamino]ethyl]phenol	OCc1cc(C(O)CNCCCCCCOCCCCc2ccccc2)ccc1O	5152.0	R23_gupta_2019:899			BBB-	C	training
InChI=1S/C25H38O5/c1-6-25(4,5)24(28)30-21-12-15(2)11-17-8-7-16(3)20(23(17)21)10-9-19-13-18(26)14-22(27)29-19/h7-8,11,15-16,18-21,23,26H,6,9-10,12-14H2,1-5H3/t15-,16-,18+,19+,20-,21-,23-/m0/s1	Simvastatin	[(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] 2,2-dimethylbutanoate	CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21	54454.0	R6_adenot_2004:1407|R14_ghose_2012:843|R26_chico_2009:379|R50_sobanska_2019:100	-0.01	A	BBB+	A	training
InChI=1S/C25H40O6/c1-6-25(4,5)24(30)31-21-12-15(2)11-17-8-7-16(3)20(23(17)21)10-9-18(26)13-19(27)14-22(28)29/h7-8,11,15-16,18-21,23,26-27H,6,9-10,12-14H2,1-5H3,(H,28,29)/t15-,16-,18+,19+,20-,21-,23-/m0/s1	Simvastatin Acid	(3R,5R)-7-[(1S,2S,6R,8S,8aR)-8-(2,2-dimethylbutanoyloxy)-2,6-dimethyl-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid	CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(=O)O)[C@H]21	64718.0	R34_broccatelli_2012:85			BBB+	C	test
InChI=1S/C25H43NO18/c1-6-11(26-8-2-7(3-27)12(30)15(33)13(8)31)14(32)19(37)24(40-6)43-22-10(5-29)42-25(20(38)17(22)35)44-21-9(4-28)41-23(39)18(36)16(21)34/h2,6,8-39H,3-5H2,1H3/t6-,8+,9-,10-,11-,12-,13+,14+,15+,16-,17-,18-,19-,20-,21-,22-,23?,24-,25-/m1/s1	Acarbose|Glucobay	(3R,4R,5S,6R)-5-[(2R,3R,4R,5S,6R)-5-[(2R,3R,4S,5S,6R)-3,4-dihydroxy-6-methyl-5-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino]oxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-(hydroxymethyl)oxane-2,3,4-triol	C[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@@H](O[C@H]3[C@H](O)[C@@H](O)C(O)O[C@@H]3CO)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1N[C@H]1C=C(CO)[C@@H](O)[C@H](O)[C@H]1O	41774.0	R7_andres_2006:2|R14_ghose_2012:319|R23_gupta_2019:322|R29_subramanian_2003:2			BBB-	C	training
InChI=1S/C25H43NO3/c1-7-29-22-14-24(3)16(12-21(22)28)8-9-17-19-11-10-18(15(2)27)25(19,4)13-20(23(17)24)26(5)6/h16-23,28H,7-14H2,1-6H3/t16-,17-,18+,19-,20+,21-,22-,23+,24-,25+/m0/s1	Minaxolone	1-[(2S,3S,5S,8S,9S,10S,11R,13S,14S,17S)-11-(dimethylamino)-2-ethoxy-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]ethanone	CCO[C@H]1C[C@@]2(C)[C@@H](CC[C@@H]3[C@@H]2[C@H](N(C)C)C[C@]2(C)[C@@H](C(C)=O)CC[C@@H]32)C[C@@H]1O	71960.0	R6_adenot_2004:943			BBB+	C	training
InChI=1S/C25H48N6O8/c1-21(32)29(37)18-9-3-6-16-27-22(33)12-14-25(36)31(39)20-10-4-7-17-28-23(34)11-13-24(35)30(38)19-8-2-5-15-26/h37-39H,2-20,26H2,1H3,(H,27,33)(H,28,34)	Deferoxamine	N-[5-[[4-[5-[acetyl(hydroxy)amino]pentylamino]-4-oxobutanoyl]-hydroxyamino]pentyl]-N'-(5-aminopentyl)-N'-hydroxybutanediamide	CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN	2973.0	R23_gupta_2019:505			BBB-	C	test
InChI=1S/C26H21N3O/c30-25-26(18-20-10-14-27-15-11-20,19-21-12-16-28-17-13-21)23-8-4-5-9-24(23)29(25)22-6-2-1-3-7-22/h1-17H,18-19H2	Linopirdine	1-phenyl-3,3-bis(pyridin-4-ylmethyl)indol-2-one	O=C1N(c2ccccc2)c2ccccc2C1(Cc1ccncc1)Cc1ccncc1	3932.0	R6_adenot_2004:1255			BBB+	C	training
InChI=1S/C26H23FIN5O4/c1-13-22-21(23(31(3)24(13)35)30-20-10-7-15(28)11-19(20)27)25(36)33(17-8-9-17)26(37)32(22)18-6-4-5-16(12-18)29-14(2)34/h4-7,10-12,17,30H,8-9H2,1-3H3,(H,29,34)	Trametinib	N-[3-[3-cyclopropyl-5-(2-fluoro-4-iodoanilino)-6,8-dimethyl-2,4,7-trioxopyrido[4,3-d]pyrimidin-1-yl]phenyl]acetamide	CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1	11707110.0	R23_gupta_2019:993			BBB-	C	training
InChI=1S/C26H23N7O2/c1-2-6-21(34)32-15-5-7-19(32)25-31-22(23-24(27)29-14-16-33(23)25)17-9-11-18(12-10-17)26(35)30-20-8-3-4-13-28-20/h3-4,8-14,16,19H,5,7,15H2,1H3,(H2,27,29)(H,28,30,35)/t19-/m0/s1	Acalabrutinib	4-[8-amino-3-[(2S)-1-but-2-ynoylpyrrolidin-2-yl]imidazo[1,5-a]pyrazin-1-yl]-N-pyridin-2-ylbenzamide	CC#CC(=O)N1CCC[C@H]1c1nc(-c2ccc(C(=O)Nc3ccccn3)cc2)c2c(N)nccn12	71226662.0	R23_gupta_2019:321			BBB-	C	training
InChI=1S/C26H24F6N2O/c1-15-7-5-6-8-20(15)21-10-9-19(33)14-22(21)34(4)23(35)24(2,3)16-11-17(25(27,28)29)13-18(12-16)26(30,31)32/h5-14H,33H2,1-4H3	18|N-(4-Amino-2'-Methyl-Biphenyl-2-Yl)-2-(3,5-Bis-Trifluoromethyl-Phenyl)-N-Methyl-Isobutyramide	N-[5-amino-2-(2-methylphenyl)phenyl]-2-[3,5-bis(trifluoromethyl)phenyl]-N,2-dimethylpropanamide	Cc1ccccc1-c1ccc(N)cc1N(C)C(=O)C(C)(C)c1cc(C(F)(F)F)cc(C(F)(F)F)c1	18546507.0	R47_radchenko_2020:396	0.34	A	BBB+	A	training
InChI=1S/C26H24N2O/c1-3-22(19-12-6-4-7-13-19)28-26(29)24-18(2)25(20-14-8-5-9-15-20)27-23-17-11-10-16-21(23)24/h4-17,22H,3H2,1-2H3,(H,28,29)	3-Methyl-2-Phenyl-N-(1-Phenylpropyl)-Quinoline-4- Carboxamide|3-Methyl-2-Phenyl-N-(1-Phenylpropyl)Quinoline-4-Carboxamide	3-methyl-2-phenyl-N-(1-phenylpropyl)quinoline-4-carboxamide	CCC(NC(=O)c1c(C)c(-c2ccccc2)nc2ccccc12)c1ccccc1	3946663.0	R21_muehlbacher_2011:318|R41_toropov_2017:287|R46_mendoza_valencia_2017:79	0.3	B	BBB+	A	training
InChI=1S/C26H24N2O/c1-3-22(19-12-6-4-7-13-19)28-26(29)24-18(2)25(20-14-8-5-9-15-20)27-23-17-11-10-16-21(23)24/h4-17,22H,3H2,1-2H3,(H,28,29)/t22-/m0/s1	Sb222200|Sb-222200|Sb 222200|3-Methyl-2-Phenyl-N-[(1S)-1-Phenylpropyl]Quinoline-4-Carboxamide	3-methyl-2-phenyl-N-[(1S)-1-phenylpropyl]quinoline-4-carboxamide	CC[C@H](NC(=O)c1c(C)c(-c2ccccc2)nc2ccccc12)c1ccccc1	6604009.0	R3_abraham_2006:324|R12_garg_2006:150|R17_fu_2008:55|R25_brito_sanchez_2015:81|R26_chico_2009:369|R28_li_2005:135|R40_vilar_2010:240|R47_radchenko_2020:253|R48_hou_2003:90|R49_norinder_2002:106	0.3	B	BBB+	A	training
InChI=1S/C26H25ClN2O3/c1-16-6-3-4-7-20(16)25(31)28-19-10-11-21(17(2)14-19)26(32)29-13-5-8-24(30)22-15-18(27)9-12-23(22)29/h3-4,6-7,9-12,14-15,24,30H,5,8,13H2,1-2H3,(H,28,31)	Tolvaptan	N-[4-(7-chloro-5-hydroxy-2,3,4,5-tetrahydro-1-benzazepine-1-carbonyl)-3-methylphenyl]-2-methylbenzamide	Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCC(O)c3cc(Cl)ccc32)c(C)c1	216237.0	R23_gupta_2019:989			BBB-	C	training
InChI=1S/C26H25ClN2O3/c1-2-32-20-11-12-28(16-20)25(30)23-15-22(17-6-4-3-5-7-17)26(31)29-13-10-18-8-9-19(27)14-21(18)24(23)29/h3-9,14-15,20H,2,10-13,16H2,1H3/t20-/m0/s1	Lirequinil	10-chloro-1-[(3S)-3-ethoxypyrrolidine-1-carbonyl]-3-phenyl-6,7-dihydrobenzo[a]quinolizin-4-one	CCO[C@H]1CCN(C(=O)c2cc(-c3ccccc3)c(=O)n3c2-c2cc(Cl)ccc2CC3)C1	3045375.0	R6_adenot_2004:1379			BBB+	C	training
InChI=1S/C26H26F2N2/c27-24-12-8-22(9-13-24)26(23-10-14-25(28)15-11-23)30-19-17-29(18-20-30)16-4-7-21-5-2-1-3-6-21/h1-15,26H,16-20H2/b7-4+	Flunarizine	1-[bis(4-fluorophenyl)methyl]-4-[(E)-3-phenylprop-2-enyl]piperazine	Fc1ccc(C(c2ccc(F)cc2)N2CCN(C/C=C/c3ccccc3)CC2)cc1	941361.0	R14_ghose_2012:93|R23_gupta_2019:94			BBB+	C	test
InChI=1S/C26H26N2/c1-27(19-20-8-3-2-4-9-20)17-16-24-18-23-12-7-11-22-15-14-21-10-5-6-13-25(21)28(24)26(22)23/h2-13,18H,14-17,19H2,1H3	Azipramine	2-(1-azatetracyclo[8.6.1.02,7.014,17]heptadeca-2,4,6,10,12,14(17),15-heptaen-16-yl)-N-benzyl-N-methylethanamine	CN(CCc1cc2cccc3c2n1-c1ccccc1CC3)Cc1ccccc1	65468.0	R6_adenot_2004:490			BBB+	C	training
InChI=1S/C26H26N2O6S/c1-26(2)20(24(31)32)28-22(30)19(23(28)35-26)27-21(29)18(15-7-4-3-5-8-15)25(33)34-17-12-11-14-9-6-10-16(14)13-17/h3-5,7-8,11-13,18-20,23H,6,9-10H2,1-2H3,(H,27,29)(H,31,32)/t18?,19-,20+,23-/m1/s1	Carindacillin|Carbenicillin Indanyl Sodium|Carbenicillin Indanyl	(2S,5R,6R)-6-[[3-(2,3-dihydro-1H-inden-5-yloxy)-3-oxo-2-phenylpropanoyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid	CC1(C)S[C@@H]2[C@H](NC(=O)C(C(=O)Oc3ccc4c(c3)CCC4)c3ccccc3)C(=O)N2[C@H]1C(=O)O	93184.0	R6_adenot_2004:148|R14_ghose_2012:419			BBB-	C	test
InChI=1S/C26H26N4O4S/c1-18(30(17-31)16-22-15-28-19(2)29-24(22)27)23(35-26(33)21-11-7-4-8-12-21)13-14-34-25(32)20-9-5-3-6-10-20/h3-12,15,17H,13-14,16H2,1-2H3,(H2,27,28,29)/b23-18-	Bentiamine	[(Z)-4-[(4-amino-2-methylpyrimidin-5-yl)methyl-formylamino]-3-benzoylsulfanylpent-3-enyl] benzoate	C/C(=C(\CCOC(=O)c1ccccc1)SC(=O)c1ccccc1)N(C=O)Cc1cnc(C)nc1N	3036235.0	R6_adenot_2004:387			BBB+	C	training
InChI=1S/C26H27ClN2O/c1-28(19-26(30)22-13-15-23(27)16-14-22)17-6-18-29-24-9-4-2-7-20(24)11-12-21-8-3-5-10-25(21)29/h2-5,7-10,13-16H,6,11-12,17-19H2,1H3	Lofepramine	1-(4-chlorophenyl)-2-[3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)propyl-methylamino]ethanone	CN(CCCN1c2ccccc2CCc2ccccc21)CC(=O)c1ccc(Cl)cc1	3947.0	R6_adenot_2004:1588|R14_ghose_2012:124|R23_gupta_2019:125			BBB+	C	training
InChI=1S/C26H27N3OS/c1-30-23-16-24-22(29-26(31-24)19-11-6-3-7-12-19)15-20(23)17-28-21-13-8-14-27-25(21)18-9-4-2-5-10-18/h2-7,9-12,15-16,21,25,27-28H,8,13-14,17H2,1H3	163257-84-9|Pfizer Compound 23|N-[(6-Methoxy-2-Phenyl-1,3-Benzothiazol-5-Yl)Methyl]-2-Phenylpiperidin-3-Amine	N-[(6-methoxy-2-phenyl-1,3-benzothiazol-5-yl)methyl]-2-phenylpiperidin-3-amine	COc1cc2sc(-c3ccccc3)nc2cc1CNC1CCCNC1c1ccccc1	22620066.0	R4_mente_2005:98|R25_brito_sanchez_2015:550|R40_vilar_2010:197|R46_mendoza_valencia_2017:461|R47_radchenko_2020:388	1.26	B	BBB+	A	training
InChI=1S/C26H27N5O2/c27-16-18-4-6-23-22(13-18)19(17-29-23)3-1-2-8-30-9-11-31(12-10-30)21-5-7-24-20(14-21)15-25(33-24)26(28)32/h4-7,13-15,17,29H,1-3,8-12H2,(H2,28,32)	Vilazodone	5-[4-[4-(5-cyano-1H-indol-3-yl)butyl]piperazin-1-yl]-1-benzofuran-2-carboxamide	N#Cc1ccc2[nH]cc(CCCCN3CCN(c4ccc5oc(C(N)=O)cc5c4)CC3)c2c1	6918314.0	R23_gupta_2019:263			BBB+	C	training
InChI=1S/C26H27NO10/c1-10-21(30)14(27)6-17(36-10)37-15-8-26(35,16(29)9-28)7-13-18(15)25(34)20-19(24(13)33)22(31)11-4-2-3-5-12(11)23(20)32/h2-5,10,14-15,17,21,28,30,33-35H,6-9,27H2,1H3/t10-,14-,15-,17-,21+,26-/m0/s1	Medorubicin	(7S,9S)-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-8,10-dihydro-7H-tetracene-5,12-dione	C[C@@H]1O[C@@H](O[C@H]2C[C@](O)(C(=O)CO)Cc3c(O)c4c(c(O)c32)C(=O)c2ccccc2C4=O)C[C@H](N)[C@@H]1O	498156.0	R6_adenot_2004:325			BBB-	C	training
InChI=1S/C26H27NO10/c1-9-21(30)13(27)6-16(36-9)37-15-8-26(35,10(2)28)7-12-18(15)25(34)20-19(23(12)32)22(31)11-4-3-5-14(29)17(11)24(20)33/h3-5,9,13,15-16,21,29-30,32,34-35H,6-8,27H2,1-2H3/t9-,13-,15-,16-,21+,26-/m0/s1	Carubicin	(7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-4,6,9,11-tetrahydroxy-8,10-dihydro-7H-tetracene-5,12-dione	CC(=O)[C@]1(O)Cc2c(O)c3c(c(O)c2[C@@H](O[C@H]2C[C@H](N)[C@H](O)[C@H](C)O2)C1)C(=O)c1c(O)cccc1C3=O	443831.0	R6_adenot_2004:323			BBB-	C	training
InChI=1S/C26H27NO9/c1-10-21(29)15(27)7-17(35-10)36-16-9-26(34,11(2)28)8-14-18(16)25(33)20-19(24(14)32)22(30)12-5-3-4-6-13(12)23(20)31/h3-6,10,15-17,21,29,32-34H,7-9,27H2,1-2H3/t10-,15-,16-,17-,21+,26-/m0/s1	Idarubicin|Dm5	(7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-8,10-dihydro-7H-tetracene-5,12-dione	CC(=O)[C@]1(O)Cc2c(O)c3c(c(O)c2[C@@H](O[C@H]2C[C@H](N)[C@H](O)[C@H](C)O2)C1)C(=O)c1ccccc1C3=O	42890.0	R6_adenot_2004:36|R6_adenot_2004:329|R14_ghose_2012:615|R23_gupta_2019:666|R25_brito_sanchez_2015:421	0.0	A	BBB+	A	training
InChI=1S/C26H28Cl2N4O4/c1-19(33)31-10-12-32(13-11-31)21-3-5-22(6-4-21)34-15-23-16-35-26(36-23,17-30-9-8-29-18-30)24-7-2-20(27)14-25(24)28/h2-9,14,18,23H,10-13,15-17H2,1H3/t23-,26-/m0/s1	Ketoconazole|(+)-Ketoconazole	1-[4-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]ethanone	CC(=O)N1CCN(c2ccc(OC[C@H]3CO[C@](Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1	456201.0	R6_adenot_2004:40|R6_adenot_2004:351|R14_ghose_2012:641|R23_gupta_2019:693|R28_li_2005:263|R34_broccatelli_2012:43|R46_mendoza_valencia_2017:237|R51_doninger_2002:75	-0.63	A	BBB+	A	training
InChI=1S/C26H28Cl2N4O4/c1-19(33)31-10-12-32(13-11-31)21-3-5-22(6-4-21)34-15-23-16-35-26(36-23,17-30-9-8-29-18-30)24-7-2-20(27)14-25(24)28/h2-9,14,18,23H,10-13,15-17H2,1H3/t23?,26-/m1/s1	Ketoconazole|1-[4-[4-[[(2S)-2-(2,4-Dichlorophenyl)-2-(Imidazol-1-Ylmethyl)-1,3-Dioxolan-4-Yl]Methoxy]Phenyl]Piperazin-1-Yl]Ethanone	1-[4-[4-[[(2S)-2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]ethanone	CC(=O)N1CCN(c2ccc(OCC3CO[C@@](Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1	16757695.0	R25_brito_sanchez_2015:264	-0.63	A	BBB+	A	training
InChI=1S/C26H28ClN3O6S/c1-25(2,36-16-12-10-15(27)11-13-16)24(35)29-17(14-8-6-5-7-9-14)20(31)28-18-21(32)30-19(23(33)34)26(3,4)37-22(18)30/h5-13,17-19,22H,1-4H3,(H,28,31)(H,29,35)(H,33,34)/t17-,18-,19+,22-/m1/s1	Fibracillin	(2S,5R,6R)-6-[[(2R)-2-[[2-(4-chlorophenoxy)-2-methylpropanoyl]amino]-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid	CC(C)(Oc1ccc(Cl)cc1)C(=O)N[C@@H](C(=O)N[C@@H]1C(=O)N2[C@@H]1SC(C)(C)[C@@H]2C(=O)O)c1ccccc1	68683.0	R6_adenot_2004:225			BBB-	C	test
InChI=1S/C26H28ClNO/c1-28(2)19-20-29-24-15-13-23(14-16-24)26(22-11-7-4-8-12-22)25(17-18-27)21-9-5-3-6-10-21/h3-16H,17-20H2,1-2H3/b26-25-	Toremifene	2-[4-[(Z)-4-chloro-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine	CN(C)CCOc1ccc(/C(=C(/CCCl)c2ccccc2)c2ccccc2)cc1	3005573.0	R23_gupta_2019:991			BBB-	C	training
InChI=1S/C26H28ClNO/c1-3-28(4-2)19-20-29-24-17-15-22(16-18-24)25(21-11-7-5-8-12-21)26(27)23-13-9-6-10-14-23/h5-18H,3-4,19-20H2,1-2H3/b26-25+	Clomifene|Enclomiphene	2-[4-[(E)-2-chloro-1,2-diphenylethenyl]phenoxy]-N,N-diethylethanamine	CCN(CC)CCOc1ccc(/C(=C(/Cl)c2ccccc2)c2ccccc2)cc1	1548953.0	R23_gupta_2019:473			BBB-	C	training
InChI=1S/C26H28F3N3O2/c27-26(28,29)19-6-5-7-21(18-19)34-20-11-16-32(17-12-20)15-4-3-13-31-25(33)23-10-14-30-24-9-2-1-8-22(23)24/h1-2,5-10,14,18,20H,3-4,11-13,15-17H2,(H,31,33)	Piperidinederivatives 3|N-[4-[4-[3-(Trifluoromethyl)Phenoxy]Piperidin-1-Yl]Butyl]Quinoline-4-Carboxamide	N-[4-[4-[3-(trifluoromethyl)phenoxy]piperidin-1-yl]butyl]quinoline-4-carboxamide	O=C(NCCCCN1CCC(Oc2cccc(C(F)(F)F)c2)CC1)c1ccnc2ccccc12	69973370.0	R47_radchenko_2020:317	0.48	A	BBB+	A	training
InChI=1S/C26H28N2/c1-4-11-23(12-5-1)13-10-18-27-19-21-28(22-20-27)26(24-14-6-2-7-15-24)25-16-8-3-9-17-25/h1-17,26H,18-22H2/b13-10+	Cinnarizine	1-benzhydryl-4-[(E)-3-phenylprop-2-enyl]piperazine	C(=C/c1ccccc1)\CN1CCN(C(c2ccccc2)c2ccccc2)CC1	1547484.0	R14_ghose_2012:47|R23_gupta_2019:46			BBB+	C	test
InChI=1S/C26H28N3/c1-19-17-21(20(2)29(19)24-9-7-6-8-10-24)11-13-23-14-12-22-18-25(27(3)4)15-16-26(22)28(23)5/h6-18H,1-5H3/q+1	Pyrvinium|2-[2-(2,5-Dimethyl-1-Phenylpyrrol-3-Yl)Ethenyl]-N,N,1-Trimethylquinolin-1-Ium-6-Amine	2-[2-(2,5-dimethyl-1-phenylpyrrol-3-yl)ethenyl]-N,N,1-trimethylquinolin-1-ium-6-amine	Cc1cc(C=Cc2ccc3cc(N(C)C)ccc3[n+]2C)c(C)n1-c1ccccc1	22526.0	R14_ghose_2012:808			BBB-	C	training
InChI=1S/C26H29Cl2N5O3/c1-32-6-8-33(9-7-32)5-4-10-36-25-13-21-18(11-24(25)35-3)26(17(15-29)16-30-21)31-22-14-23(34-2)20(28)12-19(22)27/h11-14,16H,4-10H2,1-3H3,(H,30,31)	Bosutinib	4-(2,4-dichloro-5-methoxyanilino)-6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinoline-3-carbonitrile	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl	5328940.0	R23_gupta_2019:399			BBB-	C	training
InChI=1S/C26H29F2N7/c1-3-13-29-24-31-25(30-14-4-2)33-26(32-24)35-17-15-34(16-18-35)23(19-5-9-21(27)10-6-19)20-7-11-22(28)12-8-20/h3-12,23H,1-2,13-18H2,(H2,29,30,31,32,33)	Almitrine	6-[4-[bis(4-fluorophenyl)methyl]piperazin-1-yl]-2-N,4-N-bis(prop-2-enyl)-1,3,5-triazine-2,4-diamine	C=CCNc1nc(NCC=C)nc(N2CCN(C(c3ccc(F)cc3)c3ccc(F)cc3)CC2)n1	33887.0	R14_ghose_2012:337			BBB-	C	training
InChI=1S/C26H29FN2O2/c1-19-17-29(16-15-26(19,24(30)31)21-5-3-2-4-6-21)23-11-13-25(18-28,14-12-23)20-7-9-22(27)10-8-20/h2-10,19,23H,11-17H2,1H3,(H,30,31)	Cabastine	1-[4-cyano-4-(4-fluorophenyl)cyclohexyl]-3-methyl-4-phenylpiperidine-4-carboxylic acid	CC1CN(C2CCC(C#N)(c3ccc(F)cc3)CC2)CCC1(C(=O)O)c1ccccc1	3915.0	R46_mendoza_valencia_2017:241|R47_radchenko_2020:392	-0.7	B	BBB+	A	training
InChI=1S/C26H29FN2O2/c1-19-17-29(16-15-26(19,24(30)31)21-5-3-2-4-6-21)23-11-13-25(18-28,14-12-23)20-7-9-22(27)10-8-20/h2-10,19,23H,11-17H2,1H3,(H,30,31)/t19-,23?,25?,26-/m1/s1	Levocabastine Hydrochloride|Levocabastine	(3S,4R)-1-[4-cyano-4-(4-fluorophenyl)cyclohexyl]-3-methyl-4-phenylpiperidine-4-carboxylic acid	C[C@@H]1CN(C2CCC(C#N)(c3ccc(F)cc3)CC2)CC[C@]1(C(=O)O)c1ccccc1	54385.0	R25_brito_sanchez_2015:268|R50_sobanska_2019:74	-0.7	A	BBB+	A	training
InChI=1S/C26H29N3O3/c1-18-5-7-21-22(27-18)3-2-4-24(21)31-14-13-29-11-9-19(10-12-29)15-20-6-8-25-23(16-20)28-26(30)17-32-25/h2-8,16,19H,9-15,17H2,1H3,(H,28,30)	Sb-649915|6-[[1-[2-(2-Methylquinolin-5-Yl)Oxyethyl]Piperidin-4-Yl]Methyl]-4H-1,4-Benzoxazin-3-One	6-[[1-[2-(2-methylquinolin-5-yl)oxyethyl]piperidin-4-yl]methyl]-4H-1,4-benzoxazin-3-one	Cc1ccc2c(OCCN3CCC(Cc4ccc5c(c4)NC(=O)CO5)CC3)cccc2n1	10296414.0	R26_chico_2009:372	-0.39	A	BBB+	A	training
InChI=1S/C26H29N5O/c1-19-6-5-7-20(2)25(19)29-26-24-16-27-18-31(24)23(17-28-26)21-8-10-22(11-9-21)32-15-14-30-12-3-4-13-30/h5-11,16-18H,3-4,12-15H2,1-2H3,(H,28,29)	Compound 14B|N-(2,6-Dimethylphenyl)-5-[4-(2-Pyrrolidin-1-Ylethoxy)Phenyl]Imidazo[1,5-A]Pyrazin-8-Amine	N-(2,6-dimethylphenyl)-5-[4-(2-pyrrolidin-1-ylethoxy)phenyl]imidazo[1,5-a]pyrazin-8-amine	Cc1cccc(C)c1Nc1ncc(-c2ccc(OCCN3CCCC3)cc2)n2cncc12	16126744.0	R26_chico_2009:118	0.23	A	BBB+	A	training
InChI=1S/C26H29N5O/c1-19-7-5-8-20(2)25(19)29-26-24-16-27-18-31(24)23(17-28-26)21-9-6-10-22(15-21)32-14-13-30-11-3-4-12-30/h5-10,15-18H,3-4,11-14H2,1-2H3,(H,28,29)	Compound-14E|N-(2,6-Dimethylphenyl)-5-[3-(2-Pyrrolidin-1-Ylethoxy)Phenyl]Imidazo[1,5-A]Pyrazin-8-Amine Hydrochloride	N-(2,6-dimethylphenyl)-5-[3-(2-pyrrolidin-1-ylethoxy)phenyl]imidazo[1,5-a]pyrazin-8-amine	Cc1cccc(C)c1Nc1ncc(-c2cccc(OCCN3CCCC3)c2)n2cncc12	44422581.0	R26_chico_2009:127	-0.05	A	BBB+	A	test
InChI=1S/C26H29NO/c1-4-25(21-11-7-5-8-12-21)26(22-13-9-6-10-14-22)23-15-17-24(18-16-23)28-20-19-27(2)3/h5-18H,4,19-20H2,1-3H3	2-[4-(1,2-Diphenylbut-1-Enyl)Phenoxy]-N,N-Dimethylethanamine	2-[4-(1,2-diphenylbut-1-enyl)phenoxy]-N,N-dimethylethanamine	CCC(=C(c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1	5376.0	R46_mendoza_valencia_2017:347	0.92	A	BBB+	A	training
InChI=1S/C26H29NO/c1-4-25(21-11-7-5-8-12-21)26(22-13-9-6-10-14-22)23-15-17-24(18-16-23)28-20-19-27(2)3/h5-18H,4,19-20H2,1-3H3/b26-25-	Tamoxifen|Tamoxifen, Nolvadex	2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine	CC/C(=C(\c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1	2733526.0	R6_adenot_2004:67|R14_ghose_2012:874|R21_muehlbacher_2011:313|R25_brito_sanchez_2015:410|R26_chico_2009:401|R28_li_2005:293|R45_hemmateenejad_2006:7|R47_radchenko_2020:308|R50_sobanska_2019:68	0.92	D	BBB+	A	training
InChI=1S/C26H30Cl2F3NO/c1-3-5-10-32(11-6-4-2)12-9-25(33)23-16-22-21(14-18(27)15-24(22)28)20-13-17(26(29,30)31)7-8-19(20)23/h7-8,13-16,25,33H,3-6,9-12H2,1-2H3	Halofantrine Hydrochloride|Halofantrine	3-(dibutylamino)-1-[1,3-dichloro-6-(trifluoromethyl)phenanthren-9-yl]propan-1-ol	CCCCN(CCCC)CCC(O)c1cc2c(Cl)cc(Cl)cc2c2cc(C(F)(F)F)ccc12	37393.0	R14_ghose_2012:603			BBB-	C	test
InChI=1S/C26H30ClN3O3/c27-20-6-4-19(5-7-20)26(32)29-16-17-30(25(31)18-29)22-8-10-23(11-9-22)33-24-12-14-28(15-13-24)21-2-1-3-21/h4-11,21,24H,1-3,12-18H2	Proc-37C|4-(4-Chlorobenzoyl)-1-[4-(1-Cyclobutylpiperidin-4-Yl)Oxyphenyl]Piperazin-2-One	4-(4-chlorobenzoyl)-1-[4-(1-cyclobutylpiperidin-4-yl)oxyphenyl]piperazin-2-one	O=C(c1ccc(Cl)cc1)N1CCN(c2ccc(OC3CCN(C4CCC4)CC3)cc2)C(=O)C1	15986644.0	R26_chico_2009:324	-0.4	A	BBB+	A	training
InChI=1S/C26H31BrFN3O2/c1-2-15-30-19-31(23-11-7-21(27)8-12-23)26(25(30)33)13-17-29(18-14-26)16-3-4-24(32)20-5-9-22(28)10-6-20/h5-12H,2-4,13-19H2,1H3	Bpsp|1-(4-Bromophenyl)-8-[4-(4-Fluorophenyl)-4-Oxobutyl]-3-Propyl-1,3,8-Triazaspiro[4.5]Decan-4-One	1-(4-bromophenyl)-8-[4-(4-fluorophenyl)-4-oxobutyl]-3-propyl-1,3,8-triazaspiro[4.5]decan-4-one	CCCN1CN(c2ccc(Br)cc2)C2(CCN(CCCC(=O)c3ccc(F)cc3)CC2)C1=O	13497181.0	R3_abraham_2006:136|R25_brito_sanchez_2015:165|R40_vilar_2010:57|R41_toropov_2017:129|R47_radchenko_2020:116	-0.01	B	BBB+	A	training
InChI=1S/C26H31Cl2N5O3/c1-19(2)31-9-11-32(12-10-31)21-4-6-22(7-5-21)34-14-23-15-35-26(36-23,16-33-18-29-17-30-33)24-8-3-20(27)13-25(24)28/h3-8,13,17-19,23H,9-12,14-16H2,1-2H3/t23-,26-/m0/s1	Terconazole	1-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-4-propan-2-ylpiperazine	CC(C)N1CCN(c2ccc(OC[C@H]3CO[C@](Cn4cncn4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1	441383.0	R23_gupta_2019:968|R51_doninger_2002:130			BBB-	C	training
InChI=1S/C26H31N3O2/c1-31-25-11-5-4-10-24(25)29-18-16-28(17-19-29)15-7-6-14-27-26(30)23-13-12-21-8-2-3-9-22(21)20-23/h2-5,8-13,20H,6-7,14-19H2,1H3,(H,27,30)	Piperazinederivatives 12|2-Naphthalenecarboxamide, N-(4-(4-(2-Methoxyphenyl)-1-Piperazinyl)Butyl)-	N-[4-[4-(2-methoxyphenyl)piperazin-1-yl]butyl]naphthalene-2-carboxamide	COc1ccccc1N1CCN(CCCCNC(=O)c2ccc3ccccc3c2)CC1	3038495.0	R47_radchenko_2020:321	0.78	A	BBB+	A	training
InChI=1S/C26H32ClFO5/c1-5-6-22(32)33-26(21(31)14-27)15(2)11-19-18-8-7-16-12-17(29)9-10-23(16,3)25(18,28)20(30)13-24(19,26)4/h9-10,12,15,18-19H,5-8,11,13-14H2,1-4H3/t15-,18-,19-,23-,24-,25-,26-/m0/s1	Clobetasone-Butyrate|Clobetasone Butyrate	[(8S,9R,10S,13S,14S,16S,17R)-17-(2-chloroacetyl)-9-fluoro-10,13,16-trimethyl-3,11-dioxo-7,8,12,14,15,16-hexahydro-6H-cyclopenta[a]phenanthren-17-yl] butanoate	CCCC(=O)O[C@]1(C(=O)CCl)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)C(=O)C[C@@]21C	71386.0	R6_adenot_2004:785			BBB+	C	test
InChI=1S/C26H32F2O7/c1-13(29)33-12-20(32)26-21(34-22(2,3)35-26)10-15-16-9-18(27)17-8-14(30)6-7-23(17,4)25(16,28)19(31)11-24(15,26)5/h6-8,15-16,18-19,21,31H,9-12H2,1-5H3/t15-,16-,18-,19-,21+,23-,24-,25-,26+/m0/s1	Fluocinonide	[2-[(1S,2S,4R,8S,9S,11S,12R,13S,19S)-12,19-difluoro-11-hydroxy-6,6,9,13-tetramethyl-16-oxo-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-8-yl]-2-oxoethyl] acetate	CC(=O)OCC(=O)[C@@]12OC(C)(C)O[C@@H]1C[C@H]1[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]12C	9642.0	R6_adenot_2004:847			BBB+	C	training
InChI=1S/C26H32F2O7/c1-13-8-17-18-10-20(27)19-9-16(31)6-7-23(19,4)25(18,28)21(32)11-24(17,5)26(13,35-15(3)30)22(33)12-34-14(2)29/h6-7,9,13,17-18,20-21,32H,8,10-12H2,1-5H3/t13-,17-,18+,20-,21-,23-,24-,25-,26-/m0/s1	Diflorasone-Diacetate	[2-[(6S,8R,9R,10S,11S,13S,14S,16S,17R)-17-acetyloxy-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate	CC(=O)OCC(=O)[C@@]1(OC(C)=O)[C@@H](C)C[C@H]2[C@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C	51895260.0	R6_adenot_2004:822			BBB+	C	training
InChI=1S/C26H32F3N3O2S/c27-26(28,29)20-7-8-24-22(19-20)32(21-5-1-2-6-23(21)35-24)11-3-10-30-13-15-31(16-14-30)12-9-25-33-17-4-18-34-25/h1-2,5-8,19,25H,3-4,9-18H2	Oxaflumazine	10-[3-[4-[2-(1,3-dioxan-2-yl)ethyl]piperazin-1-yl]propyl]-2-(trifluoromethyl)phenothiazine	FC(F)(F)c1ccc2c(c1)N(CCCN1CCN(CCC3OCCCO3)CC1)c1ccccc1S2	62862.0	R6_adenot_2004:1190|R51_doninger_2002:266			BBB+	C	training
InChI=1S/C26H32N2O5/c1-18-19(2)26(29)33-23-17-24(31-4)25(16-20(18)23)32-15-7-10-27-11-13-28(14-12-27)21-8-5-6-9-22(21)30-3/h5-6,8-9,16-17H,7,10-15H2,1-4H3	Anseculin|Ensaculin	7-methoxy-6-[3-[4-(2-methoxyphenyl)piperazin-1-yl]propoxy]-3,4-dimethylchromen-2-one	COc1cc2oc(=O)c(C)c(C)c2cc1OCCCN1CCN(c2ccccc2OC)CC1	208923.0	R6_adenot_2004:1260			BBB+	C	training
InChI=1S/C26H32N2O5/c1-3-33-26(32)23(14-13-19-9-5-4-6-10-19)27-18(2)25(31)28(17-24(29)30)22-15-20-11-7-8-12-21(20)16-22/h4-12,18,22-23,27H,3,13-17H2,1-2H3,(H,29,30)/t18-,23-/m0/s1	Delapril	2-[2,3-dihydro-1H-inden-2-yl-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]amino]acetic acid	CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N(CC(=O)O)C1Cc2ccccc2C1	5362116.0	R23_gupta_2019:506			BBB-	C	training
InChI=1S/C26H32N4O4S/c1-20(2)30(16-10-11-17-34-19-24(31)29-35(3,32)33)23-18-27-25(21-12-6-4-7-13-21)26(28-23)22-14-8-5-9-15-22/h4-9,12-15,18,20H,10-11,16-17,19H2,1-3H3,(H,29,31)	Selexipag	2-[4-[(5,6-diphenylpyrazin-2-yl)-propan-2-ylamino]butoxy]-N-methylsulfonylacetamide	CC(C)N(CCCCOCC(=O)NS(C)(=O)=O)c1cnc(-c2ccccc2)c(-c2ccccc2)n1	9913767.0	R23_gupta_2019:905			BBB-	C	test
InChI=1S/C26H33FO7/c1-13(28)32-12-20(31)26-21(33-23(2,3)34-26)10-16-15-9-18(27)17-8-14(29)6-7-24(17,4)22(15)19(30)11-25(16,26)5/h6-8,15-16,18-19,21-22,30H,9-12H2,1-5H3/t15-,16-,18-,19-,21+,22+,24-,25-,26+/m0/s1	Flunisolide-Acetate|Flunisolide Acetate	[2-[(1S,2S,4R,8S,9S,11S,12S,13R,19S)-19-fluoro-11-hydroxy-6,6,9,13-tetramethyl-16-oxo-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-8-yl]-2-oxoethyl] acetate	CC(=O)OCC(=O)[C@@]12OC(C)(C)O[C@@H]1C[C@H]1[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]12C	23724908.0	R6_adenot_2004:843			BBB+	C	training
InChI=1S/C26H33NO4/c1-23(2,29)18-13-24-8-9-26(18,30-3)22-25(24)10-11-27(14-15-4-5-15)19(24)12-16-6-7-17(28)21(31-22)20(16)25/h6-9,15,18-19,22,28-29H,4-5,10-14H2,1-3H3/t18-,19-,22-,24-,25+,26-/m1/s1	Cyprenorphine	(1R,2S,6R,14R,15R,19R)-5-(cyclopropylmethyl)-19-(2-hydroxypropan-2-yl)-15-methoxy-13-oxa-5-azahexacyclo[13.2.2.12,8.01,6.02,14.012,20]icosa-8(20),9,11,16-tetraen-11-ol	CO[C@]12C=C[C@@]3(C[C@@H]1C(C)(C)O)[C@H]1Cc4ccc(O)c5c4[C@@]3(CCN1CC1CC1)[C@H]2O5	20054882.0	R6_adenot_2004:1022			BBB+	C	training
InChI=1S/C26H33NO6/c1-8-31-24(29)21-16(3)27-17(4)22(25(30)32-9-2)23(21)19-13-11-10-12-18(19)14-15-20(28)33-26(5,6)7/h10-15,23,27H,8-9H2,1-7H3/b15-14+	Lacidipine	diethyl 2,6-dimethyl-4-[2-[(E)-3-[(2-methylpropan-2-yl)oxy]-3-oxoprop-1-enyl]phenyl]-1,4-dihydropyridine-3,5-dicarboxylate	CCOC(=O)C1=C(C)NC(C)=C(C(=O)OCC)C1c1ccccc1/C=C/C(=O)OC(C)(C)C	5311217.0	R14_ghose_2012:642			BBB-	C	training
InChI=1S/C26H34F2O7/c1-22(2)34-19-11-14-15-10-17(27)16-9-13(29)7-8-23(16,3)25(15,28)18(30)12-24(14,4)26(19,35-22)20(31)21(32-5)33-6/h7-9,14-15,17-19,21,30H,10-12H2,1-6H3/t14-,15-,17-,18-,19+,23-,24-,25-,26-/m0/s1	Flumoxonide	(1S,2S,4R,8S,9S,11S,12R,13S,19S)-8-(2,2-dimethoxyacetyl)-12,19-difluoro-11-hydroxy-6,6,9,13-tetramethyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one	COC(OC)C(=O)[C@@]12OC(C)(C)O[C@@H]1C[C@H]1[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]12C	20055353.0	R6_adenot_2004:842			BBB+	C	training
InChI=1S/C26H34FNO5/c1-15(2)25-21(11-10-19(29)12-20(30)13-23(31)32)24(17-6-8-18(27)9-7-17)22(14-33-5)26(28-25)16(3)4/h6-11,15-16,19-20,29-30H,12-14H2,1-5H3,(H,31,32)/b11-10+/t19-,20-/m1/s1	Cerivastatin	(E,3R,5S)-7-[4-(4-fluorophenyl)-5-(methoxymethyl)-2,6-di(propan-2-yl)pyridin-3-yl]-3,5-dihydroxyhept-6-enoic acid	COCc1c(C(C)C)nc(C(C)C)c(/C=C/[C@@H](O)C[C@@H](O)CC(=O)O)c1-c1ccc(F)cc1	446156.0	R6_adenot_2004:1402|R25_brito_sanchez_2015:424|R26_chico_2009:101|R46_mendoza_valencia_2017:357	-1.3	D	BBB-	A	training
InChI=1S/C26H34N6O6S/c27-26(28)31-11-3-4-17(15-31)14-29-23(33)13-22(25(36)32(16-24(34)35)20-8-9-20)30-39(37,38)21-10-7-18-5-1-2-6-19(18)12-21/h1-2,5-7,10,12,17,20,22,30H,3-4,8-9,11,13-16H2,(H3,27,28)(H,29,33)(H,34,35)/t17-,22-/m0/s1	Napsagatran	2-[[(2S)-4-[[(3S)-1-carbamimidoylpiperidin-3-yl]methylamino]-2-(naphthalen-2-ylsulfonylamino)-4-oxobutanoyl]-cyclopropylamino]acetic acid	[H]/N=C(\N)N1CCC[C@@H](CNC(=O)C[C@H](NS(=O)(=O)c2ccc3ccccc3c2)C(=O)N(CC(=O)O)C2CC2)C1	6918278.0	R7_andres_2006:114|R29_subramanian_2003:111			BBB-	C	training
InChI=1S/C26H34O7/c1-4-31-25-17-21(9-7-19(25)8-12-26(29)30)33-14-6-5-13-32-20-10-11-22(24(28)16-20)23(27)15-18(2)3/h7,9-11,16-18,28H,4-6,8,12-15H2,1-3H3,(H,29,30)	Cube-8		CCOc1cc(OCCCCOc2ccc(C(=O)CC(C)C)c(O)c2)ccc1CCC(=O)O		R26_chico_2009:141	0.08	A	BBB+	A	training
InChI=1S/C26H34O8/c1-14-10-16-17-7-9-26(33,20(29)13-34-22(32)5-4-21(30)31)25(17,3)12-19(28)23(16)24(2)8-6-15(27)11-18(14)24/h6,8,11,14,16-17,19,23,28,33H,4-5,7,9-10,12-13H2,1-3H3,(H,30,31)/t14-,16-,17-,19-,23+,24-,25-,26-/m0/s1	Methylprednisolone-Hemisuccinate|Methylprednisolone Hemisuccinate	4-[2-[(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-6,10,13-trimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethoxy]-4-oxobutanoic acid	C[C@H]1C[C@@H]2[C@H]([C@@H](O)C[C@@]3(C)[C@H]2CC[C@]3(O)C(=O)COC(=O)CCC(=O)O)[C@@]2(C)C=CC(=O)C=C12	16923.0	R6_adenot_2004:882			BBB+	C	test
InChI=1S/C26H35F3O6/c1-17(2)35-25(33)11-6-4-3-5-10-21-22(24(32)15-23(21)31)13-12-19(30)16-34-20-9-7-8-18(14-20)26(27,28)29/h3,5,7-9,12-14,17,19,21-24,30-32H,4,6,10-11,15-16H2,1-2H3/b5-3-,13-12+/t19-,21-,22-,23+,24-/m1/s1	Travoprost	propan-2-yl (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]but-1-enyl]cyclopentyl]hept-5-enoate	CC(C)OC(=O)CCC/C=C\C[C@@H]1[C@@H](/C=C/[C@@H](O)COc2cccc(C(F)(F)F)c2)[C@H](O)C[C@@H]1O	5282226.0	R23_gupta_2019:995			BBB-	C	training
InChI=1S/C26H35FO5/c1-5-6-9-32-24(31)23(30)21-14(2)10-17-16-12-19(27)18-11-15(28)7-8-25(18,3)22(16)20(29)13-26(17,21)4/h7-8,11,14,16-17,19-22,29H,5-6,9-10,12-13H2,1-4H3/t14-,16+,17+,19+,20+,21-,22-,25+,26+/m1/s1	Fluocortin-Butyl|Fluocortin Butyl	butyl 2-[(6S,8S,9S,10R,11S,13S,14S,16R,17S)-6-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]-2-oxoacetate	CCCCOC(=O)C(=O)[C@H]1[C@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C	15942715.0	R6_adenot_2004:848			BBB+	C	test
InChI=1S/C26H35FO6/c1-4-5-6-22(32)33-26(21(31)14-28)10-8-17-16-12-19(27)18-11-15(29)7-9-24(18,2)23(16)20(30)13-25(17,26)3/h7,9,11,16-17,19-20,23,28,30H,4-6,8,10,12-14H2,1-3H3/t16-,17-,19-,20-,23+,24-,25-,26-/m0/s1	Fluprednisolone-Valerate|Fluprednisolone Valerate	[(6S,8S,9S,10R,11S,13S,14S,17R)-6-fluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl] pentanoate	CCCCC(=O)O[C@]1(C(=O)CO)CC[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C	11705312.0	R6_adenot_2004:857			BBB+	C	test
InChI=1S/C26H35FO6/c1-5-24(6-2)32-21-12-18-17-8-7-15-11-16(29)9-10-22(15,3)25(17,27)19(30)13-23(18,4)26(21,33-24)20(31)14-28/h9-11,17-19,21,28,30H,5-8,12-14H2,1-4H3/t17-,18-,19-,21+,22-,23-,25-,26+/m0/s1	Amcinafal	(1S,2S,4R,8S,9S,11S,12R,13S)-6,6-diethyl-12-fluoro-11-hydroxy-8-(2-hydroxyacetyl)-9,13-dimethyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one	CCC1(CC)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1	10389615.0	R6_adenot_2004:766			BBB+	C	training
InChI=1S/C26H35FO6/c1-6-22(31)33-26(21(30)14-32-5)15(2)11-19-18-8-7-16-12-17(28)9-10-23(16,3)25(18,27)20(29)13-24(19,26)4/h9-10,12,15,18-20,29H,6-8,11,13-14H2,1-5H3/t15-,18-,19-,20-,23-,24-,25-,26-/m0/s1	Amelometasone	[(8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11-hydroxy-17-(2-methoxyacetyl)-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate	CCC(=O)O[C@]1(C(=O)COC)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C	443880.0	R6_adenot_2004:831			BBB+	C	training
InChI=1S/C26H35N3O2/c1-21(2)31-25-12-5-4-11-24(25)28-17-15-27(16-18-28)20-22-9-8-10-23(19-22)26(30)29-13-6-3-7-14-29/h4-5,8-12,19,21H,3,6-7,13-18,20H2,1-2H3	Mazapertine	piperidin-1-yl-[3-[[4-(2-propan-2-yloxyphenyl)piperazin-1-yl]methyl]phenyl]methanone	CC(C)Oc1ccccc1N1CCN(Cc2cccc(C(=O)N3CCCCC3)c2)CC1	60820.0	R6_adenot_2004:1214			BBB+	C	training
InChI=1S/C26H35NO4/c1-23(2,29)18-13-24-8-9-26(18,30-3)22-25(24)10-11-27(14-15-4-5-15)19(24)12-16-6-7-17(28)21(31-22)20(16)25/h6-7,15,18-19,22,28-29H,4-5,8-14H2,1-3H3/t18-,19-,22-,24-,25+,26-/m1/s1	Diprenorphine	(1S,2S,6R,14R,15R,16R)-5-(cyclopropylmethyl)-16-(2-hydroxypropan-2-yl)-15-methoxy-13-oxa-5-azahexacyclo[13.2.2.12,8.01,6.02,14.012,20]icosa-8(20),9,11-trien-11-ol	CO[C@]12CC[C@@]3(C[C@@H]1C(C)(C)O)[C@H]1Cc4ccc(O)c5c4[C@@]3(CCN1CC1CC1)[C@H]2O5	443408.0	R6_adenot_2004:1032			BBB+	C	training
InChI=1S/C26H36N2O4/c1-19(2)26(18-27,21-9-11-23(30-4)25(17-21)32-6)13-7-14-28-15-12-20-8-10-22(29-3)24(16-20)31-5/h8-11,16-17,19,28H,7,12-15H2,1-6H3	Norverapamil	2-(3,4-dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethylamino]-2-propan-2-ylpentanenitrile	COc1ccc(CCNCCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC	104972.0	R12_garg_2006:126|R21_muehlbacher_2011:284|R25_brito_sanchez_2015:330|R40_vilar_2010:167|R46_mendoza_valencia_2017:290|R47_radchenko_2020:281	-0.64	B	BBB+	A	training
InChI=1S/C26H36N2O5/c1-27(13-9-19-7-8-22(30-2)23(15-19)31-3)11-6-12-28-14-10-20-16-24(32-4)25(33-5)17-21(20)18-26(28)29/h7-8,15-17H,6,9-14,18H2,1-5H3	Zatebradine	3-[3-[2-(3,4-dimethoxyphenyl)ethyl-methylamino]propyl]-7,8-dimethoxy-2,5-dihydro-1H-3-benzazepin-4-one	COc1ccc(CCN(C)CCCN2CCc3cc(OC)c(OC)cc3CC2=O)cc1OC	65637.0	R14_ghose_2012:941			BBB-	C	training
InChI=1S/C26H36O5/c1-5-7-22(30)31-26(16(2)27)12-6-8-20-19-10-9-17-14-18(28)11-13-24(17,3)23(19)21(29)15-25(20,26)4/h11,13-14,19-21,23,29H,5-10,12,15H2,1-4H3/t19-,20-,21-,23+,24-,25-,26-/m0/s1	Domoprednate	[(1R,4aS,4bS,10aR,10bS,11S,12aS)-1-acetyl-11-hydroxy-10a,12a-dimethyl-8-oxo-2,3,4,4a,4b,5,6,10b,11,12-decahydrochrysen-1-yl] butanoate	CCCC(=O)O[C@]1(C(C)=O)CCC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C	68868.0	R6_adenot_2004:828			BBB+	C	training
InChI=1S/C26H36O6/c1-4-5-6-22(31)32-26(21(30)15-27)12-10-19-18-8-7-16-13-17(28)9-11-24(16,2)23(18)20(29)14-25(19,26)3/h9,11,13,18-20,23,27,29H,4-8,10,12,14-15H2,1-3H3/t18-,19-,20-,23+,24-,25-,26-/m0/s1	Prednival	[(8S,9S,10R,11S,13S,14S,17R)-11-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl] pentanoate	CCCCC(=O)O[C@]1(C(=O)CO)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C	9824723.0	R6_adenot_2004:900			BBB+	C	training
InChI=1S/C26H36O7/c1-5-22(31)33-26(21(30)14-32-15(2)27)11-9-19-18-7-6-16-12-17(28)8-10-24(16,3)23(18)20(29)13-25(19,26)4/h12,18-20,23,29H,5-11,13-14H2,1-4H3/t18-,19-,20-,23+,24-,25-,26-/m0/s1	Hydrocortisone-Aceponate|Hydrocortisone Aceponate	[(8S,9S,10R,11S,13S,14S,17R)-17-(2-acetyloxyacetyl)-11-hydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] propanoate	CCC(=O)O[C@]1(C(=O)COC(C)=O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C	68921.0	R6_adenot_2004:808			BBB+	C	training
InChI=1S/C26H37N5O2/c1-5-11-30-17-19(25(32)31(26(33)27-6-2)13-8-12-29(3)4)14-21-20-9-7-10-22-24(20)18(16-28-22)15-23(21)30/h5,7,9-10,16,19,21,23,28H,1,6,8,11-15,17H2,2-4H3,(H,27,33)/t19-,21-,23-/m1/s1	Cabergoline	(6aR,9R,10aR)-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)-7-prop-2-enyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide	C=CCN1C[C@H](C(=O)N(CCCN(C)C)C(=O)NCC)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21	54746.0	R6_adenot_2004:990|R14_ghose_2012:33|R23_gupta_2019:35|R37_chen_2011:16|R50_sobanska_2019:96			BBB+	C	test
InChI=1S/C26H37NO3/c1-18(2)26(29)30-25-13-12-21(17-28)16-24(25)23(22-10-8-7-9-11-22)14-15-27(19(3)4)20(5)6/h7-13,16,18-20,23,28H,14-15,17H2,1-6H3/t23-/m1/s1	Fesoterodine	[2-[(1R)-3-[di(propan-2-yl)amino]-1-phenylpropyl]-4-(hydroxymethyl)phenyl] 2-methylpropanoate	CC(C)C(=O)Oc1ccc(CO)cc1[C@H](CCN(C(C)C)C(C)C)c1ccccc1	6918558.0	R23_gupta_2019:287			BBB+	C	training
InChI=1S/C26H38N2O4/c1-24-8-6-18(29)14-17(24)4-5-19-20-7-9-26(32,25(20,2)15-21(30)23(19)24)22(31)16-28-12-10-27(3)11-13-28/h6,8,14,19-21,23,30,32H,4-5,7,9-13,15-16H2,1-3H3/t19-,20-,21-,23+,24-,25-,26-/m0/s1	Mazipredone	(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-17-[2-(4-methylpiperazin-1-yl)acetyl]-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one	CN1CCN(CC(=O)[C@@]2(O)CC[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@@]32C)CC1	6064.0	R6_adenot_2004:874			BBB+	C	training
InChI=1S/C26H38N2O4/c1-3-13-27(20-16-21-22(31-2)9-8-10-23(21)32-19-20)14-6-7-15-28-24(29)17-26(18-25(28)30)11-4-5-12-26/h8-10,20H,3-7,11-19H2,1-2H3/t20-/m0/s1	Alnespirone	8-[4-[[(3S)-5-methoxy-3,4-dihydro-2H-chromen-3-yl]-propylamino]butyl]-8-azaspiro[4.5]decane-7,9-dione	CCCN(CCCCN1C(=O)CC2(CCCC2)CC1=O)[C@@H]1COc2cccc(OC)c2C1	178132.0	R6_adenot_2004:485			BBB+	C	test
InChI=1S/C26H38O6/c1-4-5-6-22(31)32-26(21(30)15-27)12-10-19-18-8-7-16-13-17(28)9-11-24(16,2)23(18)20(29)14-25(19,26)3/h13,18-20,23,27,29H,4-12,14-15H2,1-3H3/t18-,19-,20-,23+,24-,25-,26-/m0/s1	Hydrocortisone-Valerate|Hydrocortisone Valerate	[(8S,9S,10R,11S,13S,14S,17R)-11-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] pentanoate	CCCCC(=O)O[C@]1(C(=O)CO)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C	5282494.0	R6_adenot_2004:803			BBB+	C	training
InChI=1S/C26H40N6O2/c1-18(2)32-13-7-20(8-14-32)17-34-25-22(24(33)28-3)23(30-21(15-27)31-25)29-16-19-5-11-26(12-6-19)9-4-10-26/h18-20H,4-14,16-17H2,1-3H3,(H,28,33)(H,29,30,31)	Irie-16A|2-Cyano-4-((1-Isopropylpiperidin-4-Yl)Methoxy)-N-Methyl-6-(Spiro[3.5]Nonan-7-Ylmethylamino)Pyrimidine-5-Carboxamide	2-cyano-N-methyl-4-[(1-propan-2-ylpiperidin-4-yl)methoxy]-6-(spiro[3.5]nonan-7-ylmethylamino)pyrimidine-5-carboxamide	CNC(=O)c1c(NCC2CCC3(CCC3)CC2)nc(C#N)nc1OCC1CCN(C(C)C)CC1	44579123.0	R26_chico_2009:226	0.08	A	BBB+	A	training
InChI=1S/C26H40N6O2/c1-24(2)13-18(14-25(3,4)32-24)34-23-20(22(33)28-5)21(30-19(15-27)31-23)29-16-17-7-11-26(12-8-17)9-6-10-26/h17-18,32H,6-14,16H2,1-5H3,(H,28,33)(H,29,30,31)	Irie-13A|2-Cyano-N-Methyl-4-(Spiro[3.5]Nonan-7-Ylmethylamino)-6-(2,2,6,6-Tetramethylpiperidin-4-Yloxy)Pyrimidine-5-Carboxamide	2-cyano-N-methyl-4-(spiro[3.5]nonan-7-ylmethylamino)-6-(2,2,6,6-tetramethylpiperidin-4-yl)oxypyrimidine-5-carboxamide	CNC(=O)c1c(NCC2CCC3(CCC3)CC2)nc(C#N)nc1OC1CC(C)(C)NC(C)(C)C1	44579172.0	R26_chico_2009:223	-0.24	A	BBB+	A	training
InChI=1S/C26H41BrNO4/c1-26(2)21-6-5-19(22(26)16-21)7-11-31-12-8-28(9-13-32-14-10-28)18-20-15-24(29-3)25(30-4)17-23(20)27/h15,17,19,21-22H,5-14,16,18H2,1-4H3/q+1	Pinaverium	4-[(2-bromo-4,5-dimethoxyphenyl)methyl]-4-[2-[2-(6,6-dimethyl-2-bicyclo[3.1.1]heptanyl)ethoxy]ethyl]morpholin-4-ium	COc1cc(Br)c(C[N+]2(CCOCCC3CCC4CC3C4(C)C)CCOCC2)cc1OC	40704.0	R14_ghose_2012:774			BBB-	C	training
InChI=1S/C26H44O9/c1-16(13-23(30)33-11-9-7-5-4-6-8-10-22(28)29)12-20-25(32)24(31)19(15-34-20)14-21-26(35-21)17(2)18(3)27/h13,17-21,24-27,31-32H,4-12,14-15H2,1-3H3,(H,28,29)/b16-13+/t17-,18-,19-,20-,21-,24+,25-,26-/m0/s1	Mupirocin	9-[(E)-4-[(2S,3R,4R,5S)-3,4-dihydroxy-5-[[(2S,3S)-3-[(2S,3S)-3-hydroxybutan-2-yl]oxiran-2-yl]methyl]oxan-2-yl]-3-methylbut-2-enoyl]oxynonanoic acid	C/C(=C\C(=O)OCCCCCCCCC(=O)O)C[C@@H]1OC[C@H](C[C@@H]2O[C@H]2[C@@H](C)[C@H](C)O)[C@@H](O)[C@H]1O	446596.0	R23_gupta_2019:762			BBB-	C	training
InChI=1S/C26H45NO6S/c1-16(4-7-23(30)27-12-13-34(31,32)33)19-5-6-20-24-21(9-11-26(19,20)3)25(2)10-8-18(28)14-17(25)15-22(24)29/h16-22,24,28-29H,4-15H2,1-3H3,(H,27,30)(H,31,32,33)/t16-,17+,18-,19-,20+,21+,22+,24+,25+,26-/m1/s1	Tauroursodeoxycholic Acid	2-[[(4R)-4-[(3R,5S,7S,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]ethanesulfonic acid	C[C@H](CCC(=O)NCCS(=O)(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C	9848818.0	R23_gupta_2019:953			BBB-	C	training
InChI=1S/C27H22Cl2N4/c1-17(2)30-24-16-27-25(15-23(24)31-20-11-7-18(28)8-12-20)32-22-5-3-4-6-26(22)33(27)21-13-9-19(29)10-14-21/h3-17,31H,1-2H3/b30-24+	Clofazimine	N,5-bis(4-chlorophenyl)-3-propan-2-yliminophenazin-2-amine	CC(C)/N=c1\cc2n(-c3ccc(Cl)cc3)c3ccccc3nc-2cc1Nc1ccc(Cl)cc1	2794.0	R6_adenot_2004:13|R14_ghose_2012:461|R23_gupta_2019:472|R28_li_2005:251			BBB-	C	training
InChI=1S/C27H23N5O4/c33-23-17-24(26-29-31-32-30-26)36-25-21(23)10-6-11-22(25)28-27(34)19-12-14-20(15-13-19)35-16-5-4-9-18-7-2-1-3-8-18/h1-3,6-8,10-15,17H,4-5,9,16H2,(H,28,34)(H,29,30,31,32)	Pranlukast	N-[4-oxo-2-(2H-tetrazol-5-yl)chromen-8-yl]-4-(4-phenylbutoxy)benzamide	O=C(Nc1cccc2c(=O)cc(-c3nn[nH]n3)oc12)c1ccc(OCCCCc2ccccc2)cc1	4887.0	R23_gupta_2019:854			BBB-	C	training
InChI=1S/C27H24N2O4/c1-2-21(18-11-5-3-6-12-18)29-27(32)24-20-15-9-10-16-22(20)28-25(19-13-7-4-8-14-19)26(24)33-17-23(30)31/h3-16,21H,2,17H2,1H3,(H,29,32)(H,30,31)/t21-/m0/s1	Sb 235375|Skb-D|(-)-(S)-N-(Alpha-Ethylbenzyl)-3-(Carboxymethoxy)-2-Phenylquinoline-4-Carboxamide	2-[2-phenyl-4-[[(1S)-1-phenylpropyl]carbamoyl]quinolin-3-yl]oxyacetic acid	CC[C@H](NC(=O)c1c(OCC(=O)O)c(-c2ccccc2)nc2ccccc12)c1ccccc1	9846078.0	R26_chico_2009:364|R28_li_2005:404	-1.0	A	BBB+	A	training
InChI=1S/C27H25F2N3OS/c1-18-24(26(33)32-16-17-34-27(32)30-18)12-15-31-13-10-21(11-14-31)25(19-2-6-22(28)7-3-19)20-4-8-23(29)9-5-20/h2-9,16-17H,10-15H2,1H3	Ritanserin	6-[2-[4-[bis(4-fluorophenyl)methylidene]piperidin-1-yl]ethyl]-7-methyl-[1,3]thiazolo[3,2-a]pyrimidin-5-one	Cc1nc2sccn2c(=O)c1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1	5074.0	R14_ghose_2012:290|R23_gupta_2019:311|R47_radchenko_2020:393	0.3	A	BBB+	A	training
InChI=1S/C27H25F2NO4/c28-21-5-1-18(2-6-21)24-11-12-30(15-25(31)19-3-7-22(29)8-4-19)14-20(24)16-32-23-9-10-26-27(13-23)34-17-33-26/h1-10,13,20,24H,11-12,14-17H2	Omiloxetine	2-[3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidin-1-yl]-1-(4-fluorophenyl)ethanone	O=C(CN1CCC(c2ccc(F)cc2)C(COc2ccc3c(c2)OCO3)C1)c1ccc(F)cc1	9981949.0	R6_adenot_2004:532			BBB+	C	training
InChI=1S/C27H25F3N2O/c28-19-5-3-18(4-6-19)27(33)2-1-14-31-15-13-26-24(17-31)23-16-21(30)9-12-25(23)32(26)22-10-7-20(29)8-11-22/h3-12,16,27,33H,1-2,13-15,17H2	Flutroline	4-[8-fluoro-5-(4-fluorophenyl)-3,4-dihydro-1H-pyrido[4,3-b]indol-2-yl]-1-(4-fluorophenyl)butan-1-ol	OC(CCCN1CCc2c(c3cc(F)ccc3n2-c2ccc(F)cc2)C1)c1ccc(F)cc1	51174.0	R6_adenot_2004:1471			BBB+	C	training
InChI=1S/C27H27ClN4O2/c1-19-14-25(27(33)30-24-11-8-20(9-12-24)16-29-2)31-32(19)17-22-15-23(28)10-13-26(22)34-18-21-6-4-3-5-7-21/h3-15,29H,16-18H2,1-2H3,(H,30,33)	Compound-10B|1-[(5-Chloro-2-Phenylmethoxyphenyl)Methyl]-5-Methyl-N-[4-(Methylaminomethyl)Phenyl]Pyrazole-3-Carboxamide	1-[(5-chloro-2-phenylmethoxyphenyl)methyl]-5-methyl-N-[4-(methylaminomethyl)phenyl]pyrazole-3-carboxamide	CNCc1ccc(NC(=O)c2cc(C)n(Cc3cc(Cl)ccc3OCc3ccccc3)n2)cc1	24894002.0	R26_chico_2009:125	0.15	A	BBB+	A	training
InChI=1S/C27H27N5O9S3/c1-12(28)24(35)41-20(15-7-5-4-6-8-15)21(33)29-18-22(34)32-19(25(36)38-9-17-13(2)39-27(37)40-17)16(10-42-23(18)32)11-43-26-31-30-14(3)44-26/h4-8,12,18,20,23H,9-11,28H2,1-3H3,(H,29,33)/t12-,18+,20+,23+/m0/s1	Cefcanel-Daloxate|Cefcanel Daloxate	(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl (6R,7R)-7-[[(2R)-2-[(2S)-2-aminopropanoyl]oxy-2-phenylacetyl]amino]-3-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate	Cc1nnc(SCC2=C(C(=O)OCc3oc(=O)oc3C)N3C(=O)[C@@H](NC(=O)[C@H](OC(=O)[C@H](C)N)c4ccccc4)[C@H]3SC2)s1	179697.0	R6_adenot_2004:166			BBB-	C	training
InChI=1S/C27H28N8O9S2/c1-27(2)19(24(40)41)35-22(39)18(23(35)45-27)32-21(38)17(12-3-7-14(36)8-4-12)33-26(42)31-16-11-29-25(34-20(16)37)30-13-5-9-15(10-6-13)46(28,43)44/h3-11,17-19,23,36H,1-2H3,(H,32,38)(H,40,41)(H2,28,43,44)(H2,31,33,42)(H2,29,30,34,37)/t17-,18-,19+,23-/m1/s1	Piroxicillin	(2S,5R,6R)-6-[[(2R)-2-(4-hydroxyphenyl)-2-[[6-oxo-2-(4-sulfamoylanilino)-1H-pyrimidin-5-yl]carbamoylamino]acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid	CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](NC(=O)Nc3cnc(Nc4ccc(S(N)(=O)=O)cc4)[nH]c3=O)c3ccc(O)cc3)C(=O)N2[C@H]1C(=O)O	3047855.0	R6_adenot_2004:255			BBB-	C	training
InChI=1S/C27H29N3O2/c1-19-9-4-5-10-22(19)26(31)28-21-16-14-20(15-17-21)27(32)30-18-8-13-24(29(2)3)23-11-6-7-12-25(23)30/h4-7,9-12,14-17,24H,8,13,18H2,1-3H3,(H,28,31)	Mozavaptan	N-[4-[5-(dimethylamino)-2,3,4,5-tetrahydro-1-benzazepine-1-carbonyl]phenyl]-2-methylbenzamide	Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCC(N(C)C)c3ccccc32)cc1	119369.0	R23_gupta_2019:761			BBB-	C	training
InChI=1S/C27H29N5O6S/c1-27(2,3)18-10-12-19(13-11-18)39(34,35)32-23-22(38-21-9-6-5-8-20(21)36-4)26(37-17-16-33)31-25(30-23)24-28-14-7-15-29-24/h5-15,33H,16-17H2,1-4H3,(H,30,31,32)	Bosentan	4-tert-butyl-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]benzenesulfonamide	COc1ccccc1Oc1c(NS(=O)(=O)c2ccc(C(C)(C)C)cc2)nc(-c2ncccn2)nc1OCCO	104865.0	R14_ghose_2012:401|R23_gupta_2019:398			BBB-	C	training
InChI=1S/C27H29NO10/c1-10-22(30)14(28)7-17(37-10)38-16-9-27(35,11(2)29)8-13-19(16)26(34)21-20(24(13)32)23(31)12-5-4-6-15(36-3)18(12)25(21)33/h4-6,10,14,16-17,22,30,32,34-35H,7-9,28H2,1-3H3/t10-,14-,16-,17-,22+,27-/m0/s1	Daunorubicin	(7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione	COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(C)=O)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1	30323.0	R6_adenot_2004:15|R6_adenot_2004:324|R23_gupta_2019:499|R28_li_2005:185			BBB-	C	training
InChI=1S/C27H29NO10/c1-11-6-12(28)7-18(37-11)38-16-9-27(35,17(30)10-29)8-14-20(16)26(34)22-21(24(14)32)23(31)13-4-3-5-15(36-2)19(13)25(22)33/h3-5,11-12,16,18,29,32,34-35H,6-10,28H2,1-2H3/t11-,12+,16-,18-,27-/m0/s1	Esorubicin	(7S,9S)-7-[(2S,4R,6S)-4-amino-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione	COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)C[C@H](C)O1	152036.0	R6_adenot_2004:328			BBB-	C	training
InChI=1S/C27H29NO11/c1-10-22(31)13(28)6-17(38-10)39-15-8-27(36,16(30)9-29)7-12-19(15)26(35)21-20(24(12)33)23(32)11-4-3-5-14(37-2)18(11)25(21)34/h3-5,10,13,15,17,22,29,31,33,35-36H,6-9,28H2,1-2H3/t10-,13-,15-,17-,22+,27-/m0/s1	Doxorubicin	(7S,9S)-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione	COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1	31703.0	R6_adenot_2004:23|R6_adenot_2004:334|R21_muehlbacher_2011:241|R25_brito_sanchez_2015:392|R28_li_2005:194|R40_vilar_2010:104|R47_radchenko_2020:360|R51_doninger_2002:43	-0.83	B	BBB+	A	training
InChI=1S/C27H29NO11/c1-10-22(31)13(28)6-17(38-10)39-15-8-27(36,16(30)9-29)7-12-19(15)26(35)21-20(24(12)33)23(32)11-4-3-5-14(37-2)18(11)25(21)34/h3-5,10,13,15,17,22,29,31,33,35-36H,6-9,28H2,1-2H3/t10-,13-,15-,17-,22-,27-/m0/s1	Epirubicin	(7S,9S)-7-[(2R,4S,5R,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione	COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@@H](O)[C@H](C)O1	41867.0	R6_adenot_2004:327|R23_gupta_2019:564			BBB-	C	training
InChI=1S/C27H30Cl2O6/c1-15-11-19-18-7-6-16-12-17(30)8-9-24(16,2)26(18,29)21(31)13-25(19,3)27(15,22(32)14-28)35-23(33)20-5-4-10-34-20/h4-5,8-10,12,15,18-19,21,31H,6-7,11,13-14H2,1-3H3/t15-,18+,19+,21+,24+,25+,26+,27+/m1/s1	Mometasone-Furoate|Mometasone Furoate	[(8S,9R,10S,11S,13S,14S,16R,17R)-9-chloro-17-(2-chloroacetyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] furan-2-carboxylate	C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)c1ccco1)C(=O)CCl	441336.0	R6_adenot_2004:883			BBB+	C	training
InChI=1S/C27H30F6N2O2/c1-24-11-9-17-15(4-8-21-25(17,2)12-10-22(36)35-21)16(24)6-7-19(24)23(37)34-20-13-14(26(28,29)30)3-5-18(20)27(31,32)33/h3,5,10,12-13,15-17,19,21H,4,6-9,11H2,1-2H3,(H,34,37)(H,35,36)/t15-,16-,17-,19+,21+,24-,25+/m0/s1	Dutasteride	(1S,3aS,3bS,5aR,9aR,9bS,11aS)-N-[2,5-bis(trifluoromethyl)phenyl]-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamide	C[C@]12C=CC(=O)N[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](C(=O)Nc3cc(C(F)(F)F)ccc3C(F)(F)F)CC[C@@H]12	6918296.0	R14_ghose_2012:516|R23_gupta_2019:542			BBB-	C	training
InChI=1S/C27H30N2O2/c1-28(25(21-11-5-2-6-12-21)20-29-18-17-24(30)19-29)27(31)26(22-13-7-3-8-14-22)23-15-9-4-10-16-23/h2-16,24-26,30H,17-20H2,1H3/t24-,25+/m0/s1	Asimadoline	N-[(1S)-2-[(3S)-3-hydroxypyrrolidin-1-yl]-1-phenylethyl]-N-methyl-2,2-diphenylacetamide	CN(C(=O)C(c1ccccc1)c1ccccc1)[C@H](CN1CC[C@H](O)C1)c1ccccc1	179340.0	R6_adenot_2004:1034|R7_andres_2006:12|R26_chico_2009:37|R29_subramanian_2003:12	-0.51	A	BBB+	A	training
InChI=1S/C27H30N2O6S/c1-16(2)25(32)34-15-18-11-8-12-19(13-18)35-26(33)22-27(3,4)36-24-21(23(31)29(22)24)28-20(30)14-17-9-6-5-7-10-17/h5-13,16,21-22,24H,14-15H2,1-4H3,(H,28,30)/t21-,22+,24-/m1/s1	Tobicillin	[3-(2-methylpropanoyloxymethyl)phenyl] (2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate	CC(C)C(=O)OCc1cccc(OC(=O)[C@@H]2N3C(=O)[C@@H](NC(=O)Cc4ccccc4)[C@H]3SC2(C)C)c1	216265.0	R6_adenot_2004:220			BBB-	C	training
InChI=1S/C27H30N4O3/c28-18-20-4-6-21(7-5-20)27(33)30-16-17-31(26(32)19-30)23-8-10-24(11-9-23)34-25-12-14-29(15-13-25)22-2-1-3-22/h4-11,22,25H,1-3,12-17,19H2	Proc-37E|4-(1-(4-(1-Cyclobutylpiperidin-4-Yloxy)Phenyl)-2-Oxopiperazine-4-Carbonyl)Benzonitrile Formic Acid	4-[4-[4-(1-cyclobutylpiperidin-4-yl)oxyphenyl]-3-oxopiperazine-1-carbonyl]benzonitrile	N#Cc1ccc(C(=O)N2CCN(c3ccc(OC4CCN(C5CCC5)CC4)cc3)C(=O)C2)cc1	15987108.0	R26_chico_2009:325	-0.7	A	BBB+	A	training
InChI=1S/C27H31N3O3/c1-19-6-8-22-23(28-19)4-3-5-25(22)32-15-14-30-12-10-20(11-13-30)16-21-7-9-26-24(17-21)29(2)27(31)18-33-26/h3-9,17,20H,10-16,18H2,1-2H3	Compound-1|4-Methyl-6-[[1-[2-(2-Methylquinolin-5-Yl)Oxyethyl]Piperidin-4-Yl]Methyl]-1,4-Benzoxazin-3-One	4-methyl-6-[[1-[2-(2-methylquinolin-5-yl)oxyethyl]piperidin-4-yl]methyl]-1,4-benzoxazin-3-one	Cc1ccc2c(OCCN3CCC(Cc4ccc5c(c4)N(C)C(=O)CO5)CC3)cccc2n1	10114480.0	R26_chico_2009:123	0.11	A	BBB+	A	training
InChI=1S/C27H31N7OS/c1-5-6-11-24-28-18(2)23(16-25(36)33(3)4)27(35)34(24)17-19-12-14-20(15-13-19)21-9-7-8-10-22(21)26-29-31-32-30-26/h7-10,12-15H,5-6,11,16-17H2,1-4H3,(H,29,30,31,32)	Fimasartan	2-[2-butyl-4-methyl-6-oxo-1-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]pyrimidin-5-yl]-N,N-dimethylethanethioamide	CCCCc1nc(C)c(CC(=S)N(C)C)c(=O)n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1	9870652.0	R23_gupta_2019:597			BBB-	C	training
InChI=1S/C27H32N2O3/c1-31-25-14-13-23(19-26(25)32-2)24(30)20-28-15-17-29(18-16-28)27(21-9-5-3-6-10-21)22-11-7-4-8-12-22/h3-14,19,24,27,30H,15-18,20H2,1-2H3	Tamolarizine	2-(4-benzhydrylpiperazin-1-yl)-1-(3,4-dimethoxyphenyl)ethanol	COc1ccc(C(O)CN2CCN(C(c3ccccc3)c3ccccc3)CC2)cc1OC	146396.0	R6_adenot_2004:1273			BBB+	C	test
InChI=1S/C27H32N2O6S2/c1-5-28(6-2)22-13-9-20(10-14-22)27(21-11-15-23(16-12-21)29(7-3)8-4)25-19-24(36(30,31)32)17-18-26(25)37(33,34)35/h9-19H,5-8H2,1-4H3,(H-,30,31,32,33,34,35)	Isosulfan Blue|Isosulfan Blue Inner Salt	2-[[4-(diethylamino)phenyl]-(4-diethylazaniumylidenecyclohexa-2,5-dien-1-ylidene)methyl]-4-sulfobenzenesulfonate	CCN(CC)c1ccc(C(=C2C=CC(=[N+](CC)CC)C=C2)c2cc(S(=O)(=O)O)ccc2S(=O)(=O)[O-])cc1	52946590.0	R23_gupta_2019:1067			BBB-	C	training
InChI=1S/C27H32N4O/c1-30(2)24-14-16-31(17-15-24)19-20-8-10-22(11-9-20)27(32)29-26-18-23(12-13-25(26)28)21-6-4-3-5-7-21/h3-13,18,24H,14-17,19,28H2,1-2H3,(H,29,32)	20		CN(C)C1CCN(Cc2ccc(C(=O)Nc3cc(-c4ccccc4)ccc3N)cc2)CC1		R47_radchenko_2020:522	-0.11	A	BBB+	A	training
InChI=1S/C27H32N4O3S2/c1-3-34-23-13-11-21(28-18-23)16-26-29-24-17-22(30(2)36(32,33)27-10-7-15-35-27)12-14-25(24)31(26)19-20-8-5-4-6-9-20/h7,10-15,17-18,20H,3-6,8-9,16,19H2,1-2H3	4|Mn7Rr3Vql7	N-[1-(cyclohexylmethyl)-2-[(5-ethoxypyridin-2-yl)methyl]benzimidazol-5-yl]-N-methylthiophene-2-sulfonamide	CCOc1ccc(Cc2nc3cc(N(C)S(=O)(=O)c4cccs4)ccc3n2CC2CCCCC2)nc1	57390958.0	R25_brito_sanchez_2015:529|R46_mendoza_valencia_2017:443	-1.15	B	BBB-	A	training
InChI=1S/C27H33ClN4O2/c1-19(2)18-34-25-11-10-24(28)15-23(25)17-32-20(3)14-26(30-32)29-27(33)22-8-6-21(7-9-22)16-31-12-4-5-13-31/h6-11,14-15,19H,4-5,12-13,16-18H2,1-3H3,(H,29,30,33)	Compound-4J|N-[1-[[5-Chloro-2-(2-Methylpropoxy)Phenyl]Methyl]-5-Methylpyrazol-3-Yl]-4-(Pyrrolidin-1-Ylmethyl)Benzamide	N-[1-[[5-chloro-2-(2-methylpropoxy)phenyl]methyl]-5-methylpyrazol-3-yl]-4-(pyrrolidin-1-ylmethyl)benzamide	Cc1cc(NC(=O)c2ccc(CN3CCCC3)cc2)nn1Cc1cc(Cl)ccc1OCC(C)C	24894001.0	R26_chico_2009:132	0.3	A	BBB+	A	training
InChI=1S/C27H33N3O6S/c1-27(2)23-14-11-20(36-3)17-22(23)24(31)30(25(27)32)16-15-18-9-12-21(13-10-18)37(34,35)29-26(33)28-19-7-5-4-6-8-19/h9-14,17,19H,4-8,15-16H2,1-3H3,(H2,28,29,33)	Gliquidone	1-cyclohexyl-3-[4-[2-(7-methoxy-4,4-dimethyl-1,3-dioxoisoquinolin-2-yl)ethyl]phenyl]sulfonylurea	COc1ccc2c(c1)C(=O)N(CCc1ccc(S(=O)(=O)NC(=O)NC3CCCCC3)cc1)C(=O)C2(C)C	91610.0	R14_ghose_2012:593|R23_gupta_2019:637			BBB-	C	training
InChI=1S/C27H33N3O8/c1-26(37)13-7-6-8-16(31)17(13)21(32)18-14(26)11-15-20(29(2)3)22(33)19(24(35)27(15,38)23(18)34)25(36)28-12-30-9-4-5-10-30/h6-8,14-15,20,31-32,35,37-38H,4-5,9-12H2,1-3H3,(H,28,36)/t14-,15-,20-,26+,27-/m0/s1	Rolitetracycline	(4S,4aS,5aS,6S,12aR)-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-N-(pyrrolidin-1-ylmethyl)-4,4a,5,5a-tetrahydrotetracene-2-carboxamide	CN(C)[C@@H]1C(=O)C(C(=O)NCN2CCCC2)=C(O)[C@@]2(O)C(=O)C3=C(O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12	54682938.0	R6_adenot_2004:319|R23_gupta_2019:893			BBB-	C	training
InChI=1S/C27H34F2O7/c1-5-6-23(34)36-26(22(33)14-35-15(2)30)10-8-17-18-12-20(28)19-11-16(31)7-9-24(19,3)27(18,29)21(32)13-25(17,26)4/h7,9,11,17-18,20-21,32H,5-6,8,10,12-14H2,1-4H3/t17-,18-,20-,21-,24-,25-,26-,27-/m0/s1	Difluprednate	[(6S,8S,9R,10S,11S,13S,14S,17R)-17-(2-acetyloxyacetyl)-6,9-difluoro-11-hydroxy-10,13-dimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] butanoate	CCCC(=O)O[C@]1(C(=O)COC(C)=O)CC[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C	443936.0	R6_adenot_2004:826			BBB+	C	training
InChI=1S/C27H34F2O7/c1-6-22(33)34-13-20(32)27-21(35-23(2,3)36-27)11-15-16-10-18(28)17-9-14(30)7-8-24(17,4)26(16,29)19(31)12-25(15,27)5/h7-9,15-16,18-19,21,31H,6,10-13H2,1-5H3/t15-,16-,18-,19-,21+,24-,25-,26-,27+/m0/s1	Procinonide	[2-[(1S,2S,4R,8S,9S,11S,12R,13S,19S)-12,19-difluoro-11-hydroxy-6,6,9,13-tetramethyl-16-oxo-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-8-yl]-2-oxoethyl] propanoate	CCC(=O)OCC(=O)[C@@]12OC(C)(C)O[C@@H]1C[C@H]1[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]12C	9806281.0	R6_adenot_2004:903			BBB+	C	training
InChI=1S/C27H34N2O7/c1-5-36-27(33)21(12-11-18-9-7-6-8-10-18)28-17(2)25(30)29-16-20-15-24(35-4)23(34-3)14-19(20)13-22(29)26(31)32/h6-10,14-15,17,21-22,28H,5,11-13,16H2,1-4H3,(H,31,32)/t17-,21-,22-/m0/s1	Moexipril Hydrochloride|Moexipril	(3S)-2-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-6,7-dimethoxy-3,4-dihydro-1H-isoquinoline-3-carboxylic acid	CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1Cc2cc(OC)c(OC)cc2C[C@H]1C(=O)O	91270.0	R14_ghose_2012:701|R23_gupta_2019:759			BBB-	C	training
InChI=1S/C27H34N4O/c28-22-26(23-10-4-1-5-11-23,24-12-6-2-7-13-24)14-19-30-20-15-27(16-21-30,25(29)32)31-17-8-3-9-18-31/h1-2,4-7,10-13H,3,8-9,14-21H2,(H2,29,32)	Piritramide	1-(3-cyano-3,3-diphenylpropyl)-4-piperidin-1-ylpiperidine-4-carboxamide	N#CC(CCN1CCC(C(N)=O)(N2CCCCC2)CC1)(c1ccccc1)c1ccccc1	9331.0	R6_adenot_2004:1102			BBB+	C	training
InChI=1S/C27H34O3/c1-27-16-15-22-21-11-9-20(28)17-19(21)8-10-23(22)24(27)12-13-25(27)30-26(29)14-7-18-5-3-2-4-6-18/h2-6,17,21-25H,7-16H2,1H3/t21-,22+,23+,24-,25-,27-/m0/s1	Nandrolone Phenpropionate	[(8R,9S,10R,13S,14S,17S)-13-methyl-3-oxo-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl] 3-phenylpropanoate	C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@H]43)[C@@H]1CC[C@@H]2OC(=O)CCc1ccccc1	229455.0	R23_gupta_2019:769			BBB-	C	training
InChI=1S/C27H35NO4/c1-29-24-5-3-4-21(17-24)16-20-10-14-28(15-11-20)23-8-12-27(30-2,13-9-23)22-6-7-25-26(18-22)32-19-31-25/h3-7,17-18,20,23H,8-16,19H2,1-2H3	167782-15-2|Bms-184111 Hcl|1-[4-(1,3-Benzodioxol-5-Yl)-4-Methoxycyclohexyl]-4-[(3-Methoxyphenyl)Methyl]Piperidine	1-[4-(1,3-benzodioxol-5-yl)-4-methoxycyclohexyl]-4-[(3-methoxyphenyl)methyl]piperidine	COc1cccc(CC2CCN(C3CCC(OC)(c4ccc5c(c4)OCO5)CC3)CC2)c1	10388384.0	R4_mente_2005:160|R40_vilar_2010:55|R47_radchenko_2020:391	0.74	B	BBB+	A	training
InChI=1S/C27H35NO4/c1-5-9-24(3,30)19-16-25-10-11-27(19,31-4)23-26(25)12-14-28(13-6-2)20(25)15-17-7-8-18(29)22(32-23)21(17)26/h6-8,10-11,19-20,23,29-30H,2,5,9,12-16H2,1,3-4H3/t19-,20-,23-,24-,25-,26+,27-/m1/s1	Alletorphine|Alletorphinum	(1R,2S,6R,14R,15R,19R)-19-[(2R)-2-hydroxypentan-2-yl]-15-methoxy-5-prop-2-enyl-13-oxa-5-azahexacyclo[13.2.2.12,8.01,6.02,14.012,20]icosa-8(20),9,11,16-tetraen-11-ol	C=CCN1CC[C@]23c4c5ccc(O)c4O[C@H]2[C@@]2(OC)C=C[C@@]3(C[C@@H]2[C@](C)(O)CCC)[C@H]1C5	15942835.0	R6_adenot_2004:1006			BBB+	C	training
InChI=1S/C27H35NO5/c1-6-9-24(3,30)19-15-25-10-11-27(19,31-5)23-26(25)12-13-28(4)20(25)14-17-7-8-18(32-16(2)29)22(33-23)21(17)26/h7-8,10-11,19-20,23,30H,6,9,12-15H2,1-5H3/t19-,20-,23-,24-,25-,26+,27-/m1/s1	Acetorphine	[(1R,2S,6R,14R,15R,19R)-19-[(2R)-2-hydroxypentan-2-yl]-15-methoxy-5-methyl-13-oxa-5-azahexacyclo[13.2.2.12,8.01,6.02,14.012,20]icosa-8(20),9,11,16-tetraen-11-yl] acetate	CCC[C@@](C)(O)[C@H]1C[C@@]23C=C[C@]1(OC)[C@@H]1Oc4c(OC(C)=O)ccc5c4[C@@]12CCN(C)[C@@H]3C5	20055090.0	R6_adenot_2004:1003			BBB+	C	training
InChI=1S/C27H35NO8/c1-15-7-10-20(31)11-8-16(2)13-23(28-25(33)18(4)29)27(6)24(32)17(3)22(36-26(27)34)14-21(12-9-15)35-19(5)30/h7-9,11-13,17,20-23,31H,10,14H2,1-6H3,(H,28,33)/b11-8+,12-9+,15-7+,16-13+/t17-,20+,21-,22-,23-,27+/m1/s1	Sedecamycin|Lankacidin A	[(1S,2R,3E,5E,7S,9E,11E,13S,15R,19R)-7-hydroxy-1,4,10,19-tetramethyl-17,18-dioxo-2-(2-oxopropanoylamino)-16-oxabicyclo[13.2.2]nonadeca-3,5,9,11-tetraen-13-yl] acetate	CC(=O)O[C@@H]1/C=C/C(C)=C/C[C@H](O)/C=C/C(C)=C/[C@@H](NC(=O)C(C)=O)[C@]2(C)C(=O)O[C@H](C1)[C@@H](C)C2=O	6917975.0	R6_adenot_2004:123			BBB-	C	training
InChI=1S/C27H36ClFO5/c1-14-9-16-17-11-19(29)18-10-15(30)7-8-26(18,6)27(17,28)21(32)12-25(16,5)22(14)20(31)13-34-23(33)24(2,3)4/h7-8,10,14,16-17,19,21-22,32H,9,11-13H2,1-6H3/t14-,16+,17+,19+,21+,22-,25+,26+,27+/m1/s1	Clocortolone-Pivalate|Clocortolone Pivalate	[2-[(6S,8S,9R,10S,11S,13S,14S,16R,17S)-9-chloro-6-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-7,8,11,12,14,15,16,17-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] 2,2-dimethylpropanoate	C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@H]1C(=O)COC(=O)C(C)(C)C	5282493.0	R6_adenot_2004:791			BBB+	C	training
InChI=1S/C27H36F2O5/c1-14-9-16-17-11-19(28)18-10-15(30)7-8-26(18,6)27(17,29)21(32)12-25(16,5)22(14)20(31)13-34-23(33)24(2,3)4/h7-8,10,14,16-17,19,21-22,32H,9,11-13H2,1-6H3/t14-,16+,17+,19+,21+,22-,25+,26+,27+/m1/s1	Diflucortolone-Pivalate|Diflucortolone Pivalate	[2-[(6S,8S,9R,10S,11S,13S,14S,16R,17S)-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-7,8,11,12,14,15,16,17-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] 2,2-dimethylpropanoate	C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@H]1C(=O)COC(=O)C(C)(C)C	66381.0	R6_adenot_2004:825			BBB+	C	training
InChI=1S/C27H36F2O6/c1-14-9-16-17-11-19(28)18-10-15(30)7-8-24(18,5)26(17,29)20(31)12-25(16,6)27(14,34)21(32)13-35-22(33)23(2,3)4/h7-8,10,14,16-17,19-20,31,34H,9,11-13H2,1-6H3/t14-,16?,17?,19+,20+,24+,25+,26+,27+/m1/s1	Flumetasone-Pivalate|Flumethazone Pivalate	[2-[(6S,9R,10S,11S,13S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] 2,2-dimethylpropanoate	C[C@@H]1CC2C3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)C(C)(C)C	5702055.0	R6_adenot_2004:841			BBB+	C	test
InChI=1S/C27H36FN3O/c1-3-29(4-2)19-22-5-8-24-18-26(12-9-23(24)17-22)31-16-15-30(20-27(31)32)14-13-21-6-10-25(28)11-7-21/h5-8,10-11,17,26H,3-4,9,12-16,18-20H2,1-2H3	Mchr Antagonist 1|1-(6-((Diethylamino)Methyl)-1,2,3,4-Tetrahydronaphthalen-2-Yl)-4-(4-Fluorophenethyl)Piperazin-2-One	1-[6-(diethylaminomethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]-4-[2-(4-fluorophenyl)ethyl]piperazin-2-one	CCN(CC)Cc1ccc2c(c1)CCC(N1CCN(CCc3ccc(F)cc3)CC1=O)C2	44592215.0	R25_brito_sanchez_2015:462|R46_mendoza_valencia_2017:387	0.48	B	BBB+	A	training
InChI=1S/C27H36N2O4/c1-4-33-25-17-20(12-13-22(25)27(31)32)18-26(30)28-23(16-19(2)3)21-10-6-7-11-24(21)29-14-8-5-9-15-29/h6-7,10-13,17,19,23H,4-5,8-9,14-16,18H2,1-3H3,(H,28,30)(H,31,32)/t23-/m0/s1	Repaglinide	2-ethoxy-4-[2-[[(1S)-3-methyl-1-(2-piperidin-1-ylphenyl)butyl]amino]-2-oxoethyl]benzoic acid	CCOc1cc(CC(=O)N[C@@H](CC(C)C)c2ccccc2N2CCCCC2)ccc1C(=O)O	65981.0	R14_ghose_2012:819|R23_gupta_2019:881			BBB-	C	training
InChI=1S/C27H36O7/c1-6-23(32)34-27(22(31)14-33-16(3)28)10-8-19-18-11-15(2)20-12-17(29)7-9-25(20,4)24(18)21(30)13-26(19,27)5/h7,9,12,15,18-19,21,24,30H,6,8,10-11,13-14H2,1-5H3/t15-,18-,19-,21-,24+,25-,26-,27-/m0/s1	Methylprednisolone-Aceponate|Methylprednisolone Aceponate	[(6S,8S,9S,10R,11S,13S,14S,17R)-17-(2-acetyloxyacetyl)-11-hydroxy-6,10,13-trimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl] propanoate	CCC(=O)O[C@]1(C(=O)COC(C)=O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C	63019.0	R6_adenot_2004:878			BBB+	C	training
InChI=1S/C27H36O8/c1-5-22(31)34-15-21(30)27(35-24(32)33-6-2)12-10-19-18-8-7-16-13-17(28)9-11-25(16,3)23(18)20(29)14-26(19,27)4/h9,11,13,18-20,23,29H,5-8,10,12,14-15H2,1-4H3/t18-,19-,20-,23+,25-,26-,27-/m0/s1	Prednicarbate	[2-[(8S,9S,10R,11S,13S,14S,17R)-17-ethoxycarbonyloxy-11-hydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] propanoate	CCOC(=O)O[C@]1(C(=O)COC(=O)CC)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C	6714002.0	R6_adenot_2004:898			BBB+	C	training
InChI=1S/C27H37FO6/c1-5-6-7-23(33)34-27(22(32)15-29)16(2)12-20-19-9-8-17-13-18(30)10-11-24(17,3)26(19,28)21(31)14-25(20,27)4/h10-11,13,16,19-21,29,31H,5-9,12,14-15H2,1-4H3/t16-,19-,20-,21-,24-,25-,26-,27-/m0/s1	Betamethasone-Valerate|Betamethasone Valerate	[(8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] pentanoate	CCCCC(=O)O[C@]1(C(=O)CO)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C	16533.0	R6_adenot_2004:777			BBB+	C	training
InChI=1S/C27H37N3O7S/c1-18(2)15-30(38(33,34)21-10-8-20(28)9-11-21)16-24(31)23(14-19-6-4-3-5-7-19)29-27(32)37-25-17-36-26-22(25)12-13-35-26/h3-11,18,22-26,31H,12-17,28H2,1-2H3,(H,29,32)/t22-,23-,24+,25-,26+/m0/s1	Darunavir	[(3aS,4R,6aR)-2,3,3a,4,5,6a-hexahydrofuro[2,3-b]furan-4-yl] N-[(2S,3R)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]carbamate	CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@H]21)S(=O)(=O)c1ccc(N)cc1	213039.0	R23_gupta_2019:497			BBB-	C	test
InChI=1S/C27H38N2O4/c1-20(2)27(19-28,22-10-12-24(31-5)26(18-22)33-7)14-8-15-29(3)16-13-21-9-11-23(30-4)25(17-21)32-6/h9-12,17-18,20H,8,13-16H2,1-7H3	Verapamil	2-(3,4-dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methylamino]-2-propan-2-ylpentanenitrile	COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC	2520.0	R3_abraham_2006:297|R3_abraham_2006:298|R5_guerra_2008:106|R6_adenot_2004:71|R12_garg_2006:173|R17_fu_2008:43|R21_muehlbacher_2011:47|R25_brito_sanchez_2015:33|R26_chico_2009:441|R28_li_2005:53|R34_broccatelli_2012:142|R37_chen_2011:104|R40_vilar_2010:296|R41_toropov_2017:265|R46_mendoza_valencia_2017:32|R47_radchenko_2020:247|R49_norinder_2002:96|R49_norinder_2002:132|R50_sobanska_2019:13|R51_doninger_2002:142|R53_friden_2009:41	-0.7	D	BBB+	A	training
InChI=1S/C27H38N2O4/c1-20(2)27(19-28,22-10-12-24(31-5)26(18-22)33-7)14-8-15-29(3)16-13-21-9-11-23(30-4)25(17-21)32-6/h9-12,17-18,20H,8,13-16H2,1-7H3/t27-/m1/s1	Dexverapamil	(2R)-2-(3,4-dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methylamino]-2-propan-2-ylpentanenitrile	COc1ccc(CCN(C)CCC[C@](C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC	65808.0	R48_hou_2003:19	-0.7	A	BBB+	A	training
InChI=1S/C27H38O6/c1-24(2,3)14-22(31)33-15-21(30)27(32)11-9-19-18-7-6-16-12-17(28)8-10-25(16,4)23(18)20(29)13-26(19,27)5/h8,10,12,18-20,23,29,32H,6-7,9,11,13-15H2,1-5H3/t18-,19+,20+,23+,25+,26+,27+/m1/s1	Prednisolone-Tebutate	[2-[(8R,9R,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] 3,3-dimethylbutanoate	CC(C)(C)CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@H]3[C@@H](O)C[C@@]21C	155903746.0	R6_adenot_2004:901			BBB+	C	training
InChI=1S/C27H39ClN2O2/c1-26(2,3)22-15-19(16-23(25(22)32)27(4,5)6)17-29-11-13-30(14-12-29)18-24(31)20-7-9-21(28)10-8-20/h7-10,15-16,24,31-32H,11-14,17-18H2,1-6H3	Am-36|1-Piperazineethanol, 4-((3,5-Bis(1,1-Dimethylethyl)-4-Hydroxyphenyl)Methyl)-Alpha-(4-Chlorophenyl)-	2,6-ditert-butyl-4-[[4-[2-(4-chlorophenyl)-2-hydroxyethyl]piperazin-1-yl]methyl]phenol	CC(C)(C)c1cc(CN2CCN(CC(O)c3ccc(Cl)cc3)CC2)cc(C(C)(C)C)c1O	9890390.0	R26_chico_2009:25	0.91	A	BBB+	A	test
InChI=1S/C27H39NO6/c1-5-28(6-2)15-23(32)34-16-22(31)27(33)12-10-20-19-8-7-17-13-18(29)9-11-25(17,3)24(19)21(30)14-26(20,27)4/h9,11,13,19-21,24,30,33H,5-8,10,12,14-16H2,1-4H3/t19-,20-,21-,24+,25-,26-,27-/m0/s1	Prednisolamate	[2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] 2-(diethylamino)acetate	CCN(CC)CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C	20055007.0	R6_adenot_2004:892			BBB+	C	training
InChI=1S/C27H40O3/c1-17(6-13-25(29)20-8-9-20)23-11-12-24-19(5-4-14-27(23,24)3)7-10-21-15-22(28)16-26(30)18(21)2/h6-7,10,13,17,20,22-26,28-30H,2,4-5,8-9,11-12,14-16H2,1,3H3/b13-6+,19-7+,21-10-/t17-,22-,23-,24+,25-,26+,27-/m1/s1	Calcipotriol|Calcipotriene	(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(E,2R,5S)-5-cyclopropyl-5-hydroxypent-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol	C=C1/C(=C\C=C2/CCC[C@]3(C)[C@@H]([C@H](C)/C=C/[C@@H](O)C4CC4)CC[C@@H]23)C[C@@H](O)C[C@@H]1O	5288783.0	R23_gupta_2019:406			BBB-	C	training
InChI=1S/C27H41NO6/c1-5-28(6-2)15-23(32)34-16-22(31)27(33)12-10-20-19-8-7-17-13-18(29)9-11-25(17,3)24(19)21(30)14-26(20,27)4/h13,19-21,24,30,33H,5-12,14-16H2,1-4H3/t19-,20-,21-,24+,25-,26-,27-/m0/s1	Hydrocortamate	[2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] 2-(diethylamino)acetate	CCN(CC)CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C	84088.0	R6_adenot_2004:867			BBB+	C	training
InChI=1S/C27H42Cl2N2O6/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-24(32)37-20-23(30-27(34)26(28)29)25(33)21-16-18-22(19-17-21)31(35)36/h16-19,23,25-26,33H,2-15,20H2,1H3,(H,30,34)/t23-,25-/m1/s1	Chloramphenicol Palmitate	[(2R,3R)-2-[(2,2-dichloroacetyl)amino]-3-hydroxy-3-(4-nitrophenyl)propyl] hexadecanoate	CCCCCCCCCCCCCCCC(=O)OC[C@@H](NC(=O)C(Cl)Cl)[C@H](O)c1ccc([N+](=O)[O-])cc1	443382.0	R14_ghose_2012:442			BBB-	C	training
InChI=1S/C27H42N2O5S/c1-15-9-8-10-27(7)22(34-27)12-20(16(2)11-19-14-35-18(4)28-19)29-23(31)13-21(30)26(5,6)25(33)17(3)24(15)32/h11,14-15,17,20-22,24,30,32H,8-10,12-13H2,1-7H3,(H,29,31)/b16-11+/t15-,17+,20-,21-,22-,24-,27+/m0/s1	Ixabepilone	(1S,3S,7S,10R,11S,12S,16R)-7,11-dihydroxy-8,8,10,12,16-pentamethyl-3-[(E)-1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl]-17-oxa-4-azabicyclo[14.1.0]heptadecane-5,9-dione	C/C(=C\c1csc(C)n1)[C@@H]1C[C@@H]2O[C@]2(C)CCC[C@H](C)[C@H](O)[C@@H](C)C(=O)C(C)(C)[C@@H](O)CC(=O)N1	6445540.0	R23_gupta_2019:691			BBB-	C	training
InChI=1S/C27H44O/c1-19(2)8-6-9-21(4)25-15-16-26-22(10-7-17-27(25,26)5)12-13-23-18-24(28)14-11-20(23)3/h12-13,19,21,24-26,28H,3,6-11,14-18H2,1-2,4-5H3/b22-12+,23-13-/t21-,24+,25-,26+,27-/m1/s1	Cholecalciferol	(1S,3Z)-3-[(2E)-2-[(1R,3aS,7aR)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol	C=C1CC[C@H](O)C/C1=C/C=C1\CCC[C@]2(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@@H]12	5280795.0	R14_ghose_2012:447|R23_gupta_2019:454			BBB-	C	training
InChI=1S/C27H44O2/c1-18(2)8-6-9-19(3)24-13-14-25-21(10-7-15-27(24,25)5)11-12-22-16-23(28)17-26(29)20(22)4/h11-12,18-19,23-26,28-29H,4,6-10,13-17H2,1-3,5H3/b21-11+,22-12-/t19-,23-,24-,25+,26+,27-/m1/s1	Alfacalcidol	(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol	C=C1/C(=C\C=C2/CCC[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@@H]23)C[C@@H](O)C[C@@H]1O	5282181.0	R14_ghose_2012:335|R23_gupta_2019:331			BBB-	C	training
InChI=1S/C27H44O2/c1-19-10-13-23(28)18-22(19)12-11-21-9-7-17-27(5)24(14-15-25(21)27)20(2)8-6-16-26(3,4)29/h11-12,20,23-25,28-29H,1,6-10,13-18H2,2-5H3/b21-11+,22-12-/t20-,23+,24-,25+,27-/m1/s1	Calcidiol|Calcifediol	(1S,3Z)-3-[(2E)-2-[(1R,3aS,7aR)-1-[(2R)-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol	C=C1CC[C@H](O)C/C1=C/C=C1\CCC[C@]2(C)[C@@H]([C@H](C)CCCC(C)(C)O)CC[C@@H]12	5283731.0	R23_gupta_2019:405			BBB-	C	training
InChI=1S/C27H44O3/c1-18(8-6-14-26(3,4)30)23-12-13-24-20(9-7-15-27(23,24)5)10-11-21-16-22(28)17-25(29)19(21)2/h10-11,18,22-25,28-30H,2,6-9,12-17H2,1,3-5H3/b20-10+,21-11-/t18-,22-,23-,24+,25+,27-/m1/s1	Calcitriol	(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(2R)-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol	C=C1/C(=C\C=C2/CCC[C@]3(C)[C@@H]([C@H](C)CCCC(C)(C)O)CC[C@@H]23)C[C@@H](O)C[C@@H]1O	5280453.0	R14_ghose_2012:412|R23_gupta_2019:407			BBB-	C	training
InChI=1S/C27H44O3/c1-18(8-9-19(2)26(3,4)30)24-12-13-25-21(7-6-14-27(24,25)5)11-10-20-15-22(28)17-23(29)16-20/h8-11,18-19,22-25,28-30H,6-7,12-17H2,1-5H3/b9-8+,21-11+/t18-,19+,22-,23-,24-,25+,27-/m1/s1	Paricalcitol	(1R,3R)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(E,2R,5S)-6-hydroxy-5,6-dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]cyclohexane-1,3-diol	C[C@H](/C=C/[C@H](C)C(C)(C)O)[C@H]1CC[C@H]2/C(=C/C=C3C[C@@H](O)C[C@H](O)C3)CCC[C@]12C	5281104.0	R23_gupta_2019:813			BBB-	C	training
InChI=1S/C27H45N5O5/c1-25(2,3)20(30-24(37)31-26(4,5)6)23(36)32-13-15-17(27(15,7)8)18(32)22(35)29-16(19(33)21(28)34)12-14-10-9-11-14/h14-18,20H,9-13H2,1-8H3,(H2,28,34)(H,29,35)(H2,30,31,37)/t15-,16?,17-,18-,20+/m0/s1	Boceprevir	(1R,2S,5S)-N-(4-amino-1-cyclobutyl-3,4-dioxobutan-2-yl)-3-[(2S)-2-(tert-butylcarbamoylamino)-3,3-dimethylbutanoyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide	CC(C)(C)NC(=O)N[C@H](C(=O)N1C[C@H]2[C@@H]([C@H]1C(=O)NC(CC1CCC1)C(=O)C(N)=O)C2(C)C)C(C)(C)C	10324367.0	R23_gupta_2019:396			BBB-	C	training
InChI=1S/C27H58NO6P/c1-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-23-32-25-27(31-5)26-34-35(29,30)33-24-22-28(2,3)4/h27H,6-26H2,1-5H3	Edelfosine	(2-methoxy-3-octadecoxypropyl) 2-(trimethylazaniumyl)ethyl phosphate	CCCCCCCCCCCCCCCCCCOCC(COP(=O)([O-])OCC[N+](C)(C)C)OC	1392.0	R25_brito_sanchez_2015:449	-0.7	A	BBB+	A	training
InChI=1S/C27H58NO6P/c1-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-23-32-25-27(31-5)26-34-35(29,30)33-24-22-28(2,3)4/h27H,6-26H2,1-5H3/p+1	3-Octadecyloxy-2-Methoxypropylphosphonocholine	2-[hydroxy-(2-methoxy-3-octadecoxypropoxy)phosphoryl]oxyethyl-trimethylazanium	CCCCCCCCCCCCCCCCCCOCC(COP(=O)(O)OCC[N+](C)(C)C)OC	1393.0	R46_mendoza_valencia_2017:375	-0.7	A	BBB+	A	training
InChI=1S/C28H22F3N7O/c1-17-5-6-19(10-25(17)37-27-33-9-7-24(36-27)20-4-3-8-32-14-20)26(39)35-22-11-21(28(29,30)31)12-23(13-22)38-15-18(2)34-16-38/h3-16H,1-2H3,(H,35,39)(H,33,36,37)	Nilotinib	4-methyl-N-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]benzamide	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1	644241.0	R23_gupta_2019:778			BBB-	C	training
InChI=1S/C28H26F4N2OS/c29-22-9-6-19(7-10-22)27(35)20-12-16-33(17-13-20)14-3-15-34-23-4-1-2-5-25(23)36-26-11-8-21(18-24(26)34)28(30,31)32/h1-2,4-11,18,20H,3,12-17H2	Duoperone	(4-fluorophenyl)-[1-[3-[2-(trifluoromethyl)phenothiazin-10-yl]propyl]piperidin-4-yl]methanone	O=C(c1ccc(F)cc1)C1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1	43876.0	R6_adenot_2004:1152			BBB+	C	training
InChI=1S/C28H26N6O10S2/c35-23(18(16-4-2-1-3-5-16)31-24(36)19-20(27(38)39)30-14-29-19)32-21-25(37)34-22(28(40)41)17(13-45-26(21)34)12-33-9-6-15(7-10-33)8-11-46(42,43)44/h1-7,9-10,14,18,21,26H,8,11-13H2,(H5-,29,30,31,32,35,36,38,39,40,41,42,43,44)/t18-,21-,26-/m1/s1	Cefpimizole	2-[1-[[(6R,7R)-2-carboxy-7-[[(2R)-2-[(5-carboxy-1H-imidazole-4-carbonyl)amino]-2-phenylacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]pyridin-1-ium-4-yl]ethanesulfonate	O=C(O)C1=C(C[n+]2ccc(CCS(=O)(=O)[O-])cc2)CS[C@@H]2[C@H](NC(=O)[C@H](NC(=O)c3nc[nH]c3C(=O)O)c3ccccc3)C(=O)N12	68597.0	R6_adenot_2004:187			BBB-	C	training
InChI=1S/C28H27ClF5NO/c29-26-12-7-21(18-25(26)28(32,33)34)27(36)13-16-35(17-14-27)15-1-2-24(19-3-8-22(30)9-4-19)20-5-10-23(31)11-6-20/h3-12,18,24,36H,1-2,13-17H2	Penfluridol	1-[4,4-bis(4-fluorophenyl)butyl]-4-[4-chloro-3-(trifluoromethyl)phenyl]piperidin-4-ol	OC1(c2ccc(Cl)c(C(F)(F)F)c2)CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1	33630.0	R6_adenot_2004:1195|R14_ghose_2012:295|R23_gupta_2019:186			BBB+	C	training
InChI=1S/C28H27NO4S/c30-21-8-4-20(5-9-21)28-26(24-13-10-22(31)18-25(24)34-28)27(32)19-6-11-23(12-7-19)33-17-16-29-14-2-1-3-15-29/h4-13,18,30-31H,1-3,14-17H2	Raloxifene Hydrochloride|Raloxifene	[6-hydroxy-2-(4-hydroxyphenyl)-1-benzothiophen-3-yl]-[4-(2-piperidin-1-ylethoxy)phenyl]methanone	O=C(c1ccc(OCCN2CCCCC2)cc1)c1c(-c2ccc(O)cc2)sc2cc(O)ccc12	5035.0	R14_ghose_2012:814|R23_gupta_2019:874|R26_chico_2009:343	-1.81	A	BBB-	A	training
InChI=1S/C28H28ClF2N3O/c29-21-7-12-27-26(18-21)32-28(35)34(27)24-13-16-33(17-14-24)15-1-2-25(19-3-8-22(30)9-4-19)20-5-10-23(31)11-6-20/h3-12,18,24-25H,1-2,13-17H2,(H,32,35)	Clopimozide	3-[1-[4,4-bis(4-fluorophenyl)butyl]piperidin-4-yl]-6-chloro-1H-benzimidazol-2-one	O=c1[nH]c2cc(Cl)ccc2n1C1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1	65449.0	R6_adenot_2004:1438|R51_doninger_2002:187			BBB+	C	training
InChI=1S/C28H28N2O2/c29-22-28(24-12-6-2-7-13-24,25-14-8-3-9-15-25)18-21-30-19-16-27(17-20-30,26(31)32)23-10-4-1-5-11-23/h1-15H,16-21H2,(H,31,32)	Difenoxin	1-(3-cyano-3,3-diphenylpropyl)-4-phenylpiperidine-4-carboxylic acid	N#CC(CCN1CCC(C(=O)O)(c2ccccc2)CC1)(c1ccccc1)c1ccccc1	34328.0	R23_gupta_2019:524			BBB-	C	training
InChI=1S/C28H28O3/c1-31-26-7-6-23(21-2-3-22-12-24(27(29)30)5-4-20(22)11-21)13-25(26)28-14-17-8-18(15-28)10-19(9-17)16-28/h2-7,11-13,17-19H,8-10,14-16H2,1H3,(H,29,30)	Adapalene	6-[3-(1-adamantyl)-4-methoxyphenyl]naphthalene-2-carboxylic acid	COc1ccc(-c2ccc3cc(C(=O)O)ccc3c2)cc1C12CC3CC(CC(C3)C1)C2	60164.0	R23_gupta_2019:325			BBB-	C	training
InChI=1S/C28H29F2N3O/c29-22-11-7-20(8-12-22)25(21-9-13-23(30)14-10-21)4-3-17-32-18-15-24(16-19-32)33-27-6-2-1-5-26(27)31-28(33)34/h1-2,5-14,24-25H,3-4,15-19H2,(H,31,34)	Pimozide	3-[1-[4,4-bis(4-fluorophenyl)butyl]piperidin-4-yl]-1H-benzimidazol-2-one	O=c1[nH]c2ccccc2n1C1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1	16362.0	R6_adenot_2004:1198|R14_ghose_2012:201|R23_gupta_2019:200|R51_doninger_2002:287			BBB+	C	training
InChI=1S/C28H29N5O2/c1-33(2)15-16-35-23-7-3-20(4-8-23)28-31-26(19-11-13-29-14-12-19)27(32-28)22-5-9-24-21(17-22)6-10-25(24)30-18-34/h3-5,7-9,11-14,17,34H,6,10,15-16,18H2,1-2H3,(H,31,32)/b30-25+	Takle-1; Sb-590885		CN(C)CCOc1ccc(-c2nc(-c3ccc4c(c3)CC/C4=N\CO)c(-c3ccncc3)[nH]2)cc1		R26_chico_2009:399	-0.85	A	BBB+	A	training
InChI=1S/C28H30N2O2/c29-27(31)28(23-7-3-1-4-8-23,24-9-5-2-6-10-24)25-14-17-30(20-25)16-13-21-11-12-26-22(19-21)15-18-32-26/h1-12,19,25H,13-18,20H2,(H2,29,31)	2-(1-(2-(2,3-Dihydrobenzofuran-5-Yl)Ethyl)Pyrrolidin-3-Yl)-2,2-Diphenylacetamide	2-[1-[2-(2,3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl]-2,2-diphenylacetamide	NC(=O)C(c1ccccc1)(c1ccccc1)C1CCN(CCc2ccc3c(c2)CCO3)C1	72054.0	R46_mendoza_valencia_2017:186	-0.62	A	BBB+	A	training
InChI=1S/C28H30N2O2/c29-27(31)28(23-7-3-1-4-8-23,24-9-5-2-6-10-24)25-14-17-30(20-25)16-13-21-11-12-26-22(19-21)15-18-32-26/h1-12,19,25H,13-18,20H2,(H2,29,31)/t25-/m1/s1	133099-04-4|Darifenacin	2-[(3S)-1-[2-(2,3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl]-2,2-diphenylacetamide	NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(CCc2ccc3c(c2)CCO3)C1	444031.0	R4_mente_2005:147|R21_muehlbacher_2011:308|R23_gupta_2019:276|R25_brito_sanchez_2015:200|R40_vilar_2010:91|R47_radchenko_2020:370	-0.62	B	BBB+	A	training
InChI=1S/C28H30N4O/c29-18-21-5-8-23-19-32(16-13-22(23)17-21)15-12-20-6-9-24(10-7-20)31-28(33)26-11-14-30-27-4-2-1-3-25(26)27/h1-5,8,11,14,17,20,24H,6-7,9-10,12-13,15-16,19H2,(H,31,33)	Sb-277011A|N-[4-[2-(6-Cyano-3,4-Dihydro-1H-Isoquinolin-2-Yl)Ethyl]Cyclohexyl]Quinoline-4-Carboxamide	N-[4-[2-(6-cyano-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]cyclohexyl]quinoline-4-carboxamide	N#Cc1ccc2c(c1)CCN(CCC1CCC(NC(=O)c3ccnc4ccccc34)CC1)C2	5311096.0	R26_chico_2009:371	0.56	A	BBB+	A	training
InChI=1S/C28H30N4O2/c33-28(18-22-8-12-26(13-9-22)34-21-23-6-2-1-3-7-23)30-25-11-10-24-20-29-32(27(24)19-25)17-16-31-14-4-5-15-31/h1-3,6-13,19-20H,4-5,14-18,21H2,(H,30,33)	Indole-Based Mchr1 Antagonist(7A)|2-[4-(Benzyloxy)Phenyl]-N-[1-(2-Pyrrolidin-1-Ylethyl)-1H-Indazol-6-Yl]Acetamide	2-(4-phenylmethoxyphenyl)-N-[1-(2-pyrrolidin-1-ylethyl)indazol-6-yl]acetamide	O=C(Cc1ccc(OCc2ccccc2)cc1)Nc1ccc2cnn(CCN3CCCC3)c2c1	11775399.0	R25_brito_sanchez_2015:443|R46_mendoza_valencia_2017:369	-0.2	B	BBB+	A	training
InChI=1S/C28H31FN2O/c1-4-28(32)14-12-24-22-10-5-19-15-25-18(16-26(19,2)23(22)11-13-27(24,28)3)17-30-31(25)21-8-6-20(29)7-9-21/h1,6-9,15,17,22-24,32H,5,10-14,16H2,2-3H3/t22-,23+,24+,26+,27+,28+/m1/s1	Nivacortol	(1S,2R,13R,14S,17R,18S)-17-ethynyl-7-(4-fluorophenyl)-2,18-dimethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-ol	C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=Cc5c(cnn5-c5ccc(F)cc5)C[C@]4(C)[C@H]3CC[C@@]21C	9910575.0	R6_adenot_2004:887			BBB+	C	training
InChI=1S/C28H31FN4O/c1-34-25-12-8-21(9-13-25)14-17-32-18-15-24(16-19-32)30-28-31-26-4-2-3-5-27(26)33(28)20-22-6-10-23(29)11-7-22/h2-13,24H,14-20H2,1H3,(H,30,31)	Astemizole|Astemizol	1-[(4-fluorophenyl)methyl]-N-[1-[2-(4-methoxyphenyl)ethyl]piperidin-4-yl]benzimidazol-2-amine	COc1ccc(CCN2CCC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC2)cc1	2247.0	R6_adenot_2004:6|R7_andres_2006:13|R14_ghose_2012:362|R23_gupta_2019:364|R25_brito_sanchez_2015:492|R28_li_2005:326|R29_subramanian_2003:13|R34_broccatelli_2012:107|R46_mendoza_valencia_2017:412|R50_sobanska_2019:72|R51_doninger_2002:12	1.1	B	BBB+	A	test
InChI=1S/C28H31FO5/c1-2-33-26(32)18-22(31)17-21(30)13-14-24-27(19-9-11-20(29)12-10-19)23-7-3-4-8-25(23)34-28(24)15-5-6-16-28/h3-4,7-14,21-22,30-31H,2,5-6,15-18H2,1H3/b14-13+/t21-,22-/m0/s1	Bervastatin	ethyl (E,3S,5R)-7-[4-(4-fluorophenyl)spiro[chromene-2,1'-cyclopentane]-3-yl]-3,5-dihydroxyhept-6-enoate	CCOC(=O)C[C@@H](O)C[C@@H](O)/C=C/C1=C(c2ccc(F)cc2)c2ccccc2OC12CCCC2	6436003.0	R6_adenot_2004:1401			BBB+	C	training
InChI=1S/C28H31N5O5S/c1-28(2)22(27(37)38)33-25(36)21(26(33)39-28)32-24(35)20(17-7-4-3-5-8-17)31-19(34)15-16-9-11-18(12-10-16)23-29-13-6-14-30-23/h3-5,7-12,20-22,26H,6,13-15H2,1-2H3,(H,29,30)(H,31,34)(H,32,35)(H,37,38)/t20-,21-,22+,26-/m1/s1	Rotamicillin	(2S,5R,6R)-3,3-dimethyl-7-oxo-6-[[(2R)-2-phenyl-2-[[2-[4-(1,4,5,6-tetrahydropyrimidin-2-yl)phenyl]acetyl]amino]acetyl]amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid	CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](NC(=O)Cc3ccc(C4=NCCCN4)cc3)c3ccccc3)C(=O)N2[C@H]1C(=O)O	3058737.0	R6_adenot_2004:262			BBB-	C	training
InChI=1S/C28H32N2O/c1-31-25-15-9-8-14-24(25)20-29-27-23-16-18-30(19-17-23)28(27)26(21-10-4-2-5-11-21)22-12-6-3-7-13-22/h2-15,23,26-29H,16-20H2,1H3	Pfizer Compound 4|(2S,3S)-2-(Diphenylmethyl)-N-[(2-Methoxyphenyl)Methyl]-1-Azabicyclo[2.2.2]Octan-3-Amine	2-benzhydryl-N-[(2-methoxyphenyl)methyl]-1-azabicyclo[2.2.2]octan-3-amine	COc1ccccc1CNC1C2CCN(CC2)C1C(c1ccccc1)c1ccccc1	9931510.0	R25_brito_sanchez_2015:553|R40_vilar_2010:200|R46_mendoza_valencia_2017:464|R47_radchenko_2020:403	0.37	B	BBB+	A	training
InChI=1S/C28H32N2O/c1-31-25-15-9-8-14-24(25)20-29-27-23-16-18-30(19-17-23)28(27)26(21-10-4-2-5-11-21)22-12-6-3-7-13-22/h2-15,23,26-29H,16-20H2,1H3/t27-,28-/m1/s1	135095-42-0|(2R,3R)-2-Benzhydryl-N-[(2-Methoxyphenyl)Methyl]-1-Azabicyclo[2.2.2]Octan-3-Amine	(2R,3R)-2-benzhydryl-N-[(2-methoxyphenyl)methyl]-1-azabicyclo[2.2.2]octan-3-amine	COc1ccccc1CN[C@@H]1C2CCN(CC2)[C@@H]1C(c1ccccc1)c1ccccc1	490428.0	R4_mente_2005:79	0.37	A	BBB+	A	training
InChI=1S/C28H32O15/c1-10-21(32)23(34)25(36)27(40-10)39-9-19-22(33)24(35)26(37)28(43-19)41-12-6-14(30)20-15(31)8-17(42-18(20)7-12)11-3-4-16(38-2)13(29)5-11/h3-8,10,19,21-30,32-37H,9H2,1-2H3/t10-,19+,21-,22+,23+,24-,25+,26+,27+,28+/m0/s1	Diosmin	5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxychromen-4-one	COc1ccc(-c2cc(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3o2)cc1O	5281613.0	R6_adenot_2004:19|R14_ghose_2012:502|R23_gupta_2019:529			BBB-	C	training
InChI=1S/C28H33ClN2/c1-28(2,3)25-13-9-22(10-14-25)21-30-17-19-31(20-18-30)27(23-7-5-4-6-8-23)24-11-15-26(29)16-12-24/h4-16,27H,17-21H2,1-3H3	Buclizine	1-[(4-tert-butylphenyl)methyl]-4-[(4-chlorophenyl)-phenylmethyl]piperazine	CC(C)(C)c1ccc(CN2CCN(C(c3ccccc3)c3ccc(Cl)cc3)CC2)cc1	6729.0	R6_adenot_2004:1423|R51_doninger_2002:165			BBB+	C	test
InChI=1S/C28H33F2N3/c29-25-12-8-23(9-13-25)28(24-10-14-26(30)15-11-24)7-4-17-32-19-21-33(22-20-32)18-16-31-27-5-2-1-3-6-27/h1-3,5-6,8-15,28,31H,4,7,16-22H2	Difluanazine	N-[2-[4-[4,4-bis(4-fluorophenyl)butyl]piperazin-1-yl]ethyl]aniline	Fc1ccc(C(CCCN2CCN(CCNc3ccccc3)CC2)c2ccc(F)cc2)cc1	21693.0	R6_adenot_2004:1448			BBB+	C	training
InChI=1S/C28H34F2O7/c1-24(2)36-22-11-16-17-10-19(29)18-9-15(31)7-8-25(18,3)27(17,30)20(32)12-26(16,4)28(22,37-24)21(33)13-35-23(34)14-5-6-14/h7-9,14,16-17,19-20,22,32H,5-6,10-13H2,1-4H3/t16-,17-,19-,20-,22+,25-,26-,27-,28+/m0/s1	Ciprocinonide	[2-[(1S,2S,4R,8S,9S,11S,12R,13S,19S)-12,19-difluoro-11-hydroxy-6,6,9,13-tetramethyl-16-oxo-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-8-yl]-2-oxoethyl] cyclopropanecarboxylate	CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)COC(=O)C2CC2)O1	11954352.0	R6_adenot_2004:784			BBB+	C	test
InChI=1S/C28H34N4O2/c1-18-5-8-24-23(11-18)30-27(28(2,3)33)32(24)25-9-10-31(17-26(25)34-4)16-20-13-21-7-6-19(15-29)12-22(21)14-20/h5-8,11-12,20,25-26,33H,9-10,13-14,16-17H2,1-4H3/t20?,25?,26-/m1/s1	Compound-10		CO[C@@H]1CN(CC2Cc3ccc(C#N)cc3C2)CCC1n1c(C(C)(C)O)nc2cc(C)ccc21		R26_chico_2009:124	-0.05	A	BBB+	A	training
InChI=1S/C28H35ClN4O/c29-23-12-11-22-10-9-21-6-1-2-7-24(21)32(25(22)20-23)16-5-15-31-18-13-28(14-19-31)27(34)30-26-8-3-4-17-33(26)28/h1-2,6-7,11-12,20,26H,3-5,8-10,13-19H2,(H,30,34)	Mosapramine	1'-[3-(2-chloro-5,6-dihydrobenzo[b][1]benzazepin-11-yl)propyl]spiro[1,5,6,7,8,8a-hexahydroimidazo[1,2-a]pyridine-3,4'-piperidine]-2-one	O=C1NC2CCCCN2C12CCN(CCCN1c3ccccc3CCc3ccc(Cl)cc31)CC2	4257.0	R6_adenot_2004:1595			BBB+	C	training
InChI=1S/C28H35FO7/c1-16(30)34-15-22(33)28-23(35-26(36-28)9-4-5-10-26)13-20-19-7-6-17-12-18(31)8-11-24(17,2)27(19,29)21(32)14-25(20,28)3/h8,11-12,19-21,23,32H,4-7,9-10,13-15H2,1-3H3/t19-,20-,21-,23+,24-,25-,27-,28+/m0/s1	Amcinonide	[2-[(1S,2S,4R,8S,9S,11S,12R,13S)-12-fluoro-11-hydroxy-9,13-dimethyl-16-oxospiro[5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-diene-6,1'-cyclopentane]-8-yl]-2-oxoethyl] acetate	CC(=O)OCC(=O)[C@@]12OC3(CCCC3)O[C@@H]1C[C@H]1[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]12C	443958.0	R6_adenot_2004:768			BBB+	C	training
InChI=1S/C28H35N3O7/c1-17(2)26-19(4)9-10-24(34)29-11-5-7-18(3)13-20(32)14-21(33)15-25-30-22(16-37-25)27(35)31-12-6-8-23(31)28(36)38-26/h5,7-10,13,16-17,19-20,26,32H,6,11-12,14-15H2,1-4H3,(H,29,34)/t19-,20-,26-/m1/s1	Virginiamycin-Factor-M1|(10R,11R,21S)-21-Hydroxy-11,19-Dimethyl-10-Propan-2-Yl-9,26-Dioxa-3,15,28-Triazatricyclo[23.2.1.03,7]Octacosa-1(27),6,12,17,19,25(28)-Hexaene-2,8,14,23-Tetrone	(10R,11R,21S)-21-hydroxy-11,19-dimethyl-10-propan-2-yl-9,26-dioxa-3,15,28-triazatricyclo[23.2.1.03,7]octacosa-1(27),6,12,17,19,25(28)-hexaene-2,8,14,23-tetrone	CC1=C[C@@H](O)CC(=O)Cc2nc(co2)C(=O)N2CCC=C2C(=O)O[C@H](C(C)C)[C@H](C)C=CC(=O)NCC=C1	443111.0	R6_adenot_2004:345			BBB-	C	test
InChI=1S/C28H36O6/c1-5-26(3,24(29)30)33-22-14-10-20(11-15-22)28(18-8-7-9-19-28)21-12-16-23(17-13-21)34-27(4,6-2)25(31)32/h10-17H,5-9,18-19H2,1-4H3,(H,29,30)(H,31,32)	Clinofibrate	2-[4-[1-[4-(2-carboxybutan-2-yloxy)phenyl]cyclohexyl]phenoxy]-2-methylbutanoic acid	CCC(C)(Oc1ccc(C2(c3ccc(OC(C)(CC)C(=O)O)cc3)CCCCC2)cc1)C(=O)O	2787.0	R23_gupta_2019:1054			BBB-	C	training
InChI=1S/C28H37ClN4O/c29-24-12-11-23-10-9-22-7-2-3-8-25(22)33(26(23)21-24)18-6-15-31-19-13-28(14-20-31,27(30)34)32-16-4-1-5-17-32/h2-3,7-8,11-12,21H,1,4-6,9-10,13-20H2,(H2,30,34)	Clocapramine	1-[3-(2-chloro-5,6-dihydrobenzo[b][1]benzazepin-11-yl)propyl]-4-piperidin-1-ylpiperidine-4-carboxamide	NC(=O)C1(N2CCCCC2)CCN(CCCN2c3ccccc3CCc3ccc(Cl)cc32)CC1	2793.0	R6_adenot_2004:1551			BBB+	C	training
InChI=1S/C28H37ClO7/c1-6-22(33)35-14-21(32)28(36-23(34)7-2)15(3)10-18-24-19(29)12-16-11-17(30)8-9-26(16,4)25(24)20(31)13-27(18,28)5/h8-9,11,15,18-20,24-25,31H,6-7,10,12-14H2,1-5H3/t15-,18+,19-,20+,24+,25+,26+,27+,28+/m1/s1	Alclometasone-Dipropionate	[2-[(7R,8R,9S,10R,11S,13S,14S,16R,17R)-7-chloro-11-hydroxy-10,13,16-trimethyl-3-oxo-17-propanoyloxy-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] propanoate	CCC(=O)OCC(=O)[C@@]1(OC(=O)CC)[C@H](C)C[C@H]2[C@@H]3[C@H]([C@@H](O)C[C@@]21C)[C@@]1(C)C=CC(=O)C=C1C[C@H]3Cl	51722976.0	R6_adenot_2004:763			BBB+	C	training
InChI=1S/C28H37ClO7/c1-6-23(33)35-15-22(32)28(36-24(34)7-2)16(3)12-20-19-9-8-17-13-18(30)10-11-25(17,4)27(19,29)21(31)14-26(20,28)5/h10-11,13,16,19-21,31H,6-9,12,14-15H2,1-5H3/t16-,19-,20-,21-,25-,26-,27-,28-/m0/s1	Beclometasone-Dipropionate|Beclomethasone Dipropionate	[2-[(8S,9R,10S,11S,13S,14S,16S,17R)-9-chloro-11-hydroxy-10,13,16-trimethyl-3-oxo-17-propanoyloxy-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] propanoate	CCC(=O)OCC(=O)[C@@]1(OC(=O)CC)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@@]21C	21700.0	R6_adenot_2004:771			BBB+	C	training
InChI=1S/C28H37ClO7/c1-6-7-24(34)36-28(23(33)15-35-17(3)30)16(2)12-21-20-9-8-18-13-19(31)10-11-25(18,4)27(20,29)22(32)14-26(21,28)5/h10-11,13,16,20-22,32H,6-9,12,14-15H2,1-5H3/t16-,20+,21+,22+,25+,26+,27+,28+/m1/s1	Icometasone-Enbutate|Icometasone Enbutate	[(8S,9R,10S,11S,13S,14S,16R,17R)-17-(2-acetyloxyacetyl)-9-chloro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] butanoate	CCCC(=O)O[C@]1(C(=O)COC(C)=O)[C@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@@]21C	65877.0	R6_adenot_2004:868			BBB+	C	training
InChI=1S/C28H37FO7/c1-15(2)24(34)36-28(23(33)14-35-17(4)30)16(3)11-21-20-8-7-18-12-19(31)9-10-25(18,5)27(20,29)22(32)13-26(21,28)6/h9-10,12,15-16,20-22,32H,7-8,11,13-14H2,1-6H3/t16-,20-,21-,22-,25-,26-,27-,28-/m0/s1	Betamethasone-Acibutate|Betamethasone Acibutate	[(8S,9R,10S,11S,13S,14S,16S,17R)-17-(2-acetyloxyacetyl)-9-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] 2-methylpropanoate	CC(=O)OCC(=O)[C@@]1(OC(=O)C(C)C)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C	111080.0	R6_adenot_2004:774			BBB+	C	training
InChI=1S/C28H37FO7/c1-6-23(33)35-15-22(32)28(36-24(34)7-2)16(3)12-20-19-9-8-17-13-18(30)10-11-25(17,4)27(19,29)21(31)14-26(20,28)5/h10-11,13,16,19-21,31H,6-9,12,14-15H2,1-5H3/t16-,19+,20+,21+,25+,26+,27+,28+/m1/s1	Dexamethasone-Dipropionate|Dexamethasone Dipropionate	[2-[(8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-17-propanoyloxy-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] propanoate	CCC(=O)OCC(=O)[C@@]1(OC(=O)CC)[C@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C	63049.0	R6_adenot_2004:817			BBB+	C	training
InChI=1S/C28H37FO7/c1-6-23(33)35-15-22(32)28(36-24(34)7-2)16(3)12-20-19-9-8-17-13-18(30)10-11-25(17,4)27(19,29)21(31)14-26(20,28)5/h10-11,13,16,19-21,31H,6-9,12,14-15H2,1-5H3/t16-,19-,20-,21-,25-,26-,27-,28-/m0/s1	Betamethasone-Dipropionate|Betamethasone Dipropionate	[2-[(8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-17-propanoyloxy-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] propanoate	CCC(=O)OCC(=O)[C@@]1(OC(=O)CC)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C	21800.0	R6_adenot_2004:776			BBB+	C	training
InChI=1S/C28H37N3O3/c1-4-34-20-19-31-25-8-6-5-7-24(25)29-26(31)22-14-17-30(18-15-22)16-13-21-9-11-23(12-10-21)28(2,3)27(32)33/h5-12,22H,4,13-20H2,1-3H3,(H,32,33)	Bilastine	2-[4-[2-[4-[1-(2-ethoxyethyl)benzimidazol-2-yl]piperidin-1-yl]ethyl]phenyl]-2-methylpropanoic acid	CCOCCn1c(C2CCN(CCc3ccc(C(C)(C)C(=O)O)cc3)CC2)nc2ccccc21	185460.0	R23_gupta_2019:395			BBB-	C	training
InChI=1S/C28H37N5O7/c1-17(2)12-23(28(39)40)33-27(38)22(14-18-6-4-3-5-7-18)32-25(36)16-30-24(35)15-31-26(37)21(29)13-19-8-10-20(34)11-9-19/h3-11,17,21-23,34H,12-16,29H2,1-2H3,(H,30,35)(H,31,37)(H,32,36)(H,33,38)(H,39,40)/t21-,22-,23-/m0/s1	Enkephalin|Leucine Enkephalin	(2S)-2-[[(2S)-2-[[2-[[2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]acetyl]amino]acetyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoic acid	CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)CNC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)O	461776.0	R51_doninger_2002:47			BBB-	C	test
InChI=1S/C28H37NO4/c1-5-25(2,30)20-15-26-10-11-28(20,32-4)24-27(26)12-13-29(16-17-6-7-17)21(26)14-18-8-9-19(31-3)23(33-24)22(18)27/h8-11,17,20-21,24,30H,5-7,12-16H2,1-4H3	Homprenorphine|2-[5-(Cyclopropylmethyl)-11,15-Dimethoxy-13-Oxa-5-Azahexacyclo[13.2.2.12,8.01,6.02,14.012,20]Icosa-8(20),9,11,18-Tetraen-16-Yl]Butan-2-Ol	2-[5-(cyclopropylmethyl)-11,15-dimethoxy-13-oxa-5-azahexacyclo[13.2.2.12,8.01,6.02,14.012,20]icosa-8(20),9,11,18-tetraen-16-yl]butan-2-ol	CCC(C)(O)C1CC23C=CC1(OC)C1Oc4c(OC)ccc5c4C12CCN(CC1CC1)C3C5	3084250.0	R6_adenot_2004:1042			BBB+	C	training
InChI=1S/C28H38N4O/c29-27(33)28(31-18-6-1-7-19-31)15-21-30(22-16-28)17-8-20-32-25-11-4-2-9-23(25)13-14-24-10-3-5-12-26(24)32/h2-5,9-12H,1,6-8,13-22H2,(H2,29,33)	Carpipramine	1-[3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)propyl]-4-piperidin-1-ylpiperidine-4-carboxamide	NC(=O)C1(N2CCCCC2)CCN(CCCN2c3ccccc3CCc3ccccc32)CC1	2580.0	R6_adenot_2004:504|R14_ghose_2012:36|R23_gupta_2019:40			BBB+	C	training
InChI=1S/C28H39FO5/c1-5-6-7-8-24(33)34-15-23(32)25-16(2)11-19-18-13-21(29)20-12-17(30)9-10-27(20,3)26(18)22(31)14-28(19,25)4/h9-10,12,16,18-19,21-22,25-26,31H,5-8,11,13-15H2,1-4H3/t16-,18+,19+,21+,22+,25-,26-,27+,28+/m1/s1	Fluocortolone-Caproate|Fluocortolone Caproate	[2-[(6S,8S,9S,10R,11S,13S,14S,16R,17S)-6-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] hexanoate	CCCCCC(=O)OCC(=O)[C@H]1[C@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C	20054915.0	R6_adenot_2004:849			BBB+	C	test
InChI=1S/C28H40N4O5/c1-5-6-14-31-24(33)22-26(35)32(27(36)23(25(31)34)28(22,2)3)15-10-9-13-29-16-18-30(19-17-29)20-11-7-8-12-21(20)37-4/h7-8,11-12,22-23H,5-6,9-10,13-19H2,1-4H3	Umespirone	3-butyl-7-[4-[4-(2-methoxyphenyl)piperazin-1-yl]butyl]-9,9-dimethyl-3,7-diazabicyclo[3.3.1]nonane-2,4,6,8-tetrone	CCCCN1C(=O)C2C(=O)N(CCCCN3CCN(c4ccccc4OC)CC3)C(=O)C(C1=O)C2(C)C	65902.0	R6_adenot_2004:1171			BBB+	C	test
InChI=1S/C28H40O7/c1-5-7-24(33)34-16-22(31)28(35-23(32)6-2)13-11-20-19-9-8-17-14-18(29)10-12-26(17,3)25(19)21(30)15-27(20,28)4/h14,19-21,25,30H,5-13,15-16H2,1-4H3/t19-,20-,21-,25+,26-,27-,28-/m0/s1	Hydrocortisone-Buteprate|[2-[(8S,9S,10R,11S,13S,14S,17R)-11-Hydroxy-10,13-Dimethyl-3-Oxo-17-Propanoyloxy-2,6,7,8,9,11,12,14,15,16-Decahydro-1H-Cyclopenta[A]Phenanthren-17-Yl]-2-Oxoethyl] Butanoate	[2-[(8S,9S,10R,11S,13S,14S,17R)-11-hydroxy-10,13-dimethyl-3-oxo-17-propanoyloxy-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] butanoate	CCCC(=O)OCC(=O)[C@@]1(OC(=O)CC)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C	10368237.0	R6_adenot_2004:797			BBB+	C	training
InChI=1S/C28H40O7/c1-6-7-24(33)35-28(23(32)15-34-17(3)29)11-9-20-19-12-16(2)21-13-18(30)8-10-26(21,4)25(19)22(31)14-27(20,28)5/h13,16,19-20,22,25,31H,6-12,14-15H2,1-5H3/t16-,19-,20-,22-,25+,26-,27-,28-/m0/s1	Amebucort	[(6S,8S,9S,10R,11S,13S,14S,17R)-17-(2-acetyloxyacetyl)-11-hydroxy-6,10,13-trimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] butanoate	CCCC(=O)O[C@]1(C(=O)COC(C)=O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C	3086167.0	R6_adenot_2004:769			BBB+	C	training
InChI=1S/C28H42N4O9/c1-4-7-14-38-18-21(40-25(29)35)16-31-23(33)28(6-3,20-12-10-9-11-13-20)24(34)32(27(31)37)17-22(41-26(30)36)19-39-15-8-5-2/h9-13,21-22H,4-8,14-19H2,1-3H3,(H2,29,35)(H2,30,36)	Difebarbamate	[1-butoxy-3-[3-(3-butoxy-2-carbamoyloxypropyl)-5-ethyl-2,4,6-trioxo-5-phenyl-1,3-diazinan-1-yl]propan-2-yl] carbamate	CCCCOCC(CN1C(=O)N(CC(COCCCC)OC(N)=O)C(=O)C(CC)(c2ccccc2)C1=O)OC(N)=O	71880.0	R6_adenot_2004:1645			BBB+	C	training
InChI=1S/C28H44O/c1-19(2)20(3)9-10-22(5)26-15-16-27-23(8-7-17-28(26,27)6)12-13-24-18-25(29)14-11-21(24)4/h9-10,12-13,19-20,22,25-27,29H,4,7-8,11,14-18H2,1-3,5-6H3/b10-9+,23-12+,24-13-/t20-,22+,25-,26+,27-,28+/m0/s1	Ergocalciferol	(1S,3Z)-3-[(2E)-2-[(1R,3aS,7aR)-1-[(E,2R,5R)-5,6-dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol	C=C1CC[C@H](O)C/C1=C/C=C1\CCC[C@]2(C)[C@@H]([C@H](C)/C=C/[C@H](C)C(C)C)CC[C@@H]12	5280793.0	R14_ghose_2012:532|R23_gupta_2019:567			BBB-	C	training
InChI=1S/C28H44O2/c1-18(2)19(3)9-10-20(4)25-13-14-26-22(8-7-15-28(25,26)6)11-12-23-16-24(29)17-27(30)21(23)5/h9-12,18-20,24-27,29-30H,5,7-8,13-17H2,1-4,6H3/b10-9+,22-11+,23-12-/t19-,20+,24+,25+,26-,27-,28+/m0/s1	Doxercalciferol	(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(E,2R,5R)-5,6-dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol	C=C1/C(=C\C=C2/CCC[C@]3(C)[C@@H]([C@H](C)/C=C/[C@H](C)C(C)C)CC[C@@H]23)C[C@@H](O)C[C@@H]1O	5281107.0	R23_gupta_2019:537			BBB-	C	training
InChI=1S/C28H44O3/c1-3-4-5-6-7-8-9-10-27(30)31-26-16-15-25-24-13-11-20-19-21(29)12-14-22(20)23(24)17-18-28(25,26)2/h19,22-26H,3-18H2,1-2H3/t22-,23+,24+,25-,26-,28-/m0/s1	Nandrolone Decanoate	[(8R,9S,10R,13S,14S,17S)-13-methyl-3-oxo-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl] decanoate	CCCCCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@]12C	9677.0	R23_gupta_2019:768			BBB-	C	training
InChI=1S/C28H46O/c1-19(2)20(3)9-10-22(5)26-15-16-27-23(8-7-17-28(26,27)6)12-13-24-18-25(29)14-11-21(24)4/h9-10,12-13,19-22,25-27,29H,7-8,11,14-18H2,1-6H3/b10-9+,23-12+,24-13+/t20-,21-,22+,25-,26+,27-,28+/m0/s1	Dihydrotachysterol	(1S,3E,4S)-3-[(2E)-2-[(1R,3aS,7aR)-1-[(E,2R,5R)-5,6-dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylcyclohexan-1-ol	CC(C)[C@@H](C)/C=C/[C@@H](C)[C@H]1CC[C@H]2/C(=C/C=C3\C[C@@H](O)CC[C@@H]3C)CCC[C@]12C	5311071.0	R14_ghose_2012:500|R23_gupta_2019:526			BBB-	C	training
InChI=1S/C28H54N8/c1-9-29-15-17-31-13-3-21-35(23-19-33-11-1)25-27-5-7-28(8-6-27)26-36-22-4-14-32-18-16-30-10-2-12-34-20-24-36/h5-8,29-34H,1-4,9-26H2	Plerixafor	1-[[4-(1,4,8,11-tetrazacyclotetradec-1-ylmethyl)phenyl]methyl]-1,4,8,11-tetrazacyclotetradecane	c1cc(CN2CCCNCCNCCCNCC2)ccc1CN1CCCNCCNCCCNCC1	65015.0	R23_gupta_2019:847			BBB-	C	training
InChI=1S/C29H25N3O5/c1-32-13-10-29-20-7-9-23(36-28(34)19-5-3-12-31-16-19)26(29)37-25-22(8-6-17(24(25)29)14-21(20)32)35-27(33)18-4-2-11-30-15-18/h2-9,11-12,15-16,20-21,23,26H,10,13-14H2,1H3/t20-,21+,23-,26-,29-/m0/s1	Nicomorphine	[(4R,4aR,7S,7aR,12bS)-3-methyl-9-(pyridine-3-carbonyloxy)-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-yl] pyridine-3-carboxylate	CN1CC[C@]23c4c5ccc(OC(=O)c6cccnc6)c4O[C@H]2[C@@H](OC(=O)c2cccnc2)C=C[C@H]3[C@H]1C5	5362460.0	R6_adenot_2004:1066			BBB+	C	training
InChI=1S/C29H26ClFN4O4S/c1-40(36,37)12-11-32-16-23-7-10-27(39-23)20-5-8-26-24(14-20)29(34-18-33-26)35-22-6-9-28(25(30)15-22)38-17-19-3-2-4-21(31)13-19/h2-10,13-15,18,32H,11-12,16-17H2,1H3,(H,33,34,35)	Lapatinib|Lapatinib, Gw 572016, Tykerb	N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(2-methylsulfonylethylamino)methyl]furan-2-yl]quinazolin-4-amine	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1	208908.0	R23_gupta_2019:699|R25_brito_sanchez_2015:459|R26_chico_2009:236|R46_mendoza_valencia_2017:384			BBB-	C	training
InChI=1S/C29H26N4O/c1-2-25(21-11-5-3-6-12-21)32-29(34)27-23-15-9-10-16-26(23)31-28(22-13-7-4-8-14-22)24(27)19-33-18-17-30-20-33/h3-18,20,25H,2,19H2,1H3,(H,32,34)/t25-/m0/s1	Skb-I		CC[C@H](NC(=O)c1c(Cn2ccnc2)c(-c2ccccc2)nc2ccccc12)c1ccccc1		R28_li_2005:409			BBB-	C	training
InChI=1S/C29H27F2NO3/c30-27-13-5-21(19-28(27)31)25-11-4-20-18-22(33)6-12-26(20)29(25)35-24-9-7-23(8-10-24)34-17-16-32-14-2-1-3-15-32/h4-13,18-19,33H,1-3,14-17H2	6-(3,4-Difluorophenyl)-5-(4-(2-(Piperidin-1-Yl)Ethoxy)Phenoxy)Naphthalen-2-Ol	6-(3,4-difluorophenyl)-5-[4-(2-piperidin-1-ylethoxy)phenoxy]naphthalen-2-ol	Oc1ccc2c(Oc3ccc(OCCN4CCCCC4)cc3)c(-c3ccc(F)c(F)c3)ccc2c1	44427374.0	R47_radchenko_2020:300	0.92	A	BBB+	A	training
InChI=1S/C29H27F3N6O/c1-20-5-6-22(16-21(20)8-10-25-18-33-27-4-3-11-34-38(25)27)28(39)35-24-9-7-23(26(17-24)29(30,31)32)19-37-14-12-36(2)13-15-37/h3-7,9,11,16-18H,12-15,19H2,1-2H3,(H,35,39)	Ponatinib	3-(2-imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]benzamide	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12	24826799.0	R23_gupta_2019:850			BBB-	C	training
InChI=1S/C29H28F4N4O4/c1-40-20-6-3-5-19(16-20)35-11-13-36(14-12-35)28-34-27-21(7-4-8-22(27)30)23(17-26(38)39)37(28)24-15-18(29(31,32)33)9-10-25(24)41-2/h3-10,15-16,23H,11-14,17H2,1-2H3,(H,38,39)/t23-/m0/s1	Letermovir	2-[(4S)-8-fluoro-2-[4-(3-methoxyphenyl)piperazin-1-yl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-4H-quinazolin-4-yl]acetic acid	COc1cccc(N2CCN(C3=Nc4c(F)cccc4[C@H](CC(=O)O)N3c3cc(C(F)(F)F)ccc3OC)CC2)c1	45138674.0	R23_gupta_2019:704			BBB-	C	training
InChI=1S/C29H28FNO3/c30-23-6-4-5-21(19-23)27-13-7-22-20-24(32)8-14-28(22)29(27)34-26-11-9-25(10-12-26)33-18-17-31-15-2-1-3-16-31/h4-14,19-20,32H,1-3,15-18H2	6-(3-Fluorophenyl)-5-(4-(2-(Piperidin-1-Yl)Ethoxy)Phenoxy)Naphthalen-2-Ol	6-(3-fluorophenyl)-5-[4-(2-piperidin-1-ylethoxy)phenoxy]naphthalen-2-ol	Oc1ccc2c(Oc3ccc(OCCN4CCCCC4)cc3)c(-c3cccc(F)c3)ccc2c1	44427373.0	R47_radchenko_2020:299	0.73	A	BBB+	A	training
InChI=1S/C29H28FNO3/c30-23-7-4-21(5-8-23)27-14-6-22-20-24(32)9-15-28(22)29(27)34-26-12-10-25(11-13-26)33-19-18-31-16-2-1-3-17-31/h4-15,20,32H,1-3,16-19H2	6-(4-Fluorophenyl)-5-{4-[2-(Piperidin-1-Yl)Ethoxy]Phenoxy}Naphthalen-2-Ol	6-(4-fluorophenyl)-5-[4-(2-piperidin-1-ylethoxy)phenoxy]naphthalen-2-ol	Oc1ccc2c(Oc3ccc(OCCN4CCCCC4)cc3)c(-c3ccc(F)cc3)ccc2c1	11720175.0	R47_radchenko_2020:298	1.25	A	BBB+	A	training
InChI=1S/C29H28N2O4/c1-2-23(20-12-5-3-6-13-20)31-29(34)26-22-16-9-10-17-24(22)30-27(21-14-7-4-8-15-21)28(26)35-19-11-18-25(32)33/h3-10,12-17,23H,2,11,18-19H2,1H3,(H,31,34)(H,32,33)/t23-/m0/s1	Skb-E|4-[2-Phenyl-4-[[(1S)-1-Phenylpropyl]Carbamoyl]Quinolin-3-Yl]Oxybutanoic Acid	4-[2-phenyl-4-[[(1S)-1-phenylpropyl]carbamoyl]quinolin-3-yl]oxybutanoic acid	CC[C@H](NC(=O)c1c(OCCCC(=O)O)c(-c2ccccc2)nc2ccccc12)c1ccccc1	9912474.0	R28_li_2005:405			BBB-	C	training
InChI=1S/C29H29NO4/c31-23-6-4-5-21(19-23)27-13-7-22-20-24(32)8-14-28(22)29(27)34-26-11-9-25(10-12-26)33-18-17-30-15-2-1-3-16-30/h4-14,19-20,31-32H,1-3,15-18H2	6-(3-Hydroxyphenyl)-5-(4-(2-(Piperidin-1-Yl)Ethoxy)Phenoxy)Naphthalen-2-Ol	6-(3-hydroxyphenyl)-5-[4-(2-piperidin-1-ylethoxy)phenoxy]naphthalen-2-ol	Oc1cccc(-c2ccc3cc(O)ccc3c2Oc2ccc(OCCN3CCCCC3)cc2)c1	12074176.0	R47_radchenko_2020:296	-0.57	A	BBB+	A	training
InChI=1S/C29H29NO4/c31-23-7-4-21(5-8-23)27-14-6-22-20-24(32)9-15-28(22)29(27)34-26-12-10-25(11-13-26)33-19-18-30-16-2-1-3-17-30/h4-15,20,31-32H,1-3,16-19H2	6-(4-Hydroxyphenyl)-5-(4-(2-(Piperidin-1-Yl)Ethoxy)Phenoxy)Naphthalen-2-Ol	6-(4-hydroxyphenyl)-5-[4-(2-piperidin-1-ylethoxy)phenoxy]naphthalen-2-ol	Oc1ccc(-c2ccc3cc(O)ccc3c2Oc2ccc(OCCN3CCCCC3)cc2)cc1	9848501.0	R47_radchenko_2020:297	-0.77	A	BBB+	A	training
InChI=1S/C29H30N6O6/c1-5-8-23-30-25(29(3,4)38)24(27(36)39-16-22-17(2)40-28(37)41-22)35(23)15-18-11-13-19(14-12-18)20-9-6-7-10-21(20)26-31-33-34-32-26/h6-7,9-14,38H,5,8,15-16H2,1-4H3,(H,31,32,33,34)	Olmesartan Medoxomil	(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 5-(2-hydroxypropan-2-yl)-2-propyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazole-4-carboxylate	CCCc1nc(C(C)(C)O)c(C(=O)OCc2oc(=O)oc2C)n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1	130881.0	R23_gupta_2019:792			BBB-	C	training
InChI=1S/C29H31F2N3O/c30-24-12-8-22(9-13-24)27(23-10-14-25(31)15-11-23)7-4-18-33-19-16-29(17-20-33)28(35)32-21-34(29)26-5-2-1-3-6-26/h1-3,5-6,8-15,27H,4,7,16-21H2,(H,32,35)	Fluspirilene	8-[4,4-bis(4-fluorophenyl)butyl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one	O=C1NCN(c2ccccc2)C12CCN(CCCC(c1ccc(F)cc1)c1ccc(F)cc1)CC2	3396.0	R6_adenot_2004:1162|R14_ghose_2012:100|R23_gupta_2019:99			BBB+	C	training
InChI=1S/C29H31N3O2/c33-29(20-23-8-12-27(13-9-23)34-22-24-6-2-1-3-7-24)30-26-11-10-25-14-17-32(28(25)21-26)19-18-31-15-4-5-16-31/h1-3,6-14,17,21H,4-5,15-16,18-20,22H2,(H,30,33)	Indole-Based Mchr1 Antagonist(2)|2-(4-Phenylmethoxyphenyl)-N-[1-(2-Pyrrolidin-1-Ylethyl)Indol-6-Yl]Acetamide	2-(4-phenylmethoxyphenyl)-N-[1-(2-pyrrolidin-1-ylethyl)indol-6-yl]acetamide	O=C(Cc1ccc(OCc2ccccc2)cc1)Nc1ccc2ccn(CCN3CCCC3)c2c1	70691333.0	R25_brito_sanchez_2015:442	-0.59	A	BBB+	A	training
InChI=1S/C29H31N7O/c1-21-5-10-25(18-27(21)34-29-31-13-11-26(33-29)24-4-3-12-30-19-24)32-28(37)23-8-6-22(7-9-23)20-36-16-14-35(2)15-17-36/h3-13,18-19H,14-17,20H2,1-2H3,(H,32,37)(H,31,33,34)	Imatinib|Gleevec, Imatinib, Sti 571	4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1	5291.0	R23_gupta_2019:672|R26_chico_2009:203	-1.5	A	BBB-	A	test
InChI=1S/C29H32O13/c1-11-36-9-20-27(40-11)24(31)25(32)29(41-20)42-26-14-7-17-16(38-10-39-17)6-13(14)21(22-15(26)8-37-28(22)33)12-4-18(34-2)23(30)19(5-12)35-3/h4-7,11,15,20-22,24-27,29-32H,8-10H2,1-3H3/t11-,15+,20-,21-,22+,24-,25-,26-,27-,29+/m1/s1	Etoposide	(5S,5aR,8aR,9R)-5-[[(2R,4aR,6R,7R,8R,8aS)-7,8-dihydroxy-2-methyl-4,4a,6,7,8,8a-hexahydropyrano[3,2-d][1,3]dioxin-6-yl]oxy]-9-(4-hydroxy-3,5-dimethoxyphenyl)-5a,6,8a,9-tetrahydro-5H-[2]benzofuro[6,5-f][1,3]benzodioxol-8-one	COc1cc([C@@H]2c3cc4c(cc3[C@@H](O[C@@H]3O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]3O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O	36462.0	R6_adenot_2004:28|R12_garg_2006:79|R21_muehlbacher_2011:73|R23_gupta_2019:585|R25_brito_sanchez_2015:229|R28_li_2005:203|R34_broccatelli_2012:124|R39_shayanfar_2011:44|R40_vilar_2010:108|R47_radchenko_2020:268	-2.0	B	BBB-	A	test
InChI=1S/C29H33FO4/c1-26-10-9-21(32)12-19(26)7-8-22-23-13-20-11-17-5-3-4-6-18(17)14-28(20,25(34)16-31)27(23,2)15-24(33)29(22,26)30/h3-6,9-10,12,20,22-24,31,33H,7-8,11,13-16H2,1-2H3/t20-,22+,23+,24+,26+,27+,28-,29+/m1/s1	Naflocort|Naflocortum	(1S,2S,10S,11R,12S,14S,15S,24S)-11-fluoro-12-hydroxy-15-(2-hydroxyacetyl)-10,14-dimethylhexacyclo[12.11.0.02,11.05,10.015,24.017,22]pentacosa-5,8,17,19,21-pentaen-7-one	C[C@]12C=CC(=O)C=C1CC[C@H]1[C@@H]3C[C@H]4Cc5ccccc5C[C@@]4(C(=O)CO)[C@@]3(C)C[C@H](O)[C@@]12F	6917657.0	R6_adenot_2004:885			BBB+	C	training
InChI=1S/C29H33FO6/c1-17-13-22-21-10-9-19-14-20(32)11-12-26(19,2)28(21,30)23(33)15-27(22,3)29(17,24(34)16-31)36-25(35)18-7-5-4-6-8-18/h4-8,11-12,14,17,21-23,31,33H,9-10,13,15-16H2,1-3H3/t17-,21-,22-,23-,26-,27-,28-,29-/m0/s1	Betamethasone-Benzoate|Betamethasone Benzoate	[(8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] benzoate	C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)c1ccccc1)C(=O)CO	5282492.0	R6_adenot_2004:775			BBB+	C	test
InChI=1S/C29H33FO6/c1-25-12-11-19(32)13-18(25)9-10-20-21-14-24-29(23(34)16-31,26(21,2)15-22(33)28(20,25)30)36-27(3,35-24)17-7-5-4-6-8-17/h4-8,11-13,20-22,24,31,33H,9-10,14-16H2,1-3H3/t20-,21-,22-,24+,25-,26-,27+,28-,29+/m0/s1	Amcinafide	(1S,2S,4R,6R,8S,9S,11S,12R,13S)-12-fluoro-11-hydroxy-8-(2-hydroxyacetyl)-6,9,13-trimethyl-6-phenyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one	C[C@@]1(c2ccccc2)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1	11954283.0	R6_adenot_2004:767			BBB+	C	test
InChI=1S/C29H33FO8/c1-16-12-21-20-8-7-18-13-19(32)9-10-26(18,3)28(20,30)23(33)14-27(21,4)29(16,24(34)15-37-17(2)31)38-25(35)22-6-5-11-36-22/h5-6,9-11,13,16,20-21,23,33H,7-8,12,14-15H2,1-4H3/t16-,20+,21+,23+,26+,27+,28+,29+/m1/s1	Dexamethasone-Acefurate|Dexamethasone Acefurate	[(8S,9R,10S,11S,13S,14S,16R,17R)-17-(2-acetyloxyacetyl)-9-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] furan-2-carboxylate	CC(=O)OCC(=O)[C@@]1(OC(=O)c2ccco2)[C@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C	656777.0	R6_adenot_2004:816			BBB+	C	training
InChI=1S/C29H34N4O/c1-32-17-5-14-29(32)15-18-33(19-16-29)21-22-8-10-24(11-9-22)28(34)31-27-20-25(12-13-26(27)30)23-6-3-2-4-7-23/h2-4,6-13,20H,5,14-19,21,30H2,1H3,(H,31,34)	19		CN1CCCC12CCN(Cc1ccc(C(=O)Nc3cc(-c4ccccc4)ccc3N)cc1)CC2		R47_radchenko_2020:521	-0.03	A	BBB+	A	training
InChI=1S/C29H35N3O10/c1-28(41)14-7-4-8-17(33)18(14)22(34)19-15(28)10-16-21(31(2)3)23(35)20(25(37)29(16,42)24(19)36)26(38)30-12-32-9-5-6-13(11-32)27(39)40/h4,7-8,13,15-16,21,33-34,37,41-42H,5-6,9-12H2,1-3H3,(H,30,38)(H,39,40)/t13?,15-,16-,21-,28+,29-/m0/s1	Pecocycline	1-[[[(4S,4aS,5aS,6S,12aR)-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carbonyl]amino]methyl]piperidine-3-carboxylic acid	CN(C)[C@@H]1C(=O)C(C(=O)NCN2CCCC(C(=O)O)C2)=C(O)[C@@]2(O)C(=O)C3=C(O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12	54688697.0	R6_adenot_2004:316			BBB-	C	test
InChI=1S/C29H35NO2/c1-5-15-29(32)16-14-26-24-12-8-20-17-22(31)11-13-23(20)27(24)25(18-28(26,29)2)19-6-9-21(10-7-19)30(3)4/h6-7,9-10,17,24-26,32H,8,11-14,16,18H2,1-4H3/t24-,25+,26-,28-,29-/m0/s1	Mifepristone	(8S,11R,13S,14S,17S)-11-[4-(dimethylamino)phenyl]-17-hydroxy-13-methyl-17-prop-1-ynyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one	CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)C)cc3)C[C@@]21C	55245.0	R28_li_2005:273			BBB-	C	training
InChI=1S/C29H37ClFNO7/c1-16(33)37-15-23(35)29-24(38-25(2,3)39-29)12-20-21-10-17(14-32)19-11-18(36-9-8-30)6-7-26(19,4)28(21,31)22(34)13-27(20,29)5/h11,20-22,24,34H,6-10,12-13,15H2,1-5H3/t20-,21-,22-,24+,26-,27-,28-,29+/m0/s1	Cicortonide	[2-[(1S,2S,4R,8S,9S,11S,12R,13S)-16-(2-chloroethoxy)-19-cyano-12-fluoro-11-hydroxy-6,6,9,13-tetramethyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-16,18-dien-8-yl]-2-oxoethyl] acetate	CC(=O)OCC(=O)[C@@]12OC(C)(C)O[C@@H]1C[C@H]1[C@@H]3CC(C#N)=C4C=C(OCCCl)CC[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]12C	20055442.0	R6_adenot_2004:783			BBB+	C	training
InChI=1S/C29H38ClFO8/c1-16(33)37-15-23(35)29-24(38-25(2,3)39-29)12-20-21-10-17(14-32)19-11-18(36-9-8-30)6-7-26(19,4)28(21,31)22(34)13-27(20,29)5/h11,14,20-22,24,34H,6-10,12-13,15H2,1-5H3/t20-,21-,22-,24+,26-,27-,28-,29+/m0/s1	Formocortal	[2-[(1S,2S,4R,8S,9S,11S,12R,13S)-16-(2-chloroethoxy)-12-fluoro-19-formyl-11-hydroxy-6,6,9,13-tetramethyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-16,18-dien-8-yl]-2-oxoethyl] acetate	CC(=O)OCC(=O)[C@@]12OC(C)(C)O[C@@H]1C[C@H]1[C@@H]3CC(C=O)=C4C=C(OCCCl)CC[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]12C	289085.0	R6_adenot_2004:861			BBB+	C	training
InChI=1S/C29H38F2O9/c1-6-8-23-39-22-13-17-18-12-20(30)19-11-16(32)9-10-26(19,4)28(18,31)21(33)14-27(17,5)29(22,40-23)24(34)37-15(3)38-25(35)36-7-2/h9-11,15,17-18,20-23,33H,6-8,12-14H2,1-5H3/t15-,17-,18-,20-,21-,22+,23+,26-,27-,28-,29-/m0/s1	Itrocinonide	[(1S)-1-ethoxycarbonyloxyethyl] (1S,2S,4R,6R,8S,9S,11S,12R,13S,19S)-12,19-difluoro-11-hydroxy-9,13-dimethyl-16-oxo-6-propyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-diene-8-carboxylate	CCC[C@@H]1O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)O[C@H](C)OC(=O)OCC)O1	9959691.0	R6_adenot_2004:871			BBB+	C	training
InChI=1S/C29H38F3N3O2S/c1-2-3-4-5-11-28(36)37-21-20-34-18-16-33(17-19-34)14-8-15-35-24-9-6-7-10-26(24)38-27-13-12-23(22-25(27)35)29(30,31)32/h6-7,9-10,12-13,22H,2-5,8,11,14-21H2,1H3	Fluphenazine-Enanthate|Fluphenazine Enanthate	2-[4-[3-[2-(trifluoromethyl)phenothiazin-10-yl]propyl]piperazin-1-yl]ethyl heptanoate	CCCCCCC(=O)OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1	3389.0	R6_adenot_2004:1572			BBB+	C	training
InChI=1S/C29H38FN3O3/c1-20(2)28-23-12-11-22(30)18-21(23)13-14-29(28,36-27(34)19-35-4)15-17-33(3)16-7-10-26-31-24-8-5-6-9-25(24)32-26/h5-6,8-9,11-12,18,20,28H,7,10,13-17,19H2,1-4H3,(H,31,32)/t28-,29-/m0/s1	Mibefradil	[(1S,2S)-2-[2-[3-(1H-benzimidazol-2-yl)propyl-methylamino]ethyl]-6-fluoro-1-propan-2-yl-3,4-dihydro-1H-naphthalen-2-yl] 2-methoxyacetate	COCC(=O)O[C@]1(CCN(C)CCCc2nc3ccccc3[nH]2)CCc2cc(F)ccc2[C@@H]1C(C)C	60663.0	R6_adenot_2004:48|R7_andres_2006:105|R29_subramanian_2003:100			BBB-	C	training
InChI=1S/C29H38N4O10/c1-28(42)13-7-6-9-17(34)18(13)22(35)19-14(28)11-15-21(33(2)3)23(36)20(25(38)29(15,43)24(19)37)26(39)32-12-31-10-5-4-8-16(30)27(40)41/h6-7,9,14-16,21,31,34-35,38,42-43H,4-5,8,10-12,30H2,1-3H3,(H,32,39)(H,40,41)/t14-,15-,16-,21-,28+,29-/m0/s1	Lymecycline	(2S)-6-[[[(4S,4aS,5aS,6S,12aR)-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carbonyl]amino]methylamino]-2-aminohexanoic acid	CN(C)[C@@H]1C(=O)C(C(=O)NCNCCCC[C@H](N)C(=O)O)=C(O)[C@@]2(O)C(=O)C3=C(O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12	54707177.0	R6_adenot_2004:310|R23_gupta_2019:719			BBB-	C	training
InChI=1S/C29H38N4O9/c1-28(41)15-5-4-6-18(35)19(15)23(36)20-16(28)13-17-22(31(2)3)24(37)21(26(39)29(17,42)25(20)38)27(40)30-14-33-9-7-32(8-10-33)11-12-34/h4-6,16-17,22,34-36,39,41-42H,7-14H2,1-3H3,(H,30,40)/t16-,17-,22-,28+,29-/m0/s1	Pipacycline	(4S,4aS,5aS,6S,12aR)-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-N-[[4-(2-hydroxyethyl)piperazin-1-yl]methyl]-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide	CN(C)[C@@H]1C(=O)C(C(=O)NCN2CCN(CCO)CC2)=C(O)[C@@]2(O)C(=O)C3=C(O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12	54686184.0	R6_adenot_2004:318			BBB-	C	training
InChI=1S/C29H38N8O8/c1-28(44)13-5-4-6-16(38)17(13)21(39)18-14(28)11-15-20(35(2)3)22(40)19(24(42)29(15,45)23(18)41)25(43)33-12-36-7-9-37(10-8-36)27(32)34-26(30)31/h4-6,14-15,20,38-39,42,44-45H,7-12H2,1-3H3,(H,33,43)(H5,30,31,32,34)/t14-,15-,20-,28+,29-/m0/s1	Guamecycline	(4S,4aS,5aS,6S,12aR)-N-[[4-[N-(diaminomethylidene)carbamimidoyl]piperazin-1-yl]methyl]-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide	[H]/N=C(\N=C(N)N)N1CCN(CNC(=O)C2=C(O)[C@@]3(O)C(=O)C4=C(O)c5c(O)cccc5[C@@](C)(O)[C@H]4C[C@H]3[C@H](N(C)C)C2=O)CC1	54688683.0	R6_adenot_2004:309			BBB-	C	training
InChI=1S/C29H39N3O3/c1-29(2,3)24-10-8-23(9-11-24)28(34)31-19-20-32(27(33)22-31)25-12-14-26(15-13-25)35-21-7-18-30-16-5-4-6-17-30/h8-15H,4-7,16-22H2,1-3H3	Proc-19M		CC(C)(C)c1ccc(C(=O)N2CCN(c3ccc(OCCCN4CCCCC4)cc3)C(=O)C2)cc1		R26_chico_2009:322	-1.0	A	BBB+	A	training
InChI=1S/C29H39N5O8/c1-28(2,3)31-11-17(35)32-15-10-16(33(4)5)13-8-12-9-14-21(34(6)7)24(38)20(27(30)41)26(40)29(14,42)25(39)18(12)23(37)19(13)22(15)36/h10,12,14,21,31,36-37,40,42H,8-9,11H2,1-7H3,(H2,30,41)(H,32,35)/t12-,14-,21-,29-/m0/s1	Tigecycline	(4S,4aS,5aR,12aR)-9-[[2-(tert-butylamino)acetyl]amino]-4,7-bis(dimethylamino)-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide	CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]3(O)C(=O)C1=C2O	54686904.0	R23_gupta_2019:979			BBB-	C	training
InChI=1S/C29H40N2O4/c1-6-18-17-31-10-8-20-14-27(33-3)29(35-5)16-23(20)25(31)12-21(18)11-24-22-15-28(34-4)26(32-2)13-19(22)7-9-30-24/h13-16,18,21,24-25,30H,6-12,17H2,1-5H3/t18-,21-,24+,25-/m0/s1	Emetine	(2S,3R,11bS)-2-[[(1R)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-1-yl]methyl]-3-ethyl-9,10-dimethoxy-2,3,4,6,7,11b-hexahydro-1H-benzo[a]quinolizine	CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21	10219.0	R6_adenot_2004:24			BBB-	C	test
InChI=1S/C29H40N4O7/c1-28(2,3)12-31-11-14-10-17(32(4)5)15-8-13-9-16-21(33(6)7)24(36)20(27(30)39)26(38)29(16,40)25(37)18(13)23(35)19(15)22(14)34/h10,13,16,21,31,34-35,38,40H,8-9,11-12H2,1-7H3,(H2,30,39)/t13-,16-,21-,29-/m0/s1	Omadacycline	(4S,4aS,5aR,12aR)-4,7-bis(dimethylamino)-9-[(2,2-dimethylpropylamino)methyl]-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide	CN(C)c1cc(CNCC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]3(O)C(=O)C1=C2O	54697325.0	R23_gupta_2019:794			BBB-	C	training
InChI=1S/C29H41F2N5O/c1-19(2)27-34-33-20(3)36(27)25-17-23-9-10-24(18-25)35(23)16-13-26(21-7-5-4-6-8-21)32-28(37)22-11-14-29(30,31)15-12-22/h4-8,19,22-26H,9-18H2,1-3H3,(H,32,37)/t23-,24+,25?,26-/m0/s1	Maraviroc	4,4-difluoro-N-[(1S)-3-[(1R,5S)-3-(3-methyl-5-propan-2-yl-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]octan-8-yl]-1-phenylpropyl]cyclohexane-1-carboxamide	Cc1nnc(C(C)C)n1C1C[C@H]2CC[C@@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1	3002977.0	R23_gupta_2019:721			BBB-	C	test
InChI=1S/C29H41NO4/c1-25(2,3)26(4,32)20-15-27-10-11-29(20,33-5)24-28(27)12-13-30(16-17-6-7-17)21(27)14-18-8-9-19(31)23(34-24)22(18)28/h8-9,17,20-21,24,31-32H,6-7,10-16H2,1-5H3/t20-,21-,24-,26+,27-,28+,29-/m1/s1	Buprenorphine	(1S,2S,6R,14R,15R,16R)-5-(cyclopropylmethyl)-16-[(2S)-2-hydroxy-3,3-dimethylbutan-2-yl]-15-methoxy-13-oxa-5-azahexacyclo[13.2.2.12,8.01,6.02,14.012,20]icosa-8(20),9,11-trien-11-ol	CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1Cc4ccc(O)c5c4[C@@]3(CCN1CC1CC1)[C@H]2O5	644073.0	R6_adenot_2004:1016|R14_ghose_2012:26|R23_gupta_2019:30|R28_li_2005:239|R37_chen_2011:14			BBB+	C	training
InChI=1S/C29H41NO7/c1-35-15-16-36-19-23(27(33)37-25-12-9-20-5-4-6-22(20)17-25)18-29(13-2-3-14-29)28(34)30-24-10-7-21(8-11-24)26(31)32/h9,12,17,21,23-24H,2-8,10-11,13-16,18-19H2,1H3,(H,30,34)(H,31,32)/t21?,23-,24?/m0/s1	Candoxatril	4-[[1-[(2S)-3-(2,3-dihydro-1H-inden-5-yloxy)-2-(2-methoxyethoxymethyl)-3-oxopropyl]cyclopentanecarbonyl]amino]cyclohexane-1-carboxylic acid	COCCOC[C@H](CC1(C(=O)NC2CCC(C(=O)O)CC2)CCCC1)C(=O)Oc1ccc2c(c1)CCC2	5362417.0	R23_gupta_2019:408			BBB-	C	training
InChI=1S/C29H42N2O4/c1-5-8-9-10-11-14-22-34-27-16-13-12-15-26(27)28(32)30-25-19-17-24(18-20-25)29(33)35-23-21-31(4,6-2)7-3/h12-13,15-20H,5-11,14,21-23H2,1-4H3/p+1	Otilonium	diethyl-methyl-[2-[4-[(2-octoxybenzoyl)amino]benzoyl]oxyethyl]azanium	CCCCCCCCOc1ccccc1C(=O)Nc1ccc(C(=O)OCC[N+](C)(CC)CC)cc1	72093.0	R14_ghose_2012:740			BBB-	C	training
InChI=1S/C29H44N2O7S2/c1-18(2)39-40-24(19(3)31(10)17-32)13-14-36-25(33)21(30)15-20-11-12-22(37-26(34)28(4,5)6)23(16-20)38-27(35)29(7,8)9/h11-12,16-18,21H,13-15,30H2,1-10H3/b24-19-	Zipr-Dopa(P)2		C/C(=C(\CCOC(=O)C(N)Cc1ccc(OC(=O)C(C)(C)C)c(OC(=O)C(C)(C)C)c1)SSC(C)C)N(C)C=O		R25_brito_sanchez_2015:454	0.53	A	BBB+	A	training
InChI=1S/C29H44O12/c1-13-22(34)23(35)24(36)25(40-13)41-15-8-19(32)28(12-30)21-17(3-5-27(28,37)9-15)29(38)6-4-16(14-7-20(33)39-11-14)26(29,2)10-18(21)31/h7,13,15-19,21-25,30-32,34-38H,3-6,8-12H2,1-2H3/t13-,15-,16+,17+,18+,19+,21+,22-,23+,24+,25-,26+,27-,28+,29-/m0/s1	Ouabain	3-[(1R,3S,5S,8R,9S,10R,11R,13R,14S,17R)-1,5,11,14-tetrahydroxy-10-(hydroxymethyl)-13-methyl-3-[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2H-furan-5-one	C[C@@H]1O[C@@H](O[C@H]2C[C@@H](O)[C@]3(CO)[C@H]4[C@H](O)C[C@]5(C)[C@@H](C6=CC(=O)OC6)CC[C@]5(O)[C@@H]4CC[C@]3(O)C2)[C@H](O)[C@H](O)[C@H]1O	439501.0	R23_gupta_2019:799			BBB-	C	training
InChI=1S/C29H48Br2O2/c1-18(2)8-7-9-19(3)23-10-11-24-22-16-26(30)29(31)17-21(33-20(4)32)12-15-28(29,6)25(22)13-14-27(23,24)5/h18-19,21-26H,7-17H2,1-6H3/t19-,21+,22+,23-,24+,25+,26-,27-,28-,29+/m1/s1	Acebrochol	[(3S,5R,6R,8S,9S,10R,13R,14S,17R)-5,6-dibromo-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-1,2,3,4,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl] acetate	CC(=O)O[C@H]1CC[C@]2(C)[C@H]3CC[C@]4(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]4[C@@H]3C[C@@H](Br)[C@@]2(Br)C1	10952056.0	R6_adenot_2004:1340			BBB+	C	training
InChI=1S/C29H50O2/c1-20(2)12-9-13-21(3)14-10-15-22(4)16-11-18-29(8)19-17-26-25(7)27(30)23(5)24(6)28(26)31-29/h20-22,30H,9-19H2,1-8H3/t21-,22-,29-/m1/s1	Alpha-Tocopherol	(2R)-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-ol	Cc1c(C)c2c(c(C)c1O)CC[C@@](C)(CCC[C@H](C)CCC[C@H](C)CCCC(C)C)O2	14985.0	R6_adenot_2004:1681			BBB+	C	training
InChI=1S/C29H53NO5/c1-5-7-9-11-12-13-14-15-16-18-24(34-29(33)26(30-22-31)20-23(3)4)21-27-25(28(32)35-27)19-17-10-8-6-2/h22-27H,5-21H2,1-4H3,(H,30,31)/t24-,25-,26-,27-/m0/s1	Orlistat	[(2S)-1-[(2S,3S)-3-hexyl-4-oxooxetan-2-yl]tridecan-2-yl] (2S)-2-formamido-4-methylpentanoate	CCCCCCCCCCC[C@@H](C[C@@H]1OC(=O)[C@H]1CCCCCC)OC(=O)[C@H](CC(C)C)NC=O	3034010.0	R14_ghose_2012:738|R23_gupta_2019:797			BBB-	C	training
InChI=1S/C2Cl2F4/c3-1(5,6)2(4,7)8	Cryofluorane|Dichlorotetrafluoroethane	1,2-dichloro-1,1,2,2-tetrafluoroethane	FC(F)(Cl)C(F)(F)Cl	6429.0	R6_adenot_2004:925			BBB+	C	training
InChI=1S/C2Cl4/c3-1(4)2(5)6	Tetrachloroethylene|Perchloroethylene	1,1,2,2-tetrachloroethene	ClC(Cl)=C(Cl)Cl	31373.0	R3_abraham_2006:45|R21_muehlbacher_2011:239|R25_brito_sanchez_2015:138|R40_vilar_2010:401|R41_toropov_2017:40|R46_mendoza_valencia_2017:136|R47_radchenko_2020:28	0.37	B	BBB+	A	training
InChI=1S/C2H2Cl2/c3-1-2-4/h1-2H	Trans 1,2-Dichloroethene|Cis 1,2-Dichloroethene|1,2-Dichloroethylene	1,2-dichloroethene	ClC=CCl	10900.0	R3_abraham_2006:43|R3_abraham_2006:44	-0.04	C	BBB+	A	training
InChI=1S/C2H2Cl2/c3-1-2-4/h1-2H/b2-1+	Dioform|Trans 1,2-Dichloroethene|Trans-1,2-Dichloroethene|Trans-1,2-Dichloroethylene	(E)-1,2-dichloroethene	Cl/C=C/Cl	638186.0	R21_muehlbacher_2011:311|R25_brito_sanchez_2015:65|R40_vilar_2010:403|R41_toropov_2017:38|R46_mendoza_valencia_2017:63|R47_radchenko_2020:26	0.04	B	BBB+	A	training
InChI=1S/C2H2Cl2/c3-1-2-4/h1-2H/b2-1-	Cis-Dichloroethylene|Cis-1,2-Dichloroethene|Cis 1,2-Dichloroethene|Cis-1,2-Dichloroethylene	(Z)-1,2-dichloroethene	Cl/C=C\Cl	643833.0	R21_muehlbacher_2011:312|R40_vilar_2010:347|R41_toropov_2017:39|R47_radchenko_2020:27	-0.13	B	BBB+	A	training
InChI=1S/C2H2Cl4/c3-1-2(4,5)6/h1H2	1,1,1,2-Tetrachloroethane	1,1,1,2-tetrachloroethane	ClCC(Cl)(Cl)Cl	12418.0	R3_abraham_2006:35|R21_muehlbacher_2011:216|R25_brito_sanchez_2015:40|R40_vilar_2010:308|R41_toropov_2017:30|R46_mendoza_valencia_2017:39|R47_radchenko_2020:20	0.33	B	BBB+	A	test
InChI=1S/C2H2ClF3/c3-1-2(4,5)6/h1H2	1-Chloro-2,2,2-Trifluroethane|2-Chloro-1,1,1-Trifluoroethane|1,1,1-Trifluoro-2-Chloroethane|Cf3Ch2Cl|Chlorotrifluoroethane|111-Trifluoro-2-Chloroethane	2-chloro-1,1,1-trifluoroethane	FC(F)(F)CCl	6408.0	R3_abraham_2006:36|R5_guerra_2008:4|R12_garg_2006:2|R12_garg_2006:56|R17_fu_2008:9|R21_muehlbacher_2011:164|R22_clark_1999:9|R25_brito_sanchez_2015:52|R28_li_2005:57|R40_vilar_2010:319|R41_toropov_2017:31|R44_bujak_2015:82|R46_mendoza_valencia_2017:51|R47_radchenko_2020:21|R48_hou_2003:80|R49_norinder_2002:63|R52_liu_2001:39	0.08	B1	BBB+	A	training
InChI=1S/C2H2F4/c3-1-2(4,5)6/h1H2	Norflurane|1,1,1,2-Tetrafluoroethane	1,1,1,2-tetrafluoroethane	FCC(F)(F)F	13129.0	R6_adenot_2004:945			BBB+	C	training
InChI=1S/C2H3Br3O/c3-2(4,5)1-6/h6H,1H2	Tribromoethanol|2,2,2-Tribromoethanol	2,2,2-tribromoethanol	OCC(Br)(Br)Br	6400.0	R6_adenot_2004:955			BBB+	C	training
InChI=1S/C2H3Cl3/c1-2(3,4)5/h1H3	1,1,1-Trichloroethane|1,1,1-Trichloroethan|Methylchloroform|111-Trichloroethane	1,1,1-trichloroethane	CC(Cl)(Cl)Cl	6278.0	R3_abraham_2006:33|R5_guerra_2008:1|R7_andres_2006:191|R12_garg_2006:1|R17_fu_2008:10|R21_muehlbacher_2011:154|R22_clark_1999:10|R25_brito_sanchez_2015:41|R26_chico_2009:2|R28_li_2005:56|R39_shayanfar_2011:99|R40_vilar_2010:309|R41_toropov_2017:28|R44_bujak_2015:1|R46_mendoza_valencia_2017:40|R47_radchenko_2020:18|R48_hou_2003:97|R49_norinder_2002:61|R52_liu_2001:40	0.4	D	BBB+	A	test
InChI=1S/C2H3Cl3/c3-1-2(4)5/h2H,1H2	1,1,2-Trichloroethane|Vinyltrichloride	1,1,2-trichloroethane	ClCC(Cl)Cl	6574.0	R3_abraham_2006:34|R21_muehlbacher_2011:169|R25_brito_sanchez_2015:571|R40_vilar_2010:310|R41_toropov_2017:29|R46_mendoza_valencia_2017:477|R47_radchenko_2020:19	-0.1	B	BBB+	A	training
InChI=1S/C2H3Cl3O2/c3-2(4,5)1(6)7/h1,6-7H	Chloralhydrate|Chloral Hydrate	2,2,2-trichloroethane-1,1-diol	OC(O)C(Cl)(Cl)Cl	2707.0	R14_ghose_2012:38|R51_doninger_2002:177			BBB+	C	training
InChI=1S/C2H4/c1-2/h1-2H2	Ethylene	ethene	C=C	6325.0	R3_abraham_2006:42|R6_adenot_2004:930|R25_brito_sanchez_2015:227|R40_vilar_2010:360|R41_toropov_2017:37|R46_mendoza_valencia_2017:209	0.3	B	BBB+	A	training
InChI=1S/C2H4Cl2/c1-2(3)4/h2H,1H3	1,1-Dichloroethane|Ethylidene Chloride	1,1-dichloroethane	CC(Cl)Cl	6365.0	R3_abraham_2006:31|R21_muehlbacher_2011:160|R25_brito_sanchez_2015:42|R40_vilar_2010:311|R41_toropov_2017:26|R46_mendoza_valencia_2017:41|R47_radchenko_2020:16	-0.28	B	BBB+	A	test
InChI=1S/C2H4Cl2/c3-1-2-4/h1-2H2	1,2-Dichloroethane	1,2-dichloroethane	ClCCCl	11.0	R3_abraham_2006:32|R21_muehlbacher_2011:1|R25_brito_sanchez_2015:46|R40_vilar_2010:314|R41_toropov_2017:27|R46_mendoza_valencia_2017:45|R47_radchenko_2020:17	-0.14	B	BBB+	A	test
InChI=1S/C2H4O/c1-2-3-1/h1-2H2	Ethylene Oxide|Oxirane	oxirane	C1CO1	6354.0	R3_abraham_2006:72|R21_muehlbacher_2011:158|R25_brito_sanchez_2015:228|R40_vilar_2010:361|R41_toropov_2017:67|R46_mendoza_valencia_2017:210|R47_radchenko_2020:54	0.01	B	BBB+	A	training
InChI=1S/C2H5Cl/c1-2-3/h2H2,1H3	Ethyl-Chloride|Chloroethane	chloroethane	CCCl	6337.0	R6_adenot_2004:931			BBB+	C	training
InChI=1S/C2H5NO2/c1-2(4)3-5/h5H,1H3,(H,3,4)	Acetohydroxamic Acid	N-hydroxyacetamide	CC(=O)NO	1990.0	R14_ghose_2012:326|R23_gupta_2019:1042			BBB-	C	training
InChI=1S/C2H6N2S/c1-5-2(3)4/h1H3,(H3,3,4)	S-Methylisothiourea|S-Methyl-Isothiourea|Carbamimidothioic Acid, Methyl Ester	methyl carbamimidothioate	[H]/N=C(/N)SC	5142.0	R3_abraham_2006:275|R21_muehlbacher_2011:124|R25_brito_sanchez_2015:162|R26_chico_2009:384|R40_vilar_2010:258|R41_toropov_2017:247|R46_mendoza_valencia_2017:157|R47_radchenko_2020:230	-0.6	B	BBB+	A	training
InChI=1S/C2H6O/c1-2-3/h3H,2H2,1H3	Ethanol	ethanol	CCO	702.0	R3_abraham_2006:55|R5_guerra_2008:41|R7_andres_2006:196|R12_garg_2006:77|R17_fu_2008:13|R21_muehlbacher_2011:11|R22_clark_1999:13|R25_brito_sanchez_2015:221|R26_chico_2009:179|R28_li_2005:81|R39_shayanfar_2011:107|R40_vilar_2010:356|R41_toropov_2017:50|R44_bujak_2015:28|R46_mendoza_valencia_2017:203|R47_radchenko_2020:37|R48_hou_2003:65|R49_norinder_2002:44|R52_liu_2001:43	-0.15	B1	BBB+	A	training
InChI=1S/C2H6O3S2/c3-7(4,5)2-1-6/h6H,1-2H2,(H,3,4,5)	Mesna|2-Mercaptoethanesulfonic Acid	2-sulfanylethanesulfonic acid	O=S(=O)(O)CCS	598.0	R28_li_2005:306			BBB-	C	test
InChI=1S/C2H7NS/c3-1-2-4/h4H,1-3H2	Cysteamine	2-aminoethanethiol	NCCS	6058.0	R23_gupta_2019:489			BBB-	C	training
InChI=1S/C2H8O7P2/c1-2(3,10(4,5)6)11(7,8)9/h3H,1H3,(H2,4,5,6)(H2,7,8,9)	Etidronate|Etidronic Acid	(1-hydroxy-1-phosphonoethyl)phosphonic acid	CC(O)(P(=O)(O)O)P(=O)(O)O	3305.0	R23_gupta_2019:583			BBB-	C	training
InChI=1S/C2HBrClF3/c3-1(4)2(5,6)7/h1H	Halothane	2-bromo-2-chloro-1,1,1-trifluoroethane	FC(F)(F)C(Cl)Br	3562.0	R3_abraham_2006:40|R5_guerra_2008:49|R6_adenot_2004:936|R7_andres_2006:197|R12_garg_2006:84|R17_fu_2008:15|R21_muehlbacher_2011:83|R22_clark_1999:15|R23_gupta_2019:651|R25_brito_sanchez_2015:246|R26_chico_2009:207|R28_li_2005:88|R39_shayanfar_2011:110|R40_vilar_2010:363|R41_toropov_2017:35|R44_bujak_2015:33|R46_mendoza_valencia_2017:221|R47_radchenko_2020:25|R52_liu_2001:45	0.35	D	BBB+	A	training
InChI=1S/C2HBrClF3/c3-1(4)2(5,6)7/h1H/t1-/m0/s1	R-Halothane|(R)-Halothane	(2R)-2-bromo-2-chloro-1,1,1-trifluoroethane	FC(F)(F)[C@H](Cl)Br	445258.0	R48_hou_2003:92|R49_norinder_2002:65	0.35	B	BBB+	A	training
InChI=1S/C2HBrF4/c3-1(4)2(5,6)7/h1H	Teflurane|Tefluranum|R-Teflurane	2-bromo-1,1,1,2-tetrafluoroethane	FC(Br)C(F)(F)F	31300.0	R3_abraham_2006:39|R6_adenot_2004:952|R7_andres_2006:164|R12_garg_2006:157|R17_fu_2008:23|R21_muehlbacher_2011:238|R22_clark_1999:25|R25_brito_sanchez_2015:151|R28_li_2005:116|R39_shayanfar_2011:88|R40_vilar_2010:399|R41_toropov_2017:34|R44_bujak_2015:60|R46_mendoza_valencia_2017:148|R47_radchenko_2020:24|R49_norinder_2002:59|R52_liu_2001:55	0.27	B	BBB+	A	training
InChI=1S/C2HBrF4/c3-1(4)2(5,6)7/h1H/t1-/m0/s1	(2R)-2-Bromo-1,1,1,2-Tetrafluoroethane	(2R)-2-bromo-1,1,1,2-tetrafluoroethane	F[C@H](Br)C(F)(F)F	76961009.0	R48_hou_2003:89	0.27	A	BBB+	A	training
InChI=1S/C2HCl3/c3-1-2(4)5/h1H	Trichloroethene|Trichloroethylene	1,1,2-trichloroethene	ClC=C(Cl)Cl	6575.0	R3_abraham_2006:51|R5_guerra_2008:104|R6_adenot_2004:956|R7_andres_2006:221|R12_garg_2006:169|R17_fu_2008:25|R21_muehlbacher_2011:170|R22_clark_1999:27|R25_brito_sanchez_2015:30|R26_chico_2009:429|R28_li_2005:122|R28_li_2005:137|R39_shayanfar_2011:97|R40_vilar_2010:404|R41_toropov_2017:46|R44_bujak_2015:64|R44_bujak_2015:83|R46_mendoza_valencia_2017:30|R47_radchenko_2020:34|R48_hou_2003:91|R49_norinder_2002:62|R52_liu_2001:57	0.34	D	BBB+	A	training
InChI=1S/C2HClF2/c3-1-2(4)5/h1H	1-Chloro-2,2-Difluroethylene|1,1-Difluorochloroethylene|1-Chloro-2,2-Difluoroethylene|2-Chloro-1,1-Difluoroethylene	2-chloro-1,1-difluoroethene	FC(F)=CCl	9664.0	R3_abraham_2006:52|R21_muehlbacher_2011:208|R25_brito_sanchez_2015:53|R41_toropov_2017:47|R46_mendoza_valencia_2017:52|R47_radchenko_2020:35	-0.02	B	BBB+	A	training
InChI=1S/C30H26F6N4O2/c31-29(32,33)20-4-3-5-22(18-20)40-14-12-39(13-15-40)16-17-42-28(41)24-6-1-2-7-25(24)38-26-10-11-37-27-19-21(30(34,35)36)8-9-23(26)27/h1-11,18-19H,12-17H2,(H,37,38)	Antrafenine	2-[4-[3-(trifluoromethyl)phenyl]piperazin-1-yl]ethyl 2-[[7-(trifluoromethyl)quinolin-4-yl]amino]benzoate	O=C(OCCN1CCN(c2cccc(C(F)(F)F)c2)CC1)c1ccccc1Nc1ccnc2cc(C(F)(F)F)ccc12	68723.0	R23_gupta_2019:357			BBB-	C	training
InChI=1S/C30H28N2O3/c31-21-22-5-4-6-23(19-22)28-13-7-24-20-25(33)8-14-29(24)30(28)35-27-11-9-26(10-12-27)34-18-17-32-15-2-1-3-16-32/h4-14,19-20,33H,1-3,15-18H2	3-(6-Hydroxy-1-(4-(2-(Piperidin-1-Yl)Ethoxy)Phenoxy)Naphthalen-2-Yl)Benzonitrile	3-[6-hydroxy-1-[4-(2-piperidin-1-ylethoxy)phenoxy]naphthalen-2-yl]benzonitrile	N#Cc1cccc(-c2ccc3cc(O)ccc3c2Oc2ccc(OCCN3CCCCC3)cc2)c1	44427372.0	R47_radchenko_2020:295	0.17	A	BBB+	A	training
InChI=1S/C30H31NO5S/c1-37(33,34)27-13-5-22(6-14-27)28-15-7-23-21-24(32)8-16-29(23)30(28)36-26-11-9-25(10-12-26)35-20-19-31-17-3-2-4-18-31/h5-16,21,32H,2-4,17-20H2,1H3	6-(4-(Methanesulfonyl)Phenyl)-5-(4-(2-(Piperidin-1-Yl)Ethoxy)Phenoxy)Naphthalen-2-Ol	6-(4-methylsulfonylphenyl)-5-[4-(2-piperidin-1-ylethoxy)phenoxy]naphthalen-2-ol	CS(=O)(=O)c1ccc(-c2ccc3cc(O)ccc3c2Oc2ccc(OCCN3CCCCC3)cc2)cc1	5327043.0	R47_radchenko_2020:293	-0.81	A	BBB+	A	training
InChI=1S/C30H33N3O2/c1-4-25(22-14-7-5-8-15-22)32-30(34)27-24-18-11-12-19-26(24)31-28(23-16-9-6-10-17-23)29(27)35-21-13-20-33(2)3/h5-12,14-19,25H,4,13,20-21H2,1-3H3,(H,32,34)/t25-/m0/s1	Skb_C|3-[3-(Dimethylamino)Propoxy]-2-Phenyl-N-[(1S)-1-Phenylpropyl]Quinoline-4-Carboxamide	3-[3-(dimethylamino)propoxy]-2-phenyl-N-[(1S)-1-phenylpropyl]quinoline-4-carboxamide	CC[C@H](NC(=O)c1c(OCCCN(C)C)c(-c2ccccc2)nc2ccccc12)c1ccccc1	10695575.0	R28_li_2005:403			BBB+	C	training
InChI=1S/C30H34N2O3/c1-22-28-20-26(34)12-15-29(28)32(30(22)24-8-10-25(33)11-9-24)21-23-6-13-27(14-7-23)35-19-18-31-16-4-2-3-5-17-31/h6-15,20,33-34H,2-5,16-19,21H2,1H3	Bazedoxifene	1-[[4-[2-(azepan-1-yl)ethoxy]phenyl]methyl]-2-(4-hydroxyphenyl)-3-methylindol-5-ol	Cc1c(-c2ccc(O)cc2)n(Cc2ccc(OCCN3CCCCCC3)cc2)c2ccc(O)cc12	154257.0	R23_gupta_2019:379			BBB-	C	training
InChI=1S/C30H35F2N3O/c1-22-5-3-6-23(2)30(22)33-29(36)21-35-19-17-34(18-20-35)16-4-7-28(24-8-12-26(31)13-9-24)25-10-14-27(32)15-11-25/h3,5-6,8-15,28H,4,7,16-21H2,1-2H3,(H,33,36)	Lidoflazine	2-[4-[4,4-bis(4-fluorophenyl)butyl]piperazin-1-yl]-N-(2,6-dimethylphenyl)acetamide	Cc1cccc(C)c1NC(=O)CN1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1	3926.0	R14_ghose_2012:655			BBB-	C	training
InChI=1S/C30H35F7N4O2/c1-18-13-24(31)5-6-26(18)27-17-25(40-11-9-39(10-12-40)20(3)42)7-8-41(27)28(43)38(4)19(2)21-14-22(29(32,33)34)16-23(15-21)30(35,36)37/h5-6,13-16,19,25,27H,7-12,17H2,1-4H3/t19-,25+,27-/m1/s1	Casopitant	(2R,4S)-4-(4-acetylpiperazin-1-yl)-N-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethyl]-2-(4-fluoro-2-methylphenyl)-N-methylpiperidine-1-carboxamide	CC(=O)N1CCN([C@H]2CCN(C(=O)N(C)[C@H](C)c3cc(C(F)(F)F)cc(C(F)(F)F)c3)[C@@H](c3ccc(F)cc3C)C2)CC1	9917021.0	R26_chico_2009:98	-0.01	A	BBB+	A	training
InChI=1S/C30H35N3O3S/c1-36-27-18-23-14-16-33(37(2,34)35)26(23)17-25(27)19-31-29-24-13-15-32(20-24)30(29)28(21-9-5-3-6-10-21)22-11-7-4-8-12-22/h3-12,17-18,24,28-31H,13-16,19-20H2,1-2H3	160502-69-2|Pfizer Compound 13		COc1cc2c(cc1CNC1C3CCN(C3)C1C(c1ccccc1)c1ccccc1)N(S(C)(=O)=O)CC2		R4_mente_2005:88|R25_brito_sanchez_2015:539|R40_vilar_2010:186|R46_mendoza_valencia_2017:450|R47_radchenko_2020:385	-1.0	B	BBB+	A	training
InChI=1S/C30H35NO11/c1-3-30(39)12-17(42-18-11-15(24(33)13(2)41-18)31-7-9-40-10-8-31)20-23(29(30)38)28(37)21-22(27(20)36)26(35)19-14(25(21)34)5-4-6-16(19)32/h4-6,13,15,17-18,24,29,32-33,36-39H,3,7-12H2,1-2H3/t13-,15-,17-,18-,24+,29+,30+/m0/s1	Morpholinyl Oxaunomycin|Antibiotic Mx 2	(7S,9R,10R)-9-ethyl-4,6,9,10,11-pentahydroxy-7-[(2R,4S,5S,6S)-5-hydroxy-6-methyl-4-morpholin-4-yloxan-2-yl]oxy-8,10-dihydro-7H-tetracene-5,12-dione	CC[C@@]1(O)C[C@H](O[C@H]2C[C@H](N3CCOCC3)[C@H](O)[C@H](C)O2)c2c(O)c3c(c(O)c2[C@H]1O)C(=O)c1cccc(O)c1C3=O	6917994.0	R25_brito_sanchez_2015:436	0.56	A	BBB+	A	training
InChI=1S/C30H36N4O4/c35-28-21-33(30(37)23-7-5-22(6-8-23)29(36)32-15-2-16-32)19-20-34(28)25-9-11-26(12-10-25)38-27-13-17-31(18-14-27)24-3-1-4-24/h5-12,24,27H,1-4,13-21H2	Proc-37J|4-[4-(Azetidine-1-Carbonyl)Benzoyl]-1-[4-(1-Cyclobutylpiperidin-4-Yl)Oxyphenyl]Piperazin-2-One	4-[4-(azetidine-1-carbonyl)benzoyl]-1-[4-(1-cyclobutylpiperidin-4-yl)oxyphenyl]piperazin-2-one	O=C(c1ccc(C(=O)N2CCN(c3ccc(OC4CCN(C5CCC5)CC4)cc3)C(=O)C2)cc1)N1CCC1	15986375.0	R26_chico_2009:326	-1.0	A	BBB+	A	test
InChI=1S/C30H38N4O11/c1-29(44)14-5-4-6-17(36)18(14)22(37)19-15(29)13-16-21(32(2)3)23(38)20(25(40)30(16,45)24(19)39)27(41)31-26(28(42)43)34-9-7-33(8-10-34)11-12-35/h4-6,15-16,21,26,35-37,40,44-45H,7-13H2,1-3H3,(H,31,41)(H,42,43)/t15-,16-,21-,26?,29+,30-/m0/s1	Apicycline	2-[[(4S,4aS,5aS,6S,12aR)-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carbonyl]amino]-2-[4-(2-hydroxyethyl)piperazin-1-yl]acetic acid	CN(C)[C@@H]1C(=O)C(C(=O)NC(C(=O)O)N2CCN(CCO)CC2)=C(O)[C@@]2(O)C(=O)C3=C(O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12	54693001.0	R6_adenot_2004:301			BBB-	C	training
InChI=1S/C30H39N5O7S2/c1-29(2)23(34-25(38)20(31)14-18-10-12-19(36)13-11-18)27(40)32-16-22(37)33-21(15-17-8-6-5-7-9-17)26(39)35-24(28(41)42)30(3,4)44-43-29/h5-13,20-21,23-24,36H,14-16,31H2,1-4H3,(H,32,40)(H,33,37)(H,34,38)(H,35,39)(H,41,42)/t20-,21-,23-,24-/m0/s1	Dpdpe	(4S,7S,13S)-13-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]-7-benzyl-3,3,14,14-tetramethyl-6,9,12-trioxo-1,2-dithia-5,8,11-triazacyclotetradecane-4-carboxylic acid	CC1(C)SSC(C)(C)[C@@H](NC(=O)[C@@H](N)Cc2ccc(O)cc2)C(=O)NCC(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@H]1C(=O)O	104787.0	R25_brito_sanchez_2015:438	-0.3	A	BBB+	A	training
InChI=1S/C30H39N5O7S2/c1-29(2)23(34-25(38)20(31)14-18-10-12-19(36)13-11-18)27(40)32-16-22(37)33-21(15-17-8-6-5-7-9-17)26(39)35-24(28(41)42)30(3,4)44-43-29/h5-13,20-21,23-24,36H,14-16,31H2,1-4H3,(H,32,40)(H,33,37)(H,34,38)(H,35,39)(H,41,42)/t20?,21?,23-,24+/m0/s1			CC1(C)SSC(C)(C)[C@@H](NC(=O)C(N)Cc2ccc(O)cc2)C(=O)NCC(=O)NC(Cc2ccccc2)C(=O)N[C@@H]1C(=O)O		R46_mendoza_valencia_2017:365	-0.3	A	BBB+	A	training
InChI=1S/C30H40Cl2O6/c1-6-8-25(35)37-17-24(34)30(38-26(36)9-7-2)18(3)14-22-21-11-10-19-15-20(33)12-13-27(19,4)29(21,32)23(31)16-28(22,30)5/h12-13,15,18,21-23H,6-11,14,16-17H2,1-5H3/t18-,21+,22+,23+,27+,28+,29+,30+/m1/s1	Meclorisone-Dibutyrate|Meclorisone Dibutyrate	[2-[(8S,9R,10S,11S,13S,14S,16R,17R)-17-butanoyloxy-9,11-dichloro-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] butanoate	CCCC(=O)OCC(=O)[C@@]1(OC(=O)CCC)[C@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](Cl)C[C@@]21C	68655.0	R6_adenot_2004:875			BBB+	C	test
InChI=1S/C30H40N4O2/c1-3-23-7-9-24(10-8-23)25-11-13-26(14-12-25)29(35)31(2)27-15-19-33(21-27)30(36)34-20-16-28(22-34)32-17-5-4-6-18-32/h7-14,27-28H,3-6,15-22H2,1-2H3	Mchr Antagonist 23C	4-(4-ethylphenyl)-N-methyl-N-[1-(3-piperidin-1-ylpyrrolidine-1-carbonyl)pyrrolidin-3-yl]benzamide	CCc1ccc(-c2ccc(C(=O)N(C)C3CCN(C(=O)N4CCC(N5CCCCC5)C4)C3)cc2)cc1	73226213.0	R25_brito_sanchez_2015:463|R46_mendoza_valencia_2017:388	0.81	B	BBB+	A	training
InChI=1S/C30H41FO7/c1-25(2,3)15-24(35)36-16-22(34)30-23(37-26(4,5)38-30)13-20-19-9-8-17-12-18(32)10-11-27(17,6)29(19,31)21(33)14-28(20,30)7/h10-12,19-21,23,33H,8-9,13-16H2,1-7H3/t19-,20-,21-,23+,27-,28-,29-,30+/m0/s1	Triamcinolone-Hexacetonide|Triamcinolone Hexacetonide	[2-[(1S,2S,4R,8S,9S,11S,12R,13S)-12-fluoro-11-hydroxy-6,6,9,13-tetramethyl-16-oxo-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-8-yl]-2-oxoethyl] 3,3-dimethylbutanoate	CC(C)(C)CC(=O)OCC(=O)[C@@]12OC(C)(C)O[C@@H]1C[C@H]1[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]12C	21826.0	R6_adenot_2004:917			BBB+	C	training
InChI=1S/C30H42O8/c1-16-24(32)25(33)26(34)27(37-16)38-19-8-11-28(2)18(14-19)5-6-22-21(28)9-12-29(3)20(10-13-30(22,29)35)17-4-7-23(31)36-15-17/h4,7,14-16,19-22,24-27,32-35H,5-6,8-13H2,1-3H3/t16-,19-,20+,21-,22+,24-,25+,26+,27-,28-,29+,30-/m0/s1	Proscillaridin	5-[(3S,8R,9S,10R,13R,14S,17R)-14-hydroxy-10,13-dimethyl-3-[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy-1,2,3,6,7,8,9,11,12,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]pyran-2-one	C[C@@H]1O[C@@H](O[C@@H]2C=C3CC[C@@H]4[C@H](CC[C@]5(C)[C@@H](c6ccc(=O)oc6)CC[C@]45O)[C@@]3(C)CC2)[C@H](O)[C@H](O)[C@H]1O	5284613.0	R7_andres_2006:146|R29_subramanian_2003:142|R51_doninger_2002:120			BBB-	C	test
InChI=1S/C30H46NO7P/c1-4-28(33)37-30(22(2)3)38-39(36,18-12-11-15-23-13-7-5-8-14-23)21-27(32)31-20-25(19-26(31)29(34)35)24-16-9-6-10-17-24/h5,7-8,13-14,22,24-26,30H,4,6,9-12,15-21H2,1-3H3,(H,34,35)	Fosinopril|4-Cyclohexyl-1-[2-[(2-Methyl-1-Propanoyloxypropoxy)-(4-Phenylbutyl)Phosphoryl]Acetyl]Pyrrolidine-2-Carboxylic Acid	4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid	CCC(=O)OC(OP(=O)(CCCCc1ccccc1)CC(=O)N1CC(C2CCCCC2)CC1C(=O)O)C(C)C	3420.0	R23_gupta_2019:614			BBB-	C	training
InChI=1S/C30H46NO7P/c1-4-28(33)37-30(22(2)3)38-39(36,18-12-11-15-23-13-7-5-8-14-23)21-27(32)31-20-25(19-26(31)29(34)35)24-16-9-6-10-17-24/h5,7-8,13-14,22,24-26,30H,4,6,9-12,15-21H2,1-3H3,(H,34,35)/t25-,26+,30?,39?/m1/s1	Fosinopril Sodium|(2S,4S)-4-Cyclohexyl-1-[2-[(2-Methyl-1-Propanoyloxypropoxy)-(4-Phenylbutyl)Phosphoryl]Acetyl]Pyrrolidine-2-Carboxylic Acid	(2S,4S)-4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid	CCC(=O)OC(OP(=O)(CCCCc1ccccc1)CC(=O)N1C[C@H](C2CCCCC2)C[C@H]1C(=O)O)C(C)C	55891.0	R14_ghose_2012:580			BBB-	C	training
InChI=1S/C30H46O4/c1-25(2)21-8-11-30(7)23(28(21,5)10-9-22(25)32)20(31)16-18-19-17-27(4,24(33)34)13-12-26(19,3)14-15-29(18,30)6/h16,19,21-23,32H,8-15,17H2,1-7H3,(H,33,34)	Glycyrrhetinic Acid|Enoxolone|Glycyrrhetin	10-hydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1H-picene-2-carboxylic acid	CC1(C(=O)O)CCC2(C)CCC3(C)C(=CC(=O)C4C5(C)CCC(O)C(C)(C)C5CCC43C)C2C1	3230.0	R3_abraham_2006:176|R21_muehlbacher_2011:69|R25_brito_sanchez_2015:244|R41_toropov_2017:163|R46_mendoza_valencia_2017:220|R47_radchenko_2020:149	-1.4	B	BBB-	A	training
InChI=1S/C30H46O4/c1-25(2)21-8-11-30(7)23(28(21,5)10-9-22(25)32)20(31)16-18-19-17-27(4,24(33)34)13-12-26(19,3)14-15-29(18,30)6/h16,19,21-23,32H,8-15,17H2,1-7H3,(H,33,34)/t19-,21-,22-,23+,26+,27-,28-,29+,30+/m0/s1	Glycyrrhetinic Acid|Enoxolone	(2S,4aS,6aR,6aS,6bR,8aR,10S,12aS,14bR)-10-hydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1H-picene-2-carboxylic acid	CC1(C)[C@@H](O)CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@@](C)(C(=O)O)CC[C@]5(C)CC[C@@]4(C)[C@]3(C)CC[C@@H]12	10114.0	R40_vilar_2010:120	-1.4	A	BBB-	A	training
InChI=1S/C30H47NO4S/c1-7-28(4)16-24(35-25(33)17-36-22-14-20-8-9-21(15-22)31(20)6)29(5)18(2)10-12-30(19(3)27(28)34)13-11-23(32)26(29)30/h7,18-22,24,26-27,34H,1,8-17H2,2-6H3/t18-,19+,20-,21+,22?,24-,26+,27+,28-,29+,30+/m1/s1	Retapamulin	[(1S,2R,3S,4S,6R,7R,8R,14R)-4-ethenyl-3-hydroxy-2,4,7,14-tetramethyl-9-oxo-6-tricyclo[5.4.3.01,8]tetradecanyl] 2-[[(1S,5R)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl]sulfanyl]acetate	C=C[C@]1(C)C[C@@H](OC(=O)CSC2C[C@H]3CC[C@@H](C2)N3C)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O	6918462.0	R23_gupta_2019:883			BBB-	C	training
InChI=1S/C30H50O5/c1-20(9-6-15-29(3,4)34)24-13-14-25-22(10-7-16-30(24,25)5)11-12-23-19-26(32)28(27(33)21(23)2)35-18-8-17-31/h11-12,20,24-28,31-34H,2,6-10,13-19H2,1,3-5H3/b22-11+,23-12-/t20-,24-,25+,26-,27-,28-,30-/m1/s1	Eldecalcitol	(1R,2R,3R,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(2R)-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-2-(3-hydroxypropoxy)-4-methylidenecyclohexane-1,3-diol	C=C1/C(=C\C=C2/CCC[C@]3(C)[C@@H]([C@H](C)CCCC(C)(C)O)CC[C@@H]23)C[C@@H](O)[C@@H](OCCCO)[C@@H]1O	6918141.0	R23_gupta_2019:552			BBB-	C	training
InChI=1S/C30H53N3O6/c1-19(2)22(14-21-10-11-26(38-8)27(15-21)39-13-9-12-37-7)16-24(31)25(34)17-23(20(3)4)28(35)33-18-30(5,6)29(32)36/h10-11,15,19-20,22-25,34H,9,12-14,16-18,31H2,1-8H3,(H2,32,36)(H,33,35)/t22-,23-,24-,25-/m0/s1	Aliskiren	(2S,4S,5S,7S)-5-amino-N-(3-amino-2,2-dimethyl-3-oxopropyl)-4-hydroxy-7-[[4-methoxy-3-(3-methoxypropoxy)phenyl]methyl]-8-methyl-2-propan-2-ylnonanamide	COCCCOc1cc(C[C@@H](C[C@H](N)[C@@H](O)C[C@H](C(=O)NCC(C)(C)C(N)=O)C(C)C)C(C)C)ccc1OC	5493444.0	R23_gupta_2019:333			BBB-	C	training
InChI=1S/C30H53NO11/c1-3-4-9-31-29-7-5-28(6-8-29)30(32)42-27-26-41-25-24-40-23-22-39-21-20-38-19-18-37-17-16-36-15-14-35-13-12-34-11-10-33-2/h5-8,31H,3-4,9-27H2,1-2H3	Benzonatate	2-[2-[2-[2-[2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethyl 4-(butylamino)benzoate	CCCCNc1ccc(C(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOC)cc1	7699.0	R14_ghose_2012:386|R23_gupta_2019:383			BBB-	C	training
InChI=1S/C30H60N3O3/c1-10-31(11-2,12-3)22-25-34-28-20-19-21-29(35-26-23-32(13-4,14-5)15-6)30(28)36-27-24-33(16-7,17-8)18-9/h19-21H,10-18,22-27H2,1-9H3/q+3	Gallamine Triethiodide|Flaxedil	2-[2,3-bis[2-(triethylazaniumyl)ethoxy]phenoxy]ethyl-triethylazanium	CC[N+](CC)(CC)CCOc1cccc(OCC[N+](CC)(CC)CC)c1OCC[N+](CC)(CC)CC	3450.0	R23_gupta_2019:624			BBB-	C	training
InChI=1S/C31H33F3N2O5S/c1-3-16-30(17-15-21-9-6-5-7-10-21)19-26(37)28(29(38)41-30)25(4-2)22-11-8-12-24(18-22)36-42(39,40)27-14-13-23(20-35-27)31(32,33)34/h5-14,18,20,25,36-37H,3-4,15-17,19H2,1-2H3/t25-,30-/m1/s1	Tipranavir	N-[3-[(1R)-1-[(2R)-4-hydroxy-6-oxo-2-(2-phenylethyl)-2-propyl-3H-pyran-5-yl]propyl]phenyl]-5-(trifluoromethyl)pyridine-2-sulfonamide	CCC[C@@]1(CCc2ccccc2)CC(O)=C([C@H](CC)c2cccc(NS(=O)(=O)c3ccc(C(F)(F)F)cn3)c2)C(=O)O1	54682461.0	R14_ghose_2012:899|R23_gupta_2019:983			BBB-	C	training
InChI=1S/C31H33N3O6S/c1-20-8-4-7-11-29(20)41(37,38)33-30(35)22-13-12-21(28(17-22)39-3)16-23-19-34(2)27-15-14-24(18-26(23)27)32-31(36)40-25-9-5-6-10-25/h4,7-8,11-15,17-19,25H,5-6,9-10,16H2,1-3H3,(H,32,36)(H,33,35)	Zafirlukast	cyclopentyl N-[3-[[2-methoxy-4-[(2-methylphenyl)sulfonylcarbamoyl]phenyl]methyl]-1-methylindol-5-yl]carbamate	COc1cc(C(=O)NS(=O)(=O)c2ccccc2C)ccc1Cc1cn(C)c2ccc(NC(=O)OC3CCCC3)cc12	5717.0	R14_ghose_2012:939|R23_gupta_2019:1036			BBB-	C	test
InChI=1S/C31H33N5O4/c1-34-15-17-36(18-16-34)20-27(37)35(2)24-12-10-23(11-13-24)32-29(21-7-5-4-6-8-21)28-25-14-9-22(31(39)40-3)19-26(25)33-30(28)38/h4-14,19,33,38H,15-18,20H2,1-3H3/b32-29+	Nintedanib	methyl 2-hydroxy-3-[N-[4-[methyl-[2-(4-methylpiperazin-1-yl)acetyl]amino]phenyl]-C-phenylcarbonimidoyl]-1H-indole-6-carboxylate	COC(=O)c1ccc2c(/C(=N/c3ccc(N(C)C(=O)CN4CCN(C)CC4)cc3)c3ccccc3)c(O)[nH]c2c1	135423438.0	R23_gupta_2019:781			BBB-	C	test
InChI=1S/C31H33NO5S/c1-2-38(34,35)28-14-6-23(7-15-28)29-16-8-24-22-25(33)9-17-30(24)31(29)37-27-12-10-26(11-13-27)36-21-20-32-18-4-3-5-19-32/h6-17,22,33H,2-5,18-21H2,1H3	6-(4-Ethanesulfonyl-Phenyl)-5-[4-(2-Piperidin-1-Yl-Ethoxy)-Phenoxy]-Naphthalen-2-Ol	6-(4-ethylsulfonylphenyl)-5-[4-(2-piperidin-1-ylethoxy)phenoxy]naphthalen-2-ol	CCS(=O)(=O)c1ccc(-c2ccc3cc(O)ccc3c2Oc2ccc(OCCN3CCCCC3)cc2)cc1	10324755.0	R47_radchenko_2020:294	-0.92	A	BBB+	A	training
InChI=1S/C31H34N2O5S/c1-32(2)39(35,36)28-14-6-23(7-15-28)29-16-8-24-22-25(34)9-17-30(24)31(29)38-27-12-10-26(11-13-27)37-21-20-33-18-4-3-5-19-33/h6-17,22,34H,3-5,18-21H2,1-2H3	4-(6-Hydroxy-1-(4-(2-(Piperidin-1-Yl)Ethoxy)Phenoxy)Naphthalen-2-Yl)-N,N-Dimethylbenzenesulfonamide	4-[6-hydroxy-1-[4-(2-piperidin-1-ylethoxy)phenoxy]naphthalen-2-yl]-N,N-dimethylbenzenesulfonamide	CN(C)S(=O)(=O)c1ccc(-c2ccc3cc(O)ccc3c2Oc2ccc(OCCN3CCCCC3)cc2)cc1	44427370.0	R47_radchenko_2020:292	-0.37	A	BBB+	A	training
InChI=1S/C31H36ClN3O5S/c1-37-26-19-22(20-27(38-2)30(26)39-3)31(36)40-18-17-34-15-13-33(14-16-34)11-6-12-35-24-7-4-5-8-28(24)41-29-10-9-23(32)21-25(29)35/h4-5,7-10,19-21H,6,11-18H2,1-3H3	Metofenazate	2-[4-[3-(2-chlorophenothiazin-10-yl)propyl]piperazin-1-yl]ethyl 3,4,5-trimethoxybenzoate	COc1cc(C(=O)OCCN2CCN(CCCN3c4ccccc4Sc4ccc(Cl)cc43)CC2)cc(OC)c1OC	9800.0	R6_adenot_2004:1179			BBB+	C	training
InChI=1S/C31H36N2O11/c1-14(2)7-8-16-13-17(9-11-19(16)34)27(37)33-21-22(35)18-10-12-20(15(3)24(18)42-28(21)38)41-29-23(36)25(43-30(32)39)26(40-6)31(4,5)44-29/h7,9-13,23,25-26,29,34-36H,8H2,1-6H3,(H2,32,39)(H,33,37)/t23-,25+,26-,29-/m1/s1	Novobiocin|Novobiocin Sodium	[(3R,4S,5R,6R)-5-hydroxy-6-[4-hydroxy-3-[[4-hydroxy-3-(3-methylbut-2-enyl)benzoyl]amino]-8-methyl-2-oxochromen-7-yl]oxy-3-methoxy-2,2-dimethyloxan-4-yl] carbamate	CO[C@@H]1[C@@H](OC(N)=O)[C@@H](O)[C@H](Oc2ccc3c(O)c(NC(=O)c4ccc(O)c(CC=C(C)C)c4)c(=O)oc3c2C)OC1(C)C	54675769.0	R6_adenot_2004:347|R14_ghose_2012:731|R23_gupta_2019:790			BBB-	C	training
InChI=1S/C31H37NO7/c1-4-5-25-38-30-12-13-31(39-25,24(35)18-37-27(36)19-9-14-32-15-10-19)29(30,3)17-23(34)26-22(30)7-6-20-16-21(33)8-11-28(20,26)2/h4-5,9-10,14-16,22-23,25-26,34H,6-8,11-13,17-18H2,1-3H3/b5-4-/t22-,23+,25?,26-,28+,29+,30-,31+/m1/s1	Nicocortonide	[2-[(1R,2R,10R,11S,12S,14S,15R)-12-hydroxy-10,14-dimethyl-7-oxo-17-[(Z)-prop-1-enyl]-16,18-dioxapentacyclo[13.3.2.01,14.02,11.05,10]icos-5-en-15-yl]-2-oxoethyl] pyridine-4-carboxylate	C/C=C\C1O[C@]2(C(=O)COC(=O)c3ccncc3)CC[C@@]3(O1)[C@@H]1CCC4=CC(=O)CC[C@]4(C)[C@H]1[C@@H](O)C[C@]23C	6436148.0	R6_adenot_2004:886			BBB+	C	training
InChI=1S/C31H38N2O/c1-22(2)26-14-15-28(34-3)27(20-26)21-32-30-25-16-18-33(19-17-25)31(30)29(23-10-6-4-7-11-23)24-12-8-5-9-13-24/h4-15,20,22,25,29-32H,16-19,21H2,1-3H3	187281-31-8|2-(Diphenylmethyl)-N-{[2-Methoxy-5-(Propan-2-Yl)Phenyl]Methyl}-1-Azabicyclo[2.2.2]Octan-3-Amine	2-benzhydryl-N-[(2-methoxy-5-propan-2-ylphenyl)methyl]-1-azabicyclo[2.2.2]octan-3-amine	COc1ccc(C(C)C)cc1CNC1C2CCN(CC2)C1C(c1ccccc1)c1ccccc1	6426143.0	R4_mente_2005:77|R46_mendoza_valencia_2017:448	0.48	B	BBB+	A	training
InChI=1S/C31H38N2O2/c1-31(2,34)26-14-15-27(35-3)25(20-26)21-32-29-24-16-18-33(19-17-24)30(29)28(22-10-6-4-7-11-22)23-12-8-5-9-13-23/h4-15,20,24,28-30,32,34H,16-19,21H2,1-3H3	161105-56-2|Pfizer Compound 3|Ezlopitant, Hydroxy-	2-[3-[[(2-benzhydryl-1-azabicyclo[2.2.2]octan-3-yl)amino]methyl]-4-methoxyphenyl]propan-2-ol	COc1ccc(C(C)(C)O)cc1CNC1C2CCN(CC2)C1C(c1ccccc1)c1ccccc1	6426129.0	R4_mente_2005:103|R25_brito_sanchez_2015:552|R40_vilar_2010:199|R46_mendoza_valencia_2017:463|R47_radchenko_2020:389	-0.89	B	BBB+	A	training
InChI=1S/C31H40O2/c1-22(2)12-9-13-23(3)14-10-15-24(4)16-11-17-25(5)20-21-27-26(6)30(32)28-18-7-8-19-29(28)31(27)33/h7-8,12,14,16,18-20H,9-11,13,15,17,21H2,1-6H3/b23-14+,24-16+,25-20+	Menatetrenone	2-methyl-3-[(2E,6E,10E)-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraenyl]naphthalene-1,4-dione	CC(C)=CCC/C(C)=C/CC/C(C)=C/CC/C(C)=C/CC1=C(C)C(=O)c2ccccc2C1=O	5282367.0	R14_ghose_2012:675			BBB-	C	training
InChI=1S/C31H41BrFNO3/c1-2-3-4-5-6-7-8-11-30(36)37-31(26-14-16-27(32)17-15-26)20-23-34(24-21-31)22-9-10-29(35)25-12-18-28(33)19-13-25/h12-19H,2-11,20-24H2,1H3	Bromperidol-Decanoate|Bromperidol Decanoate	[4-(4-bromophenyl)-1-[4-(4-fluorophenyl)-4-oxobutyl]piperidin-4-yl] decanoate	CCCCCCCCCC(=O)OC1(c2ccc(Br)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1	156321.0	R6_adenot_2004:1123			BBB+	C	training
InChI=1S/C31H41ClFNO3/c1-2-3-4-5-6-7-8-11-30(36)37-31(26-14-16-27(32)17-15-26)20-23-34(24-21-31)22-9-10-29(35)25-12-18-28(33)19-13-25/h12-19H,2-11,20-24H2,1H3	Haloperidol-Decanoate|Haloperidol Decanoate	[4-(4-chlorophenyl)-1-[4-(4-fluorophenyl)-4-oxobutyl]piperidin-4-yl] decanoate	CCCCCCCCCC(=O)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1	52919.0	R6_adenot_2004:1165			BBB+	C	training
InChI=1S/C31H44N2O5S/c1-5-8-12-29-30(27-23-25(32-39(4,35)36)15-18-28(27)38-29)31(34)24-13-16-26(17-14-24)37-22-11-21-33(19-9-6-2)20-10-7-3/h13-18,23,32H,5-12,19-22H2,1-4H3	Dronedarone	N-[2-butyl-3-[4-[3-(dibutylamino)propoxy]benzoyl]-1-benzofuran-5-yl]methanesulfonamide	CCCCc1oc2ccc(NS(C)(=O)=O)cc2c1C(=O)c1ccc(OCCCN(CCCC)CCCC)cc1	208898.0	R23_gupta_2019:538			BBB-	C	training
InChI=1S/C31H46O2/c1-22(2)12-9-13-23(3)14-10-15-24(4)16-11-17-25(5)20-21-27-26(6)30(32)28-18-7-8-19-29(28)31(27)33/h7-8,18-20,22-24H,9-17,21H2,1-6H3	Vitamin K|2-Methyl-3-(3,7,11,15-Tetramethylhexadec-2-Enyl)-1,4-Naphthoquinone	2-methyl-3-(3,7,11,15-tetramethylhexadec-2-enyl)naphthalene-1,4-dione	CC(=CCC1=C(C)C(=O)c2ccccc2C1=O)CCCC(C)CCCC(C)CCCC(C)C	4812.0	R50_sobanska_2019:112			BBB+	C	training
InChI=1S/C31H46O2/c1-22(2)12-9-13-23(3)14-10-15-24(4)16-11-17-25(5)20-21-27-26(6)30(32)28-18-7-8-19-29(28)31(27)33/h7-8,18-20,22-24H,9-17,21H2,1-6H3/b25-20+/t23-,24-/m1/s1	Phytonadione	2-methyl-3-[(E,7R,11R)-3,7,11,15-tetramethylhexadec-2-enyl]naphthalene-1,4-dione	CC1=C(C/C=C(\C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)C(=O)c2ccccc2C1=O	5284607.0	R14_ghose_2012:772|R23_gupta_2019:834			BBB-	C	training
InChI=1S/C31H48O2S2/c1-27(2,3)21-15-19(16-22(25(21)32)28(4,5)6)34-31(13,14)35-20-17-23(29(7,8)9)26(33)24(18-20)30(10,11)12/h15-18,32-33H,1-14H3	Probucol	2,6-ditert-butyl-4-[2-(3,5-ditert-butyl-4-hydroxyphenyl)sulfanylpropan-2-ylsulfanyl]phenol	CC(C)(Sc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1)Sc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1	4912.0	R14_ghose_2012:794|R23_gupta_2019:859			BBB-	C	training
InChI=1S/C31H48O6/c1-17(2)9-8-10-20(28(35)36)26-22-15-24(34)27-29(5)13-12-23(33)18(3)21(29)11-14-30(27,6)31(22,7)16-25(26)37-19(4)32/h9,18,21-25,27,33-34H,8,10-16H2,1-7H3,(H,35,36)	Fusidic|2-[2-(Acetyloxy)-7,10-Dihydroxy-3A,3B,6,9A-Tetramethyl-Dodecahydro-2H-Cyclopenta[A]Phenanthren-1-Ylidene]-6-Methylhept-5-Enoic Acid	2-(16-acetyloxy-3,11-dihydroxy-4,8,10,14-tetramethyl-2,3,4,5,6,7,9,11,12,13,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-ylidene)-6-methylhept-5-enoic acid	CC(=O)OC1CC2(C)C(CC(O)C3C4(C)CCC(O)C(C)C4CCC32C)C1=C(CCC=C(C)C)C(=O)O	3443.0	R14_ghose_2012:585			BBB-	C	test
InChI=1S/C31H48O6/c1-17(2)9-8-10-20(28(35)36)26-22-15-24(34)27-29(5)13-12-23(33)18(3)21(29)11-14-30(27,6)31(22,7)16-25(26)37-19(4)32/h9,18,21-25,27,33-34H,8,10-16H2,1-7H3,(H,35,36)/b26-20-/t18-,21-,22-,23+,24+,25-,27-,29-,30-,31-/m0/s1	Fusidic-Acid|Fusidic Acid	(2Z)-2-[(3R,4S,5S,8S,9S,10S,11R,13R,14S,16S)-16-acetyloxy-3,11-dihydroxy-4,8,10,14-tetramethyl-2,3,4,5,6,7,9,11,12,13,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-ylidene]-6-methylhept-5-enoic acid	CC(=O)O[C@H]1C[C@@]2(C)[C@@H](C[C@@H](O)[C@H]3[C@@]4(C)CC[C@@H](O)[C@@H](C)[C@@H]4CC[C@@]32C)/C1=C(\CCC=C(C)C)C(=O)O	3000226.0	R6_adenot_2004:335|R23_gupta_2019:620			BBB-	C	test
InChI=1S/C31H51NO9/c1-9-25-20(5)29-31(6,41-29)12-10-23(34)17(2)14-21(11-13-33)28(19(4)24(35)16-26(36)39-25)40-30-27(37)22(32(7)8)15-18(3)38-30/h10,12-13,17-22,24-25,27-30,35,37H,9,11,14-16H2,1-8H3/b12-10+/t17-,18-,19+,20-,21+,22+,24-,25-,27-,28-,29+,30+,31+/m1/s1	Rosaramicin	2-[(1S,2R,3R,7R,8S,9S,10R,12R,14E,16S)-9-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-3-ethyl-7-hydroxy-2,8,12,16-tetramethyl-5,13-dioxo-4,17-dioxabicyclo[14.1.0]heptadec-14-en-10-yl]acetaldehyde	CC[C@H]1OC(=O)C[C@@H](O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@@H](CC=O)C[C@@H](C)C(=O)/C=C/[C@]2(C)O[C@H]2[C@@H]1C	6537204.0	R14_ghose_2012:831			BBB-	C	training
InChI=1S/C32H26N4O2/c1-21-33-28-19-20-36(29-14-8-7-13-27(29)30(28)34-21)32(38)23-15-17-24(18-16-23)35-31(37)26-12-6-5-11-25(26)22-9-3-2-4-10-22/h2-18H,19-20H2,1H3,(H,33,34)(H,35,37)	Conivaptan	N-[4-(2-methyl-4,5-dihydro-3H-imidazo[4,5-d][1]benzazepine-6-carbonyl)phenyl]-2-phenylbenzamide	Cc1nc2c([nH]1)CCN(C(=O)c1ccc(NC(=O)c3ccccc3-c3ccccc3)cc1)c1ccccc1-2	151171.0	R23_gupta_2019:480			BBB-	C	training
InChI=1S/C32H32O13S/c1-37-19-6-13(7-20(38-2)25(19)33)23-14-8-17-18(42-12-41-17)9-15(14)28(16-10-39-30(36)24(16)23)44-32-27(35)26(34)29-21(43-32)11-40-31(45-29)22-4-3-5-46-22/h3-9,16,21,23-24,26-29,31-35H,10-12H2,1-2H3	Teniposide|Epipodophyllotoxin, 4'-Demethyl-, 9-(4,6-O-2-Thenylidene-Beta-D-Glucopyranoside)	5-[(7,8-dihydroxy-2-thiophen-2-yl-4,4a,6,7,8,8a-hexahydropyrano[3,2-d][1,3]dioxin-6-yl)oxy]-9-(4-hydroxy-3,5-dimethoxyphenyl)-5a,6,8a,9-tetrahydro-5H-[2]benzofuro[6,5-f][1,3]benzodioxol-8-one	COc1cc(C2c3cc4c(cc3C(OC3OC5COC(c6cccs6)OC5C(O)C3O)C3COC(=O)C23)OCO4)cc(OC)c1O	5396.0	R28_li_2005:308			BBB+	C	training
InChI=1S/C32H32O13S/c1-37-19-6-13(7-20(38-2)25(19)33)23-14-8-17-18(42-12-41-17)9-15(14)28(16-10-39-30(36)24(16)23)44-32-27(35)26(34)29-21(43-32)11-40-31(45-29)22-4-3-5-46-22/h3-9,16,21,23-24,26-29,31-35H,10-12H2,1-2H3/t16-,21+,23+,24-,26+,27+,28+,29+,31+,32-/m0/s1	Teniposide	(5S,5aR,8aR,9R)-5-[[(2R,4aR,6R,7R,8R,8aS)-7,8-dihydroxy-2-thiophen-2-yl-4,4a,6,7,8,8a-hexahydropyrano[3,2-d][1,3]dioxin-6-yl]oxy]-9-(4-hydroxy-3,5-dimethoxyphenyl)-5a,6,8a,9-tetrahydro-5H-[2]benzofuro[6,5-f][1,3]benzodioxol-8-one	COc1cc([C@@H]2c3cc4c(cc3[C@@H](O[C@@H]3O[C@@H]5CO[C@@H](c6cccs6)O[C@H]5[C@H](O)[C@H]3O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O	452548.0	R6_adenot_2004:68|R23_gupta_2019:963			BBB-	C	training
InChI=1S/C32H34N4O3/c1-2-25(22-12-5-3-6-13-22)36-32(38)28-24-16-9-10-17-26(24)35-29(23-14-7-4-8-15-23)30(28)39-21-20-34-31(37)27-18-11-19-33-27/h3-10,12-17,25,27,33H,2,11,18-21H2,1H3,(H,34,37)(H,36,38)/t25-,27-/m0/s1	Skb-H		CC[C@H](NC(=O)c1c(OCCNC(=O)[C@@H]2CCCN2)c(-c2ccccc2)nc2ccccc12)c1ccccc1		R28_li_2005:408			BBB-	C	test
InChI=1S/C32H35N5O11S2/c1-32(2)25(31(45)46)37-29(44)24(30(37)49-32)35-28(43)23(18-3-7-19(40)8-4-18)34-27(42)21-11-12-22(33-26(21)41)17-5-9-20(10-6-17)50(47,48)36(13-15-38)14-16-39/h3-12,23-25,30,38-40H,13-16H2,1-2H3,(H,33,41)(H,34,42)(H,35,43)(H,45,46)/t23-,24-,25+,30-/m1/s1	Piridicillin	(2S,5R,6R)-6-[[(2R)-2-[[6-[4-[bis(2-hydroxyethyl)sulfamoyl]phenyl]-2-oxo-1H-pyridine-3-carbonyl]amino]-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid	CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](NC(=O)c3ccc(-c4ccc(S(=O)(=O)N(CCO)CCO)cc4)[nH]c3=O)c3ccc(O)cc3)C(=O)N2[C@H]1C(=O)O	71978.0	R6_adenot_2004:254			BBB-	C	training
InChI=1S/C32H37ClN2O8/c1-38-24-10-16(11-25(39-2)29(24)40-3)31(36)43-26-12-17-15-35-9-8-19-21-13-18(33)6-7-22(21)34-28(19)23(35)14-20(17)27(30(26)41-4)32(37)42-5/h6-7,10-11,13,17,20,23,26-27,30,34H,8-9,12,14-15H2,1-5H3/t17-,20+,23-,26-,27+,30+/m1/s1	Chloroserpidine	methyl (1R,15S,17R,18R,19S,20S)-7-chloro-18-methoxy-17-(3,4,5-trimethoxybenzoyl)oxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate	COC(=O)[C@H]1[C@H]2C[C@@H]3c4[nH]c5ccc(Cl)cc5c4CCN3C[C@H]2C[C@@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)[C@@H]1OC	71844.0	R6_adenot_2004:1132			BBB+	C	training
InChI=1S/C32H37NO12/c1-14-31(45-21-8-3-4-9-42-21)17(33)10-22(43-14)44-19-12-32(40,20(35)13-34)11-16-24(19)30(39)26-25(28(16)37)27(36)15-6-5-7-18(41-2)23(15)29(26)38/h5-7,14,17,19,21-22,31,34,37,39-40H,3-4,8-13,33H2,1-2H3/t14-,17-,19-,21-,22-,31+,32-/m0/s1	Pirarubicin|(7S,9S)-7-[(2R,4S,5S,6S)-4-Amino-6-Methyl-5-[(2S)-Oxan-2-Yl]Oxyoxan-2-Yl]Oxy-6,9,11-Trihydroxy-9-(2-Hydroxyacetyl)-4-Methoxy-8,10-Dihydro-7H-Tetracene-5,12-Dione	(7S,9S)-7-[(2R,4S,5S,6S)-4-amino-6-methyl-5-[(2S)-oxan-2-yl]oxyoxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione	COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O[C@H]2CCCCO2)[C@H](C)O1	636397.0	R6_adenot_2004:331			BBB-	C	training
InChI=1S/C32H37NO4/c1-32(2,31(35)36)27-17-15-24(16-18-27)29(34)14-9-21-33-22-19-28(20-23-33)37-30(25-10-5-3-6-11-25)26-12-7-4-8-13-26/h3-8,10-13,15-18,28,30H,9,14,19-23H2,1-2H3,(H,35,36)	Carebastine	2-[4-[4-(4-benzhydryloxypiperidin-1-yl)butanoyl]phenyl]-2-methylpropanoic acid	CC(C)(C(=O)O)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1	65820.0	R7_andres_2006:24|R28_li_2005:334|R29_subramanian_2003:25			BBB-	C	test
InChI=1S/C32H38N2O5/c1-18-11-23-25-12-19(2)32(38,28(37)17-39-20(3)35)31(25,5)15-27(36)29(23)30(4)14-21-16-33-34(26(21)13-24(18)30)22-9-7-6-8-10-22/h6-11,13,16,19,23,25,27,29,36,38H,12,14-15,17H2,1-5H3/t19-,23+,25+,27+,29-,30+,31+,32+/m1/s1	Cortivazol	[2-[(1S,2R,13S,14S,16R,17R,18S,20S)-17,20-dihydroxy-2,11,16,18-tetramethyl-7-phenyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9,11-tetraen-17-yl]-2-oxoethyl] acetate	CC(=O)OCC(=O)[C@@]1(O)[C@H](C)C[C@H]2[C@@H]3C=C(C)C4=Cc5c(cnn5-c5ccccc5)C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C	66249.0	R6_adenot_2004:807			BBB+	C	test
InChI=1S/C32H38N4O2/c1-24(37)35-20-14-28-10-11-30(22-31(28)35)36(32(38)12-9-26-7-4-8-27(21-26)23-33)29-15-18-34(19-16-29)17-13-25-5-2-3-6-25/h4,7-12,21-22,25,29H,2-3,5-6,13-20H2,1H3/b12-9+	Jnj-5207787|Trans-N-(1-Acetyl-2,3-Dihydro-1H-Indol-6-Yl)-3-(3-Cyanophenyl)-N-(1-(2-Cyclopentylethyl)Piperidin-4-Yl)Acrylamide	(E)-N-(1-acetyl-2,3-dihydroindol-6-yl)-3-(3-cyanophenyl)-N-[1-(2-cyclopentylethyl)piperidin-4-yl]prop-2-enamide	CC(=O)N1CCc2ccc(N(C(=O)/C=C/c3cccc(C#N)c3)C3CCN(CCC4CCCC4)CC3)cc21	10324083.0	R26_chico_2009:230	-0.63	A	BBB+	A	training
InChI=1S/C32H39NO2/c1-32(2,3)28-18-16-25(17-19-28)30(34)15-10-22-33-23-20-29(21-24-33)35-31(26-11-6-4-7-12-26)27-13-8-5-9-14-27/h4-9,11-14,16-19,29,31H,10,15,20-24H2,1-3H3	Ebastine	4-(4-benzhydryloxypiperidin-1-yl)-1-(4-tert-butylphenyl)butan-1-one	CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1	3191.0	R7_andres_2006:56|R14_ghose_2012:519|R28_li_2005:139|R29_subramanian_2003:55			BBB-	C	test
InChI=1S/C32H39NO4/c1-31(2,30(35)36)25-17-15-24(16-18-25)29(34)14-9-21-33-22-19-28(20-23-33)32(37,26-10-5-3-6-11-26)27-12-7-4-8-13-27/h3-8,10-13,15-18,28-29,34,37H,9,14,19-23H2,1-2H3,(H,35,36)	153439-40-8|Fexofenadine	2-[4-[1-hydroxy-4-[4-[hydroxy(diphenyl)methyl]piperidin-1-yl]butyl]phenyl]-2-methylpropanoic acid	CC(C)(C(=O)O)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1	3348.0	R4_mente_2005:16|R6_adenot_2004:30|R21_muehlbacher_2011:75|R25_brito_sanchez_2015:231|R26_chico_2009:187|R34_broccatelli_2012:30|R40_vilar_2010:110|R46_mendoza_valencia_2017:212|R47_radchenko_2020:340|R50_sobanska_2019:8	-0.98	D	BBB+	A	training
InChI=1S/C32H40BrN5O5/c1-16(2)12-24-29(40)37-11-7-10-25(37)32(42)38(24)30(41)31(43-32,17(3)4)35-28(39)18-13-20-19-8-6-9-22-26(19)21(27(33)34-22)14-23(20)36(5)15-18/h6,8-9,13,16-18,23-25,34,42H,7,10-12,14-15H2,1-5H3,(H,35,39)/t18-,23-,24+,25+,31-,32+/m1/s1	Bromocriptine	(6aR,9R)-5-bromo-N-[(1S,2S,4R,7S)-2-hydroxy-7-(2-methylpropyl)-5,8-dioxo-4-propan-2-yl-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide	CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]c(Br)c(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12	31101.0	R12_garg_2006:47|R14_ghose_2012:23|R21_muehlbacher_2011:41|R23_gupta_2019:26|R25_brito_sanchez_2015:168|R26_chico_2009:84|R28_li_2005:238|R34_broccatelli_2012:108|R37_chen_2011:11|R39_shayanfar_2011:21|R40_vilar_2010:59|R47_radchenko_2020:263|R50_sobanska_2019:7	-1.04	B1	BBB-	A	training
InChI=1S/C32H40N2O/c1-32(2,3)27-15-16-28(35-4)26(21-27)22-33-30-25-17-19-34(20-18-25)31(30)29(23-11-7-5-8-12-23)24-13-9-6-10-14-24/h5-16,21,25,29-31,33H,17-20,22H2,1-4H3	Pfizer Compound 2|N-[(5-Tert-Butyl-2-Methoxyphenyl)Methyl]-2-(Diphenylmethyl)-1-Azabicyclo[2.2.2]Octan-3-Amine	2-benzhydryl-N-[(5-tert-butyl-2-methoxyphenyl)methyl]-1-azabicyclo[2.2.2]octan-3-amine	COc1ccc(C(C)(C)C)cc1CNC1C2CCN(CC2)C1C(c1ccccc1)c1ccccc1	17905241.0	R25_brito_sanchez_2015:546|R40_vilar_2010:193|R46_mendoza_valencia_2017:457|R47_radchenko_2020:383	0.46	B	BBB+	A	training
InChI=1S/C32H40N2O/c1-32(2,3)27-15-16-28(35-4)26(21-27)22-33-30-25-17-19-34(20-18-25)31(30)29(23-11-7-5-8-12-23)24-13-9-6-10-14-24/h5-16,21,25,29-31,33H,17-20,22H2,1-4H3/t30-,31-/m0/s1	147116-67-4|Maropitant	(2S,3S)-2-benzhydryl-N-[(5-tert-butyl-2-methoxyphenyl)methyl]-1-azabicyclo[2.2.2]octan-3-amine	COc1ccc(C(C)(C)C)cc1CN[C@H]1C2CCN(CC2)[C@H]1C(c1ccccc1)c1ccccc1	204108.0	R4_mente_2005:78	0.46	A	BBB+	A	training
InChI=1S/C32H41NO2/c1-31(2,3)26-18-16-25(17-19-26)30(34)15-10-22-33-23-20-29(21-24-33)32(35,27-11-6-4-7-12-27)28-13-8-5-9-14-28/h4-9,11-14,16-19,29-30,34-35H,10,15,20-24H2,1-3H3	50679-08-8|Terfenadine	1-(4-tert-butylphenyl)-4-[4-[hydroxy(diphenyl)methyl]piperidin-1-yl]butan-1-ol	CC(C)(C)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1	5405.0	R4_mente_2005:17|R6_adenot_2004:69|R6_adenot_2004:354|R7_andres_2006:167|R21_muehlbacher_2011:132|R25_brito_sanchez_2015:135|R26_chico_2009:409|R28_li_2005:413|R29_subramanian_2003:163|R34_broccatelli_2012:139|R40_vilar_2010:267|R46_mendoza_valencia_2017:133|R47_radchenko_2020:348			BBB-	C	training
InChI=1S/C32H43N5O5/c1-17(2)12-25-29(39)36-11-7-10-26(36)32(41)37(25)30(40)31(42-32,18(3)4)34-28(38)20-13-22-21-8-6-9-23-27(21)19(15-33-23)14-24(22)35(5)16-20/h6,8-9,15,17-18,20,22,24-26,33,41H,7,10-14,16H2,1-5H3,(H,34,38)	Ergoloidmesylate|Dihydroergokryptine	N-[2-hydroxy-7-(2-methylpropyl)-5,8-dioxo-4-propan-2-yl-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide	CC(C)CC1C(=O)N2CCCC2C2(O)OC(NC(=O)C3CC4c5cccc6[nH]cc(c56)CC4N(C)C3)(C(C)C)C(=O)N12	522609.0	R14_ghose_2012:74			BBB+	C	training
InChI=1S/C32H44O7/c1-18(2)28(36)37-17-25(35)32-26(38-29(39-32)19-8-6-5-7-9-19)15-23-22-11-10-20-14-21(33)12-13-30(20,3)27(22)24(34)16-31(23,32)4/h12-14,18-19,22-24,26-27,29,34H,5-11,15-17H2,1-4H3/t22-,23-,24-,26+,27+,29+,30-,31-,32+/m0/s1	Ciclesonide	[2-[(1S,2S,4R,6R,8S,9S,11S,12S,13R)-6-cyclohexyl-11-hydroxy-9,13-dimethyl-16-oxo-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-8-yl]-2-oxoethyl] 2-methylpropanoate	CC(C)C(=O)OCC(=O)[C@@]12O[C@H](C3CCCCC3)O[C@@H]1C[C@H]1[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]12C	6918155.0	R6_adenot_2004:782			BBB+	C	training
InChI=1S/C32H45N3O4S/c1-21-25(15-10-16-28(21)36)30(38)33-26(20-40-24-13-6-5-7-14-24)29(37)19-35-18-23-12-9-8-11-22(23)17-27(35)31(39)34-32(2,3)4/h5-7,10,13-16,22-23,26-27,29,36-37H,8-9,11-12,17-20H2,1-4H3,(H,33,38)(H,34,39)/t22-,23+,26-,27-,29+/m0/s1	159989-64-7|Nelfinavir|Nelfinavir Mesylate	(3S,4aS,8aS)-N-tert-butyl-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-phenylsulfanylbutyl]-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinoline-3-carboxamide	Cc1c(O)cccc1C(=O)N[C@@H](CSc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C	64143.0	R4_mente_2005:39|R6_adenot_2004:51|R14_ghose_2012:711|R21_muehlbacher_2011:261|R21_muehlbacher_2011:262|R23_gupta_2019:774|R25_brito_sanchez_2015:318|R25_brito_sanchez_2015:406|R28_li_2005:210|R34_broccatelli_2012:129|R40_vilar_2010:159|R47_radchenko_2020:363|R53_friden_2009:23	-0.99	B1	BBB+	A	test
InChI=1S/C32H47F5O3S/c1-30-17-15-26-25-12-11-24(38)21-23(25)20-22(29(26)27(30)13-14-28(30)39)10-7-5-3-2-4-6-8-18-41(40)19-9-16-31(33,34)32(35,36)37/h11-12,21-22,26-29,38-39H,2-10,13-20H2,1H3/t22-,26-,27+,28+,29-,30+,41?/m1/s1	Fulvestrant	(7R,8R,9S,13S,14S,17S)-13-methyl-7-[9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl]-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol	C[C@]12CC[C@@H]3c4ccc(O)cc4C[C@@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)[C@H]3[C@@H]1CC[C@@H]2O	104741.0	R23_gupta_2019:617			BBB-	C	training
InChI=1S/C32H48N4O8/c1-18-14-22-27(34-12-13-36(5)6)24(37)17-23(29(22)39)35-31(40)19(2)10-9-11-25(42-7)30(44-32(33)41)21(4)16-20(3)28(38)26(15-18)43-8/h9-11,16-18,20,25-26,28,30,34,38H,12-15H2,1-8H3,(H2,33,41)(H,35,40)/b11-9-,19-10+,21-16+/t18-,20+,25+,26+,28-,30+/m1/s1	17-Dmag|Alvespimycin	[(4E,6Z,8S,9S,10E,12S,13R,14S,16R)-19-[2-(dimethylamino)ethylamino]-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl] carbamate	CO[C@H]1/C=C\C=C(/C)C(=O)NC2=CC(=O)C(NCCN(C)C)=C(C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O)C2=O	5288674.0	R25_brito_sanchez_2015:435	-0.09	A	BBB+	A	test
InChI=1S/C32H53N2O4/c1-5-14-34(15-6-7-16-34)28-20-26-24-9-8-23-19-29(36)27(33-12-17-37-18-13-33)21-32(23,4)25(24)10-11-31(26,3)30(28)38-22(2)35/h5,23-30,36H,1,6-21H2,2-4H3/q+1/t23-,24+,25-,26-,27-,28-,29-,30-,31-,32-/m0/s1	Rocuronium	[(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-3-hydroxy-10,13-dimethyl-2-morpholin-4-yl-16-(1-prop-2-enylpyrrolidin-1-ium-1-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate	C=CC[N+]1([C@H]2C[C@H]3[C@@H]4CC[C@H]5C[C@H](O)[C@@H](N6CCOCC6)C[C@]5(C)[C@H]4CC[C@]3(C)[C@H]2OC(C)=O)CCCC1	441290.0	R23_gupta_2019:891|R25_brito_sanchez_2015:280			BBB-	C	training
InChI=1S/C32H55N4O/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-27-36(2,3)28-26-35(32-33-24-19-25-34-32)29-30-20-22-31(37-4)23-21-30/h19-25H,5-18,26-29H2,1-4H3/q+1	Thonzonium Bromide|Thonzonium	hexadecyl-[2-[(4-methoxyphenyl)methyl-pyrimidin-2-ylamino]ethyl]-dimethylazanium	CCCCCCCCCCCCCCCC[N+](C)(C)CCN(Cc1ccc(OC)cc1)c1ncccn1	5456.0	R23_gupta_2019:1089			BBB-	C	test
InChI=1S/C33H34N6O6/c1-3-42-32-34-28-15-9-14-27(31(40)43-21(2)44-33(41)45-24-10-5-4-6-11-24)29(28)39(32)20-22-16-18-23(19-17-22)25-12-7-8-13-26(25)30-35-37-38-36-30/h7-9,12-19,21,24H,3-6,10-11,20H2,1-2H3,(H,35,36,37,38)	Candesartan Cilexetil	1-cyclohexyloxycarbonyloxyethyl 2-ethoxy-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate	CCOc1nc2cccc(C(=O)OC(C)OC(=O)OC3CCCCC3)c2n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1	2540.0	R14_ghose_2012:415			BBB-	C	training
InChI=1S/C33H35FN2O5/c1-21(2)31-30(33(41)35-25-11-7-4-8-12-25)29(22-9-5-3-6-10-22)32(23-13-15-24(34)16-14-23)36(31)18-17-26(37)19-27(38)20-28(39)40/h3-16,21,26-27,37-38H,17-20H2,1-2H3,(H,35,41)(H,39,40)/t26-,27-/m1/s1	Atorvastatin|Atorvastatin Calcium	(3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoic acid	CC(C)c1c(C(=O)Nc2ccccc2)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CC[C@@H](O)C[C@@H](O)CC(=O)O	60823.0	R6_adenot_2004:7|R6_adenot_2004:1399|R14_ghose_2012:365|R23_gupta_2019:366|R26_chico_2009:41	-1.36	A	BBB-	A	training
InChI=1S/C33H35FO8/c1-29(2)41-27-15-22-21-10-9-19-14-20(35)11-12-30(19,3)32(21,34)25(36)16-31(22,4)33(27,42-29)26(37)17-39-28(38)24-13-18-7-5-6-8-23(18)40-24/h5-8,11-14,21-22,25,27,36H,9-10,15-17H2,1-4H3/t21-,22-,25-,27+,30-,31-,32-,33+/m0/s1	Triamcinolone-Furetonide|Triamcinolone Furetonide	[2-[(1S,2S,4R,8S,9S,11S,12R,13S)-12-fluoro-11-hydroxy-6,6,9,13-tetramethyl-16-oxo-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-8-yl]-2-oxoethyl] 1-benzofuran-2-carboxylate	CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)COC(=O)c2cc3ccccc3o2)O1	62964.0	R6_adenot_2004:916			BBB+	C	training
InChI=1S/C33H35N5O5/c1-32(35-29(39)21-15-23-22-10-6-11-24-28(22)20(17-34-24)16-25(23)36(2)18-21)31(41)38-26(14-19-8-4-3-5-9-19)30(40)37-13-7-12-27(37)33(38,42)43-32/h3-6,8-11,15,17,21,25-27,34,42H,7,12-14,16,18H2,1-2H3,(H,35,39)/t21-,25-,26+,27+,32-,33+/m1/s1	Ergotamine	(6aR,9R)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide	CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C=C2c3cccc4[nH]cc(c34)C[C@H]21	8223.0	R23_gupta_2019:82|R25_brito_sanchez_2015:500|R26_chico_2009:175|R34_broccatelli_2012:122	-1.1	A	BBB-	A	training
InChI=1S/C33H38O6/c34-31(22-10-19-27-13-4-1-5-14-27)37-25-30(39-33(36)24-12-21-29-17-8-3-9-18-29)26-38-32(35)23-11-20-28-15-6-2-7-16-28/h1-9,13-18,30H,10-12,19-26H2	Glycerol Phenylbutyrate	2,3-bis(4-phenylbutanoyloxy)propyl 4-phenylbutanoate	O=C(CCCc1ccccc1)OCC(COC(=O)CCCc1ccccc1)OC(=O)CCCc1ccccc1	10482134.0	R23_gupta_2019:642			BBB-	C	training
InChI=1S/C33H39NO14/c1-5-44-32(45-6-2)31(41)46-13-20(35)33(42)11-16-23(19(12-33)48-21-10-17(34)26(36)14(3)47-21)30(40)25-24(28(16)38)27(37)15-8-7-9-18(43-4)22(15)29(25)39/h7-9,14,17,19,21,26,32,36,38,40,42H,5-6,10-13,34H2,1-4H3/t14-,17-,19-,21-,26+,33-/m0/s1	Detorubicin	[2-[(2S,4S)-4-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-3,4-dihydro-1H-tetracen-2-yl]-2-oxoethyl] 2,2-diethoxyacetate	CCOC(OCC)C(=O)OCC(=O)[C@]1(O)Cc2c(O)c3c(c(O)c2[C@@H](O[C@H]2C[C@H](N)[C@H](O)[C@H](C)O2)C1)C(=O)c1c(OC)cccc1C3=O	6917660.0	R6_adenot_2004:326			BBB-	C	training
InChI=1S/C33H40N2O12/c1-13(2)8-17(34)32(43)35-18-9-22(46-14(3)27(18)38)47-20-11-33(44,21(37)12-36)10-16-24(20)31(42)26-25(29(16)40)28(39)15-6-5-7-19(45-4)23(15)30(26)41/h5-7,13-14,17-18,20,22,27,36,38,40,42,44H,8-12,34H2,1-4H3,(H,35,43)/t14-,17-,18-,20-,22-,27+,33-/m0/s1	Leurubicin	(2S)-2-amino-N-[(2S,3S,4S,6R)-3-hydroxy-2-methyl-6-[[(1S,3S)-3,5,12-trihydroxy-3-(2-hydroxyacetyl)-10-methoxy-6,11-dioxo-2,4-dihydro-1H-tetracen-1-yl]oxy]oxan-4-yl]-4-methylpentanamide	COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](NC(=O)[C@@H](N)CC(C)C)[C@H](O)[C@H](C)O1	68897.0	R6_adenot_2004:330			BBB-	C	training
InChI=1S/C33H40N2O9/c1-38-19-7-8-20-21-9-10-35-16-18-13-27(44-32(36)17-11-25(39-2)30(41-4)26(12-17)40-3)31(42-5)28(33(37)43-6)22(18)15-24(35)29(21)34-23(20)14-19/h7-8,11-12,14,18,22,24,27-28,31,34H,9-10,13,15-16H2,1-6H3/t18-,22+,24-,27-,28+,31+/m1/s1	Reserpine	methyl (1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-(3,4,5-trimethoxybenzoyl)oxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate	COC(=O)[C@H]1[C@H]2C[C@@H]3c4[nH]c5cc(OC)ccc5c4CCN3C[C@H]2C[C@@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)[C@@H]1OC	5770.0	R6_adenot_2004:361|R34_broccatelli_2012:135|R51_doninger_2002:303			BBB+	C	training
InChI=1S/C33H47NO13/c1-18-10-8-6-4-3-5-7-9-11-21(45-32-30(39)28(34)29(38)19(2)44-32)15-25-27(31(40)41)22(36)17-33(42,47-25)16-20(35)14-24-23(46-24)12-13-26(37)43-18/h3-9,11-13,18-25,27-30,32,35-36,38-39,42H,10,14-17,34H2,1-2H3,(H,40,41)/b4-3+,7-5+,8-6-,11-9+,13-12-/t18-,19-,20+,21+,22+,23-,24-,25+,27-,28+,29-,30+,32+,33-/m1/s1	Natamycin	(1R,3S,5R,7R,8Z,12R,14Z,16E,18E,20E,22R,24S,25R,26S)-22-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-1,3,26-trihydroxy-12-methyl-10-oxo-6,11,28-trioxatricyclo[22.3.1.05,7]octacosa-8,14,16,18,20-pentaene-25-carboxylic acid	C[C@@H]1C/C=C/C=C\C=C\C=C\[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@H]3O[C@@H]3/C=C\C(=O)O1)C[C@H](O)[C@H]2C(=O)O	24893610.0	R23_gupta_2019:771			BBB-	C	test
InChI=1S/C33H50N4O6S/c1-33(2,3)44(42,43)20-25(16-22-10-6-4-7-11-22)31(40)37-28(18-26-19-34-21-35-26)32(41)36-27(17-23-12-8-5-9-13-23)30(39)29(38)24-14-15-24/h4,6-7,10-11,19,21,23-25,27-30,38-39H,5,8-9,12-18,20H2,1-3H3,(H,34,35)(H,36,41)(H,37,40)/t25?,27-,28-,29-,30+/m0/s1	Remikiren		CC(C)(C)S(=O)(=O)CC(Cc1ccccc1)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CC1CCCCC1)[C@@H](O)[C@@H](O)C1CC1		R7_andres_2006:152|R23_gupta_2019:880|R29_subramanian_2003:149			BBB-	C	training
InChI=1S/C34H32N4O3/c1-2-28(24-13-5-3-6-14-24)38-34(40)31-27-18-9-10-19-29(27)37-32(25-15-7-4-8-16-25)33(31)41-22-21-36-30(39)23-26-17-11-12-20-35-26/h3-20,28H,2,21-23H2,1H3,(H,36,39)(H,38,40)/t28-/m0/s1	Skb-G|(S)-N-(A-Ethylbenzyl)-3-[2-(2-Pyridylacetyl)Aminoethoxy]-2-Phenylquinoline-4-Carboxamide	2-phenyl-N-[(1S)-1-phenylpropyl]-3-[2-[(2-pyridin-2-ylacetyl)amino]ethoxy]quinoline-4-carboxamide	CC[C@H](NC(=O)c1c(OCCNC(=O)Cc2ccccn2)c(-c2ccccc2)nc2ccccc12)c1ccccc1	70250504.0	R28_li_2005:407			BBB-	C	test
InChI=1S/C34H33N3O5/c1-40-28-9-5-7-26-32(28)36-31-25(33(26)38)6-4-8-27(31)34(39)35-24-12-10-21(11-13-24)14-16-37-17-15-22-18-29(41-2)30(42-3)19-23(22)20-37/h4-13,18-19H,14-17,20H2,1-3H3,(H,35,39)(H,36,38)	Elacridar	N-[4-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]phenyl]-5-methoxy-9-oxo-10H-acridine-4-carboxamide	COc1cc2c(cc1OC)CN(CCc1ccc(NC(=O)c3cccc4c(=O)c5cccc(OC)c5[nH]c34)cc1)CC2	119373.0	R7_andres_2006:57			BBB-	C	training
InChI=1S/C34H35N3O10/c1-15-28(38)20(35)12-23(46-15)47-22-14-34(44,16(2)36-37-33(43)17-8-5-4-6-9-17)13-19-25(22)32(42)27-26(30(19)40)29(39)18-10-7-11-21(45-3)24(18)31(27)41/h4-11,15,20,22-23,28,38,40,42,44H,12-14,35H2,1-3H3,(H,37,43)/b36-16+/t15-,20-,22-,23-,28+,34-/m0/s1	Zorubicin|Daunomycin Benzoylhydrazone	N-[(Z)-1-[(2S,4S)-4-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-3,4-dihydro-1H-tetracen-2-yl]ethylideneamino]benzamide	COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(/C(C)=N\NC(=O)c1ccccc1)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1	6321432.0	R6_adenot_2004:333			BBB-	C	test
InChI=1S/C34H36F3NO13/c1-4-5-9-21(40)49-13-20(39)33(47)11-16-24(19(12-33)51-22-10-17(27(41)14(2)50-22)38-32(46)34(35,36)37)31(45)26-25(29(16)43)28(42)15-7-6-8-18(48-3)23(15)30(26)44/h6-8,14,17,19,22,27,41,43,45,47H,4-5,9-13H2,1-3H3,(H,38,46)/t14-,17-,19-,22-,27+,33-/m0/s1	Valrubicin	[2-oxo-2-[(2S,4S)-2,5,12-trihydroxy-4-[(2R,4S,5S,6S)-5-hydroxy-6-methyl-4-[(2,2,2-trifluoroacetyl)amino]oxan-2-yl]oxy-7-methoxy-6,11-dioxo-3,4-dihydro-1H-tetracen-2-yl]ethyl] pentanoate	CCCCC(=O)OCC(=O)[C@]1(O)Cc2c(O)c3c(c(O)c2[C@@H](O[C@H]2C[C@H](NC(=O)C(F)(F)F)[C@H](O)[C@H](C)O2)C1)C(=O)c1c(OC)cccc1C3=O	454216.0	R23_gupta_2019:1016			BBB-	C	training
InChI=1S/C34H39N5O5/c1-33(32(42)39-27(16-20-8-4-3-5-9-20)31(41)38-15-7-12-28(38)34(39,43)44-33)36-30(40)22-17-24-23-10-6-11-25-29(23)21(13-14-35-25)18-26(24)37(2)19-22/h3-6,8-11,13-14,22,24-28,35,43H,7,12,15-19H2,1-2H3,(H,36,40)			CN1CC(C(=O)NC2(C)OC3(O)C4CCCN4C(=O)C(Cc4ccccc4)N3C2=O)CC2C3=CC=CC4NC=CC(=C34)CC21		R46_mendoza_valencia_2017:418	-1.1	A	BBB-	A	test
InChI=1S/C34H41N7O5/c1-4-6-7-10-21-46-34(44)39-32(35)24-12-15-26(16-13-24)37-23-30-38-27-22-25(14-17-28(27)40(30)3)33(43)41(20-18-31(42)45-5-2)29-11-8-9-19-36-29/h8-9,11-17,19,22,37H,4-7,10,18,20-21,23H2,1-3H3,(H2,35,39,44)	Dabigatran Etexilate	ethyl 3-[[2-[[4-(N-hexoxycarbonylcarbamimidoyl)anilino]methyl]-1-methylbenzimidazole-5-carbonyl]-pyridin-2-ylamino]propanoate	[H]/N=C(\NC(=O)OCCCCCC)c1ccc(NCc2nc3cc(C(=O)N(CCC(=O)OCC)c4ccccn4)ccc3n2C)cc1	135565674.0	R23_gupta_2019:490			BBB-	C	training
InChI=1S/C34H50N4O9S/c1-7-37(8-2)16-17-48(44,45)28-13-15-38-31(28)34(43)47-32(22(3)4)24(6)11-12-29(41)35-14-9-10-23(5)18-25(39)19-26(40)20-30-36-27(21-46-30)33(38)42/h9-12,18,21-22,24-25,28,31-32,39H,7-8,13-17,19-20H2,1-6H3,(H,35,41)/b10-9-,12-11-,23-18-	Dalfopristin|(12Z,17Z,19Z)-6-[2-(Diethylamino)Ethylsulfonyl]-21-Hydroxy-11,19-Dimethyl-10-Propan-2-Yl-9,26-Dioxa-3,15,28-Triazatricyclo[23.2.1.03,7]Octacosa-1(27),12,17,19,25(28)-Pentaene-2,8,14,23-Tetrone	(12Z,17Z,19Z)-6-[2-(diethylamino)ethylsulfonyl]-21-hydroxy-11,19-dimethyl-10-propan-2-yl-9,26-dioxa-3,15,28-triazatricyclo[23.2.1.03,7]octacosa-1(27),12,17,19,25(28)-pentaene-2,8,14,23-tetrone	CCN(CC)CCS(=O)(=O)C1CCN2C(=O)c3coc(n3)CC(=O)CC(O)/C=C(C)\C=C/CNC(=O)/C=C\C(C)C(C(C)C)OC(=O)C12	5353985.0	R23_gupta_2019:493			BBB-	C	training
InChI=1S/C34H50O7/c1-29(2)23-10-13-34(7)27(32(23,5)12-11-24(29)41-26(38)9-8-25(36)37)22(35)18-20-21-19-31(4,28(39)40)15-14-30(21,3)16-17-33(20,34)6/h18,21,23-24,27H,8-17,19H2,1-7H3,(H,36,37)(H,39,40)/t21-,23-,24-,27+,30+,31-,32-,33+,34+/m0/s1	Carbenoxolone	(2S,4aS,6aR,6aS,6bR,8aR,10S,12aS,14bR)-10-(3-carboxypropanoyloxy)-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1H-picene-2-carboxylic acid	CC1(C)[C@@H](OC(=O)CCC(=O)O)CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@@](C)(C(=O)O)CC[C@]5(C)CC[C@@]4(C)[C@]3(C)CC[C@@H]12	636403.0	R14_ghose_2012:420			BBB-	C	training
InChI=1S/C34H57N2O4/c1-23(37)39-31-20-25-12-13-26-27(34(25,4)22-29(31)35-16-8-6-9-17-35)14-15-33(3)28(26)21-30(32(33)40-24(2)38)36(5)18-10-7-11-19-36/h25-32H,6-22H2,1-5H3/q+1/t25-,26+,27-,28-,29-,30-,31-,32-,33-,34-/m0/s1	Vecuronium|Norcuron	[(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-17-acetyloxy-10,13-dimethyl-16-(1-methylpiperidin-1-ium-1-yl)-2-piperidin-1-yl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate	CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@H](CC[C@@]4(C)[C@H]3C[C@H]([N+]3(C)CCCCC3)[C@@H]4OC(C)=O)[C@@]2(C)C[C@@H]1N1CCCCC1	39765.0	R23_gupta_2019:1020|R25_brito_sanchez_2015:326			BBB-	C	training
InChI=1S/C34H63ClN2O6S/c1-6-8-9-10-11-12-13-14-15-16-17-18-19-21-27(38)42-32-30(40)29(39)31(43-34(32)44-5)28(24(3)35)36-33(41)26-22-25(20-7-2)23-37(26)4/h24-26,28-32,34,39-40H,6-23H2,1-5H3,(H,36,41)/t24-,25+,26-,28+,29+,30-,31+,32+,34+/m0/s1	Clindamycin Palmitate	[(2R,3R,4S,5R,6R)-6-[(1S,2S)-2-chloro-1-[[(2S,4R)-1-methyl-4-propylpyrrolidine-2-carbonyl]amino]propyl]-4,5-dihydroxy-2-methylsulfanyloxan-3-yl] hexadecanoate	CCCCCCCCCCCCCCCC(=O)O[C@@H]1[C@@H](O)[C@@H](O)[C@@H]([C@H](NC(=O)[C@@H]2C[C@@H](CCC)CN2C)[C@H](C)Cl)O[C@@H]1SC	16052039.0	R23_gupta_2019:1052			BBB-	C	training
InChI=1S/C35H38Cl2N8O4/c1-3-25(2)45-34(46)44(24-40-45)29-7-5-27(6-8-29)41-14-16-42(17-15-41)28-9-11-30(12-10-28)47-19-31-20-48-35(49-31,21-43-23-38-22-39-43)32-13-4-26(36)18-33(32)37/h4-13,18,22-25,31H,3,14-17,19-21H2,1-2H3	Itraconazole|Canditral	2-butan-2-yl-4-[4-[4-[4-[[2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-1,2,4-triazol-3-one	CCC(C)n1ncn(-c2ccc(N3CCN(c4ccc(OCC5COC(Cn6cncn6)(c6ccc(Cl)cc6Cl)O5)cc4)CC3)cc2)c1=O	3793.0	R26_chico_2009:229	-0.64	A	BBB+	A	training
InChI=1S/C35H38Cl2N8O4/c1-3-25(2)45-34(46)44(24-40-45)29-7-5-27(6-8-29)41-14-16-42(17-15-41)28-9-11-30(12-10-28)47-19-31-20-48-35(49-31,21-43-23-38-22-39-43)32-13-4-26(36)18-33(32)37/h4-13,18,22-25,31H,3,14-17,19-21H2,1-2H3/t25?,31-,35-/m0/s1	Itraconazole	2-butan-2-yl-4-[4-[4-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-1,2,4-triazol-3-one	CCC(C)n1ncn(-c2ccc(N3CCN(c4ccc(OC[C@H]5CO[C@](Cn6cncn6)(c6ccc(Cl)cc6Cl)O5)cc4)CC3)cc2)c1=O	55283.0	R6_adenot_2004:38|R6_adenot_2004:350|R14_ghose_2012:637|R23_gupta_2019:689|R28_li_2005:261|R34_broccatelli_2012:42			BBB-	C	training
InChI=1S/C35H42FNO8/c1-20(18-37-29(41)21-9-7-6-8-10-21)30(42)43-19-27(40)35-28(44-31(2,3)45-35)16-25-24-12-11-22-15-23(38)13-14-32(22,4)34(24,36)26(39)17-33(25,35)5/h6-10,13-15,20,24-26,28,39H,11-12,16-19H2,1-5H3,(H,37,41)/t20?,24-,25-,26-,28+,32-,33-,34-,35+/m0/s1	Triamcinolone-Benetonide|Triamcinolone Benetonide	[2-[(1S,2S,4R,8S,9S,11S,12R,13S)-12-fluoro-11-hydroxy-6,6,9,13-tetramethyl-16-oxo-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-8-yl]-2-oxoethyl] 3-benzamido-2-methylpropanoate	CC(CNC(=O)c1ccccc1)C(=O)OCC(=O)[C@@]12OC(C)(C)O[C@@H]1C[C@H]1[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]12C	62963.0	R6_adenot_2004:914			BBB+	C	training
InChI=1S/C35H55NO3/c1-7-8-11-15-26(3)27(4)28-23-31(38-33(37)16-14-21-36-19-12-9-10-13-20-36)34-29-22-25(2)17-18-30(29)35(5,6)39-32(34)24-28/h23-27H,7-22H2,1-6H3	Nabazenil	[6,6,9-trimethyl-3-(3-methyloctan-2-yl)-7,8,9,10-tetrahydrobenzo[c]chromen-1-yl] 4-(azepan-1-yl)butanoate	CCCCCC(C)C(C)c1cc(OC(=O)CCCN2CCCCCC2)c2c(c1)OC(C)(C)C1=C2CC(C)CC1	163326.0	R6_adenot_2004:453			BBB+	C	training
InChI=1S/C35H59NO13/c1-19-16-23(14-15-37)31(32(44-8)25(39)17-26(40)45-20(2)12-10-9-11-13-24(19)38)49-34-29(41)28(36(6)7)30(21(3)47-34)48-27-18-35(5,43)33(42)22(4)46-27/h9-11,13,15,19-25,27-34,38-39,41-43H,12,14,16-18H2,1-8H3/t19-,20-,21-,22+,23+,24+,25-,27+,28-,29-,30-,31+,32+,33+,34?,35-/m1/s1	Kitasamycin		CO[C@@H]1[C@@H](OC2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](O)[C@H](C)O3)[C@H](N(C)C)[C@H]2O)[C@@H](CC=O)C[C@@H](C)[C@@H](O)C=CC=CC[C@@H](C)OC(=O)C[C@H]1O		R6_adenot_2004:122			BBB-	C	training
InChI=1S/C35H60N2O4/c1-24(38)40-32-21-26-13-14-27-28(35(26,4)23-31(32)37(6)19-11-8-12-20-37)15-16-34(3)29(27)22-30(33(34)41-25(2)39)36(5)17-9-7-10-18-36/h26-33H,7-23H2,1-6H3/q+2/t26-,27+,28-,29-,30-,31-,32-,33-,34-,35-/m0/s1	Pancuronium	[(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-17-acetyloxy-10,13-dimethyl-2,16-bis(1-methylpiperidin-1-ium-1-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate	CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@H](CC[C@@]4(C)[C@H]3C[C@H]([N+]3(C)CCCCC3)[C@@H]4OC(C)=O)[C@@]2(C)C[C@@H]1[N+]1(C)CCCCC1	441289.0	R23_gupta_2019:810|R25_brito_sanchez_2015:344			BBB-	C	training
InChI=1S/C35H61NO12/c1-16-14-35(15-43-35)32(40)19(4)27(37)18(3)22(7)46-33(41)21(6)31(47-26-13-25(42-11)28(38)23(8)45-26)20(5)30(16)48-34-29(39)24(36(9)10)12-17(2)44-34/h16-31,34,37-39H,12-15H2,1-11H3/t16-,17+,18-,19+,20+,21+,22+,23-,24-,25-,26-,27-,28-,29+,30-,31-,34-,35+/m0/s1	Oleandomycin	(3R,5S,6S,7R,8S,9R,12R,13R,14S,15R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-hydroxy-8-[(2R,4S,5S,6S)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-5,7,9,12,13,15-hexamethyl-1,11-dioxaspiro[2.13]hexadecane-10,16-dione	CO[C@H]1C[C@H](O[C@H]2[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@H](N(C)C)[C@H]3O)[C@@H](C)C[C@@]3(CO3)C(=O)[C@H](C)[C@@H](O)[C@@H](C)[C@@H](C)OC(=O)[C@@H]2C)O[C@@H](C)[C@@H]1O	72493.0	R6_adenot_2004:295			BBB-	C	test
InChI=1S/C35H62N4O4/c1-24(40)42-32-21-26-9-10-27-28(35(26,4)23-31(32)37-15-19-39(7,8)20-16-37)11-12-34(3)29(27)22-30(33(34)43-25(2)41)36-13-17-38(5,6)18-14-36/h26-33H,9-23H2,1-8H3/q+2/t26-,27+,28-,29-,30-,31-,32-,33-,34-,35-/m0/s1	Pipecuronium	[(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-17-acetyloxy-2,16-bis(4,4-dimethylpiperazin-4-ium-1-yl)-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate	CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@H](CC[C@@]4(C)[C@H]3C[C@H](N3CC[N+](C)(C)CC3)[C@@H]4OC(C)=O)[C@@]2(C)C[C@@H]1N1CC[N+](C)(C)CC1	50192.0	R23_gupta_2019:839|R25_brito_sanchez_2015:360			BBB-	C	training
InChI=1S/C36H33N3O5/c1-2-29(24-13-5-3-6-14-24)39-35(41)32-28-19-11-12-20-30(28)38-33(25-15-7-4-8-16-25)34(32)44-22-21-37-31(40)23-26-17-9-10-18-27(26)36(42)43/h3-20,29H,2,21-23H2,1H3,(H,37,40)(H,39,41)(H,42,43)/t29-/m0/s1	Skb-F|2-[2-Oxo-2-[2-[2-Phenyl-4-[[(1S)-1-Phenylpropyl]Carbamoyl]Quinolin-3-Yl]Oxyethylamino]Ethyl]Benzoic Acid	2-[2-oxo-2-[2-[2-phenyl-4-[[(1S)-1-phenylpropyl]carbamoyl]quinolin-3-yl]oxyethylamino]ethyl]benzoic acid	CC[C@H](NC(=O)c1c(OCCNC(=O)Cc2ccccc2C(=O)O)c(-c2ccccc2)nc2ccccc12)c1ccccc1	20679021.0	R28_li_2005:406			BBB-	C	training
InChI=1S/C36H41ClN8O4S/c1-4-26(2)45-35(46)44(25-39-45)31-11-9-29(10-12-31)42-17-19-43(20-18-42)30-13-15-32(16-14-30)47-21-33-22-48-36(49-33,27-5-7-28(37)8-6-27)23-50-34-40-38-24-41(34)3/h5-16,24-26,33H,4,17-23H2,1-3H3/t26-,33-,36-/m1/s1	Mitratapid|Mitratapide	2-[(2R)-butan-2-yl]-4-[4-[4-[4-[[(2S,4R)-2-(4-chlorophenyl)-2-[(4-methyl-1,2,4-triazol-3-yl)sulfanylmethyl]-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-1,2,4-triazol-3-one	CC[C@@H](C)n1ncn(-c2ccc(N3CCN(c4ccc(OC[C@@H]5CO[C@@](CSc6nncn6C)(c6ccc(Cl)cc6)O5)cc4)CC3)cc2)c1=O	213047.0	R25_brito_sanchez_2015:303|R46_mendoza_valencia_2017:270	-0.7	B	BBB+	A	test
InChI=1S/C36H41N3O6/c1-24-31(34(40)44-6)33(28-18-13-19-29(22-28)39(42)43)32(25(2)37-24)35(41)45-36(3,4)23-38(5)21-20-30(26-14-9-7-10-15-26)27-16-11-8-12-17-27/h7-19,22,30,33,37H,20-21,23H2,1-6H3	Lercanidipine	5-O-[1-[3,3-diphenylpropyl(methyl)amino]-2-methylpropan-2-yl] 3-O-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate	COC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)(C)CN(C)CCC(c2ccccc2)c2ccccc2)C1c1cccc([N+](=O)[O-])c1	65866.0	R14_ghose_2012:648			BBB-	C	training
InChI=1S/C36H42N2/c1-37(2,35-31-21-11-7-17-27(31)28-18-8-12-22-32(28)35)25-15-5-6-16-26-38(3,4)36-33-23-13-9-19-29(33)30-20-10-14-24-34(30)36/h7-14,17-24,35-36H,5-6,15-16,25-26H2,1-4H3/q+2	Hexafluronium	9H-fluoren-9-yl-[6-[9H-fluoren-9-yl(dimethyl)azaniumyl]hexyl]-dimethylazanium	C[N+](C)(CCCCCC[N+](C)(C)C1c2ccccc2-c2ccccc21)C1c2ccccc2-c2ccccc21	3601.0	R23_gupta_2019:655			BBB-	C	test
InChI=1S/C36H47N5O4/c1-36(2,3)39-35(45)31-24-40(22-26-12-9-15-37-21-26)16-17-41(31)23-29(42)19-28(18-25-10-5-4-6-11-25)34(44)38-33-30-14-8-7-13-27(30)20-32(33)43/h4-15,21,28-29,31-33,42-43H,16-20,22-24H2,1-3H3,(H,38,44)(H,39,45)	1-[2-Hydroxy-4-[(2-Hydroxy-2,3-Dihydro-1H-Inden-1-Yl)Carbamoyl]-5-Phenyl-Pentyl]-4-(Pyridin-3-Ylmethyl)-N-Tert-Butyl-Piperazine-2-Carboxamide	1-[4-benzyl-2-hydroxy-5-[(2-hydroxy-2,3-dihydro-1H-inden-1-yl)amino]-5-oxopentyl]-N-tert-butyl-4-(pyridin-3-ylmethyl)piperazine-2-carboxamide	CC(C)(C)NC(=O)C1CN(Cc2cccnc2)CCN1CC(O)CC(Cc1ccccc1)C(=O)NC1c2ccccc2CC1O	3706.0	R41_toropov_2017:171|R46_mendoza_valencia_2017:232	-0.74	B	BBB+	A	training
InChI=1S/C36H47N5O4/c1-36(2,3)39-35(45)31-24-40(22-26-12-9-15-37-21-26)16-17-41(31)23-29(42)19-28(18-25-10-5-4-6-11-25)34(44)38-33-30-14-8-7-13-27(30)20-32(33)43/h4-15,21,28-29,31-33,42-43H,16-20,22-24H2,1-3H3,(H,38,44)(H,39,45)/t28-,29+,31+,32-,33+/m1/s1	Indinavir|150378-17-9|Indinavir Sulfate	(2S)-1-[(2S,4R)-4-benzyl-2-hydroxy-5-[[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]amino]-5-oxopentyl]-N-tert-butyl-4-(pyridin-3-ylmethyl)piperazine-2-carboxamide	CC(C)(C)NC(=O)[C@@H]1CN(Cc2cccnc2)CCN1C[C@@H](O)C[C@@H](Cc1ccccc1)C(=O)N[C@H]1c2ccccc2C[C@H]1O	5362440.0	R3_abraham_2006:185|R4_mente_2005:38|R6_adenot_2004:37|R7_andres_2006:202|R12_garg_2006:93|R14_ghose_2012:619|R21_muehlbacher_2011:256|R23_gupta_2019:677|R25_brito_sanchez_2015:258|R26_chico_2009:218|R28_li_2005:92|R34_broccatelli_2012:125|R39_shayanfar_2011:53|R40_vilar_2010:130|R45_hemmateenejad_2006:8|R47_radchenko_2020:157	-0.74	D	BBB+	A	training
InChI=1S/C36H53N7O6/c1-5-10-25(29(44)34(48)39-23-15-16-23)40-33(47)28-24-14-9-13-22(24)20-43(28)35(49)30(36(2,3)4)42-32(46)27(21-11-7-6-8-12-21)41-31(45)26-19-37-17-18-38-26/h17-19,21-25,27-28,30H,5-16,20H2,1-4H3,(H,39,48)(H,40,47)(H,41,45)(H,42,46)/t22-,24-,25-,27-,28-,30+/m0/s1	Telaprevir	(3S,3aS,6aR)-2-[(2S)-2-[[(2S)-2-cyclohexyl-2-(pyrazine-2-carbonylamino)acetyl]amino]-3,3-dimethylbutanoyl]-N-[(3S)-1-(cyclopropylamino)-1,2-dioxohexan-3-yl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-3-carboxamide	CCC[C@H](NC(=O)[C@@H]1[C@H]2CCC[C@H]2CN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)c1cnccn1)C1CCCCC1)C(C)(C)C)C(=O)C(=O)NC1CC1	3010818.0	R23_gupta_2019:958			BBB-	C	training
InChI=1S/C36H60O2/c1-7-8-9-10-11-12-13-14-15-16-17-18-19-25-35(37)38-30-28-32(3)23-20-22-31(2)26-27-34-33(4)24-21-29-36(34,5)6/h20,22-23,26-28H,7-19,21,24-25,29-30H2,1-6H3/b23-20+,27-26+,31-22+,32-28+	Vitamin A Palmitate	[(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] hexadecanoate	CCCCCCCCCCCCCCCC(=O)OC/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C	5280531.0	R14_ghose_2012:934			BBB-	C	training
InChI=1S/C37H40N2O6/c1-38-14-12-24-19-32(42-4)33-21-27(24)28(38)16-22-6-9-26(10-7-22)44-37-35-25(20-34(43-5)36(37)41)13-15-39(2,3)29(35)17-23-8-11-30(40)31(18-23)45-33/h6-11,18-21,28-29H,12-17H2,1-5H3,(H-,40,41)/p+1/t28-,29+/m0/s1	Tubocurarine	(1S,16R)-10,25-dimethoxy-15,15,30-trimethyl-7,23-dioxa-30-aza-15-azoniaheptacyclo[22.6.2.23,6.18,12.118,22.027,31.016,34]hexatriaconta-3(36),4,6(35),8(34),9,11,18(33),19,21,24,26,31-dodecaene-9,21-diol	COc1cc2c3cc1Oc1cc(ccc1O)C[C@@H]1c4c(cc(OC)c(O)c4Oc4ccc(cc4)C[C@@H]3N(C)CC2)CC[N+]1(C)C	6000.0	R23_gupta_2019:1010			BBB-	C	training
InChI=1S/C37H40N2O8S/c1-21-13-27-29-14-22(2)37(43,32(41)20-47-34(42)23-9-8-12-26(15-23)48(44,45)46)36(29,4)18-31(40)33(27)35(3)17-24-19-38-39(30(24)16-28(21)35)25-10-6-5-7-11-25/h5-13,15-16,19,22,27,29,31,33,40,43H,14,17-18,20H2,1-4H3,(H,44,45,46)/t22-,27+,29+,31+,33-,35+,36+,37+/m1/s1	Cortisuzol	3-[2-[(1S,2R,13S,14S,16R,17R,18S,20S)-17,20-dihydroxy-2,11,16,18-tetramethyl-7-phenyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9,11-tetraen-17-yl]-2-oxoethoxy]carbonylbenzenesulfonic acid	CC1=C[C@@H]2[C@H]([C@@H](O)C[C@@]3(C)[C@H]2C[C@@H](C)[C@]3(O)C(=O)COC(=O)c2cccc(S(=O)(=O)O)c2)[C@@]2(C)Cc3cnn(-c4ccccc4)c3C=C12	3037936.0	R6_adenot_2004:806			BBB+	C	test
InChI=1S/C37H42F2N8O4/c1-3-35(26(2)48)47-36(49)46(25-42-47)31-7-5-29(6-8-31)43-14-16-44(17-15-43)30-9-11-32(12-10-30)50-20-27-19-37(51-21-27,22-45-24-40-23-41-45)33-13-4-28(38)18-34(33)39/h4-13,18,23-27,35,48H,3,14-17,19-22H2,1-2H3/t26-,27+,35-,37-/m0/s1	Posaconazole	4-[4-[4-[4-[[(3R,5R)-5-(2,4-difluorophenyl)-5-(1,2,4-triazol-1-ylmethyl)oxolan-3-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-2-[(2S,3S)-2-hydroxypentan-3-yl]-1,2,4-triazol-3-one	CC[C@@H]([C@H](C)O)n1ncn(-c2ccc(N3CCN(c4ccc(OC[C@@H]5CO[C@@](Cn6cncn6)(c6ccc(F)cc6F)C5)cc4)CC3)cc2)c1=O	468595.0	R23_gupta_2019:851			BBB-	C	test
InChI=1S/C37H45Cl2N2O2/c1-28(2)43-32-11-6-8-29(24-32)25-35(42)40-19-7-14-37(27-40,31-12-13-33(38)34(39)26-31)18-23-41-20-15-36(16-21-41,17-22-41)30-9-4-3-5-10-30/h3-6,8-13,24,26,28H,7,14-23,25,27H2,1-2H3/q+1/t36?,37-,41?/m1/s1	Sr 140333|Nolpitantium	1-[(3S)-3-(3,4-dichlorophenyl)-3-[2-(4-phenyl-1-azoniabicyclo[2.2.2]octan-1-yl)ethyl]piperidin-1-yl]-2-(3-propan-2-yloxyphenyl)ethanone	CC(C)Oc1cccc(CC(=O)N2CCC[C@](CC[N+]34CCC(c5ccccc5)(CC3)CC4)(c3ccc(Cl)c(Cl)c3)C2)c1	108167.0	R26_chico_2009:388	-0.37	A	BBB+	A	training
InChI=1S/C37H47NO12/c1-16-11-10-12-17(2)36(46)38-23-15-24(40)26-27(32(23)44)31(43)21(6)34-28(26)35(45)37(8,50-34)48-14-13-25(47-9)18(3)33(49-22(7)39)20(5)30(42)19(4)29(16)41/h10-16,18-20,25,29-30,33,40-44H,1-9H3,(H,38,46)/b11-10+,14-13+,17-12-/t16-,18+,19+,20+,25-,29-,30+,33+,37-/m0/s1	Rifamycin	[(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate	CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(cc(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C	6324616.0	R6_adenot_2004:341			BBB-	C	training
InChI=1S/C37H48N4O5/c1-25(2)34(41-20-12-19-38-37(41)45)36(44)39-30(21-28-15-7-5-8-16-28)23-32(42)31(22-29-17-9-6-10-18-29)40-33(43)24-46-35-26(3)13-11-14-27(35)4/h5-11,13-18,25,30-32,34,42H,12,19-24H2,1-4H3,(H,38,45)(H,39,44)(H,40,43)/t30-,31-,32-,34-/m0/s1	Lopinavir	(2S)-N-[(2S,4S,5S)-5-[[2-(2,6-dimethylphenoxy)acetyl]amino]-4-hydroxy-1,6-diphenylhexan-2-yl]-3-methyl-2-(2-oxo-1,3-diazinan-1-yl)butanamide	Cc1cccc(C)c1OCC(=O)N[C@@H](Cc1ccccc1)[C@@H](O)C[C@H](Cc1ccccc1)NC(=O)[C@H](C(C)C)N1CCCNC1=O	92727.0	R23_gupta_2019:714			BBB-	C	training
InChI=1S/C37H48N6O5S2/c1-24(2)33(42-36(46)43(5)20-29-22-49-35(40-29)25(3)4)34(45)39-28(16-26-12-8-6-9-13-26)18-32(44)31(17-27-14-10-7-11-15-27)41-37(47)48-21-30-19-38-23-50-30/h6-15,19,22-25,28,31-33,44H,16-18,20-21H2,1-5H3,(H,39,45)(H,41,47)(H,42,46)/t28-,31-,32-,33-/m0/s1	Ritonavir	1,3-thiazol-5-ylmethyl N-[(2S,3S,5S)-3-hydroxy-5-[[(2S)-3-methyl-2-[[methyl-[(2-propan-2-yl-1,3-thiazol-4-yl)methyl]carbamoyl]amino]butanoyl]amino]-1,6-diphenylhexan-2-yl]carbamate	CC(C)c1nc(CN(C)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C[C@H](O)[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)C(C)C)cs1	392622.0	R6_adenot_2004:64|R14_ghose_2012:830|R23_gupta_2019:889|R25_brito_sanchez_2015:515|R26_chico_2009:352|R28_li_2005:282|R34_broccatelli_2012:136			BBB-	C	training
InChI=1S/C37H49N7O9S/c1-37(2,3)53-36(52)39-16-14-30(45)41-28(19-23-21-40-25-13-9-8-12-24(23)25)34(50)42-26(15-17-54-4)33(49)44-29(20-31(46)47)35(51)43-27(32(38)48)18-22-10-6-5-7-11-22/h5-13,21,26-29,40H,14-20H2,1-4H3,(H2,38,48)(H,39,52)(H,41,45)(H,42,50)(H,43,51)(H,44,49)(H,46,47)/t26-,27-,28-,29-/m0/s1	Pentagastrin	(3S)-4-[[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-3-[[(2S)-2-[[(2S)-3-(1H-indol-3-yl)-2-[3-[(2-methylpropan-2-yl)oxycarbonylamino]propanoylamino]propanoyl]amino]-4-methylsulfanylbutanoyl]amino]-4-oxobutanoic acid	CSCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CCNC(=O)OC(C)(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O	9853654.0	R23_gupta_2019:820			BBB-	C	training
InChI=1S/C37H66FNO13/c1-14-24-37(10,46)29(42)21(5)28(41)34(7,38)17-35(8,45)31(52-33-26(40)23(39(11)12)15-18(2)48-33)19(3)27(20(4)32(44)50-24)51-25-16-36(9,47-13)30(43)22(6)49-25/h18-27,29-31,33,40,42-43,45-46H,14-17H2,1-13H3/t18-,19+,20-,21+,22+,23+,24-,25+,26-,27+,29-,30+,31-,33+,34+,35-,36-,37-/m1/s1	Flurithromycin	(3R,4S,5S,6R,7R,9S,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-9-fluoro-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione	CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@](C)(F)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O	71260.0	R6_adenot_2004:292			BBB-	C	training
InChI=1S/C37H67NO12/c1-14-26-20(4)29(40)21(5)28(39)18(2)16-36(9,44)33(50-35-30(41)25(38(11)12)15-19(3)46-35)22(6)31(23(7)34(43)48-26)49-27-17-37(10,45-13)32(42)24(8)47-27/h18-27,29-33,35,40-42,44H,14-17H2,1-13H3/t18-,19-,20+,21+,22+,23-,24+,25+,26-,27+,29+,30-,31+,32+,33-,35+,36-,37-/m1/s1	Berythromycin|Erythromycin B	(3R,4S,5S,6R,7R,9R,11R,12S,13R,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12-dihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione	CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@H]1C	9918244.0	R6_adenot_2004:283			BBB-	C	training
InChI=1S/C37H67NO13/c1-14-25-37(10,45)30(41)20(4)27(39)18(2)16-35(8,44)32(51-34-28(40)24(38(11)12)15-19(3)47-34)21(5)29(22(6)33(43)49-25)50-26-17-36(9,46-13)31(42)23(7)48-26/h18-26,28-32,34,40-42,44-45H,14-17H2,1-13H3/t18-,19-,20+,21+,22-,23+,24+,25-,26+,28-,29+,30-,31+,32-,34+,35-,36-,37-/m1/s1	Erythromycin	(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione	CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O	12560.0	R6_adenot_2004:26|R6_adenot_2004:291|R14_ghose_2012:534|R23_gupta_2019:571|R34_broccatelli_2012:123|R51_doninger_2002:50			BBB-	C	training
InChI=1S/C38H42N8O6S2/c1-25(45(23-47)21-31-19-41-27(3)43-35(31)39)33(15-17-51-37(49)29-11-7-5-8-12-29)53-54-34(16-18-52-38(50)30-13-9-6-10-14-30)26(2)46(24-48)22-32-20-42-28(4)44-36(32)40/h5-14,19-20,23-24H,15-18,21-22H2,1-4H3,(H2,39,41,43)(H2,40,42,44)/b33-25+,34-26+	Bisbentiamine	[(E)-4-[(4-amino-2-methylpyrimidin-5-yl)methyl-formylamino]-3-[[(E)-2-[(4-amino-2-methylpyrimidin-5-yl)methyl-formylamino]-5-benzoyloxypent-2-en-3-yl]disulfanyl]pent-3-enyl] benzoate	C/C(=C(/CCOC(=O)c1ccccc1)SS/C(CCOC(=O)c1ccccc1)=C(\C)N(C=O)Cc1cnc(C)nc1N)N(C=O)Cc1cnc(C)nc1N	3034022.0	R6_adenot_2004:388			BBB+	C	test
InChI=1S/C38H50N6O5/c1-38(2,3)43-37(49)32-20-26-14-7-8-15-27(26)22-44(32)23-33(45)30(19-24-11-5-4-6-12-24)41-36(48)31(21-34(39)46)42-35(47)29-18-17-25-13-9-10-16-28(25)40-29/h4-6,9-13,16-18,26-27,30-33,45H,7-8,14-15,19-23H2,1-3H3,(H2,39,46)(H,41,48)(H,42,47)(H,43,49)	N-[4-[3-[(Tert-Butylamino)-Oxomethyl]-3,4,4A,5,6,7,8,8A-Octahydro-1H-Isoquinolin-2-Yl]-3-Hydroxy-1-Phenylbutan-2-Yl]-2-[[Oxo(2-Quinolinyl)Methyl]Amino]Butanediamide	N-[4-[3-(tert-butylcarbamoyl)-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]-2-(quinoline-2-carbonylamino)butanediamide	CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(O)C(Cc1ccccc1)NC(=O)C(CC(N)=O)NC(=O)c1ccc2ccccc2n1	3579812.0	R41_toropov_2017:227	-1.03	A	BBB-	A	test
InChI=1S/C38H50N6O5/c1-38(2,3)43-37(49)32-20-26-14-7-8-15-27(26)22-44(32)23-33(45)30(19-24-11-5-4-6-12-24)41-36(48)31(21-34(39)46)42-35(47)29-18-17-25-13-9-10-16-28(25)40-29/h4-6,9-13,16-18,26-27,30-33,45H,7-8,14-15,19-23H2,1-3H3,(H2,39,46)(H,41,48)(H,42,47)(H,43,49)/t26-,27+,30-,31-,32-,33+/m0/s1	Saquinavir|127779-20-8	(2S)-N-[(2S,3R)-4-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]-2-(quinoline-2-carbonylamino)butanediamide	CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1	441243.0	R3_abraham_2006:254|R4_mente_2005:41|R6_adenot_2004:65|R14_ghose_2012:839|R21_muehlbacher_2011:306|R23_gupta_2019:901|R25_brito_sanchez_2015:256|R28_li_2005:283|R34_broccatelli_2012:137|R40_vilar_2010:239|R47_radchenko_2020:210|R53_friden_2009:34	-1.03	D	BBB-	A	test
InChI=1S/C38H51NO4/c1-3-4-5-6-7-8-9-10-11-12-16-19-34(40)42-33-23-21-30-31-26-29-20-22-32(41-27-28-17-14-13-15-18-28)36-35(29)38(30,37(33)43-36)24-25-39(31)2/h13-15,17-18,20-23,30-31,33,37H,3-12,16,19,24-27H2,1-2H3/t30-,31+,33-,37-,38-/m0/s1	Myrophine	[(4R,4aR,7S,7aR,12bS)-3-methyl-9-phenylmethoxy-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-yl] tetradecanoate	CCCCCCCCCCCCCC(=O)O[C@H]1C=C[C@H]2[C@H]3Cc4ccc(OCc5ccccc5)c5c4[C@@]2(CCN3C)[C@H]1O5	5362457.0	R6_adenot_2004:1100			BBB+	C	training
InChI=1S/C38H52N6O7/c1-37(2,3)31(41-35(48)50-7)33(46)40-29(22-25-14-10-9-11-15-25)30(45)24-44(43-34(47)32(38(4,5)6)42-36(49)51-8)23-26-17-19-27(20-18-26)28-16-12-13-21-39-28/h9-21,29-32,45H,22-24H2,1-8H3,(H,40,46)(H,41,48)(H,42,49)(H,43,47)/t29-,30-,31+,32+/m0/s1	Atazanavir	methyl N-[(2S)-1-[2-[(2S,3S)-2-hydroxy-3-[[(2S)-2-(methoxycarbonylamino)-3,3-dimethylbutanoyl]amino]-4-phenylbutyl]-2-[(4-pyridin-2-ylphenyl)methyl]hydrazinyl]-3,3-dimethyl-1-oxobutan-2-yl]carbamate	COC(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)CN(Cc1ccc(-c2ccccn2)cc1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C	148192.0	R14_ghose_2012:363|R23_gupta_2019:365			BBB-	C	training
InChI=1S/C38H69NO13/c1-15-26-38(10,45)31(42)21(4)28(40)19(2)17-37(9,47-14)33(52-35-29(41)25(39(11)12)16-20(3)48-35)22(5)30(23(6)34(44)50-26)51-27-18-36(8,46-13)32(43)24(7)49-27/h19-27,29-33,35,41-43,45H,15-18H2,1-14H3/t19-,20-,21+,22+,23-,24+,25+,26-,27+,29-,30+,31-,32+,33-,35+,36-,37-,38-/m1/s1	Clarithromycin|Clathromycin	(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-12,13-dihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-7-methoxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione	CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O	84029.0	R6_adenot_2004:282|R14_ghose_2012:456|R23_gupta_2019:465|R34_broccatelli_2012:112|R50_sobanska_2019:57			BBB-	C	training
InChI=1S/C38H70N2O13/c1-15-26-38(10,46)31(42)21(4)28(39-48-14)19(2)17-36(8,45)33(53-35-29(41)25(40(11)12)16-20(3)49-35)22(5)30(23(6)34(44)51-26)52-27-18-37(9,47-13)32(43)24(7)50-27/h19-27,29-33,35,41-43,45-46H,15-18H2,1-14H3/b39-28-/t19-,20-,21+,22+,23-,24+,25+,26-,27+,29-,30+,31-,32+,33-,35+,36-,37-,38-/m1/s1	Lexithromycin	(3R,4S,5S,6R,7R,9R,10E,11S,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-10-methoxyimino-3,5,7,9,11,13-hexamethyl-oxacyclotetradecan-2-one	CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)/C(=N\OC)[C@H](C)[C@@H](O)[C@]1(C)O	6532846.0	R6_adenot_2004:294			BBB-	C	test
InChI=1S/C38H72N2O12/c1-15-27-38(10,46)31(42)24(6)40(13)19-20(2)17-36(8,45)33(52-35-29(41)26(39(11)12)16-21(3)48-35)22(4)30(23(5)34(44)50-27)51-28-18-37(9,47-14)32(43)25(7)49-28/h20-33,35,41-43,45-46H,15-19H2,1-14H3/t20-,21-,22+,23-,24-,25+,26+,27-,28+,29-,30+,31-,32+,33-,35+,36-,37-,38-/m1/s1	Azithromycin|Azithromycin Dihydrate	(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-11-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-3,4,10-trihydroxy-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,6,8,10,12,14-heptamethyl-1-oxa-6-azacyclopentadecan-15-one	CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O	447043.0	R6_adenot_2004:284|R14_ghose_2012:371|R23_gupta_2019:373|R28_li_2005:234			BBB-	C	training
InChI=1S/C39H43N5O12S/c1-37(2)29(36(53)54)44-34(52)25(35(44)57-37)42-33(51)24(16-10-7-6-8-11-16)40-15-41-32(50)23-28(47)26(43(4)5)19-14-18-22(30(48)39(19,56)31(23)49)27(46)21-17(38(18,3)55)12-9-13-20(21)45/h6-13,18-19,24-26,29,35,40,45-46,49,55-56H,14-15H2,1-5H3,(H,41,50)(H,42,51)(H,53,54)/t18-,19-,24+,25+,26-,29-,35+,38+,39-/m0/s1	Penimocycline	(2S,5R,6R)-6-[[(2R)-2-[[[(4S,4aS,5aS,6S,12aR)-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carbonyl]amino]methylamino]-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid	CN(C)[C@@H]1C(=O)C(C(=O)NCN[C@@H](C(=O)N[C@@H]2C(=O)N3[C@@H]2SC(C)(C)[C@@H]3C(=O)O)c2ccccc2)=C(O)[C@@]2(O)C(=O)C3=C(O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12	76972772.0	R6_adenot_2004:317			BBB-	C	training
InChI=1S/C3F8/c4-1(5,2(6,7)8)3(9,10)11	Perflutren	1,1,1,2,2,3,3,3-octafluoropropane	FC(F)(F)C(F)(F)C(F)(F)F	6432.0	R23_gupta_2019:824			BBB-	C	test
InChI=1S/C3H11NO7P2/c4-2-1-3(5,12(6,7)8)13(9,10)11/h5H,1-2,4H2,(H2,6,7,8)(H2,9,10,11)	Pamidronate|Pamidronic Acid	(3-amino-1-hydroxy-1-phosphonopropyl)phosphonic acid	NCCC(O)(P(=O)(O)O)P(=O)(O)O	4674.0	R14_ghose_2012:752|R23_gupta_2019:809			BBB-	C	training
InChI=1S/C3H2ClF5O/c4-1(3(7,8)9)10-2(5)6/h1-2H	Isoflurane|R-Isoflurane	2-chloro-2-(difluoromethoxy)-1,1,1-trifluoroethane	FC(F)OC(Cl)C(F)(F)F	3763.0	R3_abraham_2006:69|R6_adenot_2004:938|R7_andres_2006:204|R12_garg_2006:95|R17_fu_2008:18|R21_muehlbacher_2011:90|R22_clark_1999:18|R25_brito_sanchez_2015:261|R26_chico_2009:228|R28_li_2005:93|R39_shayanfar_2011:54|R40_vilar_2010:367|R41_toropov_2017:64|R44_bujak_2015:36|R47_radchenko_2020:51|R49_norinder_2002:48|R52_liu_2001:48	0.42	D	BBB+	A	test
InChI=1S/C3H2ClF5O/c4-1(3(7,8)9)10-2(5)6/h1-2H/t1-/m0/s1	(2R)-2-Chloro-2-(Difluoromethoxy)-1,1,1-Trifluoroethane	(2R)-2-chloro-2-(difluoromethoxy)-1,1,1-trifluoroethane	FC(F)O[C@H](Cl)C(F)(F)F	11095291.0	R48_hou_2003:98	0.42	A	BBB+	A	test
InChI=1S/C3H2ClF5O/c4-1(5)3(8,9)10-2(6)7/h1-2H	Enflurane|R-Enflurane	2-chloro-1-(difluoromethoxy)-1,1,2-trifluoroethane	FC(F)OC(F)(F)C(F)Cl	3226.0	R3_abraham_2006:70|R6_adenot_2004:929|R7_andres_2006:195|R12_garg_2006:76|R17_fu_2008:12|R21_muehlbacher_2011:68|R22_clark_1999:12|R23_gupta_2019:557|R25_brito_sanchez_2015:220|R26_chico_2009:174|R28_li_2005:80|R39_shayanfar_2011:43|R40_vilar_2010:355|R41_toropov_2017:65|R44_bujak_2015:27|R47_radchenko_2020:52|R49_norinder_2002:43|R52_liu_2001:42	0.24	D	BBB+	A	test
InChI=1S/C3H2ClF5O/c4-1(5)3(8,9)10-2(6)7/h1-2H/t1-/m0/s1	(R)-Enflurane	(2R)-2-chloro-1-(difluoromethoxy)-1,1,2-trifluoroethane	FC(F)OC(F)(F)[C@H](F)Cl	11052326.0	R5_guerra_2008:88|R48_hou_2003:87	0.22	B1	BBB+	A	test
InChI=1S/C3H2F6O/c4-1(3(7,8)9)10-2(5)6/h1-2H	Desflurane|Suprane	2-(difluoromethoxy)-1,1,1,2-tetrafluoroethane	FC(F)OC(F)C(F)(F)F	42113.0	R6_adenot_2004:937|R12_garg_2006:65|R14_ghose_2012:62|R21_muehlbacher_2011:245|R23_gupta_2019:277|R25_brito_sanchez_2015:202|R26_chico_2009:148|R39_shayanfar_2011:35|R40_vilar_2010:351|R47_radchenko_2020:267	0.11	B	BBB+	A	test
InChI=1S/C3H3BrClF3/c4-2(5)1-3(6,7)8/h2H,1H2	Lin_Train_45|Mp 001-772-915|3-Bromo-3-Chloro-1,1,1-Trifluoropropane	3-bromo-3-chloro-1,1,1-trifluoropropane	FC(F)(F)CC(Cl)Br	18356503.0	R12_garg_2006:101|R21_muehlbacher_2011:357|R25_brito_sanchez_2015:274|R40_vilar_2010:371|R46_mendoza_valencia_2017:247|R47_radchenko_2020:275	0.35	B	BBB+	A	training
InChI=1S/C3H3BrF4/c4-2(5)1-3(6,7)8/h2H,1H2	Lin_Train_55|Cid 23235109|Tetrafluoropropyl Bromide	3-bromo-1,1,1,3-tetrafluoropropane	FC(Br)CC(F)(F)F	23235109.0	R12_garg_2006:102|R21_muehlbacher_2011:359|R25_brito_sanchez_2015:275|R40_vilar_2010:372|R46_mendoza_valencia_2017:248|R47_radchenko_2020:276	0.27	B	BBB+	A	training
InChI=1S/C3H3N/c1-2-3-4/h2H,1H2	Acrylonitrile	prop-2-enenitrile	C=CC#N	7855.0	R3_abraham_2006:97|R21_muehlbacher_2011:186|R25_brito_sanchez_2015:109|R40_vilar_2010:26|R41_toropov_2017:92|R46_mendoza_valencia_2017:107|R47_radchenko_2020:79	-0.4	B	BBB+	A	training
InChI=1S/C3H4BrF3O/c1-8-3(6,7)2(4)5/h2H,1H3	Roflurane	2-bromo-1,1,2-trifluoro-1-methoxyethane	COC(F)(F)C(F)Br	12676.0	R6_adenot_2004:950			BBB+	C	training
InChI=1S/C3H4Cl2F2O/c1-8-3(6,7)2(4)5/h2H,1H3	Methoxyflurane	2,2-dichloro-1,1-difluoro-1-methoxyethane	COC(F)(F)C(Cl)Cl	4116.0	R3_abraham_2006:68|R5_guerra_2008:66|R6_adenot_2004:942|R12_garg_2006:110|R21_muehlbacher_2011:98|R23_gupta_2019:740|R25_brito_sanchez_2015:292|R28_li_2005:96|R39_shayanfar_2011:61|R40_vilar_2010:375|R41_toropov_2017:63|R44_bujak_2015:38|R46_mendoza_valencia_2017:260|R47_radchenko_2020:50|R49_norinder_2002:75	0.12	D	BBB+	A	training
InChI=1S/C3H4O/c1-2-3-4/h1,4H,3H2	Propargyl Alcohol|2-Propyn-1-Ol	prop-2-yn-1-ol	C#CCO	7859.0	R3_abraham_2006:96|R21_muehlbacher_2011:187|R25_brito_sanchez_2015:368|R40_vilar_2010:219|R41_toropov_2017:91|R46_mendoza_valencia_2017:322|R47_radchenko_2020:78	-0.23	B	BBB+	A	test
InChI=1S/C3H5N3O9/c7-4(8)13-1-3(15-6(11)12)2-14-5(9)10/h3H,1-2H2	Nitroglycerin	1,3-dinitrooxypropan-2-yl nitrate	O=[N+]([O-])OCC(CO[N+](=O)[O-])O[N+](=O)[O-]	4510.0	R14_ghose_2012:726|R23_gupta_2019:785			BBB-	C	training
InChI=1S/C3H6/c1-2-3-1/h1-3H2	Cyclopropane|Trimethylene	cyclopropane	C1CC1	6351.0	R3_abraham_2006:22|R5_guerra_2008:31|R6_adenot_2004:926|R12_garg_2006:64|R21_muehlbacher_2011:157|R25_brito_sanchez_2015:197|R26_chico_2009:144|R28_li_2005:74|R39_shayanfar_2011:34|R40_vilar_2010:349|R41_toropov_2017:17|R46_mendoza_valencia_2017:183|R47_radchenko_2020:7	0.11	D	BBB+	A	training
InChI=1S/C3H6/c1-3-2/h3H,1H2,2H3	Propene|Propylene	prop-1-ene	C=CC	8252.0	R3_abraham_2006:46|R21_muehlbacher_2011:200|R25_brito_sanchez_2015:369|R40_vilar_2010:389|R41_toropov_2017:41|R46_mendoza_valencia_2017:323|R47_radchenko_2020:29	-0.06	B	BBB+	A	test
InChI=1S/C3H6N2O2/c4-2-1-7-5-3(2)6/h2H,1,4H2,(H,5,6)/t2-/m1/s1	Cycloserine	(4R)-4-amino-1,2-oxazolidin-3-one	N[C@@H]1CONC1=O	6234.0	R28_li_2005:255			BBB+	C	test
InChI=1S/C3H6O/c1-3(2)4/h1-2H3	Acetone|Propanone|Propan-2-One	propan-2-one	CC(C)=O	180.0	R3_abraham_2006:75|R7_andres_2006:3|R12_garg_2006:142|R17_fu_2008:22|R21_muehlbacher_2011:2|R22_clark_1999:24|R25_brito_sanchez_2015:107|R28_li_2005:108|R39_shayanfar_2011:76|R40_vilar_2010:340|R41_toropov_2017:70|R44_bujak_2015:55|R46_mendoza_valencia_2017:105|R47_radchenko_2020:57|R48_hou_2003:68|R49_norinder_2002:58|R52_liu_2001:54	-0.15	B1	BBB+	A	training
InChI=1S/C3H6O2/c1-3(4)5-2/h1-2H3	Methyl Acetate|Methylacetate	methyl acetate	COC(C)=O	6584.0	R3_abraham_2006:78|R21_muehlbacher_2011:171|R25_brito_sanchez_2015:293|R40_vilar_2010:376|R41_toropov_2017:73|R46_mendoza_valencia_2017:261|R47_radchenko_2020:60	-0.13	B	BBB+	A	training
InChI=1S/C3H6O3/c1-2(4)3(5)6/h2,4H,1H3,(H,5,6)	Lactic Acid	2-hydroxypropanoic acid	CC(O)C(=O)O	612.0	R47_radchenko_2020:486	0.16	A	BBB+	A	training
InChI=1S/C3H7Br/c1-2-3-4/h2-3H2,1H3	1-Bromopropane|N-Propylbromide	1-bromopropane	CCCBr	7840.0	R3_abraham_2006:37|R21_muehlbacher_2011:184|R25_brito_sanchez_2015:50|R40_vilar_2010:317|R41_toropov_2017:32|R46_mendoza_valencia_2017:49|R47_radchenko_2020:22	0.28	B1	BBB+	A	training
InChI=1S/C3H7Br/c1-3(2)4/h3H,1-2H3	2-Bromopropane	2-bromopropane	CC(C)Br	6358.0	R3_abraham_2006:38|R21_muehlbacher_2011:159|R25_brito_sanchez_2015:68|R40_vilar_2010:327|R41_toropov_2017:33|R46_mendoza_valencia_2017:66|R47_radchenko_2020:23	0.56	B	BBB+	A	training
InChI=1S/C3H7FN2S/c4-1-2-7-3(5)6/h1-2H2,(H3,5,6)	S-2Fluoroethylisothiourea|2-(2-Fluoro-Ethyl)-Isothiourea|S-2-Fluoroethylisothiourea|S-(2-Fluoroethyl)Isothiourea	2-fluoroethyl carbamimidothioate	[H]/N=C(/N)SCCF	10011896.0	R3_abraham_2006:250|R21_muehlbacher_2011:333|R25_brito_sanchez_2015:282|R40_vilar_2010:235|R41_toropov_2017:224|R46_mendoza_valencia_2017:253|R47_radchenko_2020:207	-0.27	B	BBB+	A	training
InChI=1S/C3H7NO2/c1-2(4)3(5)6/h2H,4H2,1H3,(H,5,6)	Alanine|Dl-Alanine	2-aminopropanoic acid	CC(N)C(=O)O	602.0	R47_radchenko_2020:490	-0.17	A	BBB+	A	training
InChI=1S/C3H7NO2/c1-2-6-3(4)5/h2H2,1H3,(H2,4,5)	Urethane	ethyl carbamate	CCOC(N)=O	5641.0	R6_adenot_2004:957			BBB+	C	training
InChI=1S/C3H8O/c1-2-3-4/h4H,2-3H2,1H3	1-Propanol|Propan-1-Ol|Propanol	propan-1-ol	CCCO	1031.0	R3_abraham_2006:56|R12_garg_2006:5|R12_garg_2006:140|R17_fu_2008:21|R21_muehlbacher_2011:17|R22_clark_1999:23|R25_brito_sanchez_2015:61|R26_chico_2009:331|R28_li_2005:107|R40_vilar_2010:325|R41_toropov_2017:51|R44_bujak_2015:53|R47_radchenko_2020:38|R48_hou_2003:66|R49_norinder_2002:56|R52_liu_2001:53	-0.14	B1	BBB+	A	training
InChI=1S/C3H8O/c1-3(2)4/h3-4H,1-2H3	2-Propanol|Propan-2-Ol|Isopropanol|Isopropyl Alcohol	propan-2-ol	CC(C)O	3776.0	R3_abraham_2006:59|R5_guerra_2008:6|R12_garg_2006:9|R12_garg_2006:141|R17_fu_2008:5|R21_muehlbacher_2011:91|R22_clark_1999:5|R25_brito_sanchez_2015:77|R26_chico_2009:332|R28_li_2005:133|R39_shayanfar_2011:7|R40_vilar_2010:335|R41_toropov_2017:54|R44_bujak_2015:54|R46_mendoza_valencia_2017:75|R47_radchenko_2020:41|R48_hou_2003:67|R49_norinder_2002:57|R52_liu_2001:35	-0.14	B1	BBB+	A	training
InChI=1S/C3H8O3/c4-1-3(6)2-5/h3-6H,1-2H2	Glycerin|Glycerol	propane-1,2,3-triol	OCC(O)CO	753.0	R14_ghose_2012:599|R23_gupta_2019:1065|R47_radchenko_2020:485	-0.21	A	BBB+	A	training
InChI=1S/C3H8OS2/c4-1-3(6)2-5/h3-6H,1-2H2	Dimercaprol	2,3-bis(sulfanyl)propan-1-ol	OCC(S)CS	3080.0	R23_gupta_2019:528			BBB-	C	training
InChI=1S/C3H9NO3S/c4-2-1-3-8(5,6)7/h1-4H2,(H,5,6,7)	Tramiprosate, Alzhemed|Tramiprosate	3-aminopropane-1-sulfonic acid	NCCCS(=O)(=O)O	1646.0	R26_chico_2009:425	-0.4	A	BBB+	A	test
InChI=1S/C40H48N2O6/c1-41(2)17-15-27-22-34(44-6)36-24-30(27)31(41)19-25-9-12-29(13-10-25)47-40-38-28(23-37(45-7)39(40)46-8)16-18-42(3,4)32(38)20-26-11-14-33(43-5)35(21-26)48-36/h9-14,21-24,31-32H,15-20H2,1-8H3/q+2/t31-,32+/m0/s1	Metocurine	(1S,16R)-9,10,21,25-tetramethoxy-15,15,30,30-tetramethyl-7,23-dioxa-15,30-diazoniaheptacyclo[22.6.2.23,6.18,12.118,22.027,31.016,34]hexatriaconta-3(36),4,6(35),8(34),9,11,18(33),19,21,24,26,31-dodecaene	COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)[C@H]3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1[C@@H](C2)[N+](C)(C)CC3	21233.0	R23_gupta_2019:744			BBB-	C	training
InChI=1S/C40H53N7O5S2/c1-29(2)38-43-34(27-53-38)25-46(3)39(49)45-36(16-17-47-18-20-51-21-19-47)37(48)42-32(22-30-10-6-4-7-11-30)14-15-33(23-31-12-8-5-9-13-31)44-40(50)52-26-35-24-41-28-54-35/h4-13,24,27-29,32-33,36H,14-23,25-26H2,1-3H3,(H,42,48)(H,44,50)(H,45,49)/t32-,33-,36+/m1/s1	Cobicistat	1,3-thiazol-5-ylmethyl N-[(2R,5R)-5-[[(2S)-2-[[methyl-[(2-propan-2-yl-1,3-thiazol-4-yl)methyl]carbamoyl]amino]-4-morpholin-4-ylbutanoyl]amino]-1,6-diphenylhexan-2-yl]carbamate	CC(C)c1nc(CN(C)C(=O)N[C@@H](CCN2CCOCC2)C(=O)N[C@H](CC[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)Cc2ccccc2)cs1	25151504.0	R23_gupta_2019:477			BBB-	C	training
InChI=1S/C40H56/c1-31(19-13-21-33(3)25-27-37-35(5)23-15-29-39(37,7)8)17-11-12-18-32(2)20-14-22-34(4)26-28-38-36(6)24-16-30-40(38,9)10/h11-14,17-22,25-28H,15-16,23-24,29-30H2,1-10H3/b12-11+,19-13+,20-14+,27-25+,28-26+,31-17+,32-18+,33-21+,34-22+	Beta-Carotene	1,3,3-trimethyl-2-[(1E,3E,5E,7E,9E,11E,13E,15E,17E)-3,7,12,16-tetramethyl-18-(2,6,6-trimethylcyclohexen-1-yl)octadeca-1,3,5,7,9,11,13,15,17-nonaenyl]cyclohexene	CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C2=C(C)CCCC2(C)C)C(C)(C)CCC1	5280489.0	R14_ghose_2012:390			BBB-	C	training
InChI=1S/C40H56O2/c1-29(17-13-19-31(3)21-23-37-33(5)25-35(41)27-39(37,7)8)15-11-12-16-30(2)18-14-20-32(4)22-24-38-34(6)26-36(42)28-40(38,9)10/h11-25,35-37,41-42H,26-28H2,1-10H3/b12-11+,17-13+,18-14+,23-21+,24-22+,29-15+,30-16+,31-19+,32-20+/t35-,36+,37-/m0/s1	Xanthophyll|Lutein	(1R)-4-[(1E,3E,5E,7E,9E,11E,13E,15E,17E)-18-[(1R,4R)-4-hydroxy-2,6,6-trimethylcyclohex-2-en-1-yl]-3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaenyl]-3,5,5-trimethylcyclohex-3-en-1-ol	CC1=C[C@H](O)CC(C)(C)[C@H]1/C=C/C(C)=C/C=C/C(C)=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)C[C@@H](O)CC1(C)C	5281243.0	R23_gupta_2019:1033			BBB-	C	training
InChI=1S/C40H57N5O7/c1-27(2)22-32(36(47)40(5)26-52-40)42-39(50)34(24-30-14-10-7-11-15-30)44-38(49)33(23-28(3)4)43-37(48)31(17-16-29-12-8-6-9-13-29)41-35(46)25-45-18-20-51-21-19-45/h6-15,27-28,31-34H,16-26H2,1-5H3,(H,41,46)(H,42,50)(H,43,48)(H,44,49)/t31-,32-,33-,34-,40+/m0/s1	Carfilzomib	(2S)-4-methyl-N-[(2S)-1-[[(2S)-4-methyl-1-[(2R)-2-methyloxiran-2-yl]-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]-4-phenylbutanoyl]amino]pentanamide	CC(C)C[C@H](NC(=O)[C@H](CCc1ccccc1)NC(=O)CN1CCOCC1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)[C@@]1(C)CO1	11556711.0	R23_gupta_2019:413			BBB-	C	training
InChI=1S/C40H59NO11/c1-19-11-24-5-7-28-20(2)12-26(45-28)9-10-40-17-33-36(51-40)37-38(50-33)39(52-40)35-29(49-37)8-6-25(47-35)13-22(42)14-27-31(16-30(46-24)21(19)3)48-32(34(27)44-4)15-23(43)18-41/h19,23-39,43H,2-3,5-18,41H2,1,4H3/t19-,23+,24+,25-,26+,27+,28+,29+,30-,31+,32-,33-,34-,35+,36+,37+,38-,39+,40+/m1/s1	Eribulin	(1S,3S,6S,9S,12S,14R,16R,18S,20R,21R,22S,26R,29S,31R,32S,33R,35R,36S)-20-[(2S)-3-amino-2-hydroxypropyl]-21-methoxy-14-methyl-8,15-dimethylidene-2,19,30,34,37,39,40,41-octaoxanonacyclo[24.9.2.13,32.13,33.16,9.112,16.018,22.029,36.031,35]hentetracontan-24-one	C=C1C[C@@H]2CC[C@@]34C[C@H]5O[C@H]6[C@@H](O3)[C@H]3O[C@H](CC[C@@H]3O[C@H]6[C@H]5O4)CC(=O)C[C@@H]3[C@@H](OC)[C@@H](C[C@H](O)CN)O[C@H]3C[C@H]3O[C@@H](CC[C@@H]1O2)C[C@@H](C)C3=C	11354606.0	R23_gupta_2019:568			BBB-	C	training
InChI=1S/C40H63N3O4S2/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-22-40(44)47-32-27-34-25-30-42(31-26-34)28-19-29-43-36-20-17-18-21-38(36)48-39-24-23-35(33-37(39)43)49(45,46)41(2)3/h17-18,20-21,23-24,33-34H,4-16,19,22,25-32H2,1-3H3	Pipotiazine-Palmitate|Pipotiazine Palmitate	2-[1-[3-[2-(dimethylsulfamoyl)phenothiazin-10-yl]propyl]piperidin-4-yl]ethyl hexadecanoate	CCCCCCCCCCCCCCCC(=O)OCCC1CCN(CCCN2c3ccccc3Sc3ccc(S(=O)(=O)N(C)C)cc32)CC1	37767.0	R6_adenot_2004:1202			BBB+	C	test
InChI=1S/C40H71NO14/c1-15-27-40(11,48)33(44)22(5)30(43)20(3)18-38(9,47)35(55-37-32(53-28(42)16-2)26(41(12)13)17-21(4)50-37)23(6)31(24(7)36(46)52-27)54-29-19-39(10,49-14)34(45)25(8)51-29/h20-27,29,31-35,37,44-45,47-48H,15-19H2,1-14H3/t20-,21-,22+,23+,24-,25+,26+,27-,29+,31+,32-,33-,34+,35-,37+,38-,39-,40-/m1/s1	Erythromycin-Propionate|Erythromycin Propionate	[(2S,3R,4S,6R)-4-(dimethylamino)-2-[[(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-2,10-dioxo-oxacyclotetradec-6-yl]oxy]-6-methyloxan-3-yl] propanoate	CCC(=O)O[C@H]1[C@H](O[C@@H]2[C@@H](C)[C@H](O[C@H]3C[C@@](C)(OC)[C@@H](O)[C@H](C)O3)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@]2(C)O)O[C@H](C)C[C@@H]1N(C)C	71277.0	R6_adenot_2004:290			BBB-	C	training
InChI=1S/C40H71NO15/c1-15-27-40(11,48)32(43)22(5)29(42)20(3)18-38(9,47)34(56-36-31(55-37(46)50-16-2)26(41(12)13)17-21(4)51-36)23(6)30(24(7)35(45)53-27)54-28-19-39(10,49-14)33(44)25(8)52-28/h20-28,30-34,36,43-44,47-48H,15-19H2,1-14H3/t20-,21-,22+,23+,24-,25+,26+,27-,28+,30+,31-,32-,33+,34-,36+,38-,39-,40-/m1/s1	Erythromycin-Ethylcarbonate|Erythromycin Ethyl Carbonate	[(2S,3R,4S,6R)-4-(dimethylamino)-2-[[(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-2,10-dioxo-oxacyclotetradec-6-yl]oxy]-6-methyloxan-3-yl] ethyl carbonate	CCOC(=O)O[C@H]1[C@H](O[C@@H]2[C@@H](C)[C@H](O[C@H]3C[C@@](C)(OC)[C@@H](O)[C@H](C)O3)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@]2(C)O)O[C@H](C)C[C@@H]1N(C)C	10033317.0	R6_adenot_2004:288			BBB-	C	training
InChI=1S/C41H42N4O8/c1-9-23-20(2)29-17-34-27-13-10-26(39(49)52-7)38(40(50)53-8)41(27,5)35(45-34)19-30-22(4)24(11-14-36(46)47)32(44-30)18-33-25(12-15-37(48)51-6)21(3)28(43-33)16-31(23)42-29/h9-10,13,16-19,38,43-44H,1,11-12,14-15H2,2-8H3,(H,46,47)	Verteporfin|3-[14-Ethenyl-22,23-Bis(Methoxycarbonyl)-9-(3-Methoxy-3-Oxopropyl)-4,10,15,24-Tetramethyl-25,26,27,28-Tetrazahexacyclo[16.6.1.13,6.18,11.113,16.019,24]Octacosa-1,3,5,7,9,11(27),12,14,16,18(25),19,21-Dodecaen-5-Yl]Propanoic Acid	3-[14-ethenyl-22,23-bis(methoxycarbonyl)-9-(3-methoxy-3-oxopropyl)-4,10,15,24-tetramethyl-25,26,27,28-tetrazahexacyclo[16.6.1.13,6.18,11.113,16.019,24]octacosa-1,3,5,7,9,11(27),12,14,16,18(25),19,21-dodecaen-5-yl]propanoic acid	C=Cc1c(C)c2cc3nc(cc4[nH]c(cc5nc(cc1[nH]2)C(C)=C5CCC(=O)OC)c(CCC(=O)O)c4C)C1(C)C3=CC=C(C(=O)OC)C1C(=O)OC	9876751.0	R23_gupta_2019:1023			BBB-	C	training
InChI=1S/C41H64O13/c1-20-36(46)29(42)16-34(49-20)53-38-22(3)51-35(18-31(38)44)54-37-21(2)50-33(17-30(37)43)52-25-8-11-39(4)24(15-25)6-7-28-27(39)9-12-40(5)26(10-13-41(28,40)47)23-14-32(45)48-19-23/h14,20-22,24-31,33-38,42-44,46-47H,6-13,15-19H2,1-5H3/t20-,21-,22-,24-,25+,26-,27+,28-,29+,30+,31+,33+,34+,35+,36-,37-,38-,39+,40-,41+/m1/s1	Digitoxin	3-[(3S,5R,8R,9S,10S,13R,14S,17R)-3-[(2R,4S,5S,6R)-5-[(2S,4S,5S,6R)-5-[(2S,4S,5S,6R)-4,5-dihydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-6-methyloxan-2-yl]oxy-14-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one	C[C@H]1O[C@@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5CC[C@]5(C)[C@@H](C7=CC(=O)OC7)CC[C@]65O)C4)O[C@@H]3C)O[C@@H]2C)C[C@H](O)[C@@H]1O	441207.0	R51_doninger_2002:39			BBB-	C	training
InChI=1S/C41H64O14/c1-19-36(47)28(42)15-34(50-19)54-38-21(3)52-35(17-30(38)44)55-37-20(2)51-33(16-29(37)43)53-24-8-10-39(4)23(13-24)6-7-26-27(39)14-31(45)40(5)25(9-11-41(26,40)48)22-12-32(46)49-18-22/h12,19-21,23-31,33-38,42-45,47-48H,6-11,13-18H2,1-5H3/t19-,20-,21-,23-,24+,25-,26-,27+,28+,29+,30+,31-,33+,34+,35+,36-,37-,38-,39+,40+,41+/m1/s1	Digoxin	3-[(3S,5R,8R,9S,10S,12R,13S,14S,17R)-3-[(2R,4S,5S,6R)-5-[(2S,4S,5S,6R)-5-[(2S,4S,5S,6R)-4,5-dihydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-6-methyloxan-2-yl]oxy-12,14-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one	C[C@H]1O[C@@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5C[C@@H](O)[C@]5(C)[C@@H](C7=CC(=O)OC7)CC[C@]65O)C4)O[C@@H]3C)O[C@@H]2C)C[C@H](O)[C@@H]1O	2724385.0	R6_adenot_2004:17|R14_ghose_2012:499|R21_muehlbacher_2011:234|R23_gupta_2019:525|R25_brito_sanchez_2015:391|R34_broccatelli_2012:118|R40_vilar_2010:97|R47_radchenko_2020:359|R50_sobanska_2019:5|R51_doninger_2002:40	-1.23	D	BBB-	A	training
InChI=1S/C41H64O8/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-36(45)49-29-37(46)48-28-35(44)41(47)25-23-33-32-21-20-30-26-31(42)22-24-39(30,2)38(32)34(43)27-40(33,41)3/h22,24,26,32-34,38,43,47H,4-21,23,25,27-29H2,1-3H3/t32-,33-,34-,38+,39-,40-,41-/m0/s1	Prednisolone-Steaglate|Prednisolone Steaglate	[2-[2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethoxy]-2-oxoethyl] octadecanoate	CCCCCCCCCCCCCCCCCC(=O)OCC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C	71206.0	R6_adenot_2004:894			BBB+	C	training
InChI=1S/C41H67NO15/c1-11-30(45)54-29-21-32(47)51-24(4)16-14-13-15-17-28(44)23(3)20-27(18-19-43)37(38(29)50-10)57-40-35(48)34(42(8)9)36(25(5)53-40)56-33-22-41(7,49)39(26(6)52-33)55-31(46)12-2/h13-15,17,19,23-29,33-40,44,48-49H,11-12,16,18,20-22H2,1-10H3/t23-,24-,25-,26+,27+,28+,29-,33+,34-,35-,36-,37+,38+,39+,40+,41-/m1/s1	Midecamycin|[(4R,5S,6S,7R,9R,10R,16R)-6-[(2S,3R,4R,5S,6R)-4-(Dimethylamino)-3-Hydroxy-5-[(2S,4R,5S,6S)-4-Hydroxy-4,6-Dimethyl-5-Propanoyloxyoxan-2-Yl]Oxy-6-Methyloxan-2-Yl]Oxy-10-Hydroxy-5-Methoxy-9,16-Dimethyl-2-Oxo-7-(2-Oxoethyl)-1-Oxacyclohexadeca-11,13-Dien-4-Yl] Propanoate	[(4R,5S,6S,7R,9R,10R,16R)-6-[(2S,3R,4R,5S,6R)-4-(dimethylamino)-3-hydroxy-5-[(2S,4R,5S,6S)-4-hydroxy-4,6-dimethyl-5-propanoyloxyoxan-2-yl]oxy-6-methyloxan-2-yl]oxy-10-hydroxy-5-methoxy-9,16-dimethyl-2-oxo-7-(2-oxoethyl)-1-oxacyclohexadeca-11,13-dien-4-yl] propanoate	CCC(=O)O[C@@H]1CC(=O)O[C@H](C)CC=CC=C[C@H](O)[C@H](C)C[C@H](CC=O)[C@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](OC(=O)CC)[C@H](C)O3)[C@H](N(C)C)[C@H]2O)[C@H]1OC	443948.0	R6_adenot_2004:124			BBB-	C	training
InChI=1S/C41H67NO15/c1-19-17-41(18-49-41)38(46)23(5)34(53-27(9)43)21(3)25(7)52-39(47)24(6)35(56-32-16-31(48-14)36(26(8)51-32)54-28(10)44)22(4)33(19)57-40-37(55-29(11)45)30(42(12)13)15-20(2)50-40/h19-26,30-37,40H,15-18H2,1-14H3/t19-,20+,21-,22+,23+,24+,25+,26-,30-,31-,32-,33-,34-,35-,36-,37+,40-,41+/m0/s1	Troleandomycin	[(3R,5S,6S,7R,8S,9R,12R,13S,14S,15R)-6-[(2S,3R,4S,6R)-3-acetyloxy-4-(dimethylamino)-6-methyloxan-2-yl]oxy-8-[(2R,4S,5S,6S)-5-acetyloxy-4-methoxy-6-methyloxan-2-yl]oxy-5,7,9,12,13,15-hexamethyl-10,16-dioxo-1,11-dioxaspiro[2.13]hexadecan-14-yl] acetate	CO[C@H]1C[C@H](O[C@H]2[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@H](N(C)C)[C@H]3OC(C)=O)[C@@H](C)C[C@@]3(CO3)C(=O)[C@H](C)[C@@H](OC(C)=O)[C@@H](C)[C@@H](C)OC(=O)[C@@H]2C)O[C@@H](C)[C@@H]1OC(C)=O	202225.0	R6_adenot_2004:298|R14_ghose_2012:922			BBB-	C	test
InChI=1S/C41H69NO14/c1-14-30(43)53-35-22(5)26(9)52-39(47)25(8)36(55-32-17-29(48-13)37(27(10)51-32)54-31(44)15-2)23(6)34(20(3)18-41(19-49-41)38(46)24(35)7)56-40-33(45)28(42(11)12)16-21(4)50-40/h20-29,32-37,40,45H,14-19H2,1-13H3/t20?,21-,22+,23-,24-,25?,26-,27+,28+,29+,32+,33-,34+,35+,36+,37+,40+,41-/m1/s1	Diproleandomycin	[(3R,6S,7R,8S,12R,13S,14S,15R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-8-[(2R,4S,5S,6S)-4-methoxy-6-methyl-5-propanoyloxyoxan-2-yl]oxy-5,7,9,12,13,15-hexamethyl-10,16-dioxo-1,11-dioxaspiro[2.13]hexadecan-14-yl] propanoate	CCC(=O)O[C@H]1[C@H](C)O[C@@H](O[C@@H]2C(C)C(=O)O[C@H](C)[C@H](C)[C@H](OC(=O)CC)[C@@H](C)C(=O)[C@]3(CO3)CC(C)[C@H](O[C@@H]3O[C@H](C)C[C@H](N(C)C)[C@H]3O)[C@H]2C)C[C@@H]1OC	216261.0	R6_adenot_2004:285			BBB-	C	test
InChI=1S/C41H76N2O15/c1-15-29-41(10,49)34(45)24(4)31(42-53-21-52-17-16-50-13)22(2)19-39(8,48)36(58-38-32(44)28(43(11)12)18-23(3)54-38)25(5)33(26(6)37(47)56-29)57-30-20-40(9,51-14)35(46)27(7)55-30/h22-30,32-36,38,44-46,48-49H,15-21H2,1-14H3/b42-31+/t22-,23-,24+,25+,26-,27+,28+,29-,30+,32-,33+,34-,35+,36-,38+,39-,40-,41-/m1/s1	Roxithromycin|(Z)-Roxithromycin	(3R,4S,5S,6R,7R,9R,10Z,11S,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-10-(2-methoxyethoxymethoxyimino)-3,5,7,9,11,13-hexamethyl-oxacyclotetradecan-2-one	CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)/C(=N/OCOCCOC)[C@H](C)[C@@H](O)[C@]1(C)O	5480431.0	R6_adenot_2004:296|R14_ghose_2012:835			BBB-	C	test
InChI=1S/C42H53NO15/c1-8-42(51)17-28(33-22(35(42)41(50)52-7)14-23-34(38(33)49)37(48)32-21(36(23)47)10-9-11-26(32)45)56-30-15-24(43(5)6)39(19(3)54-30)58-31-16-27(46)40(20(4)55-31)57-29-13-12-25(44)18(2)53-29/h9-11,14,18-20,24,27-31,35,39-40,45-46,49,51H,8,12-13,15-17H2,1-7H3/t18-,19-,20-,24-,27-,28-,29-,30-,31-,35-,39+,40+,42+/m0/s1	Aclarubicin	methyl (1R,2R,4S)-4-[(2R,4S,5S,6S)-4-(dimethylamino)-5-[(2S,4S,5S,6S)-4-hydroxy-6-methyl-5-[(2R,6S)-6-methyl-5-oxooxan-2-yl]oxyoxan-2-yl]oxy-6-methyloxan-2-yl]oxy-2-ethyl-2,5,7-trihydroxy-6,11-dioxo-3,4-dihydro-1H-tetracene-1-carboxylate	CC[C@@]1(O)C[C@H](O[C@H]2C[C@H](N(C)C)[C@H](O[C@H]3C[C@H](O)[C@H](O[C@H]4CCC(=O)[C@H](C)O4)[C@H](C)O3)[C@H](C)O2)c2c(cc3c(c2O)C(=O)c2c(O)cccc2C3=O)[C@H]1C(=O)OC	451415.0	R6_adenot_2004:321			BBB-	C	test
InChI=1S/C42H55N3O11S/c1-12-45(13-2)41-44-30-27-28-34(49)24(8)37-29(27)39(51)42(10,56-37)54-18-17-26(53-11)21(5)36(55-25(9)46)23(7)33(48)22(6)32(47)19(3)15-14-16-20(4)40(52)43-31(35(28)50)38(30)57-41/h14-19,21-23,26,32-33,36,47-50H,12-13H2,1-11H3,(H,43,52)/b15-14+,18-17+,20-16-/t19-,21+,22+,23+,26-,32-,33+,36+,42-/m0/s1	Rifamexil	[(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-28-(diethylamino)-2,15,17,32-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,33-dioxa-27-thia-24,29-diazapentacyclo[23.6.1.14,7.05,31.026,30]tritriaconta-1(31),2,4,9,19,21,25(32),26(30),28-nonaen-13-yl] acetate	CCN(CC)c1nc2c(s1)c1c(O)c3c(O)c(C)c4c(c32)C(=O)[C@@](C)(O/C=C/[C@H](OC)[C@@H](C)[C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)/C=C/C=C(/C)C(=O)N1)O4	6473882.0	R6_adenot_2004:338			BBB-	C	training
InChI=1S/C42H67NO10/c1-11-26-13-12-14-35(53-37-16-15-34(43(6)7)24(4)49-37)23(3)38(45)33-20-31-29(32(33)21-36(44)51-26)17-22(2)28-18-27(19-30(28)31)52-42-41(48-10)40(47-9)39(46-8)25(5)50-42/h17,20,23-32,34-35,37,39-42H,11-16,18-19,21H2,1-10H3	Spinosad|Spinosyn D;Spinosyn-D	15-[5-(dimethylamino)-6-methyloxan-2-yl]oxy-19-ethyl-4,14-dimethyl-7-(3,4,5-trimethoxy-6-methyloxan-2-yl)oxy-20-oxatetracyclo[10.10.0.02,10.05,9]docosa-3,11-diene-13,21-dione	CCC1CCCC(OC2CCC(N(C)C)C(C)O2)C(C)C(=O)C2=CC3C(C=C(C)C4CC(OC5OC(C)C(OC)C(OC)C5OC)CC43)C2CC(=O)O1	4487556.0	R23_gupta_2019:920			BBB-	C	training
InChI=1S/C42H69NO15/c1-23(2)19-32(47)56-40-27(6)53-34(22-42(40,8)50)57-37-26(5)54-41(36(49)35(37)43(9)10)58-38-29(17-18-44)20-24(3)30(46)16-14-12-13-15-25(4)52-33(48)21-31(39(38)51-11)55-28(7)45/h12-14,16,18,23-27,29-31,34-41,46,49-50H,15,17,19-22H2,1-11H3/b13-12+,16-14+/t24-,25-,26-,27+,29+,30+,31-,34+,35-,36-,37-,38+,39+,40+,41+,42-/m1/s1	Josamycin	[(2S,3S,4R,6S)-6-[(2R,3S,4R,5R,6S)-6-[[(4R,5S,6S,7R,9R,10R,11E,13E,16R)-4-acetyloxy-10-hydroxy-5-methoxy-9,16-dimethyl-2-oxo-7-(2-oxoethyl)-1-oxacyclohexadeca-11,13-dien-6-yl]oxy]-4-(dimethylamino)-5-hydroxy-2-methyloxan-3-yl]oxy-4-hydroxy-2,4-dimethyloxan-3-yl] 3-methylbutanoate	CO[C@@H]1[C@@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](OC(=O)CC(C)C)[C@H](C)O3)[C@H](N(C)C)[C@H]2O)[C@@H](CC=O)C[C@@H](C)[C@@H](O)/C=C/C=C/C[C@@H](C)OC(=O)C[C@H]1OC(C)=O	5282165.0	R6_adenot_2004:293|R14_ghose_2012:639			BBB-	C	training
InChI=1S/C42H78N2O14/c1-15-29-42(10,49)37-24(4)32(43-30(56-37)21-52-17-16-50-13)22(2)19-40(8,48)36(58-39-33(45)28(44(11)12)18-23(3)53-39)25(5)34(26(6)38(47)55-29)57-31-20-41(9,51-14)35(46)27(7)54-31/h22-37,39,43,45-46,48-49H,15-21H2,1-14H3/t22-,23-,24+,25+,26-,27+,28+,29-,30-,31+,32+,33-,34+,35+,36-,37-,39+,40-,41-,42-/m1/s1	Dirithromycin	(1R,2R,3R,6R,7S,8S,9R,10R,12R,13S,15R,17S)-9-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-3-ethyl-2,10-dihydroxy-7-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-15-(2-methoxyethoxymethyl)-2,6,8,10,12,17-hexamethyl-4,16-dioxa-14-azabicyclo[11.3.1]heptadecan-5-one	CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)[C@@H]2N[C@@H](COCCOC)O[C@H]([C@H]2C)[C@]1(C)O	6473883.0	R6_adenot_2004:286|R14_ghose_2012:506			BBB-	C	training
InChI=1S/C43H49N7O10/c1-4-29-40(56)49-21-12-17-30(49)41(57)48(3)32(23-26-13-7-5-8-14-26)42(58)50-22-19-28(51)24-31(50)37(53)47-35(27-15-9-6-10-16-27)43(59)60-25(2)34(38(54)45-29)46-39(55)36-33(52)18-11-20-44-36/h5-11,13-16,18,20,25,29-32,34-35,52H,4,12,17,19,21-24H2,1-3H3,(H,45,54)(H,46,55)(H,47,53)	Virginiamycin-Factor-S1|Staphylomycin S	N-(3-benzyl-12-ethyl-4,16-dimethyl-2,5,11,14,18,21,24-heptaoxo-19-phenyl-17-oxa-1,4,10,13,20-pentazatricyclo[20.4.0.06,10]hexacosan-15-yl)-3-hydroxypyridine-2-carboxamide	CCC1NC(=O)C(NC(=O)c2ncccc2O)C(C)OC(=O)C(c2ccccc2)NC(=O)C2CC(=O)CCN2C(=O)C(Cc2ccccc2)N(C)C(=O)C2CCCN2C1=O	122731.0	R6_adenot_2004:346			BBB-	C	training
InChI=1S/C43H51N3O11/c1-19-14-16-46-28(18-19)44-32-29-30-37(50)25(7)40-31(29)41(52)43(9,57-40)55-17-15-27(54-10)22(4)39(56-26(8)47)24(6)36(49)23(5)35(48)20(2)12-11-13-21(3)42(53)45-33(34(32)46)38(30)51/h11-18,20,22-24,27,35-36,39,48-51H,1-10H3,(H,45,53)/b12-11+,17-15+,21-13-/t20-,22+,23+,24+,27-,35-,36+,39+,43-/m0/s1	Rifaximin	[(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,36-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22,30-octamethyl-6,23-dioxo-8,37-dioxa-24,27,33-triazahexacyclo[23.10.1.14,7.05,35.026,34.027,32]heptatriaconta-1(35),2,4,9,19,21,25(36),26(34),28,30,32-undecaen-13-yl] acetate	CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c5c(nc6cc(C)ccn65)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C	6436173.0	R6_adenot_2004:343|R14_ghose_2012:826|R23_gupta_2019:886			BBB-	C	training
InChI=1S/C43H52N4O5/c1-7-24-15-23-20-43(42(49)52-6)39-27(13-14-47(21-23)40(24)43)29-19-36(50-4)30(17-34(29)45-39)31-16-28-25(8-2)22-46(3)35(37(28)41(48)51-5)18-32-26-11-9-10-12-33(26)44-38(31)32/h8-12,17,19,23-24,28,31,35,37,40,44-45H,7,13-16,18,20-22H2,1-6H3/b25-8-	Voacamine|Voacanginine	methyl 17-ethyl-6-[(15E)-15-ethylidene-18-methoxycarbonyl-17-methyl-10,17-diazatetracyclo[12.3.1.03,11.04,9]octadeca-3(11),4,6,8-tetraen-12-yl]-7-methoxy-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4,6,8-tetraene-1-carboxylate	C/C=C1/CN(C)C2Cc3c([nH]c4ccccc34)C(c3cc4[nH]c5c(c4cc3OC)CCN3CC4CC(CC)C3C5(C(=O)OC)C4)CC1C2C(=O)OC	5371246.0	R23_gupta_2019:1030			BBB-	C	training
InChI=1S/C43H53NO14/c1-22-26(55-37(51)32(48)30(24-15-11-9-12-16-24)44-38(52)58-39(3,4)5)20-43(53)35(56-36(50)25-17-13-10-14-18-25)33-41(8,34(49)31(47)29(22)40(43,6)7)27(46)19-28-42(33,21-54-28)57-23(2)45/h9-18,26-28,30-33,35,46-48,53H,19-21H2,1-8H3,(H,44,52)/t26-,27-,28+,30-,31+,32+,33-,35-,41+,42-,43+/m0/s1	Docetaxel	[(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4-acetyloxy-1,9,12-trihydroxy-15-[(2R,3S)-2-hydroxy-3-[(2-methylpropan-2-yl)oxycarbonylamino]-3-phenylpropanoyl]oxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate	CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@H]21)C3(C)C	148124.0	R6_adenot_2004:21|R6_adenot_2004:76			BBB-	C	training
InChI=1S/C43H55N5O7/c1-6-39(52)21-25-22-42(38(51)55-5,33-27(13-17-47(23-25)24-39)26-11-8-9-12-30(26)45-33)29-19-28-31(20-32(29)54-4)46(3)35-41(28)15-18-48-16-10-14-40(7-2,34(41)48)36(49)43(35,53)37(44)50/h8-12,14,19-20,25,34-36,45,49,52-53H,6-7,13,15-18,21-24H2,1-5H3,(H2,44,50)/t25-,34+,35-,36-,39+,40-,41-,42+,43+/m1/s1	Vindesine	methyl (13S,15S,17S)-13-[(1R,9R,10S,11R,12R,19R)-10-carbamoyl-12-ethyl-10,11-dihydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraen-4-yl]-17-ethyl-17-hydroxy-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraene-13-carboxylate	CC[C@]1(O)C[C@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(N)=O)[C@H](O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1	40839.0	R6_adenot_2004:74|R23_gupta_2019:1028			BBB-	C	test
InChI=1S/C43H58N2O13/c1-12-45(13-2)31(47)20-55-30-19-28-38(51)33-32(30)34-40(26(8)37(33)50)58-43(10,41(34)52)56-18-17-29(54-11)23(5)39(57-27(9)46)25(7)36(49)24(6)35(48)21(3)15-14-16-22(4)42(53)44-28/h14-19,21,23-25,29,35-36,39,48-51H,12-13,20H2,1-11H3,(H,44,53)/b15-14+,18-17+,22-16-/t21-,23+,24+,25+,29-,35-,36+,39+,43-/m0/s1	Rifamide	[(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-27-[2-(diethylamino)-2-oxoethoxy]-2,15,17,29-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate	CCN(CC)C(=O)COc1cc2c(O)c3c(O)c(C)c4c(c13)C(=O)[C@@](C)(O/C=C/[C@H](OC)[C@@H](C)[C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)/C=C/C=C(/C)C(=O)N2)O4	6433345.0	R6_adenot_2004:339			BBB-	C	training
InChI=1S/C43H58N4O12/c1-21-12-11-13-22(2)42(55)45-33-28(20-44-47-17-15-46(9)16-18-47)37(52)30-31(38(33)53)36(51)26(6)40-32(30)41(54)43(8,59-40)57-19-14-29(56-10)23(3)39(58-27(7)48)25(5)35(50)24(4)34(21)49/h11-14,19-21,23-25,29,34-35,39,49-53H,15-18H2,1-10H3,(H,45,55)	Rifampin|[2,15,17,27,29-Pentahydroxy-11-Methoxy-3,7,12,14,16,18,22-Heptamethyl-26-[(4-Methylpiperazin-1-Yl)Iminomethyl]-6,23-Dioxo-8,30-Dioxa-24-Azatetracyclo[23.3.1.14,7.05,28]Triaconta-1(29),2,4,9,19,21,25,27-Octaen-13-Yl] Acetate	[2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-26-[(4-methylpiperazin-1-yl)iminomethyl]-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate	COC1C=COC2(C)Oc3c(C)c(O)c4c(O)c(c(C=NN5CCN(C)CC5)c(O)c4c3C2=O)NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C1C	135512673.0	R14_ghose_2012:824			BBB-	C	training
InChI=1S/C43H58N4O12/c1-21-12-11-13-22(2)42(55)45-33-28(20-44-47-17-15-46(9)16-18-47)37(52)30-31(38(33)53)36(51)26(6)40-32(30)41(54)43(8,59-40)57-19-14-29(56-10)23(3)39(58-27(7)48)25(5)35(50)24(4)34(21)49/h11-14,19-21,23-25,29,34-35,39,49-53H,15-18H2,1-10H3,(H,45,55)/b12-11+,19-14+,22-13-,44-20+/t21-,23+,24+,25+,29-,34-,35+,39+,43-/m0/s1	Rifampicin|Rifampin|[(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,27,29-Pentahydroxy-11-Methoxy-3,7,12,14,16,18,22-Heptamethyl-26-[(Z)-(4-Methylpiperazin-1-Yl)Iminomethyl]-6,23-Dioxo-8,30-Dioxa-24-Azatetracyclo[23.3.1.14,7.05,28]Triaconta-1(29),2,4,9,19,21,25,27-Octaen-13-Yl] Acetate	[(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-26-[(Z)-(4-methylpiperazin-1-yl)iminomethyl]-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate	CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N\N5CCN(C)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C	135550179.0	R6_adenot_2004:63|R6_adenot_2004:340|R25_brito_sanchez_2015:386|R51_doninger_2002:124|R53_friden_2009:32	-1.51	B	BBB-	A	training
InChI=1S/C43H65N5O10/c1-12-33-43(8)37(48(41(53)58-43)19-14-13-18-47-23-31(45-24-47)30-16-15-17-44-22-30)27(4)34(49)25(2)21-42(7,54-11)38(28(5)35(50)29(6)39(52)56-33)57-40-36(51)32(46(9)10)20-26(3)55-40/h15-17,22-29,32-33,36-38,40,51H,12-14,18-21H2,1-11H3/t25-,26-,27+,28+,29-,32+,33-,36-,37-,38-,40+,42-,43-/m1/s1	Telithromycin	(1S,2R,5R,7R,8R,9R,11R,13R,14R)-8-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,13-hexamethyl-15-[4-(4-pyridin-3-ylimidazol-1-yl)butyl]-3,17-dioxa-15-azabicyclo[12.3.0]heptadecane-4,6,12,16-tetrone	CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C	3002190.0	R14_ghose_2012:878			BBB-	C	training
InChI=1S/C43H66O14/c1-21-38(48)33(54-24(4)44)19-37(51-21)57-40-23(3)53-36(18-32(40)46)56-39-22(2)52-35(17-31(39)45)55-27-9-12-41(5)26(16-27)7-8-30-29(41)10-13-42(6)28(11-14-43(30,42)49)25-15-34(47)50-20-25/h15,21-23,26-33,35-40,45-46,48-49H,7-14,16-20H2,1-6H3/t21-,22-,23-,26-,27+,28-,29+,30-,31+,32+,33+,35+,36+,37+,38-,39-,40-,41+,42-,43+/m1/s1	Acetyldigitoxin	[(2R,3R,4S,6S)-3-hydroxy-6-[(2R,3S,4S,6S)-4-hydroxy-6-[(2R,3S,4S,6R)-4-hydroxy-6-[[(3S,5R,8R,9S,10S,13R,14S,17R)-14-hydroxy-10,13-dimethyl-17-(5-oxo-2H-furan-3-yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl]oxy]-2-methyloxan-3-yl]oxy-2-methyloxan-3-yl]oxy-2-methyloxan-4-yl] acetate	CC(=O)O[C@H]1C[C@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5CC[C@]5(C)[C@@H](C7=CC(=O)OC7)CC[C@]65O)C4)O[C@@H]3C)O[C@@H]2C)O[C@H](C)[C@H]1O	5284512.0	R14_ghose_2012:328			BBB-	C	training
InChI=1S/C43H74N2O14/c1-24-21-29(19-20-46)39(59-42-37(49)36(45(9)10)38(27(4)56-42)58-35-23-43(6,51)41(50)28(5)55-35)40(52-11)31(47)22-33(48)53-25(2)15-13-12-14-16-32(24)57-34-18-17-30(44(7)8)26(3)54-34/h12-14,16,20,24-32,34-42,47,49-51H,15,17-19,21-23H2,1-11H3/b13-12+,16-14+/t24-,25-,26-,27-,28+,29+,30+,31-,32+,34+,35+,36-,37-,38-,39+,40+,41+,42+,43-/m1/s1	Spiramycin	2-[(4R,5S,6S,7R,9R,10R,11E,13E,16R)-6-[(2S,3R,4R,5S,6R)-5-[(2S,4R,5S,6S)-4,5-dihydroxy-4,6-dimethyloxan-2-yl]oxy-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-10-[(2R,5S,6R)-5-(dimethylamino)-6-methyloxan-2-yl]oxy-4-hydroxy-5-methoxy-9,16-dimethyl-2-oxo-1-oxacyclohexadeca-11,13-dien-7-yl]acetaldehyde	CO[C@@H]1[C@@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](O)[C@H](C)O3)[C@H](N(C)C)[C@H]2O)[C@@H](CC=O)C[C@@H](C)[C@@H](O[C@H]2CC[C@H](N(C)C)[C@@H](C)O2)/C=C/C=C/C[C@@H](C)OC(=O)C[C@H]1O	5289394.0	R6_adenot_2004:297|R6_adenot_2004:352|R14_ghose_2012:850			BBB-	C	training
InChI=1S/C43H75NO16/c1-15-29-43(11,52)36(48)24(5)33(47)22(3)20-41(9,51)38(25(6)34(26(7)39(50)57-29)59-32-21-42(10,53-14)37(49)27(8)56-32)60-40-35(28(44(12)13)19-23(4)55-40)58-31(46)18-17-30(45)54-16-2/h22-29,32,34-38,40,48-49,51-52H,15-21H2,1-14H3/t22-,23-,24+,25+,26-,27+,28+,29-,32+,34+,35-,36-,37+,38-,40+,41-,42-,43-/m1/s1	Erythromycin-Ethylsuccinate|Erythromycin Ethylsuccinate	4-O-[(2S,3R,4S,6R)-4-(dimethylamino)-2-[[(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-2,10-dioxo-oxacyclotetradec-6-yl]oxy]-6-methyloxan-3-yl] 1-O-ethyl butanedioate	CCOC(=O)CCC(=O)O[C@H]1[C@H](O[C@@H]2[C@@H](C)[C@H](O[C@H]3C[C@@](C)(OC)[C@@H](O)[C@H](C)O3)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@]2(C)O)O[C@H](C)C[C@@H]1N(C)C	443953.0	R6_adenot_2004:289			BBB-	C	training
InChI=1S/C44H32N4O4/c49-29-9-1-5-25(21-29)41-33-13-15-35(45-33)42(26-6-2-10-30(50)22-26)37-17-19-39(47-37)44(28-8-4-12-32(52)24-28)40-20-18-38(48-40)43(36-16-14-34(41)46-36)27-7-3-11-31(51)23-27/h1-17,19,21-24,46-47,49-52H,18,20H2	Temoporfin	3-[10,15,20-tris(3-hydroxyphenyl)-2,3,22,24-tetrahydroporphyrin-5-yl]phenol	Oc1cccc(-c2c3nc(c(-c4cccc(O)c4)c4ccc([nH]4)c(-c4cccc(O)c4)c4nc(c(-c5cccc(O)c5)c5ccc2[nH]5)CC4)C=C3)c1	60751.0	R23_gupta_2019:1088			BBB-	C	training
InChI=1S/C44H52N8O10/c1-25-41(58)51-21-10-13-31(51)42(59)50(5)33(23-27-15-17-29(18-16-27)49(3)4)43(60)52-22-19-30(53)24-32(52)38(55)48-36(28-11-7-6-8-12-28)44(61)62-26(2)35(39(56)46-25)47-40(57)37-34(54)14-9-20-45-37/h6-9,11-12,14-18,20,25-26,31-33,35-36,54H,10,13,19,21-24H2,1-5H3,(H,46,56)(H,47,57)(H,48,55)	Pristinamycin-Ic|Pristinamycin Ic	N-[3-[[4-(dimethylamino)phenyl]methyl]-4,12,16-trimethyl-2,5,11,14,18,21,24-heptaoxo-19-phenyl-17-oxa-1,4,10,13,20-pentazatricyclo[20.4.0.06,10]hexacosan-15-yl]-3-hydroxypyridine-2-carboxamide	CC1NC(=O)C(NC(=O)c2ncccc2O)C(C)OC(=O)C(c2ccccc2)NC(=O)C2CC(=O)CCN2C(=O)C(Cc2ccc(N(C)C)cc2)N(C)C(=O)C2CCCN2C1=O	443310.0	R6_adenot_2004:85			BBB-	C	training
InChI=1S/C44H60N4O12/c1-13-48(14-2)27(9)47-45-20-29-34-39(54)32-31(38(29)53)33-41(26(8)37(32)52)60-44(11,42(33)55)58-19-18-30(57-12)23(5)40(59-28(10)49)25(7)36(51)24(6)35(50)21(3)16-15-17-22(4)43(56)46-34/h15-21,23-25,30,35-36,40,50-54H,13-14H2,1-12H3,(H,46,56)/b16-15+,19-18+,22-17-,45-20+,47-27+/t21-,23+,24+,25+,30-,35-,36+,40+,44-/m0/s1	Rifametane|[(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-26-[(Z)-[(Z)-1-(Diethylamino)Ethylidenehydrazinylidene]Methyl]-2,15,17,27,29-Pentahydroxy-11-Methoxy-3,7,12,14,16,18,22-Heptamethyl-6,23-Dioxo-8,30-Dioxa-24-Azatetracyclo[23.3.1.14,7.05,28]Triaconta-1(29),2,4,9,19,21,25,27-Octaen-13-Yl] Acetate	[(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-26-[(Z)-[(Z)-1-(diethylamino)ethylidenehydrazinylidene]methyl]-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate	CCN(CC)/C(C)=N\N=C/c1c2c(O)c3c(O)c(C)c4c(c3c1O)C(=O)[C@@](C)(O/C=C/[C@H](OC)[C@@H](C)[C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)/C=C/C=C(/C)C(=O)N2)O4	139032771.0	R6_adenot_2004:344			BBB-	C	training
InChI=1S/C44H69NO12/c1-10-13-31-19-25(2)18-26(3)20-37(54-8)40-38(55-9)22-28(5)44(52,57-40)41(49)42(50)45-17-12-11-14-32(45)43(51)56-39(29(6)34(47)24-35(31)48)27(4)21-30-15-16-33(46)36(23-30)53-7/h10,19,21,26,28-34,36-40,46-47,52H,1,11-18,20,22-24H2,2-9H3/b25-19+,27-21+/t26-,28+,29+,30-,31+,32-,33+,34-,36+,37-,38-,39+,40+,44+/m0/s1	Tacrolimus|Fujimycin	(1R,9S,12S,13R,14S,17R,18E,21S,23S,24R,25S,27R)-1,14-dihydroxy-12-[(E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-17-prop-2-enyl-11,28-dioxa-4-azatricyclo[22.3.1.04,9]octacos-18-ene-2,3,10,16-tetrone	C=CC[C@@H]1/C=C(\C)C[C@H](C)C[C@H](OC)[C@H]2O[C@@](O)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@H](/C(C)=C/[C@@H]3CC[C@@H](O)[C@H](OC)C3)[C@H](C)[C@@H](O)CC1=O)[C@H](C)C[C@@H]2OC	445643.0	R6_adenot_2004:66|R7_andres_2006:65|R14_ghose_2012:871			BBB-	C	training
InChI=1S/C45H54N4O8/c1-8-27-19-28-22-44(40(51)55-6,36-30(25-48(23-27)24-28)29-13-10-11-14-33(29)46-36)32-20-31-34(21-35(32)54-5)47(4)38-43(31)16-18-49-17-12-15-42(9-2,37(43)49)39(57-26(3)50)45(38,53)41(52)56-7/h10-15,19-21,28,37-39,46,53H,8-9,16-18,22-25H2,1-7H3/t28-,37-,38+,39+,42+,43+,44-,45-/m0/s1	Vinorelbine	methyl (1R,9R,10S,11R,12R,19R)-11-acetyloxy-12-ethyl-4-[(12S,14R)-16-ethyl-12-methoxycarbonyl-1,10-diazatetracyclo[12.3.1.03,11.04,9]octadeca-3(11),4,6,8,15-pentaen-12-yl]-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate	CCC1=C[C@@H]2CN(C1)Cc1c([nH]c3ccccc13)[C@@](C(=O)OC)(c1cc3c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]31[C@@H]54)C2	5311497.0	R23_gupta_2019:1029			BBB-	C	training
InChI=1S/C45H54N8O10/c1-6-31-42(59)52-22-11-14-32(52)43(60)51(5)34(24-27-16-18-29(19-17-27)50(3)4)44(61)53-23-20-30(54)25-33(53)39(56)49-37(28-12-8-7-9-13-28)45(62)63-26(2)36(40(57)47-31)48-41(58)38-35(55)15-10-21-46-38/h7-10,12-13,15-19,21,26,31-34,36-37,55H,6,11,14,20,22-25H2,1-5H3,(H,47,57)(H,48,58)(H,49,56)/t26-,31-,32+,33+,34+,36+,37+/m1/s1	Pristinamycin-Ia|Pristinamycin Ia	N-[(3S,6S,12R,15S,16R,19S,22S)-3-[[4-(dimethylamino)phenyl]methyl]-12-ethyl-4,16-dimethyl-2,5,11,14,18,21,24-heptaoxo-19-phenyl-17-oxa-1,4,10,13,20-pentazatricyclo[20.4.0.06,10]hexacosan-15-yl]-3-hydroxypyridine-2-carboxamide	CC[C@H]1NC(=O)[C@@H](NC(=O)c2ncccc2O)[C@@H](C)OC(=O)[C@H](c2ccccc2)NC(=O)[C@@H]2CC(=O)CCN2C(=O)[C@H](Cc2ccc(N(C)C)cc2)N(C)C(=O)[C@@H]2CCCN2C1=O	11136668.0	R6_adenot_2004:84			BBB-	C	training
InChI=1S/C46H56N4O10/c1-7-42(55)22-28-23-45(40(53)58-5,36-30(14-18-48(24-28)25-42)29-12-9-10-13-33(29)47-36)32-20-31-34(21-35(32)57-4)50(26-51)38-44(31)16-19-49-17-11-15-43(8-2,37(44)49)39(60-27(3)52)46(38,56)41(54)59-6/h9-13,15,20-21,26,28,37-39,47,55-56H,7-8,14,16-19,22-25H2,1-6H3/t28-,37+,38-,39-,42+,43-,44-,45+,46+/m1/s1	Vincristine	methyl (1R,9R,10S,11R,12R,19R)-11-acetyloxy-12-ethyl-4-[(13S,15S,17S)-17-ethyl-17-hydroxy-13-methoxycarbonyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraen-13-yl]-8-formyl-10-hydroxy-5-methoxy-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate	CC[C@]1(O)C[C@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C=O)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1	5978.0	R6_adenot_2004:73|R21_muehlbacher_2011:146|R25_brito_sanchez_2015:395|R40_vilar_2010:298|R47_radchenko_2020:352	-1.03	D	BBB-	A	test
InChI=1S/C46H58ClN5O8/c1-5-21-51(22-6-2)46(57)40(48-44(55)34-11-8-7-9-12-34)18-20-42(53)59-29-10-23-49-24-26-50(27-25-49)28-30-60-43(54)32-38-33(3)52(41-19-17-37(58-4)31-39(38)41)45(56)35-13-15-36(47)16-14-35/h7-9,11-17,19,31,40H,5-6,10,18,20-30,32H2,1-4H3,(H,48,55)	Proglumetacin	3-[4-[2-[2-[1-(4-chlorobenzoyl)-5-methoxy-2-methylindol-3-yl]acetyl]oxyethyl]piperazin-1-yl]propyl 4-benzamido-5-(dipropylamino)-5-oxopentanoate	CCCN(CCC)C(=O)C(CCC(=O)OCCCN1CCN(CCOC(=O)Cc2c(C)n(C(=O)c3ccc(Cl)cc3)c3ccc(OC)cc23)CC1)NC(=O)c1ccccc1	4921.0	R14_ghose_2012:797			BBB-	C	training
InChI=1S/C46H58N4O9/c1-8-42(54)23-28-24-45(40(52)57-6,36-30(15-19-49(25-28)26-42)29-13-10-11-14-33(29)47-36)32-21-31-34(22-35(32)56-5)48(4)38-44(31)17-20-50-18-12-16-43(9-2,37(44)50)39(59-27(3)51)46(38,55)41(53)58-7/h10-14,16,21-22,28,37-39,47,54-55H,8-9,15,17-20,23-26H2,1-7H3/t28-,37-,38+,39+,42-,43+,44+,45-,46-/m0/s1	Vinblastine	methyl (1R,9R,10S,11R,12R,19R)-11-acetyloxy-12-ethyl-4-[(13S,15R,17S)-17-ethyl-17-hydroxy-13-methoxycarbonyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraen-13-yl]-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate	CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1	13342.0	R6_adenot_2004:72|R21_muehlbacher_2011:219|R23_gupta_2019:1027|R25_brito_sanchez_2015:394|R40_vilar_2010:297|R47_radchenko_2020:357			BBB-	C	test
InChI=1S/C46H62N4O11/c1-22(2)21-50-18-16-46(17-19-50)48-34-31-32-39(54)28(8)42-33(31)43(56)45(10,61-42)59-20-15-30(58-11)25(5)41(60-29(9)51)27(7)38(53)26(6)37(52)23(3)13-12-14-24(4)44(57)47-36(40(32)55)35(34)49-46/h12-15,20,22-23,25-27,30,37-38,41,52-55H,16-19,21H2,1-11H3,(H,47,57)/b13-12+,20-15+,24-14-/t23-,25+,26+,27+,30-,37-,38+,41+,45-/m0/s1	Rifabutin	[(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,32-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-1'-(2-methylpropyl)-6,23-dioxospiro[8,33-dioxa-24,27,29-triazapentacyclo[23.6.1.14,7.05,31.026,30]tritriaconta-1(31),2,4,9,19,21,25(32),26,29-nonaene-28,4'-piperidine]-13-yl] acetate	CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c5c(c4c3C2=O)=NC2(CCN(CC(C)C)CC2)N=5)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C	135415564.0	R6_adenot_2004:337|R14_ghose_2012:823			BBB-	C	training
InChI=1S/C47H50FNO14/c1-24-31(61-43(57)36(53)35(27-13-9-7-10-14-27)49-41(55)28-17-19-30(48)20-18-28)22-47(58)40(62-42(56)29-15-11-8-12-16-29)38-45(6,32(52)21-33-46(38,23-59-33)63-26(3)51)39(54)37(60-25(2)50)34(24)44(47,4)5/h7-20,31-33,35-38,40,52-53,58H,21-23H2,1-6H3,(H,49,55)/t31-,32-,33+,35-,36+,37+,38-,40-,45+,46-,47+/m0/s1	4-Fluoropaclitaxel	[(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-diacetyloxy-15-[(2R,3S)-3-[(4-fluorobenzoyl)amino]-2-hydroxy-3-phenylpropanoyl]oxy-1,9-dihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate	CC(=O)O[C@H]1C(=O)[C@@]2(C)[C@H]([C@H](OC(=O)c3ccccc3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c4ccc(F)cc4)c4ccccc4)C(C)=C1C3(C)C)[C@]1(OC(C)=O)CO[C@@H]1C[C@@H]2O	44297352.0	R25_brito_sanchez_2015:580	0.19	A	BBB+	A	training
InChI=1S/C47H51NO14/c1-25-31(60-43(56)36(52)35(28-16-10-7-11-17-28)48-41(54)29-18-12-8-13-19-29)23-47(57)40(61-42(55)30-20-14-9-15-21-30)38-45(6,32(51)22-33-46(38,24-58-33)62-27(3)50)39(53)37(59-26(2)49)34(25)44(47,4)5/h7-21,31-33,35-38,40,51-52,57H,22-24H2,1-6H3,(H,48,54)/t31-,32-,33+,35-,36+,37+,38-,40-,45+,46-,47+/m0/s1	Paclitaxel	[(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-diacetyloxy-15-[(2R,3S)-3-benzamido-2-hydroxy-3-phenylpropanoyl]oxy-1,9-dihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate	CC(=O)O[C@H]1C(=O)[C@@]2(C)[C@H]([C@H](OC(=O)c3ccccc3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C(C)=C1C3(C)C)[C@]1(OC(C)=O)CO[C@@H]1C[C@@H]2O	36314.0	R6_adenot_2004:57|R6_adenot_2004:83|R25_brito_sanchez_2015:385|R47_radchenko_2020:504|R53_friden_2009:29	-0.55	D	BBB+	A	training
InChI=1S/C47H64N4O12/c1-24-13-12-14-25(2)46(59)49-37-32(23-48-51-20-18-50(19-21-51)31-15-10-11-16-31)41(56)34-35(42(37)57)40(55)29(6)44-36(34)45(58)47(8,63-44)61-22-17-33(60-9)26(3)43(62-30(7)52)28(5)39(54)27(4)38(24)53/h12-14,17,22-24,26-28,31,33,38-39,43,53-57H,10-11,15-16,18-21H2,1-9H3,(H,49,59)/b13-12+,22-17+,25-14-,48-23+/t24-,26+,27+,28+,33-,38-,39+,43+,47-/m0/s1	Rifapentine|[(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-26-[(Z)-(4-Cyclopentylpiperazin-1-Yl)Iminomethyl]-2,15,17,27,29-Pentahydroxy-11-Methoxy-3,7,12,14,16,18,22-Heptamethyl-6,23-Dioxo-8,30-Dioxa-24-Azatetracyclo[23.3.1.14,7.05,28]Triaconta-1(29),2,4,9,19,21,25,27-Octaen-13-Yl] Acetate	[(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-26-[(Z)-(4-cyclopentylpiperazin-1-yl)iminomethyl]-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate	CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N\N5CCN(C6CCCC6)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C	135659016.0	R6_adenot_2004:342|R14_ghose_2012:825			BBB-	C	training
InChI=1S/C47H72O14/c1-24(2)41-27(5)16-17-46(61-41)22-33-19-32(60-46)15-14-26(4)42(25(3)12-11-13-31-23-54-44-39(48)28(6)18-34(45(50)57-33)47(31,44)51)58-38-21-36(53-10)43(30(8)56-38)59-37-20-35(52-9)40(49)29(7)55-37/h11-14,18,24-25,27,29-30,32-44,48-49,51H,15-17,19-23H2,1-10H3/t25-,27-,29-,30-,32+,33-,34-,35-,36-,37-,38-,39+,40-,41+,42-,43-,44+,46+,47+/m0/s1	Ivermectin-Ii|(1R,4S,5'S,6R,6'R,8R,12S,13S,20R,21R,24S)-21,24-Dihydroxy-12-[(2R,4S,5S,6S)-5-[(2S,4S,5S,6S)-5-Hydroxy-4-Methoxy-6-Methyloxan-2-Yl]Oxy-4-Methoxy-6-Methyloxan-2-Yl]Oxy-5',11,13,22-Tetramethyl-6'-Propan-2-Ylspiro[3,7,19-Trioxatetracyclo[15.6.1.14,8.020,24]Pentacosa-10,14,16,22-Tetraene-6,2'-Oxane]-2-One	(1R,4S,5'S,6R,6'R,8R,12S,13S,20R,21R,24S)-21,24-dihydroxy-12-[(2R,4S,5S,6S)-5-[(2S,4S,5S,6S)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-5',11,13,22-tetramethyl-6'-propan-2-ylspiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2-one	CO[C@H]1C[C@H](O[C@H]2[C@H](C)O[C@@H](O[C@@H]3C(C)=CC[C@@H]4C[C@@H](C[C@]5(CC[C@H](C)[C@@H](C(C)C)O5)O4)OC(=O)[C@@H]4C=C(C)[C@@H](O)[C@H]5OCC(=CC=C[C@@H]3C)[C@]54O)C[C@@H]2OC)O[C@@H](C)[C@@H]1O	3001671.0	R6_adenot_2004:39			BBB-	C	training
InChI=1S/C47H73NO17/c1-27-17-15-13-11-9-7-5-6-8-10-12-14-16-18-34(64-46-44(58)41(48)43(57)30(4)63-46)24-38-40(45(59)60)37(54)26-47(61,65-38)25-33(51)22-36(53)35(52)20-19-31(49)21-32(50)23-39(55)62-29(3)28(2)42(27)56/h5-18,27-38,40-44,46,49-54,56-58,61H,19-26,48H2,1-4H3,(H,59,60)/b6-5+,9-7+,10-8+,13-11+,14-12+,17-15+,18-16+/t27-,28-,29-,30+,31+,32+,33-,34-,35+,36+,37-,38-,40+,41-,42+,43+,44-,46-,47+/m0/s1	Amphotericin-B|Amphotericin B	(1R,3S,5R,6R,9R,11R,15S,16R,17R,18S,19E,21E,23E,25E,27E,29E,31E,33R,35S,36R,37S)-33-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-1,3,5,6,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaene-36-carboxylic acid	C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O	5280965.0	R6_adenot_2004:348|R14_ghose_2012:350|R28_li_2005:299			BBB-	C	training
InChI=1S/C47H75NO17/c1-27-17-15-13-11-9-7-5-6-8-10-12-14-16-18-34(64-46-44(58)41(48)43(57)30(4)63-46)24-38-40(45(59)60)37(54)26-47(61,65-38)25-36(53)35(52)20-19-31(49)21-32(50)22-33(51)23-39(55)62-29(3)28(2)42(27)56/h5-6,8,10-18,27-38,40-44,46,49-54,56-58,61H,7,9,19-26,48H2,1-4H3,(H,59,60)/b6-5+,10-8+,13-11+,14-12+,17-15+,18-16+/t27-,28-,29-,30+,31?,32?,33?,34?,35?,36?,37?,38?,40?,41-,42+,43+,44-,46+,47+/m0/s1	Nystatin|Mycostatin	(1S,15S,16R,17R,18S,19E,21E,25E,27E,29E,31E)-33-[(2S,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-1,3,4,7,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,25,27,29,31-hexaene-36-carboxylic acid	C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/CC/C=C/C=C/C=C/C=C/C(O[C@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)CC2O[C@](O)(CC(O)C(O)CCC(O)CC(O)CC(O)CC(=O)O[C@H]1C)CC(O)C2C(=O)O	6433272.0	R14_ghose_2012:733			BBB-	C	training
InChI=1S/C48H64N2O17/c1-10-48(58)18-30(64-31-15-25(50(8)9)44(21(4)60-31)65-33-17-28-45(22(5)61-33)67-47-29(63-28)16-27(52)19(2)62-47)35-38(46(48)66-32-14-24(49(6)7)39(53)20(3)59-32)43(57)36-37(42(35)56)41(55)34-23(40(36)54)12-11-13-26(34)51/h11-13,19-22,24-25,28-33,39,44-47,51,53,56-58H,10,14-18H2,1-9H3/t19-,20-,21-,22-,24-,25-,28-,29-,30-,31-,32-,33-,39+,44+,45+,46+,47-,48+/m0/s1	Rodorubicin	(7S,9R,10R)-7-[(2R,4S,5S,6S)-4-(dimethylamino)-5-[[(1R,3R,5S,8S,10S,12S,14S)-5,14-dimethyl-6-oxo-2,4,9,13-tetraoxatricyclo[8.4.0.03,8]tetradecan-12-yl]oxy]-6-methyloxan-2-yl]oxy-10-[(2S,4S,5S,6S)-4-(dimethylamino)-5-hydroxy-6-methyloxan-2-yl]oxy-9-ethyl-4,6,9,11-tetrahydroxy-8,10-dihydro-7H-tetracene-5,12-dione	CC[C@@]1(O)C[C@H](O[C@H]2C[C@H](N(C)C)[C@H](O[C@H]3C[C@@H]4O[C@H]5CC(=O)[C@H](C)O[C@H]5O[C@@H]4[C@H](C)O3)[C@H](C)O2)c2c(O)c3c(c(O)c2[C@H]1O[C@H]1C[C@H](N(C)C)[C@H](O)[C@H](C)O1)C(=O)c1cccc(O)c1C3=O	57097.0	R6_adenot_2004:332			BBB-	C	training
InChI=1S/C48H74O14/c1-11-25(2)43-28(5)17-18-47(62-43)23-34-20-33(61-47)16-15-27(4)42(26(3)13-12-14-32-24-55-45-40(49)29(6)19-35(46(51)58-34)48(32,45)52)59-39-22-37(54-10)44(31(8)57-39)60-38-21-36(53-9)41(50)30(7)56-38/h12-15,19,25-26,28,30-31,33-45,49-50,52H,11,16-18,20-24H2,1-10H3	Ivermectin|6'-Butan-2-Yl-21,24-Dihydroxy-12-[5-(5-Hydroxy-4-Methoxy-6-Methyloxan-2-Yl)Oxy-4-Methoxy-6-Methyloxan-2-Yl]Oxy-5',11,13,22-Tetramethylspiro[3,7,19-Trioxatetracyclo[15.6.1.14,8.020,24]Pentacosa-10,14,16,22-Tetraene-6,2'-Oxane]-2-One	6'-butan-2-yl-21,24-dihydroxy-12-[5-(5-hydroxy-4-methoxy-6-methyloxan-2-yl)oxy-4-methoxy-6-methyloxan-2-yl]oxy-5',11,13,22-tetramethylspiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2-one	CCC(C)C1OC2(CCC1C)CC1CC(CC=C(C)C(OC3CC(OC)C(OC4CC(OC)C(O)C(C)O4)C(C)O3)C(C)C=CC=C3COC4C(O)C(C)=CC(C(=O)O1)C34O)O2	4330618.0	R14_ghose_2012:638|R47_radchenko_2020:499	-1.0	A	BBB+	A	training
InChI=1S/C48H74O14/c1-11-25(2)43-28(5)17-18-47(62-43)23-34-20-33(61-47)16-15-27(4)42(26(3)13-12-14-32-24-55-45-40(49)29(6)19-35(46(51)58-34)48(32,45)52)59-39-22-37(54-10)44(31(8)57-39)60-38-21-36(53-9)41(50)30(7)56-38/h12-15,19,25-26,28,30-31,33-45,49-50,52H,11,16-18,20-24H2,1-10H3/b13-12+,27-15+,32-14+/t25-,26-,28-,30-,31-,33+,34-,35-,36-,37-,38-,39-,40+,41-,42-,43+,44-,45+,47+,48+/m0/s1	Ivermectin B1A	(1R,4S,5'S,6R,6'R,8R,10E,12S,13S,14E,16E,20R,21R,24S)-6'-[(2S)-butan-2-yl]-21,24-dihydroxy-12-[(2R,4S,5S,6S)-5-[(2S,4S,5S,6S)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-5',11,13,22-tetramethylspiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2-one	CC[C@H](C)[C@H]1O[C@]2(CC[C@@H]1C)C[C@@H]1C[C@@H](C/C=C(\C)[C@@H](O[C@H]3C[C@H](OC)[C@@H](O[C@H]4C[C@H](OC)[C@@H](O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)/C=C/C=C3\CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2	6321424.0	R25_brito_sanchez_2015:420	0.4	A	BBB+	A	training
InChI=1S/C4H10N2/c1-2-6-4-3-5-1/h5-6H,1-4H2	Piperazine	piperazine	C1CNCCN1	4837.0	R23_gupta_2019:840			BBB-	C	training
InChI=1S/C4H10O/c1-2-3-4-5/h5H,2-4H2,1H3	1-Butanol	butan-1-ol	CCCCO	263.0	R3_abraham_2006:57|R21_muehlbacher_2011:4|R25_brito_sanchez_2015:51|R40_vilar_2010:318|R41_toropov_2017:52|R46_mendoza_valencia_2017:50|R47_radchenko_2020:39	-0.02	B	BBB+	A	training
InChI=1S/C4H10O/c1-3-5-4-2/h3-4H2,1-2H3	Diethyl Ether|Ether|Ethyl Ether|Diethylether|Diethyl-Ether	ethoxyethane	CCOCC	3283.0	R3_abraham_2006:64|R5_guerra_2008:42|R6_adenot_2004:928|R7_andres_2006:60|R12_garg_2006:74|R17_fu_2008:11|R21_muehlbacher_2011:71|R22_clark_1999:11|R25_brito_sanchez_2015:211|R28_li_2005:78|R39_shayanfar_2011:106|R40_vilar_2010:353|R41_toropov_2017:59|R44_bujak_2015:26|R44_bujak_2015:75|R46_mendoza_valencia_2017:195|R47_radchenko_2020:46|R48_hou_2003:75|R49_norinder_2002:41|R52_liu_2001:41	0.05	B1	BBB+	A	test
InChI=1S/C4H10O/c1-4(2)3-5/h4-5H,3H2,1-2H3	2-Methyl-1-Propanol|2-Methylpropanol|Isobutanol|2-Methylpropan-1-Ol	2-methylpropan-1-ol	CC(C)CO	6560.0	R3_abraham_2006:60|R12_garg_2006:8|R17_fu_2008:6|R21_muehlbacher_2011:167|R22_clark_1999:6|R25_brito_sanchez_2015:74|R26_chico_2009:8|R28_li_2005:59|R39_shayanfar_2011:6|R40_vilar_2010:332|R41_toropov_2017:55|R44_bujak_2015:4|R46_mendoza_valencia_2017:72|R47_radchenko_2020:42|R48_hou_2003:64|R49_norinder_2002:54|R52_liu_2001:36	-0.16	B1	BBB+	A	training
InChI=1S/C4H10O/c1-4(2,3)5/h5H,1-3H3	T-Butanol|Tert-Butylalcohol|Tert-Butanol	2-methylpropan-2-ol	CC(C)(C)O	6386.0	R3_abraham_2006:62|R21_muehlbacher_2011:161|R25_brito_sanchez_2015:148|R40_vilar_2010:396|R41_toropov_2017:57|R46_mendoza_valencia_2017:145|R47_radchenko_2020:44	0.11	B	BBB+	A	training
InChI=1S/C4H11NO/c1-5(2)3-4-6/h6H,3-4H2,1-2H3	Deanol	2-(dimethylamino)ethanol	CN(C)CCO	7902.0	R6_adenot_2004:1284|R51_doninger_2002:193			BBB+	C	test
InChI=1S/C4H11NO3/c5-4(1-6,2-7)3-8/h6-8H,1-3,5H2	Trometamol|Tromethamine	2-amino-2-(hydroxymethyl)propane-1,3-diol	NC(CO)(CO)CO	6503.0	R28_li_2005:228			BBB-	C	training
InChI=1S/C4H3ClF4O/c1-10-4(9)2(5,6)3(4,7)8/h1H3	Aliflurane	1-chloro-1,2,2,3-tetrafluoro-3-methoxycyclopropane	COC1(F)C(F)(F)C1(F)Cl	41967.0	R6_adenot_2004:924			BBB+	C	training
InChI=1S/C4H3F7O/c5-1-12-2(3(6,7)8)4(9,10)11/h2H,1H2	Sevoflurane	1,1,1,3,3,3-hexafluoro-2-(fluoromethoxy)propane	FCOC(C(F)(F)F)C(F)(F)F	5206.0	R3_abraham_2006:71|R6_adenot_2004:951|R21_muehlbacher_2011:128|R23_gupta_2019:908|R25_brito_sanchez_2015:180|R26_chico_2009:377|R28_li_2005:284|R40_vilar_2010:393|R41_toropov_2017:66|R47_radchenko_2020:53	0.3	B	BBB+	A	training
InChI=1S/C4H4F2O/c5-1-3-7-4-2-6/h1-4H/b3-1+,4-2+	Di-(2-Fluroethene) Ether|S111|(E)-1-Fluoro-2-[(E)-2-Fluoroethenoxy]Ethene	(E)-1-fluoro-2-[(E)-2-fluoroethenoxy]ethene	F/C=C/O/C=C/F	87737353.0	R25_brito_sanchez_2015:417|R46_mendoza_valencia_2017:354|R47_radchenko_2020:322	0.13	B	BBB+	A	test
InChI=1S/C4H4F2O/c5-1-3-7-4-2-6/h1-4H/b3-1-,4-2+			F/C=C\O/C=C/F		R48_hou_2003:83	0.13	A	BBB+	A	test
InChI=1S/C4H4N2O/c7-4-2-1-3-5-6-4/h1-3H,(H,6,7)	Pyridazinone|3(2H)-Pyridazinone	1H-pyridazin-6-one	O=c1cccn[nH]1	68153.0	R51_doninger_2002:300			BBB+	C	training
InChI=1S/C4H5BrClF3/c5-3(6)1-2-4(7,8)9/h3H,1-2H2	4-Bromo-4-Chloro-1,1,1-Trifluoro-Butane		FC(F)(F)CCC(Cl)Br		R25_brito_sanchez_2015:87|R46_mendoza_valencia_2017:85	0.35	B	BBB+	A	training
InChI=1S/C4H5F3O/c1-2-8-3-4(5,6)7/h2H,1,3H2	Fluroxene|Cf3Ch2Och=Ch2|Fluoromar|Fluoroxene	2-ethenoxy-1,1,1-trifluoroethane	C=COCC(F)(F)F	9844.0	R3_abraham_2006:73|R5_guerra_2008:47|R6_adenot_2004:935|R7_andres_2006:72|R12_garg_2006:57|R17_fu_2008:14|R21_muehlbacher_2011:209|R22_clark_1999:14|R25_brito_sanchez_2015:63|R26_chico_2009:191|R28_li_2005:86|R39_shayanfar_2011:47|R40_vilar_2010:362|R41_toropov_2017:68|R44_bujak_2015:31|R46_mendoza_valencia_2017:61|R47_radchenko_2020:55|R48_hou_2003:84|R49_norinder_2002:45|R52_liu_2001:44	0.13	B1	BBB+	A	test
InChI=1S/C4H6/c1-3-4-2/h3-4H,1-2H2	1,3-Butadiene|Divinyl	buta-1,3-diene	C=CC=C	7845.0	R3_abraham_2006:50|R21_muehlbacher_2011:185|R25_brito_sanchez_2015:48|R40_vilar_2010:316|R41_toropov_2017:45|R46_mendoza_valencia_2017:47|R47_radchenko_2020:33	-0.17	B	BBB+	A	training
InChI=1S/C4H6N2/c1-4-2-5-6-3-4/h2-3H,1H3,(H,5,6)	Fomepizole	4-methyl-1H-pyrazole	Cc1cn[nH]c1	3406.0	R23_gupta_2019:607			BBB-	C	test
InChI=1S/C4H6N2S/c1-6-3-2-5-4(6)7/h2-3H,1H3,(H,5,7)	Methimazole	3-methyl-1H-imidazole-2-thione	Cn1cc[nH]c1=S	1349907.0	R14_ghose_2012:685|R23_gupta_2019:736			BBB-	C	test
InChI=1S/C4H6N4O12/c9-5(10)17-1-3(19-7(13)14)4(20-8(15)16)2-18-6(11)12/h3-4H,1-2H2	Erythrityl|Cardilate	1,3,4-trinitrooxybutan-2-yl nitrate	O=[N+]([O-])OCC(O[N+](=O)[O-])C(CO[N+](=O)[O-])O[N+](=O)[O-]	23723.0	R14_ghose_2012:533			BBB-	C	training
InChI=1S/C4H6N4O12/c9-5(10)17-1-3(19-7(13)14)4(20-8(15)16)2-18-6(11)12/h3-4H,1-2H2/t3-,4+	Erythrityl Tetranitrate	[(2R,3S)-1,3,4-trinitrooxybutan-2-yl] nitrate	O=[N+]([O-])OC[C@H](O[N+](=O)[O-])[C@@H](CO[N+](=O)[O-])O[N+](=O)[O-]	5284553.0	R23_gupta_2019:570			BBB-	C	training
InChI=1S/C4H6N4O3S2/c1-2(9)6-3-7-8-4(12-3)13(5,10)11/h1H3,(H2,5,10,11)(H,6,7,9)	Acetazolamide	N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)acetamide	CC(=O)Nc1nnc(S(N)(=O)=O)s1	1986.0	R6_adenot_2004:1408|R14_ghose_2012:1|R26_chico_2009:16	-0.52	A	BBB+	A	test
InChI=1S/C4H6O/c1-3-5-4-2/h3-4H,1-2H2	Divinyl Ether|Vinyl-Ether|Divinylether|Vinyl Ether	ethenoxyethene	C=COC=C	8024.0	R3_abraham_2006:74|R5_guerra_2008:39|R6_adenot_2004:961|R12_garg_2006:75|R25_brito_sanchez_2015:214|R28_li_2005:79|R39_shayanfar_2011:41|R40_vilar_2010:354|R41_toropov_2017:69|R44_bujak_2015:69|R46_mendoza_valencia_2017:198|R47_radchenko_2020:56	0.1	B1	BBB+	A	training
InChI=1S/C4H6O4S2/c5-3(6)1(9)2(10)4(7)8/h1-2,9-10H,(H,5,6)(H,7,8)/t1-,2+	Succimer	(2S,3R)-2,3-bis(sulfanyl)butanedioic acid	O=C(O)[C@@H](S)[C@@H](S)C(=O)O	2724354.0	R14_ghose_2012:855			BBB-	C	training
InChI=1S/C4H7Cl3N2O2/c1-8-3(11)9-2(10)4(5,6)7/h2,10H,1H3,(H2,8,9,11)	Mecloralurea	1-methyl-3-(2,2,2-trichloro-1-hydroxyethyl)urea	CNC(=O)NC(O)C(Cl)(Cl)Cl	71808.0	R6_adenot_2004:1333			BBB+	C	test
InChI=1S/C4H7Cl3O/c1-3(2,8)4(5,6)7/h8H,1-2H3	Chlorobutanol	1,1,1-trichloro-2-methylpropan-2-ol	CC(C)(O)C(Cl)(Cl)Cl	5977.0	R6_adenot_2004:1328			BBB+	C	test
InChI=1S/C4H8O/c1-3-4(2)5/h3H2,1-2H3	2-Butanone|Butanone|Methyl Ethyl Ketone	butan-2-one	CCC(C)=O	6569.0	R3_abraham_2006:76|R5_guerra_2008:20|R7_andres_2006:21|R12_garg_2006:50|R17_fu_2008:1|R21_muehlbacher_2011:168|R22_clark_1999:1|R25_brito_sanchez_2015:173|R28_li_2005:71|R39_shayanfar_2011:23|R40_vilar_2010:328|R41_toropov_2017:71|R44_bujak_2015:17|R44_bujak_2015:84|R46_mendoza_valencia_2017:163|R47_radchenko_2020:58|R48_hou_2003:71|R49_norinder_2002:40|R52_liu_2001:31	-0.1	B1	BBB+	A	test
InChI=1S/C4H8O2/c1-3-6-4(2)5/h3H2,1-2H3	Ethyl Acetate	ethyl acetate	CCOC(C)=O	8857.0	R3_abraham_2006:79|R21_muehlbacher_2011:203|R25_brito_sanchez_2015:224|R40_vilar_2010:357|R41_toropov_2017:74|R46_mendoza_valencia_2017:206|R47_radchenko_2020:61	0.0	B	BBB+	A	training
InChI=1S/C4H8O3/c5-3-1-2-4(6)7/h5H,1-3H2,(H,6,7)	Gamma Hydroxybutyric Acid|4-Hydroxybutanoic Acid	4-hydroxybutanoic acid	O=C(O)CCCO	10413.0	R23_gupta_2019:105			BBB+	C	training
InChI=1S/C51H79NO13/c1-30-16-12-11-13-17-31(2)42(61-8)28-38-21-19-36(7)51(60,65-38)48(57)49(58)52-23-15-14-18-39(52)50(59)64-43(33(4)26-37-20-22-40(53)44(27-37)62-9)29-41(54)32(3)25-35(6)46(56)47(63-10)45(55)34(5)24-30/h11-13,16-17,25,30,32-34,36-40,42-44,46-47,53,56,60H,14-15,18-24,26-29H2,1-10H3/b13-11+,16-12-,31-17+,35-25+/t30-,32-,33-,34-,36-,37+,38+,39+,40-,42+,43+,44-,46-,47+,51-/m1/s1	Sirolimus|Rapamycin (Sirolimus)	(1R,9S,12S,15R,16E,18R,19R,21R,23S,24Z,26E,28E,30S,32S,35R)-1,18-dihydroxy-12-[(2R)-1-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]propan-2-yl]-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(/C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C\C=C\1C	21944094.0	R14_ghose_2012:844|R26_chico_2009:380			BBB-	C	training
InChI=1S/C5H10N2O7P2/c8-5(15(9,10)11,16(12,13)14)3-7-2-1-6-4-7/h1-2,4,8H,3H2,(H2,9,10,11)(H2,12,13,14)	Zoledronate|Zoledronic Acid	(1-hydroxy-2-imidazol-1-yl-1-phosphonoethyl)phosphonic acid	O=P(O)(O)C(O)(Cn1ccnc1)P(=O)(O)O	68740.0	R23_gupta_2019:1040			BBB-	C	training
InChI=1S/C5H10O/c1-3-4-5(2)6/h3-4H2,1-2H3	2-Pentanone	pentan-2-one	CCCC(C)=O	7895.0	R3_abraham_2006:77|R21_muehlbacher_2011:189|R25_brito_sanchez_2015:76|R40_vilar_2010:334|R41_toropov_2017:72|R46_mendoza_valencia_2017:74|R47_radchenko_2020:59	-0.01	B	BBB+	A	test
InChI=1S/C5H10O2/c1-3-4-7-5(2)6/h3-4H2,1-2H3	Propyl Acetate	propyl acetate	CCCOC(C)=O	7997.0	R3_abraham_2006:80|R21_muehlbacher_2011:193|R25_brito_sanchez_2015:371|R40_vilar_2010:390|R41_toropov_2017:75|R47_radchenko_2020:62	0.12	B	BBB+	A	training
InChI=1S/C5H10O2/c1-4(2)7-5(3)6/h4H,1-3H3	Isopropyl Acetate	propan-2-yl acetate	CC(=O)OC(C)C	7915.0	R3_abraham_2006:83|R21_muehlbacher_2011:190|R25_brito_sanchez_2015:263|R40_vilar_2010:369|R41_toropov_2017:78|R46_mendoza_valencia_2017:236|R47_radchenko_2020:65	0.4	B	BBB+	A	training
InChI=1S/C5H10O5/c6-2-1-10-5(9)4(8)3(2)7/h2-9H,1H2/t2-,3+,4-,5?/m1/s1	Xylose|D-Xylose	(3R,4S,5R)-oxane-2,3,4,5-tetrol	OC1OC[C@@H](O)[C@H](O)[C@H]1O	135191.0	R23_gupta_2019:1090			BBB-	C	training
InChI=1S/C5H11Cl2N/c1-8(4-2-6)5-3-7/h2-5H2,1H3	Mechlorethamine	2-chloro-N-(2-chloroethyl)-N-methylethanamine	CN(CCCl)CCCl	4033.0	R23_gupta_2019:725			BBB-	C	test
InChI=1S/C5H11NO2/c1-2-3-4-5-8-6-7/h2-5H2,1H3	Amyl Nitrite|Pentyl Nitrite	pentyl nitrite	CCCCCON=O	10026.0	R23_gupta_2019:353			BBB-	C	test
InChI=1S/C5H11NO2S/c1-5(2,9)3(6)4(7)8/h3,9H,6H2,1-2H3,(H,7,8)/t3-/m0/s1	Penicillamine	(2S)-2-amino-3-methyl-3-sulfanylbutanoic acid	CC(C)(S)[C@@H](N)C(=O)O	5852.0	R14_ghose_2012:757|R23_gupta_2019:819			BBB-	C	training
InChI=1S/C5H11NO4S/c1-5(7)6-3-2-4-11(8,9)10/h2-4H2,1H3,(H,6,7)(H,8,9,10)	Acamprosate	3-acetamidopropane-1-sulfonic acid	CC(=O)NCCCS(=O)(=O)O	71158.0	R37_chen_2011:1			BBB+	C	training
InChI=1S/C5H12/c1-3-5-4-2/h3-5H2,1-2H3	Pentane|N-Pentane	pentane	CCCCC	8003.0	R3_abraham_2006:9|R5_guerra_2008:79|R7_andres_2006:209|R12_garg_2006:130|R17_fu_2008:20|R21_muehlbacher_2011:194|R22_clark_1999:22|R25_brito_sanchez_2015:346|R26_chico_2009:302|R28_li_2005:104|R39_shayanfar_2011:70|R40_vilar_2010:387|R41_toropov_2017:4|R44_bujak_2015:47|R46_mendoza_valencia_2017:302|R47_radchenko_2020:377|R48_hou_2003:102|R49_norinder_2002:55|R52_liu_2001:52	0.74	B1	BBB+	A	training
InChI=1S/C5H12O/c1-2-3-4-5-6/h6H,2-5H2,1H3	1-Pentanol	pentan-1-ol	CCCCCO	6276.0	R3_abraham_2006:58|R21_muehlbacher_2011:153|R25_brito_sanchez_2015:60|R40_vilar_2010:324|R41_toropov_2017:53|R46_mendoza_valencia_2017:59|R47_radchenko_2020:40	0.2	B	BBB+	A	training
InChI=1S/C5H12O/c1-3-5(2)4-6/h5-6H,3-4H2,1-2H3	Sec-Butylcarbinol|2-Methyl-1-Butanol	2-methylbutan-1-ol	CCC(C)CO	8723.0	R21_muehlbacher_2011:202|R25_brito_sanchez_2015:402|R41_toropov_2017:56|R46_mendoza_valencia_2017:342	0.04	B	BBB+	A	training
InChI=1S/C5H12O/c1-4-5(2,3)6/h6H,4H2,1-3H3	Amylene-Hydrate|Amylene Hydrate|2-Methyl-2-Butanol	2-methylbutan-2-ol	CCC(C)(C)O	6405.0	R3_abraham_2006:63|R6_adenot_2004:420|R21_muehlbacher_2011:163|R25_brito_sanchez_2015:126|R40_vilar_2010:341|R41_toropov_2017:58|R46_mendoza_valencia_2017:124|R47_radchenko_2020:45	0.07	B	BBB+	A	training
InChI=1S/C5H12O/c1-5(2)3-4-6/h5-6H,3-4H2,1-2H3	3-Methyl-1-Butanol|Isoamyl Alcohol	3-methylbutan-1-ol	CC(C)CCO	31260.0	R25_brito_sanchez_2015:80|R40_vilar_2010:336|R46_mendoza_valencia_2017:78|R47_radchenko_2020:43	0.04	B	BBB+	A	training
InChI=1S/C5H12O/c1-5(2,3)6-4/h1-4H3	Methyl T-Butyl Ether|Tert-Butylmethylether|Methyl Tert-Butyl Ether	2-methoxy-2-methylpropane	COC(C)(C)C	15413.0	R3_abraham_2006:66|R21_muehlbacher_2011:222|R25_brito_sanchez_2015:294|R40_vilar_2010:377|R41_toropov_2017:61|R46_mendoza_valencia_2017:262|R47_radchenko_2020:48	0.36	B	BBB+	A	training
InChI=1S/C5H14NO/c1-6(2,3)4-5-7/h7H,4-5H2,1-3H3/q+1	Choline	2-hydroxyethyl(trimethyl)azanium	C[N+](C)(C)CCO	305.0	R51_doninger_2002:182			BBB+	C	training
InChI=1S/C5H15N2O3PS/c6-2-1-3-7-4-5-12-11(8,9)10/h7H,1-6H2,(H2,8,9,10)	Amifostine	2-(3-aminopropylamino)ethylsulfanylphosphonic acid	NCCCNCCSP(=O)(O)O	2141.0	R23_gupta_2019:341|R28_li_2005:180			BBB-	C	test
InChI=1S/C5H4Cl6O3/c6-4(7,8)1-13-3(12)14-2-5(9,10)11/h1-2H2	Cloretate|Clorethate	bis(2,2,2-trichloroethyl) carbonate	O=C(OCC(Cl)(Cl)Cl)OCC(Cl)(Cl)Cl	21851.0	R6_adenot_2004:1355			BBB+	C	training
InChI=1S/C5H4N4S/c10-5-3-4(7-1-6-3)8-2-9-5/h1-2H,(H2,6,7,8,9,10)	Mercaptopurine|6-Mercaptopurine	3,7-dihydropurine-6-thione	S=c1nc[nH]c2nc[nH]c12	667490.0	R14_ghose_2012:678|R23_gupta_2019:730|R26_chico_2009:13	-0.71	A	BBB+	A	test
InChI=1S/C5H5N3O/c6-5(9)4-3-7-1-2-8-4/h1-3H,(H2,6,9)	Pyrazinamide	pyrazine-2-carboxamide	NC(=O)c1cnccn1	1046.0	R28_li_2005:277			BBB+	C	training
InChI=1S/C5H5N5/c6-4-3-5(9-1-7-3)10-2-8-4/h1-2H,(H3,6,7,8,9,10)	Adenine	7H-purin-6-amine	Nc1ncnc2nc[nH]c12	190.0	R23_gupta_2019:326			BBB-	C	test
InChI=1S/C5H5N5S/c6-5-9-3-2(4(11)10-5)7-1-8-3/h1H,(H4,6,7,8,9,10,11)	Thioguanine	2-amino-3,7-dihydropurine-6-thione	Nc1nc(=S)c2[nH]cnc2[nH]1	2723601.0	R14_ghose_2012:890|R23_gupta_2019:974|R51_doninger_2002:135			BBB-	C	test
InChI=1S/C5H5NOS/c7-6-4-2-1-3-5(6)8/h1-4,7H	Pyrithione	1-hydroxypyridine-2-thione	On1ccccc1=S	1570.0	R23_gupta_2019:1082			BBB-	C	training
InChI=1S/C5H6N2/c6-5-1-3-7-4-2-5/h1-4H,(H2,6,7)	Dalfampridine	pyridin-4-amine	Nc1ccncc1	1727.0	R23_gupta_2019:57			BBB+	C	training
InChI=1S/C5H7NO3/c1-5(2)3(7)6-4(8)9-5/h1-2H3,(H,6,7,8)	Dimethadione	5,5-dimethyl-1,3-oxazolidine-2,4-dione	CC1(C)OC(=O)NC1=O	3081.0	R6_adenot_2004:438			BBB+	C	test
InChI=1S/C5H8Cl3NO3/c1-2-12-4(11)9-3(10)5(6,7)8/h3,10H,2H2,1H3,(H,9,11)	Carbocloral	ethyl N-(2,2,2-trichloro-1-hydroxyethyl)carbamate	CCOC(=O)NC(O)C(Cl)(Cl)Cl	10944.0	R6_adenot_2004:427			BBB+	C	test
InChI=1S/C5H8N2S/c6-2-1-5-7-3-4-8-5/h3-4H,1-2,6H2	Y-G 16|18453-07-1|Y-G16|Thiazole-22-Aminoethyl|Zinc 11886332|Yg16|5-68|2-(2-Aminoethyl)Thiazole	2-(1,3-thiazol-2-yl)ethanamine	NCCc1nccs1	87653.0	R3_abraham_2006:301|R4_mente_2005:110|R12_garg_2006:177|R21_muehlbacher_2011:275|R21_muehlbacher_2011:361|R25_brito_sanchez_2015:78|R28_li_2005:126|R28_li_2005:146|R40_vilar_2010:303|R41_toropov_2017:268|R46_mendoza_valencia_2017:76|R47_radchenko_2020:249|R48_hou_2003:30|R49_norinder_2002:80|R52_liu_2001:60	-0.42	D	BBB+	A	training
InChI=1S/C5H8N4O3S2/c1-3(10)7-4-9(2)8-5(13-4)14(6,11)12/h1-2H3,(H2,6,11,12)/b7-4-	Methazolamide	N-(3-methyl-5-sulfamoyl-1,3,4-thiadiazol-2-ylidene)acetamide	CC(=O)/N=c1\sc(S(N)(=O)=O)nn1C	4100.0	R14_ghose_2012:684|R23_gupta_2019:735			BBB-	C	training
InChI=1S/C5H8N4S/c1-3-2-10-5(8-3)9-4(6)7/h2H,1H3,(H4,6,7,8,9)	Skb2|Ici17148|7120-01-6|Cds1 000170|B-038, Ici17148|2|N-(4-Methyl-1,3-Thiazol-2-Yl)Guanidine	2-(4-methyl-1,3-thiazol-2-yl)guanidine	Cc1csc(N=C(N)N)n1	2776666.0	R3_abraham_2006:260|R3_abraham_2006:323|R4_mente_2005:125|R21_muehlbacher_2011:314|R26_chico_2009:42|R28_li_2005:158|R28_li_2005:315|R40_vilar_2010:246|R41_toropov_2017:232|R47_radchenko_2020:215|R48_hou_2003:73|R49_norinder_2002:2|R52_liu_2001:2	-0.04	B	BBB+	A	training
InChI=1S/C5H8N4S/c1-3-2-8-5(10-3)9-4(6)7/h2H,1H3,(H4,6,7,8,9)	Ici 17148|Ici17148|2-(5-Methyl-1,3-Thiazol-2-Yl)Guanidine	2-(5-methyl-1,3-thiazol-2-yl)guanidine	Cc1cnc(N=C(N)N)s1	23545906.0	R12_garg_2006:90|R25_brito_sanchez_2015:1|R46_mendoza_valencia_2017:1	-0.04	B	BBB+	A	training
InChI=1S/C5H9Cl2N3O2/c6-1-3-8-5(11)10(9-12)4-2-7/h1-4H2,(H,8,11)	Carmustine|Bcnu|Bis(Chloroethyl)Nitrosourea	1,3-bis(2-chloroethyl)-1-nitrosourea	O=NN(CCCl)C(=O)NCCCl	2578.0	R3_abraham_2006:143|R12_garg_2006:44|R17_fu_2008:48|R21_muehlbacher_2011:50|R23_gupta_2019:414|R25_brito_sanchez_2015:153|R28_li_2005:10|R28_li_2005:243|R40_vilar_2010:71|R41_toropov_2017:135|R46_mendoza_valencia_2017:150|R47_radchenko_2020:121|R48_hou_2003:23|R49_norinder_2002:108	-0.52	B	BBB+	A	training
InChI=1S/C5H9N3/c6-3-1-5-2-4-7-8-5/h2,4H,1,3,6H2,(H,7,8)	Betazole	2-(1H-pyrazol-5-yl)ethanamine	NCCc1ccn[nH]1	7741.0	R23_gupta_2019:388			BBB-	C	test
InChI=1S/C5H9NO3S/c1-3(10)5(9)6-2-4(7)8/h3,10H,2H2,1H3,(H,6,9)(H,7,8)	Tiopronin	2-(2-sulfanylpropanoylamino)acetic acid	CC(S)C(=O)NCC(=O)O	5483.0	R14_ghose_2012:898			BBB-	C	training
InChI=1S/C5H9NO3S/c1-3(7)6-4(2-10)5(8)9/h4,10H,2H2,1H3,(H,6,7)(H,8,9)/t4-/m0/s1	Acetylcysteine	(2R)-2-acetamido-3-sulfanylpropanoic acid	CC(=O)N[C@@H](CS)C(=O)O	12035.0	R14_ghose_2012:327			BBB-	C	training
InChI=1S/C5H9NO4/c6-3(5(9)10)1-2-4(7)8/h3H,1-2,6H2,(H,7,8)(H,9,10)/t3-/m0/s1	Glutamic Acid	(2S)-2-aminopentanedioic acid	N[C@@H](CCC(=O)O)C(=O)O	33032.0	R14_ghose_2012:597			BBB-	C	training
InChI=1S/C5H9NO4S/c6-3(5(9)10)1-11-2-4(7)8/h3H,1-2,6H2,(H,7,8)(H,9,10)/t3-/m0/s1	Carbocysteine	(2R)-2-amino-3-(carboxymethylsulfanyl)propanoic acid	N[C@@H](CSCC(=O)O)C(=O)O	193653.0	R14_ghose_2012:424			BBB-	C	training
InChI=1S/C6H10N2O2/c7-5(9)4-8-3-1-2-6(8)10/h1-4H2,(H2,7,9)	Piracetam	2-(2-oxopyrrolidin-1-yl)acetamide	NC(=O)CN1CCCC1=O	4843.0	R6_adenot_2004:1266|R7_andres_2006:134|R14_ghose_2012:204|R23_gupta_2019:203|R29_subramanian_2003:130|R37_chen_2011:73			BBB+	C	training
InChI=1S/C6H10N2O3/c7-5(10)3-8-2-4(9)1-6(8)11/h4,9H,1-3H2,(H2,7,10)	Oxiracetam	2-(4-hydroxy-2-oxopyrrolidin-1-yl)acetamide	NC(=O)CN1CC(O)CC1=O	4626.0	R6_adenot_2004:1265|R14_ghose_2012:177			BBB+	C	training
InChI=1S/C6H10N4/c1-2-4-6-7-8-9-10(6)5-3-1/h1-5H2	Pentylenetetrazole|Pentetrazol|Pentylenetetrazol	6,7,8,9-tetrahydro-5H-tetrazolo[1,5-a]azepine	C1CCc2nnnn2CC1	5917.0	R3_abraham_2006:224|R6_adenot_2004:760|R21_muehlbacher_2011:144|R25_brito_sanchez_2015:350|R40_vilar_2010:180|R41_toropov_2017:203|R46_mendoza_valencia_2017:306|R47_radchenko_2020:188	-0.03	B	BBB+	A	test
InChI=1S/C6H10O/c1-4-6(3,7)5-2/h1,7H,5H2,2-3H3	Methylpentynol|3-Methyl-1-Pentyn-3-Ol	3-methylpent-1-yn-3-ol	C#CC(C)(O)CC	6494.0	R6_adenot_2004:1370|R51_doninger_2002:253			BBB+	C	training
InChI=1S/C6H10O4/c7-3-1-9-6-4(8)2-10-5(3)6/h3-8H,1-2H2/t3-,4+,5-,6-/m1/s1	Isosorbide	(3S,3aR,6R,6aR)-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-3,6-diol	O[C@@H]1CO[C@H]2[C@@H]1OC[C@@H]2O	12597.0	R23_gupta_2019:686			BBB-	C	test
InChI=1S/C6H10O6/c7-1-2-3(8)4(9)5(10)6(11)12-2/h2-5,7-10H,1H2/t2-,3-,4+,5-/m1/s1	Gluconolactone	(3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-one	O=C1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O	7027.0	R23_gupta_2019:1064			BBB-	C	training
InChI=1S/C6H11BrN2O2/c1-3(2)4(7)5(10)9-6(8)11/h3-4H,1-2H3,(H3,8,9,10,11)	Bromisoval	2-bromo-N-carbamoyl-3-methylbutanamide	CC(C)C(Br)C(=O)NC(N)=O	2447.0	R6_adenot_2004:1346			BBB+	C	test
InChI=1S/C6H11NO2/c1-2-5(7)3-4-6(8)9/h2,5H,1,3-4,7H2,(H,8,9)	Vigabatrin	4-aminohex-5-enoic acid	C=CC(N)CCC(=O)O	5665.0	R6_adenot_2004:478|R7_andres_2006:182|R14_ghose_2012:269|R23_gupta_2019:262|R29_subramanian_2003:177|R37_chen_2011:105			BBB+	C	training
InChI=1S/C6H11NO2/c7-6(5(8)9)3-1-2-4-6/h1-4,7H2,(H,8,9)	Aminocyclopentanecarboxylic Acid|Cycloleucine	1-aminocyclopentane-1-carboxylic acid	NC1(C(=O)O)CCCC1	2901.0	R25_brito_sanchez_2015:468|R46_mendoza_valencia_2017:393	-0.43	B	BBB+	A	training
InChI=1S/C6H11NO3/c1-10-6(9)3-2-5(8)4-7/h2-4,7H2,1H3	Methyl Aminolevulinate	methyl 5-amino-4-oxopentanoate	COC(=O)CCC(=O)CN	157922.0	R23_gupta_2019:742			BBB-	C	training
InChI=1S/C6H12/c1-2-4-6-5-3-1/h1-6H2	Cyclohexane	cyclohexane	C1CCCCC1	8078.0	R3_abraham_2006:24|R5_guerra_2008:30|R12_garg_2006:63|R21_muehlbacher_2011:197|R25_brito_sanchez_2015:196|R26_chico_2009:143|R28_li_2005:73|R39_shayanfar_2011:33|R40_vilar_2010:348|R41_toropov_2017:19|R44_bujak_2015:76|R46_mendoza_valencia_2017:182|R47_radchenko_2020:9	1.11	D	BBB+	A	training
InChI=1S/C6H12/c1-6-4-2-3-5-6/h6H,2-5H2,1H3	Methylcyclopentane	methylcyclopentane	CC1CCCC1	7296.0	R3_abraham_2006:23|R5_guerra_2008:67|R12_garg_2006:111|R17_fu_2008:19|R21_muehlbacher_2011:177|R22_clark_1999:20|R25_brito_sanchez_2015:297|R26_chico_2009:266|R28_li_2005:97|R39_shayanfar_2011:62|R40_vilar_2010:379|R41_toropov_2017:18|R44_bujak_2015:39|R44_bujak_2015:77|R46_mendoza_valencia_2017:265|R47_radchenko_2020:8|R48_hou_2003:107|R49_norinder_2002:50|R52_liu_2001:50	0.93	B	BBB+	A	training
InChI=1S/C6H12Br2O4/c7-1-3(9)5(11)6(12)4(10)2-8/h3-6,9-12H,1-2H2/t3-,4+,5+,6-	Mitolactol	(2R,3S,4R,5S)-1,6-dibromohexane-2,3,4,5-tetrol	O[C@H]([C@H](O)[C@@H](O)CBr)[C@H](O)CBr	5284380.0	R14_ghose_2012:698			BBB-	C	training
InChI=1S/C6H12N2O4S2/c7-3(5(9)10)1-13-14-2-4(8)6(11)12/h3-4H,1-2,7-8H2,(H,9,10)(H,11,12)/t3-,4-/m0/s1	L-Cystine|Cystine	(2R)-2-amino-3-[[(2R)-2-amino-2-carboxyethyl]disulfanyl]propanoic acid	N[C@@H](CSSC[C@H](N)C(=O)O)C(=O)O	67678.0	R23_gupta_2019:702			BBB-	C	training
InChI=1S/C6H12NO5P/c1-4(3-13(10,11)12)2-5(7)6(8)9/h2,5H,3,7H2,1H3,(H,8,9)(H2,10,11,12)/b4-2+	Cgp-37849|(E)-2-Amino-4-Methyl-5-Phosphonopent-3-Enoic Acid	(E)-2-amino-4-methyl-5-phosphonopent-3-enoic acid	C/C(=C\C(N)C(=O)O)CP(=O)(O)O	5950212.0	R29_subramanian_2003:19			BBB+	C	training
InChI=1S/C6H12O2/c1-3-4-5-8-6(2)7/h3-5H2,1-2H3	Butyl Acetate	butyl acetate	CCCCOC(C)=O	31272.0	R3_abraham_2006:81|R21_muehlbacher_2011:235|R25_brito_sanchez_2015:176|R40_vilar_2010:344|R41_toropov_2017:76|R46_mendoza_valencia_2017:166|R47_radchenko_2020:63	0.28	B	BBB+	A	training
InChI=1S/C6H12O2/c1-5(2)4-8-6(3)7/h5H,4H2,1-3H3	Isobutyl Acetate	2-methylpropyl acetate	CC(=O)OCC(C)C	8038.0	R3_abraham_2006:84|R21_muehlbacher_2011:195|R25_brito_sanchez_2015:260|R40_vilar_2010:366|R41_toropov_2017:79|R46_mendoza_valencia_2017:234|R47_radchenko_2020:66	0.45	B	BBB+	A	test
InChI=1S/C6H12O3/c1-4-7-5(2)9-6(3)8-4/h4-6H,1-3H3	Paraldehyde	2,4,6-trimethyl-1,3,5-trioxane	CC1OC(C)OC(C)O1	31264.0	R6_adenot_2004:1373|R14_ghose_2012:181|R23_gupta_2019:307			BBB+	C	training
InChI=1S/C6H13NO2/c1-4(2)3-5(7)6(8)9/h4-5H,3,7H2,1-2H3,(H,8,9)/t5-/m0/s1	Leucine	(2S)-2-amino-4-methylpentanoic acid	CC(C)C[C@H](N)C(=O)O	6106.0	R47_radchenko_2020:487	0.0	A	BBB+	A	test
InChI=1S/C6H13NO2/c7-5-3-1-2-4-6(8)9/h1-5,7H2,(H,8,9)	Aminocaproic Acid	6-aminohexanoic acid	NCCCCCC(=O)O	564.0	R14_ghose_2012:343			BBB-	C	training
InChI=1S/C6H13NO5/c7-3-5(10)4(9)2(1-8)12-6(3)11/h2-6,8-11H,1,7H2/t2-,3-,4-,5-,6?/m1/s1	Glucosamine|D-Glucosamine	(3R,4R,5S,6R)-3-amino-6-(hydroxymethyl)oxane-2,4,5-triol	N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O	439213.0	R14_ghose_2012:596|R23_gupta_2019:639			BBB-	C	training
InChI=1S/C6H14/c1-3-5-6-4-2/h3-6H2,1-2H3	Hexane|N-Hexane	hexane	CCCCCC	8058.0	R3_abraham_2006:10|R5_guerra_2008:52|R7_andres_2006:82|R12_garg_2006:86|R17_fu_2008:17|R21_muehlbacher_2011:196|R22_clark_1999:17|R25_brito_sanchez_2015:249|R28_li_2005:90|R39_shayanfar_2011:50|R40_vilar_2010:365|R41_toropov_2017:5|R44_bujak_2015:44|R44_bujak_2015:68|R46_mendoza_valencia_2017:224|R47_radchenko_2020:378|R48_hou_2003:103|R49_norinder_2002:47|R52_liu_2001:47	0.78	B1	BBB+	A	training
InChI=1S/C6H14/c1-4-5-6(2)3/h6H,4-5H2,1-3H3	2-Methylpentane|Isohexane	2-methylpentane	CCCC(C)C	7892.0	R3_abraham_2006:15|R5_guerra_2008:5|R12_garg_2006:7|R17_fu_2008:7|R21_muehlbacher_2011:188|R22_clark_1999:7|R25_brito_sanchez_2015:75|R26_chico_2009:7|R28_li_2005:58|R39_shayanfar_2011:5|R40_vilar_2010:333|R41_toropov_2017:10|R44_bujak_2015:3|R46_mendoza_valencia_2017:73|R47_radchenko_2020:380|R48_hou_2003:108|R49_norinder_2002:52|R52_liu_2001:37	0.97	B	BBB+	A	training
InChI=1S/C6H14/c1-4-6(3)5-2/h6H,4-5H2,1-3H3	3-Methylpentane	3-methylpentane	CCC(C)CC	7282.0	R3_abraham_2006:19|R5_guerra_2008:9|R12_garg_2006:11|R17_fu_2008:3|R21_muehlbacher_2011:176|R22_clark_1999:3|R25_brito_sanchez_2015:83|R26_chico_2009:10|R28_li_2005:62|R39_shayanfar_2011:100|R40_vilar_2010:338|R41_toropov_2017:14|R44_bujak_2015:6|R46_mendoza_valencia_2017:81|R47_radchenko_2020:4|R48_hou_2003:111|R49_norinder_2002:53|R52_liu_2001:33	1.01	B	BBB+	A	training
InChI=1S/C6H14/c1-5-6(2,3)4/h5H2,1-4H3	2,2-Dimethylbutane|Hexane|22-Dimethylbutane	2,2-dimethylbutane	CCC(C)(C)C	6403.0	R3_abraham_2006:21|R5_guerra_2008:7|R7_andres_2006:98|R12_garg_2006:6|R17_fu_2008:8|R21_muehlbacher_2011:162|R22_clark_1999:8|R25_brito_sanchez_2015:64|R26_chico_2009:5|R28_li_2005:60|R39_shayanfar_2011:4|R40_vilar_2010:326|R41_toropov_2017:16|R44_bujak_2015:2|R46_mendoza_valencia_2017:62|R47_radchenko_2020:6|R48_hou_2003:112|R49_norinder_2002:42|R52_liu_2001:38	1.04	B	BBB+	A	test
InChI=1S/C6H14FO3P/c1-5(2)9-11(7,8)10-6(3)4/h5-6H,1-4H3	Isoflurophate	2-[fluoro(propan-2-yloxy)phosphoryl]oxypropane	CC(C)OP(=O)(F)OC(C)C	5936.0	R23_gupta_2019:684			BBB-	C	training
InChI=1S/C6H14N2O2/c1-8(2,3)4-5-10-6(7)9/h4-5H2,1-3H3,(H-,7,9)/p+1	Carbachol|Carbamoylcholine	2-carbamoyloxyethyl(trimethyl)azanium	C[N+](C)(C)CCOC(N)=O	2551.0	R23_gupta_2019:410			BBB-	C	training
InChI=1S/C6H14O/c1-5-6(2,3)7-4/h5H2,1-4H3	Tertiary-Amyl Methyl Ether|Tert-Amylmethylether|Tert-Amyl Methyl Ether	2-methoxy-2-methylbutane	CCC(C)(C)OC	61247.0	R3_abraham_2006:67|R21_muehlbacher_2011:258|R25_brito_sanchez_2015:137|R40_vilar_2010:400|R41_toropov_2017:62|R46_mendoza_valencia_2017:135|R47_radchenko_2020:49	0.17	B	BBB+	A	training
InChI=1S/C6H14O/c1-5-7-6(2,3)4/h5H2,1-4H3	Ethyl T-Butyl Ether|Tert-Butylethylether|Tert-Butyl Ethyl Ether	2-ethoxy-2-methylpropane	CCOC(C)(C)C	12512.0	R3_abraham_2006:65|R21_muehlbacher_2011:217|R25_brito_sanchez_2015:225|R40_vilar_2010:358|R41_toropov_2017:60|R46_mendoza_valencia_2017:207|R47_radchenko_2020:47	0.22	B	BBB+	A	training
InChI=1S/C6H14O6/c7-1-3(9)5(11)6(12)4(10)2-8/h3-12H,1-2H2	Hexitol	hexane-1,2,3,4,5,6-hexol	OCC(O)C(O)C(O)C(O)CO	453.0	R41_toropov_2017:177|R46_mendoza_valencia_2017:254	-1.6	B	BBB-	A	training
InChI=1S/C6H14O6/c7-1-3(9)5(11)6(12)4(10)2-8/h3-12H,1-2H2/t3-,4-,5-,6-/m1/s1	Mannitol|D-Mannitol	(2R,3R,4R,5R)-hexane-1,2,3,4,5,6-hexol	OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO	6251.0	R3_abraham_2006:193|R7_andres_2006:97|R21_muehlbacher_2011:152|R25_brito_sanchez_2015:283|R26_chico_2009:252|R28_li_2005:267|R29_subramanian_2003:92|R31_carpenter_2014:1|R40_vilar_2010:142|R47_radchenko_2020:163|R51_doninger_2002:78	-1.73	B1	BBB-	A	training
InChI=1S/C6H14O8S2/c1-15(9,10)13-3-5(7)6(8)4-14-16(2,11)12/h5-8H,3-4H2,1-2H3/t5-,6-/m0/s1	Treosulfan	[(2S,3S)-2,3-dihydroxy-4-methylsulfonyloxybutyl] methanesulfonate	CS(=O)(=O)OC[C@H](O)[C@@H](O)COS(C)(=O)=O	9882105.0	R14_ghose_2012:910			BBB-	C	training
InChI=1S/C6H18N4/c7-1-3-9-5-6-10-4-2-8/h9-10H,1-8H2	Trientine Hydrochloride|Trientine	N'-[2-(2-aminoethylamino)ethyl]ethane-1,2-diamine	NCCNCCNCCN	5565.0	R14_ghose_2012:917			BBB-	C	test
InChI=1S/C6H5NO2/c8-6(9)5-2-1-3-7-4-5/h1-4H,(H,8,9)	Niacin|Nicotinic Acid	pyridine-3-carboxylic acid	O=C(O)c1cccnc1	938.0	R14_ghose_2012:714			BBB-	C	training
InChI=1S/C6H6/c1-2-4-6-5-3-1/h1-6H	Benzene	benzene	c1ccccc1	241.0	R3_abraham_2006:86|R7_andres_2006:17|R12_garg_2006:45|R17_fu_2008:2|R21_muehlbacher_2011:3|R22_clark_1999:2|R25_brito_sanchez_2015:155|R26_chico_2009:76|R28_li_2005:68|R39_shayanfar_2011:19|R40_vilar_2010:343|R41_toropov_2017:81|R44_bujak_2015:16|R46_mendoza_valencia_2017:152|R47_radchenko_2020:68|R48_hou_2003:94|R49_norinder_2002:39|R52_liu_2001:32	0.37	D	BBB+	A	training
InChI=1S/C6H6Cl2N2O4S2/c7-4-1-3(15(9,11)12)2-5(6(4)8)16(10,13)14/h1-2H,(H2,9,11,12)(H2,10,13,14)	Dichlorphenamide	4,5-dichlorobenzene-1,3-disulfonamide	NS(=O)(=O)c1cc(Cl)c(Cl)c(S(N)(=O)=O)c1	3038.0	R14_ghose_2012:491|R23_gupta_2019:516			BBB-	C	test
InChI=1S/C6H6Cl6/c7-1-2(8)4(10)6(12)5(11)3(1)9/h1-6H	Lindane|Hexachlorocyclohexane	1,2,3,4,5,6-hexachlorocyclohexane	ClC1C(Cl)C(Cl)C(Cl)C(Cl)C1Cl	727.0	R23_gupta_2019:712			BBB-	C	training
InChI=1S/C6H6N2O/c7-6(9)5-2-1-3-8-4-5/h1-4H,(H2,7,9)	Nicotinamide|Niacinamide	pyridine-3-carboxamide	NC(=O)c1cccnc1	936.0	R6_adenot_2004:1680			BBB+	C	training
InChI=1S/C6H6N4O4/c7-6(11)9-8-3-4-1-2-5(14-4)10(12)13/h1-3H,(H3,7,9,11)/b8-3+	Nitrofurazone|(E)-2-((5-Nitrofuran-2-Yl)Methylene)Hydrazinecarboxamide	[(Z)-(5-nitrofuran-2-yl)methylideneamino]urea	NC(=O)N/N=C\c1ccc([N+](=O)[O-])o1	5353356.0	R23_gupta_2019:784			BBB-	C	training
InChI=1S/C6H6N6O2/c1-11-6(14)12-2-8-3(4(7)13)5(12)9-10-11/h2H,1H3,(H2,7,13)	Temozolomide	3-methyl-4-oxoimidazo[5,1-d][1,2,3,5]tetrazine-8-carboxamide	Cn1nnc2c(C(N)=O)ncn2c1=O	5394.0	R14_ghose_2012:880|R26_chico_2009:406	-0.47	A	BBB+	A	training
InChI=1S/C6H6O/c7-6-4-2-1-3-5-6/h1-5,7H	Phenol	phenol	Oc1ccccc1	996.0	R23_gupta_2019:829			BBB-	C	test
InChI=1S/C6H7NO/c8-5-6-2-1-3-7-4-6/h1-4,8H,5H2	Nicotinyl Alcohol|3-Pyridinemethanol	pyridin-3-ylmethanol	OCc1cccnc1	7510.0	R51_doninger_2002:97			BBB-	C	training
InChI=1S/C6H8ClN7O/c7-2-4(9)13-3(8)1(12-2)5(15)14-6(10)11/h(H4,8,9,13)(H4,10,11,14,15)	Amiloride	3,5-diamino-6-chloro-N-(diaminomethylidene)pyrazine-2-carboxamide	NC(N)=NC(=O)c1nc(Cl)c(N)nc1N	16231.0	R6_adenot_2004:4|R23_gupta_2019:343			BBB-	C	training
InChI=1S/C6H8ClNS/c1-5-6(2-3-7)9-4-8-5/h4H,2-3H2,1H3	Clomethiazole|Chlomethiazole	5-(2-chloroethyl)-4-methyl-1,3-thiazole	Cc1ncsc1CCCl	10783.0	R6_adenot_2004:431|R14_ghose_2012:37			BBB+	C	training
InChI=1S/C6H8FN3O2/c7-2-1-4-9-5-3-8-6(9)10(11)12/h3,5H,1-2,4H2	1-(3-Fluoropropyl)-2-Nitroimidazole|Moli001288	1-(3-fluoropropyl)-2-nitroimidazole	O=[N+]([O-])c1nccn1CCCF	10352163.0	R3_abraham_2006:98|R21_muehlbacher_2011:337|R25_brito_sanchez_2015:38|R40_vilar_2010:1|R41_toropov_2017:93|R46_mendoza_valencia_2017:37|R47_radchenko_2020:80	-0.24	B	BBB+	A	training
InChI=1S/C6H8FN3O3/c7-3-5(11)4-9-2-1-8-6(9)10(12)13/h1-2,5,11H,3-4H2	Fluoromisonidazole	1-fluoro-3-(2-nitroimidazol-1-yl)propan-2-ol	O=[N+]([O-])c1nccn1CC(O)CF	92242.0	R21_muehlbacher_2011:280|R47_radchenko_2020:368	-0.01	B	BBB+	A	training
InChI=1S/C6H8N2O/c1-4-3-5(2)7-8-6(4)9/h3H,1-2H3,(H,8,9)	Cetohexazine	3,5-dimethyl-1H-pyridazin-6-one	Cc1cc(C)c(=O)[nH]n1	193965.0	R6_adenot_2004:1353			BBB+	C	training
InChI=1S/C6H8N2O2/c9-5-3-8-4(7-5)1-2-6(8)10/h4H,1-3H2,(H,7,9)	Dimiracetam	3,6,7,7a-tetrahydro-1H-pyrrolo[1,2-a]imidazole-2,5-dione	O=C1CN2C(=O)CCC2N1	65955.0	R6_adenot_2004:1247			BBB+	C	training
InChI=1S/C6H8N2O2/c9-6-4-1-2-7-3-5(4)10-8-6/h7H,1-3H2,(H,8,9)	Gaboxadol	4,5,6,7-tetrahydro-[1,2]oxazolo[5,4-c]pyridin-3-one	O=c1[nH]oc2c1CCNC2	3448.0	R6_adenot_2004:444			BBB+	C	test
InChI=1S/C6H8N2O2S/c7-5-1-3-6(4-2-5)11(8,9)10/h1-4H,7H2,(H2,8,9,10)	Sulfanilamide	4-aminobenzenesulfonamide	Nc1ccc(S(N)(=O)=O)cc1	5333.0	R23_gupta_2019:939			BBB-	C	test
InChI=1S/C6H8N2O8/c9-7(10)15-3-1-13-6-4(16-8(11)12)2-14-5(3)6/h3-6H,1-2H2/t3-,4+,5-,6-/m1/s1	Isosorbide Dinitrate	[(3S,3aS,6R,6aS)-3-nitrooxy-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-6-yl] nitrate	O=[N+]([O-])O[C@H]1CO[C@H]2[C@@H]1OC[C@H]2O[N+](=O)[O-]	6883.0	R23_gupta_2019:687			BBB-	C	test
InChI=1S/C6H8O6/c7-1-2(8)5-3(9)4(10)6(11)12-5/h2,5,7-10H,1H2	Ascorbic|D-Erythro-Hex-2-Enonic Acid, Gamma-Lactone	2-(1,2-dihydroxyethyl)-3,4-dihydroxy-2H-furan-5-one	O=C1OC(C(O)CO)C(O)=C1O	54676860.0	R14_ghose_2012:360			BBB-	C	training
InChI=1S/C6H9N3/c1-9(2)6-5-7-3-4-8-6/h3-5H,1-2H3	Ampyzine	N,N-dimethylpyrazin-2-amine	CN(C)c1cnccn1	23483.0	R6_adenot_2004:1315			BBB+	C	training
InChI=1S/C6H9NO3/c1-6(2)4(8)7(3)5(9)10-6/h1-3H3	Trimethadione	3,5,5-trimethyl-1,3-oxazolidine-2,4-dione	CN1C(=O)OC(C)(C)C1=O	5576.0	R6_adenot_2004:474|R14_ghose_2012:262|R23_gupta_2019:255|R26_chico_2009:434			BBB+	C	test
InChI=1S/C6H9NO6/c8-3-1-11-6-4(13-7(9)10)2-12-5(3)6/h3-6,8H,1-2H2/t3-,4+,5+,6+/m0/s1	Isosorbide Mononitrate	[(3S,3aR,6R,6aS)-3-hydroxy-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-6-yl] nitrate	O=[N+]([O-])O[C@@H]1CO[C@H]2[C@@H]1OC[C@@H]2O	27661.0	R14_ghose_2012:632|R23_gupta_2019:688			BBB-	C	test
InChI=1S/C7H10FN3O4/c8-5-15-4-6(12)3-10-2-1-9-7(10)11(13)14/h1-2,6,12H,3-5H2	Misonidazole,Fluoro	1-(fluoromethoxy)-3-(2-nitroimidazol-1-yl)propan-2-ol	O=[N+]([O-])c1nccn1CC(O)COCF	23274095.0	R41_toropov_2017:161|R41_toropov_2017:185|R46_mendoza_valencia_2017:217	-0.01	B	BBB+	A	training
InChI=1S/C7H10N2O2S/c1-3-11-7(10)9-5-4-8(2)6(9)12/h4-5H,3H2,1-2H3	Carbimazole	ethyl 3-methyl-2-sulfanylideneimidazole-1-carboxylate	CCOC(=O)n1ccn(C)c1=S	31072.0	R14_ghose_2012:423|R23_gupta_2019:412			BBB-	C	test
InChI=1S/C7H10N2O2S/c8-5-6-1-3-7(4-2-6)12(9,10)11/h1-4H,5,8H2,(H2,9,10,11)	Mafenide Acetate|Mafenide	4-(aminomethyl)benzenesulfonamide	NCc1ccc(S(N)(=O)=O)cc1	3998.0	R23_gupta_2019:1071			BBB-	C	test
InChI=1S/C7H10N2O3/c1-3-7(2)4(10)8-6(12)9-5(7)11/h3H2,1-2H3,(H2,8,9,10,11,12)	5-Methyl-5-Ethyl Barbituric Acid|Nsc 30403|5-Ethyl-5-Methyl-1H,3H,5H-Pyrimidin-2,4,6-Trione	5-ethyl-5-methyl-1,3-diazinane-2,4,6-trione	CCC1(C)C(=O)NC(=O)NC1=O	95705.0	R3_abraham_2006:112|R21_muehlbacher_2011:283|R25_brito_sanchez_2015:98|R40_vilar_2010:19|R41_toropov_2017:107|R46_mendoza_valencia_2017:96|R47_radchenko_2020:94	-0.19	B1	BBB+	A	test
InChI=1S/C7H10N2OS/c1-2-3-5-4-6(10)9-7(11)8-5/h4H,2-3H2,1H3,(H2,8,9,10,11)	Propylthiouracil	6-propyl-2-sulfanylidene-1H-pyrimidin-4-one	CCCc1cc(=O)[nH]c(=S)[nH]1	657298.0	R14_ghose_2012:801			BBB-	C	test
InChI=1S/C7H11Cl3O4/c8-7(9,10)5-13-3-6(1-11,2-12)4-14-5/h5,11-12H,1-4H2	Penthrichloral	[5-(hydroxymethyl)-2-(trichloromethyl)-1,3-dioxan-5-yl]methanol	OCC1(CO)COC(C(Cl)(Cl)Cl)OC1	71839.0	R6_adenot_2004:1336			BBB+	C	test
InChI=1S/C7H11NO2/c1-3-7(2)4-5(9)8-6(7)10/h3-4H2,1-2H3,(H,8,9,10)	Ethosuximide	3-ethyl-3-methylpyrrolidine-2,5-dione	CCC1(C)CC(=O)NC1=O	3291.0	R6_adenot_2004:1648|R14_ghose_2012:88|R23_gupta_2019:86|R25_brito_sanchez_2015:501|R26_chico_2009:180|R28_li_2005:202|R34_broccatelli_2012:29|R37_chen_2011:34|R46_mendoza_valencia_2017:419|R51_doninger_2002:215	-0.3	D	BBB+	A	training
InChI=1S/C7H11NO3/c1-4-7(2)5(9)8(3)6(10)11-7/h4H2,1-3H3	Paramethadione	5-ethyl-3,5-dimethyl-1,3-oxazolidine-2,4-dione	CCC1(C)OC(=O)N(C)C1=O	8280.0	R6_adenot_2004:457|R14_ghose_2012:182|R23_gupta_2019:183			BBB+	C	test
InChI=1S/C7H11NO4S/c1-2-12-7(11)8-4-13-3-5(8)6(9)10/h5H,2-4H2,1H3,(H,9,10)/t5-/m0/s1	Telmesteine	(4R)-3-ethoxycarbonyl-1,3-thiazolidine-4-carboxylic acid	CCOC(=O)N1CSC[C@H]1C(=O)O	65946.0	R23_gupta_2019:1087|R26_chico_2009:403	-1.72	A	BBB-	A	training
InChI=1S/C7H11NO7P2/c9-7(16(10,11)12,17(13,14)15)4-6-2-1-3-8-5-6/h1-3,5,9H,4H2,(H2,10,11,12)(H2,13,14,15)	Risedronate|Risedronic Acid	(1-hydroxy-1-phosphono-2-pyridin-3-ylethyl)phosphonic acid	O=P(O)(O)C(O)(Cc1cccnc1)P(=O)(O)O	5245.0	R23_gupta_2019:888			BBB-	C	training
InChI=1S/C7H12N2O2/c1-3-5(4-2)6(10)9-7(8)11/h3H,4H2,1-2H3,(H3,8,9,10,11)/b5-3-	Ectylurea	(Z)-N-carbamoyl-2-ethylbut-2-enamide	C/C=C(/CC)C(=O)NC(N)=O	5895404.0	R6_adenot_2004:1456|R51_doninger_2002:208			BBB+	C	training
InChI=1S/C7H12N2O4/c1-4(10)9-5(7(12)13)2-3-6(8)11/h5H,2-3H2,1H3,(H2,8,11)(H,9,10)(H,12,13)/t5-/m0/s1	Aceglutamide	(2S)-2-acetamido-5-amino-5-oxopentanoic acid	CC(=O)N[C@@H](CCC(N)=O)C(=O)O	182230.0	R6_adenot_2004:357			BBB+	C	training
InChI=1S/C7H13BrN2O2/c1-3-7(8,4-2)5(11)10-6(9)12/h3-4H2,1-2H3,(H3,9,10,11,12)	Carbromal	2-bromo-N-carbamoyl-2-ethylbutanamide	CCC(Br)(CC)C(=O)NC(N)=O	6488.0	R6_adenot_2004:1349			BBB+	C	training
InChI=1S/C7H14/c1-7-5-3-2-4-6-7/h7H,2-6H2,1H3	Methylcyclohexane|Cyclohexylmethane	methylcyclohexane	CC1CCCCC1	7962.0	R3_abraham_2006:25|R21_muehlbacher_2011:192|R25_brito_sanchez_2015:296|R40_vilar_2010:378|R41_toropov_2017:20|R46_mendoza_valencia_2017:264|R47_radchenko_2020:10	0.96	B	BBB+	A	training
InChI=1S/C7H14BrNO/c1-4-7(8,5(2)3)6(9)10/h5H,4H2,1-3H3,(H2,9,10)	Ibrotamide	2-bromo-2-ethyl-3-methylbutanamide	CCC(Br)(C(N)=O)C(C)C	216287.0	R6_adenot_2004:1366			BBB+	C	training
InChI=1S/C7H14NO5P/c9-7(10)6-3-5(1-2-8-6)4-14(11,12)13/h5-6,8H,1-4H2,(H,9,10)(H2,11,12,13)/t5-,6+/m1/s1	Cgs-19755|Selfotel	(2S,4R)-4-(phosphonomethyl)piperidine-2-carboxylic acid	O=C(O)[C@@H]1C[C@H](CP(=O)(O)O)CCN1	68736.0	R7_andres_2006:31|R29_subramanian_2003:21			BBB+	C	training
InChI=1S/C7H14O2/c1-3-4-5-6-9-7(2)8/h3-6H2,1-2H3	Pentyl Acetate	pentyl acetate	CCCCCOC(C)=O	12348.0	R3_abraham_2006:82|R21_muehlbacher_2011:215|R25_brito_sanchez_2015:349|R40_vilar_2010:388|R41_toropov_2017:77|R46_mendoza_valencia_2017:305|R47_radchenko_2020:64	0.4	B	BBB+	A	training
InChI=1S/C7H14O2/c1-6(2)4-5-9-7(3)8/h6H,4-5H2,1-3H3	Isopentylacetate|Isopentyl Acetate|Isoamyl Acetate	3-methylbutyl acetate	CC(=O)OCCC(C)C	31276.0	R3_abraham_2006:85|R21_muehlbacher_2011:236|R25_brito_sanchez_2015:262|R40_vilar_2010:368|R41_toropov_2017:80|R46_mendoza_valencia_2017:235|R47_radchenko_2020:67	0.55	B	BBB+	A	training
InChI=1S/C7H15Cl2N2O2P/c8-2-4-10-14(12)11(6-3-9)5-1-7-13-14/h1-7H2,(H,10,12)	Ifosfamide	N,3-bis(2-chloroethyl)-2-oxo-1,3,2lambda5-oxazaphosphinan-2-amine	O=P1(NCCCl)OCCCN1CCCl	3690.0	R23_gupta_2019:668			BBB-	C	training
InChI=1S/C7H15Cl2N2O2P/c8-2-5-11(6-3-9)14(12)10-4-1-7-13-14/h1-7H2,(H,10,12)	Cyclophosphamide	N,N-bis(2-chloroethyl)-2-oxo-1,3,2lambda5-oxazaphosphinan-2-amine	O=P1(N(CCCl)CCCl)NCCCO1	2907.0	R14_ghose_2012:475|R23_gupta_2019:486			BBB-	C	training
InChI=1S/C7H15NO2/c1-4-7(3,5-2)10-6(8)9/h4-5H2,1-3H3,(H2,8,9)	Emylcamate	3-methylpentan-3-yl carbamate	CCC(C)(CC)OC(N)=O	6526.0	R6_adenot_2004:1457|R51_doninger_2002:209			BBB+	C	training
InChI=1S/C7H16/c1-3-5-7-6-4-2/h3-7H2,1-2H3	Heptane|N-Heptane	heptane	CCCCCCC	8900.0	R3_abraham_2006:11|R5_guerra_2008:51|R7_andres_2006:198|R12_garg_2006:85|R17_fu_2008:16|R21_muehlbacher_2011:204|R22_clark_1999:16|R25_brito_sanchez_2015:248|R26_chico_2009:208|R28_li_2005:89|R39_shayanfar_2011:111|R40_vilar_2010:364|R41_toropov_2017:6|R44_bujak_2015:43|R44_bujak_2015:74|R46_mendoza_valencia_2017:223|R47_radchenko_2020:379|R48_hou_2003:104|R49_norinder_2002:46|R52_liu_2001:46	0.75	B1	BBB+	A	training
InChI=1S/C7H16/c1-4-5-6-7(2)3/h7H,4-6H2,1-3H3	2-Methyl Heptane|2-Methylhexane	2-methylhexane	CCCCC(C)C	11582.0	R3_abraham_2006:16|R41_toropov_2017:11	0.86	B	BBB+	A	training
InChI=1S/C7H16/c1-4-6-7(3)5-2/h7H,4-6H2,1-3H3	3-Methylhexane|2-Ethylpentane	3-methylhexane	CCCC(C)CC	11507.0	R3_abraham_2006:20|R5_guerra_2008:8|R12_garg_2006:10|R17_fu_2008:4|R21_muehlbacher_2011:213|R22_clark_1999:4|R25_brito_sanchez_2015:82|R26_chico_2009:9|R28_li_2005:61|R39_shayanfar_2011:8|R40_vilar_2010:337|R41_toropov_2017:15|R44_bujak_2015:5|R46_mendoza_valencia_2017:80|R47_radchenko_2020:5|R49_norinder_2002:51|R52_liu_2001:34	0.9	B	BBB+	A	training
InChI=1S/C7H16/c1-4-6-7(3)5-2/h7H,4-6H2,1-3H3/t7-/m1/s1	(-)-3-Methylhexane	(3R)-3-methylhexane	CCC[C@H](C)CC	13800357.0	R48_hou_2003:106	0.9	A	BBB+	A	training
InChI=1S/C7H16N2/c8-9-6-7-4-2-1-3-5-7/h7,9H,1-6,8H2	Cimemoxin	cyclohexylmethylhydrazine	NNCC1CCCCC1	71824.0	R6_adenot_2004:987			BBB+	C	training
InChI=1S/C7H16N2O/c1-2-3-4-5-9-6-7(8)10/h9H,2-6H2,1H3,(H2,8,10)	Milacemide	2-(pentylamino)acetamide	CCCCCNCC(N)=O	53569.0	R6_adenot_2004:451|R7_andres_2006:107|R29_subramanian_2003:102			BBB+	C	training
InChI=1S/C7H16N2O2/c1-6(11-7(8)10)5-9(2,3)4/h6H,5H2,1-4H3,(H-,8,10)/p+1	Bethanechol Chloride|Bethanechol	2-carbamoyloxypropyl(trimethyl)azanium	CC(C[N+](C)(C)C)OC(N)=O	2370.0	R14_ghose_2012:392|R23_gupta_2019:389|R28_li_2005:236			BBB-	C	training
InChI=1S/C7H16N4O4S2/c12-16(13)3-1-10(5-8-16)7-11-2-4-17(14,15)9-6-11/h8-9H,1-7H2	Taurolidine	4-[(1,1-dioxo-1,2,4-thiadiazinan-4-yl)methyl]-1,2,4-thiadiazinane 1,1-dioxide	O=S1(=O)CCN(CN2CCS(=O)(=O)NC2)CN1	29566.0	R23_gupta_2019:1085			BBB-	C	test
InChI=1S/C7H16O4S2/c1-5-12(8,9)7(3,4)13(10,11)6-2/h5-6H2,1-4H3	Sulfonmethane	2,2-bis(ethylsulfonyl)propane	CCS(=O)(=O)C(C)(C)S(=O)(=O)CC	8262.0	R6_adenot_2004:1382			BBB+	C	training
InChI=1S/C7H3F12N3/c8-4(9,10)2(5(11,12)13)1(20)21-3(22-2,6(14,15)16)7(17,18)19/h22H,(H2,20,21)	Midaflur	2,2,5,5-tetrakis(trifluoromethyl)-1H-imidazol-4-amine	NC1=NC(C(F)(F)F)(C(F)(F)F)NC1(C(F)(F)F)C(F)(F)F	32068.0	R6_adenot_2004:1487			BBB+	C	test
InChI=1S/C7H4ClF3/c8-6-3-1-5(2-4-6)7(9,10)11/h1-4H	4-Chlorobenzotrifluoride	1-chloro-4-(trifluoromethyl)benzene	FC(F)(F)c1ccc(Cl)cc1	7394.0	R3_abraham_2006:95|R21_muehlbacher_2011:179|R25_brito_sanchez_2015:88|R40_vilar_2010:339|R41_toropov_2017:90|R46_mendoza_valencia_2017:86|R47_radchenko_2020:77	0.17	B	BBB+	A	training
InChI=1S/C7H4ClNO2/c8-4-1-2-6-5(3-4)9-7(10)11-6/h1-3H,(H,9,10)	Chlorzoxazone	5-chloro-3H-1,3-benzoxazol-2-one	O=c1[nH]c2cc(Cl)ccc2o1	2733.0	R14_ghose_2012:46|R23_gupta_2019:45|R51_doninger_2002:181			BBB+	C	training
InChI=1S/C7H6ClN3O4S2/c8-4-1-5-7(2-6(4)16(9,12)13)17(14,15)11-3-10-5/h1-3H,(H,10,11)(H2,9,12,13)	Chlorothiazide	6-chloro-1,1-dioxo-4H-1lambda6,2,4-benzothiadiazine-7-sulfonamide	NS(=O)(=O)c1cc2c(cc1Cl)NC=NS2(=O)=O	2720.0	R14_ghose_2012:444|R23_gupta_2019:450|R28_li_2005:247|R34_broccatelli_2012:15|R51_doninger_2002:23			BBB-	C	test
InChI=1S/C7H6N4O2/c8-7-9-11(13)6-4-2-1-3-5(6)10(7)12/h1-4H,(H2,8,9)	Tirapazamine	1,4-dioxido-1,2,4-benzotriazine-1,4-diium-3-amine	Nc1n[n+]([O-])c2ccccc2[n+]1[O-]	135413511.0	R14_ghose_2012:900			BBB-	C	training
InChI=1S/C7H6O3/c8-5-1-2-6-7(3-5)10-4-9-6/h1-3,8H,4H2	Sesamol|3,4-Methylenedioxyphenol	1,3-benzodioxol-5-ol	Oc1ccc2c(c1)OCO2	68289.0	R26_chico_2009:376	-0.04	A	BBB+	A	training
InChI=1S/C7H6O3/c8-6-4-2-1-3-5(6)7(9)10/h1-4,8H,(H,9,10)	Salicylic Acid|69-72-7|Salicylate	2-hydroxybenzoic acid	O=C(O)c1ccccc1O	338.0	R3_abraham_2006:252|R3_abraham_2006:253|R4_mente_2005:24|R5_guerra_2008:90|R7_andres_2006:213|R12_garg_2006:148|R17_fu_2008:28|R21_muehlbacher_2011:6|R25_brito_sanchez_2015:266|R26_chico_2009:362|R31_carpenter_2014:3|R39_shayanfar_2011:82|R40_vilar_2010:237|R41_toropov_2017:226|R46_mendoza_valencia_2017:239|R47_radchenko_2020:209|R48_hou_2003:47|R49_norinder_2002:66|R49_norinder_2002:116|R50_sobanska_2019:6|R51_doninger_2002:125|R53_friden_2009:33	-1.12	B1	BBB-	A	training
InChI=1S/C7H6O4/c8-4-1-2-6(9)5(3-4)7(10)11/h1-3,8-9H,(H,10,11)	Gentisic Acid|2,5-Dihydroxybenzoic Acid	2,5-dihydroxybenzoic acid	O=C(O)c1cc(O)ccc1O	3469.0	R5_guerra_2008:48|R12_garg_2006:82|R21_muehlbacher_2011:80|R25_brito_sanchez_2015:243|R39_shayanfar_2011:48|R40_vilar_2010:119|R47_radchenko_2020:270	0.09	B1	BBB+	A	training
InChI=1S/C7H7NO2/c8-6-3-1-5(2-4-6)7(9)10/h1-4H,8H2,(H,9,10)	P-Aminobenzoic Acid|4-Aminobenzoic Acid	4-aminobenzoic acid	Nc1ccc(C(=O)O)cc1	978.0	R47_radchenko_2020:489	-1.4	A	BBB-	A	training
InChI=1S/C7H7NO3/c8-4-1-2-5(7(10)11)6(9)3-4/h1-3,9H,8H2,(H,10,11)	Aminosalicylic Acid|Aminosalicylicacid|4-Aminosalicylic Acid	4-amino-2-hydroxybenzoic acid	Nc1ccc(C(=O)O)c(O)c1	4649.0	R14_ghose_2012:345|R28_li_2005:182			BBB-	C	training
InChI=1S/C7H7NO3/c8-4-1-2-6(9)5(3-4)7(10)11/h1-3,9H,8H2,(H,10,11)	Mesalamine	5-amino-2-hydroxybenzoic acid	Nc1ccc(O)c(C(=O)O)c1	4075.0	R14_ghose_2012:679			BBB-	C	training
InChI=1S/C7H7NO4S/c8-13(11,12)6-3-1-5(2-4-6)7(9)10/h1-4H,(H,9,10)(H2,8,11,12)	Carzenide	4-sulfamoylbenzoic acid	NS(=O)(=O)c1ccc(C(=O)O)cc1	8739.0	R6_adenot_2004:1351			BBB+	C	training
InChI=1S/C7H8/c1-7-5-3-2-4-6-7/h2-6H,1H3	Toluene	toluene	Cc1ccccc1	1140.0	R3_abraham_2006:87|R5_guerra_2008:103|R7_andres_2006:220|R12_garg_2006:167|R17_fu_2008:24|R21_muehlbacher_2011:18|R22_clark_1999:26|R25_brito_sanchez_2015:69|R28_li_2005:119|R39_shayanfar_2011:95|R40_vilar_2010:402|R41_toropov_2017:82|R44_bujak_2015:62|R46_mendoza_valencia_2017:67|R47_radchenko_2020:69|R48_hou_2003:95|R49_norinder_2002:60|R52_liu_2001:56	0.35	B1	BBB+	A	test
InChI=1S/C7H8ClN3O4S2/c8-4-1-5-7(2-6(4)16(9,12)13)17(14,15)11-3-10-5/h1-2,10-11H,3H2,(H2,9,12,13)	Hydrochlorothiazide	6-chloro-1,1-dioxo-3,4-dihydro-2H-1lambda6,2,4-benzothiadiazine-7-sulfonamide	NS(=O)(=O)c1cc2c(cc1Cl)NCNS2(=O)=O	3639.0	R14_ghose_2012:609|R23_gupta_2019:659|R28_li_2005:257|R51_doninger_2002:66			BBB-	C	test
InChI=1S/C7H8N2O/c1-9-5-3-2-4-7(9)6-8-10/h2-6H,1H3/p+1	Pralidoxime Chloride|Pralidoxime|Duodote	N-[(1-methylpyridin-1-ium-2-yl)methylidene]hydroxylamine	C[n+]1ccccc1C=NO	4884.0	R14_ghose_2012:787|R23_gupta_2019:853|R25_brito_sanchez_2015:453|R46_mendoza_valencia_2017:379	-0.17	B	BBB+	A	training
InChI=1S/C7H8N4O2/c1-10-3-8-5-4(10)6(12)11(2)7(13)9-5/h3H,1-2H3,(H,9,13)	Paraxanthine	1,7-dimethyl-3H-purine-2,6-dione	Cn1c(=O)[nH]c2ncn(C)c2c1=O	4687.0	R3_abraham_2006:219|R5_guerra_2008:78|R12_garg_2006:129|R21_muehlbacher_2011:108|R25_brito_sanchez_2015:345|R28_li_2005:103|R39_shayanfar_2011:69|R40_vilar_2010:177|R41_toropov_2017:200|R44_bujak_2015:79|R47_radchenko_2020:185	0.07	B1	BBB+	A	training
InChI=1S/C7H8N4O2/c1-10-3-8-5-4(10)6(12)9-7(13)11(5)2/h3H,1-2H3,(H,9,12,13)	Theobromine|83-67-0	3,7-dimethylpurine-2,6-dione	Cn1cnc2c1c(=O)[nH]c(=O)n2C	5429.0	R3_abraham_2006:281|R4_mente_2005:181|R5_guerra_2008:96|R6_adenot_2004:1687|R12_garg_2006:160|R21_muehlbacher_2011:134|R25_brito_sanchez_2015:139|R28_li_2005:117|R39_shayanfar_2011:90|R40_vilar_2010:269|R41_toropov_2017:253|R46_mendoza_valencia_2017:137|R47_radchenko_2020:236	-0.29	B	BBB+	A	training
InChI=1S/C7H8N4O2/c1-10-5-4(8-3-9-5)6(12)11(2)7(10)13/h3H,1-2H3,(H,8,9)	Theophylline|58-55-9|Theophyline|9-C1|Aminophylline	1,3-dimethyl-7H-purine-2,6-dione	Cn1c(=O)c2[nH]cnc2n(C)c1=O	2153.0	R3_abraham_2006:282|R4_mente_2005:182|R5_guerra_2008:97|R12_garg_2006:161|R14_ghose_2012:243|R17_fu_2008:31|R21_muehlbacher_2011:30|R25_brito_sanchez_2015:140|R26_chico_2009:412|R28_li_2005:48|R28_li_2005:170|R31_carpenter_2014:6|R40_vilar_2010:270|R41_toropov_2017:254|R42_ciura_2020:42|R46_mendoza_valencia_2017:138|R47_radchenko_2020:237|R48_hou_2003:1|R49_norinder_2002:88|R49_norinder_2002:113|R50_sobanska_2019:16|R51_doninger_2002:6|R51_doninger_2002:134	-0.31	B1	BBB+	A	training
InChI=1S/C7H8O/c8-6-7-4-2-1-3-5-7/h1-5,8H,6H2	Benzyl-Alcohol|Benzyl Alcohol	phenylmethanol	OCc1ccccc1	244.0	R6_adenot_2004:959			BBB+	C	training
InChI=1S/C7H8O2/c1-9-7-4-2-6(8)3-5-7/h2-5,8H,1H3	Mequinol	4-methoxyphenol	COc1ccc(O)cc1	9015.0	R23_gupta_2019:1073			BBB-	C	training
InChI=1S/C7H9ClO/c1-3-7(9,4-2)5-6-8/h1,5-6,9H,4H2,2H3/b6-5+	Ethchlorvynol	(E)-1-chloro-3-ethylpent-1-en-4-yn-3-ol	C#CC(O)(/C=C/Cl)CC	5281077.0	R6_adenot_2004:1332|R14_ghose_2012:314|R23_gupta_2019:85|R51_doninger_2002:213			BBB+	C	training
InChI=1S/C7H9NO3/c1-3-4-8-6(9)5(2)11-7(8)10/h3,5H,1,4H2,2H3	Allomethadione	5-methyl-3-prop-2-enyl-1,3-oxazolidine-2,4-dione	C=CCN1C(=O)OC(C)C1=O	10683.0	R6_adenot_2004:418			BBB+	C	test
InChI=1S/C7H9NO4S2/c9-7(6-2-1-4-13-6)8-3-5-14(10,11)12/h1-2,4H,3,5H2,(H,8,9)(H,10,11,12)	Taurosteine	2-(thiophene-2-carbonylamino)ethanesulfonic acid	O=C(NCCS(=O)(=O)O)c1cccs1	3086612.0	R23_gupta_2019:1086			BBB-	C	training
InChI=1S/C8BrF17/c9-7(22,23)5(18,19)3(14,15)1(10,11)2(12,13)4(16,17)6(20,21)8(24,25)26	Perflubron	1-bromo-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluorooctane	FC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)Br	9873.0	R14_ghose_2012:761			BBB-	C	training
InChI=1S/C8H10/c1-2-8-6-4-3-5-7-8/h3-7H,2H2,1H3	Ethylbenzene	ethylbenzene	CCc1ccccc1	7500.0	R3_abraham_2006:91|R5_guerra_2008:43|R12_garg_2006:78|R21_muehlbacher_2011:180|R25_brito_sanchez_2015:226|R28_li_2005:82|R39_shayanfar_2011:108|R40_vilar_2010:359|R41_toropov_2017:86|R44_bujak_2015:70|R46_mendoza_valencia_2017:208|R47_radchenko_2020:73	0.23	B1	BBB+	A	training
InChI=1S/C8H10/c1-7-3-5-8(2)6-4-7/h3-6H,1-2H3	P-Xylene	1,4-xylene	Cc1ccc(C)cc1	7809.0	R3_abraham_2006:90|R5_guerra_2008:76|R12_garg_2006:144|R21_muehlbacher_2011:183|R25_brito_sanchez_2015:327|R28_li_2005:132|R39_shayanfar_2011:78|R40_vilar_2010:391|R41_toropov_2017:85|R44_bujak_2015:71|R46_mendoza_valencia_2017:287|R47_radchenko_2020:72	0.35	B1	BBB+	A	training
InChI=1S/C8H10/c1-7-4-3-5-8(2)6-7/h3-6H,1-2H3	M-Xylene	1,3-xylene	Cc1cccc(C)c1	7929.0	R3_abraham_2006:89|R5_guerra_2008:60|R12_garg_2006:117|R21_muehlbacher_2011:191|R25_brito_sanchez_2015:308|R28_li_2005:130|R39_shayanfar_2011:65|R40_vilar_2010:380|R41_toropov_2017:84|R44_bujak_2015:80|R46_mendoza_valencia_2017:272|R47_radchenko_2020:71	0.25	B1	BBB+	A	training
InChI=1S/C8H10/c1-7-5-3-4-6-8(7)2/h3-6H,1-2H3	O-Xylene	1,2-xylene	Cc1ccccc1C	7237.0	R3_abraham_2006:88|R5_guerra_2008:75|R12_garg_2006:128|R21_muehlbacher_2011:174|R25_brito_sanchez_2015:342|R28_li_2005:131|R39_shayanfar_2011:68|R40_vilar_2010:386|R41_toropov_2017:83|R44_bujak_2015:81|R46_mendoza_valencia_2017:300|R47_radchenko_2020:70	0.39	B1	BBB+	A	training
InChI=1S/C8H10BFO3/c1-2-13-7-5-3-4-6(10)8(7)9(11)12/h3-5,11-12H,2H2,1H3	Pyridostigminebromide|2-Ethoxy-6-Fluorophenylboronic Acid	(2-ethoxy-6-fluorophenyl)boronic acid	CCOc1cccc(F)c1B(O)O	16217469.0	R28_li_2005:278			BBB+	C	training
InChI=1S/C8H10FN3O3S/c9-4-1-12(8(14)11-7(4)10)5-3-16-6(2-13)15-5/h1,5-6,13H,2-3H2,(H2,10,11,14)/t5-,6+/m0/s1	Emtricitabine|Ftc; Emtricitabine	4-amino-5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one	Nc1nc(=O)n([C@@H]2CS[C@H](CO)O2)cc1F	60877.0	R14_ghose_2012:523|R23_gupta_2019:555|R26_chico_2009:200	-1.22	A	BBB-	A	training
InChI=1S/C8H10N2O3S/c1-6(11)10-14(12,13)8-4-2-7(9)3-5-8/h2-5H,9H2,1H3,(H,10,11)	Sulfacetamide	N-(4-aminophenyl)sulfonylacetamide	CC(=O)NS(=O)(=O)c1ccc(N)cc1	5320.0	R23_gupta_2019:928			BBB-	C	test
InChI=1S/C8H10N2O4/c9-5(8(13)14)3-10-2-1-6(11)7(12)4-10/h1-2,4-5,12H,3,9H2,(H,13,14)	Mimosine|2-Amino-3-(3-Hydroxy-4-Oxopyridin-1-Yl)Propanoic Acid	2-amino-3-(3-hydroxy-4-oxopyridin-1-yl)propanoic acid	NC(Cn1ccc(=O)c(O)c1)C(=O)O	3862.0	R23_gupta_2019:751			BBB-	C	training
InChI=1S/C8H10N2OS/c11-8-7(9-3-4-10-8)6-2-1-5-12-6/h1-2,5,7,9H,3-4H2,(H,10,11)	Tenilsetam	3-thiophen-2-ylpiperazin-2-one	O=C1NCCNC1c1cccs1	65649.0	R6_adenot_2004:1275			BBB+	C	training
InChI=1S/C8H10N4O2/c1-10-4-9-6-5(10)7(13)12(3)8(14)11(6)2/h4H,1-3H3	Caffeine|58-08-2	1,3,7-trimethylpurine-2,6-dione	Cn1c(=O)c2c(ncn2C)n(C)c1=O	2519.0	R3_abraham_2006:140|R3_abraham_2006:141|R4_mente_2005:180|R5_guerra_2008:21|R12_garg_2006:51|R14_ghose_2012:34|R17_fu_2008:32|R21_muehlbacher_2011:46|R25_brito_sanchez_2015:177|R26_chico_2009:91|R28_li_2005:11|R34_broccatelli_2012:12|R37_chen_2011:17|R40_vilar_2010:68|R41_toropov_2017:133|R44_bujak_2015:18|R46_mendoza_valencia_2017:167|R47_radchenko_2020:119|R48_hou_2003:2|R49_norinder_2002:89|R49_norinder_2002:114|R50_sobanska_2019:22|R51_doninger_2002:170	-0.04	B1	BBB+	A	training
InChI=1S/C8H10N4O2/c1-2-3-12-6-5(9-4-10-6)7(13)11-8(12)14/h4H,2-3H2,1H3,(H,9,10)(H,11,13,14)	Enprofylline	3-propyl-7H-purine-2,6-dione	CCCn1c(=O)[nH]c(=O)c2[nH]cnc21	1676.0	R14_ghose_2012:528|R23_gupta_2019:560			BBB-	C	training
InChI=1S/C8H10N6S/c1-4-11-2-5(12-4)6-3-15-8(13-6)14-7(9)10/h2-3H,1H3,(H,11,12)(H4,9,10,13,14)	Zaltidine	2-[4-(2-methyl-1H-imidazol-5-yl)-1,3-thiazol-2-yl]guanidine	Cc1ncc(-c2csc(N=C(N)N)n2)[nH]1	56051.0	R25_brito_sanchez_2015:416|R46_mendoza_valencia_2017:353	-0.04	B	BBB+	A	training
InChI=1S/C8H10O4/c1-5(2)8(11)6(12-3)4-7(9)10/h4H,1H2,2-3H3,(H,9,10)/b6-4+	Penicillic Acid	(2E)-3-methoxy-5-methyl-4-oxohexa-2,5-dienoic acid	C=C(C)C(=O)/C(=C\C(=O)O)OC	5385314.0	R25_brito_sanchez_2015:439|R46_mendoza_valencia_2017:366	-0.79	B	BBB+	A	training
InChI=1S/C8H11Cl2N3O2/c9-1-3-13(4-2-10)6-5-11-8(15)12-7(6)14/h5H,1-4H2,(H2,11,12,14,15)	Uracil Mustard	5-[bis(2-chloroethyl)amino]-1H-pyrimidine-2,4-dione	O=c1[nH]cc(N(CCCl)CCCl)c(=O)[nH]1	6194.0	R14_ghose_2012:925|R23_gupta_2019:1012			BBB-	C	training
InChI=1S/C8H11Cl3O6/c9-8(10,11)7-16-5-3(14)4(2(13)1-12)15-6(5)17-7/h2-7,12-14H,1H2/t2-,3+,4-,5-,6-,7-/m1/s1	Chloralose	(1R)-1-[(2R,3aR,5R,6S,6aR)-6-hydroxy-2-(trichloromethyl)-3a,5,6,6a-tetrahydrofuro[2,3-d][1,3]dioxol-5-yl]ethane-1,2-diol	OC[C@@H](O)[C@H]1O[C@@H]2O[C@H](C(Cl)(Cl)Cl)O[C@@H]2[C@H]1O	7057995.0	R6_adenot_2004:1327			BBB+	C	training
InChI=1S/C8H11N3O3S/c9-5-1-2-11(8(13)10-5)6-4-15-7(3-12)14-6/h1-2,6-7,12H,3-4H2,(H2,9,10,13)/t6-,7+/m0/s1	Lamivudine	4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one	Nc1ccn([C@@H]2CS[C@H](CO)O2)c(=O)n1	60825.0	R14_ghose_2012:645|R23_gupta_2019:697			BBB-	C	training
InChI=1S/C8H11N5O2/c9-8-10-3-6-7(12-8)13(4-11-6)5-15-2-1-14/h3-4,14H,1-2,5H2,(H2,9,10,12)	Desciclovir	2-[(2-aminopurin-9-yl)methoxy]ethanol	Nc1ncc2ncn(COCCO)c2n1	55256.0	R6_adenot_2004:675			BBB+	C	training
InChI=1S/C8H11N5O3/c9-8-11-6-5(7(15)12-8)10-3-13(6)4-16-2-1-14/h3,14H,1-2,4H2,(H3,9,11,12,15)	Aciclovir|Acyclovir	2-amino-9-(2-hydroxyethoxymethyl)-1H-purin-6-one	Nc1nc2c(ncn2COCCO)c(=O)[nH]1	135398513.0	R6_adenot_2004:671|R25_brito_sanchez_2015:390|R26_chico_2009:18|R28_li_2005:176|R40_vilar_2010:27|R46_mendoza_valencia_2017:335|R47_radchenko_2020:334|R50_sobanska_2019:10	-0.78	B1	BBB+	A	training
InChI=1S/C8H11NO2/c1-11-7-4-2-3-6(5-9)8(7)10/h2-4,10H,5,9H2,1H3	3-Mosa|2-(Aminomethyl)-6-Methoxyphenol	2-(aminomethyl)-6-methoxyphenol	COc1cccc(CN)c1O	16775572.0	R47_radchenko_2020:374	0.56	A	BBB+	A	test
InChI=1S/C8H11NO2/c1-3-9-5-4-7(10)8(11)6(9)2/h4-5,11H,3H2,1-2H3	Cp21|1-Ethyl-3-Hydroxy-2-Methylpyridin-4(1H)-One	1-ethyl-3-hydroxy-2-methylpyridin-4-one	CCn1ccc(=O)c(O)c1C	94413.0	R28_li_2005:342			BBB+	C	training
InChI=1S/C8H11NO2/c9-5-8(11)6-2-1-3-7(10)4-6/h1-4,8,10-11H,5,9H2	Norfenefrine	3-(2-amino-1-hydroxyethyl)phenol	NCC(O)c1cccc(O)c1	4538.0	R6_adenot_2004:95|R7_andres_2006:120|R29_subramanian_2003:116|R51_doninger_2002:99			BBB-	C	training
InChI=1S/C8H11NO3/c1-5-8(12)7(4-11)6(3-10)2-9-5/h2,10-12H,3-4H2,1H3	Pyridoxine	4,5-bis(hydroxymethyl)-2-methylpyridin-3-ol	Cc1ncc(CO)c(CO)c1O	1054.0	R23_gupta_2019:868			BBB-	C	training
InChI=1S/C8H11NO3/c9-4-8(12)5-1-2-6(10)7(11)3-5/h1-3,8,10-12H,4,9H2/t8-/m0/s1	Norepinephrine	4-[(1R)-2-amino-1-hydroxyethyl]benzene-1,2-diol	NC[C@H](O)c1ccc(O)c(O)c1	439260.0	R28_li_2005:211			BBB-	C	training
InChI=1S/C8H12N2/c1-5-6(2)10-8(4)7(3)9-5/h1-4H3	2,3,5,6-Tetramethylpyrazine	2,3,5,6-tetramethylpyrazine	Cc1nc(C)c(C)nc1C	14296.0	R26_chico_2009:6	-0.1	A	BBB+	A	training
InChI=1S/C8H12N2/c1-7(10-9)8-5-3-2-4-6-8/h2-7,10H,9H2,1H3	Mebanazine	1-phenylethylhydrazine	CC(NN)c1ccccc1	6179.0	R6_adenot_2004:974			BBB+	C	training
InChI=1S/C8H12N2/c1-9-7-5-8-4-2-3-6-10-8/h2-4,6,9H,5,7H2,1H3	Betahistine|5638-76-6|Y-G14|5-66	N-methyl-2-pyridin-2-ylethanamine	CNCCc1ccccn1	2366.0	R3_abraham_2006:132|R4_mente_2005:112|R12_garg_2006:175|R14_ghose_2012:20|R21_muehlbacher_2011:38|R23_gupta_2019:23|R25_brito_sanchez_2015:159|R28_li_2005:124|R28_li_2005:144|R40_vilar_2010:302|R41_toropov_2017:125|R42_ciura_2020:7|R46_mendoza_valencia_2017:154|R47_radchenko_2020:112|R48_hou_2003:28|R48_hou_2003:57|R49_norinder_2002:78|R50_sobanska_2019:15	-0.3	D	BBB+	A	training
InChI=1S/C8H12N2/c9-10-7-6-8-4-2-1-3-5-8/h1-5,10H,6-7,9H2	Phenelzine|Phenelzinesulfate	2-phenylethylhydrazine	NNCCc1ccccc1	3675.0	R6_adenot_2004:978|R14_ghose_2012:194|R23_gupta_2019:194|R25_brito_sanchez_2015:510|R26_chico_2009:308|R51_doninger_2002:281	-0.2	A	BBB+	A	test
InChI=1S/C8H12N2O3/c1-3-8(4-2)5(11)9-7(13)10-6(8)12/h3-4H2,1-2H3,(H2,9,10,11,12,13)	Barbital	5,5-diethyl-1,3-diazinane-2,4,6-trione	CCC1(CC)C(=O)NC(=O)NC1=O	2294.0	R3_abraham_2006:129|R6_adenot_2004:1639|R21_muehlbacher_2011:36|R25_brito_sanchez_2015:133|R26_chico_2009:75|R40_vilar_2010:42|R41_toropov_2017:122|R42_ciura_2020:5|R46_mendoza_valencia_2017:131|R47_radchenko_2020:109	-0.14	B	BBB+	A	test
InChI=1S/C8H12N2S/c1-9-6-2-3-7-8(4-6)11-5-10-7/h5-6,9H,2-4H2,1H3	Etrabamine	N-methyl-4,5,6,7-tetrahydro-1,3-benzothiazol-6-amine	CNC1CCc2ncsc2C1	68895.0	R6_adenot_2004:538			BBB+	C	training
InChI=1S/C8H12N4/c1-2-10-8(11-3-1)12-6-4-9-5-7-12/h1-3,9H,4-7H2	1-(2-Pyrimidinyl)-Piperazine|2-(1-Piperazinyl)Pyrimidine	2-piperazin-1-ylpyrimidine	c1cnc(N2CCNCC2)nc1	88747.0	R26_chico_2009:1	0.6	A	BBB+	A	training
InChI=1S/C8H12N4O4/c9-7-10-3-12(8(15)11-7)6-1-4(14)5(2-13)16-6/h3-6,13-14H,1-2H2,(H2,9,11,15)/t4-,5+,6+/m0/s1	Decitabine	4-amino-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,3,5-triazin-2-one	Nc1ncn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)n1	451668.0	R23_gupta_2019:502			BBB-	C	training
InChI=1S/C8H12N4O5/c9-6(16)7-10-2-12(11-7)8-5(15)4(14)3(1-13)17-8/h2-5,8,13-15H,1H2,(H2,9,16)	1-[3,4-Dihydroxy-5-(Hydroxymethyl)Oxolan-2-Yl]-1H-1,2,4-Triazole-3-Carboxamide	1-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,4-triazole-3-carboxamide	NC(=O)c1ncn(C2OC(CO)C(O)C2O)n1	5064.0	R46_mendoza_valencia_2017:336	-0.67	A	BBB+	A	training
InChI=1S/C8H12N4O5/c9-6(16)7-10-2-12(11-7)8-5(15)4(14)3(1-13)17-8/h2-5,8,13-15H,1H2,(H2,9,16)/t3-,4-,5-,8-/m1/s1	Ribavirin	1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,4-triazole-3-carboxamide	NC(=O)c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)n1	37542.0	R14_ghose_2012:821|R21_muehlbacher_2011:120|R25_brito_sanchez_2015:393|R28_li_2005:281|R40_vilar_2010:229|R47_radchenko_2020:344	-0.67	B	BBB+	A	training
InChI=1S/C8H12N4O5/c9-7-10-2-12(8(16)11-7)6-5(15)4(14)3(1-13)17-6/h2-6,13-15H,1H2,(H2,9,11,16)/t3-,4-,5-,6-/m1/s1	Azacitidine	4-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,3,5-triazin-2-one	Nc1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1	9444.0	R14_ghose_2012:367|R23_gupta_2019:370			BBB-	C	training
InChI=1S/C8H12N5O4P/c9-7-6-8(11-3-10-7)13(4-12-6)1-2-17-5-18(14,15)16/h3-4H,1-2,5H2,(H2,9,10,11)(H2,14,15,16)	Adefovir	2-(6-aminopurin-9-yl)ethoxymethylphosphonic acid	Nc1ncnc2c1ncn2CCOCP(=O)(O)O	60172.0	R14_ghose_2012:330			BBB-	C	training
InChI=1S/C8H13N3O4S/c1-3-16(14,15)5-4-10-7(2)9-6-8(10)11(12)13/h6H,3-5H2,1-2H3	Tinidazole	1-(2-ethylsulfonylethyl)-2-methyl-5-nitroimidazole	CCS(=O)(=O)CCn1c([N+](=O)[O-])cnc1C	5479.0	R14_ghose_2012:897|R23_gupta_2019:981			BBB-	C	training
InChI=1S/C8H13NO2/c1-3-8(2)4-6(10)9-7(11)5-8/h3-5H2,1-2H3,(H,9,10,11)	Bemegride	4-ethyl-4-methylpiperidine-2,6-dione	CCC1(C)CC(=O)NC(=O)C1	2310.0	R6_adenot_2004:394			BBB+	C	training
InChI=1S/C8H13NO2/c1-9-5-3-4-7(6-9)8(10)11-2/h4H,3,5-6H2,1-2H3	Arecoline	methyl 1-methyl-3,6-dihydro-2H-pyridine-5-carboxylate	COC(=O)C1=CCCN(C)C1	2230.0	R51_doninger_2002:156			BBB+	C	training
InChI=1S/C8H14N2O/c1-10-5-3-4-8(7-10)6-9-11-2/h4,6H,3,5,7H2,1-2H3/b9-6+	Milameline|N-Methoxy-1-(1-Methyl-5,6-Dihydro-2H-Pyridin-3-Yl)Methanimine	(Z)-N-methoxy-1-(1-methyl-3,6-dihydro-2H-pyridin-5-yl)methanimine	CO/N=C\C1=CCCN(C)C1	6435812.0	R6_adenot_2004:1269			BBB+	C	training
InChI=1S/C8H14N2O2/c1-2-6(8(9)12)10-5-3-4-7(10)11/h6H,2-5H2,1H3,(H2,9,12)	Etiracetam	2-(2-oxopyrrolidin-1-yl)butanamide	CCC(C(N)=O)N1CCCC1=O	59708.0	R6_adenot_2004:1258			BBB+	C	training
InChI=1S/C8H14N2O2/c1-2-6(8(9)12)10-5-3-4-7(10)11/h6H,2-5H2,1H3,(H2,9,12)/t6-/m0/s1	Levetiracetam|Memantine, Namenda	(2S)-2-(2-oxopyrrolidin-1-yl)butanamide	CC[C@@H](C(N)=O)N1CCCC1=O	5284583.0	R6_adenot_2004:1261|R14_ghose_2012:120|R23_gupta_2019:122|R25_brito_sanchez_2015:445|R26_chico_2009:237|R26_chico_2009:256|R37_chen_2011:44|R46_mendoza_valencia_2017:371	-0.04	B	BBB+	A	training
InChI=1S/C8H14N3O6P/c9-7-1-2-11(8(13)10-7)3-6(4-12)17-5-18(14,15)16/h1-2,6,12H,3-5H2,(H2,9,10,13)(H2,14,15,16)/t6-/m0/s1	Cidofovir	[(2S)-1-(4-amino-2-oxopyrimidin-1-yl)-3-hydroxypropan-2-yl]oxymethylphosphonic acid	Nc1ccn(C[C@@H](CO)OCP(=O)(O)O)c(=O)n1	60613.0	R23_gupta_2019:457			BBB-	C	training
InChI=1S/C8H14O2/c1-3-9-7-5-6-8-10-4-2/h3-4H,1-2,5-8H2	1,4-Divinyloxybutane|Butane, 1,4-Bis(Ethenyloxy)-	1,4-bis(ethenoxy)butane	C=COCCCCOC=C	77501.0	R21_muehlbacher_2011:271|R25_brito_sanchez_2015:407|R46_mendoza_valencia_2017:345|R47_radchenko_2020:366	0.12	B	BBB+	A	training
InChI=1S/C8H15Cl3O3/c1-5(4-7(2,3)13)14-6(12)8(9,10)11/h5-6,12-13H,4H2,1-3H3	Chloralodol	2-methyl-4-(2,2,2-trichloro-1-hydroxyethoxy)pentan-2-ol	CC(CC(C)(C)O)OC(O)C(Cl)(Cl)Cl	19094.0	R6_adenot_2004:1326			BBB+	C	training
InChI=1S/C8H15N3O7/c1-11(10-17)8(16)9-4-6(14)5(13)3(2-12)18-7(4)15/h3-7,12-15H,2H2,1H3,(H,9,16)	Streptozotocin|Streptozotocin;U 9889	1-methyl-1-nitroso-3-[2,4,5-trihydroxy-6-(hydroxymethyl)oxan-3-yl]urea	CN(N=O)C(=O)NC1C(O)OC(CO)C(O)C1O	5300.0	R28_li_2005:307			BBB-	C	training
InChI=1S/C8H15N3O7/c1-11(10-17)8(16)9-4-6(14)5(13)3(2-12)18-7(4)15/h3-7,12-15H,2H2,1H3,(H,9,16)/t3-,4-,5-,6-,7+/m1/s1	Streptozocin	1-methyl-1-nitroso-3-[(2S,3R,4R,5S,6R)-2,4,5-trihydroxy-6-(hydroxymethyl)oxan-3-yl]urea	CN(N=O)C(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O	29327.0	R23_gupta_2019:926			BBB-	C	training
InChI=1S/C8H15NO2/c1-3-5-6-8(4-2,11-6)7(9)10/h6H,3-5H2,1-2H3,(H2,9,10)	Oxanamide	2-ethyl-3-propyloxirane-2-carboxamide	CCCC1OC1(CC)C(N)=O	31365.0	R6_adenot_2004:1497			BBB+	C	training
InChI=1S/C8H15NO2/c9-5-6-1-3-7(4-2-6)8(10)11/h6-7H,1-5,9H2,(H,10,11)	Tranexamic Acid	4-(aminomethyl)cyclohexane-1-carboxylic acid	NCC1CCC(C(=O)O)CC1	5526.0	R14_ghose_2012:908			BBB-	C	training
InChI=1S/C8H16/c1-3-5-7-8-6-4-2/h3H,1,4-8H2,2H3	1-Octene	oct-1-ene	C=CCCCCCC	8125.0	R3_abraham_2006:47|R21_muehlbacher_2011:198|R25_brito_sanchez_2015:59|R40_vilar_2010:323|R41_toropov_2017:42|R46_mendoza_valencia_2017:58|R47_radchenko_2020:30	0.74	B	BBB+	A	training
InChI=1S/C8H16/c1-7-5-3-4-6-8(7)2/h7-8H,3-6H2,1-2H3	1,2-Dimethylcyclohexane|Hexahydro-O-Xylene	1,2-dimethylcyclohexane	CC1CCCCC1C	11416.0	R3_abraham_2006:26|R21_muehlbacher_2011:212|R25_brito_sanchez_2015:47|R40_vilar_2010:315|R41_toropov_2017:21|R46_mendoza_valencia_2017:46|R47_radchenko_2020:11	1.07	B	BBB+	A	training
InChI=1S/C8H16N2O4/c1-4(5(2)13-7(9)11)6(3)14-8(10)12/h4-6H,1-3H3,(H2,9,11)(H2,10,12)	Pentabamate	(4-carbamoyloxy-3-methylpentan-2-yl) carbamate	CC(OC(N)=O)C(C)C(C)OC(N)=O	3047822.0	R6_adenot_2004:1659			BBB+	C	training
InChI=1S/C8H16NO5P/c1-3-14-8(10)7(9)4-6(2)5-15(11,12)13/h4,7H,3,5,9H2,1-2H3,(H2,11,12,13)/b6-4+	Cgp-39551|(E)-(4-Amino-5-Ethoxy-2-Methyl-5-Oxopent-2-En-1-Yl)Phosphonic Acid	[(E)-4-amino-5-ethoxy-2-methyl-5-oxopent-2-enyl]phosphonic acid	CCOC(=O)C(N)/C=C(\C)CP(=O)(O)O	6372334.0	R7_andres_2006:77|R29_subramanian_2003:20			BBB+	C	training
InChI=1S/C8H16O2/c1-3-5-7(6-4-2)8(9)10/h7H,3-6H2,1-2H3,(H,9,10)	Valproic Acid|99-66-1|Sodium Valproate|Valproic-Acid|Valproicacid	2-propylpentanoic acid	CCCC(CCC)C(=O)O	3121.0	R3_abraham_2006:296|R4_mente_2005:29|R5_guerra_2008:91|R6_adenot_2004:475|R7_andres_2006:222|R12_garg_2006:172|R14_ghose_2012:267|R17_fu_2008:27|R21_muehlbacher_2011:64|R25_brito_sanchez_2015:32|R26_chico_2009:439|R28_li_2005:52|R39_shayanfar_2011:98|R41_toropov_2017:264|R46_mendoza_valencia_2017:31|R47_radchenko_2020:246|R48_hou_2003:62|R49_norinder_2002:69|R49_norinder_2002:112|R51_doninger_2002:324	-0.22	D	BBB+	A	training
InChI=1S/C8H17NO/c1-3-5-7(6-4-2)8(9)10/h7H,3-6H2,1-2H3,(H2,9,10)	Valpromide	2-propylpentanamide	CCCC(CCC)C(N)=O	71113.0	R6_adenot_2004:476			BBB+	C	training
InChI=1S/C8H17NO/c1-4-6(3)7(5-2)8(9)10/h6-7H,4-5H2,1-3H3,(H2,9,10)	Valnoctamide	2-ethyl-3-methylpentanamide	CCC(C)C(CC)C(N)=O	20140.0	R6_adenot_2004:1525			BBB+	C	training
InChI=1S/C8H17NO2/c1-6(2)3-7(5-9)4-8(10)11/h6-7H,3-5,9H2,1-2H3,(H,10,11)	Pregabalin|3-(Aminomethyl)-5-Methylhexanoic Acid	3-(aminomethyl)-5-methylhexanoic acid	CC(C)CC(CN)CC(=O)O	4715169.0	R6_adenot_2004:458|R14_ghose_2012:208|R26_chico_2009:318|R37_chen_2011:75	-0.54	A	BBB+	A	test
InChI=1S/C8H17NO5/c10-2-1-9-3-6(12)8(14)7(13)5(9)4-11/h5-8,10-14H,1-4H2/t5-,6+,7-,8-/m1/s1	Miglitol	(2R,3R,4R,5S)-1-(2-hydroxyethyl)-2-(hydroxymethyl)piperidine-3,4,5-triol	OCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO	441314.0	R7_andres_2006:106|R14_ghose_2012:695|R29_subramanian_2003:101			BBB-	C	training
InChI=1S/C8H18/c1-3-5-7-8-6-4-2/h3-8H2,1-2H3	Octane	octane	CCCCCCCC	356.0	R3_abraham_2006:12|R21_muehlbacher_2011:7|R25_brito_sanchez_2015:331|R40_vilar_2010:385|R41_toropov_2017:7|R46_mendoza_valencia_2017:291|R47_radchenko_2020:492	0.69	B	BBB+	A	training
InChI=1S/C8H18/c1-4-5-6-7-8(2)3/h8H,4-7H2,1-3H3	2-Methylheptane|2-Methyl Heptane	2-methylheptane	CCCCCC(C)C	11594.0	R21_muehlbacher_2011:214|R25_brito_sanchez_2015:71|R40_vilar_2010:329|R41_toropov_2017:12|R46_mendoza_valencia_2017:69|R47_radchenko_2020:1	0.88	B1	BBB+	A	training
InChI=1S/C8H18NO2/c1-7(11-8(2)10)6-9(3,4)5/h7H,6H2,1-5H3/q+1	Methacholine	2-acetyloxypropyl(trimethyl)azanium	CC(=O)OC(C)C[N+](C)(C)C	1993.0	R23_gupta_2019:732			BBB-	C	training
InChI=1S/C8H18O4S2/c1-5-8(4,13(9,10)6-2)14(11,12)7-3/h5-7H2,1-4H3	Sulfonethylmethane	2,2-bis(ethylsulfonyl)butane	CCC(C)(S(=O)(=O)CC)S(=O)(=O)CC	6433.0	R6_adenot_2004:1390			BBB+	C	training
InChI=1S/C8H20N2/c1-3-4-5-6-7-8(2)10-9/h8,10H,3-7,9H2,1-2H3	Octamoxin	octan-2-ylhydrazine	CCCCCCC(C)NN	20811.0	R6_adenot_2004:977			BBB+	C	training
InChI=1S/C8H3Cl2N3O4/c9-2-1-3-5(6(4(2)10)13(16)17)12-8(15)7(14)11-3/h1H,(H,11,14)(H,12,15)	Licostinel	6,7-dichloro-5-nitro-1,4-dihydroquinoxaline-2,3-dione	O=c1[nH]c2cc(Cl)c(Cl)c([N+](=O)[O-])c2[nH]c1=O	5486198.0	R6_adenot_2004:1636			BBB+	C	training
InChI=1S/C8H5F3N2OS/c9-8(10,11)14-4-1-2-5-6(3-4)15-7(12)13-5/h1-3H,(H2,12,13)	Riluzole	6-(trifluoromethoxy)-1,3-benzothiazol-2-amine	Nc1nc2ccc(OC(F)(F)F)cc2s1	5070.0	R6_adenot_2004:463|R14_ghose_2012:828|R23_gupta_2019:219|R26_chico_2009:349|R34_broccatelli_2012:78|R37_chen_2011:83	0.3	A	BBB+	A	training
InChI=1S/C8H6Cl3NO2/c9-8(10,11)7(14)12-5-1-3-6(13)4-2-5/h1-4,13H,(H,12,14)	Triclacetamol	2,2,2-trichloro-N-(4-hydroxyphenyl)acetamide	O=C(Nc1ccc(O)cc1)C(Cl)(Cl)Cl	242364.0	R6_adenot_2004:412			BBB+	C	training
InChI=1S/C8H6N2O2/c11-7-4-2-1-3-6(7)8-10-9-5-12-8/h1-5,11H	Fenadiazole	2-(1,3,4-oxadiazol-2-yl)phenol	Oc1ccccc1-c1nnco1	13883.0	R6_adenot_2004:1361			BBB+	C	training
InChI=1S/C8H6N4O5/c13-6-4-11(8(14)10-6)9-3-5-1-2-7(17-5)12(15)16/h1-3H,4H2,(H,10,13,14)/b9-3+	Nitrofurantoin|Hydantoin, 1-(5-Nitro-Furfurylideneamino)-	1-[(Z)-(5-nitrofuran-2-yl)methylideneamino]imidazolidine-2,4-dione	O=C1CN(/N=C\c2ccc([N+](=O)[O-])o2)C(=O)N1	5353830.0	R14_ghose_2012:725|R25_brito_sanchez_2015:576|R46_mendoza_valencia_2017:481|R53_friden_2009:24	-2.09	B	BBB-	A	test
InChI=1S/C8H7ClN2O2S/c1-5-10-7-3-2-6(9)4-8(7)14(12,13)11-5/h2-4H,1H3,(H,10,11)	Diazoxide	7-chloro-3-methyl-4H-1lambda6,2,4-benzothiadiazine 1,1-dioxide	CC1=NS(=O)(=O)c2cc(Cl)ccc2N1	3019.0	R14_ghose_2012:490			BBB-	C	test
InChI=1S/C8H7N3O5/c12-8-10(3-4-15-8)9-5-6-1-2-7(16-6)11(13)14/h1-2,5H,3-4H2/b9-5+	Furazolidone|Furazolidona	3-[(Z)-(5-nitrofuran-2-yl)methylideneamino]-1,3-oxazolidin-2-one	O=C1OCCN1/N=C\c1ccc([N+](=O)[O-])o1	5353636.0	R14_ghose_2012:583|R23_gupta_2019:618			BBB-	C	training
InChI=1S/C8H8/c1-2-8-6-4-3-5-7-8/h2-7H,1H2	Styrene|Vinylbenzene	styrene	C=Cc1ccccc1	7501.0	R3_abraham_2006:92|R21_muehlbacher_2011:181|R25_brito_sanchez_2015:143|R40_vilar_2010:394|R41_toropov_2017:87|R46_mendoza_valencia_2017:141|R47_radchenko_2020:74	0.45	B	BBB+	A	training
InChI=1S/C8H8BrNO2/c1-4-2-5(9)3-6(7(4)11)8(10)12/h2-3,11H,1H3,(H2,10,12)	Brosotamide	5-bromo-2-hydroxy-3-methylbenzamide	Cc1cc(Br)cc(C(N)=O)c1O	38706.0	R6_adenot_2004:424			BBB+	C	test
InChI=1S/C8H8Cl2N4/c9-6-2-1-3-7(10)5(6)4-13-14-8(11)12/h1-4H,(H4,11,12,14)/b13-4+	Guanabenz|2-[(Z)-(2,6-Dichlorophenyl)Methylideneamino]Guanidine	2-[(Z)-(2,6-dichlorophenyl)methylideneamino]guanidine	NC(N)=N/N=C\c1c(Cl)cccc1Cl	5353646.0	R7_andres_2006:78|R23_gupta_2019:646|R29_subramanian_2003:72|R51_doninger_2002:62			BBB-	C	training
InChI=1S/C8H8Cl3N3O4S2/c9-3-1-4-6(2-5(3)19(12,15)16)20(17,18)14-8(13-4)7(10)11/h1-2,7-8,13-14H,(H2,12,15,16)	Trichlormethiazide	6-chloro-3-(dichloromethyl)-1,1-dioxo-3,4-dihydro-2H-1lambda6,2,4-benzothiadiazine-7-sulfonamide	NS(=O)(=O)c1cc2c(cc1Cl)NC(C(Cl)Cl)NS2(=O)=O	5560.0	R14_ghose_2012:914|R23_gupta_2019:998|R51_doninger_2002:140			BBB-	C	test
InChI=1S/C8H8F3N3O4S2/c9-8(10,11)4-1-5-7(2-6(4)19(12,15)16)20(17,18)14-3-13-5/h1-2,13-14H,3H2,(H2,12,15,16)	Hydroflumethiazide	1,1-dioxo-6-(trifluoromethyl)-3,4-dihydro-2H-1lambda6,2,4-benzothiadiazine-7-sulfonamide	NS(=O)(=O)c1cc2c(cc1C(F)(F)F)NCNS2(=O)=O	3647.0	R14_ghose_2012:612|R23_gupta_2019:660|R51_doninger_2002:68			BBB-	C	test
InChI=1S/C8H8FNO5/c9-8(6(14)15)3-2(11)1-7(10,4(3)8)5(12)13/h3-4H,1,10H2,(H,12,13)(H,14,15)/t3-,4-,7+,8-/m1/s1	Mgs0028|Bicyclo(3.1.0)Hexane-2,6-Dicarboxylic Acid, 2-Amino-6-Fluoro-4-Oxo-, (1R,2S,5S,6S)-	(1R,2S,5S,6S)-2-amino-6-fluoro-4-oxobicyclo[3.1.0]hexane-2,6-dicarboxylic acid	N[C@@]1(C(=O)O)CC(=O)[C@@H]2[C@H]1[C@@]2(F)C(=O)O	9837317.0	R25_brito_sanchez_2015:440|R46_mendoza_valencia_2017:367	-0.41	B	BBB+	A	test
InChI=1S/C8H8N2O3S/c9-14(11,12)5-7-6-3-1-2-4-8(6)13-10-7/h1-4H,5H2,(H2,9,11,12)	Zonisamide	1,2-benzoxazol-3-ylmethanesulfonamide	NS(=O)(=O)Cc1noc2ccccc12	5734.0	R6_adenot_2004:480|R7_andres_2006:186|R14_ghose_2012:273|R23_gupta_2019:268|R26_chico_2009:448|R28_li_2005:298|R29_subramanian_2003:181|R34_broccatelli_2012:102|R37_chen_2011:110			BBB+	C	training
InChI=1S/C8H8N4/c9-11-8-7-4-2-1-3-6(7)5-10-12-8/h1-5H,9H2,(H,11,12)	Hydralazine Hydrochloride|Hydralazine	phthalazin-1-ylhydrazine	NNc1nncc2ccccc12	3637.0	R14_ghose_2012:608|R23_gupta_2019:658|R51_doninger_2002:65			BBB-	C	training
InChI=1S/C8H8OS/c1-7(9)4-5-8-3-2-6-10-8/h2-6H,1H3/b5-4+	Sr-4688|4-(2-Thienyl)But-3-En-2-One	(E)-4-thiophen-2-ylbut-3-en-2-one	CC(=O)/C=C/c1cccs1	735949.0	R26_chico_2009:389	-0.14	A	BBB+	A	training
InChI=1S/C8H9FN2O3/c9-5-4-11(6-2-1-3-14-6)8(13)10-7(5)12/h4,6H,1-3H2,(H,10,12,13)	Tegafur	5-fluoro-1-(oxolan-2-yl)pyrimidine-2,4-dione	O=c1[nH]c(=O)n(C2CCCO2)cc1F	5386.0	R14_ghose_2012:877			BBB-	C	training
InChI=1S/C8H9FO2S/c1-2-12(10,11)8-5-3-7(9)4-6-8/h3-6H,2H2,1H3	Fluoresone	1-ethylsulfonyl-4-fluorobenzene	CCS(=O)(=O)c1ccc(F)cc1	71814.0	R6_adenot_2004:1469			BBB+	C	test
InChI=1S/C8H9N3O4/c12-8(7-2-1-3-9-6-7)10-4-5-15-11(13)14/h1-3,6H,4-5H2,(H,10,12)	Nicorandil	2-(pyridine-3-carbonylamino)ethyl nitrate	O=C(NCCO[N+](=O)[O-])c1cccnc1	47528.0	R14_ghose_2012:717|R23_gupta_2019:776			BBB-	C	training
InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)	Paracetamol|103-90-2|Acetaminophen|Acetaminophen/Paracetamol|P-Acetamidophenol	N-(4-hydroxyphenyl)acetamide	CC(=O)Nc1ccc(O)cc1	1983.0	R3_abraham_2006:218|R4_mente_2005:18|R5_guerra_2008:77|R6_adenot_2004:408|R7_andres_2006:188|R12_garg_2006:15|R14_ghose_2012:278|R17_fu_2008:29|R21_muehlbacher_2011:25|R23_gupta_2019:1|R25_brito_sanchez_2015:106|R26_chico_2009:15|R28_li_2005:64|R28_li_2005:214|R39_shayanfar_2011:118|R40_vilar_2010:25|R41_toropov_2017:199|R42_ciura_2020:2|R44_bujak_2015:7|R46_mendoza_valencia_2017:104|R47_radchenko_2020:184|R48_hou_2003:5|R49_norinder_2002:68|R49_norinder_2002:118|R50_sobanska_2019:14|R51_doninger_2002:1|R51_doninger_2002:271	-0.36	B1	BBB+	A	training
InChI=1S/C8H9NO2/c1-6(10)9-7-3-2-4-8(11)5-7/h2-5,11H,1H3,(H,9,10)	Metacetamol	N-(3-hydroxyphenyl)acetamide	CC(=O)Nc1cccc(O)c1	12124.0	R6_adenot_2004:406			BBB+	C	test
InChI=1S/C8H9NO3/c1-5-8(12)7(4-11)6(3-10)2-9-5/h2,4,10,12H,3H2,1H3	Pyridoxal	3-hydroxy-5-(hydroxymethyl)-2-methylpyridine-4-carbaldehyde	Cc1ncc(CO)c(C=O)c1O	1050.0	R23_gupta_2019:867			BBB-	C	training
InChI=1S/C9H10ClN3/c1-5-8-6(10)3-2-4-7(8)13-9(11)12-5/h2-5H,1H3,(H3,11,12,13)	5-Chloro-4-Methyl-1,4-Dihydroquinazolin-2-Amine	5-chloro-4-methyl-1,4-dihydroquinazolin-2-amine	CC1N=C(N)Nc2cccc(Cl)c21	16006492.0	R46_mendoza_valencia_2017:394	-0.7	A	BBB+	A	training
InChI=1S/C9H10ClN3S/c10-6-1-2-8(7(11)5-6)13-3-4-14-9(13)12/h1-2,5,12H,3-4,11H2/b12-9-	Timirdine	5-chloro-2-(2-imino-1,3-thiazolidin-3-yl)aniline	[H]/N=C1\SCCN1c1ccc(Cl)cc1N	3063289.0	R6_adenot_2004:621			BBB+	C	training
InChI=1S/C9H10FN/c10-7-3-1-6(2-4-7)8-5-9(8)11/h1-4,8-9H,5,11H2/t8-,9+/m1/s1	( + )-4-Fluorotranylcypromine|(1S,2R)-2-(4-Fluorophenyl)Cyclopropanamine	(1S,2R)-2-(4-fluorophenyl)cyclopropan-1-amine	N[C@H]1C[C@@H]1c1ccc(F)cc1	39235321.0	R25_brito_sanchez_2015:447|R46_mendoza_valencia_2017:373	0.81	B	BBB+	A	test
InChI=1S/C9H10N2O2/c10-9(13)11-8(12)6-7-4-2-1-3-5-7/h1-5H,6H2,(H3,10,11,12,13)	Phenacemide	N-carbamoyl-2-phenylacetamide	NC(=O)NC(=O)Cc1ccccc1	4753.0	R6_adenot_2004:459|R14_ghose_2012:191|R23_gupta_2019:191			BBB+	C	training
InChI=1S/C9H10N2O3/c10-7-3-1-6(2-4-7)9(14)11-5-8(12)13/h1-4H,5,10H2,(H,11,14)(H,12,13)	Aminohippurate|Aminohippuric Acid	2-[(4-aminobenzoyl)amino]acetic acid	Nc1ccc(C(=O)NCC(=O)O)cc1	2148.0	R23_gupta_2019:344			BBB-	C	training
InChI=1S/C9H10N4O2S2/c1-6-11-12-9(16-6)13-17(14,15)8-4-2-7(10)3-5-8/h2-5H,10H2,1H3,(H,12,13)	Sulfamethizole	4-amino-N-(5-methyl-1,3,4-thiadiazol-2-yl)benzenesulfonamide	Cc1nnc(NS(=O)(=O)c2ccc(N)cc2)s1	5328.0	R14_ghose_2012:860|R23_gupta_2019:936			BBB-	C	training
InChI=1S/C9H11Cl/c1-2-3-8-4-6-9(10)7-5-8/h4-7H,2-3H2,1H3	Salicylicacid|1-Chloro-4-Propylbenzene	1-chloro-4-propylbenzene	CCCc1ccc(Cl)cc1	521435.0	R28_li_2005:46			BBB-	C	test
InChI=1S/C9H11Cl2N3O4S2/c1-14-9(4-10)13-6-2-5(11)7(19(12,15)16)3-8(6)20(14,17)18/h2-3,9,13H,4H2,1H3,(H2,12,15,16)	Methyclothiazide	6-chloro-3-(chloromethyl)-2-methyl-1,1-dioxo-3,4-dihydro-1lambda6,2,4-benzothiadiazine-7-sulfonamide	CN1C(CCl)Nc2cc(Cl)c(S(N)(=O)=O)cc2S1(=O)=O	4121.0	R14_ghose_2012:688|R23_gupta_2019:741|R51_doninger_2002:90			BBB-	C	test
InChI=1S/C9H11ClO3/c10-7-1-3-9(4-2-7)13-6-8(12)5-11/h1-4,8,11-12H,5-6H2	Chlorphenesin	3-(4-chlorophenoxy)propane-1,2-diol	OCC(O)COc1ccc(Cl)cc1	7697.0	R14_ghose_2012:42|R23_gupta_2019:273			BBB+	C	training
InChI=1S/C9H11F2N3O4/c10-9(11)6(16)4(3-15)18-7(9)14-2-1-5(12)13-8(14)17/h1-2,4,6-7,15-16H,3H2,(H2,12,13,17)/t4-,6-,7-/m1/s1	Gemcitabine	4-amino-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one	Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1	60750.0	R23_gupta_2019:627			BBB-	C	training
InChI=1S/C9H11FN2O4/c10-5-3-8(16-6(5)4-13)12-2-1-7(14)11-9(12)15/h2,5-6,8,13H,1,3-4H2/p+1			O=C1CC=[N+](C2CC(F)C(CO)O2)C(=O)N1		R45_hemmateenejad_2006:4	-0.69	A	BBB+	A	test
InChI=1S/C9H11FN2O5/c10-4-2-12(9(16)11-8(4)15)7-1-5(14)6(3-13)17-7/h2,5-7,13-14H,1,3H2,(H,11,15,16)/t5-,6+,7+/m0/s1	Floxuridine	5-fluoro-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione	O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1F	5790.0	R23_gupta_2019:602|R51_doninger_2002:56			BBB-	C	training
InChI=1S/C9H11IN2O5/c10-4-2-12(9(16)11-8(4)15)7-1-5(14)6(3-13)17-7/h2,5-7,13-14H,1,3H2,(H,11,15,16)/t5-,6+,7+/m0/s1	Idoxuridine	1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-iodopyrimidine-2,4-dione	O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1I	5905.0	R23_gupta_2019:667			BBB-	C	training
InChI=1S/C9H11N/c1-2-4-9-7-10-6-5-8(9)3-1/h1-4,10H,5-7H2	Nsc 15312|1,2,3,4-Tetrahydroisoquinoline	1,2,3,4-tetrahydroisoquinoline	c1ccc2c(c1)CCNC2	7046.0	R26_chico_2009:290	0.56	A	BBB+	A	training
InChI=1S/C9H11N/c1-2-6-9-8(4-1)5-3-7-10-9/h1-2,4,6,10H,3,5,7H2	1,2,3,4-Tetrahydroquinoline|Kusol	1,2,3,4-tetrahydroquinoline	c1ccc2c(c1)CCCN2	69460.0	R5_guerra_2008:2|R12_garg_2006:3|R21_muehlbacher_2011:268|R25_brito_sanchez_2015:43|R39_shayanfar_2011:2|R40_vilar_2010:3|R46_mendoza_valencia_2017:42|R47_radchenko_2020:257	0.66	B1	BBB+	A	training
InChI=1S/C9H11N/c10-9-6-8(9)7-4-2-1-3-5-7/h1-5,8-9H,6,10H2	Tranylcypromine|Parnate	2-phenylcyclopropan-1-amine	NC1CC1c1ccccc1	5530.0	R6_adenot_2004:985|R14_ghose_2012:256|R23_gupta_2019:249			BBB+	C	test
InChI=1S/C9H11N/c10-9-6-8(9)7-4-2-1-3-5-7/h1-5,8-9H,6,10H2/t8-,9+/m0/s1	Tranylcypromine	(1R,2S)-2-phenylcyclopropan-1-amine	N[C@@H]1C[C@H]1c1ccccc1	19493.0	R7_andres_2006:178|R26_chico_2009:426|R29_subramanian_2003:173|R51_doninger_2002:314			BBB+	C	test
InChI=1S/C9H11N3/c1-2-4-8(5-3-1)12-9-10-6-7-11-9/h1-5H,6-7H2,(H2,10,11,12)	138474-57-4|Tz-15|Imidazolidine, 2-(Phenylimino)-	N-phenyl-4,5-dihydro-1H-imidazol-2-amine	c1ccc(NC2=NCCN2)cc1	137235.0	R4_mente_2005:7|R25_brito_sanchez_2015:563|R40_vilar_2010:287|R46_mendoza_valencia_2017:470|R47_radchenko_2020:494	-1.89	B	BBB-	A	training
InChI=1S/C9H11N3/c10-5-4-8-7-12-6-2-1-3-9(12)11-8/h1-3,6-7H,4-5,10H2	43170-96-3|Y-G20|Yg20|1-47|2-(Imidazo[1,2-A]Pyridin-2-Yl)Ethanamine	2-imidazo[1,2-a]pyridin-2-ylethanamine	NCCc1cn2ccccc2n1	7536516.0	R4_mente_2005:115|R12_garg_2006:179|R25_brito_sanchez_2015:178|R28_li_2005:2|R28_li_2005:128|R48_hou_2003:25|R48_hou_2003:88|R49_norinder_2002:82|R52_liu_2001:62			BBB-	C	training
InChI=1S/C9H11NO/c1-7(10)9(11)8-5-3-2-4-6-8/h2-7H,10H2,1H3/t7-/m0/s1	Cathinone	(2S)-2-amino-1-phenylpropan-1-one	C[C@H](N)C(=O)c1ccccc1	62258.0	R6_adenot_2004:1280			BBB+	C	training
InChI=1S/C9H11NO/c11-9-6-10-5-7-3-1-2-4-8(7)9/h1-4,9-11H,5-6H2	4-Oh-Tiq|1,2,3,4-Tetrahydroisoquinolin-4-Ol	1,2,3,4-tetrahydroisoquinolin-4-ol	OC1CNCc2ccccc21	11744792.0	R26_chico_2009:12	0.32	A	BBB+	A	training
InChI=1S/C9H11NO2/c1-2-12-8-6-4-3-5-7(8)9(10)11/h3-6H,2H2,1H3,(H2,10,11)	Ethenzamide	2-ethoxybenzamide	CCOc1ccccc1C(N)=O	3282.0	R3_abraham_2006:166|R21_muehlbacher_2011:70|R25_brito_sanchez_2015:222|R40_vilar_2010:106|R41_toropov_2017:154|R46_mendoza_valencia_2017:204|R47_radchenko_2020:140	-0.05	B	BBB+	A	training
InChI=1S/C9H11NO2/c1-2-12-9(11)7-3-5-8(10)6-4-7/h3-6H,2,10H2,1H3	Ethyl 4-Aminobenzoate|Benzocaine	ethyl 4-aminobenzoate	CCOC(=O)c1ccc(N)cc1	2337.0	R3_abraham_2006:167|R14_ghose_2012:385|R21_muehlbacher_2011:37|R23_gupta_2019:382|R25_brito_sanchez_2015:223|R40_vilar_2010:107|R41_toropov_2017:155|R42_ciura_2020:6|R46_mendoza_valencia_2017:205|R47_radchenko_2020:141|R51_doninger_2002:160	0.27	B	BBB+	A	training
InChI=1S/C9H11NO2/c1-2-9(12)10-7-3-5-8(11)6-4-7/h3-6,11H,2H2,1H3,(H,10,12)	Parapropamol	N-(4-hydroxyphenyl)propanamide	CCC(=O)Nc1ccc(O)cc1	74325.0	R6_adenot_2004:409			BBB+	C	training
InChI=1S/C9H11NO4/c10-6(9(13)14)3-5-1-2-7(11)8(12)4-5/h1-2,4,6,11-12H,3,10H2,(H,13,14)	Dl-Dopa	2-amino-3-(3,4-dihydroxyphenyl)propanoic acid	NC(Cc1ccc(O)c(O)c1)C(=O)O	836.0	R46_mendoza_valencia_2017:242	-0.77	A	BBB+	A	test
InChI=1S/C9H11NO4/c10-6(9(13)14)3-5-1-2-7(11)8(12)4-5/h1-2,4,6,11-12H,3,10H2,(H,13,14)/t6-/m0/s1	Levodopa	(2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid	N[C@@H](Cc1ccc(O)c(O)c1)C(=O)O	6047.0	R5_guerra_2008:58|R6_adenot_2004:41|R6_adenot_2004:651|R12_garg_2006:98|R14_ghose_2012:121|R21_muehlbacher_2011:149|R25_brito_sanchez_2015:269|R26_chico_2009:238|R28_li_2005:320|R39_shayanfar_2011:55|R40_vilar_2010:135|R47_radchenko_2020:273|R51_doninger_2002:77	-0.78	B	BBB+	A	test
InChI=1S/C9H11NO5/c10-7(9(14)15)8(13)4-1-2-5(11)6(12)3-4/h1-3,7-8,11-13H,10H2,(H,14,15)/t7-,8+/m0/s1	Droxidopa	(2S,3R)-2-amino-3-(3,4-dihydroxyphenyl)-3-hydroxypropanoic acid	N[C@H](C(=O)O)[C@H](O)c1ccc(O)c(O)c1	92974.0	R14_ghose_2012:84|R23_gupta_2019:282			BBB+	C	training
InChI=1S/C9H12/c1-7-4-5-8(2)9(3)6-7/h4-6H,1-3H3	1,2,4-Trimethylbenzene|Pseudocumene	1,2,4-trimethylbenzene	Cc1ccc(C)c(C)c1	7247.0	R3_abraham_2006:94|R21_muehlbacher_2011:175|R25_brito_sanchez_2015:44|R40_vilar_2010:312|R41_toropov_2017:89|R46_mendoza_valencia_2017:43|R47_radchenko_2020:76	0.16	B	BBB+	A	training
InChI=1S/C9H12ClNO3S/c10-9-3-1-7(2-4-9)8(5-11)6-15(12,13)14/h1-4,8H,5-6,11H2,(H,12,13,14)	Saclofen	3-amino-2-(4-chlorophenyl)propane-1-sulfonic acid	NCC(CS(=O)(=O)O)c1ccc(Cl)cc1	122150.0	R7_andres_2006:154|R29_subramanian_2003:152			BBB+	C	training
InChI=1S/C9H12N2/c1-3-8(7-10-5-1)9-4-2-6-11-9/h1,3,5,7,9,11H,2,4,6H2	Nornicotine|Nor-Nicotine	3-pyrrolidin-2-ylpyridine	c1cncc(C2CCCN2)c1	412.0	R21_muehlbacher_2011:9|R25_brito_sanchez_2015:328|R40_vilar_2010:165	0.32	B	BBB+	A	test
InChI=1S/C9H12N2/c1-3-8(7-10-5-1)9-4-2-6-11-9/h1,3,5,7,9,11H,2,4,6H2/t9-/m0/s1	494-97-3|3-[(2S)-Pyrrolidin-2-Yl]Pyridine	3-[(2S)-pyrrolidin-2-yl]pyridine	c1cncc([C@@H]2CCCN2)c1	91462.0	R4_mente_2005:177|R46_mendoza_valencia_2017:288	0.32	B	BBB+	A	test
InChI=1S/C9H12N2O6/c12-3-4-6(14)7(15)8(17-4)11-2-1-5(13)10-9(11)16/h1-2,4,6-8,12,14-15H,3H2,(H,10,13,16)/t4-,6-,7-,8-/m1/s1	Uridine	1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione	O=c1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)[nH]1	6029.0	R51_doninger_2002:323			BBB+	C	training
InChI=1S/C9H12N6/c1-15(2)7-5-6(3-4-11-7)8-12-9(10)14-13-8/h3-5H,1-2H3,(H3,10,12,13,14)	Bbcpd10|112598-26-2|Chebi: 163710|B-047|Y-G12|28|11|4-(3-Amino-1H-1,2,4-Triazol-5-Yl)-N,N-Dimethylpyridin-2-Amine	4-(3-amino-1H-1,2,4-triazol-5-yl)-N,N-dimethylpyridin-2-amine	CN(C)c1cc(-c2nc(N)n[nH]2)ccn1	12889418.0	R3_abraham_2006:305|R4_mente_2005:120|R12_garg_2006:27|R21_muehlbacher_2011:344|R25_brito_sanchez_2015:5|R26_chico_2009:46|R28_li_2005:169|R40_vilar_2010:300|R41_toropov_2017:272|R46_mendoza_valencia_2017:5|R47_radchenko_2020:252|R48_hou_2003:44|R49_norinder_2002:11|R49_norinder_2002:166|R52_liu_2001:11	-1.17	B	BBB-	A	test
InChI=1S/C9H13ClNO3P/c10-9-3-1-7(2-4-9)8(5-11)6-15(12,13)14/h1-4,8H,5-6,11H2,(H2,12,13,14)	Phaclofen	[3-amino-2-(4-chlorophenyl)propyl]phosphonic acid	NCC(CP(=O)(O)O)c1ccc(Cl)cc1	1641.0	R7_andres_2006:130|R29_subramanian_2003:126			BBB+	C	training
InChI=1S/C9H13N/c1-8(10)7-9-5-3-2-4-6-9/h2-6,8H,7,10H2,1H3	Amfetamine|Amphetamine	1-phenylpropan-2-amine	CC(N)Cc1ccccc1	3007.0	R6_adenot_2004:371|R12_garg_2006:22|R14_ghose_2012:9|R21_muehlbacher_2011:60|R25_brito_sanchez_2015:124|R28_li_2005:179|R37_chen_2011:4|R39_shayanfar_2011:16|R40_vilar_2010:36|R46_mendoza_valencia_2017:122|R47_radchenko_2020:260|R51_doninger_2002:153	0.93	B	BBB+	A	training
InChI=1S/C9H13N/c1-8(10)7-9-5-3-2-4-6-9/h2-6,8H,7,10H2,1H3/t8-/m0/s1	Dexamphetamine|Dextroamphetamine, Dexedrine|Dexamfetamine|Dextroamphetamine	(2S)-1-phenylpropan-2-amine	C[C@H](N)Cc1ccccc1	5826.0	R6_adenot_2004:368|R26_chico_2009:155|R28_li_2005:302|R51_doninger_2002:197			BBB+	C	training
InChI=1S/C9H13N/c1-8(10)7-9-5-3-2-4-6-9/h2-6,8H,7,10H2,1H3/t8-/m1/s1	Levamphetamine|Levamfetamine	(2R)-1-phenylpropan-2-amine	C[C@@H](N)Cc1ccccc1	32893.0	R6_adenot_2004:377			BBB+	C	training
InChI=1S/C9H13N3O/c1-7(2)11-12-9(13)8-3-5-10-6-4-8/h3-7,11H,1-2H3,(H,12,13)	Iproniazid	N'-propan-2-ylpyridine-4-carbohydrazide	CC(C)NNC(=O)c1ccncc1	3748.0	R6_adenot_2004:970|R26_chico_2009:220			BBB+	C	training
InChI=1S/C9H13N3O3/c10-7-3-4-12(9(14)11-7)8-2-1-6(5-13)15-8/h3-4,6,8,13H,1-2,5H2,(H2,10,11,14)/t6-,8+/m0/s1	7481-89-2|Zalcitabine|2',3'-Dideoxycytidine	4-amino-1-[(2R,5S)-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one	Nc1ccn([C@H]2CC[C@@H](CO)O2)c(=O)n1	24066.0	R4_mente_2005:35|R14_ghose_2012:940|R21_muehlbacher_2011:232|R23_gupta_2019:1037|R25_brito_sanchez_2015:37|R28_li_2005:297|R40_vilar_2010:304|R47_radchenko_2020:479	-1.5	D	BBB-	A	training
InChI=1S/C9H13N3O3/c10-7-3-4-12(9(14)11-7)8-2-1-6(5-13)15-8/h3-4,6,8,13H,1-2,5H2,(H2,10,11,14)/t6-,8-/m0/s1	4-Amino-1-[(2S,5S)-5-(Hydroxymethyl)Tetrahydrofuran-2-Yl]Pyrimidin-2-One	4-amino-1-[(2S,5S)-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one	Nc1ccn([C@@H]2CC[C@@H](CO)O2)c(=O)n1	676643.0	R46_mendoza_valencia_2017:36	-1.5	A	BBB-	A	training
InChI=1S/C9H13N3O5/c10-5-1-2-12(9(16)11-5)8-7(15)6(14)4(3-13)17-8/h1-2,4,6-8,13-15H,3H2,(H2,10,11,16)/t4-,6-,7+,8-/m1/s1	Cytarabine	4-amino-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one	Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O)c(=O)n1	6253.0	R28_li_2005:183			BBB+	C	training
InChI=1S/C9H13N3O6/c10-7(16)4-8(17)12(2-11-4)9-6(15)5(14)3(1-13)18-9/h2-3,5-6,9,13-15,17H,1H2,(H2,10,16)/t3-,5-,6-,9-/m1/s1	Mizoribine	1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-hydroxyimidazole-4-carboxamide	NC(=O)c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c1O	104762.0	R14_ghose_2012:700|R23_gupta_2019:758			BBB-	C	test
InChI=1S/C9H13N5O3/c10-9-12-7-6(8(17)13-9)11-4-14(7)2-1-5(16)3-15/h4-5,15-16H,1-3H2,(H3,10,12,13,17)/t5-/m1/s1	Buciclovir	2-amino-9-[(3R)-3,4-dihydroxybutyl]-1H-purin-6-one	Nc1nc2c(ncn2CC[C@@H](O)CO)c(=O)[nH]1	135410214.0	R6_adenot_2004:674			BBB+	C	training
InChI=1S/C9H13NO/c1-7(10)6-8-2-4-9(11)5-3-8/h2-5,7,11H,6,10H2,1H3	Hydroxyamphetamine|4-(2-Aminopropyl)Phenol	4-(2-aminopropyl)phenol	CC(N)Cc1ccc(O)cc1	3651.0	R6_adenot_2004:91			BBB-	C	training
InChI=1S/C9H13NO2/c1-3-7-9(12)8(11)5-6-10(7)4-2/h5-6,12H,3-4H2,1-2H3	Cp94|1,2-Diethyl-3-Hydroxypyridin-4-One	1,2-diethyl-3-hydroxypyridin-4-one	CCc1c(O)c(=O)ccn1CC	86322.0	R28_li_2005:347			BBB+	C	training
InChI=1S/C9H13NO2/c1-3-9(4-2)7(11)5-6-10-8(9)12/h5-6H,3-4H2,1-2H3,(H,10,12)	Pyrithyldione	3,3-diethyl-1H-pyridine-2,4-dione	CCC1(CC)C(=O)C=CNC1=O	4994.0	R6_adenot_2004:1377			BBB+	C	test
InChI=1S/C9H13NO2/c1-6(10)9(12)7-3-2-4-8(11)5-7/h2-6,9,11-12H,10H2,1H3/t6-,9-/m0/s1	Metaraminol	3-[(1R,2S)-2-amino-1-hydroxypropyl]phenol	C[C@H](N)[C@H](O)c1cccc(O)c1	5906.0	R28_li_2005:269			BBB-	C	training
InChI=1S/C9H13NO3/c1-10-5-9(13)6-2-3-7(11)8(12)4-6/h2-4,9-13H,5H2,1H3/t9-/m0/s1	Epinephrine	4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol	CNC[C@H](O)c1ccc(O)c(O)c1	5816.0	R6_adenot_2004:88|R28_li_2005:198|R51_doninger_2002:49			BBB-	C	training
InChI=1S/C9H13NO3/c1-2-7-9(13)8(12)3-4-10(7)5-6-11/h3-4,11,13H,2,5-6H2,1H3	Cp102|4(1H)-Pyridinone, 2-Ethyl-3-Hydroxy-1-(2-Hydroxyethyl)-	2-ethyl-3-hydroxy-1-(2-hydroxyethyl)pyridin-4-one	CCc1c(O)c(=O)ccn1CCO	86379.0	R28_li_2005:339			BBB-	C	training
InChI=1S/C9H13NO3/c1-7-9(13)8(12)3-5-10(7)4-2-6-11/h3,5,11,13H,2,4,6H2,1H3	Cp41|4(1H)-Pyridinone, 3-Hydroxy-1-(3-Hydroxypropyl)-2-Methyl-	3-hydroxy-1-(3-hydroxypropyl)-2-methylpyridin-4-one	Cc1c(O)c(=O)ccn1CCCO	93513.0	R28_li_2005:346			BBB-	C	training
InChI=1S/C9H14N2/c1-11(2)8-6-9-5-3-4-7-10-9/h3-5,7H,6,8H2,1-2H3	Y-G 15|6304-27-4|Y-G15|N,N-Dimethylpyridine-2-Ethylamine|Yg15|5-67|2-(2-Dimethylaminoethyl)Pyridine	N,N-dimethyl-2-pyridin-2-ylethanamine	CN(C)CCc1ccccn1	80554.0	R3_abraham_2006:300|R4_mente_2005:109|R12_garg_2006:176|R21_muehlbacher_2011:273|R25_brito_sanchez_2015:131|R28_li_2005:125|R28_li_2005:145|R41_toropov_2017:267|R46_mendoza_valencia_2017:129|R47_radchenko_2020:248|R48_hou_2003:29|R49_norinder_2002:79|R52_liu_2001:59			BBB+	C	training
InChI=1S/C9H14N2/c1-8(11-10)7-9-5-3-2-4-6-9/h2-6,8,11H,7,10H2,1H3	Pheniprazine	1-phenylpropan-2-ylhydrazine	CC(Cc1ccccc1)NN	5929.0	R6_adenot_2004:979			BBB+	C	training
InChI=1S/C9H14N2O/c1-8(11-10)7-12-9-5-3-2-4-6-9/h2-6,8,11H,7,10H2,1H3	Fenoxypropazine|Phenoxypropazine	1-phenoxypropan-2-ylhydrazine	CC(COc1ccccc1)NN	71467.0	R6_adenot_2004:968			BBB+	C	training
InChI=1S/C9H14N2O2/c1-6-7(12)11-9(8(13)10-6)4-2-3-5-9/h6H,2-5H2,1H3,(H,10,13)(H,11,12)/t6-/m0/s1	Alaptide	(8S)-8-methyl-6,9-diazaspiro[4.5]decane-7,10-dione	C[C@@H]1NC(=O)C2(CCCC2)NC1=O	119329.0	R3_abraham_2006:119|R21_muehlbacher_2011:290|R26_chico_2009:20|R47_radchenko_2020:101	-0.28	B1	BBB+	A	training
InChI=1S/C9H14N2O3/c1-3-5-9(4-2)6(12)10-8(14)11-7(9)13/h3-5H2,1-2H3,(H2,10,11,12,13,14)	5-Propyl-5-Ethyl Barbituric Acid|5-Ethyl-5-Propyl-1,3-Diazinane-2,4,6-Trione|5-Ethyl-5-Propylpyrimidine-2,4,6(1H,3H,5H)-Trione	5-ethyl-5-propyl-1,3-diazinane-2,4,6-trione	CCCC1(CC)C(=O)NC(=O)NC1=O	46516.0	R3_abraham_2006:115|R21_muehlbacher_2011:247|R25_brito_sanchez_2015:101|R40_vilar_2010:22|R41_toropov_2017:110|R46_mendoza_valencia_2017:99|R47_radchenko_2020:97	0.09	B	BBB+	A	test
InChI=1S/C9H14N2O3/c1-4-9(5-2)6(12)10-8(14)11(3)7(9)13/h4-5H2,1-3H3,(H,10,12,14)	Metharbital	5,5-diethyl-1-methyl-1,3-diazinane-2,4,6-trione	CCC1(CC)C(=O)NC(=O)N(C)C1=O	4099.0	R6_adenot_2004:1657			BBB+	C	test
InChI=1S/C9H14N5O4P/c1-6(18-5-19(15,16)17)2-14-4-13-7-8(10)11-3-12-9(7)14/h3-4,6H,2,5H2,1H3,(H2,10,11,12)(H2,15,16,17)/t6-/m1/s1	Tenofovir	[(2R)-1-(6-aminopurin-9-yl)propan-2-yl]oxymethylphosphonic acid	C[C@H](Cn1cnc2c(N)ncnc21)OCP(=O)(O)O	464205.0	R14_ghose_2012:881|R23_gupta_2019:964			BBB-	C	training
InChI=1S/C9H15BrN2O2/c1-9(2,3)11-5-6(13)7-4-8(10)12-14-7/h4,6,11,13H,5H2,1-3H3	Broxaterol	1-(3-bromo-1,2-oxazol-5-yl)-2-(tert-butylamino)ethanol	CC(C)(C)NCC(O)c1cc(Br)no1	71149.0	R14_ghose_2012:406			BBB-	C	training
InChI=1S/C9H15BrN2O3/c1-4-9(10,5-2)7(14)12-8(15)11-6(3)13/h4-5H2,1-3H3,(H2,11,12,13,14,15)	Acecarbromal	N-(acetylcarbamoyl)-2-bromo-2-ethylbutanamide	CCC(Br)(CC)C(=O)NC(=O)NC(C)=O	6489.0	R6_adenot_2004:1341			BBB+	C	training
InChI=1S/C9H15N5O/c10-7-6-8(12-9(11)14(7)15)13-4-2-1-3-5-13/h6,11,15H,1-5,10H2/b11-9+	Minoxidil	3-hydroxy-2-imino-6-piperidin-1-ylpyrimidin-4-amine	[H]/N=c1\nc(N2CCCCC2)cc(N)n1O	4201.0	R7_andres_2006:108|R14_ghose_2012:697|R23_gupta_2019:753|R29_subramanian_2003:103			BBB-	C	training
InChI=1S/C9H15N5O3/c1-3(15)6(16)4-2-11-7-5(12-4)8(17)14-9(10)13-7/h3-4,6,12,15-16H,2H2,1H3,(H4,10,11,13,14,17)	Tetrahydrobiopterin	2-amino-6-(1,2-dihydroxypropyl)-5,6,7,8-tetrahydro-3H-pteridin-4-one	CC(O)C(O)C1CNc2nc(N)[nH]c(=O)c2N1	135402045.0	R23_gupta_2019:971			BBB-	C	test
InChI=1S/C9H15N5O3/c1-3(15)6(16)4-2-11-7-5(12-4)8(17)14-9(10)13-7/h3-4,6,12,15-16H,2H2,1H3,(H4,10,11,13,14,17)/t3-,4+,6-/m0/s1	Sapropterin	(6R)-2-amino-6-[(1R,2S)-1,2-dihydroxypropyl]-5,6,7,8-tetrahydro-3H-pteridin-4-one	C[C@H](O)[C@H](O)[C@H]1CNc2nc(N)[nH]c(=O)c2N1	135398654.0	R14_ghose_2012:838			BBB-	C	test
InChI=1S/C9H15NO3S/c1-6(5-14)8(11)10-4-2-3-7(10)9(12)13/h6-7,14H,2-5H2,1H3,(H,12,13)/t6-,7+/m1/s1	Captopril	(2S)-1-[(2S)-2-methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid	C[C@H](CS)C(=O)N1CCC[C@H]1C(=O)O	44093.0	R7_andres_2006:22|R14_ghose_2012:417|R23_gupta_2019:409|R29_subramanian_2003:22			BBB-	C	training
InChI=1S/C9H16ClN3O2/c10-6-7-13(12-15)9(14)11-8-4-2-1-3-5-8/h8H,1-7H2,(H,11,14)	Lomustine	1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea	O=NN(CCCl)C(=O)NC1CCCCC1	3950.0	R28_li_2005:305			BBB+	C	training
InChI=1S/C9H16N2O4/c1-6(12)10-5-3-4-8(9(14)15)11-7(2)13/h8H,3-5H2,1-2H3,(H,10,12)(H,11,13)(H,14,15)/t8-/m0/s1	Bisorcic	(2S)-2,5-diacetamidopentanoic acid	CC(=O)NCCC[C@H](NC(C)=O)C(=O)O	65977.0	R6_adenot_2004:1279			BBB+	C	test
InChI=1S/C9H16O4/c10-8(11)6-4-2-1-3-5-7-9(12)13/h1-7H2,(H,10,11)(H,12,13)	Azelaicacid|Azelaic Acid	nonanedioic acid	O=C(O)CCCCCCCC(=O)O	2266.0	R28_li_2005:233			BBB-	C	test
InChI=1S/C9H17NO/c1-4-7-9(5-2,6-3)8(10)11/h4H,1,5-7H2,2-3H3,(H2,10,11)	Valdetamide	2,2-diethylpent-4-enamide	C=CCC(CC)(CC)C(N)=O	68845.0	R6_adenot_2004:1357			BBB+	C	training
InChI=1S/C9H17NO2/c10-7-9(6-8(11)12)4-2-1-3-5-9/h1-7,10H2,(H,11,12)	Gabapentin	2-[1-(aminomethyl)cyclohexyl]acetic acid	NCC1(CC(=O)O)CCCCC1	3446.0	R6_adenot_2004:443|R7_andres_2006:75|R14_ghose_2012:103|R25_brito_sanchez_2015:375|R26_chico_2009:201|R28_li_2005:207|R29_subramanian_2003:71|R34_broccatelli_2012:34|R46_mendoza_valencia_2017:328|R53_friden_2009:11	-0.19	B	BBB+	A	training
InChI=1S/C9H17NO3/c1-9(2,3)8(13)10-6-4-5-7(11)12/h4-6H2,1-3H3,(H,10,13)(H,11,12)	Pivagabine	4-(2,2-dimethylpropanoylamino)butanoic acid	CC(C)(C)C(=O)NCCCC(=O)O	68888.0	R6_adenot_2004:462			BBB+	C	training
InChI=1S/C9H17NO5/c1-9(2,5-11)7(14)8(15)10-4-3-6(12)13/h7,11,14H,3-5H2,1-2H3,(H,10,15)(H,12,13)	Pantothenic|Dl-Pantothenic Acid	3-[(2,4-dihydroxy-3,3-dimethylbutanoyl)amino]propanoic acid	CC(C)(CO)C(O)C(=O)NCCC(=O)O	988.0	R14_ghose_2012:754			BBB-	C	training
InChI=1S/C9H18/c1-3-5-7-9-8-6-4-2/h3H,1,4-9H2,2H3	1-Nonene	non-1-ene	C=CCCCCCCC	31285.0	R3_abraham_2006:48|R21_muehlbacher_2011:237|R25_brito_sanchez_2015:58|R40_vilar_2010:322|R41_toropov_2017:43|R46_mendoza_valencia_2017:57|R47_radchenko_2020:31	0.86	B	BBB+	A	training
InChI=1S/C9H18/c1-7-4-5-8(2)9(3)6-7/h7-9H,4-6H2,1-3H3	1,2,4-Trimethylcyclohexane|Tripropylphosphine	1,2,4-trimethylcyclohexane	CC1CCC(C)C(C)C1	91517.0	R3_abraham_2006:28|R21_muehlbacher_2011:278|R25_brito_sanchez_2015:45|R40_vilar_2010:313|R41_toropov_2017:23|R46_mendoza_valencia_2017:44|R47_radchenko_2020:13	1.02	B	BBB+	A	training
InChI=1S/C9H18Cl3N2O2P/c10-2-6-13-5-1-9-16-17(13,15)14(7-3-11)8-4-12/h1-9H2	Trofosfamide	N,N,3-tris(2-chloroethyl)-2-oxo-1,3,2lambda5-oxazaphosphinan-2-amine	O=P1(N(CCCl)CCCl)OCCCN1CCCl	65702.0	R14_ghose_2012:921			BBB-	C	training
InChI=1S/C9H18N2O2/c1-4-6(3)7(5-2)8(12)11-9(10)13/h6-7H,4-5H2,1-3H3,(H3,10,11,12,13)	Capuride	N-carbamoyl-2-ethyl-3-methylpentanamide	CCC(C)C(CC)C(=O)NC(N)=O	231285.0	R6_adenot_2004:1348|R51_doninger_2002:172			BBB+	C	training
InChI=1S/C9H18N2O4/c1-3-4-9(2,5-14-7(10)12)6-15-8(11)13/h3-6H2,1-2H3,(H2,10,12)(H2,11,13)	Meprobamate	[2-(carbamoyloxymethyl)-2-methylpentyl] carbamate	CCCC(C)(COC(N)=O)COC(N)=O	4064.0	R6_adenot_2004:1484|R7_andres_2006:101|R14_ghose_2012:136|R23_gupta_2019:138|R25_brito_sanchez_2015:483|R26_chico_2009:258|R29_subramanian_2003:95|R34_broccatelli_2012:48|R37_chen_2011:48|R46_mendoza_valencia_2017:304|R51_doninger_2002:244	-0.15	D	BBB+	A	training
InChI=1S/C9H18N6/c1-13(2)7-10-8(14(3)4)12-9(11-7)15(5)6/h1-6H3	Altretamine	2-N,2-N,4-N,4-N,6-N,6-N-hexamethyl-1,3,5-triazine-2,4,6-triamine	CN(C)c1nc(N(C)C)nc(N(C)C)n1	2123.0	R14_ghose_2012:340			BBB-	C	training
InChI=1S/C9H19N/c1-8(2)6-5-7-9(3)10-4/h6,9-10H,5,7H2,1-4H3	Isometheptene	N,6-dimethylhept-5-en-2-amine	CNC(C)CCC=C(C)C	22297.0	R23_gupta_2019:118			BBB+	C	training
InChI=1S/C9H19NO4/c1-9(2,6-12)7(13)8(14)10-4-3-5-11/h7,11-13H,3-6H2,1-2H3,(H,10,14)/t7-/m0/s1	Dexpanthenol	(2R)-2,4-dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutanamide	CC(C)(CO)[C@@H](O)C(=O)NCCCO	131204.0	R14_ghose_2012:486			BBB-	C	training
InChI=1S/C9H20/c1-3-5-7-9-8-6-4-2/h3-9H2,1-2H3	Nonane|N-Nonane	nonane	CCCCCCCCC	8141.0	R3_abraham_2006:13|R21_muehlbacher_2011:199|R25_brito_sanchez_2015:323|R40_vilar_2010:384|R41_toropov_2017:8|R46_mendoza_valencia_2017:284|R47_radchenko_2020:493	0.52	B	BBB+	A	training
InChI=1S/C9H20/c1-4-5-6-7-8-9(2)3/h9H,4-8H2,1-3H3	2-Methyl Octane|2-Methyl Nonane|Isononane|2-Methyloctane	2-methyloctane	CCCCCCC(C)C	18591.0	R3_abraham_2006:17|R3_abraham_2006:18|R21_muehlbacher_2011:227|R25_brito_sanchez_2015:73|R40_vilar_2010:331|R41_toropov_2017:13|R46_mendoza_valencia_2017:71|R47_radchenko_2020:2	1.0	B1	BBB+	A	training
InChI=1S/C9H23NO3PS/c1-6-12-14(11,13-7-2)15-9-8-10(3,4)5/h6-9H2,1-5H3/q+1	Echothiophate	2-diethoxyphosphorylsulfanylethyl(trimethyl)azanium	CCOP(=O)(OCC)SCC[N+](C)(C)C	10548.0	R23_gupta_2019:546			BBB-	C	training
InChI=1S/C9H23NO7P2/c1-3-4-5-7-10(2)8-6-9(11,18(12,13)14)19(15,16)17/h11H,3-8H2,1-2H3,(H2,12,13,14)(H2,15,16,17)	Ibandronate|Ibandronic Acid	[1-hydroxy-3-[methyl(pentyl)amino]-1-phosphonopropyl]phosphonic acid	CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O	60852.0	R14_ghose_2012:614			BBB-	C	training
InChI=1S/C9H4Cl3IO/c10-6-4-8(12)9(5-7(6)11)14-3-1-2-13/h4-5H,3H2	Haloprogin	1,2,4-trichloro-5-(3-iodoprop-2-ynoxy)benzene	Clc1cc(Cl)c(OCC#CI)cc1Cl	3561.0	R23_gupta_2019:650			BBB-	C	training
InChI=1S/C9H5Cl2NO/c10-6-4-7(11)9(13)8-5(6)2-1-3-12-8/h1-4,13H	Chloroxine	5,7-dichloroquinolin-8-ol	Oc1c(Cl)cc(Cl)c2cccnc12	2722.0	R23_gupta_2019:452			BBB-	C	training
InChI=1S/C9H5ClINO/c10-6-4-7(11)9(13)8-5(6)2-1-3-12-8/h1-4,13H	Clioquinol	5-chloro-7-iodoquinolin-8-ol	Oc1c(I)cc(Cl)c2cccnc12	2788.0	R26_chico_2009:108	-2.4	A	BBB-	A	training
InChI=1S/C9H5I2NO/c10-6-4-7(11)9(13)8-5(6)2-1-3-12-8/h1-4,13H	Iodoquinol	5,7-diiodoquinolin-8-ol	Oc1c(I)cc(I)c2cccnc12	3728.0	R14_ghose_2012:623			BBB-	C	training
InChI=1S/C9H6N2O3/c12-8-4-3-7(11(13)14)6-2-1-5-10-9(6)8/h1-5,12H	Nitroxoline	5-nitroquinolin-8-ol	O=[N+]([O-])c1ccc(O)c2ncccc12	19910.0	R23_gupta_2019:786			BBB-	C	training
InChI=1S/C9H6O2/c10-9-6-5-7-3-1-2-4-8(7)11-9/h1-6H	Coumarin	chromen-2-one	O=c1ccc2ccccc2o1	323.0	R7_andres_2006:43|R29_subramanian_2003:44|R51_doninger_2002:32			BBB-	C	test
InChI=1S/C9H7Cl2N5/c10-5-3-1-2-4(6(5)11)7-8(12)14-9(13)16-15-7/h1-3H,(H4,12,13,14,16)	Lamotrigine	6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine	Nc1nnc(-c2cccc(Cl)c2Cl)c(N)n1	3878.0	R3_abraham_2006:188|R6_adenot_2004:446|R7_andres_2006:91|R14_ghose_2012:118|R21_muehlbacher_2011:92|R23_gupta_2019:120|R25_brito_sanchez_2015:267|R26_chico_2009:235|R29_subramanian_2003:85|R34_broccatelli_2012:44|R40_vilar_2010:134|R41_toropov_2017:173|R42_ciura_2020:23|R46_mendoza_valencia_2017:240|R47_radchenko_2020:159|R50_sobanska_2019:34|R53_friden_2009:13	0.48	D	BBB+	A	training
InChI=1S/C9H7N7O2S/c1-15-4-14-7(16(17)18)9(15)19-8-5-6(11-2-10-5)12-3-13-8/h2-4H,1H3,(H,10,11,12,13)	Azathioprine	6-(3-methyl-5-nitroimidazol-4-yl)sulfanyl-7H-purine	Cn1cnc([N+](=O)[O-])c1Sc1ncnc2nc[nH]c12	2265.0	R14_ghose_2012:370|R23_gupta_2019:371			BBB-	C	training
InChI=1S/C9H8Br3N3/c10-5-3-6(11)8(7(12)4-5)15-9-13-1-2-14-9/h3-4H,1-2H2,(H2,13,14,15)	38941-33-2|Tz-19|2-(2,4,6-Tribromophenylimino)Imidazolidine	N-(2,4,6-tribromophenyl)-4,5-dihydro-1H-imidazol-2-amine	Brc1cc(Br)c(NC2=NCCN2)c(Br)c1	12406843.0	R4_mente_2005:10|R25_brito_sanchez_2015:566|R40_vilar_2010:290|R46_mendoza_valencia_2017:472|R47_radchenko_2020:429	0.58	B	BBB+	A	training
InChI=1S/C9H8BrCl2N3/c10-5-3-6(11)8(7(12)4-5)15-9-13-1-2-14-9/h3-4H,1-2H2,(H2,13,14,15)	40065-09-6|Tz-21|2-(4-Bromo-2,6-Dichlorophenylimino)Imidazoline	N-(4-bromo-2,6-dichlorophenyl)-4,5-dihydro-1H-imidazol-2-amine	Clc1cc(Br)cc(Cl)c1NC1=NCCN1	12406842.0	R4_mente_2005:12|R25_brito_sanchez_2015:568|R40_vilar_2010:292|R46_mendoza_valencia_2017:474|R47_radchenko_2020:456	0.41	B	BBB+	A	training
InChI=1S/C9H8Cl2N2O/c10-6-2-1-3-7(11)8(6)13-9-12-4-5-14-9/h1-3H,4-5H2,(H,12,13)	Clidafidine	N-(2,6-dichlorophenyl)-4,5-dihydro-1,3-oxazol-2-amine	Clc1cccc(Cl)c1NC1=NCCO1	193994.0	R6_adenot_2004:1391			BBB+	C	training
InChI=1S/C9H8Cl3N3/c10-5-3-6(11)8(7(12)4-5)15-9-13-1-2-14-9/h3-4H,1-2H2,(H2,13,14,15)	21571-08-4|Tz-18|1H-Imidazol-2-Amine, 4,5-Dihydro-N-(2,4,6-Trichlorophenyl)-	N-(2,4,6-trichlorophenyl)-4,5-dihydro-1H-imidazol-2-amine	Clc1cc(Cl)c(NC2=NCCN2)c(Cl)c1	10470115.0	R4_mente_2005:9|R25_brito_sanchez_2015:565|R40_vilar_2010:289|R46_mendoza_valencia_2017:471|R47_radchenko_2020:468	0.47	B	BBB+	A	training
InChI=1S/C9H8ClN5S/c10-5-1-2-6-8(15-16-14-6)7(5)13-9-11-3-4-12-9/h1-2H,3-4H2,(H2,11,12,13)	Tizanidine	5-chloro-N-(4,5-dihydro-1H-imidazol-2-yl)-2,1,3-benzothiadiazol-4-amine	Clc1ccc2nsnc2c1NC1=NCCN1	5487.0	R23_gupta_2019:317			BBB+	C	training
InChI=1S/C9H8N2O2/c10-9-11-8(12)7(13-9)6-4-2-1-3-5-6/h1-5,7H,(H2,10,11,12)	Pemoline|Pemolina [Italian]	2-imino-5-phenyl-1,3-oxazolidin-4-one	[H]/N=C1/NC(=O)C(c2ccccc2)O1	137628477.0	R6_adenot_2004:1302|R14_ghose_2012:184|R23_gupta_2019:185|R51_doninger_2002:273			BBB+	C	training
InChI=1S/C9H8O4/c1-6(10)13-8-5-3-2-4-7(8)9(11)12/h2-5H,1H3,(H,11,12)	50-78-2|Aspirin|Acetylsalicylic Acid|Acetyl Salicilic Acid|Acetylsalicylic Acid, Aspirin|Acetylsalicylate	2-acetyloxybenzoic acid	CC(=O)Oc1ccccc1C(=O)O	2244.0	R4_mente_2005:19|R5_guerra_2008:11|R6_adenot_2004:1316|R7_andres_2006:187|R12_garg_2006:16|R17_fu_2008:26|R21_muehlbacher_2011:34|R25_brito_sanchez_2015:108|R26_chico_2009:17|R28_li_2005:9|R39_shayanfar_2011:10|R46_mendoza_valencia_2017:106|R47_radchenko_2020:259|R48_hou_2003:54|R49_norinder_2002:67|R49_norinder_2002:111|R50_sobanska_2019:69|R51_doninger_2002:2|R51_doninger_2002:11	-0.57	B1	BBB+	A	training
InChI=1S/C9H9Br2N3/c10-6-2-1-3-7(11)8(6)14-9-12-4-5-13-9/h1-3H,4-5H2,(H2,12,13,14)	4205-93-0|Tz-2|N-(2,6-Dibromophenyl)-4,5-Dihydro-1H-Imidazol-2-Amine	N-(2,6-dibromophenyl)-4,5-dihydro-1H-imidazol-2-amine	Brc1cccc(Br)c1NC1=NCCN1	10245368.0	R4_mente_2005:11|R25_brito_sanchez_2015:567|R40_vilar_2010:291|R46_mendoza_valencia_2017:473|R47_radchenko_2020:455	0.33	B	BBB+	A	training
InChI=1S/C9H9BrFN3/c10-6-2-1-3-7(11)8(6)14-9-12-4-5-13-9/h1-3H,4-5H2,(H2,12,13,14)	Romifidine	N-(2-bromo-6-fluorophenyl)-4,5-dihydro-1H-imidazol-2-amine	Fc1cccc(Br)c1NC1=NCCN1	71969.0	R6_adenot_2004:1381			BBB+	C	training
InChI=1S/C9H9Cl2N3/c10-6-1-2-7(11)8(5-6)14-9-12-3-4-13-9/h1-2,5H,3-4H2,(H2,12,13,14)	59465-39-3|Tz-11|N-(2,5-Dichlorophenyl)-4,5-Dihydro-1H-Imidazol-2-Amine	N-(2,5-dichlorophenyl)-4,5-dihydro-1H-imidazol-2-amine	Clc1ccc(Cl)c(NC2=NCCN2)c1	11777724.0	R4_mente_2005:3|R25_brito_sanchez_2015:559|R40_vilar_2010:283|R46_mendoza_valencia_2017:468|R47_radchenko_2020:476	0.38	B	BBB+	A	training
InChI=1S/C9H9Cl2N3/c10-6-1-2-8(7(11)5-6)14-9-12-3-4-13-9/h1-2,5H,3-4H2,(H2,12,13,14)	23830-88-8|St 363|Tz-10|2-(2,4-Dichlorophenylimino)-Imidazolidine	N-(2,4-dichlorophenyl)-4,5-dihydro-1H-imidazol-2-amine	Clc1ccc(NC2=NCCN2)c(Cl)c1	90274.0	R4_mente_2005:2|R21_muehlbacher_2011:277|R25_brito_sanchez_2015:408|R40_vilar_2010:282|R46_mendoza_valencia_2017:346|R47_radchenko_2020:481	0.16	B	BBB+	A	training
InChI=1S/C9H9Cl2N3/c10-6-2-1-3-7(11)8(6)14-9-12-4-5-13-9/h1-3H,4-5H2,(H2,12,13,14)	Clonidine|4205-90-7|Tz-1	N-(2,6-dichlorophenyl)-4,5-dihydro-1H-imidazol-2-amine	Clc1cccc(Cl)c1NC1=NCCN1	2803.0	R3_abraham_2006:149|R4_mente_2005:15|R5_guerra_2008:28|R7_andres_2006:192|R12_garg_2006:61|R14_ghose_2012:54|R21_muehlbacher_2011:57|R23_gupta_2019:274|R25_brito_sanchez_2015:62|R26_chico_2009:112|R28_li_2005:16|R29_subramanian_2003:41|R34_broccatelli_2012:19|R39_shayanfar_2011:31|R40_vilar_2010:79|R41_toropov_2017:139|R42_ciura_2020:11|R44_bujak_2015:22|R46_mendoza_valencia_2017:60|R47_radchenko_2020:125|R47_radchenko_2020:491|R49_norinder_2002:6|R49_norinder_2002:120|R49_norinder_2002:149|R50_sobanska_2019:25	0.12	B1	BBB+	A	training
InChI=1S/C9H9Cl2N3/c10-6-2-1-3-7(11)8(6)14-9-12-4-5-13-9/h1-4,9,13-14H,5H2	6|N-(2,6-Dichlorophenyl)-2,5-Dihydro-1H-Imidazol-2-Amine	N-(2,6-dichlorophenyl)-2,5-dihydro-1H-imidazol-2-amine	Clc1cccc(Cl)c1NC1N=CCN1	13071367.0	R52_liu_2001:6	0.11	A	BBB+	A	training
InChI=1S/C9H9Cl2N3/c10-6-2-1-3-7(11)8(6)14-9-12-4-5-13-9/h1-4,9,13-14H,5H2/t9-/m1/s1		(2R)-N-(2,6-dichlorophenyl)-2,5-dihydro-1H-imidazol-2-amine	Clc1cccc(Cl)c1N[C@@H]1N=CCN1	29935466.0	R48_hou_2003:82	0.11	A	BBB+	A	training
InChI=1S/C9H9Cl2N3/c10-7-3-6-5-13-14(2-1-12)9(6)4-8(7)11/h3-5H,1-2,12H2	9-C7|S114|2-(5,6-Dichloroindazol-1-Yl)Ethanamine	2-(5,6-dichloroindazol-1-yl)ethanamine	NCCn1ncc2cc(Cl)c(Cl)cc21	44214615.0	R28_li_2005:173|R47_radchenko_2020:324|R48_hou_2003:7	0.11	B	BBB+	A	training
InChI=1S/C9H9Cl2NO2/c1-12(9(14)8(10)11)6-2-4-7(13)5-3-6/h2-5,8,13H,1H3	Diloxanide	2,2-dichloro-N-(4-hydroxyphenyl)-N-methylacetamide	CN(C(=O)C(Cl)Cl)c1ccc(O)cc1	11367.0	R14_ghose_2012:501|R23_gupta_2019:527			BBB-	C	training
InChI=1S/C9H9F2N3/c10-6-2-1-3-7(11)8(6)14-9-12-4-5-13-9/h1-3H,4-5H2,(H2,12,13,14)	59465-54-2|2-(2,6-Difl Ph Imino)Imidazolidine	N-(2,6-difluorophenyl)-4,5-dihydro-1H-imidazol-2-amine	Fc1cccc(F)c1NC1=NCCN1	12296941.0	R4_mente_2005:14|R46_mendoza_valencia_2017:475	-0.2	B	BBB+	A	training
InChI=1S/C9H9N3O2S2/c10-7-1-3-8(4-2-7)16(13,14)12-9-11-5-6-15-9/h1-6H,10H2,(H,11,12)	Sulfathiazole	4-amino-N-(1,3-thiazol-2-yl)benzenesulfonamide	Nc1ccc(S(=O)(=O)Nc2nccs2)cc1	5340.0	R23_gupta_2019:941			BBB-	C	training
InChI=1S/C9H9NO/c1-11-8-2-3-9-7(6-8)4-5-10-9/h2-6,10H,1H3	Bz3|5-Methoxyindole	5-methoxy-1H-indole	COc1ccc2[nH]ccc2c1	13872.0	R50_sobanska_2019:70			BBB+	C	training
InChI=1S/C9H9NO4/c11-7-4-2-1-3-6(7)9(14)10-5-8(12)13/h1-4,11H,5H2,(H,10,14)(H,12,13)	Salicyluric Acid|Salicylurate|Salicyluricacid	2-[(2-hydroxybenzoyl)amino]acetic acid	O=C(O)CNC(=O)c1ccccc1O	10253.0	R12_garg_2006:149|R21_muehlbacher_2011:210|R25_brito_sanchez_2015:255|R26_chico_2009:363|R28_li_2005:114|R39_shayanfar_2011:83|R40_vilar_2010:238|R46_mendoza_valencia_2017:230|R47_radchenko_2020:286	-0.44	B	BBB+	A	training
InChI=1S/CH2Cl2/c2-1-3/h1H2	Dichloromethane|Methylene-Chloride|Methylenechloride|Methylene Chloride	dichloromethane	ClCCl	6344.0	R3_abraham_2006:29|R5_guerra_2008:37|R6_adenot_2004:927|R12_garg_2006:72|R21_muehlbacher_2011:155|R25_brito_sanchez_2015:574|R26_chico_2009:160|R28_li_2005:77|R39_shayanfar_2011:40|R40_vilar_2010:352|R41_toropov_2017:24|R46_mendoza_valencia_2017:479|R47_radchenko_2020:14	-0.34	D	BBB+	A	test
InChI=1S/CH4/h1H4	Methane	methane	C	297.0	R3_abraham_2006:8|R5_guerra_2008:63|R12_garg_2006:107|R21_muehlbacher_2011:5|R22_clark_1999:19|R25_brito_sanchez_2015:288|R26_chico_2009:263|R39_shayanfar_2011:59|R40_vilar_2010:373|R41_toropov_2017:3|R44_bujak_2015:37|R46_mendoza_valencia_2017:257|R48_hou_2003:79|R49_norinder_2002:49|R52_liu_2001:49	0.04	B	BBB+	A	test
InChI=1S/CH4Cl2O6P2/c2-1(3,10(4,5)6)11(7,8)9/h(H2,4,5,6)(H2,7,8,9)	Clodronate|Clodronic Acid	[dichloro(phosphono)methyl]phosphonic acid	O=P(O)(O)C(Cl)(Cl)P(=O)(O)O	25419.0	R23_gupta_2019:470			BBB-	C	training
InChI=1S/CH4N2O/c2-1(3)4/h(H4,2,3,4)	Urea	urea	NC(N)=O	1176.0	R21_muehlbacher_2011:19|R25_brito_sanchez_2015:398|R26_chico_2009:438|R28_li_2005:230|R40_vilar_2010:295|R46_mendoza_valencia_2017:338|R47_radchenko_2020:332	-0.14	D	BBB+	A	training
InChI=1S/CH4O/c1-2/h2H,1H3	Methanol	methanol	CO	887.0	R3_abraham_2006:54|R21_muehlbacher_2011:12|R25_brito_sanchez_2015:289|R40_vilar_2010:374|R41_toropov_2017:49|R46_mendoza_valencia_2017:258|R47_radchenko_2020:36	0.02	B	BBB+	A	training
InChI=1S/CH5N3/c2-1(3)4/h(H5,2,3,4)	Guanidine	guanidine	[H]N=C(N)N	3520.0	R23_gupta_2019:649			BBB-	C	training
InChI=1S/CHBr3/c2-1(3)4/h1H	Bromoform	bromoform	BrC(Br)Br	5558.0	R6_adenot_2004:1324			BBB+	C	training
InChI=1S/CHCl3/c2-1(3)4/h1H	Chloroform|Trichloromethane	chloroform	ClC(Cl)Cl	6212.0	R3_abraham_2006:30|R5_guerra_2008:25|R6_adenot_2004:960|R7_andres_2006:190|R12_garg_2006:170|R21_muehlbacher_2011:151|R25_brito_sanchez_2015:186|R26_chico_2009:430|R28_li_2005:123|R39_shayanfar_2011:28|R39_shayanfar_2011:121|R40_vilar_2010:346|R41_toropov_2017:25|R44_bujak_2015:65|R46_mendoza_valencia_2017:173|R47_radchenko_2020:15|R49_norinder_2002:74	0.29	D	BBB+	A	training
InChI=1S/CS2/c2-1-3	Carbon Disulfide|Carbon Disulphide|Carbon Bisulfide		S=C=S	6348.0	R3_abraham_2006:53|R12_garg_2006:54|R21_muehlbacher_2011:156|R25_brito_sanchez_2015:179|R40_vilar_2010:345|R41_toropov_2017:48|R46_mendoza_valencia_2017:168|R49_norinder_2002:77	0.6	B	BBB+	A	training
InChI=1S/F6S/c1-7(2,3,4,5)6	Sulphur Hexafluoride|Sulfur Hexafluoride|Elegas	hexafluoro-lambda6-sulfane	FS(F)(F)(F)(F)F	17358.0	R3_abraham_2006:41|R5_guerra_2008:93|R12_garg_2006:155|R21_muehlbacher_2011:224|R25_brito_sanchez_2015:145|R40_vilar_2010:395|R41_toropov_2017:36|R44_bujak_2015:59|R46_mendoza_valencia_2017:143|R48_hou_2003:93|R49_norinder_2002:76	0.37	B1	BBB+	A	training
InChI=1S/H2O/h1H2	Water	oxidane	O	962.0	R3_abraham_2006:299|R21_muehlbacher_2011:16|R40_vilar_2010:299|R41_toropov_2017:266	-0.04	B	BBB+	A	training
InChI=1S/H4N2/c1-2/h1-2H2	Hydrazine	hydrazine	NN	9321.0	R41_toropov_2017:1	0.03	A	BBB+	A	training
InChI=1S/Kr	Krypton	krypton	[Kr]	5416.0	R3_abraham_2006:2|R12_garg_2006:96|R21_muehlbacher_2011:133|R40_vilar_2010:370	-0.16	B	BBB+	A	test
InChI=1S/Li	Lithium	lithium	[Li]	3028194.0	R26_chico_2009:242	-0.3	A	BBB+	A	training
InChI=1S/N2/c1-2	Nitrogen	molecular nitrogen	N#N	947.0	R12_garg_2006:121|R21_muehlbacher_2011:14|R22_clark_1999:21|R40_vilar_2010:382|R44_bujak_2015:45|R48_hou_2003:77|R49_norinder_2002:64|R52_liu_2001:51	0.03	B	BBB+	A	training
InChI=1S/N2O/c1-2-3	Nitrous Oxide|Nitrous-Oxide	nitrous oxide	[N-]=[N+]=O	948.0	R3_abraham_2006:7|R6_adenot_2004:944|R21_muehlbacher_2011:15|R26_chico_2009:284|R40_vilar_2010:383|R41_toropov_2017:2|R44_bujak_2015:46|R48_hou_2003:78	0.03	B	BBB+	A	training
InChI=1S/Ne	Neon	neon	[Ne]	23935.0	R3_abraham_2006:3|R12_garg_2006:119|R21_muehlbacher_2011:229|R40_vilar_2010:381|R44_bujak_2015:42|R49_norinder_2002:70	0.2	B	BBB+	A	test
InChI=1S/Rn	Radon|Thoron	radon	[Rn]	24857.0	R3_abraham_2006:4|R21_muehlbacher_2011:259|R40_vilar_2010:392	-0.12	B	BBB+	A	training
InChI=1S/Xe	Xenon	xenon	[Xe]	23991.0	R3_abraham_2006:5|R12_garg_2006:174|R21_muehlbacher_2011:231|R40_vilar_2010:405|R44_bujak_2015:66|R49_norinder_2002:72	0.07	B1	BBB+	A	training
